PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Alhaddad, H; Zhang, C; Rannala, B; Lyons, LA				Alhaddad, Hasan; Zhang, Chi; Rannala, Bruce; Lyons, Leslie A.			A Glance at Recombination Hotspots in the Domestic Cat	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; HUMAN GENOME; HOT-SPOTS; PRDM9; RATES; EVOLUTION; INFERENCE; HUMANS; MOUSE	Recombination has essential roles in increasing genetic variability within a population and in ensuring successful meiotic events. The objective of this study is to (i) infer the population-scaled recombination rate (rho), and (ii) identify and characterize regions of increased recombination rate for the domestic cat, Felis silvestris catus. SNPs (n = 701) were genotyped in twenty-two East Asian feral cats (random bred). The SNPs covered ten different chromosomal regions (A1, A2, B3, C2, D1, D2, D4, E2, F2, X) with an average region size of 850 Kb and an average SNP density of 70 SNPs/region. The Bayesian method in the program inferRho was used to infer regional population recombination rates and hotspots localities. The regions exhibited variable population recombination rates and four decisive recombination hotspots were identified on cat chromosome A2, D1, and E2 regions. As a description of the identified hotspots, no correlation was detected between the GC content and the locality of recombination spots, and the hotspots enclosed L2 LINE elements and MIR and tRNA-Lys SINE elements.	[Alhaddad, Hasan] Kuwait Univ, Coll Sci, Dept Biol Sci, Safat 13060, Kuwait; [Zhang, Chi] Swedish Museum Nat Hist, Dept Bioinformat & Genet, Box 50007, SE-10405 Stockholm, Sweden; [Rannala, Bruce] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Lyons, Leslie A.] Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA	Kuwait University; Swedish Museum of Natural History; University of California System; University of California Davis; University of Missouri System; University of Missouri Columbia	Alhaddad, H (corresponding author), Kuwait Univ, Coll Sci, Dept Biol Sci, Safat 13060, Kuwait.	hassan.alhaddad@ku.edu.kw		Lyons, Leslie/0000-0002-1628-7726	National Center for Research Resources [R24 RR016094]; Office of Research Infrastructure Programs [OD R24OD010928]; Winn Feline Foundation [W10-014, W11-041]; George and Phyllis Miller Feline Health Fund; Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016094] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010928] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs; Winn Feline Foundation; George and Phyllis Miller Feline Health Fund; Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	LAL funding from National Center for Research Resources R24 RR016094 and is currently supported by the Office of Research Infrastructure Programs OD R24OD010928, the Winn Feline Foundation (W10-014, W11-041), the George and Phyllis Miller Feline Health Fund, and the Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhaddad H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053537; Auton A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003984; Axelsson E, 2012, GENOME RES, V22, P51, DOI 10.1101/gr.124123.111; Baker CL, 2014, GENOME RES, V24, P724, DOI 10.1101/gr.170167.113; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Bighignoli B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-27; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Comeron JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002905; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; Hellenthal G, 2006, CURR OPIN GENET DEV, V16, P565, DOI 10.1016/j.gde.2006.10.001; Hudson RR, 1991, OXF SURV EVOL BIOL, V7, P1; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Lee YS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-434; McVean G, 2002, GENETICS, V160, P1231; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Menotti-Raymond M, 2009, GENOMICS, V93, P305, DOI 10.1016/j.ygeno.2008.11.004; Munoz-Fuentes V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025498; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; STEINMETZ M, 1982, NATURE, V300, P35, DOI 10.1038/300035a0; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Tortereau F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-586; Wang Y, 2008, PHILOS T R SOC B, V363, P3921, DOI 10.1098/rstb.2008.0172; Wang Y, 2009, P NATL ACAD SCI USA, V106, P6215, DOI 10.1073/pnas.0900418106; Wu ZK, 2010, NUCLEIC ACIDS RES, V38, P2346, DOI 10.1093/nar/gkp1251; Zheng J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r103	34	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148710	10.1371/journal.pone.0148710	http://dx.doi.org/10.1371/journal.pone.0148710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859385	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400067
J	Bonthala, VS; Mayes, K; Moreton, J; Blythe, M; Wright, V; May, ST; Massawe, F; Mayes, S; Twycross, J				Bonthala, Venkata Suresh; Mayes, Katie; Moreton, Joanna; Blythe, Martin; Wright, Victoria; May, Sean Tobias; Massawe, Festo; Mayes, Sean; Twycross, Jamie			Identification of Gene Modules Associated with Low Temperatures Response in Bambara Groundnut by Network-Based Analysis	PLOS ONE			English	Article							WRKY FAMILY GENES; TRANSCRIPTION FACTORS; EXPRESSION; ARABIDOPSIS; STRESS; CROP	Bambara groundnut (Vigna subterranea (L.) Verdc.) is an African legume and is a promising underutilized crop with good seed nutritional values. Low temperature stress in a number of African countries at night, such as Botswana, can effect the growth and development of bambara groundnut, leading to losses in potential crop yield. Therefore, in this study we developed a computational pipeline to identify and analyze the genes and genemodules associated with low temperature stress responses in bambara groundnut using the cross-species microarray technique (as bambara groundnut has nomicroarray chip) coupled with network-based analysis. Analyses of the bambara groundnut transcriptome using cross-species gene expression data resulted in the identification of 375 and 659 differentially expressed genes (p<0.01) under the sub-optimal (23 degrees C) and very sub-optimal (18 degrees C) temperatures, respectively, of which 110 genes are commonly shared between the two stress conditions. The construction of a Highest Reciprocal Rank-based gene co-expression network, followed by its partition using a Heuristic Cluster Chiseling Algorithm resulted in 6 and 7 gene modules in sub-optimal and very sub-optimal temperature stresses being identified, respectively. Modules of sub-optimal temperature stress are principally enriched with carbohydrate and lipid metabolic processes, while most of the modules of very sub-optimal temperature stress are significantly enriched with responses to stimuli and various metabolic processes. Several transcription factors (from MYB, NAC, WRKY, WHIRLY & GATA classes) that may regulate the down-streamgenes involved in response to stimulus in order for the plant to withstand very sub-optimal temperature stress were highlighted. The identified genemodules could be useful in breeding for low-temperature stress tolerant bambara groundnut varieties.	[Bonthala, Venkata Suresh] Univ Nottingham, Sch Comp Sci, Jubilee Campus, Nottingham NG7 2RD, England; [Bonthala, Venkata Suresh; Massawe, Festo] Univ Nottingham Malaysia Campus, Sch Biosci, Kuala Lumpur, Malaysia; [Bonthala, Venkata Suresh; Mayes, Sean] Crops Future, Jalan Broga, Semenyih 43500, Malaysia; [Mayes, Katie; May, Sean Tobias; Mayes, Sean] Sutton Bonington Campus, Plant & Crop Sci, Biosci, Loughborough, Leics, England; [Moreton, Joanna] Univ Nottingham, Adv Data Anal Ctr, Sutton Bonington Campus, Loughborough, Leics, England; [Moreton, Joanna] Univ Nottingham, Sch Vet Med & Sci, Sutton Bonington Campus, Loughborough, Leics, England; [Moreton, Joanna; Blythe, Martin; Wright, Victoria] Univ Nottingham, Sch Med, Queens Med Ctr, Deep Seq,Sch Life Sci, Nottingham, England	University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham	Bonthala, VS (corresponding author), Univ Nottingham, Sch Comp Sci, Jubilee Campus, Nottingham NG7 2RD, England.; Bonthala, VS (corresponding author), Univ Nottingham Malaysia Campus, Sch Biosci, Kuala Lumpur, Malaysia.; Bonthala, VS (corresponding author), Crops Future, Jalan Broga, Semenyih 43500, Malaysia.	psxvb@nottingham.ac.uk	may, sean t/B-6838-2012; Twycross, Jamie/N-9010-2016; Massawe, Festo/K-4555-2013; Bonthala, Venkata Suresh/G-9852-2013	may, sean t/0000-0001-5282-3250; Twycross, Jamie/0000-0002-1684-0886; Massawe, Festo/0000-0002-0744-4777; Bonthala, Venkata Suresh/0000-0001-6550-1648; Moreton, Joanna/0000-0003-3193-1812; Mayes, Sean/0000-0003-4770-3662	Crops for Future (CFF); University of Nottingham; BBSRC [BB/E022758/1, BB/L010100/1, BB/J018961/1, BB/I001271/1, BB/E01772X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [G17764, BB/E01772X/1, BB/L010100/1, BB/E022758/1, BBS/B/1356X, BB/J018961/1, BB/I001271/1, G18881] Funding Source: researchfish	Crops for Future (CFF); University of Nottingham; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Crops for Future (CFF) and University of Nottingham.	Ahmad NS, 2013, BREEDING ACTA HORTIC, P979; Al Shareef I, 2014, EXP AGR, V50, P72, DOI 10.1017/S0014479713000379; Al-Whaibi Mohamed H., 2011, Journal of King Saud University Science, V23, P139, DOI 10.1016/j.jksus.2010.06.022; Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Atkinson NJ, 2013, PLANT PHYSIOL, V162, P2028, DOI 10.1104/pp.113.222372; Azam-Ali SN, 2001, EXP AGR, V37, P433, DOI 10.1017/S0014479701000412; Bagnaresi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-176; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cai B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095176; Dash S, 2012, NUCLEIC ACIDS RES, V40, pD1194, DOI 10.1093/nar/gkr938; Davey MW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-436; Desveaux D, 2004, DEV CELL, V6, P229, DOI 10.1016/S1534-5807(04)00028-0; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fabi JP, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-242; Gao RH, 2013, INT J GENOMICS, V2013, DOI 10.1155/2013/972852; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; GREGORY A, 2007, BRIEFINGS BIOINFORMA, V0008; Hammond JP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-10; Kang YJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6443; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kayum MA, 2015, MOL GENET GENOMICS, V290, P79, DOI 10.1007/s00438-014-0898-1; Kong FY, 2014, J EXP BOT, V65, P143, DOI 10.1093/jxb/ert357; Lata C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113092; Linnemann AR, 1993, UNDERUTILIZED CROPS; Makanda I, 2009, AFRICAN CROP SCI J, V16, P175; Mao LY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-346; Mishra AM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095280, 10.1371/journal.pone.0086852]; Muthamilarasan M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00910; Muthamilarasan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109920; Muthamilarasan M, 2014, FUNCT INTEGR GENOMIC, V14, P531, DOI 10.1007/s10142-014-0383-2; Mutwil M, 2010, PLANT PHYSIOL, V152, P29, DOI 10.1104/pp.109.145318; Nguyen HT, 2009, PLANT PHYSIOL BIOCH, V47, P116, DOI 10.1016/j.plaphy.2008.10.010; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Ogata Y, 2010, BIOINFORMATICS, V26, P1267, DOI 10.1093/bioinformatics/btq121; Ohnishi S, 2010, ENVIRON EXP BOT, V69, P56, DOI 10.1016/j.envexpbot.2010.02.007; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Singh M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0404-2; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Srinivasasainagendra V, 2008, PLANT PHYSIOL, V147, P1004, DOI 10.1104/pp.107.115535; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1633, DOI 10.1111/j.1365-3040.2009.02040.x; Valliyodan B, 2014, INT J MOL SCI, V15, P17622, DOI 10.3390/ijms151017622; Wang LN, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-103; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; Wang Z, 2015, BMC GENOMICS, V16, DOI [10.1186/s12864-015-1988-0, 10.1186/s12864-015-1216-y]; Wong DCJ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-186; Wong DCJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-882; Yim WC, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-83; Yin GJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-148; Zhang B, 2012, PLANT CELL REP, V31, P281, DOI 10.1007/s00299-011-1162-3; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033748, 10.1371/journal.pone.0037211]; Zhu MK, 2014, PLANT CELL REP, V33, P1851, DOI 10.1007/s00299-014-1662-z; Zhu MZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-437	55	31	35	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148771	10.1371/journal.pone.0148771	http://dx.doi.org/10.1371/journal.pone.0148771			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859686	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000370038400079
J	Le Roy, B; Tixier, L; Pereira, B; Sauvanet, P; Buc, E; Petorin, C; Dechelotte, P; Pezet, D; Balayssac, D				Le Roy, Bertrand; Tixier, Lucie; Pereira, Bruno; Sauvanet, Pierre; Buc, Emmanuel; Petorin, Caroline; Dechelotte, Pierre; Pezet, Denis; Balayssac, David			Assessment of the Relation between the Expression of Oxaliplatin Transporters in Colorectal Cancer and Response to FOLFOX-4 Adjuvant Chemotherapy: A Case Control Study	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTERS; 1ST-LINE TREATMENT; 3 SLC22A3; FLUOROURACIL; LEUCOVORIN; IRINOTECAN; SURVIVAL; PREDICTOR; MEMBRANE; OCT1	Background Adjuvant chemotherapy for colorectal cancer is mainly based on the combination of 5-fluorouracil, folinic acid and oxaliplatin (FOLFOX-4). The pharmacological target of oxaliplatin remains intracellular and therefore dependent on its entry into cells. The intracellular distribution of oxaliplatin is mediated by organic cation transporters 1, 2 and 3 (OCT1, 2 and 3), copper transporter 1 (CTR1) and ATPase Cu2+ transporting beta polypeptide (ATP7B) and may modulate the efficacy of oxaliplatin-based chemotherapy. The aim of this study was to perform a retrospective study to assess the relation between the expression of oxaliplatin transporters in colorectal cancer before chemotherapy and the response to FOLFOX-4 adjuvant chemotherapy in responder and non-responder patients. Methods This retrospective study was conducted at a single center (University Hospital of ClermontFerrand, France). The target population was patients with resectable colorectal cancer operated between 2006 and 2013. Inclusion criteria were defined for the responder patients as no cancer recurrence 3 years after the end of chemotherapy, and for the non-responder patients as cancer recurrence within 1 year. Other inclusion criteria were stages IIb-IV cancers, first-line adjuvant FOLFOX-4 chemotherapy, and the availability of resected primary tumor samples. Exclusion criteria were preoperative chemotherapy and/or radiotherapy, a targeted therapy, other anticancer drugs, cancer recurrence between the first and the third year after the end of chemotherapy and follow-up < 3 years. Immunostaining of oxaliplatin transporters (OCT1, 2, 3, CTR1 and ATP7B) and Ki-67 was assessed in tumor samples. Results Retrospectively, 31 patients have been selected according to inclusion and exclusion criteria (15 responders and 16 non-responders). Before FOLFOX-4 regimen, OCT3 expression was significantly lower in responder patients compared to non-responders (p<0.001). According to multivariate analysis, OCT3 remains an independent criterion for adjuvant FOLFOX chemotherapy response (p = 0.039). No significant relation is reported between chemotherapy response and the expression of OCT1 (p = 0.49), OCT2 (p = 0.09), CTR1 (p = 0.45), ATP7B (p = 0.94) and Ki-67 (p = 0.34) in tumors. Conclusions High expression of OCT3 could be an independent factor related to resistance to FOLFOX-4 chemotherapy.	[Le Roy, Bertrand; Sauvanet, Pierre; Buc, Emmanuel; Petorin, Caroline; Pezet, Denis] CHU Clermont Ferrand, Serv Chirurg & Oncol Digest, F-63003 Clermont Ferrand, France; [Tixier, Lucie; Dechelotte, Pierre] CHU Clermont Ferrand, Serv Anatomopathol, F-63003 Clermont Ferrand, France; [Pereira, Bruno; Balayssac, David] CHU Clermont Ferrand, Delegat Rech Clin & Innovat, F-63003 Clermont Ferrand, France; [Sauvanet, Pierre; Buc, Emmanuel; Pezet, Denis] INRA, INSERM, UdA U1071, USC 2018,M2iSH, F-63001 Clermont Ferrand, France; [Dechelotte, Pierre] Univ Auvergne, R2D2, EA 7281, F-63001 Clermont Ferrand, France; [Balayssac, David] INSERM, U1107, Neurodol, F-63001 Clermont Ferrand, France	CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Balayssac, D (corresponding author), CHU Clermont Ferrand, Delegat Rech Clin & Innovat, F-63003 Clermont Ferrand, France.; Balayssac, D (corresponding author), INSERM, U1107, Neurodol, F-63001 Clermont Ferrand, France.	dbalayssac@chu-clermontferrand.fr	Balayssac, David/K-2265-2015; Balayssac, David/AAZ-3007-2020; Pezet, Denis/I-4423-2017	Balayssac, David/0000-0002-6126-6588; Pezet, Denis/0000-0001-9416-2876; Le Roy, Bertrand/0000-0002-4668-9275; Pereira, Bruno/0000-0003-3778-7161; Tixier, Lucie/0000-0002-1325-3141				COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Gallagher DJ, 2010, ONCOLOGY-BASEL, V78, P237, DOI 10.1159/000315730; Gupta S, 2012, J PHARMACOL EXP THER, V341, P16, DOI 10.1124/jpet.111.190561; Han T, 2013, MOL PHARMACOL, V84, P182, DOI 10.1124/mol.112.084517; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jennison C, 2000, GROUP SEQUENTIAL MET; Jonker JW, 2001, MOL CELL BIOL, V21, P5471, DOI 10.1128/MCB.21.16.5471-5477.2001; Kitada N, 2008, CANCER CHEMOTH PHARM, V62, P577, DOI 10.1007/s00280-007-0640-3; Lee N, 2014, J BIOL CHEM, V289, P27055, DOI 10.1074/jbc.M114.570564; Ma YL, 2010, MED ONCOL, V27, P304, DOI 10.1007/s12032-009-9210-3; Martinez-Balibrea E, 2009, INT J CANCER, V124, P2905, DOI 10.1002/ijc.24273; Mulgaonkar A, 2013, ANTIMICROB AGENTS CH, V57, P2705, DOI 10.1128/AAC.02289-12; Muller J, 2005, BIOCHEM PHARMACOL, V70, P1851, DOI 10.1016/j.bcp.2005.09.011; Nies AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022163; NOETHER GE, 1987, J AM STAT ASSOC, V82, P645, DOI 10.2307/2289477; Noordhuis P, 2008, BIOCHEM PHARMACOL, V76, P53, DOI 10.1016/j.bcp.2008.04.007; Nordlinger B, 2013, LANCET ONCOL, V14, P1208, DOI 10.1016/S1470-2045(13)70447-9; Pawlik TM, 2005, ANN SURG, V241, P715, DOI 10.1097/01.sla.0000160703.75808.7d; Phua LC, 2013, CANCER CHEMOTH PHARM, V71, P817, DOI 10.1007/s00280-012-2054-0; Pirker R, 2012, LANCET ONCOL, V13, P33, DOI 10.1016/S1470-2045(11)70318-7; Ray P, 2010, ANESTHESIOLOGY, V112, P1023, DOI 10.1097/ALN.0b013e3181d47604; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Tang SC, 2013, CURR OPIN PHARMACOL, V13, P853, DOI 10.1016/j.coph.2013.08.011; Tashiro A, 2014, AM J CANCER RES, V4, P528; Tatsumi S, 2014, INT J CLIN EXP PATHO, V7, P204; Tournigand C, 2012, J CLIN ONCOL, V30, P3353, DOI 10.1200/JCO.2012.42.5645; Tzvetkov MV, 2013, BIOCHEM PHARMACOL, V86, P666, DOI 10.1016/j.bcp.2013.06.019; Yokoo S, 2008, DRUG METAB DISPOS, V36, P2299, DOI 10.1124/dmd.108.023168; Yonezawa A, 2006, J PHARMACOL EXP THER, V319, P879, DOI 10.1124/jpet.106.110346; Zhang SZ, 2006, CANCER RES, V66, P8847, DOI 10.1158/0008-5472.CAN-06-0769	33	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148739	10.1371/journal.pone.0148739	http://dx.doi.org/10.1371/journal.pone.0148739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859833	Green Published, gold, Green Submitted			2022-12-27	WOS:000370038400072
J	Li, Z; Tan, Z; Hao, SY; Jin, B; Deng, XH; Hu, G; Liu, XD; Zhang, J; Jin, H; Huang, M; Kanegaye, JT; Tremoulet, AH; Burns, JC; Wu, JM; Cohen, HJ; Ling, XFB				Li, Zhen; Tan, Zhou; Hao, Shiying; Jin, Bo; Deng, Xiaohong; Hu, Guang; Liu, Xiaodan; Zhang, Jie; Jin, Hua; Huang, Min; Kanegaye, John T.; Tremoulet, Adriana H.; Burns, Jane C.; Wu, Jianmin; Cohen, Harvey J.; Ling, Xuefeng B.		Emergency Med Kawasaki Dis Res Grp	Urinary Colorimetric Sensor Array and Algorithm to Distinguish Kawasaki Disease from Other Febrile Illnesses	PLOS ONE			English	Article							NITRIC-OXIDE; IDENTIFICATION; DIPHENYLAMINE; DIAGNOSIS	Objectives Kawasaki disease (KD) is an acute pediatric vasculitis of infants and young children with unknown etiology and no specific laboratory-based test to identify. A specific molecular diagnostic test is urgently needed to support the clinical decision of proper medical intervention, preventing subsequent complications of coronary artery aneurysms. We used a simple and low-cost colorimetric sensor array to address the lack of a specific diagnostic test to differentiate KD from febrile control (FC) patients with similar rash/fever illnesses. Study Design Demographic and clinical data were prospectively collected for subjects with KD and FCs under standard protocol. After screening using a genetic algorithm, eleven compounds including metalloporphyrins, pH indicators, redox indicators and solvatochromic dye categories, were selected from our chromatic compound library (n = 190) to construct a colorimetric sensor array for diagnosing KD. Quantitative color difference analysis led to a decision-tree-based KD diagnostic algorithm. Results This KD sensing array allowed the identification of 94% of KD subjects (receiver operating characteristic [ROC] area under the curve [AUC] 0.981) in the training set (33 KD, 33 FC) and 94% of KD subjects (ROC AUC: 0.873) in the testing set (16 KD, 17 FC). Color difference maps reconstructed from the digital images of the sensing compounds demonstrated distinctive patterns differentiating KD from FC patients. Conclusions The colorimetric sensor array, composed of common used chemical compounds, is an easily accessible, low-cost method to realize the discrimination of subjects with KD from other febrile illness.	[Li, Zhen; Wu, Jianmin] Zhejiang Univ, Inst Microanalyt Syst, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Zhen; Tan, Zhou; Hao, Shiying; Jin, Bo; Deng, Xiaohong; Hu, Guang; Liu, Xiaodan; Zhang, Jie; Jin, Hua; Ling, Xuefeng B.] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Huang, Min] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Shanghai 200030, Peoples R China; [Kanegaye, John T.; Tremoulet, Adriana H.; Burns, Jane C.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Kanegaye, John T.; Tremoulet, Adriana H.; Burns, Jane C.] Rady Childrens Hosp San Diego, San Diego, CA USA; [Cohen, Harvey J.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	Zhejiang University; Stanford University; Shanghai Jiao Tong University; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Stanford University	Ling, XFB (corresponding author), Stanford Univ, Dept Surg, Stanford, CA 94305 USA.	bxling@stanford.edu		Hao, Shiying/0000-0002-7527-2460; Ling, Bruce/0000-0002-5386-3884	Stanford University Spark Program; American Heart Association [14GRNT20510026]; Chinese Scholarship Council (CSC)	Stanford University Spark Program(Stanford University); American Heart Association(American Heart Association); Chinese Scholarship Council (CSC)(China Scholarship Council)	This work was supported by Stanford University Spark Program (2013-2014) (URL: http://med.stanford.edu/sparkmed.html) to XBL and HJC, and American Heart Association (14GRNT20510026) (URL: www.heart.org) to XBL and HJC. This work was supported by the Chinese Scholarship Council (CSC) (URL: http://en.csc.edu.cn/) to ZL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buhimschi IA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008808; Feng LA, 2010, ANAL CHEM, V82, P9433, DOI 10.1021/ac1020886; Holman RC, 2003, PEDIATRICS, V112, P495, DOI 10.1542/peds.112.3.495; Iizuka T, 1997, ACTA PAEDIATR, V86, P470, DOI 10.1111/j.1651-2227.1997.tb08915.x; Ishwaran H, 2008, RANDOM SURVIVAL FORE, P841, DOI [DOI 10.1214/08-A0AS169, 10.1214/08-AOAS169]; Janzen MC, 2006, ANAL CHEM, V78, P3591, DOI 10.1021/ac052111s; Kentsis A, 2013, EMBO MOL MED, V5, P210, DOI 10.1002/emmm.201201494; Kolthoff IM, 1933, J AM CHEM SOC, V55, P1448, DOI 10.1021/ja01331a019; Korbel JO, 2005, PLOS BIOL, V3, P815, DOI 10.1371/journal.pbio.0030134; Lin HW, 2011, J AM CHEM SOC, V133, P16786, DOI 10.1021/ja207718t; Ling XB, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-130; Ling XB, 2010, ADV CLIN CHEM, V51, P181, DOI 10.1016/S0065-2423(10)51007-2; LUCASIUS CB, 1993, CHEMOMETR INTELL LAB, V19, P1, DOI 10.1016/0169-7439(93)80079-W; Lussier LS, 2000, PROPELL EXPLOS PYROT, V25, P117, DOI 10.1002/1521-4087(200006)25:3<117::AID-PREP117>3.3.CO;2-#; MAYATEPEK E, 1995, ARCH DIS CHILD, V72, P526, DOI 10.1136/adc.72.6.526; Mazzone PJ, 2007, THORAX, V62, P565, DOI 10.1136/thx.2006.072892; Mitchell M., 1996, INTRO GENETIC ALGORI; Musto CJ, 2009, ANAL CHEM, V81, P6526, DOI 10.1021/ac901019g; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Rakow NA, 2000, NATURE, V406, P710, DOI 10.1038/35021028; Rakow NA, 2005, ANGEW CHEM INT EDIT, V44, P4528, DOI 10.1002/anie.200500939; TAUBERT KA, 1991, J PEDIATR-US, V119, P279, DOI 10.1016/S0022-3476(05)80742-5; Tsukahara H, 1997, SCAND J CLIN LAB INV, V57, P43, DOI 10.3109/00365519709057817; Zhang C, 2005, J AM CHEM SOC, V127, P11548, DOI 10.1021/ja052606z; Zhang C, 2007, J AGR FOOD CHEM, V55, P237, DOI 10.1021/jf0624695	26	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0146733	10.1371/journal.pone.0146733	http://dx.doi.org/10.1371/journal.pone.0146733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859297	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400003
J	Maruthapillai, V; Murugappan, M				Maruthapillai, Vasanthan; Murugappan, Murugappan			Optimal Geometrical Set for Automated Marker Placement to Virtualized Real-Time Facial Emotions	PLOS ONE			English	Article							EXPRESSION RECOGNITION; NEURAL-NETWORK; CLASSIFICATION	In recent years, real-time face recognition has been a major topic of interest in developing intelligent human-machine interaction systems. Over the past several decades, researchers have proposed different algorithms for facial expression recognition, but there has been little focus on detection in real-time scenarios. The present work proposes a new algorithmic method of automated marker placement used to classify six facial expressions: happiness, sadness, anger, fear, disgust, and surprise. Emotional facial expressions were captured using a webcam, while the proposed algorithm placed a set of eight virtual markers on each subject's face. Facial feature extraction methods, including marker distance (distance between each marker to the center of the face) and change in marker distance (change in distance between the original and new marker positions), were used to extract three statistical features (mean, variance, and root mean square) from the real-time video sequence. The initial position of each marker was subjected to the optical flow algorithm for marker tracking with each emotional facial expression. Finally, the extracted statistical features were mapped into corresponding emotional facial expressions using two simple non-linear classifiers, K-nearest neighbor and probabilistic neural network. The results indicate that the proposed automated marker placement algorithm effectively placed eight virtual markers on each subject's face and gave a maximum mean emotion classification rate of 96.94% using the probabilistic neural network.	[Maruthapillai, Vasanthan; Murugappan, Murugappan] Univ Malaysia Perlis, Sch Mechatron Engn, Perlis 02600, West Malaysia, Malaysia	Universiti Malaysia Perlis	Murugappan, M (corresponding author), Univ Malaysia Perlis, Sch Mechatron Engn, Perlis 02600, West Malaysia, Malaysia.	murugappan@unimap.edu.my	Murugappan, M/E-2402-2014	Murugappan, M/0000-0002-5839-4589; Maruthapillai, Vasanthan/0000-0001-6557-5444	Journal Incentive Fund of University Malaysia Perlis [9007-00190]	Journal Incentive Fund of University Malaysia Perlis	The study was supported by a grant from the Journal Incentive Fund of University Malaysia Perlis (Grant no: 9007-00190). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1978, FAC ACT COD SYST TEC; Anwar S., 2014, ADV HUMAN COMPUT INT, V2014, P4; Bajpai A, 2010, INT J ADV COMPUT SC, V1, P37; Bartneck C., 2000, AFFECTIVE EXPRESSION; Bradski G., 2005, INTEL TECHNOL J, V9, P119; Cantos S, 2013, THEORY PRACTICE COMP, V7, P221; Casas R, 2008, LECT NOTES COMPUT SC, V5105, P114, DOI 10.1007/978-3-540-70540-6_15; Deriso DM, 2012, LECT NOTES COMPUT SC, V7584, P270, DOI 10.1007/978-3-642-33868-7_27; EKMAN P, 1980, J PERS SOC PSYCHOL, V39, P1125, DOI 10.1037/h0077722; Ekman P., 2005, WHAT FACE REVEALS BA, DOI DOI 10.1093/ACPROF:OSO/9780195179644.001.0001; Essa IA, 1997, IEEE T PATTERN ANAL, V19, P757, DOI 10.1109/34.598232; Fasel B, 2003, PATTERN RECOGN, V36, P259, DOI 10.1016/S0031-3203(02)00052-3; Ghandi Bashir Mohammed, 2010, 2010 IEEE Symposium on Industrial Electronics and Applications (ISIEA 2010), P40, DOI 10.1109/ISIEA.2010.5679500; Ghimire D, 2013, SENSORS-BASEL, V13, P7714, DOI 10.3390/s130607714; Hay M, 2014, COULD MACHINE AI EVE; Horlings R, 2008, INT C COMP SYST TECH; HUANG K-C, 2012, INTERNATIONAL JOURNA, V8; Jain V., 2010, TECH REP; Kaliouby R.E, 2003, P 5 INT C MULT INT I; Kapoor A, 2003, AN MOD FAC GEST 2003; Kolakowska A, 2013, C HUM SYST INTERACT, P532, DOI 10.1109/HSI.2013.6577877; Kotsia I, 2005, IEEE IMAGE PROC, P1721; Kulic D, 2007, IEEE T ROBOT, V23, P991, DOI 10.1109/TRO.2007.904899; LEE H, 1995, INFORM PROCESS MANAG, V31, P59, DOI 10.1016/0306-4573(94)E0011-P; Liu Z, 2008, SIGN PROC 2008 ICSP; Loconsole C, 2014, REAL TIME EMOTION RE; Loconsole C, 2014, LECT NOTES COMPUT SC, V8588, P320, DOI 10.1007/978-3-319-09333-8_35; Lonare A., 2013, INT J ADV RES COMPUT, V2, P4647; Lotfi A, 2014, TURK J ELECTR ENG CO, V22, P979, DOI 10.3906/elk-1209-35; Lucas B.D., 1981, P 7 INT JOINT C ARTI, P674, DOI DOI 10.5555/1623264.1623280; Lucey P., 2010, 2010 IEEE COMPUTER S, P94, DOI [10.1109/cvprw.2010.5543262, DOI 10.1109/CVPRW.2010.5543262, 10.1109/CVPRW.2010.5543262]; Lyons M, 1998, AUTOMATIC FACE AND GESTURE RECOGNITION - THIRD IEEE INTERNATIONAL CONFERENCE PROCEEDINGS, P200, DOI 10.1109/AFGR.1998.670949; Maaoui Choubeila, 2010, Cutting Edge Robotics 2010, P317; Martinez A, 2012, J MACH LEARN RES, V13, P1589; Monajati M., 2012, INT J INTELL SCI, V02, P166, DOI [10.4236/ijis.2012.224022, DOI 10.4236/IJIS.2012.224022]; Rani P, 2006, PATTERN ANAL APPL, V9, P58, DOI 10.1007/s10044-006-0025-y; Rowley HA, 1998, IEEE T PATTERN ANAL, V20, P23, DOI 10.1109/34.655647; Ryan Andrew, 2009, 2009 IEEE 43rd International Carnahan Conference on Security Technology. ICCST 2009, P172, DOI 10.1109/CCST.2009.5335546; Ryu S-J, 2014, ROBOT INTELLIGENCE T, V2, P593; Sally JD, 2007, ROOTS RES VERTICAL D; Srivastava S., 2012, INT J MULTIMED ITS A, V4, P49, DOI [DOI 10.5121/IJMA.2012.4204, 10.5121/ijma.2012.4204]; Suk M, 2014, IEEE COMPUT SOC CONF, P132, DOI 10.1109/CVPRW.2014.25; Sutton O.., 2012, INTRO K NEAREST NEIG; Tablado A, 2003, ENG MED BIOL SOC ANN, P78; Takahashi K., 2009, IEEE INT C ROB BIOM; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Tripathy R., 2014, INT J ELECT COMPUT S, V3, P175; Viola P., 2001, P IEEE COMP SOC C CO, P1; Wilson PI, 2006, J COMPUTING SCI COLL, V21, P127, DOI DOI 10.5555/1127389.1127416; Yang X, 2013, LECT NOTES I COMPUTE, V110, P149; Youssif A. A. A., 2011, COMPUTER INFORM SCI, DOI [10.5539/cis.v4n2p115., DOI 10.5539/CIS.V4N2P115]; Zhan C., 2006, JT INT C CYBERGAMES, P52; Zhang L., 2014, P 2014 INT C AUT AG; Zhang L, 2008, LECT NOTES COMPUT SC, V5303, P706, DOI 10.1007/978-3-540-88688-4_52	54	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0149003	10.1371/journal.pone.0149003	http://dx.doi.org/10.1371/journal.pone.0149003			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859884	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400118
J	Marck, CH; Neate, SL; Taylor, KL; Weiland, TJ; Jelinek, GA				Marck, Claudia Helena; Neate, Sandra Leanne; Taylor, Keryn Louise; Weiland, Tracey Joy; Jelinek, George Alexander			Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors	PLOS ONE			English	Article							QUALITY-OF-LIFE; ADVERSE LIPID PROFILE; PHYSICAL-ACTIVITY; HEALTH BEHAVIORS; DISEASE-ACTIVITY; RELAPSE RATE; DISABILITY; RISK; MS; PROGRESSION	Multiple sclerosis (MS) is a chronic neurological disorder, often affecting young people. Comorbid disorders such as depression, anxiety and hypertension are common and can affect disease course, treatment, and quality of life (QOL) of people with MS (PwMS). The associations between comorbidities, body mass index (BMI) and health outcomes are not well studied in MS, although research shows most PwMS are overweight. Most data on the prevalence of comorbidities and obesity in PwMS comes from North American populations. This study describes the prevalence of comorbidities, overweight and obesity and associations with modifiable factors in an international sample of PwMS recruited online through social media, MS societies and websites. The online survey consisted of validated and researcher-devised instruments to assess self-reported health outcomes and lifestyle behaviors. Of the 2399 respondents, 22.5% were overweight, 19.4% were obese and 67.2% reported at least one comorbidity, with back pain (36.2%), depression (31.7%), anxiety (29.1%) and arthritis (13.7%) most prevalent and most limiting in daily activities. Obesity and most comorbid disorders were significantly more prevalent in North America. Obese participants were more likely to have comorbidities, especially diabetes (OR 4.8) and high blood pressure (OR 4.5) but also depression (OR 2.2). Being overweight, obese, or a former, or current smoker was associated with an increase in the number of comorbidities; while healthy diet, physical activity (borderline significant) and moderate alcohol consumption were associated with decreased number of comorbidities. Increasing number of comorbidities was related to worse QOL, increased odds of disability and prior relapse. Obese PwMS had higher odds of disability and lower QOL. The associations between BMI, comorbidities and health outcomes are likely to be bi-directional and associated with lifestyle behaviors. Preventing and treating comorbid disorders and obesity in PwMS is warranted, and advice regarding healthy and risky lifestyle may assist in improving health outcomes.	[Marck, Claudia Helena; Neate, Sandra Leanne; Taylor, Keryn Louise; Weiland, Tracey Joy; Jelinek, George Alexander] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Neuroepidemiol Unit, Melbourne, Vic, Australia	University of Melbourne	Marck, CH (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Neuroepidemiol Unit, Melbourne, Vic, Australia.	Claudia.marck@unimelb.edu.au	Weiland, Tracey/Y-2029-2018	Weiland, Tracey/0000-0002-4053-5507; Jelinek, George/0000-0001-6157-0910; TAYLOR, KERYN/0000-0001-7543-4362; Marck, Claudia/0000-0002-3173-1522	Bloom Foundation; Horne Family Charitable Trust	Bloom Foundation; Horne Family Charitable Trust	The study was funded by philanthropic funders the Bloom Foundation and the Horne Family Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth HP, 2014, FAM PRACT, V31, P38, DOI 10.1093/fampra/cmt061; Cambil-Martin J., 2014, NUTR NEUROSCI; Culpepper WJ, 2015, NEUROLOGY, V84, P335, DOI 10.1212/WNL.0000000000001194; Hadgkiss EJ, 2015, NEUROL SCI, V36, P845, DOI 10.1007/s10072-015-2089-1; Hadgkiss EJ, 2015, NUTR NEUROSCI, V18, P125, DOI 10.1179/1476830514Y.0000000117; Hadgkiss EJ, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/580596; HOHOL MJ, 1995, NEUROLOGY, V45, P251, DOI 10.1212/WNL.45.2.251; Holper L, 2010, J NEUROL, V257, P103, DOI 10.1007/s00415-009-5282-4; Jelinek GA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0394-1; Jelinek GA, 2015, NEUROL RES, V37, P662, DOI 10.1179/1743132815Y.0000000036; Jelinek GA, 2013, INT J NEUROSCI, V123, P792, DOI 10.3109/00207454.2013.803104; Khurana SR, 2009, AM J PHYS MED REHAB, V88, P83, DOI 10.1097/PHM.0b013e318194f8b5; Levin AB, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/916519; Marck CH, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-143; Marrie R, 2015, OVERVIEW, V21, P263, DOI DOI 10.1177/1352458514564491; Marrie RA, 2008, MULT SCLER J, V14, P1091, DOI 10.1177/1352458508092263; Marrie RA, 2012, ACTA NEUROL SCAND, V125, P180, DOI 10.1111/j.1600-0404.2011.01526.x; Marrie RA, 2010, NEUROLOGY, V74, P1041, DOI 10.1212/WNL.0b013e3181d6b125; Marrie RA, 2009, MULT SCLER J, V15, P105, DOI 10.1177/1352458508096680; Marrie RA, 2015, NEUROLOGY, V85, P240, DOI 10.1212/WNL.0000000000001718; Marrie RA, 2015, MULT SCLER J, V21, P332, DOI 10.1177/1352458514564488; Marrie RA, 2015, MULT SCLER J, V21, P305, DOI 10.1177/1352458514564487; Marrie RA, 2015, MULT SCLER J, V21, P318, DOI 10.1177/1352458514564485; Marrie RA, 2015, MULT SCLER J, V21, P294, DOI 10.1177/1352458514564489; Marrie RA, 2015, NEUROLOGY, V84, P350, DOI 10.1212/WNL.0000000000001187; Marrie RA, 2011, NEUROEPIDEMIOLOGY, V36, P85, DOI 10.1159/000323948; Merlino G, 2009, SLEEP MED, V10, P26, DOI 10.1016/j.sleep.2007.11.004; Midaglia L, 2012, MULT SCLER J, V18, P1644, DOI 10.1177/1352458512442262; Morrie RA, 2010, LANCET NEUROL, V9, P820, DOI 10.1016/S1474-4422(10)70135-6; Motl RW, 2011, NEUROEPIDEMIOLOGY, V36, P183, DOI 10.1159/000327749; Pilutti LA, 2012, MULT SCLER RELAT DIS, V1, P139, DOI 10.1016/j.msard.2012.02.004; Pilutti LA, 2012, J OBES, V2012, DOI 10.1155/2012/868256; Pinhas-Hamiel O, 2015, EUR J NEUROL, V22, P1275, DOI 10.1111/ene.12738; Renzaho A, 2010, QUAL LIFE RES, V19, P515, DOI 10.1007/s11136-010-9610-z; Salem R, 2014, DISABIL HEALTH J, V7, P124, DOI 10.1016/j.dhjo.2013.10.003; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Slawta JN, 2003, ARCH PHYS MED REHAB, V84, P1823, DOI 10.1016/S0003-9993(03)00466-0; Sprangers MAG, 2000, J CLIN EPIDEMIOL, V53, P895, DOI 10.1016/S0895-4356(00)00204-3; Sundh J, 2015, INT J CHRONIC OBSTR, V10, P173, DOI 10.2147/COPD.S74645; Taylor KL, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0327-3; Tettey P, 2014, J NEUROL SCI, V347, P23, DOI 10.1016/j.jns.2014.10.020; Tettey P, 2014, MULT SCLER J, V20, P1737, DOI 10.1177/1352458514533162; Tettey P, 2014, J NEUROL SCI, V340, P230, DOI 10.1016/j.jns.2014.02.038; Turpin KVL, 2007, MULT SCLER J, V13, P1038, DOI 10.1177/1352458507078393; VICKREY BG, 1995, QUAL LIFE RES, V4, P187, DOI 10.1007/BF02260859; Weiland TJ, 2014, J NEUROL SCI, V336, P211, DOI 10.1016/j.jns.2013.10.046; World Health Organization, 2015, WORLD HEALTH STATIST	47	68	68	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148573	10.1371/journal.pone.0148573	http://dx.doi.org/10.1371/journal.pone.0148573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849357	gold, Green Published			2022-12-27	WOS:000369554000129
J	Sento, S; Sasabe, E; Yamamoto, T				Sento, Shinya; Sasabe, Eri; Yamamoto, Tetsuya			Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes	PLOS ONE			English	Article							CANCER METASTASIS; BREAST-CANCER; T-CELL; MICROVESICLES; PROGRESSION; APOPTOSIS; MICROENVIRONMENT; ANTICOAGULANTS; EXPRESSION; HEPARANASE	Exosomes are 30-100 nm-sized membranous vesicles, secreted from a variety of cell types into their surrounding extracellular space. Various exosome components including lipids, proteins, and nucleic acids are transferred to recipient cells and affect their function and activity. Numerous studies have showed that tumor cell-derived exosomes play important roles in tumor growth and progression. However, the effect of exosomes released from oral squamous cell carcinoma (OSCC) into the tumor microenvironment remains unclear. In the present study, we isolated exosomes from OSCC cells and investigated the influence of OSCC cell-derived exosomes on the tumor cell behavior associated with tumor development. We demonstrated that OSCC cell-derived exosomes were taken up by OSCC cells themselves and significantly promoted proliferation, migration, and invasion through the activation of the PI3K/Akt, MAPK/ERK, and JNK-1/2 pathways in vitro. These effects of OSCC cell-derived exosomes were obviously attenuated by treatment with PI3K, ERK-1/2, and JNK-1/2 pharmacological inhibitors. Furthermore, the growth rate of tumor xenografts implanted into nude mice was promoted by treatment with OSCC cell-derived exosomes. The uptake of exosomes by OSCC cells and subsequent tumor progression was abrogated in the presence of heparin. Taken together, these data suggest that OSCC cell-derived exosomes might be a novel therapeutic target and the use of heparin to inhibit the uptake of OSCC-derived exosomes by OSCC cells may be useful for treatment.	[Sento, Shinya; Sasabe, Eri; Yamamoto, Tetsuya] Kochi Univ, Kochi Med Sch, Dept Oral & Maxillofacial Surg, Kohoku Ku, Oko Cho, Nankoku, Kochi 7838505, Japan	Kochi University	Sento, S (corresponding author), Kochi Univ, Kochi Med Sch, Dept Oral & Maxillofacial Surg, Kohoku Ku, Oko Cho, Nankoku, Kochi 7838505, Japan.	jm-shinya-sento@kochi-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [26670867]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (26670867). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The additional funding has come from internal organization (laboratory office expenses).	Altevogt P, 2014, SEMIN CANCER BIOL, V28, P51, DOI 10.1016/j.semcancer.2014.04.008; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007; Bendas Gerd, 2012, Int J Cell Biol, V2012, P676731, DOI 10.1155/2012/676731; Bobrie A, 2012, CANCER RES, V72, P4920, DOI 10.1158/0008-5472.CAN-12-0925; Broek RV, 2015, ORAL DIS, V21, P815, DOI 10.1111/odi.12206; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Franzen CA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/619829; Hall K, 2010, FRONT BIOSCI-LANDMRK, V15, P195, DOI 10.2741/3615; Henderson MC, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00038; Jackson LL, 2007, LARYNGOSCOPE, V117, P868, DOI 10.1097/MLG.0b013e318033c810; Jiang HG, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-34; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Kahlert C, 2013, J MOL MED, V91, P431, DOI 10.1007/s00109-013-1020-6; Kawamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034045; Koga K, 2005, ANTICANCER RES, V25, P3703; Kosaka N, 2014, FUTURE ONCOL, V10, P671, DOI [10.2217/fon.13.222, 10.2217/FON.13.222]; Kuderer NM, 2007, CANCER-AM CANCER SOC, V110, P1149, DOI 10.1002/cncr.22892; Lee JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084256; Lin RZ, 2013, MOL CELL BIOCHEM, V383, P13, DOI 10.1007/s11010-013-1746-z; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Melero-Martin JM, 2011, STEM CELLS, V29, P163, DOI 10.1002/stem.583; Mrizak D, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju363; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; OSAKI T, 1994, ORAL ONCOL, V30B, P296, DOI 10.1016/0964-1955(94)90028-0; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Potolicchio A, 2005, J IMMUNOL, V175, P2237, DOI 10.4049/jimmunol.175.4.2237; Principe S, 2013, PROTEOMICS, V13, P1608, DOI 10.1002/pmic.201200533; Qu JL, 2009, DIGEST LIVER DIS, V41, P875, DOI 10.1016/j.dld.2009.04.006; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ristorcelli E, 2008, FASEB J, V22, P3358, DOI 10.1096/fj.07-102855; Saleem SN, 2015, CELL MOL LIFE SCI, V72, P1, DOI 10.1007/s00018-014-1710-4; Segrelles C, 2006, ONCOGENE, V25, P1174, DOI 10.1038/sj.onc.1209155; Somasundaram R, 2012, NAT MED, V18, P853, DOI 10.1038/nm.2775; Stevenson CE, 2012, FUTURE ONCOL, V8, P403, DOI [10.2217/FON.12.22, 10.2217/fon.12.22]; Sun Y, 2014, CLIN THER, V36, P863, DOI 10.1016/j.clinthera.2014.04.018; Tagalakis V, 2007, CANCER TREAT REV, V33, P358, DOI 10.1016/j.ctrv.2007.02.004; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Verderio C, 2012, ANN NEUROL, V72, P610, DOI 10.1002/ana.23627; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Whiteside TL, 2013, BIOCHEM SOC T, V41, P245, DOI 10.1042/BST20120265; Yang CJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/842849; Yang L, 2013, MOL MED REP, V8, P1272, DOI 10.3892/mmr.2013.1634; Ye SB, 2014, ONCOTARGET, V5, P5439, DOI 10.18632/oncotarget.2118; Zhang Y, 2012, BLOOD, V120, P1678, DOI 10.1182/blood-2012-02-410647; Zhao L, 2015, CANCER LETT, V356, P339, DOI 10.1016/j.canlet.2014.10.027	51	50	54	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148454	10.1371/journal.pone.0148454	http://dx.doi.org/10.1371/journal.pone.0148454			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849680	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000097
J	Timms, VJ; Daskalopoulos, G; Mitchell, HM; Neilan, BA				Timms, Verlaine J.; Daskalopoulos, George; Mitchell, Hazel M.; Neilan, Brett A.			The Association of Mycobacterium avium subsp paratuberculosis with Inflammatory Bowel Disease	PLOS ONE			English	Article							CROHNS-DISEASE; ULCERATIVE-COLITIS; PCR ASSAYS; DNA; CLASSIFICATION; INDIVIDUALS; SMEGMATIS; CHILDREN; GROWTH; IS900	The association of Mycobacterium avium subspecies paratuberculosis (M. paratuberculosis) with Crohn's disease is a controversial issue. M. paratuberculosis is detected by amplifying the IS900 gene, as microbial culture is unreliable from humans. We determined the presence of M. paratuberculosis in patients with Crohn's disease (CD) (n = 22), ulcerative colitis (UC) (n = 20), aphthous ulcers (n = 21) and controls (n = 42) using PCR assays validated on bovine tissue. Culture from human tissue was also performed. M. paratuberculosis prevalence in the CD and UC groups was compared to the prevalence in age and sex matched non-inflammatory bowel disease controls. Patients and controls were determined to be M. paratuberculosis positive if all three PCR assays were positive. A significant association was found between M. paratuberculosis and Crohn's disease (p = 0.02) that was not related to age, gender, place of birth, smoking or alcohol intake. No significant association was detected between M. paratuberculosis and UC or aphthous ulcers; however, one M. paratuberculosis isolate was successfully cultured from a patient with UC. We report the resistance of this isolate to ethambutol, rifampin, clofazamine and streptomycin. Interestingly this isolate could not only survive but could grow slowly at 5 degrees C. We demonstrate a significant association between M. paratuberculosis and CD using multiple pre-validated PCR assays and that M. paratuberculosis can be isolated from patients with UC.	[Timms, Verlaine J.; Mitchell, Hazel M.; Neilan, Brett A.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Level 3,Biosci Bldg, Sydney, NSW, Australia; [Daskalopoulos, George] Endoscopy Serv Pty Ltd, Inner West Endoscopy Ctr, Sydney, NSW, Australia; [Timms, Verlaine J.] ICPMR Westmead Hosp, Ctr Infect Dis & Microbiol Publ Hlth, Level 3, Sydney, NSW, Australia	University of New South Wales Sydney; University of Sydney	Neilan, BA (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Level 3,Biosci Bldg, Sydney, NSW, Australia.	b.neilan@unsw.edu.au	Timms, Verlaine/E-8326-2011; Neilan, Brett A/I-5767-2012	Timms, Verlaine/0000-0002-3883-4428; Neilan, Brett A/0000-0001-6113-772X	Endoscopy Services Pty. Ltd.; Australian Research Council	Endoscopy Services Pty. Ltd.; Australian Research Council(Australian Research Council)	Initial funding was provided by Endoscopy Services Pty. Ltd. (for sample collection). BAN is supported by multiple grants from the Australian Research Council. Endoscopy Services Pty. Ltd., provided support in the form of salaries for authors GD & VJT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADURIZ JJ, 1995, VET MICROBIOL, V45, P211, DOI 10.1016/0378-1135(95)00037-B; Ahmad T, 2002, GASTROENTEROLOGY, V122, P854, DOI 10.1053/gast.2002.32413; Ambrosini R, 2007, EUR J RADIOL, V61, P442, DOI 10.1016/j.ejrad.2006.07.028; Autschbach F, 2005, GUT, V54, P944, DOI 10.1136/gut.2004.045526; Bannantine JP, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-10; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Behr MA, 2008, CURR OPIN GASTROEN, V24, P17, DOI 10.1097/MOG.0b013e3282f1dcc4; Bernstein CN, 2004, J CLIN MICROBIOL, V42, P1129, DOI 10.1128/JCM.42.3.1129-1135.2004; Bonen DK, 2003, GASTROENTEROLOGY, V124, P521, DOI 10.1053/gast.2003.50045; Bull TJ, 2003, J CLIN MICROBIOL, V41, P2915, DOI 10.1128/JCM.41.7.2915-2923.2003; CHIODINI RJ, 1984, J CLIN MICROBIOL, V20, P966, DOI 10.1128/JCM.20.5.966-971.1984; Chiodini RJ, 2011, APPL ENVIRON MICROB, V77, P4; Chiodini RJ, 2011, APPL ENVIRON MICROB, V77, P1923, DOI 10.1128/AEM.02715-10; Collins DM, 2002, J CLIN MICROBIOL, V40, P4760, DOI 10.1128/JCM.40.12.4760-4762.2002; Ellingson Jay L E, 2003, Clin Med Res, V1, P217; Feller M, 2007, LANCET INFECT DIS, V7, P607, DOI 10.1016/S1473-3099(07)70211-6; Grant IR, 2003, ACTA VET SCAND, V44, P261; Janagama HK, 2009, MICROBIOL-SGM, V155, P3683, DOI 10.1099/mic.0.031948-0; Kalfus I, 2013, RANDOMIZED DOUBLE BL; Kirkwood CD, 2009, INFLAMM BOWEL DIS, V15, P1643, DOI 10.1002/ibd.20967; Krishnan MY, 2009, J ANTIMICROB CHEMOTH, V64, P310, DOI 10.1093/jac/dkp184; Mackenzie N, 2009, J CLIN MICROBIOL, V47, P1002, DOI 10.1128/JCM.01313-08; Mobius P, 2008, VET MICROBIOL, V126, P324, DOI 10.1016/j.vetmic.2007.07.016; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; *OIE, 2008, OIE TERR MAN, P276; Orholm M, 2000, SCAND J GASTROENTERO, V35, P1075; PARISH T, 1998, MYCOBACTERIA PROTOCO; Parrish Nicole M, 2004, Clin Med Res, V2, P107; Phavichitr N, 2003, J GASTROEN HEPATOL, V18, P329, DOI 10.1046/j.1440-1746.2003.02975.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Selby W, 2007, GASTROENTEROLOGY, V132, P2313, DOI 10.1053/j.gastro.2007.03.031; Shires K, 2001, MOL MICROBIOL, V39, P994, DOI 10.1046/j.1365-2958.2001.02291.x; Shleeva M, 2004, MICROBIOL-SGM, V150, P1687, DOI 10.1099/mic.0.26893-0; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Tasara T, 2005, INT J FOOD MICROBIOL, V104, P279, DOI 10.1016/j.ijfoodmicro.2005.03.009; Timms VJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1889-2; Timms VJ, 2015, J MICROBIOL METH, V112, P99, DOI 10.1016/j.mimet.2015.03.016; Tran QT, 2014, J CLIN MICROBIOL; Tuci A, 2011, DIGEST DIS SCI, V56, P2957, DOI 10.1007/s10620-011-1699-6; Uchiya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071831; Vansnick E, 2004, VET MICROBIOL, V100, P197, DOI 10.1016/j.vetmic.2004.02.006; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	43	31	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148731	10.1371/journal.pone.0148731	http://dx.doi.org/10.1371/journal.pone.0148731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849125	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000163
J	Vu, KN; Ballantyne, CM; Hoogeveen, RC; Nambi, V; Volcik, KA; Boerwinkle, E; Morrison, AC				Vu, Khanh N.; Ballantyne, Christie M.; Hoogeveen, Ron C.; Nambi, Vijay; Volcik, Kelly A.; Boerwinkle, Eric; Morrison, Alanna C.			Causal Role of Alcohol Consumption in an Improved Lipid Profile: The Atherosclerosis Risk in Communities (ARIC) Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HIGH-DENSITY-LIPOPROTEIN; IMPROVED LIPOLYTIC EFFICIENCY; APOLIPOPROTEIN-A-I; MIDDLE-AGED MEN; MENDELIAN RANDOMIZATION; AFRICAN-AMERICANS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ENZYMATIC DETERMINATION	Introduction Health benefits of low-to-moderate alcohol consumption may operate through an improved lipid profile. A Mendelian randomization (MR) approach was used to examine whether alcohol consumption causally affects lipid levels. Methods This analysis involved 10,893 European Americans (EA) from the Atherosclerosis Risk in Communities (ARIC) study. Common and rare variants in alcohol dehydrogenase and acetaldehyde dehydrogenase genes were evaluated for MR assumptions. Five variants, residing in the ADH1B, ADH1C, and ADH4 genes, were selected as genetic instruments and were combined into an unweighted genetic score. Triglycerides (TG), total cholesterol, high-density lipoprotein cholesterol (HDL-c) and its subfractions (HDL2-c and HDL3-c), low-density lipoprotein cholesterol (LDL-c), small dense LDL-c (sdLDL-c), apolipoprotein B (apoB), and lipoprotein (a) (Lp(a)) levels were analyzed. Results Alcohol consumption significantly increased HDL2-c and reduced TG, total cholesterol, LDL-c, sdLDL-c, and apoB levels. For each of these lipids a non-linear trend was observed. Compared to the first quartile of alcohol consumption, the third quartile had a 12.3% lower level of TG (p < 0.001), a 7.71 mg/dL lower level of total cholesterol (p = 0.007), a 10.3% higher level of HDL2-c (p = 0.007), a 6.87 mg/dL lower level of LDL-c (p = 0.012), a 7.4% lower level of sdLDL-c (p = 0.037), and a 3.5% lower level of apoB (p = 0.058, p(overall) = 0.022). Conclusions This study supports the causal role of regular low-to-moderate alcohol consumption in increasing HDL2-c, reducing TG, total cholesterol, and LDL-c, and provides evidence for the novel finding that low-to-moderate consumption of alcohol reduces apoB and sdLDL-c levels among EA. However, given the nonlinearity of the effect of alcohol consumption, even within the range of low-to-moderate drinking, increased consumption does not always result in a larger benefit.	[Vu, Khanh N.; Boerwinkle, Eric; Morrison, Alanna C.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Ballantyne, Christie M.; Hoogeveen, Ron C.; Nambi, Vijay] Baylor Coll Med, Sect Cardiovasc Res, Houston, TX 77030 USA; [Ballantyne, Christie M.; Hoogeveen, Ron C.; Nambi, Vijay] Houston Methodist Debakey Heart & Vasc Ctr, Houston, TX USA; [Nambi, Vijay] Michael E DeBakey Vet Affairs Hosp, Houston, TX USA; [Volcik, Kelly A.] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Morrison, AC (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA.	Alanna.C.Morrison@uth.tmc.edu	Ballantyne, Christie/A-6599-2008	Morrison, Alanna/0000-0001-6381-4296; Hoogeveen, Ron/0000-0003-2399-4653; Ballantyne, Christie/0000-0002-6432-1730	National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health [HHSN268200625226C]; National Institutes of Health and NIH Roadmap for Medical Research [UL1RR025005]; "Building on GWAS for NHLBI-diseases: the U.S. CHARGE; NIH through the American Recovery and Reinvestment Act (ARRA) [5RC2HL102419];  [R03 AA021272]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059367, R01HL086694, RC2HL102419, R01HL087641] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R03AA021272] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health and NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Building on GWAS for NHLBI-diseases: the U.S. CHARGE; NIH through the American Recovery and Reinvestment Act (ARRA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. Funding support for "Building on GWAS for NHLBI-diseases: the U.S. CHARGE consortium" was provided by the NIH through the American Recovery and Reinvestment Act of 2009 (ARRA) (5RC2HL102419). Analysis support was provided by R03 AA021272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-88; Agrawal A, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.54; Agrawal A, 2012, ALCOHOL RES-CURR REV, V34, P274; Agrawal A, 2012, AM J CLIN NUTR, V95, P539, DOI 10.3945/ajcn.111.015545; Baum C.F., 2009, INSTRUMENTAL VARIABL; Baum CF, 2007, STATA J, V7, P465, DOI 10.1177/1536867X0800700402; Beulens JWJ, 2004, J LIPID RES, V45, P1716, DOI 10.1194/jlr.M400109-JLR200; Biernacka JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058798; Bierut LJ, 2012, MOL PSYCHIATR, V17, P445, DOI 10.1038/mp.2011.124; Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636; Brinton EA, 2012, CURR ATHEROSCLER REP, V14, P108, DOI 10.1007/s11883-012-0230-7; BROWN SA, 1993, ARTERIOSCLER THROMB, V13, P1139, DOI 10.1161/01.ATV.13.8.1139; Brunzell JD, 2005, ARTERIOSCL THROM VAS, V25, P474, DOI 10.1161/01.ATV.0000156537.78366.1d; Bryant EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063469; Burgess S, 2013, INT J EPIDEMIOL, V42, P1134, DOI 10.1093/ije/dyt093; Burgess S, 2011, INT J EPIDEMIOL, V40, P755, DOI 10.1093/ije/dyr036; Carlson CS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001661; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chrysohoou Christina, 2003, Eur J Cardiovasc Prev Rehabil, V10, P355, DOI 10.1097/01.hjr.0000065928.57001.4d; Contois JH, 2011, J CLIN LIPIDOL, V5, P264, DOI 10.1016/j.jacl.2011.05.004; Deo RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000342; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Dumitrescu L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002138; Ferrari P, 2012, EUR J CLIN NUTR, V66, P1303, DOI 10.1038/ejcn.2012.173; Foster EM, 1997, SOC SCI RES, V26, P487, DOI 10.1006/ssre.1997.0606; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gardner CD, 2000, PREV MED, V31, P346, DOI 10.1006/pmed.2000.0716; GAUBATZ JW, 1987, J LIPID RES, V28, P69; GAZIANO JM, 1993, NEW ENGL J MED, V329, P1829, DOI 10.1056/NEJM199312163292501; Gelernter J, 2014, MOL PSYCHIATR, V19, P41, DOI 10.1038/mp.2013.145; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Han HG, 2013, GENE, V526, P134, DOI 10.1016/j.gene.2013.05.002; Havard School of Public Health, EIGENSOFT; Hines LM, 2001, NEW ENGL J MED, V344, P549, DOI 10.1056/NEJM200102223440802; Hoogeveen RC, 2014, ARTERIOSCL THROM VAS, V34, P1069, DOI 10.1161/ATVBAHA.114.303284; Hurley TD, 2012, ALCOHOL RES-CURR REV, V34, P339; Jacobson TA, 2011, MAYO CLIN PROC, V86, P762, DOI 10.4065/mcp.2011.0128; Kechagias S, 2011, ANN MED, V43, P545, DOI 10.3109/07853890.2011.588246; Keebler ME, 2010, CIRC-CARDIOVASC GENE, V3, P358, DOI 10.1161/CIRCGENETICS.109.914267; Klop B, 2013, CURR OPIN LIPIDOL, V24, P321, DOI 10.1097/MOL.0b013e3283606845; Lawlor DA, 2013, EUR HEART J, V34, P2519, DOI 10.1093/eurheartj/eht081; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Li DW, 2012, HUM GENET, V131, P1361, DOI 10.1007/s00439-012-1163-5; Li DW, 2011, BIOL PSYCHIAT, V70, P504, DOI 10.1016/j.biopsych.2011.02.024; Liu CT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003681; Luo XG, 2005, PHARMACOGENET GENOM, V15, P755, DOI 10.1097/01.fpc.0000180141.77036.dc; Macgregor S, 2009, HUM MOL GENET, V18, P580, DOI 10.1093/hmg/ddn372; Martin SS, 2014, TRENDS ENDOCRIN MET, V25, P329, DOI 10.1016/j.tem.2014.05.005; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; Mukamal KJ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-118; Murray MP, 2006, J ECON PERSPECT, V20, P111, DOI 10.1257/jep.20.4.111; Musunuru K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036473; Muth ND, 2010, BRIT J NUTR, V104, P1034, DOI 10.1017/S0007114510001595; NAGELE U, 1984, J CLIN CHEM CLIN BIO, V22, P165; Naimi TS, 2005, AM J PREV MED, V28, P369, DOI 10.1016/j.amepre.2005.01.011; Norden-Krichmar TM, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0136-z; Ordovas JM, 2000, ARTERIOSCL THROM VAS, V20, P1323, DOI 10.1161/01.ATV.20.5.1323; Park H, 2012, ALCOHOL ALCOHOLISM, V47, P282, DOI 10.1093/alcalc/ags019; Pierce BL, 2011, INT J EPIDEMIOL, V40, P740, DOI 10.1093/ije/dyq151; Rakic V, 1998, ATHEROSCLEROSIS, V137, P243, DOI 10.1016/S0021-9150(97)00269-4; Rasmussen-Torvik LJ, 2012, CTS-CLIN TRANSL SCI, V5, P394, DOI 10.1111/j.1752-8062.2012.00446.x; Rassen JA, 2009, AM J EPIDEMIOL, V169, P273, DOI 10.1093/aje/kwn299; Rietschel M, 2013, ANN NY ACAD SCI, V1282, P39, DOI 10.1111/j.1749-6632.2012.06794.x; Rifler JP, 2012, MOL NUTR FOOD RES, V56, P345, DOI [10.1002/mnfr.201100336, 10.1002/mnfr.760]; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Shahar E, 2003, STROKE, V34, P623, DOI 10.1161/01.STR.0000057812.51734.FF; SIEDEL J, 1983, CLIN CHEM, V29, P1075; Silva ERDE, 2000, CIRCULATION, V102, P2347, DOI 10.1161/01.CIR.102.19.2347; Superko HR, 2012, J CLIN LIPIDOL, V6, P496, DOI 10.1016/j.jacl.2012.03.001; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thanassoulis G, 2013, CAN J CARDIOL, V29, P30, DOI 10.1016/j.cjca.2012.09.014; Toth R, 2011, DIS MARKERS, V31, P267, DOI [10.1155/2011/350528, 10.3233/DMA-2011-0828]; US Department of Agriculture US Department of Health and Human Services, 2010, DIET GUID AM; van der Gaag MS, 2001, J LIPID RES, V42, P2077; Virani SS, 2012, CIRCULATION, V125, P241, DOI 10.1161/CIRCULATIONAHA.111.045120; Volcik KA, 2008, ANN EPIDEMIOL, V18, P101, DOI 10.1016/j.annepidem.2007.07.103; Wakabayashi I, 2008, ALCOHOL ALCOHOLISM, V43, P274, DOI 10.1093/alcalc/agn005; Wakabayashi I, 2002, DIABETES CARE, V25, P1223, DOI 10.2337/diacare.25.7.1223; Wakabayashi I, 2013, ALCOHOL ALCOHOLISM, V48, P535, DOI 10.1093/alcalc/agt032; Walldius G, 2005, EUR HEART J, V26, P210, DOI 10.1093/eurheartj/ehi003; Walldius G, 2004, J INTERN MED, V255, P188, DOI 10.1046/j.1365-2796.2003.01276.x; WARNICK GR, 1982, AM J CLIN PATHOL, V78, P718; Way M, 2015, ADDICT BIOL, V20, P594, DOI 10.1111/adb.12141; Whitfield JB, 2013, ALCOHOL CLIN EXP RES, V37, P575, DOI 10.1111/acer.12015; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Williams PT, 2012, J LIPID RES, V53, P266, DOI 10.1194/jlr.M019356; Williams PT, 2011, ATHEROSCLEROSIS, V214, P196, DOI 10.1016/j.atherosclerosis.2010.10.024; Yeung SLA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068054; Zakhari S, 2006, ALCOHOL RES HEALTH, V29, P245; Zuccolo L, 2009, HUM MOL GENET, V18, P4457, DOI 10.1093/hmg/ddp388	92	42	44	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148765	10.1371/journal.pone.0148765	http://dx.doi.org/10.1371/journal.pone.0148765			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849558	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000167
J	Wong, JGX; Thein, TL; Leo, YS; Pang, JX; Lye, DC				Wong, Joshua G. X.; Thein, Tun Linn; Leo, Yee-Sin; Pang, Junxiong; Lye, David C.			Identifying Adult Dengue Patients at Low Risk for Clinically Significant Bleeding	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; SHOCK SYNDROME; INFECTION; CHILDREN; MANIFESTATIONS; VALIDATION; PREDICTORS; SINGAPORE	Background Clinically significant bleeding is important for subsequent optimal case management in dengue patients, but most studies have focused on dengue severity as an outcome. Our study objective was to identify differences in admission parameters between patients who developed clinically significant bleeding and those that did not. We sought to develop a model for discriminating between these patients. Methods We conducted a retrospective study of 4,383 adults aged > 18 years who were hospitalized with dengue infection at Tan Tock Seng Hospital, Singapore from 2005 to 2008. Patients were divided into those with clinically significant bleeding (n = 188), and those without (n = 4,195). Demographic, clinical, and laboratory variables on admission were compared between groups to determine factors associated with clinically significant bleeding during hospitalization. Results On admission, female gender (p< 0.001); temperature > 38 degrees C (p< 0.001); nausea/vomiting (p = 0.009) and abdominal pain/tenderness (p = 0.005); lower systolic blood pressure (p< 0.001); higher pulse rate (p< 0.001); increased absolute neutrophil count (ANC; p< 0.001); reduced absolute lymphocyte count (ALC; p< 0.001), haematocrit percentage (p< 0.001) and platelet count (p = 0.04), and increased prothrombin time (p = 0.003) were significantly associated with clinically significant bleeding on univariate analysis. Multivariate analysis showed that independent variables in the final model were female gender (aOR 2.85; 95% CI: 1.9-4.33); temperature > 38 degrees C (aOR 1.81; 95% CI: 1.27-2.61), nausea/vomiting (aOR 1.39; 95% CI: 0.94-2.12), ANC (aOR 1.3; 95% CI: 1.15-1.46), ALC (aOR 0.4; 95% CI: 0.25-0.64), hematocrit percentage (aOR 0.96; 95% CI: 0.92-1.002) and platelet count (aOR 0.993; 95% CI: 0.988-0.998). At the cutoff of -3.919, the model achieved an AUC of 0.758 (sensitivity: 0.87, specificity: 0.38, PPV: 0.06, NPV: 0.98). Conclusion Clinical risk factors associated with clinically significant bleeding were identified. This model may be useful to complement clinical judgement in triaging adult dengue patients given the dynamic nature of acute dengue, particularly in pre-identifying those less likely to develop clinically significant bleeding.	[Wong, Joshua G. X.; Thein, Tun Linn; Leo, Yee-Sin; Pang, Junxiong; Lye, David C.] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore; [Wong, Joshua G. X.] Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore; [Leo, Yee-Sin] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Leo, Yee-Sin; Pang, Junxiong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Leo, Yee-Sin; Lye, David C.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore	Tan Tock Seng Hospital; Tan Tock Seng Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore	Wong, JGX (corresponding author), Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore.	Joshua_Gx_Wong@ttsh.com.sg	Pang, Junxiong/AAI-5115-2021; Thein, Tun-Linn/Y-9520-2018; Lye, David/ABF-4402-2021; Thein, Tun-Linn/K-5281-2019	Thein, Tun-Linn/0000-0002-5254-032X; Thein, Tun-Linn/0000-0002-5254-032X; Pang, Junxiong, Vincent/0000-0002-9788-701X; Wong, Joshua/0000-0001-8268-5610; Lye, David/0000-0003-0324-0205	National Medical Research Council Translational Clinical Research STOP-Dengue grant [NMRC/TCR/005/2008]	National Medical Research Council Translational Clinical Research STOP-Dengue grant	This work was supported by research funding from the National Medical Research Council Translational Clinical Research STOP-Dengue grant [NMRC/TCR/005/2008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Diaz-Quijano FA, 2010, J CLIN VIROL, V49, P11, DOI 10.1016/j.jcv.2010.06.011; Almas A, 2010, SE ASIAN J TROP MED, V41, P333; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Carrasco L R, 2014, PLOS NEGLECT TROP D, V8, pe2972, DOI DOI 10.1371/J0URNAL.PNTD.0002972; Chamnanchanunt S, 2012, SE ASIAN J TROP MED, V43, P890; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cavalcanti LPD, 2010, REV SOC BRAS MED TRO, V43, P355, DOI 10.1590/S0037-86822010000400003; Dinh TT, 2010, AM J TROP MED HYG, V83, P774, DOI 10.4269/ajtmh.2010.10-0090; Fariz-Safhan MN, 2014, TROP BIOMED, V31, P270; Branco MDFC, 2014, CLINICS, V69, P55, DOI 10.6061/clinics/2014(01)08; Gjenero-Margan I, 2011, EURO SURVEILL BULL E, P16; Gupta V, 2011, J TROP PEDIATRICS, V57, P451, DOI 10.1093/tropej/fmr020; Hanna JN, 1990, COMMUN DIS INTELL, P33; Huhtamo E, 2012, EUROSURVEILLANCE, P18; KUO CH, 1992, AM J TROP MED HYG, V47, P265, DOI 10.4269/ajtmh.1992.47.265; Larrieu S, 2012, RE EMERGENCE OF DENG; Lee IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001532; Lee LK, 2013, T ROY SOC TROP MED H, V107, P37, DOI 10.1093/trstmh/trs009; Lee LK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001676; Lee VJ, 2008, J CLIN VIROL, V42, P34, DOI 10.1016/j.jcv.2007.12.017; Loong TW, 2003, BMJ-BRIT MED J, V327, P716, DOI 10.1136/bmj.327.7417.716; National Enviroment Agency, 2014, FACTSHEET ON MANAGIN; Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412; Nguyen TL, 1997, RES VIROLOGY, V148, P273, DOI 10.1016/S0923-2516(97)88364-1; Orsi FA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-350; Pham TB, 2009, J CLIN VIROL, V45, P276, DOI 10.1016/j.jcv.2009.04.004; R Core Team, 2013, R A LANGUAGE AND ENV; Rowe EK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002777; Shivbalan So., 2004, Indian Journal of Pediatrics, V71, P33, DOI 10.1007/BF02725653; Sousa CA, 2012, PRELIMINARY REPORT; Tee H P, 2009, Med J Malaysia, V64, P316; Thein TL, 2011, AM J TROP MED HYG, V85, P942, DOI 10.4269/ajtmh.2011.11-0149; 'Thein TL, 2014, AM J TROP MED HYG, V90, P984, DOI 10.4269/ajtmh.14-0004; Thein TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081060; The TD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001679; Villar-Centeno LA, 2008, AM J TROP MED HYG, V78, P370, DOI 10.4269/ajtmh.2008.78.370; WHO, DENGUE HAEMORRHAGIC; WHO, 2009, DENGUE GUIDELINES FO; WHO, DENGUE AND SEVERE DE; Wichmann O, 2004, TROP MED INT HEALTH, V9, P1022, DOI 10.1111/j.1365-3156.2004.01295.x; Wichmann O, 2007, J INFECT DIS, V195, P1089, DOI 10.1086/512680; Yacoub S, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0147-9; Zhang H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/359308	43	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148579	10.1371/journal.pone.0148579	http://dx.doi.org/10.1371/journal.pone.0148579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849556	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000131
J	Cui, JY; Miao, H; Ding, LH; Wehner, TC; Liu, PN; Wang, Y; Zhang, SP; Gu, XF				Cui, Jin-Ying; Miao, Han; Ding, Li-Hong; Wehner, Todd C.; Liu, Pan-Na; Wang, Ye; Zhang, Sheng-Ping; Gu, Xing-Fang			A New Glabrous Gene (csgl3) Identified in Trichome Development in Cucumber (Cucumis sativus L.)	PLOS ONE			English	Article							CELL-DIFFERENTIATION; ARABIDOPSIS; ENCODES; PROTEIN; MODEL; FRUIT; MARKERS; MEMBERS; FAMILY	Spines or trichomes on the fruit of cucumbers enhance their commercial value in China. In addition, glabrous mutants exhibit resistance to aphids and therefore their use by growers can reduce pesticide residues. Previous studies have reported two glabrous mutant plants containing the genes, csgl1 and csgl2. In the present study, a new glabrous mutant, NCG157, was identified showing a gene interaction effect with csgl1 and csgl2. This mutant showed the glabrous character on stems, leaves, tendrils, receptacles and ovaries, and there were no spines or tumors on the fruit surface. Inheritance analysis showed that a single recessive gene, named csgl3, determined the glabrous trait. An F-2 population derived from the cross of two inbred lines 9930 (a fresh market type from Northern China that exhibits trichomes) and NCG157 (an American processing type with glabrous surfaces) was used for genetic mapping of the csgl3 gene. By combining bulked segregant analysis (BAS) with molecular markers, 18 markers, including two simple sequence repeats (SSR), nine insertion deletions (InDel) and seven derived cleaved amplified polymorphism sequences (dCAPs), were identified to link to the csgl3 gene. All of the linked markers were used as anchor loci to locate the csgl3 gene on cucumber chromosome 6. The csgl3 gene was mapped between the dCAPs markers dCAPs-21 and dCAPs-19, at genetic distances of 0.05 cM and 0.15 cM, respectively. The physical distance of this region was 19.6 kb. Three markers, InDel-19, dCAPs-2 and dCAPs-11, co-segregated with csgl3. There were two candidate genes in the region, Csa6M514860 and Csa6M514870. Quantitative real-time PCR showed that the expression of Csa6M514870 was higher in the tissues of 9930 than that of NCG157, and this was consistent with their phenotypic characters. Csa6M514870 is therefore postulated to be the candidate gene for the development of trichomes in cucumber. This study will facilitate marker-assisted selection (MAS) of the smooth plant trait in cucumber breeding and provide for future cloning of csgl3.	[Cui, Jin-Ying; Miao, Han; Ding, Li-Hong; Liu, Pan-Na; Wang, Ye; Zhang, Sheng-Ping; Gu, Xing-Fang] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Wehner, Todd C.] N Carolina State Univ, Dept Hort Sci, Raleigh, NC 27695 USA	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of North Carolina; North Carolina State University	Zhang, SP; Gu, XF (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China.	zhangshengping@caas.cn; guxingfang@caas.cn			National Natural Science Foundation of China [31372082]; earmarked fund for Modern Agro-industry Technology Research System [CARS-25]; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for Modern Agro-industry Technology Research System; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, China	This work was supported by National Natural Science Foundation of China (31372082); the earmarked fund for Modern Agro-industry Technology Research System (CARS-25), and the Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2003, DEVELOPMENT, V130, P635, DOI 10.1242/dev.00292; Aso K, 1999, MOL BIOL EVOL, V16, P544, DOI 10.1093/oxfordjournals.molbev.a026135; BASSAM BJ, 1991, ANAL BIOCHEM, V198, P217; Cao ChenXing, 1999, China Vegetables, P29; Chen CH, 2014, J EXP BOT, V65, P4943, DOI 10.1093/jxb/eru258; Guan, 2008, THESIS SHANGHAI JIAO; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Hulskamp M, 1999, INT REV CYTOL, V186, P147; Hulskamp M, 2004, NAT REV MOL CELL BIO, V5, P471, DOI 10.1038/nrm1404; HULSKAMP M, 1994, CELL, V76, P555, DOI 10.1016/0092-8674(94)90118-X; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; Jiang S, 2005, PLANT MOL BIOL, V57, P835, DOI 10.1007/s11103-005-2859-x; Kamata N, 2013, PLANT J, V75, P430, DOI 10.1111/tpj.12211; Kang JH, 2010, J EXP BOT, V61, P1053, DOI 10.1093/jxb/erp370; Kirik V, 2004, DEV BIOL, V268, P506, DOI 10.1016/j.ydbio.2003.12.037; Kunz HH, 2010, PLANT BIOLOGY, V12, P115, DOI 10.1111/j.1438-8677.2010.00349.x; Li Q, 2015, J EXP BOT, V66, P2515, DOI 10.1093/jxb/erv046; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; Payne CT, 2000, GENETICS, V156, P1349; Pesch M, 2004, CURR OPIN GENET DEV, V14, P422, DOI 10.1016/j.gde.2004.06.007; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; RERIE WG, 1994, GENE DEV, V8, P1388, DOI 10.1101/gad.8.12.1388; SAMUELS AL, 1993, ANN BOT-LONDON, V72, P433, DOI 10.1006/anbo.1993.1129; Schellmann S, 2005, INT J DEV BIOL, V49, P579, DOI 10.1387/ijdb.051983ss; SCHENA M, 1992, P NATL ACAD SCI USA, V89, P3894, DOI 10.1073/pnas.89.9.3894; Serna L, 2006, TRENDS PLANT SCI, V11, P274, DOI 10.1016/j.tplants.2006.04.008; Sessa G, 1998, PLANT MOL BIOL, V38, P609, DOI 10.1023/A:1006016319613; Staub J, 1996, HORTSCIENCE, V31, P262, DOI 10.21273/HORTSCI.31.2.262; Tominaga-Wada R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054019; Walker AR, 1999, PLANT CELL, V11, P1337, DOI 10.1105/tpc.11.7.1337; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Yang CX, 2011, P NATL ACAD SCI USA, V108, P11836, DOI 10.1073/pnas.1100532108; Yang ShuangJuan, 2011, Acta Horticulturae Sinica, V38, P1685; Zhang Chi, 2009, Journal of Shanghai Jiaotong University - Agricultural Science, V27, P380; Zhang WW, 2010, THEOR APPL GENET, V120, P645, DOI 10.1007/s00122-009-1182-3	36	39	44	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148422	10.1371/journal.pone.0148422	http://dx.doi.org/10.1371/journal.pone.0148422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845560	Green Submitted, Green Published, gold			2022-12-27	WOS:000369552800056
J	Ku, HC; Lee, SY; Yang, KC; Kuo, YH; Su, MJ				Ku, Hui-Chun; Lee, Shih-Yi; Yang, Kai-Chien; Kuo, Yueh-Hsiung; Su, Ming-Jai			Modification of Caffeic Acid with Pyrrolidine Enhances Antioxidant Ability by Activating AKT/HO-1 Pathway in Heart	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; PRESERVES CARDIAC-FUNCTION; HEME OXYGENASE-1; OXIDATIVE STRESS; TRANSGENIC MICE; INFARCT SIZE; EXPRESSION; PROTECTION; RATS; AKT	Overproduction of free radicals during ischemia/reperfusion (I/R) injury leads to an interest in using antioxidant therapy. Activating an endogenous antioxidant signaling pathway is more important due to the fact that the free radical scavenging behavior in vitro does not always correlate with a cytoprotection effect in vivo. Caffeic acid (CA), an antioxidant, is a major phenolic constituent in nature. Pyrrolidinyl caffeamide (PLCA), a derivative of CA, was compared with CA for their antioxidant and cytoprotective effects. Our results indicate that CA and PLCA exert the same ability to scavenge DPPH in vitro. In response to myocardial I/R stress, PLCA was shown to attenuate lipid peroxydation and troponin release more than CA. These responses were accompanied with a prominent elevation in AKT and HO-1 expression and a preservation of mnSOD expression and catalase activity. PLCA also improved cell viability and alleviated the intracellular ROS level more than CA in cardiomyocytes exposed to H2O2. When inhibiting the AKT or HO-1 pathways, PLCA lost its ability to recover mnSOD expression and catalase activity to counteract with oxidative stress, suggesting AKT/HO-1 pathway activation by PLCA plays an important role. In addition, inhibition of AKT signaling further abolished HO-1 activity, while inhibition of HO-1 signaling attenuated AKT expression, indicating cross-talk between the AKT and HO-1 pathways. These protective effects may contribute to the cardiac function improvement by PLCA. These findings provide new insight into therapeutic approaches using a modified natural compound against oxidative stress from myocardial injuries.	[Ku, Hui-Chun; Lee, Shih-Yi; Yang, Kai-Chien; Su, Ming-Jai] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan; [Lee, Shih-Yi] Mackay Mem Hosp, Div Pulm & Crit Care Med, Taipei, Taiwan; [Lee, Shih-Yi] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Kuo, Yueh-Hsiung] China Med Univ, Dept Chinese Pharmaceut Sci, Taichung, Taiwan; [Kuo, Yueh-Hsiung] China Med Univ, Chinese Med Resources, Taichung, Taiwan; [Kuo, Yueh-Hsiung] Asia Univ, Dept Biotechnol, Taichung, Taiwan	National Taiwan University; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Su, MJ (corresponding author), Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.	kcyang@ntu.edu.tw; mingja@ntu.edu.tw	Yang, Kai-Chien/AAO-6991-2021	Yang, Kai-Chien/0000-0002-9128-9166	Ministry of Science and Technology [MOST 103-2325-B-002-020]; National Taiwan University [NTU 104R4000]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Taiwan University(National Taiwan University)	The author work was supported by the grant from Ministry of Science and Technology (MOST 103-2325-B-002-020), and National Taiwan University (NTU 104R4000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunt KR, 2006, ARTERIOSCL THROM VAS, V26, P2027, DOI 10.1161/01.ATV.0000236204.37119.8d; Burgoyne JR, 2012, CIRC RES, V111, P1091, DOI 10.1161/CIRCRESAHA.111.255216; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Collino M, 2013, DIS MODEL MECH, V6, P1012, DOI 10.1242/dmm.011528; Dhalla NS, 2000, CARDIOVASC RES, V47, P446, DOI 10.1016/S0008-6363(00)00078-X; Galiuto L, 2000, Ital Heart J, V1, P108; Golias C, 2007, IN VIVO, V21, P757; Gulcin I, 2006, TOXICOLOGY, V217, P213, DOI 10.1016/j.tox.2005.09.011; He MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084800; Hori M, 2009, CARDIOVASC RES, V81, P457, DOI 10.1093/cvr/cvn335; Jayasooriya RGPT, 2014, FOOD CHEM TOXICOL, V65, P82, DOI 10.1016/j.fct.2013.12.011; Jordan JE, 1999, CARDIOVASC RES, V43, P860, DOI 10.1016/S0008-6363(99)00187-X; Koskenkorva-Frank TS, 2013, FREE RADICAL BIO MED, V65, P1174, DOI 10.1016/j.freeradbiomed.2013.09.001; Kristinova V, 2009, J AGR FOOD CHEM, V57, P10377, DOI 10.1021/jf901072t; Ku HC, 2015, N-S ARCH PHARMACOL, V388, P539, DOI 10.1007/s00210-015-1098-1; Ku HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085634; Ku HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054518; Ku HC, 2011, N-S ARCH PHARMACOL, V384, P197, DOI 10.1007/s00210-011-0665-3; Ku HC, 2010, N-S ARCH PHARMACOL, V382, P463, DOI 10.1007/s00210-010-0559-9; Lakkisto P, 2009, SCAND J CLIN LAB INV, V69, P209, DOI 10.1080/00365510802474392; Lee SY, 2015, J BIOMED SCI, V22, DOI [10.1186/s12929-015-0188-1, 10.1186/s12929-015-0125-3]; LITT MR, 1989, CIRCULATION, V80, P1816, DOI 10.1161/01.CIR.80.6.1816; Liu XQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054077, 10.1371/journal.pone.0077367, 10.1371/journal.pone.0058489]; LLESUY SF, 1994, BBA-MOL CELL RES, V1223, P9, DOI 10.1016/0167-4889(94)90067-1; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; Meng X, 2014, FREE RADICAL RES, V48, P823, DOI 10.3109/10715762.2014.911853; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; NAYLER WG, 1992, J CARDIOVASC PHARM, V20, pS14; Novo G, 2011, TRANSL RES, V157, P285, DOI 10.1016/j.trsl.2011.01.003; Pae HO, 2008, J CLIN BIOCHEM NUTR, V42, P197, DOI 10.3164/jcbn.2008029; Pan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114186; Ramaraj R, 2007, NEW ENGL J MED, V357, P2408; Ravingerova T, 2007, MOL CELL BIOCHEM, V297, P111, DOI 10.1007/s11010-006-9335-z; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sedlak TW, 2004, PEDIATRICS, V113, P1776, DOI 10.1542/peds.113.6.1776; Senthil K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123360; Siow RCM, 2007, REDOX REP, V12, P11, DOI 10.1179/135100007X162167; Son Y, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/639541; Turkseven S, 2005, AM J PHYSIOL-HEART C, V289, pH701, DOI 10.1152/ajpheart.00024.2005; Uang YS, 1997, BIOPHARM DRUG DISPOS, V18, P727, DOI 10.1002/(SICI)1099-081X(199711)18:8<727::AID-BDD58>3.3.CO;2-6; Verma S, 2002, CIRCULATION, V105, P2332, DOI 10.1161/01.CIR.0000016602.96363.36; Wang Chao-Yung, 2010, Chang Gung Med J, V33, P13; Wang SJ, 2014, PHARM BIOL, V52, P1150, DOI 10.3109/13880209.2013.879906; Wu ML, 2011, AM J CARDIOVASC DIS, V1, P150; Xu X, 2015, MEDIAT INFLAMM, V2015, DOI [10.1155/2015/810798, 10.1155/2015/380218]; Yang J, 2012, BIOMED CHROMATOGR, V26, P594, DOI 10.1002/bmc.1702; Yang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108024; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; Yoshida T, 2001, CIRCULATION, V103, P1695, DOI 10.1161/01.CIR.103.12.1695	52	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148545	10.1371/journal.pone.0148545	http://dx.doi.org/10.1371/journal.pone.0148545			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845693	Green Submitted, Green Published, gold			2022-12-27	WOS:000369552800067
J	Wilder, HK; Raffel, SJ; Barbour, AG; Porcella, SF; Sturdevant, DE; Vaisvil, B; Kapatral, V; Schmitt, DP; Schwan, TG; Lopez, JE				Wilder, Hannah K.; Raffel, Sandra J.; Barbour, Alan G.; Porcella, Stephen F.; Sturdevant, Daniel E.; Vaisvil, Benjamin; Kapatral, Vinayak; Schmitt, Daniel P.; Schwan, Tom G.; Lopez, Job E.			Transcriptional Profiling the 150 kb Linear Megaplasmid of Borrelia turicatae Suggests a Role in Vector Colonization and Initiating Mammalian Infection	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; ACIDIC REPETITIVE PROTEINS; RELAPSING FEVER; SURFACE PROTEIN; ORNITHODOROS-TURICATA; ANTIGENIC VARIATION; TRYPANOSOMA-BRUCEI; GENOME SEQUENCE; GENE-EXPRESSION; SALIVARY-GLANDS	Adaptation is key for survival as vector-borne pathogens transmit between the arthropod and vertebrate, and temperature change is an environmental signal inducing alterations in gene expression of tick-borne spirochetes. While plasmids are often associated with adaptation, complex genomes of relapsing fever spirochetes have hindered progress in understanding the mechanisms of vector colonization and transmission. We utilized recent advances in genome sequencing to generate the most complete version of the Borrelia turicatae 150 kb linear megaplasmid (lp150). Additionally, a transcriptional analysis of open reading frames (ORFs) in lp150 was conducted and identified regions that were up-regulated during in vitro cultivation at tick-like growth temperatures (22 degrees C), relative to bacteria grown at 35 degrees C and infected murine blood. Evaluation of the 3' end of lp150 identified a cluster of ORFs that code for putative surface lipoproteins. With a microbe's surface proteome serving important roles in pathogenesis, we confirmed the ORFs expression in vitro and in the tick compared to spirochetes infecting murine blood. Transcriptional evaluation of lp150 indicates the plasmid likely has essential roles in vector colonization and/or initiating mammalian infection. These results also provide a much needed transcriptional framework to delineate the molecular mechanisms utilized by relapsing fever spirochetes during their enzootic cycle.	[Wilder, Hannah K.; Lopez, Job E.] Baylor Coll Med, Dept Pediat, Sect Trop Med, Houston, TX 77030 USA; [Wilder, Hannah K.; Lopez, Job E.] Texas Childrens Hosp, Houston, TX 77030 USA; [Raffel, Sandra J.; Schwan, Tom G.] NIAID, Rocky Mt Labs, Lab Zoonot Pathogens, NIH, Hamilton, MT 59840 USA; [Barbour, Alan G.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Barbour, Alan G.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Barbour, Alan G.] Univ Calif Irvine, Dept Ecol & Evolut Biol, Irvine, CA 92717 USA; [Porcella, Stephen F.; Sturdevant, Daniel E.] NIAID, Rocky Mt Labs, Genom Unit, Res Technol Sect,NIH, Hamilton, MT 59840 USA; [Vaisvil, Benjamin; Kapatral, Vinayak; Schmitt, Daniel P.] Igenbio Inc, Chicago, IL USA; [Lopez, Job E.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Baylor College of Medicine	Lopez, JE (corresponding author), Baylor Coll Med, Dept Pediat, Sect Trop Med, Houston, TX 77030 USA.; Lopez, JE (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.; Lopez, JE (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	job.lopez@bcm.edu		Lopez, Job/0000-0003-4802-5779; Vaisvil, Benjamin/0000-0003-1688-0295; Barbour, Alan/0000-0002-0719-5248; KAPATRAL, VINAYAK/0000-0002-0501-3738	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Igenbio, Inc.;  [AI091652];  [AI103724];  [AI065359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI091652, R21AI103724, U54AI065359] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Igenbio, Inc.; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by AI091652 (JEL), AI103724 (JEL), AI065359 (AGB), and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Igenbio, Inc. provided support in the form of salaries for authors BV, VK and DPS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barbour AG, 2000, INFECT IMMUN, V68, P7114, DOI 10.1128/IAI.68.12.7114-7121.2000; Barbour AG, 2014, GENOME ANNOUNC, V2; Barbour AG, 2006, P NATL ACAD SCI USA, V103, P18290, DOI 10.1073/pnas.0605302103; Battisti James M., 2008, V431, P69; BENACH JL, 1983, NEW ENGL J MED, V308, P740, DOI 10.1056/NEJM198303313081302; Boyle WK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002767; Bykowski T, 2007, INFECT IMMUN, V75, P4227, DOI 10.1128/IAI.00604-07; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; CLAYTON CE, 1989, J BIOL CHEM, V264, P15088; COFFEY EM, 1967, J INFECT DIS, V117, P29, DOI 10.1093/infdis/117.1.29; Dai QY, 2006, MOL MICROBIOL, V60, P1329, DOI 10.1111/j.1365-2958.2006.05177.x; Davis GE, 1943, PUBLIC HEALTH REP, V58, P839, DOI 10.2307/4584474; Davis GE, 1941, PUBLIC HEALTH REP, V56, P1799, DOI 10.2307/4583854; Elbir H, 2014, GENOME ANNOUNC, V2; Elbir H, 2012, J BACTERIOL, V194, P3723, DOI 10.1128/JB.00118-12; Fikrig E, 2000, J IMMUNOL, V164, P5344, DOI 10.4049/jimmunol.164.10.5344; Fine LM, 2014, INFECT IMMUN, V82, P3324, DOI 10.1128/IAI.01892-14; Fine LM, 2011, J BACTERIOL, V193, P3241, DOI 10.1128/JB.05037-11; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gilmore RD, 2010, P NATL ACAD SCI USA, V107, P7515, DOI 10.1073/pnas.1000268107; Guyard C, 2005, INFECT IMMUN, V73, P3025, DOI 10.1128/IAI.73.5.3025-3037.2005; Iyer R, 2015, MOL MICROBIOL, V95, P509, DOI 10.1111/mmi.12882; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; KITTEN T, 1990, P NATL ACAD SCI USA, V87, P6077, DOI 10.1073/pnas.87.16.6077; Lescot M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000185; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez JE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002514; Lopez JE, 2008, VECTOR-BORNE ZOONOT, V8, P813, DOI 10.1089/vbz.2008.0033; Marcsisin RA, 2012, INFECT IMMUN, V80, P1881, DOI 10.1128/IAI.06419-11; Meri T, 2006, INFECT IMMUN, V74, P4157, DOI 10.1128/IAI.00007-06; Miller SC, 2013, J BACTERIOL, V195, P3629, DOI 10.1128/JB.00347-13; MOWATT MR, 1989, MOL CELL BIOL, V9, P1332, DOI 10.1128/MCB.9.3.1332; Nagamune K, 2000, P NATL ACAD SCI USA, V97, P10336, DOI 10.1073/pnas.180230697; Overbeek R, 2003, NUCLEIC ACIDS RES, V31, P164, DOI 10.1093/nar/gkg148; Pal U, 2000, J CLIN INVEST, V106, P561, DOI 10.1172/JCI9427; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Pennington PM, 1999, MOL MICROBIOL, V34, P1120, DOI 10.1046/j.1365-2958.1999.01675.x; Pettersson J, 2007, INFECT IMMUN, V75, P3877, DOI 10.1128/IAI.00199-07; PIESMAN J, 1991, J INFECT DIS, V163, P895, DOI 10.1093/infdis/163.4.895; PIESMAN J, 1987, J CLIN MICROBIOL, V25, P557, DOI 10.1128/JCM.25.3.557-558.1987; PIESMAN J, 1995, J MED ENTOMOL, V32, P519, DOI 10.1093/jmedent/32.4.519; PIESMAN J, 1993, J INFECT DIS, V167, P1082, DOI 10.1093/infdis/167.5.1082; PIESMAN J, 1990, AM J TROP MED HYG, V42, P352, DOI 10.4269/ajtmh.1990.42.352; PLASTERK RHA, 1985, NATURE, V318, P257, DOI 10.1038/318257a0; Porcella SF, 2005, INFECT IMMUN, V73, P6647, DOI 10.1128/IAI.73.10.6647-6658.2005; Raffel SJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004056; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; RESTREPO BI, 1994, CELL, V78, P867, DOI 10.1016/S0092-8674(94)90642-4; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Rossmann E, 2007, J IMMUNOL, V178, P7292, DOI 10.4049/jimmunol.178.11.7292; Ruepp S, 1997, J CELL BIOL, V137, P1369, DOI 10.1083/jcb.137.6.1369; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Schwan TG, 2002, EMERG INFECT DIS, V8, P115, DOI 10.3201/eid0802.010198; Schwan TG, 2005, J CLIN MICROBIOL, V43, P3851, DOI 10.1128/JCM.43.8.3851-3859.2005; Schwan TG, 1996, INFECT AGENT DIS, V5, P167; Schwan TG, 1998, SCIENCE, V280, P1938, DOI 10.1126/science.280.5371.1938; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; SIMPSON WJ, 1990, MICROB PATHOGENESIS, V8, P109, DOI 10.1016/0882-4010(90)90075-2; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; Varma MGR, 1962, S ZOOLOGICAL SOC LON; Woodman ME, 2009, J LEUKOCYTE BIOL, V86, P727, DOI 10.1189/jlb.0309169	61	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147707	10.1371/journal.pone.0147707	http://dx.doi.org/10.1371/journal.pone.0147707			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845332	Green Published, gold			2022-12-27	WOS:000369552800014
J	Eikenberg, JD; Savla, J; Marinik, EL; Davy, KP; Pownall, J; Baugh, ME; Flack, KD; Boshra, S; Winett, RA; Davy, BM				Eikenberg, Joshua D.; Savla, Jyoti; Marinik, Elaina L.; Davy, Kevin P.; Pownall, John; Baugh, Mary E.; Flack, Kyle D.; Boshra, Soheir; Winett, Richard A.; Davy, Brenda M.			Prediabetes Phenotype Influences Improvements in Glucose Homeostasis with Resistance Training	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; LIFE-STYLE INTERVENTION; RANDOMIZED CONTROLLED-TRIAL; GLYCEMIC CONTROL; INSULIN SENSITIVITY; DIABETES-MELLITUS; SKELETAL-MUSCLE; TOLERANCE; EXERCISE; PEOPLE	Purpose To determine if prediabetes phenotype influences improvements in glucose homeostasis with resistance training (RT). Methods Older, overweight individuals with prediabetes (n = 159; aged 60 +/- 5 yrs; BMI 33 +/- 4 kg/m(2)) completed a supervised RT program twice per week for 12 weeks. Body weight and composition, strength, fasting plasma glucose, 2-hr oral glucose tolerance, and Matsuda-Defronza estimated insulin sensitivity index (ISI) were assessed before and after the intervention. Participants were categorized according to their baseline prediabetes phenotype as impaired fasting glucose only (IFG) (n = 73), impaired glucose tolerance only (IGT) (n = 21), or combined IFG and IGT (IFG/IGT) (n = 65). Results Chest press and leg press strength increased 27% and 18%, respectively, following the 12-week RT program (both p<0.05). Waist circumference (-1.0%; pre 109.3 +/- 10.3 cm, post 108.2 +/- 10.6 cm) and body fat (-0.6%; pre 43.7 +/- 6.8%, post 43.1 +/- 6.8%) declined, and lean body mass (+1.3%; pre 52.0 +/- 10.4 kg, post 52.7 +/- 10.7 kg) increased following the intervention. Fasting glucose concentrations did not change (p>0.05) following the intervention. However, 2-hr oral glucose tolerance improved in those with IGT (pre 8.94 +/- 0.72 mmol/l, post 7.83 +/- 1.11 mmol/l, p<0.05) and IFG/IGT (pre 9.66 +/- 1.11mmol/l, post 8.60 +/- 2.00 mmol/l) but not in those with IFG (pre 6.27 +/- 1.28mmol/l, post 6.33 +/- 1.55 mmol/l). There were no significant changes in ISI or glucose area under the curve following the RT program. Conclusions RT without dietary intervention improves 2-hr oral glucose tolerance in individuals with prediabetes. However, the improvements in glucose homeostasis with RT appear limited to those with IGT or combined IFG and IGT.	[Eikenberg, Joshua D.; Boshra, Soheir] Virginia Tech Caril Sch Med, Caril Clin, Dept Internal Med, Roanoke, VA USA; [Savla, Jyoti] Virginia Tech, Ctr Gerontol, Blacksburg, VA USA; [Savla, Jyoti] Virginia Tech, Dept Human Dev, Blacksburg, VA USA; [Marinik, Elaina L.; Davy, Kevin P.; Pownall, John; Baugh, Mary E.; Flack, Kyle D.; Davy, Brenda M.] Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA USA; [Winett, Richard A.] Virginia Tech, Dept Psychol, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Eikenberg, JD (corresponding author), Virginia Tech Caril Sch Med, Caril Clin, Dept Internal Med, Roanoke, VA USA.	jdeikenberg@carilionclinic.org	Savla, Jyoti/N-6085-2019; Savla, Jyoti/J-7125-2015	Savla, Jyoti/0000-0001-7142-3770; Savla, Jyoti/0000-0001-7142-3770; Flack, Kyle/0000-0001-7622-4770; Baugh, Mary Elizabeth/0000-0002-3469-7040	National Institute of Diabetes and Digestive and Kidney Diseases (US) [NCT01112709]	National Institute of Diabetes and Digestive and Kidney Diseases (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (US) grant number NCT01112709 (RAW and BMD are the principal investigators on this grant), URL: http://www.niddk.nih.gov/Pages/default.aspx.	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Abdul-Ghani MA, 2006, DIABETES, V55, P1430, DOI 10.2337/db05-1200; Abdul-Ghani MA, 2009, CURR DIABETES REP, V9, P193, DOI 10.1007/s11892-009-0032-7; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Baldi JC, 2003, INT J SPORTS MED, V24, P419, DOI 10.1055/s-2003-41173; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Basu R, 2013, J CLIN ENDOCR METAB, V98, pE409, DOI 10.1210/jc.2012-3056; Buford TW, 2012, PREV MED, V55, P34, DOI 10.1016/j.ypmed.2012.05.001; Castaneda C, 2002, DIABETES CARE, V25, P2335, DOI 10.2337/diacare.25.12.2335; Cauza E, 2005, ARCH PHYS MED REHAB, V86, P1527, DOI 10.1016/j.apmr.2005.01.007; Dunstan DW, 2006, DIABETES CARE, V29, P2586, DOI 10.2337/dc06-1310; Dunstan DW, 2002, DIABETES CARE, V25, P1729, DOI 10.2337/diacare.25.10.1729; Dunstan DW, 1998, DIABETES RES CLIN PR, V40, P53, DOI 10.1016/S0168-8227(98)00027-8; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Fenicchia LM, 2004, METABOLISM, V53, P284, DOI 10.1016/j.metabol.2003.10.007; Geirsdottir OG, 2012, J GERONTOL A-BIOL, V67, P1259, DOI 10.1093/gerona/gls096; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Grontved A, 2012, ARCH INTERN MED, V172, P1306, DOI 10.1001/archinternmed.2012.3138; Holten MK, 2004, DIABETES, V53, P294, DOI 10.2337/diabetes.53.2.294; Ibanez J, 2005, DIABETES CARE, V28, P662, DOI 10.2337/diacare.28.3.662; Iglay HB, 2007, AM J CLIN NUTR, V85, P1005, DOI 10.1093/ajcn/85.4.1005; Ishii T, 1998, DIABETES CARE, V21, P1353, DOI 10.2337/diacare.21.8.1353; Joseph LJO, 2001, DIABETES CARE, V24, P1863, DOI 10.2337/diacare.24.11.1863; Kanat M, 2011, ACTA DIABETOL, V48, P209, DOI 10.1007/s00592-011-0285-x; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; KOHL HW, 1988, AM J EPIDEMIOL, V127, P1228, DOI 10.1093/oxfordjournals.aje.a114915; Kraemer WJ, 2002, MED SCI SPORT EXER, V34, P364, DOI 10.1097/00005768-200202000-00027; Lau C, 2009, J NUTR, V139, P588, DOI 10.3945/jn.108.100339; Lindahl B, 1999, J INTERN MED, V246, P105, DOI 10.1046/j.1365-2796.1999.00537.x; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Marinik EL, 2014, CONTEMP CLIN TRIALS, V37, P19, DOI 10.1016/j.cct.2013.11.006; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Mensink M, 2003, OBES RES, V11, P1588, DOI 10.1038/oby.2003.211; Muthen LK, 2002, STRUCT EQU MODELING, V9, P599, DOI 10.1207/S15328007SEM0904_8; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Oldroyd JC, 2006, DIABETES RES CLIN PR, V72, P117, DOI 10.1016/j.diabres.2005.09.018; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; SATORRA A, 1985, PSYCHOMETRIKA, V50, P83, DOI 10.1007/BF02294150; SMUTOK MA, 1994, INT J SPORTS MED, V15, P283, DOI 10.1055/s-2007-1021061; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wasada T, 2004, DIABETOLOGIA, V47, P759, DOI 10.1007/s00125-004-1339-1; Weyer C, 1999, DIABETES, V48, P2197, DOI 10.2337/diabetes.48.11.2197; Whaley MH, 2006, ACSMS GUIDELINES FOR, Vxxi	46	17	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148009	10.1371/journal.pone.0148009	http://dx.doi.org/10.1371/journal.pone.0148009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840904	Green Submitted, gold, Green Published			2022-12-27	WOS:000369550200075
J	Toby, GG; Liu, TY; Yang, BY; Zhang, X; Bitonti, AJ; Pierce, GF; Sommer, JM; Jiang, HY; Peters, RT				Toby, Garabet G.; Liu, Tongyao; Yang Buyue; Zhang, Xin; Bitonti, Alan J.; Pierce, Glenn F.; Sommer, Jurg M.; Jiang, Haiyan; Peters, Robert T.			Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice	PLOS ONE			English	Article							FACTOR-VIII; BLOOD-COAGULATION; DOSING FREQUENCY; PROPHYLAXIS; ADHERENCE; IMMUNOGLOBULINS; CATABOLISM; RECEPTOR; MODERATE; THERAPY	Introduction Hemophilia B is an inherited X chromosome-linked disorder characterized by impaired blood clotting owing to the absence of functional coagulation factor IX. Due to the relatively short half-life of factor IX, patients with hemophilia B require frequent factor IX infusions to maintain prophylaxis. We have developed a recombinant factor IX (rFIX) fused to the Fc region of IgG (rFIXFc) with an extended half-life in animals and humans. Materials and Methods Procoagulant properties of rFIXFc and rFIX (BENEFIX (R)) were compared to determine the effect of the Fc region on rFIXFc hemostatic function. Specifically, we assessed rFIXFc activation, intermolecular interactions within the Xase complex, inactivation by antithrombin III (AT) and thrombin generation potential compared with rFIX. We also assessed the acute and prophylactic efficacy profiles of rFIXFc and rFIX in vivo in hemophilia B mouse bleeding models. Results and Conclusions The activation by factor XIa or factor VIIa/tissue factor, inhibition by AT, interaction profiles with phospholipids, affinities for factor VIIIa within the context of the Xase complex, and thrombin generation profiles were similar for rFIXFc and rFIX. Xase complexes formed with either molecule exhibited similar kinetic profiles for factor Xa generation. In acute efficacy models, mice infused with rFIXFc or rFIX were equally protected from bleeding. However, in prophylactic efficacy models, protection from bleeding was maintained approximately three times longer in rFIXFc-dosed mice than in those given rFIX; this prolonged efficacy correlates with the previously observed half-life extension. We conclude that rFIXFc retains critical FIX procoagulant attributes and that the extension in rFIXFc half-life translates into prolonged efficacy in hemophilia B mice.	[Toby, Garabet G.; Liu, Tongyao; Yang Buyue; Zhang, Xin; Bitonti, Alan J.; Pierce, Glenn F.; Sommer, Jurg M.; Jiang, Haiyan; Peters, Robert T.] Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA	Biogen	Peters, RT (corresponding author), Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	robert.peters@biogen.com			Biogen	Biogen(Biogen)	This study was funded by Biogen. Garabet G. Toby, Tongyao Liu, Yang Buyue, Xin Zhang, Alan J. Bitonti, Glenn F. Pierce, Jurg M. Sommer, Haiyan Jiang, and Robert T. Peters were employees of and held equity interest in Biogen at the time of this research. This work is directly related to the marketed product, ALPROLIX (R) (rFIXFc), and several of the authors are named as inventors on a number of patents and pending applications covering rFIXFc, filed in the US and throughout the world (for example, US Patent Nos. 7,404,956; 7,348,004; 7,862,820; 8,329,182; and 8,932,830: "Immunoglobulin chimeric monomer-dimer hybrids"; and USSN 13/793,796: "Factor IX polypeptides and methods of use thereof"). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Biss TT, 2008, HAEMOPHILIA, V14, P923, DOI 10.1111/j.1365-2516.2008.01810.x; Bond M, 1998, SEMIN HEMATOL, V35, P11; BRAMBELL FW, 1964, NATURE, V203, P1352, DOI 10.1038/2031352a0; BRAMBELL FW, 1966, LANCET, V2, P1087, DOI 10.1016/S0140-6736(66)92190-8; Chang JY, 1997, J CLIN INVEST, V100, P886, DOI 10.1172/JCI119604; De Moerloose P, 2008, HAEMOPHILIA, V14, P931, DOI 10.1111/j.1365-2516.2008.01843.x; Dumont JA, 2006, BIODRUGS, V20, P151, DOI 10.2165/00063030-200620030-00002; Dumont JA, 2015, THROMB RES, V136, P371, DOI 10.1016/j.thromres.2015.01.020; Ewenstein BM, 2002, TRANSFUSION, V42, P190, DOI 10.1046/j.1537-2995.2002.00039.x; Fay PJ, 2006, INT J HEMATOL, V83, P103, DOI 10.1532/IJH97.05113; Giangrande P, 2005, EXPERT OPIN PHARMACO, V6, P1517, DOI 10.1517/14656566.6.9.1517; GRAY E, 1995, THROMB HAEMOSTASIS, V73, P675; Hacker MR, 2001, HAEMOPHILIA, V7, P392, DOI 10.1046/j.1365-2516.2001.00534.x; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Krishnan S, 2015, HAEMOPHILIA, V21, P64, DOI 10.1111/hae.12533; Larson PJ, 1996, J BIOL CHEM, V271, P3869; Ljung RCR, 1999, THROMB HAEMOSTASIS, V82, P525; LOZIER JN, 1990, BLOOD, V75, P1097; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Mann KG, 1999, THROMB HAEMOSTASIS, V82, P165; McCue J, 2014, HAEMOPHILIA, V20, pe327, DOI 10.1111/hae.12451; Mei BS, 2010, BLOOD, V116, P270, DOI 10.1182/blood-2009-11-254755; Pan JL, 2009, BLOOD, V114, P2802, DOI 10.1182/blood-2009-03-212423; Peters RT, 2013, J THROMB HAEMOST, V11, P132, DOI 10.1111/jth.12076; Peters RT, 2010, BLOOD, V115, P2057, DOI 10.1182/blood-2009-08-239665; PIETERS J, 1988, J BIOL CHEM, V263, P15313; Powell J, 2015, BRIT J HAEMATOL, V168, P113, DOI 10.1111/bjh.13109; Powell JS, 2013, NEW ENGL J MED, V369, P2313, DOI 10.1056/NEJMoa1305074; Recker RR, 2005, MAYO CLIN PROC, V80, P856, DOI 10.4065/80.7.856; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Saini SD, 2009, AM J MANAG CARE, V15, pE22; SIMISTER NE, 1985, EUR J IMMUNOL, V15, P733, DOI 10.1002/eji.1830150718; Theusinger OM, 2010, EUR J CARDIO-THORAC, V37, P677, DOI 10.1016/j.ejcts.2009.07.038; WALDMANN TA, 1969, PROG ALLERGY, V13, P1, DOI 10.1159/000287491; White GC, 1997, THROMB HAEMOSTASIS, V78, P261; World Federation of Hemophilia, 2012, GUIDELINES FOR THE M	36	1	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148255	10.1371/journal.pone.0148255	http://dx.doi.org/10.1371/journal.pone.0148255			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840952	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200113
J	Wang, PZ; Zhang, FJ; He, QL; Wang, JQ; Shiu, HT; Shu, YL; Tsang, WP; Liang, S; Zhao, K; Wan, C				Wang, Pengzhen; Zhang, Fengjie; He, Qiling; Wang, Jianqi; Shiu, Hoi Ting; Shu, Yinglan; Tsang, Wing Pui; Liang, Shuang; Zhao, Kai; Wan, Chao			Flavonoid Compound Icariin Activates Hypoxia Inducible Factor-1 alpha in Chondrocytes and Promotes Articular Cartilage Repair	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX SYNTHESIS; BONE MORPHOGENETIC PROTEIN-2; MESENCHYMAL STEM-CELLS; LIMB BUD MESENCHYME; OXYGEN-TENSION; GROWTH-PLATE; IN-VITRO; ENDOCHONDRAL OSSIFICATION; INFLAMMATORY RESPONSES; FRACTURE REPAIR	Articular cartilage has poor capability for repair following trauma or degenerative pathology due to avascular property, low cell density and migratory ability. Discovery of novel therapeutic approaches for articular cartilage repair remains a significant clinical need. Hypoxia is a hallmark for cartilage development and pathology. Hypoxia inducible factor-1alpha (HIF-1 alpha) has been identified as a key mediator for chondrocytes to response to fluctuations of oxygen availability during cartilage development or repair. This suggests that HIF-1 alpha may serve as a target for modulating chondrocyte functions. In this study, using phenotypic cellular screen assays, we identify that Icariin, an active flavonoid component from Herba Epimedii, activates HIF-1 alpha expression in chondrocytes. We performed systemic in vitro and in vivo analysis to determine the roles of Icariin in regulation of chondrogenesis. Our results show that Icariin significantly increases hypoxia responsive element luciferase reporter activity, which is accompanied by increased accumulation and nuclear translocation of HIF-1 alpha in murine chondrocytes. The phenotype is associated with inhibiting PHD activity through interaction between Icariin and iron ions. The upregulation of HIF-1 alpha mRNA levels in chondrocytes persists during chondrogenic differentiation for 7 and 14 days. Icariin (10(-6) M) increases the proliferation of chondrocytes or chondroprogenitors examined by MTT, BrdU incorporation or colony formation assays. Icariin enhances chondrogenic marker expression in a micromass culture including Sox9, collagen type 2 (Col2 alpha 1) and aggrecan as determined by real-time PCR and promotes extracellular matrix (ECM) synthesis indicated by Alcian blue staining. ELISA assays show dramatically increased production of aggrecan and hydroxyproline in Icariin-treated cultures at day 14 of chondrogenic differentiation as compared with the controls. Meanwhile, the expression of chondrocyte catabolic marker genes including Mmp2, Mmp9, Mmp13, Adamts4 and Adamts5 was downregulated following Icariin treatment for 14 days. In a differentiation assay using bone marrow mesenchymal stem cells (MSCs) carrying HIF-1 alpha floxed allele, the promotive effect of Icariin on chondrogenic differentiation is largely decreased following Cre recombinase-mediated deletion of HIF-1 alpha in MSCs as indicated by Alcian blue staining for proteoglycan synthesis. In an alginate hydrogel 3D culture system, Icariin increases Safranin O positive (SO+) cartilage area. This phenotype is accompanied by upregulation of HIF-1 alpha, increased proliferating cell nuclear antigen positive (PCNA+) cell numbers, SOX9+ chondrogenic cell numbers, and Col2 expression in the newly formed cartilage. Coincide with the micromass culture, Icariin treatment upregulates mRNA levels of Sox9, Col2 alpha 1, aggrecan and Col10 alpha 1 in the 3D cultures. We then generated alginate hydrogel 3D complexes incorporated with Icariin. The 3D complexes were transplanted in a mouse osteochondral defect model. ICRS II histological scoring at 6 and 12 weeks post-transplantation shows that 3D complexes incorporated with Icariin significantly enhance articular cartilage repair with higher scores particularly in selected parameters including SO+ cartilage area, subchondral bone and overall assessment than that of the controls. The results suggest that Icariin may inhibit PHD activity likely through competition for cellular iron ions and therefore it may serve as an HIF-1 alpha activator to promote articular cartilage repair through regulating chondrocyte proliferation, differentiation and integration with subchondral bone formation.	[Wang, Pengzhen; Wan, Chao] Chinese Univ Hong Kong, Jinan Univ, Key Lab Regenerat Med, Minist Educ, Guangzhou 510000, Guangdong, Peoples R China; [Wang, Pengzhen; Zhang, Fengjie; Shu, Yinglan; Tsang, Wing Pui; Liang, Shuang; Zhao, Kai; Wan, Chao] Chinese Univ Hong Kong, Shenzhen Res Inst, Inst Stem Cell Genom & Translat Res, Sch Biomed Sci,Core Lab, Shenzhen 518057, Peoples R China; [Zhang, Fengjie; Shiu, Hoi Ting; Shu, Yinglan; Tsang, Wing Pui; Liang, Shuang; Zhao, Kai; Wan, Chao] Chinese Univ Hong Kong, Jinan Univ, Sch Biomed Sci, Minist Educ,Key Lab Regenerat Med,Fac Med, Shatin, Hong Kong, Peoples R China; [He, Qiling] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Wang, Jianqi] Chinese Univ Hong Kong, Fac Sci, Dept Chem, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Jinan University; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong; University of Alabama System; University of Alabama Birmingham; Chinese University of Hong Kong	Wan, C (corresponding author), Chinese Univ Hong Kong, Jinan Univ, Key Lab Regenerat Med, Minist Educ, Guangzhou 510000, Guangdong, Peoples R China.	cwan@cuhk.edu.hk	Wan, Chao/J-9277-2013	Wan, Chao/0000-0001-6780-2006	Hong Kong RGC GRF [475910]; National Natural Science Foundation of China (NSFC) [81130034]; Guangdong Science and Technology Department [20130501C]; Shenzhen Synergistic Innovation Program [GJHS20120702105445379]	Hong Kong RGC GRF(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department; Shenzhen Synergistic Innovation Program	The work was partially supported by Hong Kong RGC GRF (475910), National Natural Science Foundation of China (NSFC) (81130034), Guangdong Science and Technology Department (20130501C), and Shenzhen Synergistic Innovation Program GJHS20120702105445379 to CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Araldi E, 2011, NAT MED, V17, P25, DOI 10.1038/nm0111-25; BRIGHTON CT, 1971, J BONE JOINT SURG AM, VA 53, P719, DOI 10.2106/00004623-197153040-00011; Cao H, 2012, INT J MOL MED, V29, P435, DOI 10.3892/ijmm.2011.845; Chen KM, 2007, PHARMAZIE, V62, P388, DOI 10.1691/ph.2007.5.6682; Danisovic L, 2012, TISSUE CELL, V44, P69, DOI 10.1016/j.tice.2011.11.005; Eltawil NM, 2009, OSTEOARTHR CARTILAGE, V17, P695, DOI 10.1016/j.joca.2008.11.003; Fan HB, 2010, J BIOMED MATER RES A, V95A, P982, DOI 10.1002/jbm.a.32899; Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Gelse K, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2508; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; Hsieh TP, 2011, PHYTOMEDICINE, V18, P176, DOI 10.1016/j.phymed.2010.04.003; Hsieh TP, 2010, PHYTOMEDICINE, V17, P414, DOI 10.1016/j.phymed.2009.08.007; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Komatsu DE, 2004, BONE, V34, P680, DOI 10.1016/j.bone.2003.12.024; Lafont JE, 2008, J BIOL CHEM, V283, P4778, DOI 10.1074/jbc.M707729200; Leopoldini M, 2006, J AGR FOOD CHEM, V54, P6343, DOI 10.1021/jf060986h; Li B, 2014, INT IMMUNOPHARMACOL, V19, P381, DOI 10.1016/j.intimp.2014.01.009; Li D, 2012, OSTEOARTHR CARTILAGE, V20, P1647, DOI 10.1016/j.joca.2012.08.009; Li TF, 2006, J BIOL CHEM, V281, P21296, DOI 10.1074/jbc.M600514200; Li ZJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/391512; Liu MH, 2010, NUTR RES, V30, P57, DOI 10.1016/j.nutres.2009.10.020; Lopiz-Morales Y, 2010, EUR CELLS MATER, V20, P367; LUNDOLESEN K, 1970, ARTHRITIS RHEUM-US, V13, P769, DOI 10.1002/art.1780130606; Mainil-Varlet P, 2010, AM J SPORT MED, V38, P880, DOI 10.1177/0363546509359068; Makris EA, 2015, NAT REV RHEUMATOL, V11, P21, DOI 10.1038/nrrheum.2014.157; Oldershaw RA, 2012, INT J EXP PATHOL, V93, P389, DOI 10.1111/j.1365-2613.2012.00837.x; Park SS, 2008, J CELL BIOCHEM, V103, P1989, DOI 10.1002/jcb.21588; Pfander D, 2003, J CELL SCI, V116, P1819, DOI 10.1242/jcs.00385; Pfander D, 2004, DEVELOPMENT, V131, P2497, DOI 10.1242/dev.01138; Provot S, 2007, ANN NY ACAD SCI, V1117, P26, DOI 10.1196/annals.1402.076; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Schindler OS, 2011, ACTA ORTHOP BELG, V77, P709; Schipani E, 2001, GENE DEV, V15, P2865; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2000, GENE DEV, V14, P1983; Shen X, 2009, J ORTHOP RES, V27, P1298, DOI 10.1002/jor.20886; Solchaga LA, 2010, TISSUE ENG PT A, V16, P1009, DOI [10.1089/ten.tea.2009.0100, 10.1089/ten.TEA.2009.0100]; Song YH, 2011, J PHARM PHARMACOL, V63, P541, DOI 10.1111/j.2042-7158.2010.01241.x; Stewart AJ, 2006, J CELL PHYSIOL, V206, P435, DOI 10.1002/jcp.20481; Thoms BL, 2013, ARTHRITIS RHEUM-US, V65, P1302, DOI 10.1002/art.37867; Tiwary R, 2014, CARTILAGE, V5, P43, DOI 10.1177/1947603513499366; TREUHAFT PS, 1971, ARTHRITIS RHEUM, V14, P475, DOI 10.1002/art.1780140407; Tuan RS, 2013, J AM ACAD ORTHOP SUR, V21, P303, DOI 10.5435/JAAOS-21-05-303; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wan L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102010; Wang L, 2009, EUR J PHARMACOL, V609, P40, DOI 10.1016/j.ejphar.2009.03.033; Wang ZC, 2014, EXP THER MED, V8, P1528, DOI 10.3892/etm.2014.1950; Xu CQ, 2010, EUR J PHARMACOL, V642, P146, DOI 10.1016/j.ejphar.2010.05.012; Yang HS, 2011, TISSUE ENG PT A, V17, P1809, DOI 10.1089/ten.tea.2010.0540; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Zhang L, 2012, PHYTOTHER RES, V26, P1385, DOI 10.1002/ptr.3733; Zhao J, 2008, BIOCHEM BIOPH RES CO, V369, P444, DOI 10.1016/j.bbrc.2008.02.054; Zhao JY, 2010, TISSUE ENG PT A, V16, P233, DOI [10.1089/ten.tea.2009.0165, 10.1089/ten.TEA.2009.0165]	57	57	64	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148372	10.1371/journal.pone.0148372	http://dx.doi.org/10.1371/journal.pone.0148372			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841115	Green Submitted, gold, Green Published			2022-12-27	WOS:000369550200129
J	Dua, TK; Dewanjee, S; Khanra, R; Joardar, S; Barma, S; Das, S; Zia-Ul-Haq, M; De Feo, V				Dua, Tarun K.; Dewanjee, Saikat; Khanra, Ritu; Joardar, Swarnalata; Barma, Sujata; Das, Shilpa; Zia-Ul-Haq, M.; De Feo, Vincenzo			Cytoprotective and Antioxidant Effects of an Edible Herb, Enhydra fluctuans Lour. (Asteraceae), against Experimentally Induced Lead Acetate Intoxication	PLOS ONE			English	Article							OXYGEN SPECIES ROS; OXIDATIVE STRESS; APOPTOSIS; CADMIUM; INVOLVEMENT; IMAGE; ACID; QUANTIFICATION; INJURY	Background Enhydra fluctuans Lour. (Asteraceae), an edible aquatic herb, is traditionally employed against toxic effects of heavy metals in India. The present study was planned to discover the protective effect of edible extract of E. fluctuans (AEEF) against Pb toxicity. Methods The cytoprotective role of AEEF was determined on murine hepatocytes employing MTT assay and Hoechst staining. The effects on lipid peroxidation, protein carbonylation, endogenous redox systems and the transcription levels of apoptotic proteins were studied after incubating the hepatocytes with AEEF (400 mu g/ml) + Pb-acetate (6.8 mu M). The defensive role of AEEF (100 mg/kg) against Pb-acetate (5 mg/kg) intoxication was measured in mice by in vivo assays. Biochemical, haematological and histological parameters, intracellular Pb burden and redox status were measured. Results AEEF exhibited a concentration dependent cytoprotective effect against Pb-induced cytotoxicity in vitro. Pb-acetate incubation significantly (p < 0.01) altered the extents of ROS production up arrow, protein carbonylation up arrow, lipid peroxidation up arrow, endogenous antioxidant enzymes down arrow and GSH down arrow in vitro. Besides, Pb-acetate significantly (p < 0.01) induced apoptosis in the hepatocytes apparent from the altered expressions of apoptotic proteins viz. Apaf-1 up arrow, Bad up arrow, Bcl-2 down arrow, Cyt C up arrow, cleaved caspases up arrow, Bid up arrow and Fas up arrow. However, AEEF (400 mu g/ml) could significantly (p < 0.05-0.01) attenuate the Pb-acetate mediated toxic manifestation in vitro. In in vivo assay, Pb-acetate (5 mg/kg) treated mice exhibited significantly (p < 0.01) high intracellular Pb content. A high Pb-burden within the tissues caused significant (p < 0.05-0.01) patho-physiological alterations viz. ROS production up arrow, protein carbonylation up arrow, lipid peroxidation up arrow, DNA fragmentation up arrow, ATPformation up arrow, mitochondrial co-enzymes Q down arrow, endogenous antioxidant enzymes down arrow and GSH down arrow within the selected tissues. The haematological and serum biochemical parameters were significantly (p < 0.05-0.01) different in the Pb-acetate treated mice. Finally, histological assessment imposed significant toxic occurrence within the organs of Pb-intoxicated animals. However, concurrent administration of AEEF (100 mg/kg) could significantly (p < 0.05-0.01) reinstate the Pb-acetate mediated toxicity. Conclusion Presence of metal chelators and phyto-antioxidants within AEEF would offer overall protection through promoting Pb clearance coupled with restoring redox balance.	[Dua, Tarun K.; Dewanjee, Saikat; Khanra, Ritu; Joardar, Swarnalata; Barma, Sujata; Das, Shilpa] Jadavpur Univ, Dept Pharmaceut Technol, Adv Pharmacognosy Res Lab, Kolkata 700032, India; [Zia-Ul-Haq, M.] Patent Off, Karchi 75400, Pakistan; [De Feo, Vincenzo] Univ Salerno, Dept Pharm, I-84084 Salerno, Italy	Jadavpur University; University of Salerno	Dewanjee, S (corresponding author), Jadavpur Univ, Dept Pharmaceut Technol, Adv Pharmacognosy Res Lab, Kolkata 700032, India.; De Feo, V (corresponding author), Univ Salerno, Dept Pharm, I-84084 Salerno, Italy.	s.dewanjee@yahoo.com; defeo@unisa.it	Dewanjee, Saikat/U-9778-2017; De Feo, Vincenzo/AAF-2293-2019; KHANRA, RITU/AAV-4351-2021; Dua, Tarun Kumar/AAM-4891-2020	De Feo, Vincenzo/0000-0002-1070-3207; Dua, Tarun Kumar/0000-0001-5136-7564; Dewanjee, Saikat/0000-0001-9085-4226	Council for Scientific and Industrial Research (CSIR), New Delhi, India [09/096(773)/2013-EMR-I]	Council for Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	The financial support of the Council for Scientific and Industrial Research (CSIR), New Delhi, India is gratefully acknowledged through Senior Research Fellowship to Mr. Tarun K. Dua [Council for Scientific and Industrial Research-senior research fellowship Ref. No.: 09/096(773)/2013-EMR-I dated 15th March, 2013].; The financial support of the Council for Scientific and Industrial Research (CSIR), New Delhi, India is gratefully acknowledged through Senior Research Fellowship to Mr. Tarun K. Dua [Council for Scientific and Industrial Research-senior research fellowship Ref. No.: 09/096(773)/2013-EMR-I dated 15th March, 2013]. Authors are thankful to Jadavpur University, Kolkata, India for providing necessary facilities for this study. All authors are thankful to Prof. Biswajit Mukherjee, Department of Pharmaceutical Technology, Jadavpur University for his kind help for histological studies. Finally, the authors would like to say thanks to the reviewers for their time and valuable comments to improve the quality of this manuscript.	Ahmad RS, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0436-x; ALI E, 1972, TETRAHEDRON, V28, P2285, DOI 10.1016/S0040-4020(01)93572-0; Bolner A, 2011, CLIN LAB, V57, P859; Chander K, 2014, FOOD CHEM TOXICOL, V68, P297, DOI 10.1016/j.fct.2014.02.012; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Das AK, 2010, FOOD CHEM TOXICOL, V48, P1210, DOI 10.1016/j.fct.2010.02.012; Das AK, 2010, FOOD CHEM TOXICOL, V48, P326, DOI 10.1016/j.fct.2009.10.020; Das AK, 2010, ENVIRON TOXICOL PHAR, V29, P64, DOI 10.1016/j.etap.2009.10.002; DEFIGUEIREDO RJP, 1995, NEUROBIOL AGING, V16, P211, DOI 10.1016/0197-4580(94)00151-0; Dewanjee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139831; Dewanjee S, 2014, ENZYME MICROB TECH, V66, P1, DOI 10.1016/j.enzmictec.2014.07.006; Dewanjee S, 2013, FOOD CHEM TOXICOL, V60, P188, DOI 10.1016/j.fct.2013.07.043; Dewanjee S, 2013, FOOD CHEM TOXICOL, V55, P78, DOI 10.1016/j.fct.2012.12.040; Dewanjee S, 2009, FOOD CHEM TOXICOL, V47, P2679, DOI 10.1016/j.fct.2009.07.038; Dua TK, 2016, REDOX REP, V21, P147, DOI 10.1179/1351000215Y.0000000021; Dua TK, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0598-6; Dua TK, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0430-3; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; Ghosh J, 2010, FOOD CHEM, V123, P1062, DOI 10.1016/j.foodchem.2010.05.062; Gurer H, 2000, FREE RADICAL BIO MED, V29, P927, DOI 10.1016/S0891-5849(00)00413-5; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hong KJ, 2000, CHEMOSPHERE, V41, P345, DOI 10.1016/S0045-6535(99)00489-0; Hsu PC, 2002, TOXICOLOGY, V180, P33, DOI 10.1016/S0300-483X(02)00380-3; Jackie Tan, 2011, BMC Res Notes, V4, P67, DOI 10.1186/1756-0500-4-67; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Khanra R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0364-1; Kim JD, 1996, AGING-CLIN EXP RES, V8, P123, DOI 10.1007/BF03339566; Kuri Sourov, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P299, DOI 10.12980/APJTB.4.2014C677; LEBEL CP, 1990, NEUROCHEM INT, V17, P435, DOI 10.1016/0197-0186(90)90025-O; Lin KT, 1997, BIOCHEM BIOPH RES CO, V230, P115, DOI 10.1006/bbrc.1996.5897; Mansoor TA, 2013, J ETHNOPHARMACOL, V149, P463, DOI 10.1016/j.jep.2013.06.051; Matovic V, 2015, FOOD CHEM TOXICOL, V78, P130, DOI [10.1016/j.fct.2015.02.011, 10.1016/jict.2015.02.011]; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pal S, 2011, TOXICOLOGY, V283, P129, DOI 10.1016/j.tox.2011.03.006; PHS (Public Health Service), 1986, PUBL HLTH SERV POL H; Rahman MT, 2002, FITOTERAPIA, V73, P707, DOI 10.1016/S0367-326X(02)00212-5; Rangan GK, 2007, NEPHROLOGY, V12, P553, DOI 10.1111/j.1440-1797.2007.00855.x; Ruegg MA, 2014, HISTOPATHOLOGY HEMAT; Saeed K, 2015, J PAK MED ASSOC, V65, P43; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Sultan MT, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0853-7; UCHIDA K, 1993, J BIOL CHEM, V268, P6388; Wu DD, 2015, MED GAS RES, V5, DOI 10.1186/s13618-014-0022-y; ZHANG YY, 1995, J NUTR, V125, P446	47	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148757	10.1371/journal.pone.0148757	http://dx.doi.org/10.1371/journal.pone.0148757			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859407	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400076
J	Gaetano, J; van der Zwan, R; Oxner, M; Hayward, WG; Doring, N; Blair, D; Brooks, A				Gaetano, Justin; van der Zwan, Rick; Oxner, Matthew; Hayward, William G.; Doring, Natalie; Blair, Duncan; Brooks, Anna			Converging Evidence of Ubiquitous Male Bias in Human Sex Perception	PLOS ONE			English	Article							OWN-RACE BIAS; GENDER; FACES; CATEGORIZATION; RECOGNITION; CUES	Visually judging the sex of another can be achieved easily in most social encounters. When the signals that inform such judgements are weak (e.g. outdoors at night), observers tend to expect the presence of males-an expectation that may facilitate survival-critical decisions under uncertainty. The present aim was to examine whether this male bias depends on expertise. To that end, Caucasian and Asian observers targeted female and male hand images that were either the same or different to the observers' race (i.e. long term experience was varied) while concurrently, the proportion of targets changed across presentation blocks (i.e. short term experience change). It was thus found that: (i) observers of own-race stimuli were more likely to report the presence of males and absence of females, however (ii) observers of other-race stimuli-while still tending to accept stimuli as male-were not prone to rejecting female cues. Finally, (iii) male-biased measures did not track the relative frequency of targets or lures, disputing the notion that male bias derives from prior expectation about the number of male exemplars in a set. Findings are discussed in concert with the pan-stimulus model of human sex perception.	[Gaetano, Justin; van der Zwan, Rick; Doring, Natalie; Blair, Duncan; Brooks, Anna] So Cross Univ, Cognit Neurosci Res Cluster, Coffs Harbour, Australia; [Oxner, Matthew; Hayward, William G.] Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Oxner, Matthew; Hayward, William G.] Univ Auckland, Sch Psychol, Auckland 1, New Zealand	Southern Cross University; University of Hong Kong; University of Auckland	Gaetano, J (corresponding author), So Cross Univ, Cognit Neurosci Res Cluster, Coffs Harbour, Australia.	justin.gaetano@scu.edu.au	; Gaetano, Justin/E-9469-2012	Oxner, Matt/0000-0002-4419-6020; Gaetano, Justin/0000-0002-4200-163X; Doring, Natalie/0000-0001-5648-0160; Hayward, William/0000-0002-7248-0301				Barzut V, 2013, PSIHOLOGIJA, V46, P45, DOI 10.2298/PSI1301045B; Bird K. D., 2004, ANAL VARIANCE VIA CO; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Bramwell S, 2014, PSYCHOPHYSIOLOGY, V51, P152, DOI 10.1111/psyp.12155; Brielmann AA, 2014, J VIS; Brielmann AA, 2014, VISION RES, V100, P105, DOI 10.1016/j.visres.2014.04.011; Brooks A, 2008, CURR BIOL, V18, pR728, DOI 10.1016/j.cub.2008.06.054; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Central Intelligence Agency, 2014, WORLD FACT BOOK; Chatterjee G, 2012, COGN NEUROPSYCHOL, V29, P482, DOI 10.1080/02643294.2012.756809; Chiroro PM, 2008, PSYCHON B REV, V15, P1089, DOI 10.3758/PBR.15.6.1089; Clifford CWG, CONSCIOUS C IN PRESS; Dahl CD, 2014, SCI REP-UK, V4, DOI 10.1038/srep06654; Davidenko N, 2007, J VISION, V7, DOI 10.1167/7.4.6; DeGutis J, 2012, VIS COGN, V20, P1242, DOI 10.1080/13506285.2012.744788; Fitzgerald SA, 2014, I-PERCEPTION, V5, P120, DOI 10.1068/i0612; Freeman JB, 2011, PSYCHOL REV, V118, P247, DOI 10.1037/a0022327; Fu GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037688; Gaetano JM, 2012, CURRENT TRENDS EXPT, V1, P105; Gaetano J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091032; Geniole SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030366; Goldinger SD, 2009, J EXP PSYCHOL LEARN, V35, P1105, DOI 10.1037/a0016548; Golkar A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00123; Hacker Graeme, 2013, BMC Psychol, V1, P10, DOI 10.1186/2050-7283-1-10; Hall J, 2012, FRONT HUM NEUROSCI; Heenan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099902; HILDEBRANDT KA, 1977, PERCEPT MOTOR SKILL, V45, P472, DOI 10.2466/pms.1977.45.2.472; Ishak NI, 2012, FORENSIC SCI INT, V221, DOI 10.1016/j.forsciint.2012.04.017; Jaquet E, 2008, VIS COGN, V16, P734, DOI 10.1080/13506280701350647; Johnson KL, 2012, P ROY SOC B-BIOL SCI, V279, P4982, DOI 10.1098/rspb.2012.2060; Lai M, 2012, CORTEX, V48, P477, DOI 10.1016/j.cortex.2010.11.014; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Le Grand R, 2006, BRAIN COGNITION, V61, P139, DOI 10.1016/j.bandc.2005.11.005; Lundstrom JN, 2005, BIOL PSYCHOL, V70, P197, DOI 10.1016/j.biopsycho.2005.01.008; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Miellet S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00034; Millar JA, 1996, J HUM HYPERTENS, V10, P449; Nagy E, 2000, PERCEPT MOTOR SKILL, V90, P102, DOI 10.2466/PMS.90.1.102-104; Navarrete CD, 2009, PSYCHOL SCI, V20, P155, DOI 10.1111/j.1467-9280.2009.02273.x; Ng M, 2006, P NATL ACAD SCI USA, V103, P19552, DOI 10.1073/pnas.0605358104; Olsson A, 2005, SCIENCE, V309, P785, DOI 10.1126/science.1113551; OToole AJ, 1996, PERCEPTION, V25, P669, DOI 10.1068/p250669; Packer C, 2000, PHILOS T ROY SOC B, V355, P1627, DOI 10.1098/rstb.2000.0725; Palumbo R, 2013, VIS COGN, V21, P1, DOI 10.1080/13506285.2012.753970; Pedersen F A, 1991, Hum Nat, V2, P271, DOI 10.1007/BF02692189; Plant EA, 2011, PERS SOC PSYCHOL B, V37, P1274, DOI 10.1177/0146167211408617; Podrebarac SK, 2013, EXP BRAIN RES, V226, P241, DOI 10.1007/s00221-013-3429-0; Quek GL, 2014, ADV COGN PSYCHOL, V10, P131, DOI 10.5709/acp-0164-8; Quek GL, 2014, COGN AFFECT BEHAV NE, V14, P1407, DOI 10.3758/s13415-014-0282-y; ROBERTS T, 1988, PERCEPTION, V17, P475, DOI 10.1068/p170475; Rodger H, 2010, PERCEPTION, V39, P1491, DOI 10.1068/p6750; Schouten B, 2010, ATTEN PERCEPT PSYCHO, V72, P1256, DOI 10.3758/APP.72.5.1256; Sigala R, 2011, J NEUROPHYSIOL, V105, P2740, DOI 10.1152/jn.00882.2010; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Troje NF, 2006, J VISION, V6, P850, DOI 10.1167/6.8.7; van der Zwan R, 2009, EXP BRAIN RES, V198, P373, DOI 10.1007/s00221-009-1800-y; Wallis J, 2012, ATTEN PERCEPT PSYCHO, P1; Weech S, 2014, J VISION, V14, DOI 10.1167/14.12.10; Wheeler A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018621; Wild HA, 2000, J EXP CHILD PSYCHOL, V77, P269, DOI 10.1006/jecp.1999.2554; Winer B.J., 1962, STAT PRINCIPLES EXPT	61	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148623	10.1371/journal.pone.0148623	http://dx.doi.org/10.1371/journal.pone.0148623			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859570	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400060
J	Khan, SG; Melikian, N; Mushemi-Blake, S; Dennes, W; Jouhra, F; Monaghan, M; Shah, AM				Khan, Sitara G.; Melikian, Narbeh; Mushemi-Blake, Sitali; Dennes, William; Jouhra, Fadi; Monaghan, Mark; Shah, Ajay M.			Physiological Reduction in Left Ventricular Contractile Function in Healthy Postpartum Women: Potential Overlap with Peripartum Cardiomyopathy	PLOS ONE			English	Article							NORMAL HUMAN-PREGNANCY; ATRIAL-NATRIURETIC-PEPTIDE; HEART-FAILURE ASSOCIATION; CARDIOLOGY WORKING GROUP; 3D ECHOCARDIOGRAPHY; EUROPEAN-SOCIETY; CARDIAC-OUTPUT; RECOMMENDATIONS; PREECLAMPSIA; ADRENOMEDULLIN	Aims Peripartum cardiomyopathy is a potentially life-threatening cause of heart failure, commoner in Afro-Caribbean than Caucasian women. Its diagnosis can be challenging due to physiological changes in cardiac function that also occur in healthy women during the early postpartum period. This study aimed to (i) establish the overlap between normal cardiac physiology in the immediate postpartum period and pathological changes in peripartum cardiomyopathy ii) identify any ethnicity-specific changes in cardiac function and cardiac biomarkers in healthy postpartum women. Methods and Results We conducted a cross-sectional study of 58 healthy postpartum women within 48 hours of delivery and 18 matched non-pregnant controls. Participants underwent cardiac assessment by echocardiography and strain analysis, including 3D echocardiography in 40 postpartum women. Results were compared with 12 retrospectively studied peripartum cardiomyopathy patients. Healthy postpartum women had significantly higher left ventricular volumes and mass, and lower ejection fraction and global longitudinal strain than nonpregnant controls. These parameters were significantly more impaired in peripartum cardiomyopathy patients but with overlapping ranges of values. Healthy postpartum women had higher levels of adrenomedullin, placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt1) compared to controls. The postpartum state, adrenomedullin, sFlt1 and the sFlt1: PlGF ratio were independent predictors of LV remodelling and function in healthy postpartum women. Conclusion Healthy postpartum women demonstrate several echocardiographic indicators of left ventricular remodelling and reduced function, which are associated with altered levels of angiogenic and cardiac biomarkers.	[Khan, Sitara G.; Melikian, Narbeh; Mushemi-Blake, Sitali; Monaghan, Mark; Shah, Ajay M.] Kings Coll London, British Heart Fdn Ctr, Dept Cardiol, London, England; [Khan, Sitara G.; Melikian, Narbeh; Mushemi-Blake, Sitali; Jouhra, Fadi; Monaghan, Mark; Shah, Ajay M.] Kings Coll Hosp London, Dept Cardiol, London, England; [Dennes, William] Kings Coll Hosp London, Dept Obstet & Gynaecol, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital	Shah, AM (corresponding author), Kings Coll London, British Heart Fdn Ctr, Dept Cardiol, London, England.; Shah, AM (corresponding author), Kings Coll Hosp London, Dept Cardiol, London, England.	ajay.shah@kcl.ac.uk		Shah, Ajay/0000-0002-6547-0631	Academy of Medical Science (UK); British Heart Foundation	Academy of Medical Science (UK); British Heart Foundation(British Heart Foundation)	Funded by grants from the Academy of Medical Science (UK), and British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamfo JEAK, 2007, ULTRASOUND OBST GYN, V29, P414, DOI 10.1002/uog.3966; Bamfo JEAK, 2007, EUR J ECHOCARDIOGR, V8, P360, DOI 10.1016/j.euje.2006.12.004; Belo L, 2005, EUR J OBSTET GYN R B, V123, P46, DOI 10.1016/j.ejogrb.2005.02.022; Belo L, 2004, ATHEROSCLEROSIS, V177, P391, DOI 10.1016/j.atherosclerosis.2004.07.023; Desai DK, 2004, OBSTET GYNECOL, V104, P20, DOI 10.1097/01.AOG.0000128170.15161.1d; Estensen ME, 2013, ULTRASOUND OBST GYN, V41, P659, DOI 10.1002/uog.12296; Estensen ME, 2012, ULTRASOUND OBST GYN, DOI [10.1002/uog.12296, DOI 10.1002/U0G.12296]; Feigenbaum H, 2012, CIRC J, V76, P1550, DOI 10.1253/circj.CJ-12-0665; Gati S, 2014, CIRCULATION, V130, P475, DOI 10.1161/CIRCULATIONAHA.114.008554; Geva T, 1997, AM HEART J, V133, P53, DOI 10.1016/S0002-8703(97)70247-3; Hilfiker-Kleiner D, 2014, NAT REV CARDIOL, V11, P364, DOI 10.1038/nrcardio.2014.37; JOUGASAKI M, 1995, CIRCULATION, V92, P286, DOI 10.1161/01.CIR.92.3.286; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Lang RM, 2012, EUR HEART J-CARD IMG, V13, P1, DOI 10.1093/ehjci/jer316; MABIE WC, 1994, AM J OBSTET GYNECOL, V170, P849, DOI 10.1016/S0002-9378(94)70297-7; Mannaerts HFJ, 2004, EUR HEART J, V25, P680, DOI 10.1016/j.ehj.2004.02.030; Melchiorre K, 2014, CIRCULATION, V130, P703, DOI 10.1161/CIRCULATIONAHA.113.003664; Minegishi T, 1999, MOL HUM REPROD, V5, P767, DOI 10.1093/molehr/5.8.767; Monaghan MJ, 2006, HEART, V92, P131, DOI 10.1136/hrt.2004.058388; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nanno H, 1998, MOL HUM REPROD, V4, P609, DOI 10.1093/molehr/4.6.609; Ntusi NBA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133466; Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040; ROBSON SC, 1989, AM J PHYSIOL, V256, pH1060, DOI 10.1152/ajpheart.1989.256.4.H1060; Sanghavi M, 2014, CIRCULATION, V130, P1003, DOI 10.1161/CIRCULATIONAHA.114.009029; Savu O, 2012, CIRC-CARDIOVASC IMAG, V5, P289, DOI 10.1161/CIRCIMAGING.111.970012; Sliwa K, 2014, EUR J HEART FAIL, V16, P583, DOI 10.1002/ejhf.68; Sliwa K, 2010, EUR J HEART FAIL, V12, P767, DOI 10.1093/eurjhf/hfq120; Verlohren S, 2014, HYPERTENSION, V63, P346, DOI 10.1161/HYPERTENSIONAHA.113.01787; YOSHIMURA T, 1994, J ENDOCRINOL, V140, P393, DOI 10.1677/joe.0.1400393	30	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0147074	10.1371/journal.pone.0147074	http://dx.doi.org/10.1371/journal.pone.0147074			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859567	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400006
J	Li, JJ; Li, T; Sun, P; Yu, QH; Wang, K; Chang, WL; Song, ZF; Zheng, QC				Li, Jinjin; Li, Tong; Sun, Ping; Yu, Qihong; Wang, Kun; Chang, Weilong; Song, Zifang; Zheng, Qichang			Covered versus Uncovered Self-Expandable Metal Stents for Managing Malignant Distal Biliary Obstruction: A Meta-Analysis	PLOS ONE			English	Article							COMMON BILE-DUCT; PALLIATIVE TREATMENT; RANDOMIZED MULTICENTER; ENDOSCOPIC REMOVAL; NO BENEFIT; TRIAL; EFFICACY; WALLSTENTS; MANAGEMENT; PATENCY	Aim To compare the efficacy of using covered self-expandable metal stents (CSEMSs) and uncovered self-expandable metal stents (UCSEMSs) to treat objective jaundice caused by an unresectable malignant tumor. Methods We performed a comprehensive electronic search from 1980 to May 2015. All randomized controlled trials comparing the use of CSEMSs and UCSEMSs to treat malignant distal biliary obstruction were included. Results The analysis included 1417 patients enrolled in 14 trials. We did not detect significant differences between the UCSEMS group and the CSEMS group in terms of cumulative stent patency (hazard ratio (HR) 0.93, 95% confidence interval (CI) 0.19-4.53; p = 0.93, I-2 = 0%), patient survival (HR 0.77, 95% CI 0.05-10.87; p = 0.85, I-2 = 0%), overall stent dysfunction (relative ratio (RR) 0.85, M-H, random, 95% CI 0.57-1.25; p = 0.83, I-2 = 63%), the overall complication rate (RR 1.26, M-H, fixed, 95% CI 0.94-1.68; p = 0.12, I-2 = 0%) or the change in serum bilirubin (weighted mean difference (WMD) -0.13, IV fixed, 95% CI 0.56-0.3; p = 0.55, I-2 = 0%). However, we did detect a significant difference in the main causes of stent dysfunction between the two groups. In particular, the CSEMS group exhibited a lower rate of tumor ingrowth (RR 0.25, M-H, random, 95% CI 0.12-0.52; p = 0.002, I-2 = 40%) but a higher rate of tumor overgrowth (RR 1.76, M-H, fixed, 95% CI 1.03-3.02; p = 0.04, I-2 = 0%). Patients with CSEMSs also exhibited a higher migration rate (RR 9.33, M-H, fixed, 95% CI 2.54-34.24; p = 0.008, I-2 = 0%) and a higher rate of sludge formation (RR 2.47, M-H, fixed, 95% CI 1.36-4.50; p = 0.003, I-2 = 0%). Conclusions Our meta-analysis indicates that there is no significant difference in primary stent patency and stent dysfunction between CSEMSs and UCSEMSs during the period from primary stent insertion to primary stent dysfunction or patient death. However, when taking further management for occluded stents into consideration, CSEMSs is a better choice for patients with malignant biliary obstruction due to their removability.	[Li, Jinjin; Li, Tong; Sun, Ping; Yu, Qihong; Wang, Kun; Song, Zifang; Zheng, Qichang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Hepatobiliary Surg, Wuhan 430074, Peoples R China; [Chang, Weilong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gastrointestinal Surg, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Song, ZF; Zheng, QC (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Hepatobiliary Surg, Wuhan 430074, Peoples R China.	zfsongmd@sina.com; qczhengmd@sina.com	Song, Zifang/AAA-8467-2022; Li, Tong/GRN-9847-2022	Li, Tong/0000-0002-4283-0091				Aadam AA, 2012, GASTROINTEST ENDOSC, V76, P67, DOI 10.1016/j.gie.2012.02.041; Abraham NS, 2002, GASTROINTEST ENDOSC, V56, P835, DOI 10.1067/mge.2002.129868; Almadi MA, 2013, CLIN GASTROENTEROL H, V11, P27, DOI 10.1016/j.cgh.2012.10.019; Beissert M, 2002, Z GASTROENTEROL, V40, P503, DOI 10.1055/s-2002-32806; Cho YD, 2009, GASTROINTEST ENDOSC, V69, pAB137, DOI 10.1016/j.gie.2009.03.187; Costamagna G, 2011, ENDOSCOPY, V43, P317, DOI 10.1055/s-0030-1256294; Familiari P, 2005, GASTROINTEST ENDOSC, V62, P903, DOI 10.1016/j.gie.2005.08.051; Fukuda W, 2012, J GASTROEN HEPATOL, V27, P54; Fumex F, 2006, ENDOSCOPY, V38, P787, DOI 10.1055/s-2006-944515; Gonzalez-Huix F, 2008, GASTROINTEST ENDOSC, V67, pAB166, DOI 10.1016/j.gie.2008.03.379; Hayashi T, 2015, CLIN GASTROENTEROL H, V13, P1151, DOI 10.1016/j.cgh.2015.01.008; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Il Gwon D, 2010, AM J ROENTGENOL, V195, pW463, DOI 10.2214/AJR.10.4658; Isayama H, 2000, GASTROINTEST ENDOSC, V51, pAB191, DOI 10.1016/S0016-5107(00)14490-6; Isayama H, 2004, GUT, V53, P729, DOI 10.1136/gut.2003.018945; Isayama H, 2011, DIGEST ENDOSC, V23, P310, DOI 10.1111/j.1443-1661.2011.01124.x; Isayama H, 2010, SURG ENDOSC, V24, P131, DOI 10.1007/s00464-009-0537-9; Kaassis M, 2003, GASTROINTEST ENDOSC, V57, P178, DOI 10.1067/mge.2003.66; Kahaleh M, 2004, GASTROINTEST ENDOSC, V60, P640, DOI 10.1016/S0016-5107(04)01959-5; Kida M, 2012, KOREAN J RADIOL, V13, pS62, DOI 10.3348/kjr.2012.13.S1.S62; Kitano M, 2013, AM J GASTROENTEROL, V108, P1713, DOI 10.1038/ajg.2013.305; Krokidis M, 2011, CARDIOVASC INTER RAD, V34, P352, DOI 10.1007/s00270-010-9880-4; Krokidis M, 2010, CARDIOVASC INTER RAD, V33, P97, DOI 10.1007/s00270-009-9604-9; Kullman E, 2010, GASTROINTEST ENDOSC, V72, P915, DOI 10.1016/j.gie.2010.07.036; Kullman EP, 2009, GASTROINTEST ENDOSC, V69, pAB132, DOI 10.1016/j.gie.2009.03.169; Lee SH, 2004, GASTROINTEST ENDOSC, V59, pAB188; Lee SJ, 2014, J VASC INTERV RADIOL, V25, P1912, DOI 10.1016/j.jvir.2014.05.021; Mangiavillano B, 2015, DIGEST LIVER DIS, V47, pE105; Menon K, 2001, AM J GASTROENTEROL, V96, P1435; Moss AC, 2007, EUR J GASTROEN HEPAT, V19, P1119, DOI 10.1097/MEG.0b013e3282f16206; Moy BT, 2015, J CLIN TRANSL HEPATO, V3, P67, DOI 10.14218/JCTH.2015.00040; Nakai Y, 2005, GASTROINTEST ENDOSC, V62, P742, DOI 10.1016/j.gie.2005.06.030; Noon WJ, 2006, GASTROINTEST ENDOSC, V63, P996, DOI 10.1016/j.gie.2005.11.054; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pfau PR, 2013, GASTROINTEST ENDOSC, V77, P319, DOI 10.1016/j.gie.2012.09.026; Rossi P, 1997, CARDIOVASC INTER RAD, V20, P441, DOI 10.1007/s002709900190; Saleem A, 2011, GASTROINTEST ENDOSC, V74, P321, DOI 10.1016/j.gie.2011.03.1249; Shin HP, 2006, ENDOSCOPY, V38, P1250, DOI 10.1055/s-2006-944969; SMITS ME, 1995, GASTROINTEST ENDOSC, V41, P416, DOI 10.1016/S0016-5107(05)80520-6; Soderlund C, 2006, GASTROINTEST ENDOSC, V63, P986, DOI 10.1016/j.gie.2005.11.052; SPEER AG, 1988, GASTROINTEST ENDOSC, V34, P412, DOI 10.1016/S0016-5107(88)71407-8; Telford JJ, 2010, GASTROINTEST ENDOSC, V72, P907, DOI 10.1016/j.gie.2010.08.021; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Trujillo Bueno J, 2003, GASTROINTEST ENDOSC, V58, P879, DOI 10.1016/S0016-5107(03)02309-5; Tsuchiya T, 2011, DIGEST DIS SCI, V56, P1889, DOI 10.1007/s10620-011-1581-6; Ung KA, 2013, SCAND J GASTROENTERO, V48, P459, DOI 10.3109/00365521.2012.758766; van Berkel AM, 2003, ENDOSCOPY, V35, P478; Weber A, 2009, PANCREAS, V38, pE7, DOI 10.1097/MPA.0b013e3181870ab8	48	44	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0149066	10.1371/journal.pone.0149066	http://dx.doi.org/10.1371/journal.pone.0149066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859673	Green Submitted, gold, Green Published			2022-12-27	WOS:000370038400124
J	Marco-Jimenez, F; Jimenez-Trigos, E; Almela-Miralles, V; Vicente, JS				Marco-Jimenez, Francisco; Jimenez-Trigos, Estrella; Almela-Miralles, Victoria; Salvador Vicente, Jose			Development of Cheaper Embryo Vitrification Device Using the Minimum Volume Method	PLOS ONE			English	Article							HIGHLY EFFICIENT VITRIFICATION; CRYOTOP VITRIFICATION; RABBIT EMBRYOS; SURVIVAL RATE; HUMAN OOCYTES; CRYOPRESERVATION; STAGE; BLASTOCYSTS; EQUIVALENT; BOVINE	This study was designed to compare the efficiency of the Cryotop and Calibrated plastic inoculation loop (CPIL) devices for vitrification of rabbit embryos on in vitro development and implantation rate, offspring rate at birth and embryonic and fetal losses. CPIL is a simple tool used mainly by microbiologists to retrieve an inoculum from a culture of microorganisms. In experiment 1, embryos were vitrified using a Cryotop device and a CPIL device. There were no significant differences in hatched/hatching blastocyst stage rates after 48 h of culture among the vitrified groups (62 +/- 4.7% and 62 +/- 4.9%, respectively); however, the rates were significantly lower (P< 0.05) than those of the fresh group (95 +/- 3.4%). In experiment 2, vitrified embryos were transferred using laparoscopic technique. The number of implanted embryos was estimated by laparoscopy as number of implantation sites at day 14 of gestation. At birth, total offspring were recorded. Embryonic and fetal losses were calculated as the difference between implanted embryos and embryos transferred and total born at birth and implanted embryos, respectively. The rate of implantation and development to term was similar between both vitrification devices (56 +/- 7.2% and 50 +/- 6.8% for implantation rate and 40 +/- 7.1% and 35 +/- 6.5% for offspring rate at birth); but significantly lower than in the fresh group (78 +/- 6.6% for implantation rate and 70 +/- 7.2% for offspring rate at birth, P< 0.05). Likewise, embryonic losses were similar between both vitrification devices (44 +/- 7.2% and 50 +/- 6.8%), but significantly higher than in the fresh group (23 +/- 6.6%, P < 0.05). However, fetal losses were similar between groups (10 +/- 4.4%, 15 +/- 4.8% and 8 +/- 4.2%, for vitrified, Cryotop or CPIL and fresh, respectively). These results indicate that the CPIL device is as effective as the Cryotop device for vitrification of rabbit embryos, but at a cost of (sic)0.05 per device.	[Marco-Jimenez, Francisco; Almela-Miralles, Victoria; Salvador Vicente, Jose] Univ Politecn Valencia, Inst Ciencia & Tecnol Anim, E-46022 Valencia, Spain; [Jimenez-Trigos, Estrella] CEU Cardenal Herrera Univ, Fac Vet Med, Dept Anim Prod Anim Hlth & Sci & Food Technol, Inst Biomed Sci, Valencia, Spain	Universitat Politecnica de Valencia; Universidad CEU Cardenal Herrera	Marco-Jimenez, F (corresponding author), Univ Politecn Valencia, Inst Ciencia & Tecnol Anim, E-46022 Valencia, Spain.	fmarco@dca.upv.es	Jiménez, Francisco Marco/I-7126-2012; Trigos, M Estrella Jiménez/M-2254-2017; Vicente, Jose/F-7738-2017	Jiménez, Francisco Marco/0000-0002-5226-4118; Jimenez Trigos/0000-0002-0320-4813; Vicente, Jose/0000-0003-0481-3802	Comision Interministerial de Ciencia y Tecnologia [AGL2014-53405-C2-1-P]; Generalitat Valenciana research program [Prometeo II 2014/036]	Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Generalitat Valenciana research program	This research was supported by the projects Spanish Research project AGL2014-53405-C2-1-P Comision Interministerial de Ciencia y Tecnologia (FMJ, JSV) and Generalitat Valenciana research program (Prometeo II 2014/036, JSV, FMJ).	Arav A., 1992, Embryonic development and manipulation in animal production: trends in research and applications., P255; Arav A, 2014, THERIOGENOLOGY, V81, P96, DOI 10.1016/j.theriogenology.2013.09.011; Arav A, 2002, MOL CELL ENDOCRINOL, V187, P77, DOI 10.1016/S0303-7207(01)00700-6; Arav A., 1997, Theriogenology, V47, P341, DOI 10.1016/S0093-691X(97)82468-5; Arav A., 1989, THESIS BOLOGNA U BOL; Arav A., 1987, IVF M BARCELONA, V373, P118; Attanasio L, 2010, REPROD DOMEST ANIM, V45, P997, DOI 10.1111/j.1439-0531.2009.01475.x; BESENFELDER U, 1993, J REPROD FERTIL, V99, P53, DOI 10.1530/jrf.0.0990053; Casillas F, 2015, CRYOBIOLOGY, V71, P299, DOI 10.1016/j.cryobiol.2015.08.003; Cobo A, 2008, REPROD BIOMED ONLINE, V17, P68, DOI 10.1016/S1472-6483(10)60295-7; Saenz-de-Juano MD, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100677; Esaki R, 2004, BIOL REPROD, V71, P432, DOI 10.1095/biolreprod.103.026542; Fischer B, 2012, REPRODUCTION, V144, P1, DOI 10.1530/REP-12-0091; Garcia ML, 2002, LIVEST PROD SCI, V74, P45, DOI 10.1016/S0301-6226(01)00280-9; Hochi S, 2004, THERIOGENOLOGY, V61, P267, DOI 10.1016/S0093-691X(03)00232-2; Isachenko V, 2001, CRYO-LETT, V22, P157; Kasai M., 1992, BIOL REPROD, V39, P284; Katayama KP, 2003, FERTIL STERIL, V80, P223, DOI 10.1016/S0015-0282(03)00551-X; Kato O, 2012, EUR J OBSTET GYN R B, V161, P46, DOI 10.1016/j.ejogrb.2011.12.005; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P300, DOI 10.1016/S1472-6483(10)60837-1; Kuwayama M., 2000, J ASSIST REPROD GEN, P477, DOI DOI 10.1023/A:1017399518757; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; Laowtammathron C, 2005, THERIOGENOLOGY, V64, P1185, DOI 10.1016/j.theriogenology.2005.02.001; Lavara R, 2011, THERIOGENOLOGY, V76, P652, DOI 10.1016/j.theriogenology.2011.03.018; Liang YY, 2012, ANIM SCI J, V83, P630, DOI 10.1111/j.1740-0929.2012.01013.x; Ling XF, 2009, REPROD BIOMED ONLINE, V19, P708, DOI 10.1016/j.rbmo.2009.09.006; Lopez-Bejar M, 2002, THERIOGENOLOGY, V58, P1541, DOI 10.1016/S0093-691X(02)01045-2; Marco-Jimenez F, 2013, THERIOGENOLOGY, V79, P1124, DOI 10.1016/j.theriogenology.2013.02.008; Marco-Jimenez F, 2014, CRYOLETTERS, V35, P320; Marco-Jimenez F, 2014, CRYOLETTERS, V35, P286; Mazur P, 2011, CRYOBIOLOGY, V62, P1, DOI 10.1016/j.cryobiol.2010.10.159; Mikolajewska N, 2012, REPROD DOMEST ANIM, V47, P295, DOI 10.1111/rda.12044; Moce ML, 2010, THERIOGENOLOGY, V73, P704, DOI 10.1016/j.theriogenology.2009.11.010; Morato R, 2008, CRYOBIOLOGY, V57, P137, DOI 10.1016/j.cryobiol.2008.07.003; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Roy TK, 2014, HUM REPROD, V29, P2431, DOI 10.1093/humrep/deu214; Roy TK, 2014, FERTIL STERIL, V101, P1294, DOI 10.1016/j.fertnstert.2014.01.046; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; Takahashi K, 2005, FERTIL STERIL, V84, P88, DOI 10.1016/j.fertnstert.2004.12.051; Ushijima H, 2004, J REPROD DEVELOP, V50, P481, DOI 10.1262/jrd.50.481; Vicente JS, 2013, REPROD DOMEST ANIM, V48, P402, DOI 10.1111/rda.12087; VICENTE JS, 1994, THERIOGENOLOGY, V42, P1205, DOI 10.1016/0093-691X(94)90869-9; Vicente JS, 1999, REPROD NUTR DEV, V42, P1205	43	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148661	10.1371/journal.pone.0148661	http://dx.doi.org/10.1371/journal.pone.0148661			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848960	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000149
J	Montminy, ML; Gauvin, V; Turcotte, S; Milot, A; Douville, Y; Bairati, I				Montminy, Myriam L.; Gauvin, Valerie; Turcotte, Stephane; Milot, Alain; Douville, Yvan; Bairati, Isabelle			Factors Influencing the Prescription of Cardiovascular Preventive Therapies in Patients with Peripheral Arterial Disease	PLOS ONE			English	Article							MISSED OPPORTUNITIES; HIGH-RISK; RAMIPRIL; CLAUDICATION; IMPROVEMENT; QUALITY; SOCIETY; IMPACT	Background Guidelines recommend that patients with peripheral arterial disease should be medically treated to reduce the occurrence of serious cardiovascular events. Despite these recommendations, studies conducted in the early 2000s reported that medical therapies for secondary cardiovascular prevention are not given systematically to patients with peripheral arterial disease (PAD). We identified factors associated with the prescription of preventive therapies in patients with symptomatic PAD. Methods and Findings Consecutive patients with symptomatic peripheral arterial disease (n = 362) treated between 2008 and 2010 in one tertiary care center (CHU de Quebec, Canada) were considered. Data were collected from the medical charts. The main outcome was the combined prescription of three therapies: 1) statins, 2) antiplatelets, 3) angiotensin-convertingenzyme inhibitors or angiotensin receptor blockers. The mean age was 70 years and 43% had a pre-existing coronary artery disease. Antiplatelet therapy was the most prescribed drug (83%). A total of 52% of the patients received the three combined therapies. Less than 10% of patients had a known contraindication to one class of medication. Having at least three cardiovascular risk factors (Odds Ratio (OR) = 4.51; 95% CI: 2.76-7.37) was the factor most strongly associated with the prescription of the combined therapies. Preexisting coronary artery disease (OR = 2.28; 95% CI: 1.43-3.65) and history of peripheral vascular surgery (OR = 2.30; 95% CI: 1.37-3.86) were two factors independently associated with the prescription of the combined therapies. However, peripheral arterial disease patients with chronic critical limb ischemia were less likely to receive the combined therapies (OR = 0.53; 95% CI: 0.32-0.87) than those with claudication. The retrospective nature of this study, not allowing for an exhaustive report of the contraindication to medication prescription, is the main limitation. Conclusion About half of the patients with peripheral arterial disease were not optimally managed. Patients with multiple cardiovascular risk factors were more likely to receive the combined therapies. We still need to better understand the barriers and facilitators to the application of the guidelines.	[Montminy, Myriam L.; Gauvin, Valerie; Douville, Yvan] Ctr Hosp Univ Quebec, Dept Vasc Surg, Quebec City, PQ, Canada; [Montminy, Myriam L.; Turcotte, Stephane] Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ, Canada; [Milot, Alain] Ctr Hosp Univ Quebec, Dept Vasc Med, Quebec City, PQ, Canada; [Bairati, Isabelle] Ctr Hosp Univ Quebec, Dept Publ Hlth, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University	Montminy, ML (corresponding author), Ctr Hosp Univ Quebec, Dept Vasc Surg, Quebec City, PQ, Canada.; Montminy, ML (corresponding author), Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ, Canada.	myriam.letourneau-montminy.1@ulaval.ca						Abramson BL, 2005, CAN J CARDIOL, V21, P997; Ardati AK, 2012, CIRC-CARDIOVASC INTE, V5, P850, DOI 10.1161/CIRCINTERVENTIONS.112.975862; Aronow WS, 2003, AM J CARDIOL, V92, P711, DOI 10.1016/S0002-9149(03)00833-6; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Cacoub Patrice P, 2009, Atherosclerosis, V204, pe86, DOI 10.1016/j.atherosclerosis.2008.10.023; Cassar K, 2003, EUR J VASC ENDOVASC, V26, P262, DOI 10.1053/ejvs.2002.1948; Charlson ME, 2002, NEW METHOD CLASSIFYI, P1; Collaboration AT, 1994, BMJ-BRIT MED J, V308, P159, DOI [10.1136/bmj.308.6922.159, DOI 10.1136/BMJ.308.6922.159]; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; CRIQUI MH, 1985, CIRCULATION, V71, P510, DOI 10.1161/01.CIR.71.3.510; Heart Protection Study Collaborative Group, 2007, J VASC SURG, V45, P644; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hosmer DW, 2004, APPL LOGISTIC REGRES, P392; Khan S, 2007, EUR J VASC ENDOVASC, V33, P442, DOI 10.1016/j.ejvs.2006.11.010; Kidney disease outcomes quality initiative (KDOQI), KIDNEY DIS OUTCOMES, V39, pS46, DOI [10.1053/ajkd.2002.30943, DOI 10.1053/AJKD.2002.30943]; Kundhal KK, 2007, CAN J CARDIOL, V23, P357, DOI 10.1016/S0828-282X(07)70768-7; Mukherjee D, 2002, CIRCULATION, V106, P1909, DOI 10.1161/01.CIR.0000035649.39669.CE; Ostergren J, 2004, EUR HEART J, V25, P17, DOI 10.1016/j.ehj.2003.10.033; Pampalon R, 2000, Chronic Dis Can, V21, P104; Rooke TW, 2011, CATHETER CARDIOVASC; Subherwal S, 2012, CIRCULATION, V126, P1345, DOI 10.1161/CIRCULATIONAHA.112.108787; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; Welten GMJM, 2008, J AM COLL CARDIOL, V51, P1588, DOI 10.1016/j.jacc.2007.11.077; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	25	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148069	10.1371/journal.pone.0148069	http://dx.doi.org/10.1371/journal.pone.0148069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849679	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000037
J	Nagpal, S; Haque, MM; Mande, SS				Nagpal, Sunil; Haque, Mohammed Monzoorul; Mande, Sharmila S.			Vikodak - A Modular Framework for Inferring Functional Potential of Microbial Communities from 16S Metagenomic Datasets	PLOS ONE			English	Article							LACTAMASE-PRODUCING BACTERIA; TAXONOMIC CLASSIFICATION; PERIODONTITIS; DATABASE; ALGORITHM; PROFILES; RESOURCE; SERVER	Background The overall metabolic/functional potential of any given environmental niche is a function of the sum total of genes/proteins/enzymes that are encoded and expressed by various interacting microbes residing in that niche. Consequently, prior (collated) information pertaining to genes, enzymes encoded by the resident microbes can aid in indirectly (re) constructing/inferring the metabolic/functional potential of a given microbial community (given its taxonomic abundance profile). In this study, we present Vikodak-a multi-modular package that is based on the above assumption and automates inferring and/or comparing the functional characteristics of an environment using taxonomic abundance generated from one or more environmental sample datasets. With the underlying assumptions of co-metabolism and independent contributions of different microbes in a community, a concerted effort has been made to accommodate microbial co-existence patterns in various modules incorporated in Vikodak. Results Validation experiments on over 1400 metagenomic samples have confirmed the utility of Vikodak in (a) deciphering enzyme abundance profiles of any KEGG metabolic pathway, (b) functional resolution of distinct metagenomic environments, (c) inferring patterns of functional interaction between resident microbes, and (d) automating statistical comparison of functional features of studied microbiomes. Novel features incorporated in Vikodak also facilitate automatic removal of false positives and spurious functional predictions. Conclusions With novel provisions for comprehensive functional analysis, inclusion of microbial co-existence pattern based algorithms, automated inter-environment comparisons; in-depth analysis of individual metabolic pathways and greater flexibilities at the user end, Vikodak is expected to be an important value addition to the family of existing tools for 16S based function prediction. Availability and Implementation A web implementation of Vikodak can be publicly accessed at: http://metagenomics.atc.tcs.com/vikodak. This web service is freely available for all categories of users (academic as well as commercial).	[Nagpal, Sunil; Haque, Mohammed Monzoorul; Mande, Sharmila S.] Tata Res Dev & Design Ctr, TCS Innovat Labs, Biosci R&D Div, 54-B Hadapsar Ind Estate, Pune 411013, Maharashtra, India		Mande, SS (corresponding author), Tata Res Dev & Design Ctr, TCS Innovat Labs, Biosci R&D Div, 54-B Hadapsar Ind Estate, Pune 411013, Maharashtra, India.	sharmila.mande@tcs.com	Nagpal, Sunil/K-8617-2019	Nagpal, Sunil/0000-0001-9221-1443	Tata Consultancy Services Limited - a commercial company	Tata Consultancy Services Limited - a commercial company	The authors [SN, MMH, and SSM] of this study declare that they are employees of Tata Consultancy Services Limited - a commercial company. The company has provided support for this study in the form of salaries to authors [SN, MMH, and SSM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko AV, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-31; Arndt D, 2012, NUCLEIC ACIDS RES, V40, pW88, DOI 10.1093/nar/gks497; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Asshauer KP, 2015, BIOINFORMATICS, V31, P2882, DOI 10.1093/bioinformatics/btv287; Chew J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-189; Cui ZL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-276; Dhotre P.S., 2012, EUR J GEN MED, V9, P81, DOI [10.29333/ejgm/82469, DOI 10.29333/EJGM/82469]; Eid H., 2014, SAUDI J HLTH SCI, V3, P80, DOI [DOI 10.4103/2278-0521.134855, 10.4103/2278-0521.134855]; Botero LE, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-29; Ghosh TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095547; Ghosh TS, 2012, GENOMICS, V99, P195, DOI 10.1016/j.ygeno.2012.01.008; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Handal T, 2000, EUR J ORAL SCI, V108, P163, DOI 10.1034/j.1600-0722.2000.108003163.x; Herrera D, 2000, J CLIN PERIODONTOL, V27, P520, DOI 10.1034/j.1600-051x.2000.027007520.x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kato T, 2014, DNA RES, V21, P469, DOI 10.1093/dnares/dsu013; Kesic L, 2008, MED BIOL, V15, P1; LAI CH, 1983, INT J SYST BACTERIOL, V33, P628, DOI 10.1099/00207713-33-3-628; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lu R, 2014, J PERIODONTAL RES, V49, P574, DOI 10.1111/jre.12137; Maidak BL, 1996, NUCLEIC ACIDS RES, V24, P82, DOI 10.1093/nar/24.1.82; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mohammed MH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S4; Mohammed MH, 2011, BIOINFORMATICS, V27, P22, DOI 10.1093/bioinformatics/btq608; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Ochiai K, 2011, J ORAL BIOSCI, V53, P213, DOI 10.2330/joralbiosci.53.213; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rams TE, 2013, J PERIODONTAL RES, V48, P493, DOI 10.1111/jre.12031; Rams TE, 2015, ODONTOLOGY, V103, P286, DOI 10.1007/s10266-014-0166-1; Reddy RM, 2012, GENE, V505, P259, DOI 10.1016/j.gene.2012.06.014; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; VITTEK J, 1984, J PERIODONTAL RES, V19, P545, DOI 10.1111/j.1600-0765.1984.tb01311.x; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Xiao SM, 2014, FEMS MICROBIOL ECOL, V87, P357, DOI 10.1111/1574-6941.12228; Zakrzewski M, 2013, J BIOTECHNOL, V167, P156, DOI 10.1016/j.jbiotec.2012.09.013	39	37	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148347	10.1371/journal.pone.0148347	http://dx.doi.org/10.1371/journal.pone.0148347			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848568	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000074
J	Kanzaki, M; Asano, Y; Ishibashi-Ueda, H; Oiki, E; Nishida, T; Asanuma, H; Kato, H; Oka, T; Ohtani, T; Tsukamoto, O; Higo, S; Kioka, H; Matsuoka, K; Sawa, Y; Komuro, I; Kitakaze, M; Takashima, S; Sakata, Y				Kanzaki, Machiko; Asano, Yoshihiro; Ishibashi-Ueda, Hatsue; Oiki, Eiji; Nishida, Tomoki; Asanuma, Hiroshi; Kato, Hisakazu; Oka, Toru; Ohtani, Tomohito; Tsukamoto, Osamu; Higo, Shuichiro; Kioka, Hidetaka; Matsuoka, Ken; Sawa, Yoshiki; Komuro, Issei; Kitakaze, Masafumi; Takashima, Seiji; Sakata, Yasushi			A Development of Nucleic Chromatin Measurements as a New Prognostic Marker for Severe Chronic Heart Failure	PLOS ONE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; VENTRICULAR ASSIST DEVICES; COLLEGE-OF-CARDIOLOGY; MANAGEMENT; ASSOCIATION; RECOVERY; THERAPY	Background Accurate prediction of both mortality and morbidity is of significant importance, but it is challenging in patients with severe heart failure. It is especially difficult to detect the optimal time for implanting mechanical circulatory support devices in such patients. We aimed to analyze the morphometric ultrastructure of nuclear chromatin in cardiomyocytes by developing an original clinical histopathological method. Using this method, we developed a biomarker to predict poor outcome in patients with dilated cardiomyopathy (DCM). Methods and Results As a part of their diagnostic evaluation, 171 patients underwent endomyocardial biopsy (EMB). Of these, 63 patients diagnosed with DCM were included in this study. We used electron microscopic imaging of cardiomyocyte nuclei and an automated image analysis software program to assess whether it was possible to detect discontinuity of the nuclear periphery. Twelve months after EMB, all patients with a discontinuous nuclear periphery (Group A, n = 11) died from heart failure or underwent left ventricular assist device (VAD) implantation. In contrast, in patients with a continuous nuclear periphery (Group N, n = 52) only 7 patients (13%) underwent VAD implantation and there were no deaths (p<0.01). We then evaluated chromatin particle density (Nuc-CS) and chromatin thickness in the nuclear periphery (Per-CS) in Group N patients; these new parameters were able to identify patients with poor prognosis. Conclusions We developed novel morphometric methods based on cardiomyocyte nuclear chromatin that may provide pivotal information for early prediction of poor prognosis in patients with DCM.	[Kanzaki, Machiko; Asano, Yoshihiro; Oka, Toru; Ohtani, Tomohito; Higo, Shuichiro; Kioka, Hidetaka; Matsuoka, Ken; Komuro, Issei; Takashima, Seiji; Sakata, Yasushi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan; [Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Suita, Osaka, Japan; [Oiki, Eiji] Osaka Univ, Grad Sch Med, Ctr Med Res & Educ, Suita, Osaka, Japan; [Nishida, Tomoki] Osaka Univ, Res Ctr Ultra High Voltage Electron Microscopy, Osaka, Japan; [Asanuma, Hiroshi] Kyoto Prefectural Univ, Sch Med, Dept Cardiovasc Sci & Technol, Kyoto 606, Japan; [Kato, Hisakazu; Tsukamoto, Osamu; Takashima, Seiji] Osaka Univ, Grad Sch Med, Dept Med Biochem, Suita, Osaka, Japan; [Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan; [Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Kitakaze, Masafumi] Natl Cerebral & Cardiovasc Ctr, Dept Clin Med & Dev, Suita, Osaka, Japan	Osaka University; National Cerebral & Cardiovascular Center - Japan; Osaka University; Osaka University; Kyoto Prefectural University; Osaka University; Osaka University; University of Tokyo; National Cerebral & Cardiovascular Center - Japan	Asano, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan.	asano@cardiology.med.osaka-u.ac.jp		Kato, Hisakazu/0000-0003-4619-3680; Tsukamoto, Osamu/0000-0002-9504-8001; Ohtani, Tomohito/0000-0002-2963-7895; Sakata, Yasushi/0000-0002-5618-4721	Japanese Circulation Society Grant for Translational Research; Ministry of Health, Labor, and Welfare-Japan; Japan agency for medical research and development [15Aek0109069h0002]; Japan Society for the Promotion of Science [24591097, 15K09139]; Ministry of Education, Culture, Sports, Science, and Technology-Japan [26670402]; Japan Heart Foundation; Japan Intractable Diseases Research Foundation; Inoue Foundation for Science; Japan vascular disease research foundation; Takeda Science Foundation; Japan Foundation of Applied Enzymology; Mochida Memorial Foundation; Banyu Foundation; Osaka Medical Research foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [12024046]	Japanese Circulation Society Grant for Translational Research; Ministry of Health, Labor, and Welfare-Japan(Ministry of Health, Labour and Welfare, Japan); Japan agency for medical research and development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Heart Foundation; Japan Intractable Diseases Research Foundation; Inoue Foundation for Science(Inoue Foundation for Science); Japan vascular disease research foundation(Japan Vascular Disease Research Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Foundation of Applied Enzymology(Japan Foundation of Applied Enzymology); Mochida Memorial Foundation; Banyu Foundation; Osaka Medical Research foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Japanese Circulation Society Grant for Translational Research 2014 to Y. Sakata (http://www.j-circ.or.jp/translational_research/index.htm); the Ministry of Health, Labor, and Welfare-Japan to IK (http://www.mhlw.go.jp/english/); the Japan agency for medical research and development, Grant number 15Aek0109069h0002 to ST (http://www.amed.go.jp/); the Japan Society for the Promotion of Science, Grant numbers 24591097 and 15K09139 to YA (http://www.jsps.go.jp/english/); the Ministry of Education, Culture, Sports, Science, and Technology-Japan, Project numbers 26670402 to ST (http://www.mext.go.jp/english/); Japan Heart Foundation to YA (http://www.jhf.or.jp/english/); Japan Intractable Diseases Research Foundation to YA (http://www.nanbyou.or.jp/english/index.htm); Inoue Foundation for Science to YA (http://www.inoue-zaidan.or.jp/); Japan vascular disease research foundation to YA (http://www.disclo-koeki.org/02b/00412/); Takeda Science Foundation to YA (http://www.takeda-sci.or.jp/); Japan Foundation of Applied Enzymology to YA (https://www.jfae.or.jp/); Mochida Memorial Foundation to YA (http://www.mochida.co.jp/zaidan/); Banyu Foundation to YA (http://www.banyu-zaidan.or.jp/); Osaka Medical Research foundation for intractable diseases to YA (http://www.nanbyo.or.jp/zaidan/info2013.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the staffs of "Nanotechnology Platform (project No. 12024046) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan" for the technical help in the ultra-HVEM study.	Alba AC, 2009, J HEART LUNG TRANSPL, V28, P827, DOI 10.1016/j.healun.2009.04.033; Allen LA, 2012, CIRCULATION, V125, P1928, DOI 10.1161/CIR.0b013e31824f2173; Asano Y, 2004, NAT GENET, V36, P123, DOI 10.1038/ng1294; Asimaki A, 2009, NEW ENGL J MED, V360, P1075, DOI 10.1056/NEJMoa0808138; Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; BARRETTO ACP, 1989, CIRCULATION, V80, P177; Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063; Cooper LT, 2007, CIRCULATION, V116, P2216, DOI 10.1161/CIRCULATIONAHA.107.186093; CROSS AM, 1995, AM HEART J, V129, P24, DOI 10.1016/0002-8703(95)90038-1; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; GAUBATZ JW, 1990, J BIOL CHEM, V265, P17753; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Krishnamani R, 2010, NAT REV CARDIOL, V7, P71, DOI 10.1038/nrcardio.2009.222; Kubanek M, 2013, J AM COLL CARDIOL, V61, P54, DOI 10.1016/j.jacc.2012.07.072; Miller LW, 2013, J AM COLL CARDIOL, V61, P1209, DOI 10.1016/j.jacc.2012.08.1029; Moravsky G, 2013, J AM SOC ECHOCARDIOG, V26, P893, DOI 10.1016/j.echo.2013.05.012; Nohria A, 2002, JAMA-J AM MED ASSOC, V287, P628, DOI 10.1001/jama.287.5.628; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; PELLICCIA F, 1994, AM HEART J, V128, P316, DOI 10.1016/0002-8703(94)90485-5; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; SCHWARZ F, 1983, AM J CARDIOL, V51, P501, DOI 10.1016/S0002-9149(83)80088-5; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Shimura Shinichiro, 2009, Tokai J Exp Clin Med, V34, P1; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Takaoka A, 2008, ULTRAMICROSCOPY, V108, P230, DOI 10.1016/j.ultramic.2007.06.008; Towbin JA, 2002, NATURE, V415, P227, DOI 10.1038/415227a; YAMADA T, 1993, J AM COLL CARDIOL, V21, P628, DOI 10.1016/0735-1097(93)90094-H; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yokota Takashi, 2011, Nihon Rinsho, V69, P1691; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	33	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148209	10.1371/journal.pone.0148209	http://dx.doi.org/10.1371/journal.pone.0148209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845691	Green Published, Green Submitted, gold			2022-12-27	WOS:000369552800037
J	Komoto, S; Tacharoenmuang, R; Guntapong, R; Ide, T; Tsuji, T; Yoshikawa, T; Tharmaphornpilas, P; Sangkitporn, S; Taniguchi, K				Komoto, Satoshi; Tacharoenmuang, Ratana; Guntapong, Ratigorn; Ide, Tomihiko; Tsuji, Takao; Yoshikawa, Tetsushi; Tharmaphornpilas, Piyanit; Sangkitporn, Somchai; Taniguchi, Koki			Reassortment of Human and Animal Rotavirus Gene Segments in Emerging DS-1-Like G1P[8] Rotavirus Strains	PLOS ONE			English	Article							WHOLE-GENOMIC ANALYSIS; SEQUENCE ANALYSES; BOVINE; PORCINE; IDENTIFICATION; CLASSIFICATION; GENOTYPE; REVEALS; NSP4	The emergence and rapid spread of novel DS-1-like G1P[8] human rotaviruses in Japan were recently reported. More recently, such intergenogroup reassortant strains were identified in Thailand, implying the ongoing spread of unusual rotavirus strains in Asia. During rotavirus surveillance in Thailand, three DS-1-like intergenogroup reassortant strains having G3P[8] (RVA/Human-wt/THA/SKT-281/2013/G3P[8] and RVA/Human-wt/THA/SKT289/2013/G3P[8]) and G2P[8] (RVA/Human-wt/THA/LS-04/2013/G2P[8]) genotypes were identified in fecal samples from hospitalized children with acute gastroenteritis. In this study, we sequenced and characterized the complete genomes of strains SKT-281, SKT-289, and LS-04. On whole genomic analysis, all three strains exhibited unique genotype constellations including both genogroup 1 and 2 genes: G3-P[8]-I2-R2-C2-M2-A2-N2-T2-E2-H2 for strains SKT-281 and SKT-289, and G2-P[8]-I2-R2-C2-M2-A2-N2-T2-E2-H2 for strain LS-04. Except for the G genotype, the unique genotype constellation of the three strains (P[8]-I2-R2-C2-M2-A2-N2-T2-E2-H2) is commonly shared with DS-1-like G1P[8] strains. On phylogenetic analysis, nine of the 11 genes of strains SKT-281 and SKT-289 (VP4, VP6, VP1-3, NSP1-3, and NSP5) appeared to have originated from DS-1-like G1P[8] strains, while the remaining VP7 and NSP4 genes appeared to be of equine and bovine origin, respectively. Thus, strains SKT-281 and SKT-289 appeared to be reassortant strains as to DS-1-like G1P[8], animal-derived human, and/or animal rotaviruses. On the other hand, seven of the 11 genes of strain LS-04 (VP7, VP6, VP1, VP3, and NSP3-5) appeared to have originated from locally circulating DS-1-like G2P[4] human rotaviruses, while three genes (VP4, VP2, and NSP1) were assumed to be derived from DS-1-like G1P[8] strains. Notably, the remaining NSP2 gene of strain LS-04 appeared to be of bovine origin. Thus, strain LS-04 was assumed to be a multiple reassortment strain as to DS-1-like G1P[8], locally circulating DS-1-like G2P[4], bovine-like human, and/or bovine rotaviruses. Overall, the great genomic diversity among the DS-1-like G1P[8] strains seemed to have been generated through reassortment involving human and animal strains. To our knowledge, this is the first report on whole genome-based characterization of DS-1-like intergenogroup reassortant strains having G3P[8] and G2P[8] genotypes that have emerged in Thailand. Our observations will provide important insights into the evolutionary dynamics of emerging DS-1-like G1P[8] strains and related reassortant ones.	[Komoto, Satoshi; Ide, Tomihiko; Taniguchi, Koki] Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi 47011, Japan; [Tacharoenmuang, Ratana; Guntapong, Ratigorn; Sangkitporn, Somchai] Natl Inst Hlth, Dept Med Sci, Nonthaburi, Thailand; [Tsuji, Takao] Fujita Hlth Univ, Sch Med, Dept Microbiol, Toyoake, Aichi 47011, Japan; [Yoshikawa, Tetsushi] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi 47011, Japan; [Tharmaphornpilas, Piyanit] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand	Fujita Health University; Ministry of Public Health - Thailand; Fujita Health University; Fujita Health University; Ministry of Public Health - Thailand	Komoto, S (corresponding author), Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi 47011, Japan.	satoshik@fujita-hu.ac.jp			MEXT; Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development, AMED; Original Rotavirus Vaccine Effectiveness Study Program of the Ministry of Public Health of Thailand; Grants-in-Aid for Scientific Research [15K08478] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Original Rotavirus Vaccine Effectiveness Study Program of the Ministry of Public Health of Thailand; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2010-2014 (KT), the Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development, AMED (KT), and the Original Rotavirus Vaccine Effectiveness Study Program of the Ministry of Public Health of Thailand (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooney MA, 2001, J MED MICROBIOL, V50, P462, DOI 10.1099/0022-1317-50-5-462; Donato CM, 2014, INFECT GENET EVOL, V25, P97, DOI 10.1016/j.meegid.2014.04.009; Doro R, 2014, INFECT GENET EVOL, V28, P495, DOI 10.1016/j.meegid.2014.09.016; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fujii Y, 2014, INFECT GENET EVOL, V28, P426, DOI 10.1016/j.meegid.2014.08.001; Ghosh S, 2011, FUTURE MICROBIOL, V6, P1049, DOI [10.2217/FMB.11.90, 10.2217/fmb.11.90]; Gulati BR, 2007, J CLIN MICROBIOL, V45, P972, DOI 10.1128/JCM.01696-06; Heiman EM, 2008, J VIROL, V82, P11106, DOI 10.1128/JVI.01402-08; Ide T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124965; Jere KC, 2012, VET MICROBIOL, V159, P245, DOI 10.1016/j.vetmic.2012.03.040; Kahn G, 2012, INDIAN PEDIATR, V49, P467, DOI 10.1007/s13312-012-0076-7; Komoto S, 2006, P NATL ACAD SCI USA, V103, P4646, DOI 10.1073/pnas.0509385103; Komoto S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141739; Komoto S, 2014, VET MICROBIOL, V174, P577, DOI 10.1016/j.vetmic.2014.09.033; Komoto S, 2014, INFECT GENET EVOL, V27, P277, DOI 10.1016/j.meegid.2014.08.002; Kuzuya M, 2014, J MED VIROL, V86, P1056, DOI 10.1002/jmv.23746; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Malasao R, 2015, VIRUS GENES, V50, P129, DOI 10.1007/s11262-014-1135-z; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; McDonald SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000634; Nyaga MM, 2015, INFECT GENET EVOL, V31, P321, DOI 10.1016/j.meegid.2015.02.011; O'Shea H, 2014, VET MICROBIOL, V170, P151, DOI 10.1016/j.vetmic.2014.01.012; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Schoondermark-van de Ven E, 2013, VET MICROBIOL, V166, P154, DOI 10.1016/j.vetmic.2013.05.028; Steyer A, 2013, INFECT GENET EVOL, V13, P89, DOI 10.1016/j.meegid.2012.09.004; Tacharoenmuang R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139381; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Yamamoto SP, 2014, EMERG INFECT DIS, V20, P1030, DOI 10.3201/eid2006.131326	35	62	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148416	10.1371/journal.pone.0148416	http://dx.doi.org/10.1371/journal.pone.0148416			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845439	gold, Green Submitted, Green Published			2022-12-27	WOS:000369552800055
J	Zelle, DM; Corpeleijn, E; Klaassen, G; Schutte, E; Navis, G; Bakker, SJL				Zelle, Dorien M.; Corpeleijn, Eva; Klaassen, Gerald; Schutte, Elise; Navis, Gerjan; Bakker, Stephan J. L.			Fear of Movement and Low Self-Efficacy Are Important Barriers in Physical Activity after Renal Transplantation	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; LEISURE-TIME; KIDNEY-TRANSPLANTATION; ACTIVITY QUESTIONNAIRE; HEMODIALYSIS-PATIENTS; PSYCHOMETRIC PROPERTIES; PRIMARY PREVENTION; DIABETES-MELLITUS; AVOIDANCE MODEL; CHRONIC PAIN	Background Physical activity (PA) and exercise are commonly used as preventive measures for cardiovascular disease in the general population, and could be effective in the management of post-transplantation cardiovascular risk. PA levels are low after renal transplantation and very few renal transplant recipients (RTR) meet the PA guidelines. Identification of barriers to regular PA is important to identify targets for intervention to improve PA levels after renal transplantation. We investigated fear of movement and physical self-efficacy as barriers to PA in RTR. Methods RTR were investigated between 2001-2003. The Tampa Score of Kinesiophobia-Dutch Version (TSK-11) was used to assess fear of movement. Physical self-efficacy was measured with the LIVAS-scale. PA was assessed using validated questionnaires (Tecumseh Occupational Activity Questionnaire and the Minnesota Leisure Time Physical Activity Questionnaire). Results A total of 487 RTR (age 51+/-12 years, 55% men) were studied. Median score [interquartile range] on TSK-11 was 22 [17-26]. Low physical self-efficacy (Exp B:0.41[0.31-0.54], p<0.001) and history of myocardial infarction, transient ischemic attack and cerebrovascular accident (Exp B: 1.30[1.03-1.63], p = 0.03) were independent determinants for fear of movement. Fear of movement was associated with lower daily PA, occupational, sports and leisure time PA. Mediation-analysis showed that a large part (73%) of the effect of fear of movement on PA was explained by low physical self-efficacy. Conclusions This study was the first to examine fear of movement and self-efficacy in relation to PA in RTR. Fear of movement was associated with a low PA level, and the larger part of this relation was mediated by low physical self-efficacy. Both fear of movement and physical self-efficacy level are important targets for intervention during rehabilitation after renal transplantation.	[Zelle, Dorien M.; Klaassen, Gerald; Schutte, Elise; Navis, Gerjan; Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Corpeleijn, Eva] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; University of Groningen	Zelle, DM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands.	d.m.zelle@umcg.nl		Corpeleijn, Eva/0000-0002-2974-3305				Aakhus S, 2004, CLIN TRANSPLANT, V18, P596, DOI 10.1111/j.1399-0012.2004.00235.x; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; AINSWORTH BE, 1993, J OCCUP ENVIRON MED, V35, P1017; Ainsworth BE, 1999, J CLIN EPIDEMIOL, V52, P219, DOI 10.1016/S0895-4356(98)00158-9; [Anonymous], 2009, AM J TRANSPLANT, V9, pS1, DOI [10.1111/j.1600-6143.2009.02834.x, DOI 10.1111/J.1600-6143.2009.02834.X]; Arrindell WA, 2003, SCL 90 SYMPTOM CHECK; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Beddhu S, 2003, J AM SOC NEPHROL, V14, P2366, DOI 10.1097/01.ASN.0000083905.72794.E6; Blanchard C, 2015, REHABIL PSYCHOL, V60, P59, DOI 10.1037/rep0000024; Buse JB, 2007, CIRCULATION, V115, P114, DOI 10.1161/CIRCULATIONAHA.106.179294; Conway JM, 2002, J CLIN EPIDEMIOL, V55, P392, DOI 10.1016/S0895-4356(01)00497-8; Cook AJ, 2006, PAIN, V121, P195, DOI 10.1016/j.pain.2005.11.018; de Vries APJ, 2004, AM J TRANSPLANT, V4, P1675, DOI 10.1111/j.1600-6143.2004.00558.x; Dontje ML, 2014, CLIN TRANSPLANT, V28, P394, DOI 10.1111/ctr.12325; FOLSOM AR, 1986, J CHRON DIS, V39, P505, DOI 10.1016/0021-9681(86)90195-5; Goedendorp MM, 2013, TRANSPL INT, V26, P1007, DOI 10.1111/tri.12166; Gordon EJ, 2009, CHRONIC ILLN, V5, P75, DOI 10.1177/1742395309103558; Hart DL, 2009, PHYS THER, V89, P770, DOI 10.2522/ptj.20080227; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; JENNINGS G, 1986, CIRCULATION, V73, P30, DOI 10.1161/01.CIR.73.1.30; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Koho P, 2011, J REHABIL MED, V43, P794, DOI 10.2340/16501977-0850; Kumar R, 2012, TRANSPL P, V44, P1270, DOI 10.1016/j.transproceed.2012.01.111; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee LL, 2008, INT J NURS STUD, V45, P1690, DOI 10.1016/j.ijnurstu.2008.02.012; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Leventhal H., 2003, SELF REGULATION HLTH, P42, DOI DOI 10.4324/9780203553220; Luk WSC, 2004, J CLIN NURS, V13, P201; MERCIER JG, 1995, AM J RESP CRIT CARE, V151, P1532, DOI 10.1164/ajrccm.151.5.7735611; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Montoye HJ, 1996, MEASURING PHYS ACTIV; Nijs J, 2004, ARCH PHYS MED REHAB, V85, P1586, DOI 10.1016/j.apmr.2003.12.033; Olander EK, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-29; Oterdoom LH, 2009, ATHEROSCLEROSIS, V207, P534, DOI 10.1016/j.atherosclerosis.2009.05.010; Oterdoom LH, 2009, TRANSPLANTATION, V87, P1562, DOI 10.1097/TP.0b013e3181a4bb80; Painter P, 1999, ADV RENAL REPLACE TH, V6, P159, DOI 10.1016/S1073-4449(99)70034-8; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Proctor DN, 1999, AM J PHYSIOL-ENDOC M, V277, pE489, DOI 10.1152/ajpendo.1999.277.3.E489; RICHARDSON MT, 1994, J CLIN EPIDEMIOL, V47, P271, DOI 10.1016/0895-4356(94)90008-6; RYCKMAN RM, 1982, J PERS SOC PSYCHOL, V42, P891, DOI 10.1037/0022-3514.42.5.891; Sato Y, 2003, EXP BIOL MED, V228, P1208, DOI 10.1177/153537020322801017; Schakman O, 2013, INT J BIOCHEM CELL B, V45, P2163, DOI 10.1016/j.biocel.2013.05.036; Sofi F, 2008, EUR J CARDIOV PREV R, V15, P247, DOI 10.1097/HJR.0b013e3282f232ac; Stevens M, 2005, PATIENT EDUC COUNS, V58, P121, DOI 10.1016/j.pec.2004.07.005; Tkachuk GA, 2012, J PAIN, V13, P970, DOI 10.1016/j.jpain.2012.07.001; van den Ham ECH, 2005, AM J TRANSPLANT, V5, P1957, DOI 10.1111/j.1600-6143.2005.00944.x; van den Ham ECH, 2007, TRANSPLANTATION, V83, P1059, DOI 10.1097/01.tp.0000259552.55689.fd; Van der Mei SF, 2007, DISABIL REHABIL, V29, P473, DOI 10.1080/09638280600841257; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Williams SL, 2011, HEALTH EDUC RES, V26, P308, DOI 10.1093/her/cyr005; Woby SR, 2005, PAIN, V117, P137, DOI 10.1016/j.pain.2005.05.029; Young MD, 2014, OBES REV, V15, P983, DOI 10.1111/obr.12225; Zelle DM, 2013, CLIN TRANSPLANT, V27, pE484, DOI 10.1111/ctr.12149; Zelle DM, 2012, TRANSPLANTATION, V94, P1033, DOI 10.1097/TP.0b013e31826bc3c8; Zelle DM, 2011, CLIN J AM SOC NEPHRO, V6, P898, DOI 10.2215/CJN.03340410	59	48	57	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147609	10.1371/journal.pone.0147609	http://dx.doi.org/10.1371/journal.pone.0147609			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PF	26844883	gold, Green Published, Green Submitted			2022-12-27	WOS:000369552800011
J	Hevia, A; Milani, C; Lopez, P; Donado, CD; Cuervo, A; Gonzalez, S; Suarez, A; Turroni, F; Gueimonde, M; Ventura, M; Sanchez, B; Margolles, A				Hevia, Arancha; Milani, Christian; Lopez, Patricia; Donado, Carmen D.; Cuervo, Adriana; Gonzalez, Sonia; Suarez, Ana; Turroni, Francesca; Gueimonde, Miguel; Ventura, Marco; Sanchez, Borja; Margolles, Abelardo			Allergic Patients with Long-Term Asthma Display Low Levels of Bifidobacterium adolescentis	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; FECAL MICROBIOTA; GUT MICROBIOTA; IMMUNE-RESPONSES; DISEASE; DIVERSITY; INFANTS; HEALTHY; RISK; MILK	Accumulated evidence suggests a relationship between specific allergic processes, such as atopic eczema in children, and an aberrant fecal microbiota. However, little is known about the complete microbiota profile of adult individuals suffering from asthma. We determined the fecal microbiota in 21 adult patients suffering allergic asthma (age 39.43 +/- 10.98 years old) and compare it with the fecal microbiota of 22 healthy controls (age 39.29 +/- 9.21 years old) using culture independent techniques. An Ion-Torrent 16S rRNA gene-based amplification and sequencing protocol was used to determine the fecal microbiota profile of the individuals. Sequence microbiota analysis showed that the microbial alpha-diversity was not significantly different between healthy and allergic individuals and no clear clustering of the samples was obtained using an unsupervised principal component analysis. However, the analysis of specific bacterial groups allowed us to detect significantly lower levels of bifidobacteria in patients with long-term asthma. Also, in allergic individuals the Bifidobacterium adolescentis species prevailed within the bifidobacterial population. The reduction in the levels on bifidobacteria in patients with long-term asthma suggests a new target in allergy research and opens possibilities for the therapeutic modulation of the gut microbiota in this group of patients.	[Hevia, Arancha; Gueimonde, Miguel; Sanchez, Borja; Margolles, Abelardo] CSIC, IPLA, Villaviciosa, Asturias, Spain; [Milani, Christian; Turroni, Francesca; Ventura, Marco] Univ Parma, Dept Life Sci, Lab Probiogen, I-43100 Parma, Italy; [Lopez, Patricia; Suarez, Ana] Univ Oviedo, Dept Funct Biol, Immunol Area, Oviedo, Asturias, Spain; [Donado, Carmen D.] Hosp Univ Cent Asturias, Allergy Unit, Oviedo, Asturias, Spain; [Cuervo, Adriana; Gonzalez, Sonia] Univ Oviedo, Dept Funct Biol, Physiol Area, Oviedo, Asturias, Spain; [Sanchez, Borja] Univ Vigo, Fac Food Sci & Technol, Dept Analyt Chem & Food Sci, Orense, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA); University of Parma; University of Oviedo; Central University Hospital Asturias; University of Oviedo; Universidade de Vigo	Sanchez, B; Margolles, A (corresponding author), CSIC, IPLA, Villaviciosa, Asturias, Spain.; Sanchez, B (corresponding author), Univ Vigo, Fac Food Sci & Technol, Dept Analyt Chem & Food Sci, Orense, Spain.	borja.sanchez@uvigo.es; amargolles@ipla.csic.es	Turroni, Francesca/K-9660-2016; Milani, Christian/ABA-8160-2020; Margolles, Abelardo/H-3871-2012; López, Patricia/B-8603-2018; González-Solares, Sonia/P-6720-2015; ventura, marco/M-8230-2015; Gueimonde, Miguel/A-2106-2008; Donado, Carmen Diaz/AAL-5678-2021; Suarez, Ana/F-4492-2015; Hevia-Gonzalez, Arancha/Q-9758-2017	Turroni, Francesca/0000-0001-5363-0231; Margolles, Abelardo/0000-0003-2278-1816; López, Patricia/0000-0002-1843-0653; González-Solares, Sonia/0000-0003-2602-7036; Gueimonde, Miguel/0000-0002-0192-901X; Donado, Carmen Diaz/0000-0001-8919-972X; Suarez, Ana/0000-0002-4452-7539; Hevia-Gonzalez, Arancha/0000-0001-8446-7203	 [AGL2010-14952]		This work was supported by AGL2010-14952, http://www.idi.mineco.gob.es/.	[Anonymous], 1997, J ALLERGY CLIN IMMUN, V99, P583; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V128, P646, DOI 10.1016/j.jaci.2011.04.060; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Executive Committee GEMA 2009, 2010, J Investig Allergol Clin Immunol, V20 Suppl 1, P1; Fiocchi A, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0055-2; Fujimoto T, 2013, J GASTROEN HEPATOL, V28, P613, DOI 10.1111/jgh.12073; GINA Global Initiative for Asthma, 2014, NHBLI WHO WORKSH; Gronlund MM, 2007, CLIN EXP ALLERGY, V37, P1764, DOI 10.1111/j.1365-2222.2007.02849.x; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; He F, 2001, FEMS IMMUNOL MED MIC, V30, P43, DOI 10.1111/j.1574-695X.2001.tb01548.x; Hevia A, 2014, MBIO, V5, DOI 10.1128/mBio.01548-14; Lau S, 2006, LANCET, V367, P1556, DOI 10.1016/S0140-6736(06)68670-4; Ling ZX, 2014, APPL ENVIRON MICROB, V80, P2546, DOI 10.1128/AEM.00003-14; Maizels RM, 2014, CLIN EXP IMMUNOL, V177, P38, DOI 10.1111/cei.12353; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Matsumoto M, 2007, MICROBIOL IMMUNOL, V51, P37, DOI 10.1111/j.1348-0421.2007.tb03888.x; McLoughlin RM, 2011, J ALLERGY CLIN IMMUN, V127, P1097, DOI 10.1016/j.jaci.2011.02.012; Milani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068739; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Nylund L, 2015, ALLERGY, V70, P241, DOI 10.1111/all.12549; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Singh M, 2010, PEDIAT ALLERG IMM-UK, V21, pE368, DOI 10.1111/j.1399-3038.2009.00921.x; Stsepetove J, 2007, FEMS IMMUNOL MED MIC, V51, P260, DOI 10.1111/j.1574-695X.2007.00306.x; Thompson-Chagoyan OC, 2010, PEDIAT ALLERG IMM-UK, V21, pE394, DOI 10.1111/j.1399-3038.2009.00961.x; West CE, 2015, CLIN EXP ALLERGY, V45, P43, DOI 10.1111/cea.12332; Wopereis H, 2014, PEDIAT ALLERG IMM-UK, V25, P428, DOI 10.1111/pai.12232	28	62	67	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147809	10.1371/journal.pone.0147809	http://dx.doi.org/10.1371/journal.pone.0147809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840903	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200062
J	Schaefer, A; Schneeberger, Y; Stenzig, J; Biermann, D; Jelinek, M; Reichenspurner, H; Eschenhagen, T; Ehmke, H; Schwoerer, AP				Schaefer, Andreas; Schneeberger, Yvonne; Stenzig, Justus; Biermann, Daniel; Jelinek, Marisa; Reichenspurner, Hermann; Eschenhagen, Thomas; Ehmke, Heimo; Schwoerer, Alexander P.			A New Animal Model for Investigation of Mechanical Unloading in Hypertrophic and Failing Hearts: Combination of Transverse Aortic Constriction and Heterotopic Heart Transplantation	PLOS ONE			English	Article							RATS; FAILURE; DIAGNOSIS	Objectives Previous small animal models for simulation of mechanical unloading are solely performed in healthy or infarcted hearts, not representing the pathophysiology of hypertrophic and dilated hearts emerging in heart failure patients. In this article, we present a new and economic small animal model to investigate mechanical unloading in hypertrophic and failing hearts: the combination of transverse aortic constriction (TAC) and heterotopic heart transplantation (hHTx) in rats. Methods To induce cardiac hypertrophy and failure in rat hearts, three-week old rats underwent TAC procedure. Three and six weeks after TAC, hHTx with hypertrophic and failing hearts in Lewis rats was performed to induce mechanical unloading. After 14 days of mechanical unloading animals were euthanatized and grafts were explanted for further investigations. Results 50 TAC procedures were performed with a survival of 92% (46/50). When compared to healthy rats left ventricular surface decreased to 5.8 +/- 1.0 mm(2) (vs. 9.6 +/- 2.4 mm(2)) (p = 0.001) after three weeks with a fractional shortening (FS) of 23.7 +/- 4.3% vs. 28.2 +/- 1.5% (p = 0.01). Six weeks later, systolic function decreased to 17.1 +/- 3.2% vs. 28.2 +/- 1.5% (p = 0.0001) and left ventricular inner surface increased to 19.9 +/- 1.1 mm(2) (p = 0.0001). Intraoperative graft survival during hHTx was 80% with 46 performed procedures (37/46). All transplanted organs survived two weeks of mechanical unloading. Discussion Combination of TAC and hHTx in rats offers an economic and reproducible small animal model enabling serial examination of mechanical unloading in a truly hypertrophic and failing heart, representing the typical pressure overloaded and dilated LV, occurring in patients with moderate to severe heart failure.	[Schaefer, Andreas; Schneeberger, Yvonne; Biermann, Daniel; Reichenspurner, Hermann] Univ Heart Ctr Hamburg, Dept Cardiovasc Surg, Hamburg, Germany; [Schaefer, Andreas; Schneeberger, Yvonne; Stenzig, Justus; Reichenspurner, Hermann; Eschenhagen, Thomas; Ehmke, Heimo; Schwoerer, Alexander P.] DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany; [Stenzig, Justus; Eschenhagen, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Expt Pharmacol & Toxicol, Hamburg, Germany; [Jelinek, Marisa; Ehmke, Heimo; Schwoerer, Alexander P.] Univ Med Ctr Hamburg Eppendorf, Dept Cellular & Integrat Physiol, Ctr Med Expt, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schaefer, A (corresponding author), Univ Heart Ctr Hamburg, Dept Cardiovasc Surg, Hamburg, Germany.; Schaefer, A (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany.	and.schaefer@uke.de	Schäfer, Andreas/GPJ-9458-2022					Bernhardt AM, 2014, CURR OPIN ORGAN TRAN, V19, P494, DOI 10.1097/MOT.0000000000000118; Demirozu ZT, 2011, J HEART LUNG TRANSPL, V30, P849, DOI 10.1016/j.healun.2011.03.008; Didie M, 2013, AM J PHYSIOL-HEART C, V305, pH533, DOI 10.1152/ajpheart.00218.2013; El-Armouche A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014263; Guha K, 2013, CURR CARDIOL REV, V9, P123, DOI 10.2174/1573403X11309020005; Khush KK, 2015, AM J TRANSPLANT, V15, P642, DOI 10.1111/ajt.13055; Kirklin JK, 2014, J HEART LUNG TRANSPL, V33, P555, DOI 10.1016/j.healun.2014.04.010; Knapp J, 2013, RESUSCITATION, V84, P1450, DOI 10.1016/j.resuscitation.2013.04.012; Liu YH, 2015, J HEART LUNG TRANSPL, V34, P594, DOI 10.1016/j.healun.2014.11.015; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; ONO K, 1969, J THORAC CARDIOV SUR, V57, P225, DOI 10.1016/S0022-5223(19)42744-X; Schwoerer AP, 2013, PFLUG ARCH EUR J PHY, V465, P1763, DOI 10.1007/s00424-013-1316-y; Schwoerer AP, 2008, J MOL CELL CARDIOL, V45, P846, DOI 10.1016/j.yjmcc.2008.09.003; Schwoerer AP, 2008, J MOL CELL CARDIOL, V45, P633, DOI 10.1016/j.yjmcc.2008.02.271; Shingu Y, 2013, THORAC CARDIOV SURG, V61, P718, DOI 10.1055/s-0032-1326775; Sperry BW, 2015, HEART FAIL REV, V20, P251, DOI 10.1007/s10741-014-9459-2; Wang DH, 2006, MICROSURG, V26, P470, DOI 10.1002/micr.20272; Wang WJ, 2012, MOL BIOL REP, V39, P277, DOI 10.1007/s11033-011-0736-z; Zaha V, 2003, THORAC CARDIOV SURG, V51, P211	19	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148259	10.1371/journal.pone.0148259	http://dx.doi.org/10.1371/journal.pone.0148259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841021	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200114
J	Zhang, H; Yi, HP; Wu, MZ; Zhang, YB; Zhang, XJ; Li, MH; Wang, GZ				Zhang, Hong; Yi, Hongping; Wu, Mingzhu; Zhang, Yongbin; Zhang, Xuejin; Li, Meihua; Wang, Guangzhi			Mapping the Flavor Contributing Traits on "Fengwei Melon" (Cucumis melo L.) Chromosomes Using Parent Resequencing and Super Bulked-Segregant Analysis	PLOS ONE			English	Article							MITOCHONDRIAL CITRATE SYNTHASE; MOLECULAR MARKERS; SNP DISCOVERY; GENETIC-MAP; FRUIT; IDENTIFICATION; ACCUMULATION; EXPRESSION; GENOME; DEHYDROGENASE	We used a next-generation high-throughput sequencing platform to resequence the Xinguowei and Shouxing melon cultivars, the parents of Fengwei melon. We found 84% of the reads (under a coverage rate of "13x") placed on the reference genome DHL92. There were 2,550,000 single-nucleotide polymorphisms and 140,000 structural variations in the two genomes. We also identified 1,290 polymorphic genes between Xinguowei and Shouxing. We combined specific length amplified fragment sequencing (SLAF-seq) and bulked-segregant analysis (super-BSA) to analyze the two parents and the F-2 extreme phenotypes. This combined method yielded 12,438,270 reads, 46,087 SLAF tags, and 4,480 polymorphic markers (average depth of 161.81x). There were six sweet trait-related regions containing 13 differential SLAF markers, and 23 sour trait-related regions containing 48 differential SLAF markers. We further fine-mapped the sweet trait to the genomic regions on chromosomes 6, 10, 11, and 12. Correspondingly, we mapped the sour trait-related genomic regions to chromosomes 2, 3, 4, 5, 9, and 12. Finally, we positioned nine of the 61 differential markers in the sweet and sour trait candidate regions on the parental genome. These markers corresponded to one sweet and eight sour trait-related genes. Our study provides a basis for marker-assisted breeding of desirable sweet and sour traits in Fengwei melons.	[Zhang, Hong; Yi, Hongping; Wu, Mingzhu; Zhang, Yongbin; Zhang, Xuejin; Li, Meihua; Wang, Guangzhi] Xinjiang Acad Agr Sci, Hami Melon Res Ctr, Urumqi, Xinjiang, Peoples R China		Zhang, H (corresponding author), Xinjiang Acad Agr Sci, Hami Melon Res Ctr, Urumqi, Xinjiang, Peoples R China.	hzhang0625@163.com			National Natural Science Foundation of China [31160395]; Key Laboratory of Crop Biotechnology, Xinjiang Uighur Autonomous Region, China [XJYS03022011-01];  [131620]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Crop Biotechnology, Xinjiang Uighur Autonomous Region, China; 	This research was supported by the National Natural Science Foundation of China (31160395, http://www.nsfc.gov.cn), the postdoctoral program (131620, http://res.chinapostdoctor.org.cn/BshWeb/index.shtml) and the Key Laboratory of Crop Biotechnology, Xinjiang Uighur Autonomous Region, China (XJYS03022011-01) to HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073514; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Burger Y, 2003, J AM SOC HORTIC SCI, V128, P537, DOI 10.21273/JASHS.128.4.0537; Burger Y., 2009, HORTICULT REV J AM S, V36, P165; Burger Y, 2007, J AM SOC HORTIC SCI, V132, P704, DOI 10.21273/JASHS.132.5.704; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cohen S, 2012, THEOR APPL GENET, V125, P343, DOI 10.1007/s00122-012-1837-3; Cohen S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5026; Dai N, 2011, PLANT MOL BIOL, V76, P1, DOI 10.1007/s11103-011-9757-1; Danin-Poleg Y, 2002, EUPHYTICA, V125, P373, DOI 10.1023/A:1016021926815; Diaz A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-111; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Harel-Beja R, 2010, THEOR APPL GENET, V121, P511, DOI 10.1007/s00122-010-1327-4; Iannetta PPM, 2004, PHYSIOL PLANTARUM, V121, P15, DOI 10.1111/j.0031-9317.2004.00302.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KUBICKI B., 1962, GENET POLON, V3, P265; Leone A, 2006, J AGR FOOD CHEM, V54, P6835, DOI 10.1021/jf061457g; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-444; [刘蓉蓉 Liu Rongrong], 2008, [生物技术通报, Biotechnology Bulletin], P10; Liu SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036406; Lucchetta L, 2007, J AGR FOOD CHEM, V55, P5213, DOI 10.1021/jf070210w; Manriquez D, 2006, PLANT MOL BIOL, V61, P675, DOI 10.1007/s11103-006-0040-9; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Blanca JM, 2011, PLANT GENOME-US, V4, P118, DOI 10.3835/plantgenome2011.01.0003; Moing A, 2000, PHYSIOL PLANTARUM, V108, P1, DOI 10.1034/j.1399-3054.2000.108001001.x; Murray MG, 1980, NUCLEIC ACIDS RES, V8, P668; Pitrat M, 2000, ACTA HORTIC, P29, DOI 10.17660/ActaHortic.2000.510.4; Rowan DD, 1996, J AGR FOOD CHEM, V44, P3276, DOI 10.1021/jf9508209; Sadka A, 2000, PLANT SCI, V158, P173, DOI 10.1016/S0168-9452(00)00328-9; Sadka A, 2001, AUST J PLANT PHYSIOL, V28, P383, DOI 10.1071/PP00136; Sadka A, 2000, PHYSIOL PLANTARUM, V2000, P3, DOI DOI 10.1034/J.1399-3054.2000.108003255.X.108; Saradhuldhat P, 2007, SCI HORTIC-AMSTERDAM, V112, P297, DOI 10.1016/j.scienta.2006.12.031; Schaffer A., 1996, PHOTOASSIMILATE DIST; Sherman A, 2013, THEOR APPL GENET, V126, P349, DOI 10.1007/s00122-012-1983-7; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Tang GM, 2008, STUDIES ON VOLATILE; TAUREILLESSAUREL C, 1995, AM J ENOL VITICULT, V46, P29; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Wang YM, 1996, J AGR FOOD CHEM, V44, P210, DOI 10.1021/jf9503568; Wenger JW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000942; Wu MZ, 2005, CHINA WATERMELON MUS, V1, P1; Wyllie SG, 2000, J AGR FOOD CHEM, V48, P3493, DOI 10.1021/jf0001841; Xia C, 2015, EUPHYTICA, V202, P35, DOI 10.1007/s10681-014-1202-5; Xu XW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15829; YAMAGUCHI M, 1977, SCI HORTIC-AMSTERDAM, V6, P59, DOI 10.1016/0304-4238(77)90079-6; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; [伊鸿平 Yi Hongping], 2013, [园艺学报, Acta Horticulturae Sinica], V40, P1779; Zhang Bo, 2007, Acta Horticulturae Sinica, V34, P245; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141; Zheng LY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r114; Zhou T., 2011, THESIS CHINESE ACAD; ZHU H. Q, 2013, CHINA VEGETABLES, V18, P29	58	24	29	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148150	10.1371/journal.pone.0148150	http://dx.doi.org/10.1371/journal.pone.0148150			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840947	Green Submitted, gold, Green Published			2022-12-27	WOS:000369550200087
J	Christian, LM; Blair, LM; Porter, K; Lower, M; Cole, RM; Belury, MA				Christian, Lisa M.; Blair, Lisa M.; Porter, Kyle; Lower, Mary; Cole, Rachel M.; Belury, Martha A.			Polyunsaturated Fatty Acid (PUFA) Status in Pregnant Women: Associations with Sleep Quality, Inflammation, and Length of Gestation	PLOS ONE			English	Article							ACTIVATING PEPTIDE-1 INTERLEUKIN-8; FADS GENE VARIANTS; C-REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; PRETERM BIRTH; LONGITUDINAL CHANGES; DHA SUPPLEMENTATION; ARACHIDONIC-ACID; RISK PREGNANCIES; GROWTH MEASURES	Mechanistic pathways linking maternal polyunsaturated fatty acid (PUFA) status with gestational length are poorly delineated. This study examined whether inflammation and sleep quality serve as mediators, focusing on the antiinflammatory.-3 docosahexaenoic acid (DHA; 22:6n3) and proinflammatory omega-6 arachidonic acid (AA; 20:4n6). Pregnant women (n = 135) provided a blood sample and completed the Pittsburgh Sleep Quality Index (PSQI) at 20-27 weeks gestation. Red blood cell (RBC) fatty acid levels were determined by gas chromatography and serum inflammatory markers [interleukin (IL)-6, IL-8, tumor necrosis factor-a, IL-1 beta, and C-reactive protein] by electrochemiluminescence using high sensitivity kits. Both higher serum IL-8 (95% CI = 0.10,3.84) and poor sleep (95% CI = 0.03,0.28) served as significant mediators linking lower DHA: AA ratios with shorter gestation. Further, a serial mediation model moving from the DHA: AA ratio! sleep! IL-8! length of gestation was statistically significant (95% CI = 0.02, 0.79). These relationships remained after adjusting for depressive symptoms, age, BMI, income, race, and smoking. No interactions with race were observed in relation to length of gestation as a continuous variable. However, a significant interaction between race and the DHA: AA ratio in predicting preterm birth was observed (p = 0.049); among African Americans only, odds of preterm birth decreased as DHA: AA increased (p = 0.048). These data support a role for both inflammatory pathways and sleep quality in linking less optimal RBC PUFA status with shorter gestation in African American and European American women and suggest that African-Americans have greater risk for preterm birth in the context of a low DHA: AA ratio.	[Christian, Lisa M.; Lower, Mary] Ohio State Univ, Dept Psychiat & Behav Hlth, Wexner Med Ctr, Columbus, OH 43210 USA; [Christian, Lisa M.; Lower, Mary] Ohio State Univ, Inst Behav Med Res, Wexner Med Ctr, Columbus, OH 43210 USA; [Christian, Lisa M.] Ohio State Univ, Dept Obstet & Gynecol, Wexner Med Ctr, Columbus, OH 43210 USA; [Christian, Lisa M.] Ohio State Univ, Dept Psychol, Columbus, OH USA; [Blair, Lisa M.] Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA; [Porter, Kyle] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Cole, Rachel M.; Belury, Martha A.] Ohio State Univ, Program Nutr, Dept Human Sci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Christian, LM (corresponding author), Ohio State Univ, Dept Psychiat & Behav Hlth, Wexner Med Ctr, Columbus, OH 43210 USA.; Christian, LM (corresponding author), Ohio State Univ, Inst Behav Med Res, Wexner Med Ctr, Columbus, OH 43210 USA.; Christian, LM (corresponding author), Ohio State Univ, Dept Obstet & Gynecol, Wexner Med Ctr, Columbus, OH 43210 USA.; Christian, LM (corresponding author), Ohio State Univ, Dept Psychol, Columbus, OH USA.	Lisa.Christian@osumc.edu	Blair, Lisa M./I-8088-2019; Christian, Lisa/E-2892-2011	Blair, Lisa M./0000-0002-6169-5876; Christian, Lisa/0000-0001-5571-050X	NICHD [HD061644, HD067670]; Ohio State University College of Dentistry; Ruth L. Kirschstein National Research Service Award [T32NR014225]; Ohio State University Clinical Research Center - National Center for Research Resources [UL1TR001070]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD067670] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD061644] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [T32NR014225] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ohio State University College of Dentistry; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University Clinical Research Center - National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study and manuscript preparation was supported by NICHD (HD061644 and HD067670) and a seed grant from the Ohio State University College of Dentistry. Manuscript preparation by LMB was supported by a Ruth L. Kirschstein National Research Service Award (T32NR014225). The project described was supported by the Ohio State University Clinical Research Center, funded by the National Center for Research Resources (UL1TR001070). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. NIH had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2015, OM 3 FATT AC MAT CHI; Allen KGD, 2001, EXP BIOL MED, V226, P498, DOI 10.1177/153537020122600602; [Anonymous], 2013, Obstet Gynecol, V122, P1139, DOI 10.1097/01.AOG.0000437385.88715.4a; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Bayer JK, 2007, J PAEDIATR CHILD H, V43, P66, DOI 10.1111/j.1440-1754.2007.01005.x; Belury MA, 1997, LIPIDS, V32, P199, DOI 10.1007/s11745-997-0025-0; Bhati S, 2015, JOGNN-J OBST GYN NEO, V44, P350, DOI 10.1111/1552-6909.12562; Blair LM, 2015, SLEEP, V38, P1259, DOI 10.5665/sleep.4904; Block Robert C, 2012, World J Cardiovasc Dis, V2, P14; Boekholdt SM, 2004, ARTERIOSCL THROM VAS, V24, P1503, DOI 10.1161/01.ATV.0000134294.54422.2e; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Calcagni SC, 2012, BEHAV SLEEP MED, V10, P167, DOI 10.1080/15402002.2012.668147; Carlson SE, 2013, AM J CLIN NUTR, V97, P808, DOI 10.3945/ajcn.112.050021; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; CHEROUNY PH, 1993, AM J OBSTET GYNECOL, V169, P1299, DOI 10.1016/0002-9378(93)90297-V; Chilton FH, 2014, NUTRIENTS, V6, P1993, DOI 10.3390/nu6051993; Christian LM, 2014, CYTOKINE, V70, P134, DOI 10.1016/j.cyto.2014.06.018; Combs CA, 2015, AM J OBSTET GYNECOL, V212, pe1, DOI DOI 10.1016/J.AJ0G.2015.02.007; Coussons-Read ME, 2012, BRAIN BEHAV IMMUN, V26, P650, DOI 10.1016/j.bbi.2012.02.009; Dennis CL, 2005, BIRTH-ISS PERINAT C, V32, P187, DOI 10.1111/j.0730-7659.2005.00368.x; Denomme J, 2005, J NUTR, V135, P206, DOI 10.1093/jn/135.2.206; Facco FL, 2010, OBSTET GYNECOL, V115, P77, DOI 10.1097/AOG.0b013e3181c4f8ec; FAGIOLI I, 1989, SLEEP, V12, P495; Frew L, 2013, PROSTAG LEUKOTR ESS, V89, P221, DOI 10.1016/j.plefa.2013.07.001; Frey DJ, 2007, BRAIN BEHAV IMMUN, V21, P1050, DOI 10.1016/j.bbi.2007.04.003; Haghiac M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137309; Hall Martica H, 2015, F1000Prime Rep, V7, P63, DOI 10.12703/P7-63; Hall MH, 2009, SLEEP, V32, P73; Hall WL, 2013, INT J CARDIOL, V168, P4439, DOI 10.1016/j.ijcard.2013.06.153; Hayes AF, 2011, COMMUN SER, P434; Hiscock H, 2006, ARCH DIS CHILD; Hiscock H, 2008, PEDIATRICS, V122, pE621, DOI 10.1542/peds.2007-3783; Hong S, 2005, BRAIN BEHAV IMMUN, V19, P165, DOI 10.1016/j.bbi.2004.07.008; Horvath A, 2007, BRIT J NUTR, V98, P253, DOI 10.1017/S0007114507709078; Imhoff-Kunsch B, 2012, PAEDIATR PERINAT EP, V26, P91, DOI 10.1111/j.1365-3016.2012.01292.x; Jackson CL, 2013, AM J EPIDEMIOL, V178, P1442, DOI 10.1093/aje/kwt159; Jia XM, 2015, APPL PHYSIOL NUTR ME, V40, P474, DOI 10.1139/apnm-2014-0313; Jorgensen MH, 2006, MATERN CHILD NUTR, V2, P29, DOI 10.1111/j.1740-8709.2006.00039.x; Judge MP, 2012, EARLY HUM DEV, V88, P531, DOI 10.1016/j.earlhumdev.2011.12.016; Kamysheva E, 2010, J AFFECT DISORDERS, V123, P317, DOI 10.1016/j.jad.2009.09.015; Kelley DS, 2009, J NUTR, V139, P495, DOI 10.3945/jn.108.100354; Ladesich JB, 2011, J CLIN SLEEP MED, V7, P391, DOI 10.5664/JCSM.1198; Lauritzen L, 2015, PEDIATR RES, V77, P263, DOI 10.1038/pr.2014.166; Lavialle M, 2008, J NUTR, V138, P1719, DOI 10.1093/jn/138.9.1719; Leung BMY, 2009, J AM DIET ASSOC, V109, P1566, DOI 10.1016/j.jada.2009.06.368; Lewis N. M., 1995, Journal of Agromedicine, V2, P49, DOI 10.1300/J096v02n04_05; Makrides M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003402.pub2; Medina AM, 2009, FAM SYST HEALTH, V27, P153, DOI 10.1037/a0015762; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Miles EA, 2011, AM J CLIN NUTR, V94, p1986S, DOI 10.3945/ajcn.110.001636; Misra VK, 2009, PLACENTA, V30, P619, DOI 10.1016/j.placenta.2009.04.007; Mocellin MC, 2016, CLIN NUTR, V35, P359, DOI 10.1016/j.clnu.2015.04.013; Molto-Puigmarti C, 2014, J NUTR, V144, P1430, DOI 10.3945/jn.114.194035; Montgomery P, 2014, J SLEEP RES, V23, P364, DOI 10.1111/jsr.12135; Nadeem R, 2013, J CLIN SLEEP MED, V9, P1003, DOI 10.5664/jcsm.3070; Nordgren TM, 2014, NUTRIENTS, V6, P5434, DOI 10.3390/nu6125434; O'Brien LM, 2013, BMC PREGNANCY CHILDB, V13, DOI [10.1186/1471-2393-13-S1-S12, 10.1186/1471-2393-13-113]; Oken E, 2004, AM J EPIDEMIOL, V160, P774, DOI 10.1093/aje/kwh282; Okun ML, 2015, CURR OPIN PSYCHIATR, V28, P490, DOI 10.1097/YCO.0000000000000206; Okun ML, 2011, SLEEP, V34, P1493, DOI 10.5665/sleep.1384; Okun ML, 2011, DEPRESS ANXIETY, V28, P676, DOI 10.1002/da.20828; Okun ML, 2011, J AFFECT DISORDERS, V130, P378, DOI 10.1016/j.jad.2010.07.015; Palagini L, 2014, SLEEP MED, V15, P853, DOI 10.1016/j.sleep.2014.02.013; Papandreou C, 2013, J SLEEP RES, V22, P569, DOI 10.1111/jsr.12043; Prather AA, 2009, BRAIN BEHAV IMMUN, V23, P1109, DOI 10.1016/j.bbi.2009.07.001; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rangel-Huerta OD, 2012, BRIT J NUTR, V107, pS159, DOI 10.1017/S0007114512001559; Reutrakul S, 2011, DIABETES CARE, V34, P2454, DOI 10.2337/dc11-0780; ROMERO R, 1991, AM J OBSTET GYNECOL, V165, P813, DOI 10.1016/0002-9378(91)90422-N; Roth T, 2011, BIOL PSYCHIAT, V69, P592, DOI 10.1016/j.biopsych.2010.10.023; Ruiter ME, 2011, SLEEP MED, V12, P209, DOI 10.1016/j.sleep.2010.12.010; Saccone G, 2016, J MATERN-FETAL NEO M, V29, P2389, DOI 10.3109/14767058.2015.1086742; Saccone G, 2015, AM J OBSTET GYNECOL, V213, P135, DOI 10.1016/j.ajog.2015.03.013; Saccone G, 2015, OBSTET GYNECOL, V125, P663, DOI 10.1097/AOG.0000000000000668; SAITO S, 1993, CYTOKINE, V5, P81, DOI 10.1016/1043-4666(93)90027-3; Sergeant S, 2012, BRIT J NUTR, V107, P547, DOI 10.1017/S0007114511003230; Signal TL, 2014, SLEEP MED, V15, P1477, DOI 10.1016/j.sleep.2014.07.007; Simhan HN, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.038; Simopoulos AP, 2000, PROSTAG LEUKOTR ESS, V63, P119, DOI 10.1054/plef.2000.0176; Skouteris H, 2009, WOMEN HEALTH ISS, V19, P45, DOI 10.1016/j.whi.2008.10.004; Skulas-Ray AC, 2015, PROSTAG OTH LIPID M, V116, P104, DOI 10.1016/j.prostaglandins.2015.02.001; Storey A, 2005, J INVEST DERMATOL, V124, P248, DOI 10.1111/j.0022-202X.2004.23543.x; Sun Q, 2007, AM J CLIN NUTR, V86, P74, DOI 10.1093/ajcn/86.1.74; Szajewska H, 2006, AM J CLIN NUTR, V83, P1337, DOI 10.1093/ajcn/83.6.1337; Thomas KS, 2011, BRAIN BEHAV IMMUN, V25, P53, DOI 10.1016/j.bbi.2010.07.245; Tornblom SA, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-39; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Yee LD, 2010, AM J CLIN NUTR, V91, P1185, DOI 10.3945/ajcn.2009.29036; Yehuda S, 2011, EUR J CLIN NUTR, V65, P1167, DOI 10.1038/ejcn.2011.80; Zaslavsky O, 2015, SLEEP MED, V16, P364, DOI 10.1016/j.sleep.2014.11.008	90	32	35	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148752	10.1371/journal.pone.0148752	http://dx.doi.org/10.1371/journal.pone.0148752			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859301	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400075
J	Park, AM; Kanai, K; Itoh, T; Sato, T; Tsukui, T; Inagaki, Y; Selman, M; Matsushima, K; Yoshie, O				Park, Ah-Mee; Kanai, Kyosuke; Itoh, Tatsuki; Sato, Takao; Tsukui, Tatsuya; Inagaki, Yutaka; Selman, Moises; Matsushima, Kouji; Yoshie, Osamu			Heat Shock Protein 27 Plays a Pivotal Role in Myofibroblast Differentiation and in the Development of Bleomycin-Induced Pulmonary Fibrosis	PLOS ONE			English	Article							TGF-BETA; EXPRESSION; HSP27; PATHOGENESIS; INHIBITION; MECHANISMS; PROTEOMICS; EMT	Heat shock protein 27 (HSP27) is a member of the small molecular weight HSP family. Upon treatment with transforming growth factor beta 1 (TGF-beta 1), we observed upregulation of HSP27 along with that of alpha-smooth muscle actin (alpha-SMA), a marker of myofibroblast differentiation, in cultured human and mouse lung fibroblasts. Furthermore, by using siRNA knockdown, we demonstrated that HSP27 was involved in cell survival and upregulation of fibronectin, osteopontin (OPN) and type 1 collagen, all functional markers of myofibroblast differentiation, in TGF-beta 1-treated MRC-5 cells. In lung tissues of bleomycin-treated mice, HSP27 was strongly upregulated and substantially co-localized with alpha-SMA, OPN and type I collagen but not with proSP-C (a marker of type II alveolar epithelial cells), E-cadherin (a marker of epithelial cells) or F4/80 (a marker of macrophages). A similar co-localization of HSP27 and alpha-SMA was observed in lung tissues of patients with idiopathic pulmonary fibrosis. Furthermore, airway delivery of HSP27 siRNA effectively suppressed bleomycin-induced pulmonary fibrosis in mice. Collectively, our findings indicate that HSP27 is critically involved in myofibroblast differentiation of lung fibroblasts and may be a promising therapeutic target for lung fibrotic diseases.	[Park, Ah-Mee; Kanai, Kyosuke; Yoshie, Osamu] Dept Microbiol, Osaka, Japan; [Park, Ah-Mee; Kanai, Kyosuke; Yoshie, Osamu] Kindai Univ, Fac Med, Osaka, Japan; [Itoh, Tatsuki; Sato, Takao] Kindai Univ, Fac Med, Dept Pathol, Osaka, Japan; [Tsukui, Tatsuya; Matsushima, Kouji] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Tokyo, Japan; [Inagaki, Yutaka] Tokai Univ, Sch Med, Dept Regenerat Med, Sagamihara, Kanagawa, Japan; [Selman, Moises] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico	Kindai University (Kinki University); Kindai University (Kinki University); University of Tokyo; Tokai University	Yoshie, O (corresponding author), Dept Microbiol, Osaka, Japan.; Yoshie, O (corresponding author), Kindai Univ, Fac Med, Osaka, Japan.	o.yoshie@med.kindai.ac.jp	Park, Ah-Mee/AAS-2545-2020	Park, Ah-Mee/0000-0001-8453-3872; Yoshie, Osamu/0000-0003-4353-5809; Tsukui, Tatsuya/0000-0003-3100-6934	Ministry of Education, Culture, Sports, Science and Technology of Japan [22790772]; Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [25293179] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to AMP (22790772), and by a grant of Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency to OY.	ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Bratt C, 2001, J CHROMATOGR A, V909, P279, DOI 10.1016/S0021-9673(00)01103-1; Burkhardt AM, 2012, J IMMUNOL, V188, P6399, DOI 10.4049/jimmunol.1102903; Chilosi M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-95; Christians ES, 2012, INT J BIOCHEM CELL B, V44, P1632, DOI 10.1016/j.biocel.2012.06.006; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Foster MW, 2015, J PROTEOME RES, V14, P1238, DOI 10.1021/pr501149m; Hagiwara S, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-37; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Higashiyama R, 2009, GASTROENTEROLOGY, V137, P1459, DOI 10.1053/j.gastro.2009.07.006; Honda E, 2013, TOHOKU J EXP MED, V230, P67, DOI 10.1620/tjem.230.67; Honda E, 2010, TOHOKU J EXP MED, V220, P319, DOI 10.1620/tjem.220.319; Korfei M, 2011, J PROTEOME RES, V10, P2185, DOI 10.1021/pr1009355; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Malmstrom J, 2004, MOL CELL PROTEOMICS, V3, P466, DOI 10.1074/mcp.M300108-MCP200; Nakatani T, 2008, MOL CELL BIOCHEM, V308, P201, DOI 10.1007/s11010-007-9629-9; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Seluanov Andrei, 2010, J Vis Exp, DOI 10.3791/2033; Senoo T, 2010, THORAX, V65, P334, DOI 10.1136/thx.2009.119974; Thakur SA, 2009, TOXICOL SCI, V108, P462, DOI 10.1093/toxsci/kfp011; Tsukui T, 2013, AM J PATHOL, V183, P758, DOI 10.1016/j.ajpath.2013.06.005; Valles P, 2003, PEDIATR NEPHROL, V18, P527, DOI 10.1007/s00467-003-1096-2; Vidyasagar A, 2008, AM J PHYSIOL-RENAL, V295, pF707, DOI 10.1152/ajprenal.90240.2008; Vidyasagar A, 2013, KIDNEY INT, V83, P84, DOI 10.1038/ki.2012.336; Wettstein G, 2012, INT J BIOCHEM CELL B, V44, P1680, DOI 10.1016/j.biocel.2012.05.024; Wettstein G, 2013, FASEB J, V27, P1549, DOI 10.1096/fj.12-220053; Wight TN, 2011, AM J PHYSIOL-GASTR L, V301, pG950, DOI 10.1152/ajpgi.00132.2011; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yang Y, 2002, CLIN EXP IMMUNOL, V128, P169, DOI 10.1046/j.1365-2249.2002.01811.x; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zoubeidi A, 2012, INT J BIOCHEM CELL B, V44, P1646, DOI 10.1016/j.biocel.2012.04.010	34	25	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148998	10.1371/journal.pone.0148998	http://dx.doi.org/10.1371/journal.pone.0148998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859835	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400117
J	Pascual, V; Medrano, LM; Lopez-Palacios, N; Bodas, A; Dema, B; Fernandez-Arquero, M; Gonzalez-Perez, B; Salazar, I; Nunez, C				Pascual, V.; Medrano, L. M.; Lopez-Palacios, N.; Bodas, A.; Dema, B.; Fernandez-Arquero, M.; Gonzalez-Perez, B.; Salazar, I.; Nunez, C.			Different Gene Expression Signatures in Children and Adults with Celiac Disease	PLOS ONE			English	Article							TH17 CELLS; MULTIPLE COMMON; ASSOCIATION; RISK; INFLAMMATION; VARIANTS; MUCOSA	Celiac disease (CD) is developed after gluten ingestion in genetically susceptible individuals. It can appear at any time in life, but some differences are commonly observed between individuals with onset early in life or in adulthood. We aimed to investigate the molecular basis underlying those differences. We collected 19 duodenal biopsies of children and adults with CD and compared the expression of 38 selected genes between each other and with the observed in 13 non-CD controls matched by age. A Bayesian methodology was used to analyze the differences of gene expression between groups. We found seven genes with a similarly altered expression in children and adults with CD when compared to controls (C2orf74, CCR6, FASLG, JAK2, IL23A, TAGAP and UBE2L3). Differences were observed in 13 genes: six genes being altered only in adults (IL1RL1, CD28, STAT3, TMEM187, VAMP3 and ZFP36L1) and two only in children (TNFSF18 and ICOSLG); and four genes showing a significantly higher alteration in adults (CCR4, IL6, IL18RAP and PLEK) and one in children (C1orf106). This is the first extensive study comparing gene expression in children and adults with CD. Differences in the expression level of several genes were found between groups, being notorious the higher alteration observed in adults. Further research is needed to evaluate the possible genetic influence underlying these changes and the specific functional consequences of the reported differences.	[Pascual, V.; Medrano, L. M.; Dema, B.; Fernandez-Arquero, M.; Nunez, C.] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Serv Inmunol Clin, Madrid, Spain; [Bodas, A.] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Serv Pediat, Madrid, Spain; [Lopez-Palacios, N.] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Serv Aparato Digestivo, Madrid, Spain; [Gonzalez-Perez, B.] Univ Complutense Madrid, Fac Matemet, Dept Estadist & Invest Operativa 1, Madrid, Spain; [Salazar, I.] Univ Complutense Madrid, Fac Vet, Dept Anim Prod, Madrid, Spain	Hospital Clinico San Carlos; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Complutense University of Madrid; Complutense University of Madrid	Nunez, C (corresponding author), Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Serv Inmunol Clin, Madrid, Spain.	conchita.npardo@gmail.com	Núñez, Concepción/H-8517-2017; de dios, luz maria medrano/K-1946-2016; Pérez, Beatriz González/ABG-2414-2020; Dema, Barbara/AAM-2354-2020; Palacios, Natalia Lopez/AAZ-7954-2020	de dios, luz maria medrano/0000-0003-3717-5384; Pérez, Beatriz González/0000-0003-2631-8503; SALAZAR MENDOZA/0000-0002-1605-5407	Fundacion Eugenio Rodriguez Pascual CN; de Investigaciones Sanitarias, Instituto de Salud Carlos III (AES)-Fondo Europeo de Desarrollo Regional (FEDER) [PI11/00614]	Fundacion Eugenio Rodriguez Pascual CN; de Investigaciones Sanitarias, Instituto de Salud Carlos III (AES)-Fondo Europeo de Desarrollo Regional (FEDER)	Ths work was supported by PI11/00614 (http://www.isciii.es/Fondo) de Investigaciones Sanitarias, Instituto de Salud Carlos III (AES 2011)-Fondo Europeo de Desarrollo Regional (FEDER) to CN, (https://www.fundacioneugeniorodriguezpascual.es/); Fundacion Eugenio Rodriguez Pascual CN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, GASTROENTEROLOGY, V131, P1977, DOI 10.1053/j.gastro.2006.10.003; [Anonymous], 2005, NORMFINDER VERSION0; [Anonymous], 2007, GENORM VERSION3 5; Ausin MC, 2011, COMMUN STAT-THEOR M, V40, P2276, DOI 10.1080/03610921003778183; Burkett PR, 2015, J CLIN INVEST, V125, P2211, DOI 10.1172/JCI78085; Castellanos-Rubio A, 2009, AUTOIMMUNITY, V42, P69, DOI 10.1080/08916930802350789; Ciccocioppo R, 2015, NUTRIENTS, V7, P8733, DOI 10.3390/nu7105426; Comani GB, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0482-2; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fernandez S, 2011, AM J GASTROENTEROL, V106, P528, DOI 10.1038/ajg.2010.465; Fernandez-Jimenez N, 2014, HUM MOL GENET, V23, P1298, DOI 10.1093/hmg/ddt520; Galatola M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074747; Gomez-Villegas MA, 2014, STAT APPL GENET MOL, V13, P49, DOI 10.1515/sagmb-2012-0076; Gutierrez-Achury J, 2015, NAT GENET, V47, P577, DOI 10.1038/ng.3268; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Jauregi-Miguel A, 2014, J PEDIATR GASTR NUTR, V58, P762, DOI 10.1097/MPG.0000000000000338; Kelly CP, 2015, GASTROENTEROLOGY, V148, P1175, DOI 10.1053/j.gastro.2015.01.044; Kumar V, 2015, HUM MOL GENET, V24, P397, DOI 10.1093/hmg/ddu453; Lahdenpera AI, 2014, SCAND J GASTROENTERO, V49, P145, DOI 10.3109/00365521.2013.863966; Monteleone I, 2010, J IMMUNOL, V184, P2211, DOI 10.4049/jimmunol.0901919; Plaza-Izurieta L, 2015, EUR J HUM GENET, V23, P1100, DOI 10.1038/ejhg.2014.244; Plaza-Izurieta L, 2011, J MED GENET, V48, P493, DOI 10.1136/jmg.2011.089714; Poddar U, 2013, INDIAN J GASTROENTER, V32, P283, DOI 10.1007/s12664-013-0339-9; Saez LR, 2011, REV ESP ENFERM DIG, V103, P238; Singh RP, 2014, AUTOIMMUN REV, V13, P1174, DOI 10.1016/j.autrev.2014.08.019; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; van Leeuwen MA, 2013, MUCOSAL IMMUNOL, V6, P1202, DOI 10.1038/mi.2013.19; Vivas Santiago, 2015, World J Gastrointest Pharmacol Ther, V6, P207, DOI 10.4292/wjgpt.v6.i4.207; 1990, ARCH DIS CHILD, V65, P909	32	12	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0146276	10.1371/journal.pone.0146276	http://dx.doi.org/10.1371/journal.pone.0146276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859134	Green Published, gold, Green Submitted			2022-12-27	WOS:000370038400002
J	Quetglas, A; Rueda, L; Alvarez-Berastegui, D; Guijarro, B; Massut-, E				Quetglas, Antoni; Rueda, Lucia; Alvarez-Berastegui, Diego; Guijarro, Beatriz; Massut-, Enric			Contrasting Responses to Harvesting and Environmental Drivers of Fast and Slow Life History Species	PLOS ONE			English	Article							OCTOPUS ELEDONE-CIRRHOSA; BALEARIC-ISLANDS; REPRODUCTIVE-BIOLOGY; POPULATION-DYNAMICS; GALEUS-MELASTOMUS; CLIMATE-CHANGE; BODY-SIZE; SHARKS; CEPHALOPOD; FISHERIES	According to their main life history traits, organisms can be arranged in a continuum from fast (species with small body size, short lifespan and high fecundity) to slow (species with opposite characteristics). Life history determines the responses of organisms to natural and anthropogenic factors, as slow species are expected to be more sensitive than fast species to perturbations. Owing to their contrasting traits, cephalopods and elasmobranchs are typical examples of fast and slow strategies, respectively. We investigated the responses of these two contrasting strategies to fishing exploitation and environmental conditions (temperature, productivity and depth) using generalized additive models. Our results confirmed the foreseen contrasting responses of cephalopods and elasmobranchs to natural (environment) and anthropogenic (harvesting) influences. Even though a priori foreseen, we did expect neither the clear-cut differential responses between groups nor the homogeneous sensitivity to the same factors within the two taxonomic groups. Apart from depth, which affected both groups equally, cephalopods and elasmobranchs were exclusively affected by environmental conditions and fishing exploitation, respectively. Owing to its short, annual cycle, cephalopods do not have overlapping generations and consequently lack the buffering effects conferred by different age classes observed in multi-aged species such as elasmobranchs. We suggest that cephalopods are sensitive to short-term perturbations, such as seasonal environmental changes, because they lack this buffering effect but they are in turn not influenced by continuous, long-term moderate disturbances such as fishing because of its high population growth and turnover. The contrary would apply to elasmobranchs, whose multi-aged population structure would buffer the seasonal environmental effects, but they would display strong responses to uninterrupted harvesting due to its low population resilience. Besides providing empirical evidence to the theoretically predicted contrasting responses of cephalopods and elasmobranchs to disturbances, our results are useful for the sustainable exploitation of these resources.	[Quetglas, Antoni; Rueda, Lucia; Guijarro, Beatriz; Massut-, Enric] Ctr Oceanog Balears, Inst Espanol Oceanog, Palma De Mallorca, Spain; [Alvarez-Berastegui, Diego] SOCIB Balear Isl Coastal Observing & Forecast Sys, Palma De Mallorca, Spain	Spanish Institute of Oceanography	Quetglas, A (corresponding author), Ctr Oceanog Balears, Inst Espanol Oceanog, Palma De Mallorca, Spain.	toni.quetglas@ba.ieo.es	Quetglas, Antoni/K-9089-2014; Massutí, Enric/AAG-5117-2021; Guijarro, Beatriz/I-2480-2015	Quetglas, Antoni/0000-0002-1303-8003; Guijarro, Beatriz/0000-0002-2083-4681; Massuti, Enric/0000-0002-9524-5873; Alvarez-Berastegui, Diego/0000-0003-1304-7185; Rueda, Lucia/0000-0001-6105-6559	European Community [289257]; project ECLIPSAME (Synergistics effects of Climate and Fishing on the demersal ecosystems of the North Atlantic and western Mediterranean) - Spanish Ministry of Economy and Competitiveness [CTM2012-37701]; European Commission (EC); EC; Instituto Espanol de Oceanografia (IEO)	European Community(European Commission); project ECLIPSAME (Synergistics effects of Climate and Fishing on the demersal ecosystems of the North Atlantic and western Mediterranean) - Spanish Ministry of Economy and Competitiveness; European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); EC(European CommissionEuropean Commission Joint Research Centre); Instituto Espanol de Oceanografia (IEO)	The research leading to these results has received funding from: 1) the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement MYFISH no 289257; and 2) the project ECLIPSAME (Synergistics effects of Climate and Fishing on the demersal ecosystems of the North Atlantic and western Mediterranean, CTM2012-37701) co-financed by the Spanish Ministry of Economy and Competitiveness and the European Commission (EC). The article does not necessarily reflect the views of the EC. Spanish MEDITS surveys are co-financed by the EC and the Instituto Espanol de Oceanografia (IEO).	Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; Andre J, 2010, GLOBAL CHANGE BIOL, V16, P2866, DOI 10.1111/j.1365-2486.2010.02223.x; Barausse A, 2011, J FISH BIOL, V79, P1453, DOI 10.1111/j.1095-8649.2011.03139.x; Barausse A, 2014, ICES J MAR SCI, V71, P1593, DOI 10.1093/icesjms/fst222; Barnett LAK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065000; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; Boyle P. R., 2005, CEPHALOPODS ECOLOGY; Bradley D, 2014, ELIFE, V3, DOI 10.7554/eLife.02199; Bromham L, 2011, PHILOS T R SOC B, V366, P2503, DOI 10.1098/rstb.2011.0014; Caddy JF, 1998, REV FISH BIOL FISHER, V8, P431, DOI 10.1023/A:1008807129366; Capape C, 2008, J MAR BIOL ASSOC UK, V88, P415, DOI 10.1017/S002531540800060X; Cavanagh R.D., 2007, OVERVIEW CONSERVATIO; Chang SK, 2014, CAN J FISH AQUAT SCI, V71, P1363, DOI 10.1139/cjfas-2013-0552; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Cook RM, 1997, NATURE, V385, P521, DOI 10.1038/385521a0; Cuccu D, 2013, J MAR BIOL ASSOC UK, V93, P843, DOI 10.1017/S0025315412000203; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Dulvy NK, 2000, CONSERV BIOL, V14, P283, DOI 10.1046/j.1523-1739.2000.98540.x; Eastwood PD, 2007, ICES J MAR SCI, V64, P453, DOI 10.1093/icesjms/fsm001; ELLIS JR, 1995, J FISH BIOL, V46, P903, DOI 10.1111/j.1095-8649.1995.tb01613.x; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Ferretti F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01057; Field IC, 2009, ADV MAR BIOL, V56, P275, DOI 10.1016/S0065-2881(09)56004-X; Finley C, 2013, ICES J MAR SCI, V70, P245, DOI 10.1093/icesjms/fss192; Fortibuoni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015502; Gonzalez AF, 2013, ADV SQUID BIOL ECO 2, P49; Guijarro B, 2012, SCI MAR, V76, P87, DOI 10.3989/scimar.03432.22A; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Hutchings JA, 2012, ECOL APPL, V22, P1061, DOI 10.1890/11-1313.1; Ivory P., 2005, Journal of Northwest Atlantic Fishery Science, V35, P89; Jackson GD, 2003, ICES J MAR SCI, V60, P290, DOI 10.1016/S1054-3139(03)00007-9; Jennings S, 1999, J ANIM ECOL, V68, P617, DOI 10.1046/j.1365-2656.1999.00312.x; Jennings S, 2011, FISH FISH, V12, P125, DOI 10.1111/j.1467-2979.2011.00409.x; Jeschke J.M., 2008, ENCY ECOLOGY, V4, P3113, DOI DOI 10.1016/B978-008045405-4.00648-0; Jeschke JM, 2009, EVOL ECOL, V23, P867, DOI 10.1007/s10682-008-9276-y; Juan-Jorda MJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0322; Kadri H, 2014, MAR BIOL RES, V10, P416, DOI 10.1080/17451000.2013.797584; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kousteni V, 2010, MAR BIOL RES, V6, P390, DOI 10.1080/17451000903233771; LARKIN PA, 1977, T AM FISH SOC, V106, P1, DOI 10.1577/1548-8659(1977)106<1:AEFTCO>2.0.CO;2; Le Quesne WJF, 2012, J APPL ECOL, V49, P20, DOI 10.1111/j.1365-2664.2011.02087.x; Lee J, 2010, ICES J MAR SCI, V67, P1260, DOI 10.1093/icesjms/fsq010; Link JS, 2013, FISHERIES, V38, P463, DOI 10.1080/03632415.2013.851556; Lloret J, 2001, FISH OCEANOGR, V10, P33, DOI 10.1046/j.1365-2419.2001.00151.x; de Puelles MLF, 2007, PROG OCEANOGR, V74, P329, DOI 10.1016/j.pocean.2007.04.009; Mackinson S, 2009, CAN J FISH AQUAT SCI, V66, P1107, DOI 10.1139/F09-057; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; Merino G, 2015, FISH RES, V161, P131, DOI 10.1016/j.fishres.2014.06.010; Moltschaniwskyj N, 2002, B MAR SCI, V71, P501; Moore DM, 2013, J MAR BIOL ASSOC UK, V93, P1941, DOI 10.1017/S0025315413000374; Mueter FJ, 2006, FISH RES, V81, P189, DOI 10.1016/j.fishres.2006.07.010; Nogueira A, 2015, ICES J MAR SCI, V72, P753, DOI 10.1093/icesjms/fsu182; Okie JG, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1007; Oli MK, 2004, BASIC APPL ECOL, V5, P449, DOI 10.1016/j.baae.2004.06.002; Pierce GJ, 2008, HYDROBIOLOGIA, V612, P49, DOI 10.1007/s10750-008-9489-7; Puerta P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133439; Puerta P, 2014, MAR ECOL PROG SER, V514, P105, DOI 10.3354/meps10972; Quetglas A, 2015, FISHERIES MANAG ECOL, V22, P349, DOI 10.1111/fme.12131; Quetglas A, 2012, SCI MAR, V76, P17, DOI 10.3989/scimar.2012.76n1017; Quetglas A, 2011, ACTA OECOL, V37, P476, DOI 10.1016/j.actao.2011.06.002; Ravard D, 2014, FISH RES, V157, P86, DOI 10.1016/j.fishres.2014.03.007; Regueira M, 2015, SCI MAR, V79, P71, DOI 10.3989/scimar.04137.23A; Regueira M, 2013, J MAR BIOL ASSOC UK, V93, P1641, DOI 10.1017/S0025315413000118; Reynolds John D., 2003, P195; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; Rochet MJ, 2000, OIKOS, V91, P255, DOI 10.1034/j.1600-0706.2000.910206.x; Rodhouse PGK, 2014, ADV MAR BIOL, V67, P99, DOI 10.1016/B978-0-12-800287-2.00002-0; Roff Derek, 2002, pi; Rogers SI, 1999, J ANIM ECOL, V68, P769, DOI 10.1046/j.1365-2656.1999.00327.x; Rueffler C, 2006, AM NAT, V168, pE148, DOI 10.1086/508618; Saether BE, 2013, AM NAT, V182, P743, DOI 10.1086/673497; Schindler DE, 2002, ECOL APPL, V12, P735, DOI 10.2307/3060985; Schultner J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2090; Scott RD, 2011, MAR POLICY, V35, P79, DOI 10.1016/j.marpol.2010.08.005; Shelton AO, 2011, P NATL ACAD SCI USA, V108, P7075, DOI 10.1073/pnas.1100334108; Sibly RM, 2007, P NATL ACAD SCI USA, V104, P17707, DOI 10.1073/pnas.0707725104; Silva L, 2002, B MAR SCI, V71, P837; Smith JM, 2005, AQUAT LIVING RESOUR, V18, P341, DOI 10.1051/alr:2005038; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005; Wiedmann MA, 2014, ECOL EVOL, V4, P3596, DOI 10.1002/ece3.1203; Witt MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001111; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	92	27	29	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148770	10.1371/journal.pone.0148770	http://dx.doi.org/10.1371/journal.pone.0148770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859577	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400078
J	Xu, Y; Ji, RJ; Wei, RL; Yin, B; He, FP; Luo, BY				Xu, Yang; Ji, Renjie; Wei, Ruili; Yin, Bo; He, Fangping; Luo, Benyan			The Efficacy of Hyperbaric Oxygen Therapy on Middle Cerebral Artery Occlusion in Animal Studies: A Meta-Analysis	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; RAT MODEL; HEMORRHAGIC TRANSFORMATION; EMBOLIC STROKE; INFARCT VOLUME; MCAO RATS; REPERFUSION INJURY; OXIDATIVE DAMAGE; BRAIN ISCHEMIA	Background Inconsistent results have been reported for hyperbaric oxygen therapy (HBO) for acute stroke. We conducted a systematic review and meta-analysis to evaluate the benefit of HBO in animal studies of middle cerebral artery occlusion (MCAO). Methods A systematic search of the literature published prior to September 2015 was performed using Embase, Medline (OvidSP), Web of Science and PubMed. Keywords included "hyperoxia" OR "hyperbaric oxygen" OR "HBO" AND "isch(a)emia" OR "focal cerebral ischemia" OR "stroke" OR "infarct" OR "middle cerebral artery occlusion (MCAO)." The primary endpoints were the infarct size and/or neurological outcome score evaluated after HBO treatment in MCAO. Heterogeneity was analyzed using Cochrane Library's RevMan 5.3.5. Results Fifty-one studies that met the inclusion criteria were identified among the 1198 studies examined. When compared with control group data, HBO therapy resulted in infarct size reduction or improved neurological function (32% decrease in infarct size; 95% confidence interval (CI), range 28%-37%; p < 0.00001). Mortality was 18.4% in the HBO group and 26.7% in the control group (RR 0.72, 95% CI, 0.54-0.98; p = 0.03). Subgroup analysis showed that a maximal neuro-protective effect was reached when HBO was administered immediately after MCAO with an absolute atmospheric pressure (ATA) of 2.0 (50% decrease; 95% CI, 43% -57% decrease; p < 0.0001) and more than 6 hours HBO treatment (53% decrease; 95% CI, 41%-64% decrease; p = 0.0005). Conclusions HBO had a neuro-protective effect and improved survival in animal models of MCAO, especially in animals given more than 6 hours of HBO and when given immediately after MCAO with 2.0 ATA.	[Xu, Yang; Ji, Renjie; Wei, Ruili; He, Fangping; Luo, Benyan] Zhejiang Univ, Affiliated Hosp 1, Brain Med Ctr, Sch Med,Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China; [Yin, Bo] Wuhan Univ, Renmin Hosp, Dept Neurol, Wuhan 430072, Peoples R China	Zhejiang University; Wuhan University	Luo, BY (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Brain Med Ctr, Sch Med,Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China.	luobenyan@zju.edu.cn	Yang, Xu/AGR-8189-2022; mohamady, mahin/G-2175-2016	Yang, Xu/0000-0001-8778-3885; 	National Natural Science Foundation of China [81271272]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81271272) by BL. The funder designed the experiments and made the decision to publish.	Acka G, 2007, PHYSIOL RES, V56, P369, DOI 10.33549/physiolres.930907; ANDERSON DC, 1991, STROKE, V22, P1137, DOI 10.1161/01.STR.22.9.1137; Badr AE, 2001, AM J PHYSIOL-REG I, V280, pR766, DOI 10.1152/ajpregu.2001.280.3.R766; Badr AE, 2001, BRAIN RES, V916, P85, DOI 10.1016/S0006-8993(01)02867-0; Beynon C, 2007, NEUROSCI LETT, V425, P141, DOI 10.1016/j.neulet.2007.07.009; Bian HT, 2015, EXP NEUROL, V265, P22, DOI 10.1016/j.expneurol.2014.12.016; Carson S, 2005, CLIN REHABIL, V19, P819, DOI 10.1191/0269215505cr907oa; Chang CF, 2000, EXP NEUROL, V166, P298, DOI 10.1006/exnr.2000.7506; Chavko M, 2001, BRAIN RES, V900, P227, DOI 10.1016/S0006-8993(01)02301-0; Chen CH, 2012, SCI WORLD J, DOI 10.1100/2012/694703; Chen LF, 2014, J FORMOS MED ASSOC, V113, P620, DOI 10.1016/j.jfma.2014.03.012; Sanchez EC, 2013, CRIT CARE NURS Q, V36, P290, DOI 10.1097/CNQ.0b013e318294e9e3; Demchenko IT, 2000, NITRIC OXIDE-BIOL CH, V4, P597, DOI 10.1006/niox.2000.0313; Edwards Dorothy F, 2006, J Stroke Cerebrovasc Dis, V15, P151, DOI 10.1016/j.jstrokecerebrovasdis.2006.04.001; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Eschenfelder CC, 2008, CEREBROVASC DIS, V25, P193, DOI 10.1159/000113856; Garcia-Covarrubias L, 2000, Gac Med Mex, V136, P45; Gu GJ, 2008, J APPL PHYSIOL, V104, P1185, DOI 10.1152/japplphysiol.00323.2007; Gunther A, 2005, EUR J NEUROSCI, V21, P3189, DOI 10.1111/j.1460-9568.2005.04151.x; Harman F, 2012, NEUROSCIENCES, V17, P121; Henninger N, 2006, EXP NEUROL, V201, P316, DOI 10.1016/j.expneurol.2006.04.011; Hou HH, 2007, PHYSIOL MEAS, V28, P963, DOI 10.1088/0967-3334/28/8/017; Huang KL, 2000, NEUROSCI LETT, V293, P159, DOI 10.1016/S0304-3940(00)01493-2; Huang ZX, 2007, BRAIN RES, V1153, P204, DOI 10.1016/j.brainres.2007.03.061; Imai K, 2006, NEUROL MED-CHIR, V46, P373, DOI 10.2176/nmc.46.373; [蒋杞英 Jiang Jiying], 2006, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V21, P890; KAWAMURA S, 1990, SURG NEUROL, V34, P101, DOI 10.1016/0090-3019(90)90104-W; Korkmaz A, 2008, NEUROCHEM RES, V33, P160, DOI 10.1007/s11064-007-9428-4; Kuppers-Tiedt L, 2011, ACTA NEUROCHIR SUPPL, V111, P167, DOI 10.1007/978-3-7091-0693-8_28; Lei XM, 2015, MOL MED REP, V12, P3688, DOI 10.3892/mmr.2015.3857; Li JS, 2009, NEUROSCIENCE, V159, P1309, DOI 10.1016/j.neuroscience.2009.01.011; Li JS, 2008, BRAIN RES, V1210, P223, DOI 10.1016/j.brainres.2008.03.007; Li Z, 2008, BRAIN RES, V1196, P151, DOI 10.1016/j.brainres.2007.12.039; Liu JR, 2010, NEUROPATH APPL NEURO, V36, P211, DOI 10.1111/j.1365-2990.2009.01047.x; Liu R, 2013, BRAIN RES, V1514, P83, DOI 10.1016/j.brainres.2013.01.023; Lou M, 2007, NEUROSCIENCE, V146, P555, DOI 10.1016/j.neuroscience.2007.01.046; Lou M, 2006, BRAIN RES BULL, V69, P109, DOI 10.1016/j.brainresbull.2005.11.009; Lou M, 2004, STROKE, V35, P578, DOI 10.1161/01.STR.0000111599.77426.A0; Lu YX, 2014, EUR J PHARMACOL, V728, P93, DOI 10.1016/j.ejphar.2014.01.066; Miljkovic-Lolic M, 2003, BRAIN RES, V971, P90, DOI 10.1016/S0006-8993(03)02364-3; Mu J, 2013, NEUROBIOL DIS, V51, P133, DOI 10.1016/j.nbd.2012.11.003; NIGHOGHOSSIAN N, 1995, STROKE, V26, P1369, DOI 10.1161/01.STR.26.8.1369; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pablos MI, 1997, J APPL PHYSIOL, V83, P354, DOI 10.1152/jappl.1997.83.2.354; Paciaroni M, 2009, EUR NEUROL, V61, P321, DOI 10.1159/000210544; Prass K, 2000, BRAIN RES, V871, P146, DOI 10.1016/S0006-8993(00)02264-2; Qin ZY, 2007, STROKE, V38, P1362, DOI 10.1161/01.STR.0000259660.62865.eb; Rink C, 2010, J CEREBR BLOOD F MET, V30, P1275, DOI 10.1038/jcbfm.2010.7; Rusyniak DE, 2003, STROKE, V34, P571, DOI 10.1161/01.STR.0000050644.48393.D0; Schabitz WR, 2004, STROKE, V35, P1175, DOI 10.1161/01.STR.0000125868.86298.8e; Sena E, 2007, STROKE, V38, P388, DOI 10.1161/01.STR.0000254462.75851.22; Soejima Y, 2013, EXP NEUROL, V247, P737, DOI 10.1016/j.expneurol.2013.03.019; Soejima Y, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-9; Sun L, 2008, STROKE, V39, P1000, DOI 10.1161/STROKEAHA.107.490599; Sun L, 2014, NEUROSCI LETT, V577, P1, DOI 10.1016/j.neulet.2014.05.060; Sun L, 2011, BRAIN RES, V1415, P103, DOI 10.1016/j.brainres.2011.07.064; Sunami K, 2000, CRIT CARE MED, V28, P2831, DOI 10.1097/00003246-200008000-00025; Veltkamp R, 2005, BRAIN RES, V1037, P134, DOI 10.1016/j.brainres.2005.01.006; Veltkamp R, 2000, BRAIN RES, V853, P68, DOI 10.1016/S0006-8993(99)02250-7; Veltkamp R, 2005, STROKE, V36, P1679, DOI 10.1161/01.STR.0000173408.94728.79; Veltkamp R, 2006, BRAIN RES, V1107, P185, DOI 10.1016/j.brainres.2006.05.108; Wang RY, 2012, EUR J APPL PHYSIOL, V112, P215, DOI 10.1007/s00421-011-1976-2; WEINSTEIN PR, 1987, NEUROSURGERY, V20, P518, DOI 10.1227/00006123-198704000-00002; Xiong LZ, 2000, CHINESE MED J-PEKING, V113, P836; Xue LB, 2008, NEUROL RES, V30, P389, DOI 10.1179/174313208X300413; Yan WJ, 2013, J CEREBR BLOOD F MET, V33, P396, DOI 10.1038/jcbfm.2012.179; Yan WJ, 2011, BRAIN RES, V1402, P109, DOI 10.1016/j.brainres.2011.05.049; Yang ZJ, 2010, EUR J APPL PHYSIOL, V108, P513, DOI 10.1007/s00421-009-1229-9; Yin DL, 2005, NEUROCRIT CARE, V2, P206, DOI 10.1385/NCC:2:2:206; Yin DL, 2003, J CEREBR BLOOD F MET, V23, P855, DOI 10.1097/01.WCB.0000073946.29308.55; Yin W, 2002, BRAIN RES, V926, P165, DOI 10.1016/S0006-8993(01)03304-2; Zhou Jian-Guang, 2012, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V28, P38	72	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148324	10.1371/journal.pone.0148324	http://dx.doi.org/10.1371/journal.pone.0148324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859390	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400031
J	Zheng, DN; Arima, H; Sato, S; Gasparrini, A; Heeley, E; Delcourt, C; Lo, S; Huang, YN; Wang, JG; Stapf, C; Robinson, T; Lavados, P; Chalmers, J; Anderson, CS				Zheng, Danni; Arima, Hisatomi; Sato, Shoichiro; Gasparrini, Antonio; Heeley, Emma; Delcourt, Candice; Lo, Serigne; Huang, Yining; Wang, Jiguang; Stapf, Christian; Robinson, Thompson; Lavados, Pablo; Chalmers, John; Anderson, Craig S.		INTERACT2 Investigators	Low Ambient Temperature and Intracerebral Hemorrhage: The INTERACT2 Study	PLOS ONE			English	Article							REFERENT SELECTION-STRATEGIES; BLOOD-PRESSURE; CASE-CROSSOVER; HOSPITAL ADMISSIONS; ISCHEMIC-STROKE; HEART-DISEASE; MULTICENTER; PATTERNS; EXPOSURE; ONSET	Background Rates of acute intracerebral hemorrhage (ICH) increase in winter months but the magnitude of risk is unknown. We aimed to quantify the association of ambient temperature with the risk of ICH in the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT2) participants on an hourly timescale. Methods INTERACT2 was an international, open, blinded endpoint, randomized controlled trial of patients with spontaneous ICH (<6h of onset) and elevated systolic blood pressure (SBP, 150-220 mmHg) assigned to intensive (target SBP < 140 mmHg) or guideline-recommended (SBP < 180 mmHg) BP treatment. We linked individual level hourly temperature to baseline data of 1997 participants, and performed case-crossover analyses using a distributed lag non-linear model with 24h lag period to assess the association of ambient temperature and risk of ICH. Results were presented as overall cumulative odds ratios (ORs) and 95% CI. Results Low ambient temperature (<= 10 degrees C) was associated with increased risks of ICH: overall cumulative OR was 1.37 (0.99-1.91) for 10 degrees C, 1.92 (1.31-2.81) for 0 degrees C, 3.13 (1.89-5.19) for -10 degrees C, and 5.76 (2.30-14.42) for -20 degrees C, as compared with a reference temperature of 20 degrees C. There was no clear relation of low temperature beyond three hours after exposure. Results were consistent in sensitivity analyses. Conclusions Exposure to low ambient temperature within several hours increases the risk of ICH.	[Zheng, Danni; Arima, Hisatomi; Sato, Shoichiro; Delcourt, Candice; Chalmers, John; Anderson, Craig S.] George Inst Global Hlth, Div Neurol & Mental Hlth, Sydney, NSW, Australia; [Zheng, Danni; Arima, Hisatomi; Heeley, Emma; Delcourt, Candice; Lo, Serigne; Anderson, Craig S.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Arima, Hisatomi] Shiga Univ, Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Shiga, Japan; [Gasparrini, Antonio] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, Keppel St, London WC1E 7HT, England; [Delcourt, Candice; Anderson, Craig S.] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia; [Huang, Yining] Peking Univ, Hosp 1, Dept Neurol, Beijing 100871, Peoples R China; [Wang, Jiguang] Shanghai Jiao Tong Univ, Shanghai Inst Hypertens, Ctr Epidemiol Studies & Clin Trials, Ruijin Hosp,Sch Med, Shanghai 200030, Peoples R China; [Stapf, Christian] Univ Paris Diderot, Sorbonne Paris Cite, DHU NeuroVasc Paris Sorbonne, Hop Lariboisiere,APHP,Dept Neurol, Paris, France; [Stapf, Christian] Univ Montreal, Dept Neurosci, CRCHUM, Montreal, PQ, Canada; [Robinson, Thompson] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Robinson, Thompson] Univ Leicester, NIHR Biomed Res Unit Cardiovasc Dis, Leicester, Leics, England; [Lavados, Pablo] Univ Desarrollo, Clin Alemana Santiago, Dept Internal Med, Vasc Neurol Program,Neurol Serv, Santiago, Chile	George Institute for Global Health; University of Sydney; University of Sydney; Shiga University; Shiga University of Medical Science; University of London; London School of Hygiene & Tropical Medicine; University of Sydney; Peking University; Shanghai Jiao Tong University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite de Montreal; University of Leicester; University of Leicester; Clinica Alemana; Universidad del Desarrollo	Anderson, CS (corresponding author), George Inst Global Hlth, Div Neurol & Mental Hlth, Sydney, NSW, Australia.; Anderson, CS (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.; Anderson, CS (corresponding author), Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia.	canderson@georgeinstitute.org.au	Azevedo, Elsa I/C-1060-2014; Zini, Andrea/K-1136-2014; Urra, Xabier/B-7637-2019; Brouns, Raf/E-1044-2013; Lo, Serigne/L-6220-2018; Gasparrini, Antonio/F-7627-2012; Cordonnier, Charlotte/O-3258-2017; Gregório, Tiago/K-2013-2019; Billot, Laurent/Y-1241-2019; Demchuk, Andrew M/E-1103-2012; Martin, Oscar Ayo/Q-8541-2017; Lindley, Richard/B-8148-2013; De Raedt, Sylvie/AAX-4965-2020; Werring, David/Q-8435-2019; Klijn, C.J.M./E-1700-2016; Wang, Ji Guang/AAP-4045-2021; Curtze, Sami/AAK-8595-2020; FRACP, Tissa Wijeratne MD PhD/I-2086-2019; Hankey, Graeme J/H-4968-2014	Azevedo, Elsa I/0000-0003-3731-4508; Zini, Andrea/0000-0003-1486-4507; Urra, Xabier/0000-0002-4763-5252; Brouns, Raf/0000-0001-6540-5699; Lo, Serigne/0000-0001-5092-5544; Gasparrini, Antonio/0000-0002-2271-3568; Cordonnier, Charlotte/0000-0002-5697-6892; Gregório, Tiago/0000-0002-0131-9430; Billot, Laurent/0000-0002-4975-9793; Demchuk, Andrew M/0000-0002-4930-7789; Martin, Oscar Ayo/0000-0002-3632-1696; Lindley, Richard/0000-0002-0104-5679; De Raedt, Sylvie/0000-0001-8042-2024; Werring, David/0000-0003-2074-1861; Klijn, C.J.M./0000-0002-8495-4578; Wang, Ji Guang/0000-0001-8511-1524; Curtze, Sami/0000-0003-1545-8500; FRACP, Tissa Wijeratne MD PhD/0000-0002-1701-7111; Hankey, Graeme J/0000-0002-6044-7328; Touze, Emmanuel/0000-0002-7254-2162; Delcourt, Candice/0000-0003-2257-4286; Robinson, Thompson/0000-0003-2144-2468; Woodward, Mark/0000-0001-9800-5296; Chalmers, John/0000-0002-9931-0580; Heeley, Emma/0000-0001-9190-2832; Blacker, David/0000-0003-0046-9776; Timsit, Serge/0000-0003-0346-8576; Stapf, Christian/0000-0002-3193-1006; Strbian, Daniel/0000-0001-9095-2344; Haunton, Victoria/0000-0001-6078-5469; Anderson, Craig/0000-0002-7248-4863; Kwan, Joseph/0000-0003-4635-3322; Neal, Bruce/0000-0002-0490-7465; Li, Qiang/0000-0002-4384-8226; Kaste, Markku/0000-0001-6557-6412; De Smedt, Ann/0000-0003-0252-0600; Herve, Dominique/0000-0001-6197-6275; corea, francesco/0000-0002-5864-9991	National Health and Medical Research Council (NHMRC) of Australia [512402, 1004170, 571281]; Medical Research Council-UK [MR/M022625/1]; Medical Research Council [MR/M022625/1] Funding Source: researchfish; MRC [MR/M022625/1] Funding Source: UKRI	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council-UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The second Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial study was supported by Program (571281) and Project (512402 and 1004170) grants from the National Health and Medical Research Council (NHMRC) of Australia (URL: https://www.nhmrc.gov.au). AG was supported by Medical Research Council-UK (Grant ID: MR/M022625/1) (URL: https://www.mrc.ac.uk/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperovitch A, 2009, ARCH INTERN MED, V169, P75, DOI 10.1001/archinternmed.2008.512; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Aubiniere-Robb L, 2013, HYPERTENSION, V62, P190, DOI 10.1161/HYPERTENSIONAHA.111.00686; Bhaskaran K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3823; Dawson J, 2008, ACTA NEUROL SCAND, V117, P85, DOI 10.1111/j.1600-0404.2007.00916.x; Delcourt C, 2010, INT J STROKE, V5, P110, DOI 10.1111/j.1747-4949.2010.00415.x; Fang CW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000842; Fischer U, 2014, LANCET NEUROL, V13, P374, DOI 10.1016/S1474-4422(14)70031-6; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2015, LANCET, V386, P369, DOI 10.1016/S0140-6736(14)62114-0; Gasparrini A, 2014, STAT MED, V33, P881, DOI 10.1002/sim.5963; Gomes J, 2015, CLIN NEUROL NEUROSUR, V129, P72, DOI 10.1016/j.clineuro.2014.12.002; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Jeong Tae Seok, 2013, J Cerebrovasc Endovasc Neurosurg, V15, P152, DOI 10.7461/jcen.2013.15.3.152; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Mittleman MA, 2005, EPIDEMIOLOGY, V16, P715, DOI 10.1097/01.ede.0000183170.92955.25; Ohwaki K, 2004, INT J BIOMETEOROL, V49, P86, DOI 10.1007/s00484-004-0219-1; Passero S, 2000, STROKE, V31, P1538, DOI 10.1161/01.STR.31.7.1538; Rothwell PM, 1996, LANCET, V347, P934, DOI 10.1016/S0140-6736(96)91415-4; Schwartz J, 2004, EPIDEMIOLOGY, V15, P755, DOI 10.1097/01.ede.0000134875.15919.0f; SOBEL E, 1987, STROKE, V18, P38, DOI 10.1161/01.STR.18.1.38; TEASDALE G, 1974, LANCET, V2, P81; Wei JW, 2010, CEREBROVASC DIS, V29, P321, DOI 10.1159/000278927; Whitaker HJ, 2007, ENVIRONMETRICS, V18, P157, DOI 10.1002/env.809	28	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0149040	10.1371/journal.pone.0149040	http://dx.doi.org/10.1371/journal.pone.0149040			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859491	Green Published, gold, Green Accepted			2022-12-27	WOS:000370038400122
J	Ernst, M; Kriston, L; Romero, JM; Frolich, AM; Jansen, O; Fiehler, J; Buhk, JH				Ernst, Marielle; Kriston, Levente; Romero, Javier M.; Froelich, Andreas M.; Jansen, Olav; Fiehler, Jens; Buhk, Jan-Hendrik			Quantitative Evaluation of Performance in Interventional Neuroradiology: An Integrated Curriculum Featuring Theoretical and Practical Challenges	PLOS ONE			English	Article							SIMULATION; SKILLS; MAINTENANCE; OCCLUSION	Purpose We sought to develop a standardized curriculum capable of assessing key competencies in Interventional Neuroradiology by the use of models and simulators in an objective, quantitative, and efficient way. In this evaluation we analyzed the associations between the practical experience, theoretical knowledge, and the skills lab performance of interventionalists. Materials and Methods We evaluated the endovascular skills of 26 participants of the Advanced Course in Endovascular Interventional Neuroradiology of the European Society of Neuroradiology with a set of three tasks (aneurysm coiling and thrombectomy in a virtual simulator and placement of an intra-aneurysmal flow disruptor in a flow model). Practical experience was assessed by a survey. Participants completed a written and oral examination to evaluate theoretical knowledge. Bivariate and multivariate analyses were performed. Results In multivariate analysis knowledge of materials and techniques in Interventional Neuroradiology was moderately associated with skills in aneurysm coiling and thrombectomy. Experience in mechanical thrombectomy was moderately associated with thrombectomy skills, while age was negatively associated with thrombectomy skills. We found no significant association between age, sex, or work experience and skills in aneurysm coiling. Conclusion Our study gives an example of how an integrated curriculum for reasonable and cost-effective assessment of key competences of an interventional neuroradiologist could look. In addition to traditional assessment of theoretical knowledge practical skills are measured by the use of endovascular simulators yielding objective, quantitative, and constructive data for the evaluation of the current performance status of participants as well as the evolution of their technical competency over time.	[Ernst, Marielle; Froelich, Andreas M.; Fiehler, Jens; Buhk, Jan-Hendrik] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Ctr Radiol & Endoscopy, Martinistr 52, D-20246 Hamburg, Germany; [Kriston, Levente] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Martinistr 52, D-20246 Hamburg, Germany; [Romero, Javier M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol,Div Neuroradiol, Boston, MA USA; [Jansen, Olav] Univ Kiel, Dept Radiol & Neuroradiol, Arnold Heller Str 3, D-24105 Kiel, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Kiel	Ernst, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Ctr Radiol & Endoscopy, Martinistr 52, D-20246 Hamburg, Germany.	m.ernst@uke.de	Kriston, Levente/D-1713-2013; Jansen, Olav/CAF-4179-2022	Kriston, Levente/0000-0003-0748-264X; Romero, Javier/0000-0001-5749-3000	Philips Healthcare	Philips Healthcare	The authors would like to thank all participants of the Advanced Course in Endovascular Interventional Neuroradiology of the European Society of Neuroradiology, cycle 2014-2015, and Philips Healthcare for the support and realization of the "Hermann Zeumer Research Laboratory" including a Philips Allura Clarity Angiography system.	Ahmed K, 2010, J VASC INTERV RADIOL, V21, P55, DOI 10.1016/j.jvir.2009.09.019; Arthur A, 2015, J NEUROINTERVENTI S1, V7, pA91, DOI [10.1136/neurintsurg-2015-011917.185, DOI 10.1136/NEURINTSURG-2015-011917.185]; Austin PC, 2015, J CLIN EPIDEMIOL, V68, P627, DOI 10.1016/j.jclinepi.2014.12.014; Boulet JR, 2003, ANESTHESIOLOGY, V99, P1270, DOI 10.1097/00000542-200312000-00007; Drazen JM, 2010, NEW ENGL J MED, V362, P946, DOI 10.1056/NEJMe1000174; Eva KW, 2002, ACAD MED, V77, pS1, DOI 10.1097/00001888-200210001-00002; Fiorella D, 2015, J NEUROINTERV SURG, V7, P591, DOI 10.1136/neurintsurg-2014-011251; Levinson W, 2010, NEW ENGL J MED, V362, P948, DOI 10.1056/NEJMclde0911205; Miranpuri AS, 2014, J NEUROINTERV SURG, V6, P561, DOI 10.1136/neurintsurg-2013-010826; Nayak S, 2015, SNIS 12 ANN M; Nguyen Ngan, 2014, Stud Health Technol Inform, V196, P297; Specialists EUoM, 2012, EJMINT; Spiotta AM, 2013, J NEUROINTERV SURG, V5, P376, DOI 10.1136/neurintsurg-2012-010319; Suzuki Y, 2005, NEUROL MED-CHIR, V45, P567, DOI 10.2176/nmc.45.567; VONOFAKOS D, 1983, AM J NEURORADIOL, V4, P525; Wong JA, 2008, NAT CLIN PRACT UROL, V5, P47, DOI 10.1038/ncpuro0991; Yousem DM, 2010, AM J NEURORADIOL, V31, P1369, DOI 10.3174/ajnr.A2029	17	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148694	10.1371/journal.pone.0148694	http://dx.doi.org/10.1371/journal.pone.0148694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848840	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000160
J	Jung, SI; Shin, JH; Kim, SH; Kim, J; Kim, JH; Choi, MJ; Chung, EK; Lee, K; Koo, SH; Chang, HH; Bougnoux, ME; d'Enfert, C				Jung, Sook-In; Shin, Jong Hee; Kim, Soo Hyun; Kim, Jin; Kim, Joo Hee; Choi, Min Ji; Chung, Eun-Kyung; Lee, Kyungwon; Koo, Sun Hoe; Chang, Hyun Ha; Bougnoux, Marie-Elisabeth; d'Enfert, Christophe			Comparison of E,E-Farnesol Secretion and the Clinical Characteristics of Candida albicans Bloodstream Isolates from Different Multilocus Sequence Typing Clades	PLOS ONE			English	Article							QUORUM-SENSING MOLECULE; INVASIVE CANDIDIASIS; BIOFILM FORMATION; MOUSE MODEL; MORTALITY; FARNESOL; EPIDEMIOLOGY; GROWTH; INFECTIONS; PREDICTORS	Using multilocus sequence typing (MLST), Candida albicans can be subdivided into 18 different clades. Farnesol, a quorum-sensing molecule secreted by C. albicans, is thought to play an important role in the development of C. albicans biofilms and is also a virulence factor. This study evaluated whether C. albicans bloodstream infection (BSI) strains belonging to different MLST clades secrete different levels of E, E-farnesol (FOH) and whether they have different clinical characteristics. In total, 149 C. albicans BSI isolates from ten Korean hospitals belonging to clades 18 (n = 28), 4 (n = 23), 1 (n = 22), 12 (n = 17), and other clades (n = 59) were assessed. For each isolate, the FOH level in 24-hour biofilms was determined in filtered (0.45 mu m) culture supernatant using high-performance liquid chromatography. Marked differences in FOH secretion from biofilms (0.10-6.99 mu M) were observed among the 149 BSI isolates. Clade 18 isolates secreted significantly more FOH than did non-clade 18 isolates (mean +/- SEM; 2.66 +/- 0.22 vs. 1.69 +/- 0.10 mu M; P < 0.001). Patients with isolates belonging to clade 18 had a lower mean severity of illness than other patients, as measured using the "acute physiology and chronic health evaluation" (APACHE) III score (14.4 +/- 1.1 vs. 18.0 +/- 0.7; P < 0.05). This study provides evidence that C. albicans BSI isolates belonging to the most prevalent MLST clade (clade 18) in Korea are characterized by increased levels of FOH secretion and less severe illness.	[Jung, Sook-In] Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea; [Shin, Jong Hee; Kim, Soo Hyun; Kim, Joo Hee; Choi, Min Ji] Chonnam Natl Univ, Sch Med, Dept Lab Med, Gwangju, South Korea; [Kim, Jin] Chonnam Natl Univ Hosp, Biomed Res Inst, Gwangju, South Korea; [Chung, Eun-Kyung] Chonnam Natl Univ, Sch Med, Dept Med Educ, Gwangju, South Korea; [Lee, Kyungwon] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Lee, Kyungwon] Yonsei Univ, Coll Med, Res Inst Bacterial Resistance, Seoul, South Korea; [Koo, Sun Hoe] Chungnam Natl Univ, Coll Med, Dept Lab Med, Daejeon, South Korea; [Chang, Hyun Ha] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Bougnoux, Marie-Elisabeth; d'Enfert, Christophe] Inst Pasteur, Unite Biol & Pathogenicite Fong, F-75015 Paris, France; [Bougnoux, Marie-Elisabeth; d'Enfert, Christophe] INRA, USC2019, F-75015 Paris, France; [Bougnoux, Marie-Elisabeth] Univ Paris 05, Fac Med, Microbiol Serv, Lab Parasitol Mycol,Hop Necker Enfants Malad, F-75015 Paris, France	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University Hospital; Chonnam National University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Chungnam National University; Kyungpook National University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Shin, JH (corresponding author), Chonnam Natl Univ, Sch Med, Dept Lab Med, Gwangju, South Korea.	shinjh@chonnam.ac.kr		Lee, Kyungwon/0000-0003-3788-2134; Koo, Sun Hoe/0000-0003-3715-7151; d'Enfert, Christophe/0000-0002-6235-3886	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2A10058555]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2A10058555). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirante B, 2005, J CLIN MICROBIOL, V43, P1829, DOI 10.1128/JCM.43.4.1829-1835.2005; Andes D, 2004, INFECT IMMUN, V72, P6023, DOI 10.1128/IAI.72.10.6023-6031.2004; Andes DR, 2012, CLIN INFECT DIS, V54, P1110, DOI 10.1093/cid/cis021; Bassetti M, 2014, INTENS CARE MED, V40, P839, DOI 10.1007/s00134-014-3310-z; Chandra J, 2008, NAT PROTOC, V3, P1909, DOI 10.1038/nprot.2008.192; Charles PE, 2003, INTENS CARE MED, V29, P2162, DOI 10.1007/s00134-003-2002-x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Crump JA, 2000, EUR J CLIN MICROBIOL, V19, P1, DOI 10.1007/s100960050001; Dumitru R, 2004, ANTIMICROB AGENTS CH, V48, P2350, DOI 10.1128/AAC.48.7.2350-2354.2004; Escribano P, 2013, J CLIN MICROBIOL, V51, P2118, DOI 10.1128/JCM.00516-13; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Hargarten JC, 2015, INFECT IMMUN, V83, P3857, DOI 10.1128/IAI.00886-15; Hornby JM, 2001, APPL ENVIRON MICROB, V67, P2982, DOI 10.1128/AEM.67.7.2982-2992.2001; Joo MY, 2013, MED MYCOL, V51, P892, DOI 10.3109/13693786.2013.824623; Kim MN, 2009, CLIN INFECT DIS, V48, pe57, DOI 10.1086/597108; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Kuhn DM, 2002, INFECT IMMUN, V70, P878, DOI 10.1128/IAI.70.2.878-888.2002; Lim CSY, 2012, EUR J CLIN MICROBIOL, V31, P21, DOI 10.1007/s10096-011-1273-3; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; McManus BA, 2014, INFECT GENET EVOL, V21, P166, DOI 10.1016/j.meegid.2013.11.008; Navarathna DHMLP, 2007, INFECT IMMUN, V75, P4006, DOI 10.1128/IAI.00397-07; Navarathna DHMLP, 2007, INFECT IMMUN, V75, P1609, DOI 10.1128/IAI.01182-06; Odds FC, 2008, EUKARYOT CELL, V7, P1075, DOI 10.1128/EC.00062-08; Odds FC, 2010, FUTURE MICROBIOL, V5, P67, DOI 10.2217/FMB.09.113; Pfaller MA, 1998, J CLIN MICROBIOL, V36, P1518, DOI 10.1128/JCM.36.6.1518-1529.1998; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; Saisho Y, 1997, ANAL BIOCHEM, V252, P89, DOI 10.1006/abio.1997.2314; Schmid J, 2011, J CLIN MICROBIOL, V49, P3250, DOI 10.1128/JCM.00941-11; Shin JH, 2011, J CLIN MICROBIOL, V49, P2572, DOI 10.1128/JCM.02153-10; Tumbarello Mario, 2012, PLoS One, V7, pe33705, DOI 10.1371/journal.pone.0033705; Uppuluri P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000828; Weber K, 2008, ANTIMICROB AGENTS CH, V52, P1859, DOI 10.1128/AAC.01646-07; Weber K, 2010, YEAST, V27, P727, DOI 10.1002/yea.1769	34	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148400	10.1371/journal.pone.0148400	http://dx.doi.org/10.1371/journal.pone.0148400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848577	gold, Green Submitted, Green Published			2022-12-27	WOS:000369554000086
J	Moriguchi, K; Yamamoto, S; Ohmine, Y; Suzuki, K				Moriguchi, Kazuki; Yamamoto, Shinji; Ohmine, Yuta; Suzuki, Katsunori			A Fast and Practical Yeast Transformation Method Mediated by Escherichia coli Based on a Trans-Kingdom Conjugal Transfer System: Just Mix Two Cultures and Wait One Hour	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ALKALI CATIONS; INCP PLASMIDS; DNA TRANSFER; CELLS; TOOL	Trans-kingdom conjugation is a phenomenon by which DNA is transferred into a eukaryotic cell by a bacterial conjugal transfer system. Improvement in this method to facilitate the rapid co-cultivation of donor bacterial and recipient eukaryotic cell cultures could make it the simplest transformation method, requiring neither isolation of vector DNA nor preparation of competent recipient cells. To evaluate this potential advantage of trans-kingdom conjugation, we examined this simple transformation method using vector combinations, helper plasmids, and recipient Saccharomyces cerevisiae strains. Mixing donor Escherichia coli and recipient S. cerevisiae overnight cultures (50 mu L each) consistently yielded on the order of 10(1) transformants using the popular experimental strain BY4742 derived from S288c and a shuttle vector for trans-kingdom conjugation. Transformation efficiency increased to the order of 10(2) using a high receptivity trans-kingdom conjugation strain. In addition, either increasing the amount of donor cells or pretreating the recipient cells with thiols such as dithiothreitol improved the transformation efficiency by one order of magnitude. This simple trans-kingdom conjugation-mediated transformation method could be used as a practical yeast transformation method upon enrichment of available vectors and donor E. coli strains.	[Moriguchi, Kazuki; Yamamoto, Shinji; Ohmine, Yuta; Suzuki, Katsunori] Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, 1-3-1 Kagamiyama, Higashihiroshima 7398526, Japan	Hiroshima University	Moriguchi, K (corresponding author), Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, 1-3-1 Kagamiyama, Higashihiroshima 7398526, Japan.	kmoriguc@hiroshima-u.ac.jp			JSPS [21510209, 25660007]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by JSPS KAKENHI (21510209 and 25660007). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates S, 1998, J BACTERIOL, V180, P6538, DOI 10.1128/JB.180.24.6538-6543.1998; BRZOBOHATY B, 1986, J GEN MICROBIOL, V132, P3089; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; HEINEMANN JA, 1989, NATURE, V340, P205, DOI 10.1038/340205a0; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; ITO H, 1984, AGR BIOL CHEM TOKYO, V48, P341, DOI 10.1080/00021369.1984.10866161; Kawai S, 2004, BIOCHEM BIOPH RES CO, V317, P100, DOI 10.1016/j.bbrc.2004.03.011; Mizuta M, 2012, MICROBIOL RES, V167, P311, DOI 10.1016/j.micres.2011.10.001; Moriguchi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074590; Moriguchi K, 2013, APPL ENVIRON MICROB, V79, P4393, DOI 10.1128/AEM.00770-13; NISHIKAWA M, 1992, CURR GENET, V21, P101, DOI 10.1007/BF00318467; NISHIKAWA M, 1990, JPN J GENET, V65, P323, DOI 10.1266/jjg.65.323; Nishikawa M, 1998, GENET ANAL-BIOMOL E, V14, P65, DOI 10.1016/S1050-3862(97)10003-1; Simon R., 1983, NAT BIOTECHNOL, V1, P784, DOI [10.1038/nbt1183-784, DOI 10.1038/NBT1183-784]; SUZUKI K, 1986, PLANT CELL PHYSIOL, V27, P523; Thompson JR, 1998, YEAST, V14, P565, DOI 10.1002/(SICI)1097-0061(19980430)14:6<565::AID-YEA251>3.0.CO;2-B	16	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148989	10.1371/journal.pone.0148989	http://dx.doi.org/10.1371/journal.pone.0148989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849654	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000192
J	Souza, RT; Cecatti, JG; Passini, R; Tedesco, RP; Lajos, GJ; Nomura, ML; Rehder, PM; Dias, TZ; Haddad, SM; Pacagnella, RC; Costa, ML				Souza, Renato T.; Cecatti, Jose G.; Passini, Renato, Jr.; Tedesco, Ricardo P.; Lajos, Giuliane J.; Nomura, Marcelo L.; Rehder, Patricia M.; Dias, Tabata Z.; Haddad, Samira M.; Pacagnella, Rodolfo C.; Costa, Maria L.		Brazilian Multictr Study Preterm	The Burden of Provider-Initiated Preterm Birth and Associated Factors: Evidence from the Brazilian Multicenter Study on Preterm Birth (EMIP)	PLOS ONE			English	Article							ORGANIZATION MULTICOUNTRY SURVEY; RISK-FACTORS; SECONDARY ANALYSIS; ANTENATAL CORTICOSTEROIDS; PERINATAL-MORTALITY; SYSTEMATIC ANALYSIS; UNITED-STATES; TIME TRENDS; COUNTRIES; OBESITY	Background About 15 million children are born under 37 weeks of gestation worldwide. Prematurity is the leading cause of neonatal deaths and short/long term morbidities, entailing consequences not only for the individual, but also their family, health agencies, facilities and all community. The provider-initiated preterm birth is currently one of the most important obstetric conditions related to preterm births, particularly in middle and high income countries, thus decreasing the need for therapeutic preterm birth is essential to reduce global prematurity. Therefore detailed knowledge on the factors associated with provider-initiated preterm birth is essential for the efforts to reduce preterm birth rates and its consequences. In this current analysis we aimed to assess the proportion of provider-initiated (pi-PTB) among preterm births in Brazil and identify associated factors. Methods and Findings This is an analysis of a multicenter cross-sectional study with a nested case-control component called Brazilian Multicenter Study on Preterm Birth (EMIP). EMIP was conducted in 20 referral obstetric hospitals located in the three most populated of the five Brazilian regions. We analysed data of women with pi-PTB, defined as childbirth occurring at less than 37 weeks, medically indicated for maternal/fetal compromise or both; and women with term birth, childbirth at or after 37 weeks. Maternal, sociodemographic, obstetric, prenatal care, delivery, and postnatal characteristics were assessed as possible factors associated with pi-PTB, compared to term births. The overall prevalence of preterm births was 12.3%. Of these, approximately one-third of cases were initiated by the provider. Hypertensive disorders, placental abruption, and diabetes were the main maternal conditions leading to pi-PTB. Caesarean section was the most common mode of delivery. Chronic hypertension (OR 7.47; 95% CI 4.02-13.88), preeclampsia/eclampsia/HELLP syndrome (OR 15.35; 6.57-35.88), multiple pregnancy (OR 12.49; 4.86-32.05), and chronic diabetes (OR 5.24; 2.68-10.25) were the most significant factors independently associated with pi-PTB. Conclusions pi-PTB is responsible for about one-third of all preterm births, requiring special attention. The decision-making process relative to the choice of provider-initiated birth is complex, and many factors should be elucidated to improve strategies for its prevention, including evidence-based guidelines on proper management of the corresponding clinical conditions.	[Souza, Renato T.; Cecatti, Jose G.; Passini, Renato, Jr.; Tedesco, Ricardo P.; Lajos, Giuliane J.; Nomura, Marcelo L.; Rehder, Patricia M.; Dias, Tabata Z.; Haddad, Samira M.; Pacagnella, Rodolfo C.; Costa, Maria L.] Univ Estadual Campinas, UNICAMP, Sch Med, Dept Obstet & Gynecol, Campinas, SP, Brazil; [Tedesco, Ricardo P.] Jundiai Med Sch, Dept Obstet & Gynecol, Jundiai, SP, Brazil	Universidade Estadual de Campinas; Faculdade de Medicina de Jundiai	Cecatti, JG (corresponding author), Univ Estadual Campinas, UNICAMP, Sch Med, Dept Obstet & Gynecol, Campinas, SP, Brazil.	cecatti@unicamp.br	de Carvalho Pacagnella, Rodolfo/H-9390-2019; Leite, Debora F B/D-7299-2018; Costa, Maria Laura/I-4980-2019; Cecatti, Jose Guilherme/M-5945-2013; Dias, TÃbata/U-4512-2019; Jesus Lajos, Giuliane/GQZ-0157-2022; Souza, Renato T/G-4205-2017; Passini Junior, Renato/O-6169-2016; Amorim, Melania/C-5807-2013; Pacagnella, Rodolfo/H-6247-2012; Nomura, Marcelo Luís/H-9534-2019	de Carvalho Pacagnella, Rodolfo/0000-0002-5739-0009; Leite, Debora F B/0000-0001-8839-3934; Costa, Maria Laura/0000-0001-8280-3234; Cecatti, Jose Guilherme/0000-0003-1285-8445; Souza, Renato T/0000-0002-9075-9269; Passini Junior, Renato/0000-0001-8247-4549; Amorim, Melania/0000-0003-1047-2514; Pacagnella, Rodolfo/0000-0002-5739-0009; Nomura, Marcelo Luís/0000-0002-2664-4475	FAPESP (Foundation for Support to Research of the State of Sao Paulo) [2009/53245-5, Fapesp 2009/53245-5]; CNPq (Brazilian National Research Council) Brazil; CNPq (Brazilian National Research Council)	FAPESP (Foundation for Support to Research of the State of Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Brazilian National Research Council) Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); CNPq (Brazilian National Research Council)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Grant 2009/53245-5 from FAPESP (Foundation for Support to Research of the State of Sao Paulo), and by CNPq (Brazilian National Research Council) Brazil (JGC). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors acknowledge CNPq (Brazilian National Research Council) and FAPESP (Foundation for Support to Research of the State of Sao Paulo) for financial sponsorship of the study, Process Fapesp 2009/53245-5 (Call AP.PPSUS-1). These organizations did not participate in the study proposal, implementation or interpretation of results.	Abalos E, 2014, BJOG-INT J OBSTET GY, V121, P14, DOI 10.1111/1471-0528.12629; Ananth CV, 2005, OBSTET GYNECOL, V105, P1084, DOI 10.1097/01.AOG.0000158124.96300.c7; Barros FC, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S3; Baschat AA, 2015, ULTRASOUND OBST GYN, V45, P119, DOI 10.1002/uog.14770; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Berkowitz GS, 1998, EPIDEMIOLOGY, V9, P279, DOI 10.1097/00001648-199805000-00011; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Blencowe H, 2013, PEDIATR RES, V74, P4, DOI 10.1038/pr.2013.203; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Brazilian Ministry of Health, 2006, SINASC NAT INF SYST; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; de Jongh BE, 2014, MATERN CHILD HLTH J, V18, P511, DOI 10.1007/s10995-013-1296-8; de Oliveira FC, 2013, CLINICS, V68, P922, DOI 10.6061/clinics/2013(07)06; Dean SV, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S3; Di Renzo GC, 2009, J MATERN-FETAL NEO M, V22, P633, DOI 10.1080/14767050902866804; Farrar D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007122.pub3; Friedman AM, 2014, SEMIN PERINATOL, V38, P177, DOI 10.1053/j.semperi.2014.03.002; Gigante DP, 2009, REV SAUDE PUBL, V43, P83, DOI 10.1590/S0034-89102009000900011; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goldenberg RL, 2012, AM J OBSTET GYNECOL, V206, P113, DOI 10.1016/j.ajog.2011.10.865; Gyamfi-Bannerman C, 2012, SEMIN FETAL NEONAT M, V17, P132, DOI 10.1016/j.siny.2012.01.014; Gyamfi-Bannerman C, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.08.007; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; Joseph KS, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-117; Kattah AG, 2013, ADV CHRONIC KIDNEY D, V20, P229, DOI 10.1053/j.ackd.2013.01.014; Lajos Giuliane J, 2015, ScientificWorldJournal, V2015, P719104, DOI 10.1155/2015/719104; Lajos GJ, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-54; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S6; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Machado LC, 2014, J PEDIAT-BRAZIL, V90, P221, DOI 10.1016/j.jped.2013.08.012; Malloy MH, 2009, BIRTH-ISS PERINAT C, V36, P26, DOI 10.1111/j.1523-536X.2008.00292.x; McDonald Sarah D, 2010, BMJ, V341, pc3428, DOI 10.1136/bmj.c3428; Morisaki N, 2014, BJOG-INT J OBSTET GY, V121, P101, DOI 10.1111/1471-0528.12631; Nizard J, 2013, J GYNECOL OBST BIO R, V42, P1008, DOI 10.1016/j.jgyn.2013.09.022; Parker MG, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-153; Passini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109069; Passini R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-22; Rasmussen K, 2009, WEIGHT GAIN PREGN RE; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Roberts JM, 2014, SEMIN PERINATOL, V38, P139, DOI 10.1053/j.semperi.2014.03.005; Santos IS, 2008, CAD SAUDE PUBLICA, V24, pS381, DOI 10.1590/S0102-311X2008001500003; Serruya Suzanne Jacob, 2004, Cad. Saúde Pública, V20, P1281, DOI 10.1590/S0102-311X2004000500022; Tandu-Umba B, 2014, INT J WOMENS HEALTH, V6, P1011, DOI 10.2147/IJWH.S69230; Torloni MR, 2009, J MATERN-FETAL NEO M, V22, P957, DOI 10.3109/14767050903042561; Tranquilli AL, 2013, J MATERN-FETAL NEO M, V26, P1425, DOI 10.3109/14767058.2013.784263; Vogel JP, 2014, BJOG-INT J OBSTET GY, V121, P76, DOI 10.1111/1471-0528.12633; Vogel JP, 2014, LANCET, V384, P1869, DOI 10.1016/S0140-6736(14)60580-8; Vogel JP, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-56	49	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148244	10.1371/journal.pone.0148244	http://dx.doi.org/10.1371/journal.pone.0148244			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849228	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000056
J	Stoner, DC; Sexton, JO; Nagol, J; Bernales, HH; Edwards, TC				Stoner, David C.; Sexton, Joseph O.; Nagol, Jyoteshwar; Bernales, Heather H.; Edwards, Thomas C., Jr.			Ungulate Reproductive Parameters Track Satellite Observations of Plant Phenology across Latitude and Climatological Regimes	PLOS ONE			English	Article							DIFFERENCE VEGETATION INDEX; POPULATION-DYNAMICS; CLIMATE-CHANGE; RED DEER; SYNCHRONY; HERBIVORE; NDVI; PRODUCTIVITY; PARTURITION; GRADIENTS	The effect of climatically-driven plant phenology on mammalian reproduction is one key to predicting species-specific demographic responses to climate change. Large ungulates face their greatest energetic demands from the later stages of pregnancy through weaning, and so in seasonal environments parturition dates should match periods of high primary productivity. Interannual variation in weather influences the quality and timing of forage availability, which can influence neonatal survival. Here, we evaluated macro-scale patterns in reproductive performance of a widely distributed ungulate (mule deer, Odocoileus hemionus) across contrasting climatological regimes using satellite-derived indices of primary productivity and plant phenology over eight degrees of latitude (890 km) in the American Southwest. The dataset comprised > 180,000 animal observations taken from 54 populations over eight years (2004-2011). Regionally, both the start and peak of growing season ("Start" and "Peak", respectively) are negatively and significantly correlated with latitude, an unusual pattern stemming from a change in the dominance of spring snowmelt in the north to the influence of the North American Monsoon in the south. Corresponding to the timing and variation in both the Start and Peak, mule deer reproduction was latest, lowest, and most variable at lower latitudes where plant phenology is timed to the onset of monsoonal moisture. Parturition dates closely tracked the growing season across space, lagging behind the Start and preceding the Peak by 27 and 23 days, respectively. Mean juvenile production increased, and variation decreased, with increasing latitude. Temporally, juvenile production was best predicted by primary productivity during summer, which encompassed late pregnancy, parturition, and early lactation. Our findings offer a parsimonious explanation of two key reproductive parameters in ungulate demography, timing of parturition and mean annual production, across latitude and changing climatological regimes. Practically, this demonstrates the potential for broad-scale modeling of couplings between climate, plant phenology, and animal populations using space-borne observations.	[Stoner, David C.; Edwards, Thomas C., Jr.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Sexton, Joseph O.; Nagol, Jyoteshwar] Univ Maryland, Global Landcover Facil, Dept Geog Sci, College Pk, MD 20742 USA; [Bernales, Heather H.] Utah Div Wildlife Resources, Salt Lake City, UT USA; [Edwards, Thomas C., Jr.] US Geol Survey, Utah Cooperat Fish & Wildlife Res Unit, Logan, UT USA	Utah System of Higher Education; Utah State University; University System of Maryland; University of Maryland College Park; United States Department of the Interior; United States Geological Survey	Stoner, DC (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	david.stoner@usu.edu			National Aeronautics and Space Administration, Biodiversity and Ecological Forecasting Program [NNH10ZDA001N]	National Aeronautics and Space Administration, Biodiversity and Ecological Forecasting Program	Funding for this work was provided by National Aeronautics and Space Administration, Biodiversity and Ecological Forecasting Program, Grant no. NNH10ZDA001N.	Adams DK, 1997, B AM METEOROL SOC, V78, P2197, DOI 10.1175/1520-0477(1997)078<2197:TNAM>2.0.CO;2; ALBON SD, 1992, OIKOS, V65, P502, DOI 10.2307/3545568; Arizona Game and Fish Department, 2012, HUNG AR 2012 ED SURV; Bartlam-Brooks HLA, 2013, J GEOPHYS RES-BIOGEO, V118, P1427, DOI 10.1002/jgrg.20096; Bender LC, 2006, WILDLIFE SOC B, V34, P1225, DOI 10.2193/0091-7648(2006)34[1225:UOHCAA]2.0.CO;2; Bernales HH, 2013, UTAB DIVISION WILDLI, V13-21; Bernales HH, 2010, THESIS UTAH STATE U; Bischof R, 2012, AM NAT, V180, P407, DOI 10.1086/667590; Bishop CJ, 2009, WILDLIFE MONOGR, P1, DOI 10.2193/2008-107; Bissonette John A., 2008, Human-Wildlife Conflicts, V2, P17; Bonenfant C, 2005, J APPL ECOL, V42, P361, DOI 10.1111/j.1365-2664.2005.01008.x; Boone RB, 2006, ECOLOGY, V87, P1987, DOI 10.1890/0012-9658(2006)87[1987:SWMPMF]2.0.CO;2; BOWYER RT, 1991, J MAMMAL, V72, P138, DOI 10.2307/1381988; Bowyer RT, 1998, J MAMMAL, V79, P1332, DOI 10.2307/1383025; Cayan DR, 2010, P NATL ACAD SCI USA, V107, P21271, DOI 10.1073/pnas.0912391107; CLUTTONBROCK TH, 1987, J ANIM ECOL, V56, P53, DOI 10.2307/4799; Connolly GE, 1981, MULE BLACK TAILED DE, P245; Forrester TD, 2013, MAMMAL REV, V43, P292, DOI 10.1111/mam.12002; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Garel M, 2011, J MAMMAL, V92, P1112, DOI 10.1644/10-MAMM-A-056.1; Garrott RA, 2003, CAN J ZOOL, V81, P33, DOI 10.1139/Z02-218; GILBERT P F, 1970, Journal of Wildlife Management, V34, P15, DOI 10.2307/3799486; Hamel S, 2009, J APPL ECOL, V46, P582, DOI 10.1111/j.1365-2664.2009.01643.x; Hansen AJ, 2014, ECOL APPL, V24, P484, DOI 10.1890/13-0905.1; Harris NC, 2008, J WILDLIFE MANAGE, V60, P695; Hass CC, 1997, J MAMMAL, V78, P1251, DOI 10.2307/1383068; Heffelfinger J. R., 2006, DEER SW; Heffelfinger J.R., 2003, MULE DEER CONSERVATI, P63; Herfindal I, 2006, OECOLOGIA, V150, P213, DOI 10.1007/s00442-006-0519-8; Hurley MA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0196; Hurley MA, 2011, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.4; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; Kerby J., 2013, PHENOLOGY INTEGRATIV, P467, DOI [10.1007/978-94-007-6925-0_25, DOI 10.1007/978-94-007-6925-0_25]; Lendrum PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064548; Linnell JDC, 1998, J ZOOL, V244, P497, DOI 10.1017/S0952836998004038; Loe LE, 2005, J ANIM ECOL, V74, P579, DOI 10.1111/j.1365-2656.2005.00987.x; MacDonald GM, 2010, P NATL ACAD SCI USA, V107, P21256, DOI 10.1073/pnas.0909651107; Mackie R. J., 2003, WILD MAMMALS N AM BI, P889; Melis C, 2010, ECOSCIENCE, V17, P166, DOI 10.2980/17-2-3314; Monteith KL, 2014, WILDLIFE MONOGR, V186, P1, DOI 10.1002/wmon.1011; Monteith KL, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00096.1; Morellet N, 2013, J ANIM ECOL, V82, P1326, DOI 10.1111/1365-2656.12105; Ogutu JO, 2013, WILDLIFE RES, V40, P698, DOI 10.1071/WR13117; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Peek J., 2003, WILD MAMMALS N AM, P877; Pettorelli N, 2006, OIKOS, V112, P565, DOI 10.1111/j.0030-1299.2006.14447.x; Pettorelli N, 2007, ECOLOGY, V88, P381, DOI 10.1890/06-0875; Pettorelli N, 2014, J APPL ECOL, V51, P839, DOI 10.1111/1365-2664.12261; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Pierce BM, 2012, J MAMMAL, V93, P977, DOI 10.1644/12-MAMM-A-014.1; Plard F, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001828; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Post E, 2005, ECOLOGY, V86, P2320, DOI 10.1890/04-0823; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rabe MJ, 2002, WILDLIFE SOC B, V30, P46; Robinette WL, 1977, UTAH DIVISION WILDLI, V77-15; Rose RA, 2015, CONSERV BIOL, V29, P350, DOI 10.1111/cobi.12397; Rouse JW, 1973, 3 EARTH RES TECHN SA, VI; Ryan SJ, 2012, J WILDLIFE MANAGE, V76, P1499, DOI 10.1002/jwmg.407; Sadleir RMFS, 1969, ECOLOGY REPROD DOMES; Sawyer H, 2011, J ANIM ECOL, V80, P1078, DOI 10.1111/j.1365-2656.2011.01845.x; Schwartz M. D., 2013, PHENOLOGY INTEGRATIV, P1, DOI DOI 10.1109/ICAT.2013.6684065; Seager R, 2013, NAT CLIM CHANGE, V3, P482, DOI [10.1038/nclimate1787, 10.1038/NCLIMATE1787]; Singh NJ, 2010, DIVERS DISTRIB, V16, P663, DOI 10.1111/j.1472-4642.2010.00671.x; Swetnam TW, 2010, ADV GLOB CHANGE RES, V41, P329, DOI 10.1007/978-90-481-8736-2_32; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Turner W, 2014, SCIENCE, V346, P301, DOI 10.1126/science.1256014; Tveraa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056450; Unsworth JW, 1999, J WILDLIFE MANAGE, V63, P315, DOI 10.2307/3802515; Vermote E, 2009, IEEE T GEOSCI REMOTE, V47, P898, DOI 10.1109/TGRS.2008.2005977; Vermote EF, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009662; Wakeling B, 2000, P 5 BIENN C RES COL, P73; Western Association of Fish and Wildlife Agencies, 2004, W STAT PROV MUL DEER; Whiting JC, 2012, WILDLIFE RES, V39, P565, DOI 10.1071/WR12059	75	25	27	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148780	10.1371/journal.pone.0148780	http://dx.doi.org/10.1371/journal.pone.0148780			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849642	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000168
J	Wu, K; Su, XF; Li, GH; Zhang, NF				Wu, Kang; Su, Xiaofen; Li, Guihua; Zhang, Nuofu			Antioxidant Carbocysteine Treatment in Obstructive Sleep Apnea Syndrome: A Randomized Clinical Trial	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; INTIMA-MEDIA THICKNESS; OXIDATIVE STRESS; CAROTID-ARTERY; ENDOTHELIAL DYSFUNCTION; SYMPATHETIC ACTIVITY; BRACHIAL-ARTERY; CPAP TREATMENT; CARBOCISTEINE; VASODILATION	Objective This study aimed to examine the effects of carbocysteine in OSAS patients. Methods A total of 40 patients with moderate to severe obstructive sleep apnea syndrome (OSAS) were randomly divided into two groups. One group was treated with 1500 mg carbocysteine daily, and the other was treated with continuous positive airway pressure (CPAP) at night. Before treatment and after 6 weeks of treatment, all patients underwent polysomnography and completed questionnaires. Treatment compliance was compared between the two groups. Plasma was collected for various biochemical analyses. Endothelial function was assessed with ultrasound in the carbocysteine group. Results The proportion of patients who fulfilled the criteria for good compliance was higher in the carbocysteine group (n = 17) than in the CPAP group (n = 11; 100% vs. 64.7%). Compared with baseline values, the carbocysteine group showed significant improvement in their Epworth Sleepiness Scale score (10.18 +/- 4.28 vs. 6.82 +/- 3.66; P <= 0.01), apnea-hypopnea index (55.34 +/- 25.03 vs. 47.56 +/- 27.32; P <= 0.01), time and percentage of 90% oxygen desaturation (12.66 (2.81; 50.01) vs. 8.9 (1.41; 39.71); P <= 0.01), and lowest oxygen saturation level (65.88 +/- 14.86 vs. 70.41 +/- 14.34; P <= 0.01). Similar changes were also observed in the CPAP group. The CPAP group also showed a decreased oxygen desaturation index and a significant increase in the mean oxygen saturation after treatment, but these increases were not observed in the carbocysteine group. Snoring volume parameters, such as the power spectral density, were significantly reduced in both groups after the treatments. The plasma malondialdehyde level decreased and the superoxide dismutase and nitric oxide levels increased in both groups. The endothelin-1 level decreased in the CPAP group but did not significantly change in the carbocysteine group. Ultrasonography showed that the intima-media thickness decreased (0.71 +/- 0.15 vs. 0.66 +/- 0.15; P <= 0.05) but that flow-mediated dilation did not significantly change in the carbocysteine group. Conclusions Oral carbocysteine slightly improves sleep disorders by attenuating oxidative stress in patients with moderate to severe OSAS. Carbocysteine may have a role in the treatment of OSAS patients with poor compliance with CPAP treatment. However, the efficiency and feasibility of carbocysteine treatment for OSAS needs further evaluation.	[Wu, Kang; Su, Xiaofen; Li, Guihua; Zhang, Nuofu] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou Inst Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Zhang, NF (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou Inst Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	nfzhanggird@163.com			Science and Technology Planning Project of Guangdong Province, China [2008B03031254]	Science and Technology Planning Project of Guangdong Province, China	NFZ received the funding from Science and Technology Planning Project of Guangdong Province, China (2008B03031254). http://pro.gdstc.gov.cn/egrantweb/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, Adv Cardiol, V46, P139, DOI 10.1159/000325108; Fiz JA, 2010, LARYNGOSCOPE, V120, P854, DOI 10.1002/lary.20815; Barcelo A, 2006, EUR RESPIR J, V27, P756, DOI 10.1183/09031936.06.00067605; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Ciccone MM, 2012, RESP MED, V106, P740, DOI 10.1016/j.rmed.2011.12.016; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Dunleavy M, 2008, ADV EXP MED BIOL, V605, P458; El Solh AA, 2006, EUR RESPIR J, V27, P997, DOI 10.1183/09031936.06.00101005; Evans MD, 2004, BIOESSAYS, V26, P533, DOI 10.1002/bies.20027; Gong L, 2011, CHINA CONTINUING MED, V7, P318; Grebe M, 2006, AM J RESP CRIT CARE, V173, P897, DOI 10.1164/rccm.200508-1223OC; Grimpen F, 2000, EUR RESPIR J, V15, P320, DOI 10.1034/j.1399-3003.2000.15b17.x; Guizzardi F, 2006, J MOL MED, V84, P97, DOI 10.1007/s00109-005-0720-y; Hashimoto M, 1999, ARTERIOSCL THROM VAS, V19, P2795, DOI 10.1161/01.ATV.19.11.2795; Hatipoglu U, 2003, RESPIRATION, V70, P665, DOI 10.1159/000075218; HEDNER J, 1995, EUR RESPIR J, V8, P222, DOI 10.1183/09031936.95.08020222; Hon QYBMS, 2006, SLEEP, V29, P545, DOI 10.1093/sleep/29.4.545; Hui DS, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-22; Ip MSM, 2000, AM J RESP CRIT CARE, V162, P2166, DOI 10.1164/ajrccm.162.6.2002126; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jurado-Gamez B, 2011, EUR RESPIR J, V37, P873, DOI 10.1183/09031936.00027910; Jurkovicova I, 2004, ACTA MED AUST, V31, P45; Kakkar RK, 2007, CHEST, V132, P1057, DOI 10.1378/chest.06-2432; Lavie L, 2003, SLEEP MED REV, V7, P35, DOI 10.1053/smrv.2002.0261; Lavie Lena, 2012, Front Biosci (Elite Ed), V4, P1391; Lei X, 2013, ELECT MEASUREMENT TE, V36, P6; Nguyen PK, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-50; Nogawa H, 2009, RESPIROLOGY, V14, P53, DOI 10.1111/j.1440-1843.2008.01424.x; Phillips BG, 1999, J HYPERTENS, V17, P61, DOI 10.1097/00004872-199917010-00010; Phillips CL, 2007, J SLEEP RES, V16, P217, DOI 10.1111/j.1365-2869.2007.00589.x; REMMERS JE, 1978, J APPL PHYSIOL, V44, P931, DOI 10.1152/jappl.1978.44.6.931; Sadasivam K, 2011, Indian J Chest Dis Allied Sci, V53, P153; Singh T D, 2009, Indian J Chest Dis Allied Sci, V51, P217; Sola-Soler J, 2012, MED ENG PHYS, V34, P1213, DOI 10.1016/j.medengphy.2011.12.008; Stepnowsky CJ, 2003, J PSYCHOSOM RES, V54, P599, DOI 10.1016/S0022-3999(03)00038-2; Suzuki T, 2004, SLEEP, V27, P129, DOI 10.1093/sleep/27.1.129; van den Oord SCH, 2013, ATHEROSCLEROSIS, V228, P1, DOI 10.1016/j.atherosclerosis.2013.01.025; Veasey SC, 2004, AM J RESP CRIT CARE, V170, P665, DOI 10.1164/rccm.200403-261OC; Yim-Yeh S, 2010, SLEEP, V33, P1177, DOI 10.1093/sleep/33.9.1177; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zheng JP, 2008, LANCET, V371, P2013, DOI 10.1016/S0140-6736(08)60869-7	41	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148519	10.1371/journal.pone.0148519	http://dx.doi.org/10.1371/journal.pone.0148519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849119	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000115
J	Charest-Morin, X; Marceau, F				Charest-Morin, Xavier; Marceau, Francois			Biotechnological Fluorescent Ligands of the Bradykinin B-1 Receptor: Protein Ligands for a Peptide Receptor	PLOS ONE			English	Article							MONONUCLEAR-CELLS; KININ RECEPTORS; EXPRESSION; B1; TRANSLOCATION	The bradykinin (BK) B-1 receptor (B1R) is a peculiar G protein coupled receptor that is strongly regulated to the point of being inducible in immunopathology. Limited clinical evidence suggests that its expression in peripheral blood mononuclear cells is a biomarker of active inflammatory states. In an effort to develop a novel imaging/diagnostic tool, we report the rational design and testing of a fusion protein that is a ligand of the human B1R but not likely to label peptidases. This ligand is composed of a fluorescent protein (FP) (enhanced green FP [EGFP] or mCherry) prolonged at its N-terminus by a spacer peptide and a classical peptide agonist or antagonist (des-Arg(9)-BK, [Leu(8)]des-Arg(9)-BK, respectively). The design of the spacer-ligand joint peptide was validated by a competition assay for [H-3]Lysdes-Arg(9)-BK binding to the human B1R applied to 4 synthetic peptides of 18 or 19 residues. The labeling of B1R-expressing cells with EGFP or mCherry fused with 7 of such peptides was performed in parallel (microscopy). Both assays indicated that the best design was FP(Asn-Gly)(n)-Lys-des-Arg(9)-BK; n = 15 was superior to n = 5, suggesting benefits from minimizing steric hindrance between the FP and the receptor. Cell labeling concerned mostly plasma membranes and was inhibited by a B1R antagonist. EGFP-(Asn-Gly)(15)-Lys-des-Arg(9)-BK competed for the binding of [H-3]Lys-des-Arg(9)-BK to human recombinant B1R, being only 10-fold less potent than the unlabeled form of Lys-des-Arg(9)-BK to do so. The fusion protein did not label HEK 293a cells expressing recombinant human BK B-2 receptors or angiotensin converting enzyme. This study identifies a modular C-terminal sequence that can be adapted to protein cargoes, conferring high affinity for the BK B1R, with possible applications in diagnostic cytofluorometry, histology and drug delivery (e.g., in oncology).	[Marceau, Francois] Univ Laval, CHU Quebec, Ctr Rech Rhumatol & Immunol, Quebec City, PQ G1V 4G2, Canada; [Marceau, Francois] Univ Laval, Dept Microbiol Infect Dis & Immunol, Quebec City, PQ G1V 4G2, Canada	Laval University; Laval University	Marceau, F (corresponding author), Univ Laval, CHU Quebec, Ctr Rech Rhumatol & Immunol, Quebec City, PQ G1V 4G2, Canada.; Marceau, F (corresponding author), Univ Laval, Dept Microbiol Infect Dis & Immunol, Quebec City, PQ G1V 4G2, Canada.	francois.marceau@crchul.ulaval.ca	Marceau, François/C-7471-2011	Marceau, François/0000-0003-1691-6083	Canadian Institutes of Health Research [MOP-93773]; Fonds de recherche du Quebec - Sante	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec)	This study was supported by the Canadian Institutes of Health Research (grant MOP-93773 to F.M.) and the Fonds de recherche du Quebec - Sante (Studentship to X.C.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Bastian S, 1997, BRIT J PHARMACOL, V122, P393, DOI 10.1038/sj.bjp.0701380; Bawolak MT, 2009, J PHARMACOL EXP THER, V329, P159, DOI 10.1124/jpet.108.149724; Charest-Morin X, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.119; Charest-Morin X, 2013, PHARMACOL RES PERSPE, V1, DOI 10.1002/prp2.4; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Cyr M, 2001, AM J PHYSIOL-HEART C, V281, pH275, DOI 10.1152/ajpheart.2001.281.1.H275; Dabek J, 2008, INTERN MED J, V38, P892, DOI 10.1111/j.1445-5994.2008.01718.x; Dabek J, 2007, SCAND CARDIOVASC J, V41, P391, DOI 10.1080/14017430701499379; Enquist J, 2007, MOL PHARMACOL, V71, P494, DOI 10.1124/mol.106.030858; Fortin JP, 2009, P NATL ACAD SCI USA, V106, P8049, DOI 10.1073/pnas.0900149106; Gera L, 2011, J PHARMACOL EXP THER, V337, P33, DOI 10.1124/jpet.110.177147; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Koumbadinga GA, 2010, EUR J PHARMACOL, V647, P117, DOI 10.1016/j.ejphar.2010.08.008; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Lin KS, 2015, CANCER RES, V75, P387, DOI 10.1158/0008-5472.CAN-14-1603; Liu ZB, 2015, MOL PHARMACEUT, V12, P974, DOI 10.1021/acs.molpharmaceut.5b00003; Marceau F, 1997, CAN J PHYSIOL PHARM, V75, P725, DOI 10.1139/cjpp-75-6-725; Marceau F., 2013, J ANGIOEDEMA, V1, P9; Moreau ME, 2007, MOL PHARMACOL, V71, P949, DOI 10.1124/mol.106.030684; Morissette G, 2004, J PHARMACOL EXP THER, V311, P1121, DOI 10.1124/jpet.104.071266; Morissette G, 2008, PEPTIDES, V29, P606, DOI 10.1016/j.peptides.2007.12.004; Morissette G, 2006, CAN J PHYSIOL PHARM, V84, P1107, DOI 10.1139/Y06-031; Prat A, 2005, ARCH NEUROL-CHICAGO, V62, P795, DOI 10.1001/archneur.62.5.795; Sabourin T, 2002, MOL PHARMACOL, V61, P546, DOI 10.1124/mol.61.3.546	25	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148246	10.1371/journal.pone.0148246	http://dx.doi.org/10.1371/journal.pone.0148246			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844555	Green Published, gold, Green Submitted			2022-12-27	WOS:000369552800039
J	Vallejos, MAV; Padial, AA; Vitule, JRS				Villegas Vallejos, Marcelo Alejandro; Padial, Andre Andrian; Simoes Vitule, Jean Ricardo			Human-Induced Landscape Changes Homogenize Atlantic Forest Bird Assemblages through Nested Species Loss	PLOS ONE			English	Article							URBAN-RURAL GRADIENT; BIOTIC HOMOGENIZATION; ARAUCARIA FOREST; BETA-DIVERSITY; CITIZEN SCIENCE; GLOBAL PATTERNS; URBANIZATION; COMMUNITIES; CONSERVATION; BIODIVERSITY	The increasing number of quantitative assessments of homogenization using citizen science data is particularly important in the Neotropics, given its high biodiversity and ecological peculiarity, and whose communities may react differently to landscape changes. We looked for evidence of taxonomic homogenization in terrestrial birds by investigating patterns of beta diversity along a gradient of human-altered landscapes (HAL), trying to identify species associated with this process. We analyzed bird data from 87 sites sampled in a citizen science program in the south Brazilian Atlantic Forest. Regional-scale taxonomic homogenization was assessed by comparing beta diversity among sites in different HALs (natural, rural or urban landscapes) accounting for variation derived from geographical distance and zoogeographical affinities by georeferencing sites and determining their position in a phytogeographical domain. Beta diversity was calculated by multivariate dispersion and by testing compositional changes due to turnover and nestedness among HALs and phytogeographical domains. Finally, we assessed which species were typical for each group using indicator species analysis. Bird homogenization was indicated by decreases in beta diversity following landscape changes. Beta diversity of rural sites was roughly half that of natural habitats, while urban sites held less than 10% of the natural areas' beta diversity. Species composition analysis revealed that the turnover component was important in differentiating sites depending on HAL and phytogeography; the nestedness component was important among HALs, where directional species loss is maintained even considering effects of sampling effort. A similar result was obtained among phytogeographical domains, indicating nested-pattern dissimilarity among compositions of overlapping communities. As expected, a few native generalists and non-native urban specialists were characteristic of rural and urban sites. We generated strong evidence that taxonomic homogenization occurs in the south Brazilian Atlantic Forest as a result of a directional and nested species loss, with the resultant assemblages composed of few disturbance-tolerant birds.	[Villegas Vallejos, Marcelo Alejandro] Hori Consultoria Ambiental, Curitiba, Parana, Brazil; [Padial, Andre Andrian] Univ Fed Parana, Dept Bot, BR-80060000 Curitiba, Parana, Brazil; [Padial, Andre Andrian; Simoes Vitule, Jean Ricardo] Univ Fed Parana, Setor Ciencias Biol, Programa Posgrad Ecol & Conservacao, BR-80060000 Curitiba, Parana, Brazil; [Simoes Vitule, Jean Ricardo] Univ Fed Parana, Setor Tecnol, Dept Engn Ambiental, Lab Ecol & Conservacao, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal do Parana; Universidade Federal do Parana	Vallejos, MAV (corresponding author), Hori Consultoria Ambiental, Curitiba, Parana, Brazil.	mvillegas.bio@gmail.com	Vitule, Jean Ricardo Simões/D-9822-2012; Padial, Andre Andrian/H-8977-2012; Villegas, Marcelo/Z-1438-2019	Vitule, Jean Ricardo Simões/0000-0001-6543-7439; Padial, Andre Andrian/0000-0002-8766-5974; Villegas, Marcelo/0000-0002-0275-1719	Brazilian National Council for Scientific and Technological Development (CNPq)	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	JRSV and AAP thank the Brazilian National Council for Scientific and Technological Development (CNPq) for providing constant financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Neto M, 2012, GLOBAL ECOL BIOGEOGR, V21, P772, DOI 10.1111/j.1466-8238.2011.00709.x; Borges FJA, 2010, BIODIVERS CONSERV, V19, P223, DOI 10.1007/s10531-009-9718-z; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Gonzalez-Oreja JA, 2011, BIOL CONSERV, V144, P234, DOI 10.1016/j.biocon.2010.08.021; Aronson MFJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3330; Baeten L, 2012, BIODIVERS CONSERV, V21, P1399, DOI 10.1007/s10531-012-0251-0; Baiser B, 2012, P ROY SOC B-BIOL SCI, V279, P4772, DOI 10.1098/rspb.2012.1651; Banks-Leite C, 2014, SCIENCE, V345, P1041, DOI 10.1126/science.1255768; Baselga A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127913; Baselga A, 2015, METHODS ECOL EVOL, V6, P1069, DOI 10.1111/2041-210X.12388; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1223, DOI 10.1111/j.1466-8238.2011.00756.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Behling H, 2007, PHILOS T R SOC B, V362, P243, DOI 10.1098/rstb.2006.1984; Bispo AA, 2010, BIOTA NEOTROP, V10, P121, DOI 10.1590/S1676-06032010000100012; Blair R, 2004, ECOL SOC, V9; Bregman TP, 2014, BIOL CONSERV, V169, P372, DOI 10.1016/j.biocon.2013.11.024; BROWN JH, 1978, AM ZOOL, V18, P687; Cardoso GC, 2014, GLOBAL CHANGE BIOL, V20, P803, DOI 10.1111/gcb.12410; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Carvalho JC, 2013, OIKOS, V122, P825, DOI 10.1111/j.1600-0706.2012.20980.x; CAVALCANTI RB, 1988, CONDOR, V90, P40, DOI 10.2307/1368430; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; Clergeau P, 2006, BIOL CONSERV, V127, P336, DOI 10.1016/j.biocon.2005.06.035; Clergeau P, 1998, CONDOR, V100, P413, DOI 10.2307/1369707; Cockle KL, 2011, FRONT ECOL ENVIRON, V9, P377, DOI 10.1890/110013; Conole LE, 2014, PEERJ, V2, DOI 10.7717/peerj.306; Costa Lilian Mariana, 2013, Ornitologia Neotropical, V24, P95; Croci S, 2008, CONDOR, V110, P223, DOI 10.1525/cond.2008.8409; Daga VS, 2015, HYDROBIOLOGIA, V746, P327, DOI 10.1007/s10750-014-2032-0; Solar RRD, 2015, ECOL LETT, V18, P1108, DOI 10.1111/ele.12494; Vasconcelos Marcelo Ferreira de, 2013, Pap. Avulsos Zool. (São Paulo), V53, P327, DOI 10.1590/S0031-10492013002500001; Devictor V, 2008, GLOBAL ECOL BIOGEOGR, V17, P252, DOI 10.1111/j.1466-8238.2007.00364.x; Devictor V, 2007, CONSERV BIOL, V21, P741, DOI 10.1111/j.1523-1739.2007.00671.x; Devictor V, 2010, DIVERS DISTRIB, V16, P354, DOI 10.1111/j.1472-4642.2009.00615.x; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Dobson A. J, 2002, INTRO GEN LINEAR MOD; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ellis EC, 2015, ECOL MONOGR, V85, P287, DOI 10.1890/14-2274.1; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; EMLEN JT, 1974, CONDOR, V76, P184, DOI 10.2307/1366729; Ensing DJ, 2015, ECOL COMPLEX, V21, P62, DOI 10.1016/j.ecocom.2014.11.008; Ferenc M, 2014, GLOBAL ECOL BIOGEOGR, V23, P479, DOI 10.1111/geb.12130; Fleishman E., 2005, Animal Biodiversity and Conservation, V28, P45; Fontana CS, 2011, URBAN ECOSYST, V14, P341, DOI 10.1007/s11252-011-0156-9; Fontana Carla Suertegaray, 2005, Comunicacoes do Museu de Ciencias e Tecnologia da PUCRS Serie Zoologia, V18, P161; Franz I, 2010, BRAZ J BIOL, V70, P1137, DOI 10.1590/S1519-69842010000600002; Fuller RA, 2009, DIVERS DISTRIB, V15, P328, DOI 10.1111/j.1472-4642.2008.00537.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harris DJ, 2011, AM NAT, V177, P535, DOI 10.1086/658990; Hernandez-Brito D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100593; Isaac B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091049; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Karp DS, 2012, ECOL LETT, V15, P963, DOI 10.1111/j.1461-0248.2012.01815.x; KRUGEL M.M., 2000, ORNITOL NEOTROP, V11, P315; La Sorte FA, 2007, J BIOGEOGR, V34, P2159, DOI 10.1111/j.1365-2699.2007.01761.x; Las-Casas FMG, 2012, BRAZ J BIOL, V72, P51, DOI 10.1590/S1519-69842012000100006; Lees AC, 2014, IBIS; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; Lim HC, 2004, LANDSCAPE URBAN PLAN, V66, P199, DOI 10.1016/S0169-2046(03)00111-7; Luck GW, 2007, J BIOGEOGR, V34, P201, DOI 10.1111/j.1365-2699.2006.01575.x; Luck GW, 2011, J BIOGEOGR, V38, P894, DOI 10.1111/j.1365-2699.2010.02449.x; Luzar JB, 2011, BIOSCIENCE, V61, P771, DOI 10.1525/bio.2011.61.10.7; MacGregor-Fors I, 2012, REV MEX BIODIVERS, V83, P477; Maron M, 2013, DIVERS DISTRIB, V19, P1468, DOI 10.1111/ddi.12128; McGill BJ, 2015, TRENDS ECOL EVOL, V30, P104, DOI 10.1016/j.tree.2014.11.006; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Meffert PJ, 2013, LANDSCAPE ECOL, V28, P943, DOI 10.1007/s10980-013-9867-z; Melo FPL, 2013, TRENDS ECOL EVOL, V28, P462, DOI 10.1016/j.tree.2013.01.001; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI 10.1111/j.1466-822x.2006.00214.x; Olden JD, 2006, J BIOGEOGR, V33, P2027, DOI 10.1111/j.1365-2699.2006.01572.x; Ortega-Alvarez R, 2011, LANDSCAPE URBAN PLAN, V101, P1, DOI 10.1016/j.landurbplan.2010.12.020; Parker TA III, 1996, NEOTROPICAL BIRDS EC, P131; Pautasso M, 2011, GLOBAL ECOL BIOGEOGR, V20, P426, DOI 10.1111/j.1466-8238.2010.00616.x; Pinheiro RT, 2008, REV BRAS ORNITOL, V16, P339; Pizo MA, 2001, WILSON BULL, V113, P388, DOI 10.1676/0043-5643(2001)113[0388:TDLOTS]2.0.CO;2; Podani J, 2011, OIKOS, V120, P1625, DOI 10.1111/j.1600-0706.2011.19451.x; Puttker T, 2015, OIKOS, V124, P206, DOI 10.1111/oik.01018; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; RAUP DM, 1979, J PALEONTOL, V53, P1213; Reis E, 2012, LANDSCAPE URBAN PLAN, V107, P31, DOI 10.1016/j.landurbplan.2012.04.009; Reynaud PA, 2000, J ENVIRON MANAGE, V59, P121, DOI 10.1006/jema.2000.0338; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Roberts D., 2007, LABDSV ORDINATION MU; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Roderjan CV, 2002, CIENCIA AMBIENTE, V24, P75; Sarukhan J, 2015, BIOSCIENCE, V65, P164, DOI 10.1093/biosci/biu195; Scherer-Neto P, 2012, IHERINGIA SER ZOOL, V102, P412, DOI 10.1590/S0073-47212012000400007; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Vitule JRS, 2012, DIVERS DISTRIB, V18, P111, DOI 10.1111/j.1472-4642.2011.00821.x; Sol D, 2014, ECOL LETT, V17, P942, DOI 10.1111/ele.12297; STRAUBE FC, 2007, CIENCIA AMBIENTE, V35, P137; Straube FC, 2009, AVES CURITIBA COLETA; Straube FC, 2013, IPAVE 2012 INVENTARI; Tabarelli M, 2012, BIOL CONSERV, V155, P136, DOI 10.1016/j.biocon.2012.06.020; Tewksbury JJ, 2006, ECOLOGY, V87, P759, DOI 10.1890/04-1790; Toledo MCB, 2008, BRAZ J BIOL, V68, P419, DOI 10.1590/S1519-69842008000200027; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Turner IM, 1996, J APPL ECOL, V33, P200, DOI 10.2307/2404743; van Rensburg BJ, 2009, LANDSCAPE URBAN PLAN, V92, P233, DOI 10.1016/j.landurbplan.2009.05.002; Villegas Mariana, 2010, Urban Ecosystems, V13, P375, DOI 10.1007/s11252-010-0126-7; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Volpato GH, 2010, FOREST ECOL MANAG, V260, P1156, DOI 10.1016/j.foreco.2010.07.006	114	17	17	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147058	10.1371/journal.pone.0147058	http://dx.doi.org/10.1371/journal.pone.0147058			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840957	Green Submitted, gold, Green Published			2022-12-27	WOS:000369550200023
J	Walachowski, S; Tabouret, G; Foucras, G				Walachowski, Sarah; Tabouret, Guillaume; Foucras, Gilles			Triggering Dectin-1-Pathway Alone Is Not Sufficient to Induce Cytokine Production by Murine Macrophages	PLOS ONE			English	Article							BETA-GLUCAN RECEPTOR; INFLAMMATORY RESPONSES; IMMUNE-RESPONSES; TNF-ALPHA; RECOGNITION; INNATE; PARTICULATE; ACTIVATION; MONOCYTES; YEAST	beta-glucans (BG) are abundant polysaccharides of the Saccharomyces cerevisiae cell wall (Sc CW), an industry byproduct. They have immuno-stimulatory properties upon engagement of dectin-1 (Clec7a), their main receptor on particular immune cells, and they actually become of great interest because of their preventive or therapeutic potentials. Zymosan, a crude extract of Sc CW was studied as a prototypic BG, despite its miscellaneous PAMPs content. Here, we examined the response of murine wild type or Clec7a(-/-) bone marrow-derived macrophages (BMDM) to products with increasing BG content (15, 65 or 75%) and compared their effects with those of other dectin-1 ligands. The enrichment process removed TLR ligands while preserving dectin-1 activity. The most enriched extracts have very low NF kappa B activity and triggered low amounts of cytokine production in contrast with crude products like zymosan and BG15. Furthermore, MyD88(-/-) BMDM did not produce TNF alpha in response to crude Sc CW extracts, whereas their response to BG-enriched extracts was unaffected, suggesting that BG alone are not able to initiate cytokine secretion. Although Sc CW-derived BG stimulated the late and strong expression of Csf2 in a dectin-1-dependent manner, they remain poor inducers of chemokine and cytokine production in murine macrophages.	[Walachowski, Sarah; Tabouret, Guillaume; Foucras, Gilles] Univ Toulouse, INP ENVT, UMR 1225, IHAP, Toulouse, France; [Walachowski, Sarah; Tabouret, Guillaume; Foucras, Gilles] INRA, UMR1225, IHAP, F-31931 Toulouse, France	Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; INRAE	Foucras, G (corresponding author), Univ Toulouse, INP ENVT, UMR 1225, IHAP, Toulouse, France.	g.foucras@envt.fr	FOUCRAS, Gilles/A-3061-2014	FOUCRAS, Gilles/0000-0002-0363-0337; Walachowski, Sarah/0000-0001-5702-3404; TABOURET, Guillaume/0000-0002-7976-4438	Phileo-Lesaffre Animal Care; Institut National de la Recherche Agronomique (INRA); Institut National Polytechnique - Ecole Nationale Veterinaire de Toulouse (INP-ENVT)	Phileo-Lesaffre Animal Care; Institut National de la Recherche Agronomique (INRA); Institut National Polytechnique - Ecole Nationale Veterinaire de Toulouse (INP-ENVT)	This work was partly financed by Phileo-Lesaffre Animal Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Other sources of funding were from Institut National de la Recherche Agronomique (INRA) and Institut National Polytechnique - Ecole Nationale Veterinaire de Toulouse (INP-ENVT).	Accarias S, 2015, EUR J IMMUNOL, V45, P794, DOI 10.1002/eji.201445098; Adams EL, 2008, J PHARMACOL EXP THER, V325, P115, DOI 10.1124/jpet.107.133124; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Chen JZ, 2007, MYCOL RES, V111, P635, DOI 10.1016/j.mycres.2007.02.011; Dabritz J, 2015, J IMMUNOL, V194, P2424, DOI 10.4049/jimmunol.1401482; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Dennehy KM, 2009, EUR J IMMUNOL, V39, P1379, DOI 10.1002/eji.200838543; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Elcombe SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060086; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gersuk GM, 2008, J IMMUNOL METHODS, V329, P157, DOI 10.1016/j.jim.2007.10.003; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Huang HB, 2012, J IMMUNOL, V189, P312, DOI 10.4049/jimmunol.1200603; Huang HB, 2009, INFECT IMMUN, V77, P1774, DOI 10.1128/IAI.00086-09; Ifrim DC, 2013, J IMMUNOL, V190, P4129, DOI 10.4049/jimmunol.1202611; Ito K, 2009, INT IMMUNOPHARMACOL, V9, P1189, DOI 10.1016/j.intimp.2009.06.007; Jimenez-A MD, 2008, GENES IMMUN, V9, P338, DOI 10.1038/gene.2008.23; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Kataoka K, 2002, J BIOL CHEM, V277, P36825, DOI 10.1074/jbc.M206756200; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Lastrucci C, 2015, FASEB J, V29, P1914, DOI 10.1096/fj.14-259341; Le Cabec V, 2000, INFECT IMMUN, V68, P4736, DOI 10.1128/IAI.68.8.4736-4745.2000; Li XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080399; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; MacKenzie S, 2002, J LEUKOCYTE BIOL, V71, P1026; Masuda Y, 2012, J LEUKOCYTE BIOL, V91, P547, DOI 10.1189/jlb.0711386; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; McKenzie CGJ, 2010, INFECT IMMUN, V78, P1650, DOI 10.1128/IAI.00001-10; Min L, 2012, J IMMUNOL, V188, P1789, DOI 10.4049/jimmunol.1101755; Munemoto Y, 2002, INT J ONCOL, DOI [10.3892/ijo.20.2.403, DOI 10.3892/IJO.20.2.403]; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Ohman T, 2014, J IMMUNOL, V192, P5952, DOI 10.4049/jimmunol.1303213; OLIVAS E, 1995, J IMMUNOL METHODS, V182, P73, DOI 10.1016/0022-1759(95)00024-5; PILLEMER L, 1956, J EXP MED, V103, P1, DOI 10.1084/jem.103.1.1; Qi CJ, 2011, BLOOD, V117, P6825, DOI 10.1182/blood-2011-02-339812; Rice PJ, 2002, J LEUKOCYTE BIOL, V72, P140; RIGGI SJ, 1961, AM J PHYSIOL, V200, P297, DOI 10.1152/ajplegacy.1961.200.2.297; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Roy S, 2011, WOUND REPAIR REGEN, V19, P411, DOI 10.1111/j.1524-475X.2011.00688.x; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Shah VB, 2008, J IMMUNOL, V180, P2777, DOI 10.4049/jimmunol.180.5.2777; SKLAR MD, 1985, J CELL PHYSIOL, V125, P403, DOI 10.1002/jcp.1041250307; Tada H, 2002, MICROBIOL IMMUNOL, V46, P503, DOI 10.1111/j.1348-0421.2002.tb02727.x; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Viriyakosol S, 2013, MBIO, V4, DOI 10.1128/mBio.00597-12; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406	56	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148464	10.1371/journal.pone.0148464	http://dx.doi.org/10.1371/journal.pone.0148464			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840954	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200140
J	Dimala, CA; Atashili, J; Mbuagbaw, JC; Wilfred, A; Monekosso, GL				Dimala, Christian Akem; Atashili, Julius; Mbuagbaw, Josephine C.; Wilfred, Akam; Monekosso, Gottlieb L.			Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naive Patients at the Limbe Regional Hospital, Cameroon	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; BLOOD-PRESSURE; INSULIN-RESISTANCE; GLUCOSE; INDIVIDUALS; INHIBITORS; COHORT; IMPACT	Background Highly active antiretroviral therapy (HAART) has greatly reduced the morbidity and mortality of HIV/AIDS patients but has also been associated with increased metabolic complications and cardiovascular diseases. Data on the association between HAART and hypertension (HTN) in Africa are scarce. Objectives Primarily to compare the prevalence of HTN in HIV/AIDS patients on HAART and HAART-naive patients in Limbe, Cameroon; and secondarily to assess other socio-demographic and clinical factors associated with HTN in this population. Methods A cross-sectional study was conducted at the Limbe Regional Hospital HIV treatment center between April and June 2013, involving 200 HIV/AIDS patients (100 on first-line HAART regimens for at least 12 months matched by age and sex to 100 HAART-naive patients). HTN was defined as a systolic blood pressure (BP) >= 140 mmHg and/or diastolic BP >= 90 mmHg. Results The prevalence of HTN in patients on HAART was twice (38%; 95% CI: 28.5-48.3) that of the HAART-naive patients (19%; 95% CI, 11.8-28.1), p = 0.003. In multivariate analyses adjusted for age, gender, smoking, family history of HTN, and BMI-defined overweight, HAART was associated with HTN, the adjusted odds ratio of the HAART-treated versus HAART-naive group was 2.20 (95% CI: 1.07-4.52), p = 0.032. HTN was associated with older age and male gender, in the HAART group and with BMI-defined overweight in the HAART-naive group. Conclusion The prevalence of hypertension in HIV/AIDS patients in Limbe stands out to be elevated, higher in patients on HAART compared to those not on treatment. Blood pressure and cardiovascular risk factors should be routinely monitored. Other factors such as diet, weight control and physical exercise should also be considered.	[Dimala, Christian Akem] London Sch Hyg & Trop Med, London WC1, England; [Atashili, Julius; Mbuagbaw, Josephine C.; Wilfred, Akam; Monekosso, Gottlieb L.] Univ Buea, Fac Hlth Sci, Buea, Cameroon	University of London; London School of Hygiene & Tropical Medicine	Dimala, CA (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	akdimch@yahoo.com		Akem Dimala, Christian/0000-0002-0064-0126				[Anonymous], 2009, FAST FACTS HIV TREAT; Behrens G, 1999, AIDS, V13, pF63, DOI 10.1097/00002030-199907090-00001; Bergersen BM, 2003, EUR J CLIN MICROBIOL, V22, P731, DOI 10.1007/s10096-003-1034-z; Bloomfield GS, 2014, JAIDS-J ACQ IMM DEF, V67, pS40, DOI 10.1097/QAI.0000000000000257; Brown TT, 2005, AIDS, V19, P1375, DOI 10.1097/01.aids.0000181011.62385.91; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Cattelan AM, 2001, AIDS, V15, P805, DOI 10.1097/00002030-200104130-00021; Chow DC, 2003, HIV CLIN TRIALS, V4, P411, DOI 10.1310/5E7Q-PGWB-16UE-J48U; Ekali LG, 2013, DIABETES METAB, V39, P71, DOI 10.1016/j.diabet.2012.08.012; Eng J, 2003, RADIOLOGY, V227, P309, DOI 10.1148/radiol.2272012051; Fleischman A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1666, DOI 10.1152/ajpendo.00550.2006; Gazzaruso C, 2003, J HYPERTENS, V21, P1377, DOI 10.1097/00004872-200307000-00028; Holmberg SD, 2002, LANCET, V360, P1747, DOI 10.1016/S0140-6736(02)11672-2; de la Serna JIB, 2010, ENFERM INFEC MICR CL, V28, P32, DOI 10.1016/j.eimc.2008.07.005; Institut National de la Statistique, 2011, RAPP PREL PREV VIH; Jerico C, 2005, AM J HYPERTENS, V18, P1396, DOI 10.1016/j.amjhyper.2005.05.016; Jung O, 2004, NEPHROL DIAL TRANSPL, V19, P2250, DOI 10.1093/ndt/gfh393; Khatib OM., 2005, CLIN GUIDELINES MANA; Mateen FJ, 2013, J HYPERTENS, V31, P1372, DOI 10.1097/HJH.0b013e328360de1c; Muhammad Sanusi, 2013, Niger Med J, V54, P185, DOI 10.4103/0300-1652.114591; Palacios R, 2006, HIV MED, V7, P10, DOI 10.1111/j.1468-1293.2005.00333.x; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Seaberg EC, 2005, AIDS, V19, P953, DOI 10.1097/01.aids.0000171410.76607.f8; Sherer R., 2014, Journal of the International Association of Providers of AIDS Care, V13, P342, DOI 10.1177/2325957414530473; Ssinabulya I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089537; Thiebaut R, 2005, ANTIVIR THER, V10, P811; Yone EWP, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-33	28	48	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148100	10.1371/journal.pone.0148100	http://dx.doi.org/10.1371/journal.pone.0148100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862763	gold, Green Published			2022-12-27	WOS:000370046600043
J	Fismen, AS; Smith, ORF; Torsheim, T; Rasmussen, M; Pagh, TP; Augustine, L; Ojala, K; Samdal, O				Fismen, Anne-Siri; Smith, Otto Robert Frans; Torsheim, Torbjorn; Rasmussen, Mette; Pagh, Trine Pedersen; Augustine, Lilly; Ojala, Kristiina; Samdal, Oddrun			Trends in Food Habits and Their Relation to Socioeconomic Status among Nordic Adolescents 2001/2002-2009/2010	PLOS ONE			English	Article							SUGAR-SWEETENED BEVERAGES; VEGETABLE CONSUMPTION; PHYSICAL-ACTIVITY; SOCIAL INEQUALITIES; FAMILY AFFLUENCE; SECULAR TRENDS; FRUIT; SCHOOL; HEALTH; CHILDREN	Background In the Nordic countries, substantial policy and intervention efforts have been made to increase adolescents' consumption of fruit and vegetables and to reduce their intake of sweets and soft drinks. Some initiatives have been formulated in a Nordic collaboration and implemented at national level. In recent years, social inequalities in food habits have been attracted particular governmental interest and several initiatives addressing the socioeconomic gradient in food habits have been highlighted. However, few internationally published studies have evaluated how trends in adolescents' food habits develop in the context of Nordic nutrition policy, or have compared differences between the Nordic countries. Methods The study was based on Danish, Finnish, Norwegian and Swedish cross-sectional data from the international Health Behaviour in School-Aged Children (HBSC) study, collected via three nationally representative and comparable questionnaire surveys in 2001/2002, 2005/2006 and 2009/2010. Food habits were identified by students' consumption of fruit, vegetables, sweets and sugar sweetened soft drink. Socioeconomic status (SES) was measured with the Family Affluence Scale (FAS). Multilevel logistic regression was used to analyze the data. Results Trends in fruit consumption developed differently across countries, characterized by an increase in Denmark and Norway and more stable trends in Sweden and Finland. Vegetable consumption increased particularly in Denmark and to a lesser extent in Norway, whereas Sweden and Finland displayed stable trends. Decreased trends were observed for sweet and soft drink consumption and were similar in Norway, Sweden and Finland. Sweet consumption decreased across all survey years, whereas soft drink consumption decreased between 2001/2002-2005/2006 and was stable thereafter. Denmark displayed an increase between 2001/2002-2005/2006 followed by a similar decrease between 2005/2006-2009/2010 for both sweet and soft drink consumption. Socioeconomic inequalities in fruit and vegetable consumption were observed in all countries, with no cross-country differences, and no changes over time. Small but not significant cross-country variation was identified for SES inequalities in sweet consumption. Reduced SES inequalities were observed in Sweden between 2005/2006 and 2009/2010. SES was not associated with soft drink consumption in this study population, with the exception of Denmark for the survey year 2009/2010. Conclusion Different trends resulted in increased country differences in food habits during the time of observations. In survey year 2009/2010, Danish students reported a higher intake of fruit and vegetable consumption than their counterparts in the other Nordic countries. Finnish students reported the lowest frequency of sweets and soft drink consumption. Despite the positive dietary trends documented in the present study, the majority of Nordic adolescents are far from meeting national dietary recommendations. Our findings underline the need for more comprehensive initiatives targeting young people's food habits as well as a more deliberate and focused action to close gaps in social inequalities that affect food choices.	[Fismen, Anne-Siri; Samdal, Oddrun] Univ Bergen, Dept Hlth Promot & Dev, Bergen, Norway; [Smith, Otto Robert Frans] Norwegian Inst Publ Hlth, Div Mental Hlth, Bergen, Norway; [Torsheim, Torbjorn] Univ Bergen, Dept Psychosocial Sci, Bergen, Norway; [Rasmussen, Mette; Pagh, Trine Pedersen] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Augustine, Lilly] Kristianstad Univ, Sch Educ & Environm, Kristianstad, Sweden; [Ojala, Kristiina] Univ Jyvaskyla, Res Ctr Hlth Promot, Jyvaskyla, Finland	University of Bergen; Norwegian Institute of Public Health (NIPH); University of Bergen; University of Southern Denmark; Kristianstad University; University of Jyvaskyla	Fismen, AS (corresponding author), Univ Bergen, Dept Hlth Promot & Dev, Bergen, Norway.	Anne-Siri.Fismen@uib.no	Augustine, Lilly/ABC-6152-2020	Augustine, Lilly/0000-0003-4079-8902; Pedersen, Trine Pagh/0000-0003-4622-6534; Ojala, Kristiina/0000-0001-9081-1891; Torsheim, Torbjorn/0000-0001-7825-4463; Rasmussen, Mette/0000-0002-6276-7341				[Anonymous], 2012, NORDIC NUTR RECOMMEN; [Anonymous], 2013, OPPLYSNINGSKONTOERT; [Anonymous], 1987, J SOC POLICY, V16, P125; [Anonymous], 2004, YOUNG PEOPLES HLTH C; Barnekow V., 2008, INEQUALITIES YOUNG P; Bere E, 2005, PREV MED, V41, P463, DOI 10.1016/j.ypmed.2004.11.024; Bere E, 2010, BRIT J NUTR, V104, P589, DOI 10.1017/S0007114510000814; Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y; Bronfnbrenner U., 1979, ECOLOGY HUMAN DEV; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; CARSTAIRS V R M, 1990, Health Bulletin (Edinburgh), V48, P162; Choi J., 2020, THESIS SEOUL NATL U; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; Currie C., 2000, HLTH HLTH BEHAV YOUN; Currie C., 2012, SOCIAL DETERMINANTS; Dahl HJ, 2011, KOST SKOLE BARNEHAGE; Dowler E, 2001, Public Health Nutr, V4, P701; Due P, 2011, SCAND J PUBLIC HEALT, V39, P62, DOI 10.1177/1403494810395989; Eriksen K, 2003, PUBLIC HEALTH NUTR, V6, P57, DOI 10.1079/PHN2002356; Fischer C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-141; Fismen A. S., 2012, BMC Public Health, V12; Fismen AS, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0115-y; Giskes K, 2006, PUBLIC HEALTH NUTR, V9, P75, DOI 10.1079/PHN2005758; Griebler RM, HLTH BEHAV SCH AGED; Groth MV, 2014, SCAND J PUBLIC HEALT, V42, P611, DOI 10.1177/1403494814547668; Hanson MD, 2007, J BEHAV MED, V30, P263, DOI 10.1007/s10865-007-9098-3; Hilsen M, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-108; Kainulainen K, 2012, APPETITE, V59, P53, DOI 10.1016/j.appet.2012.03.012; KELDER SH, 1994, AM J PUBLIC HEALTH, V84, P1121, DOI 10.2105/AJPH.84.7.1121; Kit BK, 2013, AM J CLIN NUTR, V98, P180, DOI 10.3945/ajcn.112.057943; Kjaernes U, 2003, P NUTR SOC, V62, P563, DOI 10.1079/PNS2003269; Krolner R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-191; Leversen I, 2012, INT J CHILD YOUTH FA, V3, P355; Levin KA, 2012, J PUBLIC HEALTH-UK, V34, P523, DOI 10.1093/pubmed/fds021; Levin KA, 2011, SOC INDIC RES, V104, P179, DOI 10.1007/s11205-010-9747-8; Lynch C, 2014, PUBLIC HEALTH NUTR, V17, P2436, DOI 10.1017/S1368980014001347; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Manor O, 1997, SOC SCI MED, V45, P761, DOI 10.1016/S0277-9536(96)00412-1; Matthiessen J, 2014, SCAND J PUBLIC HEALT, V42, P385, DOI 10.1177/1403494813520356; McLaren L, 2010, INT J EPIDEMIOL, V39, P372, DOI 10.1093/ije/dyp315; Ministers TNCo, 2006, BETT LIF DIET PHYS A, P28; Moraeus L, 2014, ACTA PAEDIATR, V103, P1277, DOI 10.1111/apa.12785; Nilsen SM, 2010, EUR J PUBLIC HEALTH, V20, P299, DOI 10.1093/eurpub/ckp137; Pietinen P, 2010, PUBLIC HEALTH NUTR, V13, P920, DOI 10.1017/S1368980010001102; Rasmussen M, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-22; Rasmussen M, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-6; Roberts C, 2009, INT J PUBLIC HEALTH, V54, P140, DOI 10.1007/s00038-009-5405-9; Roos G, 2001, PUBLIC HEALTH NUTR, V4, P35, DOI 10.1079/PHN200048; Roos G PR, 1999, DISPARITIES FOOD HAB; Samdal O., 2013, ACTIONS EQUALIZE SOC; Samdal O, 2008, EVALUERINGSRAPPORT 2; Schnohr C., 2008, SOCIAL INDICATORS RE, V89, P79; Skardal M, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.23590; Stea TH, 2012, PUBLIC HEALTH NUTR, V15, P379, DOI 10.1017/S1368980011001959; Telama R, 2009, PEDIATR EXERC SCI, V21, P462, DOI 10.1123/pes.21.4.462; The Nordic Council og Ministers, 2006, BETT LIF DIET PHYS A, P28; Totland TH, 2013, BRIT J NUTR, V110, P926, DOI 10.1017/S0007114512005946; Vereecken CA, 2005, EUR J PUBLIC HEALTH, V15, P224, DOI 10.1093/eurpub/cki005; Vereecken CA, 2003, PUBLIC HEALTH NUTR, V6, P581, DOI 10.1079/PHN2003466; Vereecken C, 2015, EUR J PUBLIC HEALTH, V25, P16, DOI 10.1093/eurpub/ckv012; WHO, 2006, ADR SOC DET HLTH EAT; World Health Organization, 2004, GLOB STRAT DIET PHYS; Zaborskis A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-52	65	49	54	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148541	10.1371/journal.pone.0148541	http://dx.doi.org/10.1371/journal.pone.0148541			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859568	Green Published, gold			2022-12-27	WOS:000370038400051
J	Kratky, J; McGraw, JJ; Xygalatas, D; Mitkidis, P; Reddish, P				Kratky, Jan; McGraw, John J.; Xygalatas, Dimitris; Mitkidis, Panagiotis; Reddish, Paul			It Depends Who Is Watching You: 3-D Agent Cues Increase Fairness	PLOS ONE			English	Article							MIND PERCEPTION; MECHANISMS; EVOLUTION; EYES; COOPERATION; ACTIVATION; BEHAVIOR; BELIEF; NORM; GAME	Laboratory and field studies have demonstrated that exposure to cues of intentional agents in the form of eyes can increase prosocial behavior. However, previous research mostly used 2-dimensional depictions as experimental stimuli. Thus far no study has examined the influence of the spatial properties of agency cues on this prosocial effect. To investigate the role of dimensionality of agency cues on fairness, 345 participants engaged in a decision-making task in a naturalistic setting. The experimental treatment included a 3-dimensional pseudo-realistic model of a human head and a 2-dimensional picture of the same object. The control stimuli consisted of a real plant and its 2-D image. Our results partly support the findings of previous studies that cues of intentional agents increase prosocial behavior. However, this effect was only found for the 3-D cues, suggesting that dimensionality is a critical variable in triggering these effects in a real-world settings. Our research sheds light on a hitherto unexplored aspect of the effects of environmental cues and their morphological properties on decision-making.	[Kratky, Jan; Xygalatas, Dimitris; Reddish, Paul] Masaryk Univ, Lab Expt Res Relig, Brno, Czech Republic; [McGraw, John J.; Xygalatas, Dimitris; Mitkidis, Panagiotis] Aarhus Univ, Interacting Minds Ctr, Dept Culture & Soc, Aarhus, Denmark; [McGraw, John J.] Calif State Univ Northridge, Dept Religious Studies, Northridge, CA 91330 USA; [McGraw, John J.] Calif State Univ Northridge, Dept Cent Amer Studies, Northridge, CA 91330 USA; [Xygalatas, Dimitris] Univ Connecticut, Dept Anthropol, Storrs, CT USA; [Mitkidis, Panagiotis] Duke Univ, Ctr Adv Hindsight, Social Sci Res Inst, Durham, NC USA; [Mitkidis, Panagiotis] Aarhus Univ, Interdisciplinary Ctr Org Architecture, Dept Management, Sch Business & Social Sci, Aarhus, Denmark	Masaryk University Brno; Aarhus University; California State University System; California State University Northridge; California State University System; California State University Northridge; University of Connecticut; Duke University; Aarhus University	Kratky, J (corresponding author), Masaryk Univ, Lab Expt Res Relig, Brno, Czech Republic.	jan.kratky@mail.muni.cz	Xygalatas, Dimitris/P-3376-2019; Krátký, Jan/AAQ-3944-2021	Xygalatas, Dimitris/0000-0003-1561-9327; Mitkidis, Panagiotis/0000-0001-9646-6961	Laboratory for the Experimental Research of Religion at Masaryk University (LEVYNA) [CZ.1.07/2.3.00/20.0048]; European Social Fund; state budget of the Czech Republic; Faculty of Arts, Masaryk University; Velux Foundation core research group Technologies of the Mind; Canadian Social Sciences and Humanities Research Council (SSHRC) project "The Evolution of Religion and Morality"; Redbull corp.	Laboratory for the Experimental Research of Religion at Masaryk University (LEVYNA); European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; Faculty of Arts, Masaryk University; Velux Foundation core research group Technologies of the Mind; Canadian Social Sciences and Humanities Research Council (SSHRC) project "The Evolution of Religion and Morality"; Redbull corp.	The authors acknowledge support from the Laboratory for the Experimental Research of Religion at Masaryk University (LEVYNA, CZ.1.07/2.3.00/20.0048), co-financed by the European Social Fund and the state budget of the Czech Republic, and the Faculty of Arts, Masaryk University; the Velux Foundation core research group Technologies of the Mind; and the Canadian Social Sciences and Humanities Research Council (SSHRC) project "The Evolution of Religion and Morality". The authors also thank Redbull corp. for supporting the study by supplying the Redbull drinks and refrigerator. The authors have no affiliation with Redbull and the only involvement was through the sponsorship of drinks. The Redbull corp. had no involvement in gathering of data, analysis or publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jesper Sorensen and Kristoffer L. Nielbo for their valuable suggestions in the formative phases of the project and John Shaver for his contribution and comments on early drafts of this paper. We are grateful to research assistants Lenka Sakalosova, Martin Smira, Dagmar Adamcova and Lucia Moravanska for their support during the execution of the experiment. We acknowledge support from the Laboratory for the Experimental Research of Religion at Masaryk University (LEVYNA, CZ.1.07/2.3.00/20.0048), co-financed by the European Social Fund and the state budget of the Czech Republic, and the Faculty of Arts, Masaryk University; the Velux Foundation core research group Technologies of the Mind; and the Canadian Social Sciences and Humanities Research Council (SSHRC) project "The Evolution of Religion and Morality". We also thank Redbull corp. for supporting the study by supplying the Redbull drinks and refrigerator. The authors have no affiliation with Redbull and the only involvement was through the sponsorship of drinks. The Redbull corp. had no involvement in gathering of data, analysis or publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aarts H, 2003, SOC COGNITION, V21, P447, DOI 10.1521/soco.21.6.447.28687; Aarts H, 2003, J PERS SOC PSYCHOL, V84, P18, DOI 10.1037/0022-3514.84.1.18; Ahmed A, 2013, J SCI STUD RELIG, V52, P627, DOI 10.1111/jssr.12045; ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; BALDWIN MW, 1990, J EXP SOC PSYCHOL, V26, P435, DOI 10.1016/0022-1031(90)90068-W; Bargh JA, 2006, EUR J SOC PSYCHOL, V36, P147, DOI 10.1002/ejsp.336; Bargh JA, 2001, J PERS SOC PSYCHOL, V81, P1014, DOI 10.1037//0022-3514.81.6.1014; BARGH JA, 1992, AM J PSYCHOL, V105, P181, DOI 10.2307/1423027; Bargh JA, 2014, SCI AM, V310, P30; Baron-Cohen S, 1995, MINDBLINDNESS ESSAY, P1; Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Bateson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082055; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Boyd R, 2011, P NATL ACAD SCI USA, V108, P10918, DOI 10.1073/pnas.1100290108; Boyer Pascal, 2001, RELIG EXPLAINED EVOL; Burnham TC, 2007, HUM NATURE-INT BIOS, V18, P88, DOI 10.1007/s12110-007-9012-2; Changeux Jean-Pierre, 2000, WHAT MAKES US THINK; Ekstrom M, 2012, EXP ECON, V15, P530, DOI 10.1007/s10683-011-9312-6; Emery NJ, 2000, EYES HAVE IT NEUROET, P24; Epley N, 2008, SOC COGNITION, V26, P143, DOI 10.1521/soco.2008.26.2.143; Epley N, 2007, PSYCHOL REV, V114, P864, DOI 10.1037/0033-295X.114.4.864; Ernest-Jones M, 2011, EVOL HUM BEHAV, V32, P172, DOI 10.1016/j.evolhumbehav.2010.10.006; Falk A, 2008, GAME ECON BEHAV, V62, P287, DOI 10.1016/j.geb.2007.06.001; Fathi M, 2014, EVOL PSYCHOL-US, V12, P878, DOI 10.1177/147470491401200502; Fehr E, 2000, J ECON PERSPECT, V14, P159, DOI 10.1257/jep.14.3.159; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2010, P ROY SOC B-BIOL SCI, V277, P1315, DOI 10.1098/rspb.2009.1900; Field T, 1985, SOCIAL PERCEPTION IN; Fox N., 1985, SOCIAL PERCEPTION IN; Francey D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037397; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gervais WM, 2013, PERSPECT PSYCHOL SCI, V8, P380, DOI 10.1177/1745691613489836; Gray HM, 2007, SCIENCE, V315, P619, DOI 10.1126/science.1134475; Gray K, 2012, PSYCHOL INQ, V23, P101, DOI 10.1080/1047840X.2012.651387; Guglielmo S, 2009, INQUIRY, V52, P449, DOI 10.1080/00201740903302600; Guthrie SE, RELIG ART COGNITIVE, P1; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; HIGGINS ET, 1977, J EXP SOC PSYCHOL, V13, P141; Kay AC, 2004, ORGAN BEHAV HUM DEC, V95, P83, DOI 10.1016/j.obhdp.2004.06.003; Lamba S, 2010, EVOL HUM BEHAV, V31, P271, DOI 10.1016/j.evolhumbehav.2010.02.002; Levy J, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0850; Mifune N, 2010, EVOL HUM BEHAV, V31, P109, DOI 10.1016/j.evolhumbehav.2009.09.004; Nettle D, 2013, ANIM BEHAV, V86, P595, DOI 10.1016/j.anbehav.2013.06.015; Nettle D, 2013, EVOL HUM BEHAV, V34, P35, DOI 10.1016/j.evolhumbehav.2012.08.004; NEUDECKER S, 1989, ENVIRON BIOL FISH, V25, P142; Noe A, 2000, J CONSCIOUSNESS STUD, V7, P123; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Panchanathan K, 2003, J THEOR BIOL, V224, P115, DOI 10.1016/S0022-5193(03)00154-1; Piazza J, 2011, J EXP CHILD PSYCHOL, V109, P311, DOI 10.1016/j.jecp.2011.02.003; Powell KL, 2012, ETHOLOGY, V118, P1096, DOI 10.1111/eth.12011; RABIN M, 1993, AM ECON REV, V83, P1281; Raihani J. N, 2012, P R SOC B; Rigdon M, 2009, J ECON PSYCHOL, V30, P358, DOI 10.1016/j.joep.2009.02.002; Sparks A, 2013, EVOL HUM BEHAV, V34, P317, DOI 10.1016/j.evolhumbehav.2013.05.001; Sperber D., 1995, CAUSAL COGNITION MUL; Stevens M, 2005, BIOL REV, V80, P573, DOI 10.1017/S1464793105006810; Takezawa M., 2011, LETT EVOLUTIONARY BE, V2, P24, DOI [DOI 10.5178/LEBS.2011.15, 10.5178/lebs.2011.15]; Waytz A, 2010, TRENDS COGN SCI, V14, P383, DOI 10.1016/j.tics.2010.05.006; Wheeler SC, 2009, SOC PERSONAL PSYCHOL, V3, P566, DOI 10.1111/j.1751-9004.2009.00187.x; Xygalatas D, 2013, RELIG BRAIN BEHAV, V3, P91, DOI 10.1080/2153599X.2012.724547	60	16	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148845	10.1371/journal.pone.0148845	http://dx.doi.org/10.1371/journal.pone.0148845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859562	Green Published, gold, Green Submitted			2022-12-27	WOS:000370038400096
J	Lin, C; Agnes, JT; Behrens, N; Shao, M; Tagawa, Y; Gershwin, LJ; Corbeil, LB				Lin, C.; Agnes, J. T.; Behrens, N.; Shao, M.; Tagawa, Y.; Gershwin, L. J.; Corbeil, L. B.			Histophilus somni Stimulates Expression of Antiviral Proteins and Inhibits BRSV Replication in Bovine Respiratory Epithelial Cells	PLOS ONE			English	Article							IMMUNOGLOBULIN BINDING-PROTEINS; HAEMOPHILUS-SOMNUS; SYNCYTIAL VIRUS; HEMOPHILUS-SOMNUS; GENE-EXPRESSION; DENDRITIC CELLS; CALVES; PNEUMONIA; CHALLENGE; INFECTION	Our previous studies showed that bovine respiratory syncytial virus (BRSV) followed by Histophilus somni causes more severe bovine respiratory disease and a more permeable alveolar barrier in vitro than either agent alone. However, microarray analysis revealed the treatment of bovine alveolar type 2 (BAT2) epithelial cells with H. somni concentrated culture supernatant (CCS) stimulated up-regulation of four antiviral protein genes as compared with BRSV infection or dual treatment. This suggested that inhibition of viral infection, rather than synergy, may occur if the bacterial infection occurred before the viral infection. Viperin (or radical S-adenosyl methionine domain containing 2-RSAD2) and ISG15 (IFN-stimulated gene 15-ubiquitin-like modifier) were most up-regulated. CCS dose and time course for up-regulation of viperin protein levels were determined in treated bovine turbinate (BT) upper respiratory cells and BAT2 lower respiratory cells by Western blotting. Treatment of BAT2 cells with H. somni culture supernatant before BRSV infection dramatically reduced viral replication as determined by qRT PCR, supporting the hypothesis that the bacterial infection may inhibit viral infection. Studies of the role of the two known H. somni cytotoxins showed that viperin protein expression was induced by endotoxin (lipooligosaccharide) but not by IbpA, which mediates alveolar permeability and H. somni invasion. A naturally occurring IbpA negative asymptomatic carrier strain of H. somni (129Pt) does not cause BAT2 cell retraction or permeability of alveolar cell monolayers, so lacks virulence in vitro. To investigate initial steps of pathogenesis, we showed that strain 129Pt attached to BT cells and induced a strong viperin response in vitro. Thus colonization of the bovine upper respiratory tract with an asymptomatic carrier strain lacking virulence may decrease viral infection and the subsequent enhancement of bacterial respiratory infection in vivo.	[Lin, C.; Agnes, J. T.; Corbeil, L. B.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Behrens, N.; Shao, M.; Gershwin, L. J.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Tagawa, Y.] NARO, Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki, Japan; [Corbeil, L. B.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	University of California System; University of California San Diego; University of California System; University of California Davis; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; University of California System; University of California Davis	Corbeil, LB (corresponding author), Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA.; Corbeil, LB (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	lcorbeil@ucsd.edu			United States Department of Agriculture, National Institute of Food and Agriculture [2011-67015-30177]	United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	The only grant funding for this work was provided by the United States Department of Agriculture, National Institute of Food and Agriculture, Award number 2011-67015-30177: LBC. URL: (http://nifa.usda.gov/program/afri-foundational-program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnes JT, 2013, INFECT IMMUN, V81, P2592, DOI 10.1128/IAI.00108-13; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Caswell JL, 2014, VET PATHOL, V51, P393, DOI 10.1177/0300985813502821; Challacombe JF, 2007, J BACTERIOL, V189, P1890, DOI 10.1128/JB.01422-06; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; COLE SP, 1992, MOL MICROBIOL, V6, P1895, DOI 10.1111/j.1365-2958.1992.tb01362.x; COLE SP, 1993, J GEN MICROBIOL, V139, P2135, DOI 10.1099/00221287-139-9-2135; Corbeil LB, 1997, INFECT IMMUN, V65, P4250, DOI 10.1128/IAI.65.10.4250-4257.1997; CORBEIL LB, 1985, J CLIN MICROBIOL, V22, P192, DOI 10.1128/JCM.22.2.192-198.1985; CORBEIL LB, 1985, J CLIN MICROBIOL, V21, P803, DOI 10.1128/JCM.21.5.803-807.1985; Dieterich C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027535; Geertsema RS, 2011, VACCINE, V29, P4805, DOI 10.1016/j.vaccine.2011.04.075; Gershwin LJ, 2005, VET IMMUNOL IMMUNOP, V107, P119, DOI 10.1016/j.vetimm.2005.04.004; GOGOLEWSKI RP, 1989, J CLIN MICROBIOL, V27, P1767, DOI 10.1128/JCM.27.8.1767-1774.1989; GOGOLEWSKI RP, 1987, VET PATHOL, V24, P250, DOI 10.1177/030098588702400309; GOGOLEWSKI RP, 1987, INFECT IMMUN, V55, P1403, DOI 10.1128/IAI.55.6.1403-1411.1987; Gu XX, 1998, INFECT IMMUN, V66, P1891, DOI 10.1128/IAI.66.5.1891-1897.1998; Hoshinoo K, 2009, MICROB PATHOGENESIS, V46, P273, DOI 10.1016/j.micpath.2009.02.003; Humphrey J. D., 1983, Veterinary Bulletin, V53, P987; INZANA TJ, 1988, INFECT IMMUN, V56, P2830, DOI 10.1128/IAI.56.11.2830-2837.1988; Kalina WV, 2005, VACCINE, V23, P4625, DOI 10.1016/j.vaccine.2005.04.032; Kalina WV, 2004, VACCINE, V22, P1465, DOI 10.1016/j.vaccine.2003.10.024; Kandasamy S, 2012, J DAIRY SCI, V95, P3852, DOI 10.3168/jds.2011-5251; McGillivary G, 2013, J INNATE IMMUN, V5, P60, DOI 10.1159/000342473; Morales DJ, 2013, J MOL BIOL, V425, P4995, DOI 10.1016/j.jmb.2013.09.041; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, pS121, DOI 10.1097/INF.0b013e3181b6d7ec; Proud D, 2008, AM J RESP CRIT CARE, V178, P962, DOI 10.1164/rccm.200805-670OC; Proud D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040762; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Sandal I, 2007, J BACTERIOL, V189, P8179, DOI 10.1128/JB.00479-07; Sandal I, 2009, MICROBES INFECT, V11, P254, DOI 10.1016/j.micinf.2008.11.011; Sanders JD, 2003, MICROB PATHOGENESIS, V34, P131, DOI 10.1016/S0882-4010(02)00188-2; Schmidt U, 2002, J VIROL, V76, P12355, DOI 10.1128/JVI.76.23.12355-12359.2002; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schoggins JW, 2014, CURR OPIN VIROL, V6, P40, DOI 10.1016/j.coviro.2014.03.006; Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Smirnova NP, 2012, VIRUS RES, V167, P329, DOI 10.1016/j.virusres.2012.05.018; Sylte MJ, 2001, INFECT IMMUN, V69, P1650, DOI 10.1128/IAI.69.3.1650-1660.2001; Tagawa Y, 2005, MICROB PATHOGENESIS, V39, P159, DOI 10.1016/j.micpath.2005.08.002; Verhelst J, 2013, MICROBIOL MOL BIOL R, V77, P551, DOI 10.1128/MMBR.00024-13; Weiss G, 2010, IMMUNOLOGY, V131, P268, DOI 10.1111/j.1365-2567.2010.03301.x; Woolums AR, 2004, COMP IMMUNOL MICROB, V27, P57, DOI 10.1016/S0147-9571(03)00036-5; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Zekarias B, 2011, VET MICROBIOL, V149, P177, DOI 10.1016/j.vetmic.2010.10.012; Zekarias B, 2010, INFECT IMMUN, V78, P1850, DOI 10.1128/IAI.01277-09; Zhao C, 2013, TRENDS MICROBIOL, V21, P181, DOI 10.1016/j.tim.2013.01.005	48	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148551	10.1371/journal.pone.0148551	http://dx.doi.org/10.1371/journal.pone.0148551			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859677	Green Published, gold, Green Submitted			2022-12-27	WOS:000370038400052
J	Miller, GE; Engen, PA; Gillevet, PM; Shaikh, M; Sikaroodi, M; Forsyth, CB; Mutlu, E; Keshavarzian, A				Miller, Gregory E.; Engen, Phillip A.; Gillevet, Patrick M.; Shaikh, Maliha; Sikaroodi, Masoumeh; Forsyth, Christopher B.; Mutlu, Ece; Keshavarzian, Ali			Lower Neighborhood Socioeconomic Status Associated with Reduced Diversity of the Colonic Microbiota in Healthy Adults	PLOS ONE			English	Article							GUT MICROBIOTA; INTESTINAL MICROBIOTA; CARDIOVASCULAR HEALTH; UNITED-STATES; DISEASE; AGE; DISPARITIES; MORTALITY; US; PERMEABILITY	In the United States, there are persistent and widening socioeconomic gaps in morbidity and mortality from chronic diseases. Although most disparities research focuses on person-level socioeconomic-status, mounting evidence suggest that chronic diseases also pattern by the demographic characteristics of neighborhoods. Yet the biological mechanisms underlying these associations are poorly understood. There is increasing recognition that chronic diseases share common pathogenic features, some of which involve alterations in the composition, diversity, and functioning of the gut microbiota. This study examined whether socioeconomic-status was associated with alpha-diversity of the colonic microbiota. Forty-four healthy adults underwent un-prepped sigmoidoscopy, during which mucosal biopsies and fecal samples were collected. Subjects' zip codes were geocoded, and census data was used to form a composite indicator of neighborhood socioeconomic-status, reflecting household income, educational attainment, employment status, and home value. In unadjusted analyses, neighborhood socioeconomic-status explained 12-18 percent of the variability in alpha-diversity of colonic microbiota. The direction of these associations was positive, meaning that as neighborhood socioeconomic-status increased, so did alpha-diversity of both the colonic sigmoid mucosa and fecal microbiota. The strength of these associations persisted when models were expanded to include covariates reflecting potential demographic (age, gender, race/ethnicity) and lifestyle (adiposity, alcohol use, smoking) confounds. In these models neighborhood socioeconomic-status continued to explain 11-22 percent of the variability in diversity indicators. Further analyses suggested these patterns reflected socioeconomic variations in evenness, but not richness, of microbial communities residing in the sigmoid. We also found indications that residence in neighborhoods of higher socioeconomic-status was associated with a greater abundance of Bacteroides and a lower abundance of Prevotella, suggesting that diet potentially underlies differences in microbiota composition. These findings suggest the presence of socioeconomic variations in colonic microbiota diversity. Future research should explore whether these variations contribute to disparities in chronic disease outcomes.	[Miller, Gregory E.] Northwestern Univ, Dept Psychol, Evanston, IL USA; [Miller, Gregory E.] Northwestern Univ, Inst Policy Res, Evanston, IL USA; [Engen, Phillip A.; Shaikh, Maliha; Forsyth, Christopher B.; Mutlu, Ece; Keshavarzian, Ali] Rush Univ, Med Ctr, Dept Internal Med, Div Gastroenterol, Chicago, IL 60612 USA; [Gillevet, Patrick M.; Sikaroodi, Masoumeh] George Mason Univ, Microbiome Anal Ctr, Dept Environm Sci & Policy, Sci & Technol Campus, Manassas, VA USA	Northwestern University; Northwestern University; Rush University; George Mason University	Miller, GE (corresponding author), Northwestern Univ, Dept Psychol, Evanston, IL USA.; Miller, GE (corresponding author), Northwestern Univ, Inst Policy Res, Evanston, IL USA.	greg.miller@northwestern.edu			National Heart, Lung, and Blood Institute [HL122328]; National Institute on Drug Abuse [DA027827]; National Institutes of Health NIAAA [RC2AA019405, RO1AA013745]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013745, RC2AA019405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA027827] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grants to GEM from the National Heart, Lung, and Blood Institute (HL122328), the National Institute on Drug Abuse (DA027827), and to AK from the National Institutes of Health NIAAA (RC2AA019405 and RO1AA013745).	Abreu MT, 2014, GASTROENTEROLOGY, V146, P1534, DOI 10.1053/j.gastro.2014.01.001; Adler NE, 2008, ANNU REV PUBL HEALTH, V29, P235, DOI 10.1146/annurev.publhealth.29.020907.090852; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Bailey MT, 2012, HORM BEHAV, V62, P286, DOI 10.1016/j.yhbeh.2012.02.006; Bengmark S, 2013, PHARMACOL RES, V69, P87, DOI 10.1016/j.phrs.2012.09.002; Blaser MJ, 2014, J CLIN INVEST, V124, P4162, DOI 10.1172/JCI78366; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Brown AF, 2011, STROKE, V42, P3363, DOI 10.1161/STROKEAHA.111.622134; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caricilli Andrea Moro, 2014, World J Gastrointest Pathophysiol, V5, P18, DOI 10.4291/wjgp.v5.i1.18; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017; Couch RD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119362; Couch RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081163; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Fasano A, 2012, CLIN REV ALLERG IMMU, V42, P71, DOI 10.1007/s12016-011-8291-x; Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032; Frazier Thomas H, 2011, JPEN J Parenter Enteral Nutr, V35, p14S, DOI 10.1177/0148607111413772; Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972; Gillevet P, 2010, CHEM BIODIVERS, V7, P1065, DOI 10.1002/cbdv.200900322; Gillevet PM, 2009, FUNGAL ECOL, V2, P160, DOI 10.1016/j.funeco.2009.04.001; Hansen TH, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0157-z; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Heintz C, 2014, CELL, V156, P408, DOI 10.1016/j.cell.2014.01.025; Hollister EB, 2014, GASTROENTEROLOGY, V146, P1449, DOI 10.1053/j.gastro.2014.01.052; Hopkins MJ, 2001, GUT, V48, P198, DOI 10.1136/gut.48.2.198; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V135, P25, DOI 10.1016/j.jaci.2014.11.011; Keshavarzian A, 2009, J HEPATOL, V50, P538, DOI 10.1016/j.jhep.2008.10.028; Krishnan S, 2010, AM J EPIDEMIOL, V171, P564, DOI 10.1093/aje/kwp443; Lotfipour S, 2013, J EMERG MED, V44, P861, DOI 10.1016/j.jemermed.2012.09.038; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lynch J, 2005, ANNU REV PUBL HEALTH, V26, P1, DOI 10.1146/annurev.publhealth.26.021304.144505; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Makivuokko H, 2010, BRIT J NUTR, V103, P227, DOI 10.1017/S0007114509991553; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Masters RK, 2012, AM SOCIOL REV, V77, P548, DOI 10.1177/0003122412451019; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Mutlu EA, 2012, AM J PHYSIOL-GASTR L, V302, pG966, DOI 10.1152/ajpgi.00380.2011; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Natividad JM, 2012, PHARM RES; O'Connor PG, 1998, NEW ENGL J MED, V338, P592, DOI 10.1056/NEJM199802263380907; Rehman Tayyab, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P361; Rook GAW, 2014, CLIN EXP IMMUNOL, V177, P1, DOI 10.1111/cei.12269; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shaikh M, 2015, CLIN CHIM ACTA, V442, P24, DOI 10.1016/j.cca.2014.12.040; Shankardass K, 2011, J EPIDEMIOL COMMUN H, V65, P859, DOI 10.1136/jech.2009.102806; Signorello LB, 2014, AM J PUBLIC HEALTH, V104, pE98, DOI 10.2105/AJPH.2014.302156; Sikaroodi M, 2012, BIOTECHNIQUES, V53, P381, DOI 10.2144/000113967; Singh GK, 2010, ANN EPIDEMIOL, V20, P40, DOI 10.1016/j.annepidem.2009.09.008; Swanson GR, 2015, AM J PHYSIOL-GASTR L, V308, pG1004, DOI 10.1152/ajpgi.00002.2015; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Ursell LK, 2012, J ALLERGY CLIN IMMUN, V129, P1204, DOI 10.1016/j.jaci.2012.03.010; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; World Health Organization, 2008, THE GLOBAL BURDEN OF; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xu ZJ, 2015, BRIT J NUTR, V113, pS1, DOI 10.1017/S0007114514004127; Xuan CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083744; Zhang YJ, 2015, INT J MOL SCI, V16, P7493, DOI 10.3390/ijms16047493	69	81	82	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148952	10.1371/journal.pone.0148952	http://dx.doi.org/10.1371/journal.pone.0148952			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859894	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400109
J	Andresen, L; Theodorou, K; Grunewald, S; Czech-Zechmeister, B; Konnecke, B; Luhder, F; Trendelenburg, G				Andresen, Lena; Theodorou, Konstantina; Gruenewald, Sarah; Czech-Zechmeister, Bozena; Koennecke, Birte; Luehder, Fred; Trendelenburg, George			Evaluation of the Therapeutic Potential of Anti-TLR4-Antibody MTS510 in Experimental Stroke and Significance of Different Routes of Application	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; BRAIN-INJURY; TOLL-LIKE-RECEPTOR-4; ACTIVATION; PROTECTS; ACCUMULATION; INFLAMMATION; IMMUNOLOGY; COMPLEX; GAMMA	Toll-like receptors (TLRs) are central sensors for the inflammatory response in ischemia-reperfusion injury. We therefore investigated whether TLR4 inhibition could be used to treat stroke in a standard model of focal cerebral ischemia. Anti-TLR4/MD2-antibody (mAb clone MTS510) blocked TLR4-induced cell activation in vitro, as reported previously. Here, different routes of MTS510 application in vivo were used to study the effects on stroke outcome up to 2d after occlusion of the middle cerebral artery (MCAO) for 45min in adult male C57Bl/6 wild-type mice. Improved neurological performance, reduced infarct volumes, and reduced brain swelling showed that intravascular application of MTS510 had a protective effect in the model of 45min MCAO. Evaluation of potential long-term adverse effects of anti-TLR4-mAb-treament revealed no significant deleterious effect on infarct volumes nor neurological deficit after 14d of reperfusion in a mild model of stroke (15min MCAO). Interestingly, inhibition of TLR4 resulted in an altered adaptive immune response at 48 hours after reperfusion. We conclude that blocking TLR4 by the use of specific mAb is a promising strategy for stroke therapy. However, long-term studies with increased functional sensitivity, larger sampling sizes and use of other species are required before a clinical use could be envisaged.	[Andresen, Lena; Theodorou, Konstantina; Gruenewald, Sarah; Czech-Zechmeister, Bozena; Koennecke, Birte; Trendelenburg, George] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany; [Luehder, Fred] Hertie Fdn, Inst Multiple Sclerosis Res, Dept Neuroimmunol, Gottingen, Germany; [Luehder, Fred] MPI Expt Med, Gottingen, Germany	University of Gottingen	Trendelenburg, G (corresponding author), Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany.	george.trendelenburg@med.uni-goettingen.de			Deutsche Studienstiftung; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony; Deutsche Forschungsgemeinschaft [SFB-TRR43]; Georg-August-University Gottingen Foundation	Deutsche Studienstiftung; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Georg-August-University Gottingen Foundation	This work was supported by the Deutsche Studienstiftung to LA, Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony and Deutsche Forschungsgemeinschaft SFB-TRR43 TP B11 to FL, and Georg-August-University Gottingen Foundation to GT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Arslan F, 2010, CIRCULATION, V121, P80, DOI 10.1161/CIRCULATIONAHA.109.880187; Babcock AA, 2008, J IMMUNOL, V181, P6481, DOI 10.4049/jimmunol.181.9.6481; Babcock AA, 2006, J NEUROSCI, V26, P12826, DOI 10.1523/JNEUROSCI.4937-05.2006; Baron JC, 2013, CEREBROVASC DIS, V36, P306, DOI 10.1159/000355027; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bell MT, 2013, CIRCULATION, V128, pS152, DOI 10.1161/CIRCULATIONAHA.112.000024; Bohacek I, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-191; Cao AT, 2014, J LEUKOCYTE BIOL, V96, P895, DOI 10.1189/jlb.3A0114-056RR; Cao CX, 2007, BIOCHEM BIOPH RES CO, V353, P509, DOI 10.1016/j.bbrc.2006.12.057; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; Chekhonin VP, 2004, B EXP BIOL MED+, V138, P343, DOI 10.1007/s10517-005-0037-4; Cohen J.E., 1988, STAT POWER ANAL BEHA; Czech B, 2009, BIOCHEM BIOPH RES CO, V389, P251, DOI 10.1016/j.bbrc.2009.08.142; Daubeuf B, 2007, J IMMUNOL, V179, P6107, DOI 10.4049/jimmunol.179.9.6107; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dunn-Siegrist I, 2007, J BIOL CHEM, V282, P34817, DOI 10.1074/jbc.M706440200; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Harhausen D, 2010, J IMMUNOL, V184, P6407, DOI 10.4049/jimmunol.0902342; Harhausen D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-15; Hua F, 2015, J CEREBR BLOOD F MET, V35, P536, DOI 10.1038/jcbfm.2014.240; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Lin YC, 2005, ATHEROSCLEROSIS, V180, P305, DOI 10.1016/j.atherosclerosis.2004.12.022; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Qi HY, 2005, J BIOL CHEM, V280, P38969, DOI 10.1074/jbc.M509352200; Suzuki Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00896; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Ziegler G, 2007, BIOCHEM BIOPH RES CO, V359, P574, DOI 10.1016/j.bbrc.2007.05.157; Ziegler G, 2011, J CEREBR BLOOD F MET, V31, P757, DOI 10.1038/jcbfm.2010.161	31	21	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148428	10.1371/journal.pone.0148428	http://dx.doi.org/10.1371/journal.pone.0148428			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849209	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000092
J	Czyzewski, AM; Jenssen, H; Fjell, CD; Waldbrook, M; Chongsiriwatana, NP; Yuen, E; Hancock, REW; Barron, AE				Czyzewski, Ann M.; Jenssen, Havard; Fjell, Christopher D.; Waldbrook, Matt; Chongsiriwatana, Nathaniel P.; Yuen, Eddie; Hancock, Robert E. W.; Barron, Annelise E.			In Vivo, In Vitro, and In Silico Characterization of Peptoids as Antimicrobial Agents	PLOS ONE			English	Article							N-SUBSTITUTED GLYCINES; HOST-DEFENSE PEPTIDES; PSEUDOMONAS-AERUGINOSA; OUTER-MEMBRANE; SIDE-CHAINS; ANTIBACTERIAL PEPTIDES; SECONDARY STRUCTURE; ANTIBIOTICS; LIPOPOLYSACCHARIDE; RESISTANCE	Bacterial resistance to conventional antibiotics is a global threat that has spurred the development of antimicrobial peptides (AMPs) and their mimetics as novel anti-infective agents. While the bioavailability of AMPs is often reduced due to protease activity, the non-natural structure of AMP mimetics renders them robust to proteolytic degradation, thus offering a distinct advantage for their clinical application. We explore the therapeutic potential of N-substituted glycines, or peptoids, as AMP mimics using a multi-faceted approach that includes in silico, in vitro, and in vivo techniques. We report a new QSAR model that we developed based on 27 diverse peptoid sequences, which accurately correlates antimicrobial peptoid structure with antimicrobial activity. We have identified a number of peptoids that have potent, broad-spectrum in vitro activity against multi-drug resistant bacterial strains. Lastly, using a murine model of invasive S. aureus infection, we demonstrate that one of the best candidate peptoids at 4 mg/kg significantly reduces with a two-log order the bacterial counts compared with saline-treated controls. Taken together, our results demonstrate the promising therapeutic potential of peptoids as antimicrobial agents.	[Czyzewski, Ann M.; Chongsiriwatana, Nathaniel P.; Barron, Annelise E.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Jenssen, Havard; Fjell, Christopher D.; Waldbrook, Matt; Yuen, Eddie; Hancock, Robert E. W.] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V6T 1Z4, Canada; [Jenssen, Havard] Roskilde Univ, Dept Sci Syst & Models, DK-4000 Roskilde, Denmark; [Barron, Annelise E.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Northwestern University; University of British Columbia; Roskilde University; Stanford University	Barron, AE (corresponding author), Univ British Columbia, Ctr Microbial Dis & Immun Res, 232-2259 Lower Mall Res Stn, Vancouver, BC V6T 1Z4, Canada.	bob@hancocklab.com; aebarron@stanford.edu	Hancock, Robert E. W./E-1145-2013; Czyzewski, Ann/R-3421-2019	Hancock, Robert E. W./0000-0001-5989-8503; Fjell, Christopher/0000-0001-6304-2628; Jenssen, Havard/0000-0003-0007-0335; Barron, Annelise/0000-0002-0735-6873	Northwestern University's Institute for Bioengineering and Nanoscience in Advanced Medicine; Dreyfus Foundation; DuPont Young Investigator award; NIH/NIAID [5R01-AI072666]; Canadian Institutes for Health Research (CIHR); Foundation of the National Institutes of Health; CIHR through the Grand Challenges in Global Health Initiative; 3M graduate research fellowship; Danish Council for Independent Research [10-085287]; Department of Homeland Security graduate fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072666] Funding Source: NIH RePORTER	Northwestern University's Institute for Bioengineering and Nanoscience in Advanced Medicine; Dreyfus Foundation; DuPont Young Investigator award; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Foundation of the National Institutes of Health; CIHR through the Grand Challenges in Global Health Initiative(Canadian Institutes of Health Research (CIHR)); 3M graduate research fellowship(3M); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Department of Homeland Security graduate fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AEB acknowledges support from Northwestern University's Institute for Bioengineering and Nanoscience in Advanced Medicine, the Dreyfus Foundation, a DuPont Young Investigator award, and NIH/NIAID Grant 5R01-AI072666. REWH gratefully acknowledges financial support from the Canadian Institutes for Health Research (CIHR) and the Foundation of the National Institutes of Health and CIHR through the Grand Challenges in Global Health Initiative. REWH is the recipient of a Canada Research Chair. AMC was supported by a 3M graduate research fellowship. HJ acknowledges support from the Danish Council for Independent Research grant #10-085287. NPC was supported by a Department of Homeland Security graduate fellowship.	Armand P, 1997, FOLD DES, V2, P369, DOI 10.1016/S1359-0278(97)00051-5; Bhunia A, 2010, J BIOL CHEM, V285, P3883, DOI 10.1074/jbc.M109.065672; Bowdish DME, 2005, J ENDOTOXIN RES, V11, P230, DOI 10.1179/096805105X37394; Cherkasov A, 2009, ACS CHEM BIOL, V4, P65, DOI 10.1021/cb800240j; Chongsiriwatana NP, 2008, P NATL ACAD SCI USA, V105, P2794, DOI 10.1073/pnas.0708254105; Domadia PN, 2010, J AM CHEM SOC, V132, P18417, DOI 10.1021/ja1083255; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; Fidai S, 1997, Methods Mol Biol, V78, P187; Fjell CD, 2009, J MED CHEM, V52, P2006, DOI 10.1021/jm8015365; Fritsche TR, 2008, J ANTIMICROB CHEMOTH, V61, P1092, DOI 10.1093/jac/dkn074; Fritsche TR, 2008, DIAGN MICR INFEC DIS, V60, P399, DOI 10.1016/j.diagmicrobio.2007.11.004; Giacometti A, 2004, J ANTIMICROB CHEMOTH, V54, P654, DOI 10.1093/jac/dkh390; Godballe T, 2011, CHEM BIOL DRUG DES, V77, P107, DOI 10.1111/j.1747-0285.2010.01067.x; Goodson B, 1999, ANTIMICROB AGENTS CH, V43, P1429, DOI 10.1128/AAC.43.6.1429; Hamill P, 2008, CURR OPIN BIOTECH, V19, P628, DOI 10.1016/j.copbio.2008.10.006; HANCOCK REW, 1981, ANTIMICROB AGENTS CH, V19, P777, DOI 10.1128/AAC.19.5.777; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Haug BE, 2008, J MED CHEM, V51, P4306, DOI 10.1021/jm701600a; Jacobs MR, 2007, FUTURE MICROBIOL, V2, P591, DOI 10.2217/17460913.2.6.591; Jenssen H, 2008, J PEPT SCI, V14, P110, DOI 10.1002/psc.908; Jenssen H, 2007, CHEM BIOL DRUG DES, V70, P134, DOI 10.1111/j.1747-0285.2007.00543.x; Jenssen H, 2006, CHEM BIOL DRUG DES, V68, P58, DOI 10.1111/j.1747-0285.2006.00412.x; Jenssen H, 2010, METHODS MOL BIOL, V618, P329, DOI 10.1007/978-1-60761-594-1_20; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kaur KJ, 2008, PROTEIN SCI, V17, P545, DOI 10.1110/ps.073145008; Kirikae T, 1998, INFECT IMMUN, V66, P1861, DOI 10.1128/IAI.66.5.1861-1868.1998; Kirshenbaum K, 1998, P NATL ACAD SCI USA, V95, P4303, DOI 10.1073/pnas.95.8.4303; Leeb M, 2004, NATURE, V431, P892, DOI 10.1038/431892a; Livermore DM, 2004, CLIN MICROBIOL INFEC, V10, P1, DOI 10.1111/j.1465-0691.2004.1004.x; Mojsoska B, 2015, PHARMACEUTICALS-BASE, V8, P366, DOI 10.3390/ph8030366; Mojsoska B, 2015, ANTIMICROB AGENTS CH, V59, P4112, DOI 10.1128/AAC.00237-15; MOORE RA, 1986, ANTIMICROB AGENTS CH, V29, P496, DOI 10.1128/AAC.29.3.496; Nahra R, 2008, CURR OPIN ANESTHESIO, V21, P98, DOI 10.1097/ACO.0b013e3282f5335c; Nemoto H, 2001, BLOOD PURIFICAT, V19, P361, DOI 10.1159/000046966; Overbye KM, 2005, DRUG DISCOV TODAY, V10, P45, DOI 10.1016/S1359-6446(04)03285-4; Patch JA, 2003, J AM CHEM SOC, V125, P12092, DOI 10.1021/ja037320d; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; Radzishevsky IS, 2007, NAT BIOTECHNOL, V25, P657, DOI 10.1038/nbt1309; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Sanborn TJ, 2002, BIOPOLYMERS, V63, P12, DOI 10.1002/bip.1058; Schurek KN, 2009, ANTIMICROB AGENTS CH, V53, P4345, DOI 10.1128/AAC.01267-08; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; STEINBERG IZ, 1960, J AM CHEM SOC, V82, P5263, DOI 10.1021/ja01505a001; Tew GN, 2006, BBA-BIOMEMBRANES, V1758, P1387, DOI 10.1016/j.bbamem.2006.03.001; Wu CW, 2003, J AM CHEM SOC, V125, P13525, DOI 10.1021/ja037540r; Wu CW, 2001, J AM CHEM SOC, V123, P2958, DOI 10.1021/ja003153v; Wu MH, 1999, ANTIMICROB AGENTS CH, V43, P1274, DOI 10.1128/AAC.43.5.1274; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; ZUCKERMANN RN, 1992, J AM CHEM SOC, V114, P10646, DOI 10.1021/ja00052a076	54	61	62	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0135961	10.1371/journal.pone.0135961	http://dx.doi.org/10.1371/journal.pone.0135961			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849681	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000001
J	Jefferson, A; Leonard, H; Siafarikas, A; Woodhead, H; Fyfe, S; Ward, LM; Munns, C; Motil, K; Tarquinio, D; Shapiro, JR; Brismar, T; Ben-Zeev, B; Bisgaard, AM; Coppola, G; Ellaway, C; Freilinger, M; Geerts, S; Humphreys, P; Jones, M; Lane, J; Larsson, G; Lotan, M; Percy, A; Pineda, M; Skinner, S; Syhler, B; Thompson, S; Weiss, B; Engerstrom, IW; Downs, J				Jefferson, Amanda; Leonard, Helen; Siafarikas, Aris; Woodhead, Helen; Fyfe, Sue; Ward, Leanne M.; Munns, Craig; Motil, Kathleen; Tarquinio, Daniel; Shapiro, Jay R.; Brismar, Torkel; Ben-Zeev, Bruria; Bisgaard, Anne-Marie; Coppola, Giangennaro; Ellaway, Carolyn; Freilinger, Michael; Geerts, Suzanne; Humphreys, Peter; Jones, Mary; Lane, Jane; Larsson, Gunilla; Lotan, Meir; Percy, Alan; Pineda, Mercedes; Skinner, Steven; Syhler, Birgit; Thompson, Sue; Weiss, Batia; Engerstrom, Ingegerd Witt; Downs, Jenny			Clinical Guidelines for Management of Bone Health in Rett Syndrome Based on Expert Consensus and Available Evidence	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; VITAMIN-D DEFICIENCY; MINERAL DENSITY; QUANTITATIVE ULTRASOUND; POSITION STATEMENT; OFFICIAL POSITIONS; ENDOCRINE-SOCIETY; PUBERTAL CHANGES; CEREBRAL-PALSY; MECP2 MUTATION	Objectives We developed clinical guidelines for the management of bone health in Rett syndrome through evidence review and the consensus of an expert panel of clinicians. Methods An initial guidelines draft was created which included statements based upon literature review and 11 open-ended questions where literature was lacking. The international expert panel reviewed the draft online using a 2-stage Delphi process to reach consensus agreement. Items describe the clinical assessment of bone health, bone mineral density assessment and technique, and pharmacological and non-pharmacological interventions. Results Agreement was reached on 39 statements which were formulated from 41 statements and 11 questions. When assessing bone health in Rett syndrome a comprehensive assessment of fracture history, mutation type, prescribed medication, pubertal development, mobility level, dietary intake and biochemical bone markers is recommended. A baseline densitometry assessment should be performed with accommodations made for size, with the frequency of surveillance determined according to individual risk. Lateral spine x-rays are also suggested. Increasing physical activity and initiating calcium and vitamin D supplementation when low are the first approaches to optimizing bone health in Rett syndrome. If individuals with Rett syndrome meet the ISCD criterion for osteoporosis in children, the use of bisphosphonates is recommended. Conclusion A clinically significant history of fracture in combination with low bone densitometry findings is necessary for a diagnosis of osteoporosis. These evidence and consensus-based guidelines have the potential to improve bone health in those with Rett syndrome, reduce the frequency of fractures, and stimulate further research that aims to ameliorate the impacts of this serious comorbidity.	[Jefferson, Amanda] Curtin Univ, Sch Biomed Sci, Curtin Hlth Innovat Res Inst Biosci, Perth, WA 6845, Australia; [Leonard, Helen; Downs, Jenny] Univ Western Australia, Telethon Kids Inst, Ctr Child Hlth Res, Perth, WA, Australia; [Siafarikas, Aris] Princess Margaret Childrens Hosp, Dept Endocrinol & Diabet, Perth, WA, Australia; [Woodhead, Helen] Sydney Childrens Hosp, Dept Paediat Endocrinol, Randwick, NSW, Australia; [Fyfe, Sue] Curtin Univ, Fac Hlth Sci, Perth, WA 6845, Australia; [Ward, Leanne M.] Univ Ottawa, Dept Pediat, Fac Med, Ottawa, ON K1N 6N5, Canada; [Ward, Leanne M.] Childrens Hosp Eastern Ontario, Div Endocrinol & Metab, Ottawa, ON K1H 8L1, Canada; [Munns, Craig] Childrens Hosp Westmead, Inst Endocrinol & Diabet, Sydney, NSW, Australia; [Motil, Kathleen] Baylor Univ, USDA ARS, Childrens Nutr Res Ctr, Dept Pediat,Baylor Coll Med, Houston, TX 77030 USA; [Motil, Kathleen] Texas Childrens Hosp, Sect Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Tarquinio, Daniel] Emory Univ, Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Shapiro, Jay R.] Kennedy Krieger Inst, Bone & Osteogenesis Imperfecta Dept, Baltimore, MD USA; [Brismar, Torkel] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Ben-Zeev, Bruria] Edmond & Lily Safra Childrens Hosp, Pediat Neurol Unit, Chaim Sheba Med Ctr, Tel Hashomer, Israel; [Bisgaard, Anne-Marie; Syhler, Birgit] Ctr Rett Syndrome, Copenhagen, Denmark; [Bisgaard, Anne-Marie; Syhler, Birgit] Rigshosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Coppola, Giangennaro] Univ Salerno, Clin Child & Adolescent Neuropsychiat, Dept Med & Surg, I-84100 Salerno, Italy; [Ellaway, Carolyn] Childrens Hosp Westmead, Western Sydney Genet Program, Sydney, NSW, Australia; [Ellaway, Carolyn] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Ellaway, Carolyn] Univ Sydney, Discipline Genet Med, Sydney, NSW 2006, Australia; [Freilinger, Michael] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Geerts, Suzanne; Lane, Jane] Univ Alabama Birmingham, Civitan Int Res Ctr, Birmingham, AL USA; [Humphreys, Peter] Childrens Hosp Eastern Ontario, Div Neurol, Ottawa, ON K1H 8L1, Canada; [Jones, Mary] UCSF Benioff Childrens Hosp, Katies Clin Rett Syndrome & Related Disorders, Oakland, CA USA; [Larsson, Gunilla] Swedish Natl Rett Ctr, Froson, Sweden; [Larsson, Gunilla] Umea Univ, Dept Community Med & Rehabil, Physiotherapy, Froson, Sweden; [Lotan, Meir] Ariel Univ, Dept Physiotherapy, Ariel, Israel; [Percy, Alan] Univ Alabama Birmingham, Dept Pediat & Neurol, Birmingham, AL USA; [Pineda, Mercedes] Fundacio Hosp St Joan Deu, Barcelona, Spain; [Pineda, Mercedes] Inst Salud Carlos III, Ctr Biomed Res Rare Dis, Barcelona, Spain; [Skinner, Steven] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Thompson, Sue] Childrens Hosp Westmead, Genet Metab Disorders Serv, Sydney, NSW, Australia; [Weiss, Batia] Edmond & Lily Safra Childrens Hosp, Div Pediat Gastroenterol & Nutr, Tel Hashomer, Israel; [Weiss, Batia] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Engerstrom, Ingegerd Witt] Swedish Natl Rett Ctr, Neuropediatr, Froson, Sweden; [Downs, Jenny] Curtin Univ, Sch Physiotherapy & Exercise Sci, Perth, WA 6845, Australia	Curtin University; Telethon Kids Institute; University of Western Australia; Curtin University; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Sydney; Baylor College of Medicine; Baylor University; United States Department of Agriculture (USDA); Baylor College of Medicine; Children's Healthcare of Atlanta (CHOA); Emory University; Kennedy Krieger Institute; Karolinska Institutet; Chaim Sheba Medical Center; Rigshospitalet; University of Copenhagen; University of Salerno; University of Sydney; University of Sydney; University of Sydney; Medical University of Vienna; University of Alabama System; University of Alabama Birmingham; University of Ottawa; Children's Hospital of Eastern Ontario; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Umea University; Ariel University; University of Alabama System; University of Alabama Birmingham; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Greenwood Genetic Center; University of Sydney; Chaim Sheba Medical Center; Curtin University	Downs, J (corresponding author), Univ Western Australia, Telethon Kids Inst, Ctr Child Hlth Res, Perth, WA, Australia.	Jenny.Downs@telethonkids.org.au	lotan, Meir/AAH-8569-2019; Downs, Jenny/R-9947-2017; Munns, Craig F/A-8719-2015; Leonard, Helen/A-1010-2013; Ward, Leanne Marie/AAF-8482-2020; Brismar, Torkel B/H-2872-2019	lotan, Meir/0000-0003-1330-5148; Downs, Jenny/0000-0001-7358-9037; Munns, Craig F/0000-0001-5898-5808; Leonard, Helen/0000-0001-6405-5834; Ward, Leanne Marie/0000-0003-1557-9185; Brismar, Torkel B/0000-0002-3409-1938; Coppola, Giangennaro/0000-0002-9574-0081	Rett Syndrome Association UK; National Institutes of Health [5R01HD043100-05]; National Medical and Health Research Council (NHMRC) [303189, 1004384]; Rett syndrome.org.; NIH; NHMRC; International Rett Syndrome Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043100] Funding Source: NIH RePORTER	Rett Syndrome Association UK; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Medical and Health Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Rett syndrome.org.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); International Rett Syndrome Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding for this project was provided by the Rett Syndrome Association UK. The Australian Rett Syndrome program has previously been funded by the National Institutes of Health (5R01HD043100-05) and also the National Medical and Health Research Council (NHMRC) project grant #303189 and #1004384 for certain clinical aspects. The International Rett Syndrome Research Program is funded by the Rett syndrome.org.; The authors wish to thank our panel of parents from the Australian Consumer Reference Group for their useful insights and the International Rett Syndrome Foundation, Rettsyndrome.org for organising the listserv RettNet. We would also like to thank the UK for funding this stud, the NIH and NHMRC for funding the Australian Rett Syndrome research program, the NIH for funding the Natural History Study in the US and the International Rett Syndrome Foundation for funding InterRett research program. The authors also acknowledge the valuable contributions of the expert panel who participated in the Delphi technique. The expert panel comprised: Chhavi Agarwal, MD, MS, MRCP, FAAP, Pediatric Endocrinology of New York, New York, USA; Arthur Beisang, MD, Gillette Children's Hospital, St.; Paul, Minnesota, USA; Bruria Ben-Zeev, MD, Pediatric Neurology Unit, Edmond & Lily Safra Children's Hospital, Chaim Sheba Medical Center, Tel Hashomer, Israel; Anne-Marie Bisgaard, MD, PhD, Center for Rett Syndrome, Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark; Torkel Brismar, MD, PhD, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Solna, Stockholm, Sweden; Angus Clarke, DM, FRCP, School of Medicine, Medical genetics, Cardiff University, Wales, UK; Giangennaro Coppola, MD, Clinic of Child and Adolescent Neuropsychiatry, Department of Medicine and Surgery, University of Salerno, Salerno, Italy; Matthew Drake, MD, PhD, Endocrinology, Diabetes, Metabolism and Nutrition Department, Mayo Clinic, Minnesota, USA; Carolyn Ellaway, MBBS, PhD, FRACP, Western Sydney Genetics Program, The Children's Hospital at Westmead, Disciplines of Paediatrics and Child Health and Genetic Medicine, University of Sydney, Sydney, New South Wales, Australia; Michael Freilinger, MD, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria; Suzanne Geerts, RD, MS, Civitan International Research Center, University of Alabama at Birmingham, Birmingham, Alabama, USA; Richard Haas, MD, Department of Neurosciences, University of California San Diego, La Jolla, California, USA; Gabriele Haeusler, MD, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Italy; Ingrid Holm, MD, MPH, Division of genetics and Genomics, Boston Children's Hospital, Boston, USA; Peter Humphreys, MD, FRCP, Division of Neurology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada; Mary Jones, MD, MPH, Katie's Clinic for Rett syndrome and related disorders, UCSF Benioff Children's Hospital, Oakland, California, USA; Walter Kaufmann, MD, Centre for Genetic Disorders of Cognition & Behavior, Kennedy Krieger Institute, School of Medicine, Johns Hopkins University, Baltimore; Salman Kirmani, BS, MBBS, MD, Mayo Clinic, Rochester, New York, USA; Jane Lane, RN BSN, Civitan International Research Center, University of Alabama at Birmingham, Birmingham, Alabama, USA; Gunilla Larsson, PhD, Swedish Rett Centre, Froson, Sweden; Agnes Linglart, MD, French Institute of Health and Medical Research, Pediatric Endocrinology and Diabetes Service, Bicetre Hospital, Paris, France; Meir Lotan, PhD, Department of Physiotherapy, Ariel University, Ariel, Israel; Kathleen Motil, MD, PhD, Department of Pediatrics, USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Section of Gastroenterology, Hepatology and Nutrition, Texas Children's Hospital, Houston, Texas, USA; Craig Munns, MBBS, PhD, FRACP, Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia; Yoshiko Nomura, MD, Segawa Neurological Clinic For Children, Tokyo, Japan; Alan Percy, MD, Department of Pediatrics and Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Mercedes Pineda, MD, PhD, Fundacio Hospital Sant Joan de Deu, Centre for Biomedical Research on Rare Diseases, Instituto de Salud Carlos III, Barcelona, Spain; Carolyn Schanen, MD, PhD, Nemours Biomedical Research, Alfred I. duPont Hosptial for Children, Wilmington, DE, USA; Jay Shapiro, MD, Bone and Osteogenesis Imperfecta Department, Kennedy Krieger Institute, Baltimore, MD, USA; Kevin Sheridan, MD, Gillette Children's Hospital, St.; Paul, Minnesota, USA; Steven Skinner, MD, Greenwood Genetic Center, Greenwood, South Carolina, USA; Bronwyn Stuckey, BA, MBBS, FRACP, Keogh Institute for Medical Research, Perth, WA, Australia; Birgit Syhler, BSc, Center for Rett Syndrome, Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark; Daniel Tarquinio, DO, MS, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA; Sue Thompson, BSc, AdvAPD, Genetic Metabolic Disorders Service, The Children's Hospital at Westmead, Sydney, New South Wales, Australia; Leanne Ward, MD, FRCPC, Research Chair in Pediatric Bone Health, Department of Pediatrics, Faculty of Medicine, University of Ottawa, Division of Endocrinology and Metabolism, Children's Hospital of Eastern Ontario, Ottawa, Canada; Batia Weiss, MD, Division of Pediatric Gastroenterology and Nutrition, Edmond & Lily Safra Children's Hospital, Chaim Sheba Medical Center, Tel Hashomer, Israel; Ingegerd Witt Engerstrom, MD, PhD, Swedish National Rett Center, Froson, Sweden.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anderson A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-87; Archer H, 2007, J MED GENET, V44, P148, DOI 10.1136/jmg.2006.045260; Baim S, 2008, J CLIN DENSITOM, V11, P75, DOI 10.1016/j.jocd.2007.12.007; Baroncelli GI, 2008, PEDIATR RES, V63, P220, DOI 10.1203/PDR.0b013e318163a286; Bebbington A, 2008, NEUROLOGY, V70, P868, DOI 10.1212/01.wnl.0000304752.50773.ec; Bebbington A, 2010, J MED GENET, V47, P242, DOI 10.1136/jmg.2009.072553; Bishop N, 2014, J CLIN DENSITOM, V17, P275, DOI 10.1016/j.jocd.2014.01.004; CARTER DR, 1992, J BONE MINER RES, V7, P137; Caulton JM, 2004, ARCH DIS CHILD, V89, P131, DOI 10.1136/adc.2002.009316; Cepollaro C, 2001, CALCIFIED TISSUE INT, V69, P259, DOI 10.1007/s002230010027; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Cooper C, 2004, J BONE MINER RES, V19, P1976, DOI 10.1359/JBMR.040902; Cuddapah VA, 2014, J MED GENET, V51, P152, DOI 10.1136/jmedgenet-2013-102113; Davies JH, 2005, ARCH DIS CHILD, V90, P373, DOI 10.1136/adc.2004.053553; Downs JA, 2008, NEUROPEDIATRICS, V39, P205, DOI 10.1055/s-0028-1104575; Downs J, 2008, PEDIATRICS, V121, P540, DOI 10.1542/peds.2007-1641; Downs J, 2010, AM J MED GENET A, V152A, P1197, DOI 10.1002/ajmg.a.33314; Downs J, 2009, SPINE, V34, pE607, DOI 10.1097/BRS.0b013e3181a95ca4; Fehr S, 2011, PEDIATR RES, V70, P313, DOI 10.1203/PDR.0b013e3182242461; Fewtrell MS, 2003, ARCH DIS CHILD, V88, P795, DOI 10.1136/adc.88.9.795; Foley KR, 2011, J CHILD NEUROL, V26, P1237, DOI 10.1177/0883073811402688; Glaze DG, 2010, NEUROLOGY, V74, P909, DOI 10.1212/WNL.0b013e3181d6b852; Glorieux FH, 2007, PEDIATRICS, V119, pS163, DOI 10.1542/peds.2006-2023I; Gonnelli S, 2008, BONE, V42, P737, DOI 10.1016/j.bone.2007.12.003; Haas RH, 1997, J PEDIATR-US, V131, P771, DOI 10.1016/S0022-3476(97)70113-6; Halton J, 2009, J BONE MINER RES, V24, P1326, DOI [10.1359/JBMR.090202, 10.1359/jbmr.090202]; Hogler W, 2015, OSTEOPOROSIS IN CHIL, V28, P176; Holick MF, 2012, J CLIN ENDOCR METAB, V97, P1153, DOI 10.1210/jc.2011-2601; Janz KF, 2006, J PEDIATR-US, V148, P793, DOI 10.1016/j.jpeds.2006.01.045; Jefferson AL, 2011, PEDIATR RES, V69, P293, DOI 10.1203/PDR.0b013e31820b937d; Jian L, 2006, J PEDIATR-US, V149, P542, DOI 10.1016/j.jpeds.2006.06.015; Julu POO, 2001, ARCH DIS CHILD, V85, P29, DOI 10.1136/adc.85.1.29; Killian JT, 2014, PEDIATR NEUROL, V51, P769, DOI 10.1016/j.pediatrneurol.2014.08.013; Knight O, 2013, BRAIN DEV-JPN, V35, P912, DOI 10.1016/j.braindev.2012.11.007; Laurvick CL, 2006, PEDIATRICS, V118, pE1152, DOI 10.1542/peds.2006-0439; Leonard H, 2010, ARCH DIS CHILD, V95, P444, DOI 10.1136/adc.2008.148932; Leonard H, 2013, J PEDIATR GASTR NUTR, V57, P451, DOI 10.1097/MPG.0b013e31829e0b65; Lotan M, 2004, J INTELL DISABIL RES, V48, P730, DOI 10.1111/j.1365-2788.2003.00589.x; Ma JH, 2015, J CLIN ENDOCR METAB, V100, P1018, DOI 10.1210/jc.2014-3096; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; Moayyeri A, 2009, J BONE MINER RES, V24, P1319, DOI [10.1359/jbmr.090212, 10.1359/JBMR.090212]; Motil KJ, 2008, PEDIATR RES, V64, P435, DOI 10.1203/PDR.0b013e318180ebcd; Motil KJ, 2014, J PEDIATR GASTR NUTR, V59, P386, DOI 10.1097/MPG.0000000000000440; Motil KJ, 2012, J PEDIATR GASTR NUTR, V55, P292, DOI 10.1097/MPG.0b013e31824b6159; Motil KJ, 2011, J PEDIATR GASTR NUTR, V53, P569, DOI 10.1097/MPG.0b013e3182267a66; Neul JL, 2008, NEUROLOGY, V70, P1313, DOI 10.1212/01.wnl.0000291011.54508.aa; Oddy WH, 2007, J PEDIATR GASTR NUTR, V45, P582, DOI 10.1097/MPG.0b013e318073cbf7; Paxton GA, 2013, MED J AUSTRALIA, V198, P142, DOI 10.5694/mja11.11592; Percy AK, 2010, PEDIATR RES, V67, P435, DOI 10.1203/PDR.0b013e3181d0187f; Reilly S, 2001, DISABIL REHABIL, V23, P118; Reilly S, 2000, SCHEDULE FOR ORAL MO; Roende G, 2011, J BONE MINER RES, V26, P2280, DOI 10.1002/jbmr.423; Roende G, 2011, PEDIATR RES, V69, P359, DOI 10.1203/PDR.0b013e31820bc6d3; Rosen CJ, 2012, J CLIN ENDOCR METAB, V97, P1146, DOI 10.1210/jc.2011-2218; Sanders KM, 2009, MED J AUSTRALIA, V190, P316, DOI 10.5694/j.1326-5377.2009.tb02421.x; Schoenau E, 2002, BONE, V31, P110, DOI 10.1016/S8756-3282(02)00802-5; SCHULTZ RJ, 1993, AM J DIS CHILD, V147, P633, DOI 10.1001/archpedi.1993.02160300039018; Scottish Intercolleagiate Guidelines Network, 2011, SIGN 50 A GUIDELINE; Segawa M, 2005, BRAIN DEV-JPN, V27, pS54, DOI 10.1016/j.braindev.2004.11.010; Shapiro JR, 2010, PEDIATR RES, V68, P446, DOI 10.1203/PDR.0b013e3181f2edd2; Simm PJ, 2011, BONE, V49, P939, DOI 10.1016/j.bone.2011.07.031; Tarquinio DC, 2012, NEUROLOGY, V79, P1653, DOI 10.1212/WNL.0b013e31826e9a70; Wang MC, 2005, BONE, V37, P474, DOI 10.1016/j.bone.2005.04.038; Watson KC, 2006, WOMEN HEALTH ISS, V16, P346, DOI 10.1016/j.whi.2006.09.003; Winzenberg T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7254; Wort UU, 2013, DEV MED CHILD NEUROL, V55, P821, DOI 10.1111/dmcn.12178; Zadik Z, 2003, OSTEOPOROSIS INT, V14, P857, DOI 10.1007/s00198-003-1456-6	68	34	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0146824	10.1371/journal.pone.0146824	http://dx.doi.org/10.1371/journal.pone.0146824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849438	Green Submitted, gold, Green Published			2022-12-27	WOS:000369554000010
J	Kariisa, AT; Weeks, K; Tamayo, R				Kariisa, Ankunda T.; Weeks, Kevin; Tamayo, Rita			The RNA Domain Vc1 Regulates Downstream Gene Expression in Response to Cyclic Diguanylate in Vibrio cholerae	PLOS ONE			English	Article							C-DI-GMP; CLOSTRIDIUM-DIFFICILE; BACTERIAL 2ND-MESSENGER; COLONIZATION FACTOR; BIOFILM FORMATION; LIGAND-BINDING; PROTEIN DOMAIN; PHOSPHODIESTERASE; RIBOSWITCH; SHAPE	In many bacterial species, including the aquatic bacterium and human pathogen Vibrio cholerae, the second messenger cyclic diguanylate (c-di-GMP) modulates processes such as biofilm formation, motility, and virulence factor production. By interacting with various effectors, c-di-GMP regulates gene expression or protein function. One type of c-di-GMP receptor is the class I riboswitch, representatives of which have been shown to bind c-di-GMP in vitro. Herein, we examined the in vitro and in vivo function of the putative class I riboswitch in Vibrio cholerae, Vc1, which lies upstream of the gene encoding GbpA, a colonization factor that contributes to attachment of V. cholerae to environmental and host surfaces containing N-acetylglucosamine moieties. We provide evidence that Vc1 RNA interacts directly with c-di-GMP in vitro, and that nucleotides conserved among this class of riboswitch are important for binding. Yet the mutation of these conserved residues individually in the V. cholerae chromosome inconsistently affects the expression of gbpA and production of the GbpA protein. By isolating the regulatory function of Vc1, we show that the Vc1 element positively regulates downstream gene expression in response to c-di-GMP. Together these data suggest that the Vc1 element responds to c-di-GMP in vivo. Positive regulation of gbpA expression by c-di-GMP via Vc1 may influence the ability of V. cholerae to associate with chitin in the aquatic environment and the host intestinal environment.	[Kariisa, Ankunda T.; Tamayo, Rita] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Weeks, Kevin] Univ N Carolina, Dept Chem, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Tamayo, R (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA.	rita_tamayo@med.unc.edu			American Society for Microbiology; UNC-CH; National Science Foundation [MCB-1121024]; ASM Robert D. Watkins Fellowship; NSF [MCB-1121024]; NIH [R01 AI107029]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107029] Funding Source: NIH RePORTER	American Society for Microbiology; UNC-CH; National Science Foundation(National Science Foundation (NSF)); ASM Robert D. Watkins Fellowship; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AK received a Robert D. Watkins Fellowship from the American Society for Microbiology; RT is supported by a Simmons Scholars Award from UNC-CH; KW is supported by award MCB-1121024 from the National Science Foundation. The funding bodies had no role in the experimental design, in the collection, analysis or interpretation of the data, in the preparation of the manuscript, or in the decision to submit the manuscript for publication.; We thank Robert W. McKee for his help with 5' RACE studies. This work was supported by an ASM Robert D. Watkins Fellowship to A.K and by NSF award MCB-1121024 to K.W. R.T. is supported by NIH award R01 AI107029. The funding bodies had no role in the experimental design, in the collection, analysis or interpretation of the data, in the preparation of the manuscript, or in the decision to submit the manuscript for publication.	Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x; Bhowmick R, 2008, INFECT IMMUN, V76, P4968, DOI 10.1128/IAI.01615-07; Bordeleau E, 2015, J BACTERIOL, V197, P819, DOI 10.1128/JB.02340-14; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Gao XH, 2014, APPL ENVIRON MICROB, V80, P6167, DOI 10.1128/AEM.01638-14; Hensbergen PJ, 2014, MOL CELL PROTEOMICS, V13, P1231, DOI 10.1074/mcp.M113.034728; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Karabiber F, 2013, RNA, V19, P63, DOI 10.1261/rna.036327.112; Kariisa AT, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0506-5; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Kulshina N, 2009, NAT STRUCT MOL BIOL, V16, P1212, DOI 10.1038/nsmb.1701; Lee ER, 2010, SCIENCE, V329, P845, DOI 10.1126/science.1190713; Leonard CW, 2013, BIOCHEMISTRY-US, V52, P588, DOI 10.1021/bi300755u; Lim B, 2006, MOL MICROBIOL, V60, P331, DOI 10.1111/j.1365-2958.2006.05106.x; Marden JN, 2013, P NATL ACAD SCI USA, V110, P15055, DOI 10.1073/pnas.1307217110; McGinnis JL, 2012, J AM CHEM SOC, V134, P6617, DOI 10.1021/ja2104075; McKee RW, 2013, J BACTERIOL, V195, P5174, DOI 10.1128/JB.00501-13; Miller J.H., 1972, EXPT MOL GENETICS; Mudrak B, 2012, INFECT IMMUN, V80, P1794, DOI 10.1128/IAI.06277-11; Peltier J, 2015, J BIOL CHEM; Pultz IS, 2012, MOL MICROBIOL, V86, P1424, DOI 10.1111/mmi.12066; Purcell EB, 2015, J BACTERIOL; Purcell EB, 2012, J BACTERIOL, V194, P3307, DOI 10.1128/JB.00100-12; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Smith KD, 2010, BIOCHEMISTRY-US, V49, P7351, DOI 10.1021/bi100671e; Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702; Soutourina OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003493; Stauder M, 2012, ENV MICROBIOL REP, V4, P439, DOI 10.1111/j.1758-2229.2012.00356.x; Steen KA, 2011, NAT PROTOC, V6, P1683, DOI 10.1038/nprot.2011.373; Steen KA, 2010, J AM CHEM SOC, V132, P9940, DOI 10.1021/ja103781u; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Syed KA, 2009, J BACTERIOL, V191, P6555, DOI 10.1128/JB.00949-09; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Tamayo R, 2008, INFECT IMMUN, V76, P1617, DOI 10.1128/IAI.01337-07; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Wong E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002373	45	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148478	10.1371/journal.pone.0148478	http://dx.doi.org/10.1371/journal.pone.0148478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849223	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000104
J	Leung, NHL; Zhou, J; Chu, DKW; Yu, H; Lindsley, WG; Beezhold, DH; Yen, HL; Li, YG; Seto, WH; Peiris, JSM; Cowling, BJ				Leung, Nancy H. L.; Zhou, Jie; Chu, Daniel K. W.; Yu, Han; Lindsley, William G.; Beezhold, Donald H.; Yen, Hui-Ling; Li, Yuguo; Seto, Wing-Hong; Peiris, Joseph S. M.; Cowling, Benjamin J.			Quantification of Influenza Virus RNA in Aerosols in Patient Rooms	PLOS ONE			English	Article							TRANSMISSION; SEASONALITY; HUMIDITY	Background The potential for human influenza viruses to spread through fine particle aerosols remains controversial. The objective of our study was to determine whether influenza viruses could be detected in fine particles in hospital rooms. Methods and Findings We sampled the air in 2-bed patient isolation rooms for four hours, placing cyclone samplers at heights of 1.5m and 1.0m. We collected ten air samples each in the presence of at least one patient with confirmed influenza A virus infection, and tested the samples by reverse transcription polymerase chain reaction. We recovered influenza A virus RNA from 5/10 collections (50%); 4/5 were from particles> 4 mu m, 1/5 from 1-4 mu m, and none in particles< 1 mu m. Conclusions Detection of influenza virus RNA in aerosols at low concentrations in patient rooms suggests that healthcare workers and visitors might have frequent exposure to airborne influenza virus in proximity to infected patients. A limitation of our study was the small sample size. Further studies should be done to quantify the concentration of viable influenza virus in healthcare settings, and factors affecting the detection of influenza viruses in fine particles in the air.	[Leung, Nancy H. L.; Yen, Hui-Ling; Seto, Wing-Hong; Peiris, Joseph S. M.; Cowling, Benjamin J.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China; [Zhou, Jie; Chu, Daniel K. W.; Yen, Hui-Ling; Peiris, Joseph S. M.] Univ Hong Kong, Li Ka Shing Fac Med, Influenza Res Ctr, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China; [Yu, Han; Li, Yuguo] Univ Hong Kong, Dept Mech Engn, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China; [Lindsley, William G.; Beezhold, Donald H.] NIOSH, Allergy & Clin Immunol Branch, Hlth Effects Lab Div, Ctr Dis Control & Prevent, Morgantown, WV USA	University of Hong Kong; World Health Organization; University of Hong Kong; University of Hong Kong; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Cowling, BJ (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	bcowling@hku.hk	Cowling, Benjamin John/C-4263-2009; Yen, Hui-Ling/C-4501-2009; Yen, Hui-Ling/GNH-5083-2022; Li, Yuguo/A-9469-2010; Leung, Nancy Hiu Lan/M-9080-2016; Peiris, Joseph Sriyal Malik/C-4380-2009	Cowling, Benjamin John/0000-0002-6297-7154; Yen, Hui-Ling/0000-0003-2493-3609; Li, Yuguo/0000-0002-2281-4529; Leung, Nancy Hiu Lan/0000-0001-7314-840X; Seto, Wing Hong/0000-0002-1139-9200; Lindsley, William/0000-0003-0720-5829; Beezhold, Donald/0000-0001-5543-5747; Zhou, Jie/0000-0002-6413-2454; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Chu, Daniel Ka Wing/0000-0002-9219-8979	Research Grants Council of the Hong Kong Special Administrative Region, China [T11-705/14N]; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; Health and Medical Research Fund, Food and Health Bureau, Government of the Hong Kong Special Administrative Region; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; Health and Medical Research Fund, Food and Health Bureau, Government of the Hong Kong Special Administrative Region; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Theme-based Research Scheme from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. T11-705/14N), the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant no. U54 GM088558), and a commissioned grant from the Health and Medical Research Fund, Food and Health Bureau, Government of the Hong Kong Special Administrative Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD RH, 1966, P SOC EXP BIOL MED, V122, P800, DOI 10.3181/00379727-122-31255; Bischoff WE, 2013, J INFECT DIS, V207, P1037, DOI 10.1093/infdis/jis773; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Gralton J, 2011, J INFECTION, V62, P1, DOI 10.1016/j.jinf.2010.11.010; Lindsley WG, 2006, J ENVIRON MONITOR, V8, P1136, DOI 10.1039/b609083d; Lindsley WG, 2015, J OCCUP ENVIRON HYG, V12, P107, DOI 10.1080/15459624.2014.973113; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; Lowen AC, 2014, J VIROL, V88, P7692, DOI 10.1128/JVI.03544-13; Milton DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003205; Noti JD, 2012, CLIN INFECT DIS, V54, P1569, DOI 10.1093/cid/cis237; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Tang JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107338; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; World Health Organization (WHO), 2014, GUID VOL ORG VOL PRA	15	43	44	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148669	10.1371/journal.pone.0148669	http://dx.doi.org/10.1371/journal.pone.0148669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849130	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000151
J	Onos, KD; Francoeur, MJ; Wormwood, BA; Miller, RLA; Gibson, BM; Mair, RG				Onos, Kristen D.; Francoeur, Miranda J.; Wormwood, Benjamin A.; Miller, Rikki L. A.; Gibson, Brett M.; Mair, Robert G.			Prefrontal Neurons Encode Actions and Outcomes in Conjunction with Spatial Location in Rats Performing a Dynamic Delayed Non-Match to Position Task	PLOS ONE			English	Article							WORKING-MEMORY; FRONTAL-CORTEX; PREPARATORY ATTENTION; PRELIMBIC CORTEX; CINGULATE CORTEX; LESIONS; HIPPOCAMPAL; REPRESENTATION; DISSOCIATION; INFORMATION	To respond adaptively to change organisms must utilize information about recent events and environmental context to select actions that are likely to produce favorable outcomes. We developed a dynamic delayed nonmatching to position task to study the influence of spatial context on event-related activity of medial prefrontal cortex neurons during reinforcement-guided decision-making. We found neurons with responses related to preparation, movement, lever press responses, reinforcement, and memory delays. Combined eventrelated and video tracking analyses revealed variability in spatial tuning of neurons with similar event-related activity. While all correlated neurons exhibited spatial tuning broadly consistent with relevant task events, for instance reinforcement-related activity concentrated in locations where reinforcement was delivered, some had elevated activity in more specific locations, for instance reinforcement-related activity in one of several locations where reinforcement was delivered. Timing analyses revealed a limited set of distinct response types with activity time-locked to critical behavioral events that represent the temporal organization of dDNMTP trials. Our results suggest that reinforcement-guided decision-making emerges from discrete populations of medial prefrontal neurons that encode information related to planned or ongoing movements and actions and anticipated or actual action-outcomes in conjunction with information about spatial context.	[Onos, Kristen D.; Francoeur, Miranda J.; Wormwood, Benjamin A.; Miller, Rikki L. A.; Gibson, Brett M.; Mair, Robert G.] Univ New Hampshire, Dept Psychol, Durham, NH 03824 USA; [Onos, Kristen D.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA	University System Of New Hampshire; University of New Hampshire; Jackson Laboratory	Mair, RG (corresponding author), Univ New Hampshire, Dept Psychol, Durham, NH 03824 USA.	rgm@unh.edu	Miller, Rikki/AAI-2830-2020; Francoeur, Miranda/ABD-6626-2021	Francoeur, Miranda/0000-0001-5694-8122; Onos, Kristen/0000-0001-6443-6557	Research Leveraging Initiative grant from the University of New Hampshire	Research Leveraging Initiative grant from the University of New Hampshire	This work was funded by a Research Leveraging Initiative grant from the University of New Hampshire.	Ables M, 1982, J NEUROSCI METH, V4, P317; AGGLETON JP, 1995, J NEUROSCI, V15, P7270; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Aminoff EM, 2013, TRENDS COGN SCI, V17, P379, DOI 10.1016/j.tics.2013.06.009; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Bailey KR, 2007, EUR J NEUROSCI, V25, P2905, DOI 10.1111/j.1460-9568.2007.05492.x; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Chang JY, 2002, EXP BRAIN RES, V142, P67, DOI 10.1007/s00221-001-0918-3; Chudasama Y, 2011, BEHAV NEUROSCI, V125, P327, DOI 10.1037/a0023766; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Cowen SL, 2007, J NEUROPHYSIOL, V98, P303, DOI 10.1152/jn.00150.2007; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; de Saint Blanquat P, 2010, BEHAV BRAIN RES, V209, P267, DOI 10.1016/j.bbr.2010.02.004; Dwyer DM, 2010, Q J EXP PSYCHOL, V63, P417, DOI 10.1080/17470210903411049; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Euston DR, 2006, J NEUROSCI, V26, P13143, DOI 10.1523/JNEUROSCI.3803-06.2006; Funahashi S, 2006, NEUROSCIENCE, V139, P251, DOI 10.1016/j.neuroscience.2005.07.003; Funahashi S, 2013, PROG NEUROBIOL, V103, P131, DOI 10.1016/j.pneurobio.2012.04.002; Gemmell C, 2002, BEHAV BRAIN RES, V133, P1; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Grillner S, 2015, CURR OPIN NEUROBIOL, V33, P47, DOI 10.1016/j.conb.2015.01.019; Hayden BY, 2010, J NEUROSCI, V30, P3339, DOI 10.1523/JNEUROSCI.4874-09.2010; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; Hok V, 2005, P NATL ACAD SCI USA, V102, P4602, DOI 10.1073/pnas.0407332102; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Horst NK, 2012, J NEUROPHYSIOL, V108, P3276, DOI 10.1152/jn.01192.2011; Hyman JM, 2013, CEREB CORTEX, V23, P1257, DOI 10.1093/cercor/bhs104; Hyman JM, 2012, P NATL ACAD SCI USA, V109, P5086, DOI 10.1073/pnas.1114415109; Insel N, 2015, CEREB CORTEX, V25, P2631, DOI 10.1093/cercor/bhu062; Jin X, 2014, NAT NEUROSCI, V17, P423, DOI 10.1038/nn.3632; Jung MW, 1998, CEREB CORTEX, V8, P437, DOI 10.1093/cercor/8.5.437; Kennerley SW, 2004, J NEUROPHYSIOL, V91, P978, DOI 10.1152/jn.00651.2003; Kesner RP, 2011, NEUROBIOL LEARN MEM, V96, P417, DOI 10.1016/j.nlm.2011.07.002; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Kim J, 2013, J NEUROSCI, V33, P13834, DOI 10.1523/JNEUROSCI.1443-13.2013; Liu D, 2014, SCIENCE, V346, P458, DOI 10.1126/science.1256573; Mair RG, 1998, BEHAV NEUROSCI, V112, P772, DOI 10.1037/0735-7044.112.4.772; Merten K, 2013, J NEUROPHYSIOL, V110, P19, DOI 10.1152/jn.00686.2012; MULLER RU, 1987, J NEUROSCI, V7, P1935; Murakami M, 2015, CURR OPIN NEUROBIOL, V33, P40, DOI 10.1016/j.conb.2015.01.005; Ostlund SB, 2009, J NEUROSCI, V29, P8280, DOI 10.1523/JNEUROSCI.1176-09.2009; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peters J, 2009, HIPPOCAMPUS, V19, P141, DOI 10.1002/hipo.20490; Plakke B, 2013, NEUROSCIENCE, V244, P62, DOI 10.1016/j.neuroscience.2013.04.002; Porter MC, 2000, BEHAV BRAIN RES, V109, P69, DOI 10.1016/S0166-4328(99)00161-8; Poucet B, 1997, BEHAV BRAIN RES, V84, P151, DOI 10.1016/S0166-4328(96)00144-1; Powell NJ, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00120; Pratt WE, 2001, BEHAV BRAIN RES, V123, P165, DOI 10.1016/S0166-4328(01)00204-2; Preston AR, 2013, CURR BIOL, V23, pR764, DOI 10.1016/j.cub.2013.05.041; Ragozzino ME, 2001, NEUROSCI LETT, V308, P145, DOI 10.1016/S0304-3940(01)02020-1; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Robbins AA, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00181; Ruitenberg MFL, 2014, NEUROPSYCHOLOGIA, V56, P229, DOI 10.1016/j.neuropsychologia.2014.01.014; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Sloan HL, 2006, BEHAV BRAIN RES, V171, P116, DOI 10.1016/j.bbr.2006.03.030; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Totah NKB, 2013, CEREB CORTEX, V23, P729, DOI 10.1093/cercor/bhs057; Totah NKB, 2009, J NEUROSCI, V29, P6418, DOI 10.1523/JNEUROSCI.1142-09.2009; Warden MR, 2007, CEREB CORTEX, V17, pI41, DOI 10.1093/cercor/bhm070	60	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0149019	10.1371/journal.pone.0149019	http://dx.doi.org/10.1371/journal.pone.0149019			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848579	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000194
J	Sevin, DC; Stahlin, JN; Pollak, GR; Kuehne, A; Sauer, U				Sevin, Daniel C.; Staehlin, Jacqueline N.; Pollak, Georg R.; Kuehne, Andreas; Sauer, Uwe			Global Metabolic Responses to Salt Stress in Fifteen Species	PLOS ONE			English	Article							ESCHERICHIA-COLI; OSMOTIC-STRESS; COMPATIBLE SOLUTES; COENZYME-A; TOLERANCE; OSMOREGULATION; TREHALOSE; SODIUM; YEAST; ACCUMULATION	Cells constantly adapt to unpredictably changing extracellular solute concentrations. A cornerstone of the cellular osmotic stress response is the metabolic supply of energy and building blocks to mount appropriate defenses. Yet, the extent to which osmotic stress impinges on the metabolic network remains largely unknown. Moreover, it is mostly unclear which, if any, of the metabolic responses to osmotic stress are conserved among diverse organisms or confined to particular groups of species. Here we investigate the global metabolic responses of twelve bacteria, two yeasts and two human cell lines exposed to sustained hyperosmotic salt stress by measuring semiquantitative levels of hundreds of cellular metabolites using nontargeted metabolomics. Beyond the accumulation of osmoprotectants, we observed significant changes of numerous metabolites in all species. Global metabolic responses were predominantly species-specific, yet individual metabolites were characteristically affected depending on species' taxonomy, natural habitat, envelope structure or salt tolerance. Exploiting the breadth of our dataset, the correlation of individual metabolite response magnitudes across all species implicated lower glycolysis, tricarboxylic acid cycle, branched-chain amino acid metabolism and heme biosynthesis to be generally important for salt tolerance. Thus, our findings place the global metabolic salt stress response into a phylogenetic context and provide insights into the cellular phenotype associated with salt tolerance.	[Sevin, Daniel C.; Staehlin, Jacqueline N.; Pollak, Georg R.; Kuehne, Andreas; Sauer, Uwe] ETH, Inst Mol Syst Biol, Zurich, Switzerland; [Sevin, Daniel C.; Kuehne, Andreas] Life Sci Zurich, PhD Program Syst Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Sevin, DC; Sauer, U (corresponding author), ETH, Inst Mol Syst Biol, Zurich, Switzerland.; Sevin, DC (corresponding author), Life Sci Zurich, PhD Program Syst Biol, Zurich, Switzerland.	dsevin@ethz.ch; sauer@ethz.ch	Sauer, Uwe/Y-3556-2019		MetaNetX project of the Swiss Initiative for Systems Biology (SystemsX.ch); Swiss Federal Government through the Federal Office of Education and Science	MetaNetX project of the Swiss Initiative for Systems Biology (SystemsX.ch); Swiss Federal Government through the Federal Office of Education and Science	This work was funded by the MetaNetX project of the Swiss Initiative for Systems Biology (SystemsX.ch; http://www.metanetx.org/) evaluated by the Swiss National Science Foundation, and the Swiss Federal Government through the Federal Office of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argandona M, 2010, APPL ENVIRON MICROB, V76, P3575, DOI 10.1128/AEM.03136-09; Balcells L, 1997, EUR J BIOCHEM, V250, P476, DOI 10.1111/j.1432-1033.1997.0476a.x; Behrends V, 2010, MOL BIOSYST, V6, P562, DOI 10.1039/b918710c; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BOTSFORD JL, 1990, APPL ENVIRON MICROB, V56, P488, DOI 10.1128/AEM.56.2.488-494.1990; Bougouffa S, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau100; BURG MB, 1995, AM J PHYSIOL-RENAL, V268, pF983, DOI 10.1152/ajprenal.1995.268.6.F983; CALAMITA G, 1995, J BIOL CHEM, V270, P29063, DOI 10.1074/jbc.270.49.29063; Canelas AB, 2009, ANAL CHEM, V81, P7379, DOI 10.1021/ac900999t; CAYLEY S, 1992, J BACTERIOL, V174, P1586, DOI 10.1128/jb.174.5.1586-1595.1992; Chae YK, 2013, B KOREAN CHEM SOC, V34, P3602, DOI 10.5012/bkcs.2013.34.12.3602; Chohnan S, 1998, BIOSCI BIOTECH BIOCH, V62, P1122, DOI 10.1271/bbb.62.1122; Christen S, 2011, FEMS YEAST RES, V11, P263, DOI 10.1111/j.1567-1364.2010.00713.x; Chubukov V, 2014, NAT REV MICROBIOL, V12, P327, DOI 10.1038/nrmicro3238; Courtenay ES, 2000, BIOCHEMISTRY-US, V39, P4455, DOI 10.1021/bi992887l; da Costa M. S., 1998, V61, P117; Empadinhas N., 2009, CONTRIB SCI, V5, P95, DOI DOI 10.2436/20.7010.01.65; Empadinhas N, 2008, INT MICROBIOL, V11, P151, DOI 10.2436/20.1501.01.55; Flowers TJ, 2015, ANN BOT-LONDON, V115, P419, DOI 10.1093/aob/mcu217; Fuhrer T, 2011, ANAL CHEM, V83, P7074, DOI 10.1021/ac201267k; GARNER MM, 1994, AM J PHYSIOL, V266, pC877, DOI 10.1152/ajpcell.1994.266.4.C877; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; GIAEVER HM, 1988, J BACTERIOL, V170, P2841, DOI 10.1128/jb.170.6.2841-2849.1988; Hamada-Kanazawa M, 2011, BIOL PHARM BULL, V34, P1455, DOI 10.1248/bpb.34.1455; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; Hernandez VA, 2015, BBA-BIOMEMBRANES, V1848, P2233, DOI 10.1016/j.bbamem.2015.05.002; Horta BAC, 2010, J MOL GRAPH MODEL, V29, P331, DOI 10.1016/j.jmgm.2010.09.013; JIA ZP, 1992, EMBO J, V11, P1631, DOI 10.1002/j.1460-2075.1992.tb05209.x; KALIR A, 1981, ANN BOT-LONDON, V47, P75, DOI 10.1093/oxfordjournals.aob.a086002; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Klumpp S, 2014, CURR OPIN BIOTECH, V28, P96, DOI 10.1016/j.copbio.2014.01.001; Kol S, 2010, APPL ENVIRON MICROB, V76, P2574, DOI 10.1128/AEM.01992-09; Kono N, 2009, PLOS ONE, V4, pA47, DOI 10.1371/journal.pone.0007710; KOPPENOL WH, 1993, FREE RADICAL BIO MED, V15, P645, DOI 10.1016/0891-5849(93)90168-T; LAIMINS LA, 1981, P NATL ACAD SCI-BIOL, V78, P464, DOI 10.1073/pnas.78.1.464; Lowe RGT, 2008, FUNGAL GENET BIOL, V45, P1479, DOI 10.1016/j.fgb.2008.08.006; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; Mika JT, 2010, MOL MICROBIOL, V77, P200, DOI 10.1111/j.1365-2958.2010.07201.x; OSMOND CB, 1972, PLANT PHYSIOL, V49, P260, DOI 10.1104/pp.49.2.260; PALEG LG, 1985, PLANT SOIL, V89, P83, DOI 10.1007/BF02182235; Pereira CS, 2008, BIOPHYS J, V95, P3525, DOI 10.1529/biophysj.108.131656; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P190, DOI 10.1016/S0968-0004(98)01207-9; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P143, DOI 10.1016/S0968-0004(98)01196-7; RESCIGNO M, 1994, BIOCHEMISTRY-US, V33, P5721, DOI 10.1021/bi00185a008; ROBERTSON GL, 1976, KIDNEY INT, V10, P25, DOI 10.1038/ki.1976.76; Romantsov T, 2009, BBA-BIOMEMBRANES, V1788, P2092, DOI 10.1016/j.bbamem.2009.06.010; Rubio S, 2008, PLANT PHYSIOL, V148, P546, DOI 10.1104/pp.108.124057; Sevin DC, 2015, CURR OPIN BIOTECH, V34, P1, DOI 10.1016/j.copbio.2014.10.001; Sevin DC, 2014, NAT CHEM BIOL, V10, P266, DOI 10.1038/nchembio.1437; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Smirnova GV, 2000, FEMS MICROBIOL LETT, V186, P209, DOI 10.1111/j.1574-6968.2000.tb09106.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; Ventosa A, 1998, MICROBIOL MOL BIOL R, V62, P504, DOI 10.1128/MMBR.62.2.504-544.1998; Virlouvet L, 2011, PLANT PHYSIOL, V157, P917, DOI 10.1104/pp.111.176818; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2521, DOI 10.1099/00221287-136-12-2521; Wood JM, 2011, ANNU REV MICROBIOL, V65, P215, DOI 10.1146/annurev-micro-090110-102815; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; Yoshida H, 1998, J GEN APPL MICROBIOL, V44, P19, DOI 10.2323/jgam.44.19	60	40	40	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148888	10.1371/journal.pone.0148888	http://dx.doi.org/10.1371/journal.pone.0148888			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848578	Green Submitted, gold, Green Published			2022-12-27	WOS:000369554000182
J	Stoller, O; Schindelholz, M; Hunt, KJ				Stoller, Oliver; Schindelholz, Matthias; Hunt, Kenneth J.			Robot-Assisted End-Effector-Based Stair Climbing for Cardiopulmonary Exercise Testing: Feasibility, Reliability, and Repeatability	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; MAXIMAL OXYGEN-UPTAKE; CARDIORESPIRATORY FITNESS; CRITERIA; STROKE; WALKING; RECOMMENDATIONS; CONSUMPTION; STATEMENT; VALIDITY	Background Neurological impairments can limit the implementation of conventional cardiopulmonary exercise testing (CPET) and cardiovascular training strategies. A promising approach to provoke cardiovascular stress while facilitating task-specific exercise in people with disabilities is feedback-controlled robot-assisted end-effector-based stair climbing (RASC). The aim of this study was to evaluate the feasibility, reliability, and repeatability of augmented RASC-based CPET in able-bodied subjects, with a view towards future research and applications in neurologically impaired populations. Methods Twenty able-bodied subjects performed a familiarisation session and 2 consecutive incremental CPETs using augmented RASC. Outcome measures focussed on standard cardiopulmonary performance parameters and on accuracy of work rate tracking (RMSEP-root mean square error). Criteria for feasibility were cardiopulmonary responsiveness and technical implementation. Relative and absolute test-retest reliability were assessed by intra-class correlation coefficients (ICC), standard error of the measurement (SEM), and minimal detectable change (MDC). Mean differences, limits of agreement, and coefficients of variation (CoV) were estimated to assess repeatability. Results All criteria for feasibility were achieved. Mean V'O-2peak was 106 +/- 9% of predicted V'(O2max) and mean HRpeak was 99 +/- 3% of predicted HRmax. 95% of the subjects achieved at least 1 criterion for V'O-2max, and the detection of the sub-maximal ventilatory thresholds was successful (ventilatory anaerobic threshold 100%, respiratory compensation point 90% of the subjects). Excellent reliability was found for peak cardiopulmonary outcome measures (ICC >= 0.890, SEM <= 0.60%, MDC <= 1.67%). Repeatability for the primary outcomes was good (CoV <= 0.12). Conclusions RASC-based CPET with feedback-guided exercise intensity demonstrated comparable or higher peak cardiopulmonary performance variables relative to predicted values, achieved the criteria for V'O-2max, and allowed determination of sub-maximal ventilatory thresholds. The reliability and repeatability were found to be high. There is potential for augmented RASC to be used for exercise testing and prescription in populations with neurological impairments who would benefit from repetitive task-specific training.	[Stoller, Oliver; Schindelholz, Matthias; Hunt, Kenneth J.] Bern Univ Appl Sci, Inst Rehabil & Performance Technol, Div Mech Engn, Dept Engn & Informat Technol, Burgdorf, Switzerland		Stoller, O (corresponding author), Bern Univ Appl Sci, Inst Rehabil & Performance Technol, Div Mech Engn, Dept Engn & Informat Technol, Burgdorf, Switzerland.	stoller.oliver@gmail.com		Hunt, Kenneth/0000-0002-6521-9455	Swiss Commission for Technology and Innovation CTI	Swiss Commission for Technology and Innovation CTI	This work was supported in part by the Swiss Commission for Technology and Innovation CTI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1990, PRACTICAL STAT MED R, DOI DOI 10.1201/9780429258589; [Anonymous], 2013, ACSMS GUID EX TEST P; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; Billinger SA, 2008, PHYS THER, V88, P1188, DOI 10.2522/ptj.20080072; Billinger SA, 2008, J STRENGTH COND RES, V22, P1556, DOI 10.1519/JSC.0b013e3181739dd7; Binder RK, 2008, EUR J CARDIOV PREV R, V15, P726, DOI 10.1097/HJR.0b013e328304fed4; David D, 2006, ARCH PHYS MED REHAB, V87, P482, DOI 10.1016/j.apmr.2005.11.034; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; French B, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006073.pub2; Hesse S, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-30; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; Jurca R, 2005, AM J PREV MED, V29, P185, DOI 10.1016/j.amepre.2005.06.004; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Loe H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064319; MCKAY GA, 1976, EUR J APPL PHYSIOL, V35, P191, DOI 10.1007/BF02336193; Midgley AW, 2007, SPORTS MED, V37, P1019, DOI 10.2165/00007256-200737120-00002; Mier CM, 2012, J STRENGTH COND RES, V26, P2648, DOI 10.1519/JSC.0b013e31823f8de9; Poole DC, 2008, EUR J APPL PHYSIOL, V102, P403, DOI 10.1007/s00421-007-0596-3; Robergs RA, 2010, SPORTS MED, V40, P95, DOI 10.2165/11319670-000000000-00000; Saengsuwan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122767; Shephard RJ, 1988, J SPORTS MED PHYS FI, V5, P185; SKINNER JS, 1980, RES Q EXERCISE SPORT, V51, P234, DOI 10.1080/02701367.1980.10609285; Stoller O, 2014, MED ENG PHYS, V36, P425, DOI 10.1016/j.medengphy.2013.12.016; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Tang A, 2006, ARCH PHYS MED REHAB, V87, P1100, DOI 10.1016/j.apmr.2006.04.016; Teh KC, 2002, MED SCI SPORT EXER, V34, P695, DOI 10.1097/00005768-200204000-00021; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2007, GUID POP BAS APPR IN	31	6	6	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148932	10.1371/journal.pone.0148932	http://dx.doi.org/10.1371/journal.pone.0148932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849137	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000187
J	Vikse, J; Henry, BM; Roy, J; Ramakrishnan, PK; Hsieh, WC; Walocha, JA; Tomaszewski, KA				Vikse, Jens; Henry, Brandon Michael; Roy, Joyeeta; Ramakrishnan, Piravin Kumar; Hsieh, Wan Chin; Walocha, Jerzy A.; Tomaszewski, Krzysztof A.			Anatomical Variations in the Sinoatrial Nodal Artery: A Meta-Analysis and Clinical Considerations	PLOS ONE			English	Article							MITRAL-VALVE SURGERY; SINUS NODE; CORONARY-ARTERY; ATRIOVENTRICULAR NODES; COMPUTED-TOMOGRAPHY; CONDUCTING SYSTEM; ATRIAL; SINUATRIAL; ORIGIN; BRANCH	Background and Objective The sinoatrial nodal artery (SANa) is a highly variable vessel which supplies blood to the sinoatrial node (SAN). Due to its variability and susceptibility to iatrogenic injury, our study aimed to assess the anatomy of the SANa and determine the prevalence of its anatomical variations. Study Design An extensive search of major electronic databases was performed to identify all articles reporting anatomical data on the SANa. No lower date limit or language restrictions were applied. Anatomical data regarding the artery were extracted and pooled into a meta-analysis. Results Sixty-six studies (n = 21455 hearts) were included in the meta-analysis. The SANa usually arose as a single vessel with a pooled prevalence of 95.5% (95% CI: 93.6-96.9). Duplication and triplication of the artery were also observed with pooled prevalence of 4.3% (95% CI: 2.8-6.0) and 0.3% (95% CI: 0-0.7), respectively. The most common origin of the SANa was from the right coronary artery (RCA), found in 68.0% (95% CI: 55.6-68.9) of cases, followed by origin from the left circumflex artery, and origin from the left coronary artery with pooled prevalence of 22.1%(95% CI: 15.0-26.2) and 2.7 (95% CI: 0.7-5.2), respectively. A retrocaval course of the SANa was the most common course of the artery with a pooled prevalence of 47.1%(95% CI: 36.0-55.5). The pooled prevalence of an S-shaped SANa was 7.6% (95% CI: 2.9-14.1). Conclusions The SANa is most commonly reported as a single vessel, originating from the RCA, and taking a retrocaval course to reach the SAN. Knowledge of high risk anatomical variants of the SANa, such as an S-shaped artery, must be taken into account by surgeons to prevent iatrogenic injuries. Specifically, interventional or cardiosurgical procedures, such as the Cox maze procedure for atrial fibrillation, open heart surgeries through the right atrium or intraoperative cross-clamping or dissection procedures during mitral valve surgery using the septal approach can all potentiate the risk for injury in the setting of high-risk morphological variants of the SANa.	[Vikse, Jens; Henry, Brandon Michael; Roy, Joyeeta; Ramakrishnan, Piravin Kumar; Walocha, Jerzy A.; Tomaszewski, Krzysztof A.] Int Evidence Based Anat Working Grp, Krakow, Poland; [Vikse, Jens; Henry, Brandon Michael; Roy, Joyeeta; Ramakrishnan, Piravin Kumar; Walocha, Jerzy A.; Tomaszewski, Krzysztof A.] Jagiellonian Univ, Dept Anat, Coll Med, Krakow, Poland; [Hsieh, Wan Chin] Charles Univ Prague, Fac Med 1, Prague, Czech Republic	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Charles University Prague	Henry, BM (corresponding author), Int Evidence Based Anat Working Grp, Krakow, Poland.; Henry, BM (corresponding author), Jagiellonian Univ, Dept Anat, Coll Med, Krakow, Poland.	bmhenry55@gmail.com	Walocha, Jerzy/AAS-9174-2020; Vikse, Jens/J-6485-2019; Walocha, Jerzy/ABB-9607-2021; HSIEH, WAN CHIN/M-5910-2018	Ramakrishnan, Piravin Kumar/0000-0002-1068-8481; Tomaszewski, Krzysztof/0000-0001-5077-6948; HSIEH, WAN CHIN/0000-0002-6020-4553	Faculty of Medicine of the Jagiellonian University Medical College KNOW (Leading National Research Centre); Foundation for Polish Science (FNP)	Faculty of Medicine of the Jagiellonian University Medical College KNOW (Leading National Research Centre); Foundation for Polish Science (FNP)(Foundation for Polish Science)	The publication of this manuscript was supported by the Faculty of Medicine of the Jagiellonian University Medical College KNOW (Leading National Research Centre 2012-2017) funds.; Krzysztof A. Tomaszewski is supported by the Foundation for Polish Science (FNP).	ANDERSON KR, 1979, BRIT HEART J, V41, P28; Andreini D, 2010, INT J CARDIOL, V145, P388, DOI 10.1016/j.ijcard.2010.02.057; Ballesteros Luis E, 2010, Rev. Colomb. Cardiol., V17, P265; Berdajs D, 2003, ANN THORAC SURG, V76, P732, DOI 10.1016/S0003-4975(03)00660-X; Bokeriia L A, 2014, Vestn Rentgenol Radiol, P19; BOKERIYA LA, 1984, COR VASA, V26, P220; Boppana V, 2011, J ATR FIBRILLATION, V4; BUSQUET J, 1984, INT J CARDIOL, V6, P223, DOI 10.1016/0167-5273(84)90357-7; Cademartiri F, 2008, EUR RADIOL, V18, P781, DOI 10.1007/s00330-007-0821-9; Caetano A G, 1995, Rev Assoc Med Bras (1992), V41, P94; Cezlan T, 2012, SURG RADIOL ANAT, V34, P357, DOI 10.1007/s00276-011-0902-y; Chen H, 1978, PEOPLES MIL SURG, V2, P47; Chi X, 2013, JILIN MED J, V33, P7143; Chiu IS, 2012, ANN THORAC SURG, V94, P1751, DOI 10.1016/j.athoracsur.2012.05.133; CHRISTIDES C, 1975, ARCH MAL COEUR VAISS, V68, P1237; Crainicianu A, 1922, VIRCHOWS ARCH A, V238, P1, DOI 10.1007/BF01944331; DIDIO LJA, 1995, SURG RADIOL ANAT, V17, P19, DOI 10.1007/BF01629494; Dong X, 2013, CHIN J CLIN, V7, P1931; ELISKA O, 1990, CARDIOLOGY, V77, P1, DOI 10.1159/000174573; ENGEL TR, 1975, CIRCULATION, V52, P286, DOI 10.1161/01.CIR.52.2.286; Ballesteros LE, 2011, REV BRAS CIR CARDIOV, V26, P230, DOI 10.1590/S0102-76382011000200013; Erol C, 2012, ACTA RADIOL, V53, P278, DOI 10.1258/ar.2011.110394; Futami C, 2003, SURG RADIOL ANAT, V25, P42, DOI 10.1007/s00276-002-0085-7; Garcia-Villarreal OA, 2003, EUR J CARDIO-THORAC, V24, P862, DOI 10.1016/S1010-7940(03)00613-4; Gaudino M, 2003, ANN THORAC SURG, V75, P1181, DOI 10.1016/S0003-4975(02)04665-9; Henry BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136477; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; HROMADA J, 1969, Sbornik Vedeckych Praci Lekarske Fakulty University Karlovy v Hradci Kralove, V12, P353; HROMADA J, 1970, Folia Morphologica (Prague), V18, P308; Hurle A, 2010, ANN THORAC SURG, V89, P38, DOI 10.1016/j.athoracsur.2009.10.008; HUTCHINSON MCE, 1978, J ANAT, V125, P39; Iaizzo PA, 2009, HANDBOOK OF CARDIAC ANATOMY, PHYSIOLOGY, AND DEVICES, SECOND EDITION, P1, DOI 10.1007/978-1-60327-372-5; James T, 1958, CIRCULATION, V17; JAMES TN, 1961, CIRCULATION, V24, P761, DOI 10.1161/01.CIR.24.4.761; Kawashima T, 2003, HEART VESSELS, V18, P213, DOI 10.1007/s00380-003-0710-3; KENNEL AJ, 1972, MAYO CLIN PROC, V47, P556; Kosar P, 2009, DIAGN INTERV RADIOL, V15, P275, DOI 10.4261/1305-3825.DIR.2550-09.1; Krupa U, 1993, Folia Morphol (Warsz), V52, P29; KUBLER W, 1985, J AM COLL CARDIOL, V5, pB157; KYRIAKIDIS M, 1988, CHEST, V94, P1054, DOI 10.1378/chest.94.5.1054; Li H, 2005, CHIN J INTERV CARDIO, V13, P90; Lienhard G, 1972, Arch Anat Histol Embryol, V55, P361; MANDARD J C, 1968, Annales d'Anatomie Pathologique, V13, P217; Ndiaye M, 1994, Dakar Med, V39, P1; NERANTZIS C, 1980, CHEST, V78, P274, DOI 10.1378/chest.78.2.274; NERANTZIS CE, 1983, ACTA CARDIOL, V38, P35; Nerantzis CE, 2011, SURG RADIOL ANAT, V33, P373, DOI 10.1007/s00276-010-0717-2; Nerantzis CE, 2010, SURG RADIOL ANAT, V32, P983, DOI 10.1007/s00276-010-0635-3; Okmen AS, 2009, ANATOL J CARDIOL, V9, P481; Onciu M, 2006, Rev Med Chir Soc Med Nat Iasi, V110, P667; Ortale José Roberto, 2006, Clinics, V61, P551, DOI 10.1590/S1807-59322006000600011; Ou X, 2010, ACTA ACAD MED SIN, V32, P690; Ovcina F, 1997, SURG RADIOL ANAT, V19, P359, DOI 10.1007/BF01628501; Ozturk E, 2011, INT J CARDIOVAS IMAG, V27, P619, DOI 10.1007/s10554-010-9705-1; Pejkovic B, 2008, J INT MED RES, V36, P691, DOI 10.1177/147323000803600410; [彭泽华 PENG Ze-hua], 2009, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V25, P237; Ramanathan L, 2009, ARQ BRAS CARDIOL, V92, P314; Rigatelli G, 2007, INT J CARDIOL, V116, P401, DOI 10.1016/j.ijcard.2006.02.035; ROMHILT DW, 1968, AM HEART J, V75, P279, DOI 10.1016/S0002-8703(68)90075-6; Sahni D, 1988, Indian Heart J, V40, P29; Saremi F, 2008, AM J ROENTGENOL, V190, P1569, DOI 10.2214/AJR.07.3127; Saremi F, 2008, RADIOLOGY, V246, P99, DOI 10.1148/radiol.2461070030; Shi Z, 1998, ACTA ACAD MED XUZHOU, V3, P12; Shimotakahara R, 2014, ANAT SCI INT, V89, P79, DOI 10.1007/s12565-013-0202-1; Sohinki D, 2014, OCHSNER J, V14, P586; Song J, 2002, SICHUAN J ANAT, V10, P145; Song YS, 2012, KOREAN J RADIOL, V13, P572, DOI 10.3348/kjr.2012.13.5.572; Sow ML, 1996, SURG RADIOL ANAT, V18, P103, DOI 10.1007/BF01795227; Tian B, 2012, J MED IMAGING, V22, P1661; VERHAEGHE L, 1967, BRIT HEART J, V29, P801; VIEWEG WVR, 1975, CATHETER CARDIO DIAG, V1, P361, DOI 10.1002/ccd.1810010405; Wei X, 1987, ZHEJIANG MED J, V9, P25; Xiao J, 1984, ACAD J GUANGZHOU MED, V12, P23; Yangni- Angate H, W AFR J MED, V14, P181; YAO ZB, 1995, CHIN CLIN ANAT J, V13, P171; Yildirim D, 2010, TURK GOGUS KALP DAMA, V18, P290; Yokokawa M, 2012, HEART RHYTHM, V9, P1395, DOI 10.1016/j.hrthm.2012.04.016; Yu Y, 1980, ACTA ANAT SIN, V11, P5; Zhang LJ, 2008, CIRC J, V72, P1615, DOI 10.1253/circj.CJ-08-0149	79	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148331	10.1371/journal.pone.0148331	http://dx.doi.org/10.1371/journal.pone.0148331			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849441	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000070
J	Begin, C; Schelten, CK; Nugues, MM; Hawkins, J; Roberts, C; Cote, IM				Begin, Chantale; Schelten, Christiane K.; Nugues, Maggy M.; Hawkins, Julie; Roberts, Callum; Cote, Isabelle M.			Effects of Protection and Sediment Stress on Coral Reefs in Saint Lucia	PLOS ONE			English	Article							REGION-WIDE DECLINES; FALSE DISCOVERY RATE; GREAT-BARRIER-REEF; MARINE RESERVES; PHASE-SHIFTS; SURFACE SEDIMENT; CONSERVATION; CARBONATE; GROWTH; COVER	The extent to which Marine Protected Areas (MPAs) benefit corals is contentious. On one hand, MPAs could enhance coral growth and survival through increases in herbivory within their borders; on the other, they are unlikely to prevent disturbances, such as terrestrial runoff, that originate outside their boundaries. We examined the effect of spatial protection and terrestrial sediment on the benthic composition of coral reefs in Saint Lucia. In 2011 (10 to 16 years after MPAs were created), we resurveyed 21 reefs that had been surveyed in 2001 and analyzed current benthic assemblages as well as changes in benthic cover over that decade in relation to protection status, terrestrial sediment influence (measured as the proportion of terrigenous material in reef-associated sediment) and depth. The cover of all benthic biotic components has changed significantly over the decade, including a decline in coral and increase in macroalgae. Protection status was not a significant predictor of either current benthic composition or changes in composition, but current cover and change in cover of several components were related to terrigenous content of sediment deposited recently. Sites with a higher proportion of terrigenous sediment had lower current coral cover, higher macroalgal cover and greater coral declines. Our results suggest that terrestrial sediment is an important factor in the recent degradation of coral reefs in Saint Lucia and that the current MPA network should be complemented by measures to reduce runoff from land.	[Begin, Chantale; Cote, Isabelle M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Schelten, Christiane K.] Helmholtz Ctr Ocean Res Kiel, GEOMAR, Dusternbrooker Weg 20, D-24105 Kiel, Germany; [Nugues, Maggy M.] Lab Excellence CORAIL, 58 Ave Paul Alduy, F-66860 Perpignan, France; [Nugues, Maggy M.] USR 3278 CRIOBE EPHE CNRS UPVD, 58 Ave Paul Alduy, F-66860 Perpignan, France; [Hawkins, Julie; Roberts, Callum] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England	Simon Fraser University; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); University of York - UK	Begin, C (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	cbegin@usf.edu	Cote, Isabelle/ABD-5898-2021; Nugues, Maggy M/O-4314-2015	Nugues, Maggy M/0000-0002-1399-9787	International Coral Reef Conservation Grant from the National Oceanic and Atmospheric Administration [NA09NOS4630011]; Natural Science and Engineering Research Council of Canada (NSERC) [328224-2012]	International Coral Reef Conservation Grant from the National Oceanic and Atmospheric Administration; Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by an International Coral Reef Conservation Grant #NA09NOS4630011 from the National Oceanic and Atmospheric Administration to CB and IMC and Discovery Grant #328224-2012 from the Natural Science and Engineering Research Council of Canada (NSERC) to IMC. Neither funding agency was involved in the study design, analysis or decision to publish.	Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; [Anonymous], 2001, CORAL REEFS, V20, P137; [Anonymous], 2011, MACROSOCIOECONOMIC E; [Anonymous], 2010, DISASTER RISK MANAGE; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; BABCOCK R, 1991, CORAL REEFS, V9, P205, DOI 10.1007/BF00290423; Badran MI, 2005, AMBIO, V34, P615, DOI 10.1639/0044-7447(2005)034[0615:EQOJCS]2.0.CO;2; Begin C., 2012, LAND USE SEDIMENTATI; Begin C, 2014, OCEAN COAST MANAGE, V95, P35, DOI 10.1016/j.ocecoaman.2014.03.018; Begin C, 2013, MAR BIOL, V160, P343, DOI 10.1007/s00227-012-2092-5; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Brooks GR, 2007, CARIBB J SCI, V43, P226; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burke L., 2008, COASTAL CAPITAL EC V; Burkepile DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008963; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; Dearing JA, 2003, GLOBAL PLANET CHANGE, V39, P147, DOI 10.1016/S0921-8181(03)00022-5; DODGE RE, 1974, NATURE, V247, P574, DOI 10.1038/247574a0; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Ferrari R, 2012, CORAL REEFS, V31, P683, DOI 10.1007/s00338-012-0889-9; Ferrario F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4794; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Harborne AR, 2006, ECOLOGY, V87, P2871, DOI 10.1890/0012-9658(2006)87[2871:MTBDOC]2.0.CO;2; Hawkins JP, 2006, BIOL CONSERV, V127, P487, DOI 10.1016/j.biocon.2005.09.008; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; HODGSON G, 1990, CORAL REEFS, V9, P41, DOI 10.1007/BF00686720; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jameson SC, 2002, MAR POLLUT BULL, V44, P1177, DOI 10.1016/S0025-326X(02)00258-8; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kahng SE, 2007, CORAL REEFS, V26, P679, DOI 10.1007/s00338-007-0253-7; Klein CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012431; Lewis D.W., 1994, ANAL SEDIMENTOLOGY; Magdaong ET, 2014, HYDROBIOLOGIA, V733, P5, DOI 10.1007/s10750-013-1720-5; Manfrino C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075432; MAXWELL WGH, 1970, GEOL SOC AM BULL, V81, P691, DOI 10.1130/0016-7606(1970)81[691:GBRRVI]2.0.CO;2; McClanahan TR, 1998, ENVIRON CONSERV, V25, P122, DOI 10.1017/S0376892998000174; MILLIMAN JD, 1992, J GEOL, V100, P525, DOI 10.1086/629606; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Nowlis JS, 1997, AMBIO, V26, P515; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Nugues MM, 2003, CORAL REEFS, V22, P507, DOI 10.1007/s00338-003-0338-x; Nugues MM, 2002, MAR ECOL PROG SER, V229, P61, DOI 10.3354/meps229061; Nugues MM, 2003, MAR POLLUT BULL, V46, P314, DOI 10.1016/S0025-326X(02)00402-2; Orpin AR, 2004, AUST J EARTH SCI, V51, P665, DOI 10.1111/j.1400-0952.2004.01083.x; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pandolfi JM, 2008, MAR ECOL PROG SER, V369, P89, DOI 10.3354/meps07570; Perry CT, 1996, J SEDIMENT RES, V66, P459; Perry CT, 2004, J COASTAL RES, V20, P1070, DOI 10.2112/03-0016.1; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Piniak GA, 2008, PAC SCI, V62, P39, DOI 10.2984/1534-6188(2008)62[39:GAMOCT]2.0.CO;2; Richmond RH, 2007, BIOSCIENCE, V57, P598, DOI 10.1641/B570710; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; ROGERS CS, 1983, MAR POLLUT BULL, V14, P378, DOI 10.1016/0025-326X(83)90602-1; Ryan KE, 2008, MAR POLLUT BULL, V56, P1177, DOI 10.1016/j.marpolbul.2008.02.017; Schelten CK, 2002, IMPACTS MULTIPLE STR; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; SHEPPARD CRC, 1982, MAR ECOL PROG SER, V7, P83, DOI 10.3354/meps007083; Shulman MJ, 1996, CORAL REEFS, V15, P231, DOI 10.1007/s003380050048; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Sotka EE, 2009, CORAL REEFS, V28, P555, DOI 10.1007/s00338-009-0529-1; Tallis H, 2008, CONSERV BIOL, V22, P120, DOI 10.1111/j.1523-1739.2007.00861.x; Torres JL, 2002, CARIBB J SCI, V38, P222; Toth LT, 2014, CORAL REEFS, V33, P565, DOI 10.1007/s00338-014-1158-x; Tulsie B, 2006, NAT RESOUR FORUM, V30, P102, DOI 10.1111/j.1477-8947.2006.00163.x; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Waite TA, 2006, ECOSCIENCE, V13, P439, DOI 10.2980/1195-6860(2006)13[439:CTFDRA]2.0.CO;2; Wilkinson C, 2005, STATUS CARIBBEAN COR; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; Zuur Alain F., 2009, P1	78	21	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0146855	10.1371/journal.pone.0146855	http://dx.doi.org/10.1371/journal.pone.0146855			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845451	Green Accepted, gold, Green Published			2022-12-27	WOS:000369552800005
J	Ho, JY; Chang, FW; Huang, FS; Liu, JM; Liu, YP; Chen, SP; Liu, YL; Cheng, KC; Yu, CP; Hsu, RJ				Ho, Jar-Yi; Chang, Fung-Wei; Huang, Fong Shung; Liu, Jui-Ming; Liu, Yueh-Ping; Chen, Shu-Pin; Liu, Yung-Liang; Cheng, Kuan-Chen; Yu, Cheng-Ping; Hsu, Ren-Jun			Estrogen Enhances the Cell Viability and Motility of Breast Cancer Cells through the ER alpha-Delta Np63-Integrin beta 4 Signaling Pathway	PLOS ONE			English	Article							ALPHA-6-BETA-4 INTEGRIN; STEM-CELL; MESENCHYMAL TRANSITION; CARCINOMA-CELLS; MAMMARY-GLAND; P53 HOMOLOG; P63; EXPRESSION; DELTA-NP63; METASTASIS	Estrogen induces ER alpha-positive breast cancer aggressiveness via the promotion of cell proliferation and survival, the epithelial-mesenchymal transition, and stem-like properties. Integrin beta 4 signaling has been implicated in estrogen/ER alpha-induced tumorigenicity and antiapoptosis; however, this signaling cascade poorly understood. Delta Np63, an N-terminally truncated isoform of the p63 transcription factor, functions as a transcription factor of integrin-beta 4 and therefore regulates cellular adhesion and survival. Therefore, the aim of the present study was to investigate the estrogen-induced interaction between ER alpha, Delta Np63 and integrin beta 4 in breast cancer cells. In ER alpha-positive MCF-7 cells, estrogen activated ER alpha transcription, which induced Delta Np63 expression. And Delta Np63 subsequently induced integrin beta 4 expression, which resulted in AKT phosphorylation and enhanced cell viability and motility. Conversely, there was no inductive effect of estrogen on Delta Np63-integrin beta 4-AKT signaling or on cell viability and motility in ER alpha-negative MDA-MB-231 cells. Delta Np63 knockdown abolishes these estrogen-induced effects and reduces cell viability and motility in MCF-7 cells. Nevertheless, Delta Np63 knockdown also inhibited cell migration in MDA-MB-231 cells through reducing integrin beta 4 expression and AKT phosphorylation. In conclusion, estrogen enhances ER alpha-positive breast cancer cell viability and motility through activating the ER alpha-Delta Np63-integrin beta 4 signaling pathway to induce AKT phosphorylated activation. Those findings should be useful to elucidate the crosstalk between estrogen/ER signaling and Delta Np63 signaling and provide novel insights into the effects of estrogen on breast cancer progression.	[Ho, Jar-Yi; Yu, Cheng-Ping; Hsu, Ren-Jun] Natl Def Med Ctr, Dept Pathol, Triserv Gen Hosp, Taipei, Taiwan; [Ho, Jar-Yi; Yu, Cheng-Ping; Hsu, Ren-Jun] Natl Def Med Ctr, Grad Inst Pathol & Parasitol, Taipei, Taiwan; [Chang, Fung-Wei; Liu, Yung-Liang] Natl Def Med Ctr, Triserv Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Huang, Fong Shung] Natl Taiwan Univ Hosp, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan; [Liu, Jui-Ming] Minist Hlth & Welf, Taoyuan Gen Hosp, Div Urol, Dept Surg, Taoyuan, Taiwan; [Liu, Yueh-Ping; Yu, Cheng-Ping] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Chen, Shu-Pin] Chang Gung Childrens Hosp, Div Med Genet, Dept Pediat, Taoyuan, Taiwan; [Cheng, Kuan-Chen] Natl Taiwan Univ, Inst Biotechnol, 1 Sec 4,Roosevelt Rd, Taipei 10764, Taiwan; [Hsu, Ren-Jun] Natl Def Med Ctr, Biobank Management Ctr, Triserv Gen Hosp, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; National Taiwan University; National Defense Medical Center; Tri-Service General Hospital	Yu, CP; Hsu, RJ (corresponding author), Natl Def Med Ctr, Dept Pathol, Triserv Gen Hosp, Taipei, Taiwan.; Yu, CP; Hsu, RJ (corresponding author), Natl Def Med Ctr, Grad Inst Pathol & Parasitol, Taipei, Taiwan.; Yu, CP (corresponding author), Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan.; Hsu, RJ (corresponding author), Natl Def Med Ctr, Biobank Management Ctr, Triserv Gen Hosp, Taipei, Taiwan.	cpyupath@yahoo.com.tw; hsurnai@gmail.com	Jui-Ming, Liu/H-3452-2019	Jui-Ming, Liu/0000-0003-3868-085X; Ho, Jar-Yi/0000-0001-6933-041X; Yu, Cheng-Ping/0000-0002-0693-5056	Ministry of Science and Technology Taiwan [MOST 104-2320-B-016-012-MY3, MOST 103-2320-B-016-013, MOST 103-2320-B-016-019]; Tri-Service General Hospital [TSGH-C103-101, TSGH-C104-072, TSGH-C104-188, TSGH-C104-210, TSGH-C105-003, TSGH-C105-070, TSGH-C105-168]; Teh-Tzer Study Group for Human Medical Research Foundation [A1021094]	Ministry of Science and Technology Taiwan(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital; Teh-Tzer Study Group for Human Medical Research Foundation	This work was supported by grants from the Ministry of Science and Technology Taiwan (MOST 104-2320-B-016-012-MY3, MOST 103-2320-B-016-013 and MOST 103-2320-B-016-019), the Tri-Service General Hospital (TSGH-C103-101, TSGH-C104-072, TSGH-C104-188, TSGH-C104-210, TSGH-C105-003, TSGH-C105-070, and TSGH-C105-168), and the Teh-Tzer Study Group for Human Medical Research Foundation (A1021094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam A, 2014, CELL PHYSIOL BIOCHEM, V34, P491, DOI 10.1159/000363017; Bachelder RE, 1999, J CELL BIOL, V147, P1063, DOI 10.1083/jcb.147.5.1063; Balboni AL, 2013, CANCER RES, V73, P1020, DOI 10.1158/0008-5472.CAN-12-2862; Band AM, 2011, J MAMMARY GLAND BIOL, V16, P109, DOI 10.1007/s10911-011-9203-7; Bid HK, 2014, CANCER RES, V74, P320, DOI 10.1158/0008-5472.CAN-13-0894; Bon G, 2006, CLIN CANCER RES, V12, P3280, DOI 10.1158/1078-0432.CCR-05-2223; Bouris P, 2015, MATRIX BIOL, V43, P42, DOI 10.1016/j.matbio.2015.02.008; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chalcrabarti R, 2014, NAT CELL BIOL, V16, P1004, DOI 10.1038/ncb3040; DeYoung MP, 2006, CANCER RES, V66, P9362, DOI 10.1158/0008-5472.CAN-06-1619; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; Du ZJ, 2010, CANCER SCI, V101, P2417, DOI 10.1111/j.1349-7006.2010.01700.x; Gallegos JR, 2008, J BIOL CHEM, V283, P66, DOI 10.1074/jbc.M704686200; Gaya JM, 2015, J UROLOGY, V193, P1144, DOI 10.1016/j.juro.2014.10.098; Giacobbe A, 2016, ONCOGENE, V35, P1602, DOI 10.1038/onc.2015.230; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hagiwara K, 1999, CANCER RES, V59, P4165; Hanstein B, 2004, EUR J ENDOCRINOL, V150, P243, DOI 10.1530/eje.0.1500243; Humphries LA, 2013, BRIT J HAEMATOL, V163, P590, DOI 10.1111/bjh.12580; Kayisli UA, 2005, ACTA HISTOCHEM, V107, P173, DOI 10.1016/j.acthis.2005.01.005; Khokhar SK, 2008, CELL RES, V18, P1061, DOI 10.1038/cr.2008.82; Kumar RMR, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-559; Latina A, 2016, ONCOGENE, V35, P1493, DOI 10.1038/onc.2015.222; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Leary A, 2006, BRIT J CANCER, V95, P661, DOI 10.1038/sj.bjc.6603316; Lewis-Wambi Joan S, 2005, Breast Dis, V24, P93; Lombardo Y, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3675; Marjon NA, 2014, MOL CANCER RES, V12, P1644, DOI 10.1158/1541-7786.MCR-14-0128-T; Martini M, 2014, ANN MED, V46, P372, DOI 10.3109/07853890.2014.912836; Massion PP, 2003, CANCER RES, V63, P7113; Matsubara R, 2011, INT J ONCOL, V39, P1391, DOI 10.3892/ijo.2011.1151; Melino G, 2011, CELL DEATH DIFFER, V18, P1487, DOI 10.1038/cdd.2011.81; Memmi EM, 2015, P NATL ACAD SCI USA, V112, P3499, DOI 10.1073/pnas.1500762112; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; O'Connor KL, 1998, J CELL BIOL, V143, P1749, DOI 10.1083/jcb.143.6.1749; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Park BJ, 2000, CANCER RES, V60, P3370; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Planas-Silva MD, 2007, J STEROID BIOCHEM, V104, P11, DOI 10.1016/j.jsbmb.2006.09.039; Raymond K, 2007, MOL BIOL CELL, V18, P4210, DOI 10.1091/mbc.E06-08-0720; Rhodes LV, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-295; Saji S, 2005, ONCOGENE, V24, P4531, DOI 10.1038/sj.onc.1208646; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Soltysik K, 2013, J PHYSIOL PHARMACOL, V64, P129; Spiesbach K, 2005, INT J CANCER, V114, P555, DOI 10.1002/ijc.20766; Stewart RL, 2015, LAB INVEST, V95, P976, DOI 10.1038/labinvest.2015.82; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Sun Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-137; Tsunoda T, 1999, BIOINFORMATICS, V15, P622, DOI 10.1093/bioinformatics/15.7.622; Tyson JJ, 2011, NAT REV CANCER, V11, P523, DOI 10.1038/nrc3081; Vieira AF, 2014, ONCOTARGET, V5, P679, DOI 10.18632/oncotarget.1459; Wan X, 2009, ONCOGENE, V28, P3401, DOI 10.1038/onc.2009.206; Wu J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.239; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang XF, 2009, J CELL SCI, V122, P2473, DOI 10.1242/jcs.049148; Yang ZY, 2015, SCI REP-UK, V5, DOI 10.1038/srep07758; Ye S, 2014, INT J ONCOL, V44, P2153, DOI 10.3892/ijo.2014.2374; Zhang XHF, 2013, CLIN CANCER RES, V19, P6389, DOI 10.1158/1078-0432.CCR-13-0838; Zheng SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022439	68	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148301	10.1371/journal.pone.0148301	http://dx.doi.org/10.1371/journal.pone.0148301			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845172	gold, Green Submitted, Green Published			2022-12-27	WOS:000369552800043
J	Wei, Y; Li, JL; Qing, J; Huang, MJ; Wu, M; Gao, FH; Li, DM; Hong, ZY; Kong, LB; Huang, WQ; Lin, JP				Wei, Yu; Li, Jinlong; Qing, Jie; Huang, Mingjie; Wu, Ming; Gao, Fenghua; Li, Dongmei; Hong, Zhangyong; Kong, Lingbao; Huang, Weiqiang; Lin, Jianping			Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; STRUCTURE-BASED DESIGN; MACHINE LEARNING-METHODS; ALLOSTERIC INHIBITORS; HCVNS5B POLYMERASE; MOLECULAR DOCKING; NONNUCLEOSIDE INHIBITORS; BINDING AFFINITIES; POTENT INHIBITORS; CRYSTAL-STRUCTURE	The NS5B polymerase is one of the most attractive targets for developing new drugs to block Hepatitis C virus (HCV) infection. We describe the discovery of novel potent HCV NS5B polymerase inhibitors by employing a virtual screening (VS) approach, which is based on random forest (RB-VS), e-pharmacophore (PB-VS), and docking (DB-VS) methods. In the RB-VS stage, after feature selection, a model with 16 descriptors was used. In the PB-VS stage, six energy-based pharmacophore (e-pharmacophore) models from different crystal structures of the NS5B polymerase with ligands binding at the palm I, thumb I and thumb II regions were used. In the DB-VS stage, the Glide SP and XP docking protocols with default parameters were employed. In the virtual screening approach, the RB-VS, PB-VS and DB-VS methods were applied in increasing order of complexity to screen the InterBioScreen database. From the final hits, we selected 5 compounds for further anti-HCV activity and cellular cytotoxicity assay. All 5 compounds were found to inhibit NS5B polymerase with IC50 values of 2.01-23.84 mu M and displayed anti-HCV activities with EC50 values ranging from 1.61 to 21.88 mu M, and all compounds displayed no cellular cytotoxicity (CC50 > 100 mu M) except compound N2, which displayed weak cytotoxicity with a CC50 value of 51.3 mu M. The hit compound N2 had the best antiviral activity against HCV, with a selective index of 32.1. The 5 hit compounds with new scaffolds could potentially serve as NS5B polymerase inhibitors through further optimization and development.	[Wei, Yu; Li, Jinlong; Li, Dongmei; Lin, Jianping] Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Wei, Yu; Li, Jinlong; Li, Dongmei; Lin, Jianping] Nankai Univ, Tianjin Key Lab Mol Drug Res, Tianjin 300071, Peoples R China; [Li, Jinlong; Lin, Jianping] Tianjin Joint Acad Biomed & Technol, High Throughput Mol Drug Discovery Ctr, Tianjin 300457, Peoples R China; [Huang, Weiqiang] PracticaChem China, Tianjin 300192, Peoples R China; [Qing, Jie; Wu, Ming; Gao, Fenghua] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Hong, Zhangyong] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Huang, Mingjie; Kong, Lingbao] Jiangxi Agr Univ, Coll Biosci & Engn, Nanchang 330045, Peoples R China	Nankai University; Nankai University; Tsinghua University; Nankai University; Jiangxi Agricultural University	Lin, JP (corresponding author), Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.; Lin, JP (corresponding author), Nankai Univ, Tianjin Key Lab Mol Drug Res, Tianjin 300071, Peoples R China.; Lin, JP (corresponding author), Tianjin Joint Acad Biomed & Technol, High Throughput Mol Drug Discovery Ctr, Tianjin 300457, Peoples R China.; Huang, WQ (corresponding author), PracticaChem China, Tianjin 300192, Peoples R China.; Kong, LB (corresponding author), Jiangxi Agr Univ, Coll Biosci & Engn, Nanchang 330045, Peoples R China.	lingbaok@hotmail.com; practicachem@gmail.com; jianpinglin@nankai.edu.cn			National Basic Research Program (973 Program) [2011CBA00800, 2013CB911100]; National Natural Science Foundation (NSFC) [21203101, 31270926]; Natural Science Foundation of Tianjin [13JCZDJC28300]; PracticaChem	National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); PracticaChem	This work was supported by the National Basic Research Program (973 Program, No. 2011CBA00800 and No. 2013CB911100), the National Natural Science Foundation (NSFC, No. 21203101 and No. 31270926), and the Natural Science Foundation of Tianjin (13JCZDJC28300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PracticaChem provided support in the form of salaries for author [WH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. WH (founder of PracticaChem) played a role in synthesizing 5 compounds in our study. However, PracticaChem (a commercial affiliation) did not provide funding for this study.	Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Anilkumar GN, 2011, BIOORG MED CHEM LETT, V21, P5336, DOI 10.1016/j.bmcl.2011.07.021; [Anonymous], 2013, SCHROD SUIT 2013 PRO; [Anonymous], 2013, GLID VERS 6 1; [Anonymous], 2011, DRAGON VERS 6 0; [Anonymous], 2013, LIGPREP VERS 2 8; [Anonymous], 2013, EPIK VERS 2 5; [Anonymous], 2013, QIKPROP VERSION 3 8; [Anonymous], 2013, PHAS VERS 3 7; Barreca ML, 2014, J CHEM INF MODEL, V54, P481, DOI 10.1021/ci400367m; Barreca ML, 2011, FUTURE MED CHEM, V3, P1027, DOI [10.4155/FMC.11.53, 10.4155/fmc.11.53]; Beaulieu PL, 2013, BIOORG MED CHEM LETT, V23, P4132, DOI 10.1016/j.bmcl.2013.05.037; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Canales E, 2012, BIOORG MED CHEM LETT, V22, P4288, DOI 10.1016/j.bmcl.2012.05.025; Cao HY, 2008, CURR MED CHEM, V15, P1462, DOI 10.2174/092986708784638906; Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104; Cereto-Massague A, 2012, BIOINFORMATICS, V28, P1661, DOI 10.1093/bioinformatics/bts249; CHAVKIN C, 1984, P NATL ACAD SCI-BIOL, V81, P7253, DOI 10.1073/pnas.81.22.7253; Corbeil CR, 2008, J CHEM INF MODEL, V48, P902, DOI 10.1021/ci700398h; Cui HK, 2013, BIOORGAN MED CHEM, V21, P3547, DOI 10.1016/j.bmc.2013.02.011; Cummings MD, 2012, ANGEW CHEM INT EDIT, V51, P4637, DOI 10.1002/anie.201200110; Das D, 2011, BIOORGAN MED CHEM, V19, P4690, DOI 10.1016/j.bmc.2011.06.079; de Vicente J, 2009, BIOORG MED CHEM LETT, V19, P5652, DOI 10.1016/j.bmcl.2009.08.022; Deng YQ, 2009, BIOORG MED CHEM LETT, V19, P5363, DOI 10.1016/j.bmcl.2009.07.124; Di Marco S, 2005, J BIOL CHEM, V280, P29765, DOI 10.1074/jbc.M505423200; Dillon JF, 2004, J VIRAL HEPATITIS, V11, P23, DOI 10.1111/j.1365-2893.2004.00573.x; Ding M, 2011, ORG BIOMOL CHEM, V9, P6654, DOI 10.1039/c1ob05525a; Dixon SL, 2006, J COMPUT AID MOL DES, V20, P647, DOI 10.1007/s10822-006-9087-6; Donner P, 2013, BIOORG MED CHEM LETT, V23, P4367, DOI 10.1016/j.bmcl.2013.05.078; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Golub AG, 2012, EUR J MED CHEM, V58, P258, DOI 10.1016/j.ejmech.2012.09.010; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Han QX, 2009, VIRUS RES, V145, P63, DOI 10.1016/j.virusres.2009.06.005; Harper S, 2005, J MED CHEM, V48, P4547, DOI 10.1021/jm050056+; Huang SD, 2014, ORG BIOMOL CHEM, V12, P2344, DOI 10.1039/c3ob42525h; Hucke O, 2014, J MED CHEM, V57, P1932, DOI 10.1021/jm4004522; Jin G, 2014, EUR J MED CHEM, V75, P413, DOI 10.1016/j.ejmech.2014.01.062; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kim SH, 2008, BIOORG MED CHEM LETT, V18, P4181, DOI 10.1016/j.bmcl.2008.05.083; Kong LB, 2013, ANTIVIR RES, V98, P44, DOI 10.1016/j.antiviral.2013.02.003; Krueger AC, 2013, BIOORG MED CHEM LETT, V23, P3487, DOI 10.1016/j.bmcl.2013.04.057; Kumar DV, 2011, BIOORG MED CHEM LETT, V21, P82, DOI 10.1016/j.bmcl.2010.11.068; Lam AM, 2012, ANTIMICROB AGENTS CH, V56, P3359, DOI 10.1128/AAC.00054-12; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Le Pogam S, 2006, J VIROL, V80, P6146, DOI 10.1128/JVI.02628-05; Lee JC, 2010, ANAL BIOCHEM, V403, P52, DOI 10.1016/j.ab.2010.04.004; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Louise-May S, 2007, BIOORG MED CHEM LETT, V17, P3905, DOI 10.1016/j.bmcl.2007.04.103; Loving K, 2009, J COMPUT AID MOL DES, V23, P541, DOI 10.1007/s10822-009-9268-1; Lu W, 2011, ACTA PHYS-CHIM SIN, V27, P1407, DOI 10.3866/PKU.WHXB20110608; Lv W, 2010, EUR J MED CHEM, V45, P1167, DOI 10.1016/j.ejmech.2009.12.038; Martin TM, 2012, J CHEM INF MODEL, V52, P2570, DOI 10.1021/ci300338w; May MM, 2012, ANTIVIR RES, V95, P182, DOI 10.1016/j.antiviral.2012.04.008; Maynard A, 2014, J MED CHEM, V57, P1902, DOI 10.1021/jm400317w; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; Melagraki G, 2007, BIOORGAN MED CHEM, V15, P7237, DOI 10.1016/j.bmc.2007.08.036; Moradpour D, 2004, J VIROL, V78, P13278, DOI 10.1128/JVI.78.23.13278-13284.2004; Musmuca I, 2010, J CHEM INF MODEL, V50, P662, DOI 10.1021/ci9004749; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Obrezanova O, 2010, J CHEM INF MODEL, V50, P1053, DOI 10.1021/ci900406x; Palmer DS, 2007, J CHEM INF MODEL, V47, P150, DOI 10.1021/ci060164k; Patel PD, 2008, J CHEM INF MODEL, V48, P42, DOI 10.1021/ci700266z; Patil VM, 2011, MED CHEM RES, V20, P1616, DOI 10.1007/s00044-010-9435-x; Pourbasheer E, 2011, MOL DIVERS, V15, P645, DOI 10.1007/s11030-010-9283-0; Ren JX, 2011, J CHEM INF MODEL, V51, P1364, DOI 10.1021/ci100464b; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Ruebsam F, 2009, BIOORG MED CHEM LETT, V19, P6404, DOI 10.1016/j.bmcl.2009.09.045; Ryckmans T, 2009, BIOORG MED CHEM LETT, V19, P4406, DOI 10.1016/j.bmcl.2009.05.062; Ryu K, 2009, BIOORGAN MED CHEM, V17, P2975, DOI 10.1016/j.bmc.2009.03.024; Salam NK, 2009, J CHEM INF MODEL, V49, P2356, DOI 10.1021/ci900212v; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Shaw AN, 2009, BIOORG MED CHEM LETT, V19, P4350, DOI 10.1016/j.bmcl.2009.05.091; Sofia MJ, 2012, J MED CHEM, V55, P2481, DOI 10.1021/jm201384j; Stammers TA, 2013, BIOORG MED CHEM LETT, V23, P6879, DOI 10.1016/j.bmcl.2013.09.102; Stammers TA, 2013, BIOORG MED CHEM LETT, V23, P2585, DOI 10.1016/j.bmcl.2013.02.110; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Talele TT, 2010, BIOORGAN MED CHEM, V18, P4630, DOI 10.1016/j.bmc.2010.05.030; Teixeira AL, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-9; Therese PJ, 2014, J CHEM INF MODEL, V54, P539, DOI 10.1021/ci400644r; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Vandyck K, 2009, J MED CHEM, V52, P4099, DOI 10.1021/jm9005548; Venkatraman S, 2014, BIOORGAN MED CHEM, V22, P447, DOI 10.1016/j.bmc.2013.11.007; Wang MT, 2003, J BIOL CHEM, V278, P9489, DOI 10.1074/jbc.M209397200; Watts KS, 2010, J CHEM INF MODEL, V50, P534, DOI 10.1021/ci100015j; Weidlich IE, 2013, BIOORGAN MED CHEM, V21, P3127, DOI 10.1016/j.bmc.2013.03.032; Xue WW, 2014, ANTIVIR RES, V104, P40, DOI 10.1016/j.antiviral.2014.01.006; Yan SQ, 2007, BIOORG MED CHEM LETT, V17, P1991, DOI 10.1016/j.bmcl.2007.01.024; Yan SQ, 2007, BIOORG MED CHEM LETT, V17, P63, DOI 10.1016/j.bmcl.2006.09.095; Yan SQ, 2006, BIOORG MED CHEM LETT, V16, P5888, DOI 10.1016/j.bmcl.2006.08.056; Yang HB, 2010, BIOORG MED CHEM LETT, V20, P4614, DOI 10.1016/j.bmcl.2010.06.008; Ye L, 2005, ACTA VIROL, V49, P83; Zeng QB, 2013, BIOORG MED CHEM LETT, V23, P6585, DOI 10.1016/j.bmcl.2013.10.060	95	39	40	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148181	10.1371/journal.pone.0148181	http://dx.doi.org/10.1371/journal.pone.0148181			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845440	gold, Green Published, Green Submitted			2022-12-27	WOS:000369552800035
J	Liu, YN; Zhou, JL; Luo, XM; Yang, CX; Zhang, Y; Shi, SJ				Liu, Yani; Zhou, Jiali; Luo, Xiaomei; Yang, Chunxiao; Zhang, Yu; Shi, Shaojun			Association of RAC1 Gene Polymorphisms with Primary End-Stage Renal Disease in Chinese Renal Recipients	PLOS ONE			English	Article							KIDNEY-FUNCTION; ACTIVATION; GTPASE; RISK; HYPERTENSION; EXPRESSION	Background/Objective RAC1 gene could influence susceptibility to renal failure by altering the activity and expression of Rac1, which is a member of the Rho family of small GTP-binding proteins. In clinical practice, renal transplantation provides the optimal treatment for people with end-stage renal disease (ESRD). The objective of this present study was to determine whether the RAC1 gene polymorphisms were associated with primary ESRD susceptibility in Chinese renal recipients. Methods Six single nucleotide polymorphisms (SNPs) of RAC1 gene, including rs836488 T>C, rs702482 A>T, rs10951982 G>A, rs702483 A>G, rs6954996 G>A, and rs9374 G>A, were genotyped in 300 renal transplant recipients (cases) and 998 healthy Chinese subjects (controls) by using TaqMan SNP genotyping assay. Allele, genotype, and haplotype frequencies of the six SNPs were compared between cases and controls. Odds ratios (OR) and 95% confidence intervals (CI) were calculated in logistic regression models to evaluate the associations of the six SNPs with ESRD risk. Results The genotype distributions for the six SNPs in controls were consistent with Hardy-Weinberg equilibrium (P > 0.05). Association analysis revealed that three SNPs were significantly associated with ESRD risk. Positive associations with ESRD risk were found for the rs836488, rs702482, and rs702483 in the co-dominant model (minor allele homozygotes versus major allele homozygotes); specifically, the frequencies of the minor allele homozygotes and the minor allele for the three SNPs were higher in the cases than in the controls. In addition, these three SNPs also had associations with increased ESRD risk under the additive model (P < 0.05), and positive associations were also found for the rs836488 in the dominant model (P < 0.05) and for the rs702483 in the recessive model (P < 0.05). All these associations were independent of confounding factors. The other three SNPs (rs10951982, rs6954996, and rs9374), in all comparison models, were not associated with ESRD risk (P > 0.05). In haplotype analysis, carriers with "C-T-G-G-G-G" haplotype had a significantly higher risk of ESRD compared with the most common haplotype "T-A-G-A-G-G" (P = 0.011, OR = 1.46, 95% CI = 1.09-1.94). Conclusion This study suggested that polymorphisms of RAC1 gene might influence the susceptibility to ESRD in Chinese Han population. Further studies are necessary to confirm our findings.	[Liu, Yani; Zhou, Jiali; Luo, Xiaomei; Yang, Chunxiao; Zhang, Yu; Shi, Shaojun] Huazhong Univ Sci & Technol, Dept Pharm, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Shi, SJ (corresponding author), Huazhong Univ Sci & Technol, Dept Pharm, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	sjshicn@163.com			National Natural Science Foundation of China [81273591]; Natural Science Foundation of Hubei Province (P.R. China) [2009CDB380]; Fundamental Research Funds for the Central Universities (P.R. China) [2014YGYL003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province (P.R. China)(Natural Science Foundation of Hubei Province); Fundamental Research Funds for the Central Universities (P.R. China)(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (grant number 81273591), the Natural Science Foundation of Hubei Province (P.R. China) (grant number 2009CDB380), and the Fundamental Research Funds for the Central Universities (P.R. China) (grant number 2014YGYL003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Borkar M, 2011, INFLAMM RES, V60, P399, DOI 10.1007/s00011-010-0284-3; Bourgine J, 2011, PHARMACOGENET GENOM, V21, P313, DOI 10.1097/FPC.0b013e3283449200; Cao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090869; Chambers JC, 2010, NAT GENET, V42, P373, DOI 10.1038/ng.566; Derijks LJJ, 2010, CURR PHARM DESIGN, V16, P145, DOI 10.2174/138161210790112773; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Gastonguay AJ, 2012, CANCER BIOL THER, V13, P647, DOI 10.4161/cbt.20082; George GP, 2011, TRANSPL IMMUNOL, V24, P220, DOI 10.1016/j.trim.2011.03.003; Hwang H, 2014, INTEGR BIOL-UK, V6, P267, DOI 10.1039/c3ib40183a; Iwashima F, 2008, ENDOCRINOLOGY, V149, P1009, DOI 10.1210/en.2007-0864; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Koh MS, 2011, BIOCHEM BIOPH RES CO, V406, P25, DOI 10.1016/j.bbrc.2011.01.092; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Ma Q, 2009, P NATL ACAD SCI USA, V106, P8683, DOI 10.1073/pnas.0812688106; Mao S, 2013, INTERNAL MED, V52, P2423, DOI 10.2169/internalmedicine.52.0866; Matos P, 2000, BIOCHEM BIOPH RES CO, V277, P741, DOI 10.1006/bbrc.2000.3743; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Misra MK, 2014, J INTERF CYTOK RES, V34, P148, DOI 10.1089/jir.2013.0069; Muise AM, 2011, GASTROENTEROLOGY, V141, P633, DOI 10.1053/j.gastro.2011.04.057; Nagase M, 2013, CURR OPIN NEPHROL HY, V22, P148, DOI 10.1097/MNH.0b013e32835d0751; Nagase M, 2013, NAT REV NEPHROL, V9, P86, DOI 10.1038/nrneph.2012.282; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Prakash S, 2012, CYTOKINE, V58, P261, DOI 10.1016/j.cyto.2012.01.020; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Skvortsov S, 2011, RADIOTHER ONCOL, V101, P177, DOI 10.1016/j.radonc.2011.05.067; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Taher M, 2014, CLIN RES HEPATOL GAS; Tapia-Castillo A, 2014, AM J HYPERTENS, V27, P299, DOI 10.1093/ajh/hpt277; Trabulus S, 2012, MOL BIOL REP, V39, P6995, DOI 10.1007/s11033-012-1529-8; Wang TX, 2008, NEUROSCI LETT, V437, P71, DOI 10.1016/j.neulet.2008.01.022; Yalovsky S, 2008, PLANT PHYSIOL, V147, P1527, DOI 10.1104/pp.108.122150; Zuo L, 2010, CLIN NEPHROL, V74, pS20	34	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148270	10.1371/journal.pone.0148270	http://dx.doi.org/10.1371/journal.pone.0148270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841219	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200116
J	Beyer, S; von Bueren, AO; Klautke, G; Guckenberger, M; Kortmann, RD; Pietschmann, S; Muller, K				Beyer, Stefanie; von Bueren, Andre O.; Klautke, Gunther; Guckenberger, Matthias; Kortmann, Rolf-Dieter; Pietschmann, Sophie; Mueller, Klaus			A Systematic Review on the Characteristics, Treatments and Outcomes of the Patients with Primary Spinal Glioblastomas or Gliosarcomas Reported in Literature until March 2015	PLOS ONE			English	Review							NEWLY-DIAGNOSED GLIOBLASTOMA; MALIGNANT ASTROCYTOMAS; PROGNOSTIC-FACTORS; NERVOUS-SYSTEM; CORD; RADIOTHERAPY; TEMOZOLOMIDE; MULTIFORME; SURVIVAL; GLIOMA	Our aim was to determine the characteristics, treatments and outcomes of patients with primary spinal glioblastomas (GB) or gliosarcomas (GS) reported in literature until March 2015. PubMed and Web of Science were searched for peer-reviewed articles pertaining to cases of glioblastomas / gliosarcomas with primary spinal origin, using predefined search terms. Furthermore we performed hand searches tracking the references from the selected papers. Eighty-two articles published between 1938 and March 2015 were eligible. They reported on 157 patients. Median age at diagnosis was 22 years. The proportion of patients who received adjuvant chemo-or radiotherapy clearly increased from the time before 1980 until present. Median overall survival from diagnosis was 8.0 +/- 0.9 months. On univariate analysis age influenced overall survival, whereas tumor location, gender and the extent of initial resection did not. Outcomes did not differ between children (< 18 years) and adults. However, the patients who were treated after 1980 achieved longer survival times than the patients treated before. On multivariable analysis only age (< 60 years) and the time period of treatment (>= 1980) were confirmed as positive independent prognostic factors. In conclusion, primary spinal GB / GS mainly affect younger patients and are associated with a dismal prognosis. However, most likely due to the increasing use of adjuvant treatment, modest therapeutic progress has been achieved over recent decades. The characteristics and treatments of primary spinal glioblastomas should be entered into a central registry in order to gain more information about the ideal treatment approach in the future.	[Beyer, Stefanie] Univ Med Ctr Leipzig, Ctr Dent & Oral Med, Leipzig, Saxony, Germany; [von Bueren, Andre O.] Univ Med Ctr Goettingen, Div Pediat Hematol & Oncol, Dept Pediat & Adolescent Med, Gottingen, Lower Saxony, Germany; [Klautke, Gunther; Mueller, Klaus] Hosp Chemnitz, Dept Radiat Oncol, Chemnitz, Germany; [Guckenberger, Matthias] Univ Zurich Hosp, Dept Radiat Oncol, CH-8091 Zurich, Switzerland; [Kortmann, Rolf-Dieter; Pietschmann, Sophie; Mueller, Klaus] Univ Med Ctr Leipzig, Dept Radiat Oncol, Leipzig, Saxony, Germany	Leipzig University; University of Gottingen; Chemnitz Clinic; University of Zurich; University Zurich Hospital; Leipzig University	Beyer, S (corresponding author), Univ Med Ctr Leipzig, Ctr Dent & Oral Med, Leipzig, Saxony, Germany.	BeyerSt@medizin.uni-leipzig.de	Guckenberger, Matthias/AAX-4994-2020; Guckenberger, Matthias/M-5114-2019; von Bueren, Andre/AAF-2065-2020	Guckenberger, Matthias/0000-0002-7146-9071; von Bueren, Andre/0000-0003-4197-6264	German Research Foundation (DFG); University of Leipzig	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Leipzig	The authors acknowledge support from the German Research Foundation (DFG) and the University of Leipzig within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to the authors of articles, who provided the data for this study that otherwise would not have been possible. We would like to thank Mrs. Christiane Hofmann for assisting the literature search and Ms. Ines Held for proofreading this article. We furthermore acknowledge support from the German Research Foundation (DFG) and the University of Leipzig within the program of Open Access Publishing.	Adams H, 2012, SPINE, V37, pE727, DOI 10.1097/BRS.0b013e31824584c0; Allen JC, 1998, J NEUROSURG, V88, P215, DOI 10.3171/jns.1998.88.2.0215; CARSTENS PHB, 1995, ANN CLIN LAB SCI, V25, P241; Chakrabarti I, 2005, CANCER-AM CANCER SOC, V104, P2798, DOI 10.1002/cncr.21539; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; COHEN AR, 1989, J NEUROSURG, V70, P50, DOI 10.3171/jns.1989.70.1.0050; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Kaatsch P, 2001, CANCER-AM CANCER SOC, V92, P3155, DOI 10.1002/1097-0142(20011215)92:12<3155::AID-CNCR10158>3.0.CO;2-C; Konig SA, 2012, J NEUROL SURG PART A, V73, P256, DOI 10.1055/s-0032-1313634; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; MacDonald TJ, 2011, NEURO-ONCOLOGY, V13, P1049, DOI 10.1093/neuonc/nor092; Marchan EM, 2007, J NEUROSURG-SPINE, V7, P656, DOI 10.3171/SPI-07/12/656; McGirt MJ, 2008, NEUROSURGERY, V63, P55, DOI 10.1227/01.NEU.0000335070.37943.09; Merchant TE, 1999, PEDIATR NEUROSURG, V30, P1, DOI 10.1159/000028751; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Pietschmann S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121592; Pietschmann S, 2014, J NEURO-ONCOL, V120, P451, DOI 10.1007/s11060-014-1596-x; Raco A, 2010, J NEUROSURG-SPINE, V12, P144, DOI 10.3171/2009.6.SPINE08910; ROESSMANN U, 1972, ACTA NEUROPATHOL, V20, P264, DOI 10.1007/BF00686908; Santi M, 2003, CANCER-AM CANCER SOC, V98, P554, DOI 10.1002/cncr.11514; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; SHIRATO H, 1995, INT J RADIAT ONCOL, V33, P323, DOI 10.1016/0360-3016(95)00179-3; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tendulkar RD, 2010, INT J RADIAT ONCOL, V78, P1451, DOI 10.1016/j.ijrobp.2009.09.071; Viljoen Stephanus, 2014, Surg Neurol Int, V5, P101, DOI 10.4103/2152-7806.135305; Zwiener I, 2011, DTSCH ARZTEBL INT, V108, P163, DOI [10.3238/arztebl.2011.0163, 10.3238/arztebl.2010.0163]	28	15	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148312	10.1371/journal.pone.0148312	http://dx.doi.org/10.1371/journal.pone.0148312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859136	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000370038400029
J	Kyrkjeeide, MO; Hassel, K; Flatberg, KI; Shaw, AJ; Yousefi, N; Stenoien, HK				Kyrkjeeide, Magni Olsen; Hassel, Kristian; Flatberg, Kjell Ivar; Shaw, A. Jonathan; Yousefi, Narjes; Stenoien, Hans K.			Spatial Genetic Structure of the Abundant and Widespread Peatmoss Sphagnum magellanicum Brid.	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; TIERRA-DEL-FUEGO; POPULATION-STRUCTURE; DIVERSITY; DIVERGENCE; INFERENCE; ALLOPOLYPLOIDY; BIOGEOGRAPHY; DISJUNCTIONS; BRYOPHYTES	Spore-producing organisms have small dispersal units enabling them to become widespread across continents. However, barriers to gene flow and cryptic speciation may exist. The common, haploid peatmoss Sphagnum magellanicum occurs in both the Northern and Southern hemisphere, and is commonly used as a model in studies of peatland ecology and peatmoss physiology. Even though it will likely act as a rich source in functional genomics studies in years to come, surprisingly little is known about levels of genetic variability and structuring in this species. Here, we assess for the first time how genetic variation in S. magellanicum is spatially structured across its full distribution range (Northern Hemisphere and South America). The morphologically similar species S. alaskense was included for comparison. In total, 195 plants were genotyped at 15 microsatellite loci. Sequences from two plastid loci (trnG and trnL) were obtained from 30 samples. Our results show that S. alaskense and almost all plants of S. magellanicum in the northern Pacific area are diploids and share the same gene pool. Haploid plants occur in South America, Europe, eastern North America, western North America, and southern Asia, and five genetically differentiated groups with different distribution ranges were found. Our results indicate that S. magellanicum consists of several distinct genetic groups, seemingly with little or no gene flow among them. Noteworthy, the geographical separation of diploids and haploids is strikingly similar to patterns found within other haploid Sphagnum species spanning the Northern Hemisphere. Our results confirm a genetic division between the Beringian and the Atlantic that seems to be a general pattern in Sphagnum taxa. The pattern of strong genetic population structuring throughout the distribution range of morphologically similar plants need to be considered in future functional genomic studies of S. magellanicum.	[Kyrkjeeide, Magni Olsen; Hassel, Kristian; Flatberg, Kjell Ivar; Yousefi, Narjes] Norwegian Univ Sci & Technol, NTNU Univ Museum, NO-7491 Trondheim, Norway; [Kyrkjeeide, Magni Olsen] Norwegian Inst Nat Res, N-7485 Trondheim, Norway; [Shaw, A. Jonathan] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Stenoien, Hans K.] Norwegian Univ Sci & Technol, NTNU Univ Museum, Ctr Biodivers Dynam, NO-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian Institute Nature Research; Duke University; Norwegian University of Science & Technology (NTNU)	Stenoien, HK (corresponding author), Norwegian Univ Sci & Technol, NTNU Univ Museum, Ctr Biodivers Dynam, NO-7491 Trondheim, Norway.	stenoien@ntnu.no	Hassel, Kristian/AAD-7241-2022	Hassel, Kristian/0000-0002-1906-8166	NTNU University Museum	NTNU University Museum	The funding source of this work has been NTNU University Museum. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L. E., 2009, PEAT MOSSES SE US; Andrus RE, 2003, BRYOLOGIST, V106, P435, DOI 10.1639/08; [Anonymous], 2008, BRYOPHYTE BIOL, DOI [10.1017/CBO9780511754807.010, DOI 10.1017/CBO9780511754807.010., DOI 10.1017/CBO9780511754807.010]; Bridel SE, 1798, MUSCOLOGIA RECENTIOR; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; Buschbom J, 2007, MOL ECOL, V16, P1835, DOI 10.1111/j.1365-294X.2007.03258.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Crespo A, 2010, IMA FUNGUS, V1, P167, DOI 10.5598/imafungus.2010.01.02.09; Crespo A, 2009, AN JARDIN BOT MADRID, V66, P71, DOI 10.3989/ajbm.2225; Cuesta F, 2012, IMCG NEWSLETTER, P4; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Donoghue MJ, 2011, P NATL ACAD SCI USA, V108, P6341, DOI 10.1073/pnas.1103801108; Eddy A., 1985, B BRIT MUS NAT HIST, V12, P77; Eidesen PB, 2013, NEW PHYTOL, V200, P898, DOI 10.1111/nph.12412; Escudero M, 2010, FLORA, V205, P118, DOI 10.1016/j.flora.2009.01.005; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fernandez-Mendoza F, 2013, MOL ECOL, V22, P1961, DOI 10.1111/mec.12210; Flatberg K. I., 2013, NORGES TORVMOSER; Flatberg K. I., 2008, LINDBERGIA, V33, P2; Frahm JP, 2008, BIODIVERS CONSERV, V17, P277, DOI 10.1007/s10531-007-9251-x; FRAHM JP, 1993, NOVA HEDWIGIA, V56, P307; Geml J, 2010, J BIOGEOGR, V37, P1529, DOI 10.1111/j.1365-2699.2010.02287.x; Grootjans A, 2014, MIRES PEAT, V14; Grootjans A, 2010, MIRES PEAT, V6; Hajek T, 2014, ADV PHOTOSYNTH RESP, V37, P233, DOI 10.1007/978-94-007-6988-5_13; Hanssen L, 2000, BRYOLOGIST, V103, P93, DOI 10.1639/0007-2745(2000)103[0093:PSATOS]2.0.CO;2; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Karlin EF, 2011, MOL ECOL, V20, P753, DOI 10.1111/j.1365-294X.2010.04982.x; Karlin EF, 2012, NEW PHYTOL, V193, P1088, DOI 10.1111/j.1469-8137.2011.03999.x; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kyrkjeeide MO, 2015, THESIS; Kyrkjeeide MO, J BRYOLOGY IN PRESS; Leavitt SD, 2012, BIOL J LINN SOC, V107, P920, DOI 10.1111/j.1095-8312.2012.01978.x; Lewis Lily R, 2014, PeerJ, V2, pe424, DOI 10.7717/peerj.424; Lewis LR, 2014, J BIOGEOGR, V41, P2385, DOI 10.1111/jbi.12385; Lucking R, 2003, LICHENOLOGIST, V35, P33, DOI 10.1006/lich.2002.0430; [Максимов А.И. Maksimov Anatoly I.], 2008, [Arctoa, Arctoa], V17, P109; McQueen C. B., 1997, Tropical Bryology, P65; McQueen C. B., 2007, FLORA N AM N MEXICO, V27, P45; MCQUEEN CB, 1991, BRYOLOGIST, V94, P39, DOI 10.2307/3243715; McQueen CB, 1995, TROP BRYOL, V11, P119; Medina NG., 2011, BIOGEOGRAPHY MICROSC, P209, DOI [10.1017/CBO9780511974878.012, DOI 10.1017/CBO9780511974878.012]; Ochyra R, 2003, BRYOLOGIST, V106, P532, DOI 10.1639/0007-2745(2003)106[532:AFNTTD]2.0.CO;2; Pante E, 2015, MOL ECOL, V24, P525, DOI 10.1111/mec.13048; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; PENTECOST A, 1981, NEW PHYTOL, V89, P667, DOI 10.1111/j.1469-8137.1981.tb02345.x; Pineiro R, 2012, J BIOGEOGR, V39, P2041, DOI 10.1111/j.1365-2699.2012.02765.x; Popp M, 2011, P NATL ACAD SCI USA, V108, P6520, DOI 10.1073/pnas.1012249108; Printzen C, 2008, PLANT ECOL DIVERS, V1, P265, DOI 10.1080/17550870802328702; Pritchard JK, 2000, GENETICS, V155, P945; Proches S, 2013, J BIOGEOGR, V40, P1819, DOI 10.1111/jbi.12125; R Core Team, 2021, R LANGUAGE ENV STAT; Ramaiya M, 2010, AM J BOT, V97, P1707, DOI 10.3732/ajb.1000171; Ricca M, 2008, AM J BOT, V95, P1606, DOI 10.3732/ajb.0800148; Ricca M, 2010, BIOL J LINN SOC, V99, P135; Rydin H, 2013, BIO HABIT, P65; SCHOFIELD WB, 1988, BOT J LINN SOC, V98, P211, DOI 10.1111/j.1095-8339.1988.tb02425.x; Shaw AJ, 2008, MOL PHYLOGENET EVOL, V49, P304, DOI 10.1016/j.ympev.2008.06.009; Shaw AJ, 2008, BRYOLOGIST, V111, P271, DOI 10.1639/0007-2745(2008)111[271:GVITCP]2.0.CO;2; Shaw AJ, 2014, BIOL J LINN SOC, V111, P17, DOI 10.1111/bij.12200; Shaw AJ, 2010, MOL PHYLOGENET EVOL, V55, P1139, DOI 10.1016/j.ympev.2010.01.020; Shaw AJ, 2001, J BIOGEOGR, V28, P253; Shaw AJ, 2003, AM J BOT, V90, P1777, DOI 10.3732/ajb.90.12.1777; Shepherd LD, 2009, J BIOGEOGR, V36, P1972, DOI 10.1111/j.1365-2699.2009.02120.x; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Stech M, 2011, TAXON, V60, P79, DOI 10.1002/tax.601007; Stenoien HK, 2011, HEREDITY, V106, P370, DOI 10.1038/hdy.2010.96; Stenoien HK, 2014, BRYOLOGIST, V117, P95, DOI 10.1639/0007-2745-117.2.095; Stenoien HK, 2011, EVOLUTION, V65, P1181, DOI 10.1111/j.1558-5646.2010.01191.x; Sundberg S, 2002, J ECOL, V90, P268, DOI 10.1046/j.1365-2745.2001.00653.x; Szovenyi P, 2008, MOL ECOL, V17, P5364, DOI 10.1111/j.1365-294X.2008.04003.x; Szweykowski J, 2005, PLANT SYST EVOL, V253, P133, DOI 10.1007/s00606-005-0301-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Temsch EM, 1998, BOT ACTA, V111, P325, DOI 10.1111/j.1438-8677.1998.tb00716.x; Thingsgaard K, 2001, HEREDITY, V87, P485, DOI 10.1046/j.1365-2540.2001.00939.x; Villarreal JC, 2014, MOL PHYLOGENET EVOL, V78, P25, DOI 10.1016/j.ympev.2014.04.014; Villaverde T, 2015, J BIOGEOGR, V42, P1514, DOI 10.1111/jbi.12521; Wang JY, 2008, HEREDITY, V101, P145, DOI 10.1038/hdy.2008.40; Werth S., 2011, BIOGEOGRAPHY MICROSC, P191, DOI [DOI 10.1017/CBO9780511974878.011, 10.1017/CBO9780511974878.011]; Wolfe J, 1992, TROPICAL BRYOLOGY, V5, P73; Xiang JY, 2015, J SYST EVOL, V53, P2, DOI 10.1111/jse.12141	85	28	29	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148447	10.1371/journal.pone.0148447	http://dx.doi.org/10.1371/journal.pone.0148447			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859563	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400042
J	Wotschofsky, Z; Gummlich, L; Liep, J; Stephan, C; Kilic, E; Jung, K; Billaud, JN; Meyer, HA				Wotschofsky, Zofia; Gummlich, Linda; Liep, Julia; Stephan, Carsten; Kilic, Ergin; Jung, Klaus; Billaud, Jean-Noel; Meyer, Hellmuth-Alexander			Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; CLINICAL-SIGNIFICANCE; TUMOR-SUPPRESSOR; PROSTATE-CANCER; REFERENCE GENES; UP-REGULATION; EXPRESSION; UHRF1; IDENTIFICATION	Background MicroRNAs (miRNAs) regulate gene expression by interfering translation or stability of target transcripts. This interplay between miRNA and their mRNA has been proposed as an important process in cancer development and progression. We have investigated molecular networks impacted by predicted mRNA targets of differentially expressed miRNAs in patients with clear cell renal cell carcinoma (ccRCC) diagnosed with or without metastasis. Material and Methods miRNA and mRNA microarray expression profiles derived from primary ccRCC from patients with (16 samples) or without diagnosed metastasis (22 samples) were used to identify anti-correlated miRNA-mRNA interaction in ccRCC. For this purpose, Ingenuity pathway analysis microRNA Target Filter, which enables prioritization of experimentally validated and predicted mRNA targets was used. By applying an expression pairing tool, the analysis was focused on targets exhibiting altered expression in our analysis, finding miRNAs and their target genes with opposite or same expression. The resulting identified interactions were revalidated by RT-qPCR in another cohort of ccRCC patients. A selection of the predicted miRNA-mRNA interactions was tested by functional analyses using miRNA knockdown and overexpression experiments in renal cancer cell lines. Results Among the significantly differentially expressed miRNAs, we have identified three miRNAs (miR-146a-5p, miR-128a-3p, and miR-17-5p) that were upregulated in primary tumors from patients without metastasis and downregulated in primary tumors from patients with metastasis. We have further identified mRNA targets, which expression were inversely correlated to these 3 miRNAs, and have been previously experimentally demonstrated in cancer setting in humans. Specifically, we showed that CXCL8/IL8, UHRF1, MCM10, and CDKN3 were downregulated and targeted by miR-146a-5p. The interaction between miR-146a-5p and their targets CXCL8 and UHRF1 was validated in cell culture experiments. Conclusions We identified novel target genes of dysregulated miRNAs, which are involved in the transition from primary RCC without metastases into tumors generating distant metastasis.	[Wotschofsky, Zofia; Liep, Julia; Stephan, Carsten; Jung, Klaus; Meyer, Hellmuth-Alexander] Charite, Dept Urol, D-13353 Berlin, Germany; [Wotschofsky, Zofia; Gummlich, Linda; Liep, Julia; Stephan, Carsten; Jung, Klaus] Berlin Inst Urol Res, Berlin, Germany; [Gummlich, Linda] Charite, Dept Gen Visceral Vasc & Thorac Surg, Div Mol Biol, D-13353 Berlin, Germany; [Kilic, Ergin] Charite, Inst Pathol, D-13353 Berlin, Germany; [Billaud, Jean-Noel] QIAGEN, 1700 Seaport Blvd, Redwood City, CA USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Meyer, HA (corresponding author), Charite, Dept Urol, D-13353 Berlin, Germany.; Billaud, JN (corresponding author), QIAGEN, 1700 Seaport Blvd, Redwood City, CA USA.	jean-noel.billaud@qiagen.com; hellmuth.meyer@web.de	Jung, Klaus/Z-2122-2018	Jung, Klaus/0000-0001-9797-5362; Stephan, Carsten/0000-0002-3270-258X	Foundation Urologic Research, Berlin, Germany; QIAGEN	Foundation Urologic Research, Berlin, Germany; QIAGEN	This work was supported by fellowships from the Foundation Urologic Research, Berlin, Germany for Julia Liep (JL) and Linda Gummlich (LG) as part of their doctoral thesis. The sponsor had no involvement in the study design; in the collection, analysis and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication. QIAGEN provided support in the form of salaries (JNB) for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Andel M, 2015, METHODS, V83, P88, DOI 10.1016/j.ymeth.2015.04.006; Arima Y, 2004, GENES CELLS, V9, P131, DOI 10.1111/j.1356-9597.2004.00710.x; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bouyssou JMC, 2014, BBA-REV CANCER, V1845, P255, DOI 10.1016/j.bbcan.2014.02.002; Bronner C, 2013, BIOCHEM PHARMACOL, V86, P1643, DOI 10.1016/j.bcp.2013.10.002; Busch J, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0180-3; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butz H, 2014, CLIN CHEM, V60, P1314, DOI 10.1373/clinchem.2014.225854; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Cui L, 2015, MOL CELL BIOCHEM, V400, P223, DOI 10.1007/s11010-014-2279-9; Das M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069607; De Mulder PHM, 2007, EUR UROL SUPPL, V6, P665, DOI 10.1016/j.eursup.2007.03.010; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Fendler A, 2011, CLIN CHEM, V57, P954, DOI 10.1373/clinchem.2010.157727; Ficarra V, 2007, EUR UROL SUPPL, V6, P623, DOI 10.1016/j.eursup.2007.03.008; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gales Dominique, 2013, ISRN Oncol, V2013, P859154, DOI 10.1155/2013/859154; Garcia AI, 2011, EMBO MOL MED, V3, P279, DOI 10.1002/emmm.201100136; Gowrishankar B, 2014, CANCER BIOL THER, V15, P329, DOI 10.4161/cbt.27314; Ha E, 2010, MOL MED REP, V3, P275, DOI 10.3892/mmr_00000251; Heinzelmann J, 2014, ANN SURG ONCOL, V21, P1046, DOI 10.1245/s10434-013-3361-3; Heinzelmann J, 2011, WORLD J UROL, V29, P367, DOI 10.1007/s00345-010-0633-4; Howlader N., 2017, SEER CANC STAT REV 1; Huang PX, 2014, J CELL MOL MED, V18, P218, DOI 10.1111/jcmm.12153; Huang WJ, 2015, GASTROENTEROLOGY, V149, P1053, DOI 10.1053/j.gastro.2015.05.058; Jenkins Y, 2005, MOL BIOL CELL, V16, P5621, DOI 10.1091/mbc.E05-03-0194; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Jung M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-47; Jung M, 2010, CLIN CHEM, V56, P998, DOI 10.1373/clinchem.2009.141580; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Khella HWZ, 2012, TUMOR BIOL, V33, P131, DOI 10.1007/s13277-011-0255-5; Kogo R, 2011, CLIN CANCER RES, V17, P4277, DOI 10.1158/1078-0432.CCR-10-2866; Lai MW, 2012, UROL ONCOL-SEMIN ORI, V30, P871, DOI 10.1016/j.urolonc.2010.09.010; Li HL, 2014, INT J ONCOL, V45, P197, DOI 10.3892/ijo.2014.2415; Li M, 2015, ONCOL REP, V33, P1571, DOI 10.3892/or.2015.3799; Li TR, 2014, ONCOL REP, V31, P1825, DOI 10.3892/or.2014.3045; Li W, 2013, KIDNEY BLOOD PRESS R, V37, P506, DOI 10.1159/000355726; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; Li XL, 2012, ONCOL REP, V28, P375, DOI 10.3892/or.2012.1792; Lin F, 2012, CANCER CHEMOTH PHARM, V69, P1079, DOI 10.1007/s00280-011-1801-y; Ljungberg B., 2015, GUIDELINES RENAL CEL; M'hamed IF, 2015, CELL ONCOL, V38, P433, DOI 10.1007/s13402-015-0239-3; Ma J, 2015, BIOCHEM BIOPH RES CO, V464, P147, DOI 10.1016/j.bbrc.2015.06.104; Meyer HA, 2009, EUR UROL, V55, P669, DOI 10.1016/j.eururo.2008.04.001; Okamoto K, 2006, BIOCHEM BIOPH RES CO, V351, P216, DOI 10.1016/j.bbrc.2006.10.022; Pacifico F, 2010, J CLIN ENDOCR METAB, V95, P1421, DOI 10.1210/jc.2009-1128; Petillo D, 2009, INT J ONCOL, V35, P109, DOI 10.3892/ijo_00000318; Rabien A, 2007, EUR UROL, V51, P1259, DOI 10.1016/j.eururo.2006.05.050; Sanmamed MF, 2014, CLIN CANCER RES, V20, P5697, DOI 10.1158/1078-0432.CCR-13-3203; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Schaefer A, 2010, NAT REV UROL, V7, P286, DOI 10.1038/nrurol.2010.45; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Slaby O, 2012, GENE CHROMOSOME CANC, V51, P707, DOI 10.1002/gcc.21957; Sobin LH, 2002, TNM CLASSIFICATION M, P193; Sun M, 2015, CANCER BIOMARK, V15, P33, DOI 10.3233/CBM-140431; Sun Q, 2014, PROSTATE, V74, P1613, DOI 10.1002/pros.22878; Tang K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10272; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Van Poppel H, 2007, EUR UROL, V51, P1606, DOI 10.1016/j.eururo.2006.11.013; Wang RJ, 2015, INT J CLIN EXP PATHO, V8, P765; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Warnecke-Eberz U, 2015, TUMOR BIOL, V36, P4643, DOI 10.1007/s13277-015-3112-0; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; White NMA, 2011, BRIT J CANCER, V105, P1741, DOI 10.1038/bjc.2011.401; White NMA, 2011, J UROLOGY, V186, P1077, DOI 10.1016/j.juro.2011.04.110; Wotschofsky Z, 2013, CLIN CHIM ACTA, V416, P5, DOI 10.1016/j.cca.2012.11.010; Wotschofsky Z, 2012, INT J BIOL SCI, V8, P1363, DOI 10.7150/ijbs.5106; Wotschofsky Z, 2011, ANAL BIOCHEM, V417, P233, DOI 10.1016/j.ab.2011.06.009; Wu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035661; Xing CY, 2012, BIOCHEM BIOPH RES CO, V420, P29, DOI 10.1016/j.bbrc.2012.02.107; Xu CF, 2015, BRIT J CANCER, V112, P1190, DOI 10.1038/bjc.2015.64; Yang Cheng, 2015, Asian Pac J Cancer Prev, V16, P965; Yang CR, 2013, MOL BIOL REP, V40, P5225, DOI 10.1007/s11033-013-2559-6; Yeh CT, 2003, BIOCHEM BIOPH RES CO, V305, P311, DOI 10.1016/S0006-291X(03)00757-5; Yoo KH, 2013, ONCOL LETT, V5, P39, DOI 10.3892/ol.2012.992; Yoshida K, 2004, ONCOGENE, V23, P6250, DOI 10.1038/sj.onc.1207829; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224; Zhou L, 2013, FASEB J, V27, P4929, DOI 10.1096/fj.13-233387	82	70	74	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148746	10.1371/journal.pone.0148746	http://dx.doi.org/10.1371/journal.pone.0148746			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859141	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400074
J	Betella, A; Verschure, PFMJ				Betella, Alberto; Verschure, Paul F. M. J.			The Affective Slider: A Digital Self-Assessment Scale for the Measurement of Human Emotions	PLOS ONE			English	Article							RATINGS	Self-assessment methods are broadly employed in emotion research for the collection of subjective affective ratings. The Self-Assessment Manikin (SAM), a pictorial scale developed in the eighties for the measurement of pleasure, arousal, and dominance, is still among the most popular self-reporting tools, despite having been conceived upon design principles which are today obsolete. By leveraging on state-of-the-art user interfaces and metacommunicative pictorial representations, we developed the Affective Slider (AS), a digital self-reporting tool composed of two slider controls for the quick assessment of pleasure and arousal. To empirically validate the AS, we conducted a systematic comparison between AS and SAM in a task involving the emotional assessment of a series of images taken from the International Affective Picture System (IAPS), a database composed of pictures representing a wide range of semantic categories often used as a benchmark in psychological studies. Our results show that the AS is equivalent to SAM in the self-assessment of pleasure and arousal, with two added advantages: the AS does not require written instructions and it can be easily reproduced in latest-generation digital devices, including smartphones and tablets. Moreover, we compared new and normative IAPS ratings and found a general drop in reported arousal of pictorial stimuli. Not only do our results demonstrate that legacy scales for the self-report of affect can be replaced with new measurement tools developed in accordance to modern design principles, but also that standardized sets of stimuli which are widely adopted in research on human emotion are not as effective as they were in the past due to a general desensitization towards highly arousing content.	[Betella, Alberto; Verschure, Paul F. M. J.] Univ Pompeu Fabra, N RAS DTIC, SPECS Lab, Barcelona, Spain; [Verschure, Paul F. M. J.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Pompeu Fabra University; ICREA	Betella, A; Verschure, PFMJ (corresponding author), Univ Pompeu Fabra, N RAS DTIC, SPECS Lab, Barcelona, Spain.; Verschure, PFMJ (corresponding author), Univ Pompeu Fabra, Dept Informat & Commun Technol DTIC, Barcelona, Spain.	alberto@betella.net; paul.verschure@upf.edu			European Research Council [341196]; ICREA Funding Source: Custom	European Research Council(European Research Council (ERC)European Commission); ICREA(ICREA)	This work was supported by European Research Council grant 341196 (CDAC).	Betella A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00286; Betella A, 2013, INT CONF AFFECT, P435, DOI 10.1109/ACII.2013.78; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Bradley M.M., 2007, HDB EMOTION ELICITAT, P29; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cacioppo JT, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P1, DOI 10.2277/ 0521844711; Carnagey NL, 2007, J EXP SOC PSYCHOL, V43, P489, DOI 10.1016/j.jesp.2006.05.003; Darwin C., 1965, EXPRESS EMOT MAN; Fahrenberg J, 2007, EUR J PSYCHOL ASSESS, V23, P206, DOI 10.1027/1015-5759.23.4.206; Gruhn D, 2008, BEHAV RES METHODS, V40, P512, DOI 10.3758/BRM.40.2.512; James W., 1884, MIND, V9, P34, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; Krahe B, 2011, J PERS SOC PSYCHOL, V100, P630, DOI 10.1037/a0021711; Krantz J. H., 2000, PSYCHOL EXPT INTERNE, P35, DOI DOI 10.1016/B978-012099980-4/50003-4; Lang P. J., 1999, INT AFFECTIVE PICTUR; Lang PJ, 2008, INT AFFECTIVE PICTUR, pA; Lang PJ, 1988, 1A1D U FLOR CTR STUD; Laurans G, 2009, 2009 3 INT C AFF COM; Libkuman TM, 2007, BEHAV RES METHODS, V39, P326, DOI 10.3758/BF03193164; Lottridge D, 2009, LECT NOTES COMPUT SC, V5726, P111, DOI 10.1007/978-3-642-03655-2_12; MacKenzie I. S., 2012, HUMAN COMPUTER INTER; Meyerson P, 2003, BEHAV RES METH INS C, V35, P614, DOI 10.3758/BF03195541; Picard R. W., 1997, PERSONAL TECHNOLOGIE, V1, P231, DOI [10.1007/BF01682026, DOI 10.1007/BF01682026]; Ringeval F., 2013, AUT FAC GEST REC FG, P1, DOI [DOI 10.1109/FG.2013.6553805, 10.1109/FG.2013.6553805]; Romer D, 2014, PEDIATRICS; Russell, 1974, APPROACH ENV PSYCHOL; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; VALDEZ P, 1994, J EXP PSYCHOL GEN, V123, P394, DOI 10.1037/0096-3445.123.4.394	28	115	116	10	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148037	10.1371/journal.pone.0148037	http://dx.doi.org/10.1371/journal.pone.0148037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26849361	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000033
J	Bonventre, JA; Zielke, RA; Korotkov, KV; Sikora, AE				Bonventre, Josephine A.; Zielke, Ryszard A.; Korotkov, Konstantin V.; Sikora, Aleksandra E.			Targeting an Essential GTPase Obg for the Development of Broad-Spectrum Antibiotics	PLOS ONE			English	Article							50S RIBOSOMAL-SUBUNIT; THROUGHPUT SCREENING ASSAYS; BINDING PROTEIN OBG; NEISSERIA-GONORRHOEAE; ANTIMICROBIAL RESISTANCE; ANTIBACTERIAL DISCOVERY; BACILLUS-SUBTILIS; IDENTIFICATION; CHALLENGES; DRUGS	A promising new drug target for the development of novel broad-spectrum antibiotics is the highly conserved small GTPase Obg (YhbZ, CgtA), a protein essential for the survival of all bacteria including Neisseria gonorrhoeae (GC). GC is the agent of gonorrhea, a prevalent sexually transmitted disease resulting in serious consequences on reproductive and neonatal health. A preventive anti-gonorrhea vaccine does not exist, and options for effective antibiotic treatments are increasingly limited. To address the dire need for alternative antimicrobial strategies, we have designed and optimized a 384-well GTPase assay to identify inhibitors of Obg using as a model Obg protein from GC, Obg(GC). The assay was validated with a pilot screen of 40,000 compounds and achieved an average Z' value of 0.58 +/- 0.02, which suggests a robust assay amenable to high-throughput screening. We developed secondary assessments for identified lead compounds that utilize the interaction between Obg(GC) and fluorescent guanine nucleotide analogs, mant-GTP and mant-GDP, and an Obg(GC) variant with multiple alterations in the G-domains that prevent nucleotide binding. To evaluate the broad-spectrum potential of Obg(GC) inhibitors, Obg proteins of Klebsiella pneumoniae and methicillin-resistant Staphylococcus aureus were assessed using the colorimetric and fluorescence-based activity assays. These approaches can be useful in identifying broad-spectrum Obg inhibitors and advancing the therapeutic battle against multidrug resistant bacteria.	[Bonventre, Josephine A.; Zielke, Ryszard A.; Sikora, Aleksandra E.] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97330 USA; [Korotkov, Konstantin V.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Korotkov, Konstantin V.] Univ Kentucky, Struct Biol Ctr, Lexington, KY 40536 USA	Oregon State University; University of Kentucky; University of Kentucky	Sikora, AE (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97330 USA.	Aleksandra.Sikora@oregonstate.edu	Sikora, Aleksandra E/HGD-6641-2022	Korotkov, Konstantin/0000-0002-2182-6843	National Institute of Allergy and Infectious Diseases, National Institutes of Health [R01-AI117235]; College of Pharmacy (OSU); National Institute of General Medical Sciences of the National Institutes of Health [P20GM103486]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI117235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103486] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); College of Pharmacy (OSU); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was provided to AES by grant R01-AI117235 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health and by a pilot grant provided by the College of Pharmacy (OSU). Research reported in this publication was partially supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103486 to KVK.	Arias CA, 2015, NEW ENGL J MED, V372, P1168, DOI 10.1056/NEJMcibr1500292; Arigoni F, 1998, NAT BIOTECHNOL, V16, P851, DOI 10.1038/nbt0998-851; Bharat A, 2013, J BIOMOL SCREEN, V18, P830, DOI 10.1177/1087057113486001; Blaxill Z, 2009, J BIOMOL SCREEN, V14, P547, DOI 10.1177/1087057109335327; Blombach F, 2011, BIOCHEM SOC T, V39, P45, DOI 10.1042/BST0390045; Bolken TC, 2008, ANTIVIR RES, V77, P1, DOI 10.1016/j.antiviral.2007.07.003; Buglino J, 2002, STRUCTURE, V10, P1581, DOI 10.1016/S0969-2126(02)00882-1; Buxser S, 2005, ANAL BIOCHEM, V340, P1, DOI 10.1016/j.ab.2005.01.034; CDC, 2013, ANT ANT RES 2013; Cent. Dis. Control Prev, 2013, ANT RES THREATS US 2; Coates A, 2002, NAT REV DRUG DISCOV, V1, P895, DOI 10.1038/nrd940; Copeland RA, 2003, ANAL BIOCHEM, V320, P1, DOI 10.1016/S0003-2697(03)00346-4; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P1433, DOI 10.1086/375081; Edwards JL, 2004, CLIN MICROBIOL REV, V17, P965, DOI 10.1128/CMR.17.4.965-981.2004; Feng BY, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001866; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; Holmes NE, 2015, SEMIN RESP CRIT CARE, V36, P17, DOI 10.1055/s-0034-1397040; Hook EW, 2013, MMWR-MORBID MORTAL W, V62, P103; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; ITAYA K, 1966, CLIN CHIM ACTA, V14, P361, DOI 10.1016/0009-8981(66)90114-8; Jiang MX, 2006, J BACTERIOL, V188, P6757, DOI 10.1128/JB.00444-06; Jones RN, 2010, CLIN INFECT DIS, V51, pS81, DOI 10.1086/653053; Kint C, 2014, CRIT REV MICROBIOL, V40, P207, DOI 10.3109/1040841X.2013.776510; Kukimoto-Niino M, 2004, J MOL BIOL, V337, P761, DOI 10.1016/j.jmb.2004.01.047; Larson RA, 2008, J VIROL, V82, P10768, DOI 10.1128/JVI.00941-08; Lee Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012597; Lin B, 1999, J BACTERIOL, V181, P5825, DOI 10.1128/JB.181.18.5825-5832.1999; Lin B, 2004, J BACTERIOL, V186, P481, DOI 10.1128/JB.186.2.481-489.2004; Lin B, 2001, FEBS LETT, V489, P107, DOI 10.1016/S0014-5793(00)02214-6; Lin B, 2001, MOL MICROBIOL, V39, P924, DOI 10.1046/j.1365-2958.2001.02285.x; Llor C, 2014, THER ADV DRUG SAF, V5, P229, DOI 10.1177/2042098614554919; Maddock J, 1997, J BACTERIOL, V179, P6426, DOI 10.1128/jb.179.20.6426-6431.1997; Monroy CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062247; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Okamoto S, 1998, MOL MICROBIOL, V30, P107, DOI 10.1046/j.1365-2958.1998.01042.x; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15; Sandoz KM, 2012, ANTIMICROB AGENTS CH, V56, P4296, DOI 10.1128/AAC.00356-12; Schroter G, 2015, J BIOL CHEM, V290, P17085, DOI 10.1074/jbc.M115.651190; Shah S, 2008, J BACTERIOL, V190, P4764, DOI 10.1128/JB.02021-07; Sikora AE, 2006, J BACTERIOL, V188, P1205, DOI 10.1128/JB.188.3.1205-1210.2006; Sikora AE, 2006, BIOCHEM BIOPH RES CO, V339, P1165, DOI 10.1016/j.bbrc.2005.11.129; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Tenson T, 2006, MOL MICROBIOL, V59, P1664, DOI 10.1111/j.1365-2958.2006.05063.x; TRACH K, 1989, J BACTERIOL, V171, P1362, DOI 10.1128/jb.171.3.1362-1371.1989; Unemo M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1029-2; Unemo M, 2014, PATHOG GLOB HEALTH, V108, P214, DOI 10.1179/2047772414Z.000000000216; Verstraeten N, 2015, MOL CELL, V59, P9, DOI 10.1016/j.molcel.2015.05.011; Verstraeten N, 2011, MICROBIOL MOL BIOL R, V75, P507, DOI 10.1128/MMBR.00009-11; WELSH KM, 1994, J BACTERIOL, V176, P7161, DOI 10.1128/JB.176.23.7161-7168.1994; Wilson DN, 2014, NAT REV MICROBIOL, V12, P35, DOI 10.1038/nrmicro3155; World Health Organization, 2014, ANT RES GLOB REP SUR, P232; World Health Organization, 2012, GLOB ACT PLAN CONTR; World Health Organization (WHO), 2015, ANT RES DRAFT GLOB A; Wout P, 2004, J BACTERIOL, V186, P5249, DOI 10.1128/JB.186.16.5249-5257.2004; Zalacain M, 2003, J MOL MICROB BIOTECH, V6, P109, DOI 10.1159/000076741; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zielke RA, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0453-1; Zitha-Bovens E, 2009, J BIOMOL SCREEN, V14, P557, DOI 10.1177/1087057109336953	59	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148222	10.1371/journal.pone.0148222	http://dx.doi.org/10.1371/journal.pone.0148222			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848972	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000053
J	Han, T; Lee, W; Lee, S; Park, IG; Park, H				Han, Taeman; Lee, Wonhoon; Lee, Seunghwan; Park, In Gyun; Park, Haechul			Reassessment of Species Diversity of the Subfamily Denticollinae (Coleoptera: Elateridae) through DNA Barcoding	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; MAXIMUM-LIKELIHOOD; IDENTIFICATION; EVOLUTIONARY; BEETLES; INTROGRESSION; BIODIVERSITY; TAXONOMY; DIPTERA; HYBRIDIZATION	The subfamily Denticollinae is a taxonomically diverse group in the family Elateridae. Denticollinae includes many morphologically similar species and crop pests, as well as many undescribed species at each local fauna. To construct a rapid and reliable identification system for this subfamily, the effectiveness of molecular species identification was assessed based on 421 cytochrome c oxidase subunit I (COI) sequences of 84 morphologically identified species. Among the 84 morphospecies, molecular species identification of 60 species (71.4%) was consistent with their morphological identifications. Six cryptic and/or pseudocryptic species with large genetic divergence (> 5%) were confirmed by their sympatric or allopatric distributions. However, 18 species, including a subspecies, had ambiguous genetic distances and shared overlapping intra-and interspecific genetic distances (range: 2.12%-3.67%) suggesting incomplete lineage sorting, introgression of mitochondrial genome, or affection by endosymbionts, such as Wolbachia infection, between species and simple genetic variation within species. In this study, we propose a conservative threshold of 3.6% for convenient molecular operational taxonomic unit (MOTU) identification in the subfamily Denticollinae based on the results of pairwise genetic distances analyses using neighbor-joining, mothur, Automatic Barcode Gap Discovery analysis, and tree-based species delimitation by Poisson Tree Processes analysis. Using the 3.6% threshold, we identified 87 MOTUs and found 8 MOTUs in the interval between 2.5% to 3.5%. Evaluation of MOTUs identified in this range requires integrative species delimitation, including review of morphological and ecological differences as well as sensitive genetic markers. From this study, we confirmed that COI sequence is useful for reassessing species diversity for polymorphic and polytypic species occurring in sympatric and allopatric distributions, and for a single species having an extensively large habitat.	[Han, Taeman; Park, In Gyun; Park, Haechul] Natl Acad Agr Sci, Dept Agr Biol, Appl Entomol Div, Jeonju, South Korea; [Lee, Wonhoon] Anim & Plant Quarantine Agcy, Anyang Si, Gyeonggi Do, South Korea; [Lee, Seunghwan] Seoul Natl Univ, Sch Agr Biotechnol, Div Entomol, Seoul, South Korea	Animal & Plant Quarantine Agency; Seoul National University (SNU)	Park, H (corresponding author), Natl Acad Agr Sci, Dept Agr Biol, Appl Entomol Div, Jeonju, South Korea.	culent@korea.kr	Lee, Seunghwan/E-4992-2011		Cooperative Research Program for Agricultural Science AMP; Technology Development, Rural Development Administration, Republic of Korea [PJ00939502]	Cooperative Research Program for Agricultural Science AMP; Technology Development, Rural Development Administration, Republic of Korea	This study was carried out with the support of the Cooperative Research Program for Agricultural Science & Technology Development (Project No. PJ00939502), Rural Development Administration, Republic of Korea. The funder had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dhafer HM, 2009, T AM ENTOMOL SOC, V135, P209, DOI 10.3157/061.135.0301; Alix B, 2012, NUCLEIC ACIDS RES, V40, pW573, DOI 10.1093/nar/gks485; Amoldi FGC, 2007, GENE, V405, P1, DOI 10.1016/j.gen.e.2007.07.035; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Cate P, 2007, CATALOGUE PALAEARCTI, P89; Costa C, 2010, HBK ZOOL, P75; Denisova L. A., 1948, Entomologicheskoe Obozrenie, V30, P40; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dolin VG, 1978, IDENTIFICATION TABLE; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2015, MAR BIODIVERS, V45, P433, DOI 10.1007/s12526-015-0319-7; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Glen R., 1950, SMITHSONIAN MISCELLA, V111, P1; Gurjeva EL, 1989, KEY BOOK INSECT SP 1, V3, P489; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Han TM, 2009, ZOOTAXA, P60, DOI 10.11646/zootaxa.2134.1.5; Han T, 2012, ZOOTAXA, P47; Han T, 2013, ZOOTAXA, V 3745, P379, DOI 10.11646/zootaxa.3745.3.5; Han Taeman, 2012, Korean Journal of Applied Entomology, V51, P79, DOI 10.5656/KSAE.2012.01.1.69; Han T, 2012, ZOOL J LINN SOC-LOND, V164, P71, DOI 10.1111/j.1096-3642.2011.00763.x; Hausmann A, 2009, ZOOTAXA, P1; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heyden L, 1887, HORAE SOC ENTOMOLOGI, V21, P243; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kelley ST, 1999, ANN ENTOMOL SOC AM, V92, P193, DOI 10.1093/aesa/92.2.193; Kim J. I., 1987, REPORT KOREAN ASS CO, V25, P91; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kishii T., 1987, P1; Kishii T., 2000, NEJIREBANE, V90, P5; Kishii T, 1996, B HEIAN HIGH SCH KYO, V39, P1; Kishii Takashi, 2002, Entomological Review of Japan, V57, P1; Kishii Takashi, 1993, Entomological Review of Japan, V48, P154; Kobayashi N, 2000, ZOOL SCI, V17, P1159, DOI 10.2108/zsj.17.1159; Kompantzeva TV, 1989, ENTOMOL OBOZR, V1989, P322; Kundrata R, 2011, ZOOL SCR, V40, P364, DOI 10.1111/j.1463-6409.2011.00476.x; Kwon Min, 2000, Korean Journal of Applied Entomology, V39, P157; Laibner S., 2000, ELATERIDAE CZECH SLN; Lanchester Horace P., 1946, ANN ENT SOC AMERICA, V39, P619; Lee W, 2014, J ASIA-PAC ENTOMOL, V17, P617, DOI 10.1016/j.aspen.2014.06.008; Lee W, 2011, MOL ECOL RESOUR, V11, P32, DOI 10.1111/j.1755-0998.2010.02877.x; Leseigneur L., 1972, Bulletin mens Soc linn Lyon, V41, P1; Leseigneur Lucien, 2010, Bulletin de la Societe Entomologique de France, V115, P381; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lin XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138993; Mapondera TS, 2012, AUST J ENTOMOL, V51, P175, DOI 10.1111/j.1440-6055.2011.00853.x; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Min Kwon, 1997, Korean Journal of Applied Entomology, V36, P145; MIWA Y., 1928, INSECTA MAT SUMURANA, V2, P133; Monaghan MT, 2005, PHILOS T R SOC B, V360, P1925, DOI 10.1098/rstb.2005.1724; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Muska F, 2008, LISTY CUKROV REPAR, V124, P89; Narita S, 2006, MOL ECOL, V15, P1095, DOI 10.1111/j.1365-294X.2006.02857.x; Nei M, 1996, ANNU REV GENET, V30, P371, DOI 10.1146/annurev.genet.30.1.371; NEI M, 1991, PHYLOGENETIC ANALYSIS OF DNA SEQUENCES, P90; Nzelu CO, 2015, ACTA TROP, V145, P45, DOI 10.1016/j.actatropica.2015.02.003; Ohira H., 1962, MORPHOLOGICAL TAXONO; Ohira H, 1992, HIBAKAKU, V153, P9; Ohira Hitoo, 2006, Elytra, V34, P337; Ohira Hitoo, 2006, Nanki Seibutu, V48, P27; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Page RDM, 1998, TRENDS ECOL EVOL, V13, P356, DOI 10.1016/S0169-5347(98)01438-4; Park DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018749; Plaisance L, 2009, CORAL REEFS, V28, P977, DOI 10.1007/s00338-009-0543-3; Plaisance L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025026; Platia G, 1994, FAUNA DITALIA, V33, P1; Platia Giuseppe, 2010, Boletin de la SEA, V46, P121; Porco D, 2014, MOL ECOL RESOUR, V14, P249, DOI 10.1111/1755-0998.12172; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Raupach MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106940; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Renaud AK, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-24; Saez AG, 2005, NATURE, V433, P111, DOI 10.1038/433111a; Sagegami-Oba R, 2008, ELYTRA, V36, P79; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sasakawa K, 2005, ENTOMOL SCI, V8, P389, DOI 10.1111/j.1479-8298.2005.00139.x; Schimmel Rainer, 2013, Genus (Wroclaw), V24, P191; Schlick-Steiner BC, 2007, TRENDS ECOL EVOL, V22, P391, DOI 10.1016/j.tree.2007.05.004; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt S, 2015, MOL ECOL RESOUR, V15, P985, DOI 10.1111/1755-0998.12363; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Staudacher K, 2011, B ENTOMOL RES, V101, P201, DOI 10.1017/S0007485310000337; Takano SI, 2011, ANN ENTOMOL SOC AM, V104, P121, DOI 10.1603/AN10106; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tarnawski Dariusz, 1995, Genus (Wroclaw), P1; Tosevski I, 2011, SYST ENTOMOL, V36, P741, DOI 10.1111/j.1365-3113.2011.00593.x; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Wan XL, 2013, MOL BIOL REP, V40, P6333, DOI 10.1007/s11033-013-2748-3; Webb JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038063; Wirta H, 2009, BIOL J LINN SOC, V96, P942, DOI 10.1111/j.1095-8312.2008.01156.x; Wysocka A, 2011, ANN ZOOL, V61, P629, DOI 10.3161/000345411X622471; Zahiri R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092797; Zakharov EV, 2009, HEREDITY, V102, P590, DOI 10.1038/hdy.2009.26; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zhou X, 2010, J N AM BENTHOL SOC, V29, P814, DOI 10.1899/09-121.1	101	25	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148602	10.1371/journal.pone.0148602	http://dx.doi.org/10.1371/journal.pone.0148602			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848744	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000135
J	Li, J; Ge, X; Wang, XN; Liu, X; Ma, JM				Li, Jing; Ge, Xin; Wang, Xiaona; Liu, Xiao; Ma, Jianmin			Complement System in the Pathogenesis of Benign Lymphoepithelial Lesions of the Lacrimal Gland	PLOS ONE			English	Article							AUTOIMMUNE PANCREATITIS; IGG4-RELATED DISEASE; ACTIVATION	Objective We aimed to examine the potential involvement of local complement system gene expression in the pathogenesis of benign lymphoepithelial lesions (BLEL) of the lacrimal gland. Methods We collected data from 9 consecutive pathologically confirmed patients with BLEL of the lacrimal gland and 9 cases with orbital cavernous hemangioma as a control group, and adopted whole genome microarray to screen complement system-related differential genes, followed by RT-PCR verification and in-depth enrichment analysis (Gene Ontology analysis) of the gene sets. Results The expression of 14 complement system-related genes in the pathologic tissue, including C2, C3, ITGB2, CR2, C1QB, CR1, ITGAX, CFP, C1QA, C4B vertical bar C4A, FANCA, C1QC, C3AR1 and CFHR4, were significantly upregulated while 7 other complement system-related genes, C5, CFI, CFHR1 vertical bar CFH, CFH, CD55, CR1L and CFD were significantly downregulated in the lacrimal glands of BLEL patients. The microarray results were consistent with RT-PCR analysis results. Immunohistochemistry analysis of C3c and C1q complement component proteins in the resected tissue were positive in BLEL patients, while the control group had negative expression of these proteins. Gene ontology (GO) analysis revealed that activation of the genes of complement system-mediated signaling pathways were the most enriched differential gene group in BLEL patients. Conclusions Local expression of complement components is prominently abnormal in BLEL, and may well play a role in its pathogenesis.	[Li, Jing; Ge, Xin; Wang, Xiaona; Liu, Xiao; Ma, Jianmin] Capital Med Univ, Beijing Tongren Eye Ctr, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Li, Jing; Wang, Xiaona] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Ma, JM (corresponding author), Capital Med Univ, Beijing Tongren Eye Ctr, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China.	jmma@sina.com		Li, Jing/0000-0001-9392-6600	National Natural Science Foundation of China [81371052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was funded by National Natural Science Foundation of China (grant number: 81371052; http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abud-Mendoza C, 2013, REUMATOL CLIN, V9, P133, DOI [10.1016/j.reumae.2013.02.002, 10.1016/j.reuma.2013.02.003]; Bora NS, 2008, SEMIN IMMUNOPATHOL, V30, P85, DOI 10.1007/s00281-008-0110-y; Cornell LD, 2007, AM J SURG PATHOL, V31, P1586, DOI 10.1097/PAS.0b013e318059b87c; Deshpande V, 2006, AM J SURG PATHOL, V30, P1537, DOI 10.1097/01.pas.0000213331.09864.2c; Divatia M, 2012, YONSEI MED J, V53, P15, DOI 10.3349/ymj.2012.53.1.15; Jeon H, 2014, J IMMUNOL METHODS, V415, P57, DOI 10.1016/j.jim.2014.09.002; Kawano M, 2011, CLIN EXP NEPHROL, V15, P615, DOI 10.1007/s10157-011-0521-2; Ma JM, 2015, CHINESE MED J-PEKING, V128, P493, DOI 10.4103/0366-6999.151102; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Muraki T, 2006, PANCREAS, V32, P16, DOI 10.1097/01.mpa.0000188308.75043.e4; Osthoff M, 2014, MOL VIS, V20, P38; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; WANG J, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/748435; Yang MM, 2012, INVEST OPHTH VIS SCI, V53, P4969, DOI 10.1167/iovs.12-9478; Yu WK, 2015, JPN J OPHTHALMOL, V59, P8, DOI 10.1007/s10384-014-0353-1	15	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148290	10.1371/journal.pone.0148290	http://dx.doi.org/10.1371/journal.pone.0148290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849056	Green Published, gold			2022-12-27	WOS:000369554000066
J	van Twillert, I; Marinovic, AAB; van Gaans-van den Brink, JAM; Kuipers, B; Berbers, GAM; van der Maas, NAT; Verheij, TJM; Versteegh, FGA; Teunis, PFM; van Els, CACM				van Twillert, Inonge; Marinovic, Axel A. Bonacic; van Gaans-van den Brink, Jacqueline A. M.; Kuipers, Betsy; Berbers, Guy A. M.; van der Maas, Nicoline A. T.; Verheij, Theo J. M.; Versteegh, Florens G. A.; Teunis, Peter F. M.; van Els, Cecile A. C. M.			The Use of Innovative Two-Component Cluster Analysis and Serodiagnostic Cut-Off Methods to Estimate Prevalence of Pertussis Reinfections	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; ANTIBODY-RESPONSES; TOXIN IGG; INFECTION; VACCINATION; VACCINES; SEROEPIDEMIOLOGY; EPIDEMIOLOGY; IMMUNIZATION; IMMUNOASSAY	Bordetella pertussis circulates even in highly vaccinated countries affecting all age groups. Insight into the scale of concealed reinfections is important as they may contribute to transmission. We therefore investigated whether current single-point serodiagnostic methods are suitable to estimate the prevalence of pertussis reinfection. Two methods based on IgG-Ptx plasma levels alone were used to evaluate the proportion of renewed seroconversions in the past year in a cohort of retrospective pertussis cases >= 24 months after a proven earlier symptomatic infection. A Dutch population database was used as a baseline. Applying a classical 62.5 IU/ml IgG-Ptx cut-off, we calculated a seroprevalence of 15% in retrospective cases, higher than the 10% observed in the population baseline. However, this method could not discriminate between renewed seroconversion and waning of previously infection-enhanced IgG-Ptx levels. Two-component cluster analysis of the IgG-Ptx datasets of both pertussis cases and the general population revealed a continuum of intermediate IgG-Ptx levels, preventing the establishment of a positive population and the comparison of prevalence by this alternative method. Next, we investigated the complementary serodiagnostic value of IgA-Ptx levels. When modelling datasets including both convalescent and retrospective cases we obtained new cut-offs for both IgG-Ptx and IgA-Ptx that were optimized to evaluate renewed seroconversions in the ex-cases target population. Combining these cut-offs two-dimensionally, we calculated 8.0% reinfections in retrospective cases, being below the baseline seroprevalence. Our study for the first time revealed the shortcomings of using only IgG-Ptx data in conventional serodiagnostic methods to determine pertussis reinfections. Improved results can be obtained with two-dimensional serodiagnostic profiling. The proportion of reinfections thus established suggests a relatively increased period of protection to renewed infection after clinical pertussis.	[van Twillert, Inonge; Marinovic, Axel A. Bonacic; van Gaans-van den Brink, Jacqueline A. M.; Kuipers, Betsy; Berbers, Guy A. M.; van der Maas, Nicoline A. T.; Teunis, Peter F. M.; van Els, Cecile A. C. M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Verheij, Theo J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Versteegh, Florens G. A.] Groene Hart Ziekenhuis, Dept Pediat, Gouda, Netherlands; [Versteegh, Florens G. A.] Ghent Univ Hosp, Dept Pediat, Ghent, Belgium; [Teunis, Peter F. M.] Emory Univ, RSPH, Atlanta, GA 30322 USA	Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Ghent University; Ghent University Hospital; Emory University	van Els, CACM (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	Cecile.van.Els@rivm.nl		Versteegh, Florens G.A./0000-0003-4773-5592	European research network 'Child Innovac', E.C. FP7 program [201502]; Dutch Ministry of Health, Welfare and Sport	European research network 'Child Innovac', E.C. FP7 program; Dutch Ministry of Health, Welfare and Sport	The project was partly funded by the European research network 'Child Innovac', E.C. FP7 program, grant agreement #201502, and partly funded by the Dutch Ministry of Health, Welfare and Sport.	Baron S, 1998, PEDIATR INFECT DIS J, V17, P412, DOI 10.1097/00006454-199805000-00013; Baughman AL, 2006, STAT MED, V25, P2994, DOI 10.1002/sim.2442; Bonhoeffer J, 2005, INFECTION, V33, P13, DOI 10.1007/s15010-005-4004-9; Cagney M, 2006, EPIDEMIOL INFECT, V134, P1208, DOI 10.1017/S095026880600625X; Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; Dalby T, 2010, J MED MICROBIOL, V59, P1029, DOI 10.1099/jmm.0.020826-0; de Greeff SC, 2012, CLIN VACCINE IMMUNOL, V19, P1452, DOI 10.1128/CVI.00229-12; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; de Melker HE, 2000, J CLIN MICROBIOL, V38, P800, DOI 10.1128/JCM.38.2.800-806.2000; DEVILLE JG, 1995, CLIN INFECT DIS, V21, P639, DOI 10.1093/clinids/21.3.639; Fry NK, 2013, J MED MICROBIOL, V62, P1281, DOI 10.1099/jmm.0.062000-0; Giammanco A, 2008, VACCINE, V26, P4486, DOI 10.1016/j.vaccine.2008.06.051; Giuliano M, 1998, J PEDIATR-US, V132, P983, DOI 10.1016/S0022-3476(98)70395-6; Guiso N, 2011, EUR J CLIN MICROBIOL, V30, P307, DOI 10.1007/s10096-010-1104-y; Hallander HO, 2009, APMIS, V117, P797, DOI 10.1111/j.1600-0463.2009.02530.x; Han WGH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083583; He Q, 2012, EURO SURVEILL, V17; HEININGER U, 1994, VACCINE, V12, P81, DOI 10.1016/0264-410X(94)90014-0; Hendrikx LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027681; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; Hodder SL, 2000, CLIN INFECT DIS, V31, P7, DOI 10.1086/313913; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; Klement E, 2003, EPIDEMIOL INFECT, V131, P1049, DOI 10.1017/S0950268803001110; LAMBERT HJ, 1965, PUBLIC HEALTH REP, V80, P365, DOI 10.2307/4592424; Le T, 2004, J INFECT DIS, V190, P535, DOI 10.1086/422035; Masseria C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1269-1; May ML, 2013, PATHOLOGY, V45, P172, DOI 10.1097/PAT.0b013e32835c76e2; May ML, 2012, CLIN VACCINE IMMUNOL, V19, P190, DOI 10.1128/CVI.05430-11; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Pebody RG, 2005, EPIDEMIOL INFECT, V133, P159, DOI 10.1017/S0950268804003012; Prince HE, 2012, CLIN VACCINE IMMUNOL, V19, P545, DOI 10.1128/CVI.05725-11; Tan TN, 2015, PEDIATR INFECT DIS J, V34, pE222, DOI 10.1097/INF.0000000000000795; van Boven M, 2005, P ROY SOC B-BIOL SCI, V272, P1617, DOI 10.1098/rspb.2005.3108; van der Klis FRM, 2009, NETH J MED, V67, P301; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; van Twillert I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085227; Versteegh FGA, 2005, EPIDEMIOL INFECT, V133, P737, DOI 10.1017/S0950268805003833; Versteegh FGA, 2002, ACTA PAEDIATR, V91, P95, DOI 10.1080/080352502753458030; von Konig CHW, 1999, EUR J CLIN MICROBIOL, V18, P341, DOI 10.1007/PL00015016; VONKONIG CHW, 1995, LANCET, V346, P1326, DOI 10.1016/S0140-6736(95)92343-8; Warfel JM, 2015, CURR OPIN IMMUNOL, V35, P48, DOI 10.1016/j.coi.2015.05.008; Warfel JM, 2014, P NATL ACAD SCI USA, V111, P787, DOI 10.1073/pnas.1314688110; Wearing HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000647; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41	44	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148507	10.1371/journal.pone.0148507	http://dx.doi.org/10.1371/journal.pone.0148507			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848833	Green Published, gold			2022-12-27	WOS:000369554000112
J	Wu, KM; Riley, S				Wu, Kendra M.; Riley, Steven			Estimation of the Basic Reproductive Number and Mean Serial Interval of a Novel Pathogen in a Small, Well-Observed Discrete Population	PLOS ONE			English	Article							INFLUENZA; VIRUS; AGENT	Background Accurately assessing the transmissibility and serial interval of a novel human pathogen is public health priority so that the timing and required strength of interventions may be determined. Recent theoretical work has focused on making best use of data from the initial exponential phase of growth of incidence in large populations. Methods We measured generational transmissibility by the basic reproductive number R-0 and the serial interval by its mean T-g. First, we constructed a simulation algorithm for case data arising from a small population of known size with R-0 and Tg also known. We then developed an inferential model for the likelihood of these case data as a function of R-0 and Tg. The model was designed to capture a) any signal of the serial interval distribution in the initial stochastic phase b) the growth rate of the exponential phase and c) the unique combination of R-0 and Tg that generates a specific shape of peak incidence when the susceptible portion of a small population is depleted. Findings Extensive repeat simulation and parameter estimation revealed no bias in univariate estimates of either R-0 and Tg. We were also able to simultaneously estimate both R-0 and Tg. However, accurate final estimates could be obtained only much later in the outbreak. In particular, estimates of Tg were considerably less accurate in the bivariate case until the peak of incidence had passed. Conclusions The basic reproductive number and mean serial interval can be estimated simultaneously in real time during an outbreak of an emerging pathogen. Repeated application of these methods to small scale outbreaks at the start of an epidemic would permit accurate estimates of key parameters.	[Wu, Kendra M.] Univ Hong Kong, LKS Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Wu, Kendra M.; Riley, Steven] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Ctr Outbreak Anal & Modelling, MRC, London, England	University of Hong Kong; Imperial College London	Wu, KM (corresponding author), Univ Hong Kong, LKS Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	kendrawu@connect.hku.hk	Wu, Kendra M./J-7587-2019	Wu, Kendra M./0000-0001-6464-4874; Riley, Steven/0000-0001-7904-4804	Swire Company; University of Hong Kong; LKS Faculty of Medicine of The University of Hong Kong; Medical Research Council (UK) [MR/J008761/1]; Wellcome Trust (UK) [093488/Z/10/Z]; Fogarty International Centre (USA) [R01 TW008246-01]; Fogarty International Centre; Science & Technology Directorate, Department of Homeland Security (USA, RAPIDD program); National Institute for Health Research (UK); MRC Centre for Outbreak Analysis and Modelling of Imperial College London; John Swire Sons; MRC [MR/J008761/1, MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1, MR/K010174/1B, MR/J008761/1] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [R01TW008246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110721] Funding Source: NIH RePORTER	Swire Company; University of Hong Kong(University of Hong Kong); LKS Faculty of Medicine of The University of Hong Kong; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (UK)(Wellcome Trust); Fogarty International Centre (USA); Fogarty International Centre(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Science & Technology Directorate, Department of Homeland Security (USA, RAPIDD program); National Institute for Health Research (UK)(National Institute for Health Research (NIHR)); MRC Centre for Outbreak Analysis and Modelling of Imperial College London(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); John Swire Sons; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	KMW has received scholarships from Swire Company and The University of Hong Kong as well as funding from the LKS Faculty of Medicine of The University of Hong Kong. SR has received research funding from the Medical Research Council (UK, Project MR/J008761/1), the Wellcome Trust (UK, Project 093488/Z/10/Z), the Fogarty International Centre (USA, R01 TW008246-01), Fogarty International Centre with the Science & Technology Directorate, Department of Homeland Security (USA, RAPIDD program), and the National Institute for Health Research (UK, for Health Protection Research Unit funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KMW thanks MRC Centre for Outbreak Analysis and Modelling of Imperial College London for hosting her visiting research fellowship and thanks LKS Faculty of Medicine of The University of Hong Kong for funding her stay in London, where the foundation of the theoretical work on this paper was partially completed. KMW also acknowledges scholarship support from John Swire & Sons and The University of Hong Kong, as well as funding from the LKS Faculty of Medicine of The University of Hong Kong.	Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; Anderson RM, 1992, INFECT DIS HUMANS DY, P17; Boelle PY, 2011, INFLUENZA OTHER RESP, V5, P306, DOI 10.1111/j.1750-2659.2011.00234.x; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Griffin JT, 2011, BIOSTATISTICS, V12, P303, DOI 10.1093/biostatistics/kxq058; Kenah E, 2008, MATH BIOSCI, V213, P71, DOI 10.1016/j.mbs.2008.02.007; Kucharski A, 2013, PLOS CURRENTS, V6; Kucharski AJ, 2015, EMERG INFECT DIS, V21, P852, DOI 10.3201/eid2105.141137; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; R Core Team, 2021, R LANGUAGE ENV STAT; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Svensson A, 2007, MATH BIOSCI, V208, P300, DOI 10.1016/j.mbs.2006.10.010; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	18	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148061	10.1371/journal.pone.0148061	http://dx.doi.org/10.1371/journal.pone.0148061			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849644	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000036
J	Zhao, WJ; Pan, JM; Li, HP; Huang, YJ; Liu, F; Tao, MF; Jia, WP				Zhao, Weijing; Pan, Jiemin; Li, Huaping; Huang, Yajuan; Liu, Fang; Tao, Minfang; Jia, Weiping			Relationship between High Serum Cystatin C Levels and the Risk of Gestational Diabetes Mellitus	PLOS ONE			English	Article							INSULIN-RESISTANCE; KIDNEY-FUNCTION; RENAL-FUNCTION; HOMOCYSTEINE; ASSOCIATION; WOMEN; CREATININE; MORTALITY; MARKER; ADULTS	Aims Serum cystatin C (CysC) has recently been shown to be associated with the incidence of type 2 diabetes mellitus (T2DM) and progression to the pre-diabetic state. The aim of this study was to explore the relationship between serum CysC and the risk of gestational diabetes mellitus (GDM) in Chinese pregnant women. Methods This cross-sectional study consisted of 400 pregnant women including111 with GDM and 289 with normal glucose tolerance at 24-28 weeks of gestation. The subjects were further divided into four groups according to the CysC quartiles, and their clinical characteristics were compared. The serum CysC concentration was measured using immunoturbidimetry and the degree of insulin resistance was assessed by the homeostasis model assessment of insulin resistance (HOMA-IR). Results Serum CysC levels were significantly higher in pregnant women with GDM than in the healthy pregnant women[1.0(0.8-1.8) vs 0.7(0.6-1.0), P<0.01). The Spearman's correlation analysis showed that serum CysC was positively associated with HOMA-IR(r = 0.118, P<0.05) and the occurrence of GDM(r = 0.348, P<0.01). The pregnant women were divided into quartiles according to their serum CysC concentrations. Compared to the first quartile, pregnant women in Q2 (OR, 2.441; P = 0.025), Q3 (OR, 3.383; P = 0.001) and Q4 (OR, 5.516; P<0.001) had higher risk of GDM after adjusted for age, BMI, HbA1c and HOMA-IR. Further, with a rise in the serum CysC, there was an increasing trend in the HOMA-IR levels (P<0.05). A binary logistic regression analysis after adjusting for other confounding variables revealed a significant and independent association between serum CysC and GDM [OR = 14.269; 95% confidence interval, 4.977-40.908, P<0.01]. The receiver operating characteristic curve analysis revealed that the optimal cutoff point for serum CysC to indicate GDM was 0.95mg/L. Conclusions Serum CysC is significantly and independently associated with insulin resistance and GDM. It may be a helpful biomarker to identify the risk of GDM in Chinese pregnant women.	[Zhao, Weijing; Pan, Jiemin; Liu, Fang; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Med Ctr Diabet,Shanghai Key Lab Dia, Shanghai Key Clin Ctr Metab Dis,Shanghai Inst Dia, Shanghai 200030, Peoples R China; [Li, Huaping; Huang, Yajuan; Tao, Minfang] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, F (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Med Ctr Diabet,Shanghai Key Lab Dia, Shanghai Key Clin Ctr Metab Dis,Shanghai Inst Dia, Shanghai 200030, Peoples R China.; Huang, YJ (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China.	huangyajuan2006@126.com; f-liu@sjtu.edu.cn			National Science Foundation of China [81270397, 81500625]; Specific Program for Public Welfare by National Health and Family Planning Commission [201502011]; Shanghai Science & Technology Pillar Program in the Field of Medicine and Agriculture [15411953100]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specific Program for Public Welfare by National Health and Family Planning Commission; Shanghai Science & Technology Pillar Program in the Field of Medicine and Agriculture	This study was supported by grants from the National Science Foundation of China (81270397 for FL, 81500625 for JP), the Specific Program for Public Welfare supported by the National Health and Family Planning Commission (201502011 for FL and YH) and the Shanghai Science & Technology Pillar Program in the Field of Medicine and Agriculture (15411953100 for FL).	Alanbay I, 2012, GYNECOL ENDOCRINOL, V28, P208, DOI 10.3109/09513590.2011.588756; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Artenisio AC, 1999, DIABETES NUTR METAB, V12, P264; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Chang Y, 2014, DIABETES RES CLIN PR, V106, P236, DOI 10.1016/j.diabres.2014.08.020; Cho NH, 2005, DIABETES CARE, V28, P2750, DOI 10.2337/diacare.28.11.2750; Clark CM, 1997, DIABETES CARE, V20, P867, DOI 10.2337/diacare.20.5.867; Dandana A, 2014, J CLIN LAB ANAL, V28, P191, DOI 10.1002/jcla.21665; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Donahue RP, 2007, DIABETES CARE, V30, P1724, DOI 10.2337/dc07-0040; Emoto M, 2001, DIABETES CARE, V24, P533, DOI 10.2337/diacare.24.3.533; Golbahar J, 2007, DIABETES RES CLIN PR, V76, P1, DOI 10.1016/j.diabres.2006.07.026; He R, 2013, EUR J EPIDEMIOL, V28, P775, DOI 10.1007/s10654-013-9839-2; Hu YY, 2014, EUR J ENDOCRINOL, V171, P641, DOI 10.1530/EJE-14-0381; Idzior-Walus B, 2008, ARCH GYNECOL OBSTET, V278, P309, DOI 10.1007/s00404-008-0571-1; Iyidir OT, 2014, GYNECOL ENDOCRINOL, V30, P640, DOI 10.3109/09513590.2014.922946; Laterza OF, 2002, CLIN CHEM, V48, P699; Lee SH, 2010, METABOLISM, V59, P241, DOI 10.1016/j.metabol.2009.07.019; Li Y, 2013, J BIOL CHEM, V288, P9583, DOI 10.1074/jbc.M112.431627; Liu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066907; Liu H, 2015, J CLIN DIAGN RES, V9, pOC14, DOI 10.7860/JCDR/2015/11585.5475; Medina MA, 2000, EUR J CLIN INVEST, V30, P754; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Muntner P, 2008, AM J MED, V121, P341, DOI 10.1016/j.amjmed.2008.01.003; Nagalla Srinivasa R, 2015, Indian J Endocrinol Metab, V19, P155, DOI 10.4103/2230-8210.140226; Naour N, 2009, OBESITY, V17, P2121, DOI 10.1038/oby.2009.96; Norlund L, 1998, CLIN CHEM LAB MED, V36, P175, DOI 10.1515/CCLM.1998.032; Pucci L, 2007, CLIN CHEM, V53, P480, DOI 10.1373/clinchem.2006.076042; Reutens AT, 2013, NEPHROL DIAL TRANSPL, V28, P1820, DOI 10.1093/ndt/gfs561; Ristiniemi N, 2012, CLIN BIOCHEM, V45, P535, DOI 10.1016/j.clinbiochem.2012.02.012; Roos JF, 2007, CLIN BIOCHEM, V40, P383, DOI 10.1016/j.clinbiochem.2006.10.026; Sabanayagam C, 2013, EUR J EPIDEMIOL, V28, P311, DOI 10.1007/s10654-013-9781-3; Sahakyan K, 2011, DIABETOLOGIA, V54, P1335, DOI 10.1007/s00125-011-2096-6; Servais A, 2008, AM J MED, V121, P426, DOI 10.1016/j.amjmed.2008.01.040; Shankar A, 2011, J CLIN HYPERTENS, V13, P925, DOI 10.1111/j.1751-7176.2011.00548.x; Song G, 2010, BIOL REPROD, V82, P854, DOI 10.1095/biolreprod.109.080929; Sridhar SB, 2014, DIABETES CARE, V37, P1878, DOI 10.2337/dc13-2229; Stehouwer CDA, 1999, KIDNEY INT, V55, P308, DOI 10.1046/j.1523-1755.1999.00256.x; Surendar J, 2010, DIABETES TECHNOL THE, V12, P907, DOI 10.1089/dia.2010.0077; Uruska A, 2014, CLIN BIOCHEM, V47, P1235, DOI 10.1016/j.clinbiochem.2014.06.014; van Leeuwen M, 2010, BJOG-INT J OBSTET GY, V117, P69, DOI 10.1111/j.1471-0528.2009.02425.x; Xie Q, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-108; Yousefzadeh G, 2014, DIABETES METAB SYND, V8, P33, DOI 10.1016/j.dsx.2013.10.016; Yu X, 2009, ACTA BIOCH BIOPH SIN, V41, P1027, DOI 10.1093/abbs/gmp097	45	7	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147277	10.1371/journal.pone.0147277	http://dx.doi.org/10.1371/journal.pone.0147277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849560	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000011
J	Zhou, W; Wu, S; Ding, M; Li, JJ; Shi, ZB; Wei, W; Guo, J; Zhang, H; Jiang, YR; Rong, JK				Zhou, Wei; Wu, Shasha; Ding, Mingquan; Li, Jingjuan; Shi, Zhaobin; Wei, Wei; Guo, Jialian; Zhang, Hua; Jiang, Yurong; Rong, Junkang			Mapping of Ppd-B1, a Major Candidate Gene for Late Heading on Wild Emmer Chromosome Arm 2BS and Assessment of Its Interactions with Early Heading QTLs on 3AL	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PSEUDO-RESPONSE-REGULATOR; FLOWERING-TIME GENES; LYCOPERSICON-PENNELLII; SUBSTITUTION LINES; EMERGENCE TIME; COMPLEX TRAITS; LINKAGE MAP; BREAD WHEAT; PHOTOPERIOD	Wheat heading date is an important agronomic trait determining maturation time and yield. A set of common wheat (Triticum aestivum var. Chinese Spring; CS)-wild emmer (T. turgidum L. subsp. dicoccoides (TDIC)) chromosome arm substitution lines (CASLs) was used to identify and allocate QTLs conferring late or early spike emergence by examining heading date. Genetic loci accelerating heading were found on TDIC chromosome arms 3AL and 7BS, while loci delaying heading were located on 4AL and 2BS. To map QTLs conferring late heading on 2BS, F-2 populations derived from two cross combinations of CASL2BS x CS and CASL3AL x CASL2BS were developed and each planted at two times, constituting four F2 mapping populations. Heading date varied continuously among individuals of these four populations, suggesting quantitative characteristics. A genetic map of 2BS, consisting of 23 SSR and one single-stranded conformation polymorphism (SSCP) marker(s), was constructed using these F-2 populations. This map spanned a genetic length of 53.2 cM with average marker density of 2.3 cM. The photoperiod-sensitivity gene Ppd-B1 was mapped to chromosome arm 2BS as a SSCP molecular marker, and was validated as tightly linked to a major QTL governing late heading of CASL2BS in all mapping populations. A significant dominance by additive effect of Ppd-B1 with the LUX gene located on 3AL was also detected. CS had more copies of Ppd-B1 than CASL2BS, implying that increased copy number could elevate the expression of Ppd-1 in CS, also increasing expression of LUX and FT genes and causing CS to have an earlier heading date than CASL2BS in long days.	[Zhou, Wei; Wu, Shasha; Ding, Mingquan; Li, Jingjuan; Shi, Zhaobin; Wei, Wei; Guo, Jialian; Zhang, Hua; Jiang, Yurong; Rong, Junkang] Zhejiang A&F Univ, Sch Agr & Food Sci, Key Lab Qual Improvement Agr Prod Zhejiang Prov, Hangzhou 311300, Zhejiang, Peoples R China	Zhejiang A&F University	Rong, JK (corresponding author), Zhejiang A&F Univ, Sch Agr & Food Sci, Key Lab Qual Improvement Agr Prod Zhejiang Prov, Hangzhou 311300, Zhejiang, Peoples R China.	junkangrong@126.com		Yurong, Jiang/0000-0003-2245-265X	National Natural Science Foundation of China [31201208, 31071421]; Zhejiang province public technology applied research projects [2014C32027]; Zhejiang Provincial Natural Science Foundation of China [LQ12C13003]; Zhejiang province science and technology development special project on breeding new varieties of wheat and barley [2012C12902-2-6]; Program for Zhejiang Leading Team of ST Innovation [2011R50026-24]; NSFC [31071421]; ZJNSF [LQ12C13003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang province public technology applied research projects; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang province science and technology development special project on breeding new varieties of wheat and barley; Program for Zhejiang Leading Team of ST Innovation; NSFC(National Natural Science Foundation of China (NSFC)); ZJNSF(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China (31201208 sponsored for WZ and 31071421 sponsored for JKR, the URL is http://www.nsfc.gov.cn/), Zhejiang province public technology applied research projects (2014C32027 sponsored for YRJ, the URL is http://www.zjkjt.gov.cn/), Zhejiang Provincial Natural Science Foundation of China (LQ12C13003 sponsored for WZ, the URL is http://www.zjnsf.gov.cn/index.aspx), Zhejiang province science and technology development special project on breeding new varieties of wheat and barley (2012C12902-2-6 sponsored for WZ, the URL is http://www.zjkjt.gov.cn/) and the Program for Zhejiang Leading Team of S&T Innovation (2011R50026-24 sponsored for WZ and the URL is http://www.zjkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The 28 CASLs and their parents (CS and TDIC 140) were kindly provided by Prof. M. Feldman at Weizmann Institute of Science, Israel. This work was supported by NSFC (31071421), Zhejiang province public technology applied research projects (2014C32027), ZJNSF(LQ12C13003), the Zhejiang province science and technology development special project on breeding new varieties of wheat and barley (2012C12902-2-6) and the Program for Zhejiang Leading Team of S&T Innovation (2011R50026-24).	Alpert KB, 1996, P NATL ACAD SCI USA, V93, P15503, DOI 10.1073/pnas.93.26.15503; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Bennett D, 2012, THEOR APPL GENET, V124, P697, DOI 10.1007/s00122-011-1740-3; Bonnin I, 2008, THEOR APPL GENET, V116, P383, DOI 10.1007/s00122-007-0676-0; Borner A, 2002, THEOR APPL GENET, V105, P921, DOI 10.1007/s00122-002-0994-1; CHAO S, 1989, THEOR APPL GENET, V78, P495, DOI 10.1007/BF00290833; Deng WW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6882; Diaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033234; Distelfeld A, 2009, PLANT PHYSIOL, V149, P245, DOI 10.1104/pp.108.129353; Doerge RW, 1996, GENETICS, V142, P285; Dubcovsky J, 1998, THEOR APPL GENET, V97, P968, DOI 10.1007/s001220050978; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; ESHED Y, 1995, GENETICS, V141, P1147; FELDMAN M, 1981, SCI AM, V244, P102, DOI 10.1038/scientificamerican0181-102; Feldman M., 1994, P EUR ASS RES PLANT, P151; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Fujita M, 2003, P 10 INT WHEAT GEN S, V3, P971; Gawronski P, 2014, GENETICS, V196, P1253, DOI 10.1534/genetics.113.158444; Griffiths S, 2009, THEOR APPL GENET, V119, P383, DOI 10.1007/s00122-009-1046-x; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; He SE, 2013, PLANT BREEDING, V132, P337, DOI 10.1111/pbr.12030; Holtan HEE, 2003, GENETICS, V165, P1541; HOOGENDOORN J, 1985, EUPHYTICA, V34, P545, DOI 10.1007/BF00022954; JOPPA LR, 1993, CROP SCI, V33, P908, DOI 10.2135/cropsci1993.0011183X003300050006x; Kato H, 2001, PLANT BREEDING, V120, P115, DOI 10.1046/j.1439-0523.2001.00586.x; Kato K, 1999, PLANT BREEDING, V118, P391, DOI 10.1046/j.1439-0523.1999.00395.x; Kato K, 1999, THEOR APPL GENET, V98, P472, DOI 10.1007/s001220051094; Khavkin E, 1997, THEOR APPL GENET, V95, P343, DOI 10.1007/s001220050569; Kitagawa S, 2012, GENES GENET SYST, V87, P161, DOI 10.1266/ggs.87.161; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kulwal PL, 2003, PLANT SCI, V164, P267, DOI 10.1016/S0168-9452(02)00409-0; Laurie DA, 1997, PLANT MOL BIOL, V35, P167, DOI 10.1023/A:1005726329248; LAW CN, 1978, HEREDITY, V41, P185, DOI 10.1038/hdy.1978.87; Lin F, 2008, EUPHYTICA, V164, P769, DOI 10.1007/s10681-008-9724-3; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; MANGIN B, 1994, GENETICS, V138, P1301; Millet E, 2013, EUPHYTICA, V190, P1, DOI 10.1007/s10681-012-0725-x; Mohler V, 2004, EUPHYTICA, V138, P33, DOI 10.1023/B:EUPH.0000047056.58938.76; Nakamichi N, 2011, PLANT CELL PHYSIOL, V52, P1709, DOI 10.1093/pcp/pcr118; Nishida H, 2013, MOL BREEDING, V31, P27, DOI 10.1007/s11032-012-9765-0; Paillard S, 2003, THEOR APPL GENET, V107, P1235, DOI 10.1007/s00122-003-1361-6; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Pestsova E, 2000, THEOR APPL GENET, V101, P95, DOI 10.1007/s001220051455; PUGSLEY AT, 1971, AUST J AGR RES, V22, P21, DOI 10.1071/AR9710021; Rawson HM, 1998, FIELD CROP RES, V57, P289, DOI 10.1016/S0378-4290(98)00073-2; Reif JC, 2005, THEOR APPL GENET, V110, P859, DOI 10.1007/s00122-004-1881-8; Roder MS, 1998, GENOME, V41, P278, DOI 10.1139/gen-41-2-278; Rong JK, 2000, EUPHYTICA, V115, P121, DOI 10.1023/A:1003950431049; SCARTH R, 1983, HEREDITY, V51, P607, DOI 10.1038/hdy.1983.73; Shaw LM, 2012, PLANT J, V71, P71, DOI 10.1111/j.1365-313X.2012.04971.x; Shindo C, 2003, HEREDITY, V90, P56, DOI 10.1038/sj.hdy.6800178; Snape JW, 2001, EUPHYTICA, V119, P185, DOI 10.1023/A:1017594422176; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Song QJ, 2005, THEOR APPL GENET, V110, P550, DOI 10.1007/s00122-004-1871-x; Sourdille P, 2003, THEOR APPL GENET, V106, P530, DOI 10.1007/s00122-002-1044-8; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Wilhelm EP, 2009, THEOR APPL GENET, V118, P285, DOI 10.1007/s00122-008-0898-9; Worland AJ, 1996, EUPHYTICA, V89, P49, DOI 10.1007/BF00015718; Xin Z.Y., 1995, P 8 INT WHEAT GENETI, P19; Xue SL, 2008, THEOR APPL GENET, V117, P181, DOI 10.1007/s00122-008-0764-9; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; Yang J, 2007, BIOINFORMATICS, V23, P1527, DOI 10.1093/bioinformatics/btm143; Yoshida T, 2010, THEOR APPL GENET, V120, P543, DOI 10.1007/s00122-009-1174-3; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zhang KP, 2009, GENETICA, V135, P257, DOI 10.1007/s10709-008-9274-6; Zhou W, 2013, CROP SCI, V53, P1555, DOI 10.2135/cropsci2012.05.0287	69	11	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147377	10.1371/journal.pone.0147377	http://dx.doi.org/10.1371/journal.pone.0147377			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848576	Green Published, gold			2022-12-27	WOS:000369554000014
J	Kinstlinger, IS; Bastian, A; Paulsen, SJ; Hwang, DH; Ta, AH; Yalacki, DR; Schmidt, T; Miller, JS				Kinstlinger, Ian S.; Bastian, Andreas; Paulsen, Samantha J.; Hwang, Daniel H.; Ta, Anderson H.; Yalacki, David R.; Schmidt, Tim; Miller, Jordan S.			Open-Source Selective Laser Sintering (OpenSLS) of Nylon and Biocompatible Polycaprolactone	PLOS ONE			English	Article							TRICALCIUM PHOSPHATE SCAFFOLDS; IN-VITRO; OSTEOGENIC-DIFFERENTIATION; MECHANICAL-PROPERTIES; SURFACE-ROUGHNESS; POROUS SCAFFOLD; STEM-CELLS; STEREOLITHOGRAPHY; FABRICATION; NETWORKS	Selective Laser Sintering (SLS) is an additive manufacturing process that uses a laser to fuse powdered starting materials into solid 3D structures. Despite the potential for fabrication of complex, high-resolution structures with SLS using diverse starting materials (including biomaterials), prohibitive costs of commercial SLS systems have hindered the wide adoption of this technology in the scientific community. Here, we developed a low-cost, open-source SLS system (OpenSLS) and demonstrated its capacity to fabricate structures in nylon with sub-millimeter features and overhanging regions. Subsequently, we demonstrated fabrication of polycaprolactone (PCL) into macroporous structures such as a diamond lattice. Widespread interest in using PCL for bone tissue engineering suggests that PCL lattices are relevant model scaffold geometries for engineering bone. SLS of materials with large powder grain size (similar to 500 mu m) leads to part surfaces with high roughness, so we further introduced a simple vapor-smoothing technique to reduce the surface roughness of sintered PCL structures which further improves their elastic modulus and yield stress. Vapor-smoothed PCL can also be used for sacrificial templating of perfusable fluidic networks within orthogonal materials such as poly(dimethylsiloxane) silicone. Finally, we demonstrated that human mesenchymal stem cells were able to adhere, survive, and differentiate down an osteogenic lineage on sintered and smoothed PCL surfaces, suggesting that OpenSLS has the potential to produce PCL scaffolds useful for cell studies. OpenSLS provides the scientific community with an accessible platform for the study of laser sintering and the fabrication of complex geometries in diverse materials.	[Kinstlinger, Ian S.; Bastian, Andreas; Paulsen, Samantha J.; Hwang, Daniel H.; Ta, Anderson H.; Yalacki, David R.; Miller, Jordan S.] Rice Univ, Dept Bioengn, Houston, TX USA; [Schmidt, Tim] Lansing Makers Network, Lansing, MI USA	Rice University	Miller, JS (corresponding author), Rice Univ, Dept Bioengn, Houston, TX USA.	jmil@rice.edu		Kinstlinger, Ian/0000-0002-7335-6644	John S. Dunn Collaborative Research Award of the Gulf Coast Consortia; Cancer Prevention Research Institute of Texas [RP120713-P2]	John S. Dunn Collaborative Research Award of the Gulf Coast Consortia; Cancer Prevention Research Institute of Texas	This work was supported by a 2013 John S. Dunn Collaborative Research Award of the Gulf Coast Consortia and the Cancer Prevention Research Institute of Texas (RP120713-P2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centenero SAH, 2012, J CRANIO MAXILL SURG, V40, P162, DOI 10.1016/j.jcms.2011.03.014; Agarwala M, 1995, RAPID PROTOTYPING J, V1, P26, DOI 10.1108/13552549510078113; [Anonymous], 2015, SCI TRANSL MED; [Anonymous], 2008, P 3 INT C POL MOULDS; Antonov EN, 2006, LASER PHYS, V16, P774, DOI 10.1134/S1054660X06050070; Arcaute K, 2006, ANN BIOMED ENG, V34, P1429, DOI 10.1007/s10439-006-9156-y; Arcaute K, 2010, ACTA BIOMATER, V6, P1047, DOI 10.1016/j.actbio.2009.08.017; Beaman J. J., 1990, U.S. Patent, Patent No. [4938816A, 4938816, US4938816A]; Berman B, 2012, BUS HORIZONS, V55, P155, DOI 10.1016/j.bushor.2011.11.003; Berry E, 1997, MED ENG PHYS, V19, P90, DOI 10.1016/S1350-4533(96)00039-2; Bertassoni LE, 2014, LAB CHIP, V14, P2202, DOI 10.1039/c4lc00030g; Bertrand P, 2007, APPL SURF SCI, V254, P989, DOI 10.1016/j.apsusc.2007.08.085; Bertsch A, 2000, RAPID PROTOTYPING J, V6, P259, DOI 10.1108/13552540010373362; Binder TM, 2000, J AM COLL CARDIOL, V35, P230, DOI 10.1016/S0735-1097(99)00498-2; Bugeda G, 1999, RAPID PROTOTYPING J, V5, P21, DOI 10.1108/13552549910251846; Campbell TA, 2013, TECHNOL INNOV, V15, P67, DOI 10.3727/194982413X13608676060655; Chen AA, 2011, P NATL ACAD SCI USA, V108, P11842, DOI 10.1073/pnas.1101791108; Chen TB, 2006, J MANUF SCI E-T ASME, V128, P299, DOI 10.1115/1.2122947; Childs T.H.C., 1994, CIRP ANN, V43, P163, DOI [10.1016/S0007-8506(07)62187-8, DOI 10.1016/S0007-8506(07)62187-8]; Chung H, 2010, J MECH SCI TECHNOL, V24, P241, DOI 10.1007/s12206-009-1141-6; Crump SS., 1992, United States Patent, Patent No. [No. 5,121,329A, 5121329, 5,121,329]; D'Urso PS, 2000, BRIT J PLAST SURG, V53, P200, DOI 10.1054/bjps.1999.3268; Deckard CR, 1989, United States Patent, Patent No. [US4863538A, 4863538, 4,863,538]; Dhariwala B, 2004, TISSUE ENG, V10, P1316, DOI 10.1089/1076327042500256; Doyle H, 2014, ANN BIOMED ENG, V42, P661, DOI 10.1007/s10439-013-0913-4; Ejaz F, 2014, RAPID PROTOTYPING J, V20, P336, DOI 10.1108/RPJ-11-2012-0105; Eosoly S, 2010, ACTA BIOMATER, V6, P2511, DOI 10.1016/j.actbio.2009.07.018; Eshraghi S, 2010, ACTA BIOMATER, V6, P2467, DOI 10.1016/j.actbio.2010.02.002; Faia-Torres AB, 2014, BIOMATERIALS, V35, P9023, DOI 10.1016/j.biomaterials.2014.07.015; Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029; Goodridge RD, 2007, ACTA BIOMATER, V3, P221, DOI 10.1016/j.actbio.2006.10.005; Gu DD, 2009, MATER DESIGN, V30, P2903, DOI 10.1016/j.matdes.2009.01.013; Hao L, 2007, P ROY SOC A-MATH PHY, V463, P1857, DOI 10.1098/rspa.2007.1854; Hockaday LA, 2014, 3D PRINT ADDIT MANUF, V1, P122, DOI 10.1089/3dp.2014.0018; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037; Hull CW, 1986, US Patent, Patent No. [4575330A, 4575330, 4,575,330]; Jacobs Stephan, 2008, Interact Cardiovasc Thorac Surg, V7, P6, DOI 10.1510/icvts.2007.156588; Karuppuswamy P, 2015, MATER LETT, V141, P180, DOI 10.1016/j.matlet.2014.11.044; Kaveh K, 2011, J ANIM VET ADV, V10, P2317, DOI 10.3923/javaa.2011.2317.2330; Khajavi SH, 2014, COMPUT IND, V65, P50, DOI 10.1016/j.compind.2013.07.008; Kim MP, 2015, INT J SURG CASE REP, V16, P127, DOI 10.1016/j.ijscr.2015.09.037; Kolan KCR, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/025004; Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506; Kruth J., 2010, P 16 INT S EL, V16; Kruth JP, 2007, CIRP ANN-MANUF TECHN, V56, P730, DOI 10.1016/j.cirp.2007.10.004; Kruth JP, 2004, J MATER PROCESS TECH, V149, P616, DOI 10.1016/j.jmatprotec.2003.11.051; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Layerwise 3D Systems, ADD MAN EN INN SHOCK; Leiggener C, 2009, INT J ORAL MAX SURG, V38, P187, DOI 10.1016/j.ijom.2008.11.026; Liao HT, 2011, VIRTUAL PHYS PROTOTY, V6, P57, DOI 10.1080/17452759.2011.559742; Lohfeld S., 2010, Journal of Biomedical Science & Engineering, V3, P138, DOI 10.4236/jbise.2010.32019; Madurantakam PA, 2009, BIOMATERIALS, V30, P5456, DOI 10.1016/j.biomaterials.2009.06.043; Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0; Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]; Murr LE, 2010, PHILOS T R SOC A, V368, P1999, DOI 10.1098/rsta.2010.0010; Myers JG, 2001, ANN BIOMED ENG, V29, P109, DOI 10.1114/1.1349703; Partee B, 2006, J MANUF SCI E-T ASME, V128, P531, DOI 10.1115/1.2162589; Pereira TF, 2012, VIRTUAL PHYS PROTOTY, V7, P275, DOI 10.1080/17452759.2012.738551; Pham DT, 1998, INT J MACH TOOL MANU, V38, P1257, DOI 10.1016/S0890-6955(97)00137-5; Pham DT, 1999, P I MECH ENG B-J ENG, V213, P435, DOI 10.1243/0954405991516912; Rai B, 2010, BIOMATERIALS, V31, P7960, DOI 10.1016/j.biomaterials.2010.07.001; Roszelle BN, 2013, NEURORADIOLOGY, V55, P751, DOI 10.1007/s00234-013-1169-2; Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8; Saggiomo V, 2015, ADV SCI, V2, DOI 10.1002/advs.201500125; Salerno A, 2009, ACTA BIOMATER, V5, P1082, DOI 10.1016/j.actbio.2008.10.012; Salmoria GV, 2014, ADV MECH ENG, DOI 10.1155/2014/640496; Salmoria GV, 2012, POLYM TEST, V31, P411, DOI 10.1016/j.polymertesting.2011.12.006; Sharaf B, 2012, J ORAL MAXIL SURG, V70, P647, DOI 10.1016/j.joms.2011.07.029; Shirazi SFS, 2015, SCI TECHNOL ADV MAT, V16, DOI 10.1088/1468-6996/16/3/033502; Shuai CJ, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/28/285703; Simchi A, 2003, J MATER PROCESS TECH, V141, P319, DOI 10.1016/S0924-0136(03)00283-8; Tan KH, 2003, BIOMATERIALS, V24, P3115, DOI 10.1016/S0142-9612(03)00131-5; Tarafder S, 2014, ACS APPL MATER INTER, V6, P9955, DOI 10.1021/am501048n; Thadavirul N, 2014, J BIOMED MATER RES A, V102, P3379, DOI 10.1002/jbm.a.35010; Therriault D, 2003, NAT MATER, V2, P265, DOI 10.1038/nmat863; Trachtenberg JE, 2014, J BIOMED MATER RES A, V102, P4326, DOI 10.1002/jbm.a.35108; Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057; Wiria FE, 2007, ACTA BIOMATER, V3, P1, DOI 10.1016/j.actbio.2006.07.008; Wittbrodt BT, 2013, MECHATRONICS, V23, P713, DOI 10.1016/j.mechatronics.2013.06.002; Wong Kaufui V., 2012, ISRN Mechanical Engineering, DOI 10.5402/2012/208760; Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002; Wurm G, 2004, SURG NEUROL, V62, P510, DOI 10.1016/j.surneu.2004.01.025; Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004; Zhou LJ, 2012, BIOMATERIALS, V33, P2734, DOI 10.1016/j.biomaterials.2011.11.009; Zhou WY, 2008, J MATER SCI-MATER M, V19, P2535, DOI 10.1007/s10856-007-3089-3; Zopf DA, 2013, NEW ENGL J MED, V368, P2043, DOI 10.1056/NEJMc1206319; Zorlutuna P, 2011, ADV FUNCT MATER, V21, P3642, DOI 10.1002/adfm.201101023	88	54	59	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147399	10.1371/journal.pone.0147399	http://dx.doi.org/10.1371/journal.pone.0147399			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841023	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200037
J	Saif, Z; Dyson, RM; Palliser, HK; Wright, IMR; Lu, N; Clifton, VL				Saif, Zarqa; Dyson, Rebecca M.; Palliser, Hannah K.; Wright, Ian M. R.; Lu, Nick; Clifton, Vicki L.			Identification of Eight Different Isoforms of the Glucocorticoid Receptor in Guinea Pig Placenta: Relationship to Preterm Delivery, Sex and Betamethasone Exposure	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ANTENATAL BETAMETHASONE; TISSUE DISTRIBUTION; GESTATIONAL-AGE; MATERNAL ASTHMA; P-GLYCOPROTEIN; BIRTH-WEIGHT; FETAL SHEEP; FOLLOW-UP; EXPRESSION	The placental glucocorticoid receptor (GR) is central to glucocorticoid signalling and for mediating steroid effects on pathways associated with fetal growth and lung maturation but the GR has not been examined in the guinea pig placenta even though this animal is regularly used as a model of preterm birth and excess glucocorticoid exposure. Guinea pig dams received subcutaneous injections of either vehicle or betamethasone at 24 and 12 hours prior to preterm or term caesarean-section delivery. At delivery pup and organ weights were recorded. Placentae were dissected, weighed and analysed using Western blot to examine GR isoform expression in nuclear and cytoplasmic extracts. A comparative examination of the guinea pig GR gene identified it is capable of producing seven of the eight translational GR isoforms which include GRa-A, C1, C2, C3, D1, D2, and D3. GR alpha-B is not produced in the Guinea Pig. Total GR antibody identified 10 specific bands from term (n = 29) and preterm pregnancies (n = 27). Known isoforms included GR., GRa A, GR beta, GRP, GRA and GRa D1-3. There were sex and gestational age differences in placental GR isoform expression. Placental GRa A was detected in the cytoplasm of all groups but was significantly increased in the cytoplasm and nucleus of preterm males and females exposed to betamethasone and untreated term males (KW-ANOVA, P = 0.0001, P = 0.001). Cytoplasmic expression of GR beta was increased in female preterm placentae and preterm and term male placentae exposed to betamethasone (P = 0.01). Nuclear expression of GR beta was increased in all placentae exposed to betamethasone (P = 0.0001). GRa D2 and GRa D3 were increased in male preterm placentae when exposed to betamethasone (P = 0.01, P = 0.02). The current data suggests the sex-specific placental response to maternal betamethasone may be dependent on the expression of a combination of GR isoforms.	[Saif, Zarqa; Clifton, Vicki L.] Univ Queensland, Mater Med Res Inst, Brisbane, Qld, Australia; [Saif, Zarqa; Clifton, Vicki L.] Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Res Inst, Adelaide, SA, Australia; [Dyson, Rebecca M.; Palliser, Hannah K.; Wright, Ian M. R.] Mothers & Babies Res Ctr, New Lambton Hts, NSW 2305, Australia; [Dyson, Rebecca M.; Palliser, Hannah K.; Wright, Ian M. R.] Hunter Med Res Inst, New Lambton Hts, NSW 2305, Australia; [Dyson, Rebecca M.; Palliser, Hannah K.; Wright, Ian M. R.] Univ Newcastle, Fac Hlth, Callaghan, NSW 2308, Australia; [Dyson, Rebecca M.; Wright, Ian M. R.] Univ Wollongong, Grad Sch Med, Wollongong, NSW 2522, Australia; [Dyson, Rebecca M.; Wright, Ian M. R.] Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Lu, Nick] Northwestern Univ, Dept Med, Div Allergy Immunol, Chicago, IL 60611 USA	Mater Research; University of Queensland; Robinson Research Institute; University of Adelaide; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Wollongong; University of Wollongong; Northwestern University	Clifton, VL (corresponding author), Univ Queensland, Mater Med Res Inst, Brisbane, Qld, Australia.; Clifton, VL (corresponding author), Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Res Inst, Adelaide, SA, Australia.	Vicki.clifton@mater.uq.edu.au	saif, zarqa/V-3562-2018; Clifton, Vicki/A-1445-2012; Clifton, Vicki/AAV-2749-2021; Saif, Zarqa/AAE-8327-2020	saif, zarqa/0000-0002-2916-1428; Clifton, Vicki/0000-0002-4892-6748; Clifton, Vicki/0000-0002-4892-6748; Saif, Zarqa/0000-0002-2916-1428; Palliser, Hannah/0000-0001-5783-9737; Dyson, Rebecca/0000-0003-2319-6897; Wright, Ian/0000-0001-5337-0134	National Health and Medical Research Council [APP1041918]; Hunter Children's Research Foundation; National Institute of Allergy and Infectious Diseases [R21AI113935]; National Heart, Lung, and Blood Institute [R37HL068546]; John Hunter Hospital Charitable Trust; University of Adelaide; Mater Medical Research Institute-University of Queensland; Translational Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL068546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI113935] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Hunter Children's Research Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); John Hunter Hospital Charitable Trust; University of Adelaide; Mater Medical Research Institute-University of Queensland; Translational Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	VC's salary is funded by the National Health and Medical Research Council senior Research Fellowship (APP1041918). RD was supported by the Hunter Children's Research Foundation. NL is funded by National Institute of Allergy and Infectious Diseases (R21AI113935) National Heart, Lung, and Blood Institute (R37HL068546). Animal work was funded by project grants from the John Hunter Hospital Charitable Trust awarded to IMRW, HKP, and RMD. This research work was funded by the University of Adelaide, Mater Medical Research Institute-University of Queensland and Translational Research Institute.	[Anonymous], 1985, N ENGL J MED, V313, P517; Beger C, 2003, BRIT J HAEMATOL, V122, P245, DOI 10.1046/j.1365-2141.2003.04426.x; Braun T, 2014, REPROD SCI; Crowther CA, 2007, NEW ENGL J MED, V357, P1179, DOI 10.1056/NEJMoa071152; Crudo A, 2012, ENDOCRINOLOGY, V153, P3269, DOI 10.1210/en.2011-2160; Dalziel SR, 2006, THORAX, V61, P678, DOI 10.1136/thx.2005.051763; Dalziel SR, 2007, INT J EPIDEMIOL, V36, P907, DOI 10.1093/ije/dym067; Dalziel SR, 2007, DEV MED CHILD NEUROL, V49, P597, DOI 10.1111/j.1469-8749.2007.00597.x; Dalziel SR, 2006, J BONE MINER RES, V21, P1175, DOI 10.1359/JBMR.060516; Dunn E, 2010, J PHYSIOL-LONDON, V588, P887, DOI 10.1113/jphysiol.2009.182139; Gatford KL, 2008, AM J PHYSIOL-ENDOC M, V295, pE170, DOI 10.1152/ajpendo.00047.2008; Haarman EG, 2004, LEUKEMIA, V18, P530, DOI 10.1038/sj.leu.2403225; Hodyl NA, 2013, PLACENTA, V34, P325, DOI 10.1016/j.placenta.2013.01.013; Hodyl NA, 2010, THORAX, V65, P677, DOI 10.1136/thx.2009.123091; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; Jobe AH, 1998, PEDIATRICS, V102, P1116, DOI 10.1542/peds.102.5.1116; Jobe AH, 2003, AM J OBSTET GYNECOL, V188, P22, DOI 10.1067/mob.2003.61; KEIGHTLEY MC, 1995, STEROIDS, V60, P87, DOI 10.1016/0039-128X(94)00014-4; KRAFT N, 1979, ENDOCRINOLOGY, V104, P344, DOI 10.1210/endo-104-2-344; Lu NZ, 2007, MOL CELL BIOL, V27, P7143, DOI 10.1128/MCB.00253-07; Lu NZ, 2005, MOL CELL, V18, P331, DOI 10.1016/j.molcel.2005.03.025; Mathai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081840; Mathai S, 2012, DIABETES, V61, P2479, DOI 10.2337/db11-1672; Matthews S G, 2001, Semin Neonatol, V6, P309, DOI 10.1053/siny.2001.0066; Moss TJM, 2003, J SOC GYNECOL INVEST, V10, P474, DOI 10.1016/S1071-5576(03)00152-7; Murphy VE, 2003, AM J RESP CRIT CARE, V168, P1317, DOI 10.1164/rccm.200303-374OC; Murphy VE, 2003, PLACENTA, V24, P739, DOI 10.1016/S0143-4004(03)00103-6; Palliser HK, 2010, REPROD SCI, V17, P776, DOI 10.1177/1933719110371517; Saif Z, 2015, PLACENTA, V36, P723, DOI 10.1016/j.placenta.2015.05.001; Saif Z, 2014, PLACENTA, V35, P260, DOI 10.1016/j.placenta.2014.01.012; Sampath-Kumar R, 1998, BIOL REPROD, V59, P1378, DOI 10.1095/biolreprod59.6.1378; Soo PS, 2012, REPROD TOXICOL, V33, P374, DOI 10.1016/j.reprotox.2012.01.013; Turner JD, 2005, J MOL ENDOCRINOL, V35, P283, DOI 10.1677/jme.1.01822; Turner JD, 2007, ANN NY ACAD SCI, V1095, P334, DOI 10.1196/annals.1397.037; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001	35	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148226	10.1371/journal.pone.0148226	http://dx.doi.org/10.1371/journal.pone.0148226			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840867	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000369550200101
J	Seppelt, PC; Schwill, S; Weymann, A; Arif, R; Weber, A; Zaradzki, M; Richter, K; Ensminger, S; Robinson, PN; Wagner, AH; Karck, M; Kallenbach, K				Seppelt, Philipp Christian; Schwill, Simon; Weymann, Alexander; Arif, Rawa; Weber, Antje; Zaradzki, Marcin; Richter, Karsten; Ensminger, Stephan; Robinson, Peter Nicholas; Wagner, Andreas H.; Karck, Matthias; Kallenbach, Klaus			Loss of Endothelial Barrier in Marfan Mice (mgR/mgR) Results in Severe Inflammation after Adenoviral Gene Therapy	PLOS ONE			English	Article							MUSCLE-CELL MIGRATION; MOLECULAR-MECHANISMS; NEOINTIMA FORMATION; TISSUE INHIBITOR; VEIN GRAFTS; MOUSE MODEL; OVEREXPRESSION; ANEURYSM; TIMP-1	Objectives Marfan syndrome is an autosomal dominant inherited disorder of connective tissue. The vascular complications of Marfan syndrome have the biggest impact on life expectancy. The aorta of Marfan patients reveals degradation of elastin layers caused by increased proteolytic activity of matrix metalloproteinases (MMPs). In this study we performed adenoviral gene transfer of human tissue inhibitor of matrix metalloproteinases-1 (hTIMP-1) in aortic grafts of fibrillin-1 deficient Marfan mice (mgR/mgR) in order to reduce elastolysis. Methods We performed heterotopic infrarenal transplantation of the thoracic aorta in female mice (n = 7 per group). Before implantation, mgR/mgR and wild-type aortas (WT, C57BL/6) were transduced ex vivo with an adenoviral vector coding for human TIMP-1 (Ad.hTIMP-1) or beta-galactosidase (Ad.beta-Gal). As control mgR/mgR and wild-type aortas received no gene therapy. Thirty days after surgery, overexpression of the transgene was assessed by immunohistochemistry (IHC) and collagen in situ zymography. Histologic staining was performed to investigate inflammation, the neointimal index (NI), and elastin breaks. Endothelial barrier function of native not virus-exposed aortas was evaluated by perfusion of fluorescent albumin and examinations of virus-exposed tissue were performed by transmission electron microscopy (TEM). Results IHC and ISZ revealed sufficient expression of the transgene. Severe cellular inflammation and intima hyperplasia were seen only in adenovirus treated mgR/mgR aortas (Ad.beta-Gal, Ad.hTIMP-1 NI: 0.23; 0.43), but not in native and Ad.hTIMP-1 treated WT (NI: 0.01; 0.00). Compared to native mgR/mgR and Ad.hTIMP-1 treated WT aorta, the NI is highly significant greater in Ad.hTIMP-1 transduced mgR/mgR aorta (p = 0.001; p = 0.001). As expected, untreated Marfan grafts showed significant more elastolysis compared to WT (p = 0.001). However, elastolysis in Marfan aortas was not reduced by adenoviral overexpression of hTIMP-1 (compared to untreated Marfan aorta: Ad.hTIMP-1 p = 0.902; control Ad.beta-Gal. p = 0.165). The virus-untreated and not transplanted mgR/mgR aorta revealed a significant increase of albumin diffusion through the endothelial barrier (p = 0.037). TEM analysis of adenovirus-exposed mgR/mgR aortas displayed disruption of the basement membrane and basolateral space. Conclusions Murine Marfan aortic grafts developed severe inflammation after adenoviral contact. We demonstrated that fibrillin-1 deficiency is associated with relevant dysfunction of the endothelial barrier that enables adenovirus to induce vessel-harming inflammation. Endothelial dysfunction may play a pivotal role in the development of the vascular phenotype of Marfan syndrome.	[Seppelt, Philipp Christian; Schwill, Simon; Weymann, Alexander; Arif, Rawa; Weber, Antje; Zaradzki, Marcin; Karck, Matthias; Kallenbach, Klaus] Univ Heidelberg Hosp, Dept Cardiac Surg, Heidelberg, Germany; [Richter, Karsten] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany; [Ensminger, Stephan] Clin Thorac & Cardiovasc Surg, Heart & Diabet Ctr NRW, Bad Oeynhausen, Germany; [Robinson, Peter Nicholas] Charite, Inst Med Genet & Human Genet, Berlin, Germany; [Robinson, Peter Nicholas] Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany; [Robinson, Peter Nicholas] Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany; [Wagner, Andreas H.] Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruhr University Bochum; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Ruprecht Karls University Heidelberg	Seppelt, PC (corresponding author), Univ Heidelberg Hosp, Dept Cardiac Surg, Heidelberg, Germany.	Philipp.Seppelt@med.uni-heidelberg.de	Weymann, Alexander/AAQ-5115-2021; Ensminger, Stephan Prof. Dr./AAQ-2141-2021	Ensminger, Stephan Prof. Dr./0000-0002-9508-3261	Deutsche Forschungsgemeinschaft [KA 1169/3-1]; Deutsche Herzstiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Herzstiftung	The work was supported by grant from the Deutsche Forschungsgemeinschaft (KA 1169/3-1), www.dfg.de. S. Schwill received personal funding from the Deutsche Herzstiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2007, STROKE, V38, P2337, DOI 10.1161/STROKEAHA.107.481838; Bode W, 1999, ANN NY ACAD SCI, V878, P73, DOI 10.1111/j.1749-6632.1999.tb07675.x; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Chung AWY, 2007, CIRC RES, V101, P512, DOI 10.1161/CIRCRESAHA.107.157776; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; Fernandez HA, 1999, J SURG RES, V82, P156, DOI 10.1006/jsre.1998.5534; Fernandez HA, 1998, SURGERY, V124, P129, DOI 10.1016/S0039-6060(98)70112-6; Forough R, 1998, ARTERIOSCL THROM VAS, V18, P803, DOI 10.1161/01.ATV.18.5.803; George SJ, 2000, CIRCULATION, V101, P296, DOI 10.1161/01.CIR.101.3.296; George SJ, 1998, HUM GENE THER, V9, P867, DOI 10.1089/hum.1998.9.6-867; Guo G, 2011, PLOS ONE, V6, P7; Guo G, 2006, CIRCULATION, V114, P1855, DOI 10.1161/CIRCULATIONAHA.105.601674; Guo Gao, 2013, Aorta (Stamford), V1, P5, DOI 10.12945/j.aorta.2013.13.007; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Kallenbach K, 2003, ARTERIOSCL THROM VAS, V23, P1008, DOI 10.1161/01.ATV.0000069880.81136.38; Kallenbach K, 2008, CLIN RES CARDIOL, V97, pP110; Kallenbach K, 2007, ANN THORAC SURG, V83, pS764, DOI 10.1016/j.athoracsur.2006.10.097; Kallenbach K, 2009, J VASC SURG, V49, P750, DOI 10.1016/j.jvs.2008.11.001; Karck M, 2004, J THORAC CARDIOV SUR, V127, P391, DOI 10.1016/j.jtcvs.2003.07.049; Kroner ESJ, 2013, INT J CARDIOL, V167, P2977, DOI 10.1016/j.ijcard.2012.08.057; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Nasuno A, 2004, CARDIOVASC PATHOL, V13, P79, DOI 10.1016/s1054-8807(03)00137-6; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Newman KD, 1995, J CLIN INVEST, V96, P2955, DOI 10.1172/JCI118367; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Rigg AS, 2001, CANCER GENE THER, V8, P869, DOI 10.1038/sj.cgt.7700387; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Schwill S, 2013, J VASC SURG, V57, P1628, DOI 10.1016/j.jvs.2012.10.007; Sekhon BS, 2010, RES REP BIOL, V1, P1, DOI 10.2147/RRB.S12043; STERN DM, 1991, DIABETES CARE, V14, P160, DOI 10.2337/diacare.14.2.160; Subbotin VM, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-41; Walters RW, 1999, J BIOL CHEM, V274, P10219, DOI 10.1074/jbc.274.15.10219; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wilson DG, 1999, CIRCULATION, V99, P909, DOI 10.1161/01.CIR.99.7.909; Xiong W, 2008, J VASC SURG, V47, P166, DOI 10.1016/j.jvs.2007.09.016	38	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148012	10.1371/journal.pone.0148012	http://dx.doi.org/10.1371/journal.pone.0148012			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840980	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200076
J	Zhao, YN; Wang, FZ; Zhang, XY; Zhang, SH; Guo, SL; Zhu, GP; Liu, Q; Li, M				Zhao, Yanni; Wang, Fengzhu; Zhang, Xinyue; Zhang, Suhua; Guo, Shilong; Zhu, Gengping; Liu, Qiang; Li, Min			Transcriptome and Expression Patterns of Chemosensory Genes in Antennae of the Parasitoid Wasp Chouioia cunea	PLOS ONE			English	Article							PHEROMONE-BINDING-PROTEINS; NEURON MEMBRANE-PROTEINS; ODORANT-BINDING; DIFFERENTIAL EXPRESSION; OLFACTORY RECEPTORS; MOLECULAR EVOLUTION; REGENERATING LEGS; DROSOPHILA; FAMILY; IDENTIFICATION	Chouioia cunea Yang is an endoparasitic wasp that attacks pupae of Hyphantria cunea (Drury), an invasive moth species that severely damages forests in China. Chemosensory systems of insects are used to detect volatile chemical odors such as female sex pheromones and host plant volatiles. The antennae of parasite wasps are important for host detection and other sensory-mediated behaviors. We identified and documented differential expression profiles of chemoreception genes in C. cunea antennae. A total of 25 OBPs, 80 ORs, 10 IRs, 11 CSP, 1 SNMPs, and 17 GRs were annotated from adult male and female C. cunea antennal transcriptomes. The expression profiles of 25 OBPs, 16 ORs, and 17 GRs, 5 CSP, 5 IRs and 1 SNMP were determined by RT-PCR and RT-qPCR for the antenna, head, thorax, and abdomen of male and female C. cunea. A total of 8 OBPs, 14 ORs, and 8 GRs, 1 CSP, 4 IRs and 1 SNMPs were exclusively or primarily expressed in female antennae. These female antennal-specific or dominant expression profiles may assist in locating suitable host and oviposition sites. These genes will provide useful targets for advanced study of their biological functions.	[Zhao, Yanni; Wang, Fengzhu; Zhang, Xinyue; Guo, Shilong; Zhu, Gengping; Liu, Qiang; Li, Min] Tianjin Normal Univ, Tianjin Key Lab Anim & Plant Resistance, Tianjin 300387, Peoples R China; [Zhang, Suhua] Nat Enemy Breeding Ctr Luohe Cent South Forestry, Luohe 462000, Henan, Peoples R China	Tianjin Normal University	Li, M (corresponding author), Tianjin Normal Univ, Tianjin Key Lab Anim & Plant Resistance, Tianjin 300387, Peoples R China.	skylm@mail.tjnu.edu.cn	Zhu, Gengping/CAF-4192-2022	Zhu, Gengping/0000-0001-6823-5840	Natural Science Foundation of China [31401962, 31201730]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the Natural Science Foundation of China (No. 31401962, No. 31201730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latief M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001319; Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson I, 1998, BIOINFORMATICS, V14, P349, DOI 10.1093/bioinformatics/14.4.349; Andersson MN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-501; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; Barbarossa IT, 1998, ITAL J ZOOL, V65, P367, DOI 10.1080/11250009809386775; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bigiani A, 2005, REV PHYSIOL BIOCH P, V154, P1, DOI 10.1007/s10254-004-0038-0; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corcoran JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128596; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Fiala A, 2007, CURR OPIN NEUROBIOL, V17, P720, DOI 10.1016/j.conb.2007.11.009; Forstner M, 2008, CHEM SENSES, V33, P291, DOI 10.1093/chemse/bjm087; Gardiner A, 2008, MOL ECOL, V17, P1648, DOI 10.1111/j.1365-294X.2008.03713.x; Godfray H. C. J., 1994, Parasitoids: behavioral and evolutionary ecology.; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Gonzalez D, 2009, INSECT MOL BIOL, V18, P395, DOI 10.1111/j.1365-2583.2009.00883.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073524; Gu SH, 2013, J INSECT PHYSIOL, V59, P430, DOI 10.1016/j.jinsphys.2013.02.003; Gu SH, 2013, INSECT BIOCHEM MOLEC, V43, P237, DOI 10.1016/j.ibmb.2012.12.009; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Gu XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125159; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Jacquin-Joly E, 2004, J CHEM ECOL, V30, P2359, DOI 10.1007/s10886-004-7941-3; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jin X, 2005, CELL MOL LIFE SCI, V62, P1156, DOI 10.1007/s00018-005-5014-6; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; Koenig C, 2015, INSECT BIOCHEM MOLEC, V66, P51, DOI 10.1016/j.ibmb.2015.09.007; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121504; Li ZQ, 2015, COMP BIOCHEM PHYS D, V15, P28, DOI 10.1016/j.cbd.2015.05.002; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; Mamidala P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056555; McBride CS, 2007, GENETICS, V177, P1395, DOI 10.1534/genetics.107.078683; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagnan-Le Meillour P, 2000, CHEM SENSES, V25, P541, DOI 10.1093/chemse/25.5.541; Nishimura O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050664; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Pitts RJ, 2014, P NATL ACAD SCI USA, V111, P2566, DOI 10.1073/pnas.1322923111; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Poivet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060263; Qu B. X., 1987, J NW COLL FOR, V2, P41; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Robertson HM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1901; Rogers ME, 2001, CELL TISSUE RES, V303, P433, DOI 10.1007/s004410000305; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Schoonhoven L. M., 2005, Insect-plant biology; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Vinson SB, 1998, BIOL CONTROL, V11, P79, DOI 10.1006/bcon.1997.0601; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang SN, 2015, INT J BIOL SCI, V11, P737, DOI 10.7150/ijbs.11786; Wang ZF, 2015, CELL MOL LIFE SCI, V72, P4429, DOI 10.1007/s00018-015-2009-9; WANG ZP, 1995, INTEGRATED CONTROL T; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Wu ZZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129794; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Xu XiaoRui, 2013, Journal of Shenyang Agricultural University, V44, P42; YANG Z, 1989, Entomotaxonomia, V11, P117; Yang Z. Q., 1990, FOREST PEST DIS, V2, P17; Yang ZQ, 2006, BIOCONTROL, V51, P401, DOI 10.1007/s10526-006-9010-z; Yang Zhongqi, 1998, Chinese Journal of Biological Control, V14, P49; YANG ZQ, 1990, SCI SILVAE SINICAE, V31, P23; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang J, 2014, INSECT SCI IN PRESS, DOI [10.1111/1744-7917.12131, DOI 10.1111/1744-7917.12131]; Zhang J, 2015, INSECT SCI, V22, P399, DOI 10.1111/1744-7917.12131; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhao Yan-Ni, 2014, Chinese Journal of Applied Entomology, V51, P1026, DOI 10.7679/j.issn.2095-1353.2014.121; Zhou JingJiang, 2010, Outlooks on Pest Management, V21, P31, DOI 10.1564/21feb08; Zhou SH, 2008, J APPL ENTOMOL, V132, P439, DOI 10.1111/j.1439-0418.2007.01255.x	105	39	45	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148159	10.1371/journal.pone.0148159	http://dx.doi.org/10.1371/journal.pone.0148159			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841106	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200089
J	Di Caro, G; Carvello, M; Pesce, S; Erreni, M; Marchesi, F; Todoric, J; Sacchi, M; Montorsi, M; Allavena, P; Spinelli, A				Di Caro, Giuseppe; Carvello, Michele; Pesce, Samantha; Erreni, Marco; Marchesi, Federica; Todoric, Jelena; Sacchi, Matteo; Montorsi, Marco; Allavena, Paola; Spinelli, Antonino			Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; LONG PENTRAXIN PTX3; INNATE IMMUNITY; KAPPA-B; SURVIVAL; INTERLEUKIN-6; RECRUITMENT; CHEMOKINES; CORRELATE; CELLS	Background Cytokines and chemokines in the tumor microenvironment drive metastatic development and their serum levels might mirror the ongoing inflammatory reaction at the tumor site. Novel highly sensitive tools are needed to identify colorectal cancer patients at high risk of recurrence that should be more closely monitored during post-surgical follow up. Here we study whether circulating inflammatory markers might be used to predict recurrence in CRC patients. Methods Circulating levels of the inflammatory cytokines IL-1, IL-6, IL-10, TNFalpha, CCL2, CXCL8, VEGF and the acute phase protein Pentraxin-3 were measured by ELISA in preoperative serum samples prospectively collected from a cohort of sixty-nine patients undergoing surgical resection for stage 0-IV CRC and associated with post-operative disease recurrence. Results Cox multivariate analysis showed that combined high levels (>= ROC cut off-value) of CXCL8, VEGF and Pentraxin3 were associated with increased risk of disease recurrence [HR: 14.28; 95%CI: (3.13-65.1)] independently of TNM staging. Kaplan-Meier analysis showed that CXCL8, VEGF and Pentraxin3 levels were significantly associated with worse survival (P<0.001). Conclusions Circulating inflammatory mediators efficiently predicted postoperative recurrence after CRC surgery. Therefore, this study suggest that their validation in large-scale clinical trials may help in tailoring CRC post-surgical management.	[Di Caro, Giuseppe; Pesce, Samantha; Erreni, Marco; Marchesi, Federica; Allavena, Paola] Humanitas Clin & Res Ctr, Dept Immunol & Inflammat, Milan, Italy; [Carvello, Michele; Sacchi, Matteo; Montorsi, Marco; Spinelli, Antonino] Humanitas Clin & Res Ctr, Dept Colon & Rectal Surg, Milan, Italy; [Di Caro, Giuseppe; Todoric, Jelena] Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA; [Di Caro, Giuseppe; Todoric, Jelena] Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Di Caro, G (corresponding author), Humanitas Clin & Res Ctr, Dept Immunol & Inflammat, Milan, Italy.; Spinelli, A (corresponding author), Humanitas Clin & Res Ctr, Dept Colon & Rectal Surg, Milan, Italy.; Di Caro, G (corresponding author), Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA.; Di Caro, G (corresponding author), Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pathol, La Jolla, CA 92093 USA.	gdicaro@ucsd.edu; Antonino.spinelli@humanitas.it	Montorsi, Marco/GYD-3896-2022; Spinelli, Antonino/ABI-1441-2020; Marchesi, Federica/E-5163-2017; carvello, michele/HHN-5282-2022; Allavena, Paola/HHM-5218-2022; Erreni, Marco/K-2522-2016	Montorsi, Marco/0000-0002-3887-3451; Spinelli, Antonino/0000-0002-1493-1768; Marchesi, Federica/0000-0002-7212-5721; carvello, michele/0000-0002-8650-2321; Allavena, Paola/0000-0002-6697-6028; Erreni, Marco/0000-0002-1922-0818; SACCHI, MATTEO/0000-0001-8313-4909	Associazione Italiana per la ricerca sul cancro [16230]; Associazione Italiana per la ricerca sul cancro (AIRC)	Associazione Italiana per la ricerca sul cancro(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la ricerca sul cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	The work was supported by 16230 Associazione Italiana per la ricerca sul cancro to GDC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Giuseppe Di Caro is supported by iCare fellowship from Associazione Italiana per la ricerca sul cancro (AIRC).	Allin KH, 2010, JNCI-J NATL CANCER I, V102, P202, DOI 10.1093/jnci/djp459; Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Austin PC, 2015, J CLIN EPIDEMIOL, V68, P627, DOI 10.1016/j.jclinepi.2014.12.014; Belluco C, 2000, ANN SURG ONCOL, V7, P133, DOI 10.1007/s10434-000-0133-7; Bonavita E, 2015, CELL, V160, P700, DOI 10.1016/j.cell.2015.01.004; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Chan AT, 2011, GASTROENTEROLOGY, V140, P799, DOI 10.1053/j.gastro.2010.11.041; Chen ZY, 2015, INT J CANCER, V136, P584, DOI 10.1002/ijc.29017; De Vita F, 2004, CANCER-AM CANCER SOC, V100, P270, DOI 10.1002/cncr.11911; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Di Caro G, 2014, EXPERT REV MOL DIAGN, V14, P387, DOI 10.1586/14737159.2014.900443; Diamandis EP, 2011, CLIN CANCER RES, V17, P2395, DOI 10.1158/1078-0432.CCR-10-3024; Doni A, 2003, EUR J IMMUNOL, V33, P2886, DOI 10.1002/eji.200324390; DUKES CE, 1950, AM J SURG, V79, P66, DOI 10.1016/0002-9610(50)90194-2; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Germano G, 2010, CANCER RES, V70, P2235, DOI 10.1158/0008-5472.CAN-09-2335; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hamilton TD, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-542; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ibrahim JG, 2012, J CLIN ONCOL, V30, P3297, DOI 10.1200/JCO.2011.38.7589; Jeon H, 2010, J NEUROIMMUNOL, V229, P63, DOI 10.1016/j.jneuroim.2010.07.001; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Locatelli M, 2013, J NEUROIMMUNOL, V260, P99, DOI 10.1016/j.jneuroim.2013.04.009; Mantovani A, 2004, SEMIN CANCER BIOL, V14, P155, DOI 10.1016/j.semcancer.2003.10.001; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mejia A, 2012, J SURG ONCOL, V105, P468, DOI 10.1002/jso.21858; Muller B, 2001, CRIT CARE MED, V29, P1404, DOI 10.1097/00003246-200107000-00017; Noonan DM, 2008, CANCER METAST REV, V27, P31, DOI 10.1007/s10555-007-9108-5; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Ogino S, 2011, NAT REV CLIN ONCOL, V8, P711, DOI 10.1038/nrclinonc.2011.122; Platz EA, 2010, CANCER CAUSE CONTROL, V21, P847, DOI 10.1007/s10552-010-9511-z; Sasaki Y, 2012, CLIN CANCER RES, V18, P392, DOI 10.1158/1078-0432.CCR-11-0896; Song M, 2013, BRIT J CANCER, V108, P1891, DOI 10.1038/bjc.2013.172; Stallone G, 2014, CANCER RES, V74, P4230, DOI 10.1158/0008-5472.CAN-14-0369; Strieter RM, 2001, NAT IMMUNOL, V2, P285, DOI 10.1038/86286; Toiyama Y, 2012, INT J ONCOL, V40, P560, DOI 10.3892/ijo.2011.1247; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Werther K, 2001, EUR J SURG, V167, P287; Willeke F, 2006, EUR J CANCER, V42, P2639, DOI 10.1016/j.ejca.2006.05.035	42	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148186	10.1371/journal.pone.0148186	http://dx.doi.org/10.1371/journal.pone.0148186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859579	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400024
J	Liu, SZ; Zhao, ZZ; Han, L; Liu, S; Luo, B				Liu, Shuzhen; Zhao, Zhenzhen; Han, Lu; Liu, Song; Luo, Bing			Epstein-Barr Virus Infection in Gastric Remnant Carcinoma and Recurrent Gastric Carcinoma in Qingdao of Northern China	PLOS ONE			English	Article							TO-CELL CONTACT; HUMAN EPITHELIAL-CELLS; NASOPHARYNGEAL CARCINOMA; GENOTYPIC ANALYSIS; SOUTHERN CHINA; PERIPHERAL-BLOOD; HEALTHY CARRIERS; NPC BIOPSIES; STUMP CANCER; TUMOR-CELLS	Background Epstein-Barr virus (EBV) is associated with a subset of gastric carcinoma which was defined as EBV associated gastric carcinoma (EBVaGC). The proportion of EBVaGC in gastric remnant carcinoma (GRC) which occurs in the intact stomach five or more years after gastric surgery for benign disease is significantly higher than that in conventional gastric carcinoma (CGC). The infection of EBV in recurrent gastric carcinoma (RGC) with local anastomotic recurrence is poorly understood. Methods 53 cases of GRC and 58 cases of RGC were analyzed for the presence of EBV, and the variants of EBV Encoded RNAs (EBER), EBV Nuclear Antigen 1 (EBNA1) and Latent Membrane Protein 1 (LMP1) gene in both groups were investigated. Results Thirteen (24.5%) out of 53 GRC cases and 3 (5.2%) out of 58 RGC cases were identified as EBVaGCs. In 17 paired RGC cases, only one case was classified as EBVaGC in both times specimen. Another one case was identified as EBVaGC in the primary gastroectomy specimen while the recurrent gastric cancer was not. The third EBVaGC in RGC was identified while the primary gastric cancer was not EBVaGC. In GRC and RGC cases, type 1, type F, EB-6m, V-val subtype, del-LMP1 were predominant type or variants, accounting for 10 (76.9%) and 2(66.7%), 13(100%) and 3(100%), 13(100%) and 3(100%), 9(69.2%) and 3 (100%), 12(92.3%) and 3(100%), respectively. However, Type C was the predominant type in GRC accounting for 9(69.2%) cases while type D was the predominant one accounting for 2(66.7%) cases in RGC. Conclusions The prevalence of EBVaGc in GRC and RGC was significantly different. The distributions of these variants were similar to each other in the two groups which indicated that there were no more aggressive EBV variants in EBVaGC in GRC compared with that in RGC.	[Liu, Shuzhen] Affiliated Hosp Qingdao Univ, Dept Blood Transfus, 16 Jiangsu Rd, Qingdao 266003, Peoples R China; [Zhao, Zhenzhen; Liu, Song; Luo, Bing] Qingdao Univ, Coll Med, Dept Med Microbiol, 38 Dengzhou Rd, Qingdao 266021, Peoples R China; [Han, Lu] Affiliated Hosp Qingdao Univ, Dept Clin Lab, 16 Jiangsu Rd, Qingdao 266003, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Luo, B (corresponding author), Qingdao Univ, Coll Med, Dept Med Microbiol, 38 Dengzhou Rd, Qingdao 266021, Peoples R China.	qdluobing@163.com			Ministry of Education of China [20133706110001]; Department of Science & Technology of Shandong Province [ZR2011CM016]; Qingdao Municipal Science and Technology Commission [13-1-3-50-jch]	Ministry of Education of China(Ministry of Education, China); Department of Science & Technology of Shandong Province; Qingdao Municipal Science and Technology Commission	This work was supported by the Ministry of Education of China, grant number: 20133706110001 (http://www.moe.gov.cn/), the Department of Science & Technology of Shandong Province, grant number: ZR2011CM016 (http://www.sdstc.gov.cn/), and the Qingdao Municipal Science and Technology Commission, grant number: 13-1-3-50-jch (http://www.qdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELHAMID M, 1992, VIROLOGY, V190, P168, DOI 10.1016/0042-6822(92)91202-6; Akiba S, 2008, CANCER SCI, V99, P195, DOI 10.1111/j.1349-7006.2007.00674.x; Baas IO, 1998, J CLIN PATHOL, V51, P662, DOI 10.1136/jcp.51.9.662; BORISCH B, 1993, INT J CANCER, V55, P748, DOI 10.1002/ijc.2910550509; Bornkamm GW, 2009, INT J CANCER, V124, P1745, DOI 10.1002/ijc.24223; BOUZID M, 1994, INT J CANCER, V56, P468, DOI 10.1002/ijc.2910560403; Camargo MC, 2011, BRIT J CANCER, V105, P38, DOI 10.1038/bjc.2011.215; Chang MS, 2000, PATHOL INT, V50, P486, DOI 10.1046/j.1440-1827.2000.01072.x; Chang Y, 1999, J VIROL, V73, P8857, DOI 10.1128/JVI.73.10.8857-8866.1999; Chen JN, 2011, VIRUS RES, V160, P191, DOI 10.1016/j.virusres.2011.06.011; Chen JP, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-170; Correa RM, 2004, J MED VIROL, V73, P583, DOI 10.1002/jmv.20129; Cui Y, 2011, INTERVIROLOGY, V54, P131, DOI 10.1159/000319632; Dawson CW, 2000, VIROLOGY, V272, P204, DOI 10.1006/viro.2000.0344; Fielding CA, 2001, J VIROL, V75, P9129, DOI 10.1128/JVI.75.19.9129-9141.2001; Gutierrez MI, 1998, BLOOD, V92, P600, DOI 10.1182/blood.V92.2.600.414k33_600_606; Gutierrez MI, 1997, J GEN VIROL, V78, P1663, DOI 10.1099/0022-1317-78-7-1663; Iizasa H, 2012, VIRUSES-BASEL, V4, P3420, DOI 10.3390/v4123420; Imai S, 1998, J VIROL, V72, P4371, DOI 10.1128/JVI.72.5.4371-4378.1998; Kaizaki Y, 2005, J GASTROENTEROL, V40, P570, DOI 10.1007/s00535-005-1590-3; Khanim F, 1996, BLOOD, V88, P3491, DOI 10.1182/blood.V88.9.3491.bloodjournal8893491; Klemenc P, 2006, J MED VIROL, V78, P1083, DOI 10.1002/jmv.20666; Koriyama C, 2005, J EXP CLIN CANC RES, V24, P547; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee JH, 2009, J GASTROEN HEPATOL, V24, P354, DOI 10.1111/j.1440-1746.2009.05775.x; LUNG ML, 1990, VIROLOGY, V177, P44, DOI 10.1016/0042-6822(90)90458-4; LUNG ML, 1994, INT J CANCER, V59, P743; LUNG ML, 1992, INT J CANCER, V52, P34, DOI 10.1002/ijc.2910520108; LUNG ML, 1991, VIROLOGY, V185, P67, DOI 10.1016/0042-6822(91)90754-Y; LUNG ML, 1992, INT J CANCER, V52, P174, DOI 10.1002/ijc.2910520203; Luo B, 2005, WORLD J GASTROENTERO, V11, P629, DOI 10.3748/wjg.v11.i5.629; Mai SJ, 2007, ONCOL REP, V17, P141; Niedobitek G, 2000, J CLIN PATHOL-MOL PA, V53, P248, DOI 10.1136/mp.53.5.248; Nishikawa J, 2002, SCAND J GASTROENTERO, V37, P825, DOI 10.1080/713786518; RICKINSON AB, 1987, J VIROL, V61, P1310, DOI 10.1128/JVI.61.5.1310-1317.1987; Safatle-Ribeiro AV, 1998, DIGEST DIS, V16, P159, DOI 10.1159/000016860; SAMPLE J, 1990, J VIROL, V64, P4084, DOI 10.1128/JVI.64.9.4084-4092.1990; Shannon-Lowe CD, 2006, P NATL ACAD SCI USA, V103, P7065, DOI 10.1073/pnas.0510512103; Shannon-Lowe C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001338; Sidagis J, 1997, INT J CANCER, V72, P72, DOI 10.1002/(SICI)1097-0215(19970703)72:1&lt;72::AID-IJC11&gt;3.0.CO;2-C; Sinning C, 2007, EJSO-EUR J SURG ONC, V33, P133, DOI 10.1016/j.ejso.2006.09.006; Speck P, 2000, J NATL CANCER I, V92, P1849, DOI 10.1093/jnci/92.22.1849; Sugiura M, 1996, BRIT J CANCER, V74, P625, DOI 10.1038/bjc.1996.412; Takada K, 2000, J CLIN PATHOL-MOL PA, V53, P255, DOI 10.1136/mp.53.5.255; TAMURA S, 1993, JPN J CANCER RES, V84, P246, DOI 10.1111/j.1349-7006.1993.tb02863.x; Thompson MP, 2004, CLIN CANCER RES, V10, P803, DOI 10.1158/1078-0432.CCR-0670-3; Uozaki H, 2008, INT J CLIN EXP PATHO, V1, P198; Wang Y, 2005, WORLD J GASTROENTERO, V11, P3234, DOI 10.3748/wjg.v11.i21.3234; Wang Y, 2010, J MED VIROL, V82, P829, DOI 10.1002/jmv.21714; Wang Y, 2010, VIRUS RES, V147, P258, DOI 10.1016/j.virusres.2009.11.010; YAMAMOTO N, 1994, CANCER, V74, P805, DOI 10.1002/1097-0142(19940801)74:3<805::AID-CNCR2820740304>3.0.CO;2-L; Yang Ting-ting, 2009, Chinese Journal of Virology, V25, P29; ZIMBER U, 1986, VIROLOGY, V154, P56, DOI 10.1016/0042-6822(86)90429-0	53	6	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148342	10.1371/journal.pone.0148342	http://dx.doi.org/10.1371/journal.pone.0148342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859565	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400033
J	Malanga, D; Belmonte, S; Colelli, F; Scarfo, M; De Marco, C; Oliveira, DM; Mirante, T; Camastra, C; Gagliardi, M; Rizzuto, A; Mignogna, C; Paciello, O; Papparella, S; Fagman, H; Viglietto, G				Malanga, Donatella; Belmonte, Stefania; Colelli, Fabiana; Scarfo, Marzia; De Marco, Carmela; Oliveira, Duarte Mendes; Mirante, Teresa; Camastra, Caterina; Gagliardi, Monica; Rizzuto, Antonia; Mignogna, Chiara; Paciello, Orlando; Papparella, Serenella; Fagman, Henrik; Viglietto, Giuseppe			AKT1(E17K) Is Oncogenic in Mouse Lung and Cooperates with Chemical Carcinogens in Inducing Lung Cancer	PLOS ONE			English	Article							BRONCHIOALVEOLAR STEM-CELLS; E17K MUTATION; SIGNALING PATHWAY; HIGH-FREQUENCY; RAS ONCOGENE; PIK3CA; AKT1; TUMORIGENESIS; GENE; EXPRESSION	The hotspot AKT1(E17K) mutation in the pleckstrin homology domain of AKT1 occurs in approximately 0.6-2% of human lung cancers. Recently, we have demonstrated that AKT1(E17K) transforms immortalized human bronchial cells. Here by use of a transgenic Cre-inducible murine strain in the wild type Rosa26 (R26) locus (R26-AKT1(E17)K mice) we demonstrate that AKT1(E17K) is a bona-fide oncogene and plays a role in the development of lung cancer in vivo. In fact, we report that mutant AKT1(E17K) induces bronchial and/or bronchiolar hyperplastic lesions in murine lung epithelium, which progress to frank carcinoma at very low frequency, and accelerates tumor formation induced by chemical carcinogens. In conclusion, AKT1(E17K) induces hyperplasia of mouse lung epithelium in vivo and cooperates with urethane to induce the fully malignant phenotype.	[Malanga, Donatella; De Marco, Carmela; Oliveira, Duarte Mendes; Mirante, Teresa; Viglietto, Giuseppe] Magna Graecia Univ Catanzaro, Dipartimento Med Sperimentale & Clin, Catanzaro, Italy; [Malanga, Donatella; Belmonte, Stefania; Colelli, Fabiana; Scarfo, Marzia; De Marco, Carmela; Viglietto, Giuseppe] BIOGEM, Ist Ric Genet, Ariano Irpino, AV, Italy; [Camastra, Caterina] Magna Graecia Univ Catanzaro, Dipartimento Sci Salute, Unita Anat Patol, Catanzaro, Italy; [Gagliardi, Monica] Magna Graecia Univ Catanzaro, IBFM CNR, Catanzaro, Italy; [Rizzuto, Antonia] Magna Graecia Univ Catanzaro, Dipartimento Sci Med & Chirurg, Catanzaro, Italy; [Paciello, Orlando; Papparella, Serenella] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy; [Fagman, Henrik] Sahlgrens Univ Hosp, Dept Clin Pathol & Genet, Gothenburg, Sweden	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; University of Naples Federico II; Sahlgrenska University Hospital	Malanga, D; Viglietto, G (corresponding author), Magna Graecia Univ Catanzaro, Dipartimento Med Sperimentale & Clin, Catanzaro, Italy.; Malanga, D; Viglietto, G (corresponding author), BIOGEM, Ist Ric Genet, Ariano Irpino, AV, Italy.	malanga@unicz.it; viglietto@unicz.it	rizzuto, antonia/GVT-4842-2022; Viglietto, Giuseppe/AAC-2852-2019; Malanga, Donatella/J-4877-2018; De Marco, Carmela/J-6797-2015	rizzuto, antonia/0000-0003-4359-4702; Viglietto, Giuseppe/0000-0003-2327-7515; Malanga, Donatella/0000-0002-0491-7698; De Marco, Carmela/0000-0002-4893-4246; Mendes Oliveira, Duarte/0000-0003-3922-3060; Mignogna, Chiara/0000-0001-5576-4946	Associazione Italiana Ricerca sul Cancro (AIRC) [IG_12969]; Ministero Istruzione Universita e Ricerca (MIUR PRIN) [2010W4J4RM_001, PONa3_00239, PON01_02782]; Vastra Gotalandsregionen; Assar Gabrielssons Foundation; Magnus Bergvalls Foundation	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero Istruzione Universita e Ricerca (MIUR PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Vastra Gotalandsregionen; Assar Gabrielssons Foundation; Magnus Bergvalls Foundation	This work was supported by Associazione Italiana Ricerca sul Cancro (AIRC 2012-14, IG_12969) and Ministero Istruzione Universita e Ricerca (MIUR PRIN, prot. 2010W4J4RM_001; PONa3_00239; PON01_02782) to GV. HF was supported by Vastra Gotalandsregionen under the LUA/ALF agreement and by the Assar Gabrielssons and Magnus Bergvalls Foundations.; The authors thank Marzia Scarfo, Andrea Affuso and Antonio Dionisio (Biogem s.c.a r.l., Ariano Irpino, Italy) for mouse experiments. This work was supported by Associazione Italiana Ricerca sul Cancro (AIRC 2012-14, IG_12969) and Ministero Istruzione Universita Ricerca (MIUR, PRIN, prot. 2010W4J4RM_001; PONa3_00239; PON01_02782) to GV. HF was supported by Vastra Gotalandsregionen under the LUA/ALF agreement and by the Assar Gabrielssons and Magnus Bergvalls Foundations.	Almendro V, 2011, CLIN TRANSL ONCOL, V13, P767, DOI 10.1007/s12094-011-0731-9; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Balli D, 2011, CANCER RES, V71, P40, DOI 10.1158/0008-5472.CAN-10-2004; Beaver JA, 2013, CLIN CANCER RES, V19, P5413, DOI 10.1158/1078-0432.CCR-13-0884; Bleeker FE, 2008, ONCOGENE, V27, P5648, DOI 10.1038/onc.2008.170; Boch C, 2013, BMJ OPEN, V3; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; De Marco C, 2015, ONCOTARGET; deFelice M, 2003, J BIOL CHEM, V278, P35574, DOI 10.1074/jbc.M304885200; Do HD, 2010, CELL CYCLE, V9, P4411, DOI 10.4161/cc.9.21.13654; Do H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-142; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Felip E, 2011, ANN ONCOL, V22, P1507, DOI 10.1093/annonc/mdr150; Freeman D, 2006, CANCER RES, V66, P6492, DOI 10.1158/0008-5472.CAN-05-4143; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hayashi SM, 2001, TOXICOL PATHOL, V29, P422, DOI 10.1080/01926230152499908; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; Iwanaga K, 2008, CANCER RES, V68, P1119, DOI 10.1158/0008-5472.CAN-07-3117; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kawano O, 2006, LUNG CANCER, V54, P209, DOI 10.1016/j.lungcan.2006.07.006; KAWANO R, 1995, JPN J CANCER RES, V86, P802, DOI 10.1111/j.1349-7006.1995.tb03089.x; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim MS, 2008, BRIT J CANCER, V98, P1533, DOI 10.1038/sj.bjc.6604212; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P12260, DOI 10.1021/bi801683k; Lauring J, 2010, ONCOGENE, V29, P2337, DOI 10.1038/onc.2009.516; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Liu XM, 2006, METHOD ENZYMOL, V419, P285, DOI 10.1016/S0076-6879(06)19012-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Malanga D, 2008, CELL CYCLE, V7, P665, DOI 10.4161/cc.7.5.5485; Mason RJ, 2000, AM J PATHOL, V156, P175, DOI 10.1016/S0002-9440(10)64717-7; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; NUZUM EO, 1990, MOL CARCINOGEN, V3, P287, DOI 10.1002/mc.2940030509; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Redente EF, 2007, AM J PATHOL, V170, P693, DOI 10.2353/ajpath.2007.060566; Rekhtman N, 2012, CLIN CANCER RES, V18, P1167, DOI 10.1158/1078-0432.CCR-11-2109; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; RODENHUIS S, 1992, CANCER RES, V52, pS2665; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tsao AS, 2003, CANCER EPIDEM BIOMAR, V12, P660; Tuveson DA, 1999, ONCOGENE, V18, P5318, DOI 10.1038/sj.onc.1203107; Viglietto G, 2009, CELL CYCLE, V8, P2869, DOI 10.4161/cc.8.18.9757; Xu Cheng-Xiong, 2010, Front Biosci (Elite Ed), V2, P1472; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Yi KH, 2013, ONCOTARGET, V4, P29, DOI 10.18632/oncotarget.755; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070; Zheng DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071028	65	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0147334	10.1371/journal.pone.0147334	http://dx.doi.org/10.1371/journal.pone.0147334			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859676	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400007
J	Manell, E; Hedenqvist, P; Svensson, A; Jensen-Waern, M				Manell, Elin; Hedenqvist, Patricia; Svensson, Anna; Jensen-Waern, Marianne			Establishment of a Refined Oral Glucose Tolerance Test in Pigs, and Assessment of Insulin, Glucagon and Glucagon-Like Peptide-1 Responses	PLOS ONE			English	Article							BETA-CELL FUNCTION; FASTING SERUM-INSULIN; DIABETES-MELLITUS; GENE-EXPRESSION; LIFE EXPECTANCY; POLYPEPTIDE; TYPE-1; SENSITIVITY; SECRETION; INCRETIN	Diabetes mellitus is increasing worldwide and reliable animal models are important for progression of the research field. The pig is a commonly used large animal model in diabetes research and the present study aimed to refine a model for oral glucose tolerance test (OGTT) in young growing pigs, as well as describing intravenous glucose tolerance test (IVGTT) in the same age group. The refined porcine OGTT will reflect that used in children and adolescents. Eighteen pigs were obtained one week after weaning and trained for two weeks to bottle-feed glucose solution, mimicking the human OGTT. The pigs subsequently underwent OGTT (1.75 g/kg BW) and IVGTT (0.5 g/kg BW). Blood samples were collected from indwelling vein catheters for measurements of glucose and the diabetes related hormones insulin, glucagon and active glucagon-like peptide-1. The study confirmed that pigs can be trained to bottle-feed glucose dissolved in water and thereby undergo an OGTT more similar to the human standard OGTT than previously described methods in pigs. With the refined method for OGTT, oral intake only consists of glucose and water, which is an advantage over previously described methods in pigs where glucose is given together with feed which will affect glucose absorption. Patterns of hormonal secretion in response to oral and intravenous glucose were similar to those in humans; however, the pigs were more glucose tolerant with lower insulin levels than humans. In translational medicine, this refined OGTT and IVGTT methods provide important tools in diabetes research when pigs are used as models for children and adolescents in diabetes research.	[Manell, Elin; Hedenqvist, Patricia; Svensson, Anna; Jensen-Waern, Marianne] Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Dept Clin Sci, Uppsala, Sweden	Swedish University of Agricultural Sciences	Manell, E (corresponding author), Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Dept Clin Sci, Uppsala, Sweden.	elin.manell@slu.se	Hedenqvist, Patricia/B-7871-2017	Hedenqvist, Patricia/0000-0003-4540-6250; Svensson, Anna/0000-0003-4015-2001; Jensen-Waern, Marianne/0000-0001-6195-7066; Manell, Elin/0000-0002-4491-7609	Michael Forsgrens Foundation [2015-1]	Michael Forsgrens Foundation	The study was supported by Michael Forsgrens Foundation (2015-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DM, 1970, Q J EXP PHYSIOL CMS, V55, P104, DOI 10.1113/expphysiol.1970.sp002055; Bagger JI, 2014, DIABETOLOGIA, V57, P1720, DOI 10.1007/s00125-014-3264-2; Bagger JI, 2011, J CLIN ENDOCR METAB, V96, P737, DOI 10.1210/jc.2010-2435; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bellinger DA, 2012, MINIPIG IN BIOMEDICAL RESEARCH, P445; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; Bervoets L, 2015, HORM METAB RES, V47, P445, DOI 10.1055/s-0034-1395551; Christensen M, 2011, DIABETES, V60, P3103, DOI 10.2337/db11-0979; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Deacon CF, 1996, AM J PHYSIOL-ENDOC M, V271, pE458, DOI 10.1152/ajpendo.1996.271.3.E458; DUPRE J, 1973, J CLIN ENDOCR METAB, V37, P826, DOI 10.1210/jcem-37-5-826; ELRICK H, 1964, J CLIN ENDOCR METAB, V24, P1076, DOI 10.1210/jcem-24-10-1076; Faerch K, 2015, DIABETES; Fagot-Campagna A, 2000, J PEDIATR ENDOCR MET, V13, P1395; Franco OH, 2007, ARCH INTERN MED, V167, P1145, DOI 10.1001/archinte.167.11.1145; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Garansson L., 2011, NUTR RECOMMENDATIONS; George P, 2013, DIABETIC MED, V30, P179, DOI 10.1111/j.1464-5491.2012.03744.x; GRANT DB, 1967, ARCH DIS CHILD, V42, P375, DOI 10.1136/adc.42.224.375; Greenbaum CJ, 2002, DIABETES, V51, P951, DOI 10.2337/diabetes.51.4.951; Hare KJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE832, DOI 10.1152/ajpendo.00700.2009; Issa CM, 2012, CURR DIABETES REP, V12, P560, DOI 10.1007/s11892-012-0291-6; Jeffery AN, 2012, DIABETES CARE, V35, P536, DOI 10.2337/dc11-1281; JENKINS DJA, 1978, BRIT MED J, V1, P1392, DOI 10.1136/bmj.1.6124.1392; Kanauchi M, 2005, INT J CLIN PRACT, V59, P427, DOI 10.1111/j.1368-5031.2005.00422.x; Knop FK, 2010, REGUL PEPTIDES, V164, P144, DOI 10.1016/j.regpep.2010.05.011; KREYMANN B, 1987, LANCET, V2, P1300; Larsen Marianne Olholm, 2003, Exp Diabesity Res, V4, P93, DOI 10.1155/EDR.2003.93; Livingstone SJ, 2015, JAMA-J AM MED ASSOC, V313, P37, DOI 10.1001/jama.2014.16425; Manell EAK, 2014, LAB ANIM-UK, V48, P261, DOI 10.1177/0023677213517683; Matsuo T, 2014, DIABETES RES CLIN PR, V106, pE25, DOI 10.1016/j.diabres.2014.09.002; Meier JJ, 2007, DIABETOLOGIA, V50, P806, DOI 10.1007/s00125-007-0598-z; Messenger B, 2003, J ENDOCRINOL, V177, P407, DOI 10.1677/joe.0.1770407; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; Peplies J, 2014, INT J OBESITY, V38, pS39, DOI 10.1038/ijo.2014.134; Privatdnanupunt J, 2014, ACTA HISTOCHEM, V116, P545, DOI 10.1016/j.acthis.2013.11.007; Renner S, 2010, DIABETES, V59, P1228, DOI 10.2337/db09-0519; SANDHU KS, 1987, GASTROENTEROLOGY, V92, P486, DOI 10.1016/0016-5085(87)90146-6; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Swindle M.M, 2007, SWINE LAB SURG ANEST; TORSDOTTIR I, 1989, J NUTR, V119, P1925, DOI 10.1093/jn/119.12.1925; Tschritter O, 2003, DIABETES CARE, V26, P1026, DOI 10.2337/diacare.26.4.1026; TSENG CC, 1995, MOL CELL ENDOCRINOL, V115, P13, DOI 10.1016/0303-7207(95)03665-T; Vilsboll T, 2001, DIABETES, V50, P609, DOI 10.2337/diabetes.50.3.609; World Health Organization, 2006, DEF DIAGN DIAB MELL; Yeung CM, 1999, MOL CELL ENDOCRINOL, V154, P161, DOI 10.1016/S0303-7207(99)00106-9	47	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148896	10.1371/journal.pone.0148896	http://dx.doi.org/10.1371/journal.pone.0148896			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859145	Green Published, gold			2022-12-27	WOS:000370038400101
J	Martinez-Reina, J; Ojeda, J; Mayo, J				Martinez-Reina, Javier; Ojeda, Joaquin; Mayo, Juana			On the Use of Bone Remodelling Models to Estimate the Density Distribution of Bones. Uniqueness of the Solution	PLOS ONE			English	Article							PROXIMAL FEMUR; ADAPTATION; ELASTICITY; REPAIR; BEHAVIOR; POROSITY; LOADS	Bone remodelling models are widely used in a phenomenological manner to estimate numerically the distribution of apparent density in bones from the loads they are daily subjected to. These simulations start from an arbitrary initial distribution, usually homogeneous, and the density changes locally until a bone remodelling equilibrium is achieved. The bone response to mechanical stimulus is traditionally formulated with a mathematical relation that considers the existence of a range of stimulus, called dead or lazy zone, for which no net bone mass change occurs. Implementing a relation like that leads to different solutions depending on the starting density. The non-uniqueness of the solution has been shown in this paper using two different bone remodelling models: one isotropic and another anisotropic. It has also been shown that the problem of non-uniqueness is only mitigated by removing the dead zone, but it is not completely solved unless the bone formation and bone resorption rates are limited to certain maximum values.	[Martinez-Reina, Javier; Ojeda, Joaquin; Mayo, Juana] Univ Seville, Dept Mech Engn, Seville, Spain	University of Sevilla	Martinez-Reina, J (corresponding author), Univ Seville, Dept Mech Engn, Seville, Spain.	jmreina@us.es	Ojeda, Joaquín/AAA-3222-2021; Mayo, Juana/L-1448-2015; Ojeda, Joaquín/I-2380-2014	Ojeda, Joaquín/0000-0002-6894-197X; Mayo, Juana/0000-0001-8752-8585; Ojeda, Joaquín/0000-0002-6894-197X	Ministerio de Economia y Competitividad (ES) grant [DPI2013-44371-P, DPI2014-58233-P]	Ministerio de Economia y Competitividad (ES) grant	This work was supported by Ministerio de Economia y Competitividad (ES) grant number DPI2013-44371-P (author: JM) and Ministerio de Economia y Competitividad (ES) grant number DPI2014-58233-P (author: JMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 1997, J BIOMECH, V30, P671, DOI 10.1016/S0021-9290(97)00004-3; BEAUPRE GS, 1990, J ORTHOPAED RES, V8, P662, DOI 10.1002/jor.1100080507; BEAUPRE GS, 1990, J ORTHOP RES, V8, P651, DOI 10.1002/jor.1100080506; Behrens BA, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-7; Buenzli PR, 2011, BONE, V48, P918, DOI 10.1016/j.bone.2010.12.009; CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954, DOI 10.2106/00004623-197759070-00021; CARTER DR, 1987, J BIOMECH, V20, P1095, DOI 10.1016/0021-9290(87)90027-3; Christen P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5855; COWIN SC, 1976, J ELASTICITY, V6, P313, DOI 10.1007/BF00041724; COWIN SC, 1978, J ELASTICITY, V8, P285, DOI 10.1007/BF00130467; CURREY JD, 1988, J BIOMECH, V21, P131, DOI 10.1016/0021-9290(88)90006-1; Doblare M, 2002, J BIOMECH, V35, P1, DOI 10.1016/S0021-9290(01)00178-6; Doblare M, 2001, J BIOMECH, V34, P1157, DOI 10.1016/S0021-9290(01)00069-0; Fernandes P., 1999, Comput Methods Biomech Biomed Engin, V2, P125, DOI 10.1080/10255849908907982; Franzoso G, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005162; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Garcia-Aznar JM, 2005, BIOMECH MODEL MECHAN, V4, P147, DOI 10.1007/s10237-005-0067-x; Garijo N, 2014, COMPUT METHOD APPL M, V268, P437, DOI 10.1016/j.cma.2013.10.005; Geraldes DM, 2014, INT J NUMER METH BIO, V30, P873, DOI 10.1002/cnm.2633; Heller MO, 2005, J BIOMECH, V38, P1155, DOI 10.1016/j.jbiomech.2004.05.022; Hernandez CJ, 2001, BONE, V29, P74, DOI 10.1016/S8756-3282(01)00467-7; HUISKES R, 1987, J BIOMECH, V20, P1135, DOI 10.1016/0021-9290(87)90030-3; Jacobs C, 1994, THESIS STANFORD U; JACOBS CR, 1995, J BIOMECH, V28, P449, DOI 10.1016/0021-9290(94)00087-K; Klika V, 2014, J MATH BIOL, V69, P1383, DOI 10.1007/s00285-013-0736-9; LANYON LE, 1984, J BIOMECH, V17, P897, DOI 10.1016/0021-9290(84)90003-4; Lenaerts L, 2015, COMPUT METHOD BIOMEC, V18, P1392, DOI 10.1080/10255842.2014.908856; Machado MM, 2013, J BIOMECH, V46, P2179, DOI 10.1016/j.jbiomech.2013.06.031; MARTIN RB, 1984, CRIT REV BIOMED ENG, V10, P179; Martinez-Reina J, 2009, BIOMECH MODEL MECHAN, V8, P111, DOI 10.1007/s10237-008-0122-5; Mengoni M, 2015, COMPUT METHOD BIOMEC, V18, P1367, DOI 10.1080/10255842.2014.903933; Monnier J, 1998, COMPUT METHOD APPL M, V151, P539, DOI 10.1016/S0045-7825(97)00164-3; WEINANS H, 1992, J BIOMECH, V25, P1425, DOI 10.1016/0021-9290(92)90056-7; Zysset PK, 2003, J BIOMECH, V36, P1469, DOI 10.1016/S0021-9290(03)00128-3	34	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148603	10.1371/journal.pone.0148603	http://dx.doi.org/10.1371/journal.pone.0148603			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859888	Green Submitted, gold, Green Published			2022-12-27	WOS:000370038400055
J	von Baczko, MB; Desojo, JB				Belen von Baczko, Maria; Brenda Desojo, Julia			Cranial Anatomy and Palaeoneurology of the Archosaur Riojasuchus tenuisceps from the Los Colorados Formation, La Rioja, Argentina	PLOS ONE			English	Article							EARLY EVOLUTION; BRAINCASE; OSTEOLOGY; TAXONOMY; DIAPSIDA; REPTILE; REDESCRIPTION; AETOSAURIA; EUPARKERIA; DINOSAURS	Riojasuchus tenuisceps Bonaparte 1967 is currently known from four specimens, including two complete skulls, collected in the late 1960s from the upper levels of the Los Colorados Formation (Late Triassic), La Rioja, Argentina. Computed tomography (CT) scans of the skulls of the holotype and a referred specimen of Riojasuchus tenuisceps and the repreparation of the latter allows recognition of new features for a detailed analysis of its cranial anatomy and its comparison with a wide variety of other archosauriform taxa. The diagnosis of Riojasuchus tenuisceps is emended and two autapomorphies are identified on the skull: (1) a deep antorbital fossa with its anterior and ventral edges almost coinciding with the same edges of the maxilla itself and (2) a suborbital fenestra equal in size to the palatinepterygoid fenestra. Also, the first digital 3D reconstruction of the encephalon of Riojasuchus tenuisceps was carried out to study its neuroanatomy, showing a shape and cranial nerve disposition consistent to that of other pseudosuchians.	[Belen von Baczko, Maria; Brenda Desojo, Julia] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Belen von Baczko, Maria; Brenda Desojo, Julia] Museo Argentino Ciencias Nat Bernardino Rivadavia, Secc Paleontol Vertebrados, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN)	von Baczko, MB (corresponding author), Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.	belen_vb@macn.gov.ar		von Baczko, Maria Belen/0000-0003-2570-3418; Desojo, Julia Brenda/0000-0002-2739-3276	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 2014-609]; Deutscher Akademischer Austausch Dienst (DAAD)	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Deutscher Akademischer Austausch Dienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The research was funded by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) though PICT 2014-609 granted to JBD and the European collection visits were funded by a project granted to MBvB during 2014 by the Deutscher Akademischer Austausch Dienst (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcober O, 2000, J VERTEBR PALEONTOL, V20, P302, DOI 10.1671/0272-4634(2000)020[0302:ROTSOS]2.0.CO;2; ARCUCCI A, 1990, Ameghiniana, V27, P365; Arcucci AB, 2004, GEOBIOS-LYON, V37, P557, DOI 10.1016/j.geobios.2003.04.008; BARBERENA MC, 1978, PESQUISAS, V7, P111; Von Baczko MB, 2014, J VERTEBR PALEONTOL, V34, P1342, DOI 10.1080/02724634.2014.860150; Von Baczko MB, 2013, GEOL SOC SPEC PUBL, V379, P187, DOI 10.1144/SP379.4; Benton M.J., 1988, PHYLOGENY CLASSIFICA, V35A, P295, DOI DOI 10.1017/S0016756800006476; Bittencourt JS, 2015, J SYST PALAEONTOL, V13, P189, DOI 10.1080/14772019.2013.878758; Bona P, 2013, ANAT REC, V296, P227, DOI 10.1002/ar.22625; Bona P, 2011, J MORPHOL, V272, P780, DOI 10.1002/jmor.10894; Bonaparte J.F., 1981, Revista del Museo Argentino de Ciencias Naturales "Bernardino Rivadavia" y Instituto Nacional de Investigacion de las Ciencias Naturales Palaeontologia, V3, P55; Bonaparte J.F, 1970, P PAP 2 GONDW S S AF, P665; Bonaparte J. F., 1967, GONDWANA S P PAPERS, V1, P283; BONAPARTE J.F., 1973, 5 C GEOL ARG ACT, VIII, P123; Bonaparte JF, 1972, OPERA LILLOANA, V22, P13; Desojo JB, 2007, PALAEONTOLOGY, V50, P266; Brochu CA, 1999, J VERTEBR PALEONTOL, V19, P9, DOI 10.1080/02724634.1999.10011201; Brusatte SL, 2010, J SYST PALAEONTOL, V8, P3, DOI 10.1080/14772010903537732; Brusatte SL, 2009, ACTA PALAEONTOL POL, V54, P221, DOI 10.4202/app.2008.0065; Butler RJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-128; Case EC, 1921, J COMP NEUROL, V33, P133; Clark JM, 2002, ZOOL J LINN SOC-LOND, V136, P77, DOI 10.1046/j.1096-3642.2002.00026.x; Clark JM, 2000, J VERTEBR PALEONTOL, V20, P683, DOI 10.1671/0272-4634(2000)020[0683:ANSOHA]2.0.CO;2; Cope ED., 1871, SYNOPSIS EXTINCT BAT; CROMPTON AW, 1962, NATURE, V196, P1074, DOI 10.1038/1961074a0; Desojo JB, 2013, ANAT REC, P296; Desojo JB, 2013, GEOL SOC SPEC PUBL, V379, P203, DOI 10.1144/SP379.17; Desojo JB, 2011, J VERTEBR PALEONTOL, V31, P596, DOI 10.1080/02724634.2011.572936; Desojo JB, 2009, J VERTEBR PALEONTOL, V29, P1311, DOI 10.1671/039.029.0422; Dilkes D, 2012, PALAEONTOLOGY, V55, P853, DOI 10.1111/j.1475-4983.2012.01170.x; Dilkes D, 2009, J VERTEBR PALEONTOL, V29, P58, DOI 10.1080/02724634.2009.10010362; Dzik J, 2003, J VERTEBR PALEONTOL, V23, P556, DOI 10.1671/A1097; Dzik Jerzy, 2007, PALAEONTOLOGIA POLONICA, P3; EWER RF, 1965, PHILOS T ROY SOC B, V248, P379, DOI 10.1098/rstb.1965.0003; Ezcurra MD, 2015, PALAEONTOLOGY, V58, P141, DOI 10.1111/pala.12130; Ferigolo J., 2006, HIST BIOL, V19, P1, DOI DOI 10.1080/08912960600845767; Gauthier J., 1985, P185; GOW C E, 1975, Palaeontologia Africana, V18, P89; Gow CE, 2000, J VERTEBR PALEONTOL, V20, P49, DOI 10.1671/0272-4634(2000)020[0049:TSOPHA]2.0.CO;2; Gower DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111154; Gower David John, 2003, Annals of the South African Museum, V110, P1; Gower DJ, 1997, J ZOOL, V242, P557; Gower DJ, 2002, ZOOL J LINN SOC-LOND, V136, P7, DOI 10.1046/j.1096-3642.2002.00023.x; Gower DJ, 2002, ZOOL J LINN SOC-LOND, V136, P49, DOI 10.1046/j.1096-3642.2002.00025.x; Gower DJ, 1997, J VERTEBR PALEONTOL, V17, P60, DOI 10.1080/02724634.1997.10010954; Gower DJ, 1998, BIOL REV, V73, P367, DOI 10.1017/S0006323198005222; Gower DJ, 1996, PALAEONTOLOGY, V39, P883; Gower DJ, 2010, J VERTEBR PALEONTOL, V26, P79; Holliday CM, 2013, GEOL SOC SPEC PUBL, V379, P555, DOI 10.1144/SP379.2; Holliday CM, 2008, J VERTEBR PALEONTOL, V28, P1073, DOI 10.1671/0272-4634-28.4.1073; Huene F.von, 1908, GEOLOGISCHE PALAON S, P1; Hungerbuhler A, 2000, NEUES JAHRB GEOL P-M, P467; Hungerbuhler A, 2002, PALAEONTOLOGY, V45, P377, DOI 10.1111/1475-4983.00242; HUNT A P, 1990, Palaeontologische Zeitschrift, V64, P317; Huxley TH, 1877, MEM GEOL SURV UK, VIII, P5; Trotteyn MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111388; Kent DV, 2014, P NATL ACAD SCI USA, V111, P7958, DOI 10.1073/pnas.1402369111; Langer MC, 2013, GEOL SOC SPEC PUBL, V379, P353, DOI 10.1144/SP379.16; Langer MC, 2005, J S AM EARTH SCI, V19, P219, DOI 10.1016/j.jsames.2005.04.002; Lautenschlager S, 2015, ZOOL J LINN SOC-LOND, V173, P55, DOI 10.1111/zoj.12196; Lecuona A, 2011, EARTH ENV SCI T R SO, V102, P105, DOI 10.1017/S1755691011000181; Li C, 2006, NATURWISSENSCHAFTEN, V93, P200, DOI 10.1007/s00114-006-0097-y; Lucas S. G., 2007, NEW MEXICO MUSEUM NA, V41, P259; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Mastrantonio BM, 2013, GEOL SOC SPEC PUBL, V379, P425, DOI 10.1144/SP379.10; Nesbitt SJ, 2006, P ROY SOC B-BIOL SCI, V273, P1045, DOI 10.1098/rspb.2005.3426; Nesbitt S, 2007, B AM MUS NAT HIST, P1; Nesbitt Sterling J., 2005, Historical Biology, V17, P19, DOI 10.1080/08912960500476499; Nesbitt SJ, 2013, GEOL SOC SPEC PUBL, V379, P241, DOI 10.1144/SP379.1; Nesbitt SJ, 2012, EARTH ENV SCI T R SO, V103, P365, DOI 10.1017/S1755691013000224; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Norman DB, 2011, ZOOL J LINN SOC-LOND, V163, P182, DOI 10.1111/j.1096-3642.2011.00697.x; Parker W, 2008, J VERTEBR PALEONTOL, V28, p125A; PARRISH JM, 1994, J VERTEBR PALEONTOL, V14, P196, DOI 10.1080/02724634.1994.10011552; Paulina Carabajal Ariana, 2012, Vertebrata Palasiatica, V50, P85; Paulina-Carabajal A, 2015, J VERTEBR PALEONTOL, V34, P870, DOI [10.1080/02724634.2014.838174, DOI 10.1080/02724634.2014.838174]; Paulina-Carabajal A., 2015, REPTILES EXTINTOS VO; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Romer A. S., 1971, Breviora, VNo. 379, P1; Romer A.S., 1972, Breviora, VNo. 389, P1; Romer A.S., 1972, Breviora, VNo. 390, P1; Schoch RR, 2007, NEUES JAHRB GEOL P-A, V246, P1, DOI 10.1127/0077-7749/2007/0246-0001; Sereno P.C., 1991, Journal of Vertebrate Paleontology, V11, P1; Sereno PC, 2012, J VERTEBR PALEONTOL, V32, P83, DOI 10.1080/02724634.2013.820113; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P451; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; SERENO PC, 1994, J VERTEBR PALEONTOL, V14, P53, DOI 10.1080/02724634.1994.10011538; Sues HD, 2003, J VERTEBR PALEONTOL, V23, P329, DOI 10.1671/0272-4634(2003)023[0329:ANCAFT]2.0.CO;2; Sulej T, 2005, J VERTEBR PALEONTOL, V25, P78, DOI 10.1671/0272-4634(2005)025[0078:ANRRDA]2.0.CO;2; Taborda JRA, 2012, AMEGHINIANA, V49, p4R; Trotteyn MJ, 2012, J VERTEBR PALEONTOL, V32, P867, DOI 10.1080/02724634.2012.670178; Trotteyn MJ, 2010, 10 C ARG PAL BIOESTR; von Baczko MB, 2012, THESIS U BUENOS AIRE; WALKER AD, 1990, PHILOS T ROY SOC B, V330, P1, DOI 10.1098/rstb.1990.0185; WALKER AD, 1961, PHILOS T R SOC B, V244, P103, DOI 10.1098/rstb.1961.0007; WALKER AD, 1964, PHILOS T ROY SOC B, V248, P53, DOI 10.1098/rstb.1964.0009; WEEMS RE, 1980, T AM PHILOS SOC, V70, P3; Weinbaum Jonathan C., 2011, Paleobios, V30, P18; Welman J, 1998, J VERTEBR PALEONTOL, V18, P340, DOI 10.1080/02724634.1998.10011062; Welman J, 1995, S AFR J SCI, V91, P533; Wu XC, 2001, J VERTEBR PALEONTOL, V21, P40, DOI 10.1671/0272-4634(2001)021[0040:ROTDAA]2.0.CO;2; Wu Xiao-Chun, 1993, Journal of Vertebrate Paleontology, V13, P58; Young C.C., 1973, MEMOIRS I VERTEBRA B, V10, P15; Zittel KA, 1887, HDB PALAONTOLOGIE 1, VIII	104	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148575	10.1371/journal.pone.0148575	http://dx.doi.org/10.1371/journal.pone.0148575			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849433	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000130
J	Koenig, S; Wolf, R; Heisenberg, M				Koenig, Sebastian; Wolf, Reinhard; Heisenberg, Martin			Vision in Flies: Measuring the Attention Span	PLOS ONE			English	Article							VISUAL FLIGHT ORIENTATION; DROSOPHILA-MELANOGASTER; FINE-STRUCTURE; YAW TORQUE; BEHAVIOR; CORTEX; FLY	A visual stimulus at a particular location of the visual field may elicit a behavior while at the same time equally salient stimuli in other parts do not. This property of visual systems is known as selective visual attention (SVA). The animal is said to have a focus of attention (FoA) which it has shifted to a particular location. Visual attention normally involves an attention span at the location to which the FoA has been shifted. Here the attention span is measured in Drosophila. The fly is tethered and hence has its eyes fixed in space. It can shift its FoA internally. This shift is revealed using two simultaneous test stimuli with characteristic responses at their particular locations. In tethered flight a wild type fly keeps its FoA at a certain location for up to 4s. Flies with a mutation in the radish gene, that has been suggested to be involved in attention-like mechanisms, display a reduced attention span of only 1s.	[Koenig, Sebastian; Wolf, Reinhard; Heisenberg, Martin] Rudolf Virchow Ctr, Joseph Schneider Str 2, D-97080 Wurzburg, Germany	University of Wurzburg	Heisenberg, M (corresponding author), Rudolf Virchow Ctr, Joseph Schneider Str 2, D-97080 Wurzburg, Germany.	heisenberg@biozentrum.uni-wuerzburg.de			German Science Foundation [He986/20-1]; Rudolf-Virchow-Center	German Science Foundation(German Research Foundation (DFG)); Rudolf-Virchow-Center	This work was funded by the German Science Foundation (Reinhart Koselleck Project, He986/20-1). The fundershad no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank A. Haberberger for help with the experiments, K. Oechsner and H. Kaderschabek for technical support and J. Dubnau, Cold Spring Harbor Laboratories for fly stocks. This work was supported by the Rudolf-Virchow-Center.	COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; HEISENBERG M, 1979, J COMP PHYSIOL, V130, P113, DOI 10.1007/BF00611046; Heisenberg M., 1984, VISION DROSOPHILA GE; KLEIN R, 1988, NATURE, V334, P430, DOI 10.1038/334430a0; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Paulk AC, 2014, P NATL ACAD SCI US; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Sareen P, 2011, VISUAL ATTENTION DRO; Sareen P, 2011, P NATL ACAD SCI US, V2011; Sareen P, 2011, P NATL ACAD SCI USA, V108, P7230, DOI 10.1073/pnas.1102522108; Serences JT, 2004, CEREB CORTEX, V14, P1346, DOI 10.1093/cercor/bhh095; Tang SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014455; Tang SM, 2004, SCIENCE, V305, P1020, DOI 10.1126/science.1099839; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; TIPPER SP, 1991, Q J EXP PSYCHOL-A, V43, P289, DOI 10.1080/14640749108400971; van Swinderen B, 2007, FLY, V1, P187, DOI 10.4161/fly.4561; van Swinderen B, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00096; van Swinderen B, 2010, J NEUROSCI, V30, P1003, DOI 10.1523/JNEUROSCI.4516-09.2010; van Swinderen B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005989; von Helmholtz H., 1866, HDB PHYSL OPTIK; Warren RM, 1986, HELMHOLTZ PERCEPTION; WOLF R, 1980, J COMP PHYSIOL, V140, P69, DOI 10.1007/BF00613749; WOLF R, 1991, J COMP PHYSIOL A, V169, P699; WURTZ RH, 1972, INVEST OPHTH VISUAL, V11, P441; Ye YZ, 2004, EUR J NEUROSCI, V20, P1001, DOI 10.1111/j.1460-9568.2004.03575.x	26	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148208	10.1371/journal.pone.0148208	http://dx.doi.org/10.1371/journal.pone.0148208			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848852	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000052
J	Korn, CW; Rosenblau, G; Buritica, JMR; Heekeren, HR				Korn, Christoph W.; Rosenblau, Gabriela; Buritica, Julia M. Rodriguez; Heekeren, Hauke R.			Performance Feedback Processing Is Positively Biased As Predicted by Attribution Theory	PLOS ONE			English	Article							FACIAL EXPRESSIONS; CAUSAL ATTRIBUTION; EMOTION; IMPLICIT; EXPLICIT; FACES; PERSPECTIVE; HISTORY; WELL; FMRI	A considerable literature on attribution theory has shown that healthy individuals exhibit a positivity bias when inferring the causes of evaluative feedback on their performance. They tend to attribute positive feedback internally (e. g., to their own abilities) but negative feedback externally (e. g., to environmental factors). However, all empirical demonstrations of this bias suffer from at least one of the three following drawbacks: First, participants directly judge explicit causes for their performance. Second, participants have to imagine events instead of experiencing them. Third, participants assess their performance only after receiving feedback and thus differences in baseline assessments cannot be excluded. It is therefore unclear whether the classically reported positivity bias generalizes to setups without these drawbacks. Here, we aimed at establishing the relevance of attributions for decision-making by showing an attribution-related positivity bias in a decision-making task. We developed a novel task, which allowed us to test how participants changed their evaluations in response to positive and negative feedback about performance. Specifically, we used videos of actors expressing different facial emotional expressions. Participants were first asked to evaluate the actors' credibility in expressing a particular emotion. After this initial rating, participants performed an emotion recognition task and did-or did not-receive feedback on their veridical performance. Finally, participants re-rated the actors' credibility, which provided a measure of how they changed their evaluations after feedback. Attribution theory predicts that participants change their evaluations of the actors' credibility toward the positive after receiving positive performance feedback and toward the negative after negative performance feedback. Our results were in line with this prediction. A control condition without feedback showed that correct or incorrect performance alone could not explain the observed positivity bias. Furthermore, participants' behavior in our task was linked to the most widely used measure of attribution style. In sum, our findings suggest that positive and negative performance feedback influences the evaluation of task-related stimuli, as predicted by attribution theory. Therefore, our study points to the relevance of attribution theory for feedback processing in decision-making and provides a novel outlook for decision-making biases.	[Korn, Christoph W.; Rosenblau, Gabriela; Buritica, Julia M. Rodriguez; Heekeren, Hauke R.] Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany; [Korn, Christoph W.] Univ Zurich, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland; [Korn, Christoph W.] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Rosenblau, Gabriela] Yale Univ, Ctr Translat Dev Neurosci, Ctr Child Study, New Haven, CT USA; [Buritica, Julia M. Rodriguez] Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany	Free University of Berlin; University of Zurich; University of Zurich; Yale University; Humboldt University of Berlin	Korn, CW (corresponding author), Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany.; Korn, CW (corresponding author), Univ Zurich, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland.; Korn, CW (corresponding author), Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland.	christoph.w.korn@gmail.com		Heekeren, Hauke/0000-0001-7912-6826; Korn, Christoph/0000-0002-8228-2624	Excellence Initiative of the German Federal Ministry of Education and Research Deutsche Forschungsgemeinschaft [EXC 302]	Excellence Initiative of the German Federal Ministry of Education and Research Deutsche Forschungsgemeinschaft	This work was supported by Excellence Initiative of the German Federal Ministry of Education and Research Deutsche Forschungsgemeinschaft Grant EXC 302. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Alicke MD, 2009, EUR REV SOC PSYCHOL, V20, P1, DOI 10.1080/10463280802613866; Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BANAJI MR, 1995, J PERS SOC PSYCHOL, V68, P181, DOI 10.1037/0022-3514.68.2.181; Blackwood NJ, 2003, NEUROIMAGE, V20, P1076, DOI 10.1016/S1053-8119(03)00331-8; Cabanis M, 2013, COGN AFFECT BEHAV NE, V13, P330, DOI 10.3758/s13415-012-0143-5; CROCKER J, 1991, J PERS SOC PSYCHOL, V60, P218, DOI 10.1037/0022-3514.60.2.218; Dienes Z, 1999, BEHAV BRAIN SCI, V22, P735, DOI 10.1017/S0140525X99002186; Eastwood JD, 2001, PERCEPT PSYCHOPHYS, V63, P1004, DOI 10.3758/BF03194519; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Fawcett TW, 2014, TRENDS COGN SCI, V18, P153, DOI 10.1016/j.tics.2013.12.012; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Frith CD, 2008, NEURON, V60, P503, DOI 10.1016/j.neuron.2008.10.032; Garrett N, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00639; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; Harris LT, 2005, NEUROIMAGE, V28, P763, DOI 10.1016/j.neuroimage.2005.05.021; Haselton MG, 2009, SOC COGNITION, V27, P733, DOI 10.1521/soco.2009.27.5.733; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Heine SJ, 2007, PERS SOC PSYCHOL REV, V11, P4, DOI 10.1177/1088868306294587; Hepach R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00266; KELLEY HH, 1980, ANNU REV PSYCHOL, V31, P457, DOI 10.1146/annurev.ps.31.020180.002325; Kliemann D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00376; Korn CW, 2014, PSYCHOL MED, V44, P579, DOI 10.1017/S0033291713001074; Korn CW, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00192; Korn CW, 2012, J NEUROSCI, V32, P16832, DOI 10.1523/JNEUROSCI.3016-12.2012; Krumhuber EG, 2013, EMOT REV, V5, P41, DOI 10.1177/1754073912451349; Krusemark EA, 2008, PSYCHOPHYSIOLOGY, V45, P511, DOI 10.1111/j.1469-8986.2008.00659.x; Leary MR, 2007, ANNU REV PSYCHOL, V58, P317, DOI 10.1146/annurev.psych.58.110405.085658; Lee D, 2012, ANNU REV NEUROSCI, V35, P287, DOI 10.1146/annurev-neuro-062111-150512; Mezulis AH, 2004, PSYCHOL BULL, V130, P711, DOI 10.1037/0033-2909.130.5.711; MILLER DT, 1975, PSYCHOL BULL, V82, P213, DOI 10.1037/h0076486; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; Nosek BA, 2011, TRENDS COGN SCI, V15, P152, DOI 10.1016/j.tics.2011.01.005; O'Toole AJ, 2002, TRENDS COGN SCI, V6, P261, DOI 10.1016/S1364-6613(02)01908-3; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; PETERSON C, 1982, COGNITIVE THER RES, V6, P287, DOI 10.1007/BF01173577; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Poppe P, 2005, ASF E ATTRIBUTIONSST; Prehn K, 2015, SOC COGN AFFECT NEUR, V10, P435, DOI 10.1093/scan/nsu066; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Recio G, 2013, COGNITION EMOTION, V27, P1486, DOI 10.1080/02699931.2013.794128; Rosenblau G, 2015, J AUTISM DEV DISORD, V45, P953, DOI 10.1007/s10803-014-2249-9; Schulreich S, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00981; Seidel EM, 2012, J AFFECT DISORDERS, V138, P268, DOI 10.1016/j.jad.2012.01.041; Seidel EM, 2010, SOC NEUROSCI-UK, V5, P335, DOI 10.1080/17470911003615997; Shadlen MN, 2013, NEURON, V80, P791, DOI 10.1016/j.neuron.2013.10.047; Sharot T, 2011, NAT NEUROSCI, V14, P1475, DOI 10.1038/nn.2949; Shepperd J, 2008, SOC PERSONAL PSYCHOL, V2, P895, DOI 10.1111/j.1751-9004.2008.00078.x; Suter RS, 2015, PLOS ONE, P1, DOI [10.5061/dryad.64732, DOI 10.5061/DRYAD.64732]; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Terbeck S, 2008, J NEUROSCI METH, V173, P13, DOI 10.1016/j.jneumeth.2008.05.011; Toelch U, 2014, SOC COGN AFFECT NEUR, V9, P1746, DOI 10.1093/scan/nst173; Trope Y, 1998, MOTIV EMOTION, V22, P53, DOI 10.1023/A:1023044625309; Weber EU, 2009, ANNU REV PSYCHOL, V60, P53, DOI 10.1146/annurev.psych.60.110707.163633; WEINER B, 1970, J PERS SOC PSYCHOL, V15, P1, DOI 10.1037/h0029211; Weiner B, 1987, ATTRIBUTIONAL THEORY, V92, P548; Weiner B, 2008, SOC PSYCHOL-GERMANY, V39, P151, DOI 10.1027/1864-9335.39.3.151; Weiner B, 2010, EDUC PSYCHOL-US, V45, P28, DOI 10.1080/00461520903433596; Zinck A, 2008, SYNTHESE, V161, P1, DOI 10.1007/s11229-006-9149-2; ZUCKERMAN M, 1979, J PERS, V47, P245, DOI 10.1111/j.1467-6494.1979.tb00202.x	62	8	8	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148581	10.1371/journal.pone.0148581	http://dx.doi.org/10.1371/journal.pone.0148581			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26849646	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000132
J	Lu, ML; Wu, YX; Chen, CH; Kuo, PT; Chen, YH; Lin, CH; Wu, TH				Lu, Mong-Liang; Wu, Yi-Xiu; Chen, Chun-Hsin; Kuo, Pei-Ting; Chen, Yi-Hua; Lin, Chia-Hui; Wu, Tzu-Hua			Application of Plasma Levels of Olanzapine and N-Desmethyl-Olanzapine to Monitor Clinical Efficacy in Patients with Schizophrenia	PLOS ONE			English	Article							SMOKING; DRUG; SEX; AGE; COMEDICATION; GUIDELINES; MANAGEMENT; SERUM; PANSS	Background This therapeutic drug monitoring (TDM) study aimed to determine the role of olanzapine (OLZ) and N-desmethyl-OLZ (DMO) levels in the therapeutic efficacy of OLZ in patients with schizophrenia. Method Plasma concentrations of OLZ (C-OLZ) and DMO (C-DMO) in schizophrenic patients 12 hours post-dose were assessed. The correlations of C-OLZ and C-DMO with the various scores of the Positive and Negative Syndrome Scale (PANSS) were evaluated. A receiver operating characteristic curve (ROC) was utilized to identify the threshold C-OLZ and C-OLZ/C-DMO ratio for maintenance of satisfactory efficacy. Results A total of 151 samples from patients with schizophrenia were analyzed for individual C-OLZ and C-DMO levels. The mean C-OLZ and C-DMO levels were 37.0 +/- 25.6 and 6.9 +/- 4.7 ng/mL, respectively, and C-OLZ was similar to 50% higher in female or nonsmokers (p<0.01). In all patients, the daily dose of OLZ was positively correlated with C-OLZ and C-DMO. Linear relationships between C-OLZ and OLZ dose were observed in both nonsmokers and smokers (r(s) = 0.306, 0.426, p<0.01), although C-DMO was only correlated with OLZ dose in smokers (r(s) = 0.485, p<0.01) and not nonsmokers. In all patients, C-OLZ was marginally negatively correlated with the total PANSS score. The total PANSS score was significantly negatively correlated with the C-OLZ/C-DMO ratio (p<0.005), except in smokers. The ROC analysis identified a C-OLZ/C-DMO ratio >= 2.99 or C-OLZ >= 22.77 ng/mL as a predictor of maintenance of an at least mildly ill status (PANSS score <= 58) of schizophrenia in all patients. Conclusions A significantly negative correlation between the steady-state C-OLZ/C-DMO ratio and total PANSS score was observed in Taiwanese schizophrenic patients. TDM of both OLZ and DMO levels could assist clinical practice when individualizing OLZ dosage adjustments for patients with schizophrenia.	[Lu, Mong-Liang; Chen, Chun-Hsin] Taipei Med Univ, Wan Fang Hosp, Dept Psychiat, Taipei, Taiwan; [Lu, Mong-Liang; Chen, Chun-Hsin] Taipei Med Univ, Coll Med, Sch Med, Dept Psychiat, Taipei, Taiwan; [Wu, Yi-Xiu; Kuo, Pei-Ting; Lin, Chia-Hui; Wu, Tzu-Hua] Taipei Med Univ, Coll Pharm, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Chen, Yi-Hua] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University	Wu, TH (corresponding author), Taipei Med Univ, Coll Pharm, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan.	thwu@tmu.edu.tw		Lu, Mong-Liang/0000-0003-3184-6554; Chen, Yi-Hua/0000-0003-2464-2537	Ministry of Science and Technology [NSC-96-2314-B-038-031-MY3, MOST104-2320-B-038-018]; Department of Health, Executive Yuan [DOH96-TD-D-113-033]; National Health Research Institute [NHRI-EX99-9741PI]; Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan [103TMU-WFH-13]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Department of Health, Executive Yuan; National Health Research Institute(National Health Research Institutes - Taiwan); Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan	The Ministry of Science and Technology (NSC-96-2314-B-038-031-MY3; MOST104-2320-B-038-018), Department of Health, Executive Yuan (DOH96-TD-D-113-033), National Health Research Institute (NHRI-EX99-9741PI), and Taipei Medical University-Wan Fang Hospital (103TMU-WFH-13), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, ANN STAT, V29, P1165; Bigos KL, 2008, J CLIN PHARMACOL, V48, P157, DOI 10.1177/0091270007310385; Bishara D, 2013, J CLIN PSYCHOPHARM, V33, P329, DOI 10.1097/JCP.0b013e31828b28d5; Callaghan JT, 1999, CLIN PHARMACOKINET, V37, P177, DOI 10.2165/00003088-199937030-00001; Citrome L, 2009, J CLIN PSYCHOPHARM, V29, P278, DOI 10.1097/JCP.0b013e3181a289cb; Fellows L, 2003, THER DRUG MONIT, V25, P682, DOI 10.1097/00007691-200312000-00006; Fulton B, 1997, DRUGS, V53, P281, DOI 10.2165/00003495-199753020-00007; Gex-Fabry M, 2003, THER DRUG MONIT, V25, P46, DOI 10.1097/00007691-200302000-00007; Hasan A, 2012, WORLD J BIOL PSYCHIA, V13, P318, DOI 10.3109/15622975.2012.696143; Hatta K, 2009, SCHIZOPHR RES, V113, P49, DOI 10.1016/j.schres.2009.05.030; Hiemke C, 2011, PHARMACOPSYCHIATRY, V44, P195, DOI 10.1055/s-0031-1286287; Kassahun K, 1997, DRUG METAB DISPOS, V25, P81; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Komossa K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006654.pub2; Leucht S, 2005, SCHIZOPHR RES, V79, P231, DOI 10.1016/j.schres.2005.04.008; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065719; Mauri MC, 2005, EUR PSYCHIAT, V20, P55, DOI 10.1016/j.eurpsy.2004.09.009; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; Nozawa M, 2008, THER DRUG MONIT, V30, P35, DOI 10.1097/FTD.0b013e31816336fd; Opler MGA, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-35; Perry PJ, 1997, J CLIN PSYCHOPHARM, V17, P472, DOI 10.1097/00004714-199712000-00006; Perry PJ, 2001, J CLIN PSYCHOPHARM, V21, P14, DOI 10.1097/00004714-200102000-00004; Skogh E, 2002, THER DRUG MONIT, V24, P518, DOI 10.1097/00007691-200208000-00010; Skogh E, 2011, J CLIN PSYCHOPHARM, V31, P4, DOI 10.1097/JCP.0b013e318204d9e2; Takahashi M, 2015, OPEN J PSYCHIAT, V5, P301; Taylor D, 2009, MAUDSLEY PRESCRIBING; Theisen FM, 2006, THER DRUG MONIT, V28, P750, DOI 10.1097/01.ftd.0000249950.75462.7f; Wakamatsu Akihide, 2013, Innov Clin Neurosci, V10, P23; Weiss U, 2005, J CLIN PSYCHOPHARM, V25, P570, DOI 10.1097/01.jcp.0000185427.08268.db; Wu TH, 2008, PROG NEURO-PSYCHOPH, V32, P1889, DOI 10.1016/j.pnpbp.2008.08.022	31	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148539	10.1371/journal.pone.0148539	http://dx.doi.org/10.1371/journal.pone.0148539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849777	Green Submitted, gold, Green Published			2022-12-27	WOS:000369554000121
J	Meredith, SL; Bryant, JL; Babur, M; Riddell, PW; Behrouzi, R; Williams, KJ; White, A				Meredith, Suzanne L.; Bryant, Jennifer L.; Babur, Muhammad; Riddell, Philip W.; Behrouzi, Roya; Williams, Kaye J.; White, Anne			Irradiation Decreases the Neuroendocrine Biomarker Pro-Opiomelanocortin in Small Cell Lung Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION; RADIATION; LINES	Background Small cell lung cancer (SCLC) is an extremely aggressive disease, commonly displaying therapy-resistant relapse. We have previously identified neuroendocrine and epithelial phenotypes in SCLC tumours and the neuroendocrine marker, pro-opiomelanocortin (POMC), correlated with worse overall survival in patients. However, the effect of treatment on these phenotypes is not understood. The current study aimed to determine the effect of repeated irradiation treatment on SCLC cell phenotype, focussing on the neuroendocrine marker, POMC. Results Human SCLC cells (DMS 79) were established as subcutaneous xenograft tumours in CBA nude mice and then exposed to repeated 2Gy irradiation. In untreated animals, POMC in the blood closely mirrored tumour growth; an ideal characteristic for a circulating biomarker. Following repeated localised irradiation in vivo, circulating POMC decreased (p< 0.01), in parallel with a decrease in tumour size, but remained low even when the tumours re-established. The excised tumours displayed reduced and distinctly heterogeneous expression of POMC compared to untreated tumours. There was no difference in the epithelial marker, cytokeratin. However, there were significantly more N-cadherin positive cells in the irradiated tumours. To investigate the tumour response to irradiation, DMS79 cells were repeatedly irradiated in vitro and the surviving cells selected. POMC expression was reduced, while mesenchymal markers N-cadherin, beta 1-integrin, fibroblast-specific protein 1, beta-catenin and Zeb1 expression were amplified in the more irradiation-primed cells. There were no consistent changes in epithelial marker expression. Cell morphology changed dramatically with repeatedly irradiated cells displaying a more elongated shape, suggesting a switch to a more mesenchymal phenotype. Conclusions In summary, POMC biomarker expression and secretion were reduced in SCLC tumours which regrew after irradiation and in repeatedly irradiation (irradiation-primed) cells. Therefore, POMC was no longer predictive of tumour burden. This highlights the importance of fully evaluating biomarkers during and after therapy to assess clinical utility. Furthermore, the gain in mesenchymal characteristics in irradiated cells could be indicative of a more invasive phenotype.	[Meredith, Suzanne L.; Bryant, Jennifer L.; Babur, Muhammad; Behrouzi, Roya; Williams, Kaye J.; White, Anne] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England; [Bryant, Jennifer L.; Riddell, Philip W.; White, Anne] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester	White, A (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England.; White, A (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	anne.white@manchester.ac.uk	White, Anne/G-7717-2015	White, Anne/0000-0002-7686-2884; Behrouzi, Roya/0000-0002-1978-6539	Barbara Mawer Endowment fund, BBSRC, Society for Endocrinology; EU FP7 Metoxia Grant [222741]; Biotechnology and Biological Sciences Research Council [1065661] Funding Source: researchfish	Barbara Mawer Endowment fund, BBSRC, Society for Endocrinology; EU FP7 Metoxia Grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for SLM, JLB, PWR and RB was provided by The Barbara Mawer Endowment fund, BBSRC, Society for Endocrinology. Funding was also provided by the EU FP7 Metoxia Grant agreement no. 222741 (to K.J. Williams, supporting M. Babur).	Bryant JL, 2012, BRIT J CANCER, V106, P148, DOI 10.1038/bjc.2011.465; Burrows N, 2013, RADIOTHER ONCOL; Canadas I, 2014, ONCOTARGET, V5, P5246, DOI 10.18632/oncotarget.2124; Chen XF, 2012, MOL BIOL REP, V39, P3549, DOI 10.1007/s11033-011-1128-0; Dasari V, 2006, AM J RESP CELL MOL, V35, P3, DOI 10.1165/rcmb.2006-0051SF; Davey RA, 2004, ANTICANCER RES, V24, P465; Gibson S, 1996, J CLIN ENDOCR METAB, V81, P497, DOI 10.1210/jc.81.2.497; Gomez-Casal R, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-94; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henness S, 2002, INT J RADIAT ONCOL, V54, P895, DOI 10.1016/S0360-3016(02)03037-7; Jung JW, 2007, EUR J CANCER, V43, P1214, DOI 10.1016/j.ejca.2007.01.034; Kalemkerian GP, 2011, J NATL COMPR CANC NE, V9, P1086, DOI 10.6004/jnccn.2011.0092; Kawata M, 2012, J BIOCHEM, V151, P205, DOI 10.1093/jb/mvr136; Komaki R, 2012, INT J RADIAT ONCOL, V83, pE531, DOI 10.1016/j.ijrobp.2012.01.075; Krohn A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100249; Oliver Robert L, 2003, Pituitary, V6, P119, DOI 10.1023/B:PITU.0000011172.26649.df; Page-Wilson G, 2014, J CLIN ENDOCR METAB, V99, pE1838, DOI 10.1210/jc.2014-1448; PETTENGILL OS, 1980, CANCER-AM CANCER SOC, V45, P906, DOI 10.1002/1097-0142(19800301)45:5<906::AID-CNCR2820450513>3.0.CO;2-H; Pirozzi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021548; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Riaz SP, 2012, LUNG CANCER, V75, P280, DOI 10.1016/j.lungcan.2011.08.004; Sato M, 2012, RESPIROLOGY, V17, P1048, DOI 10.1111/j.1440-1843.2012.02173.x; Shintani Y, 2011, ANN THORAC SURG, V92, P1794, DOI 10.1016/j.athoracsur.2011.07.032; STEWART PM, 1994, CLIN ENDOCRINOL, V40, P199, DOI 10.1111/j.1365-2265.1994.tb02468.x; Stovold R, 2013, BRIT J CANCER, V108, P1704, DOI 10.1038/bjc.2013.112; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; West MJ, 2012, BASIC STEREOLOGY BIO; WHITE A, 1989, J MOL ENDOCRINOL, V3, P65, DOI 10.1677/jme.0.0030065; Yamamoto H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14579; Zhang X, 2011, BIOCHEM BIOPH RES CO, V412, P188, DOI 10.1016/j.bbrc.2011.07.074	30	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148404	10.1371/journal.pone.0148404	http://dx.doi.org/10.1371/journal.pone.0148404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848743	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000087
J	van Dijk, A; van Eldik, M; Veldhuizen, EJA; Tjeerdsma-van Bokhoven, HLM; de Zoete, MR; Bikker, FJ; Haagsman, HP				van Dijk, Albert; van Eldik, Mandy; Veldhuizen, Edwin J. A.; Tjeerdsma-van Bokhoven, Hanne L. M.; de Zoete, Marcel R.; Bikker, Floris J.; Haagsman, Henk P.			Immunomodulatory and Anti-Inflammatory Activities of Chicken Cathelicidin-2 Derived Peptides	PLOS ONE			English	Article							OUTER-MEMBRANE-PERMEABILIZATION; CATIONIC ANTIMICROBIAL PEPTIDES; HOST-DEFENSE PEPTIDES; ANTIBIOTIC USE; POLYMYXIN-B; LIPOPOLYSACCHARIDE; BINDING; LL-37; DIFFERENTIATION; NEUTRALIZATION	Host Defence Peptides and derived peptides are promising classes of antimicrobial and immunomodulatory lead compounds. For this purpose we examined whether chicken cathelicidin-2 (CATH-2)-derived peptides modulate the function and inflammatory response of avian immune cells. Using a chicken macrophage cell line (HD11) we found that full-length CATH-2 dose-dependently induced transcription of chemokines CXCLi2/IL-8, MCP3 and CCLi4/RANTES, but not of pro-inflammatory cytokine IL-1 beta. In addition, CATH-2 efficiently inhibited IL-1 beta and nitric oxide production by HD11 cells induced by different sources of lipopolysaccharides (LPS). N-terminal truncated CATH-2 derived peptides maintained the capacity to selectively induce chemokine transcription, but despite their high LPS affinity several analogs lacked LPS-neutralizing capacity. Substitution of phenylalanine residues by tryptophan introduced endotoxin neutralization capacity in inactive truncated CATH-2 derived peptides. In contrast, amino acid substitution of phenylalanine by tyrosine abrogated endotoxin neutralization activity of CATH-2 analogs. These findings support a pivotal role for aromatic residues in peptide-mediated endotoxin neutralization by CATH-2 analogs and were shown to be independent of LPS affinity. The capacity to modulate chemokine production and dampen endotoxin-induced pro-inflammatory responses in chicken immune cells implicates that small CATH-2 based peptides could serve as leads for the design of CATH-2 based immunomodulatory anti-infectives.	[van Dijk, Albert; van Eldik, Mandy; Veldhuizen, Edwin J. A.; Tjeerdsma-van Bokhoven, Hanne L. M.; Haagsman, Henk P.] Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, Div Mol Host Def, Utrecht, Netherlands; [de Zoete, Marcel R.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Bikker, Floris J.] Vrije Univ Amsterdam, Univ Amsterdam, Dept Oral Biochem, Acad Ctr Dent Amsterdam, Amsterdam, Netherlands	Utrecht University; Yale University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Haagsman, HP (corresponding author), Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, Div Mol Host Def, Utrecht, Netherlands.	h.p.haagsman@uu.nl	Bikker, Floris/R-1941-2019; Haagsman, Henk P/F-8919-2010; de Zoete, Marcel R/O-3012-2014; de Zoete, Marcel/ABA-7918-2021; Bikker, Floris/B-1187-2012	Bikker, Floris/0000-0002-9453-4630; de Zoete, Marcel/0000-0002-6561-5810	Immuno Valley ALTANT ASIA2 program of the Dutch Ministry of Economic Affairs	Immuno Valley ALTANT ASIA2 program of the Dutch Ministry of Economic Affairs	The work was financially supported by the Immuno Valley ALTANT ASIA2 program of the Dutch Ministry of Economic Affairs.	BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Bhunia A, 2010, J BIOL CHEM, V285, P3883, DOI 10.1074/jbc.M109.065672; Bommineni YR, 2010, PEPTIDES, V31, P1225, DOI 10.1016/j.peptides.2010.03.037; Bosca L, 2005, TOXICOLOGY, V208, P249, DOI 10.1016/j.tox.2004.11.035; Bowdish DME, 2004, J IMMUNOL, V172, P3758, DOI 10.4049/jimmunol.172.6.3758; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Brogden KA, 2005, NAT IMMUNOL, V6, P558, DOI 10.1038/ni1209; Davidson DJ, 2004, J IMMUNOL, V172, P1146, DOI 10.4049/jimmunol.172.2.1146; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Ferguson AD, 2000, STRUCTURE, V8, P585; Hancock REW, 2005, LANCET INFECT DIS, V5, P209, DOI 10.1016/S1473-3099(05)70051-7; JACOBS RE, 1989, BIOCHEMISTRY-US, V28, P3421, DOI 10.1021/bi00434a042; Japelj B, 2005, J BIOL CHEM, V280, P16955, DOI 10.1074/jbc.M500266200; Kaiser P, 2005, J INTERF CYTOK RES, V25, P467, DOI 10.1089/jir.2005.25.467; KARKHANIS YD, 1978, ANAL BIOCHEM, V85, P595, DOI 10.1016/0003-2697(78)90260-9; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Li XZ, 2007, VET MICROBIOL, V121, P197, DOI 10.1016/j.vetmic.2007.01.015; Molhoek EM, 2010, INT J ANTIMICROB AG, V36, P271, DOI 10.1016/j.ijantimicag.2010.06.001; Mookherjee N, 2006, J LEUKOCYTE BIOL, V80, P1563, DOI 10.1189/jlb.0106048; MOORE RA, 1986, ANTIMICROB AGENTS CH, V29, P496, DOI 10.1128/AAC.29.3.496; Nagaoka I, 2002, CLIN DIAGN LAB IMMUN, V9, P972, DOI 10.1128/CDLI.9.5.972-982.2002; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; Nijnik A, 2010, J IMMUNOL, V184, P2539, DOI 10.4049/jimmunol.0901813; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Pristovsek P, 1999, J MED CHEM, V42, P4604, DOI 10.1021/jm991031b; Ramanathan B, 2004, DEV COMP IMMUNOL, V28, P163, DOI 10.1016/S0145-305X(03)00135-6; Sanchez KM, 2011, BIOPHYS J, V100, P2121, DOI 10.1016/j.bpj.2011.03.018; SCHINDLER PRG, 1975, ANTIMICROB AGENTS CH, V8, P95, DOI 10.1128/AAC.8.1.95; Scott MG, 2000, J IMMUNOL, V164, P549, DOI 10.4049/jimmunol.164.2.549; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Scrutton NS, 1996, BIOCHEM J, V319, P1; Shryock TR, 2010, ANN NY ACAD SCI, V1213, P92, DOI 10.1111/j.1749-6632.2010.05788.x; Tsubery H, 2002, MOL PHARMACOL, V62, P1036, DOI 10.1124/mol.62.5.1036; van Dijk A, 2009, MOL IMMUNOL, V46, P2465, DOI 10.1016/j.molimm.2009.05.019; Van Dijk A, 2009, MOL IMMUNOL, V46, P1517, DOI 10.1016/j.molimm.2008.12.015; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; WIMLEY WC, 1993, BIOCHEMISTRY-US, V32, P6307, DOI 10.1021/bi00076a001; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	42	45	45	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147919	10.1371/journal.pone.0147919	http://dx.doi.org/10.1371/journal.pone.0147919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848845	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000028
J	Verma, R; Venkatareddy, M; Kalinowski, A; Patel, SR; Garg, P				Verma, Rakesh; Venkatareddy, Madhusudan; Kalinowski, Anne; Patel, Sanjeevkumar R.; Garg, Puneet			Integrin Ligation Results in Nephrin Tyrosine Phosphorylation In Vitro	PLOS ONE			English	Article							FOCAL ADHESION KINASE; SRC-FAMILY KINASES; ADAPTER PROTEIN NCK; CELL MOTILITY; ACTIN POLYMERIZATION; CYTOPLASMIC DOMAIN; SIGNAL-TRANSDUCTION; GLOMERULAR INJURY; CANCER-CELLS; KIDNEY	Nephrin is expressed at the basolateral aspect of podocytes and is an important signaling protein at the glomerular slit diaphragm. In vitro studies have demonstrated that Nephrin phosphorylation-dependent signaling is able to assemble a protein complex that is able to polymerize actin. However, proximal signaling events that result in nephrin tyrosine phosphorylation are not well understood. Nephrin deletion in mice and human nephrin mutations result in developmental failure of the podocyte intercellular junction resutling in proteinuria. This has been presumed to be due to a failure to respond to an external polarized cue in the absence of nephrin or a failure to transduce an outside-in signal in patients with nephrin mutations. The nephrin extracellular domain binds to itself or neph1 across the foot process intercellular junction. Nephrin is tyrosine phosphorylation-silent in healthy glomeruli when presumably the nephrin extracellular domain is in an engaged state. These observations raise the possibility of an alternate proximal signaling mechanism that might be responsible for nephrin tyrosine phosphorylation. Here we present data showing that integrin engagement at the basal aspect of cultured podocytes results in nephrin tyrosine phosphorylation. This is abrogated by incubating podocytes with an antibody that prevents integrin beta 1 ligation and activation in response to binding to extracellular matrix. Furthermore, nephrin tyrosine phosphorylation was observed in podocytes expressing a membrane-targeted nephrin construct that lacks the extracellular domain. We propose, integrin-activation based signaling might be responsible for nephrin phosphorylation rather than engagment of the nephrin extracellular domain by a ligand.	[Verma, Rakesh; Venkatareddy, Madhusudan; Kalinowski, Anne; Patel, Sanjeevkumar R.; Garg, Puneet] Univ Michigan, Dept Internal Med, Div Nephrol, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Garg, P (corresponding author), Univ Michigan, Dept Internal Med, Div Nephrol, Sch Med, Ann Arbor, MI 48109 USA.	pungarg@umich.edu		Garg, Puneet/0000-0001-7439-459X	NIDDK [DK097027, DK081403, DK096053]; American Society of Nephrology Carl Gottshalk Research Scholar Award; University of Michigan's George M. O'Brien Translational Research Core Center [P30 DK0801943]; MDTRC Cell and Molecular Biology Core Grant [P60 DK020572];  [DK082409]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK081403, P60DK020572, R01DK082409, R03DK096053, R01DK097027] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Society of Nephrology Carl Gottshalk Research Scholar Award; University of Michigan's George M. O'Brien Translational Research Core Center; MDTRC Cell and Molecular Biology Core Grant; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants to P. Garg from NIDDK (DK097027, DK081403, and DK096053) and American Society of Nephrology Carl Gottshalk Research Scholar Award (PG). The work was also supported by grant to Sanjeevkumar Patel (DK082409). Support was also obtained from the cores of the University of Michigan's George M. O'Brien Translational Research Core Center Grant P30 DK0801943 and MDTRC Cell and Molecular Biology Core Grant P60 DK020572. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; Borza CM, 2008, J AM SOC NEPHROL, V19, P677, DOI 10.1681/ASN.2007070793; Borza CM, 2012, J AM SOC NEPHROL, V23, P1027, DOI 10.1681/ASN.2011040367; Borza CM, 2012, EXP CELL RES, V318, P1001, DOI 10.1016/j.yexcr.2012.02.033; Bouchard V, 2008, APOPTOSIS, V13, P531, DOI 10.1007/s10495-008-0192-y; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; Eke I, 2012, J CLIN INVEST, V122, P1529, DOI 10.1172/JCI61350; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Gardner H, 1996, DEV BIOL, V175, P301, DOI 10.1006/dbio.1996.0116; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Garg P, 2007, NEPHRON EXP NEPHROL, V106, pE67, DOI 10.1159/000101795; Garg P, 2011, ADV CHRONIC KIDNEY D, V18, P233, DOI 10.1053/j.ackd.2011.06.001; Garg P, 2010, J BIOL CHEM, V285, P22676, DOI 10.1074/jbc.M110.122929; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; Goerge B, 2012, J CLIN INVESTIGATION; Has C, 2012, NEW ENGL J MED, V366, P1508, DOI 10.1056/NEJMoa1110813; Heikkila E, 2011, BIOCHEM J, V435, P619, DOI 10.1042/BJ20101599; Holzman LB, 1999, KIDNEY INT, V56, P1481, DOI 10.1046/j.1523-1755.1999.00719.x; Hsia DA, 2005, MOL CELL BIOL, V25, P9700, DOI 10.1128/MCB.25.21.9700-9712.2005; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ikonomov OC, 2015, BIOCH BIOPHYS ACTA; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kanasaki K, 2008, DEV BIOL, V313, P584, DOI 10.1016/j.ydbio.2007.10.047; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Kreidberg JA, 2000, AM J PHYSIOL-RENAL, V279, pF233, DOI 10.1152/ajprenal.2000.279.2.F233; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Li HP, 2006, BIOCHEM BIOPH RES CO, V349, P310, DOI 10.1016/j.bbrc.2006.08.053; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nagashima KI, 2002, MOL BIOL CELL, V13, P4231, DOI 10.1091/mbc.E02-04-0181; Ni L, 2012, NEPHROLOGY, V17, P525, DOI 10.1111/j.1440-1797.2012.01619.x; Nykvist P, 2000, J BIOL CHEM, V275, P8255, DOI 10.1074/jbc.275.11.8255; Oh ES, 1999, MOL CELL BIOL, V19, P3205; Pozzi A, 2008, DEV BIOL, V316, P288, DOI 10.1016/j.ydbio.2008.01.022; Pozzi A, 2013, J AM SOC NEPHROL, V24, P1034, DOI 10.1681/ASN.2013010012; Rivera GM, 2004, CURR BIOL, V14, P11, DOI 10.1016/j.cub.2003.12.033; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Sachs N, 2006, J CELL BIOL, V175, P33, DOI 10.1083/jcb.200603073; Sawai H, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-37; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; SYMINGTON BE, 1995, J CELL SCI, V108, P831; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Uchida K, 2008, KIDNEY INT, V73, P926, DOI [10.1038/ki.2008.19, 10.1038/KI.2008.19]; Venkatareddy M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028710; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Verma R, 2015, MOL CELL BIOL; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; Yang XQ, 2010, MOL CELL BIOL, V30, P5306, DOI 10.1128/MCB.00326-10; Yuan HP, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134946; Yuan HP, 2002, AM J PHYSIOL-RENAL, V282, pF585, DOI 10.1152/ajprenal.00290.2001; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	62	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148906	10.1371/journal.pone.0148906	http://dx.doi.org/10.1371/journal.pone.0148906			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848974	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000185
J	Tezuka, M; Kitamura, N; Tanaka, K; Miki, N				Tezuka, Mayuko; Kitamura, Norihide; Tanaka, Kohei; Miki, Norihisa			Presentation of Various Tactile Sensations Using Micro-Needle Electrotactile Display	PLOS ONE			English	Article							HUMAN HAND; TOUCH; SKIN	Tactile displays provoke tactile sensations by artificially stimulating tactile receptors. While many types of tactile displays have been developed, electrotactile displays that exploit electric stimulation can be designed to be thin, light, flexible and thus, wearable. However, the high voltages required to stimulate tactile receptors and limited varieties of possible sensations pose problems. In our previous work, we developed an electrotactile display using a micro-needle electrode array that can drastically reduce the required voltage by penetrating through the high-impedance stratum corneum painlessly, but displaying various tactile sensations was still a challenge. In this work, we demonstrate presentation of tactile sensation of different roughness to the subjects, which is enabled by the arrangement of the electrodes; the needle electrodes are on the fingertip and the ground electrode is on the fingernail. With this arrangement, the display can stimulate the tactile receptors that are located not only in the shallow regions of the finger but also those in the deep regions. It was experimentally revealed that the required voltage was further reduced compared to previous devices and that the roughness presented by the display was controlled by the pulse frequency and the switching time, or the stimulation flow rate. The proposed electrotactile display is readily applicable as a new wearable haptic device for advanced information communication technology.	[Tezuka, Mayuko; Kitamura, Norihide; Tanaka, Kohei; Miki, Norihisa] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 223, Japan; [Miki, Norihisa] JST PRESTO, Chiyoda Ku, Tokyo, Japan	Keio University; Japan Science & Technology Agency (JST)	Tezuka, M; Miki, N (corresponding author), Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 223, Japan.; Miki, N (corresponding author), JST PRESTO, Chiyoda Ku, Tokyo, Japan.	mayukotezuka@a8.keio.jp; miki@mech.keio.ac.jp	Miki, Norihisa/F-7659-2014		Precursory Research for Embryonic Science and Technology (PRESTO, Information Environment and Human), Japan Science and Technology Agency	Precursory Research for Embryonic Science and Technology (PRESTO, Information Environment and Human), Japan Science and Technology Agency	This work was supported by Precursory Research for Embryonic Science and Technology (PRESTO, Information Environment and Human), Japan Science and Technology Agency (http://www.jst.go.jp/kisoken/presto/en/). NM recieved this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arouette X, 2010, SENSORS-BASEL, V10, P2946, DOI 10.3390/s100402946; Biet M, 2007, IEEE T ULTRASON FERR, V54, P2678, DOI 10.1109/TUFFC.2007.596; Deguchi T., 2010, J SURF FINISH SOC JA, V61, P305, DOI [10.4139/sfj.61.305, DOI 10.4139/SFJ.61.305]; Hirayama H, 1961, J MED ASS NIPPON MED, V28, P81; Hoshi T, 2010, IEEE T HAPTICS, V3, P155, DOI [10.1109/ToH.2010.4, 10.1109/TOH.2010.4]; Ishii T., 2002, Sixth International Conference on Motion and Vibration Control. Proceedings, P547; JOHANSSON RS, 1978, J PHYSIOL-LONDON, V281, P101, DOI 10.1113/jphysiol.1978.sp012411; Ju BF, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3529880; Jungmann M, 2002, P EUR 2002, P12; Kajimoto H, 2004, IEEE COMPUT GRAPH, V24, P36, DOI 10.1109/MCG.2004.1255807; Kajimoto H, 2003, 11TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS - HAPTICS 2003, PROCEEDINGS, P40, DOI 10.1109/HAPTIC.2003.1191225; Kajimoto H, 2002, 10TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P303, DOI 10.1109/HAPTIC.2002.998973; Kajimoto H, 2001, P IEEE VIRT REAL ANN, P289, DOI 10.1109/VR.2001.913801; Kajimoto H., 2003, PROC 13 INT S MEAS C, V13, P83; KAJIMOTO H, 1999, P 9 INT C ART REAL T, P107; Kitamura N, 2015, J MICROMECH MICROENG, V25, DOI 10.1088/0960-1317/25/2/025016; Kitamura N., 2013, 2013 Transducers & Eurosensors XXVII: 17th International Conference on Solid-State Sensors, Actuators and Microsystems (TRANSDUCERS & EUROSENSORS XXVII), P106, DOI 10.1109/Transducers.2013.6626712; KITAMURA N, 2014, MEMS 14, P1183, DOI DOI 10.1109/MEMSYS.2014.6765858; Kosemura Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.06JM11; Martanto W, 2006, J CONTROL RELEASE, V112, P357, DOI 10.1016/j.jconrel.2006.02.017; Montagna W, 1964, THE EPIDERMIS; Nakagawa H., 2010, J SURF FINISH SOC JA, V61, P58, DOI DOI 10.4139/SFJ.61.58; Srinivasan MA, 1996, J BIOMECH ENG-T ASME, V118, P48, DOI 10.1115/1.2795945; VALLBO AB, 1984, HUM NEUROBIOL, V3, P3; WATANABE T, 1995, IEEE INT CONF ROBOT, P1134, DOI 10.1109/ROBOT.1995.525433; Yang TH, 2009, WORLD HAPTICS 2009: THIRD JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P13, DOI 10.1109/WHC.2009.4810818; Zhang Y., 2011, IEEJ T SENSORS MICRO, V131, P141, DOI DOI 10.1541/ieejsmas.131.141; Zhang YH, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/8/085012	28	20	21	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148410	10.1371/journal.pone.0148410	http://dx.doi.org/10.1371/journal.pone.0148410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845336	Green Submitted, Green Published, gold			2022-12-27	WOS:000369552800054
J	Chen, TT; Zhang, L; Shang, HH; Liu, SD; Peng, J; Gong, WK; Shi, YZ; Zhang, SP; Li, JW; Gong, JW; Ge, Q; Liu, AY; Ma, HJ; Zhao, XH; Yuan, YL				Chen, Tingting; Zhang, Lei; Shang, Haihong; Liu, Shaodong; Peng, Jun; Gong, Wankui; Shi, Yuzhen; Zhang, Siping; Li, Junwen; Gong, Juwu; Ge, Qun; Liu, Aiying; Ma, Huijuan; Zhao, Xinhua; Yuan, Youlu			iTRAQ-Based Quantitative Proteomic Analysis of Cotton Roots and Leaves Reveals Pathways Associated with Salt Stress	PLOS ONE			English	Article							PROTEIN PROFILE ANALYSIS; SALINITY TOLERANCE; NA+/H+ ANTIPORT; PLANT-GROWTH; NACL STRESS; LIGNIN; MECHANISMS; BIOSYNTHESIS; RESPONSES; DROUGHT	Salinity is a major abiotic stress that affects plant growth and development. In this study, we performed a proteomic analysis of cotton roots and leaf tissue following exposure to saline stress. 611 and 1477 proteins were differentially expressed in the roots and leaves, respectively. In the roots, 259 (42%) proteins were up-regulated and 352 (58%) were down-regulated. In the leaves, 748 (51%) proteins were up-regulated and 729 (49%) were down-regulated. On the basis of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, we concluded that the phenylalanine metabolism and starch and sucrose metabolism were active for energy homeostasis to cope with salt stress in cotton roots. Moreover, photosynthesis, pyruvate metabolism, glycolysis/gluconeogenesis, carbon fixation in photosynthetic organisms and phenylalanine metabolism were inhabited to reduce energy consumption. Characterization of the signaling pathways will help elucidate the mechanism activated by cotton in response to salt stress.	[Chen, Tingting; Zhang, Lei; Shang, Haihong; Liu, Shaodong; Peng, Jun; Gong, Wankui; Shi, Yuzhen; Zhang, Siping; Li, Junwen; Gong, Juwu; Ge, Qun; Liu, Aiying; Ma, Huijuan; Zhao, Xinhua; Yuan, Youlu] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Yuan, YL (corresponding author), CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Peoples R China.	zhaoxh510@163.com; yylcri@126.com	Gǒng, Wànkuí/AAL-5622-2020	Gǒng, Wànkuí/0000-0002-8556-0669	National Natural Science Foundation of China [31301262, 31501343]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31301262 and 31501343).	Aharon GS, 2003, PLANT SOIL, V253, P245, DOI 10.1023/A:1024577205697; [Anonymous], [No title captured]; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; BLUMWALD E, 1987, PLANT PHYSIOL, V83, P884, DOI 10.1104/pp.83.4.884; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Casado-Vela J, 2010, PROTEOMICS, V10, P343, DOI 10.1002/pmic.200900509; Chu P, 2015, J PROTEOMICS, V113, P244, DOI 10.1016/j.jprot.2014.10.005; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Degenhardt B, 2000, J EXP BOT, V51, P595, DOI 10.1093/jexbot/51.344.595; Ferrer JL, 2008, PLANT PHYSIOL BIOCH, V46, P356, DOI 10.1016/j.plaphy.2007.12.009; Gao L, 2011, PHYTOCHEMISTRY, V72, P1180, DOI 10.1016/j.phytochem.2010.12.008; Garratt LC, 2002, FREE RADICAL BIO MED, V33, P502, DOI 10.1016/S0891-5849(02)00838-9; Ge XY, 2015, J PROTEOME RES, V14, P268, DOI 10.1021/pr500688g; GOSSETT DR, 1994, CROP SCI, V34, P706, DOI 10.2135/cropsci1994.0011183X003400030020x; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; Guo WX, 2012, PRECIS AGRIC, V13, P678, DOI 10.1007/s11119-012-9277-2; Hansson A, 2009, PHYSIOL PLANTARUM, V135, P214, DOI 10.1111/j.1399-3054.2008.01181.x; Hassan, 2002, ASIAN J PLANT SCI, DOI [10.3923/ajps.2002.715.719, DOI 10.3923/AJPS.2002.715.719]; Huang JL, 2010, PLANT PHYSIOL, V153, P1526, DOI 10.1104/pp.110.157370; Jorrin-Novo JV, 2013, PLANT PROTEOMICS; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCL ACIDS RES; Lan P, 2011, PLANT PHYSIOL, V155, P821, DOI 10.1104/pp.110.169508; LANGE BM, 1995, PLANT PHYSIOL, V108, P1277, DOI 10.1104/pp.108.3.1277; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Liu J, 2015, J PROTEOMICS, V126, P68, DOI 10.1016/j.jprot.2015.05.031; Makowski GS, 2010, ADV CLIN CHEM, P188; Malakshah SN, 2007, BIOSCI BIOTECH BIOCH, V71, P2144, DOI 10.1271/bbb.70027; MARCUM KB, 1994, J AM SOC HORTIC SCI, V119, P779, DOI 10.21273/JASHS.119.4.779; Meloni DA, 2001, J PLANT NUTR, V24, P599, DOI 10.1081/PLN-100104983; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Neves GYS, 2010, J AGRON CROP SCI, V196, P467, DOI 10.1111/j.1439-037X.2010.00432.x; Nogueira FCS, 2012, J PROTEOME RES, V11, P3046, DOI 10.1021/pr300192f; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Ow SY, 2009, J PROTEOME RES, V8, P5347, DOI 10.1021/pr900634c; Owiti J, 2011, PLANT J, V67, P145, DOI 10.1111/j.1365-313X.2011.04582.x; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Qian P-Y, 2009, HUMAN GENOMICS PROTE, V2009, P239; Qidar M, 1997, J AGRON CROP SCI, V179, P101; Rogers LA, 2004, NEW PHYTOL, V164, P17, DOI 10.1111/j.1469-8137.2004.01143.x; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Salekdeh GH, 2007, PROTEOMICS, V7, P2976, DOI 10.1002/pmic.200700181; Sanchez-Aguayo I, 2004, PLANTA, V220, P278, DOI 10.1007/s00425-004-1350-2; Saravanan RS, 2004, PROTEOMICS, V4, P2522, DOI 10.1002/pmic.200300789; Schulze WX, 2010, ANNU REV PLANT BIOL, V61, P491, DOI 10.1146/annurev-arplant-042809-112132; Shi HT, 2014, PLANT PHYSIOL BIOCH, V82, P218, DOI 10.1016/j.plaphy.2014.06.006; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; SINGH AK, 1995, PHOTOSYNTHETICA, V31, P489; Song Y, 2011, J PROTEOMICS, V74, P1045, DOI 10.1016/j.jprot.2011.03.009; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Wienkoop S, 2006, J EXP BOT, V57, P1529, DOI 10.1093/jxb/erj157; Xie FL, 2014, PLANT BIOTECHNOL J, V12, P354, DOI 10.1111/pbi.12142; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Yang LT, 2013, J PROTEOMICS, V93, P179, DOI 10.1016/j.jprot.2013.04.025; Yao Y, 2006, ELECTROPHORESIS, V27, P4559, DOI 10.1002/elps.200600111; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112807; Zhang L, 2013, J PLANT RES, V126, P293, DOI 10.1007/s10265-012-0533-3; Zhao Q, 2013, J PROTEOMICS, V82, P230, DOI 10.1016/j.jprot.2013.01.024; Zhou YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065906; Zhu MM, 2009, MOL CELL PROTEOMICS, V8, P752, DOI 10.1074/mcp.M800343-MCP200	63	61	64	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148487	10.1371/journal.pone.0148487	http://dx.doi.org/10.1371/journal.pone.0148487			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841024	Green Submitted, gold, Green Published			2022-12-27	WOS:000369550200141
J	Espinoza, M; Heupel, MR; Tobin, AJ; Simpfendorfer, CA				Espinoza, Mario; Heupel, Michelle R.; Tobin, Andrew J.; Simpfendorfer, Colin A.			Evidence of Partial Migration in a Large Coastal Predator: Opportunistic Foraging and Reproduction as Key Drivers?	PLOS ONE			English	Article							SHARKS CARCHARHINUS-LEUCAS; BULL SHARKS; SEASONAL DISTRIBUTION; ACOUSTIC RECEIVERS; MOVEMENT PATTERNS; CORAL-REEFS; HABITAT USE; EAST-COAST; BEHAVIOR; FISHES	Understanding animal movement decisions that involve migration is critical for evaluating population connectivity, and thus persistence. Recent work on sharks has shown that often only a portion of the adult population will undertake migrations, while the rest may be resident in an area for long periods. Defining the extent to which adult sharks use specific habitats and their migratory behaviour is essential for assessing their risk of exposure to threats such as fishing and habitat degradation. The present study used acoustic telemetry to examine residency patterns and migratory behaviour of adult bull sharks (Carcharhinus leucas) along the East coast of Australia. Fifty-six VR2W acoustic receivers were used to monitor the movements of 33 bull sharks in the central Great Barrier Reef (GBR). Both males and females were detected year-round, but their abundance and residency peaked between September and December across years (2012-2014). High individual variability in reef use patterns was apparent, with some individuals leaving the array for long periods, whereas others (36%) exhibited medium (0.20-0.40) or high residency (>0.50). A large portion of the population (51%) undertook migrations of up to 1,400 km to other coral reefs and/or inshore coastal habitats in Queensland and New South Wales. Most of these individuals (76%) were mature females, and the timing of migrations coincided with the austral summer (Dec-Feb). All migrating individuals (except one) returned to the central GBR, highlighting its importance as a potential foraging ground. Our findings suggest that adult bull sharks appear to be highly dependent on coral reef resources and provide evidence of partial migration, where only a portion of the female population undertook seasonal migrations potentially to give birth. Given that estuarine habitats face constant anthropogenic pressures, understanding partial migration and habitat connectivity of large coastal predators should be a priority for their management.	[Espinoza, Mario; Heupel, Michelle R.; Tobin, Andrew J.; Simpfendorfer, Colin A.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Espinoza, Mario; Heupel, Michelle R.; Tobin, Andrew J.; Simpfendorfer, Colin A.] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia; [Espinoza, Mario] James Cook Univ, Coll Marine & Environm Sci, Australian Inst Marine Sci, AIMS JCU, Townsville, Qld 4811, Australia; [Heupel, Michelle R.] Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia	James Cook University; James Cook University; Australian Institute of Marine Science; James Cook University; Australian Institute of Marine Science	Espinoza, M (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia.; Espinoza, M (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia.; Espinoza, M (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Australian Inst Marine Sci, AIMS JCU, Townsville, Qld 4811, Australia.	marioespinozamen@gmail.com	Espinoza, Mario/AAV-3460-2020; Simpfendorfer, Colin A/G-9681-2011	Espinoza, Mario/0000-0002-8355-2411; Simpfendorfer, Colin A/0000-0002-0295-2238; Heupel, Michelle/0000-0002-8245-7332	Australian Government [6.1]; Australian Research Council [FT100101004]; PADI Foundation; College of Marine and Environmental Sciences; Australian Endeavour; AIMS@JCU Scholarships	Australian Government(Australian GovernmentCGIAR); Australian Research Council(Australian Research Council); PADI Foundation; College of Marine and Environmental Sciences; Australian Endeavour(Australian GovernmentDepartment of Industry, Innovation and Science); AIMS@JCU Scholarships	This project was funded by the Australian Government's National Environmental Research Program (Tropical Ecosystems Hub Project 6.1). MRH was supported by a Future Fellowship (#FT100101004) from the Australian Research Council and ME was supported by the PADI Foundation, internal funding from the College of Marine and Environmental Sciences, Australian Endeavour and AIMS@JCU Scholarships.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Brunnschweiler JM, 2010, J FISH BIOL, V77, P1343, DOI 10.1111/j.1095-8649.2010.02757.x; Brunnschweiler JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058522; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; Carlson JK, 2010, J FISH BIOL, V77, P661, DOI 10.1111/j.1095-8649.2010.02707.x; Chapman BB, 2012, J FISH BIOL, V81, P456, DOI 10.1111/j.1095-8649.2012.03342.x; Chapman BB, 2012, J FISH BIOL, V81, P479, DOI 10.1111/j.1095-8649.2012.03349.x; Chapman DD, 2005, MAR TECHNOL SOC J, V39, P42, DOI 10.4031/002533205787521640; Chapman DD, 2015, ANNU REV MAR SCI, V7, P547, DOI 10.1146/annurev-marine-010814-015730; Chapman DD, 2009, MOL ECOL, V18, P3500, DOI 10.1111/j.1365-294X.2009.04289.x; CLARK EUGENIE, 1965, BULL MAR SCI, V15, P13; Cooke SJ, 2011, FISHERIES, V36, P583, DOI 10.1080/03632415.2011.633464; Curtis TH, 2013, MAR COAST FISH, V5, P28, DOI 10.1080/19425120.2012.756438; Curtis TH, 2011, T AM FISH SOC, V140, P1213, DOI 10.1080/00028487.2011.618352; Daly R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109357; Dicken ML, 2007, MAR FRESHWATER RES, V58, P127, DOI 10.1071/MF06018; Dicken ML, 2006, ICES J MAR SCI, V63, P1640, DOI 10.1016/j.icesjms.2006.06.009; Done T.J., 1982, Coral Reefs, V1, P95, DOI 10.1007/BF00301691; Espinoza M., 2015, ECOL APPL; Espinoza M, 2015, CORAL REEFS, V34, P807, DOI 10.1007/s00338-015-1312-0; Espinoza M, 2015, MAR BIOL, V162, P343, DOI 10.1007/s00227-014-2572-x; Espinoza M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106885; Espinoza M, 2011, FISH RES, V108, P364, DOI 10.1016/j.fishres.2011.01.011; Fitzpatrick R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051927; Frisk MG, 2014, FISH FISH, V15, P242, DOI 10.1111/faf.12014; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Hammerschlag N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045958; Heithaus MR, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00028; Heupel MR, 2014, MAR ECOL PROG SER, V496, P47, DOI 10.3354/meps10529; Heupel MR, 2009, FISH RES, V95, P350, DOI 10.1016/j.fishres.2008.10.005; Heupel M.R., 2001, ELECT TAGGING TRACKI, P217, DOI DOI 10.1007/978-94-017-1402-0_10; Heupel MR, 2008, AQUAT BIOL, V1, P277, DOI 10.3354/ab00030; Heupel MR, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00012; Heupel MR, 2012, J EXP MAR BIOL ECOL, V432, P131, DOI 10.1016/j.jembe.2012.07.013; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Hueter R. E., 2005, Journal of Northwest Atlantic Fishery Science, V35, P239; Hussey NE, SCIENCE, V80; IMOS, 2009, AUSTR AN TAGG MON SY; Keeney DB, 2005, MOL ECOL, V14, P1911, DOI 10.1111/j.1365-294X.2005.02549.x; Ketchum JT, 2014, MAR BIOL, V161, P939, DOI 10.1007/s00227-014-2393-y; Knip DM, 2012, BIOL CONSERV, V148, P200, DOI 10.1016/j.biocon.2012.01.008; Lea JSE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11202; Mapstone BD, 2004, 52 CRC REEF RES CTR; Matich P, 2014, J ANIM ECOL, V83, P199, DOI 10.1111/1365-2656.12106; McCauley DJ, 2012, ECOL APPL, V22, P1711, DOI 10.1890/11-1653.1; Meyer CG, 2010, MAR BIOL, V157, P1857, DOI 10.1007/s00227-010-1457-x; Mill A, 2010, 2A PASSION TARPON, P266; Olds AD, 2012, CONSERV LETT, V5, P56, DOI 10.1111/j.1755-263X.2011.00204.x; Papastamatiou YP, 2013, ECOLOGY, V94, P2595, DOI 10.1890/12-2014.1; R Development Core Team, 2014, R LANG ENV STAT COMP; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Simpfendorfer CA, 2002, CAN J FISH AQUAT SCI, V59, P23, DOI 10.1139/F01-191; Simpfendorfer CA, 2008, CAN J FISH AQUAT SCI, V65, P482, DOI 10.1139/F07-180; Sims DW, 2003, MAR ECOL PROG SER, V248, P187, DOI 10.3354/meps248187; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Tillett J, 2012, J FISH BIOL, V80, P2140, DOI 10.1111/j.1095-8649.2012.03228.x; Tobin A, 2013, FISH RES, V143, P47, DOI 10.1016/j.fishres.2013.01.011; Vianna GMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060331; Welsh JQ, 2012, CORAL REEFS, V31, P693, DOI 10.1007/s00338-012-0892-1; Werry JM, 2011, MAR FRESHWATER RES, V62, P1421, DOI 10.1071/MF11136; Werry J.M., 2010, HABITAT ECOLOGY BULL; Werry JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083249; Werry JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049796; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Zuur Alain F., 2009, P1	67	56	56	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147608	10.1371/journal.pone.0147608	http://dx.doi.org/10.1371/journal.pone.0147608			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841110	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000369550200050
J	Logan, JJ; Jolly, AM; Blanford, JI				Logan, James J.; Jolly, Ann M.; Blanford, Justine I.			The Sociospatial Network: Risk and the Role of Place in the Transmission of Infectious Diseases	PLOS ONE			English	Article							INJECTION-DRUG USERS; SEXUAL NETWORK; HIV; GONORRHEA; TUBERCULOSIS; PREVALENCE; CENTRALITY; DYNAMICS; OUTBREAK; MEXICO	Control of sexually transmitted infections and blood-borne pathogens is challenging due to their presence in groups exhibiting complex social interactions. In particular, sharing injection drug use equipment and selling sex (prostitution) puts people at high risk. Previous work examining the involvement of risk behaviours in social networks has suggested that social and geographic distance of persons within a group contributes to these pathogens' endemicity. In this study, we examine the role of place in the connectedness of street people, selected by respondent driven sampling, in the transmission of blood-borne and sexually transmitted pathogens. A sample of 600 injection drug users, men who have sex with men, street youth and homeless people were recruited in Winnipeg, Canada from January to December, 2009. The residences of participants and those of their social connections were linked to each other and to locations where they engaged in risk activity. Survey responses identified 101 unique sites where respondents participated in injection drug use or sex transactions. Risk sites and respondents' residences were geocoded, with residence representing the individuals. The sociospatial network and estimations of geographic areas most likely to be frequented were mapped with network graphs and spatially using a Geographic Information System (GIS). The network with the most nodes connected 7.7% of respondents; consideration of the sociospatial network increased this to 49.7%. The mean distance between any two locations in the network was within 3.5 kilometres. Kernel density estimation revealed key activity spaces where the five largest networks overlapped. Here, the combination of spatial and social entities in network analysis defines the overlap of vulnerable populations in risk space, over and above the person to person links. Implications of this work are far reaching, not just for understanding transmission dynamics of sexually transmitted infections by identifying activity "hotspots" and their intersection with each social network, but also for the spread of other diseases (e.g. tuberculosis) and targeting prevention services.	[Logan, James J.; Jolly, Ann M.] Univ Ottawa, Sch Epidemiol Publ Hlth & Preventat Med, Ottawa, ON, Canada; [Logan, James J.; Blanford, Justine I.] Penn State Univ, Dept Geog, Dutton Inst E Educ, University Pk, PA 16802 USA; [Logan, James J.; Blanford, Justine I.] Penn State Univ, GeoVISTA Ctr, University Pk, PA 16802 USA	University of Ottawa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Logan, JJ (corresponding author), Univ Ottawa, Sch Epidemiol Publ Hlth & Preventat Med, Ottawa, ON, Canada.; Logan, JJ (corresponding author), Penn State Univ, Dept Geog, Dutton Inst E Educ, University Pk, PA 16802 USA.; Logan, JJ (corresponding author), Penn State Univ, GeoVISTA Ctr, University Pk, PA 16802 USA.	jay.logan@gmail.com		Blanford, Justine/0000-0003-0844-9390	Canadian Institutes of Health Research [177297]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The work in this manuscript was funded by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) grant number 177297. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alere, 2012, ACT PROM SUMM CLIN E; ArcGIS. Environmental Systems Research Institute, ARCGIS; Batagelj V., 1996, PAJEK PROGRAM LARGE; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brewer DD, 2002, ADV MED SOC, V8, P131; Brouwer KC, 2012, ANN ASSOC AM GEOGR, V102, P1190, DOI 10.1080/00045608.2012.674896; Cabral T, 2003, J INFECT DIS, V187, P279, DOI 10.1086/346048; Centers for Disease Control and Prevention, 2013, CDC FACT SHEET INC P; City of Winnipeg, CITY OF WINNIPEG OPE; Cummins S, 2007, SOC SCI MED, V65, P1825, DOI 10.1016/j.socscimed.2007.05.036; DAngelo-Scott H, 2015, CAN J INFEC IN PRESS; De P, 2004, SEX TRANSM INFECT, V80, P280, DOI 10.1136/sti.2003.007187; De P, 2007, ADDICTION, V102, P1730, DOI 10.1111/j.1360-0443.2007.01936.x; Emch M, 2012, ANN ASSOC AM GEOGR, V102, P1004, DOI 10.1080/00045608.2012.671129; Frost SDW, 2006, J URBAN HEALTH, V83, pI83, DOI 10.1007/s11524-006-9104-z; Gile KJ, 2010, SOCIOL METHODOL, V40, P285, DOI 10.1111/j.1467-9531.2010.01223.x; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; Handcock MS, 2004, THEOR POPUL BIOL, V65, P413, DOI 10.1016/j.tpb.2003.09.006; Heckathorn DD, 2002, AIDS BEHAV, V6, P55; Jolly AM, 2001, SEX TRANSM DIS, V28, P200, DOI 10.1097/00007435-200104000-00003; Khan K, 2011, EMERG INFECT DIS, V17, P357, DOI 10.3201/eid1703.100833; Klovdahl AS, 2001, SOC SCI MED, V52, P681, DOI 10.1016/S0277-9536(00)00170-2; Martinez AN, 2014, INT J DRUG POLICY, V25, P516, DOI 10.1016/j.drugpo.2013.11.008; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; POTTERAT JJ, 1985, SEX TRANSM DIS, V12, P25, DOI 10.1097/00007435-198501000-00006; Public Health Agency of Canada, 2014, GLANC HIV AIDS CAN S; Public Health Agency of Canada, 2010, CAN GUID SEX TRANSM; Remis RS, 2007, MODELLING INCIDENCE; Rothenberg R, 2005, SEX TRANSM DIS, V32, P506, DOI 10.1097/01.olq.0000161191.12026.ca; ROTHENBERG RB, 1983, AM J EPIDEMIOL, V117, P688, DOI 10.1093/oxfordjournals.aje.a113602; Rudolph AE, 2013, ANN EPIDEMIOL, V23, P267, DOI 10.1016/j.annepidem.2013.02.006; Shane A, 2011, ISS SUBST C VANC BC; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHO, 2012, GLOB INC PREV SEL CU; Wylie JL, 2005, J INFECT DIS, V191, P899, DOI 10.1086/427661; Wylie JL, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-93	38	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146915	10.1371/journal.pone.0146915	http://dx.doi.org/10.1371/journal.pone.0146915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26840891	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200022
J	Blomfeldt, A; Hasan, AA; Aamot, HV				Blomfeldt, Anita; Hasan, Abdullahi Abdi; Aamot, Hege Vangstein			Can MLVA Differentiate among Endemic-Like MRSA Isolates with Identical Spa-Type in a Low-Prevalence Region?	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; FIELD GEL-ELECTROPHORESIS; TANDEM REPEAT ANALYSIS; TRANSMISSION; SUFFICIENT	The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in Norway is low, but an endemic-like MRSA clone with Staphylococcal protein A (spa)-type t304 has been established especially in nursing homes in the Oslo region causing several large outbreaks. The challenge was that spa-typing and the gold standard Pulsed-Field Gel Electrophoresis (PFGE) were inadequate in discriminating isolates in outbreak investigations. Additional higher resolution genotyping methods were needed. The aims of this study were a) to evaluate whether Multiple-Locus Variable number of tandem repeat Analysis (MLVA) could differentiate within the PFGE clusters between epidemiologically related and unrelated endemiclike ST8-MRSA-IV-t304-PVL-neg (MRSA-t304) isolates and b) investigate the evolution of the endemic-like MRSA-t304 clone over a 15-year time period. All MRSA-t304 isolates detected in the region from 1998 through April 2013 were included. In total, 194 of 197 isolates were available for PFGE and MLVA analyses. PFGE results on isolates from 19982010 have been published previously. Two PFGE clusters subdivided into eight MLVA types were detected. One major outbreak clone (PFGE cluster C2/MLVA type MT5045) appeared from 2004 to 2011 causing long-lasting and large outbreaks in seven nursing homes and one hospital. Five new MLVA types (N = 9 isolates) differing in only one VNTR compared to the outbreak clone C2/MT5045 were detected, but only one (C2/MT5044) was seen after 2011. We suggest that MLVA can replace PFGE analysis, but MLVA may not be the optimal method in this setting as it did not discriminate between all epidemiologically unrelated isolates. The results may indicate that all eight outbreaks in different locations within the PFGE C2 cluster may be branches of one large regional outbreak. The major outbreak strain C2/MT5045 may now, however, be under control, extinguished or has moved geographically.	[Blomfeldt, Anita; Aamot, Hege Vangstein] Akershus Univ Hosp, Dept Microbiol & Infect Control, Lorenskog, Norway; [Hasan, Abdullahi Abdi] Oslo & Akershus Univ, Fac Hlth Sci, Coll Appl Sci, Oslo, Norway; [Aamot, Hege Vangstein] Akershus Univ Hosp, Dept Clin Mol Biol EpiGen, Div Med, Lorenskog, Norway; [Aamot, Hege Vangstein] Univ Oslo, Lorenskog, Norway	University of Oslo; Oslo Metropolitan University (OsloMet); University of Oslo; University of Oslo	Aamot, HV (corresponding author), Akershus Univ Hosp, Dept Microbiol & Infect Control, Lorenskog, Norway.; Aamot, HV (corresponding author), Akershus Univ Hosp, Dept Clin Mol Biol EpiGen, Div Med, Lorenskog, Norway.; Aamot, HV (corresponding author), Univ Oslo, Lorenskog, Norway.	hege.vangstein.aamot@ahus.no		Blomfeldt, aNita/0000-0003-2044-412X				[Anonymous], 2009, NAT GUID PREV SPREAD; Azarian T, 2015, INFECT CONT HOSP EP, V36, P777, DOI 10.1017/ice.2015.73; Bartels MD, 2015, EURO SURVEILL, V20; Bosch T, 2015, FUTURE MICROBIOL, V10, P1155, DOI 10.2217/fmb.15.35; Chroboczek T, 2013, J TRAVEL MED, V20, P283, DOI 10.1111/jtm.12047; Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2; Helgason KO, 2008, J CLIN MICROBIOL, V46, P832, DOI 10.1128/JCM.02154-07; Moen AEF, 2014, J HOSP INFECT, V88, P72, DOI 10.1016/j.jhin.2014.06.008; Monecke Stefan, 2013, BMC Res Notes, V6, P548, DOI 10.1186/1756-0500-6-548; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Price JR, 2014, CLIN INFECT DIS, V58, P609, DOI 10.1093/cid/cit807; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Steen Tore Walgaard, 2013, Tidsskr Nor Laegeforen, V133, P1800, DOI 10.4045/tidsskr.13.0191; Steen Tore Walgaard, 2013, Tidsskr Nor Laegeforen, V133, P1819, DOI 10.4045/tidsskr.12.0935; Uhlemann AC, 2012, EUR J CLIN MICROBIOL, V31, P505, DOI 10.1007/s10096-011-1339-2; Uhlemann AC, 2014, P NATL ACAD SCI USA, V111, P6738, DOI 10.1073/pnas.1401006111; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x	17	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148772	10.1371/journal.pone.0148772	http://dx.doi.org/10.1371/journal.pone.0148772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859765	Green Published, gold			2022-12-27	WOS:000370038400080
J	Hall, E; Bishop, DC; Gee, TI				Hall, Emma; Bishop, Daniel C.; Gee, Thomas I.			Effect of Plyometric Training on Handspring Vault Performance and Functional Power in Youth Female Gymnasts	PLOS ONE			English	Article							RELIABILITY; ELITE	This study aimed to determine the effect of plyometric training (PT) when added to habitual gymnastic training (HT) on handspring vault (HV) performance variables. Twenty youth female competitive gymnasts (Age: 12.5 +/- 1.67 y) volunteered to participate and were randomly assigned to two independent groups. The experimental plyometric training group (PTG) undertook a six-week plyometric program, involving two additional 45 min PT sessions a week, alongside their HT, while the control group (CG) performed regular HT only. Videography was used (120 Hz) in the sagittal plane to record both groups performing three HVs for both the baseline and post-intervention trials. Furthermore, participants completed a countermovement jump test (CMJ) to assess the effect of PT on functional power. Through the use of Quintic biomechanics software, significant improvements (P < 0.05) were found for the PTG for run-up velocity, take-off velocity, hurdle to board distance, board contact time, table contact time and post-flight time and CMJ height. However, there were no significant improvements on pre-flight time, shoulder angle or hip angle on the vault for the PTG. The CG demonstrated no improvement for all HV measures. A sport-specific PT intervention improved handspring vault performance measures and functional power when added to the habitual training of youth female gymnasts. The additional two hours plyometric training seemingly improved the power generating capacity of movement-specific musculature, which consequently improved aspects of vaulting performance. Future research is required to examine the whether the improvements are as a consequence of the additional volume of sprinting and jumping activities, as a result of the specific PT method or a combination of these factors.	[Hall, Emma; Bishop, Daniel C.; Gee, Thomas I.] Lincoln Univ, Sch Sport & Exercise Sci, Lincoln, NE 68505 USA		Gee, TI (corresponding author), Lincoln Univ, Sch Sport & Exercise Sci, Lincoln, NE 68505 USA.	tgee@lincoln.ac.uk		Gee, Thomas/0000-0001-7253-2055; Bishop, Daniel/0000-0002-2094-7045				Aagaard P, 2003, EXERC SPORT SCI REV, V31, P61, DOI 10.1097/00003677-200304000-00002; Adams K., 1992, J STRENGTH COND RES, V6, P36, DOI DOI 10.1519/00124278-199202000-00006; Ahmet A, 2013, SERB J SPORTS SCI, V7, P45; Arazi H, 2012, S AFR J RES SPORT PH, V34, P1; Arkaev L., 2004, GYMNASTICS CREATE CH; Atikovic A, 2012, J HUM KINET, V35, P119, DOI 10.2478/v10078-012-0085-6; BALE P, 1990, SPORTS MED, V10, P139, DOI 10.2165/00007256-199010030-00001; Ball NB, 2009, J STRENGTH COND RES, V23, P1433, DOI 10.1519/JSC.0b013e3181a4e97f; Bencke J, 2002, SCAND J MED SCI SPOR, V12, P171, DOI 10.1034/j.1600-0838.2002.01128.x; Bishop DC, 2009, J STRENGTH COND RES, V23, P2137, DOI 10.1519/JSC.0b013e3181b866d0; Bobbert MF, 1996, MED SCI SPORT EXER, V28, P1402, DOI 10.1097/00005768-199611000-00009; Bradshaw EJ, 2014, P INT C BIOM SPORT 1; Bradshaw E, 2010, SPORT BIOMECH, V9, P79, DOI 10.1080/14763141.2010.488298; Bradshaw Elizabeth J, 2004, Sports Biomech, V3, P249, DOI 10.1080/14763140408522844; Chimera NJ, 2004, J ATHL TRAINING, V39, P24; FIG (Federation International de Gymnastique), 2013, 2013 COD POINTS WOM; Ford P, 2011, J SPORT SCI, V29, P389, DOI 10.1080/02640414.2010.536849; Hopkins WG, 2003, SPREADSHEET ANAL STR; Jemni M, 2006, J STRENGTH COND RES, V20, P899; Kums T, 2005, BIOL SPORT, V22, P237; Lockwood K, 2004, SPORT J, V7, P184; Makanuk H, 2010, HUMAN MOVEMENT, V11, P17; Marina M, 2014, J STRENGTH COND RES, V28, P1015, DOI 10.1519/JSC.0000000000000247; Meylan C, 2009, J STRENGTH COND RES, V23, P2605, DOI 10.1519/JSC.0b013e3181b1f330; Potteiger JA, 1999, J STRENGTH COND RES, V13, P275, DOI 10.1519/00124278-199908000-00016; Ramirez-Campillo R, 2013, J STRENGTH COND RES, V27, P2714, DOI 10.1519/JSC.0b013e318280c9e9; Slinde F, 2008, J STRENGTH COND RES, V22, P640, DOI 10.1519/JSC.0b013e3181660475; TAKEI Y, 1990, INT J SPORT BIOMECH, V6, P29, DOI 10.1123/ijsb.6.1.29; Takei Y, 1998, J APPL BIOMECH, V14, P190, DOI 10.1123/jab.14.2.190; Vassal K, 2010, J HUM SPORT EXERC, V7, P34	30	83	90	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148790	10.1371/journal.pone.0148790	http://dx.doi.org/10.1371/journal.pone.0148790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859381	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000370038400085
J	Hwang, SH; Kang, JM; Seo, JH; Han, KD; Joo, YH				Hwang, Se-Hwan; Kang, Jun-Myung; Seo, Jae-Hyun; Han, Kyung-do; Joo, Young-Hoon			Gender Difference in the Epidemiological Association between Metabolic Syndrome and Olfactory Dysfunction: The Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							DIABETES-MELLITUS; HORMONES; SMELL; RISK	Metabolic syndrome (MetS) is associated with a higher risk of morbidity and/or mortality for various chronic diseases. The aim of this study was to investigate the relationships of MetS and its components with olfactory dysfunction in a representative Korean population. We analyzed the data from the Korean National Health and Nutrition Examination Survey (2008-2010). A total of 11,609 adults who underwent otolaryngological examination were evaluated. The olfactory function was classified as normosmia or hyposmia by a self-report questionnaire according to the sense problems of smell during the past 3 months. MetS was diagnosed if a participant had at least three of the following: (1) WC >= 90 cm in men and >= 80 cm in women; (2) fasting blood sugar >= 100 mg/dL or medication use for elevated glucose; (3) fasting triglyceride >= 150 mg/dL or cholesterol-lowering medication use; (4) HDL-cholesterol <40 mg/dL in men and <50 mg/dL in women or cholesterol-lowering medication use; and (5) SBP >= 130 mmHg and/or DBP >= 85 mmHg or antihypertensive drug use for patients with a history of hypertension. The prevalence of olfactory dysfunction in the study population was 6.3%. The prevalence of olfactory dysfunction was significantly higher in older people with MetS than in those without MetS in both sexes (male, 42.0 +/- 3.4% vs. 34.7 +/- 0.9%, p = 0.0354; female, 46.2 +/- 2.8% vs. 37.8 +/- 0.8%, p = 0.0026). However, elevated waist circumference, elevated fasting glucose, elevated triglycerides, reduced HDL cholesterol, elevated blood pressure, severe stress, depressed mood, and suicidal ideation were significantly associated with olfactory dysfunction only in women. After controlling for confounders, olfactory dysfunction was significantly associated with MetS (odds ratio, 1.352; 95% confidence interval, 1.005-1.820) only in women. MetS are associated with olfactory dysfunction only in Korean women.	[Hwang, Se-Hwan; Kang, Jun-Myung; Seo, Jae-Hyun; Joo, Young-Hoon] Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Han, Kyung-do] Catholic Univ Korea, Dept Biostat, Coll Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Joo, YH (corresponding author), Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	joodoct@catholic.ac.kr	Joo, Young Hoon/AAU-7285-2020	Joo, Young Hoon/0000-0002-4662-1916; Hwang, Se Hwan/0000-0002-2838-7820				Banos G., 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P137; Brady S, 2013, CHEM SENSES, V38, P497, DOI 10.1093/chemse/bjt013; Gouveri E, 2014, ANGIOLOGY, V65, P869, DOI 10.1177/0003319714520956; Henkin RI, 2014, NUTRITION, V30, P690, DOI 10.1016/j.nut.2013.11.003; HUBERT HB, 1980, SCIENCE, V208, P607, DOI 10.1126/science.7189296; Johnson P, 2015, WORKPLACE HEALTH SAF, V63, P245, DOI 10.1177/2165079915576920; Joo YH, 2015, AM J RHINOL ALLERGY, V29, P268, DOI 10.2500/ajra.2015.29.4194; Kim Yangho, 2013, J Prev Med Public Health, V46, P96, DOI 10.3961/jpmph.2013.46.2.96; Lee DH, 2013, DIABETES METAB J, V37, P132, DOI 10.4093/dmj.2013.37.2.132; Lee WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062725; Lim W, 2015, J PHYS THER SCI, V27, P555, DOI 10.1589/jpts.27.555; Obrebowski A, 2000, INT J PEDIATR OTORHI, V55, P191, DOI 10.1016/S0165-5876(00)00397-9; Oh SW, 2004, OBES RES, V12, P2031, DOI 10.1038/oby.2004.254; Pankevich DE, 2008, OBESITY, V16, P1539, DOI 10.1038/oby.2008.221; Park HA, 2013, KOREAN J FAM MED, V34, P79, DOI 10.4082/kjfm.2013.34.2.79; Park SH, 2010, INT J CARDIOL, V139, P234, DOI 10.1016/j.ijcard.2008.10.011; Rhee CS, 2014, AM J RHINOL ALLERGY, V28, pE107, DOI 10.2500/ajra.2014.28.4040; Sanchez I, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0471-5; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Thiebaud N, 2014, J NEUROSCI, V34, P6970, DOI 10.1523/JNEUROSCI.3366-13.2014; Tucker KR, 2012, PHYSIOL BEHAV, V107, P424, DOI 10.1016/j.physbeh.2012.09.007; WEINSTOCK RS, 1993, PHYSIOL BEHAV, V53, P17, DOI 10.1016/0031-9384(93)90005-Z; Zamora R, 2012, CLIN NEUROPHYSIOL, V123, P918, DOI 10.1016/j.clinph.2011.09.001	23	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148813	10.1371/journal.pone.0148813	http://dx.doi.org/10.1371/journal.pone.0148813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859830	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400090
J	Weinkauf, MFG; Kunze, JG; Waniek, JJ; Kucera, M				Weinkauf, Manuel F. G.; Kunze, Jose G.; Waniek, Joanna J.; Kucera, Michal			Seasonal Variation in Shell Calcification of Planktonic Foraminifera in the NE Atlantic Reveals Species-Specific Response to Temperature, Productivity, and Optimum Growth Conditions	PLOS ONE			English	Article							CARBONATE ION CONCENTRATION; SEA-SURFACE TEMPERATURES; CLIMATE-CHANGE; INTERANNUAL VARIABILITY; SECONDARY CALCIFICATION; AZORES FRONT; OCEAN; WEIGHT; SIZE; ASSEMBLAGES	Using shells collected from a sediment trap series in the Madeira Basin, we investigate the effects of seasonal variation of temperature, productivity, and optimum growth conditions on calcification in three species of planktonic Foraminifera. The series covers an entire seasonal cycle and reflects conditions at the edge of the distribution of the studied species, manifesting more suitable growth conditions during different parts of the year. The seasonal variation in seawater carbonate saturation at the studied site is negligible compared to other oceanic regions, allowing us to assess the effect of parameters other than carbonate saturation. Shell calcification is quantified using weight and size of individual shells. The size-weight scaling within each species is robust against changes in environmental parameters, but differs among species. An analysis of the variation in calcification intensity (size-normalized weight) reveals species-specific response patterns. In Globigerinoides ruber (white) and Globigerinoides elongatus, calcification intensity is correlated with temperature (positive) and productivity (negative), whilst in Globigerina bulloides no environmental forcing is observed. The size-weight scaling, calcification intensity, and response of calcification intensity to environmental change differed between G. ruber (white) and G. elongatus, implying that patterns extracted from pooled analyses of these species may reflect their changing proportions in the samples. Using shell flux as a measure of optimum growth conditions, we observe significant positive correlation with calcification intensity in G. elongatus, but negative correlation in G. bulloides. The lack of a consistent response of calcification intensity to optimum growth conditions is mirrored by the results of shell size analyses. We conclude that calcification intensity in planktonic Foraminifera is affected by factors other than carbonate saturation. These factors include temperature, productivity, and optimum growth conditions, but the strength and sign of the relationships differ among species, potentially complicating interpretations of calcification data from the fossil record.	[Weinkauf, Manuel F. G.; Kunze, Jose G.] Univ Tubingen, Dept Geosci, Tubingen, Germany; [Weinkauf, Manuel F. G.; Kucera, Michal] Univ Bremen, MARUM, D-28359 Bremen, Germany; [Waniek, Joanna J.] Leibniz Inst Baltic Sea Res Warnemunde, Marine Chem Sect, Rostock, Germany; [Weinkauf, Manuel F. G.] Univ Geneva, Dept Earth Sci, Geneva, Switzerland	Eberhard Karls University of Tubingen; University of Bremen; Leibniz Institut fur Ostseeforschung Warnemunde; University of Geneva	Weinkauf, MFG (corresponding author), Univ Tubingen, Dept Geosci, Tubingen, Germany.; Weinkauf, MFG (corresponding author), Univ Bremen, MARUM, D-28359 Bremen, Germany.; Weinkauf, MFG (corresponding author), Univ Geneva, Dept Earth Sci, Geneva, Switzerland.	Manuel.Weinkauf@unige.ch	Kucera, Michal/ABH-6065-2020; Kucera, Michal/B-9277-2009; Weinkauf, Manuel/AAL-5704-2020; Kucera, Michal/AAE-8115-2020	Kucera, Michal/0000-0002-7817-9018; Kucera, Michal/0000-0002-7817-9018; Weinkauf, Manuel F. G./0000-0002-4640-9659; Waniek, Joanna J./0000-0003-3724-073X	Landesgraduiertenforderung of the Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg; Joanna M. Resig Foraminiferal Research Fellowship of the Cushman Foundation for Foraminiferal Research	Landesgraduiertenforderung of the Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg; Joanna M. Resig Foraminiferal Research Fellowship of the Cushman Foundation for Foraminiferal Research	MFGW received funding from the Landesgraduiertenforderung of the Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg (https://mwk.baden-wuerttemberg.de/de/startseite/) and the Joanna M. Resig Foraminiferal Research Fellowship of the Cushman Foundation for Foraminiferal Research (http://www.cushmanfoundation.org/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aldridge D, 2012, BIOGEOSCIENCES, V9, P1725, DOI 10.5194/bg-9-1725-2012; [Anonymous], 2013, NOAA ATLAS NESDIS; Aurahs R, 2011, MAR MICROPALEONTOL, V79, P1, DOI 10.1016/j.marmicro.2010.12.001; Barker S, 2002, SCIENCE, V297, P833, DOI 10.1126/science.1072815; Barrows TT, 2005, QUATERNARY SCI REV, V24, P1017, DOI 10.1016/j.quascirev.2004.07.020; Be A.W.H., 1977, OCEANIC MICROPALEONT, P1; BE AWH, 1964, SCIENCE, V145, P823, DOI 10.1126/science.145.3634.823; Beer CJ, 2010, BIOGEOSCIENCES, V7, P2193, DOI 10.5194/bg-7-2193-2010; Beer CJ, 2010, GEOLOGY, V38, P103, DOI 10.1130/G30150.1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bijma J, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2002GC000388; Bijma J., 1999, USE PROXIES PALEOCEA, DOI DOI 10.1007/978-3-642-58646-0_20; Broecker W, 2001, PALEOCEANOGRAPHY, V16, P531, DOI 10.1029/2000PA000600; Broecker WS, 2001, PALEOCEANOGRAPHY, V16, P669, DOI 10.1029/2001PA000660; Brummer G.J., 1988, PLANKTONIC FORAMINIF; CARON DA, 1982, J MAR BIOL ASSOC UK, V62, P435, DOI 10.1017/S0025315400057374; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; Davis CV, 2013, BIOGEOSCIENCES, V10, P6131, DOI 10.5194/bg-10-6131-2013; Davison AC, 1997, CAMBRIDGE SERIES STA, V1; de Moel H, 2009, BIOGEOSCIENCES, V6, P1917, DOI 10.5194/bg-6-1917-2009; de Villiers S, 2004, MAR BIOL, V144, P45, DOI 10.1007/s00227-003-1183-8; Dixon P. M., 2002, ENCY ENV, P212; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; EREZ J, 1981, PALAEOGEOGR PALAEOCL, V33, P129, DOI 10.1016/0031-0182(81)90035-3; FLIGNER MA, 1976, J AM STAT ASSOC, V71, P210, DOI 10.2307/2285771; Frundt B, 2012, CENT EUR J GEOSCI, V4, P531, DOI 10.2478/s13533-012-0102-2; Gonzalez-Davila M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001993; Gonzalez-Davila M, 2008, SURFACE CARBON DIOXI; Gonzalez-Mora B, 2008, QUATERNARY SCI REV, V27, P956, DOI 10.1016/j.quascirev.2008.01.008; Good SA, 2013, J GEOPHYS RES-OCEANS, V118, P6704, DOI 10.1002/2013JC009067; Goyet C., 2000, GLOBAL DISTRIBUTION; HECHT A D, 1976, Journal of Foraminiferal Research, V6, P295; Helsel D. R., 2002, TECHNIQUES WATER RES, V4, pA3, DOI DOI 10.2307/1269385; Hemleben C., 1989, MODERN PLANKTONIC FO, DOI [DOI 10.1016/S0016-6995(89)80108-1, DOI 10.1007/978-1-4612-3544-6_2]; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; KLEIN B, 1989, J GEOPHYS RES-OCEANS, V94, P6159, DOI 10.1029/JC094iC05p06159; Kremling K, 1996, REV SCI INSTRUM, V67, P4360, DOI 10.1063/1.1147582; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kucera M, 2005, QUATERNARY SCI REV, V24, P951, DOI 10.1016/j.quascirev.2004.07.014; Kucera M, 2007, DEV MARINE GEOL, V1, P213, DOI 10.1016/S1572-5480(07)01011-1; Levitus S, 2013, NOAA ATLAS NESDIS, V4, P1; Lewis E., 1998, PROGRAM DEV CO2 SYST; Locarnini RA, 2013, NOAA ATLAS NESDIS, V73, P1; LOHMANN GP, 1995, PALEOCEANOGRAPHY, V10, P445, DOI 10.1029/95PA00059; Lombard F, 2010, BIOGEOSCIENCES, V7, P247, DOI 10.5194/bg-7-247-2010; Longhurst A, 1995, PROG OCEANOGR, V36, P77, DOI 10.1016/0079-6611(95)00015-1; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Manno C, 2012, POLAR BIOL, V35, P1311, DOI 10.1007/s00300-012-1174-7; Marshall BJ, 2013, PALEOCEANOGRAPHY, V28, P363, DOI 10.1002/palo.20034; McDonald J.H., 2009, HDB BIOL STAT; Media Cybernetics Inc., 2006, IM PROPL VERS 6 0 WI; Mohan R, 2015, ACTA GEOL SIN-ENGL, V89, P27; Moy AD, 2009, NAT GEOSCI, V2, P276, DOI 10.1038/NGEO460; Naik SS, 2013, J EARTH SYST SCI, V122, P1153, DOI 10.1007/s12040-013-0330-y; Naik SS, 2011, CURR SCI INDIA, V101, P1370; Naik SS, 2010, MAR GEOL, V275, P278, DOI 10.1016/j.margeo.2010.05.004; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Numberger L, 2009, MAR MICROPALEONTOL, V73, P90, DOI 10.1016/j.marmicro.2009.07.004; Parket F. L., 1962, Micropaleontology, V8, P219, DOI 10.2307/1484745; Peeters F, 1999, MAR MICROPALEONTOL, V36, P31, DOI 10.1016/S0377-8398(98)00026-7; R Development Core Team, 2014, R LANG ENV STAT COMP; ROBBINS LL, 1988, J FORAMIN RES, V18, P326, DOI 10.2113/gsjfr.18.4.326; Schiebel R, 2002, DEEP-SEA RES PT II, V49, P4035, DOI 10.1016/S0967-0645(02)00141-8; Schlitzer R., 2014, OCEAN DATA VIEW; Schmidt DN, 2004, MAR MICROPALEONTOL, V50, P319, DOI 10.1016/S0377-8398(03)00098-7; Schmidt DN, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000831; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; SPERO HJ, 1988, MAR BIOL, V99, P9, DOI 10.1007/BF00644972; Steinke S, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000926; Storz D, 2006, THESIS EBERHARD KARL; Storz D, 2009, DEEP-SEA RES PT I, V56, P107, DOI 10.1016/j.dsr.2008.08.009; Tabor J, 2010, J STAT ED, V18, P1; Theil H., 1950, P KONINKLIJKE NEDERL, V53, P1397; van Sebille E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7521; Wang LJ, 2000, PALAEOGEOGR PALAEOCL, V161, P381, DOI 10.1016/S0031-0182(00)00094-8; Waniek JJ, 2005, DEEP-SEA RES PT I, V52, P33, DOI 10.1016/j.dsr.2004.08.008; Weinkauf MFG, 2013, BIOGEOSCIENCES, V10, P6639, DOI 10.5194/bg-10-6639-2013; Yoder J, 2005, LIVE ACCESS US JGOFS; YOHAI VJ, 1991, IMA V MATH, V34, P365	82	30	31	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148363	10.1371/journal.pone.0148363	http://dx.doi.org/10.1371/journal.pone.0148363			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859838	Green Published, gold			2022-12-27	WOS:000370038400036
J	Chaves, OM; Bicca-Marques, JC				Chaves, Oscar M.; Bicca-Marques, Julio Cesar			Feeding Strategies of Brown Howler Monkeys in Response to Variations in Food Availability	PLOS ONE			English	Article							ALOUATTA-PALLIATA-MEXICANA; FALLBACK FOODS; BEHAVIORAL FLEXIBILITY; FOREST FRAGMENTATION; PRIMATE RESPONSES; ACTIVITY PATTERN; RAIN-FOREST; DIET; ECOLOGY; FRUIT	Primates display varying degrees of behavioral flexibility that allow them to adjust their diet to temporal changes in food availability. This trait might be critical for the survival of folivorous-frugivorous species inhabiting small forest fragments, where the availability of food resources tends to be lower than in large fragments and continuous forests. However, the scarcity of studies addressing this issue hampers our understanding of the adaptive behaviors that favor the survival of these primates in low-quality habitats. We conducted a 36-mo study testing the hypothesis that brown howler monkeys (Alouatta guariba clamitans) are able to adjust their diet in response to local and seasonal changes in resource availability. We compared the diet of six free-ranging groups inhabiting three small (<10 ha) and three large (>90 ha) Atlantic forest fragments in southern Brazil and estimated the temporal availability of their top food species (i.e., those species that together contribute >= 80% of total feeding records). We found that brown howlers exploited similarly rich diets in small (45, 54, and 57 plant species) and large (48, 51, and 56 species) fragments. However, intermonth diet similarity was higher for groups in small fragments, where howlers also fed on plant items from nine alien species. Fruits and leaves were the most consumed plant items in both small (42% and 49% of feeding records, respectively) and large (51% and 41%, respectively) fragments. The consumption of young leaves was higher in small than in large fragments, whereas the consumption of other plant items did not show a pattern related to fragment size. Regarding the contribution of growth forms as food sources, only the exploitation of palms showed a pattern related to fragment size. Palms contributed more to the diet of groups inhabiting large fragments. The availability of seasonal food items-ripe fruits and young leaves-influenced their consumption in both habitat types. Therefore, brown howlers cope with local and seasonal fluctuations in food availability by opportunistically exploiting resources. We believe that this feeding flexibility is a key component of the phenotypic plasticity that enables howlers to thrive in disturbed habitat patches, where periods of scarcity of preferred foods shall be more common.	[Chaves, Oscar M.; Bicca-Marques, Julio Cesar] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul	Bicca-Marques, JC (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil.	jcbicca@pucrs.br	Bicca-Marques, Júlio César/F-7487-2012; Chaves, Óscar M./AAF-1886-2021	Bicca-Marques, Júlio César/0000-0002-5400-845X; Chaves, Óscar M./0000-0001-6246-1265	Programa Nacional de Pos-Doutorado of the Brazilian Higher Education Authority/CAPES (PNPD grant) [2755/2010]; PNPD postdoctoral fellowship; Brazilian National Research Council/CNPq [303154/2009-8, 303306/2013-0]	Programa Nacional de Pos-Doutorado of the Brazilian Higher Education Authority/CAPES (PNPD grant); PNPD postdoctoral fellowship; Brazilian National Research Council/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by a grant from the Programa Nacional de Pos-Doutorado of the Brazilian Higher Education Authority/CAPES (PNPD grant # 2755/2010). OMC was supported by a PNPD postdoctoral fellowship. JCBM thanks the Brazilian National Research Council/CNPq for research fellowships (PQ # 303154/2009-8 and 303306/2013-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini I, 2010, AM J PRIMATOL, V72, P173, DOI 10.1002/ajp.20775; Alonso A, 2004, MONOGRAPH U FEDERAL; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anderson J, 2007, BIOL CONSERV, V135, P212, DOI 10.1016/j.biocon.2006.10.022; Arroyo-Rodriguez V, 2007, BIOTROPICA, V39, P760, DOI 10.1111/j.1744-7429.2007.00330.x; Arroyo-Rodriguez V, 2015, ECOLOGY OF LIANAS, P407; ARROYORODRIGUEZ V, 2010, AM J PRIMATOL, V72, P1, DOI DOI 10.1002/ajp.20753; Asensio N, 2009, BIOTROPICA, V41, P768, DOI 10.1111/j.1744-7429.2009.00533.x; Behie AM, 2015, DEV PRIMATOL-PROG PR, P357, DOI 10.1007/978-1-4939-1960-4_13; Bicca-Marques JC, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P283; BICCAMARQUES JC, 1994, FOLIA PRIMATOL, V63, P209, DOI 10.1159/000156821; BICCAMARQUES JC, 1994, FOLIA PRIMATOL, V63, P216, DOI 10.1159/000156823; BUSS G, 2001, THESIS U FEDERAL RIO; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; CHAPMAN C, 1987, FOLIA PRIMATOL, V49, P90, DOI 10.1159/000156311; CHAPMAN CA, 1990, PRIMATES, V31, P121, DOI 10.1007/BF02381035; Chapman CA, 2013, DEV PRIMATOL-PROG PR, P89, DOI 10.1007/978-1-4614-8839-2_7; Chaves OM, 2013, AM J PRIMATOL, V75, P16, DOI 10.1002/ajp.22075; Chaves OM, 2012, BIOTROPICA, V44, P105, DOI 10.1111/j.1744-7429.2011.00766.x; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Colwell RK, 2005, ESTIMATES STAT ESTIM, V7, P5; Constantino PJ, 2009, AM J PHYS ANTHROPOL, V140, P599, DOI 10.1002/ajpa.20978; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Cristobal-Azkarate J, 2007, AM J PRIMATOL, V69, P1013, DOI 10.1002/ajp.20420; Dias PAD, 2015, DEV PRIMATOL-PROG PR, P21, DOI 10.1007/978-1-4939-1960-4_2; Dias PAD, 2014, AM J PRIMATOL, V76, P1151, DOI 10.1002/ajp.22300; DILL LM, 1983, CAN J FISH AQUAT SCI, V40, P398, DOI 10.1139/f83-058; Dunn JC, 2012, BIOTROPICA, V44, P705, DOI 10.1111/j.1744-7429.2012.00856.x; Dunn JC, 2010, INT J PRIMATOL, V31, P887, DOI 10.1007/s10764-010-9436-0; Dunn JC, 2009, AM J PRIMATOL, V71, P654, DOI 10.1002/ajp.20700; FOURNIER LA, 1974, TURRIALBA, V24, P422; GENTRY AH, 1982, EVOL BIOL, V15, P1; Gouveia SF, 2014, J ANIM ECOL, V83, P1523, DOI 10.1111/1365-2656.12241; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hemingway CA, 2005, CAM S BIO EVOL ANTHR, V44, P57, DOI 10.1017/CBO9780511542343.004; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Jones CB., 2005, BEHAV FLEXIBILITY PR, DOI [10.1007/978-0-387-23327-7, DOI 10.1007/978-0-387-23327-7]; Kinzey WG., 1982, BIOL DIVERSIFICATION, P455; Lambert JE, 2011, PRIMATES PERSPECTIVE, P512, DOI DOI 10.1002/ECY.2106; Lambert JE, 2015, ANNU REV ANTHROPOL, V44, P493, DOI 10.1146/annurev-anthro-102313-025928; Lansky EP, 2011, FIGS THE GENUS FICUS; Lowry H, 2013, BIOL REV, V88, P537, DOI 10.1111/brv.12012; Ludwig G, 2008, REV BRAS ZOOL, V25, P419, DOI 10.1590/S0101-81752008000300006; Maibeche Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118596; Marshall AJ, 2009, AM J PHYS ANTHROPOL, V140, P603, DOI 10.1002/ajpa.21082; McKinney T, 2015, DEV PRIMATOL-PROG PR, P281, DOI 10.1007/978-1-4939-1960-4_11; MILTON K, 1991, J ECOL, V79, P1, DOI 10.2307/2260781; Nowak K, 2013, DEV PRIMATOL-PROG PR, P199, DOI 10.1007/978-1-4614-8839-2_14; Onderdonk DA, 2000, INT J PRIMATOL, V21, P587, DOI 10.1023/A:1005509119693; PERES CA, 1994, BIOTROPICA, V26, P98, DOI 10.2307/2389114; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Printes Rodrigo C., 2001, Neotropical Primates, V9, P118; R Core Team, 2013, R LANG ENV STAT COMP; REICH PB, 1995, CAN J BOT, V73, P164, DOI 10.1139/b95-020; Rivera A, 2006, DEV PRIMATOL-PROG PR, P189, DOI 10.1007/0-387-25872-8_9; Salomao R. P., 2012, Floresta, V42, P115; Schnell JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065357; Serio-Silva JC, 2002, J TROP ECOL, V18, P913, DOI 10.1017/S0266467402002596; Setubal RB, 2011, CAMPOS MORROS PORTO; Sica YV, 2014, BIOTROPICA, V46, P696, DOI 10.1111/btp.12152; Silver SC, 1998, AM J PRIMATOL, V45, P263, DOI 10.1002/(SICI)1098-2345(1998)45:3<263::AID-AJP3>3.0.CO;2-U; Sobral M., 2006, FLORA ARBORESCENTE R; Sol D, 2002, ANIM BEHAV, V63, P495, DOI 10.1006/anbe.2001.1953; Sol D, 2013, ANIM BEHAV, V85, P1101, DOI 10.1016/j.anbehav.2013.01.023; Strier KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114099; Turner IM, 1996, J APPL ECOL, V33, P200, DOI 10.2307/2404743; Weinbeer M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00342; Whitman D. W., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P1; Wong BBM, 2015, BEHAV ECOL, V26, P665, DOI 10.1093/beheco/aru183; Zimmerman JK, 2007, J TROP ECOL, V23, P231, DOI 10.1017/S0266467406003890	71	25	25	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0145819	10.1371/journal.pone.0145819	http://dx.doi.org/10.1371/journal.pone.0145819			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848959	Green Published, gold			2022-12-27	WOS:000369554000005
J	Frankel, ML; Demeter, MA; Lemire, JA; Turner, RJ				Frankel, Mathew L.; Demeter, Marc A.; Lemire, Joe A.; Turner, Raymond J.			Evaluating the Metal Tolerance Capacity of Microbial Communities Isolated from Alberta Oil Sands Process Water	PLOS ONE			English	Article							NAPHTHENIC ACIDS; WASTE-WATER; HEAVY-METALS; BIOFILM; TOXICITY; MECHANISMS; BIODEGRADATION; METABOLISM; RESISTANCE; SYSTEMS	Anthropogenic activities have resulted in the intensified use of water resources. For example, open pit bitumen extraction by Canada's oil sands operations uses an estimated volume of three barrels of water for every barrel of oil produced. The waste tailings-oil sands process water (OSPW)-are stored in holding ponds, and present an environmental concern as they are comprised of residual hydrocarbons and metals. Following the hypothesis that endogenous OSPWmicrobial communities have an enhanced tolerance to heavy metals, we tested the capacity of planktonic and biofilm populations from OSPW to withstand metal ion challenges, using Cupriavidus metallidurans, a known metal-resistant organism, for comparison. The toxicity of the metals toward biofilm and planktonic bacterial populations was determined by measuring the minimum biofilm inhibitory concentrations (MBICs) and planktonic minimum inhibitory concentrations (MICs) using the MBEC T assay. We observed that the OSPW community and C. metallidurans had similar tolerances to 22 different metals. While thiophillic elements (Te, Ag, Cd, Ni) were found to be most toxic, the OSPW consortia demonstrated higher tolerance to metals reported in tailings ponds (Al, Fe, Mo, Pb). Metal toxicity correlated with a number of physicochemical characteristics of the metals. Parameters reflecting metal-ligand affinities showed fewer and weaker correlations for the community compared to C. metallidurans, suggesting that the OSPW consortia may have developed tolerance mechanisms toward metals present in their environment.	[Frankel, Mathew L.; Demeter, Marc A.; Lemire, Joe A.; Turner, Raymond J.] Univ Calgary, Dept Biol Sci, Biofilm Res Grp, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada	University of Calgary	Turner, RJ (corresponding author), Univ Calgary, Dept Biol Sci, Biofilm Res Grp, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	turner@ucalgary.ca	Turner, Raymond J./M-3961-2015	Turner, Raymond J./0000-0002-9263-0776	Natural Sciences and Engineering Research Council of Canada [NSERC DG RGPIN 216887-2010]; Alberta Innovates [201300520] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates	This work was funded by The Natural Sciences and Engineering Research Council of Canada (Grant no. NSERC DG RGPIN 216887-2010, URL: http://www.nserc-crsng.gc.ca/index_eng.asp), and received by RJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolfazlzadehdoshanbehbazari M., 2011, CHARACTERIZING TRANS; Allen EW, 2008, J ENVIRON ENG SCI, V7, P123, DOI 10.1139/S07-038; BAATH E, 1989, WATER AIR SOIL POLL, V47, P335, DOI 10.1007/BF00279331; Baes C.F., 1976, HYDROLYSIS CATIONS, DOI 10.1002/bbpc.19770810252; Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006; Barranguet C, 2000, EUR J PHYCOL, V35, P397, DOI 10.1080/09670260010001736001; Beech WB, 2004, CURR OPIN BIOTECH, V15, P181, DOI 10.1016/j.copbio.2004.05.001; BIESINGER KE, 1972, J FISH RES BOARD CAN, V29, P1691, DOI 10.1139/f72-269; Booth SC, 2013, METALLOMICS, V5, P723, DOI 10.1039/c3mt20240b; Booth SC, 2011, J PROTEOME RES, V10, P3190, DOI 10.1021/pr2002353; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Bushnell LD, 1941, J BACTERIOL, V41, P653, DOI 10.1128/JB.41.5.653-673.1941; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; COLLINS YE, 1992, APPL ENVIRON MICROB, V58, P1592, DOI 10.1128/AEM.58.5.1592-1600.1992; Cornelis G, 2008, APPL GEOCHEM, V23, P955, DOI 10.1016/j.apgeochem.2008.02.001; Danielli JF, 1951, ADV ENZYMOL RELAT AR, P69; Demeter MA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00936; Demeter MA, 2014, CHEMOSPHERE, V97, P78, DOI 10.1016/j.chemosphere.2013.11.016; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; EPA, 2013, SUMM DAT 2013 PRIOR; Golby S, 2014, MICROB ECOL, V68, P70, DOI 10.1007/s00248-013-0331-z; Golby S, 2012, FEMS MICROBIOL ECOL, V79, P240, DOI 10.1111/j.1574-6941.2011.01212.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Harrison JJ, 2004, ENVIRON MICROBIOL, V6, P1220, DOI 10.1111/j.1462-2920.2004.00656.x; Harrison JJ, 2005, ENVIRON MICROBIOL, V7, P981, DOI 10.1111/j.1462-2920.2005.00777.x; Harrison JJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-53; Harrison JJ, 2008, ANTIMICROB AGENTS CH, V52, P2870, DOI 10.1128/AAC.00203-08; Harrison JJ, 2007, NAT REV MICROBIOL, V5, P928, DOI 10.1038/nrmicro1774; Haynes WM, 2016, CRC HDB CHEM PHYS, V95th, DOI [10.1097/00000441-196906000-00020, DOI 10.233]; HERMAN DC, 1994, CAN J MICROBIOL, V40, P467, DOI 10.1139/m94-076; Hulecki JC, 2010, J IND MICROBIOL BIOT, V37, P471, DOI 10.1007/s10295-010-0693-x; Janssen PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010433; JONES MM, 1978, J INORG NUCL CHEM, V40, P2081, DOI 10.1016/0022-1902(78)80212-7; KAISER KL, 1980, CAN J FISH AQUAT SCI, V37, P211, DOI 10.1139/f80-027; Kannel PR, 2012, J ENVIRON SCI HEAL A, V47, P1, DOI 10.1080/10934529.2012.629574; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; LICHT S, 1988, J ELECTROCHEM SOC, V135, P2971, DOI 10.1149/1.2095471; MacKinnon MD, 1981, SYNCRUDE ENV RES MON, V1981-1; Mendoza-Cozatl D, 2005, FEMS MICROBIOL REV, V29, P653, DOI 10.1016/j.femsre.2004.09.004; Monchy S, 2006, INT J ENVIRON AN CH, V86, P677, DOI 10.1080/03067310600583824; Monsieurs P, 2011, BIOMETALS, V24, P1133, DOI 10.1007/s10534-011-9473-y; National Energy Board, 2006, CAN OIL SANDS OPP CH; Nicolella C, 2000, J BIOTECHNOL, V80, P1, DOI 10.1016/S0168-1656(00)00229-7; PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001; Pearson RG, 1967, HALOGEN CHEM, P55, DOI [10.1016/B978-0-12-395589-0.50007-9, DOI 10.1016/B978-0-12-395589-0.50007-9]; Quagraine EK, 2005, J ENVIRON SCI HEAL A, V40, P685, DOI 10.1081/ESE-200046649; Rawlings DE, 2007, MICROBIOL-SGM, V153, P315, DOI 10.1099/mic.0.2006/001206-0; Sandrin TR, 2003, ENVIRON HEALTH PERSP, V111, P1093, DOI 10.1289/ehp.5840; Sandrin TR, 2007, ENV BIOREMEDIATION S; SHAW WHR, 1954, J AM CHEM SOC, V76, P2160, DOI 10.1021/ja01637a034; Singh R, 2006, TRENDS MICROBIOL, V14, P389, DOI 10.1016/j.tim.2006.07.001; Siwik PL, 2000, ENVIRON TOXICOL CHEM, V19, P1837, DOI 10.1002/etc.5620190718; Smith MB, 2015, MBIO, V6, DOI 10.1128/mBio.00326-15; SOMERS E, 1961, ANN APPL BIOL, V49, P246, DOI 10.1111/j.1744-7348.1961.tb03612.x; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Suncor, 2013, SUNC REP SUST 2013; Syncrude, 2008, SYNCR 2008 09 SUST R; Tatara CP, 1997, AQUAT TOXICOL, V39, P279, DOI 10.1016/S0166-445X(97)00030-1; Taylor DE, 1999, TRENDS MICROBIOL, V7, P111, DOI 10.1016/S0966-842X(99)01454-7; Teitzel GM, 2003, APPL ENVIRON MICROB, V69, P2313, DOI 10.1128/AEM.69.4.2313-2320.2003; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Walker JD, 2003, ENVIRON TOXICOL CHEM, V22, P1916, DOI 10.1897/02-568; Workentine ML, 2008, ENVIRON MICROBIOL, V10, P238, DOI 10.1111/j.1462-2920.2007.01448.x; Wuertz S, 2004, WATER SCI TECHNOL, V49, P327, DOI 10.2166/wst.2004.0873; WYNDHAM RC, 1981, APPL ENVIRON MICROB, V41, P783, DOI 10.1128/AEM.41.3.783-790.1981; Yang LA, 2011, INT J ORAL SCI, V3, P74, DOI 10.4248/IJOS11027	67	9	9	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148682	10.1371/journal.pone.0148682	http://dx.doi.org/10.1371/journal.pone.0148682			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849649	gold, Green Submitted, Green Published			2022-12-27	WOS:000369554000156
J	Lee, JY; Paik, JS; Yun, M; Lee, SB; Yang, SW				Lee, Ji-Young; Paik, Ji-Sun; Yun, Mihee; Lee, Seong-Beom; Yang, Suk-Woo			The Effect of (-)- Epigallocatechin-3-Gallate on IL-1 beta Induced IL-8 Expression in Orbital Fibroblast from Patients with Thyroid-Associated Ophthalmopathy	PLOS ONE			English	Article							INDUCED SECRETION; EGCG; TISSUE; PATHOGENESIS; MECHANISMS	Orbital fibroblasts have been reported to be an important effector cells for the development of thyroid-associated ophthalmopathy (TAO). Orbital fibroblasts secrete various inflammatory cytokines in response to an inflammatory stimulation, leading to TAO-related tissue swelling. It has also been reported that (-)-epigallocatechin-3-gallate (EGCG), a major polyphenolic constituent of green tea, has antioxidant and anti-inflammatory properties. In the current study, we investigated the issue of whether or how EGCG affects the interleukin (IL)-1 beta-induced secretion of IL-8 in human orbital fibroblasts from TAO patients. Treatment with EGCG significantly reduced the level of IL-1 beta-induced secretion of IL-8 and the expression of IL-8 mRNA. IL-1 beta-induced the degradation of I kappa B alpha, and the phosphorylation of p38 and ERK, and the IL-1 beta-induced expression of IL-8 mRNA was inhibited by specific inhibitors, such as BAY-117085 for NF-kappa B, SB203580 for p38, and PD98059 for ERK. In addition, treatment with EGCG inhibited the IL-1 beta-induced degradation of I kappa B alpha, and the phosphorylation of p38 and ERK. However, pre-treatment with antioxidants, NVN and NAC, which suppressed ROS generation, did not reduce IL-8 expression in IL-1 beta-treated orbital fibroblasts, suggesting that the IL-1 beta-induced IL-8 expression is not mediated by the generation of ROS. These results show that EGCG suppresses the IL-1 beta-induced expression of IL-8 through inhibition of the NF-kappa B, p38, and ERK pathways. These findings could contribute to the development of new types of EGCG-containing pharmacological agents for use in the treatment of TAO.	[Lee, Ji-Young; Paik, Ji-Sun; Yang, Suk-Woo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Lee, Ji-Young; Yun, Mihee; Lee, Seong-Beom] Catholic Univ Korea, Coll Med, Dept Pathol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Paik, JS (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	rollipopp@hanmail.net		Lee, Seong-Beom/0000-0002-2767-6188	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013R1A1A3007696]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by Basic Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013R1A1A3007696).	BAGGIOLINI M, 1995, INT J IMMUNOPHARMACO, V17, P103, DOI 10.1016/0192-0561(94)00088-6; Bahn RS, 2010, NEW ENGL J MED, V362, P726, DOI 10.1056/NEJMra0905750; Chang JZC, 2013, CLIN ORAL INVEST, V17, P455, DOI 10.1007/s00784-012-0713-5; Chang YC, 2012, J AGR FOOD CHEM, V60, P8395, DOI 10.1021/jf302223g; Chen BL, 2005, J IMMUNOL, V175, P1310, DOI 10.4049/jimmunol.175.2.1310; Douglas RS, 2011, CURR OPIN OPHTHALMOL, V22, P385, DOI 10.1097/ICU.0b013e3283499446; Gu LQ, 2009, ENDOCRINE, V36, P452, DOI 10.1007/s12020-009-9240-9; Hardtner C, 2012, EUR J PHARMACOL, V684, P36, DOI 10.1016/j.ejphar.2012.03.039; Hiromatsu Y, 2000, J CLIN ENDOCR METAB, V85, P1194, DOI 10.1210/jc.85.3.1194; Honicke AS, 2012, INT J ONCOL, V41, P753, DOI 10.3892/ijo.2012.1498; Hsieh SR, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-86; Hwang CJ, 2009, INVEST OPHTH VIS SCI, V50, P2262, DOI 10.1167/iovs.08-2328; Hwang YS, 2004, ONCOGENE, V23, P6603, DOI 10.1038/sj.onc.1207867; Inokawa S, 2015, GRAEF ARCH CLIN EXP, V253, P557, DOI 10.1007/s00417-014-2879-9; Kang JS, 2014, PHYTOTHER RES, V28, P98, DOI 10.1002/ptr.4971; KENDALLTAYLOR P, 1985, CLIN ENDOCRINOL META, V14, P331, DOI 10.1016/S0300-595X(85)80037-2; Ko JW, 2014, INT J BIOCHEM CELL B, V55, P164, DOI 10.1016/j.biocel.2014.08.017; Lee WM, 2013, CURR EYE RES, V38, P699, DOI 10.3109/02713683.2012.750368; Li M, 2012, PHARMACOL REP, V64, P912, DOI 10.1016/S1734-1140(12)70886-1; Nagle DG, 2006, PHYTOCHEMISTRY, V67, P1849, DOI 10.1016/j.phytochem.2006.06.020; Paik JS, 2012, MOL VIS, V18, P1467; Raychaudhuri Nupur, 2010, PLoS One, V5, pe15296, DOI 10.1371/journal.pone.0015296; Stan MN, 2012, MED CLIN N AM, V96, P311, DOI 10.1016/j.mcna.2012.01.014; van Steensel L, 2010, INVEST OPHTH VIS SCI, V51, P1002, DOI 10.1167/iovs.09-4338; Vezina A, 2012, CANCER IMMUNOL IMMUN, V61, P2321, DOI 10.1007/s00262-012-1301-x; Wakelkamp IMMJ, 2003, CLIN ENDOCRINOL, V58, P280, DOI 10.1046/j.1365-2265.2003.01708.x; Wang Y, 2014, INVEST OPHTH VIS SCI, V55, P1735, DOI 10.1167/iovs.14-14002; Wen WC, 2014, J PERIODONTOL, V85, P868, DOI 10.1902/jop.2013.120714; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yang J, 2013, LIFE SCI, V92, P589, DOI 10.1016/j.lfs.2013.01.025; Yoon JS, 2012, BRIT J OPHTHALMOL, V96, P1117, DOI 10.1136/bjophthalmol-2012-301537	31	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148645	10.1371/journal.pone.0148645	http://dx.doi.org/10.1371/journal.pone.0148645			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848751	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000147
J	Romanienko, PJ; Giacalone, J; Ingenito, J; Wang, YJ; Isaka, M; Johnson, T; You, Y; Mark, WH				Romanienko, Peter J.; Giacalone, Joseph; Ingenito, Joanne; Wang, Yijie; Isaka, Mayumi; Johnson, Thomas; You, Yun; Mark, Willie H.			A Vector with a Single Promoter for In Vitro Transcription and Mammalian Cell Expression of CRISPR gRNAs	PLOS ONE			English	Article							MICE; SPECIFICITY; ZEBRAFISH; DELIVERY; KNOCKOUT; SYSTEM; CAS9; GENE	The genomes of more than 50 organisms have now been manipulated due to rapid advancement of gene editing technology. One way to perform gene editing in the mouse using the CRISPR/CAS system, guide RNA (gRNA) and CAS9 mRNA transcribed in vitro are microinjected into fertilized eggs that are then allowed to develop to term. As a rule, gRNAs are tested first in tissue culture cells and the one with the highest locus-specific cleavage activity is chosen for microinjection. For cell transfections, gRNAs are typically expressed using the human U6 promoter (hU6). However, gRNAs for microinjection into zygotes are obtained by in vitro transcription from a T7 bacteriophage promoter in a separate plasmid vector. Here, we describe the design and construction of a combined U6T7 hybrid promoter from which the same gRNA sequence can be expressed. An expression vector containing such a hybrid promoter can now be used to generate gRNA for testing in mammalian cells as well as for microinjection purposes. The gRNAs expressed and transcribed from this vector are found to be functional in cells as well as in mice.	[Romanienko, Peter J.; Giacalone, Joseph; Ingenito, Joanne; Wang, Yijie; Isaka, Mayumi; Johnson, Thomas; You, Yun; Mark, Willie H.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mouse Genet Core Facil, 1275 York Ave, New York, NY 10021 USA; [Romanienko, Peter J.; You, Yun; Mark, Willie H.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Romanienko, PJ (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mouse Genet Core Facil, 1275 York Ave, New York, NY 10021 USA.; Romanienko, PJ (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA.	romaniep@mskcc.org		Romanienko, Peter/0000-0001-6586-3841	NIH/NCI Cancer Center Support Grant [P30 CA008748]; Sloan Kettering Institute; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NIH/NCI Cancer Center Support Grant; Sloan Kettering Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the NIH/NCI Cancer Center Support Grant P30 CA008748 and internal funding from Sloan Kettering Institute (institutional funding).	Aida T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0653-x; Behringer R, 2014, MANIPULATING MOUSE E, V4; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; D'Astolfo DS, 2015, CELL, V161, P674, DOI 10.1016/j.cell.2015.03.028; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fujihara Y, 2014, METHOD ENZYMOL, V546, P319, DOI 10.1016/B978-0-12-801185-0.00015-5; GOOMER RS, 1992, NUCLEIC ACIDS RES, V20, P4903, DOI 10.1093/nar/20.18.4903; Horii T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04513; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Maggio I, 2015, TRENDS BIOTECHNOL, V33, P280, DOI 10.1016/j.tibtech.2015.02.011; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025	16	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148362	10.1371/journal.pone.0148362	http://dx.doi.org/10.1371/journal.pone.0148362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849369	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000081
J	Woo, JH; Park, KN; Lee, JY; Lee, SW				Woo, Joo Hyun; Park, Ki Nam; Lee, Jae Yong; Lee, Seung Won			Predictive Factors of Superior Mediastinal Nodal Metastasis from Papillary Thyroid Carcinoma-A Prospective Observational Study	PLOS ONE			English	Article							NECK DISSECTION; MANAGEMENT; LYMPHADENECTOMY; CLASSIFICATION; PATTERN	Objectives The purpose of this study was to demonstrate the incidence rates and predictive factors of superior mediastinal lymph node (SMLN) metastasis in PTC (papillary thyroid carcinoma) patients. Methods A prospective observational study was performed between January 2009 and January 2011. PTC patients who had tumors with a maximal diameter greater than 1 cm and clinically negative SMLNs were included in this study. Finally, a total of 217 patients who underwent total thyroidectomy with central compartment neck dissection (CND) and elective superior mediastinal lymph node dissection (SMLND), with or without modified radical neck dissection (MRND) and revisional CND, were included. Results Occult SMLN metastasis was present in 15.7%(34/217). Cytological classifications of tumor, BRAFV600E mutation, Tumor size, T-stage, perithyroidal extension, lymphovascular invasion, multifocality, and paratracheal pN(+) were not predictive of SMLN metastasis (P > .05), while revision surgery, pretracheal pN(+), and multiple lateral pN(+) were associated with SMLN metastasis. There were no major complications related to SMLND. Transient and permanent hypoparathyroidism was observed in 69 cases (31.8%) and 8 cases (3.6%), respectively. Conclusions Despite clinically negative SMLN in preoperative evaluation, SMLN metastasis can be predicted for patients with a PTC tumor size larger than 1 cm, pretracheal LN metastasis, multiple lateral metastasis, and revisional surgery.	[Woo, Joo Hyun] Gachon Univ, Grad Sch Med, Gil Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Inchon, South Korea; [Park, Ki Nam; Lee, Jae Yong; Lee, Seung Won] Soonchunhyang Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Bucheon Hosp, Bucheon, South Korea	Gachon University; Soonchunhyang University	Lee, SW (corresponding author), Soonchunhyang Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Bucheon Hosp, Bucheon, South Korea.	lsw0922@schmc.ac.kr		LEE, SEUNGWON/0000-0002-0468-8143	Soonchunhyang University Research Fund	Soonchunhyang University Research Fund	This work was supported by the Soonchunhyang University Research Fund.	COBURN MC, 1992, AM J SURG, V164, P671, DOI 10.1016/S0002-9610(05)80732-9; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Ducic Y, 2009, AM J OTOLARYNG, V30, P221, DOI 10.1016/j.amjoto.2008.05.003; Hughes CJ, 1996, HEAD NECK-J SCI SPEC, V18, P127, DOI 10.1002/(SICI)1097-0347(199603/04)18:2<127::AID-HED3>3.3.CO;2-H; Khoo MLC, 2003, HEAD NECK-J SCI SPEC, V25, P10, DOI 10.1002/hed.10173; Koo BS, 2009, ANN SURG, V249, P840, DOI 10.1097/SLA.0b013e3181a40919; Lallemant B, 2007, ACTA OTO-LARYNGOL, V127, P318, DOI 10.1080/00016480600806299; Liu J, 2013, ORL J OTO-RHINO-LARY, V75, P228, DOI 10.1159/000353549; Machens A, 2002, WORLD J SURG, V26, P22; Machens A, 2004, BRIT J SURG, V91, P709, DOI 10.1002/bjs.4525; Machens A, 2009, ANN SURG ONCOL, V16, P171, DOI 10.1245/s10434-008-0201-y; Maillard AAJ, 1997, AM J OTOLARYNG, V18, P47, DOI 10.1016/S0196-0709(97)90048-X; Miao SS, 2013, ORL J OTO-RHINO-LARY, V75, P265, DOI 10.1159/000354267; Pelizzo MR, 2014, EJSO-EUR J SURG ONC, V40, P865, DOI 10.1016/j.ejso.2014.03.007; Robbins KT, 2002, ARCH OTOLARYNGOL, V128, P751, DOI 10.1001/archotol.128.7.751; Roh JL, 2008, ANN SURG ONCOL, V15, P2482, DOI 10.1245/s10434-008-0044-6; Roh JL, 2007, HEAD NECK-J SCI SPEC, V29, P901, DOI 10.1002/hed.20606; Rotstein L, 2009, J SURG ONCOL, V99, P186, DOI 10.1002/jso.21234; SCHULLER DE, 1981, ARCH OTOLARYNGOL, V107, P715; Smith VA, 2012, J SURG ONCOL, V106, P357, DOI 10.1002/jso.23090; Stulak JM, 2006, ARCH SURG-CHICAGO, V141, P489, DOI 10.1001/archsurg.141.5.489; SUGENOYA A, 1993, SURGERY, V113, P541	22	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148420	10.1371/journal.pone.0148420	http://dx.doi.org/10.1371/journal.pone.0148420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848952	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000089
J	Abegunde, D; Orobaton, N; Bassi, A; Oguntunde, O; Bamidele, M; Abdulkrim, M; Nwizugbe, E				Abegunde, Dele; Orobaton, Nosa; Bassi, Amos; Oguntunde, Olugbenga; Bamidele, Moyosola; Abdulkrim, Masduq; Nwizugbe, Ezenwa			The Impact of Integrated Community Case Management of Childhood Diseases Interventions to Prevent Malaria Fever in Children Less than Five Years Old in Bauchi State of Nigeria	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; BED NETS; COUNTRIES	Background Malaria accounts for about 300,000 childhood deaths and 30% of under-five year old mortality in Nigeria annually. We assessed the impact of intervention strategies that integrated Patent Medicines Vendors into community case management of childhood-diseases, improved access to artemisinin combination therapy (ACT) and distributed bed nets to households. We explored the influence of household socioeconomic characteristics on the impact of the interventions on fever in the under-five year olds in Bauchi State Nigeria. Methods A cross-sectional case-controlled, interventional study, which sampled 3077 and 2737 under-5 year olds from 1,588 and 1601 households in pre- and post-intervention periods respectively, was conducted from 2013 to 2015. Difference-in-differences and logistic regression analyses were performed to estimate the impact attributable to the interventions: integrated community case management of childhood illness which introduced trained public and private sector health providers and the possession of nets on the prevalence of fever. Results Two-week prevalence of fever among under-fives declined from 56.6% at pre-intervention to 42.5% at post-intervention. Fever-prevention fraction attributable to nets was statistically significant (OR = 0.217, 95% CI: 0.08-0.33). Children in the intervention group had significantly fewer incidence of fever than children in the control group had (OR = 0.765, 95% CI: 0.67-0.87). Although being in the intervention group significantly provided 23.5% protection against fever (95% CI: 0.13-0.33), the post-intervention likelihood of fever was also significantly less than at pre-intervention (OR = 0.57, 95% CI: 0.50-0.65). The intervention protection fraction against fever was statistically significant at 43.4%(OR = 0.434, 95% CI: 0.36-0.50). Logistic regression showed that the odds of fever were lower in households with nets (OR = 0.72, 95% CI: 0.60-0.88), among children whose mothers had higher education, in the post-intervention period (OR = 0.39, 95% CI: 0.33-0.46) and in the intervention group (OR = 0.52, 95% CI: 0.48-0.66). The odds of fever increased with higher socio-economic status of households (17.9%-19.5%). Difference-in-differences showed that the interventions significantly reduced occurrence of fever in the intervention group (OR = 1.70, 95% CI: 1.36-2.14). Conclusion The interventions were effective in reducing the prevalence and the likelihood of childhood malaria fever. Taken to scale, these can significantly reduce the burden of malaria fever in the under-five year old children.	[Abegunde, Dele; Orobaton, Nosa; Bassi, Amos; Oguntunde, Olugbenga; Bamidele, Moyosola; Abdulkrim, Masduq; Nwizugbe, Ezenwa] John Snow Inc, Res & Training Inst, Boston, MA USA; [Oguntunde, Olugbenga] Futures Grp Inc, Chapel Hill, NC USA		Abegunde, D (corresponding author), John Snow Inc, Res & Training Inst, Boston, MA USA.	dele.abegunde@yahoo.com		Bamidele, Moyosola/0000-0001-8444-7966				Consortium M, 2014, SOL WORLD RESP 2014; CORTINOVIS I, 1993, SOC SCI MED, V36, P1087, DOI 10.1016/0277-9536(93)90127-P; Eteng M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-316; Federal Ministry of Health NMCP Abuja Nigeria, 2008, ROAD MAP MAL CONTR N; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fund TG, 2014, GRANT PORTF 2014; Jagannathan P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-435; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; Kilian A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0640-4; Le Menach A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-10; Nankinga Z, 2012, J COMMUN HEALTH, V37, P1006, DOI 10.1007/s10900-012-9546-z; National Population Commission (NPC) [Nigeria] ICF International, 2014, NIG DEM HLTH SURV 20; Njau JD, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-245; Okafor IP, 2012, NIGER J CLIN PRACT, V15, P220, DOI 10.4103/1119-3077.97325; Oladosu O.O., 2013, ISRN INFECT DIS, V2013, P6, DOI DOI 10.5402/2013/914675; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN MA; Sirima SB, 2003, TROP MED INT HEALTH, V8, P133, DOI 10.1046/j.1365-3156.2003.00997.x; Tanner M, 2008, B WORLD HEALTH ORGAN, V86, P82, DOI 10.2471/BLT.07.050633; United States Agency for interational Development, 2002, TOOLK COMM CAS MAN C; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World Health Organization, 2009, INT COMM CAS MAN ICC; World Health Organization, 2012, EQ FOC STRAT IMPR AC	23	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148586	10.1371/journal.pone.0148586	http://dx.doi.org/10.1371/journal.pone.0148586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PF	26845546	Green Published, gold, Green Submitted			2022-12-27	WOS:000369552800076
J	Cavada, N; Barelli, C; Ciolli, M; Rovero, F				Cavada, Nathalie; Barelli, Claudia; Ciolli, Marco; Rovero, Francesco			Primates in Human-Modified and Fragmented Landscapes: The Conservation Relevance of Modelling Habitat and Disturbance Factors in Density Estimation	PLOS ONE			English	Article							UDZUNGWA RED COLOBUS; SPECIES DISTRIBUTION; IMPERFECT DETECTION; ABUNDANCE; MOUNTAINS; CONSEQUENCES; DIVERSITY; ECOLOGY; FOREST; DIET	Accurate density estimations of threatened animal populations is essential for management and conservation. This is particularly critical for species living in patchy and altered landscapes, as is the case for most tropical forest primates. In this study, we used a hierarchical modelling approach that incorporates the effect of environmental covariates on both the detection (i.e. observation) and the state (i.e. abundance) processes of distance sampling. We applied this method to already published data on three arboreal primates of the Udzungwa Mountains of Tanzania, including the endangered and endemic Udzungwa red colobus (Procolobus gordonorum). The area is a primate hotspot at continental level. Compared to previous, 'canonical' density estimates, we found that the inclusion of covariates in the modelling makes the inference process more informative, as it takes in full account the contrasting habitat and protection levels among forest blocks. The correction of density estimates for imperfect detection was especially critical where animal detectability was low. Relative to our approach, density was underestimated by the canonical distance sampling, particularly in the less protected forest. Group size had an effect on detectability, determining how the observation process varies depending on the socio-ecology of the target species. Lastly, as the inference on density is spatially-explicit to the scale of the covariates used in the modelling, we could confirm that primate densities are highest in low-to-mid elevations, where human disturbance tend to be greater, indicating a considerable resilience by target monkeys in disturbed habitats. However, the marked trend of lower densities in unprotected forests urgently calls for effective forest protection.	[Cavada, Nathalie; Ciolli, Marco] Univ Trento, DICAM Dept Civil Environm & Mech Engn, Trento, Italy; [Cavada, Nathalie; Barelli, Claudia; Rovero, Francesco] MUSE Museo Sci, Trop Biodivers Sect, Trento, Italy; [Barelli, Claudia] Res & Innovat Ctr Fdn Edmund Mach, Biodivers & Mol Ecol Dept, San Michele All Adige, TN, Italy; [Rovero, Francesco] Udzungwa Ecol Monitoring Ctr, Udzungwa Mountains Natl Pk, Mangula, Tanzania	University of Trento; Fondazione Edmund Mach	Cavada, N (corresponding author), Univ Trento, DICAM Dept Civil Environm & Mech Engn, Trento, Italy.; Cavada, N (corresponding author), MUSE Museo Sci, Trop Biodivers Sect, Trento, Italy.	nathalie.cavada@gmail.com	Ciolli, Marco/D-8613-2014; Rovero, Francesco/AAI-3157-2020	Ciolli, Marco/0000-0001-8370-9039; Rovero, Francesco/0000-0001-6688-1494; Cavada, Nathalie/0000-0002-9251-6471	MUSE-Museo delle Scienze; University of Trento	MUSE-Museo delle Scienze; University of Trento	The work was funded through doctoral scholarship to NC from MUSE-Museo delle Scienze and the University of Trento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Anderson J, 2007, INT J PRIMATOL, V28, P637, DOI 10.1007/s10764-007-9143-7; Araldi A, 2014, INT J PRIMATOL, V35, P941, DOI 10.1007/s10764-014-9772-6; Arroyo-Rodriguez V, 2015, ECOLOGY OF LIANAS, P407; Arroyo-Rodriguez V, 2014, AM J PRIMATOL, V76, P901, DOI 10.1002/ajp.22282; Baillie SR, 2000, J APPL ECOL, V37, P88, DOI 10.1046/j.1365-2664.2000.00555.x; Barelli C, 2015, INT J PRIMATOL, V36, P209, DOI 10.1007/s10764-015-9815-7; Barton K, 2014, MULTIMODEL INFERENCE, P46; Buckland S.T., 2001, pi; Buckland ST, 2010, INT J PRIMATOL, V31, P833, DOI 10.1007/s10764-010-9431-5; Buckland ST, 2010, INT J PRIMATOL, V31, P485, DOI 10.1007/s10764-010-9408-4; Chandler R, 2014, DISTANCE SAMPLING AN, P1; Chapman CA, 2001, EVOL ANTHROPOL, V10, P16, DOI 10.1002/1520-6505(2001)10:1<16::AID-EVAN1010>3.0.CO;2-O; Chapman CA, 1999, PRIMATES, V40, P215, DOI 10.1007/BF02557712; Davies A. Glyn, 1994, P285; Dunn JC, 2012, BIOTROPICA, V44, P705, DOI 10.1111/j.1744-7429.2012.00856.x; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; Johns AD, 1983, ECOLOGICAL EFFECTS S; Jones JPG, 2011, J APPL ECOL, V48, P9, DOI 10.1111/j.1365-2664.2010.01917.x; Kellner KF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111436; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kumpel NF, 2008, INT J PRIMATOL, V29, P1065, DOI [10.1007/s10764-008-9254-9, 10.1007/s10764-008-9277-2]; Lahoz-Monfort JJ, 2014, GLOBAL ECOL BIOGEOGR, V23, P504, DOI 10.1111/geb.12138; Levi T, 2009, J APPL ECOL, V46, P804, DOI 10.1111/j.1365-2664.2009.01661.x; Linder JM, 2011, BIOL CONSERV, V144, P738, DOI 10.1016/j.biocon.2010.10.023; Linkie M, 2006, J APPL ECOL, V43, P576, DOI 10.1111/j.1365-2664.2006.01153.x; Lovett JC, 1993, BIOGEOGRAPHY AND ECO; Manduell KL, 2012, RESEARCH ARTICLE FOR, V15, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marques FFC, 2003, BIOMETRICS, V59, P924, DOI 10.1111/j.0006-341X.2003.00107.x; Marques TA, 2007, AUK, V124, P1229, DOI 10.1642/0004-8038(2007)124[1229:IEOBDU]2.0.CO;2; Marsh LK, 2013, DEV PRIMATOL-PROG PR, P3, DOI 10.1007/978-1-4614-8839-2_1; Marsh LK, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P1; Marshall AR, 2010, AM J PRIMATOL, V72, P325, DOI 10.1002/ajp.20787; Marshall AR, 2008, ECOLOGICAL REPORT MA; Marshall AR, 2007, DISTURBANCE UDZUNGWA; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; McGraw WS, 1996, AM J PHYS ANTHROPOL, V100, P507, DOI 10.1002/(SICI)1096-8644(199608)100:4<507::AID-AJPA5>3.0.CO;2-N; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Rodriguez JP, 2007, DIVERS DISTRIB, V13, P243, DOI 10.1111/j.1472-4642.2007.00356.x; Platts PJ, 2011, ENVIRON CONSERV, V38, P312, DOI 10.1017/S0376892911000191; Ramos-Fernandez G, 2013, DEV PRIMATOL-PROG PR, P475, DOI 10.1007/978-1-4614-8839-2_32; Rodriguez-Luna E, 2013, DEV PRIMATOL-PROG PR, P47, DOI 10.1007/978-1-4614-8839-2_4; Rovero F, 2007, AM J PRIMATOL, V69, P1242, DOI 10.1002/ajp.20431; Rovero F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118330; Rovero F, 2012, BIOL CONSERV, V146, P89, DOI 10.1016/j.biocon.2011.09.017; Rovero F, 2009, J ANTHROPOL SCI, V87, P93; Royle JA, 2004, ECOLOGY, V85, P1591, DOI 10.1890/03-3127; ROYSTON JP, 1982, J R STAT SOC C-APPL, V31, P115; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schmidt JH, 2012, J WILDLIFE MANAGE, V76, P317, DOI 10.1002/jwmg.216; Sillett TS, 2012, ECOL APPL, V22, P1997, DOI 10.1890/11-1400.1; Struhsaker TT, 2010, RED COLOBUS MONKEYS: VARIATION IN DEMOGRAPHY, BEHAVIOR, AND ECOLOGY OF ENDANGERED SPECIES, P1, DOI 10.1093/acprof:oso/9780198529583.001.0001; Struhsaker TT, 2004, INT J PRIMATOL, V25, P615, DOI 10.1023/B:IJOP.0000023578.08343.4e; Underhill L, 2002, CONSERV BIOL SER, V7, P34; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	56	11	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148289	10.1371/journal.pone.0148289	http://dx.doi.org/10.1371/journal.pone.0148289			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844891	Green Submitted, Green Published, gold			2022-12-27	WOS:000369552800041
J	Fu, YL; Ong, LC; Ranganath, SH; Zheng, L; Kee, I; Zhan, WB; Yu, S; Chow, PKH; Wang, CH				Fu, Yilong; Ong, Lai-Chun; Ranganath, Sudhir H.; Zheng, Lin; Kee, Irene; Zhan, Wenbo; Yu, Sidney; Chow, Pierce K. H.; Wang, Chi-Hwa			A Dual Tracer F-18-FCH/F-18-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft Model	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MINIMALLY INVASIVE SURGERY; RADIATION-DOSE ESCALATION; C-11 CHOLINE PET; GLIOBLASTOMA-MULTIFORME; FOLLOW-UP; F-18-FLUOROCHOLINE; PROLIFERATION; F-18-FDG; GLIOMAS	Early diagnosis of low grade glioma has been a challenge to clinicians. Positron Emission Tomography (PET) using F-18-FDG as a radio-tracer has limited utility in this area because of the high background in normal brain tissue. Other radiotracers such as F-18-Fluorocholine (F-18-FCH) could provide better contrast between tumor and normal brain tissue but with high incidence of false positives. In this study, the potential application of a dual tracer F-18-FCH/F-18-FDG-PET is investigated in order to improve the sensitivity of PET imaging for low grade glioma diagnosis based on a mouse orthotopic xenograft model. BALB/c nudemice with and without orthotopic glioma xenografts from U87 MG-luc2 glioma cell line are used for the study. The animals are subjected to F-18-FCH and F-18-FDG PET imaging, and images acquired from two separate scans are superimposed for analysis. The F-18-FCH counts are subtracted from the merged images to identify the tumor. Micro-CT, bioluminescence imaging (BLI), histology and measurement of the tumor diameter are also conducted for comparison. Results show that there is a significant contrast in F-18-FCH uptake between tumor and normal brain tissue (2.65 +/- 0.98), but with a high false positive rate of 28.6%. The difficulty of identifying the tumor by F-18-FDG only is also proved in this study. All the tumors can be detected based on the dual tracer technique of F-18-FCH/F-18-FDG-PET imaging in this study, while the false-positive caused by F-18-FCH can be eliminated. Dual tracer F-18-FCH/F-18-FDG PET imaging has the potential to improve the visualization of low grade glioma. F-18-FCH delineates tumor areas and the tumor can be identified by subtracting the F-18-FCH counts. The sensitivity was over 95%. Further studies are required to evaluate the possibility of applying this technique in clinical trials.	[Fu, Yilong; Ong, Lai-Chun; Ranganath, Sudhir H.; Wang, Chi-Hwa] Natl Univ Singapore, Dept Chem & Biomol Engn, 4 Engn Dr 4, Singapore 117585, Singapore; [Zheng, Lin; Kee, Irene] Singapore Gen Hosp, SingHlth Expt Med Ctr, Block 9,Level 3,Outram Rd, Singapore 169608, Singapore; [Zhan, Wenbo] Natl Univ Singapore, NUS Environm Res Inst, 1 Create Way,Create Tower 15-02, Singapore 138602, Singapore; [Yu, Sidney; Chow, Pierce K. H.] Natl Canc Ctr, 11 Hosp Dr, Singapore 169610, Singapore; [Chow, Pierce K. H.] Duke NUS Grad Med Sch, Off Clin Sci, Singapore 169857, Singapore; [Ranganath, Sudhir H.] Siddaganga Inst Technol, Dept Chem Engn, BH Rd, Tumkur 572103, India	National University of Singapore; Singapore General Hospital; National University of Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore; Siddaganga Institute of Technology	Wang, CH (corresponding author), Natl Univ Singapore, Dept Chem & Biomol Engn, 4 Engn Dr 4, Singapore 117585, Singapore.; Yu, S (corresponding author), Natl Canc Ctr, 11 Hosp Dr, Singapore 169610, Singapore.	sidney.yu.w.k@sgh.com.sg; chewch@nus.edu.sg	Zhan, Wenbo/O-7709-2018	Zhan, Wenbo/0000-0003-0268-5042; Chow, Pierce/0000-0003-0584-2584	Biomedical Research Council (BMRC), A*STAR [BMRC/07/1/21/19/508]; National Research Foundation (NRF), Prime Minister's Office, Singapore under its Campus for Research Excellence and Technological Enterprise (CREATE) programme; National University of Singapore [R-706-001-101-281]	Biomedical Research Council (BMRC), A*STAR(Agency for Science Technology & Research (A*STAR)); National Research Foundation (NRF), Prime Minister's Office, Singapore under its Campus for Research Excellence and Technological Enterprise (CREATE) programme(National Research Foundation, Singapore); National University of Singapore(National University of Singapore)	The authors acknowledge the funding support from Biomedical Research Council (BMRC), A*STAR under the grant numbers BMRC/07/1/21/19/508. CHW and WZ acknowledge the support from the National Research Foundation (NRF), Prime Minister's Office, Singapore under its Campus for Research Excellence and Technological Enterprise (CREATE) programme. Grant Number R-706-001-101-281, National University of Singapore.	BLASBERG RG, 1994, J NEURO-ONCOL, V22, P281, DOI 10.1007/BF01052934; Bradbury MS, 2008, J NUCL MED, V49, P422, DOI 10.2967/jnumed.107.047092; Casara D, 2001, EUR J NUCL MED, V28, P1351, DOI 10.1007/s002590100564; Chen W, 2007, J NUCL MED, V48, P1468, DOI 10.2967/jnumed.106.037689; Cook G, 2014, BRIT J RADIOLOGY; DeGrado TR, 2001, J NUCL MED, V42, P1805; Delbeke D, 1999, J NUCL MED, V40, P591; Douglas JG, 2006, INT J RADIAT ONCOL, V64, P886, DOI 10.1016/j.ijrobp.2005.08.013; Engel H, 1996, J NUCL MED, V37, P441; GALLAGHER BM, 1978, J NUCL MED, V19, P1154; Gomez-Rio M, 2015, EUR J NUCL MED MOL I, V42, P886, DOI 10.1007/s00259-015-2997-6; HAEFFNER EW, 1975, EUR J BIOCHEM, V51, P219, DOI 10.1111/j.1432-1033.1975.tb03922.x; Hara T, 1997, J NUCL MED, V38, P842; Hara T, 2001, J NUCL MED, V42, P1815; HernandezAlcoceba R, 1997, ONCOGENE, V15, P2289, DOI 10.1038/sj.onc.1201414; Joshi A, 2007, SOC NUCL MED ANN M S; Katz-Brull R, 1996, ANTICANCER RES, V16, P1375; Kwee SA, 2007, RADIOLOGY, V244, P557, DOI 10.1148/radiol.2442060898; Lam WWC, 2011, CLIN NEUROL NEUROSUR, V113, P156, DOI 10.1016/j.clineuro.2010.09.012; Rubello D, 2003, EUR J NUCL MED MOL I, V30, P189, DOI 10.1007/s00259-002-0983-2; Schaller B, 2004, NEUROBIOL DIS, V15, P437, DOI 10.1016/j.nbd.2003.11.023; Shinoura N, 1997, RADIOLOGY, V202, P497, DOI 10.1148/radiology.202.2.9015080; Strauss LG, 1996, EUR J NUCL MED, V23, P1409, DOI 10.1007/BF01367602; Tosi R, 2005, NUCL MAGNETIC RESONA; Tralins KS, 2002, J NUCL MED, V43, P1667; Utriainen M, 2003, J NEURO-ONCOL, V62, P329, DOI 10.1023/A:1023342516925; Vallabhajosula S, 2007, SEMINARS NUCL MED; Weber WA, 2000, EUR J NUCL MED, V27, P542, DOI 10.1007/s002590050541; Wong TZ, 2002, NEUROIMAG CLIN N AM, V12, P615, DOI 10.1016/S1052-5149(02)00033-3; Wyss MT, 2007, J NUCL MED, V48, P608, DOI 10.2967/jnumed.106.036251; Yoshimoto M, 2004, NUCL MED BIOL, V31, P859, DOI 10.1016/j.nucmedbio.2004.05.002	31	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148123	10.1371/journal.pone.0148123	http://dx.doi.org/10.1371/journal.pone.0148123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844770	gold, Green Published, Green Submitted			2022-12-27	WOS:000369552800030
J	Liao, ZF; Tang, H; Xu, XJ; Liang, YP; Xiong, YZ; Ni, JD				Liao, Zhengfa; Tang, Hao; Xu, Xiaojia; Liang, Yaping; Xiong, Yongzhen; Ni, Jindong			Immunogenicity and Safety of Influenza Vaccination in Systemic Lupus Erythematosus Patients Compared with Healthy Controls: A Meta-Analysis	PLOS ONE			English	Article							MEDIATED IMMUNE-RESPONSES; DISEASE-ACTIVITY INDEX; ANTIBODY-RESPONSES; RHEUMATIC-DISEASES; REDUCED IMMUNOGENICITY; A/H1N1; IMMUNIZATION; EFFICACY; VACCINES	Objective To assess the immunogenicity and safety of influenza vaccine in patients with systemic lupus erythematosus (SLE). Methods Relevant articles were retrieved from electronic databases. Seroprotection rate, seroconversion rate and factors that increase antibody geometric mean titer (GMT) were used as indices to measure the immunogenicity. The safety of vaccine was assessed through monitoring adverse events, which included side effects and SLE exacerbations. We performed a meta-analysis of influenza vaccine seroprotection, seroconversion and adverse effects. SLE exacerbation after vaccination was comprehensively described. We used the Committee for Proprietary Medicinal Products (CPMP) guidelines to determine whether influenza can induce adequate immunogenicity in patients with SLE. Results Eighteen studies with 1966 subjects met the inclusion criteria. At least 565 of the subjects were patients with low-to-moderate SLE Disease Activity Index (SLEDAI) score or stable SLE disease. Compared with the general population, seroprotection rate in SLE patients was significantly decreased in patients with H1N1 [odds ratio (OR) = 0.36, 95% confidence interval (CI): 0.27-0.50] and H3N2 vaccination (OR = 0.48, 95% CI: 0.24-0.93), but not influenza B vaccination (OR = 0.55, 95% CI: 0.24-1.25). Seroconversion rate also significantly decreased in patients with H1N1 (OR = 0.39, 95% CI: 0.27-0.57) and influenza B (OR = 0.47, 95% CI: 0.29-0.76) vaccination, but not H3N2 vaccination (OR = 0.62, 95% CI: 0.21-1.79). However, the immunogenicity of influenza vaccine in SLE patients almost reached that of the CPMP guidelines. The OR for side effects (patients versus healthy controls) was 3.24 (95% CI: 0.62-16.76). Among 1966 patients with SLE, 32 experienced mild exacerbation of SLE and five had serious side effects for other reasons. Conclusion Influenza vaccine has moderate effect on protecting patients with SLE. The side effects of influenza vaccine are not serious and are manageable. With consideration of a higher risk of SLE exacerbation and a more severe course of infection among SLE patients, influenza vaccination should be promoted among SLE patients with a low-to-moderate SLEDAI score or stable disease.	[Liao, Zhengfa; Tang, Hao; Xu, Xiaojia; Liang, Yaping; Ni, Jindong] Guangdong Med Univ, Dept Epidemiol & Biostat, Dongguan, Peoples R China; [Xiong, Yongzhen] Guangdong Med Univ, Sch Clin, Dongguan, Peoples R China	Guangdong Medical University; Guangdong Medical University	Ni, JD (corresponding author), Guangdong Med Univ, Dept Epidemiol & Biostat, Dongguan, Peoples R China.	david3847@sina.com			Science Foundation of Dongguan [2012105102020]; special fund for discipline construction of colleges and universities in Guangdong Province [2013KJCX0091]	Science Foundation of Dongguan; special fund for discipline construction of colleges and universities in Guangdong Province	This work was partly supported by grants from Science Foundation of Dongguan (2012105102020), and special fund for discipline construction of colleges and universities in Guangdong Province (2013KJCX0091).	Agency EM, 1996, NOT GUID HARM REQ IN; Aikawa NE, 2012, J RHEUMATOL, V39, P167, DOI 10.3899/jrheum.110721; Aron-Maor A, 2001, LUPUS, V10, P237, DOI 10.1191/096120301673085478; Belshe RB, 2004, NEW ENGL J MED, V351, P2286, DOI 10.1056/NEJMoa043555; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Borba EF, 2012, RHEUMATOLOGY, V51, P1061, DOI 10.1093/rheumatology/ker427; Borba EF, 2010, ARTHRITIS RHEUMATISM, V62, P481; BRODMAN R, 1978, ANN INTERN MED, V88, P735, DOI 10.7326/0003-4819-88-6-735; Campos LMA, 2013, ARTHRIT CARE RES, V65, P1121, DOI 10.1002/acr.21948; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Del Porto F, 2006, VACCINE, V24, P3217, DOI 10.1016/j.vaccine.2006.01.028; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elkayam O, 2011, ARTHRIT CARE RES, V63, P1062, DOI 10.1002/acr.20465; Fessler BJ, 2002, BEST PRACT RES CL RH, V16, P281, DOI 10.1053/berh.2001.0226; Gladman DD, 2002, J RHEUMATOL, V29, P288; Holvast A, 2006, ANN RHEUM DIS, V65, P913, DOI 10.1136/ard.2005.043943; Holvast A, 2009, RHEUMATOLOGY, V48, P1294, DOI 10.1093/rheumatology/kep200; Holvast A, 2009, ARTHRITIS RHEUM, V60, P2438, DOI 10.1002/art.24679; Lawson EF, 2015, SEMIN ARTHRITIS RHEU, V44, P666, DOI 10.1016/j.semarthrit.2015.01.002; Long CB, 2012, J PEDIATR-US, V160, P74, DOI 10.1016/j.jpeds.2011.06.045; LOUIE JS, 1978, ANN INTERN MED, V88, P790, DOI 10.7326/0003-4819-88-6-790; Lu CC, 2011, VACCINE, V29, P444, DOI 10.1016/j.vaccine.2010.10.081; MANTEL N, 1959, J NATL CANCER I, V22, P719; McMahan ZH, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0506-0; Mercado U, 2004, REV INVEST CLIN, V56, P16; Murdaca G, 2014, AUTOIMMUN REV, V13, P75, DOI 10.1016/j.autrev.2013.07.007; Reed C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118369; RISTOW SC, 1978, ANN INTERN MED, V88, P786, DOI 10.7326/0003-4819-88-6-786; Saad CGS, 2011, ANN RHEUM DIS, V70, P1068, DOI 10.1136/ard.2011.150250; Scofield RH, 1999, SEMIN ARTHRITIS RHEU, V29, P140; Wallin L, SAFETY EFFICIENCY IN, P0303; Wiesik-Szewczyk E, 2010, CLIN RHEUMATOL, V29, P605, DOI 10.1007/s10067-010-1373-y	33	35	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147856	10.1371/journal.pone.0147856	http://dx.doi.org/10.1371/journal.pone.0147856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845680	Green Submitted, Green Published, gold			2022-12-27	WOS:000369552800017
J	Lopera-Vasquez, R; Hamdi, M; Fernandez-Fuertes, B; Maillo, V; Beltran-Brena, P; Calle, A; Redruello, A; Lopez-Martin, S; Gutierrez-Adan, A; Yanez-Mo, M; Ramirez, MA; Rizos, D				Lopera-Vasquez, Ricaurte; Hamdi, Meriem; Fernandez-Fuertes, Beatriz; Maillo, Veronica; Beltran-Brena, Paula; Calle, Alexandra; Redruello, Alberto; Lopez-Martin, Soraya; Gutierrez-Adan, Alfonso; Yanez-Mo, Maria; Angel Ramirez, Miguel; Rizos, Dimitrios			Extracellular Vesicles from BOEC in In Vitro Embryo Development and Quality	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; OVIDUCT EPITHELIAL-CELLS; DIFFERENT CULTURE SYSTEMS; BOVINE EMBRYOS; GENE-EXPRESSION; CONDITIONED MEDIUM; BLASTOCYST DEVELOPMENT; GENOME ACTIVATION; VIVO; PREGNANCY	To evaluate the effect of conditioned media (CM) and Extracellular Vesicles (EVs) derived from bovine oviduct epithelial cell (BOEC) lines on the developmental capacity of bovine zygotes and the quality of embryos produced in vitro, presumptive zygotes were cultured under specific conditions. In experiment 1, zygotes were cultured either on monolayers from BOEC extended culture (E), together with fresh BOEC suspension cells, or with BOEC-CM from fresh or E-monolayers. In experiment 2, EVs were isolated from BOEC-CM and characterized (150-200 nm) by Nanosight (R) and electron microscopy. Zygotes were cultured in the presence of 3x10(5)EVs/mL, 1.5x10(5)EVs/mL or 7.5x10(4)EVs/mL of fresh or frozen BOEC-EVs. In experiment 3, zygotes were cultured in absence of FCS but with EVs from BOEC-E that had been cultured in different culture media. In experiment 4, zygotes were cultured in SOF+5% normal-FCS, or EV-depleted-FCS. In all cases, cleavage rate (Day 2) and blastocyst development (Day 7-9) was assessed. Blastocysts on Days 7/8 were used for quality evaluation through differential cell count, cryotolerance and gene expression patterns. No differences were found among all FCS-containing groups in cleavage rate or blastocyst yield. However, embryos derived from BOEC-CM had more trophectoderm cells, while embryos derived from BOEC-EVs, both fresh and frozen, has more trophectoderm and total cells. More embryos survived vitrification in the BOEC-CM and BOEC-EV groups. In contrast, more embryos survived in the EV-depleted-FCS than in normal-FCS group. Gene expression patterns were modified for PAG1 for embryos cultured with EVs in the presence of FCS and for IFN-T, PLAC8, PAG1, CX43, and GAPDH in the absence of FCS. In conclusion, EVs from FCS have a deleterious effect on embryo quality. BOEC-CM and EVs during in vitro culture had a positive effect on the quality of in vitro produced bovine embryos, suggesting that EVs have functional communication between the oviduct and the embryo in the early stages of development.	[Lopera-Vasquez, Ricaurte; Hamdi, Meriem; Fernandez-Fuertes, Beatriz; Maillo, Veronica; Beltran-Brena, Paula; Calle, Alexandra; Gutierrez-Adan, Alfonso; Angel Ramirez, Miguel; Rizos, Dimitrios] INIA, Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Reprod Anim, Madrid, Spain; [Redruello, Alberto; Lopez-Martin, Soraya; Yanez-Mo, Maria] Hosp Univ Santa Cristina, Inst Invest Sanitarias Princesa IIs IP, Madrid, Spain; [Yanez-Mo, Maria] UAM, CBM SO, Dept Biol Mol, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Rizos, D (corresponding author), INIA, Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Reprod Anim, Madrid, Spain.	drizos@inia.es	Fernandez-Fuertes, Beatriz/T-3307-2018; Hamdi, Meriem/AAT-3131-2020; de Paz, Miguel Ángel Ramírez/H-3171-2015; Rizos, Dimitrios/E-7058-2012; Gutierrez-Adan, Alfonso/A-1485-2014; Hamdi, Meriem/AAB-3539-2020; Maillo, Veronica/A-4934-2016	Fernandez-Fuertes, Beatriz/0000-0003-2303-8733; Hamdi, Meriem/0000-0002-5210-4915; de Paz, Miguel Ángel Ramírez/0000-0002-5868-2134; Rizos, Dimitrios/0000-0001-6813-3940; Gutierrez-Adan, Alfonso/0000-0001-9893-9179; Calle Arias, Alexandra/0000-0003-3903-5019; Maillo, Veronica/0000-0002-1154-3882	Spanish Ministry of Economy and Competitiveness [AGL2012-37510-AGA: AGL2012-39652-C02-01]; Spanish Institute of Health Carlos III [PI11/01645]; FPI [BES-2010-031873]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Institute of Health Carlos III(Instituto de Salud Carlos III); FPI(Spanish Government)	This work was supported by the Spanish Ministry of Economy and Competitiveness (DR: AGL2012-37510-AGA: AGL2012-39652-C02-01) and by the Spanish Institute of Health Carlos III (PI11/01645) to MYM. RLV was supported by FPI scholarship BES-2010-031873.	Abe H, 2002, MOL REPROD DEV, V61, P57, DOI 10.1002/mrd.1131; Abe H, 1996, HISTOL HISTOPATHOL, V11, P743; Al-Dossary AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080181; Aliotta JM, 2010, EXP HEMATOL, V38, P233, DOI 10.1016/j.exphem.2010.01.002; Andreu Z, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00442; Austin KJ, 1996, BIOL REPROD, V54, P600, DOI 10.1095/biolreprod54.3.600; Balasubramanian S, 2007, THERIOGENOLOGY, V68, P265, DOI 10.1016/j.theriogenology.2007.05.044; Bermejo-Alvarez P, 2008, PHYSIOL GENOMICS, V32, P264, DOI 10.1152/physiolgenomics.00234.2007; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; Burns DA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086855, 10.1371/journal.pone.0090913]; Cordova A, 2014, THERIOGENOLOGY, V81, P1163, DOI 10.1016/j.theriogenology.2014.01.012; da Silveira Juliano C, 2012, Biol Reprod, V86, P71, DOI 10.1095/biolreprod.111.093252; Ealy AD, 2009, AM J REPROD IMMUNOL, V61, P95, DOI 10.1111/j.1600-0897.2008.00673.x; Edwards LJ, 1997, MOL REPROD DEV, V46, P146, DOI 10.1002/(SICI)1098-2795(199702)46:2&lt;146::AID-MRD5&gt;3.0.CO;2-Q; El-Sayed A, 2006, PHYSIOL GENOMICS, V28, P84, DOI 10.1152/physiolgenomics.00111.2006; ELLINGTON JE, 1990, BIOL REPROD, V43, P97, DOI 10.1095/biolreprod43.1.97; ELLINGTON JE, 1993, BIOL REPROD, V48, P851, DOI 10.1095/biolreprod48.4.851; EYESTONE WH, 1989, J REPROD FERTIL, V85, P715, DOI 10.1530/jrf.0.0850715; EYESTONE WH, 1991, J REPROD FERTIL, V92, P59, DOI 10.1530/jrf.0.0920059; Fair T, 2001, MOL REPROD DEV, V58, P186, DOI 10.1002/1098-2795(200102)58:2&lt;186::AID-MRD8&gt;3.0.CO;2-N; FARIN CE, 1990, BIOL REPROD, V43, P210, DOI 10.1095/biolreprod43.2.210; Farin PW, 2006, THERIOGENOLOGY, V65, P178, DOI 10.1016/j.theriogenology.2005.09.022; Farin PW, 2001, THERIOGENOLOGY, V55, P151, DOI 10.1016/S0093-691X(00)00452-0; Fazeli A, 2008, THERIOGENOLOGY, V70, P1182, DOI 10.1016/j.theriogenology.2008.06.010; Gad A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099697; Galaviz-Hernandez C, 2003, GENE, V309, P81, DOI 10.1016/S0378-1119(03)00508-0; Garbayo JM, 2008, ANIM REPROD SCI, V103, P120, DOI 10.1016/j.anireprosci.2006.12.002; Garcia-Herreros M, 2012, REPROD FERT DEVELOP, V24, P344, DOI 10.1071/RD11080; Graf A, 2014, ANIM REPROD SCI, V149, P46, DOI 10.1016/j.anireprosci.2014.05.016; Guerin B, 1997, THERIOGENOLOGY, V47, P33, DOI 10.1016/S0093-691X(96)00337-8; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Gutierrez-Adan A, 2000, MOL REPROD DEV, V55, P146, DOI 10.1002/(SICI)1098-2795(200002)55:2&lt;146::AID-MRD3&gt;3.0.CO;2-F; Gutierrez-Adan A, 2004, MOL REPROD DEV, V68, P441, DOI 10.1002/mrd.20113; HACKETT AJ, 1993, THERIOGENOLOGY, V40, P1147, DOI 10.1016/0093-691X(93)90285-D; Hashizume K, 2007, REPROD FERT DEVELOP, V19, P79, DOI 10.1071/RD06118; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; HERNANDEZLEDEZMA JJ, 1993, THERIOGENOLOGY, V39, P1267, DOI 10.1016/0093-691X(93)90229-X; Holm P, 1999, THERIOGENOLOGY, V52, P683, DOI 10.1016/S0093-691X(99)00162-4; Kubisch HM, 1998, MOL REPROD DEV, V49, P254, DOI 10.1002/(SICI)1098-2795(199803)49:3&lt;254::AID-MRD5&gt;3.0.CO;2-N; Lazzari G, 2002, BIOL REPROD, V67, P767, DOI 10.1095/biolreprod.102.004481; Leese HJ, 2008, MOL HUM REPROD, V14, P667, DOI 10.1093/molehr/gan065; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd RE, 2009, REPRODUCTION, V137, P679, DOI 10.1530/REP-08-0405; Lonergan P, 2003, BIOL REPROD, V69, P1424, DOI 10.1095/biolreprod.103.018168; Lopes AS, 2007, THERIOGENOLOGY, V68, P223, DOI 10.1016/j.theriogenology.2007.04.055; Lopez-Gatius F, 2007, THERIOGENOLOGY, V67, P502, DOI 10.1016/j.theriogenology.2006.08.014; Luchsinger C, 2014, ZYGOTE, V22, P505, DOI 10.1017/S0967199413000099; Machado GM, 2013, MOL REPROD DEV, V80, P936, DOI 10.1002/mrd.22230; MERMILLOD P, 1993, BIOL REPROD, V49, P582, DOI 10.1095/biolreprod49.3.582; NANCARROW CD, 1994, CELL BIOL INT, V18, P1105, DOI 10.1006/cbir.1994.1037; Ng YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058502; Nicholls C, 2012, CLIN EXP PHARMACOL P, V39, P674, DOI 10.1111/j.1440-1681.2011.05599.x; Niemann H, 2000, THERIOGENOLOGY, V53, P21, DOI 10.1016/S0093-691X(99)00237-X; Patel OV, 1997, EUR J ENDOCRINOL, V137, P423, DOI 10.1530/eje.0.1370423; Perez-Hernandez D, 2013, J BIOL CHEM, V288, P11649, DOI 10.1074/jbc.M112.445304; Piehl LL, 2013, THERIOGENOLOGY, V79, P1071, DOI 10.1016/j.theriogenology.2013.01.028; Plourde D, 2012, THERIOGENOLOGY, V77, P1767, DOI 10.1016/j.theriogenology.2011.12.021; Pontes JHF, 2009, THERIOGENOLOGY, V71, P690, DOI 10.1016/j.theriogenology.2008.09.031; Ramos-Ibeas P, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.118430; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rief S, 2002, REPRODUCTION, V124, P543, DOI 10.1530/rep.0.1240543; RIEGER D, 1995, J REPROD FERTIL, V105, P91, DOI 10.1530/jrf.0.1050091; Rizos D, 2008, REPROD DOMEST ANIM, V43, P44, DOI 10.1111/j.1439-0531.2008.01230.x; Rizos D, 2003, BIOL REPROD, V68, P236, DOI 10.1095/biolreprod.102.007799; Rizos D, 2010, THERIOGENOLOGY, V73, P777, DOI 10.1016/j.theriogenology.2009.10.001; Rizos D, 2002, BIOL REPROD, V66, P589, DOI 10.1095/biolreprod66.3.589; Rizos D, 2002, MOL REPROD DEV, V61, P234, DOI 10.1002/mrd.1153; Rizos D, 2002, MOL REPROD DEV, V62, P320, DOI 10.1002/mrd.10138; Rodriguez-Martinez H, 2007, THERIOGENOLOGY, V68, pS138, DOI 10.1016/j.theriogenology.2007.03.018; Rottmayer R, 2006, REPRODUCTION, V132, P637, DOI 10.1530/rep.1.01136; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Schmaltz-Panneau B, 2014, ANIM REPROD SCI, V149, P103, DOI 10.1016/j.anireprosci.2014.06.022; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Thery C, 2006, CURRENT PROTOCOLS CE; Thompson JG, 1997, REPROD FERT DEVELOP, V9, P341, DOI 10.1071/R96079; Thouas G. A., 2001, Reprod Biomed Online, V3, P25; Trigal B, 2011, THERIOGENOLOGY, V75, P584, DOI 10.1016/j.theriogenology.2010.09.010; Tse PK, 2008, ENDOCRINOLOGY, V149, P1268, DOI 10.1210/en.2007-1277; Ulbrich SE, 2010, THERIOGENOLOGY, V73, P802, DOI 10.1016/j.theriogenology.2009.09.036; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; VanLangendonckt A, 1997, J REPROD FERTIL, V109, P87, DOI 10.1530/jrf.0.1090087; WANG W L, 1990, Theriogenology, V33, P343, DOI 10.1016/0093-691X(90)90767-N; Wooding FBP, 2005, PLACENTA, V26, P807, DOI 10.1016/j.placenta.2004.10.014; Wrenzycki C, 2001, HUM REPROD, V16, P893, DOI 10.1093/humrep/16.5.893; Wrenzycki C, 2003, BIOL REPROD, V68, P2073, DOI 10.1095/biolreprod.102.012104; Wrenzycki C, 2002, BIOL REPROD, V66, P127, DOI 10.1095/biolreprod66.1.127; Wrenzycki Christine, 2005, Birth Defects Res C Embryo Today, V75, P1, DOI 10.1002/bdrc.20035	88	119	122	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148083	10.1371/journal.pone.0148083	http://dx.doi.org/10.1371/journal.pone.0148083			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845570	Green Published, gold, Green Submitted			2022-12-27	WOS:000369552800026
J	Paco, A; Brigido, C; Alexandre, A; Mateos, PF; Oliveira, S				Paco, Ana; Brigido, Clarisse; Alexandre, Ana; Mateos, Pedro F.; Oliveira, Solange			The Symbiotic Performance of Chickpea Rhizobia Can Be Improved by Additional Copies of the clpB Chaperone Gene	PLOS ONE			English	Article							MESORHIZOBIUM-LOTI MAFF303099; SINORHIZOBIUM-MELILOTI; LEGUME SYMBIOSIS; HEAT-SHOCK; PROTEIN DISAGGREGATION; BACTEROID DEVELOPMENT; MOLECULAR CHAPERONES; AGGREGATED PROTEINS; NITROGEN-FIXATION; HSP100 CHAPERONES	The ClpB chaperone is known to be involved in bacterial stress response. Moreover, recent studies suggest that this protein has also a role in the chickpea-rhizobia symbiosis. In order to improve both stress tolerance and symbiotic performance of a chickpea microsymbiont, the Mesorhizobium mediterraneum UPM-Ca36(T) strain was genetically transformed with pPHU231 containing an extra-copy of the clpB gene. To investigate if the clpB-transformed strain displays an improved stress tolerance, bacterial growth was evaluated under heat and acid stress conditions. In addition, the effect of the extra-copies of the clpB gene in the symbiotic performance was evaluated using plant growth assays (hydroponic and pot trials). The clpB-transformed strain is more tolerant to heat shock than the strain transformed with pPHU231, supporting the involvement of ClpB in rhizobia heat shock tolerance. Both plant growth assays showed that ClpB has an important role in chickpea-rhizobia symbiosis. The nodulation kinetics analysis showed a higher rate of nodule appearance with the clpB-transformed strain. This strain also induced a greater number of nodules and, more notably, its symbiotic effectiveness increased similar to 60% at pH5 and 83% at pH7, compared to the wild-type strain. Furthermore, a higher frequency of root hair curling was also observed in plants inoculated with the clpB-transformed strain, compared to the wild-type strain. The superior root hair curling induction, nodulation ability and symbiotic effectiveness of the clpB-transformed strain may be explained by an increased expression of symbiosis genes. Indeed, higher transcript levels of the nodulation genes nodA and nodC (similar to 3 folds) were detected in the clpB-transformed strain. The improvement of rhizobia by addition of extracopies of the clpB gene may be a promising strategy to obtain strains with enhanced stress tolerance and symbiotic effectiveness, thus contributing to their success as crop inoculants, particularly under environmental stresses. This is the first report on the successful improvement of a rhizobium with a chaperone gene.	[Paco, Ana; Brigido, Clarisse; Alexandre, Ana; Oliveira, Solange] Univ Evora, Lab Microbiol Solo, ICAAM, Nucleo Mitra, Ap 94, P-7002554 Evora, Portugal; [Brigido, Clarisse; Alexandre, Ana] Univ Evora, IIFA, Ap 94, P-7002554 Evora, Portugal; [Mateos, Pedro F.] Univ Salamanca, Ctr Hispano Luso Invest Agr, Dept Microbiol & Genet, Salamanca 37007, Spain	University of Evora; University of Evora; University of Salamanca	Oliveira, S (corresponding author), Univ Evora, Lab Microbiol Solo, ICAAM, Nucleo Mitra, Ap 94, P-7002554 Evora, Portugal.	ismo@uevora.pt	Mateos, Pedro/L-6001-2014; Teixeira, Ana Isabel do Paço/AAE-9104-2021; Brígido, Clarisse/M-2784-2016	Mateos, Pedro/0000-0003-1628-598X; Brígido, Clarisse/0000-0002-4167-5253; Alexandre, Ana/0000-0001-7033-4186	FEDER through the Operational Programme for Competitiveness Factors - COMPETE; National Funds through FCT-Foundation for Science and Technology [PEst-OE/AGR/UI0115/2014, FCOMP-01-0124-FEDER-028316 (PTDC/BIA-EVF/4158/2012)]; InAlentejo [ALENT-07-0262-FEDER-001871]; FCT [SFRH/BPD/73243/2010, SFRH/BPD/94751/2013]	FEDER through the Operational Programme for Competitiveness Factors - COMPETE; National Funds through FCT-Foundation for Science and Technology; InAlentejo; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by funds from FEDER through the Operational Programme for Competitiveness Factors - COMPETE, National Funds through FCT-Foundation for Science and Technology, under the Strategic Project PEst-OE/AGR/UI0115/2014 (ICAAM), Project no FCOMP-01-0124-FEDER-028316 (PTDC/BIA-EVF/4158/2012) and InAlentejo ALENT-07-0262-FEDER-001871. A.A. and C.B. acknowledge Post-Doc fellowships (SFRH/BPD/73243/2010 and SFRH/BPD/94751/2013) from FCT.	Acebron SP, 2009, FEBS LETT, V583, P2991, DOI 10.1016/j.febslet.2009.08.020; Adesemoye AO, 2009, MICROB ECOL, V58, P921, DOI 10.1007/s00248-009-9531-y; Alexandre A, 2014, DNA RES, V21, P195, DOI 10.1093/dnares/dst050; Alexandre A, 2013, CRIT REV MICROBIOL, V39, P219, DOI 10.3109/1040841X.2012.702097; Alexandre A, 2009, MICROB ECOL, V58, P930, DOI 10.1007/s00248-009-9536-6; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Biter AB, 2012, P NATL ACAD SCI USA, V109, P12515, DOI 10.1073/pnas.1207040109; Bittner AN, 2007, J BACTERIOL, V189, P1884, DOI 10.1128/JB.01542-06; Brigido C, 2007, LETT APPL MICROBIOL, V44, P168, DOI 10.1111/j.1472-765X.2006.02061.x; Brigido C, 2013, MICROB ECOL, V65, P145, DOI 10.1007/s00248-012-0098-7; Brigido C, 2012, MOL PLANT MICROBE IN, V25, P1594, DOI 10.1094/MPMI-05-12-0140-R; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; CADAHIA E, 1986, ARCH MICROBIOL, V146, P239, DOI 10.1007/BF00403223; Cooper JE, 2007, J APPL MICROBIOL, V103, P1355, DOI 10.1111/j.1365-2672.2007.03366.x; de Lucena DKC, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-265; DeSantis ME, 2012, BBA-MOL CELL RES, V1823, P29, DOI 10.1016/j.bbamcr.2011.07.014; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Djordjevic MA, 2004, PROTEOMICS, V4, P1859, DOI 10.1002/pmic.200300802; Dominguez-Ferreras A, 2006, J BACTERIOL, V188, P7617, DOI 10.1128/JB.00719-06; Downie JA, 2014, CURR BIOL, V24, pR184, DOI 10.1016/j.cub.2014.01.028; Ekaza E, 2001, J BACTERIOL, V183, P2677, DOI 10.1128/JB.183.8.2677-2681.2001; Eriksson MJ, 2000, CELL STRESS CHAPERON, V5, P255, DOI 10.1379/1466-1268(2000)005<0255:TECHSP>2.0.CO;2; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Gibson A. H., 1987, Symbiotic Nitrogen Fixation Technology, P321; Haag AF, 2013, FEMS MICROBIOL REV, V37, P364, DOI 10.1111/1574-6976.12003; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Haslberger T, 2008, NAT STRUCT MOL BIOL, V15, P641, DOI 10.1038/nsmb.1425; HUBNER P, 1991, J BACTERIOL, V173, P2993; Karunakaran R, 2009, J BACTERIOL, V191, P4002, DOI 10.1128/JB.00165-09; Kedzierska S, 2001, FEMS MICROBIOL LETT, V204, P355; Kereszt A, 2011, MOL PLANT MICROBE IN, V24, P1300, DOI 10.1094/MPMI-06-11-0152; Laranjo M, 2004, FEMS MICROBIOL ECOL, V48, P101, DOI 10.1016/j.femsec.2003.12.015; Laranjo M, 2008, FEMS MICROBIOL ECOL, V66, P391, DOI 10.1111/j.1574-6941.2008.00584.x; Laranjo M, 2014, APPL MICROBIOL BIOT, V98, P7137, DOI 10.1007/s00253-014-5875-4; Laranjo M, 2011, ANTON LEEUW INT J G, V99, P651, DOI 10.1007/s10482-010-9539-9; Mergaert P, 1997, MOL MICROBIOL, V25, P811, DOI 10.1111/j.1365-2958.1997.mmi526.x; Moscatiello R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-206; Nag S, 2005, BIOCHEM BIOPH RES CO, V331, P1365, DOI 10.1016/j.bbrc.2005.04.052; Nakazaki Y, 2014, GENES CELLS, V19, P891, DOI 10.1111/gtc.12188; Nascimento F, 2012, PLANT SOIL, V353, P221, DOI 10.1007/s11104-011-1025-2; Nomura M, 2010, SOIL SCI PLANT NUTR, V56, P579, DOI 10.1111/j.1747-0765.2010.00500.x; OGAWA J, 1995, GENE DEV, V9, P714, DOI 10.1101/gad.9.6.714; Oke V, 1999, CURR OPIN MICROBIOL, V2, P641, DOI 10.1016/S1369-5274(99)00035-1; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Priefer UB, 2001, J BIOTECHNOL, V91, P223, DOI 10.1016/S0168-1656(01)00329-7; Puskas LG, 2004, MOL GENET GENOMICS, V272, P275, DOI 10.1007/s00438-004-1051-3; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; Rivas R, 2001, ELECTROPHORESIS, V22, P1086, DOI 10.1002/1522-2683()22:6<1086::AID-ELPS1086>3.0.CO;2-6; ROBERTSEN BK, 1981, PLANT PHYSIOL, V67, P389, DOI 10.1104/pp.67.3.389; Robledo M, 2011, MOL PLANT MICROBE IN, V24, P798, DOI 10.1094/MPMI-10-10-0249; Sambrook J., 2001, MOL CLONING LAB MANU; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Sarma AD, 2005, PROTEOMICS, V5, P4170, DOI 10.1002/pmic.200401296; Sauviac L, 2007, J BACTERIOL, V189, P4204, DOI 10.1128/JB.00175-07; SINGLETON PW, 1982, APPL ENVIRON MICROB, V44, P884, DOI 10.1128/AEM.44.4.884-890.1982; Srivastava P, 1999, MICROBIOL RES, V154, P49, DOI 10.1016/S0944-5013(99)80034-2; Uchiumi T, 2004, J BACTERIOL, V186, P2439, DOI 10.1128/JB.186.8.2439-2448.2004; Ventura M, 2005, MICROBIOL-SGM, V151, P2861, DOI 10.1099/mic.0.28176-0; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999; Zolkiewski M, 2012, ARCH BIOCHEM BIOPHYS, V520, P1, DOI 10.1016/j.abb.2012.01.012	63	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148221	10.1371/journal.pone.0148221	http://dx.doi.org/10.1371/journal.pone.0148221			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845770	Green Published, Green Submitted, gold			2022-12-27	WOS:000369552800038
J	Rady, HF; Dai, GX; Huang, WT; Shellito, JE; Ramsay, AJ				Rady, Hamada F.; Dai, Guixiang; Huang, Weitao; Shellito, Judd E.; Ramsay, Alistair J.			Flagellin Encoded in Gene-Based Vector Vaccines Is a Route-Dependent Immune Adjuvant	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; T-CELL EPITOPE; MYCOBACTERIUM-TUBERCULOSIS; PROTECTIVE EFFICACY; ENHANCED IMMUNOGENICITY; DIRECT STIMULATION; DNA VACCINATION; FUSION PROTEINS; BOOST STRATEGY; RESPONSES	Flagellin has been tested as a protein-based vaccine adjuvant, with the majority of studies focused on antibody responses. Here, we evaluated the adjuvant activity of flagellin for both cellular and humoral immune responses in BALB/c mice in the setting of gene-based immunization, and have made several novel observations. DNA vaccines and adenovirus (Ad) vectors were engineered to encode mycobacterial protein Ag85B, with or without flagellin of Salmonella typhimurium (FliC). DNA-encoded flagellin given IM enhanced splenic CD4+ and CD8+ T cell responses to co-expressed vaccine antigen, including memory responses. Boosting either IM or intranasally with Ad vectors expressing Ag85B without flagellin led to durable enhancement of Ag85B-specific antibody and CD4+ and CD8+ T cell responses in both spleen and pulmonary tissues, correlating with significantly improved protection against challenge with pathogenic aerosolized M. tuberculosis. However, inclusion of flagellin in both DNA prime and Ad booster vaccines induced localized pulmonary inflammation and transient weight loss, with route-dependent effects on vaccine-induced T cell immunity. The latter included marked reductions in levels of mucosal CD4+ and CD8+ T cell responses following IM DNA/IN Ad mucosal prime-boosting, although antibody responses were not diminished. These findings indicate that flagellin has differential and route-dependent adjuvant activity when included as a component of systemic or mucosally-delivered gene-based prime-boost immunization. Clear adjuvant activity for both T and B cell responses was observed when flagellin was included in the DNA priming vaccine, but side effects occurred when given in an Ad boosting vector, particularly via the pulmonary route.	[Rady, Hamada F.; Dai, Guixiang; Huang, Weitao; Ramsay, Alistair J.] Louisiana State Univ Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA; [Shellito, Judd E.; Ramsay, Alistair J.] Louisiana State Univ Hlth Sci Ctr, Dept Med, New Orleans, LA USA; [Rady, Hamada F.; Dai, Guixiang; Shellito, Judd E.; Ramsay, Alistair J.] Louisiana State Univ Hlth Sci Ctr, Louisiana Vaccine Ctr, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Ramsay, AJ (corresponding author), Louisiana State Univ Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA.	aramsa@lsuhsc.edu			National Institutes of Health [5R01AI58810, 3R01AI58810-06S2, P01HL076100]; Louisiana Vaccine Center - Louisiana Board of Regents; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058810] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Vaccine Center - Louisiana Board of Regents; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (http://nih.gov/) Grants 5R01AI58810 (AJR), 3R01AI58810-06S2 (AJR), and P01HL076100 (AJR and JES) and by the Louisiana Vaccine Center, funded by the Louisiana Board of Regents (http://www.regents.la.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Auten MW, 2012, VACCINE, V30, P2768, DOI 10.1016/j.vaccine.2012.02.020; Bates JT, 2008, MECH AGEING DEV, V129, P271, DOI 10.1016/j.mad.2008.01.009; Bates JT, 2009, J IMMUNOL, V182, P7539, DOI 10.4049/jimmunol.0804225; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Ben-Yedidia T, 1999, INFECT IMMUN, V67, P4360, DOI 10.1128/IAI.67.9.4360-4366.1999; Ben-Yedidia T, 1998, IMMUNOL LETT, V64, P9, DOI 10.1016/S0165-2478(98)00073-X; Boog CJP, 2009, IMMUNOL LETT, V122, P104, DOI 10.1016/j.imlet.2008.11.009; Braga CJM, 2010, VACCINE, V28, P1373, DOI 10.1016/j.vaccine.2009.11.003; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Nguyen CT, 2013, VACCINE, V31, P3879, DOI 10.1016/j.vaccine.2013.06.054; Ciacci-Woolwine F, 1998, INFECT IMMUN, V66, P1127, DOI 10.1128/IAI.66.3.1127-1134.1998; Cuadros C, 2004, INFECT IMMUN, V72, P2810, DOI 10.1128/IAI.72.5.2810-2816.2004; D'Souza S, 2006, INFECT IMMUN, V74, P2751, DOI 10.1128/IAI.74.5.2751-2759.2006; D'Souza S, 2003, INFECT IMMUN, V71, P483, DOI 10.1128/IAI.71.1.483-493.2003; Dalmia N, 2012, EXPERT REV VACCINES, V11, P1221, DOI [10.1586/erv.12.94, 10.1586/ERV.12.94]; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; DINARELLO CA, 1992, INT J TISSUE REACT, V14, P65; Estcourt MJ, 2002, INT IMMUNOL, V14, P31, DOI 10.1093/intimm/14.1.31; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Geiben-Lynn R, 2008, CLIN VACCINE IMMUNOL, V15, P691, DOI 10.1128/CVI.00418-07; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; HIRANO T, 1992, CLIN IMMUNOL IMMUNOP, V62, pS60, DOI 10.1016/0090-1229(92)90042-M; Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Huleatt JW, 2007, VACCINE, V25, P763, DOI 10.1016/j.vaccine.2006.08.013; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Kaufmann SHE, 2005, TRENDS IMMUNOL, V26, P660, DOI 10.1016/j.it.2005.09.012; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kowalczyk DW, 1999, CELL MOL LIFE SCI, V55, P751, DOI 10.1007/s000180050330; Lee SE, 2006, INFECT IMMUN, V74, P694, DOI 10.1128/IAI.74.1.694-702.2006; Liaudet L, 2002, INFECT IMMUN, V70, P192, DOI 10.1128/IAI.70.1.192-198.2002; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Morris AE, 2009, AM J PHYSIOL-LUNG C, V297, pL1112, DOI 10.1152/ajplung.00155.2009; Murray PJ, 1999, TRENDS MICROBIOL, V7, P366, DOI 10.1016/S0966-842X(99)01567-X; NEWTON SMC, 1995, RES MICROBIOL, V146, P203, DOI 10.1016/0923-2508(96)80276-2; Qian F, 2015, SALMONELLA FLAGELLIN, VS0264-410X, P00292; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Ramsay AJ, 1997, IMMUNOL CELL BIOL, V75, P382, DOI 10.1038/icb.1997.60; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Rigato PO, 2011, INFECT IMMUN, V79, P2120, DOI 10.1128/IAI.01190-10; Rollier CS, 2011, CURR OPIN IMMUNOL, V23, P377, DOI 10.1016/j.coi.2011.03.006; Saade F, 2012, EXPERT REV VACCINES, V11, P189, DOI [10.1586/erv.11.188, 10.1586/ERV.11.188]; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; SCHUMACHER C, 1992, P NATL ACAD SCI USA, V89, P10542, DOI 10.1073/pnas.89.21.10542; Schwarz K, 2003, EUR J IMMUNOL, V33, P1465, DOI 10.1002/eji.200323919; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shi W, 2012, J DENT RES, V91, P249, DOI 10.1177/0022034511424283; Skinner MA, 2003, IMMUNOLOGY, V108, P548, DOI 10.1046/j.1365-2567.2003.01589.x; Skountzou I, 2010, VACCINE, V28, P4103, DOI 10.1016/j.vaccine.2009.07.058; Strindelius L, 2004, VACCINE, V22, P3797, DOI 10.1016/j.vaccine.2003.12.035; Taylor DN, 2012, VACCINE, V30, P5761, DOI 10.1016/j.vaccine.2012.06.086; Treanor JJ, 2010, VACCINE, V28, P8268, DOI 10.1016/j.vaccine.2010.10.009; Tseng J, 2006, AM J PHYSIOL-CELL PH, V290, pC678, DOI 10.1152/ajpcell.00166.2005; van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005; VERMA NK, 1995, VACCINE, V13, P235, DOI 10.1016/0264-410X(95)93308-V; Wang BZ, 2008, J VIROL, V82, P11813, DOI 10.1128/JVI.01076-08; Weimer ET, 2009, VACCINE, V27, P6762, DOI 10.1016/j.vaccine.2009.08.080; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009; Xiao Y, 2015, CELL MOL IMMUNOL, V12, P729, DOI 10.1038/cmi.2014.110; Yang JY, 2013, HUM VACC IMMUNOTHER, V9, P1084, DOI 10.4161/hv.23809	63	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148701	10.1371/journal.pone.0148701	http://dx.doi.org/10.1371/journal.pone.0148701			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844553	Green Published, Green Submitted, gold			2022-12-27	WOS:000369552800079
J	Zhang, KH; Liu, S; Feng, B; Yang, YL; Zhang, HY; Dong, R; Liu, Y; Gai, ZT				Zhang, Kaihui; Liu, Shu; Feng, Bing; Yang, Yali; Zhang, Haiyan; Dong, Rui; Liu, Yi; Gai, Zhongtao			Clinical Application of an Innovative Multiplex-Fluorescent-Labeled STRs Assay for Prader-Willi Syndrome and Angelman Syndrome	PLOS ONE			English	Article							UNIPARENTAL DISOMY; REGION; POPULATION; MECHANISMS; DIAGNOSIS; DELETION; UPDATE	Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are two clinically distinct neurodevelopmental disorders caused by absence of paternally or maternally expressed imprinted genes on chr15q11.2-q13.3. Three mechanisms are known to be involved in the pathogenesis: microdeletions, uniparental disomy (UPD) and imprinting defects. Both disorders are difficult to be definitely diagnosed at early age if no available molecular cytogenetic tests. In this study, we identified 5 AS patients with the maternal deletion and 26 PWS patients with paternal deletion on chr15q11-q13 by using an innovative multiplex-fluorescent-labeled short tandem repeats (STRs) assay based on linkage analysis, and validated by the methylation-specific PCR and array comparative genomic hybridization techniques. More interesting, one of these PWS patients was confirmed as maternal uniparental isodisomy by the STR linkage analysis. The phenotypic and genotypic characteristics of these individuals were also presented. Our results indicate that the new linkage analysis is much faster and easier for large-scale screening deletion and uniparental disomy, thus providing a valuable method for early diagnosis of PWS/AS patients, which is critical for genetic diagnosis, management and improvement of prognosis.	[Zhang, Kaihui; Zhang, Haiyan; Dong, Rui; Liu, Yi; Gai, Zhongtao] Shandong Univ, Qilu Childrens Hosp, Pediat Res Inst, Jinan 250022, Peoples R China; [Liu, Shu] Guangzhou Med Univ, Guangdong Women & Childrens Hosp, Ctr Med Genet, Guangzhou 511442, Guangdong, Peoples R China; [Feng, Bing] Shandong Univ, Qilu Childrens Hosp, Pediat Hlth Care Inst, Jinan 250022, Peoples R China; [Yang, Yali] Shandong Univ, Qilu Childrens Hosp, Rehabil Ctr, Jinan 250022, Peoples R China	Shandong University; Guangzhou Medical University; Shandong University; Shandong University	Liu, Y; Gai, ZT (corresponding author), Shandong Univ, Qilu Childrens Hosp, Pediat Res Inst, Jinan 250022, Peoples R China.	y.liu99@yahoo.com; gaizhongtao@sina.com	Yang, Ya-Li/GYU-4320-2022; Lang, Ming/HIK-0758-2022; yang, yang/HGT-7999-2022		Natural Science Training Foundation of Shandong Province [ZR2014HP051]; Science and Technology Developmental Plan of Shandong Province [2013GSF11829]; Ji'nan Science and Technology Bureau	Natural Science Training Foundation of Shandong Province; Science and Technology Developmental Plan of Shandong Province; Ji'nan Science and Technology Bureau	This study was funded by Natural Science Training Foundation of Shandong Province (ZR2014HP051) and Science and Technology Developmental Plan of Shandong Province (2013GSF11829).; The authors are grateful to the patients and their families for their contribution to the work. We'd like to thank Natural Science Training Foundation of Shandong Province (ZR2014HP051), Science and Technology Developmental Plan of Shandong Province (2013GSF11829), Ji'nan Science and Technology Bureau for financial support of Excellent Science Technology Innovation Team.	Bai JL, 2014, CLIN GENET, V85, P273, DOI 10.1111/cge.12155; Bhatt Arpan D, 2013, Indian J Hum Genet, V19, P311, DOI 10.4103/0971-6866.120819; Buiting K, 2010, AM J MED GENET C, V154C, P365, DOI 10.1002/ajmg.c.30273; Chen C, 2007, CLIN PEDIATR, V46, P580, DOI 10.1177/0009922807299314; Dimitropoulos A, 2013, J COMMUN DISORD, V46, P193, DOI 10.1016/j.jcomdis.2012.12.001; Engel E, 2006, EUR J HUM GENET, V14, P1158, DOI 10.1038/sj.ejhg.5201619; Gunay-Aygun M, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.5.e92; Hashemi B, 2015, AM J MED GENET A, V167, P2098, DOI 10.1002/ajmg.a.37134; Horsthemke B, 2008, AM J MED GENET A, V146A, P2041, DOI 10.1002/ajmg.a.32364; Li Hongyi, 2007, Journal of Genetics and Genomics, V34, P885, DOI 10.1016/S1673-8527(07)60100-3; Liu Li-jun, 2009, Zhonghua Yixue Yichuanxue Zazhi, V26, P495, DOI 10.3760/cma.j.issn.1003-9406.2009.05.003; Lu W, 2014, EUR J PEDIATR, V173, P81, DOI 10.1007/s00431-013-2124-2; Margolis SS, 2015, NEUROTHERAPEUTICS, V12, P641, DOI 10.1007/s13311-015-0361-y; MICHAELIS RC, 1995, AM J MED GENET, V55, P120, DOI 10.1002/ajmg.1320550131; Rice LJ, 2015, CURR OPIN PSYCHIATR, V28, P102, DOI 10.1097/YCO.0000000000000135; Robinson WP, 2000, BIOESSAYS, V22, P452; Rocha CF, 2014, GENET MOL RES, V13, P2290, DOI 10.4238/2014.March.31.9; Sadikovic B, 2014, HUM MUTAT, V35, P1407, DOI 10.1002/humu.22687; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Tauber M, 2014, FRONT HORM RES, V42, P93, DOI 10.1159/000358317; Teng YN, 2002, J FORMOS MED ASSOC, V101, P488; Yamazawa K, 2010, AM J MED GENET C, V154C, P329, DOI 10.1002/ajmg.c.30270; Zhu JZ, 2013, INTRACTABLE RARE DIS, V2, P123, DOI 10.5582/irdr.2013.v2.4.123	23	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147824	10.1371/journal.pone.0147824	http://dx.doi.org/10.1371/journal.pone.0147824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841067	gold, Green Submitted, Green Published			2022-12-27	WOS:000369550200064
J	Lin, XL; Tang, XD; Cai, ZX; Wang, FY; Li, P; Sui, H; Guo, HS				Lin, Xue-Lian; Tang, Xu-Dong; Cai, Zheng-Xu; Wang, Feng-Yun; Li, Ping; Sui, Hua; Guo, Hui-Shu			NPs/NPRs Signaling Pathways May Be Involved in Depression-Induced Loss of Gastric ICC by Decreasing the Production of mSCF	PLOS ONE			English	Article							FUNCTIONAL GASTROINTESTINAL DISORDERS; RECEPTOR-C EXPRESSION; INDUCED DIABETIC MICE; SMOOTH-MUSCLE-CELLS; NATRIURETIC-PEPTIDE; INTERSTITIAL-CELLS; PSYCHOSOCIAL-ASPECTS; CAJAL; TRACT; RATS	It is well known that natriuretic peptides (NPs) are involved in the regulation of gastrointestinal motility. Interstitial cells of Cajal (ICC) are the pacemaker cells of gastrointestinal motility and gastrointestinal dyskinesia is one of the important digestive tract symptoms of depression. However, it is unclear whether they are involved in depression-induced loss of ICC. The aim of the present study was to investigate the relationship between the natriuretic peptide signaling pathway and depression-induced loss of gastric ICC in depressed rats. These results showed that the expression of c-kit and stem cell factor (SCF) in smooth muscle layers of stomach were down-regulated in depressed rats at the mRNA and protein levels. The expression of natriuretic peptide receptor (NPR)-A, B and C were up-regulated in the stomach of depressed rats at the mRNA and protein levels. NPR-A, B and C can significantly decrease the expression of SCF to treat cultured gastric smooth muscle cells (GSMCs) obtained from normal rats with different concentrations of C-type natriuretic peptide (CNP). Pretreatment of cultured GSMCs with 8-Brom-cGMP (8-Br-cGMP, a membrane permeable cGMP analog), cANF (a specific NPR-C agonist) and CNP (10(-6) mol/L) demonstrated that 8-Br-cGMP had a similar effect as CNP, but treatment with cANF did not. The results of the methyl thiazolyl tetrazolium bromide (MTT) assay indicated that high concentrations of cANF (10(-6) mol/L) restrained the proliferation of cultured GSMCs. Taken together, these results indicate that the up-regulation of the NPs/NPR-C and NPs/NPR-A, B/cGMP signaling pathways may be involved in depression-induced loss of gastric ICC.	[Lin, Xue-Lian; Li, Ping; Guo, Hui-Shu] Dalian Med Univ, Affiliated Hosp 1, Cent Lab, Dalian 116011, Liaoning Provin, Peoples R China; [Tang, Xu-Dong; Wang, Feng-Yun] China Acad Chinese Med Sci, Xiyuan Hosp, Dept Gastroenterol, Beijing 100091, Peoples R China; [Cai, Zheng-Xu] Dalian Med Univ, Affiliated Hosp 1, Dept Neurol, Dalian 116011, Liaoning Provin, Peoples R China; [Sui, Hua] Dalian Med Univ, Inst Basic Res Integrat Med, Dalian 116044, Liaoning Provin, Peoples R China	Dalian Medical University; China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS; Dalian Medical University; Dalian Medical University	Guo, HS (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Cent Lab, Dalian 116011, Liaoning Provin, Peoples R China.; Cai, ZX (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Neurol, Dalian 116011, Liaoning Provin, Peoples R China.	caizhengxu999@126.com; guohuishu1@126.com			National Basic Research Program of China (973 Program) [2013CB531703]; National Natural Science Foundation of China [81273919]; Natural Science Foundation of Liaoning Province [2012225020, 2013023002]; First Affiliated Hospital of Dalian Medical University	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province); First Affiliated Hospital of Dalian Medical University	The work was supported by the following: National Basic Research Program of China (973 Program), No. 2013CB531703, HSG; The National Natural Science Foundation of China, No. 81273919, HSG; and Natural Science Foundation of Liaoning Province, No. 2012225020 and No. 2013023002, HSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to graciously acknowledge the staff at Central Laboratory, The First Affiliated Hospital of Dalian Medical University, for their help and support in this project.	Abbey-Hosch SE, 2005, BIOCHEM PHARMACOL, V70, P686, DOI 10.1016/j.bcp.2005.04.034; Al-Shboul OA, 2013, SAUDI J GASTROENTERO, V19, P3, DOI 10.4103/1319-3767.105909; Blair PJ, 2014, J NEUROGASTROENTEROL, V20, P294, DOI 10.5056/jnm14060; Bodukam V, 2011, RHEUMATOLOGY, V50, P330, DOI 10.1093/rheumatology/keq296; Breuer C, 2010, WORLD J GASTROENTERO, V16, P4363, DOI 10.3748/wjg.v16.i34.4363; Bulbul M, 2012, AM J PHYSIOL-GASTR L, V302, pG702, DOI 10.1152/ajpgi.00447.2011; Cai YL, 2009, WORLD J GASTROENTERO, V15, P2125, DOI 10.3748/wjg.15.2125; Chen ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086100; Del Ry S, 2008, PEPTIDES, V29, P2208, DOI 10.1016/j.peptides.2008.09.005; Drossman DA, 1999, GUT, V45, P25; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Fu XY, 2014, NUTR METAB, V11; Fujishige K, 1998, AM J PHYSIOL-LUNG C, V274, pL425, DOI 10.1152/ajplung.1998.274.3.L425; Geeraerts B, 2011, AM J PHYSIOL-GASTR L, V300, pG228, DOI 10.1152/ajpgi.00020.2010; Gower WR, 2006, MOL CELL BIOCHEM, V293, P103, DOI 10.1007/s11010-006-9234-3; Kim JH, 2004, REGUL PEPTIDES, V120, P93, DOI 10.1016/j.regpep.2004.02.021; Levy RL, 2006, GASTROENTEROLOGY, V130, P1447, DOI 10.1053/j.gastro.2005.11.057; Li P, 2015, WORLD J GASTROENTERO, V21, P1518, DOI 10.3748/wjg.v21.i5.1518; Li Y, 2006, CARDIOVASC RES, V72, P464, DOI 10.1016/j.cardiores.2006.08.012; Li Y, 2012, CARDIOVASC RES, V93, P350, DOI 10.1093/cvr/cvr319; Lin L, 2010, AM J PHYSIOL-GASTR L, V298, pG241, DOI 10.1152/ajpgi.90706.2008; Lorincz A, 2008, GASTROENTEROLOGY, V134, P1083, DOI 10.1053/j.gastro.2008.01.036; Mayer EA, 2006, ALIMENT PHARM THER, V24, P919, DOI 10.1111/j.1365-2036.2006.03078.x; McCann CJ, 2014, J NEUROGASTROENTEROL, V20, P326, DOI 10.5056/jnm14026; Mei F, 2009, ANAT REC, V292, P985, DOI 10.1002/ar.20928; North CS, 2007, WORLD J GASTROENTERO, V13, P2020, DOI 10.3748/wjg.v13.i14.2020; Noubani A, 2000, ENDOCRINOLOGY, V141, P551, DOI 10.1210/en.141.2.551; Pandey KN, 2011, CAN J PHYSIOL PHARM, V89, P557, DOI [10.1139/Y11-054, 10.1139/y11-054]; Park KS, 2014, J NEUROGASTROENTEROL, V20, P281, DOI 10.5056/jnm14064; Qiu ZX, 2010, WORLD J GASTROENTERO, V16, P48, DOI 10.3748/wjg.v16.i1.48; Rahmutula D, 2005, ENDOCRINOLOGY, V146, P4968, DOI 10.1210/en.2005-0262; Rao JN, 2013, DIGEST DIS SCI, V58, P1449, DOI 10.1007/s10620-013-2683-0; Sanders KM, 2014, J NEUROGASTROENTEROL, V20, P171, DOI [10.5056/jnm.20.2.171, 10.5056/jnm.2014.20.2.171]; Sellitti DF, 2004, J ENDOCRINOL, V180, P23, DOI 10.1677/joe.0.1800023; Shahi PK, 2014, J GASTROENTEROL, V49, P1001, DOI 10.1007/s00535-013-0849-3; Sogawa C, 2013, AM J PATHOL, V182, P172, DOI 10.1016/j.ajpath.2012.09.015; Sogawa C, 2010, AM J PATHOL, V177, P822, DOI 10.2353/ajpath.2010.091278; Wang LL, 2014, INT J MED SCI, V11, P262, DOI 10.7150/ijms.7287; Wu YS, 2013, PEPTIDES, V40, P104, DOI 10.1016/j.peptides.2012.12.024; Yanaka N, 1998, AM J PHYSIOL-ENDOC M, V275, pE965, DOI 10.1152/ajpendo.1998.275.6.E965	40	5	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149031	10.1371/journal.pone.0149031	http://dx.doi.org/10.1371/journal.pone.0149031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862759	Green Published, gold			2022-12-27	WOS:000370046600142
J	Fujimoto, N; Kan-o, M; Ushijima, T; Kage, Y; Tominaga, R; Sumimoto, H; Takeya, R				Fujimoto, Noriko; Kan-o, Meikun; Ushijima, Tomoki; Kage, Yohko; Tominaga, Ryuji; Sumimoto, Hideki; Takeya, Ryu			Transgenic Expression of the Formin Protein Fhod3 Selectively in the Embryonic Heart: Role of Actin-Binding Activity of Fhod3 and Its Sarcomeric Localization during Myofibrillogenesis	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; MAMMALIAN FORMIN; MUSCLE; PHOSPHORYLATION; MECHANISM; FILAMENTS; SKELETAL; COMPLEX	Fhod3 is a cardiac member of the formin family proteins that play pivotal roles in actin filament assembly in various cellular contexts. The targeted deletion of mouse Fhod3 gene leads to defects in cardiogenesis, particularly during myofibrillogenesis, followed by lethality at embryonic day (E) 11.5. However, it remains largely unknown how Fhod3 functions during myofibrillogenesis. In this study, to assess the mechanism whereby Fhod3 regulates myofibrillogenesis during embryonic cardiogenesis, we generated transgenic mice expressing Fhod3 selectively in embryonic cardiomyocytes under the control of the beta-myosin heavy chain (MHC) promoter. Mice expressing wild-type Fhod3 in embryonic cardiomyocytes survive to adulthood and are fertile, whereas those expressing Fhod3 (I1127A) defective in binding to actin die by E11.5 with cardiac defects. This cardiac phenotype of the Fhod3 mutant embryos is almost identical to that observed in Fhod3 null embryos, suggesting that the actin-binding activity of Fhod3 is crucial for embryonic cardiogenesis. On the other hand, the beta-MHC promoter-driven expression of wild-type Fhod3 sufficiently rescues cardiac defects of Fhod3-null embryos, indicating that the Fhod3 protein expressed in a transgenic manner can function properly to achieve myofibril maturation in embryonic cardiomyocytes. Using the transgenic mice, we further examined detailed localization of Fhod3 during myofibrillogenesis in situ and found that Fhod3 localizes to the specific central region of nascent sarcomeres prior to massive rearrangement of actin filaments and remains there throughout myofibrillogenesis. Taken together, the present findings suggest that, during embryonic cardiogenesis, Fhod3 functions as the essential reorganizer of actin filaments at the central region of maturating sarcomeres via the actin-binding activity of the FH2 domain.	[Fujimoto, Noriko; Kan-o, Meikun; Ushijima, Tomoki; Kage, Yohko; Sumimoto, Hideki; Takeya, Ryu] Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Higashi Ku, Fukuoka 8128582, Japan; [Fujimoto, Noriko; Ushijima, Tomoki; Kage, Yohko; Takeya, Ryu] Miyazaki Univ, Fac Med, Dept Pharmacol, Kiyotake, Miyazaki 8891692, Japan; [Kan-o, Meikun; Tominaga, Ryuji] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Surg, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University; University of Miyazaki; Kyushu University	Takeya, R (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	takeya@med.miyazaki-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [23590337, 26460371]; Japan Society for the Promotion of Science (JSPS) SHINGAKUJUTSU [25117515]; Takeda Science Foundation; Institute of Seizon and Life Sciences; Grants-in-Aid for Scientific Research [25117515] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science (JSPS) SHINGAKUJUTSU(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Institute of Seizon and Life Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI grant number 23590337 and 26460371, SHINGAKUJUTSU grant number 25117515, grants from the Takeda Science Foundation and the Institute of Seizon and Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Fritz-Six KL, 2003, J CELL BIOL, V163, P1033, DOI 10.1083/jcb.200308164; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; GROVE BK, 1984, J CELL BIOL, V98, P518, DOI 10.1083/jcb.98.2.518; HANDEL SE, 1991, CELL TISSUE RES, V263, P419, DOI 10.1007/BF00327276; Iskratsch T, 2013, CELL MOL LIFE SCI, V70, P893, DOI 10.1007/s00018-012-1154-7; Iskratsch T, 2010, J CELL BIOL, V191, P1159, DOI 10.1083/jcb.201005060; Kan-o M, 2012, BIOL OPEN, V1, P889, DOI 10.1242/bio.20121370; Kan-o M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034765; Kanaya H, 2005, GENES CELLS, V10, P665, DOI 10.1111/j.1365-2443.2005.00867.x; Kutscheidt S, 2014, NAT CELL BIOL, V16, P708, DOI 10.1038/ncb2981; Liu R, 2010, BBA-MOL CELL RES, V1803, P207, DOI 10.1016/j.bbamcr.2008.09.016; Lopez JE, 2011, CIRC RES, V109, P629, DOI 10.1161/CIRCRESAHA.111.243410; McKeown CR, 2014, DEV DYNAM, V243, P800, DOI 10.1002/dvdy.24115; Molnar I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004166; Nishii K, 2008, DEV BIOL, V322, P65, DOI 10.1016/j.ydbio.2008.07.007; Ono S, 2010, CYTOSKELETON, V67, P677, DOI 10.1002/cm.20476; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Randall TS, 2014, EUR J CELL BIOL, V93, P205, DOI 10.1016/j.ejcb.2013.11.004; RINDT H, 1993, J BIOL CHEM, V268, P5332; Sanger JW, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/858606; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Sparrow JC, 2009, NAT REV MOL CELL BIO, V10, P293, DOI 10.1038/nrm2634; Takeya R, 2003, J CELL SCI, V116, P4567, DOI 10.1242/jcs.00769; Taniguchi K, 2009, J BIOL CHEM, V284, P29873, DOI 10.1074/jbc.M109.059303; Zhukarev V, 1997, CELL MOTIL CYTOSKEL, V37, P363	30	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148472	10.1371/journal.pone.0148472	http://dx.doi.org/10.1371/journal.pone.0148472			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848968	Green Submitted, gold, Green Published			2022-12-27	WOS:000369554000101
J	Neukam, K; Mira, JA; Collado, A; Rivero-Juarez, A; Monje-Agudo, P; Ruiz-Morales, J; Rios, MJ; Merino, D; Tellez, F; Perez-Camacho, I; Galvez-Contreras, MC; Rivero, A; Pineda, JA				Neukam, Karin; Mira, Jose A.; Collado, Antonio; Rivero-Juarez, Antonio; Monje-Agudo, Patricia; Ruiz-Morales, Josefa; Jose Rios, Maria; Merino, Dolores; Tellez, Francisco; Perez-Camacho, Ines; Carmen Galvez-Contreras, Maria; Rivero, Antonio; Pineda, Juan A.		HEPAVIR SEG-HEP-2007 Study Grp Soc	Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort	PLOS ONE			English	Article							BOOSTED PROTEASE INHIBITORS; HIV/HCV-COINFECTED PATIENTS; TWICE-DAILY RALTEGRAVIR; HIV-1-INFECTED PATIENTS; ENZYME ELEVATION; RISK-FACTORS; NON-INFERIORITY; SAFETY PROFILE; C COINFECTION; DOUBLE-BLIND	Objective To assess the current frequency of ART-associated grade 3-4 transaminase elevations (TE) and grade 4 total bilirubin elevations (TBE) in HIV-infected patients with chronic hepatitis B and/or C, who start a new regimen of ART. Patients and Methods A total of 192 pre-treated or treatment-naive HIV infected patients with HBV and/or HCV-coinfection who started ART in eight Southern Spanish centers from July/2011-December/2013, were followed for 12 months in this prospective study. Results Forty-one (21.4%) subjects had been naive to ART, median (IQR) follow-up was 11.6 (5.6-12.9) months. The most frequently initiated NRTI were tenofovir/emtricitabine [49 patients (25.5%)]. Eighty-nine (46.4%) patients started a ritonavir-boosted protease inhibitor and 77 (40.1%) individuals a NNRTI. Raltegravir and maraviroc were initiated in 24 (12.5%) and 9 (4.7%) individuals. Ten [5.21%; 95% confidence interval (CI): 2.53%-9.37%] patients presented grade 3 TE, while 8 (4.17%; 95% CI: 1.82%-8.04%) subjects showed grade 4 TBE. No episodes of grade 4 TE or ART discontinuation due to hepatotoxic events were observed. The use of ritonavir-boosted atazanavir was the only independent predictor for grade 4 TBE [adjusted odds ratio: 7.327 (95% CI: 1.417-37.89); p = 0.018] in an analysis adjusted for age, sex and baseline HIV-RNA levels, while no factor could be independently associated with grade 3-4 TE. Conclusions Currently, the frequency of severe ART-associated TE and TBE under real-life conditions in patients with chronic viral hepatitis is similar to what has been reported previously. However, episodes of grade 4 TE are less frequent and severe TE appears to be of lesser concern.	[Neukam, Karin; Monje-Agudo, Patricia; Pineda, Juan A.] Hosp Univ Valme, Unit Infect Dis & Microbiol, Seville, Spain; [Neukam, Karin; Monje-Agudo, Patricia] Inst Biomed Sevilla IBiS, Seville, Spain; [Mira, Jose A.] Hosp Univ Valme, Internal Med Serv, Seville, Spain; [Collado, Antonio; Rivero-Juarez, Antonio; Carmen Galvez-Contreras, Maria] Hosp Torrecardenas, Dept Internal Med, Almeria, Spain; [Rivero, Antonio] Univ Cordoba, Maimonides Inst Biomed Res IMIBIC, Infect Dis Unit, Hosp Univ Reina Sofia, Cordoba, Spain; [Ruiz-Morales, Josefa] Hosp Univ Virgen Victoria, Infect Dis Unit, Malaga, Spain; [Jose Rios, Maria] Hosp Univ Virgen Macarena, Infect Dis Unit, Seville, Spain; [Merino, Dolores] Hosp Juan Ramon Jimenez, Internal Med Serv, Huelva, Spain; [Tellez, Francisco] Hosp La Linea Concepcion, Infect Dis Unit, Cadiz, Spain; [Perez-Camacho, Ines] Hosp Poniente, Unit Trop Med, El Ejido, Spain	Hospital Valme; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Hospital Valme; Hospital Torrecardenas; Universidad de Cordoba; Hospital Virgen de la Victoria; Hospital Universitario Virgen Macarena; Hospital Juan Ramon Jimenez	Neukam, K (corresponding author), Hosp Univ Valme, Unit Infect Dis & Microbiol, Seville, Spain.; Neukam, K (corresponding author), Inst Biomed Sevilla IBiS, Seville, Spain.	karin.neukam@gmail.com	Rivero-Juarez, Antonio/E-4528-2019; Neukam, Karin/D-9415-2018; Macias, Juan/I-9133-2019; Gordon, Ana/Q-5853-2018; Pineda, Juan A./AAO-9312-2021; Rivero, Antonio/ABE-5294-2020	Rivero-Juarez, Antonio/0000-0002-5813-6889; Neukam, Karin/0000-0003-3875-1013; Macias, Juan/0000-0002-4778-790X; Gordon, Ana/0000-0002-4911-1436; Pineda, Juan A./0000-0002-3751-0296; Ojeda Burgos, Guillermo/0000-0003-0544-4690; Rivero Roman, Antonio/0000-0002-8643-4250; Tellez, Francisco/0000-0002-9997-6761; Rivero, Antonio/0000-0001-5005-8268	Red de Investigacion en SIDA [ISCIII-RETIC RD06/006, ISCIII-RETIC RD12/0017]; Ministerio de Sanidad y Servicios Sociales [EC11-303]; Consejeria de Salud of the Junta de Andalucia [AC-0095-2013]; Instituto de Salud Carlos III [CP13/00187, I3SNS]; Fundacion Progreso y Salud of the Junta de Andalucia [RH-0024-2013]	Red de Investigacion en SIDA; Ministerio de Sanidad y Servicios Sociales; Consejeria de Salud of the Junta de Andalucia(Junta de Andalucia); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Progreso y Salud of the Junta de Andalucia	This work was supported by the Red de Investigacion en SIDA (ISCIII-RETIC RD06/006 and ISCIII-RETIC RD12/0017), the Ministerio de Sanidad y Servicios Sociales (grant number EC11-303) and the Consejeria de Salud of the Junta de Andalucia (grant number AC-0095-2013). KN is the recipient of a Miguel Servet research grant from the Instituto de Salud Carlos III (grant number CP13/00187). A.R.-J. is the recipient of a post-doctoral extension grant of the Fundacion Progreso y Salud of the Junta de Andalucia (grant number RH-0024-2013). JAP is the recipient of an intensification grant from the Instituto de Salud Carlos III (grant number Programa-I3SNS).	Aranzabal L, 2005, CLIN INFECT DIS, V40, P588, DOI 10.1086/427216; Barreiro P, 2007, J INFECT DIS, V195, P973, DOI 10.1086/512086; Calza L, 2015, INFECT DIS LOND, P1; Chihrin S, 2007, AIDS PATIENT CARE ST, V21, P469, DOI 10.1089/apc.2006.0113; Di Biagio A, 2014, HIV CLIN TRIALS, V15, P151, DOI 10.1310/hct1504-151; European AIDS Clinical Society (EACS), CLIN MAN TREATM CHRO; Gisolf EH, 2000, CLIN INFECT DIS, V31, P1234, DOI 10.1086/317449; Grupo de Estudio del SIDA, GESIDA NAT AIDS PLAN; Ha B, 2012, HIV CLIN TRIALS, V13, P171, DOI 10.1310/hct1303-171; Heil EL, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/856542; Hurt CB, 2014, ANTIVIR THER, V19, P415, DOI 10.3851/IMP2738; Labarga P, 2007, J INFECT DIS, V196, P670, DOI 10.1086/520092; Lapadula G, 2015, JAIDS-J ACQ IMM DEF, V69, P312, DOI 10.1097/QAI.0000000000000585; Laprise C, 2013, AIDS PATIENT CARE ST, V27, P378, DOI 10.1089/apc.2013.0009; Lazzarin A, 2012, HIV CLIN TRIALS, V13, P83, DOI 10.1310/hct1302-83; Lennox JL, 2014, ANN INTERN MED, V161, P461, DOI 10.7326/M14-1084; Casado JL, 2014, J INT AIDS SOC, V17, P59, DOI 10.7448/IAS.17.4.19574; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Macias J, 2012, HIV CLIN TRIALS, V13, P61, DOI 10.1310/hct1302-61; Macias J, 2011, J ANTIMICROB CHEMOTH, V66, P1346, DOI 10.1093/jac/dkr083; Martin-Carbonero L, 2003, HIV CLIN TRIALS, V4, P115; McDonald C, 2012, AIDS PATIENT CARE ST, V26, P259, DOI 10.1089/apc.2011.0092; Merchante N, 2011, AIDS PATIENT CARE ST, V25, P395, DOI 10.1089/apc.2011.0109; Merck Sharp & Dohme, VICTR BOC PRESCR INF; Mira JA, 2006, J ANTIMICROB CHEMOTH, V58, P140, DOI 10.1093/jac/dkl214; Molina JM, 2012, LANCET INFECT DIS, V12, P27, DOI 10.1016/S1473-3099(11)70249-3; National Institute of Allergy and Infectious Diseases, 2004, DIV AIDS TABL GRAD S; Neukam K, 2011, J ANTIMICROB CHEMOTH, V66, P2605, DOI 10.1093/jac/dkr357; Orkin C, 2013, HIV MED, V14, P49, DOI 10.1111/j.1468-1293.2012.01060.x; Palacios R, 2006, HIV CLIN TRIALS, V7, P319, DOI 10.1310/hct0706-319; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Pineda JA, 2008, J ANTIMICROB CHEMOTH, V61, P925, DOI 10.1093/jac/dkn045; Puls RL, 2014, LANCET, V383, P1474, DOI 10.1016/S0140-6736(13)62187-X; Raffi F, 2013, LANCET INFECT DIS, V13, P927, DOI 10.1016/S1473-3099(13)70257-3; Regazzi M, 2011, THER DRUG MONIT, V33, P303, DOI 10.1097/FTD.0b013e31821c2772; Rockstroh JK, 2012, HIV MED, V13, P127, DOI 10.1111/j.1468-1293.2011.00933.x; Sulkowski MS, 2002, HEPATOLOGY, V35, P182, DOI 10.1053/jhep.2002.30319; Taramasso L, 2015, BIOMED PHARMACOTHER, V69, P233, DOI 10.1016/j.biopha.2014.12.006; Van Welzen BJ, 2012, HIV MED, V13, P448, DOI 10.1111/j.1468-1293.2012.00995.x; Vertex Pharmaceuticals, INC TEL PRESCR INF; Vispo E, 2013, AIDS, V27, P1187, DOI 10.1097/QAD.0b013e32835cb815	41	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148104	10.1371/journal.pone.0148104	http://dx.doi.org/10.1371/journal.pone.0148104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848975	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000041
J	Solis, J; Baisakh, N; Brandt, SR; Villordon, A; La Bonte, D				Solis, Julio; Baisakh, Niranjan; Brandt, Steven R.; Villordon, Arthur; La Bonte, Don			Transcriptome Profiling of Beach Morning Glory (Ipomoea imperati) under Salinity and Its Comparative Analysis with Sweetpotato	PLOS ONE			English	Article							VACUOLAR H+-PYROPHOSPHATASE; OVERLY SENSITIVE PATHWAY; ENHANCES SALT TOLERANCE; STRESS TOLERANCE; NA+/H+ ANTIPORTER; FACTOR GENE; ROOT TRANSCRIPTOME; PROTEIN-KINASES; TOBACCO CELLS; UP-REGULATION	The response and adaption to salt remains poorly understood for beach morning glory [Ipomoea imperati (Vahl) Griseb], one of a few relatives of sweetpotato, known to thrive under salty and extreme drought conditions. In order to understand the genetic mechanisms underlying salt tolerance of a Convolvulaceae member, a genome-wide transcriptome study was carried out in beach morning glory by 454 pyrosequencing. A total of 286,584 filtered reads from both salt stressed and unstressed (control) root and shoot tissues were assembled into 95,790 unigenes with an average length of 667 base pairs (bp) and N50 of 706 bp. Putative differentially expressed genes (DEGs) were identified as transcripts over-represented under salt stressed tissues compared to the control, and were placed into metabolic pathways. Most of these DEGs were involved in stress response, membrane transport, signal transduction, transcription activity and other cellular and molecular processes. We further analyzed the gene expression of 14 candidate genes of interest for salt tolerance through quantitative reverse transcription PCR (qRT-PCR) and confirmed their differential expression under salt stress in both beach morning glory and sweetpotato. The results comparing transcripts of I. imperati against the transcriptome of other Ipomoea species, including sweetpotato are also presented in this study. In addition, 6,233 SSR markers were identified, and an in silico analysis predicted that 434 primer pairs out of 4,897 target an identifiable homologous sequence in other Ipomoea transcriptomes, including sweetpotato. The data generated in this study will help in understanding the basics of salt tolerance of beach morning glory and the SSR resources generated will be useful for comparative genomics studies and further enhance the path to the marker-assisted breeding of sweetpotato for salt tolerance.	[Solis, Julio; Baisakh, Niranjan; La Bonte, Don] Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA; [Brandt, Steven R.] Louisiana State Univ, Louisiana Digital Media Ctr, Baton Rouge, LA 70803 USA; [Villordon, Arthur] Louisiana State Univ, Ctr Agr, Sweet Potato Res Stn, Chase, LA USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	La Bonte, D (corresponding author), Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA.	nbaisakh@agcenter.lsu.edu; dlabonte@agcenter.Isu.edu	Brandt, Steven/GRJ-9979-2022	Brandt, Steven/0000-0002-7979-2906; SOLIS SARMIENTO, JULIO/0000-0001-5183-6332	HATCH grant from the USDA-NIFA	HATCH grant from the USDA-NIFA	The study was supported by a HATCH grant from the USDA-NIFA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi FS, 2013, J AGR SCI TECH-IRAN, V15, P369; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Bassil E, 2012, J EXP BOT, V63, P5727, DOI 10.1093/jxb/ers250; Batistic O, 2011, SIGNAL COMMUN PLANTS, P235, DOI 10.1007/978-3-642-20829-4_12; BINZEL ML, 1985, PLANT PHYSIOL, V79, P118, DOI 10.1104/pp.79.1.118; Brini F, 2007, J EXP BOT, V58, P301, DOI 10.1093/jxb/erl251; Cervantes-Flores JC, 2011, MOL BREEDING, V28, P201, DOI 10.1007/s11032-010-9474-5; Chakraborty K, 2012, PLANT PHYSIOL BIOCH, V51, P90, DOI 10.1016/j.plaphy.2011.10.001; Chen L, 2013, MOL BIOL REP, V40, P4759, DOI 10.1007/s11033-013-2572-9; Chen SF, 2011, MAR GENOM, V4, P129, DOI 10.1016/j.margen.2011.03.005; Chen TT, 2012, PLANT CELL REP, V31, P1737, DOI 10.1007/s00299-012-1287-z; Chen XJ, 2014, INT J MOL SCI, V15, P14819, DOI 10.3390/ijms150814819; Childs KL, 2007, NUCLEIC ACIDS RES, P35; Cosentino C, 2010, NEW PHYTOL, V186, P669, DOI 10.1111/j.1469-8137.2010.03208.x; Costa De Oliveira A, 2008, INT J PLANT GENOMICS, V2008; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; Dasgupta M, 2008, ORISSA J HORTIC, V35, P27; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Du WM, 2011, PLANT PHYSIOL, V156, P2235, DOI 10.1104/pp.111.173377; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Firon N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-460; Fraile-Escanciano A, 2010, NEW PHYTOL, V188, P750, DOI 10.1111/j.1469-8137.2010.03405.x; Fukada-Tanaka S, 2000, NATURE, V407, P581, DOI 10.1038/35036683; Goel D, 2010, PROTOPLASMA, V245, P133, DOI 10.1007/s00709-010-0158-0; Hashimoto K, 2012, J BIOL CHEM, V287, P7956, DOI 10.1074/jbc.M111.279331; Horneck D.A., 2007, 601E PNW OR STAT U, P22; Hu YZ, 2012, PLANT CELL TISS ORG, V108, P63, DOI 10.1007/s11240-011-0013-9; Jarvis DE, 2014, MOL BIOL EVOL, V31, P2094, DOI 10.1093/molbev/msu152; Jha D, 2010, PLANT CELL ENVIRON, V33, P793, DOI 10.1111/j.1365-3040.2009.02105.x; Ji HT, 2013, MOL PLANT, V6, P275, DOI 10.1093/mp/sst017; Kim YH, 2012, J PLANT PHYSIOL, V169, P1112, DOI 10.1016/j.jplph.2012.03.002; Lamesch P, 2012, NUCLEIC ACIDS RES, VD1, P40; LAROSA PC, 1989, PLANT PHYSIOL, V91, P855, DOI 10.1104/pp.91.3.855; Li DF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-517; Li H, 2013, PLANT GROWTH REGUL, V70, P207, DOI 10.1007/s10725-013-9792-9; Lin HX, 2009, PLANT CELL, V21, P1607, DOI 10.1105/tpc.109.066217; Liu DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093935; Liu DG, 2014, PLANT CELL TISS ORG, V117, P1, DOI 10.1007/s11240-013-0415-y; Liu QL, 2013, PLANT PHYSIOL BIOCH, V69, P27, DOI 10.1016/j.plaphy.2013.04.016; Lonard RI, 1999, J COASTAL RES, V15, P645; Maughan PJ, 2009, GENOME, V52, P647, DOI 10.1139/G09-041; Mondini L, 2012, OMICS, V16, P178, DOI 10.1089/omi.2011.0081; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Pasapula V, 2011, PLANT BIOTECHNOL J, V9, P88, DOI 10.1111/j.1467-7652.2010.00535.x; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Rohini G, 2014, DNA RES, V21, P69, DOI 10.1093/dnares/dst042; Roullier C, 2013, PLOS ONE, P8; Roy SJ, 2013, PLANT CELL ENVIRON, V36, P553, DOI 10.1111/j.1365-3040.2012.02595.x; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Schafleitner R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-604; Seo YJ, 2010, MOL CELLS, V30, P271, DOI 10.1007/s10059-010-0114-z; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2002, PLANT MOL BIOL, V50, P543, DOI 10.1023/A:1019859319617; SINGH NK, 1987, PLANT PHYSIOL, V85, P529, DOI 10.1104/pp.85.2.529; Solis J, 2014, J AM SOC HORTIC SCI, V139, P317, DOI 10.21273/JASHS.139.3.317; Subramanyam K, 2012, PLANTA, V236, P1909, DOI 10.1007/s00425-012-1733-8; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Trujillo LE, 2008, PLANT CELL PHYSIOL, V49, P512, DOI 10.1093/pcp/pcn025; Tsukagoshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118339; Wang LJ, 2013, J INTEGR AGR, V12, P27, DOI 10.1016/S2095-3119(13)60202-6; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Ward JA, 2012, AM J BOT, V99, P267, DOI 10.3732/ajb.1100334; Wu D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-564; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Yao MH, 2012, MOL BIOL REP, V39, P7989, DOI 10.1007/s11033-012-1645-5; Yoshida K, 2005, PLANT CELL PHYSIOL, V46, P407, DOI 10.1093/pcp/pci057; Yu QY, 2014, PLANT CELL REP, V33, P203, DOI 10.1007/s00299-013-1507-1; Yu XX, 2014, J INTEGR AGR, V13, P310, DOI 10.1016/S2095-3119(13)60357-3; Zhang ZJ, 2012, PLANT J, V71, P273, DOI 10.1111/j.1365-313X.2012.04996.x; Zheng Y, 2011, BMC BIOINFORMATICS, P12; Zhou HP, 2014, PLANT CELL, V26, P1166, DOI 10.1105/tpc.113.117069; Zhou SF, 2011, BIOTECHNOL LETT, V33, P375, DOI 10.1007/s10529-010-0418-2	75	13	15	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147398	10.1371/journal.pone.0147398	http://dx.doi.org/10.1371/journal.pone.0147398			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848754	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000015
J	Tschochner, M; Leary, S; Cooper, D; Strautins, K; Chopra, A; Clark, H; Choo, L; Dunn, D; James, I; Carroll, WM; Kermode, AG; Nolan, D				Tschochner, Monika; Leary, Shay; Cooper, Don; Strautins, Kaija; Chopra, Abha; Clark, Hayley; Choo, Linda; Dunn, David; James, Ian; Carroll, William M.; Kermode, Allan G.; Nolan, David			Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis	PLOS ONE			English	Article							T-CELL RESPONSES; VIRUS INFECTION; NASOPHARYNGEAL CARCINOMA; HLA-DR; SEQUENCE VARIATION; RISK-FACTORS; EPITOPES; PROTEIN; IDENTIFICATION; RECOGNITION	Background Epstein-Barr virus (EBV) infection represents a major environmental risk factor for multiple sclerosis (MS), with evidence of selective expansion of Epstein-Barr Nuclear Antigen-1 (EBNA1)-specific CD4+ T cells that cross-recognize MS-associated myelin antigens in MS patients. HLA-DRB1*15-restricted antigen presentation also appears to determine susceptibility given its role as a dominant risk allele. In this study, we have utilised standard and next-generation sequencing techniques to investigate EBNA-1 sequence variation and its relationship to HLA-DR15 binding affinity, as well as examining potential cross-reactive immune targets within the central nervous system proteome. Methods Sanger sequencing was performed on DNA isolated from peripheral blood samples from 73 Western Australian MS cases, without requirement for primary culture, with additional FLX 454 Roche sequencing in 23 samples to identify low-frequency variants. Patient-derived viral sequences were used to predict HLA-DRB1*1501 epitopes (NetMHCII, NetMHCIIpan) and candidates were evaluated for cross recognition with human brain proteins. Results EBNA-1 sequence variation was limited, with no evidence of multiple viral strains and only low levels of variation identified by FLX technology (8.3% nucleotide positions at a 1% cutoff). In silico epitope mapping revealed two known HLA-DRB1*1501-restricted epitopes ('AEG': aa 481-496 and 'MVF': aa 562-577), and two putative epitopes between positions 502-543. We identified potential cross-reactive targets involving a number of major myelin antigens including experimentally confirmed HLA-DRB1*15-restricted epitopes as well as novel candidate antigens within myelin and paranodal assembly proteins that may be relevant to MS pathogenesis. Conclusions This study demonstrates the feasibility of obtaining autologous EBNA-1 sequences directly from buffy coat samples, and confirms divergence of these sequences from standard laboratory strains. This approach has identified a number of immunogenic regions of EBNA-1 as well as known and novel targets for autoreactive HLA-DRB1*15-restricted T cells within the central nervous system that could arise as a result of cross-reactivity with EBNA-1-specific immune responses.	[Tschochner, Monika; Leary, Shay; Cooper, Don; Strautins, Kaija; Chopra, Abha; Clark, Hayley; Choo, Linda; Dunn, David; James, Ian; Kermode, Allan G.; Nolan, David] Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia; [Carroll, William M.; Kermode, Allan G.] Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA, Australia; [Carroll, William M.; Kermode, Allan G.] Australian Neuromuscular Res Inst, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA, Australia; [Nolan, David] Royal Perth Hosp, Dept Clin Immunol, GPO Box X2213, Perth, WA 6001, Australia	Murdoch University; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia	Tschochner, M (corresponding author), Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia.	M.Tschochner@iiid.com.au	Kermode, Allan/G-3568-2019	Kermode, Allan/0000-0002-4476-4016; Chopra, Abha/0000-0001-5008-9080; Leary, Shay/0000-0002-6966-2294	McCusker Charitable Foundation; Multiple Sclerosis Research Australia (MSRA) [12040]	McCusker Charitable Foundation; Multiple Sclerosis Research Australia (MSRA)	This project was funded by the McCusker Charitable Foundation; URL: http://www.mccuskercharitable.com.au (MT, KS, DN) and Multiple Sclerosis Research Australia (MSRA)-Grant number 12040; URL: http://www.msra.org.au (MT, WMC, AGK, DN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar A, 1998, EMBO J, V17, P6394, DOI 10.1093/emboj/17.21.6394; Bell MJ, 2008, J INFECT DIS, V197, P1594, DOI 10.1086/587848; Ben-Nun A, 2014, J AUTOIMMUN, V54, P33, DOI 10.1016/j.jaut.2014.06.004; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Bernig T, 2014, MOL BIOL REP, V41, P6995, DOI 10.1007/s11033-014-3587-6; Bollard CM, 2014, J CLIN ONCOL, V32, P798, DOI 10.1200/JCO.2013.51.5304; Cepok S, 2005, J CLIN INVEST, V115, P1352, DOI 10.1172/JCI200523661; Chia WK, 2014, MOL THER, V22, P132, DOI 10.1038/mt.2013.242; Chou YK, 2004, J NEUROSCI RES, V75, P516, DOI 10.1002/jnr.20000; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; De Jager PL, 2008, NEUROLOGY, V70, P1113, DOI 10.1212/01.wnl.0000294325.63006.f8; Derfuss T, 2010, J MOL MED, V88, P753, DOI 10.1007/s00109-010-0632-3; Dhaunchak AS, 2010, GLIA, V58, P1949, DOI 10.1002/glia.21064; Dolan A, 2006, VIROLOGY, V350, P164, DOI 10.1016/j.virol.2006.01.015; Dowd JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064921; Ehlers B, 2010, J GEN VIROL, V91, P630, DOI 10.1099/vir.0.017251-0; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Haahr S, 2006, REV MED VIROL, V16, P297, DOI 10.1002/rmv.503; Habeshaw G, 1999, J VIROL, V73, P965, DOI 10.1128/JVI.73.2.965-975.1999; Hawkins JB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003685; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Ikegaya H, 2008, J VIROL METHODS, V147, P78, DOI 10.1016/j.jviromet.2007.08.010; Junker A, 2007, BRAIN, V130, P2789, DOI 10.1093/brain/awm214; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kaushansky N, 2006, J IMMUNOL, V177, P7364, DOI 10.4049/jimmunol.177.10.7364; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Kruger S, 2003, J IMMUNOTHER, V26, P212, DOI 10.1097/00002371-200305000-00005; Kumar A, 2014, MOL BIOSYST, V10, P2043, DOI 10.1039/c4mb00203b; Kumar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059711; Kwok H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036939; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Lay MLJ, 2012, INTERVIROLOGY, V55, P372, DOI 10.1159/000334693; Leen A, 2001, J VIROL, V75, P8649, DOI 10.1128/JVI.75.18.8649-8659.2001; Liu P, 2011, J VIROL, V85, P11291, DOI 10.1128/JVI.00823-11; Long HM, 2013, J EXP MED, V210, P933, DOI 10.1084/jem.20121437; Lunemann JD, 2008, J EXP MED, V205, P1763, DOI 10.1084/jem.20072397; Mackay LK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000699; Mechelli R, 2011, MULT SCLER J, V17, P1290, DOI 10.1177/1352458511410515; Mechelli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063300; Merlo A, 2010, HAEMATOL-HEMATOL J, V95, P1769, DOI 10.3324/haematol.2010.023689; Metz I, 2014, ANN NEUROL, V75, P728, DOI 10.1002/ana.24163; Midgley RS, 2003, J VIROL, V77, P11517, DOI 10.1128/JVI.77.21.11517-11530.2003; Munz C, 2004, J EXP MED, V199, P1301, DOI 10.1084/jem.20040730; Muraro PA, 2002, J NEUROIMMUNOL, V130, P233, DOI 10.1016/S0165-5728(02)00229-1; Nolan D, 2012, NEUROLOGY, V79, P538, DOI 10.1212/WNL.0b013e318263c407; Palanichamy A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008930; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Pavlovic MD, 2014, J IMMUNOL METHODS, V407, P90, DOI 10.1016/j.jim.2014.03.027; Pedraza L, 2001, NEURON, V30, P335, DOI 10.1016/S0896-6273(01)00306-3; Pender MP, 2014, MULT SCLER J, V20, P1541, DOI 10.1177/1352458514521888; Rubicz R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003147; Santon A, 2011, MULT SCLER J, V17, P1295, DOI 10.1177/1352458511411063; Santpere G, 2014, GENOME BIOL EVOL, V6, P846, DOI 10.1093/gbe/evu054; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030; Sim ACN, 2013, SCI REP-UK, V3, DOI 10.1038/srep03232; Simon KC, 2011, ACTA NEUROL SCAND, V124, P53, DOI 10.1111/j.1600-0404.2010.01410.x; SKARE J, 1982, J VIROL, V44, P1088, DOI 10.1128/JVI.44.3.1088-1091.1982; Stern JNH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008879; Strautins K, 2014, MULT SCLER J, V20, P286, DOI 10.1177/1352458513498829; Sundstrom P, 2008, MULT SCLER J, V14, P1120, DOI 10.1177/1352458508092353; TANAKA J, 1994, J NEUROSCI, V14, P1038, DOI 10.1523/JNEUROSCI.14-03-01038.1994; Thacker EL, 2006, ANN NEUROL, V59, P499, DOI 10.1002/ana.20820; Thorley-Lawson DA, 2013, CURR OPIN VIROL, V3, P227, DOI 10.1016/j.coviro.2013.04.005; Tsai S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00321; Tsang CW, 2006, J VIROL, V80, P8263, DOI 10.1128/JVI.00400-06; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Voo KS, 2005, CANCER RES, V65, P1577, DOI 10.1158/0008-5472.CAN-04-2552; Wang WY, 2002, CLIN CANCER RES, V8, P2586; Weissert R, 2002, J IMMUNOL, V169, P548, DOI 10.4049/jimmunol.169.1.548; Willis SN, 2009, BRAIN, V132, P3318, DOI 10.1093/brain/awp200; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279; Zhang X, 2008, EUR J IMMUNOL, V38, P1297, DOI 10.1002/eji.200737519	74	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147567	10.1371/journal.pone.0147567	http://dx.doi.org/10.1371/journal.pone.0147567			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849221	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000020
J	Fang, GF; Orgun, MA; Shankaran, R; Dutkiewicz, E; Zheng, GL				Fang, Gengfa; Orgun, Mehmet A.; Shankaran, Rajan; Dutkiewicz, Eryk; Zheng, Guanglou			Truthful Channel Sharing for Self Coexistence of Overlapping Medical Body Area Networks	PLOS ONE			English	Article							SINGLE-MACHINE; SPECTRUM; COOPERATION; ALGORITHM; GAME; NEIGHBORHOOD; ALLOCATION; FRAMEWORK; MECHANISM	As defined by IEEE 802.15.6 standard, channel sharing is a potential method to coordinate inter-network interference among Medical Body Area Networks (MBANs) that are close to one another. However, channel sharing opens up new vulnerabilities as selfish MBANs may manipulate their online channel requests to gain unfair advantage over others. In this paper, we address this issue by proposing a truthful online channel sharing algorithm and a companion protocol that allocates channel efficiently and truthfully by punishing MBANs for misreporting their channel request parameters such as time, duration and bid for the channel. We first present an online channel sharing scheme for unit-length channel requests and prove that it is truthful. We then generalize our model to settings with variable-length channel requests, where we propose a critical value based channel pricing and preemption scheme. A bid adjustment procedure prevents unbeneficial preemption by artificially raising the ongoing winner's bid controlled by a penalty factor.. Our scheme can efficiently detect selfish behaviors by monitoring a trust parameter a of each MBAN and punish MBANs from cheating by suspending their requests. Our extensive simulation results show our scheme can achieve a total profit that is more than 85% of the offline optimum method in the typical MBAN settings.	[Fang, Gengfa; Zheng, Guanglou] Macquarie Univ, Dept Engn, Sydney, NSW 2109, Australia; [Orgun, Mehmet A.; Shankaran, Rajan] Macquarie Univ, Dept Comp, Sydney, NSW 2109, Australia; [Dutkiewicz, Eryk] Univ Technol, Sch Comp & Commun, Broadway, NSW 2007, Australia	Macquarie University; Macquarie University; University of Technology Sydney	Orgun, MA (corresponding author), Macquarie Univ, Dept Comp, Sydney, NSW 2109, Australia.	mehmet.orgun@mq.edu.au	Orgun, Mehmet/AAL-7178-2020; Orgun, Mehmet A/D-4671-2015	Orgun, Mehmet/0000-0002-7873-1562; Orgun, Mehmet A/0000-0002-7873-1562; Shankaran, Rajan/0000-0002-9248-4158; Dutkiewicz, Eryk/0000-0002-4268-9286	Macquarie University Research Development Grant (MQRDG); Macquarie University Research Excellence Scholarship (MQRES)	Macquarie University Research Development Grant (MQRDG); Macquarie University Research Excellence Scholarship (MQRES)	The work of MAO and RS was partially funded by a Macquarie University Research Development Grant (MQRDG). The work of GZ was partially funded by a Macquarie University Research Excellence Scholarship (MQRES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors received any other funding for the work reported in this paper.	Al-Gumaei YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109077; Amini RM, 2014, IEEE T NETW SERV MAN, V11, P188, DOI 10.1109/TNSM.2013.120413.120533; Clarke E., 1971, PUBLIC CHOICE, V11, P17, DOI [10.1007/BF01726210, DOI 10.1007/BF01726210]; Do CT, 2013, IEEE COMMUN LETT, V17, P509, DOI 10.1109/LCOMM.2013.012313.122589; Fleischer R., 2000, Journal of Scheduling, V3, P343, DOI 10.1002/1099-1425(200011/12)3:6<343::AID-JOS54>3.0.CO;2-2; Ghazvini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062925; Goemans MX, 2000, OPER RES LETT, V26, P149, DOI 10.1016/S0167-6377(00)00024-9; Hoogeveen H., 2000, Algorithms - ESA 2000. 8th Annual European Symposium. Proceedings (Lecture Notes in Computer Science Vol.1879), P268; Hoogeveen H, 2000, OPER RES LETT, V27, P193, DOI 10.1016/S0167-6377(00)00061-4; Kasbekar G., 2010, 2010 48th Annual Allerton Conference on Communication, Control, and Computing (Allerton), P1288, DOI 10.1109/ALLERTON.2010.5707062; KOREN G, 1995, SIAM J COMPUT, V24, P318, DOI 10.1137/S0097539792236882; Lavi R, 2003, ANN IEEE SYMP FOUND, P574, DOI 10.1109/SFCS.2003.1238230; Li XY, 2008, LECT NOTES COMPUT SC, V5092, P558; Li XY, 2006, J PARALLEL DISTR COM, V66, P515, DOI 10.1016/j.jpdc.2005.10.007; Manickam Saravana, 2014, ACM SIGMETRICS Performance Evaluation Review, V42, P8; Rudin JF, 2003, SIAM J COMPUT, V32, P717, DOI 10.1137/S0097539702403438; Sodagari S, 2011, IEEE J SEL AREA COMM, V29, P856, DOI 10.1109/JSAC.2011.110416; VICKREY W, 1961, J FINANC, V16, P8, DOI 10.2307/2977633; Vidal JR, 2013, AD HOC NETW, V11, P1858, DOI 10.1016/j.adhoc.2013.04.010; Wang J, 2012, CHINESE SCI BULL, V57, P724, DOI 10.1007/s11434-011-4890-4; Wang LM, 2013, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2013-5; Wang S., 2010, 2010 IEEE 37th International Conference on Plasma Sciences (ICOPS 2010), DOI 10.1109/PLASMA.2010.5534027; WG802 15-Wireless Personal Area Network (WPAN) Working Group, 2012, 802 15 6 2012 IEEE S; Xia CY, 2014, APPL MATH COMPUT, V246, P389, DOI 10.1016/j.amc.2014.08.006; Xu P, 2011, IEEE ACM T NETWORK, V19, P433, DOI 10.1109/TNET.2010.2067223; Xu P, 2009, 2009 ACM WORKSHOP ON COGNITIVE RADIO NETWORKS-CORONET 09, P49; Zhang BL, 2013, IEICE T COMMUN, VE96B, P1953, DOI 10.1587/transcom.E96.B.1953; Zhou X, 2009, IEEE INFOCOM SER, P999, DOI 10.1109/INFCOM.2009.5062011; Zhou X, 2008, MOBICOM'08: PROCEEDINGS OF THE FOURTEENTH ACM INTERNATIONAL CONFERENCE ON MOBILE COMPUTING AND NETWORKING, P2, DOI 10.1145/1409944.1409947; Zhu CJ, 2014, PHYSICA A, V406, P145, DOI 10.1016/j.physa.2014.03.035	30	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148376	10.1371/journal.pone.0148376	http://dx.doi.org/10.1371/journal.pone.0148376			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844888	Green Published, Green Submitted, gold			2022-12-27	WOS:000369552800051
J	Liu, TN; Wang, ZL; Cai, T				Liu, Tiening; Wang, Zhenlin; Cai, Tie			Canopy Apparent Photosynthetic Characteristics and Yield of Two Spike-Type Wheat Cultivars in Response to Row Spacing under High Plant Density	PLOS ONE			English	Article							WINTER-WHEAT; SEEDING-RATE; LIGHT INTERCEPTION; LEAF SENESCENCE; NARROW-ROW; MAIZE; POPULATION; MICROCLIMATE; NITROGEN; FALLOW	In northern China, large-spike wheat (Triticum aestivum L) is considered to have significant potential for increasing yields due to its greater single-plant productivity despite its lower percentage of effective tillers, and increasing the plant density is an effective means of achieving a higher grain yield. However, with increases in plant density, the amount of solar radiation intercepted by lower strata leaves is decreased and the rate of leaf senescence is accelerated. Row spacing can be manipulated to optimize the plant spatial distribution under high plant density, therefore improving light conditions within the canopy. Consequently, field experiments were conducted from 2010 to 2012 to investigate whether changes in row spacing under high plant density led to differences in canopy apparent photosynthesis (CAP), individual leaf photosynthesis and grain yield. Two different spike-type winter wheat cultivars, Jimai22 (a small-spike cultivar as a control cultivar) and Wennong6 (a large-spike cultivar), were grown at a constant plant density of 3,600,000 plants ha(-1) (a relatively higher plant density) over a wide range of row spacing as follows: 5-cm row spacing (R-0), 15-cm row spacing (R-1), 25-cm conventional row spacing (R-2), and 35-cm row spacing (R-3). The two-year investigations revealed that increased row spacing exhibited a significantly higher light transmission ratio (LT), which improved light conditions within the canopy; however, excessive light leakage losses in R-2 and R-3 treatments were not favorable to improved irradiation energy utilization efficiency. Aboveground biomass accumulation was influenced by row spacing. Two spike-type wheat accumulated greater biomass under 15-cm row spacing compared to other row spacing treatments, although a markedly improved photosynthetic rate (P-N), effective quantum yield of photosystem II (Phi(PSII)) and maximal efficiency of photosystem II photochemistry (F-v/F-m) in the penultimate and third leaves were observed in R-2 and R-3 treatments. At the same time, a longer duration of CAP and green leaf area was maintained in R-1 during grain filling. Compared with conventional row spacing, Wennong6 in R-1 treatment obtained 21.0% and 19.1% higher grain yield in 2011 and 2012, respectively, while for Jimai22 it increased by 11.3% and 11.4%, respectively. A close association of yield with CAP and LAI at mid-grain filling was observed. In conclusion, for the tested growing conditions, decreasing the row spacing to an optimal distance (15 cm) maintained a longer duration of LAI and CAP during grain filling, made a better coordination of group and individual leaf photosynthesis, and accumulated higher aboveground biomass, leading to a greater grain yield. In addition, Wennong6 had a more rational canopy architecture than Jimai22 (improved LT and higher LAI) and CAP under 15-cm row spacing, leading to a higher grain yield, which indicated that the large-spike type cultivar has the potential to obtain higher yields by increasing plant density through optimum row spacing allocation (15 cm).	[Liu, Tiening; Cai, Tie] Northwest A&F Univ, Key Lab Crop Physi Ecol & Tillage Sci Northwester, Minist Agr, Coll Agron, Yangling 712100, Shaanxi, Peoples R China; [Liu, Tiening; Cai, Tie] Northwest A&F Univ, Chinese Inst Water Saving Agr, Yangling 712100, Shaanxi, Peoples R China; [Wang, Zhenlin] Shandong Agr Univ, Agron Coll, State Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China; Shandong Agricultural University	Cai, T (corresponding author), Northwest A&F Univ, Key Lab Crop Physi Ecol & Tillage Sci Northwester, Minist Agr, Coll Agron, Yangling 712100, Shaanxi, Peoples R China.; Cai, T (corresponding author), Northwest A&F Univ, Chinese Inst Water Saving Agr, Yangling 712100, Shaanxi, Peoples R China.	sdauct@126.com		Cai, Tommaso/0000-0002-7234-3526	National Basic Research Program of China (973 Program) [2009CB118602]; Twelfth Five-Year Science and Technology Support Plan of the People's Republic of China [2015BAD22B02]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Twelfth Five-Year Science and Technology Support Plan of the People's Republic of China	This research was supported by the National Basic Research Program of China (973 Program, No. 2009CB118602) and Twelfth Five-Year Science and Technology Support Plan of the People's Republic of China (2015BAD22B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade FH, 2002, CROP SCI, V42, P1173, DOI 10.2135/cropsci2002.1173; Awal MA, 2006, AGR FOREST METEOROL, V139, P74, DOI 10.1016/j.agrformet.2006.06.001; Barbieri PA, 2000, AGRON J, V92, P283, DOI 10.1007/s100870050034; Borras L, 2003, FIELD CROP RES, V82, P13, DOI 10.1016/S0378-4290(03)00002-9; Chen CC, 2008, AGRON J, V100, P1296, DOI 10.2134/agronj2007.0198; Dong S. T., 1993, Biologia Plantarum, V35, P273, DOI 10.1007/BF02925953; EPPLIN FM, 1992, J PROD AGRIC, V5, P427, DOI 10.2134/jpa1992.0427; FREEZE DM, 1990, J PROD AGRIC, V3, P345, DOI 10.2134/jpa1990.0345; Gelang J, 2000, PHYSIOL PLANTARUM, V110, P366, DOI 10.1034/j.1399-3054.2000.1100311.x; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Guo J., 2005, MAIZE SCI, V13, P55, DOI DOI 10.13597/j.cnki.maize.science.2005.02.019; Guo TC, 2001, ACTA AGRONOMICA SINI, V27, P632; HEICHEL GH, 1970, PLANT PHYSIOL, V46, P359, DOI 10.1104/pp.46.3.359; Hu YJ, 2000, ACTA AGRONOMICA SINI, V26, P905; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Lafond GP, 1996, CAN J PLANT SCI, V76, P791, DOI 10.4141/cjps96-132; Li Na-Na, 2010, Chinese Journal of Plant Ecology, V34, P289, DOI 10.3773/j.issn.1005-264x.2010.03.006; Li NaNa, 2010, Scientia Agricultura Sinica, V43, P2869; Liu TT, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-4; Maddonni G, 2001, FIELD CROP RES, V70, P1, DOI 10.1016/S0378-4290(00)00144-1; Maddonni GA, 2001, FIELD CROP RES, V71, P183, DOI 10.1016/S0378-4290(01)00158-7; Maddonni GA, 2006, AGRON J, V98, P1532, DOI 10.2134/agronj2006.0038; Mattera J, 2013, EUR J AGRON, V45, P87, DOI 10.1016/j.eja.2012.10.008; McLeod JG, 1996, CAN J PLANT SCI, V76, P207, DOI 10.4141/cjps96-039; Porter PM, 1997, J PROD AGRIC, V10, P293, DOI 10.2134/jpa1997.0293; Qiao RQ, 2001, J TRITICEAE CROPS, V21, P84; Reta-Sanchez DG, 2002, AGRON J, V94, P1317, DOI 10.2134/agronj2002.1317; Sharratt BS, 2005, AGRON J, V97, P1129, DOI 10.2134/agronj2004.0292; Singels A, 2009, FIELD CROP RES, V113, P149, DOI 10.1016/j.fcr.2009.04.015; STOSKOPF NC, 1967, CAN J PLANT SCI, V47, P597, DOI 10.4141/cjps67-103; Wang ZF, 2001, SHANDONG AGR SCI, V4, P6; Xu HengYong, 1995, Acta Agronomica Sinica, V21, P204; Xu HY, 1996, SHANDONG AGR SCI, V1, P14; [杨吉顺 Yang Jishun], 2010, [作物学报, Acta Agronomica Sinica], V36, P1226; Yang Wen-Ping, 2008, Zhiwu Shengtai Xuebao, V32, P485, DOI 10.3773/j.issn.1005-264x.2008.02.028; Zheng Ting, 2013, Acta Agronomica Sinica, V39, P885, DOI 10.3724/SP.J.1006.2013.00885; Zhu YJ, 2001, J TRITICEAE CROPS, V21, P62	37	24	26	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148582	10.1371/journal.pone.0148582	http://dx.doi.org/10.1371/journal.pone.0148582			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845330	gold, Green Published, Green Submitted			2022-12-27	WOS:000369552800074
J	Molnar, A; Renahy, E; O'Campo, P; Muntaner, C; Freiler, A; Shankardass, K				Molnar, Agnes; Renahy, Emilie; O'Campo, Patricia; Muntaner, Carles; Freiler, Alix; Shankardass, Ketan			Using Win-Win Strategies to Implement Health in All Policies: A Cross-Case Analysis	PLOS ONE			English	Article							POLITICS	Background In spite of increasing research into intersections of public policy and health, little evidence shows how policy processes impact the implementation of Health in All Policies (HiAP) initiatives. Our research sought to understand how and why strategies for engaging partners from diverse policy sectors in the implementation of HiAP succeed or fail in order to uncover the underlying social mechanisms contributing to sustainable implementation of HiAP. Methods In this explanatory multiple case study, we analyzed grey and peer-review literature and key informant interviews to identify mechanisms leading to implementation successes and failures in relation to different strategies for engagement across three case studies (Sweden, Quebec and South Australia), after accounting for the role of different contextual conditions. Findings Our results yielded no support for the use of awareness-raising or directive strategies as standalone approaches for engaging partners to implement HiAP. However, we found strong evidence that mechanisms related to "win-win" strategies facilitated implementation by increasing perceived acceptability (or buy-in) and feasibility of HiAP implementation across sectors. Win-win strategies were facilitated by mechanisms related to several activities, including: the development of a shared language to facilitate communication between actors from different sectors; integrating health into other policy agendas (eg., sustainability) and use of dual outcomes to appeal to the interests of diverse policy sectors; use of scientific evidence to demonstrate the effectiveness of HiAP; and using health impact assessment to make policy coordination for public health outcomes more feasible and to give credibility to policies being developed by diverse policy sectors. Conclusion Our findings enrich theoretical understanding in an under-unexplored area of intersectoral action. They also provide policy makers with examples of HiAP across wealthy welfare regimes, and improve understanding of successful HiAP implementation practices, including the win-win approach.	[Molnar, Agnes; Renahy, Emilie; O'Campo, Patricia; Freiler, Alix; Shankardass, Ketan] Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, Toronto, ON, Canada; [O'Campo, Patricia; Muntaner, Carles; Shankardass, Ketan] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Muntaner, Carles] Univ Toronto, Bloomberg Sch Nursing, Toronto, ON, Canada; [Shankardass, Ketan] Wilfrid Laurier Univ, Dept Hlth Sci, Waterloo, ON N2L 3C5, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University of Toronto; University of Toronto; Wilfrid Laurier University	Shankardass, K (corresponding author), Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, Toronto, ON, Canada.; Shankardass, K (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Shankardass, K (corresponding author), Wilfrid Laurier Univ, Dept Hlth Sci, Waterloo, ON N2L 3C5, Canada.	kshankardass@wlu.ca			Peterborough KM Hunter Charitable Foundation; Canadian Institutes for Health Research Grant [111608, 96566]; Wilfrid Laurier University; Ontario Ministry of Health and Long-Term Care	Peterborough KM Hunter Charitable Foundation; Canadian Institutes for Health Research Grant(Canadian Institutes of Health Research (CIHR)); Wilfrid Laurier University; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	The authors gratefully acknowledge the support of Peterborough KM Hunter Charitable Foundation, The Canadian Institutes for Health Research Grant (http://www.cihr-irsc.gc.ca/e/193.html) grant numbers 111608 (PO) and 96566 (KS), Wilfrid Laurier University (KS) and the Ontario Ministry of Health and Long-Term Care (http://www. cihr-irsc.gc.ca/e/193.html). The views expressed in this publication are the views of the authors and do not necessarily reflect the views of the Ontario Ministry of Health and Long-Term Care.; Agnes Molnar and Emilie Renahy contributed to the work as postdoctoral fellows in the ACHIEVE Research Partnership: Action for Health Equity Interventions at the Centre for Research on Inner City Health at St. Michael's Hospital. The authors gratefully acknowledge the support of Peterborough KM Hunter Charitable Foundation, The Canadian Institutes for Health Research Grant (http://www.cihr-irsc.gc.ca/e/193.html) grant numbers 111608 (PO) and 96566 (KS), Wilfrid Laurier University (KS) and the Ontario Ministry of Health and Long-Term Care (http://www.cihr-irsc.gc.ca/e/193.html). The views expressed in this publication are the views of the authors and do not necessarily reflect the views of the Ontario Ministry of Health and Long-Term Care.	Alvarez M, 1996, STUD COMP INT DEV, V31, P3, DOI 10.1007/BF02719326; [Anonymous], 2013, MULTIPLE CASE STUDY; Baum F, 2014, HEAL PROMOT POLICY P, ppp188; Baum F, 2014, HEALTH PROMOT INT, V29, P130, DOI 10.1093/heapro/dau032; Bhaskar Roy, 1979, POSSIBILITY NATURALI, P45, DOI DOI 10.4324/9781315756332; Carey G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1087; Connelly JB, 2007, J EVAL CLIN PRACT, V13, P935, DOI 10.1111/j.1365-2753.2006.00790.x; D'Amour R., 2009, DISC WORKSH HLTH IMP; De Leeuw E, 2015, HEALTH PROMOT INT, V30, P987, DOI 10.1093/heapro/dau034; Delany T., 2015, HLTH PROMOMTION 0813; Fafard P., 2013, 1 INT C PUBL POL GRE; Freiler A, 2013, J EPIDEMIOL COMMUN H, V67, P1068, DOI 10.1136/jech-2013-202731; Gagnon F., 2008, HLTH IMP ASS QUEB LA; Katikireddi SV, 2014, MILBANK Q, V92, P250, DOI 10.1111/1468-0009.12057; Kickbush I, 2010, IMPLEMENTING HLTH AL; Kingdon J., 2003, AGENDAS ALTERNATIVES, V2nd; Lasswell H. D., 1951, POLICY SCI; Lawless A, 2012, CAN J PUBLIC HEALTH, V103, pS15, DOI 10.1007/BF03404454; Lorenc T, 2014, EUR J PUBLIC HEALTH, V24, P1041, DOI 10.1093/eurpub/cku038; Lundberg O, 2010, INT J EPIDEMIOL, V39, P632, DOI 10.1093/ije/dyn351; Marmot M., 2013, HLTH ALL POLICIES SE; McQueen D. V., 2012, OBSERVATORY STUDIES; Muntaner C, 1999, INT J HEALTH SERV, V29, P59, DOI 10.2190/G8QW-TT09-67PL-QTNC; Muntaner C, 2010, INT J EPIDEMIOL, V39, P1396, DOI 10.1093/ije/dyp220; Ollila E, 2011, SCAND J PUBLIC HEALT, V39, P11, DOI 10.1177/1403494810379895; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Pawson R., 1997, REALISTIC EVALUATION; Petticrew M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-314; Public Health Agency of Canada World Health Organization, 2008, HLTH EQ INT ACT AN 1; Shankardass K, 2011, GETTING STARTED HLTH; Shankardass K, 2015, HEALTH POLICY PLANN, V30, P462, DOI 10.1093/heapol/czu021; Shankardass K, 2012, INT J PUBLIC HEALTH, V57, P25, DOI 10.1007/s00038-011-0302-4; Stahl T., 2006, HLTH ALL POLICIES PR; Wismar M., 2007, EFFECTIVENESS HLTH I; Wong G, 2012, MED EDUC, V46, P89, DOI 10.1111/j.1365-2923.2011.04045.x; World Health Organization, 2013, HLTH 2020 EUR POL FR; Yin R.K., 2014, CASE STUD RES DES ME	37	48	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147003	10.1371/journal.pone.0147003	http://dx.doi.org/10.1371/journal.pone.0147003			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PF	26845574	gold, Green Published, Green Submitted			2022-12-27	WOS:000369552800006
J	Milano, M; Moraes, MO; Rodenbusch, R; Carvalho, CX; Delcroix, M; Mousquer, G; da Costa, LL; Unis, G; Dalla Costa, ER; Rossetti, MLR				Milano, Mariana; Moraes, Milton Ozorio; Rodenbusch, Rodrigo; Carvalho, Caroline Xavier; Delcroix, Melaine; Mousquer, Gabriel; da Costa, Lucas Laux; Unis, Gisela; Dalla Costa, Elis Regina; Rosa Rossetti, Maria Lucia			Single Nucleotide Polymorphisms in IL17A and IL6 Are Associated with Decreased Risk for Pulmonary Tuberculosis in Southern Brazilian Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; T-CELL RESPONSE; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSE; GENE POLYMORPHISMS; ADAPTIVE IMMUNITY; INTERFERON-GAMMA; IFN-GAMMA; SUSCEPTIBILITY; INNATE	In Mycobacterium tuberculosis (MTB) infection, the complex interaction of host immune system and the mycobacteria is associated with levels of cytokines production that play a major role in determining the outcome of the disease. Several single-nucleotide polymorphisms (SNPs) in cytokine genes have been associated with tuberculosis (TB) outcome. The aim of this study was to evaluate the association between previously reported SNPs IL2-330 T>G (rs2069762); IL4-590 C>T (rs2243250); IL6-174 G>C (rs1800795); IL10-592 A>C (rs1800872); IL10-1082 G>A (rs1800896); IL17A -692 C>T (rs8193036); IL17A -197 G>A (rs2275913); TNF -238 G>A (rs361525); TNF -308 G>A (rs1800629) and IFNG +874 T>A (rs2430561) and pulmonary TB (PTB) susceptibility. We conducted a case-control study in individuals from Southern Brazil who were recruited between February 2012 and October 2013 in a high incidence TB city. We performed a multiplex genotyping assay in 191 patients with PTB and 175 healthy subjects. Our results suggest a decreased risk for PTB development associated with the IL17A -197A allele (OR = 0.29; p = 0.04), AA genotype (OR = 0.12; p = 0.04) and A carrier (AG/AA) (OR = 0.29; p = 0.004) and IL6 -174C carrier (CC/CG) (OR = 0.46; p = 0.04). We could not properly analyze IL17A -692 C>T (rs8193036) and IFNG +874T>A due to genotypic inconsistencies and found no evidence of association for the IL2, IL4, IL10 and TNF polymorphisms and PTB. In conclusion, our results show a protective effect of IL17 and IL6 polymorphisms on PTB outcome in Southern Brazilian population.	[Milano, Mariana; Rosa Rossetti, Maria Lucia] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil; [Milano, Mariana; Rodenbusch, Rodrigo; da Costa, Lucas Laux; Dalla Costa, Elis Regina; Rosa Rossetti, Maria Lucia] Fundacao Estudual Prod & Pesquisa Saude, Ctr Desenvolvimento Cient & Tecnol, Porto Alegre, RS, Brazil; [Moraes, Milton Ozorio; Carvalho, Caroline Xavier] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, RJ, Brazil; [Delcroix, Melaine] Univ Calif Berkeley, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Mousquer, Gabriel] Univ Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, Brazil; [da Costa, Lucas Laux] Univ Fed Rio de Janeiro, Programa Posgrad Clin Med, Rio De Janeiro, RJ, Brazil; [Unis, Gisela] Hosp Sanatorio Partenon, Porto Alegre, RS, Brazil; [Rosa Rossetti, Maria Lucia] Univ Luterana Brazil, Canoas, RS, Brazil	Universidade Federal do Rio Grande do Sul; Fundacao Oswaldo Cruz; University of California System; University of California Berkeley; Universidade Federal de Ciencias da Saude de Porto Alegre; Universidade Federal do Rio de Janeiro	Milano, M (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil.; Milano, M (corresponding author), Fundacao Estudual Prod & Pesquisa Saude, Ctr Desenvolvimento Cient & Tecnol, Porto Alegre, RS, Brazil.; Moraes, MO (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, RJ, Brazil.	marianamilano@hotmail.com; mmoraes@fiocruz.br	Moraes, Milton Ozório/G-9753-2011; Rossetti, Maria Lucia/ABH-1935-2020; Moraes, Milton/AFF-1842-2022	Moraes, Milton Ozório/0000-0003-2653-0037; Rossetti, Maria Lucia/0000-0002-9672-9394; 				Alcais A, 2005, J EXP MED, V202, P1617, DOI 10.1084/jem.20052302; Alcais A, 2010, ANN NY ACAD SCI, V1214, P18, DOI 10.1111/j.1749-6632.2010.05834.x; Alvarado-Arnez LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136282; Ansari A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027848; APPELBERG R, 1994, IMMUNOLOGY, V82, P361; Arisawa T, 2008, J CLIN IMMUNOL, V28, P44, DOI 10.1007/s10875-007-9125-8; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Bulat-Kardum LJ, 2015, SCAND J IMMUNOL, V82, P63, DOI 10.1111/sji.12300; Cardoso CC, 2011, FUTURE MICROBIOL, V6, P533, DOI [10.2217/FMB.11.39, 10.2217/fmb.11.39]; Chen JH, 2010, J CLIN IMMUNOL, V30, P539, DOI 10.1007/s10875-010-9391-8; Chimusa ER, 2014, HUM MOL GENET, V23, P796, DOI 10.1093/hmg/ddt462; Cobat A, 2009, J EXP MED, V206, P2583, DOI 10.1084/jem.20090892; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; El Baghdadi J, 2006, J EXP MED, V203, P1679, DOI 10.1084/jem.20060269; Espinoza JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026229; Etna MP, 2014, SEMIN IMMUNOL, V26, P543, DOI 10.1016/j.smim.2014.09.011; Fairfax BP, 2014, CURR OPIN IMMUNOL, V30, P63, DOI 10.1016/j.coi.2014.07.001; Fernando SL, 2006, IMMUNOL CELL BIOL, V84, P125, DOI 10.1111/j.1440-1711.2006.01420.x; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gao X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127496; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Ocejo-Vinyals JG, 2013, CYTOKINE, V64, P58, DOI 10.1016/j.cyto.2013.05.022; Gopal R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004099; Indrigo J, 2002, MICROBIOL-SGM, V148, P1991, DOI 10.1099/00221287-148-7-1991; Isailovic N, 2015, J AUTOIMMUN, V60, P1, DOI 10.1016/j.jaut.2015.04.006; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; KALLMANN F. J., 1943, American Review of Tuberculosis and Pulmonary Diseases, V47, P549; Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; Leal IS, 1999, INFECT IMMUN, V67, P5747, DOI 10.1128/IAI.67.11.5747-5754.1999; Li X, 2011, 2011 SECOND ETP/IITA CONFERENCE ON TELECOMMUNICATION AND INFORMATION (TEIN 2011), VOL 1, P1, DOI 10.1109/ICCSN.2011.6014661; Liang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088448; Liu XKK, 2004, J BIOL CHEM, V279, P52762, DOI 10.1074/jbc.M405764200; Mabunda N, 2015, MOL BIOL REP, V42, P71, DOI 10.1007/s11033-014-3741-1; Mao X, 2015, GENE; Ministerio da Saude, 2011, MAN NAC REC CONTR TU; Ministerio da Saude (Brazilian Ministry of Health), B EP; Moller M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-154; Moraes MO, 2013, CAD SAUDE PUBLICA, V29, P2144, DOI 10.1590/0102-311XPE011113; Nagabhushanam V, 2003, J IMMUNOL, V171, P4750, DOI 10.4049/jimmunol.171.9.4750; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Pacheco AG, 2008, HUM GENET, V123, P477, DOI 10.1007/s00439-008-0497-5; Peng R, 2013, GENE, V515, P229, DOI 10.1016/j.gene.2012.11.017; Puffer R., 1944, FAMILIAL SUSCEPTIBIL; Shi GC, 2015, GENET MOL RES, V14, P8526, DOI 10.4238/2015.July.28.22; Stein CM, 2011, MAMM GENOME, V22, P91, DOI 10.1007/s00335-010-9301-7; Team R. D. C., 2008, R LANG ENV STAT COMP; Thye T, 2012, NAT GENET, V44, P257, DOI 10.1038/ng.1080; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Tian G, 2015, GENET MOL RES, V14, P5501, DOI 10.4238/2015.May.25.1; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Vidyarani M, 2006, INDIAN J MED RES, V124, P403; Wareham AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088149; WHO, 2014, GLOB TUB REP 2014; World Health Organization, 2011, GUID PROGR MAN DRUG; Wu GN, 2014, INFECT GENET EVOL, V24, P82, DOI 10.1016/j.meegid.2014.03.006; Zhang ZJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-328	65	29	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147814	10.1371/journal.pone.0147814	http://dx.doi.org/10.1371/journal.pone.0147814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840977	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200063
J	Leyh, R; Heinisch, C; Behringer, J; Reiner, I; Spangler, G				Leyh, Rainer; Heinisch, Christine; Behringer, Johanna; Reiner, Iris; Spangler, Gottfried			Maternal Attachment Representation and Neurophysiological Processing during the Perception of Infants' Emotional Expressions	PLOS ONE			English	Article							FACIAL EXPRESSIONS; SOCIAL COMPETENCE; FACE PERCEPTION; BRAIN RESPONSES; ADULT; P300; INTERVIEW; MOTHERS; ERP; RECOGNITION	The perception of infant emotions is an integral part of sensitive caregiving within the mother-child relationship, a maternal ability which develops in mothers during their own attachment history. In this study we address the association between maternal attachment representation and brain activity underlying the perception of infant emotions. Event related potentials (ERPs) of 32 primiparous mothers were assessed during a three stimulus oddball task presenting negative, positive and neutral emotion expressions of infants as target, deviant or standard stimuli. Attachment representation was assessed with the Adult Attachment Interview during pregnancy. Securely attached mothers recognized emotions of infants more accurately than insecurely attached mothers. ERPs yielded amplified N170 amplitudes for insecure mothers when focusing on negative infant emotions. Secure mothers showed enlarged P3 amplitudes to target emotion expressions of infants compared to insecure mothers, especially within conditions with frequent negative infant emotions. In these conditions, P3 latencies were prolonged in insecure mothers. In summary, maternal attachment representation was found associated with brain activity during the perception of infant emotions. This further clarifies psychological mechanisms contributing to maternal sensitivity.	[Leyh, Rainer; Heinisch, Christine; Behringer, Johanna; Spangler, Gottfried] Univ Erlangen Nurnberg, Dept Dev & Educ Psychol, D-91054 Erlangen, Germany; [Reiner, Iris] Johannes Gutenberg Univ Mainz, Klin & Poliklin Psychosomat Med & Psychotherapie, D-55122 Mainz, Germany	University of Erlangen Nuremberg; Johannes Gutenberg University of Mainz	Heinisch, C (corresponding author), Univ Erlangen Nurnberg, Dept Dev & Educ Psychol, D-91054 Erlangen, Germany.	christine.heinisch@fau.de			DFG [SP 312/18-1]	DFG(German Research Foundation (DFG))	This work was supported by DFG SP 312/18-1.	Ainsworth M., 1978, PATTERNS ATTACHMENT; ALLEY TR, 1981, DEV PSYCHOL, V17, P650, DOI 10.1037/0012-1649.17.5.650; BAKERMANSKRANENBURG MJ, 1993, DEV PSYCHOL, V29, P870, DOI 10.1037/0012-1649.29.5.870; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; BARTHOLOMEW K, 1991, J PERS SOC PSYCHOL, V61, P226, DOI 10.1037/0022-3514.61.2.226; Behringer J, 2011, J FAM PSYCHOL, V25, P210, DOI 10.1037/a0023083; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bobes MA, 2007, BIOL PSYCHOL, V75, P146, DOI 10.1016/j.biopsycho.2007.01.006; Bowlby J, 1969, VOLUME 1 ATTACHMENT, V1; Caharel S, 2005, BRAIN COGNITION, V59, P96, DOI 10.1016/j.bandc.2005.05.005; Caharel S, 2014, J COGNITIVE NEUROSCI, V26, P81, DOI 10.1162/jocn_a_00451; COHN DA, 1990, CHILD DEV, V61, P152, DOI 10.2307/1131055; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; Crowell JA, 1996, CHILD DEV, V67, P2584, DOI 10.1111/j.1467-8624.1996.tb01876.x; Darwin C., 1874, DESCENT MAN SELECTIO; de Haan M, 2004, J CHILD PSYCHOL PSYC, V45, P1209, DOI 10.1111/j.1469-7610.2004.00320.x; De Wolff MS, SENSITIVITY ATTACHME; Doi H, 2012, NEUROPSYCHOLOGIA, V50, P1297, DOI 10.1016/j.neuropsychologia.2012.02.013; Eimer M, 1998, NEUROREPORT, V9, P2945, DOI 10.1097/00001756-199809140-00005; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; EKMAN P, 1993, AM PSYCHOL, V48, P384, DOI 10.1037/0003-066X.48.4.384; Fraedrich EM, 2010, ATTACH HUM DEV, V12, P231, DOI 10.1080/14616731003759724; George C., 1985, ADULT ATTACHMENT INT; George N, 1996, COGNITIVE BRAIN RES, V4, P65, DOI 10.1016/0926-6410(95)00045-3; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Gloger-Tipplet G, 2001, PSYCHOL HDB BINDUNG; Grossmann K, 1985, GROWING POINTS ATTAC; Grossmann K, 1988, RELATIONSHIPS FAMILI, P241; Haxby JV, 2002, BIOL PSYCHIAT; Hesse E, 2008, HDB ATTACHMENT; Hoehl S, 2008, CHILD DEV, V79, P1752, DOI 10.1111/j.1467-8624.2008.01223.x; Holmes A, 2008, BIOL PSYCHOL, V77, P159, DOI 10.1016/j.biopsycho.2007.10.003; Isreal JB, 1980, PSYCHOPHYSIOLOGY, P17; Izard C.E., 1971, FACE EMOTION; Kahneman D., 1973, ATTENTION EFFORT; Kolassa IT, 2006, BRAIN RES, V1118, P130, DOI 10.1016/j.brainres.2006.08.019; Krippl M, 2010, J PSYCHOPHYSIOL, V24, P173, DOI 10.1027/0269-8803/a000008; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Leppanen JM, 2007, CHILD DEV, V78, P232, DOI 10.1111/j.1467-8624.2007.00994.x; MAGLIERO A, 1984, PSYCHOPHYSIOLOGY, V21, P171, DOI 10.1111/j.1469-8986.1984.tb00201.x; MAIN M, 1985, MONOGR SOC RES CHILD, V50, P66, DOI 10.2307/3333827; Main M, 2002, UNPUBLISHED MANUSCRI; Manassis K, 1999, AUST NZ J PSYCHIAT, V33, P559, DOI 10.1080/j.1440-1614.1999.00560.x; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; Moreira JM, 1998, PERS INDIV DIFFER, V24, P565, DOI 10.1016/S0191-8869(97)00200-6; Nishitani S, 2011, NEUROSCI RES, V70, P183, DOI 10.1016/j.neures.2011.02.007; Nitschke JB, 2004, NEUROIMAGE, V21, P583, DOI 10.1016/j.neuroimage.2003.10.005; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; POLICH J, 1987, ELECTROEN CLIN NEURO, V68, P311, DOI 10.1016/0168-5597(87)90052-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Roisman GI, 2007, J PERS SOC PSYCHOL, V92, P678, DOI 10.1037/0022-3514.92.4.678; Rossion B, 1999, BIOL PSYCHOL, V50, P173, DOI 10.1016/S0301-0511(99)00013-7; Rozenkrants B, 2008, CLIN NEUROPHYSIOL, V119, P2260, DOI 10.1016/j.clinph.2008.07.213; Schyns PG, 2007, CURR BIOL, V17, P1580, DOI 10.1016/j.cub.2007.08.048; Spangler G, 1999, Attach Hum Dev, V1, P270, DOI 10.1080/14616739900134151; Spangler G, 2001, INT J PSYCHOPHYSIOL, V41, P155, DOI 10.1016/S0167-8760(01)00127-1; Spangler G, 2010, DEV PSYCHOBIOL, V52, P411, DOI 10.1002/dev.20441; Steele H, 1996, ASS ATTACHMENT CLASS; Steele H, 2008, ATTACH HUM DEV, V10, P379, DOI 10.1080/14616730802461409; Strathearn L, 2008, PEDIATRICS, V122, P40, DOI 10.1542/peds.2007-1566; van Ijzendoorn MH, 1995, ADULT ATTACHMENT REP; Ward A, 2001, BRIT J MED PSYCHOL, V74, P497, DOI 10.1348/000711201161145; Wieser MJ, 2010, PSYCHOPHYSIOLOGY, V47, P271, DOI 10.1111/j.1469-8986.2009.00938.x; Zhang X, 2008, NEUROREPORT, V19, P437, DOI 10.1097/WNR.0b013e3282f55728	67	26	27	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147294	10.1371/journal.pone.0147294	http://dx.doi.org/10.1371/journal.pone.0147294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26862743	gold, Green Published			2022-12-27	WOS:000370046600025
J	Kim, H; Park, CM; Song, YS; Sunwoo, L; Choi, YR; Kim, JI; Kim, JH; Bae, JS; Lee, JH; Goo, JM				Kim, Hyungjin; Park, Chang Min; Song, Yong Sub; Sunwoo, Leonard; Choi, Ye Ra; Kim, Jung Im; Kim, Jae Hyun; Bae, Jae Seok; Lee, Jong Hyuk; Goo, Jin Mo			Measurement Variability of Persistent Pulmonary Subsolid Nodules on Same-Day Repeat CT: What Is the Threshold to Determine True Nodule Growth during Follow-Up?	PLOS ONE			English	Article							GROUND-GLASS NODULES; INTER-READER VARIABILITY; SOLID COMPONENT; LUNG ADENOCARCINOMA; MANAGEMENT; SIZE; CLASSIFICATION; GUIDELINES; INDICATOR; SOCIETY	Purpose To assess the measurement variability of subsolid nodules (SSNs) in follow-up situations and to compare the degree of variability between measurement metrics. Methods Two same-day repeat-CT scans of 69 patients (24 men and 45 women) with 69 SSNs were randomly assigned as initial or follow-up scans and were read by the same (situation 1) or different readers (situation 2). SSN size and solid portion size were measured in both situations. Measurement variability was calculated and coefficients of variation were used for comparisons. Results Measurement variability for the longest and average diameter of SSNs was +/- 1.3 mm (+/- 13.0%) and +/- 1.3 mm (+/- 14.4%) in situation 1, and +/- 2.2 mm (+/- 21.0%) and +/- 2.1 mm (+/- 21.3%) in situation 2, respectively. For solid portion, measurement variability on lung and mediastinal windows was +/- 1.2 mm (+/- 27.1%) and +/- 0.8 mm (+/- 24.0%) in situation 1, and +/- 3.7 mm (+/- 61.0%) and +/- 1.5 mm (+/- 47.3%) in situation 2, respectively. There were no significant differences in the degree of variability between the longest and average diameters and between the lung and mediastinal window settings (p>0.05). However, measurement variability significantly increased when the follow-up and initial CT readers were different (p<0.001). Conclusions A cutoff of +/- 2.2 mm can be reliably used to determine true nodule growth on follow-up CT. Solid portion measurements were not reliable in evaluating SSNs' change when readers of initial and follow-up CT were different.	[Kim, Hyungjin; Park, Chang Min; Song, Yong Sub; Choi, Ye Ra; Kim, Jae Hyun; Bae, Jae Seok; Lee, Jong Hyuk; Goo, Jin Mo] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Kim, Hyungjin] Air Force Educ & Training Command, Aerosp Med Grp, Jinju, South Korea; [Park, Chang Min; Goo, Jin Mo] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Park, Chang Min; Goo, Jin Mo] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Sunwoo, Leonard; Choi, Ye Ra] SMG SNU Boramae Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Jung Im] Kyung Hee Univ Hosp Gangdong, Dept Radiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Kyung Hee University; Kyung Hee University Hospital	Park, CM (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.	cmpark.morphius@gmail.com		Sunwoo, Leonard/0000-0003-0374-8658; Lee, Jong Hyuk/0000-0002-9594-683X	Korean Foundation for Cancer Research [CB-2011-02-01]	Korean Foundation for Cancer Research	CMP received research grant of the Korean Foundation for Cancer Research (grant number: CB-2011-02-01), http://www.koreanfcr.or.kr/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas-Jimenez J, 2013, RADIOLOGY, V268, P305, DOI 10.1148/radiol.13130209; Austin J.H., 2013, RADIOLOGY, V266, P62, DOI DOI 10.1148/RADI0L.12120240; Callister MEJ, 2015, THORAX, V70, P1, DOI 10.1136/thoraxjnl-2015-207168; de Hoop B, 2010, RADIOLOGY, V255, P199, DOI 10.1148/radiol.09090571; Godoy MCB, 2012, J THORAC IMAG, V27, P240, DOI 10.1097/RTI.0b013e31825d515b; Goo JM, 2011, AM J ROENTGENOL, V196, P533, DOI 10.2214/AJR.10.5813; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053, DOI 10.2214/ajr.178.5.1781053; Hwang EJ, 2015, EUR RADIOL, V25, P558, DOI 10.1007/s00330-014-3441-1; Kakinuma R, 2012, ACAD RADIOL, V19, P389, DOI 10.1016/j.acra.2011.12.002; Kim H, 2014, EUR RADIOL, V24, P2700, DOI 10.1007/s00330-014-3306-7; Kim H, 2013, RADIOLOGY, V269, P584, DOI 10.1148/radiol.13121849; Lee HJ, 2012, J THORAC IMAG, V27, P340, DOI 10.1097/RTI.0b013e3182688d62; Lee SM, 2013, RADIOLOGY, V268, P265, DOI 10.1148/radiol.13120949; MacMahon H, 2013, RADIOLOGY, V268, P306; McNitt-Gray MF, 2015, TRANSL ONCOL, V8, P55, DOI 10.1016/j.tranon.2015.01.001; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Oxnard GR, 2011, J CLIN ONCOL, V29, P3114, DOI 10.1200/JCO.2010.33.7071; Park CM, 2007, RADIOGRAPHICS, V27, P391, DOI 10.1148/rg.272065061; Penn A, 2015, ACTA RADIOL, V56, P1180, DOI 10.1177/0284185114551975; Scholten ET, 2015, EUR RADIOL, V25, P1040, DOI 10.1007/s00330-014-3478-1; Scholten ET, 2015, EUR RADIOL, V25, P488, DOI 10.1007/s00330-014-3427-z; Scholten ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080249; Zhao BS, 2013, EUR J RADIOL, V82, P959, DOI 10.1016/j.ejrad.2013.02.018	23	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148853	10.1371/journal.pone.0148853	http://dx.doi.org/10.1371/journal.pone.0148853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859665	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400097
J	Kim, OH; Cha, YS; Hwang, SO; Jang, JY; Choi, EH; Kim, HI; Cha, K; Kim, H; Lee, KH				Kim, Oh Hyun; Cha, Yong Sung; Hwang, Sung Oh; Jang, Ji Young; Choi, Eun Hee; Kim, Hyung Il; Cha, KyoungChul; Kim, Hyun; Lee, Kang Hyun			The Use of Delta Neutrophil Index and Myeloperoxidase Index for Predicting Acute Complicated Appendicitis in Children	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CLINICAL-FEATURES; PERFORATION; COUNT; PROCALCITONIN; LEUKOCYTES; INFECTION; DEFENSE; SEPSIS; ADULTS	Background In children with acute appendicitis, 30% to 75% present with a complication, such as perforation, and the early diagnosis of complications is known to improve outcomes. Serum delta neutrophil index (DNI) and myeloperoxidase index (MPXI) are new inflammatory markers, and thus, in the present study, the authors evaluated the predictive values of these two markers for the presence of a complication in children with acute appendicitis. Methods This retrospective observational study was conducted on 105 consecutive children (<12 years old) with acute appendicitis treated over a 31-month period. DNI, MPXI, C-reactive protein (CRP), and white blood cells (WBCs) were measured in an emergency department and investigated with respect to their abilities to predict the presence of acute complicated appendicitis. Results Twenty-nine of the 105 patients (median age, 9 years) were allocated to the complicated group (27.6%) and 76 to the non-complicated group (72.4%). Median serum DNI and CRP were significantly higher in the complicated group [0% vs. 2.2%, p<0.001 and 0.65 mg/dL vs. 8.0 mg/dL, p<0.001], but median MPXI was not (p = 0.316). Area under curve (AUC) for the ability of serum DNI and CRP to predict the presence of acute complicated appendicitis were 0.738 and 0.840, respectively. Multiple logistic regression analyses showed initial CRP [odds ratio 1.301, 95% confidence interval (1.092-1.549), p = 0.003] significantly predicted the presence of a complication. The optimal cutoff for serum CRP was 4.0 mg/dL (sensitivity 69%, specificity 83%, AUC 0.840). Conclusions Although serum DNI values were significantly higher in children with acute complicated appendicitis, no evidence was obtained to support the notion that serum DNI or serum MPXI aid the differentiation of acute complicated and non-complicated appendicitis in the ED setting.	[Kim, Oh Hyun; Cha, Yong Sung; Hwang, Sung Oh; Kim, Hyung Il; Cha, KyoungChul; Kim, Hyun; Lee, Kang Hyun] Yonsei Univ, Dept Emergency Med, Wonju Coll Med, Wonju, South Korea; [Jang, Ji Young] Yonsei Univ, Dept Surg, Wonju Coll Med, Wonju, South Korea; [Choi, Eun Hee] Yonsei Univ, Inst Lifestyle Med, Wonju Coll Med, Wonju, South Korea	Yonsei University; Yonsei University; Yonsei University	Cha, YS (corresponding author), Yonsei Univ, Dept Emergency Med, Wonju Coll Med, Wonju, South Korea.	zza96@hanmail.net	Cha, Yong Sung/AEF-1706-2022; Hwang, Sung Oh/AAO-5838-2021	Cha, Yong Sung/0000-0001-9897-4273; Choi, Eunhee/0000-0002-3449-0672; Hwang, Sung Oh/0000-0003-4585-3181; Jang, Ji Young/0000-0001-6372-4194				Ansari-Lari MA, 2003, AM J CLIN PATHOL, V120, P795, DOI 10.1309/LT30BV9UJJV9CFHQ; Aratani Y, 1999, INFECT IMMUN, V67, P1828; BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403; Becker T, 2007, ACAD EMERG MED, V14, P124, DOI 10.1197/j.aem.2006.08.009; Brown LL, 2004, PEDIAT RES, V55, p107a; Cornbleet PJ, 2002, CLIN LAB MED, V22, P101, DOI 10.1016/S0272-2712(03)00069-6; Gaitini D, 2008, AM J ROENTGENOL, V190, P1300, DOI 10.2214/AJR.07.2955; GAMAL R, 1990, AM J SURG, V159, P589, DOI 10.1016/S0002-9610(06)80073-5; Gavela T, 2012, PEDIATR EMERG CARE, V28, P416, DOI 10.1097/PEC.0b013e318252d875; Harris Neil, 2005, Lab Hematol, V11, P62, DOI 10.1532/LH96.04064; Harris Neil, 2005, Lab Hematol, V11, P47, DOI 10.1532/LH96.04075; HyunNahm C, 2008, ANN CLIN LAB SCI, V38, P241; Kafetzis DA, 2005, EUR J CLIN MICROBIOL, V24, P484, DOI 10.1007/s10096-005-1360-4; Kearney D, 2008, DIS COLON RECTUM, V51, P1823, DOI 10.1007/s10350-008-9373-6; Korner H, 1997, WORLD J SURG, V21, P313, DOI 10.1007/s002689900235; Kratz Alexander, 2006, Lab Hematol, V12, P63, DOI 10.1532/LH96.06010; McGowan DR, 2013, ANZ J SURG, V83, P79, DOI 10.1111/ans.12032; Nigro KG, 2005, AM J CLIN PATHOL, V123, P618, DOI 10.1309/73H7K7UBW816PBJJ; Pepys M.B., 1995, OXFORD TXB MED, VVolume 2, P1527; RAPPAPORT WD, 1989, AM SURGEON, V55, P602; Rodriguez-Sanjuan JC, 1999, DIS COLON RECTUM, V42, P1325, DOI 10.1007/BF02234223; ROTHROCK SG, 1991, ANN EMERG MED, V20, P45, DOI 10.1016/S0196-0644(05)81117-5; Seebach JD, 1997, AM J CLIN PATHOL, V107, P582; YAMAMOTO K, 1991, J INFECT DIS, V164, P8, DOI 10.1093/infdis/164.1.8; Yonezawa K, 2010, INT J LAB HEMATOL, V32, P598, DOI 10.1111/j.1751-553X.2010.01227.x	25	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148799	10.1371/journal.pone.0148799	http://dx.doi.org/10.1371/journal.pone.0148799			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859663	gold, Green Published			2022-12-27	WOS:000370038400088
J	Liu, CH; Ho, BC; Chen, CL; Chang, YH; Hsu, YC; Li, YC; Yuan, SS; Huang, YH; Chang, CS; Li, KC; Chen, HY				Liu, Chia-Hsin; Ho, Bing-Ching; Chen, Chun-Ling; Chang, Ya-Hsuan; Hsu, Yi-Chiung; Li, Yu-Cheng; Yuan, Shin-Sheng; Huang, Yi-Huan; Chang, Chi-Sheng; Li, Ker-Chau; Chen, Hsuan-Yu			ePIANNO: ePIgenomics ANNOtation tool	PLOS ONE			English	Article							TRANSCRIPTION FACTOR YY1; CHIP-SEQ; WEB SERVER; DNASE-SEQ; ASSOCIATIONS; SUPPRESSOR; DATABASE; DISEASE; MOUSE; HLJ1	Recently, with the development of next generation sequencing (NGS), the combination of chromatin immunoprecipitation (ChIP) and NGS, namely ChIP-seq, has become a powerful technique to capture potential genomic binding sites of regulatory factors, histone modifications and chromatin accessible regions. For most researchers, additional information including genomic variations on the TF binding site, allele frequency of variation between different populations, variation associated disease, and other neighbour TF binding sites are essential to generate a proper hypothesis or a meaningful conclusion. Many ChIP-seq datasets had been deposited on the public domain to help researchers make new discoveries. However, researches are often intimidated by the complexity of data structure and largeness of data volume. Such information would be more useful if they could be combined or downloaded with ChIP-seq data. To meet such demands, we built a webtool: ePIgenomic ANNOtation tool (ePIANNO, http://epianno.stat.sinica.edu.tw/index.html). ePIANNO is a web server that combines SNP information of populations (1000 Genomes Project) and gene-disease association information of GWAS (NHGRI) with ChIP-seq (hmChIP, ENCODE, and ROADMAP epigenomics) data. ePIANNO has a user-friendly website interface allowing researchers to explore, navigate, and extract data quickly. We use two examples to demonstrate how users could use functions of ePIANNO webserver to explore useful information about TF related genomic variants. Users could use our query functions to search target regions, transcription factors, or annotations. ePIANNO may help users to generate hypothesis or explore potential biological functions for their studies.	[Liu, Chia-Hsin; Chen, Chun-Ling; Chang, Ya-Hsuan; Hsu, Yi-Chiung; Li, Yu-Cheng; Yuan, Shin-Sheng; Huang, Yi-Huan; Li, Ker-Chau; Chen, Hsuan-Yu] Acad Sinica, Inst Stat Sci, Taipei 115, Taiwan; [Liu, Chia-Hsin] Acad Sinica, Taiwan Int Grad Program, Bioinformat Program, Taipei 115, Taiwan; [Liu, Chia-Hsin] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Ho, Bing-Ching] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Ho, Bing-Ching; Chang, Chi-Sheng] Natl Taiwan Univ, Coll Med, NTU Ctr Genom Med, Taipei 10764, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University	Chen, HY (corresponding author), Acad Sinica, Inst Stat Sci, Taipei 115, Taiwan.	hychen@stat.sinica.edu.tw	Li, Ker-Chau/AAQ-4886-2021; Chen, Hsuan-Yu/AAE-8428-2019; Yuan, Shinsheng/AAP-4855-2021; Chang, Ya-Hsuan/AAG-1313-2021	Liu, Chiahsin/0000-0002-2880-8365; HO, BING-CHING/0000-0003-4356-3279	Academia Sinica, Institute of Statistical Science AS [AS-100-TP-AB2, NSC 98-3112-B-001-034, NSC 99-2314-B-001-003-MY3, NSC 100-2325-B-001-027, NSC 101-2325-B-002-071, NSC 102-2325-B-002-078]; Taiwan Biosignature Project of Lung Cancer;  [NSC 101-2319-B-002-002];  [NSC 102-2319-B-002 -002];  [NSC 102-2911-I-002-303];  [NSC 101-2911-I-002-303];  [DOH101-TD-B-111-001];  [102R7557];  [NSC 102-2923-B-002-004];  [NSC 103-2923-B-002-003];  [MOST 104-2923-B-002-003]	Academia Sinica, Institute of Statistical Science AS; Taiwan Biosignature Project of Lung Cancer; ; ; ; ; ; ; ; ; 	Supported by grants from Academia Sinica, Institute of Statistical Science AS, AS-100-TP-AB2, NSC 98-3112-B-001-034, NSC 99-2314-B-001-003-MY3, NSC 100-2325-B-001-027, NSC 101-2325-B-002-071, NSC 102-2325-B-002-078, NSC 101-2319-B-002-002, NSC 102-2319-B-002 -002, NSC 102-2911-I-002-303, NSC 101-2911-I-002-303, NSC 102-2911-I-002-303, DOH101-TD-B-111-001, 102R7557, NSC 102-2923-B-002-004, NSC 103-2923-B-002-003, MOST 104-2923-B-002-003, and Taiwan Biosignature Project of Lung Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Bryzgalov LO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078833; Chen L, 2011, BIOINFORMATICS, V27, P1447, DOI 10.1093/bioinformatics/btr156; Darsigny M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007609; Fingerman IM, 2011, NUCLEIC ACIDS RES, V39, pD908, DOI 10.1093/nar/gkq1146; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Huang D, 2015, NUCLEIC ACIDS RES, V43, P225, DOI 10.1093/nar/gku1318; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Lanz RB, 2006, NUCLEIC ACIDS RES, V34, pD221, DOI 10.1093/nar/gkj029; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Orvis T, 2014, CANCER RES, V74, P6486, DOI 10.1158/0008-5472.CAN-14-0061; Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857; Pan YP, 2010, TRENDS GENET, V26, P75, DOI 10.1016/j.tig.2009.12.003; Qin B, 2012, BIOINFORMATICS, V28, P1411, DOI 10.1093/bioinformatics/bts157; Raine T, 2015, GUT, V64, P250, DOI 10.1136/gutjnl-2013-306657; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Sun HF, 2013, BIOINFORMATICS, V29, P1352, DOI 10.1093/bioinformatics/btt135; Tanaka KI, 2009, INT J HYPERTHER, V25, P668, DOI 10.3109/02656730903213366; Tang QZ, 2011, CANCER RES, V71, P6940, DOI 10.1158/0008-5472.CAN-11-2091; Wang CC, 2006, EXPERT OPIN THER TAR, V10, P253, DOI 10.1517/14728222.10.2.253; Wang CC, 2005, ONCOGENE, V24, P4081, DOI 10.1038/sj.onc.1208573; Wang CC, 2007, CANCER RES, V67, P4816, DOI 10.1158/0008-5472.CAN-07-0504; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wang QX, 2014, NUCLEIC ACIDS RES, V42, pD450, DOI 10.1093/nar/gkt1151; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wu SR, 2013, CANCER RES, V73, P1787, DOI 10.1158/0008-5472.CAN-12-0366; Yang JH, 2013, NUCLEIC ACIDS RES, V41, pD177, DOI 10.1093/nar/gks1060	37	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148321	10.1371/journal.pone.0148321	http://dx.doi.org/10.1371/journal.pone.0148321			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859295	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400030
J	Meseck, SL; Alix, JH; Swiney, KM; Long, WC; Wikfors, GH; Foy, RJ				Meseck, Shannon L.; Alix, Jennifer H.; Swiney, Katherine M.; Long, W. Christopher; Wikfors, Gary H.; Foy, Robert J.			Ocean Acidification Affects Hemocyte Physiology in the Tanner Crab (Chionoecetes bairdi)	PLOS ONE			English	Article							ACID-BASE-BALANCE; INTRACELLULAR PH MEASUREMENT; BLUE-CRAB; SEAWATER ACIDIFICATION; CRASSOSTREA-VIRGINICA; CARCINUS-MAENAS; FIDDLER-CRAB; HEMOLYMPH COMPOSITION; CALLINECTES-SAPIDUS; TEMPERATURE STRESS	We used flow cytometry to determine if there would be a difference in hematology, selected immune functions, and hemocyte pH (pH(i)), under two different, future ocean acidification scenarios (pH = 7.50, 7.80) compared to current conditions (pH = 8.09) for Chionoecetes bairdi, Tanner crab. Hemocytes were analyzed after adult Tanner crabs were held for two years under continuous exposure to acidified ocean water. Total counts of hemocytes did not vary among control and experimental treatments; however, there were significantly greater number of dead, circulating hemocytes in crabs held at the lowest pH treatment. Phagocytosis of fluorescent microbeads by hemocytes was greatest at the lowest pH treatment. These results suggest that hemocytes were dying, likely by apoptosis, at a rate faster than upregulated phagocytosis was able to remove moribund cells from circulation at the lowest pH. Crab hemolymph pH (pH(e)) averaged 8.09 and did not vary among pH treatments. There was no significant difference in internal pH (pHi) within hyalinocytes among pH treatments and the mean pHi (7.26) was lower than the mean pHe. In contrast, there were significant differences among treatments in pHi of the semi-granular+granular cells. Control crabs had the highest mean semi-granular+granular pHi compared to the lowest pH treatment. As physiological hemocyte functions changed from ambient conditions, interactions with the number of eggs in the second clutch, percentage of viable eggs, and calcium concentration in the adult crab shell was observed. This suggested that the energetic costs of responding to ocean acidification and maintaining defense mechanisms in Tanner crab may divert energy from other physiological processes, such as reproduction.	[Meseck, Shannon L.; Alix, Jennifer H.; Wikfors, Gary H.] NOAA, Natl Marine Fisheries Serv, Northeaster Fisheries Sci Ctr, Milford, CT USA; [Swiney, Katherine M.; Long, W. Christopher; Foy, Robert J.] NOAA, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Resource Assessment & Conservat Engn Div,Kodiak L, Kodiak, AK USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Meseck, SL (corresponding author), NOAA, Natl Marine Fisheries Serv, Northeaster Fisheries Sci Ctr, Milford, CT USA.	Shannon.Meseck@noaa.gov	Long, William C/C-7074-2009	Long, William C/0000-0002-7095-1245; Swiney, Katherine/0000-0001-5482-2710	NOAA Ocean Acidification Program [AFSC001]	NOAA Ocean Acidification Program	The authors would like to thank the NOAA Ocean Acidification Program for funding project AFSC001.	AbeleOeschger D, 1997, COMP BIOCHEM PHYS C, V117, P123, DOI 10.1016/S0742-8413(97)00059-5; Adamo SA, 2012, HORM BEHAV, V62, P324, DOI 10.1016/j.yhbeh.2012.02.012; Al-Sawalmih A, 2008, ADV FUNCT MATER, V18, P3307, DOI 10.1002/adfm.200800520; Bauchau AG, 2012, INVERTEBRATE BLOOD C, P385; Beesley A, 2008, CLIM RES, V37, P215, DOI 10.3354/cr00765; Bentov S, 2009, P NATL ACAD SCI USA, V106, P21500, DOI 10.1073/pnas.0906636106; Bibby R, 2008, AQUAT BIOL, V2, P67, DOI 10.3354/ab00037; BUCKLER KJ, 1990, PFLUG ARCH EUR J PHY, V417, P234, DOI 10.1007/BF00370705; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; CAMERON JN, 1985, J EXP BIOL, V114, P181; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chan B, 2013, THESIS U HONG KONG P; CHEN SL, 1995, AQUACULTURE, V131, P205, DOI 10.1016/0044-8486(94)00327-K; Chow S, 1996, CYTOMETRY, V24, P360; Chung J Sook, 2012, Aquat Biosyst, V8, P21, DOI 10.1186/2046-9063-8-21; de Nooijer LJ, 2009, P NATL ACAD SCI USA, V106, P15374, DOI 10.1073/pnas.0904306106; Dickson A.G., 2007, GUIDE BEST PRACTICES; DILLAMAN RM, 1980, J MORPHOL, V163, P135, DOI 10.1002/jmor.1051630203; Donaghy L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046594; Dupont S, 2013, MAR BIOL, V160, P1835, DOI 10.1007/s00227-012-1921-x; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; ELLINGTON WR, 1993, BIOL BULL-US, V184, P209, DOI 10.2307/1542228; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; Fan LF, 2013, J PROTEOMICS, V80, P196, DOI 10.1016/j.jprot.2012.12.017; Fan TJ, 2009, ACTA BIOCH BIOPH SIN, V41, P865, DOI 10.1093/abbs/gmp078; Fan TJ, 2002, ACTA BIOCH BIOPH SIN, V34, P589; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; FINDLEY AM, 1978, MAR BIOL, V46, P9, DOI 10.1007/BF00393814; Foy RJ, 2014, 1010 AL FISH SCI CTR; GAILLARD S, 1983, MOL PHYSIOL, V4, P231; Gimenez B, 2010, LWT-FOOD SCI TECHNOL, V43, P1240, DOI 10.1016/j.lwt.2010.02.017; Gollas-Galvan T, 1999, COMP BIOCHEM PHYS B, V122, P77, DOI 10.1016/S0305-0491(98)10143-8; Gutowska MA, 2010, J COMP PHYSIOL B, V180, P323, DOI 10.1007/s00360-009-0412-y; Heath-Heckman EAC, 2011, ZOOLOGY, V114, P191, DOI 10.1016/j.zool.2011.02.002; Hegaret H, 2003, J EXP MAR BIOL ECOL, V293, P249, DOI 10.1016/S0022-0981(03)00235-1; Hernroth B, 2012, FISH SHELLFISH IMMUN, V33, P1095, DOI 10.1016/j.fsi.2012.08.011; Hernroth B, 2011, AQUAT TOXICOL, V103, P222, DOI 10.1016/j.aquatox.2011.03.001; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Johansson MW, 2000, AQUACULTURE, V191, P45, DOI 10.1016/S0044-8486(00)00418-X; JOHANSSON MW, 1985, J COMP PHYSIOL B, V156, P175, DOI 10.1007/BF00695771; Johnson PT, 1980, HIST BLUE CRAB; Johnstone MB, 2015, J EXP MAR BIOL ECOL, V463, P8, DOI 10.1016/j.jembe.2014.10.014; KOBAYASHI M, 1990, CELL TISSUE RES, V260, P13, DOI 10.1007/BF00297485; Lavigne H., 2011, SEACARB SEAWATER CAR; Le Moullac G, 2000, AQUACULTURE, V191, P121, DOI 10.1016/S0044-8486(00)00422-1; Leyval D, 1997, J MICROBIOL METH, V29, P121, DOI 10.1016/S0167-7012(97)00031-6; LINDINGER MI, 1984, MAR BIOL LETT, V5, P371; Liu GX, 2006, FISH SHELLFISH IMMUN, V20, P47, DOI 10.1016/j.fsi.2005.03.012; Long WC, 2013, MAR POLLUT BULL, V69, P38, DOI 10.1016/j.marpolbul.2013.01.011; Long WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060959; MACKAY WC, 1970, COMP BIOCHEM PHYSIOL, V34, P273, DOI 10.1016/0010-406X(70)90166-0; Mackenzie CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086764; MAJNO G, 1995, AM J PATHOL, V146, P3; Marie D, 1999, CURR PROTOCOLS CYTOM, V11, P1, DOI [DOI 10.1002/0471142956.CY1111S10, 10.1002/0471142956.cy1111s10, 10.1002/0471142956.cy1112s11]; Matozzo V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033820; Matozzo V, 2010, FISH SHELLFISH IMMUN, V28, P534, DOI 10.1016/j.fsi.2009.12.003; MCDONALD DG, 1979, J EXP BIOL, V79, P47; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Miccoli L, 1996, BIOCHEM J, V313, P957, DOI 10.1042/bj3130957; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Naraoka T, 2003, EUR J BIOCHEM, V270, P4026, DOI 10.1046/j.1432-1033.2003.03795.x; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pallet N, 2012, NEPHROL DIAL TRANSPL, V27, P483, DOI 10.1093/ndt/gfr611; Pan JZ, 2000, ANTIVIR RES, V48, P39, DOI 10.1016/S0166-3542(00)00117-0; Pane EF, 2007, MAR ECOL PROG SER, V334, P1, DOI 10.3354/meps334001; Perazzolo LM, 2002, AQUACULTURE, V214, P19, DOI 10.1016/S0044-8486(02)00137-0; Platt N, 1998, TRENDS CELL BIOL, V8, P365, DOI 10.1016/S0962-8924(98)01329-4; Portner HO, 1998, J EXP BIOL, V201, P43; Pressman B C, 1977, Adv Exp Med Biol, V84, P285; Qin Q, 2012, AQUAT TOXICOL, V106, P140, DOI 10.1016/j.aquatox.2011.08.013; RAFFIN JP, 1988, J COMP PHYSIOL B, V158, P223, DOI 10.1007/BF01075836; RATCLIFFE NA, 1985, INT REV CYTOL, V97, P183, DOI 10.1016/S0074-7696(08)62351-7; Raven J, 2005, 1205 ROYAL SOC, P68; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; ROER R, 1984, AM ZOOL, V24, P893; Romano N, 2006, AQUACULTURE, V260, P151, DOI 10.1016/j.aquaculture.2006.06.019; Sakamoto T., 2013, HOAJ BIOL, V2, P5, DOI DOI 10.7243/2050-0874-2-5; Sartoris FJ, 1997, J EXP BIOL, V200, P785; Schrunder S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077498; SIMPSON BK, 1987, J AGR FOOD CHEM, V35, P918, DOI 10.1021/jf00078a017; Small D, 2010, AQUAT BIOL, V10, P11, DOI 10.3354/ab00266; Smith VJ, 2010, ENCY LIFE SCI ELS, DOI [10.1002/9780470015902.a0002344.pub2, DOI 10.1002/9780470015902.A0002344.PUB2]; Smith VJ, 1983, BIOL RES, V233, P295; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; SODERHALL K, 1986, CELL TISSUE RES, V245, P43; Sokolova IM, 2012, MAR ENVIRON RES, V79, P1, DOI 10.1016/j.marenvres.2012.04.003; Spicer JI, 2007, MAR BIOL, V151, P1117, DOI 10.1007/s00227-006-0551-6; STAPLES DJ, 1991, J EXP MAR BIOL ECOL, V154, P251, DOI 10.1016/0022-0981(91)90168-V; Sugumaran Manickam, 1996, P355; Sung HH, 2003, AQUAT TOXICOL, V64, P25, DOI 10.1016/S0166-445X(03)00011-0; Tanner CA, 2006, COMP BIOCHEM PHYS A, V144, P218, DOI 10.1016/j.cbpa.2006.02.042; TAYLOR EW, 1989, J EXP BIOL, V144, P417; Terwilliger NB, 2006, BIOL BULL-US, V210, P38, DOI 10.2307/4134535; Tomanek L, 2011, J EXP BIOL, V214, P1836, DOI 10.1242/jeb.055475; Trump BF, 1996, MAR ENVIRON RES, V42, P57, DOI 10.1016/0141-1136(96)00074-8; TRUSCOTT R, 1990, FUNCT ECOL, V4, P455, DOI 10.2307/2389609; VACCA LL, 1975, COMP BIOCHEM PHYS B, V51, P475, DOI 10.1016/0305-0491(75)90042-5; VACCA LL, 1975, COMP BIOCHEM PHYS B, V51, P483, DOI 10.1016/0305-0491(75)90043-7; VACCA LL, 1983, BIOL BULL, V165, P758, DOI 10.2307/1541477; VargasAlbores F, 1997, COMP BIOCHEM PHYS B, V116, P453, DOI 10.1016/S0305-0491(96)00268-4; Vazquez L, 2009, INNATE IMMUN-LONDON, V15, P179, DOI 10.1177/1753425909102876; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; VICTOR B, 1990, J ENVIRON BIOL, V11, P61; Walther K, 2009, BIOGEOSCIENCES, V6, P2207, DOI 10.5194/bg-6-2207-2009; Watson SA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2377; WEEKS JM, 1993, MAR ECOL PROG SER, V97, P91, DOI 10.3354/meps097091; Weiner S, 2011, ANNU REV MATER RES, V41, P21, DOI 10.1146/annurev-matsci-062910-095803; WHEATLY MG, 1992, J EXP ZOOL, V263, P127, DOI 10.1002/jez.1402630204; WHEATLY MG, 1991, PHYSIOL ZOOL, V64, P323, DOI 10.1086/physzool.64.1.30158527; Whiteley NM, 2011, MAR ECOL PROG SER, V430, P257, DOI 10.3354/meps09185; Whiteley Nia M., 1999, Society for Experimental Biology Seminar Series, V68, P233; Whiteley NM, 2001, J EXP BIOL, V204, P1003; WHITELEY NM, 1992, J CRUSTACEAN BIOL, V12, P19, DOI 10.2307/1548715; WIEDER ED, 1993, CYTOMETRY, V14, P916, DOI 10.1002/cyto.990140810; Yeh SP, 2009, FISH SHELLFISH IMMUN, V26, P582, DOI 10.1016/j.fsi.2008.09.010; ZANGE J, 1990, J EXP BIOL, V150, P95; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	119	30	31	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148477	10.1371/journal.pone.0148477	http://dx.doi.org/10.1371/journal.pone.0148477			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859148	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400047
J	Sharples, SA; Gould, JA; Vandenberk, MS; Kalmar, JM				Sharples, Simon A.; Gould, Jason A.; Vandenberk, Michael S.; Kalmar, Jayne M.			Cortical Mechanisms of Central Fatigue and Sense of Effort	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR-EVOKED-POTENTIALS; HUMAN MUSCLE FATIGUE; INTERVAL INTRACORTICAL INHIBITION; MAXIMAL VOLUNTARY CONTRACTIONS; FRONTAL-LOBE INPUTS; INTERHEMISPHERIC INHIBITION; CHRONIC STROKE; CORTEX; EXCITABILITY	The purpose of this study was to investigate cortical mechanisms upstream to the corticospinal motor neuron that may be associated with central fatigue and sense of effort during and after a fatigue task. We used two different isometric finger abduction protocols to examine the effects of muscle activation and fatigue the right first dorsal interosseous (FDI) of 12 participants. One protocol was intended to assess the effects of muscle activation with minimal fatigue (control) and the other was intended to elicit central fatigue (fatigue). We hypothesized that high frequency repetitive transcranial magnetic stimulation (rTMS) of the supplementary motor area (SMA) would hasten recovery from central fatigue and offset a fatigue-induced increase in sense of effort by facilitating the primary motor cortex (M1). Constant force-sensation contractions were used to assess sense of effort associated with muscle contraction. Paired-pulse TMS was used to assess intracortical inhibition (ICI) and facilitation (ICF) in the active M1 and interhemispheric inhibitory (IHI) was assessed to determine if compensation occurs via the resting M1. These measures were made during and after the muscle contraction protocols. Corticospinal excitability progressively declined with fatigue in the active hemisphere. ICF increased at task failure and ICI was also reduced at task failure with no changes in IHI found. Although fatigue is associated with progressive reductions in corticospinal excitability, compensatory changes in inhibition and facilitation may act within, but not between hemispheres of the M1. rTMS of the SMA following fatigue enhanced recovery of maximal voluntary force and higher levels of ICF were associated with lower sense of effort following stimulation. rTMS of the SMA may have reduced the amount of upstream drive required to maintain motor output, thus contributing to a lower sense of effort and increased rate of recovery of maximal force.	[Sharples, Simon A.; Gould, Jason A.; Vandenberk, Michael S.; Kalmar, Jayne M.] Wilfrid Laurier Univ, Dept Kinesiol, Waterloo, ON N2L 3C5, Canada	Wilfrid Laurier University	Kalmar, JM (corresponding author), Wilfrid Laurier Univ, Dept Kinesiol, Waterloo, ON N2L 3C5, Canada.	jkalmar@wlu.ca	Sharples, Simon/E-1064-2019	Sharples, Simon/0000-0003-2316-1504	Natural Science and Engineering Research Council of Canada [386601]; Wilfrid Laurier University Short Term Research Grant; NSERC-IPS1 graduate studentship	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Wilfrid Laurier University Short Term Research Grant; NSERC-IPS1 graduate studentship	This work was supported by the Natural Science and Engineering Research Council of Canada, grant number 386601 (JK), Wilfrid Laurier University Short Term Research Grant (JK), and NSERC-IPS1 graduate studentship (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN GM, 1995, MUSCLE NERVE, V18, P593, DOI 10.1002/mus.880180605; Benwell NM, 2006, EXP BRAIN RES, V175, P575, DOI 10.1007/s00221-006-0573-9; Benwell NM, 2006, EXP BRAIN RES, V170, P191, DOI 10.1007/s00221-005-0195-7; BRASILNETO J, 1993, EXP BRAIN RES, V93, P181; Butler JE, 2003, J NEUROSCI, V23, P10224; Chen R, 1997, CAN J NEUROL SCI, V24, P284, DOI 10.1017/S0317167100032947; Debaere F, 2003, NEUROIMAGE, V19, P764, DOI 10.1016/S1053-8119(03)00148-4; Dum RP, 2005, J NEUROSCI, V25, P1375, DOI 10.1523/JNEUROSCI.3902-04.2005; Duque J, 2005, NEUROIMAGE, V28, P940, DOI 10.1016/j.neuroimage.2005.06.033; Duque J, 2007, J COGNITIVE NEUROSCI, V19, P204, DOI 10.1162/jocn.2007.19.2.204; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Gandevia S. C., 1996, HDB PHYSL 12, P128, DOI DOI 10.1002/CPHY.CP120104; GANDEVIA SC, 1982, BRAIN, V105, P151, DOI 10.1093/brain/105.1.151; Gandevia SC, 1996, J PHYSIOL-LONDON, V490, P529, DOI 10.1113/jphysiol.1996.sp021164; GHOSH S, 1987, J COMP NEUROL, V259, P424, DOI 10.1002/cne.902590309; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; Hamada M, 2008, MOVEMENT DISORD, V23, P1524, DOI 10.1002/mds.22168; Hortobagyi T, 2011, MED SCI SPORT EXER, V43, P1188, DOI 10.1249/MSS.0b013e31820a94b8; Jenkins IH, 2000, BRAIN, V123, P1216, DOI 10.1093/brain/123.6.1216; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; JONES LA, 1983, EUR J APPL PHYSIOL O, V51, P75, DOI 10.1007/BF00952540; Kalmar JM, 2006, EXP BRAIN RES, V173, P446, DOI 10.1007/s00221-006-0383-0; Kalmar JM, 2006, J APPL PHYSIOL, V100, P1757, DOI 10.1152/japplphysiol.01347.2005; Kalmar JM, 2004, J NEUROSCI METH, V138, P15, DOI 10.1016/j.jneumeth.2004.03.006; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Liepert J, 1996, MUSCLE NERVE, V19, P1429, DOI 10.1002/(SICI)1097-4598(199611)19:11<1429::AID-MUS7>3.0.CO;2-E; Maruyama A, 2006, CLIN NEUROPHYSIOL, V117, P864, DOI 10.1016/j.clinph.2005.12.019; Matsunaga K, 2005, J PHYSIOL-LONDON, V562, P295, DOI 10.1113/jphysiol.2004.070755; McNeil CJ, 2009, J PHYSIOL-LONDON, V587, P5601, DOI 10.1113/jphysiol.2009.180968; MUAKKASSA KF, 1979, BRAIN RES, V177, P176, DOI 10.1016/0006-8993(79)90928-4; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Plaskett CJ, 2001, J APPL PHYSIOL, V91, P1535, DOI 10.1152/jappl.2001.91.4.1535; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; ROUILLER EM, 1994, EXP BRAIN RES, V102, P227; Samii A, 1996, NEUROLOGY, V46, P1376, DOI 10.1212/WNL.46.5.1376; Sharples SA, 2012, J NEUROSCI METH, V210, P178, DOI 10.1016/j.jneumeth.2012.07.018; Shibuya K, 2011, PHYSIOL MEAS, V32, P1929, DOI 10.1088/0967-3334/32/12/004; Smith JL, 2007, J APPL PHYSIOL, V103, P560, DOI 10.1152/japplphysiol.00220.2007; STEENHUIS RE, 1990, J CLIN EXP NEUROPSYC, V12, P921, DOI 10.1080/01688639008401031; Takahashi K, 2009, CLIN NEUROPHYSIOL, V120, P198, DOI 10.1016/j.clinph.2008.10.003; Tanaka M, 2012, NEUROSCI BIOBEHAV R, V36, P727, DOI 10.1016/j.neubiorev.2011.10.004; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Taylor JL, 2006, CLIN EXP PHARMACOL P, V33, P400, DOI 10.1111/j.1440-1681.2006.04363.x; Taylor JL, 1999, EXP BRAIN RES, V127, P108, DOI 10.1007/s002210050779; Terao Y, 2007, J COGNITIVE NEUROSCI, V19, P1556, DOI 10.1162/jocn.2007.19.9.1556; van Duinen H, 2007, NEUROIMAGE, V35, P1438, DOI 10.1016/j.neuroimage.2007.02.008; Wang Y, 2001, NEUROSCI RES, V39, P39, DOI 10.1016/S0168-0102(00)00198-X; Werhahn KJ, 2003, ANN NEUROL, V54, P464, DOI 10.1002/ana.10686; Williams PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093284; ZANETTE G, 1995, EXP BRAIN RES, V107, P80	52	17	17	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0149026	10.1371/journal.pone.0149026	http://dx.doi.org/10.1371/journal.pone.0149026			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859391	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400121
J	Van Laeken, N; Taylor, O; Polis, I; Neyt, S; Kersemans, K; Dobbeleir, A; Saunders, J; Goethals, I; Peremans, K; De Vos, F				Van Laeken, Nick; Taylor, Olivia; Polis, Ingeborgh; Neyt, Sara; Kersemans, Ken; Dobbeleir, Andre; Saunders, Jimmy; Goethals, Ingeborg; Peremans, Kathelijne; De Vos, Filip			In Vivo Evaluation of Blood Based and Reference Tissue Based PET Quantifications of [C-11] DASB in the Canine Brain	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SEROTONIN TRANSPORTER; GRAPHICAL ANALYSIS; HIGH-QUALITY; BINDING; MODEL; C-11-DASB; RECEPTOR; OCCUPANCY; VOLUME	This first-in-dog study evaluates the use of the PET-radioligand [C-11] DASB to image the density and availability of the serotonin transporter (SERT) in the canine brain. Imaging the serotonergic system could improve diagnosis and therapy of multiple canine behavioural disorders. Furthermore, as many similarities are reported between several human neuropsychiatric conditions and naturally occurring canine behavioural disorders, making this tracer available for use in dogs also provide researchers an interesting non-primate animal model to investigate human disorders. Five adult beagles underwent a 90 minutes dynamic PET scan and arterial whole blood was sampled throughout the scan. For each ROI, the distribution volume (V-T), obtained via the one-and two-tissue compartment model (1-TC, 2-TC) and the Logan Plot, was calculated and the goodness-of-fit was evaluated by the Akaike Information Criterion (AIC). For the preferred compartmental model BPND values were estimated and compared with those derived by four reference tissue models: 4-parameter RTM, SRTM2, MRTM2 and the Logan reference tissue model. The 2-TC model indicated in 61% of the ROIs a better fit compared to the 1-TC model. The Logan plot produced almost identical VT values and can be used as an alternative. Compared with the 2-TC model, all investigated reference tissue models showed high correlations but small underestimations of the BPND-parameter. The highest correlation was achieved with the Logan reference tissue model (Y = 0.9266 x + 0.0257; R-2 = 0.9722). Therefore, this model can be put forward as a non-invasive standard model for future PET-experiments with [C-11] DASB in dogs.	[Van Laeken, Nick; Neyt, Sara; De Vos, Filip] Univ Ghent, Dept Radiopharm, B-9000 Ghent, Belgium; [Taylor, Olivia; Saunders, Jimmy; Peremans, Kathelijne] Univ Ghent, Dept Med Imaging & Small Anim Orthoped, B-9000 Ghent, Belgium; [Polis, Ingeborgh] Univ Ghent, Dept Med & Clin Biol Small Anim, B-9000 Ghent, Belgium; [Kersemans, Ken; Dobbeleir, Andre; Goethals, Ingeborg] Ghent Univ Hosp, Dept Radiol & Nucl Med, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University; Ghent University Hospital	Van Laeken, N (corresponding author), Univ Ghent, Dept Radiopharm, B-9000 Ghent, Belgium.	nick.vanlaeken@ugent.be						Adams SV, 2002, BIOPHYS J, V83, P3268, DOI 10.1016/S0006-3495(02)75328-9; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Belanger MJ, 2004, NUCL MED BIOL, V31, P1097, DOI 10.1016/j.nucmedbio.2004.09.002; Dua-Sharma S., 1970, CANINE BRAIN STEREOT; Frankle WG, 2006, J NUCL MED, V47, P815; Frankle WG, 2004, J NUCL MED, V45, P682; Ginovart N, 2001, J CEREBR BLOOD F MET, V21, P1342, DOI 10.1097/00004647-200111000-00010; Ginovart N, 2003, SYNAPSE, V47, P123, DOI 10.1002/syn.10155; Haeusler D, 2009, APPL RADIAT ISOTOPES, V67, P1654, DOI 10.1016/j.apradiso.2009.03.005; Hesse S, 2011, INT J NEUROPSYCHOPH, V14, P606, DOI 10.1017/S1461145710001604; Hoekzema E, 2011, EXP GERONTOL, V46, P1020, DOI 10.1016/j.exger.2011.09.007; Houle S, 2000, EUR J NUCL MED, V27, P1719, DOI 10.1007/s002590000365; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Hume SP, 1998, EUR J NUCL MED, V25, P173, DOI 10.1007/s002590050211; Huot P, 2011, PROG NEUROBIOL, V95, P163, DOI 10.1016/j.pneurobio.2011.08.004; Ichise M, 2003, J CEREBR BLOOD F MET, V23, P1096, DOI 10.1097/01.WCB.0000085441.37552.CA; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Jensen SB, 2003, SYNAPSE, V49, P170, DOI 10.1002/syn.10222; KEYES SR, 1982, J BIOL CHEM, V257, P1172; Kornum BR, 2009, J CEREBR BLOOD F MET, V29, P186, DOI 10.1038/jcbfm.2008.110; Lammertsma AA, 1996, J CEREBR BLOOD F MET, V16, P42, DOI 10.1097/00004647-199601000-00005; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lanzenberger R, 2012, NEUROIMAGE, V63, P874, DOI 10.1016/j.neuroimage.2012.07.023; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Lim R. K. S., 1960, STEREOTAXIC ATLAS DO; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Lundquist P, 2007, SYNAPSE, V61, P440, DOI 10.1002/syn.20382; Meyer JH, 2007, J PSYCHIATR NEUROSCI, V32, P86; Nelissen N, 2008, KINETIC MODELLING HU; Ouchi Y, 2009, J NUCL MED, V50, P1260, DOI 10.2967/jnumed.109.063008; Parsey RV, 2006, J NUCL MED, V47, P1796; Parsey RV, 2006, BIOL PSYCHIAT, V59, P821, DOI 10.1016/j.biopsych.2005.08.010; Peremans K, 2003, EUR J NUCL MED MOL I, V30, P1538, DOI 10.1007/s00259-003-1250-x; Rudnick G, 2006, J MEMBRANE BIOL, V213, P101, DOI 10.1007/s00232-006-0878-4; Schmidt KC, 2002, Q J NUCL MED, V46, P70; Selvaraj S, 2011, PSYCHOPHARMACOLOGY, V213, P555, DOI 10.1007/s00213-009-1660-y; Tang RQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r25; Van Laeken N, 2013, APPL RADIAT ISOTOPES, V78, P62, DOI 10.1016/j.apradiso.2013.04.009; Vermeire S, 2012, PSYCHIAT RES-NEUROIM, V201, P78, DOI 10.1016/j.pscychresns.2011.06.006; Vermeire S, 2009, BRAIN IMAGING BEHAV, V3, P342, DOI 10.1007/s11682-009-9076-1; Wilson AA, 2002, NUCL MED BIOL, V29, P509, DOI 10.1016/S0969-8051(02)00316-5; Wilson AA, 2000, J MED CHEM, V43, P3103, DOI 10.1021/jm000079i; Wu YJ, 2002, J CEREBR BLOOD F MET, V22, P1440, DOI 10.1097/01.WCB.0000033967.83623.34; Yokoyama C, 2010, SYNAPSE, V64, P594, DOI 10.1002/syn.20766	45	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148943	10.1371/journal.pone.0148943	http://dx.doi.org/10.1371/journal.pone.0148943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859850	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400108
J	Xie, YJ; Peng, L; Zuo, X; Li, M				Xie, Yuanjun; Peng, Li; Zuo, Xin; Li, Min			The Psychometric Evaluation of the Connor-Davidson Resilience Scale Using a Chinese Military Sample	PLOS ONE			English	Article							CD-RISC; PSYCHOLOGICAL-RESILIENCE; DIMENSIONALITY; INDIVIDUALS; INVARIANCE; STRESS; TRAUMA	This study examined the psychometric properties of the Connor-Davidson Resilience Scale (CD-RISC) with a Chinese military population with the aim of finding a suitable instrument to quantify resilience in Chinese military service members. The confirmatory factor analysis results did not support the factorial structure of the original or the Chinese community version of the CD-RISC, but the exploratory factor analysis results revealed a three-factor model (composed of Competency, Toughness, and Adaptability) that seemed to fit. Moreover, the repeat confirmatory factory analysis replicated the three-factor model. Additionally, the CD-RISC with a Chinese military sample exhibited appropriate psychometric properties, including internal consistency, test-retest reliability, and structural and concurrent validity. The revised CD-RISC with a Chinese military sample provides insight into the resilience measurement framework and could be a reliable and valid measurement for evaluating resilience in a Chinese military population.	[Xie, Yuanjun; Peng, Li; Zuo, Xin; Li, Min] Third Mil Med Univ, Dept Mil Psychol, Coll Psychol, Chongqing, Peoples R China	Army Medical University	Li, M (corresponding author), Third Mil Med Univ, Dept Mil Psychol, Coll Psychol, Chongqing, Peoples R China.	limin52267@tmmu.edu.cn		yuanjun, xie/0000-0002-9787-8244	National Natural Science Foundation of China [31170994]; Project of Military Research Foundation of PLA of China [CWS11J049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Military Research Foundation of PLA of China	This study was financially supported by National Natural Science Foundation of China granted to Min Li (No. 31170994) and Project of Military Research Foundation of PLA of China to Min Li (No. CWS11J049).	Agaibi CE, 2005, TRAUMA VIOLENCE ABUS, V6, P195, DOI 10.1177/1524838005277438; Gonzalez VBA, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0345-y; Bartone PT, 2006, MIL PSYCHOL, V18, pS131, DOI 10.1207/s15327876mp1803s_10; Bartone PT, 1998, MIL MED, V163, P587, DOI 10.1093/milmed/163.9.587; BEARDSLEE WR, 1989, AM J ORTHOPSYCHIAT, V59, P266, DOI 10.1111/j.1939-0025.1989.tb01659.x; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Burns RA, 2010, PERS INDIV DIFFER, V48, P527, DOI 10.1016/j.paid.2009.11.026; Casey GW, 2011, AM PSYCHOL, V66, P1, DOI 10.1037/a0021930; Castro C. A., 1999, PARAMETERS, V29, P86; Clauss-Ehlers CS, 2008, J APPL DEV PSYCHOL, V29, P197, DOI 10.1016/j.appdev.2008.02.004; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Consoli MLM, 2015, HISPANIC J BEHAV SCI, V37, P304, DOI 10.1177/0739986315589141; Fletcher D, 2013, EUR PSYCHOL, V18, P12, DOI 10.1027/1016-9040/a000124; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Freeman W. D., 2010, P4591 IDA; Friedli L., 2009, MENTAL HLTH; Gadermann A. M., 2012, PRACTICAL ASSESSMENT, V17, P3, DOI [10.7275/n560-j767, DOI 10.7275/N560-J767]; Green KT, 2014, ASSESSMENT, V21, P443, DOI 10.1177/1073191114524014; Greenberger E, 2003, PERS INDIV DIFFER, V35, P1241, DOI 10.1016/S0191-8869(02)00331-8; Gu Q, 2007, TEACH TEACH EDUC, V23, P1302, DOI 10.1016/j.tate.2006.06.006; Gucciardi DF, 2015, J PERS, V83, P26, DOI 10.1111/jopy.12079; Gucciardi DF, 2011, PSYCHOL SPORT EXERC, V12, P423, DOI 10.1016/j.psychsport.2011.02.005; Hanton S, 2005, J SPORT SCI, V23, P1129, DOI 10.1080/02640410500131480; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; HUBBARD R, 1987, J BUS RES, V15, P173, DOI 10.1016/0148-2963(84)90047-X; Jung YE, 2012, STRESS HEALTH, V28, P319, DOI 10.1002/smi.1436; Karairmak O, 2010, PSYCHIAT RES, V179, P350, DOI 10.1016/j.psychres.2009.09.012; Khoshouei MS, 2009, INT J TEST, V9, P60, DOI 10.1080/15305050902733471; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P1111, DOI 10.1001/jama.2009.342; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Lyons J, 1991, J TRAUMASTRESS, V1, P93; Marsh HW, 2004, STRUCT EQU MODELING, V11, P320, DOI 10.1207/s15328007sem1103_2; Matsunaga M, 2010, INT J PSYCHOL RES, V3, P97, DOI 10.21500/20112084.854; MuthUn L.K., 2012, MPLUS USERS GUIDE CO; Newman R, 2005, PROF PSYCHOL-RES PR, V36, P227, DOI 10.1037/0735-7028.36.3.227; Peng L, 2014, PERS INDIV DIFFER, V61-62, P47, DOI 10.1016/j.paid.2014.01.006; Qiu L., 2008, APPL PSYCHOL, P249, DOI 10.1093/molbev/msx285/4596561; Richardson GE, 2002, J CLIN PSYCHOL, V58, P307, DOI 10.1002/jclp.10020; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; RUTTER M, 1985, BRIT J PSYCHIAT, V147, P598, DOI 10.1192/bjp.147.6.598; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; Tian, 2006, PSYCHOL EXPLORE, V26, P88; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; Ungar M, 2008, RES HUM DEV, V5, P166, DOI 10.1080/15427600802274019; Wagnild G M, 1993, J Nurs Meas, V1, P165; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Yu C.Y., 2002, EVALUATING CUTOFF CR; Yu XN, 2007, SOC BEHAV PERSONAL, V35, P19, DOI 10.2224/sbp.2007.35.1.19; Zumbo BD, 2007, J MOD APPL STAT METH, V6, P21, DOI 10.22237/jmasm/1177992180	53	29	29	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148843	10.1371/journal.pone.0148843	http://dx.doi.org/10.1371/journal.pone.0148843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859484	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400095
J	Aldamiz-Echevarria, T; Berenguer, J; Miralles, P; Jimenez-Sousa, MA; Carrero, A; Pineda-Tenor, D; Diez, C; Tejerina, F; Perez-Latorre, L; Bellon, JM; Resino, S				Aldamiz-Echevarria, Teresa; Berenguer, Juan; Miralles, Pilar; Jimenez-Sousa, Maria A.; Carrero, Ana; Pineda-Tenor, Daniel; Diez, Cristina; Tejerina, Francisco; Perez-Latorre, Leire; Bellon, Jose M.; Resino, Salvador			Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of Outcome	PLOS ONE			English	Article							C VIRUS-INFECTION; HEPATITIS-C; LIVER; INFLAMMATION; CIRRHOSIS; DYSFUNCTION; STATEMENT; FIBROSIS; SERUM	Background Higher serum levels of adhesion molecules (sICAM-1 and sVCAM-1) are associated with advanced liver fibrosis in patients coinfected with human immunodeficiency virus and hepatitis C virus. We assessed the relationship between serum levels of adhesion molecules and liver-related events (LRE) or death, in coinfected patients. Methods We studied clinical characteristics and outcomes of 182 coinfected patients with a baseline liver biopsy (58 with advanced fibrosis) and simultaneous plasma samples who were followed for median of 9 years. We used receiver-operating characteristic (ROC) curves to calculate optimized cutoff values (OCV) of sICAM-1 and sVCAM-1, defined as the values with the highest combination of sensitivity and specificity for LRE. We used multivariate regression analysis to test the association between OCVs of sICAM-1 and sVCAM-1 and outcomes. The variables for adjustment were age, HIV transmission category, liver fibrosis, baseline CD4+ T-cell counts, antiretroviral therapy, and sustained virologic response (SVR). Results During the study period 51 patients had SVR, 19 had LRE, and 16 died. The OCVs for LRE were 5.68 Log pg/mL for sICAM-1 and 6.25 Log pg/mL for sVCAM-1, respectively. The adjusted subhazard ratio (aSHR) (95% confidence interval [CI]) of death or LRE, whichever occurred first, for sICAM-1 and sVCAM-1 > OCV were 3.98 ([1.14; 13.89], P = 0.030) and 2.81 ([1.10; 7.19], respectively (P = 0.030). Conclusions Serum levels of sICAM-1 and sVCAM-1 can serve as markers of outcome in HIV/HCV-coinfected patients. Therapies targeting necroinflammatory damage and fibrogenesis may have a role in the management chronic hepatitis C.	[Aldamiz-Echevarria, Teresa; Berenguer, Juan; Miralles, Pilar; Carrero, Ana; Diez, Cristina; Tejerina, Francisco; Perez-Latorre, Leire] Hosp Gen Univ Gregorio Maranon, Infect Dis & HIV Unit, Madrid, Spain; [Aldamiz-Echevarria, Teresa; Berenguer, Juan; Miralles, Pilar; Carrero, Ana; Diez, Cristina; Tejerina, Francisco; Perez-Latorre, Leire; Bellon, Jose M.] Inst Invest Sanitaria Gregorio Maranon IiSGM, Madrid, Spain; [Jimenez-Sousa, Maria A.; Pineda-Tenor, Daniel; Resino, Salvador] Inst Salud Carlos III, Natl Ctr Microbiol, Madrid, Spain	General University Gregorio Maranon Hospital; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Berenguer, J (corresponding author), Hosp Gen Univ Gregorio Maranon, Infect Dis & HIV Unit, Madrid, Spain.; Berenguer, J (corresponding author), Inst Invest Sanitaria Gregorio Maranon IiSGM, Madrid, Spain.	jbb4@me.com	Berenguer, Juan/A-1347-2009; Jiménez-Sousa, Maria A./I-8725-2012; Resino, Salvador/B-2430-2008; Bellon-Cano, José María/G-6120-2016; Cano, Jose Maria Bellon/G-3061-2012	Berenguer, Juan/0000-0001-8541-8200; Jiménez-Sousa, Maria A./0000-0002-1945-6169; Resino, Salvador/0000-0001-8783-0450; Bellon-Cano, José María/0000-0002-8492-1565; Cano, Jose Maria Bellon/0000-0002-8492-1565; Pineda-Tenor, Daniel/0000-0001-6343-5384; Perez-Latorre, Leire/0000-0001-9919-3778; Tejerina, Francisco/0000-0002-4136-3575	Fondo de Investigacion de Sanidad en Espana (FIS) (Spanish Health Funds for Research) [PI11/01556, PI14/01094, PI11/00245, PI14CIII/00011]; Plan Nacional R+D+I [RD12/0017/0004, RD12/0017/0024]; ISCIII Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); Programa de Intensificacion de la Actividad Investigadora en el Sistema Nacional de Salud (I3SNS) [INT10/009, INT12/154]; ISCIII [CM12/00043, CD13/00013]	Fondo de Investigacion de Sanidad en Espana (FIS) (Spanish Health Funds for Research); Plan Nacional R+D+I; ISCIII Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); Programa de Intensificacion de la Actividad Investigadora en el Sistema Nacional de Salud (I3SNS); ISCIII(Instituto de Salud Carlos III)	This work was supported by grants PI11/01556, PI14/01094, PI11/00245 and PI14CIII/00011 given by Fondo de Investigacion de Sanidad en Espana (FIS) (Spanish Health Funds for Research) and by grants RD12/0017/0004 and RD12/0017/0024 from Plan Nacional R+D+I and cofinanced by ISCIII Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER). JB is an investigator from the Programa de Intensificacion de la Actividad Investigadora en el Sistema Nacional de Salud (I3SNS; Refs INT10/009 and INT12/154). DPT and MAJS are supported by ISCIII grants CM12/00043 and CD13/00013, respectively.	Afford SC, 2014, HEPATOLOGY, V59, P1932, DOI 10.1002/hep.26965; Ala A, 2003, INT J EXP PATHOL, V84, P1, DOI 10.1046/j.1365-2613.2003.00235.x; Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Blankenberg S, 2001, CIRCULATION, V104, P1336, DOI 10.1161/hc3701.095949; Brown PMJ, 2001, CLIN BIOCHEM, V34, P167, DOI 10.1016/S0009-9120(01)00210-7; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Bruno CM, 2005, WORLD J GASTROENTERO, V11, P4566, DOI 10.3748/wjg.v11.i29.4566; Buck M, 2014, HEPATOLOGY, V59, P1052, DOI 10.1002/hep.26755; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; de Castro IF, 2010, AIDS, V24, P2059, DOI 10.1097/QAD.0b013e32833ce54d; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Giron-Gonzalez JA, 2005, SCAND J GASTROENTERO, V40, P217, DOI 10.1080/00365520510011470; Giron-Gonzalez JA, 2004, LIVER INT, V24, P437, DOI 10.1111/j.1478-3231.2004.0951.x; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; JACOBS WH, 1989, DIGEST DIS SCI, V34, P322, DOI 10.1007/BF01536249; Jalan R, 2014, J HEPATOL, V60, P1310, DOI 10.1016/j.jhep.2014.01.024; Kaplanski G, 1997, DIGEST DIS SCI, V42, P2277, DOI 10.1023/A:1018818801824; Lin WY, 2013, J INFECT DIS, V207, pS13, DOI 10.1093/infdis/jis926; Lo Iacono O, 2008, LIVER INT, V28, P1129, DOI 10.1111/j.1478-3231.2008.01763.x; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; Male D, 2014, IMMUNOLOGY ILLUSTRAT; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Panel de expertos de GeSIDA, 2014, Enferm Infecc Microbiol Clin, V32, DOI 10.1016/j.eimc.2014.02.019; PIGOTT R, 1992, BIOCHEM BIOPH RES CO, V187, P584, DOI 10.1016/0006-291X(92)91234-H; R Development Core Team, 2015, R PROJECT STAT COMPU; Serra A, 2008, J IMMUNOL, V181, P174, DOI 10.4049/jimmunol.181.1.174; Suliman ME, 2006, NEPHROL DIAL TRANSPL, V21, P1603, DOI 10.1093/ndt/gfl005; VOLPES R, 1990, HEPATOLOGY, V12, P59, DOI 10.1002/hep.1840120110; VOLPES R, 1992, HEPATOLOGY, V15, P269, DOI 10.1002/hep.1840150216	31	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148537	10.1371/journal.pone.0148537	http://dx.doi.org/10.1371/journal.pone.0148537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849641	Green Published, gold			2022-12-27	WOS:000369554000120
J	Kristianto, J; Litscher, SJ; Johnson, MG; Patel, F; Patel, M; Fisher, J; Zastrow, RK; Radcliff, AB; Blank, RD				Kristianto, Jasmin; Litscher, Suzanne J.; Johnson, Michael G.; Patel, Forum; Patel, Mital; Fisher, Jacqueline; Zastrow, Ryley K.; Radcliff, Abigail B.; Blank, Robert D.			Congenic Strains Confirm the Pleiotropic Effect of Chromosome 4 QTL on Mouse Femoral Geometry and Biomechanical Performance	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BONE-MINERAL DENSITY; CORTICAL BONE; SEX-DIFFERENCES; GENETIC COMPOSITION; CANDIDATE GENES; SKELETAL SIZE; BODY-SIZE; MICE; STRENGTH	A pleiotropic quantitative trait locus (QTL) for bone geometry and mechanical performance in mice was mapped to distal chromosome 4 via an intercross of recombinant congenic mice HcB-8 and HcB-23. To study the QTL in isolation, we have generated C3H. B10-(rs6355453-rs13478087) (C. B. 4.3) and C3H. B10-(rs6369860-D4Mit170) (C. B. 4.2) congenic strains that harbor similar to 20 Mb and similar to 3 Mb, respectively, of chromosome 4 overlapping segments from C57BL/10ScSnA (B10) within the locus on a C3H/DiSnA (C3H) background. Using 3-point bend testing and standard beam equations, we phenotyped these mice for femoral mid-diaphyseal geometry and biomechanical performance. We analyzed the results via 2-way ANOVA, using sex and genotype as factors. In the C. B. 4.3 strain, we found that homozygous B10/B10 male mice had smaller cross sectional area (CSA) and reduced total displacement than homozygous C3H/C3H mice. Sex by genotype interaction was also observed for maximum load and stiffness for C3H/C3H and B10/B10 mice, respectively. In C. B. 4.2 strain, we found that homozygous B10/B10 mice had lower total displacement, post-yield displacement (PYD), stiffness, yield load and maximum load than mice harboring C3H allele. Sex by genotype interaction was observed in B10/B10 mice for perimeter, outer minor axis (OMA) and CSA. There were no significant differences in tissue level mechanical performance, which suggest that the QTL acts primarily on circumferential bone size. These data confirm the prior QTL mapping data and support other work demonstrating the importance of chromosome 4 QTL on bone modeling and bone responses to mechanical loading.	[Kristianto, Jasmin; Litscher, Suzanne J.; Johnson, Michael G.; Patel, Forum; Patel, Mital; Fisher, Jacqueline; Zastrow, Ryley K.; Radcliff, Abigail B.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA; [Blank, Robert D.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Blank, Robert D.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Blank, Robert D.] Milwaukee VA Med Ctr, Milwaukee, WI USA	University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Kristianto, J (corresponding author), Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA.	jkristianto@medicine.wisc.edu	Blank, Robert D./V-5995-2019	Blank, Robert D./0000-0003-2950-1944; Patel, Mital/0000-0002-0389-9600	Office of Research and Development, Rehabilitation Research and Development Service [I21 RX1440]; Merit Review Award from the Office of Research and Development, Biomedical and Laboratory Research and Development Service, the Department of Veterans Affairs; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institute of Health [NIH AR54753]; NIH [AR54753]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054753] Funding Source: NIH RePORTER; Veterans Affairs [I21RX001440] Funding Source: NIH RePORTER	Office of Research and Development, Rehabilitation Research and Development Service; Merit Review Award from the Office of Research and Development, Biomedical and Laboratory Research and Development Service, the Department of Veterans Affairs; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institute of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	We would like to thank Marc Drezner and Baozhi Yuan for helpful discussions. This material is based on work supported in part by award I21 RX1440, by the Office of Research and Development, Rehabilitation Research and Development Service, and a Merit Review Award from the Office of Research and Development, Biomedical and Laboratory Research and Development Service, the Department of Veterans Affairs, and performed in the Geriatrics Research, Education, and Clinical Center at the William S. Middleton Memorial Veterans Hospital. The views expressed here are those of the authors, and the contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.; Research reported in this publication was supported in part by National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institute of Health under Award Number NIH AR54753. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health.; Funded by NIH AR54753. www.nih.gov. (Robert Blank). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert-Bicknell CL, 2010, J BONE MINER RES, V25, P1808, DOI 10.1002/jbmr.72; Agueda L, 2010, CALCIFIED TISSUE INT, V87, P14, DOI 10.1007/s00223-010-9361-4; Beamer WG, 2012, J BONE MINER RES, V27, P47, DOI 10.1002/jbmr.515; Beamer WG, 1996, BONE, V18, P397, DOI 10.1016/8756-3282(96)00047-6; BEAMER WG, 2001, J BONE MINER RES, V20, P1701, DOI DOI 10.1359/JBMR.2005.20.9.1700; Blank RD, 2003, CONNECT TISSUE RES, V44, P134, DOI 10.1080/03008200390223918; Callewaert F, 2010, J BONE MINER RES, V25, P617, DOI 10.1359/jbmr.090828; Clark EM, 2006, PEDIATRICS, V117, pE291, DOI 10.1542/peds.2005-1404; Delahunty KM, 2006, ENDOCRINOLOGY, V147, P3915, DOI 10.1210/en.2006-0277; DEMANT P, 1986, IMMUNOGENETICS, V24, P416, DOI 10.1007/BF00377961; Dennison E, 2006, RHEUM DIS CLIN N AM, V32, P617, DOI 10.1016/j.rdc.2006.08.003; Devoto M, 2005, EUR J HUM GENET, V13, P781, DOI 10.1038/sj.ejhg.5201411; Ermakov S, 2010, BONE, V46, P1244, DOI 10.1016/j.bone.2009.11.018; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Franco GEL, 2004, J CLIN DENSITOM, V7, P326; GROOT PC, 1992, FASEB J, V6, P2826, DOI 10.1096/fasebj.6.10.1634045; Huang QY, 2009, BONE, V44, P984, DOI 10.1016/j.bone.2009.01.368; Jepsen KJ, 2011, CLIN ORTHOP RELAT R, V469, P2150, DOI 10.1007/s11999-010-1706-9; Jones BH, 2002, EPIDEMIOL REV, V24, P228, DOI 10.1093/epirev/mxf011; Kammerer CM, 1995, J MED PRIMATOL, V24, P236, DOI 10.1111/j.1600-0684.1995.tb00176.x; Karasik D, 2004, BONE, V34, P547, DOI 10.1016/j.bone.2003.11.017; Katsumura T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.2259; KELLY PJ, 1990, J BONE MINER RES, V5, P1169; Kesavan C, 2006, BONE, V39, P634, DOI 10.1016/j.bone.2006.03.005; Koller DL, 2003, J BONE MINER RES, V18, P1758, DOI 10.1359/jbmr.2003.18.10.1758; Leppanen OV, 2008, J BIOMECH, V41, P1623, DOI 10.1016/j.jbiomech.2008.03.017; LINDAHL O, 1968, ACTA ORTHOP SCAND, V39, P129, DOI 10.3109/17453676808989447; Lipkin EW, 2001, BONE, V29, P249, DOI 10.1016/S8756-3282(01)00508-7; McCaffery JM, 2003, PSYCHOSOM MED, V65, P721, DOI 10.1097/01.PSY.0000088585.67365.1D; Nieves JW, 2005, J BONE MINER RES, V20, P529, DOI 10.1359/JBMR.041005; OYSTER N, 1992, AGE AGEING, V21, P353, DOI 10.1093/ageing/21.5.353; Riggs BL, 2004, J BONE MINER RES, V19, P1945, DOI 10.1359/JBMR.040916; Robling AG, 2002, FASEB J, V16, P324, DOI 10.1096/fj.02-0393fje; Robling AG, 2007, J BONE MINER RES, V22, P984, DOI 10.1359/JBMR.070327; Saless N, 2011, CELLS TISSUES ORGANS, V194, P244, DOI 10.1159/000324774; Saless N, 2011, BONE, V48, P647, DOI 10.1016/j.bone.2010.10.165; Saless N, 2010, BONE, V46, P1251, DOI 10.1016/j.bone.2010.01.375; Saless N, 2009, FASEB J, V23, P2142, DOI 10.1096/fj.08-118679; Seeman E, 2002, LANCET, V359, P1841, DOI 10.1016/S0140-6736(02)08706-8; Seeman E, 2001, J CLIN ENDOCR METAB, V86, P4576, DOI 10.1210/jc.86.10.4576; Shultz KL, 2003, J BONE MINER RES, V18, P175, DOI 10.1359/jbmr.2003.18.2.175; Smith LM, 2014, BONE, V67, P130, DOI 10.1016/j.bone.2014.06.035; Stassen APM, 1996, MAMM GENOME, V7, P55, DOI 10.1007/s003359900013; Streeten EA, 2006, J BONE MINER RES, V21, P1433, DOI 10.1359/JBMR.060602; Tommasini SM, 2005, J BONE MINER RES, V20, P817, DOI 10.1359/JBMR.041234; Tommasini SM, 2009, J BONE MINER RES, V24, P606, DOI [10.1359/jbmr.081224, 10.1359/JBMR.081224]; Turner CH, 2001, J BONE MINER RES, V16, P206, DOI 10.1359/jbmr.2001.16.2.206; Visscher PM, 1996, GENETICS, V144, P1923; Xiao P, 2006, J BONE MINER RES, V21, P1536, DOI 10.1359/JBMR.060717; Xiong DH, 2006, J BONE MINER RES, V21, P1678, DOI 10.1359/JBMR.060808; Yershov Y, 2001, J BONE MINER RES, V16, P992, DOI 10.1359/jbmr.2001.16.6.992; Zhang H, 2009, OSTEOPOROSIS INT, V20, P341, DOI 10.1007/s00198-008-0668-1	52	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148571	10.1371/journal.pone.0148571	http://dx.doi.org/10.1371/journal.pone.0148571			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849124	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000127
J	Liu, JF; Wang, DR; Xiong, Y; Liu, B; Hao, ZL; Tao, WD; Liu, M				Liu, Junfeng; Wang, Deren; Xiong, Yao; Liu, Bian; Hao, Zilong; Tao, Wendan; Liu, Ming			Association of Elevated High Sensitivity Cardiac Troponin T(hs-cTnT) Levels with Hemorrhagic Transformation and 3-Month Mortality in Acute Ischemic Stroke Patients with Rheumatic Heart Disease in China	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; T ELEVATION; FREQUENCY; DETERMINANTS; PROGNOSIS; ASSAY; RISK	Background and Objective Elevated levels of high sensitivity cardiac troponin T (hs-cTnT) occur in a substantial proportion of patients with acute ischemic stroke (AIS) and can predict poor outcome and mortality after stroke. Whether elevated hs-cTnT levels can also predict hemorrhagic transformation (HT) or prognosis in AIS patients with rheumatic heart disease (RHD) remains unclear. Methods Data from the Chengdu Stroke Registry on consecutive AIS patients with RHD admitted to West China Hospital within1 month of stroke onset from October 2011 to February 2014 were examined. Clinico-demographic characteristics, HT, functional outcomes and stroke recurrence were compared between patients with elevated hs-cTnT levels(>= 14ng/ L) and patients with normal hs-cTnT levels (<14ng/ L). Results The final analysis involved 84 patients (31 males; mean age, 61.6 +/- 12.2years), of whom serum hs-cTnT levels were elevated in 58.3%. Renal impairment was independently associated with elevated hs-cTnT levels (OR 4.184, 95% CI 1.17 to 15.01, P = 0.028), and patients with elevated hs-cTnT levels were at significantly higher risk of HT, 3-month mortality and 3-month disability/mortality (all P <= 0.029). After controlling for age, sex, hypertension, renal impairment and National Institutes of Health Stroke Scale score on admission, the risk of HT and 3-month mortality was, respectively, 4.0- and 5.5-fold higher in patients with elevated hs-cTnT levels than in patients with normal hs-cTnT levels. Conclusion Elevated hs-cTnT levels are independently associated with HT and 3-month mortality in AIS patients with RHD. These results with a small cohort should be verified and extended in large studies.	[Liu, Junfeng; Wang, Deren; Xiong, Yao; Liu, Bian; Hao, Zilong; Tao, Wendan; Liu, Ming] Sichuan Univ, West China Hosp, Dept Neurol, Stroke Clin Res Unit, Chengdu 610064, Peoples R China	Sichuan University	Liu, M (corresponding author), Sichuan Univ, West China Hosp, Dept Neurol, Stroke Clin Res Unit, Chengdu 610064, Peoples R China.	wyplmh@hotmail.com	Wang, Deren/GLU-7114-2022	Wang, Deren/0000-0002-2388-3585	National Natural Science Foundation of China [81371282, 81400964]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (81371282 and 81400964).	Agewall S, 2011, EUR HEART J, V32, P404, DOI 10.1093/eurheartj/ehq456; AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Amarenco P, 2011, STROKE, V42, P22, DOI 10.1161/STROKEAHA.110.584086; Ay H, 2002, STROKE, V33, P286, DOI 10.1161/hs0102.101544; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Chalela JA, 2004, NEUROCRIT CARE, V1, P343, DOI 10.1385/NCC:1:3:343; DEHAAN R, 1995, STROKE, V26, P2027, DOI 10.1161/01.STR.26.11.2027; Di Angelantonio E, 2005, J NEUROL NEUROSUR PS, V76, P76, DOI 10.1136/jnnp.2004.041491; Etgen T, 2005, STROKE, V36, P270, DOI 10.1161/01.STR.0000151364.19066.a1; Faiz KW, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-96; Faiz KW, 2014, J STROKE CEREBROVASC, V23, P241, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.005; Filion KB, 2015, AM HEART J, V169, P31, DOI 10.1016/j.ahj.2014.10.005; Frankenstein L, 2011, CLIN CHEM, V57, P1068, DOI 10.1373/clinchem.2010.158964; Fure B, 2006, J INTERN MED, V259, P592, DOI 10.1111/j.1365-2796.2006.01639.x; Iltumur K, 2006, AM HEART J, V151, P1115, DOI 10.1016/j.ahj.2005.05.022; Jacobs LH, 2009, ANN CLIN BIOCHEM, V46, P283, DOI 10.1258/acb.2009.008197; James P, 2000, BRIT MED J, V320, P1502, DOI 10.1136/bmj.320.7248.1502; Jensen JK, 2012, EUR NEUROL, V68, P287, DOI 10.1159/000341340; Jensen JK, 2007, AM J CARDIOL, V99, P867, DOI 10.1016/j.amjcard.2006.10.052; Jensen JK, 2007, AM J CARDIOL, V99, P108, DOI 10.1016/j.amjcard.2006.07.071; Kral M, 2013, AM J CARDIOL, V112, P117, DOI 10.1016/j.amjcard.2013.02.067; Lankeit M, 2010, EUR HEART J, V31, P1836, DOI 10.1093/eurheartj/ehq234; Lindley Richard I, 2004, J Stroke Cerebrovasc Dis, V13, P235, DOI 10.1016/j.jstrokecerebrovasdis.2004.03.003; Liu B, 2015, CURR NEUROVASC RES; Ozdemir O, 2011, PEDIATR CARDIOL, V32, P55, DOI 10.1007/s00246-010-9814-6; Scheitz JF, 2014, INT J CARDIOL, V177, P886, DOI 10.1016/j.ijcard.2014.10.036; Scheitz JF, 2012, INT J CARDIOL, V157, P239, DOI 10.1016/j.ijcard.2012.01.055; Tan S, 2014, J NEUROL, V261, P905, DOI 10.1007/s00415-014-7297-8; Wang DR, 2012, STROKE, V43, P2853, DOI 10.1161/STROKEAHA.112.670893; Wang DR, 2011, CLIN NEUROL NEUROSUR, V113, P442, DOI 10.1016/j.clineuro.2011.01.005; Wang ZM, 2006, INT J CARDIOL, V107, P356, DOI 10.1016/j.ijcard.2005.03.048; World Health Organization, INT STAT CLASS DIS R, V10th; Wu AHB, 2007, CLIN CHEM, V53, P2086, DOI 10.1373/clinchem.2007.095679; Yoshimura S, 2008, ANN NEUROL, V64, P547, DOI 10.1002/ana.21459	34	6	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148444	10.1371/journal.pone.0148444	http://dx.doi.org/10.1371/journal.pone.0148444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849554	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000095
J	Bi, DX; Xie, YZ; Tai, C; Jiang, XF; Zhang, J; Harrison, EM; Jia, SR; Deng, ZX; Rajakumar, K; Ou, HY				Bi, Dexi; Xie, Yingzhou; Tai, Cui; Jiang, Xiaofei; Zhang, Jie; Harrison, Ewan M.; Jia, Shiru; Deng, Zixin; Rajakumar, Kumar; Ou, Hong-Yu			A Site-Specific Integrative Plasmid Found in Pseudomonas aeruginosa Clinical Isolate HS87 along with A Plasmid Carrying an Aminoglycoside-Resistant Gene	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; METALLO-BETA-LACTAMASE; NUCLEOTIDE-SEQUENCE; IDENTIFICATION; VIRULENCE; INTEGRONS; BACTERIA; ISLANDS	Plasmids play critical roles in bacterial fitness and evolution of Pseudomonas aeruginosa. Here two plasmids found in a drug-resistant P. aeruginosa clinical isolate HS87 were completely sequenced. The pHS87b plasmid (11.2 kb) carries phage-related genes and function-unknown genes. Notably, pHS87b encodes an integrase and has an adjacent tRNA(Thr)-associated attachment site. A corresponding integrated form of pHS87b at the tRNA(Thr) locus was identified on the chromosome of P. aeruginosa, showing that pHS87b is able to site-specifically integrate into the 3'-end of the tRNA(Thr) gene. The pHS87a plasmid (26.8 kb) displays a plastic structure containing a putative replication module, stability factors and a variable region. The RepA of pHS87a shows significant similarity to the replication proteins of pPT23A-family plasmids. pHS87a carries a transposon Tn6049, a truncated insertion sequence Delta IS1071 and a Tn402-like class 1 integron which contains an aacA4 cassette that may confer aminoglycoside resistance. Thus, pHS87b is a site-specific integrative plasmid whereas pHS87a is a plastic antibiotic resistance plasmid. The two native plasmids may promote the fitness and evolution of P. aeruginosa.	[Bi, Dexi; Xie, Yingzhou; Tai, Cui; Deng, Zixin; Ou, Hong-Yu] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Bi, Dexi; Xie, Yingzhou; Tai, Cui; Deng, Zixin; Ou, Hong-Yu] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Jiang, Xiaofei] Fudan Univ, Dept Lab Med, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhang, Jie; Jia, Shiru] Tianjin Univ Sci & Technol, Key Lab Ind Microbiol, Minist Educ, Tianjin, Peoples R China; [Harrison, Ewan M.; Rajakumar, Kumar] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University; Tianjin University Science & Technology; University of Leicester	Ou, HY (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.; Ou, HY (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	hyou@sjtu.edu.cn	jia, shi/HHS-4172-2022; Harrison, Ewan/I-5003-2013	Harrison, Ewan/0000-0003-2720-0507; Bi, Dexi/0000-0001-9325-8868	973 program, Ministry of Science and Technology, China [2015CB554202]; National Natural Science Foundation of China [31170082]; Specialized Research Fund for the Doctoral Program of Higher Education, China [20130073110062]; Sino-UK Higher Education Research Partnership	973 program, Ministry of Science and Technology, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education, China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Sino-UK Higher Education Research Partnership	The 973 program, Ministry of Science and Technology, China (2015CB554202); National Natural Science Foundation of China (31170082); Specialized Research Fund for the Doctoral Program of Higher Education, China (20130073110062); Sino-UK Higher Education Research Partnership for PhD Studies grant (to HYO and KR).	Borodovsky Mark, 2003, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0405s01; Boyd EF, 2009, TRENDS MICROBIOL, V17, P47, DOI 10.1016/j.tim.2008.11.003; CAMPBELL AM, 1992, J BACTERIOL, V174, P7495, DOI 10.1128/JB.174.23.7495-7499.1992; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Di Pilato V, 2014, J ANTIMICROB CHEMOTH, V69, P67, DOI 10.1093/jac/dkt311; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ENGLISH RS, 1995, PLASMID, V33, P1, DOI 10.1006/plas.1995.1001; Fouts DE, 2006, NUCLEIC ACIDS RES, V34, P5839, DOI 10.1093/nar/gkl732; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Gillings MR, 2014, MICROBIOL MOL BIOL R, V78, P257, DOI 10.1128/MMBR.00056-13; Haines AS, 2007, PLASMID, V58, P76, DOI 10.1016/j.plasmid.2007.01.001; Haines AS, 2005, J BACTERIOL, V187, P4728, DOI 10.1128/JB.187.14.4728-4738.2005; Harrison EM, 2010, INFECT IMMUN, V78, P1437, DOI 10.1128/IAI.00621-09; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jovcic B, 2013, ANTIMICROB AGENTS CH, V57, P3405, DOI 10.1128/AAC.02312-12; Klockgether J, 2004, J BACTERIOL, V186, P518, DOI 10.1128/JB.186.2.518-534.2004; Kobayashi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070557; KORFHAGEN TR, 1976, ANTIMICROB AGENTS CH, V9, P810, DOI 10.1128/AAC.9.5.810; Li HY, 2008, ANTIMICROB AGENTS CH, V52, P3099, DOI 10.1128/AAC.01093-07; Naas T, 2013, J ANTIMICROB CHEMOTH, V68, P1757, DOI 10.1093/jac/dkt094; Odumosu BT, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-29; Ou HY, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj005; PANSEGRAU W, 1994, J MOL BIOL, V239, P623, DOI 10.1006/jmbi.1994.1404; Ramirez-Diaz MI, 2011, PLASMID, V66, P7, DOI 10.1016/j.plasmid.2011.03.002; RATHER PN, 1992, J BACTERIOL, V174, P3196, DOI 10.1128/jb.174.10.3196-3203.1992; Ricker N, 2012, GENOMICS, V100, P167, DOI 10.1016/j.ygeno.2012.06.009; Roy PH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008842; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Strateva T, 2009, J MED MICROBIOL, V58, P1133, DOI 10.1099/jmm.0.009142-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Xiong JH, 2013, ANTIMICROB AGENTS CH, V57, P3775, DOI 10.1128/AAC.00423-13; Yeldho D, 2011, B ENVIRON CONTAM TOX, V86, P110, DOI 10.1007/s00128-010-0162-2; Zhao YF, 2005, J BACTERIOL, V187, P2113, DOI 10.1128/JB.187.6.2113-2126.2005	35	3	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148367	10.1371/journal.pone.0148367	http://dx.doi.org/10.1371/journal.pone.0148367			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841043	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200128
J	Cheng, YH; Jiang, Y; Wu, Y; Valentine, TA; Li, HX				Cheng, Yanhong; Jiang, Ying; Wu, Yue; Valentine, Tracy A.; Li, Huixin			Soil Nitrogen Status Modifies Rice Root Response to Nematode-Bacteria Interactions in the Rhizosphere	PLOS ONE			English	Article							FEEDING NEMATODES; PLANT-GROWTH; MICROBIAL COMMUNITIES; SYSTEM ARCHITECTURE; ARABIDOPSIS; AVAILABILITY; BIODIVERSITY; PROTOZOA; NITRATE; GENE	It has been hypothesized that faunal activity in the rhizosphere influences root growth via an auxin-dependent pathway. In this study, two methods were used to adjust nematode and bacterial populations within experimental soils. One is "exclusion", where soil mixed with pig manure was placed in two bags with different mesh sizes (1mm and 5 mu m-diameter), and then surrounded by an outer layer of unamended soil resulting in soil with a greater populations of bacterial-feeding nematodes (1mm) and a control treatment (5 mu m). The second method is "inoculation", whereby autoclaved soil was inoculated with bacteria (E. coli and Pseudomonas) and Nematodes (Cephalobus and C. elegans). In order to detect the changes in the rice's perception of auxin under different nutrient and auxin conditions in the presence of soil bacterial-feeding nematodes, responses of soil chemistry (NH4+, NO3- and indole acetic acid (IAA)), rice root growth and the expression of an auxin responsive gene GH3-2 were measured. Results showed that, under low soil nutrient conditions (exclusion), low NO3- correlated with increased root branching and IAA correlated with increased root elongation and GH3-2 expression. However, under high soil nutrient conditions (inoculation), a high NH4+ to NO3- ratio promoted an increase in root surface area and there was an additional influence of NH4+ and NO3- on GH3-2 expression. Thus it was concluded that soil bacterial-feeding nematodes influenced soil nutritional status and soil IAA content, promoting root growth via an auxin dependent pathway that was offset by soil nitrogen status.	[Cheng, Yanhong; Li, Huixin] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China; [Cheng, Yanhong] Jiang Xi Inst Red Soil, Nanchang 330000, Peoples R China; [Jiang, Ying] Henan Agr Univ, Coll Resources & Environm, Zhengzhou 450000, Peoples R China; [Wu, Yue] Soil & Fertilizer Bur Shandong Prov, Jinan 250100, Peoples R China; [Valentine, Tracy A.] James Hutton Inst, Ecol Sci, Dundee DD2 5DA, Scotland	Nanjing Agricultural University; Henan Agricultural University; James Hutton Institute	Li, HX (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China.; Valentine, TA (corresponding author), James Hutton Inst, Ecol Sci, Dundee DD2 5DA, Scotland.	tracy.valentine@hutton.ac.uk; huixinli@njau.edu.cn	Valentine, Tracy A/C-2666-2009; Li, huixin/H-5573-2011	Valentine, Tracy A/0000-0002-9064-2896; 	National Science Foundation of China [41401274, 30970537, 41301235]; Royal Society, London, UK; Scottish Government	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Royal Society, London, UK(Royal Society of London); Scottish Government	This work was supported by the National Science Foundation of China (grants 41401274, 30970537, and 41301235). The project was assisted by funding from The Royal Society, London, UK, under an International Joint Project grant. The James Hutton Institute (formerly Scottish Crop Research Institute and The Macaulay Land Use Research Institute) is financially supported by the Scottish Government. The funders all had part in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; [Anonymous], 1986, LAB METHODS WORK PLA; Blanc C, 2006, EUR J SOIL BIOL, V42, pS70, DOI 10.1016/j.ejsobi.2006.06.003; Bonkowski M, 2002, SOIL BIOL BIOCHEM, V34, P1709, DOI 10.1016/S0038-0717(02)00157-8; Bonkowski M, 2004, NEW PHYTOL, V162, P617, DOI 10.1111/j.1469-8137.2004.01066.x; BRENNER S, 1974, GENETICS, V77, P71; Cadet P, 2004, APPL SOIL ECOL, V25, P193, DOI 10.1016/j.apsoil.2003.10.001; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Cheng YH, 2011, NEMATOLOGY, V13, P369, DOI 10.1163/138855410X528253; Coleman DC, 2014, HOLISTIC APPROACH SO, P211; Djigal D, 2004, SOIL BIOL BIOCHEM, V36, P323, DOI 10.1016/j.soilbio.2003.10.007; Edwards C, 2000, SOIL INVERTEBRATE CO; Ferris H, 1997, SOIL BIOL BIOCHEM, V29, P1183, DOI 10.1016/S0038-0717(97)00035-7; FRANKENBERGER WT, 1983, SOIL SCI SOC AM J, V47, P237, DOI 10.2136/sssaj1983.03615995004700020012x; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; Goodfriend WL, 2000, PLANT SOIL, V223, P23, DOI 10.1023/A:1004756832367; Gray WM, 2004, PLOS BIOL, V2, P1270, DOI 10.1371/journal.pbio.0020311; Griffiths BS, 2001, SOIL BIOL BIOCHEM, V33, P1713, DOI 10.1016/S0038-0717(01)00094-3; Griffiths BS, 2002, NEMATOLOGY, V4, P943, DOI 10.1163/156854102321122566; HERDER GD, 2010, TRENDS PLANT SCI, V0015, P00600, DOI DOI 10.1016/J.TPLANTS.2010.08.009; INGHAM RE, 1985, ECOL MONOGR, V55, P119, DOI 10.2307/1942528; Irshad U, 2011, SOIL BIOL BIOCHEM, V43, P2121, DOI 10.1016/j.soilbio.2011.06.015; Jiang Y, 2012, EUR J SOIL BIOL, V52, P20, DOI 10.1016/j.ejsobi.2012.05.003; Lakzian A, 2007, CASPIAN J ENV SCI, V5, P87; Lambrecht M, 2000, TRENDS MICROBIOL, V8, P298, DOI 10.1016/S0966-842X(00)01732-7; Li Q, 2010, PLANT CELL ENVIRON, V33, P1529, DOI 10.1111/j.1365-3040.2010.02162.x; Linkohr BI, 2002, PLANT J, V29, P751, DOI 10.1046/j.1365-313X.2002.01251.x; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Mao XF, 2007, SOIL BIOL BIOCHEM, V39, P1816, DOI 10.1016/j.soilbio.2007.01.027; Mao XF, 2006, SOIL BIOL BIOCHEM, V38, P1615, DOI 10.1016/j.soilbio.2005.12.002; Phillips DA, 2003, ECOLOGY, V84, P816, DOI 10.1890/0012-9658(2003)084[0816:MCPIRF]2.0.CO;2; Picard C, 2003, FEMS MICROBIOL ECOL, V46, P73, DOI 10.1016/S0168-6496(03)00206-X; Ronn R, 2002, APPL ENVIRON MICROB, V68, P6094, DOI 10.1128/AEM.68.12.6094-6105.2002; Takase T, 2004, PLANT J, V37, P471, DOI 10.1046/j.1365-313X.2003.01973.x; Terol J, 2006, GENE, V371, P279, DOI 10.1016/j.gene.2005.12.014; Tu C, 2003, MICROB ECOL, V46, P134, DOI 10.1007/s00248-002-1068-2; Zhang HM, 2000, J EXP BOT, V51, P51, DOI 10.1093/jexbot/51.342.51; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407	38	6	6	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148021	10.1371/journal.pone.0148021	http://dx.doi.org/10.1371/journal.pone.0148021			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841062	gold, Green Submitted, Green Published			2022-12-27	WOS:000369550200077
J	Chalub, LLFH; Martins, CC; Ferreira, RC; Vargas, AMD				Chalub, Loliza L. F. H.; Martins, Carolina C.; Ferreira, Raquel C.; Vargas, Andrea M. D.			Functional Dentition in Brazilian Adults: An Investigation of Social Determinants of Health (SDH) Using a Multilevel Approach	PLOS ONE			English	Article							CHEWING ABILITY; DENTAL-CARIES; POPULATION; ASSOCIATION; INEQUALITIES	Objectives Estimate the prevalence of functional dentition among Brazilian adults using four different definitions and identify associated factors. Methods A cross-sectional study was conducted involving 9564 Brazilian adults aged 35-44 years who participated in the 2010 National Oral Health Survey. Data collection involved oral examinations and the administration of questionnaires. The following definitions were used: 1-WHO Functional Dentition (FDWHO: >= 20 teeth present); 2-well-distributed teeth (WDT: >= 10 teeth in each arch); 3-Functional dentition classified by esthetics and occlusion (FDClass5: dentitions that sequentially exhibit at least one tooth in each arch, at least 10 teeth in each arch, all maxillary and mandibular anterior teeth, three or four premolar posterior occluding pairs [POPs], and at least one molar POP bilaterally); 4-Functional dentition classified by esthetics, occlusion and periodontal status (FDClass6: corresponds to FDClass5 with the addition of periodontal status of all sextants in the oral cavity with, at most, shallow pockets and/or clinical attachment level of 5 mm (CPI <= 3 and/or CAL <= 1). The independent variables were individual factors (gender, self-declared skin color, schooling, monthly household income, age group, self-rated treatment need, dental pain, dental appointment in the previous 12 months and dental services) and contextual factors (Municipal Human Development Index [MHDI]), Gini coefficient, fluoridated water supply and oral health coverage). Multilevel mixed-effect Poisson regression analyses were performed. Results The prevalence of functional dentition based on the FDWHO, WDT, FDClass5 and FDClass6 definitions was 77.9%, 72.9%, 42.6% and 40.3%, respectively. Adults with >= 12 years of schooling and monthly household income from US$ 853 to 2557 had higher prevalence rates of FDWHO (PR: 1.41 and 1.10, respectively), WDT (PR: 1.58 and 1.14, respectively), FDClass5 (PR: 2.03 and 1.27, respectively) and FDClass6 (PR: 2.15 and 1.35, respectively). These values in the final models were adjusted for gender, self-declared skin color (FDClass5), age group, self-rated treatment need (FDWHO, FDClass5 and FDClass6), dental appointment in the previous 12 months (FDWHO and WDT), dental services (FDWHO and WDT) and contextual factors. A very high MHDI and presence of fluoridated water supply were associated with higher prevalence rates of the four outcomes. Conclusions The incorporation of the criteria of new definitions of functional dentition led to a lower prevalence rate among Brazilian adults. Striking individual and contextual inequalities were identified with regard to the four definitions analyzed, which need to be addressed through inter-sector efforts.	[Chalub, Loliza L. F. H.; Ferreira, Raquel C.; Vargas, Andrea M. D.] Univ Fed Minas Gerais, Sch Dent, Dept Community & Prevent Dent, Belo Horizonte, MG, Brazil; [Martins, Carolina C.] Univ Fed Minas Gerais, Sch Dent, Dept Pediat Dent & Orthodont, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Chalub, LLFH (corresponding author), Univ Fed Minas Gerais, Sch Dent, Dept Community & Prevent Dent, Belo Horizonte, MG, Brazil.	lolischalub@gmail.com	Martins, Carolina/AFD-8433-2022; Martins, Carolina Castro/O-2514-2014; Ferreira, Raquel Conceição/J-5236-2015	Martins, Carolina/0000-0001-9072-3226; Martins, Carolina Castro/0000-0001-9072-3226; Ferreira, Raquel Conceição/0000-0001-8897-9345; VARGAS, ANDREA/0000-0002-4371-9862	FAPEMIG; CNPq	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to thank the Brazilian fostering agencies FAPEMIG and CNPq for funding the publication fee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, CONCEPTUAL FRAMEWORK; Bernabe E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104808; Celeste RK, 2014, CAD SAUDE PUBLICA, V30, P511, DOI 10.1590/0102-311X00011913; Celeste RK, 2013, COMMUNITY DENT ORAL, V41, P509, DOI 10.1111/cdoe.12051; Chalub LLFH, 2016, CLIN ORAL INVEST, V20, P1567, DOI 10.1007/s00784-015-1637-7; da Silva NN, 2013, REV SAUDE PUBL, V47, P3, DOI 10.1590/S0034-8910.2013047004362; Damyanov ND, 2013, CLIN ORAL INVEST, V17, P2139, DOI 10.1007/s00784-013-0925-3; [Departamento de Atencao Basica Ministery of Health (BR) Secretaria de Atencao a Saude], 2004, PROJ SB BRAS 2003 CO; do Nascimento S, 2013, REV SAUDE PUBL, V47, P69, DOI 10.1590/S0034-8910.2013047004288; Chalub LLFH, 2014, COMMUNITY DENT ORAL, V42, P503, DOI 10.1111/cdoe.12112; Hobdell M, 2003, INT DENT J, V53, P285, DOI 10.1111/j.1875-595X.2003.tb00761.x; IBGE, 2008, PESQ NAC SAN BAS; [International Association for Dental Research World Health Organization], 1993, 4 WORLD C PREV DENT; Koltermann AP, 2011, CAD SAUDE PUBLICA, V27, P173, DOI 10.1590/S0102-311X2011000100018; Freire MDM, 2013, REV SAUDE PUBL, V47, P40, DOI 10.1590/S0034-8910.2013047004322; Ministery of Health (BR), IND DES SIST UN SAUD; Ministery of Health (BR), 2004, DIR POL NAC SAUD BUC; Ministery of Health (BR) Secretaria de Vigilancia em Saude, 2011, SB BRAS 2010 PESQ NA; Nguyen TC, 2011, INT J PROSTHODONT, V24, P428; Nguyen TC, 2011, INT J PROSTHODONT, V24, P30; Nguyen TC, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-2; Okada T, 2014, J ORAL REHABIL, V41, P912, DOI 10.1111/joor.12214; Peres MA, 2013, REV SAUDE PUBLICA S3, V47, P1; Petersen PE, 2004, COMMUNITY DENT ORAL, V32, P319, DOI 10.1111/j.1600-0528.2004.00175.x; Programa das Nacoes Unidas para o Desenvolvimento, 2013, IND DES HUM MUN BRAS; Roncalli AG, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1097; Roncalli AG, 2012, CAD SAUDE PUBLICA, V28, pS40, DOI 10.1590/S0102-311X2012001300006; Sabbah W, 2007, J DENT RES, V86, P992, DOI 10.1177/154405910708601014; UNDP, 2011, HUM DEV REP 2011 SUS; United Nations Development Programme, 2013, BRAZ ATL HUM DEV; Vettore MV, 2013, REV SAUDE PUBL, V47, P29, DOI 10.1590/S0034-8910.2013047004422; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Watt RG, 2012, COMMUNITY DENT ORAL, V40, P289, DOI 10.1111/j.1600-0528.2012.00680.x; WHO, 2011, P WORLD C SOC DET HL; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th; World Health Organization (WHO), 1992, REC ADV OR HLTH WHO; Zhang Q, 2013, CLIN ORAL INVEST, V17, P1471, DOI 10.1007/s00784-012-0834-x; Zhang Q, 2013, CLIN ORAL INVEST, V17, P1425, DOI 10.1007/s00784-012-0822-1; Zhang Q, 2012, CLIN ORAL INVEST, V16, P1251, DOI 10.1007/s00784-011-0616-x	39	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148859	10.1371/journal.pone.0148859	http://dx.doi.org/10.1371/journal.pone.0148859			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862892	Green Published, gold			2022-12-27	WOS:000370046600116
J	Hoshi, T; Fuji, Y; Nzou, SM; Tanigawa, C; Kiche, I; Mwau, M; Mwangi, AW; Karama, M; Hirayama, K; Goto, K; Kaneko, S				Hoshi, Tomonori; Fuji, Yoshito; Nzou, Samson Muuo; Tanigawa, Chihiro; Kiche, Ibrahim; Mwau, Matilu; Mwangi, Anne Wanjiru; Karama, Mohamed; Hirayama, Kenji; Goto, Kensuke; Kaneko, Satoshi			Spatial Distributions of HIV Infection in an Endemic Area of Western Kenya: Guiding Information for Localized HIV Control and Prevention	PLOS ONE			English	Article							LAKE VICTORIA; FISHING COMMUNITIES; TRANSACTIONAL SEX; FEMALE MIGRANTS; RISK BEHAVIORS; TAXI DRIVERS; YOUNG MEN; PREVALENCE; WOMEN; HIV/AIDS	HIV is still a major health problem in developing countries. Even though high HIV-risk-taking behaviors have been reported in African fishing villages, local distribution patterns of HIV infection in the communities surrounding these villages have not been thoroughly analyzed. The objective of this study was to investigate the geographical distribution patterns of HIV infection in communities surrounding African fishing villages. In 2011, we applied age-and sex-stratified random sampling to collect 1,957 blood samples from 42,617 individuals registered in the Health and Demographic Surveillance System in Mbita, which is located on the shore of Lake Victoria in western Kenya. We used these samples to evaluate existing antibody detection assays for several infectious diseases, including HIV antibody titers. Based on the results of the assays, we evaluated the prevalence of HIV infection according to sex, age, and altitude of participating households. We also used Kulldorff's spatial scan statistic to test for HIV clustering in the study area. The prevalence of HIV at our study site was 25.3%. Compared with the younger age group (15-19 years), adults aged 30-34 years were 6.71 times more likely to be HIV-positive, and the estimated HIV-positive population among women was 1.43 times larger than among men. Kulldorff's spatial scan statistic detected one marginally significant (P = 0.055) HIV-positive and one significant HIV-negative cluster (P = 0.047) in the study area. These results suggest a homogeneous HIV distribution in the communities surrounding fishing villages. In addition to individual behavior, more complex and diverse factors related to the social and cultural environment can contribute to a homogeneous distribution pattern of HIV infection outside of African fishing villages. To reduce rates of transmission in HIV-endemic areas, HIV prevention and control programs optimized for the local environment need to be developed.	[Hoshi, Tomonori; Hirayama, Kenji] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Hoshi, Tomonori; Fuji, Yoshito; Tanigawa, Chihiro; Kaneko, Satoshi] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Ecoepidemiol, Nagasaki 852, Japan; [Nzou, Samson Muuo; Mwau, Matilu; Karama, Mohamed] Nagasaki Univ Inst Trop Med Kenya Med Res Inst NU, Nairobi, Kenya; [Nzou, Samson Muuo; Mwau, Matilu] Kenya Med Res Inst KEMRI, Ctr Infect & Parasit Dis Control Res, Busia, Kenya; [Kiche, Ibrahim] Int Ctr Insect Physiol & Ecol, Thomas Odhiambo Campus, Mbita, Kenya; [Mwangi, Anne Wanjiru] Kenya Med Res Inst KEMRI, Prod Dept, Nairobi, Kenya; [Karama, Mohamed] Kenya Med Res Inst KEMRI, Ctr Publ Hlth Res, Nairobi, Kenya; [Hirayama, Kenji] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Immunogenet, Nagasaki, Japan; [Goto, Kensuke] Osaka Kyoiku Univ, Natl Mental Support Ctr Sch Children Crisis, Osaka 543, Japan; [Kaneko, Satoshi] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki 852, Japan	Nagasaki University; Nagasaki University; Kenya Medical Research Institute; Kenya Medical Research Institute; International Centre of Insect Physiology & Ecology (ICIPE); Kenya Medical Research Institute; Kenya Medical Research Institute; Nagasaki University; Osaka University of Education; Nagasaki University	Kaneko, S (corresponding author), Nagasaki Univ, Inst Trop Med NEKKEN, Dept Ecoepidemiol, Nagasaki 852, Japan.; Kaneko, S (corresponding author), Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki 852, Japan.	skaneko@nagasaki-u.ac.jp	Hirayama, Kenji/AAN-7065-2021; Nzou, Samson/V-5649-2019	Nzou, Samson/0000-0002-5789-4434; Kaneko, Satoshi/0000-0001-9464-0911; Hoshi, Tomonori/0000-0003-4569-4600	Asia-Africa Science & Technology Strategic Cooperation Promotion Program of Special Coordination Funds for Promoting Science and Technology (SCF); Program for the Strategic Promotion of International Cooperation to Accelerate Innovation in Developing Countries; Funds for Integrated Promotion of Social System Reform and Research and Development by MEXT (Ministry of Education, Sport, Culture, Science and Technology) of Japan	Asia-Africa Science & Technology Strategic Cooperation Promotion Program of Special Coordination Funds for Promoting Science and Technology (SCF); Program for the Strategic Promotion of International Cooperation to Accelerate Innovation in Developing Countries; Funds for Integrated Promotion of Social System Reform and Research and Development by MEXT (Ministry of Education, Sport, Culture, Science and Technology) of Japan	This work was supported in part by the Asia-Africa Science & Technology Strategic Cooperation Promotion Program of Special Coordination Funds for Promoting Science and Technology (SCF), the Program for the Strategic Promotion of International Cooperation to Accelerate Innovation in Developing Countries, and Funds for Integrated Promotion of Social System Reform and Research and Development by MEXT (Ministry of Education, Sport, Culture, Science and Technology) of Japan.	Agot KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014028; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Ayikukwei R, 2008, CULT HEALTH SEX, V10, P587, DOI 10.1080/13691050802012601; Bene C, 2008, WORLD DEV, V36, P875, DOI 10.1016/j.worlddev.2007.05.010; Bertozzi S, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P331; Camlin CS, 2014, SOC SCI MED, V102, P146, DOI 10.1016/j.socscimed.2013.11.004; Camlin CS, 2013, AIDS EDUC PREV, V25, P216, DOI 10.1521/aeap.2013.25.3.216; Chi BH, 2012, JAIDS-J ACQ IMM DEF, V60, pS78, DOI 10.1097/QAI.0b013e31825f3284; Eaton JW, 2014, AIDS, V28, pS507, DOI 10.1097/QAD.0000000000000412; [FAO Fisheries and Aquaculture Department Food and Agriculture Organization of the United Nations (FAO)], 2006, STAT WORLD FISH AQ 2, P94; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Fujii Y, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003040; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Graser A., 2013, LEARNING QGIS 2 0; Hontelez Jan A C, 2012, AIDS, V26 Suppl 1, pS19; Kaneko S, 2012, J EPIDEMIOL, V22, P276, DOI 10.2188/jea.JE20110078; Komazawa O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049604; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2006, STAT MED, V25, P3929, DOI 10.1002/sim.2490; Kwena ZA, 2010, INT J STD AIDS, V21, P708, DOI 10.1258/ijsa.2010.010160; Kwena ZA, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/865903; Kwena ZA, 2012, AJAR-AFR J AIDS RES, V11, P9, DOI 10.2989/16085906.2012.671267; Lakew Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-330; Lindan CP, 2015, INT J STD AIDS, V26, P336, DOI 10.1177/0956462414538006; Low N, 2006, LANCET, V368, P2001, DOI 10.1016/S0140-6736(06)69482-8; Maleche A, 2011, 3 M TECHN ADV GROUP; Maman D, 2015, AIDS, V29, P1557, DOI 10.1097/QAD.0000000000000741; Mensch BS, 2001, STUD FAMILY PLANN, V32, P285, DOI 10.1111/j.1728-4465.2001.00285.x; Mojola SA, 2011, SOC SCI MED, V72, P149, DOI 10.1016/j.socscimed.2010.11.006; NASCOP Na, 2012, KEN AIDS EP UPD 2012; National AIDS and STI Control Programme (NASCOP), 2014, KEN AIDS IND SURV 20; National AIDS Control Council of Kenya, 2014, KEN AIDS RESP PROGR; Ngesa O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103299; Opio A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070770; Perry B, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19010; Seeley J, 2012, SEX TRANSM DIS, V39, P433, DOI 10.1097/OLQ.0b013e318251555d; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; Wamuti BM, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0212-6; Wand H, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-41; Wegbreit J, 2006, AIDS, V20, P1217, DOI 10.1097/01.aids.0000232229.96134.56; Westercamp N, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-24; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2010, GUID HIV INF FEED 20; Zaidi J, 2013, AIDS, V27, P2301, DOI 10.1097/QAD.0b013e328362e832	45	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148636	10.1371/journal.pone.0148636	http://dx.doi.org/10.1371/journal.pone.0148636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862764	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600088
J	Ikeda, N				Ikeda, Nayu			Validity of Self-Reports of Height and Weight among the General Adult Population in Japan: Findings from National Household Surveys, 1986	PLOS ONE			English	Article							BODY-MASS INDEX; CATEGORIES; MORTALITY; OBESITY; HEALTH; TRENDS; BIAS; BMI	Background/Objectives Growing evidence indicates that self-reported height and weight are biased, but little is known about systematic errors in the general adult population in Japan. This study takes advantage of the unique opportunity to examine this issue provided by the 1986 National Nutrition Survey. Subjects/Methods Individual-level data on a nationally representative sample aged 20-89 years from the National Nutrition Survey (November 1986) were merged with Comprehensive Survey of Living Conditions (September 1986) data to obtain a dataset containing both self-reported and measured data on height and weight for each person (n = 10,469). Discrepancies between self-reported and measured means of height, weight, and body mass index (BMI) were tested across measured BMI categories (<18.5, 18.5-24.9, 25.0-27.4, 27.5-29.9, and >= 30.0 kg/m(2)), age groups (20-44, 45-64, and 65-89 years), and sexes. Reporting bias in mean BMI was decomposed into the contributions of misreporting height and weight. The sensitivity and specificity of self-reported BMI categories were estimated. Results Mean self-reported BMI was substantially underestimated in older women (P<0.001; Cohen's d, -0.4), and the major contributor to the bias was their over-reported height. Mean self-reported BMI was also considerably underestimated in both men and women who were overweight and obese (P<0.001; Cohen's d, -1.0 to -0.6), due mainly to their underreported weight. In contrast, mean self-reported BMI was considerably overestimated in underweight men (P<0.001; Cohen's d, 0.5), due largely to their over-reported weight. The sensitivity of self-reported BMI categories was particularly low for individuals who had a measured BMI of 27.5-29.9 kg/m(2) (40.9% for men and 26.8% for women). Conclusions Self-reported anthropometric data were not sufficiently accurate to assert the validity of their use in epidemiological studies on the general adult population in Japan in the late 1980s.	[Ikeda, Nayu] Natl Inst Biomed Innovat, Ctr Int Collaborat & Partnership, Natl Inst Hlth & Nutr, Shinjuku Ku, Tokyo, Japan	National Institute of Health & Nutrition - Japan	Ikeda, N (corresponding author), Natl Inst Biomed Innovat, Ctr Int Collaborat & Partnership, Natl Inst Hlth & Nutr, Shinjuku Ku, Tokyo, Japan.	ikedan@nibiohn.go.jp	Ikeda, Nayu/J-9890-2019	Ikeda, Nayu/0000-0002-3424-1991	Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT KAKENHI grant) [22790559]	Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT KAKENHI grant)	This work was supported by the Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT KAKENHI grant number 22790559). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen J.E., 1988, STAT POWER ANAL BEHA; Ezzati M, 2006, J ROY SOC MED, V99, P250, DOI 10.1258/jrsm.99.5.250; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Gorber SC, 2010, OBESITY, V18, P354, DOI 10.1038/oby.2009.206; Hayes AJ, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-53; Keith SW, 2011, INT J OBESITY, V35, P401, DOI 10.1038/ijo.2010.148; Krul AJ, 2011, EUR J PUBLIC HEALTH, V21, P414, DOI 10.1093/eurpub/ckp228; Merrill RM, 2009, PREV CHRONIC DIS, V6; Ministry of Health, 1988, NAT NUTR SURV JAP 19; Ministry of Health, 1988, COMPR SURV LIV COND; [Ministry of Health Labour and Welfare Ministry of Education Culture Sports Science and Technology], 2002, ETH GUID EP RES; Ministry of Health Labour and Welfare, 2014, NAT HLTH NUTR SURV J; Ministry of Health Labour and Welfare, 2015, COMPR SURV LIV COND; Nakamura K, 1999, J BIOSOC SCI, V31, P555, DOI 10.1017/S0021932099005556; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Shiely F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054386; Shiely F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-560; Stommel M, 2013, INT J OBESITY, V37, P461, DOI 10.1038/ijo.2012.67; Thomas D, 2002, SUMMARY MEASURES OF POPULATION HEALTH: CONCEPTS, ETHICS, MEASUREMENT AND APPLICATIONS, P387; Tsigilis N, 2006, EUR J PUBLIC HEALTH, V16, P532, DOI 10.1093/eurpub/ckl050; Wada K, 2005, INT J OBESITY, V29, P1093, DOI 10.1038/sj.ijo.0803012; Yong V, 2012, GERIATR GERONTOL INT, V12, P247, DOI 10.1111/j.1447-0594.2011.00759.x; Zhou XY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-190	25	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148297	10.1371/journal.pone.0148297	http://dx.doi.org/10.1371/journal.pone.0148297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862762	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600052
J	Fournier-Larente, J; Azelmat, J; Yoshioka, M; Hinode, D; Grenier, D				Fournier-Larente, Jade; Azelmat, Jabrane; Yoshioka, Masami; Hinode, Daisuke; Grenier, Daniel			The Daiokanzoto (TJ-84) Kampo Formulation Reduces Virulence Factor Gene Expression in Porphyromonas gingivalis and Possesses Anti-Inflammatory and Anti-Protease Activities	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; INFLAMMATORY RESPONSES; CREVICULAR FLUID; KAPPA-B; PERIODONTITIS; INTERLEUKIN-6; PATHOGENESIS; MEDICINE; RANTES; TISSUE	Kampo formulations used in Japan to treat a wide variety of diseases and to promote health are composed of mixtures of crude extracts from the roots, bark, leaves, and rhizomes of a number of herbs. The present study was aimed at identifying the beneficial biological properties of Daiokanzoto (TJ-84), a Kampo formulation composed of crude extracts of Rhubarb rhizomes and Glycyrrhiza roots, with a view to using it as a potential treatment for periodontal disease. Daiokanzoto dose-dependently inhibited the expression of major Porphyromonas gingivalis virulence factors involved in host colonization and tissue destruction. More specifically, Daiokanzoto reduced the expression of the fimA, hagA, rgpA, and rgpB genes, as determined by quantitative real-time PCR. The U937-3x kappa B-LUC monocyte cell line transfected with a luciferase reporter gene was used to evaluate the anti-inflammatory properties of Daiokanzoto. Daiokanzoto attenuated the P. gingivalis-mediated activation of the NF-kappa B signaling pathway. It also reduced the secretion of pro-inflammatory cytokines (IL-6 and CXCL8) by lipopolysaccharide-stimulated oral epithelial cells and gingival fibroblasts. Lastly, Daiokanzoto, dose-dependently inhibited the catalytic activity of matrix metalloproteinases (-1 and -9). In conclusion, the present study provided evidence that Daiokanzoto shows potential for treating and/or preventing periodontal disease. The ability of this Kampo formulation to act on both bacterial pathogens and the host inflammatory response, the two etiological components of periodontal disease, is of high therapeutic interest.	[Fournier-Larente, Jade; Azelmat, Jabrane; Grenier, Daniel] Univ Laval, Fac Med Dent, GREB, Quebec City, PQ, Canada; [Yoshioka, Masami] Univ Tokushima, Inst Biomed Sci, Dept Oral Hlth Sci & Social Welf, Grad Sch, Tokushima 770, Japan; [Hinode, Daisuke] Univ Tokushima, Inst Biomed Sci, Dept Hyg & Oral Hlth Sci, Grad Sch, Tokushima 770, Japan	Laval University; Tokushima University; Tokushima University	Grenier, D (corresponding author), Univ Laval, Fac Med Dent, GREB, Quebec City, PQ, Canada.	Daniel.Grenier@greb.ulaval.ca			Quebec Ministere de l'Economie, de l'Innovation et des Exportations [PSR-SIIRI-438]	Quebec Ministere de l'Economie, de l'Innovation et des Exportations	This study was supported by PSR-SIIRI-438 Quebec Ministere de l'Economie, de l'Innovation et des Exportations DG.	Andrian E, 2006, J DENT RES, V85, P392, DOI 10.1177/154405910608500502; Ara T, 2008, BIOL PHARM BULL, V31, P1141, DOI 10.1248/bpb.31.1141; Ara T, 2010, BIOL PHARM BULL, V33, P611, DOI 10.1248/bpb.33.611; Azelmat J, 2015, ARCH ORAL BIOL, V60, P342, DOI 10.1016/j.archoralbio.2014.11.006; Berezow AB, 2011, PERIODONTOL 2000, V55, P36, DOI 10.1111/j.1600-0757.2010.00350.x; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; de Souza JAC, 2012, J APPL ORAL SCI, V20, P128, DOI 10.1590/S1678-77572012000200002; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Gamonal J, 2001, J PERIODONTAL RES, V36, P194, DOI 10.1034/j.1600-0765.2001.360309.x; Gamonal J, 2000, J PERIODONTOL, V71, P1535, DOI 10.1902/jop.2000.71.10.1535; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Hassell T M, 1993, Periodontol 2000, V3, P9, DOI 10.1111/j.1600-0757.1993.tb00230.x; Herrera D, 2008, J CLIN PERIODONTOL, V35, P45, DOI 10.1111/j.1600-051X.2008.01260.x; Hosseinzadeh H, 2015, PHYTOTHER RES, V29, P1868, DOI 10.1002/ptr.5487; Imamura T, 2003, J PERIODONTOL, V74, P111, DOI 10.1902/jop.2003.74.1.111; Irwin C R, 1998, Oral Dis, V4, P43; ISHIMI Y, 1990, J IMMUNOL, V145, P3297; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Kubota T, 1996, ARCH ORAL BIOL, V41, P253, DOI 10.1016/0003-9969(95)00126-3; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kusumoto Y, 2004, J PERIODONTOL, V75, P370, DOI 10.1902/jop.2004.75.3.370; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Liao J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/436206; Liao J, 2013, PHARM BIOL, V51, P1538, DOI 10.3109/13880209.2013.801995; Liu YCG, 2010, PERIODONTOL 2000, V52, P163, DOI 10.1111/j.1600-0757.2009.00321.x; Pizzo G, 2010, EUR J INTERN MED, V21, P496, DOI 10.1016/j.ejim.2010.07.011; Sapna G, 2014, ORAL DIS, V20, P538, DOI 10.1111/odi.12159; TAKAHASHI K, 1994, J PERIODONTOL, V65, P147, DOI 10.1902/jop.1994.65.2.147; Takashiba S, 2003, J PERIODONTOL, V74, P103, DOI 10.1902/jop.2003.74.1.103; Takeda O, 2014, ARCH ORAL BIOL, V59, P1130, DOI 10.1016/j.archoralbio.2014.06.010; TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924; TENG YT, 1992, J PERIODONTAL RES, V27, P544, DOI 10.1111/j.1600-0765.1992.tb01830.x; Watanabe K, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq067; Yakubo S, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/535146; Yoshida K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112689; Zenobia C, 2015, VIRULENCE, V6, P236, DOI 10.1080/21505594.2014.999567	37	6	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148860	10.1371/journal.pone.0148860	http://dx.doi.org/10.1371/journal.pone.0148860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859747	gold, Green Published			2022-12-27	WOS:000370038400098
J	Qian, J; Nunez, S; Reed, E; Reilly, MP; Foulkes, AS				Qian, Jing; Nunez, Sara; Reed, Eric; Reilly, Muredach P.; Foulkes, Andrea S.			A Simple Test of Class-Level Genetic Association Can Reveal Novel Cardiometabolic Trait Loci	PLOS ONE			English	Article							RARE VARIANTS; SUSCEPTIBILITY LOCI; ENRICHMENT ANALYSIS; IDENTIFIES 13; METAANALYSIS	Background Characterizing the genetic determinants of complex diseases can be further augmented by incorporating knowledge of underlying structure or classifications of the genome, such as newly developed mappings of protein-coding genes, epigenetic marks, enhancer elements and non-coding RNAs. Methods We apply a simple class-level testing framework, termed Genetic Class Association Testing (GenCAT), to identify protein-coding gene association with 14 cardiometabolic (CMD) related traits across 6 publicly available genome wide association (GWA) meta-analysis data resources. GenCAT uses SNP-level meta-analysis test statistics across all SNPs within a class of elements, as well as the size of the class and its unique correlation structure, to determine if the class is statistically meaningful. The novelty of findings is evaluated through investigation of regional signals. A subset of findings are validated using recently updated, larger meta-analysis resources. A simulation study is presented to characterize overall performance with respect to power, control of family-wise error and computational efficiency. All analysis is performed using the GenCAT package, R version 3.2.1. Results We demonstrate that class-level testing complements the common first stage minP approach that involves individual SNP-level testing followed by post-hoc ascribing of statistically significant SNPs to genes and loci. GenCAT suggests 54 protein-coding genes at 41 distinct loci for the 13 CMD traits investigated in the discovery analysis, that are beyond the discoveries of minP alone. An additional application to biological pathways demonstrates flexibility in defining genetic classes. Conclusions We conclude that it would be prudent to include class-level testing as standard practice in GWA analysis. GenCAT, for example, can be used as a simple, complementary and efficient strategy for class-level testing that leverages existing data resources, requires only summary level data in the form of test statistics, and adds significant value with respect to its potential for identifying multiple novel and clinically relevant trait associations.	[Qian, Jing] Univ Massachusetts, Dept Biostat & Epidemiol, Amherst, MA 01003 USA; [Nunez, Sara; Reed, Eric; Foulkes, Andrea S.] Mt Holyoke Coll, Dept Math & Stat, S Hadley, MA 01075 USA; [Reilly, Muredach P.] Columbia Univ, Dept Med, New York, NY USA	University of Massachusetts System; University of Massachusetts Amherst; Mount Holyoke College; Columbia University	Foulkes, AS (corresponding author), Mt Holyoke Coll, Dept Math & Stat, S Hadley, MA 01075 USA.	afoulkes@mtholyoke.edu		Reilly, Muredach/0000-0002-3035-9386	National Institutes of Health, National Heart, Lung and Blood Institute [R01-HL107196, K24-HL107643, R01-HL-113147]; NIH/NHLBI [R01-HL107196, K24-HL107643, R01-HL-113147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107196, K24HL107643, R01HL113147] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support for this research is provided by National Institutes of Health, National Heart, Lung and Blood Institute R01-HL107196 (JQ, ER, SN, MPR and ASF); K24-HL107643 (MPR); and R01-HL-113147 (MPR).; Support for this research is provided by NIH/NHLBI R01-HL107196 (JQ, ER, SN, MPR and ASF); K24-HL107643 (MPR); and R01-HL-113147 (MPR).	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Foulkes AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054812; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hu YJ, 2013, AM J HUM GENET, V93, P236, DOI 10.1016/j.ajhg.2013.06.011; Huang HL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002177; Lee S, 2013, AM J HUM GENET, V93, P42, DOI 10.1016/j.ajhg.2013.05.010; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Luo L, 2010, EUR J HUM GENET, V18, P1045, DOI 10.1038/ejhg.2010.62; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Weng LJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-99; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002	32	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148218	10.1371/journal.pone.0148218	http://dx.doi.org/10.1371/journal.pone.0148218			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859766	Green Published, gold, Green Submitted			2022-12-27	WOS:000370038400026
J	Reuchlein, B; Henn, L; Brian, T; Schier, K; Hardt, J				Reuchlein, Bettina; Henn, Lea; Brian, Tamara; Schier, Katarzyna; Hardt, Jochen			Childhood Adversities and Adult Headache in Poland and Germany	PLOS ONE			English	Article							CHRONIC PAIN; RETROSPECTIVE REPORTS; MENTAL-DISORDERS; DAILY-LIFE; PREVALENCE; GENETICS; IMPACT; ABUSE; MALTREATMENT; ASSOCIATION	Objective Various childhood adversities have been found to be associated with chronic pain in adulthood. However, associations were moderate in most studies, i.e. odds ratios (OR) were between one and two. Method An internet survey was performed in 508 Polish and 500 German subjects. A total of 19 childhood adversities were selected and their associations with headaches explored. Age, gender and country were included as potential confounders, as well as their two-way interaction with the risk factors. Results Two strong risk factors were identified. (1) A combined score for physical and emotional neglect showed an odds ratio (OR) of 2.78 (p < .002) to the frequency of headache in adulthood as a main effect. (2) Father having had chronic pain showed an OR of 4.36 (p < .001) with headache in adulthood for women, but not for men (OR = 0.86, p < .556). The majority of the examined childhood adversities were not associated with adult headache, neither when tested individually nor as a sum score. Conclusion This study confirms results from previous ones that childhood adversities may play a role in the development of adult headache, but it is a rather minor one. Contrary to other studies, neglect turned out to be one of the strongest predictors.	[Reuchlein, Bettina; Henn, Lea; Brian, Tamara; Hardt, Jochen] Johannes Gutenberg Univ Mainz, Univ Med, Klin Psychosomat Med & Psychotherapie, Med Psychol & Med Soziol, D-55122 Mainz, Germany; [Schier, Katarzyna] Univ Warsaw, Fac Psychol, Warsaw, Poland	Johannes Gutenberg University of Mainz; University of Warsaw	Hardt, J (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med, Klin Psychosomat Med & Psychotherapie, Med Psychol & Med Soziol, D-55122 Mainz, Germany.	jochen.hardt@gmx.de			Heigl-Stiftung, Duesseldorf; Koehler-Stiftung, Essen [100064-06]	Heigl-Stiftung, Duesseldorf; Koehler-Stiftung, Essen	This work was supported, in part, by the Heigl-Stiftung, Duesseldorf and the Koehler-Stiftung, Essen (grant number 100064-06).	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Berger K, 2014, BUNDESGESUNDHEITSBLA, V57, P913, DOI 10.1007/s00103-014-1993-5; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Brian T, 2014, PSYCHOPATHOLOGY, V47, P17, DOI 10.1159/000348483; Brown J, 2005, CLIN J PAIN, V21, P374, DOI 10.1097/01.ajp.0000149797.16370.dc; Clarke A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105450; Cohen J.E., 1988, STAT POWER ANAL BEHA; Couch JR, 2011, CURR TREAT OPTION NE, V13, P41, DOI 10.1007/s11940-010-0104-7; Davis DA, 2005, CLIN J PAIN, V21, P398, DOI 10.1097/01.ajp.0000149795.08746.31; de Heer EW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106907; Dureja GP, 2014, PAIN PRACT, V14, pE51, DOI 10.1111/papr.12132; Egle U. T., 2004, KLIN INTERVIEWS RATI, V4, P261; ENGEL GL, 1959, AM J MED, V26, P899, DOI 10.1016/0002-9343(59)90212-8; Franz M, 2003, Z PSYCHOSOM MED PSYC, V49, P115; Franz M, 2005, SEXUELLER MISSBRAUCH, P116; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Hardt J, 2010, PSYCHOL REP, V107, P425, DOI 10.2466/02.04.09.10.16.21.PR0.107.5.425-440; Kaffman A, 2007, J CHILD PSYCHOL PSYC, V48, P224, DOI 10.1111/j.1469-7610.2007.01730.x; Kaniecki Robert G, 2012, Continuum (Minneap Minn), V18, P823, DOI 10.1212/01.CON.0000418645.32032.32; KENDALLTACKETT KA, 1993, PSYCHOL BULL, V113, P164, DOI 10.1037/0033-2909.113.1.164; Kessler RC, 2010, BRIT J PSYCHIAT, V197, P378, DOI 10.1192/bjp.bp.110.080499; Loeser JD, 2013, CLIN J PAIN, V29, P311, DOI 10.1097/AJP.0b013e3182516e64; Moore RA, 2014, PAIN PRACT, V14, P79, DOI 10.1111/papr.12050; Nicholson RA, 2003, HEADACHE, V43, P651, DOI 10.1046/j.1526-4610.2003.03108.x; Russell MB, 2007, J HEADACHE PAIN, V8, P190, DOI 10.1007/s10194-007-0389-4; Russell MB, 2007, AM J MED GENET B, V144B, P982, DOI 10.1002/ajmg.b.30497; Russell Michael Bjorn, 2007, J Headache Pain, V8, P71, DOI 10.1007/s10194-007-0366-y; Sackett DL, 1996, EVIDENCE BASED MED, V1, P164, DOI DOI 10.1136/EBM.1996.1.164; Schier K, 2005, BEZ TCHU BEZ SLOWA W; Schier K, 2011, PSYCHOTHER PSYCH MED, V61, P364, DOI 10.1055/s-0031-1277188; Scott KM, 2011, ARCH GEN PSYCHIAT, V68, P838, DOI 10.1001/archgenpsychiatry.2011.77; Scott KM, 2010, PSYCHOSOM MED, V72, P712, DOI 10.1097/PSY.0b013e3181e3333d; Shibata M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090984; Silva AA, 2012, HEADACHE, V52, P483, DOI 10.1111/j.1526-4610.2012.02090.x; StataCorp, 2011, STAT STAT SOFTW REL; Steiner TJ, 2011, J HEADACHE PAIN, V12, P501, DOI 10.1007/s10194-011-0368-7; Stoltenborgh M, 2012, SOC PSYCHIAT PSYCHIA; Traue HC, 2005, VERHALTENSTHERAPIE V, V26, P213; Turk DC, 2011, LANCET, V377, P2226, DOI 10.1016/S0140-6736(11)60402-9; Westergaard ML, 2014, PAIN, V155, P2005, DOI 10.1016/j.pain.2014.07.002; Widom CS, 2004, CHILD ABUSE NEGLECT, V28, P715, DOI 10.1016/j.chiabu.2004.03.009; World Health Organization, ADV CHILDH EXP INT Q; YARROW MR, 1970, MONOGR SOC RES CHILD, V35, P1	45	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148162	10.1371/journal.pone.0148162	http://dx.doi.org/10.1371/journal.pone.0148162			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859500	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400023
J	Shi, WB; Wang, Q; Choi, W; Li, J				Shi, Weibin; Wang, Qian; Choi, Wonseok; Li, Jing			Mapping and Congenic Dissection of Genetic Loci Contributing to Hyperglycemia and Dyslipidemia in Mice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LIPOPROTEIN CHOLESTEROL LEVELS; DEFICIENT MOUSE STRAINS; GLUCOSE-HOMEOSTASIS; ATHEROSCLEROSIS SUSCEPTIBILITY; HDL-CHOLESTEROL; CAROTID ATHEROSCLEROSIS; METABOLIC SYNDROME; ENDOTHELIAL-CELLS; APOLIPOPROTEIN-B	Background Patients with dyslipidemia have an increased risk of developing type 2 diabetes, and diabetic patients often have dyslipidemia. Potential genetic connections of fasting plasma glucose with plasma lipid profile were evaluated using hyperlipidemic mice. Methods 225 male F-2 mice were generated from BALB/cJ (BALB) and SM/J(SM) Apoe-deficient (Apoe(-/-)) mice and fed a Western diet for 5 weeks. Fasting plasma glucose and lipid levels of F2 mice were measured before and after 5 weeks of Western diet and quantitative trait locus (QTL) analysis was performed using data collected from these two time points. 144 SNP(single nucleotide polymorphism) markers across the entire genome were typed. Results One major QTL (logarithm of odds ratio (LOD): 6.46) peaked at 12.7 cM on chromosome 9, Bglu16, and 3 suggestive QTLs on chromosomes 15, 18 and X were identified for fasting glucose, and over 10 loci identified for lipid traits. Bglu16 was adjacent to a major QTL, Hdlq17, for high-density lipoprotein (HDL) cholesterol (LOD: 6.31, peak: 19.1 cM). A congenic strain with a donor chromosomal region harboring Bglu16 and Hdlq17 on the Apoe(-/-) background showed elevations in plasma glucose and HDL levels. Fasting glucose levels were significantly correlated with non-HDL cholesterol and triglyceride levels, especially on the Western diet, but only marginally correlated with HDL levels in F2 mice. Conclusions We have demonstrated a correlative relationship between fasting glucose and plasma lipids in a segregating F2 population under hyperlipidemic conditions, and this correlation is partially due to genetic linkage between the two disorders.	[Shi, Weibin; Wang, Qian; Choi, Wonseok; Li, Jing] Univ Virginia, Dept Radiol, Charlottesville, VA USA; [Shi, Weibin; Wang, Qian; Choi, Wonseok; Li, Jing] Univ Virginia, Dept Med Imaging, Charlottesville, VA USA; [Shi, Weibin] Univ Virginia, Biochem & Mol Genet, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia	Shi, WB (corresponding author), Univ Virginia, Dept Radiol, Charlottesville, VA USA.; Shi, WB (corresponding author), Univ Virginia, Dept Med Imaging, Charlottesville, VA USA.; Shi, WB (corresponding author), Univ Virginia, Biochem & Mol Genet, Charlottesville, VA USA.	ws4v@virginia.edu	, ws4v/L-4372-2019		NIH [DK097120, HL112281]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL112281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097120] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK097120 and HL112281.; This work was supported by NIH grants DK097120 and HL112281. The authors thank Dr. Ani Manichaikul for advice with the statistical analyses.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Ackert-Bicknell C, 2013, J LIPID RES, V54, P984, DOI 10.1194/jlr.M033035; Albert JS, 2014, NEW ENGL J MED, V370, P2307, DOI 10.1056/NEJMoa1315496; Bayram F, 2014, J CLIN LIPIDOL, V8, P206, DOI 10.1016/j.jacl.2013.12.011; Breslow JL, 2000, CIRCULATION, V102, P5, DOI 10.1161/01.CIR.102.1.5; Drew BG, 2012, NAT REV ENDOCRINOL, V8, P237, DOI 10.1038/nrendo.2011.235; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Farbstein D, 2012, EXPERT REV CARDIOVAS, V10, P353, DOI [10.1586/erc.11.182, 10.1586/ERC.11.182]; Hu Y, 2007, J LIPID RES, V48, P1681, DOI 10.1194/jlr.M600382-JLR200; Hwang YC, 2014, DIABETIC MED, V31, P24, DOI 10.1111/dme.12278; Hwang YC, 2014, ACTA DIABETOL, V51, P941, DOI 10.1007/s00592-014-0587-x; Ishimori N, 2004, ARTERIOSCL THROM VAS, V24, P161, DOI 10.1161/01.ATV.0000104027.52895.D7; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Ley SH, 2010, CLIN CHEM, V56, P666, DOI 10.1373/clinchem.2009.136994; Li J, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-117; Li NS, 2014, DIABETES, V63, P3149, DOI 10.2337/db13-1800; Li NS, 2014, ATHEROSCLEROSIS, V233, P130, DOI 10.1016/j.atherosclerosis.2013.12.013; Li QZ, 2008, STROKE, V39, P166, DOI 10.1161/STROKEAHA.107.492165; Liu SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120935; Lyons MA, 2004, PHYSIOL GENOMICS, V17, P114, DOI 10.1152/physiolgenomics.00168.2003; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Manichaikul A, 2011, AM J PHYSIOL-HEART C, V301, pH1056, DOI 10.1152/ajpheart.00366.2011; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Mbikay M, 2015, J DIABETES, V7, P74, DOI 10.1111/1753-0407.12139; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Rowlan JS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000260; Rowlan JS, 2013, PHYSIOL GENOMICS, V45, P332, DOI 10.1152/physiolgenomics.00099.2012; Rowlan JS, 2013, PHYSL GENOMICS; Saleheen D, 2006, INT J CARDIOL, V110, P259, DOI 10.1016/j.ijcard.2005.06.059; Sehayek E, 2003, J LIPID RES, V44, P1744, DOI 10.1194/jlr.M300139-JLR200; Seidelmann SB, 2005, ARTERIOSCL THROM VAS, V25, P204, DOI 10.1161/01.ATV.0000149146.32385.1b; Shi WB, 2000, CIRC RES, V86, P1078, DOI 10.1161/01.RES.86.10.1078; Shi WB, 2010, CIRC-CARDIOVASC GENE, V3, P409, DOI 10.1161/CIRCGENETICS.110.957449; Shike T, 2001, DIABETES, V50, P1943, DOI 10.2337/diabetes.50.8.1943; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Stylianou IM, 2008, J LIPID RES, V49, P2402, DOI 10.1194/jlr.M800244-JLR200; Stylianou IM, 2006, GENETICS, V174, P999, DOI 10.1534/genetics.106.059717; Su ZG, 2006, HUM MOL GENET, V15, P1650, DOI 10.1093/hmg/ddl088; Su ZG, 2006, GENETICS, V172, P1799, DOI 10.1534/genetics.105.051912; Su Z, 2008, J LIPID RES, V49, P1500, DOI 10.1194/jlr.M800053-JLR200; Su ZG, 2009, J LIPID RES, V50, P116, DOI 10.1194/jlr.M800411-JLR200; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tian J, 2005, BIOCHEM BIOPH RES CO, V329, P1102, DOI 10.1016/j.bbrc.2005.02.090; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Wang Q, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0292-y; Weng CY, 2013, AM J MED SCI, V346, P289, DOI 10.1097/MAJ.0b013e3182732e97; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wilson P W, 1985, Monogr Atheroscler, V13, P1; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Wittenburg H, 2006, J LIPID RES, V47, P1780, DOI 10.1194/jlr.M500544-JLR200; Yuan ZB, 2009, CIRC-CARDIOVASC GENE, V2, P220, DOI 10.1161/CIRCGENETICS.108.792499; Zhang Y, 2015, NUCL MED BIOL, V42, P381, DOI 10.1016/j.nucmedbio.2014.12.001; Zhang ZM, 2012, CIRC-CARDIOVASC GENE, V5, P190, DOI 10.1161/CIRCGENETICS.111.961649	54	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148462	10.1371/journal.pone.0148462	http://dx.doi.org/10.1371/journal.pone.0148462			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859786	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400044
J	de Kovel, CG; Mulder, F; van Setten, J; van't Slot, R; Al-Rubaish, A; Alshehri, AM; Al Faraidy, K; Al-Ali, A; Al-Madan, M; Al Aqaili, I; Larbi, E; Al-Ali, R; Alzahrani, A; Asselbergs, FW; Koeleman, BPC; Al-Ali, A				de Kovel, Carolien G.; Mulder, Flip; van Setten, Jessica; van't Slot, Ruben; Al-Rubaish, Abdullah; Alshehri, Abdullah M.; Al Faraidy, Khalid; Al-Ali, Abdullah; Al-Madan, Mohammed; Al Aqaili, Issa; Larbi, Emmanuel; Al-Ali, Rudaynah; Alzahrani, Alhusain; Asselbergs, Folkert W.; Koeleman, Bobby P. C.; Al-Ali, Amein			Exome-Wide Association Analysis of Coronary Artery Disease in the Kingdom of Saudi Arabia Population	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; RISK-FACTORS; LOCI; IMPUTATION; GENETICS	Coronary Artery Disease (CAD) remains the leading cause of mortality worldwide. Mortality rates associated with CAD have shown an exceptional increase particularly in fast developing economies like the Kingdom of Saudi Arabia (KSA). Over the past twenty years, CAD has become the leading cause of death in KSA and has reached epidemic proportions. This rise is undoubtedly caused by fast urbanization that is associated with a life-style that promotes CAD. However, the question remains whether genetics play a significant role and whether genetic susceptibility is increased in KSA compared to the well-studied Western European populations. Therefore, we performed an Exome-wide association study (EWAS) in 832 patients and 1,076 controls of Saudi Arabian origin to test whether population specific, strong genetic risk factors for CAD exist, or whether the polygenic risk score for known genetic risk factors for CAD, lipids, and Type 2 Diabetes show evidence for an enriched genetic burden. Our results do not show significant associations for a single genetic locus. However, the heritability estimate for CAD for this population was high (h(2) = 0.53, S.E. = 0.1, p = 4e(-12)) and we observed a significant association of the polygenic risk score for CAD that demonstrates that the population of KSA, at least in part, shares the genetic risk associated to CAD in Western populations.	[de Kovel, Carolien G.; Mulder, Flip; van Setten, Jessica; van't Slot, Ruben; Koeleman, Bobby P. C.] Univ Med Ctr Utrecht, Dept Genet, Utrecht, Netherlands; [Al-Rubaish, Abdullah; Alshehri, Abdullah M.; Larbi, Emmanuel; Al-Ali, Rudaynah] Univ Dammam, King Fahd Hosp Univ, Dept Med, Dammam, Saudi Arabia; [Al Faraidy, Khalid] King Fahd Mil Med Complex, Dept Cardiol, Al Khobar, Saudi Arabia; [Al-Ali, Abdullah] Prince Sultan Cardiac Ctr, Al Hasa, Saudi Arabia; [Al-Madan, Mohammed] Univ Dammam, King Fahd Hosp Univ, Dammam, Saudi Arabia; [Al Aqaili, Issa] Qatif Cent Hosp, Dept Med, Qatif, Saudi Arabia; [Alzahrani, Alhusain] King Saud Univ, Coll Appl Med Sci, Riyadh, Saudi Arabia; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Dept Cardiol, Div Heart & Lungs, Utrecht, Netherlands; [Al-Ali, Amein] Univ Dammam, Coll Med, Prince Mohammed Ctr Res & Consultat Studies, Dammam, Saudi Arabia	Utrecht University; Utrecht University Medical Center; Imam Abdulrahman Bin Faisal University; King Fahd Military Medical Complex; Prince Sultan Cardiac Center; Imam Abdulrahman Bin Faisal University; Qatif Central Hospital; King Saud University; Utrecht University; Utrecht University Medical Center; Imam Abdulrahman Bin Faisal University	Koeleman, BPC (corresponding author), Univ Med Ctr Utrecht, Dept Genet, Utrecht, Netherlands.	b.p.c.koeleman@umcutrecht.nl	Alshehri, Abdullah/AAS-9771-2020; Asselbergs, Folkert W./ABD-6752-2021; Al-Ali, Amein/AAR-3020-2020; de Kovel, Carolien/AAI-3531-2021	Alshehri, Abdullah/0000-0002-0795-1760; Asselbergs, Folkert W./0000-0002-1692-8669; de Kovel, Carolien/0000-0002-7818-1396; Al-Rubaish, Abdullah Mohammed/0000-0002-9136-2853	University of Dammam, Kingdom of Saudi Arabia; King Abdulaziz City for Science Technology	University of Dammam, Kingdom of Saudi Arabia; King Abdulaziz City for Science Technology	This study was funded by the University of Dammam, Kingdom of Saudi Arabia and King Abdulaziz City for Science & Technology. The authors would like to acknowledge the technical support extended by the Center for Research & Medical Consultation at the University of Dammam.	Borchers AT, 2010, AUTOIMMUN REV, V9, pA355, DOI 10.1016/j.autrev.2009.12.003; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chow CK, 2009, INT J EPIDEMIOL, V38, P1580, DOI 10.1093/ije/dyn258; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; DORMAN JS, 1990, P NATL ACAD SCI USA, V87, P7370, DOI 10.1073/pnas.87.19.7370; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Fahed AC, 2013, CIRC RES, V112, P707, DOI 10.1161/CIRCRESAHA.112.300853; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Gelb BD, 2014, COLD SPRING HARB PER, V4; Gonzalez-Neira A, 2006, GENOME RES, V16, P323, DOI 10.1101/gr.4138406; Kukko M, 2004, DIABETES CARE, V27, P676, DOI 10.2337/diacare.27.3.676; Levenson James W, 2002, Prev Cardiol, V5, P188, DOI 10.1111/j.1520-037X.2002.00564.x; Li M, 2014, MOL PSYCHIATR, V19, P452, DOI 10.1038/mp.2013.37; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Miller CL, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0406-4; Mokdad AH, 2014, LANCET, V383, P309, DOI 10.1016/S0140-6736(13)62189-3; O'Toole Timothy E., 2008, Reviews on Environmental Health, V23, P167; Ozaki K, 2015, J HUM GENET; Purcell S, 2007, AM J HUM GENET, P81; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sibai AM, 2011, ANN NUTR METAB, V57, P193, DOI 10.1159/000321527; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; Yuan S, 2013, CURR OPIN GENET DEV, V23, P352, DOI 10.1016/j.gde.2013.05.004	28	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0146502	10.1371/journal.pone.0146502	http://dx.doi.org/10.1371/journal.pone.0146502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849363	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000009
J	Fontenete, S; Leite, M; Cappoen, D; Santos, R; Van Ginneken, C; Figueiredo, C; Wengel, J; Cos, P; Azevedo, NF				Fontenete, Silvia; Leite, Marina; Cappoen, Davie; Santos, Rita; Van Ginneken, Chris; Figueiredo, Ceu; Wengel, Jesper; Cos, Paul; Azevedo, Nuno Filipe			Fluorescence In Vivo Hybridization (FIVH) for Detection of Helicobacter pylori Infection in a C57BL/6 Mouse Model	PLOS ONE			English	Article							CONFOCAL LASER ENDOMICROSCOPY; NUCLEIC-ACID; ANTISENSE OLIGONUCLEOTIDES; MESSENGER-RNA; LIVING CELLS; DIAGNOSIS; EXPRESSION; TRACKING; BACTERIA; STOMACH	Introduction In this study, we applied fluorescence in vivo hybridization (FIVH) using locked nucleic acid (LNA) probes targeting the bacterial rRNA gene for in vivo detection of H. pylori infecting the C57BL/6 mouse model. A previously designed Cy3_HP_LNA/2OMe_PS probe, complementary to a sequence of the H. pylori 16S rRNA gene, was used. First, the potential cytotoxicity and genotoxicity of the probe was assessed by commercial assays. Further, the performance of the probe for detecting H. pylori at different pH conditions was tested in vitro, using fluorescence in situ hybridization (FISH). Finally, the efficiency of FIVH to detect H. pylori SS1 strain in C57BL/6 infectedmice was evaluated ex vivo in mucus samples, in cryosections and paraffin-embedded sections by epifluorescence and confocal microscopy. Results H. pylori SS1 strain infecting C57BL/6 mice was successfully detected by the Cy3_HP_LNA/2OMe_PS probe in the mucus, attached to gastric epithelial cells and colonizing the gastric pits. The specificity of the probe for H. pylori was confirmed by microscopy. Conclusions In the future this methodology can be used in combination with a confocal laser endomicroscope for in vivo diagnosis of H. pylori infection using fluorescent LNA probes, which would be helpful to obtain an immediate diagnosis. Our results proved for the first time that FIVH method is applicable inside the body of a higher-order animal.	[Fontenete, Silvia; Santos, Rita; Azevedo, Nuno Filipe] Univ Porto, Fac Engn, LEPABE, Lab Proc Engn Environm Biotechnol & Energy, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Fontenete, Silvia; Leite, Marina; Santos, Rita; Figueiredo, Ceu] Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Fontenete, Silvia; Leite, Marina; Santos, Rita; Figueiredo, Ceu] Univ Porto, Inst Mol Pathol & Immunol, IPATIMUP, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Fontenete, Silvia; Wengel, Jesper] Univ Southern Denmark, Dept Phys Chem & Pharm, Nucle Acid Ctr, Odense M, Denmark; [Fontenete, Silvia] Univ Porto, Inst Biomed Sci Abel Salazar, ICBAS, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Cappoen, Davie; Cos, Paul] Univ Antwerp, Fac Pharmaceut Biomed & Vet Sci, Lab Microbiol Parasitol & Hyg, B-2020 Antwerp, Belgium; [Santos, Rita] Univ Ghent, Lab Gen Biochem & Phys Pharm, B-9000 Ghent, Belgium; [Van Ginneken, Chris] Univ Antwerp, Lab Appl Vet Morphol, Fac Pharmaceut Biomed & Vet Sci, B-2020 Antwerp, Belgium; [Figueiredo, Ceu] Univ Porto, Fac Med, FMUP, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Fontenete, Silvia] Spanish Natl Canc Res Ctr, Epithelial Cell Biol Grp, Canc Cell Biol Program, Madrid, Spain	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; University of Southern Denmark; Universidade do Porto; University of Antwerp; Ghent University; University of Antwerp; Universidade do Porto; Centro Nacional de Investigaciones Oncologicas (CNIO)	Azevedo, NF (corresponding author), Univ Porto, Fac Engn, LEPABE, Lab Proc Engn Environm Biotechnol & Energy, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	nazevedo@fe.up.pt	Fontenete, Sílvia/Q-1936-2018; Figueiredo, Ceu/B-8776-2008; Leite, Carla Marina Gonçalves/J-5976-2013; Van Ginneken, Chris/AAK-2559-2020; cos, paul/AAU-3896-2020; Guimarães, Nuno/J-6879-2013; Cos, Paul/L-9717-2015	Fontenete, Sílvia/0000-0003-1972-6349; Figueiredo, Ceu/0000-0001-5247-840X; Leite, Carla Marina Gonçalves/0000-0003-4286-0247; Van Ginneken, Chris/0000-0002-1622-9120; cos, paul/0000-0003-4361-8911; Guimarães, Nuno/0000-0002-7623-3877; Cos, Paul/0000-0003-4361-8911; Cappoen, Davie/0000-0002-3115-8797; S. Santos, Rita/0000-0002-7174-271X; Wengel, Jesper/0000-0001-9835-1009; Azevedo, Nuno/0000-0001-5864-3250	FCT/MEC; FEDER [NORTE-07-0124-FEDER-000025-RL2_EnvironmentHealth, NORTE-07-0124-FEDER-000022-ML]; FEDER funds through Programa Operacional Factores de Competitividade - COMPETE; Programa Operacional do Norte (ON2) program; FCT-Fundacao para a Ciencia e a Tecnologia [PIC/IC/82815/2007, SFRH/BD/72999/2010, SFRH/BD/84376/2012, SFRH/BPD/33420/2008]; Nucleic Acid Center, University of Southern Denmark; Research Foundation - Flanders (FWO-Vlaanderen) [12N5915N]; FEDER funds through Programa Operacional Factores de Competitividade-COMPETE; Research Foundation-Flanders (FWO-Vlaanderen) [12N5915N];  [UID/EQU/00511/2013-LEPABE]	FCT/MEC; FEDER(European Commission); FEDER funds through Programa Operacional Factores de Competitividade - COMPETE; Programa Operacional do Norte (ON2) program; FCT-Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); Nucleic Acid Center, University of Southern Denmark; Research Foundation - Flanders (FWO-Vlaanderen)(FWO); FEDER funds through Programa Operacional Factores de Competitividade-COMPETE; Research Foundation-Flanders (FWO-Vlaanderen)(FWO); 	This work was financially supported by: Project UID/EQU/00511/2013-LEPABE, by the FCT/MEC with national funds and when applicable co-funded by FEDER in the scope of the P2020 Partnership Agreement; Project NORTE-07-0124-FEDER-000025-RL2_Environment&Health, and Project NORTE-07-0124-FEDER-000022-ML, by FEDER funds through Programa Operacional Factores de Competitividade - COMPETE, by the Programa Operacional do Norte (ON2) program and by national funds through FCT-Fundacao para a Ciencia e a Tecnologia; DNA mimics Research Project PIC/IC/82815/2007], PhD grants [SFRH/BD/72999/2010 to SF and SFRH/BD/84376/2012 to RS], Post-Doctoral fellowship [SFRH/BPD/33420/2008 to ML] and by Nucleic Acid Center, University of Southern Denmark. The salary of DC is covered by the Research Foundation - Flanders (FWO-Vlaanderen) under grant 12N5915N.; This work was financially supported by: Project UID/EQU/00511/2013-LEPABE, by the FCT/MEC with national funds and when applicable co-funded by FEDER in the scope of the P2020 Partnership Agreement; Project NORTE-07-0124-FEDER-000025-RL2_Environment&Health, and Project NORTE-07-0124-FEDER-000022-ML, by FEDER funds through Programa Operacional Factores de Competitividade-COMPETE, by the Programa Operacional do Norte (ON2) program and by national funds through FCT-Fundacao para a Ciencia e a Tecnologia; DNA mimics Research Project PIC/IC/82815/2007], PhD grants [SFRH/BD/72999/2010 to SF and SFRH/BD/84376/2012 to RS], Post-Doctoral fellowship [SFRH/BPD/33420/2008 to ML] and by Nucleic Acid Center, University of Southern Denmark. The salary of DC is covered by the Research Foundation-Flanders (FWO-Vlaanderen) under grant 12N5915N.	[Anonymous], [No title captured]; Cappoen D, 2014, J MED CHEM, V57, P2895, DOI 10.1021/jm401735w; Cerqueira L, 2008, INT J MOL SCI, V9, P1944, DOI 10.3390/ijms9101944; Fluiter K, 2003, NUCLEIC ACIDS RES, V31, P953, DOI 10.1093/nar/gkg185; Fontenete S, 2015, APPL MICROBIOL BIOTE; Fontenete S, 2016, CRIT REV BIOTECHNOL, V36, P566, DOI 10.3109/07388551.2014.993589; Fontenete S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125494; Fontenete S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081230; Gheonea DI, 2011, WORLD J GASTROENTERO, V17, P21, DOI 10.3748/wjg.v17.i1.21; Gupta N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010682; Hoerr V, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-63; Hovelmann F, 2014, ANGEW CHEM INT EDIT, V53, P11370, DOI 10.1002/anie.201406022; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Ji R, 2010, J GASTROEN HEPATOL, V25, P700, DOI 10.1111/j.1440-1746.2009.06197.x; Kam Y, 2012, MOL PHARMACEUT, V9, P685, DOI 10.1021/mp200505k; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kiesslich R, 2004, GASTROENTEROLOGY, V127, P706, DOI 10.1053/j.gastro.2004.06.050; KIRSCHNER DE, 1995, J THEOR BIOL, V176, P281, DOI 10.1006/jtbi.1995.0198; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Li LL, 2014, P NATL ACAD SCI USA, V111, P17099, DOI 10.1073/pnas.1420105111; Lopes AI, 2014, WORLD J GASTROENTERO, V20, P9299, DOI 10.3748/wjg.v20.i28.9299; Lorenz U, 2011, EUR J VASC ENDOVASC, V41, P68, DOI 10.1016/j.ejvs.2010.09.007; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; McNulty CAM, 2011, HELICOBACTER, V16, P10, DOI 10.1111/j.1523-5378.2011.00875.x; Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x; Mook Orf, 2010, Artif DNA PNA XNA, V1, P36; Nedosekin DA, 2013, J BIOPHOTONICS, V6, P523, DOI 10.1002/jbio.201200242; Neumann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058753; Paramsothy S, 2010, NAT REV GASTRO HEPAT, V7, P366, DOI 10.1038/nrgastro.2010.83; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Schreiber S, 2004, P NATL ACAD SCI USA, V101, P5024, DOI 10.1073/pnas.0308386101; Shahid Muhammad W, 2011, J Interv Gastroenterol, V1, P166; Shi H, 2014, ANAL CHIM ACTA, V812, P138, DOI 10.1016/j.aca.2013.12.023; Shi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070476; Shi SR, 2008, AM J CLIN PATHOL, V129, P358, DOI 10.1309/7CXUYXT23E5AL8KQ; Sigal M, 2015, GASTROENTEROLOGY; Stanton R, 2012, NUCLEIC ACID THER, V22, P344, DOI 10.1089/nat.2012.0366; Swayze EE, 2007, NUCLEIC ACIDS RES, V35, P687, DOI 10.1093/nar/gkl1071; Testerman TL, 2014, WORLD J GASTROENTERO, V20, P12781, DOI 10.3748/wjg.v20.i36.12781; Verschaeve L, 1999, ENVIRON MOL MUTAGEN, V33, P240, DOI 10.1002/(SICI)1098-2280(1999)33:3<240::AID-EM8>3.3.CO;2-I; Wang YZ, 2013, NUCL MED BIOL, V40, P89, DOI 10.1016/j.nucmedbio.2012.10.001; Weil TT, 2010, TRENDS CELL BIOL, V20, P380, DOI 10.1016/j.tcb.2010.03.006; Westerink WMA, 2009, MUTAT RES-GEN TOX EN, V676, P113, DOI 10.1016/j.mrgentox.2009.04.008; Wiegant J, 2010, METHODS MOL BIOL, V659, P239, DOI 10.1007/978-1-60761-789-1_17; Yamamichi N, 2009, CLIN CANCER RES, V15, P4009, DOI 10.1158/1078-0432.CCR-08-3257; Zelenka J, 2014, J BIOENERG BIOMEMBR, V46, P147, DOI 10.1007/s10863-014-9543-2; Zhao XM, 2014, J NUCL MED, V55, P1008, DOI 10.2967/jnumed.113.136101	48	14	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148353	10.1371/journal.pone.0148353	http://dx.doi.org/10.1371/journal.pone.0148353			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848853	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000076
J	Han, GJ; Xu, J; Liu, Q; Li, CM; Xu, HX; Lu, ZX				Han, Guangjie; Xu, Jian; Liu, Qin; Li, Chuanming; Xu, Hongxing; Lu, Zhongxian			Genome of Cnaphalocrocis medinalis Granulovirus, the First Crambidae-Infecting Betabaculovirus Isolated from Rice Leaffolder to Sequenced	PLOS ONE			English	Article							PROTEIN; BINDING; GENE; TRANSCRIPTION; LEPIDOPTERA; REPEATS; CHITIN; LARVAE; IDENTIFICATION; BACULOVIRUSES	Cnaphalocrocis medinalis is a major pest of rice in South and South-East Asia. Insecticides are the major means farmers use for management. A naturally occurring baculovirus, C. medinalis granulovirus (CnmeGV), has been isolated from the larvae and this has the potential for use as microbial agent. Here, we described the complete genome sequence of CnmeGV and compared it to other baculovirus genomes. The genome of CnmeGV is 112,060 base pairs in length, has a G+C content of 35.2%. It contains 133 putative open reading frames (ORFs) of at least 150 nucleotides. A hundred and one (101) of these ORFs are homologous to other baculovirus genes including 37 baculovirus core genes. Thirty-two (32) ORFs are unique to CnmeGV with no homologues detected in the GeneBank and 53 tandem repeats (TRs) with sequence length from 25 to 551 nt intersperse throughout the genome of CnmeGV. Six (6) homologous regions (hrs) were identified interspersed throughout the genome. Hr2 contains 11 imperfect palindromes and a high content of AT sequence (about 73%). The unique ORF28 contains a coiled-coil region and a zinc finger-like domain of 4-50 residues specialized by two C2C2 zinc finger motifs that putatively bound two atoms of zinc. ORF21 encoding a chit-1 protein suggesting a horizontal gene transfer from alphabaculovirus. The putative protein presents two carbohydrate-binding module family 14 (CBM_14) domains rather than other homologues detected from betabaculovirus that only contains one chit-binding region. Gene synteny maps showed the colinearity of sequenced betabaculovirus. Phylogenetic analysis indicated that CnmeGV grouped in the betabaculovirus, with a close relation to AdorGV. The cladogram obtained in this work grouped the 17 complete GV genomes in one monophyletic clade. CnmeGV represents a new crambidae host-isolated virus species from the genus Betabaculovirus and is most closely relative of AdorGV. The analyses and information derived from this study will provide a better understanding of the pathological symptoms caused by this virus and its potential use as a microbial pesticide.	[Han, Guangjie; Xu, Jian; Liu, Qin; Li, Chuanming] Jiangsu Lixiahe Inst Agr Sci, Dept Biol Pesticides, Yangzhou 225007, Jiangsu, Peoples R China; [Xu, Hongxing; Lu, Zhongxian] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Inst Plant Protect & Microbiol, Hangzhou 310021, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences	Xu, J (corresponding author), Jiangsu Lixiahe Inst Agr Sci, Dept Biol Pesticides, Yangzhou 225007, Jiangsu, Peoples R China.; Lu, ZX (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Inst Plant Protect & Microbiol, Hangzhou 310021, Zhejiang, Peoples R China.	bio-xj@163.com; luzxmh@163.com	Han, Guangjie/AAE-1496-2019	Han, Guangjie/0000-0002-6921-7369; Han, Guangjie/0000-0002-3920-9413	National Natural Science Foundation of China [31071740]; Jiangsu Science Project of China [BK20141283, BE2014361]; Jiangsu Province "333 engineering" Project [BRA2014154]; Jiangsu Province Independent Innovation of Agricultural Science [CX (14)2129]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Science Project of China; Jiangsu Province "333 engineering" Project; Jiangsu Province Independent Innovation of Agricultural Science	This work was supported by the National Natural Science Foundation of China (31071740), Jiangsu Science Project of China (BK20141283, BE2014361), Jiangsu Province "333 engineering" Project (BRA2014154), and Jiangsu Province Independent Innovation of Agricultural Science (CX (14)2129).	Araki K, 2003, J NEUROCHEM, V86, P749, DOI 10.1046/j.1471-4159.2003.01875.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Buard J, 1998, EMBO J, V17, P3495, DOI 10.1093/emboj/17.12.3495; Wolff JL, 2008, J GEN VIROL, V89, P1202, DOI 10.1099/vir.0.83581-0; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Casu R, 1997, P NATL ACAD SCI USA, V94, P8939, DOI 10.1073/pnas.94.17.8939; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Cuartas PE, 2015, VIRUSES-BASEL, V7, P394, DOI 10.3390/v7010394; Oliveira JVD, 2006, J GEN VIROL, V87, P3233, DOI 10.1099/vir.0.82161-0; Ehrensberger KM, 2014, J BIOL CHEM, V289, P18087, DOI 10.1074/jbc.M114.551333; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Elvin CM, 1996, J BIOL CHEM, V271, P8925, DOI 10.1074/jbc.271.15.8925; Escasa SR, 2006, J GEN VIROL, V87, P1917, DOI 10.1099/vir.0.81792-0; Federici B.A., 1997, BACULOVIRUSES VIRUSE, P33, DOI [10.1007/978-1-4899-1834-5_3, DOI 10.1007/978-1-4899-1834-5_3]; FEUERSTEIN R, 1994, P NATL ACAD SCI USA, V91, P10655, DOI 10.1073/pnas.91.22.10655; Gaines PJ, 2003, INSECT BIOCHEM MOLEC, V33, P1061, DOI 10.1016/S0965-1748(03)00096-1; Garcia-Maruniak A, 2004, J VIROL, V78, P7036, DOI 10.1128/JVI.78.13.7036-7051.2004; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Gilbert C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4348; Hayakawa T, 1999, VIROLOGY, V262, P277, DOI 10.1006/viro.1999.9894; Herniou EA., 2011, VIRUS TAXONOMY, P163; Hilton S, 2007, J GEN VIROL, V88, P1496, DOI 10.1099/vir.0.82760-0; Inoue H, 2004, JPN J APPL ENTOMOL Z, V48, P177, DOI 10.1303/jjaez.2004.177; Jehle JA, 2006, VIROLOGY, V346, P180, DOI 10.1016/j.virol.2005.10.032; Kang WY, 1999, J VIROL, V73, P10339, DOI 10.1128/JVI.73.12.10339-10345.1999; Kawazu K, 2001, APPL ENTOMOL ZOOL, V36, P471, DOI 10.1303/aez.2001.471; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lange M, 2003, VIROLOGY, V317, P220, DOI 10.1016/S0042-6822(03)00515-4; Ferrelli ML, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-548; Li QJ, 2002, VIROLOGY, V294, P106, DOI 10.1006/viro.2001.1313; Li ZF, 2003, VIRUS RES, V96, P113, DOI 10.1016/S0168-1702(03)00179-5; Liang ZP, 2011, ARCH VIROL, V156, P1185, DOI 10.1007/s00705-011-0977-0; Liu Qin, 2013, Journal of Yangzhou University (Agricultural and Life Science Edition), V34, P89; Liu XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110023; LU A, 1995, J VIROL, V69, P975, DOI 10.1128/JVI.69.2.975-982.1995; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Miele Solange Ana Belen, 2011, Int J Evol Biol, V2011, P379424, DOI 10.4061/2011/379424; Mittelman D, 2010, CELL STRESS CHAPERON, V15, P753, DOI 10.1007/s12192-010-0191-0; Nai YS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-116; Nathan SS, 2004, PHYTOPARASITICA, V32, P433, DOI 10.1007/BF02980437; Oh S, 2013, ARCH VIROL, V158, P1701, DOI 10.1007/s00705-013-1649-z; Peng K, 2010, J VIROL, V84, P9497, DOI 10.1128/JVI.00812-10; Ardisson-Araujo DMP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-856; Pijlman GP, 2003, J GEN VIROL, V84, P2041, DOI 10.1099/vir.0.19133-0; Possee RD, 1997, BACULOVIRUSES, P109; Regier JC, 1998, MOL BIOL EVOL, V15, P1172, DOI 10.1093/oxfordjournals.molbev.a026024; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Roberts RJ, 2013, GENOME BIOL, V14, DOI [10.1186/gb-2013-14-7-405, 10.1186/gb-2013-14-6-405]; ROHRMANN GF, 1992, J GEN VIROL, V73, P749, DOI 10.1099/0022-1317-73-4-749; Shen ZC, 1998, J BIOL CHEM, V273, P17665, DOI 10.1074/jbc.273.28.17665; THEILMANN DA, 2005, VIRUS TAXONOMY, P177; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thumbi DK, 2011, VIRUSES-BASEL, V3, P2301, DOI 10.3390/v3112301; TODD JW, 1995, J VIROL, V69, P968, DOI 10.1128/JVI.69.2.968-974.1995; VanOers MM, 1997, J INVERTEBR PATHOL, V70, P1, DOI 10.1006/jipa.1997.4675; Vega FE, 2012, INSECT PATHOLOGY, 2ND EDITION, P1; Wang D, 2006, VIRUS RES, V117, P237, DOI 10.1016/j.virusres.2005.10.019; Wang Y, 2011, NEURAL REGEN RES, V6, P6, DOI 10.3969/j.issn.1673-5374.2011.01.001; Wang Y, 2008, J MICROBIOL, V46, P704, DOI 10.1007/s12275-008-0133-z; Wierdl M, 1996, GENETICS, V143, P713; WINSTANLEY D, 1993, J GEN VIROL, V74, P1599, DOI 10.1099/0022-1317-74-8-1599; Wormleaton S, 2003, VIROLOGY, V311, P350, DOI 10.1016/S0042-6822(03)00149-1; ZANOTTO PMD, 1993, J INVERTEBR PATHOL, V62, P147, DOI 10.1006/jipa.1993.1090; Zemskov EA, 2000, J VIROL, V74, P6784, DOI 10.1128/JVI.74.15.6784-6789.2000; Zheng XS, 2011, J ECON ENTOMOL, V104, P653, DOI 10.1603/EC10419	66	4	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147882	10.1371/journal.pone.0147882	http://dx.doi.org/10.1371/journal.pone.0147882			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848752	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000027
J	Kunseler, FC; Oosterman, M; de Moor, MHM; Verhage, ML; Schuengel, C				Kunseler, Florentina C.; Oosterman, Mirjam; de Moor, Marleen H. M.; Verhage, Marije L.; Schuengel, Carlo			Weakened Resilience in Parenting Self-Efficacy in Pregnant Women Who Were Abused in Childhood: An Experimental Test	PLOS ONE			English	Article							ADULT ATTACHMENT INTERVIEW; VISUAL ANALOG SCALE; POSTPARTUM DEPRESSION; COGNITIVE RESPONSES; INFANT TEMPERAMENT; MOTHERS; MALTREATMENT; TRANSITION; RISK; ADOLESCENTS	This study tested experimentally whether the combination of a history of childhood abuse and confrontation with difficult infant temperament is associated with negative changes in parenting self-efficacy. First-time pregnant women (N = 243) participated in the Adult Attachment Interview, which was used to assess the occurrence of abuse by parents in childhood and unresolved representations, and completed a task asking them to respond to infant cries. Sixty of the 243 participants (25%) experienced childhood abuse, mostly physical or sexual. The task simulated infant temperamental difficulty by manipulating soothing success in order to reflect an easy-to-soothe (80% soothing success) and a difficult-to-soothe infant (20% soothing success). Both after baseline and after each of the two stimulus series women assessed their parenting self-efficacy. Women who reported childhood abuse did not differ from women who reported no childhood abuse in parenting self-efficacy at baseline or in response to the easy-to-soothe infant (relative to baseline), but decreased more in parenting self-efficacy following the difficult-to-soothe infant. Effects did not vary according to resolution of trauma. These findings suggest that in response to infant temperamental difficulty, women who experienced childhood abuse may more easily lose confidence in their parenting abilities, which underlines the importance of preparing at-risk women for the possible challenges that come along with parenthood.	[Kunseler, Florentina C.; Oosterman, Mirjam; de Moor, Marleen H. M.; Verhage, Marije L.; Schuengel, Carlo] Vrije Univ Amsterdam, Sect Clin Child & Family Studies, Amsterdam, Netherlands; [Kunseler, Florentina C.; Oosterman, Mirjam; de Moor, Marleen H. M.; Verhage, Marije L.; Schuengel, Carlo] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Kunseler, FC (corresponding author), Vrije Univ Amsterdam, Sect Clin Child & Family Studies, Amsterdam, Netherlands.	f.c.kunseler@vu.nl	de Moor, Marleen/J-7434-2019; Schuengel, Carlo/A-7767-2008	de Moor, Marleen/0000-0001-7177-5637; Schuengel, Carlo/0000-0001-5501-3341; Verhage, Marije/0000-0001-8207-2283	foundation Stichting tot Steun Nederland; Netherlands Organization for Scientific Research (NWO) [400-09-123]	foundation Stichting tot Steun Nederland; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the foundation Stichting tot Steun Nederland [MO, CS] and a grant from the Netherlands Organization for Scientific Research (NWO; http://www.nwo.nl/). Grant number 400-09-123 [MO CS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, J AGGRESSION MALTREA, DOI [DOI 10.1080/10926771.2011.595763, 10.1080/10926771.2011.595763]; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Beijersbergen MD, 2008, CHILD DEV, V79, P1707, DOI 10.1111/j.1467-8624.2008.01220.x; Bowlby J., 1973, SEPARATION ANXIETY A, V2; Bowlby J, 1988, SECURE BASE PARENT C; Buchheim A, 2006, PSYCHOPATHOLOGY, V39, P144, DOI 10.1159/000091800; BUGENTAL DB, 1989, DEV PSYCHOL, V25, P532, DOI 10.1037/0012-1649.25.4.532; COLE PM, 1992, CHILD ABUSE NEGLECT, V16, P239, DOI 10.1016/0145-2134(92)90031-L; Coleman P. K., 1997, DEV REV, V18, P47; Crockenberg SC, 2003, J FAM PSYCHOL, V17, P80, DOI 10.1037/0893-3200.17.1.80; Crouch JL, 2008, CHILD ABUSE NEGLECT, V32, P702, DOI 10.1016/j.chiabu.2007.11.002; CROWE HP, 1992, CHILD ABUSE NEGLECT, V16, P19, DOI 10.1016/0145-2134(92)90005-C; CUTRONA CE, 1986, CHILD DEV, V57, P1507, DOI 10.1111/j.1467-8624.1986.tb00475.x; DONOVAN WL, 1990, CHILD DEV, V61, P1638, DOI 10.2307/1130771; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Gander M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00079; George C., 2008, HDB ATTACHMENT THEOR, V2nd ed., P833; Goldwyn R., 1984, ADULT ATTACHME UNPUB; Grusec JE, 1994, BELIEFS PARENTING OR, P5; Hesse E., 2008, HDB ATTACHMENT THEOR, P552; Jones TL, 2005, CLIN PSYCHOL REV, V25, P341, DOI 10.1016/j.cpr.2004.12.004; Kalichman SC, 2005, HEALTH EDUC RES, V20, P24, DOI 10.1093/her/cyg106; Leerkes EM, 2006, ATTACH HUM DEV, V8, P11, DOI 10.1080/14616730600594450; Leerkes EM, 2006, INFANT MENT HEALTH J, V27, P405, DOI 10.1002/imhj.20099; Leerkes EM, 2002, INFANCY, V3, P227, DOI 10.1207/S15327078IN0302_7; Leon K, 2004, INF MENTAL HLTH J, V25, P130, DOI 10.1002/imhj.10091; Madigan S, 2012, ATTACH HUM DEV, V14, P119, DOI 10.1080/14616734.2012.661230; Main M., 1990, ATTACHMENT PRESCHOOL, P161, DOI DOI 10.1016/J.NCL.2015.11.007; Milan S, 2004, J ABNORM CHILD PSYCH, V32, P249, DOI 10.1023/B:JACP.0000026139.01671.fd; MILNER JS, 1995, CHILD ABUSE NEGLECT, V19, P767, DOI 10.1016/0145-2134(95)00035-7; Muthen B., 2010, MPLUS USERS GUIDE; Muthen LK, 2008, GROWTH MODELING LATE; Bailey HN, 2007, ATTACH HUM DEV, V9, P139, DOI 10.1080/14616730701349721; Pedersen F.A., 1989, CONSTRUCTION SELF OF; Porter CL, 2003, J FAM PSYCHOL, V17, P54, DOI 10.1037/0893-3200.17.1.54; Putnam S., 2002, HDB PARENTING, P255; Riem MME, 2015, DEV PSYCHOPATHOL, V27, P507, DOI 10.1017/S0954579415000127; Schechter DS, 2012, SOC COGN AFFECT NEUR, V7, P969, DOI 10.1093/scan/nsr069; Schuetze P, 2005, CHILD ABUSE NEGLECT, V29, P645, DOI 10.1016/j.chiabu.2004.11.004; Sroufe L.A., 2005, POWER LONGITUDINAL A, P48; Stanley SM, 2006, PROQUEST INF LEARN, P66; TETI DM, 1991, CHILD DEV, V62, P918, DOI 10.2307/1131143; Turner NM, 2008, MED EDUC, V42, P503, DOI 10.1111/j.1365-2923.2007.02950.x; Verhage ML, 2013, J FAM PSYCHOL, V27, P844, DOI 10.1037/a0034263; Verhage ML, 2013, PARENT-SCI PRACT, V13, P253, DOI 10.1080/15295192.2013.832570; Williams T.M., 1987, INFANT MENT HEALTH J, V8, P251, DOI [10.1002/1097-0355(198723)8:3%3C251::AID-IMHJ2280080308%3E3.0.CO;2-U, DOI 10.1002/1097-0355(198723)8:3%3C251::AID-IMHJ2280080308%3E3.0.CO;2-U, DOI 10.1002/1097-0355(198723)8:3<251::AID-IMHJ2280080308>3.0.CO;2-U]	47	8	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0141801	10.1371/journal.pone.0141801	http://dx.doi.org/10.1371/journal.pone.0141801			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26848573	gold, Green Submitted, Green Published			2022-12-27	WOS:000369554000002
J	Wesner, M; Defreitas, T; Bredy, H; Pothier, L; Qin, ZL; McKillop, AB; Gross, DP				Wesner, Marni; Defreitas, Terry; Bredy, Heather; Pothier, Louisa; Qin, Ziling; McKillop, Ashley B.; Gross, Douglas P.			A Pilot Study Evaluating the Effectiveness of Platelet-Rich Plasma Therapy for Treating Degenerative Tendinopathies: A Randomized Control Trial with Synchronous Observational Cohort	PLOS ONE			English	Article							ROTATOR CUFF DISEASE; PAIN; INJECTIONS; SHOULDER; QUESTIONNAIRE; DISORDERS	Objective This pilot study aimed to inform future research evaluating the effectiveness of Platelet Rich Plasma (PRP) injection for tendinopathy. Design Randomized control trial (RCT) and synchronous observational cohort studies. For the RCT, consecutive consenting patients treated at an academic sports medicine clinic were randomly assigned to either a PRP or placebo control group. Setting The Glen Sather Sport Medicine Clinic, Edmonton, Canada. Patients The RCT included 9 participants with rotator cuff tendinopathy. The cohort study included 178 participants with a variety of tendinopathies. Interventions Patients receiving PRP were injected with 4 ml of platelets into the supraspinatus and/or infraspinatus, while patients in the placebo group were injected with 4ml of saline. All participants undertook a 3-month standardized, home-based, daily exercise program. Main Outcome Measures Participants in the RCT were re-evaluated 3, and 6 months post-injection. Change scores before and after injection on pain, disability and MRI-documented pathology outcomes were compared. In the cohort study, pain and disability were measured at 1, 2 and 3 months post-injection. Results For the RCT, 7 participants received PRP and 2 received placebo injections. Patients receiving PRP reported clinically important improvements in pain (>1.5/10 on VAS), disability (>15 point DASH change), and tendon pathology while those receiving placebo injections did not. In the observational cohort, statistically and clinically significant improvements in pain and disability were observed. Conclusion This pilot study provides information for planning future studies of PRP effectiveness. Preliminary results indicate intratendinous, ultrasound-guided PRP injection may lead to improvements in pain, function, and MRI-documented tendon pathology.	[Wesner, Marni; Defreitas, Terry; Bredy, Heather; Pothier, Louisa; Gross, Douglas P.] Univ Alberta, Glen Sather Sports Med Clin, Edmonton, AB, Canada; [Bredy, Heather; Gross, Douglas P.] Univ Alberta, Dept Phys Therapy, Edmonton, AB, Canada; [Qin, Ziling; McKillop, Ashley B.; Gross, Douglas P.] Univ Alberta, Rehabil Res Ctr, Fac Rehabil Med, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Gross, DP (corresponding author), Univ Alberta, Glen Sather Sports Med Clin, Edmonton, AB, Canada.; Gross, DP (corresponding author), Univ Alberta, Dept Phys Therapy, Edmonton, AB, Canada.; Gross, DP (corresponding author), Univ Alberta, Rehabil Res Ctr, Fac Rehabil Med, Edmonton, AB, Canada.	dgross@ualberta.ca	Gross, Douglas P./AAF-6997-2020	Gross, Douglas P./0000-0002-2427-6277	Workers' Compensation Board of Alberta Research Grants Program [RES0012970]	Workers' Compensation Board of Alberta Research Grants Program	This research was funded by the Workers' Compensation Board of Alberta Research Grants Program. Project number was RES0012970 [http://www.wcb.ab.ca/public/approved_projects.asp]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadehkhaiyat O, 2007, CLIN J PAIN, V23, P482, DOI 10.1097/AJP.0b013e31805f70fa; Andia I, 2014, BRIT MED BULL, V110, P99, DOI 10.1093/bmb/ldu007; Andres BM, 2008, CLIN ORTHOP RELAT R, V466, P1539, DOI 10.1007/s11999-008-0260-1; Anitua E, 2006, TRENDS BIOTECHNOL, V24, P227, DOI 10.1016/j.tibtech.2006.02.010; Beaton DE, 2001, BR J HAND THER, V6, P109, DOI DOI 10.1177/175899830100600401; Charousset C, 2014, AM J SPORT MED, V42, P906, DOI 10.1177/0363546513519964; Cole BJ, 2010, SPORTS HEALTH, V2, P203, DOI 10.1177/1941738110366385; Dallaudiere B, 2014, J VASC INTERV RADIOL, V25, P717, DOI 10.1016/j.jvir.2014.01.026; de Witte PB, 2012, AM J SPORT MED, V40, P1611, DOI 10.1177/0363546512446591; Finch E, 2002, PHYSICAL REHABILITAT; Flynn T, 2009, NZ J PHYSIOTHERAPY, V37, P145; Gummesson C, 2003, BMC MUSCULOSKELET DI, V4, DOI 10.1186/1471-2474-4-11; Jones B, 2003, DESIGN ANAL CROSS OV, pxxv; Kelly AM, 2001, EMERG MED J, V18, P205, DOI 10.1136/emj.18.3.205; Kesikburun S, 2013, AM J SPORT MED, V41, P2609, DOI 10.1177/0363546513496542; Kettunen JA, 2002, AM J SPORT MED, V30, P689, DOI 10.1177/03635465020300051001; Kirkley A, 2003, CLIN J SPORT MED, V13, P84, DOI 10.1097/00042752-200303000-00004; MacDermid JC, 2004, J SHOULDER ELB SURG, V13, P593, DOI 10.1016/j.jse.2004.03.009; Maffulli N, 1998, ARTHROSCOPY, V14, P840, DOI 10.1016/S0749-8063(98)70021-0; Mallinckrodt Craig H, 2003, J Biopharm Stat, V13, P179, DOI 10.1081/BIP-120019265; Malzahn DE, 1996, DISABIL REHABIL, V18, P382, DOI 10.3109/09638289609165901; Mautner K, 2013, PM&R, V5, P169, DOI 10.1016/j.pmrj.2012.12.010; Mei-Dan O, 2010, BRIT J SPORT MED, V44, P618, DOI 10.1136/bjsm.2009.067108; Mintken PE, 2009, J SHOULDER ELB SURG, V18, P920, DOI 10.1016/j.jse.2008.12.015; Miranda H, 2005, AM J EPIDEMIOL, V161, P847, DOI 10.1093/aje/kwi112; Raman Jayaprakash, 2012, J Physiother, V58, P201, DOI 10.1016/S1836-9553(12)70115-7; Rha DW, 2013, CLIN REHABIL, V27, P113, DOI 10.1177/0269215512448388; Rowan Tracy L, 2013, J Can Chiropr Assoc, V57, P301; Scarpone Michael, 2013, Glob Adv Health Med, V2, P26, DOI 10.7453/gahmj.2012.054; TURNER JA, 1994, JAMA-J AM MED ASSOC, V271, P1609, DOI 10.1001/jama.271.20.1609; VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959	31	36	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147842	10.1371/journal.pone.0147842	http://dx.doi.org/10.1371/journal.pone.0147842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849812	gold, Green Submitted, Green Published			2022-12-27	WOS:000369554000025
J	Hennegan, J; Montgomery, P				Hennegan, Julie; Montgomery, Paul			Do Menstrual Hygiene Management Interventions Improve Education and Psychosocial Outcomes for Women and Girls in Low and Middle Income Countries? A Systematic Review	PLOS ONE			English	Review							ADOLESCENT GIRLS; EXPERIENCES; HEALTH; SCHOOLGIRLS; SANITATION; PUBERTY; AGE	Background Unhygienic and ineffective menstrual hygiene management has been documented across low resource contexts and linked to negative consequences for women and girls. Objectives To summarise and critically appraise evidence for the effectiveness of menstruation management interventions in improving women and girls' education, work and psychosocial wellbeing in low and middle income countries. Methods Structured systematic searches were conducted in peer-reviewed and grey literature to identify studies evaluating education and resource provision interventions for menstruation management. Individual and cluster randomised controlled trials were eligible for inclusion, as were non-randomised controlled trials. Study characteristics, outcomes and risk of bias were extracted using a piloted form. Risk of bias was independently assessed by two researchers. Results Eight studies described in ten citations were eligible for inclusion. Studies were highly heterogeneous in design and context. Six included assessment of education-only interventions, and three provided assessment of the provision of different types of sanitary products (menstrual cups, disposable sanitary pads, and reusable sanitary pads). A moderate but non-significant standardised mean difference was found for the two studies assessing the impact of sanitary pad provision on school attendance: 0.49 (95% CI -0.13, 1.11). Included studies were heterogeneous with considerable risk of bias. Trials of education interventions reported positive impacts on menstrual knowledge and practices, however, many studies failed to assess other relevant outcomes. No trials assessed or reported harms. Conclusions There is insufficient evidence to establish the effectiveness of menstruation management interventions, although current results are promising. Eight trials have been conducted, but a high risk of bias was found and clinical heterogeneity precluded synthesis of most results. Whilst trials provided some indication of positive results, further research is needed to establish the role of menstruation hygiene management in education performance, employment and other psychosocial outcomes. This review provides a concise summary of present trials and highlights improvements for future work.	[Hennegan, Julie; Montgomery, Paul] Univ Oxford, Ctr Evidence Based Intervent, Oxford, England	University of Oxford	Hennegan, J (corresponding author), Univ Oxford, Ctr Evidence Based Intervent, Oxford, England.	julie.hennegan@spi.ox.ac.uk		Montgomery, Paul/0000-0001-8008-1370; Hennegan, Julie/0000-0003-2011-1595	Department of Social Policy & Intervention Centenary Scholarship; Fellowships Fund Inc. of Graduate Women Queensland; Green Templeton College Rosemary Stewart Scholarship; ESRC [ES/I034145/2] Funding Source: UKRI; Economic and Social Research Council [ES/I034145/2] Funding Source: researchfish	Department of Social Policy & Intervention Centenary Scholarship; Fellowships Fund Inc. of Graduate Women Queensland; Green Templeton College Rosemary Stewart Scholarship; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	JH's PhD is supported by a Department of Social Policy & Intervention Centenary Scholarship, a fellowship from the Fellowships Fund Inc. of Graduate Women Queensland and Green Templeton College Rosemary Stewart Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedian Z, 2011, J AM SCI, V7, P1; Abrahams N, 2006, TROP MED INT HEALTH, V11, P751, DOI 10.1111/j.1365-3156.2006.01600.x; Adams J, 2009, WATER SANITATION HYG; Adinma ED, 2009, AFR J REPROD HEALTH, V12, P74; Ali TS, 2010, J ADOLESCENCE, V33, P531, DOI 10.1016/j.adolescence.2009.05.013; Anderson SE, 2003, PEDIATRICS, V111, P844, DOI 10.1542/peds.111.4.844; Avasarala Atchuta Kameswararao, 2008, Indian J Community Med, V33, P246, DOI 10.4103/0970-0218.43231; Birdthistle I., 2011, WHAT IMPACT DOES PRO; BROOKSGUNN J, 1980, PSYCHOSOM MED, V42, P503, DOI 10.1097/00006842-198009000-00005; Business for Social Responsibility (BSR), 2012, HERPROJECT INV WOM B; Business for Social Responsibility (BSR), 2011, HERPROJECT HLTH EN R; Chothe V, 2014, HEALTH PROMOT PRACT, V15, P319, DOI 10.1177/1524839914525175; Crichton J, 2013, HEALTH CARE WOMEN IN, V34, P891, DOI 10.1080/07399332.2012.740112; Crofts T, 2012, J WATER SANIT HYG DE, V2, P50, DOI 10.2166/washdev.2012.067; Das P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130777; Dasgupta A, 2008, Indian J Community Med, V33, P77, DOI 10.4103/0970-0218.40872; Deo D. S., 2005, INDIAN J COMMUNITY M, V30, P33; Djalalinia S, 2012, INT J PREVENTIVE MED, V3, P622; Dolan CS, 2014, J INT DEV, V26, P643, DOI 10.1002/jid.2917; Effective Practice and Organisation of Care (EPOC) EPaOoC, 2013, EPOC RES REV AUTH; El-Gilany AH, 2005, REPROD HEALTH MATTER, V13, P147, DOI 10.1016/S0968-8080(05)26191-8; Fakhri M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-193; Fetohy Ebtisam M, 2007, J Egypt Public Health Assoc, V82, P105; Fisher Julie, 2006, WATER SANITATION HYG; Garg R, 2012, MATERN CHILD HLTH J, V16, P767, DOI 10.1007/s10995-011-0798-5; Grant M, 2013, COMP EDUC REV, V57, P260, DOI 10.1086/669121; Haver J, 2013, WASH IN SCHOOLS EMPO; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; House S., 2012, MENSTRUAL HYGIENE MA; Inter-agency Task Force on Gender and Water (GWTF), 2006, GEND WAT SAN POL BRI; Jasper C, 2012, INT J ENV RES PUB HE, V9, P2772, DOI 10.3390/ijerph9082772; Khanna A, 2005, J HEALTH MANAG, V7, P91, DOI 10.1177/097206340400700103; Kirk J., 2006, MENSTRUATION BODY AW, P1; Kumar A, 2011, SOC WORK PUBLIC HLTH, V26, P594, DOI 10.1080/19371918.2010.525144; Lloyd C. B., 2009, NEW LESSONS POWER ED; Mahon T., 2010, Gender and Development, V18, P99, DOI 10.1080/13552071003600083; Mbizvo MT, 1997, SOC SCI MED, V44, P573, DOI 10.1016/S0277-9536(96)00204-3; McMahon SA, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-7; Ministry of Health & Family Welfare Government of India, 2012, 2 YEAR 2009 2011 ACH; Mmari K, 2015, AMERICAN JOURNAL OF, pe1; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Montgomery P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048274; Oster E, 2011, AM ECON J-APPL ECON, V3, P91, DOI 10.1257/app.3.1.91; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Pillitteri S.P., 2011, SCH MENSTRUAL HYGIEN; RevMan, 2012, REV MAN REVMAN COMP; Santina T, 2012, E MEDITERR HEALTH J, V18, P1; Sommer M., 2011, International Electronic Journal of Health Education, V14, P77; Sommer M, 2015, COMPARE, V45, P589, DOI 10.1080/03057925.2013.871399; Sommer M, 2013, AM J PUBLIC HEALTH, V103, P1556, DOI 10.2105/AJPH.2013.301374; Sommer M, 2010, J ADOLESCENCE, V33, P521, DOI 10.1016/j.adolescence.2009.03.008; Sommer M, 2009, CULT HEALTH SEX, V11, P383, DOI 10.1080/13691050902722372; Sumpter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062004; Tavallaee M, 2011, J OBSTET GYNAECOL RE, V37, P442, DOI 10.1111/j.1447-0756.2010.01362.x; Wilson EF, 2012, RES REPORT SCHARR RE, V27; Wilson E, 2014, DEV PRACT, V24, P63, DOI 10.1080/09614524.2014.867305; World Bank, 2014, COUNTR LEND GROUPS D	57	94	97	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0146985	10.1371/journal.pone.0146985	http://dx.doi.org/10.1371/journal.pone.0146985			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26862750	Green Published, gold			2022-12-27	WOS:000370046600016
J	Park, JR; Ahn, JH; Jung, MH; Koh, JS; Park, Y; Hwang, SJ; Jeong, YH; Kwak, CH; Lee, YS; Seo, HG; Kim, JH; Hwang, JY				Park, Jeong Rang; Ahn, Jong Hwa; Jung, Myeong Hee; Koh, Jin-Sin; Park, Yongwhi; Hwang, Seok-Jae; Jeong, Young-Hoon; Kwak, Choong Hwan; Lee, Young Soo; Seo, Han Geuk; Kim, Jin Hyun; Hwang, Jin-Yong			Effects of Peroxisome Proliferator-Activated Receptor-delta Agonist on Cardiac Healing after Myocardial Infarction	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; MESENCHYMAL STEM-CELLS; PPAR-DELTA; MYOFIBROBLAST DIFFERENTIATION; ISCHEMIA/REPERFUSION INJURY; MATRIX METALLOPROTEINASES; FIBROBLAST PROLIFERATION; INHIBITION; MECHANISMS; HEART	Peroxisome proliferator-activated receptor-delta (PPAR-delta)-dependent signaling is associated with rapid wound healing in the skin. Here, we investigated the therapeutic effects of PPAR-delta-agonist treatment on cardiac healing in post-myocardial infarction (MI) rats. Animals were assigned to the following groups: sham-operated control group, left anterior descending coronary artery ligation (MI) group, or MI with administration of the PPAR-delta agonist GW610742 group. GW610742 (1 mg/kg) was administrated intraperitoneally after the operation and repeated every 3 days. Echocardiographic data showed no differences between the two groups in terms of cardiac function and remodeling until 4 weeks. However, the degrees of angiogenesis and fibrosis after MI were significantly higher in the GW610742-treated rats than in the untreated MI rats at 1 week following MI, which changes were not different at 2 weeks after MI. Naturally, PPAR-delta expression in infarcted myocardium was highest increased in 3 day after MI and then disappeared in 14 day after MI. GW610742 increased myofibroblast differentiation and transforming growth factor-beta 2 expression in the infarct zone at 7 days after MI. GW610742 also increased bone marrowderived mesenchymal stem cell (MSC) recruitment in whole myocardium, and increased serum platelet-derived growth factor B, stromal-derived factor-1 alpha, and matrix metallopeptidase 9 levels at day 3 after MI. PPAR-delta agonists treatment have the temporal effect on early fibrosis of infarcted myocardium, which might not sustain the functional and structural beneficial effect.	[Park, Jeong Rang; Ahn, Jong Hwa; Koh, Jin-Sin; Park, Yongwhi; Hwang, Seok-Jae; Jeong, Young-Hoon; Kwak, Choong Hwan; Hwang, Jin-Yong] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, Jinju, South Korea; [Park, Jeong Rang; Ahn, Jong Hwa; Koh, Jin-Sin; Park, Yongwhi; Hwang, Seok-Jae; Jeong, Young-Hoon; Kwak, Choong Hwan; Hwang, Jin-Yong] Gyeongsang Natl Univ Hosp, Jinju, South Korea; [Park, Jeong Rang; Ahn, Jong Hwa; Koh, Jin-Sin; Park, Yongwhi; Hwang, Seok-Jae; Jeong, Young-Hoon; Kwak, Choong Hwan; Kim, Jin Hyun; Hwang, Jin-Yong] Gyeongsang Natl Univ, Inst Hlth Sci, Jinju, South Korea; [Jung, Myeong Hee; Kim, Jin Hyun] Gyeongsang Natl Univ Hosp, Biomed Res Inst, Jinju, South Korea; [Lee, Young Soo] Gyeongsang Natl Univ, Dept Pharmacol, Sch Med, Jinju, South Korea; [Seo, Han Geuk] Konkuk Univ, Dept Anim Biotechnol, Seoul, South Korea	Gyeongsang National University; Gyeongsang National University; Gyeongsang National University Hospital; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University Hospital; Gyeongsang National University; Konkuk University	Hwang, JY (corresponding author), Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, Jinju, South Korea.; Hwang, JY (corresponding author), Gyeongsang Natl Univ Hosp, Jinju, South Korea.; Kim, JH; Hwang, JY (corresponding author), Gyeongsang Natl Univ, Inst Hlth Sci, Jinju, South Korea.; Kim, JH (corresponding author), Gyeongsang Natl Univ Hosp, Biomed Res Inst, Jinju, South Korea.	ajini7044@hanmail.net; jyhwang@gnu.ac.kr	Jeong, Young-Hoon/F-3476-2015; Jeong, Young-Hoon/AAO-4401-2020	Jeong, Young-Hoon/0000-0003-0403-3726; Kwak, Choong Hwan/0000-0001-6035-4415	Gyeongsang National University Hospital [GNUHBRIF-2013-0006]	Gyeongsang National University Hospital	This work was supported by biomedical research institute funds (GNUHBRIF-2013-0006) from Gyeongsang National University Hospital.	Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Carlson S, 2011, CARDIOVASC RES, V91, P99, DOI 10.1093/cvr/cvr061; dos Santos L, 2008, BRAZ J MED BIOL RES, V41, P199, DOI 10.1590/S0100-879X2008005000007; Frantz S, 2008, BASIC RES CARDIOL, V103, P485, DOI 10.1007/s00395-008-0739-7; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; Gajarsa JJ, 2011, HEART FAIL REV, V16, P13, DOI 10.1007/s10741-010-9181-7; Ghadge SK, 2011, PHARMACOL THERAPEUT, V129, P97, DOI 10.1016/j.pharmthera.2010.09.011; Ham SA, 2010, J CELL MOL MED, V14, P1747, DOI 10.1111/j.1582-4934.2009.00816.x; Han JK, 2008, CIRCULATION, V118, P1021, DOI 10.1161/CIRCULATIONAHA.108.777169; Han JK, 2013, EUR HEART J, V34, P1755, DOI 10.1093/eurheartj/ehr365; Hinz B, 2004, MOL BIOL CELL, V15, P4310, DOI 10.1091/mbc.E04-05-0386; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Kapoor A, 2010, SHOCK, V34, P117, DOI 10.1097/SHK.0b013e3181cd86d6; Kim HJ, 2008, CIRC RES, V102, P193, DOI 10.1161/CIRCRESAHA.107.158477; Naugle JE, 2006, AM J PHYSIOL-HEART C, V290, pH323, DOI 10.1152/ajpheart.00321.2005; Nedeau AE, 2008, EXP CELL RES, V314, P2176, DOI 10.1016/j.yexcr.2008.04.007; Olson ER, 2005, AM J PHYSIOL-HEART C, V288, pH1131, DOI 10.1152/ajpheart.00763.2004; Piqueras L, 2007, ARTERIOSCL THROM VAS, V27, P63, DOI 10.1161/01.ATV.0000250972.83623.61; Shi Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028134; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026; Vanhoutte D, 2006, CARDIOVASC RES, V69, P604, DOI 10.1016/j.cardiores.2005.10.002; Yue TL, 2008, J PHARMACOL EXP THER, V325, P466, DOI 10.1124/jpet.107.135327; Zamilpa R, 2010, J MOL CELL CARDIOL, V48, P558, DOI 10.1016/j.yjmcc.2009.06.012	26	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148510	10.1371/journal.pone.0148510	http://dx.doi.org/10.1371/journal.pone.0148510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862756	gold, Green Published			2022-12-27	WOS:000370046600079
J	Fu, X; Xie, FN; Dong, P; Li, QC; Yu, GY; Xiao, R				Fu, Xin; Xie, Fang-Nan; Dong, Ping; Li, Qiu-Chen; Yu, Guang-Yan; Xiao, Ran			High-Dose Fluoride Impairs the Properties of Human Embryonic Stem Cells via JNK Signaling	PLOS ONE			English	Article							IN-VITRO MODEL; SODIUM-FLUORIDE; DEVELOPMENTAL TOXICITY; BCL-2 FAMILY; INDUCED APOPTOSIS; PROGENITOR CELLS; DRINKING-WATER; DIFFERENTIATION; BODIES; PROTEIN	Fluoride is a ubiquitous natural substance that is often used in dental products to prevent dental caries. The biphasic actions of fluoride imply that excessive systemic exposure to fluoride can cause harmful effects on embryonic development in both animal models and humans. However, insufficient information is available on the effects of fluoride on human embryonic stem cells (hESCs), which is a novel in vitro humanized model for analyzing the embryotoxicities of chemical compounds. Therefore, we investigated the effects of sodium fluoride (NaF) on the proliferation, differentiation and viability of H9 hESCs. For the first time, we showed that 1 mM NaF did not significantly affect the proliferation of hESCs but did disturb the gene expression patterns of hESCs during embryoid body (EB) differentiation. Higher doses of NaF (2 mM and above) markedly decreased the viability and proliferation of hESCs. The mode and underlying mechanism of high-dose NaF-induced cell death were further investigated by assessing the sub-cellular morphology, mitochondrial membrane potential (MMP), caspase activities, cellular reactive oxygen species (ROS) levels and activation of mitogen-activated protein kinases (MAPKs). High-dose NaF caused the death of hESCs via apoptosis in a caspase-mediated but ROS-independent pathway, coupled with an increase in the phospho-c-Jun N-terminal kinase (p-JNK) levels. Pretreatment with a p-JNK-specific inhibitor (SP600125) could effectively protect hESCs from NaF-induced cell death in a concentration-and time-dependent manner. These findings suggest that NaF might interfere with early human embryogenesis by disturbing the specification of the three germ layers as well as osteogenic lineage commitment and that high-dose NaF could cause apoptosis through a JNK-dependent pathway in hESCs.	[Fu, Xin; Xie, Fang-Nan; Dong, Ping; Li, Qiu-Chen; Xiao, Ran] Chinese Acad Med Sci, Res Ctr Plast Surg Hosp, 33 Ba Da Chu Rd, Beijing, Peoples R China; [Fu, Xin; Xie, Fang-Nan; Dong, Ping; Li, Qiu-Chen; Xiao, Ran] Peking Union Med Coll, 33 Ba Da Chu Rd, Beijing, Peoples R China; [Yu, Guang-Yan] Peking Univ, Dept Oral & Maxillofacial Surg, Sch Stomatol, 22 Zhong Guan Cun South St, Beijing 100081, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Plastic Surgery Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University	Xiao, R (corresponding author), Chinese Acad Med Sci, Res Ctr Plast Surg Hosp, 33 Ba Da Chu Rd, Beijing, Peoples R China.; Xiao, R (corresponding author), Peking Union Med Coll, 33 Ba Da Chu Rd, Beijing, Peoples R China.	xiaoran@psh.pumc.edu.cn			National Natural Science Foundation of China [31201102, 30871433, 31071305]; International S&T Cooperation Program of China [2011DFA32190]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International S&T Cooperation Program of China	This work was supported by grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) with grants numbers as 31201102 (XF), 30871433 (RX) and 31071305 (RX); and from International S&T Cooperation Program of China (http://www.istcp.org.cn) with grant number as 2011DFA32190 (GYY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler S, 2008, TOXICOL IN VITRO, V22, P200, DOI 10.1016/j.tiv.2007.07.013; Agalakova N. I., 2012, ISRN CELL BIOL, V2012, DOI [10.5402/2012/403835, DOI 10.5402/2012/403835]; [Anonymous], 2011, ENCY ENV HLTH; Barbier O, 2010, CHEM-BIOL INTERACT, V188, P319, DOI 10.1016/j.cbi.2010.07.011; Boutin C, 2010, P NATL ACAD SCI USA, V107, P1201, DOI 10.1073/pnas.0909015107; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chalah A, 2008, ADV EXP MED BIOL, V615, P25, DOI 10.1007/978-1-4020-6554-5_3; Chlubek D, 2003, J TRACE ELEM MED BIO, V17, P57, DOI 10.1016/S0946-672X(03)80047-0; Choi AL, 2012, ENVIRON HEALTH PERSP, V120, P1362, DOI 10.1289/ehp.1104912; Cooper LF, 2006, BIOMATERIALS, V27, P926, DOI 10.1016/j.biomaterials.2005.07.009; de Jong E, 2012, TOXICOL IN VITRO, V26, P970, DOI 10.1016/j.tiv.2012.05.015; Dvash T, 2004, HUM REPROD, V19, P2875, DOI 10.1093/humrep/deh529; Everett ET, 2011, J DENT RES, V90, P552, DOI 10.1177/0022034510384626; Feraud O, 2001, LAB INVEST, V81, P1669, DOI 10.1038/labinvest.3780380; Foshay KM, 2008, STEM CELLS DEV, V17, P269, DOI 10.1089/scd.2007.0098; FRENI SC, 1994, J TOXICOL ENV HEALTH, V42, P109, DOI 10.1080/15287399409531866; Gao XG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108510; Goh EH, 2003, FOOD CHEM TOXICOL, V41, P1501, DOI 10.1016/S0278-6915(03)00166-2; Griffin SO, 2007, J DENT RES, V86, P410, DOI 10.1177/154405910708600504; Gupta RS, 2007, TOXICOL IND HEALTH, V23, P507, DOI 10.1177/0748233708089041; HALL BK, 1987, BONE, V8, P111, DOI 10.1016/8756-3282(87)90079-2; Haneline LS, 2008, ANTIOXID REDOX SIGN, V10, P1849, DOI 10.1089/ars.2008.2141; Hong EJ, 2013, TOX RESEARCH, V29, P221, DOI 10.5487/TR.2013.29.4.221; Kopper O, 2010, STEM CELLS, V28, P75, DOI 10.1002/stem.260; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Krtolica A, 2009, REGEN MED, V4, P449, DOI [10.2217/rme.09.13, 10.2217/RME.09.13]; Krug AK, 2013, ARCH TOXICOL, V87, P123, DOI 10.1007/s00204-012-0967-3; Kubota K, 2005, J BIOL CHEM, V280, P23194, DOI 10.1074/jbc.M503288200; LANTZ O, 1987, AM J KIDNEY DIS, V10, P136, DOI 10.1016/S0272-6386(87)80046-X; Lau KHW, 1998, J BONE MINER RES, V13, P1660, DOI 10.1359/jbmr.1998.13.11.1660; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lee JH, 2008, TOXICOLOGY, V243, P340, DOI 10.1016/j.tox.2007.10.026; Lee YE, 2010, J DENT, V38, P166, DOI 10.1016/j.jdent.2009.10.002; Li P, 2013, TOXICOLOGY, V308, P138, DOI 10.1016/j.tox.2013.03.016; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Meganathan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044228; Mehta A, 2008, CELL BIOL INT, V32, P1412, DOI 10.1016/j.cellbi.2008.08.012; MULLENIX PJ, 1995, NEUROTOXICOL TERATOL, V17, P169, DOI 10.1016/0892-0362(94)00070-T; Oguro A, 2003, IN VITRO CELL DEV-AN, V39, P243; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Pettinato G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100742; Reddy GB, 2003, TOXICOL SCI, V72, P363, DOI 10.1093/toxsci/kfg030; Rohwedel J, 2001, TOXICOL IN VITRO, V15, P741, DOI 10.1016/S0887-2333(01)00074-1; Sherlin DMG, 2001, NEUROTOXICOL TERATOL, V23, P197, DOI 10.1016/S0892-0362(00)00123-9; Shi Jingpu, 1995, Zhonghua Yufang Yixue Zazhi, V29, P103; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Tam DNN, 2012, TOXICOL APPL PHARM, V259, P329, DOI 10.1016/j.taap.2012.01.010; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thrane EV, 2001, TOXICOL SCI, V61, P83, DOI 10.1093/toxsci/61.1.83; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Warkus ELL, 2016, TOXICOL SCI, V149, P15, DOI 10.1093/toxsci/kfv209; Weitzer G, 2006, HANDB EXP PHARM, V174, P21; Xiong XZ, 2007, ENVIRON RES, V103, P112, DOI 10.1016/j.envres.2006.05.008; Yang SY, 2011, BIOCHEM BIOPH RES CO, V410, P910, DOI 10.1016/j.bbrc.2011.06.094; Zhang M, 2008, TOXICOL LETT, V179, P1, DOI 10.1016/j.toxlet.2008.03.002; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhou X, 2003, DEV BIOL, V255, P407, DOI 10.1016/S0012-1606(02)00080-5; Zhu JQ, 2014, ARCH TOXICOL, V88, P241, DOI 10.1007/s00204-013-1122-5	61	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148819	10.1371/journal.pone.0148819	http://dx.doi.org/10.1371/journal.pone.0148819			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859149	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400092
J	Ibitoye, MO; Hamzaid, NA; Hasnan, N; Wahab, AKA; Davis, GM				Ibitoye, Morufu Olusola; Hamzaid, Nur Azah; Hasnan, Nazirah; Wahab, Ahmad Khairi Abdul; Davis, Glen M.			Strategies for Rapid Muscle Fatigue Reduction during FES Exercise in Individuals with Spinal Cord Injury: A Systematic Review	PLOS ONE			English	Review							FUNCTIONAL ELECTRICAL-STIMULATION; FEEDBACK-CONTROLLED STIMULATION; SKELETAL-MUSCLE; THENAR MUSCLES; CONTRACTILE PROPERTIES; PARALYZED QUADRICEPS; RANDOM MODULATION; FORCE; FREQUENCY; PATTERN	Background Rapid muscle fatigue during functional electrical stimulation (FES)-evoked muscle contractions in individuals with spinal cord injury (SCI) is a significant limitation to attaining health benefits of FES-exercise. Delaying the onset of muscle fatigue is often cited as an important goal linked to FES clinical efficacy. Although the basic concept of fatigue-resistance has a long history, recent advances in biomedical engineering, physiotherapy and clinical exercise science have achieved improved clinical benefits, especially for reducing muscle fatigue during FES-exercise. This review evaluated the methodological quality of strategies underlying muscle fatigue-resistance that have been used to optimize FES therapeutic approaches. The review also sought to synthesize the effectiveness of these strategies for persons with SCI in order to establish their functional impacts and clinical relevance. Methods Published scientific literature pertaining to the reduction of FES-induced muscle fatigue was identified through searches of the following databases: Science Direct, Medline, IEEE Xplore, SpringerLink, PubMed and Nature, from the earliest returned record until June 2015. Titles and abstracts were screened to obtain 35 studies that met the inclusion criteria for this systematic review. Results Following the evaluation of methodological quality (mean (SD), 50 (6) %) of the reviewed studies using the Downs and Black scale, the largest treatment effects reported to reduce muscle fatigue mainly investigated isometric contractions of limited functional and clinical relevance (n = 28). Some investigations (n = 13) lacked randomisation, while others were characterised by small sample sizes with low statistical power. Nevertheless, the clinical significance of emerging trends to improve fatigue-resistance during FES included (i) optimizing electrode positioning, (ii) fine-tuning of stimulation patterns and other FES parameters, (iii) adjustments to the mode and frequency of exercise training, and (iv) biofeedback-assisted FES-exercise to promote selective recruitment of fatigue-resistant motor units. Conclusion Although the need for further in-depth clinical trials (especially RCTs) was clearly warranted to establish external validity of outcomes, current evidence was sufficient to support the validity of certain techniques for rapid fatigue-reduction in order to promote FES therapy as an integral part of SCI rehabilitation. It is anticipated that this information will be valuable to clinicians and other allied health professionals administering FES as a treatment option in rehabilitation and aid the development of effective rehabilitation interventions.	[Ibitoye, Morufu Olusola; Hamzaid, Nur Azah; Wahab, Ahmad Khairi Abdul; Davis, Glen M.] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia; [Ibitoye, Morufu Olusola] Univ Ilorin, Fac Engn & Technol, Dept Biomed Engn, Ilorin, Nigeria; [Hasnan, Nazirah] Univ Malaya, Fac Med, Dept Rehabil Med, Kuala Lumpur, Malaysia; [Davis, Glen M.] Univ Sydney, Discipline Exercise & Sport Sci, Sci Fac Hlth Sci, Clin Exercise & Rehabil Unit, Sydney, NSW 2006, Australia	Universiti Malaya; University of Ilorin; Universiti Malaya; University of Sydney	Hamzaid, NA (corresponding author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia.	azah.hamzaid@um.edu.my	Ibitoye, Morufu Olusola/G-2021-2014; Hamzaid, Nur Azah/AAH-4122-2020; HAMZAID, NUR AZAH/B-9417-2010; Hasnan, Nazirah/M-5081-2017; Abdul Wahab, Assoc. Prof. Ir. Dr. Ahmad Khairi/B-8162-2010; HASNAN, NAZIRAH/B-9217-2010	Ibitoye, Morufu Olusola/0000-0001-8927-0653; Hamzaid, Nur Azah/0000-0002-4277-2813; HAMZAID, NUR AZAH/0000-0002-4277-2813; Hasnan, Nazirah/0000-0002-5775-428X; Abdul Wahab, Assoc. Prof. Ir. Dr. Ahmad Khairi/0000-0001-5900-8718; HASNAN, NAZIRAH/0000-0002-5775-428X	Ministry of Higher Education, Malaysia [UM.C/625/1/HIR/MOHE/ENG/39]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	This review was financially supported by the Ministry of Higher Education, Malaysia, hir.um.edu.my, under the grant number: UM.C/625/1/HIR/MOHE/ENG/39. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ama del- AJ, 2013, J AUTOM CONTROL, V21, P19, DOI DOI 10.2298/JAC1301019A; Bickel CS, 2011, EUR J APPL PHYSIOL, V111, P2399, DOI 10.1007/s00421-011-2128-4; Bickel CS, 2004, J REHABIL RES DEV, V41, P33, DOI 10.1682/JRRD.2004.01.0033; BINDERMACLEOD SA, 1993, PHYS THER, V73, P902, DOI 10.1093/ptj/73.12.902; Burnham R, 1997, SPINAL CORD, V35, P86, DOI 10.1038/sj.sc.3100364; Butler JE, 2004, MUSCLE NERVE, V29, P575, DOI 10.1002/mus.20002; Castro MJ, 1999, EUR J APPL PHYSIOL, V80, P373, DOI 10.1007/s004210050606; Chang YJ, 2011, NEUROREHAB NEURAL RE, V25, P423, DOI 10.1177/1545968310390224; Chou LW, 2008, ARCH PHYS MED REHAB, V89, P856, DOI 10.1016/j.apmr.2007.10.027; Chudyk AM, 2009, ARCH PHYS MED REHAB, V90, P246, DOI 10.1016/j.apmr.2008.06.036; Collins DF, 2007, EXERC SPORT SCI REV, V35, P102; Crameri RM, 2002, SCAND J MED SCI SPOR, V12, P316, DOI 10.1034/j.1600-0838.2002.20106.x; Decker MJ, 2010, J ELECTROMYOGR KINES, V20, P1163, DOI 10.1016/j.jelekin.2010.07.015; Deeks J J, 2003, Health Technol Assess, V7, piii; Deley G, 2015, MUSCLE NERVE, V52, P260, DOI 10.1002/mus.24530; Doucet Barbara M., 2012, Yale Journal of Biology and Medicine, V85, P201; Downey RJ, 2014, COMP INDUCED MUSCLE, DOI [10.1109/TNSRE.2014.2364735, DOI 10.1109/TNSRE.2014.2364735]; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Dudley-Javoroski S, 2011, ARCH PHYS MED REHAB, V92, P242, DOI 10.1016/j.apmr.2010.10.031; Eser PC, 2003, IEEE T NEUR SYS REH, V11, P236, DOI 10.1109/TNSRE.2003.817677; Finsterer J, 2013, AM J HOSP PALLIAT ME, P1; Fornusek C, 2004, J REHABIL MED, V36, P232, DOI 10.1080/16501970410029843; Fornusek C, 2014, SPINAL CORD, V52, P635, DOI 10.1038/sc.2014.85; Fouad K, 2012, EXP NEUROL, V235, P91, DOI 10.1016/j.expneurol.2011.02.009; Gerrits HL, 2002, MUSCLE NERVE, V25, P559, DOI 10.1002/mus.10071; Gerrits HL, 2000, SPINAL CORD, V38, P214, DOI 10.1038/sj.sc.3100974; Gobbo M, 2006, EUR J APPL PHYSIOL, V97, P9, DOI 10.1007/s00421-006-0134-8; Gobbo M, 2011, EUR J APPL PHYSIOL, V111, P2451, DOI 10.1007/s00421-011-2047-4; Gobbo M, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-17; Godfrey S, 2002, MUSCLE NERVE, V26, P122, DOI 10.1002/mus.10173; Gorgey AS, 2007, SPINAL CORD, V45, P304, DOI 10.1038/sj.sc.3101968; Gorgey AS, 2015, J SPINAL CORD MED, V0; Gorgey AS, 2014, J REHABIL RES DEV, V51, P1455, DOI 10.1682/JRRD.2014.02.0054; Graham GM, 2006, IEEE T NEUR SYS REH, V14, P38, DOI 10.1109/TNSRE.2006.870490; Graupe D, 2000, NEUROL RES, V22, P703; Griffin L, 2002, J NEUROPHYSIOL, V87, P2271, DOI 10.1152/jn.2002.87.5.2271; Hamzaid NA, 2009, TOP SPINAL CORD INJ, V14, P88; Hartkopp A, 2003, MUSCLE NERVE, V27, P72, DOI 10.1002/mus.10290; Hatsopoulos NG, 2009, ANNU REV NEUROSCI, V32, P249, DOI 10.1146/annurev.neuro.051508.135241; Hillegass EA, 1999, SPINAL CORD, V37, P251, DOI 10.1038/sj.sc.3100792; Hunter S, 1998, J GERONTOL A-BIOL, V53, pB204, DOI 10.1093/gerona/53A.3.B204; Ibitoye MO, 2014, SENSORS-BASEL, V14, P12598, DOI 10.3390/s140712598; Jacobs PL, 2002, ARCH PHYS MED REHAB, V83, P19, DOI 10.1053/apmr.2002.26829; Jaime RP, 2002, IEEE T NEUR SYS REH, V10, P239, DOI 10.1109/TNSRE.2002.806830; KARU ZZ, 1995, IEEE T BIO-MED ENG, V42, P809, DOI 10.1109/10.398642; Kebaetse MB, 2005, ARCH PHYS MED REHAB, V86, P2157, DOI 10.1016/j.apmr.2005.06.011; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Maffiuletti NA, 2014, EUR J APPL PHYSIOL, V114, P1197, DOI 10.1007/s00421-014-2849-2; Maffiuletti NA, 2010, EUR J APPL PHYSIOL, V110, P223, DOI 10.1007/s00421-010-1502-y; Mahoney E, 2007, J SPINAL CORD MED, V30, P458, DOI 10.1080/10790268.2007.11753510; Malesevic NM, 2010, MUSCLE NERVE, V42, P556, DOI 10.1002/mus.21736; Mizrahi J., 1997, CRITICAL REV PHYSICA, V9, P93; Mohr T, 1997, SPINAL CORD, V35, P1, DOI 10.1038/sj.sc.3100343; Nash MS, 2007, ARCH PHYS MED REHAB, V88, P228, DOI 10.1016/j.apmr.2006.11.012; Nguyen R, 2011, ARTIF ORGANS, V35, P1174, DOI 10.1111/j.1525-1594.2010.01195.x; Ojha HA, 2014, PHYS THER, V94, P14, DOI 10.2522/ptj.20130096; Opperman EA, 2010, SPINAL CORD, V48, P60, DOI 10.1038/sc.2009.86; PECKHAM PH, 1976, CLIN ORTHOP RELAT R, P326; Pelletier CA., 2013, CRITICAL REV PHYS RE, V25, P143, DOI [10.1615/CritRevPhysRehabilMed.2013008225, DOI 10.1615/CRITREVPHYSREHABILMED.2013008225]; Pelletier Chelsea A., 2009, Critical Reviews in Biomedical Engineering, V37, P139, DOI 10.1615/CritRevBiomedEng.v37.i1-2.40; Popovic LZ, 2009, IEEE ENG MED BIO, P6785, DOI 10.1109/IEMBS.2009.5333983; Ragnarsson KT, 2008, SPINAL CORD, V46, P255, DOI 10.1038/sj.sc.3102091; ROUND JM, 1993, J NEUROL SCI, V116, P207, DOI 10.1016/0022-510X(93)90327-U; Sabatier MJ, 2006, SPINAL CORD, V44, P227, DOI 10.1038/sj.sc.3101834; Sayenko DG, 2015, NEUROREHAB NEURAL RE, V29, P722, DOI 10.1177/1545968314565463; Scelsi R, 2001, BASIC APPL MYOL, V11, P75; Scott WB, 2007, MUSCLE NERVE, V35, P471, DOI 10.1002/mus.20717; Scott WB, 2005, MUSCLE NERVE, V31, P581, DOI 10.1002/mus.20300; Sharma N, 2009, IEEE T NEUR SYS REH, V17, P576, DOI 10.1109/TNSRE.2009.2023294; Shields RK, 2006, J APPL PHYSIOL, V101, P1312, DOI 10.1152/japplphysiol.00385.2006; Shields RK, 2006, J APPL PHYSIOL, V101, P556, DOI 10.1152/japplphysiol.00099.2006; Shields RK, 2006, J NEUROPHYSIOL, V95, P2380, DOI 10.1152/jn.01181.2005; Sinkjaer T, 2003, MED ENG PHYS, V25, P29, DOI 10.1016/S1350-4533(02)00178-9; Tanaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070949; Thomas CK, 2003, J NEUROPHYSIOL, V89, P2055, DOI 10.1152/jn.01002.2002; Thomas CK, 2002, MUSCLE NERVE, V25, P797, DOI 10.1002/mus.10111; Thrasher A, 2005, ARTIF ORGANS, V29, P453, DOI 10.1111/j.1525-1594.2005.29076.x	77	54	54	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0149024	10.1371/journal.pone.0149024	http://dx.doi.org/10.1371/journal.pone.0149024			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859296	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400120
J	Pereboeva, L; Hubbard, M; Goldman, FD; Westin, ER				Pereboeva, Larisa; Hubbard, Meredith; Goldman, Frederick D.; Westin, Erik R.			Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells	PLOS ONE			English	Article							BONE-MARROW FAILURE; TELOMERE BIOLOGY; HEMATOPOIETIC STEM; OXIDATIVE STRESS; FANCONI-ANEMIA; LIFE-SPAN; P53; MUTATIONS; DISEASE; PROTEIN	Dyskeratosis Congenita (DC) is an inherited multisystem premature aging disorder with characteristic skin and mucosal findings as well as a predisposition to cancer and bone marrow failure. DC arises due to gene mutations associated with the telomerase complex or telomere maintenance, resulting in critically shortened telomeres. The pathogenesis of DC, as well as several congenital bone marrow failure (BMF) syndromes, converges on the DNA damage response (DDR) pathway and subsequent elevation of reactive oxygen species (ROS). Historically, DC patients have had poor outcomes following bone marrow transplantation (BMT), perhaps as a consequence of an underlying DNA hypersensitivity to cytotoxic agents. Previously, we demonstrated an activated DDR and increased ROS, augmented by chemotherapy and radiation, in somatic cells isolated from DC patients with a mutation in the RNA component of telomerase, TERC. The current study was undertaken to determine whether previous findings related to ROS and DDR in TERC patients' cells could be extended to other DC mutations. Of particular interest was whether an antioxidant approach could counter increased ROS and decrease DC pathologies. To test this, we examined lymphocytes from DC patients from different DC mutations (TERT, TINF2, and TERC) for the presence of an active DDR and increased ROS. All DC mutations led to increased steady-state p53 (2-fold to 10-fold) and ROS (1.5-fold to 2-fold). Upon exposure to ionizing radiation (XRT), DC cells increased in both DDR and ROS to a significant degree. Exposing DC cells to hydrogen peroxide also revealed that DC cells maintain a significant oxidant burden compared to controls (1.5-fold to 3-fold). DC cell culture supplemented with N-acetylcysteine, or alternatively grown in low oxygen, afforded significant proliferative benefits (proliferation: maximum 2-fold increase; NAC: 5-fold p53 decrease; low oxygen: maximum 3.5-fold p53 decrease). Together, our data supports a mechanism whereby telomerase deficiency and subsequent shortened telomeres initiate a DDR and create a pro-oxidant environment, especially in cells carrying the TINF2 mutations. Finally, the ameliorative effects of antioxidants in vitro suggest this could translate to therapeutic benefits in DC patients.	[Pereboeva, Larisa] Univ Alabama Birmingham, Dept Med, Div Hematol Oncol, Birmingham, AL 35294 USA; [Hubbard, Meredith; Goldman, Frederick D.; Westin, Erik R.] Univ Alabama Birmingham, Dept Pediat, Div Hematol Oncol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Westin, ER (corresponding author), Univ Alabama Birmingham, Dept Pediat, Div Hematol Oncol, Birmingham, AL USA.	erik.r.westin@gmail.com			DoD [W81XWH-15-1-0099]; Kaul Pediatric Research Institute (UAB School of Medicine); Kaul Pediatric Research Institute (FDG); Department of Defense (FDG) [W81XWH-15-1-0099]	DoD(United States Department of Defense); Kaul Pediatric Research Institute (UAB School of Medicine); Kaul Pediatric Research Institute (FDG); Department of Defense (FDG)(United States Department of Defense)	This work was supported by DoD: W81XWH-15-1-0099 (http://cdmrp.army.mil/default.shtml) and Kaul Pediatric Research Institute (UAB School of Medicine) (https://www.uab.edu/medicine/peds/residency-program/18-fac-staff/fac-dev/48-kprigrant-info). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially funded by the Kaul Pediatric Research Institute (FDG) and the Department of Defense (FDG; W81XWH-15-1-0099).	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370; Atkuri KR, 2007, P NATL ACAD SCI USA, V104, P4547, DOI 10.1073/pnas.0611732104; Avery-Kiejda KA, 2008, CLIN CANCER RES, V14, P1659, DOI 10.1158/1078-0432.CCR-07-1422; Bertram C, 2008, BIOL CHEM, V389, P211, DOI 10.1515/BC.2008.031; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Ceccaldi R, 2012, CELL STEM CELL, V11, P36, DOI 10.1016/j.stem.2012.05.013; Chakraborty A, 2011, WIRES RNA, V2, P507, DOI 10.1002/wrna.73; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Darbro BW, 2006, ONCOGENE, V25, P7421, DOI 10.1038/sj.onc.1209729; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dietz AC, 2011, BONE MARROW TRANSPL, V46, P98, DOI 10.1038/bmt.2010.65; Dokal I, 2015, EUR J HUM GENET, V23, DOI 10.1038/ejhg.2014.170; Dokal I, 2011, HEMATOL-AM SOC HEMAT, P480, DOI 10.1182/asheducation-2011.1.480; Du HY, 2007, AGING CELL, V6, P689, DOI 10.1111/j.1474-9726.2007.00324.x; Goldman FD, 2008, BLOOD, V111, P4523, DOI 10.1182/blood-2007-10-120204; Griffiths HR, 2011, BIOCHEM SOC T, V39, P1273, DOI 10.1042/BST0391273; Gu BW, 2011, AGING CELL, V10, P338, DOI 10.1111/j.1474-9726.2011.00674.x; Gu BW, 2009, CELL CYCLE, V8, P6, DOI 10.4161/cc.8.1.7265; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; Kirwan M, 2011, BRIT J HAEMATOL, V153, P634, DOI 10.1111/j.1365-2141.2011.08679.x; Knudson M, 2005, BLOOD, V105, P682, DOI 10.1182/blood-2004-04-1673; Lee MS, 2009, J DERMATOL SCI, V56, P154, DOI 10.1016/j.jdermsci.2009.08.008; Manguan-Garcia C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101424; Marrone A, 2004, BLOOD, V104, P3936, DOI 10.1182/blood-2004-05-1829; Mason PJ, 2011, CANCER GENET-NY, V204, P635, DOI 10.1016/j.cancergen.2011.11.002; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; PACKER L, 1977, P NATL ACAD SCI USA, V74, P1640, DOI 10.1073/pnas.74.4.1640; Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893; Pereboeva L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076473; Rani R, 2008, CANCER RES, V68, P9693, DOI 10.1158/0008-5472.CAN-08-1790; Reeves DA, 2015, BLOOD CELL MOL DIS, V55, P189, DOI 10.1016/j.bcmd.2015.06.007; Richardson C, 2015, INT J MOL SCI, V16, P2366, DOI 10.3390/ijms16022366; Richter T, 2007, EXP GERONTOL, V42, P1039, DOI 10.1016/j.exger.2007.08.005; Roesslein M, 2013, INT J MOL SCI, V14, P24320, DOI 10.3390/ijms141224320; Savage SA, 2010, GENET MED, V12, P753, DOI 10.1097/GIM.0b013e3181f415b5; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Solyakov L, 2009, ONCOGENE, V28, P3619, DOI 10.1038/onc.2009.225; Stout GJ, 2009, DIS MODEL MECH, V2, P139, DOI 10.1242/dmm.002121; Tummala H, 2015, J CLIN INVEST, V125, P2151, DOI 10.1172/JCI78963; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy TJ, 2008, BIOCHIMIE, V90, P122, DOI 10.1016/j.biochi.2007.07.017; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Westin ER, 2007, AGING CELL, V6, P383, DOI 10.1111/j.1474-9726.2007.00288.x; Westin ER, 2011, ANTIOXID REDOX SIGN, V14, P985, DOI 10.1089/ars.2010.3444; Yang D, 2011, J BIOL CHEM, V286, P23022, DOI 10.1074/jbc.M111.225870; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835	50	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148793	10.1371/journal.pone.0148793	http://dx.doi.org/10.1371/journal.pone.0148793			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859482	Green Submitted, gold, Green Published			2022-12-27	WOS:000370038400086
J	Su, YC; Davuluri, GVN; Chen, CH; Shiau, DC; Chen, CC; Chen, CL; Lin, YS; Chang, CP				Su, Yu-Chi; Davuluri, Goutham Venkata Naga; Chen, Cheng-Hao; Shiau, Dong-Che; Chen, Chien-Chin; Chen, Chia-Ling; Lin, Yee-Shin; Chang, Chih-Peng			Galectin-1-Induced Autophagy Facilitates Cisplatin Resistance of Hepatocellular Carcinoma	PLOS ONE			English	Article							INDUCED APOPTOSIS; OVARIAN-CANCER; CELL-ADHESION; LIVER-CANCER; CHEMOTHERAPY; PROGRESSION; INHIBITION; GALECTINS; DIFFERENTIATION; CHEMORESISTANCE	Hepatocellular carcinoma (HCC) is one of the most common cancers in Taiwan. Although chemotherapy is the primary treatment for HCC patients, drug resistance often leads to clinical failure. Galectin-1 is a beta-galactoside binding lectin which is up-regulated in HCC patients and promotes tumor growth by mediating cancer cell adhesion, migration and proliferation, but its role in chemoresistance of HCC is poorly understood. In this study we found that galectin-1 is able to lead to chemoresistance against cisplatin treatment, and subsequent inhibition has reversed the effect of cell death in HCC cells. Moreover, galectin-1 was found to induce autophagic flux in HCC cells. Inhibition of autophagy by inhibitors or knockdown of Atg5 cancels galectin-1-induced cisplatin resistance in HCC cells. Increase of mitophagy triggered by galectin-1 was found to reduce the mitochondrial potential loss and apoptosis induced by cisplatin treatment. Finally, using an in situ hepatoma mouse model, we clearly demonstrated that inhibition of galectin-1 by thiodigalactoside could significantly augment the anti-HCC effect of cisplatin. Taken together, our findings offer a new insight into the chemoresistance galectin-1 causes against cisplatin treatment, and points to a potential approach to improve the efficacy of cisplatin in the treatment of HCC patients.	[Su, Yu-Chi; Chen, Cheng-Hao; Shiau, Dong-Che; Lin, Yee-Shin; Chang, Chih-Peng] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 701, Taiwan; [Davuluri, Goutham Venkata Naga; Lin, Yee-Shin; Chang, Chih-Peng] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 701, Taiwan; [Chen, Chien-Chin] Chia Yi Christian Hosp, Dept Pathol, Chiayi 600, Taiwan; [Chen, Chien-Chin] Chia Nan Univ Pharm & Sci, Dept Cosmet Sci, Tainan 701, Taiwan; [Chen, Chia-Ling] Taipei Med Univ, Translat Res Ctr, Taipei 110, Taiwan; [Lin, Yee-Shin; Chang, Chih-Peng] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University; Chia Nan University of Pharmacy & Science; Taipei Medical University; National Cheng Kung University	Chang, CP (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 701, Taiwan.; Chang, CP (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 701, Taiwan.; Chang, CP (corresponding author), Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 701, Taiwan.	cpchang@mail.ncku.edu.tw	Chen, Chien-Chin/A-9977-2016	Chen, Chien-Chin/0000-0001-9599-0884; Chang, Chih-Peng/0000-0002-0061-3478	Ministry of Science and Technology, Taiwan [NSC 102-2320-B-006 -024 -MY3, MOST 104-2320-B-006 -038 -MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grant NSC 102-2320-B-006 -024 -MY3 and MOST 104-2320-B-006 -038 -MY3 from the Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando E, 2002, CANCER-AM CANCER SOC, V95, P588, DOI 10.1002/cncr.10694; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Chang CP, 2013, CELL DEATH DIFFER, V20, P515, DOI 10.1038/cdd.2012.146; Chang CP, 2007, HEPATOLOGY, V45, P286, DOI 10.1002/hep.21509; Chourasia AH, 2015, AUTOPHAGY, V11, P1937, DOI 10.1080/15548627.2015.1085136; Chung LY, 2012, CLIN CANCER RES, V18, P4037, DOI 10.1158/1078-0432.CCR-11-3348; El-Serag HB, 2007, HEPATOL RES, V37, pS88, DOI 10.1111/j.1872-034X.2007.00168.x; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Espelt MV, 2011, HEPATOLOGY, V53, P2097, DOI 10.1002/hep.24294; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Fong MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042265; Guo XL, 2012, CANCER LETT, V320, P171, DOI 10.1016/j.canlet.2012.03.002; Hikita C, 2000, J CELL BIOL, V151, P1235, DOI 10.1083/jcb.151.6.1235; Hirama M, 2006, ONCOL REP, V16, P997; Hughes RC, 2001, BIOCHIMIE, V83, P667; JONES TW, 1985, LAB INVEST, V52, P363; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Mathieu V, 2012, J INVEST DERMATOL, V132, P2245, DOI 10.1038/jid.2012.142; MURATA T, 1990, BIOCHEM INT, V20, P949; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Song YJ, 2013, CANCER LETT, V339, P70, DOI 10.1016/j.canlet.2013.07.021; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Sun Y, 2013, ONCOL RES, V21, P261, DOI 10.3727/096504014X13946388748992; TaylorRobinson SD, 1997, LANCET, V350, P1142, DOI 10.1016/S0140-6736(05)63789-0; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502; Wu H, 2012, J GASTROEN HEPATOL, V27, P1312, DOI 10.1111/j.1440-1746.2012.07130.x; Xu Y, 2012, CANCER LETT, V314, P232, DOI 10.1016/j.canlet.2011.09.034; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yeh CC, 2015, MOL CELL PROTEOMICS, V14, P1527, DOI 10.1074/mcp.M114.046417; Zhang P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.526	35	48	51	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148408	10.1371/journal.pone.0148408	http://dx.doi.org/10.1371/journal.pone.0148408			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859293	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400039
J	Tiede, J; Wemheuer, B; Traugott, M; Daniel, R; Tscharntke, T; Ebeling, A; Scherber, C				Tiede, Julia; Wemheuer, Bernd; Traugott, Michael; Daniel, Rolf; Tscharntke, Teja; Ebeling, Anne; Scherber, Christoph			Trophic and Non-Trophic Interactions in a Biodiversity Experiment Assessed by Next-Generation Sequencing	PLOS ONE			English	Article							PTEROSTICHUS-MELANARIUS COLEOPTERA; GROUND BEETLES COLEOPTERA; INTRAGUILD PREDATION; MOLECULAR-DETECTION; PLANT DIVERSITY; PREY DNA; LAND-USE; DIET; SOIL; COMMUNITIES	Plant diversity affects species richness and abundance of taxa at higher trophic levels. However, plant diversity effects on omnivores (feeding on multiple trophic levels) and their trophic and non-trophic interactions are not yet studied because appropriate methods were lacking. A promising approach is the DNA-based analysis of gut contents using next generation sequencing (NGS) technologies. Here, we integrate NGS-based analysis into the framework of a biodiversity experiment where plant taxonomic and functional diversity were manipulated to directly assess environmental interactions involving the omnivorous ground beetle Pterostichus melanarius. Beetle regurgitates were used for NGS-based analysis with universal 18S rDNA primers for eukaryotes. We detected a wide range of taxa with the NGS approach in regurgitates, including organisms representing trophic, phoretic, parasitic, and neutral interactions with P. melanarius. Our findings suggest that the frequency of (i) trophic interactions increased with plant diversity and vegetation cover; (ii) intraguild predation increased with vegetation cover, and (iii) neutral interactions with organisms such as fungi and protists increased with vegetation cover. Experimentally manipulated plant diversity likely affects multitrophic interactions involving omnivorous consumers. Our study therefore shows that trophic and non-trophic interactions can be assessed via NGS to address fundamental questions in biodiversity research.	[Tiede, Julia; Tscharntke, Teja; Scherber, Christoph] Univ Gottingen, Agroecol, Dept Crop Sci, Grisebachstr 6, D-37077 Gottingen, Germany; [Wemheuer, Bernd; Daniel, Rolf] Univ Gottingen, Inst Microbiol & Genet, Dept Genom & Appl Microbiol, Grisebachstr 8, D-37077 Gottingen, Germany; [Traugott, Michael] Univ Innsbruck, Inst Ecol, Mt Agr Res Unit, Technikerstr 25, A-6020 Innsbruck, Austria; [Ebeling, Anne] Univ Jena, Inst Ecol, Dornburger Str 159, D-07743 Jena, Germany; [Tiede, Julia; Scherber, Christoph] Univ Munster, Inst Landscape Ecol, Heisenbergstr 2, D-48149 Munster, Germany	University of Gottingen; University of Gottingen; University of Innsbruck; Friedrich Schiller University of Jena; University of Munster	Tiede, J (corresponding author), Univ Gottingen, Agroecol, Dept Crop Sci, Grisebachstr 6, D-37077 Gottingen, Germany.; Tiede, J (corresponding author), Univ Munster, Inst Landscape Ecol, Heisenbergstr 2, D-48149 Munster, Germany.	ju.tiede@gmail.com	Tscharntke, Teja/N-5123-2014; Tiede, Julia/AAG-5272-2019; Scherber, Christoph/B-6611-2009; Daniel, Rolf/AAQ-5933-2021	Tiede, Julia/0000-0003-0037-8559; Scherber, Christoph/0000-0001-7924-8911; Daniel, Rolf/0000-0002-8646-7925; Traugott, Michael/0000-0001-9719-5059	Deutsche Forschungsgemeinschaft [FOR 1451/2, SCHE 1621/3-2]; Georg-August University Goettingen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Georg-August University Goettingen	CS, JT, and AE were funded by the Deutsche Forschungsgemeinschaft (grants FOR 1451/2 and SCHE 1621/3-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We especially acknowledge Christiane Roscher for providing data on vegetation cover, Jan-Hendrik Dudenhoffer for his support during fieldwork, Sigrid Dassen, Sarah Zieger, and Stefan Geisen for information on taxa. We thank the gardeners, technical staff, and student helpers for maintaining the experimental plots. We also thank two anonymous reviewers of PLoS ONE for useful comments and suggestions. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Funds of Georg-August University Goettingen.	Barnes AD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6351; Bates ST, 2012, LICHENOLOGIST, V44, P137, DOI 10.1017/S0024282911000648; Bohan DA, 2000, J ANIM ECOL, V69, P367, DOI 10.1046/j.1365-2656.2000.00399.x; Bohan DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029028; Boyer S., 2015, FOOD WEBS, V3, P1, DOI DOI 10.1016/J.F00WEB.2015.02.001; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Brose U, 2003, OECOLOGIA, V135, P407, DOI 10.1007/s00442-003-1222-7; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Clare EL, 2014, EVOL APPL, V7, P1144, DOI 10.1111/eva.12225; Clare EL, 2014, MOL ECOL, V23, P3618, DOI 10.1111/mec.12542; Davey JS, 2013, J APPL ECOL, V50, P271, DOI 10.1111/1365-2664.12008; Deagle BE, 2013, MOL ECOL RESOUR, V13, P620, DOI 10.1111/1755-0998.12103; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Draganova S. A., 2010, Pesticidi i Fitomedicina, V25, P59; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Ebeling A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106529; Ebeling A, 2014, BASIC APPL ECOL, V15, P229, DOI 10.1016/j.baae.2014.02.003; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fain A., 1995, International Journal of Acarology, V21, P107; Foltan P, 2005, MOL ECOL, V14, P4147, DOI 10.1111/j.1365-294X.2005.02732.x; FORSYTHE T G, 1982, Coleopterists Bulletin, V36, P26; Gibb H, 2015, OECOLOGIA, V177, P519, DOI 10.1007/s00442-014-3101-9; Grace JB, 2014, FUNCT ECOL, V28, P787, DOI 10.1111/1365-2435.12269; Grant JB, 2006, J EXP BIOL, V209, P3018, DOI 10.1242/jeb.02335; Gross J, 1998, J INVERTEBR PATHOL, V72, P296, DOI 10.1006/jipa.1998.4781; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Hector A, 2007, FUNCT ECOL, V21, P998, DOI 10.1111/j.1365-2435.2007.01308.x; HENGEVELD R, 1980, NETH J ZOOL, V30, P564, DOI 10.1163/002829679X00197; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hunter MD, 2009, AGR FOREST ENTOMOL, V11, P125, DOI 10.1111/j.1461-9563.2008.00427.x; Kefi S, 2015, ECOLOGY, V96, P291, DOI 10.1890/13-1424.1; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Lefcheck JS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7936; Lilleskov EA, 2005, MYCOLOGIA, V97, P762, DOI 10.3852/mycologia.97.4.762; Lovei GL, 1996, ANNU REV ENTOMOL, V41, P231, DOI 10.1146/annurev.en.41.010196.001311; Lundgren JG, 2007, ANN ENTOMOL SOC AM, V100, P275, DOI 10.1603/0013-8746(2007)100[275:BCWDTO]2.0.CO;2; Lundgren JG, 2014, MOL ECOL, V23, P3790, DOI 10.1111/mec.12700; Lundgren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010831; LYMBERY A, 1980, J AUST ENTOMOL SOC, V19, P129; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McKemey AR, 2001, BIOCONTROL SCI TECHN, V11, P81, DOI 10.1080/09583150020029763; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; O'Rorke R, 2012, MOL ECOL RESOUR, V12, P5, DOI 10.1111/j.1755-0998.2011.03091.x; O'Rorke R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042757; Olckers T, 2000, COLEOPTS BULL, V54, P497, DOI 10.1649/0010-065X(2000)054[0497:BAPHRO]2.0.CO;2; Parker JR, 1957, GRASSHOPPER EGG PODS; Petit S, 2014, EUR J ENTOMOL, DOI 10.14411/eje.2014.086; Pinol J, 2015, MOL ECOL RESOUR, V15, P819, DOI 10.1111/1755-0998.12355; Pinol J, 2014, MOL ECOL RESOUR, V14, P18, DOI 10.1111/1755-0998.12156; Pompanon F, 2015, GENETICA, V143, P133, DOI 10.1007/s10709-015-9816-7; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Prasad RP, 2006, J APPL ECOL, V43, P343, DOI 10.1111/j.1365-2664.2006.01129.x; Quast C., 2012, NUCLEIC ACIDS RES, V41, pD590, DOI DOI 10.1093/NAR/GKS1219; Raso L, 2014, MOL ECOL, V23, P3744, DOI 10.1111/mec.12649; Robertson Ian C., 1992, Psyche (Cambridge), V99, P189, DOI 10.1155/1992/85675; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Ruggiero MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119248; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Sheppard SK, 2005, MOL ECOL, V14, P4461, DOI 10.1111/j.1365-294X.2005.02742.x; Sienkiewicz P, 2009, POL J ENTOMOL, V4; Specht J, 2008, J ANIM ECOL, V77, P1047, DOI 10.1111/j.1365-2656.2008.01395.x; Stefana G, 2014, PEDOBIOLOGIA, V57, P205, DOI 10.1016/j.pedobi.2014.10.001; Symondson WOC, 2014, MOL ECOL, V23, P3601, DOI 10.1111/mec.12831; Symondson William O.C., 2012, P166; Symondson WOC, 2000, MOL ECOL, V9, P1279, DOI 10.1046/j.1365-294x.2000.01006.x; Thiele H. -U., 1977, CARABID BEETLES THEI, DOI 10.1007/978-3-642-81154-8; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Toberman H, 2008, FEMS MICROBIOL ECOL, V66, P426, DOI 10.1111/j.1574-6941.2008.00560.x; Traugott M, 2013, ECOLOGICAL NETWORKS; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vesterinen EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082168; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; Waldner T, 2013, SOIL BIOL BIOCHEM, V63, P116, DOI 10.1016/j.soilbio.2013.03.030; Waldner T, 2012, MOL ECOL RESOUR, V12, P669, DOI 10.1111/j.1755-0998.2012.03135.x; Wallinger C, 2014, MOL ECOL, V23, P3826, DOI 10.1111/mec.12579; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wimp GM, 2013, OECOLOGIA, V171, P505, DOI 10.1007/s00442-012-2435-4; Wolkovich EM, 2014, ECOLOGY, V95, P3376, DOI 10.1890/13-1721.1; Wright AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7092	84	17	18	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148781	10.1371/journal.pone.0148781	http://dx.doi.org/10.1371/journal.pone.0148781			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859146	Green Published, gold, Green Submitted			2022-12-27	WOS:000370038400083
J	Arriagada, RA; Echeverria, CM; Moya, DE				Arriagada, Rodrigo A.; Echeverria, Cristian M.; Moya, Danisa E.			Creating Protected Areas on Public Lands: Is There Room for Additional Conservation?	PLOS ONE			English	Article							MATCHING ESTIMATORS; ENVIRONMENTAL SERVICES; FOREST COVER; DEFORESTATION; LOCATION; PAYMENTS; ROADS; BIAS	Most evaluations of the effectiveness of PAs have relied on indirect estimates based on comparisons between protected and unprotected areas. Such methods can be biased when protection is not randomly assigned. We add to the growing literature on the impact of PAs by answering the following research questions: What is the impact of Chilean PAs on deforestation which occurred between 1986 and 2011? How do estimates of the impact of PAs vary when using only public land as control units? We show that the characteristics of the areas in which protected and unprotected lands are located differ significantly. To satisfactorily estimate the effects of PAs, we use matching methods to define adequate control groups, but not as in previous research. We construct control groups using separately non-protected private areas and non-protected public lands. We find that PAs avoid deforestation when using unprotected private lands as valid controls, however results show no impact when the control group is based only on unprotected public land. Different land management regimes, and higher levels of enforcement inside public lands may reduce the opportunity to add additional conservation benefits when the national systems for PAs are based on the protection of previously unprotected public lands. Given that not all PAs are established to avoid deforestation, results also admit the potential for future studies to include other outcomes including forest degradation (not just deforestation), biodiversity, wildlife, primary forests (not forests in general), among others.	[Arriagada, Rodrigo A.; Echeverria, Cristian M.; Moya, Danisa E.] Millennium Nucleus Ctr Socioecon Impact Environm, Santiago, Chile; [Arriagada, Rodrigo A.] Pontificia Univ Catolica Chile, Dept Ecosyst & Environm, Ctr Appl Ecol & Sustainabil CAPES, Interdisciplinary Ctr Intercultural & Indigenous, Alameda 340, Santiago, Chile; [Echeverria, Cristian M.] Univ Concepcion, Dept Forest Management & Environm, Concepcion, Chile	Pontificia Universidad Catolica de Chile; Universidad de Concepcion	Arriagada, RA (corresponding author), Millennium Nucleus Ctr Socioecon Impact Environm, Santiago, Chile.; Arriagada, RA (corresponding author), Pontificia Univ Catolica Chile, Dept Ecosyst & Environm, Ctr Appl Ecol & Sustainabil CAPES, Interdisciplinary Ctr Intercultural & Indigenous, Alameda 340, Santiago, Chile.	rarriagadac@uc.cl	Echeverria, Cristian/ABD-7286-2020		Fondo Nacional de Investigacion Cientifica y Tecnologica, FONDECYT-CONICYT Chile (Proyecto FONDECYT Iniciacion) [11110271]	Fondo Nacional de Investigacion Cientifica y Tecnologica, FONDECYT-CONICYT Chile (Proyecto FONDECYT Iniciacion)	This work was funded by Fondo Nacional de Investigacion Cientifica y Tecnologica, FONDECYT-CONICYT Chile (Proyecto FONDECYT Iniciacion No 11110271). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie A, 2011, J BUS ECON STAT, V29, P1, DOI 10.1198/jbes.2009.07333; Abadie A, 2008, ECONOMETRICA, V76, P1537, DOI 10.3982/ECTA6474; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Armesto J.J., 1992, AMBIENTE DESARROLLO, V8, P19; Arriagada RA, 2012, LAND ECON, V88, P382, DOI 10.3368/le.88.2.382; Basic Z, 2012, AGRON UC, V46, P18; Carmona A, 2012, APPL GEOGR, V32, P904, DOI 10.1016/j.apgeog.2011.09.006; Chomitz KM, 1996, WORLD BANK ECON REV, V10, P487, DOI 10.1093/wber/10.3.487; Cofre H, 1999, BIOL CONSERV, V88, P53, DOI 10.1016/S0006-3207(98)00090-1; CONAF CONAMA BIRF UA CHILE PUC Chile UC Temuco., 1999, CAT EV REC VEG NAT C; Dinerstein E., 1995, CONSERVATION ASSESSM; Donoso C., 1993, ECOLOGIA FORESTAL; Ferraro PJ, 2011, ENVIRON RESOUR ECON, V48, P269, DOI 10.1007/s10640-010-9408-z; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Joppa L, 2010, ANN NY ACAD SCI, V1185, P135, DOI 10.1111/j.1749-6632.2009.05162.x; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Kamal S, 2014, BIODIVERS CONSERV, V23, P2689, DOI 10.1007/s10531-014-0744-0; Lambin E.F., 1999, LAND USE LAND COVER, V1st ed.; Lara A, 2009, FOREST ECOL MANAG, V258, P415, DOI 10.1016/j.foreco.2009.01.004; Miteva DA, 2014, NATURE BALANCE EC BI, P301, DOI [10.1093/acprof, DOI 10.1093/ACPROF]; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Neira Eduardo, 2002, CHILES FRONTIER FORE; Pauchard A, 2002, NAT AREA J, V22, P318; Pfaff A, 2007, J REGIONAL SCI, V47, P109, DOI 10.1111/j.1467-9787.2007.00502.x; Pfaff A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0273; Pfaff A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129460; Pfaff A, 2009, BE J ECON ANAL POLI, V9, DOI 10.2202/1935-1682.1990; Pfaff ASP, 1999, J ENVIRON ECON MANAG, V37, P26, DOI 10.1006/jeem.1998.1056; Robalino J., 2014, ENVIRON DEV ECON, V20, P283; Robalino JA, 2007, ENVIRON DEV ECON, V12, P521, DOI 10.1017/S1355770X07003671; Rosenbaum PR, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-1213-8; Rozzi R., 1994, Bosque, V15, P55; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Sims KRE, 2010, J ENVIRON ECON MANAG, V60, P94, DOI 10.1016/j.jeem.2010.05.003; Turner B., 1990, EARTH TRANSFORMED HU; Wunder S, 2007, CONSERV BIOL, V21, P48, DOI 10.1111/j.1523-1739.2006.00559.x	41	13	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148094	10.1371/journal.pone.0148094	http://dx.doi.org/10.1371/journal.pone.0148094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26848856	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000040
J	Best, EA; Juarez-Colunga, E; James, K; LeBlanc, WG; Serdar, B				Best, Elizabeth A.; Juarez-Colunga, Elizabeth; James, Katherine; LeBlanc, William G.; Serdar, Berrin			Biomarkers of Exposure to Polycyclic Aromatic Hydrocarbons and Cognitive Function among Elderly in the United States (National Health and Nutrition Examination Survey: 2001-2002)	PLOS ONE			English	Article							PERSONS AGED 60; US ADULTS; AIR-POLLUTION; DIGIT-SYMBOL; OLDER-ADULTS; PERFORMANCE; IMPAIRMENT; ALCOHOL; MIXTURES; BEHAVIOR	Recent studies report a link between common environmental exposures, such as particulate matter air pollution and tobacco smoke, and decline in cognitive function. The purpose of this study was to assess the association between exposure to polycyclic aromatic hydrocarbons (PAHs), a selected group of chemicals present in particulate matter and tobacco smoke, and measures of cognitive performance among elderly in the general population. This cross-sectional analysis involved data from 454 individuals aged 60 years and older from the 2001-2002 National Health and Nutrition Examination Survey. The association between PAH exposures (as measured by urinary biomarkers) and cognitive function (digit symbol substitution test (DSST)) was assessed using multiple linear regression analyses. After adjusting for age, socio-economic status and diabetes we observed a negative association between urinary 1-hydroxypyrene, the gold standard of PAH exposure biomarkers, and DSST score. A one percent increase in urinary 1-hydroxypyrene resulted in approximately a 1.8 percent poorer performance on the digit symbol substitution test. Our findings are consistent with previous publications and further suggest that PAHs, at least in part may be responsible for the adverse cognitive effects linked to tobacco smoke and particulate matter air pollution.	[Best, Elizabeth A.; Serdar, Berrin] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Juarez-Colunga, Elizabeth] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [James, Katherine; LeBlanc, William G.] Univ Colorado, Dept Family Med, Aurora, CO USA; [Serdar, Berrin] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Environm & Occupat Hlth, Aurora, CO USA	Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Serdar, B (corresponding author), Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA.	Berrin.Serdar@ucdenver.edu		Juarez-Colunga, Elizabeth/0000-0002-6369-2353	Colorado School of Public Health, University of Colorado Denver	Colorado School of Public Health, University of Colorado Denver	This work was in part supported by intramural funds from the Colorado School of Public Health, University of Colorado Denver [to B.S.].	Akhtar WZ, 2013, ENVIRON RES, V121, P64, DOI 10.1016/j.envres.2012.10.013; Alzheimer's Association, 2015, WHAT IS DEM MILD COG; Andersson H, 1998, ENVIRON RES, V76, P41, DOI 10.1006/enrs.1997.3791; Angerer J, 1997, INT ARCH OCC ENV HEA, V70, P365, DOI 10.1007/s004200050231; ATSDR, 1995, TOX PROF POL AR HYDR, P485; BAEK SO, 1991, WATER AIR SOIL POLL, V60, P279, DOI 10.1007/BF00282628; Barnes SL, 2000, CARCINOGENESIS, V21, P2123, DOI 10.1093/carcin/21.11.2123; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; BARTLE KD, 1991, FOOD CONTAMINANTS SO; Beydoun MA, 2012, NEUROBIOL AGING, V33, P1730, DOI 10.1016/j.neurobiolaging.2011.05.008; Bouchard MF, 2014, ENVIRON HEALTH PERSP, V122, P73, DOI 10.1289/ehp.1306532; Centers for Disease Control and Prevention (CDC). National Health and Examination Survey, 2001, NAT HLTH EX SURV 200; Chen JC, 2009, NEUROTOXICOLOGY, V30, P231, DOI 10.1016/j.neuro.2008.12.011; Dutta K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009984; Etgen T, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0115-4; Evans SM, 2004, BEHAV PHARMACOL, V15, P167, DOI 10.1097/01.fbp.0000131575.38620.a5; Fang M, 2015, J APPL GERONTOL; Gatto NM, 2014, NEUROTOXICOLOGY, V40, P1, DOI 10.1016/j.neuro.2013.09.004; Georgotas A, 1989, Int Psychogeriatr, V1, P135, DOI 10.1017/S1041610289000141; Greenblatt DJ, 2005, BRIT J CLIN PHARMACO, V60, P244, DOI 10.1111/j.1365-2125.2005.02409.x; Gutierrez J, 2015, JAMA NEUROL, V72, P309, DOI 10.1001/jamaneurol.2014.3873; Guxens M, 2012, SWISS MED WKLY, V141, DOI [10.4414/smw.2011.13322, 10.57187/smw.2012.13322]; He CY, 2012, AQUAT TOXICOL, V116, P109, DOI 10.1016/j.aquatox.2012.03.009; Hendrie Hugh C, 2006, Alzheimers Dement, V2, P12, DOI 10.1016/j.jalz.2005.11.004; Ifegwu C, 2012, BIOMARK CANC, V4, P7, DOI DOI 10.4137/BIC.S10065; JONGENEELEN FJ, 1990, BRIT J IND MED, V47, P454; Jongeneelen FJ, 1997, SCI TOTAL ENVIRON, V199, P141, DOI 10.1016/S0048-9697(97)00064-8; Joy S, 2004, ARCH CLIN NEUROPSYCH, V19, P759, DOI 10.1016/j.acn.2003.09.009; Karel MJ, 2012, AM PSYCHOL, V67, P184, DOI 10.1037/a0025393; Kilanowicz A, 2012, NEUROTOXICOLOGY, V33, P361, DOI 10.1016/j.neuro.2012.02.011; Kim SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130623; Lawrence NS, 2002, NEURON, V36, P539, DOI 10.1016/S0896-6273(02)01004-8; Levin ED, 2006, PSYCHOPHARMACOLOGY, V184, P523, DOI 10.1007/s00213-005-0164-7; Li Z, 2010, J EXPO SCI ENV EPID, V20, P526, DOI 10.1038/jes.2009.41; Lin FR, 2011, J GERONTOL A-BIOL, V66, P1131, DOI 10.1093/gerona/glr115; Loop MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075001; McClernon FJ, 2003, HUM PSYCHOPHARM CLIN, V18, P339, DOI 10.1002/hup.488; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Obisesan TO, 2012, CLIN INTERV AGING, V7, P35, DOI 10.2147/CIA.S26794; Obisesan TO, 2008, J AM GERIATR SOC, V56, P501, DOI 10.1111/j.1532-5415.2007.01592.x; Palanikumar L, 2012, ECOTOX ENVIRON SAFE, V75, P187, DOI 10.1016/j.ecoenv.2011.08.028; Peacock A, 2015, ALCOHOL CLIN EXP RES, V39, P733, DOI 10.1111/acer.12680; Peiffer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071413; Perera FP, 2011, ENVIRON HEALTH PERSP, V119, P1176, DOI 10.1289/ehp.1002705; Petersen RC, 2011, NEW ENGL J MED, V364, P2227, DOI 10.1056/NEJMcp0910237; Petrovitch H, 1998, AM J CARDIOL, V81, P1017, DOI 10.1016/S0002-9149(98)00082-4; Proust-Lima C, 2007, AM J EPIDEMIOL, V165, P344, DOI 10.1093/aje/kwk017; Rundle A, 2003, CANCER EPIDEM BIOMAR, V12, P911; Rush CR, 2001, HUM PSYCHOPHARM CLIN, V16, P147, DOI 10.1002/hup.240.abs; Saunders CR, 2001, NEUROTOX RES, V3, DOI 10.1007/BF03033211; Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622; Soyka M, 2008, J CLIN PSYCHOPHARM, V28, P699, DOI 10.1097/JCP.0b013e31818a6d38; STREUFERT S, 1992, J APPL PSYCHOL, V77, P515, DOI 10.1037/0021-9010.77.4.515; Tang EYH, 2015, NEURODEGENER DIS MAN, V5, P11, DOI [10.2217/NMT.14.42, 10.2217/nmt.14.42]; Tang Y, 2003, J TOXICOL ENV HEAL A, V66, P919, DOI 10.1080/15287390306455; The Psychological Corporation, 1997, WAIS 3 WMS 3 TECHNIC; University of California Irvine. Institute for Memory Impairments and Neurological Disorders, 2015, WHAT IS ALZH MILD CO; US Department of Health and Human Services, 2014, REP CARC, V13th; US Department of Health and Human Services, 2011, COGN IMP CALL ACT NO; Vignet C, 2014, ENVIRON SCI POLLUT R, V21, P13818, DOI 10.1007/s11356-014-2762-6; Wang JY, 2013, NEUROTOXICOL TERATOL, V35, P28, DOI 10.1016/j.ntt.2012.12.003; Weuve J, 2012, ARCH INTERN MED, V172, P219, DOI 10.1001/archinternmed.2011.683; Zhang M, 2015, AGING NEUROPSYCHOL C, V22, P534, DOI 10.1080/13825585.2014.997663; ZHAO ZH, 1995, AMBIO, V24, P226	64	22	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147632	10.1371/journal.pone.0147632	http://dx.doi.org/10.1371/journal.pone.0147632			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849365	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000021
J	Dipnall, JF; Pasco, JA; Berk, M; Williams, LJ; Dodd, S; Jacka, FN; Meyer, D				Dipnall, Joanna F.; Pasco, Julie A.; Berk, Michael; Williams, Lana J.; Dodd, Seetal; Jacka, Felice N.; Meyer, Denny			Fusing Data Mining, Machine Learning and Traditional Statistics to Detect Biomarkers Associated with Depression	PLOS ONE			English	Article							CELL DISTRIBUTION WIDTH; MULTIPLE IMPUTATION; REGRESSION; CLASSIFICATION; BILIRUBIN; RISK; ANTIOXIDANT; DISEASE; INFLAMMATION; DIAGNOSIS	Background Atheoretical large-scale data mining techniques using machine learning algorithms have promise in the analysis of large epidemiological datasets. This study illustrates the use of a hybrid methodology for variable selection that took account of missing data and complex survey design to identify key biomarkers associated with depression from a large epidemiological study. Methods The study used a three-step methodology amalgamating multiple imputation, a machine learning boosted regression algorithm and logistic regression, to identify key biomarkers associated with depression in the National Health and Nutrition Examination Study (2009-2010). Depression was measured using the Patient Health Questionnaire-9 and 67 biomarkers were analysed. Covariates in this study included gender, age, race, smoking, food security, Poverty Income Ratio, Body Mass Index, physical activity, alcohol use, medical conditions and medications. The final imputed weighted multiple logistic regression model included possible confounders and moderators. Results After the creation of 20 imputation data sets from multiple chained regression sequences, machine learning boosted regression initially identified 21 biomarkers associated with depression. Using traditional logistic regression methods, including controlling for possible confounders and moderators, a final set of three biomarkers were selected. The final three biomarkers from the novel hybrid variable selection methodology were red cell distribution width (OR 1.15; 95% CI 1.01, 1.30), serum glucose (OR 1.01; 95% CI 1.00, 1.01) and total bilirubin (OR 0.12; 95% CI 0.05, 0.28). Significant interactions were found between total bilirubin with Mexican American/Hispanic group (p = 0.016), and current smokers (p<0.001). Conclusion The systematic use of a hybrid methodology for variable selection, fusing data mining techniques using a machine learning algorithm with traditional statistical modelling, accounted for missing data and complex survey sampling methodology and was demonstrated to be a useful tool for detecting three biomarkers associated with depression for future hypothesis generation: red cell distribution width, serum glucose and total bilirubin.	[Dipnall, Joanna F.; Pasco, Julie A.; Berk, Michael; Williams, Lana J.; Dodd, Seetal; Jacka, Felice N.] Deakin Univ, Sch Med, IMPACT Strateg Res Ctr, Geelong, Vic 3217, Australia; [Dipnall, Joanna F.; Meyer, Denny] Swinburne Univ Technol, Dept Stat Data Sci & Epidemiol, Melbourne, Vic, Australia; [Pasco, Julie A.] Univ Melbourne, Dept Med, St Albans, Vic, Australia; [Pasco, Julie A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Pasco, Julie A.; Berk, Michael; Dodd, Seetal] Barwon Hlth, Univ Hosp Geelong, Geelong, Vic, Australia; [Berk, Michael; Dodd, Seetal; Jacka, Felice N.] Univ Melbourne, Dept Psychiat, Parkville, Vic 3052, Australia; [Berk, Michael] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Berk, Michael] Orygen, Parkville, Vic, Australia; [Jacka, Felice N.] Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Melbourne, Vic, Australia; [Jacka, Felice N.] Black Dog Inst, Sydney, NSW, Australia	Deakin University; Swinburne University of Technology; University of Melbourne; Monash University; Geelong Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Orygen, The National Centre of Excellence in Youth Mental Health; Murdoch Children's Research Institute; Black Dog Institute	Dipnall, JF (corresponding author), Deakin Univ, Sch Med, IMPACT Strateg Res Ctr, Geelong, Vic 3217, Australia.; Dipnall, JF (corresponding author), Swinburne Univ Technol, Dept Stat Data Sci & Epidemiol, Melbourne, Vic, Australia.	jdipnall@deakin.edu.au	Berk, Michael/M-7891-2013; Berk, Michael/M-3585-2019; Jacka, Felice N/D-9424-2012; Jacka, Felice N/ABE-6322-2020	Berk, Michael/0000-0002-5554-6946; Berk, Michael/0000-0002-5554-6946; Jacka, Felice N/0000-0002-9825-0328; Jacka, Felice N/0000-0002-9825-0328; Williams, Lana/0000-0002-1377-1272; Dipnall, Joanna/0000-0001-7543-0687; Dodd, Seetal/0000-0002-7918-4636	NHMRC [1059660, 1064272]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Michael Berk is supported by a NHMRC Senior Principal Research Fellowship 1059660 and Lana J Williams is supported by a NHMRC Career Development Fellowship 1064272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; ANDERSON TW, 1957, J AM STAT ASSOC, V52, P200, DOI 10.2307/2280845; Ani C, 2009, J NEUROL SCI, V277, P103, DOI 10.1016/j.jns.2008.10.024; Bauer E, 1999, MACH LEARN, V36, P105, DOI 10.1023/A:1007515423169; Berry M.J.A., 2011, DATA MINING TECHNIQU; Boksa P, 2013, J PSYCHIATR NEUROSCI, V38, P75, DOI 10.1503/jpn.130018; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Buston PM, 2011, J ANIM ECOL, V80, P528, DOI 10.1111/j.1365-2656.2011.01803.x; (CDC). CfDCaP. National Center for Health Statistics (NCHS), 2009, NHANES LAB PROC MAN; Centers for Disease Control and Prevention National Center for Health Statistics, 1999, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention National Center for Health Statistics, 2014, NAT HLTH NUTR EX SUR; Chaovalitwongse W, 2010, SPRINGER SER OPTIM A, V38, P1, DOI 10.1007/978-0-387-88630-5; Council NR, 2006, FOOD INS HUNG US ASS; Davis J, 2015, MOL PSYCHIATR, V20, P152, DOI 10.1038/mp.2014.139; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Dipnall JF, 2014, METHODS; Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Essau CA, 2010, J AFFECT DISORDERS, V127, P185, DOI 10.1016/j.jad.2010.05.016; FARRAR DE, 1967, REV ECON STAT, V49, P92, DOI 10.2307/1937887; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Friedman J, 2001, SPRINGER SERIES STAT, V10; Friedman J, 2009, R PACKAGE VERSION, P1, DOI DOI 10.18637/JSS.V033.I01; Friedman JH, 1997, COMP SCI STAT, V29, P3; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Hastie T, 2009, ELEMENTS STAT LEARNI, P33, DOI 10.1007/978-0-387-84858-7; Kenward MG, 2007, STAT METHODS MED RES, V16, P199, DOI 10.1177/0962280206075304; Kirkman MS, 2009, DIABETES CARE, V32, pS1, DOI 10.2337/dc09-S001; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Li C, 2013, STATA J, V13, P795, DOI 10.1177/1536867X1301300407; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Longadge R., 2013, INT J COMPUT NETW IJ; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P676, DOI 10.1016/j.pnpbp.2010.05.004; Malandrino N, 2012, DIABETOLOGIA, V55, P226, DOI 10.1007/s00125-011-2331-1; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Mezuk B, 2013, HEALTH PSYCHOL, V32, P254, DOI 10.1037/a0029014; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Opitz D., 1999, J ARTIF INTELL RES, V11, P169, DOI [10.1613/jair.614, DOI 10.1613/JAIR.614]; Ozturk ZA, 2013, ARCH GERONTOL GERIAT, V56, P50, DOI 10.1016/j.archger.2012.10.002; Pandya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020416; Patel P., 2010, DIABETES, V100, P13; Pearce N, 2012, INT J EPIDEMIOL, V41, P393, DOI 10.1093/ije/dys049; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Schaefer RL., 1986, J STAT COMPUT SIM, V25, P75, DOI [10.1080/00949658608810925, DOI 10.1080/00949658608810925]; Schonlau M, 2005, STATA J, V5, P330, DOI 10.1177/1536867X0500500304; Schwertner HA, 1998, ATHEROSCLEROSIS, V136, P383, DOI 10.1016/S0021-9150(97)00232-3; Sedlak TW, 2004, PEDIATRICS, V113, P1776, DOI 10.1542/peds.113.6.1776; Seref O, 2007, DATA MINING SYSTEMS; Spell DW, 2004, CANCER DETECT PREV, V28, P37, DOI 10.1016/j.cdp.2003.10.002; StataCorp L, 2015, STAT MULT IMP REF MA; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Stewart JC, 2009, BRAIN BEHAV IMMUN, V23, P936, DOI 10.1016/j.bbi.2009.04.011; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tabachnick B. G.., 2012, USING MULTIVARIATE S; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Tovar D, 2012, METHODS MOL BIOL, V829, P593, DOI 10.1007/978-1-61779-458-2_37; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; Van Hoydonck PGA, 2001, INT J EPIDEMIOL, V30, P1465; van Kimmenade RRJ, 2010, EUR J HEART FAIL, V12, P129, DOI 10.1093/eurjhf/hfp179; Van Ness PH, 2007, J CLIN EPIDEMIOL, V60, P1239, DOI 10.1016/j.jclinepi.2007.03.006; Van Voorhees BW, 2008, ANN FAM MED, V6, P503, DOI 10.1370/afm.887; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WINOKUR A, 1988, AM J PSYCHIAT, V145, P325; Witten IH, 2011, MOR KAUF D, P1; Wood Angela M, 2004, Clin Trials, V1, P368; World Health Organization, 2006, GLOB DAT BOD MASS IN; Yesil A, 2011, GUT LIVER, V5, P460, DOI 10.5009/gnl.2011.5.4.460; Yoo I, 2012, J MED SYST, V36, P2431, DOI 10.1007/s10916-011-9710-5; Zhang DS, 2004, IEEE T SYST MAN CY C, V34, P513, DOI 10.1109/TSMCC.2004.829279	85	37	38	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148195	10.1371/journal.pone.0148195	http://dx.doi.org/10.1371/journal.pone.0148195			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848571	Green Published, gold			2022-12-27	WOS:000369554000050
J	Leggatt, RA; Sundstrom, LF; Vandersteen, WE; Devlin, RH				Leggatt, Rosalind A.; Sundstrom, L. Fredrik; Vandersteen, Wendy E.; Devlin, Robert H.			Alternate Directed Anthropogenic Shifts in Genotype Result in Different Ecological Outcomes in Coho Salmon Oncorhynchus kisutch Fry	PLOS ONE			English	Article							GROWTH-HORMONE TRANSGENESIS; WILD ATLANTIC SALMON; ANTIPREDATOR BEHAVIOR; BROWN TROUT; RISK-TAKING; DOMESTICATION; SALAR; PREDATION; SIZE; CONSEQUENCES	Domesticated and growth hormone (GH) transgenic salmon provide an interesting model to compare effects of selected versus engineered phenotypic change on relative fitness in an ecological context. Phenotype in domestication is altered via polygenic selection of traits over multiple generations, whereas in transgenesis is altered by a single locus in one generation. These established and emerging technologies both result in elevated growth rates in culture, and are associated with similar secondary effects such as increased foraging, decreased predator avoidance, and similar endocrine and gene expression profiles. As such, there is concern regarding ecological consequences should fish that have been genetically altered escape to natural ecosystems. To determine if the type of genetic change influences fitness components associated with ecological success outside of the culture environments they were produced for, we examined growth and survival of domesticated, transgenic, and wild-type coho salmon fry under different environmental conditions. In simple conditions (i. e. culture) with unlimited food, transgenic fish had the greatest growth, while in naturalized stream tanks (limited natural food, with or without predators) domesticated fish had greatest growth and survival of the three fish groups. As such, the largest growth in culture conditions may not translate to the greatest ecological effects in natural conditions, and shifts in phenotype over multiple rather than one loci may result in greater success in a wider range of conditions. These differences may arise from very different historical opportunities of transgenic and domesticated strains to select for multiple growth pathways or counter-select against negative secondary changes arising from elevated capacity for growth, with domesticated fish potentially obtaining or retaining adaptive responses to multiple environmental conditions not yet acquired in recently generated transgenic strains.	[Leggatt, Rosalind A.; Sundstrom, L. Fredrik; Vandersteen, Wendy E.; Devlin, Robert H.] Fisheries & Oceans Canada, Ctr Aquaculture & Environm Res, 4160 Marine Dr, W Vancouver, BC V7V 1N6, Canada; [Sundstrom, L. Fredrik] Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, Uppsala, Sweden; [Vandersteen, Wendy E.] Miracle Springs Inc, 12443 Stave Lake Rd, Mission, BC V2V 0A6, Canada	Fisheries & Oceans Canada; Uppsala University	Leggatt, RA (corresponding author), Fisheries & Oceans Canada, Ctr Aquaculture & Environm Res, 4160 Marine Dr, W Vancouver, BC V7V 1N6, Canada.	rosalind.leggatt@gmail.com	Sundstrom, Fred/E-6736-2011	Sundstrom, Fred/0000-0002-3157-7289	Canadian Regulatory System for Biotechnology program within the Federal Government of Canada [61740]	Canadian Regulatory System for Biotechnology program within the Federal Government of Canada	All funding was provided for by the Canadian Regulatory System for Biotechnology (Grant # 61740), a program within the Federal Government of Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MV, 1999, ANIM BEHAV, V58, P933, DOI 10.1006/anbe.1999.1229; Adriaenssens B, 2011, BEHAV ECOL, V22, P135, DOI 10.1093/beheco/arq185; Berejikian BA, 1995, CAN J FISH AQUAT SCI, V52, P2476, DOI 10.1139/f95-838; BERG S, 1991, J FISH BIOL, V39, P151, DOI 10.1111/j.1095-8649.1991.tb04353.x; Biro PA, 2004, P ROY SOC B-BIOL SCI, V271, P2233, DOI 10.1098/rspb.2004.2861; Blann CA, 2006, J FISH BIOL, V69, P535, DOI 10.1111/j.1095-8649.2006.01124.x; Bourret V, 2011, HEREDITY, V106, P500, DOI 10.1038/hdy.2010.165; Crossin GT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120173; Debes PV, 2014, CAN J FISH AQUAT SCI, V71, P1371, DOI 10.1139/cjfas-2013-0618; Debes PV, 2014, GENETICS, V196, P1277, DOI 10.1534/genetics.114.161729; Devlin RH, 2013, J ANIM SCI, V91, P5247, DOI 10.2527/jas.2013-6612; Devlin RH, 1999, AQUAC RES, V30, P479, DOI 10.1046/j.1365-2109.1999.00359.x; Devlin RH, 2004, P NATL ACAD SCI USA, V101, P9303, DOI 10.1073/pnas.0400023101; Devlin RH, 2004, AQUACULTURE, V236, P607, DOI 10.1016/j.aquaculture.2004.02.026; DEVLIN RH, 1994, NATURE, V371, P209, DOI 10.1038/371209a0; Devlin RH, 2001, NATURE, V409, P781, DOI 10.1038/35057314; Devlin RH, 2015, BIOSCIENCE, V65, P685, DOI 10.1093/biosci/biv068; Devlin RH, 2010, AQUACULTURE, V304, P66, DOI 10.1016/j.aquaculture.2010.03.023; Devlin RH, 2009, P NATL ACAD SCI USA, V106, P3047, DOI 10.1073/pnas.0809798106; Dieperink C, 2001, ECOL FRESHW FISH, V10, P177, DOI 10.1034/j.1600-0633.2001.100307.x; DILL LM, 1984, BEHAV ECOL SOCIOBIOL, V16, P65, DOI 10.1007/BF00293105; Dionne M, 2002, CAN J ZOOL, V80, P2006, DOI 10.1139/Z02-176; Drew RE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-323; Einum S, 1997, J FISH BIOL, V50, P634, DOI 10.1006/jfbi.1996.0330; Fleming IA, 2002, CAN J FISH AQUAT SCI, V59, P1323, DOI 10.1139/F02-082; Fleming IA, 2000, P ROY SOC B-BIOL SCI, V267, P1517, DOI 10.1098/rspb.2000.1173; Fox J., 2019, R COMPANION APPL REG, V.; Gjedrem T, 2012, AQUACULTURE, V350, P117, DOI 10.1016/j.aquaculture.2012.04.008; Harwood AJ, 2003, BEHAV ECOL, V14, P902, DOI 10.1093/beheco/arg080; HERSHBERGER WK, 1990, AQUACULTURE, V85, P187, DOI 10.1016/0044-8486(90)90018-I; Houde ALS, 2010, ICES J MAR SCI, V67, P657, DOI 10.1093/icesjms/fsp272; Houde ALS, 2010, CONSERV GENET, V11, P785, DOI 10.1007/s10592-009-9892-2; JOHNSSON JI, 1993, CAN J FISH AQUAT SCI, V50, P480, DOI 10.1139/f93-056; Johnsson JI, 1996, CAN J FISH AQUAT SCI, V53, P1546, DOI 10.1139/cjfas-53-7-1546; Johnsson JI, 2003, J FISH BIOL, V63, P863, DOI 10.1046/j.1095-8649.2003.00187.x; Jonsson E, 1998, HORM BEHAV, V33, P9, DOI 10.1006/hbeh.1997.1426; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Metcalfe NB, 2003, J APPL ECOL, V40, P535, DOI 10.1046/j.1365-2664.2003.00815.x; Moreau DTR, 2011, J FISH BIOL, V78, P726, DOI 10.1111/j.1095-8649.2010.02888.x; Moreau DTR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095853; Morris MRJ, 2008, CAN J FISH AQUAT SCI, V65, P2807, DOI 10.1139/F08-181; Neregard L, 2008, J FISH BIOL, V73, P2341, DOI 10.1111/j.1095-8649.2008.02082.x; Oakes JD, 2007, AQUACULTURE, V265, P309, DOI 10.1016/j.aquaculture.2007.01.015; Overturf K, 2010, AQUACULTURE, V307, P111, DOI 10.1016/j.aquaculture.2010.06.010; R Core Team, 2013, R LANG ENV STAT COMP; Raven PA, 2008, GEN COMP ENDOCR, V159, P26, DOI 10.1016/j.ygcen.2008.07.011; Reinhardt UG, 1999, ANIM BEHAV, V57, P923, DOI 10.1006/anbe.1998.1051; RUZZANTE DE, 1994, AQUACULTURE, V120, P1, DOI 10.1016/0044-8486(94)90217-8; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Skaala O, 2012, CAN J FISH AQUAT SCI, V69, P1994, DOI 10.1139/f2012-118; Sloman KA, 2002, J FISH BIOL, V61, P1, DOI 10.1111/j.1095-8649.2002.tb01733.x; Solberg MF, 2015, APPL ANIM BEHAV SCI, V162, P67, DOI 10.1016/j.applanim.2014.11.012; Solberg MF, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-234; Solberg MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054469; Sundstrom LF, 2007, P NATL ACAD SCI USA, V104, P3889, DOI 10.1073/pnas.0608767104; Sundstrom LF, 2007, ETHOLOGY, V113, P403, DOI 10.1111/j.1439-0310.2007.01331.x; Sundstrom LF, 2014, J APPL ECOL, V51, P82, DOI 10.1111/1365-2664.12185; Sundstrom LF, 2011, EVOL ECOL, V25, P447, DOI 10.1007/s10682-010-9406-1; Sundstrom LF, 2010, ECOL APPL, V20, P1372, DOI 10.1890/09-0631.1; Sundstrom LF, 2009, J APPL ECOL, V46, P762, DOI 10.1111/j.1365-2664.2009.01668.x; Sundstrom LF, 2004, P ROY SOC B-BIOL SCI, V271, pS350, DOI 10.1098/rsbl.2004.0189; Sundstrom LF, 2004, ETHOLOGY, V110, P381, DOI 10.1111/j.1439-0310.2004.00985.x; Sundstrom LF, 2003, ETHOLOGY, V109, P701, DOI 10.1046/j.1439-0310.2003.00908.x; Sundstrom LF, 2005, EVOLUTION, V59, P1560, DOI 10.1111/j.0014-3820.2005.tb01805.x; Tymchuk WE, 2007, EVOLUTION, V61, P1225, DOI 10.1111/j.1558-5646.2007.00102.x; Tymchuk WE, 2006, T AM FISH SOC, V135, P442, DOI 10.1577/T05-181.1; Tymchuk WE, 2009, ENDOCRINOLOGY, V150, P1809, DOI 10.1210/en.2008-0797; Tymchuk Wendy E., 2006, Canadian Technical Report of Fisheries and Aquatic Sciences, V2450, P1; Vandersteen W, 2012, EVOL APPL, V5, P76, DOI 10.1111/j.1752-4571.2011.00210.x; Wringe BF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-63	70	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148687	10.1371/journal.pone.0148687	http://dx.doi.org/10.1371/journal.pone.0148687			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848575	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000158
J	Schuit, M; Miller, DM; Reddick-Elick, MS; Wlazlowski, CB; Filone, CM; Herzog, A; Colf, LA; Wahl-Jensen, V; Hevey, M; Noah, JW				Schuit, Michael; Miller, David M.; Reddick-Elick, Mary S.; Wlazlowski, Carly B.; Filone, Claire Marie; Herzog, Artemas; Colf, Leremy A.; Wahl-Jensen, Victoria; Hevey, Michael; Noah, James W.			Differences in the Comparative Stability of Ebola Virus Makona-C05 and Yambuku-Mayinga in Blood	PLOS ONE			English	Article							2014 OUTBREAK; TRANSMISSION; PERSISTENCE	In support of the response to the 2013-2016 Ebola virus disease (EVD) outbreak in Western Africa, we investigated the persistence of Ebola virus/H. sapiens-tc/GIN/2014/Makona-C05 (EBOV/Mak-C05) on non-porous surfaces that are representative of hospitals, air-planes, and personal protective equipment. We performed persistence studies in three clinically-relevant human fluid matrices (blood, simulated vomit, and feces), and at environments representative of in-flight airline passenger cabins, environmentally-controlled hospital rooms, and open-air Ebola treatment centers in Western Africa. We also compared the surface stability of EBOV/Mak-C05 to that of the prototype Ebola virus/H. sapiens-tc/COD/1976/Yambuku-Mayinga (EBOV/Yam-May), in a subset of these conditions. We show that on inert, non-porous surfaces, EBOV decay rates are matrix-and environment-dependent. Among the clinically-relevant matrices tested, EBOV persisted longest in dried human blood, had limited viability in dried simulated vomit, and did not persist in feces. EBOV/Mak-C05 and EBOV/Yam-May decay rates in dried matrices were not significantly different. However, during the drying process in human blood, EBOV/Yam-May showed significantly greater loss in viability than EBOV/Mak-C05 under environmental conditions relevant to the outbreak region, and to a lesser extent in conditions relevant to an environmentally-controlled hospital room. This factor may contribute to increased communicability of EBOV/Mak-C05 when surfaces contaminated with dried human blood are the vector and may partially explain the magnitude of the most recent outbreak, compared to prior outbreaks. These EBOV persistence data will improve public health efforts by informing risk assessments, structure remediation decisions, and response procedures for future EVD outbreaks.	[Schuit, Michael; Miller, David M.; Reddick-Elick, Mary S.; Wlazlowski, Carly B.; Filone, Claire Marie; Wahl-Jensen, Victoria; Hevey, Michael; Noah, James W.] Natl Biodef Anal & Countermeasures Ctr, Frederick, MD USA; [Herzog, Artemas] Censeo Consulting Grp, Washington, DC USA; [Colf, Leremy A.] Dept Homeland Secur, Sci & Technol Directorate, Washington, DC USA		Noah, JW (corresponding author), Natl Biodef Anal & Countermeasures Ctr, Frederick, MD USA.	james.noah@nbacc.dhs.gov	Wahl, Victoria/K-9267-2015	Wahl, Victoria/0000-0002-6588-4308; Hevey, Michael/0000-0001-7481-1058; Miller, David/0000-0002-5746-3909	Department of Homeland Security Science and Technology Directorate [HSHQDC-07-C-00020]; Combating Terrorism Group [CB-AT-4186]; Censeo Consulting Group	Department of Homeland Security Science and Technology Directorate(United States Department of Homeland Security (DHS)); Combating Terrorism Group; Censeo Consulting Group	This work was funded under Agreement No. HSHQDC-07-C-00020 awarded to Battelle National Biodefense Institute by the Department of Homeland Security Science and Technology Directorate for the management and operation of the National Biodefense Analysis and Countermeasures Center as a Federally Funded Research and Development Center. This work was also funded under Task CB-AT-4186 from Combating Terrorism Group. The funders reviewed and approved the study design and the manuscript, but had no role in the study execution or manuscript preparation. Censeo Consulting Group provided support in the form of a salary for author AH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Agyepong I A, 2014, Ghana Med J, V48, P168, DOI 10.4314/gmj.v48i3.9; American National Standards Institute. American National Standards Institute, 2013, 552013 ANSIASHRAE, P55; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Belanov E. F., 1996, Voprosy Virusologii, V41, P32; Centers for Disease Control and Prevention, 2015, CAS EB DIAGN US, V9, P22; Centers for Disease Control and Prevention, 2015, INT REC CLEAN HOUS S, V8, P4; Centers for Disease Control and Prevention, 2016, 2014 EB OUTBR W AFR, V1, P19; Chertow DS, 2015, J INFECT DIS, V211, P1036, DOI 10.1093/infdis/jiv001; Cook BWM, 2015, VIRUSES-BASEL, V7, P1975, DOI 10.3390/v7041975; Fischer R, 2015, EMERGING INFECT DIS, V21; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Grabmuller M, 2015, FORENSIC SCI INT-GEN, V16, P195, DOI 10.1016/j.fsigen.2015.01.006; Guehenneux S, 2012, SKIN RES TECHNOL, V18, P238, DOI 10.1111/j.1600-0846.2011.00560.x; Joint Program Executive Office for Chemical and Biological Defense, 2014, JOINT PROGR EX OFF C, V4, P15; Khan AS, 1999, J INFECT DIS S1, V179, pS76, DOI DOI 10.1086/514306; Liu SQ, 2015, INFECT GENET EVOL, V32, P51, DOI 10.1016/j.meegid.2015.02.024; Martini ML, 2009, J PEDIATR GASTR NUTR, V48, P287, DOI 10.1097/MPG.0b013e318189694f; Piercy TJ, 2010, J APPL MICROBIOL, V109, P1531, DOI 10.1111/j.1365-2672.2010.04778.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reeve M, 2014, RES PRIORITIES INFOR, V12, P9; Report of an International Commission, 1976, B WORLD HEALTH ORGAN, V56, P271; Sagripanti JL, 2010, ARCH VIROL, V155, P2035, DOI 10.1007/s00705-010-0791-0; Sieff K, 2015, WASH POST, V12, P9; Teson M, 2013, INVEST OPHTH VIS SCI, V54, P2093, DOI 10.1167/iovs.12-11361; United States Pharmacopeia and National Formulary, 2003, US PHARM NAT FORM US; World Health Organization, 2016, NEW EB CAS SIERR LEO, V1, P19; Yang H, 2010, BONE MARROW TRANSPL, V45, P1000, DOI 10.1038/bmt.2009.289	28	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148476	10.1371/journal.pone.0148476	http://dx.doi.org/10.1371/journal.pone.0148476			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849135	Green Published, gold			2022-12-27	WOS:000369554000103
J	Turmel, M; de Cambiaire, JC; Otis, C; Lemieux, C				Turmel, Monique; de Cambiaire, Jean-Charles; Otis, Christian; Lemieux, Claude			Distinctive Architecture of the Chloroplast Genome in the Chlorodendrophycean Green Algae Scherffelia dubia and Tetraselmis sp CCMP 881	PLOS ONE			English	Article							DNA-SEQUENCE; COMPLETE MITOCHONDRIAL; NEPHROSELMIS-OLIVACEA; PHYLOGENETIC ANALYSES; PEDINOMONAS-MINOR; CATALYTIC INTRONS; PLASTID GENOME; P RNA; REVEALS; TOOL	The Chlorodendrophyceae is a small class of green algae belonging to the core Chlorophyta, an assemblage that also comprises the Pedinophyceae, Trebouxiophyceae, Ulvophyceae and Chlorophyceae. Here we describe for the first time the chloroplast genomes of chlorodendrophycean algae (Scherffelia dubia, 137,161 bp; Tetraselmis sp. CCMP 881, 100,264 bp). Characterized by a very small single-copy (SSC) region devoid of any gene and an unusually large inverted repeat (IR), the quadripartite structures of the Scherffelia and Tetraselmis genomes are unique among all core chlorophytes examined thus far. The lack of genes in the SSC region is offset by the rich and atypical gene complement of the IR, which includes genes from the SSC and large single-copy regions of prasinophyte and streptophyte chloroplast genomes having retained an ancestral quadripartite structure. Remarkably, seven of the atypical IR-encoded genes have also been observed in the IRs of pedinophycean and trebouxiophycean chloroplast genomes, suggesting that they were already present in the IR of the common ancestor of all core chlorophytes. Considering that the relationships among the main lineages of the core Chlorophyta are still unresolved, we evaluated the impact of including the Chlorodendrophyceae in chloroplast phylogenomic analyses. The trees we inferred using data sets of 79 and 108 genes from 71 chlorophytes indicate that the Chlorodendrophyceae is a deep-diverging lineage of the core Chlorophyta, although the placement of this class relative to the Pedinophyceae remains ambiguous. Interestingly, some of our phylogenomic trees together with our comparative analysis of gene order data support the monophyly of the Trebouxiophyceae, thus offering further evidence that the previously observed affiliation between the Chlorellales and Pedinophyceae is the result of systematic errors in phylogenetic reconstruction.	[Turmel, Monique; de Cambiaire, Jean-Charles; Otis, Christian; Lemieux, Claude] Univ Laval, Inst Biol Integrat & Syst, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada	Laval University	Turmel, M (corresponding author), Univ Laval, Inst Biol Integrat & Syst, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada.	monique.turmel@bcm.ulaval.ca	Lemieux, Claude/L-8831-2015; Turmel, Monique/AAC-9752-2020	Lemieux, Claude/0000-0001-9580-8042; Turmel, Monique/0000-0001-7060-035X	Natural Sciences and Engineering Research Council of Canada [2830-2007]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) (Grant No. 2830-2007 to MT and CL).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen R. A., 2005, ALGAL CULTURING TECH; Brouard JS, 2011, GENOME BIOL EVOL, V3, P505, DOI 10.1093/gbe/evr037; Brouard JS, 2010, GENOME BIOL EVOL, V2, P240, DOI 10.1093/gbe/evq014; Brouard JS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-290; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Civan P, 2014, GENOME BIOL EVOL, V6, P897, DOI 10.1093/gbe/evu061; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; de Cambiaire JC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-37; de la Cruz J, 2003, GENE, V321, P47, DOI 10.1016/S0378-1119(03)00831-X; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fucikova K, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00063; Guillou L, 2004, PROTIST, V155, P193, DOI 10.1078/143446104774199592; Janouskovec J, 2013, MOL BIOL EVOL, V30, P2447, DOI 10.1093/molbev/mst144; Jansen RK, 2012, ADV PHOTOSYNTHESIS R, P103, DOI DOI 10.1007/978-94-007-2920-9_5; KELLER MD, 1987, J PHYCOL, V23, P633; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Leliaert F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1418-3; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; LEMIEUX C, 1985, PLANT MOL BIOL, V5, P77, DOI 10.1007/BF00020089; Lemieux C, 2000, NATURE, V403, P649, DOI 10.1038/35001059; Lemieux C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-857; Lemieux C, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0211-2; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maddison D. R., 2000, MACCLADE 4 ANALYSIS; Maddison W.P., 2015, MESQUITE A MODULAR S; Marin B, 2012, PROTIST, V163, P778, DOI 10.1016/j.protis.2011.11.004; Massjuk N., 2006, UKR BOT J, V63, P601; Matsumoto T, 2011, PROTIST, V162, P268, DOI 10.1016/j.protis.2010.07.001; Mattox K. R., 1984, SYSTEMATICS GREEN AL, V27, P29; Melkonian M., 1990, P600; Melton JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121020; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Nakayama T, 1998, PROTIST, V149, P367, DOI 10.1016/S1434-4610(98)70043-4; Pombert JF, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-3; Pombert JF, 2005, MOL BIOL EVOL, V22, P1903, DOI 10.1093/molbev/msi182; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robbens S, 2007, MOL BIOL EVOL, V24, P956, DOI 10.1093/molbev/msm012; Servin-Garciduenas LE, 2012, EUKARYOT CELL, V11, P1417, DOI 10.1128/EC.00244-12; Sheveleva EV, 2004, NUCLEIC ACIDS RES, V32, P803, DOI 10.1093/nar/gkh225; Siegel RW, 1996, RNA, V2, P452; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sym Stuart D., 1993, Progress in Phycological Research, V9, P281; Telford MJ, 2015, CURR BIOL, V25, pR876, DOI 10.1016/j.cub.2015.07.060; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; Turmel M, 1999, PLANT CELL, V11, P1717, DOI 10.1105/tpc.11.9.1717; Turmel M, 1999, P NATL ACAD SCI USA, V96, P10248, DOI 10.1073/pnas.96.18.10248; Turmel M, 2015, GENOME BIOL EVOL, V7, P2062, DOI 10.1093/gbe/evv130; Turmel M, 2009, MOL BIOL EVOL, V26, P2317, DOI 10.1093/molbev/msp138; Turmel M, 2009, MOL BIOL EVOL, V26, P631, DOI 10.1093/molbev/msn285; Weng ML, 2014, MOL BIOL EVOL, V31, P645, DOI 10.1093/molbev/mst257	59	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148934	10.1371/journal.pone.0148934	http://dx.doi.org/10.1371/journal.pone.0148934			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849226	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000188
J	Zhang, HY; Ehiri, J; Yang, H; Tang, SL; Li, Y				Zhang, HaiYang; Ehiri, John; Yang, Huan; Tang, Shenglan; Li, Ying			Impact of Community-Based DOT on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT-TUBERCULOSIS; RANDOMIZED CONTROLLED-TRIAL; PULMONARY TUBERCULOSIS; HEALTH-WORKERS; RISK-FACTORS; CAPE-TOWN; CARE; DISTRICT; STRATEGIES; COMPONENT	Background Poor adherence to tuberculosis (TB) treatment can lead to prolonged infectivity and poor treatment outcomes. Directly observed treatment (DOT) seeks to improve adherence to TB treatment by observing patients while they take their anti-TB medication. Although community-based DOT (CB-DOT) programs have been widely studied and promoted, their effectiveness has been inconsistent. The aim of this study was to critical appraise and summarize evidence of the effects of CB-DOT on TB treatment outcomes. Methods Studies published up to the end of February 2015 were identified from three major international literature databases: Medline/PubMed, EBSCO, and EMBASE. Unpublished data from the grey literature were identified through Google and Google Scholar searches. Results Seventeen studies involving 12,839 pulmonary TB patients (PTB) in eight randomized controlled trials (RCTs) and nine cohort studies from 12 countries met the criteria for inclusion in this review and 14 studies were included in meta-analysis. Compared with clinic-based DOT, pooled results of RCTs for all PTB cases (including smear-negative or -positive, new or retreated TB cases) and smear-positive PTB cases indicated that CB-DOT promoted successful treatment [pooled RRs (95% CIs): 1.11 (1.02-1.19) for all PTB cases and 1.11 (1.02-1.19) for smear-positive PTB cases], and completed treatment [pooled RRs (95% CIs): 1.74(1.05, 2.90) for all PTB cases and 2.22(1.16, 4.23) for smear-positive PTB cases], reduced death [pooled RRs (95% CIs): 0.44 (0.26-0.72) for all PTB cases and 0.39 (0.23-0.66) for smear-positive PTB cases], and transfer out [pooled RRs (95% CIs): 0.37 (0.23-0.61) for all PTB cases and 0.42 (0.25-0.70) for smear-positive PTB cases]. Pooled results of all studies (RCTs and cohort studies) with all PTB cases demonstrated that CB-DOT promoted successful treatment [pooled RR (95% CI): 1.13 (1.03-1.24)] and curative treatment [pooled RR (95% CI): 1.24 (1.04-1.48)] compared with self-administered treatment. Conclusions CB-DOT did improved TB treatment outcomes according to the pooled results of included studies in this review. Studies on strategies for implementation of patient-centered and community-centered CB-DOT deserve further attention.	[Zhang, HaiYang] Third Mil Med Univ, Coll Prevent Med, Chongqing, Peoples R China; [Ehiri, John] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Dept Hlth Promot Sci, Tucson, AZ USA; [Yang, Huan] Third Mil Med Univ, Minist Educ China, Dept Hyg Toxicol, Key Lab Med Protect Electromagnet Radiat, Chongqing, Peoples R China; [Tang, Shenglan] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Li, Ying] Third Mil Med Univ, Coll Prevent Med, Dept Social Med & Hlth Serv Management, Chongqing, Peoples R China	Army Medical University; University of Arizona; Army Medical University; Ministry of Education, China; Duke University; Army Medical University	Tang, SL (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC USA.; Li, Y (corresponding author), Third Mil Med Univ, Coll Prevent Med, Dept Social Med & Hlth Serv Management, Chongqing, Peoples R China.	shenglan.tang@duke.edu; lilyliying2012@163.com	Tang, Shenglan/AAO-7403-2020		National Natural Science Foundation of China [81001297]; Social Science and Technology Innovation Subject in Chongqing [cstc2015shmszx0099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Science and Technology Innovation Subject in Chongqing	This project was funded by the National Natural Science Foundation of China (Award # 81001297) and Social Science and Technology Innovation Subject in Chongqing (cstc2015shmszx0099).	Adatu F, 2003, INT J TUBERC LUNG D, V7, pS63; [Anonymous], 2008, REV MAN REVMAN COMP; Balt E, 1998, TUBERCULOSIS TRAININ; Baris E, 2000, INT J TUBERC LUNG D, V4, P595; Becx-Bleumink M, 2001, INT J TUBERC LUNG D, V5, P920; Bekker LG, 2010, INT J TUBERC LUNG D, V14, P379; Casal M, 2005, MICROB DRUG RESIST, V11, P62, DOI 10.1089/mdr.2005.11.62; Cavalcante SC, 2007, INT J TUBERC LUNG D, V11, P544; Clarke M, 2005, INT J TUBERC LUNG D, V9, P673; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Connolly C, 1999, INT J TUBERC LUNG D, V3, P1081; Cox H, 2013, LANCET INFECT DIS, V13, P644, DOI 10.1016/S1473-3099(13)70151-8; Dick J, 1996, TUBERCLE LUNG DIS, V77, P274, DOI 10.1016/S0962-8479(96)90013-1; do Prado TN, 2011, CAD SAUDE PUBLICA, V27, P944, DOI 10.1590/S0102-311X2011000500012; Dudley L, 2003, INT J TUBERC LUNG D, V7, pS48; Ferreira V, 2011, REV SAUDE PUBL, V45, P40, DOI 10.1590/S0034-89102010005000055; Hadley M, 2000, INT J TUBERC LUNG D, V4, P401; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kamolratanakul P, 1999, T ROY SOC TROP MED H, V93, P552, DOI 10.1016/S0035-9203(99)90379-6; Kangovi S, 2009, J COMMUN HEALTH, V34, P506, DOI 10.1007/s10900-009-9174-4; Kicinski M, 2015, STAT MED, V34, P2781, DOI 10.1002/sim.6525; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Lwilla F, 2003, TROP MED INT HEALTH, V8, P204, DOI 10.1046/j.1365-3156.2003.00999.x; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Nardell E, 2010, INT J TUBERC LUNG D, V14, P1233; Newell JN, 2006, LANCET, V367, P903, DOI 10.1016/S0140-6736(06)68380-3; Pasipanodya JG, 2013, CLIN INFECT DIS, V57, P21, DOI 10.1093/cid/cit167; Pungrassami P, 2002, T ROY SOC TROP MED H, V96, P695, DOI 10.1016/S0035-9203(02)90354-8; Schillinger D., 2010, INTRO EFFECTIVENESS; Shin S, 2004, SOC SCI MED, V59, P1529, DOI 10.1016/j.socscimed.2004.01.027; Sinanovic E, 2006, INT J TUBERC LUNG D, V10, P795; Sinanovic E, 2003, INT J TUBERC LUNG D, V7, pS56; Singh AA, 2004, INT J TUBERC LUNG D, V8, P800; Stanhope MLJ, 2000, COMMUNITY PUBLIC HLT, V5th; Suwankeeree W, 2014, INT J EVID-BASED HEA, V12, P3, DOI 10.1097/01.XEB.0000444614.17658.46; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Trigueiro JV, 2011, REV LAT-AM ENFERM, V19, P1289, DOI 10.1590/S0104-11692011000600003; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; Volmink Jimmy, 2007, COCHRANE DB SYST REV, V4, DOI [DOI 10.1002/14651858.CD003343.PUB4, 10.1002/14651858.CD003343.pub4]; Walley JD, 2001, LANCET, V357, P664, DOI 10.1016/S0140-6736(00)04129-5; Wandwalo E, 2004, INT J TUBERC LUNG D, V8, P1248; Wang JM, 2009, SCAND J PUBLIC HEALT, V37, P304, DOI 10.1177/1403494809103907; Wells G.A., NEWCASTLE OTTAWA SCA; WHO, 2009, GLOB TUB CONTR EP SR; WHO, GLOB TUB REP 2014; WHO, WHOCDSTB2003312; Wilkinson D, 1997, TROP MED INT HEALTH, V2, P700, DOI 10.1046/j.1365-3156.1997.d01-358.x; World Health Organization, 2004, GUID IMPL COMM TB CA; World Health Organization, 1994, WHOTB94179; Wright J, 2004, TROP MED INT HEALTH, V9, P559, DOI 10.1111/j.1365-3156.2004.01230.x; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174; Zvavamwe Z, 2009, INT J NURS STUD, V46, P302, DOI 10.1016/j.ijnurstu.2008.09.013; Zwarenstein M, 2000, INT J TUBERC LUNG D, V4, P550	55	40	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147744	10.1371/journal.pone.0147744	http://dx.doi.org/10.1371/journal.pone.0147744			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26849656	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000024
J	Zhu, SS; Zhang, CY; Wang, J; Wei, L; Quan, R; Yang, JY; Yan, X; Li, ZX; She, RP; Hu, FJ; Liu, J				Zhu, Shanshan; Zhang, Chunyan; Wang, Jing; Wei, Li; Quan, Rong; Yang, Jiayu; Yan, Xu; Li, Zixuan; She, Ruiping; Hu, Fengjiao; Liu, Jue			Immunity Elicited by an Experimental Vaccine Based on Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein in Piglets	PLOS ONE			English	Article							MULTISYSTEMIC WASTING SYNDROME; CELLULAR MECHANISMS; PROTECTIVE IMMUNITY; SYNDROME PMWS; PCV2; PIGS; VIRUS; INFECTION; CELLS; ANTIBODIES	In a recent study, we reported that a recombinant protein from fusion expression of flagellin to porcine circovirus type 2 (PCV2) Cap induced robust humoral and cell-mediated immunity that afforded full protection for PCV2 infection using BALB/c mice. Here, we further evaluated the immunogenicity and protection of the recombinant protein using specific pathogen free (SPF) pigs. Twenty-five 3-week-old piglets without passively acquired immunity were divided into 5 groups. All piglets except negative controls were challenged with a virulent PCV2 at 21 days after booster vaccination and necropsied at 21 days post-challenge. Vaccination of piglets with the recombinant protein without adjuvant induced strong humoral and cellular immune responses as observed by high levels of PCV2-specific IgG antibodies and neutralizing antibodies, as well as frequencies of PCV2-specific IFN-gamma-secreting cells that conferred good protection against PCV2 challenge, with significant reduced PCV2 viremia, mild lesions, low PCV2 antigen-positive cells, as well as improved body weight gain, comparable to piglets vaccinated with a commercial PCV2 subunit vaccine. These results further demonstrated that the recombinant flagellin-Cap fusion protein is capable of inducing solid protective humoral and cellular immunity when administered to pigs, thereby becoming an effective PCV2 vaccine candidate for control of PCV2 infection.	[Zhu, Shanshan; Zhang, Chunyan; Wang, Jing; Wei, Li; Quan, Rong; Yang, Jiayu; Yan, Xu; Li, Zixuan; Liu, Jue] Beijing Acad Agr & Forestry Sci, Beijing Key Lab Prevent & Control Infect Dis Live, Inst Anim Husb & Vet Med, 9 Shuguang Garden Middle Rd, Beijing 100097, Peoples R China; [She, Ruiping; Hu, Fengjiao] China Agr Univ, Coll Vet Med, 2 Yuanmingyuan West Rd, Beijing 100197, Peoples R China	Beijing Academy of Agriculture & Forestry; China Agricultural University	Liu, J (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Key Lab Prevent & Control Infect Dis Live, Inst Anim Husb & Vet Med, 9 Shuguang Garden Middle Rd, Beijing 100097, Peoples R China.	liujue@263.net			National Science Fund for Distinguished Young Scholars [31025028]; Beijing Municipal Science and Technology Contract Project, People's Republic of China [Z07010501780701]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Beijing Municipal Science and Technology Contract Project, People's Republic of China	This work was supported by grants from the National Science Fund for Distinguished Young Scholars (31025028) and the Beijing Municipal Science and Technology Contract Project (Z07010501780701), People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan G, 1998, VET REC, V142, P467; Bates JT, 2011, J IMMUNOL, V186, P6255, DOI 10.4049/jimmunol.1001855; Ben-Yedidia T, 1998, IMMUNOL LETT, V64, P9, DOI 10.1016/S0165-2478(98)00073-X; Blanchard P, 2003, VACCINE, V21, P4565, DOI 10.1016/S0264-410X(03)00503-6; Bucarey SA, 2009, VACCINE, V27, P5781, DOI 10.1016/j.vaccine.2009.07.061; Calsamiglia M, 2002, J CLIN MICROBIOL, V40, P1848, DOI 10.1128/JCM.40.5.1848-1850.2002; Carasova P, 2007, RES VET SCI, V83, P274, DOI 10.1016/j.rvsc.2006.11.013; Cheung AK, 2003, VIROLOGY, V305, P168, DOI 10.1006/viro.2002.1733; Cuadros C, 2004, INFECT IMMUN, V72, P2810, DOI 10.1128/IAI.72.5.2810-2816.2004; Darwich L, 2003, J GEN VIROL, V84, P3453, DOI 10.1099/vir.0.19364-0; Delaney KN, 2010, VIRAL IMMUNOL, V23, P201, DOI 10.1089/vim.2009.0107; Fan HY, 2008, J VIROL METHODS, V150, P21, DOI 10.1016/j.jviromet.2008.02.011; Fenaux M, 2004, J VIROL, V78, P6297, DOI 10.1128/JVI.78.12.6297-6303.2004; Fort M, 2008, VACCINE, V26, P1063, DOI 10.1016/j.vaccine.2007.12.019; Fort M, 2009, VACCINE, V27, P4031, DOI 10.1016/j.vaccine.2009.04.028; Fort M, 2007, VET MICROBIOL, V125, P244, DOI 10.1016/j.vetmic.2007.06.004; Fort M, 2009, VET IMMUNOL IMMUNOP, V129, P101, DOI 10.1016/j.vetimm.2008.12.024; Gilpin DF, 2003, VET IMMUNOL IMMUNOP, V94, P149, DOI 10.1016/S0165-2427(03)00087-4; Kamstrup S, 2004, VACCINE, V22, P1358, DOI 10.1016/j.vaccine.2004.01.032; Kekarainen T, 2008, J GEN VIROL, V89, P760, DOI 10.1099/vir.0.83354-0; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim T, 2009, VET MICROBIOL, V138, P318, DOI 10.1016/j.vetmic.2009.04.014; Kixmoller M, 2008, VACCINE, V26, P3443, DOI 10.1016/j.vaccine.2008.04.032; Larochelle R, 2003, CAN J VET RES, V67, P114; Letran SE, 2011, EUR J IMMUNOL, V41, P29, DOI 10.1002/eji.201040717; Liu G, 2012, VACCINE, V30, P6833, DOI 10.1016/j.vaccine.2012.09.013; Liu GM, 2011, VACCINE, V29, P8677, DOI 10.1016/j.vaccine.2011.08.118; Liu J, 2005, J VIROL, V79, P8262, DOI 10.1128/JVI.79.13.8262-8274.2005; Martelli P, 2011, VET MICROBIOL, V149, P339, DOI 10.1016/j.vetmic.2010.12.008; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; McIntosh KA, 2006, CAN J VET RES, V70, P58; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Meerts P, 2005, VIRAL IMMUNOL, V18, P333, DOI 10.1089/vim.2005.18.333; MEERTS P, 2006, BMC VET RES, V30, P2; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Mizel SB, 2009, CLIN VACCINE IMMUNOL, V16, P21, DOI 10.1128/CVI.00333-08; Nawagitgul P, 2000, J GEN VIROL, V81, P2281, DOI 10.1099/0022-1317-81-9-2281; Okuda Y, 2003, J VET DIAGN INVEST, V15, P107, DOI 10.1177/104063870301500204; Opriessnig T, 2009, VACCINE, V27, P1002, DOI 10.1016/j.vaccine.2008.11.105; Opriessnig T, 2008, CLIN VACCINE IMMUNOL, V15, P397, DOI 10.1128/CVI.00416-07; Opriessnig T, 2007, J VET DIAGN INVEST, V19, P591, DOI 10.1177/104063870701900601; Perez-Martin E, 2010, VACCINE, V28, P2340, DOI 10.1016/j.vaccine.2009.12.061; Pino O, 2005, INFECT IMMUN, V73, P6763, DOI 10.1128/IAI.73.10.6763-6770.2005; Rodriguez-Arrioja GM, 2000, VET REC, V146, P762, DOI 10.1136/vr.146.26.762; Rosell C, 1999, J COMP PATHOL, V120, P59, DOI 10.1053/jcpa.1998.0258; Segales Joaquim, 2005, Animal Health Research Reviews, V6, P119, DOI 10.1079/AHR2005106; Shen HG, 2008, J GEN VIROL, V89, P1857, DOI 10.1099/vir.0.2008/000125-0; Sibila M, 2004, AM J VET RES, V65, P88, DOI 10.2460/ajvr.2004.65.88; Sorden SD, 1999, J VET DIAGN INVEST, V11, P528, DOI 10.1177/104063879901100607; Stevenson LS, 2006, VIRAL IMMUNOL, V19, P189, DOI 10.1089/vim.2006.19.189; Wang K, 2008, J VIROL METHODS, V150, P1, DOI 10.1016/j.jviromet.2008.02.014; Wang YP, 2013, VACCINE, V31, P833, DOI 10.1016/j.vaccine.2012.11.062; Zhang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129617	54	16	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147432	10.1371/journal.pone.0147432	http://dx.doi.org/10.1371/journal.pone.0147432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848967	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000017
J	Chen, RC; Tang, XQ; Fan, BL; Liu, JF; Jia, XD; Yang, XG				Chen, Rucheng; Tang, Xiaoqiao; Fan, Bolin; Liu, Jiafa; Jia, Xudong; Yang, Xiaoguang			IgG Expression upon Oral Sensitization in Association with Maternal Exposure to Ovalbumin	PLOS ONE			English	Article							BROWN-NORWAY RAT; FOOD ALLERGY; PEANUT ALLERGY; RISK-FACTOR; MODEL; PROTEINS; ASTHMA; ALLERGENICITY; CHILDHOOD; PREGNANCY	The role of maternal allergen exposure in the allergenicity of the offspring remains controversial. Some studies have shown that maternal exposure is a risk factor for allergy in the offspring, whereas other studies have shown that maternal exposure induces immune tolerance and protects offspring from allergy disease. Therefore, we utilized maternal rat allergen exposure model to evaluate the offspring immune reactions to ovalbumin protein and to determine whether the Brown Norway (BN) rat model is a suitable animal model for studying the allergenicity of food proteins. For three generations, rats received an allergens or nonallergens by gavage during the pregnancy and lactation periods. After weaning, the offspring rats were used for oral sensitization experiment. In the sensitization experiment, the control rat, which had maternal exposure to phosphate-buffered saline (PBS), exhibited full response of IgG to oral exposure to OVA. The IgG level was significantly lower in F1 rats that were sensitized by maternal exposure to ovalbumin(OVA). Moreover, the lowest IgG level was found for the F3b sensitized by maternal rats exposed to OVA allergen for three continuous generations. Compared with maternal OVA exposure prior to postnatal sensitization, the sensitization via maternal PBS led to a higher serum level of OVA-specific IgG. However, the OVA-specific IgG levels for the two generations of maternal PBS exposure prior to postnatal sensitization was not higher than that for the one generation of maternal rats exposed to PBS prior to postnatal sensitization. Our studies demonstrate that maternal OVA exposure during the pregnancy and lactation can affect the results of oral sensitization studies using ovalbumin protein. BN rats must be bred in non-allergen conditions for at least one generation to avoid problems in rat models for studying the allergenicity of food proteins.	[Chen, Rucheng; Tang, Xiaoqiao; Fan, Bolin; Liu, Jiafa] Hubei Prov Ctr Dis Control & Prevent, Hubei Prov Key Lab Appl Toxicol, Wuhan 430079, Hubei, Peoples R China; [Chen, Rucheng] Zhejiang Chinese Med Sch, Coll Basic Med Sci, Hangzhou 310053, Zhejiang, Peoples R China; [Jia, Xudong] China Natl Ctr Food Safety Risk Assessment, Beijing 100021, Peoples R China; [Yang, Xiaoguang] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Food Safety, Beijing 100021, Peoples R China	Zhejiang Chinese Medical University; Chinese Center for Disease Control & Prevention	Fan, BL; Liu, JF (corresponding author), Hubei Prov Ctr Dis Control & Prevent, Hubei Prov Key Lab Appl Toxicol, Wuhan 430079, Hubei, Peoples R China.	vanbolin@163.com; jfllionm@sohu.com			Key Program of Transgenic Plant Breeding, National institute for nutrition and food safety, Chinese center for disease control and prevention [2011ZX08011005, 2014ZX08011005]; Hubei Province's Outstanding Medical Academic Leader Program, Hubei Provincial Key Laboratory for Applied Toxicology, Hubei provincial center for disease control and prevention; Scientific Research Project of Zhejiang Chinese Medical University, College of Basic Medical Science, Zhejiang Chinese Medical School [711200E013, 712223A06001/005/015]	Key Program of Transgenic Plant Breeding, National institute for nutrition and food safety, Chinese center for disease control and prevention; Hubei Province's Outstanding Medical Academic Leader Program, Hubei Provincial Key Laboratory for Applied Toxicology, Hubei provincial center for disease control and prevention; Scientific Research Project of Zhejiang Chinese Medical University, College of Basic Medical Science, Zhejiang Chinese Medical School	The funding of Key Program of Transgenic Plant Breeding (2011ZX08011005,2014ZX08011005), affiliating to National institute for nutrition and food safety, Chinese center for disease control and prevention(XY) played a role in study design and data collection. The funding of Hubei Province's Outstanding Medical Academic Leader Program, affiliating to Hubei Provincial Key Laboratory for Applied Toxicology, Hubei provincial center for disease control and prevention (BF JL), played a role in data analysis and decision to publish. The funding of Scientific Research Project of Zhejiang Chinese Medical University (711200E013,712223A06001/005/015), affiliating to College of Basic Medical Science, Zhejiang Chinese Medical School, played a role in preparation of the manuscript.	Alvarez Pedro A, 2012, J Allergy (Cairo), V2012, P746125, DOI 10.1155/2012/746125; Arshad SH, 2007, J ALLERGY CLIN IMMUN, V119, P307, DOI 10.1016/j.jaci.2006.12.621; Astwood JD, 1996, NAT BIOTECHNOL, V14, P1269, DOI 10.1038/nbt1096-1269; ATKINSON HAC, 1994, TOXICOLOGY, V91, P281, DOI 10.1016/0300-483X(94)90015-9; Atkinson HAC, 1996, FOOD CHEM TOXICOL, V34, P27, DOI 10.1016/0278-6915(95)00084-4; Bergmann RL, 2002, CLIN EXP ALLERGY, V32, P205, DOI 10.1046/j.1365-2222.2002.01274.x; DesRoches A, 2010, J INVEST ALLERG CLIN, V20, P289; Flodrova D, 2015, J SCI FOOD AGR, V95, P983, DOI 10.1002/jsfa.6773; Fox AT, 2009, J ALLERGY CLIN IMMUN, V123, P417, DOI 10.1016/j.jaci.2008.12.014; Gendel SM, 1998, ADV FOOD NUTR RES, V42, P63, DOI 10.1016/S1043-4526(08)60093-5; Gupta RS, 2014, PEDIATRICS, V134, P729, DOI 10.1542/peds.2014-0402; Kimber I, 2003, ENVIRON HEALTH PERSP, V111, P227, DOI 10.1289/ehp.5703; Knippels LMJ, 1999, TOXICOL APPL PHARM, V156, P161, DOI 10.1006/taap.1999.8641; Knippels LMJ, 2000, ALLERGY, V55, P251, DOI 10.1034/j.1398-9995.2000.00403.x; Knippels LMJ, 2003, ENVIRON HEALTH PERSP, V111, P233, DOI 10.1289/ehp.5704; Knippels LMJ, 2002, ANN NY ACAD SCI, V964, P151; Knippels LMJ, 1998, J ALLERGY CLIN IMMUN, V101, P815, DOI 10.1016/S0091-6749(98)70309-4; Knippels LMJ, 1998, CLIN EXP ALLERGY, V28, P368, DOI 10.1046/j.1365-2222.1998.00242.x; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Kull I, 2004, J ALLERGY CLIN IMMUN, V114, P755, DOI 10.1016/j.jaci.2004.07.036; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Ladics GS, 2009, REGUL TOXICOL PHARM, V54, pS2, DOI 10.1016/j.yrtph.2008.10.010; Ladics GS, 2003, TOXICOL SCI, V73, P8, DOI 10.1093/toxsci/kfg055; Lavado R, 2004, TOXICOL APPL PHARM, V196, P247, DOI 10.1016/j.taap.2003.12.012; Li XM, 2001, J ALLERGY CLIN IMMUN, V107, P693, DOI 10.1067/mai.2001.114110; Nestle A., 2011, FOOD ALLERGY; Pilegaard K, 2004, TOXICOLOGY, V196, P247, DOI 10.1016/j.tox.2003.11.010; Polte T, 2008, CLIN EXP ALLERGY, V38, P1950, DOI 10.1111/j.1365-2222.2008.03096.x; Prescott Susan, 2011, Ann Nutr Metab, V59 Suppl 1, P28, DOI 10.1159/000334150; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; Sears MR, 2002, LANCET, V360, P901, DOI 10.1016/S0140-6736(02)11025-7; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V126, P1191, DOI 10.1016/j.jaci.2010.08.036; WEIL GJ, 1983, J CLIN INVEST, V71, P1124, DOI 10.1172/JCI110862	33	1	1	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148251	10.1371/journal.pone.0148251	http://dx.doi.org/10.1371/journal.pone.0148251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844775	Green Published, gold, Green Submitted			2022-12-27	WOS:000369552800040
J	Feiersinger, F; Nolte, E; Wach, S; Rau, TT; Vassos, N; Geppert, C; Konrad, A; Merkel, S; Taubert, H; Sturzl, M; Croner, RS				Feiersinger, Fabian; Nolte, Elke; Wach, Sven; Rau, Tilman T.; Vassos, Nikolaos; Geppert, Carol; Konrad, Andreas; Merkel, Susanne; Taubert, Helge; Sturzl, Michael; Croner, Roland S.			MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma	PLOS ONE			English	Article							MICRORNA EXPRESSION; INVASION; MIR-21; IDENTIFY; GROWTH; GENES; RNA	Objective Metastasis is the major cause of death in colorectal cancer patients. Expression of certain miRNAs in the primary tumors has been shown to be associated with progression of colorectal cancer and the initiation of metastasis. In this study, we compared miRNA expression in primary colorectal cancer and corresponding liver metastases in order to get an idea of the oncogenic importance of the miRNAs in established metastases. Methods We analyzed the expression of miRNA-21, miRNA-31 and miRNA-373 in corresponding formalin-fixed paraffin-embedded (FFPE) tissue samples of primary colorectal cancer, liver metastasis and healthy tissues of 29 patients by quantitative real-time PCR. Results All three miRNAs were significantly up-regulated in the primary tumor tissues as compared to healthy colon mucosa of the respective patients (p < 0.01). MiRNA-21 and miRNA-31 were also higher expressed in liver metastases as compared to healthy liver tissues (p < 0.01). No significant difference of expression of miRNA-31 and miRNA-373 was observed between primary tumors and metastases. Of note, miRNA-21 expression was significantly reduced in liver metastases as compared to the primary colorectal tumors (p < 0.01). Conclusion In the context of previous studies demonstrating increased miRNA-21 expression in metastatic primary tumors, our findings raise the question whether miRNA-21 might be involved in the initiation but not in the perpetuation and growth of metastases.	[Feiersinger, Fabian; Konrad, Andreas; Sturzl, Michael] Univ Erlangen Nurnberg, Surg Clin, Div Mol & Expt Surg, Schwabachanlage 12, D-91054 Erlangen, Germany; [Nolte, Elke; Wach, Sven; Taubert, Helge] Univ Erlangen Nurnberg, Urol Clin, Krankenhausstr 12, D-91054 Erlangen, Germany; [Rau, Tilman T.; Geppert, Carol] Univ Erlangen Nurnberg, Dept Pathol, Krankenhausstr 12, D-91054 Erlangen, Germany; [Vassos, Nikolaos; Merkel, Susanne; Croner, Roland S.] Univ Erlangen Nurnberg, Surg Clin, Krankenhausstr 12, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Feiersinger, F (corresponding author), Univ Erlangen Nurnberg, Surg Clin, Div Mol & Expt Surg, Schwabachanlage 12, D-91054 Erlangen, Germany.	fabian.feiersinger@uk-erlangen.de	Stürzl, Michael/B-3019-2015	Stürzl, Michael/0000-0002-9276-2824; Merkel, Susanne/0000-0003-2676-9486	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, Polyprobe Study); Deutsche Forschungsgemeinschaft [SFB796, KFO257, DFG 136/2]; German Cancer Aid (Deutsche Krebshilfe) [109510]; Interdisciplinary Center for Clinical Research (IZKF) Erlangen	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, Polyprobe Study)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); Interdisciplinary Center for Clinical Research (IZKF) Erlangen	This work was supported by grants (to MS) of the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, Polyprobe Study), the Deutsche Forschungsgemeinschaft [SFB796 (sub-project B9), KFO257 (sub-project 4), DFG 136/2] and the German Cancer Aid (Deutsche Krebshilfe, 109510). Additional support was obtained from the Interdisciplinary Center for Clinical Research (IZKF) Erlangen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Choi SH, 2000, INT J CANCER, V85, P523, DOI 10.1002/(SICI)1097-0215(20000215)85:4<523::AID-IJC13>3.0.CO;2-6; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; de Krijger I, 2011, J PATHOL, V224, P438, DOI 10.1002/path.2922; Drusco A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096670; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Kulda V, 2010, CANCER GENET CYTOGEN, V200, P154, DOI 10.1016/j.cancergencyto.2010.04.015; Li Xiaohua, 2011, J Cell Mol Med, V15, P1887, DOI 10.1111/j.1582-4934.2010.01194.x; Liu K, 2011, J INT MED RES, V39, P2288, DOI 10.1177/147323001103900626; Nakano H, 2010, INT J CANCER, V127, P1072, DOI 10.1002/ijc.25143; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Ostalecki C, 2013, EXP MOL PATHOL, V95, P1, DOI 10.1016/j.yexmp.2013.03.008; Schee K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-505; Schetter AJ, 2012, CANCER J, V18, P244, DOI 10.1097/PPO.0b013e318258b78f; Shibuya H, 2010, ONCOLOGY-BASEL, V79, P313, DOI 10.1159/000323283; Tanaka T, 2011, ONCOL REP, V26, P1329, DOI 10.3892/or.2011.1401; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vickers MM, 2012, CLIN EXP METASTAS, V29, P123, DOI 10.1007/s10585-011-9435-3; Wolf MJ, 2012, CANCER CELL, V22, P91, DOI 10.1016/j.ccr.2012.05.023	26	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148580	10.1371/journal.pone.0148580	http://dx.doi.org/10.1371/journal.pone.0148580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845148	Green Published, gold			2022-12-27	WOS:000369552800073
J	Liu, Z; Smagghe, G; Lei, ZR; Wang, JJ				Liu, Zhao; Smagghe, Guy; Lei, Zhongren; Wang, Jin-Jun			Identification of Male- and Female-Specific Olfaction Genes in Antennae of the Oriental Fruit Fly (Bactrocera dorsalis)	PLOS ONE			English	Article							ODORANT-BINDING-PROTEINS; CANDIDATE CHEMOSENSORY GENES; SOUTHERN HOUSE MOSQUITO; EXPRESSION PROFILES; MOLECULAR CHARACTERIZATION; CHILO-SUPPRESSALIS; TRANSCRIPTOME; RECEPTORS; DIPTERA; ATTRACTION	The oriental fruit fly (Bactrocera dorsalis) is a species of tephritid fruit fly, endemic to Southeast Asia but also introduced to many regions of the US, and it is one of the major pest species with a broad host range of cultivated and wild fruits. Although males of B. dorsalis respond strongly to methyl eugenol and this is used for monitoring and estimating populations, the molecular mechanism of the oriental fruit fly olfaction has not been elucidated yet. Therefore, in this project, using next generation sequencing technologies, we sequenced the transcriptome of the antennae of male and female adults of B. dorsalis. We identified a total of 20 candidate odorant binding proteins (OBPs), 5 candidate chemosensory proteins (CSPs), 35 candidate odorant receptors (ORs), 12 candidate ionotropic receptors (IRs) and 4 candidate sensory neuron membrane proteins (SNMPs). The sex-specific expression of these genes was determined and a subset of 9 OR genes was further characterized by qPCR with male and female antenna, head, thorax, abdomen, leg and wing samples. In the male antennae, 595 genes showed a higher expression, while 128 genes demonstrated a higher expression in the female antennae. Interestingly, 2 ORs (BdorOR13 and BdorOR14) were highly and specifically expressed in the antennae of males, and 4 ORs (BdorOR13, BdorOR16, BdorOR18 and BdorOR35) clustered with DmOR677, suggesting pheromone reception. We believe this study with these antennae-enriched OBPs, CSPs, ORs, IRs and SNMPs can play an important role in the detection of pheromones and general odorants, and so in turn our data improve our current understanding of insect olfaction at the molecular level and provide important information for disrupting the behavior of the oriental fruit fly using chemical communication methods.	[Liu, Zhao; Smagghe, Guy; Wang, Jin-Jun] Southwest Univ, Inst Entomol, Coll Plant Protect, Chongqing 400715, Peoples R China; [Lei, Zhongren] Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100086, Peoples R China; [Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium	Southwest University - China; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ghent University	Wang, JJ (corresponding author), Southwest Univ, Inst Entomol, Coll Plant Protect, Chongqing 400715, Peoples R China.; Lei, ZR (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100086, Peoples R China.	leizhr@sina.com; jjwang7008@yahoo.com	Smagghe, Guy/AAE-8914-2019	Smagghe, Guy/0000-0001-8334-3313	National Natural Science Foundation of China [31201515]; China Postdoctoral Science Foundation [2013M531929]; Research Fund for the Doctoral Program of Higher Education of China [SWU111033]; Special Fund for Agro-scientific Research in the Public Interest of China [201303019]; Natural Science Foundation of Chongqing (CSTC) [2013jjB0176]; Foundation Project of Southwest University [SWU114049]; Fundamental Research Funds for the Central Universities [XDJK2012C080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Special Fund for Agro-scientific Research in the Public Interest of China; Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Foundation Project of Southwest University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was funded in part by the National Natural Science Foundation of China (31201515), the China Postdoctoral Science Foundation (2013M531929), the Research Fund for the Doctoral Program of Higher Education of China (SWU111033), the Special Fund for Agro-scientific Research in the Public Interest of China (201303019), the Natural Science Foundation of Chongqing (CSTC, 2013jjB0176), the Foundation Project of Southwest University (SWU114049), and the Fundamental Research Funds for the Central Universities (XDJK2012C080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Cao DP, 2014, INT J BIOL SCI, V10, P846, DOI 10.7150/ijbs.9297; CHRISTENSON LD, 1960, ANNU REV ENTOMOL, V5, P171, DOI 10.1146/annurev.en.05.010160.001131; Cornelius ML, 2000, J ECON ENTOMOL, V93, P93, DOI 10.1603/0022-0493-93.1.93; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dippel S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1141; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Feng B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1375-x; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Geib S M, 2014, BMC GENOMICS, P15; Glaser N, 2013, INT J BIOL SCI, V9, P481, DOI 10.7150/ijbs.6109; Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103420; He M, 2014, COMP BIOCHEM PHYS B, V174, P1, DOI 10.1016/j.cbpb.2014.04.008; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hsu JC, 2006, J ECON ENTOMOL, V99, P931, DOI 10.1603/0022-0493-99.3.931; Hsu JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040950; Jang EB, 1997, J CHEM ECOL, V23, P1389, DOI 10.1023/B:JOEC.0000006471.46161.8d; Jin T, 2011, PEST MANAG SCI, V67, P370, DOI 10.1002/ps.2076; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Leitch O, 2015, BMC GENOMICS, V16, P17, DOI [10.1186/s12864-015-1216-y, DOI 10.1186/S12864-015-1216-Y]; Li ZQ, 2015, COMP BIOCHEM PHYS D, V15, P28, DOI 10.1016/j.cbd.2015.05.002; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Liu S, 2015, COMP BIOCHEM PHYS D, V13, P44, DOI 10.1016/j.cbd.2015.01.004; Liu S, 2015, J ASIA-PAC ENTOMOL, V18, P99, DOI 10.1016/j.aspen.2014.12.006; Liu S, 2013, ANN ENTOMOL SOC AM, V106, P378, DOI 10.1603/AN12099; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Ma L, 2014, J INSECT PHYSIOL, V60, P118, DOI 10.1016/j.jinsphys.2013.11.007; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; OEPP/EPPO, 1983, BULLETIN OEPP EPPO B, P13; Pelletier J, 2011, J INSECT PHYSIOL, V57, P915, DOI 10.1016/j.jinsphys.2011.04.003; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Pelletier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006237; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rinker DC, 2013, P NATL ACAD SCI USA, V110, P8260, DOI 10.1073/pnas.1302562110; Rytz R, 2013, INSECT BIOCHEM MOLEC, V43, P888, DOI 10.1016/j.ibmb.2013.02.007; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Siderhurst MS, 2006, J CHEM ECOL, V32, P2513, DOI 10.1007/s10886-006-9160-6; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; Stengl M, 2013, J COMP PHYSIOL A, V199, P897, DOI 10.1007/s00359-013-0837-3; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Taylor AJ, 2008, CHEMOSENS PERCEPT, V1, P153, DOI 10.1007/s12078-008-9016-2; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Yan SW, 2015, J INSECT PHYSIOL, V79, P36, DOI 10.1016/j.jinsphys.2015.06.002; Yi X, 2014, J CHEM ECOL, V40, P267, DOI 10.1007/s10886-014-0406-4; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077295; Zhang J, 2015, PLOS ONE, V10, P26; Zhang SF, 2014, INSECT BIOCHEM MOLEC, V52, P69, DOI 10.1016/j.ibmb.2014.06.006; Zhang T T, 2015, PLOS ONE, V10, P22; Zheng WW, 2013, INT J MOL SCI, V14, P14936, DOI 10.3390/ijms140714936; Zheng WW, 2012, J INSECT PHYSIOL, V58, P1122, DOI 10.1016/j.jinsphys.2012.05.011; Zhou CX, 2015, COMP BIOCHEM PHYS D, V16, P10, DOI 10.1016/j.cbd.2015.06.003; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007	66	45	51	8	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147783	10.1371/journal.pone.0147783	http://dx.doi.org/10.1371/journal.pone.0147783			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845547	Green Published, gold			2022-12-27	WOS:000369552800016
J	Mao, S; Yang, G; Li, W; Zhang, J; Liang, HL; Li, J; Zhang, MZ				Mao, Shuai; Yang, Guang; Li, Winny; Zhang, Jian; Liang, Hailong; Li, Jian; Zhang, Minzhou			Gastroprotective Effects of Astragaloside IV against Acute Gastric Lesion in Rats	PLOS ONE			English	Article							HELICOBACTER-PYLORI; CALCIUM; OVEREXPRESSION; PROSTAGLANDINS; PREVENTION; PROTECTION; APOPTOSIS; ISCHEMIA; EXTRACTS; ETHANOL	Background Protection of the gastric mucosa from acute lesions induced by various irritants is a pertinent issue in the field of critical care medicine. In this study, we investigated the gastroprotective effects of astragaloside IV on acute gastric lesions in rats under stressful conditions. Methods Rats were randomized into six groups. Group 1 and 2 received 10% Tween 80 (vehicle). Group 3 received 20 mg/kg of omeprazole, a proton pump inhibitor. Groups 4, 5 and 6 received astragaloside IV at concentration of 1, 10, and 50 mg/kg, respectively. As a means to induce gastric lesions, Groups 2-6 were subjected to water immersion and restraint stress for 12 hours after treatment. Results Our present studies show that compared to rats in group 2, treatment with 1 to 50 mg/kg astragaloside IV significantly decreased the size of gastric lesions, MDA, TNF alpha and MCP1 levels, in addition to normalizing gastric pH, gastric mucus and SOD levels (P<0.05). Histomorphological examination confirmed that treatment with astragaloside IV elicited a dosage-dependent protective effect on the gastric mucosa. Furthermore, pretreatment with astragaloside IV resulted in significant elevations in HSP70 and reduction in Bax, along with over-expression of PLC. response level, which was further confirmed via immunohistochemical analysis. Conclusions The acute gastric lesions induced are attenuated by pretreatment with astragaloside IV which is possibly due to the enhancing of the expression of HSP70 with concomitant antioxidant, anti-inflammatory and anti-apoptotic capacity.	[Mao, Shuai; Yang, Guang; Zhang, Jian; Liang, Hailong; Li, Jian; Zhang, Minzhou] Guangdong Prov Hosp Chinese Med, Dept Crit Care Med, Rd Dade, Guangzhou 510120, Guangdong, Peoples R China; [Mao, Shuai; Yang, Guang; Zhang, Jian; Liang, Hailong; Li, Jian; Zhang, Minzhou] Guangzhou Univ Chinese Med, Clin Med Coll 2, Rd Jichang, Guangzhou 510405, Guangdong, Peoples R China; [Li, Winny] Univ Toronto, Fac Med, Univ Ave, Toronto, ON M5G 0A4, Canada; [Mao, Shuai] Hosp Sick Children, Physiol & Expt Med, Toronto, ON M5G 0A4, Canada	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Zhang, MZ (corresponding author), Guangdong Prov Hosp Chinese Med, Dept Crit Care Med, Rd Dade, Guangzhou 510120, Guangdong, Peoples R China.	minzhouzhang@yeah.net			Postdoctoral Science Foundation of China [2015M570701]; Science Foundation from Department of Science and Technology of Guangdong Province [S2012010010397, [2013] 137168]	Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Science Foundation from Department of Science and Technology of Guangdong Province	This work was financially supported by Postdoctoral Science Foundation of China (NO. 2015M570701), Science Foundation from Department of Science and Technology of Guangdong Province (NO. S2012010010397 & NO. [2013] 137168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2008, INT J MED MUSHROOMS, V10, P325, DOI 10.1615/IntJMedMushr.v10.i4.40; Abdulla MA, 2010, AFR J PHARM PHARMACO, V4, P226; Allen A, 2005, AM J PHYSIOL-CELL PH, V288, pC1, DOI 10.1152/ajpcell.00102.2004; AlRashdi AS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/786426; Asano T, 2009, J PHARMACOL EXP THER, V330, P458, DOI 10.1124/jpet.109.152181; Brzozowski T, 1997, J PINEAL RES, V23, P79, DOI 10.1111/j.1600-079X.1997.tb00339.x; Brzozowski T, 2000, EUR J PHARMACOL, V398, P147, DOI 10.1016/S0014-2999(00)00287-9; Chiang CY, 2012, J BIOL CHEM, V287, P3704, DOI 10.1074/jbc.C111.328559; COOK DJ, 1994, NEW ENGL J MED, V330, P377, DOI 10.1056/NEJM199402103300601; Gao XH, 2009, J NAT MED-TOKYO, V63, P421, DOI 10.1007/s11418-009-0348-2; Golbabapour S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075036; Golbabapour S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/974185; Gui DK, 2013, CYTOKINE, V61, P970, DOI 10.1016/j.cyto.2013.01.008; Huang LF, 2012, FITOTERAPIA, V83, P1514, DOI 10.1016/j.fitote.2012.08.019; Hwang JY, 2008, AM J PATHOL, V173, P1919, DOI 10.2353/ajpath.2008.070875; Ismail IF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/404012; Kang HJ, 2003, MOL PHARMACOL, V64, P228, DOI 10.1124/mol.64.2.228; KAUFFMAN GL, 1978, GASTROENTEROLOGY, V75, P1099; Kwiecien S, 2002, J PHYSIOL PHARMACOL, V53, P39; Matsuda M, 2010, J BIOL CHEM, V285, P5848, DOI 10.1074/jbc.M109.063453; Metz DC, 2005, CURR MED RES OPIN, V21, P11, DOI 10.1185/030079905X16777; Mizushima T, 2014, CURR OPIN PHARMACOL, V19, pR1, DOI 10.1016/j.coph.2014.10.006; Nartey ET, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-65; Nassar NN, 2011, WORLD J GASTROENTERO, V17, P1135, DOI 10.3748/wjg.v17.i9.1135; Navarrete A, 2005, J PHARM PHARMACOL, V57, P1059, DOI 10.1211/0022357056659; Nguelefack TB, 2008, J ETHNOPHARMACOL, V119, P135, DOI 10.1016/j.jep.2008.06.008; Padol S, 2006, AM J GASTROENTEROL, V101, P1467, DOI 10.1111/j.1572-0241.2006.00717.x; Patterson RL, 2005, TRENDS BIOCHEM SCI, V30, P688, DOI 10.1016/j.tibs.2005.10.005; Qiu LH, 2010, BIOL PHARM BULL, V33, P641, DOI 10.1248/bpb.33.641; Shah A. H., 2014, Biology and Medicine, V6, P1000197; Sofidiya MO, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-168; Suemasu S, 2009, J BIOL CHEM, V284, P19705, DOI 10.1074/jbc.M109.006817; Targa AC, 2007, GENET MOL RES, V6, P554; Zhou RN, 2012, DRUG METAB PHARMACOK, V27, P586, DOI 10.2133/dmpk.DMPK-11-RG-160	34	7	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148146	10.1371/journal.pone.0148146	http://dx.doi.org/10.1371/journal.pone.0148146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845156	Green Published, Green Submitted, gold			2022-12-27	WOS:000369552800033
J	Zabala, A; Pascual, U				Zabala, Aiora; Pascual, Unai			Bootstrapping Q Methodology to Improve the Understanding of Human Perspectives	PLOS ONE			English	Article							ESTIMATING CONFIDENCE-INTERVALS; PRINCIPAL COMPONENT ANALYSIS; EXPLORATORY FACTOR-ANALYSIS; ENVIRONMENTAL PERSPECTIVES; AGRICULTURE; STABILITY; LOADINGS	Q is a semi-qualitative methodology to identify typologies of perspectives. It is appropriate to address questions concerning diverse viewpoints, plurality of discourses, or participation processes across disciplines. Perspectives are interpreted based on rankings of a set of statements. These rankings are analysed using multivariate data reduction techniques in order to find similarities between respondents. Discussing the analytical process and looking for progress in Q methodology is becoming increasingly relevant. While its use is growing in social, health and environmental studies, the analytical process has received little attention in the last decades and it has not benefited fromrecent statistical and computational advances. Specifically, the standard procedure provides overall and arguably simplistic variability measures for perspectives and none of these measures are associated to individual statements, on which the interpretation is based. This paper presents an innovative approach of bootstrapping Q to obtain additional and more detailedmeasures of variability, which helps researchers understand better their data and the perspectives therein. This approach provides measures of variability that are specific to each statement and perspective, and additional measures that indicate the degree of certainty with which each respondent relates to each perspective. This supplementary information may add or subtract strength to particular arguments used to describe the perspectives. We illustrate and show the usefulness of this approach with an empirical example. The paper provides full details for other researchers to implement the bootstrap in Q studies with any data collection design.	[Zabala, Aiora; Pascual, Unai] Univ Cambridge, Dept Land Econ, Cambridge CB3 9EP, England; [Pascual, Unai] Basque Ctr Climate Change BC3, Bilbao, Spain; [Pascual, Unai] Basque Fdn Sci, Ikerbasque, Bilbao, Spain	University of Cambridge; Basque Centre for Climate Change (BC3); Basque Foundation for Science	Zabala, A (corresponding author), Univ Cambridge, Dept Land Econ, Cambridge CB3 9EP, England.	aiora.zabala@gmail.com	Zabala, Aiora/B-2633-2010; PASCUAL, UNAI/B-4766-2012; Pascual, Unai/O-7946-2019	Zabala, Aiora/0000-0001-8534-3325; PASCUAL, UNAI/0000-0002-5696-236X; Pascual, Unai/0000-0002-5696-236X	Department of Education, Universities and Research of the Basque Government	Department of Education, Universities and Research of the Basque Government	Research conducting to this paper was funded by a scholarship from the Department of Education, Universities and Research of the Basque Government (http://www.ejgv.euskadi.eus/) to AZ.	Babamoradi H, 2013, CHEMOMETR INTELL LAB, V120, P97, DOI 10.1016/j.chemolab.2012.10.007; Barry J, 1999, ECOL ECON, V28, P337, DOI 10.1016/S0921-8009(98)00053-6; Brown Sr, 1999, PUB ADM PP, V71, P599; Brown SR., 2008, SAGE ENCY QUALITATIV; Brown SR, 1980, POLITICAL SUBJECTIVI; Buckley C, 2012, ECOL ECON, V78, P29, DOI 10.1016/j.ecolecon.2012.02.031; CHATTERJEE S, 1990, J FINANC RES, V13, P15, DOI 10.1111/j.1475-6803.1990.tb00532.x; Cuppen E, 2010, ECOL ECON, V69, P579, DOI 10.1016/j.ecolecon.2009.09.005; Davies BB, 2007, ECOL ECON, V61, P323, DOI 10.1016/j.ecolecon.2006.03.002; Davies B, 2012, ECOL ECON, V83, P51, DOI 10.1016/j.ecolecon.2012.08.013; de Winter JCF, 2009, MULTIVAR BEHAV RES, V44, P147, DOI 10.1080/00273170902794206; DRYZEK JS, 1993, AM POLIT SCI REV, V87, P48, DOI 10.2307/2938955; Dziopa F, 2011, METHODOLOGY-EUR, V7, P39, DOI 10.1027/1614-2241/a000021; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fairweather J., 1981, OPERANT SUBJECTIVITY, V5, P2; Fairweather JR, 2001, OPERANT SUBJECTIVITY, V25, P37; ICHIKAWA M, 1995, PSYCHOMETRIKA, V60, P77, DOI 10.1007/BF02294430; Larsen R, 2010, BEHAV RES METHODS, V42, P871, DOI 10.3758/BRM.42.3.871; Linting M, 2007, PSYCHOL METHODS, V12, P359, DOI 10.1037/1082-989X.12.3.359; Lo AY, 2013, ECOL ECON, V87, P84, DOI 10.1016/j.ecolecon.2012.12.014; Markiewicz PJ, 2011, NEUROIMAGE, V56, P1382, DOI 10.1016/j.neuroimage.2011.02.036; McKeown B, 2013, Q METHODOLOGY, V2nd, DOI DOI 10.4135/9781483384412; Peres-Neto PR, 2003, ECOLOGY, V84, P2347, DOI 10.1890/00-0634; R Core Team, 2013, R LANG ENV STAT COMP; Raykov T, 1999, EDUC PSYCHOL MEAS, V59, P47, DOI 10.1177/0013164499591004; Sandbrook C, 2011, CONSERV BIOL, V25, P285, DOI 10.1111/j.1523-1739.2010.01592.x; Sandbrook CG, 2013, GEOFORUM, V50, P232, DOI 10.1016/j.geoforum.2013.09.009; Schmolck P., 2014, PQMETHOD SOFTWARE VE; Stenner P., 2008, SAGE HDB QUALITATIVE, P215, DOI 10.4135/9781848607927.n13; Stephenson W., 1953, STUDY BEHAV Q TECHNI; Stephenson W., 1978, OPERANT SUBJECTIVITY, V1, P29; Swedeen P, 2006, ECOL ECON, V57, P190, DOI 10.1016/j.ecolecon.2005.04.003; Timmerman ME, 2007, BRIT J MATH STAT PSY, V60, P295, DOI 10.1348/000711006X109636; van Exel NJA, 2011, TRANSPORTATION, V38, P383, DOI 10.1007/s11116-010-9315-8; van Exel N.J.A., 2008, SOCIAL SCI; Watts S., 2012, DOING Q METHODOLOGIC; Watts S., 2005, QUAL RES PSYCHOL, V2, P67, DOI [10.1191/1478088705qp022oa, DOI 10.1191/1478088705QP022OA]; Yu CC, 1998, J ENVIRON MANAGE, V53, P101, DOI 10.1006/jema.1998.0184; Zabala A, 2014, R J, V6, P163; Zhang GJ, 2010, MULTIVAR BEHAV RES, V45, P104, DOI 10.1080/00273170903504836; Zientek LR, 2007, BEHAV RES METHODS, V39, P318, DOI 10.3758/BF03193163	42	71	73	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148087	10.1371/journal.pone.0148087	http://dx.doi.org/10.1371/journal.pone.0148087			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PF	26845694	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000369552800027
J	Saez, I; Friedlander, MJ				Saez, Ignacio; Friedlander, Michael J.			Role of GABA(A)-Mediated Inhibition and Functional Assortment of Synapses onto Individual Layer 4 Neurons in Regulating Plasticity Expression in Visual Cortex	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DEPENDENT SYNAPTIC PLASTICITY; OCULAR DOMINANCE; MONOCULAR DEPRIVATION; CRITICAL-PERIOD; EXPERIENCE; DEPRESSION; SIGN; CAT; INNERVATION	Layer 4 (L4) of primary visual cortex (V1) is the main recipient of thalamocortical fibers from the dorsal lateral geniculate nucleus (LGN(d)). Thus, it is considered the main entry point of visual information into the neocortex and the first anatomical opportunity for intracortical visual processing before information leaves L4 and reaches supra-and infragranular cortical layers. The strength of monosynaptic connections from individual L4 excitatory cells onto adjacent L4 cells (unitary connections) is highly malleable, demonstrating that the initial stage of intracortical synaptic transmission of thalamocortical information can be altered by previous activity. However, the inhibitory network within L4 of V1 may act as an internal gate for induction of excitatory synaptic plasticity, thus providing either high fidelity throughput to supragranular layers or transmittal of a modified signal subject to recent activitydependent plasticity. To evaluate this possibility, we compared the induction of synaptic plasticity using classical extracellular stimulation protocols that recruit a combination of excitatory and inhibitory synapses with stimulation of a single excitatory neuron onto a L4 cell. In order to induce plasticity, we paired pre-and postsynaptic activity (with the onset of postsynaptic spiking leading the presynaptic activation by 10ms) using extracellular stimulation (ECS) in acute slices of primary visual cortex and comparing the outcomes with our previously published results in which an identical protocol was used to induce synaptic plasticity between individual pre-and postsynaptic L4 excitatory neurons. Our results indicate that pairing of ECS with spiking in a L4 neuron fails to induce plasticity in L4-L4 connections if synaptic inhibition is intact. However, application of a similar pairing protocol under GABA(A)Rs inhibition by bath application of 2 mu M bicuculline does induce robust synaptic plasticity, long term potentiation (LTP) or long term depression (LTD), similar to our results with pairing of pre-and postsynaptic activation between individual excitatory L4 neurons in which inhibitory connections are not activated. These results are consistent with the wellestablished observation that inhibition limits the capacity for induction of plasticity at excitatory synapses and that pre-and postsynaptic activation at a fixed time interval can result in a variable range of plasticity outcomes. However, in the current study by virtue of having two sets of experimental data, we have provided a new insight into these processes. By randomly mixing the assorting of individual L4 neurons according to the frequency distribution of the experimentally determined plasticity outcome distribution based on the calculated convergence of multiple individual L4 neurons onto a single postsynaptic L4 neuron, we were able to compare then actual ECS plasticity outcomes to those predicted by randomly mixing individual pairs of neurons. Interestingly, the observed plasticity profiles with ECS cannot account for the random assortment of plasticity behaviors of synaptic connections between individual cell pairs. These results suggest that connections impinging onto a single postsynaptic cell may be grouped according to plasticity states.	[Saez, Ignacio; Friedlander, Michael J.] Virginia Tech Carill Res Inst, 2 Riverside Circle, Roanoke, VA 24016 USA; [Saez, Ignacio] Univ Calif Berkeley, Hellen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Friedlander, MJ (corresponding author), Virginia Tech Carill Res Inst, 2 Riverside Circle, Roanoke, VA 24016 USA.	friedlan@vtc.vt.edu		Saez, Ignacio/0000-0003-0651-2069	NIH [EY12782]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by NIH grant EY12782. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aton SJ, 2013, P NATL ACAD SCI USA, V110, P3101, DOI 10.1073/pnas.1208093110; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Campanac E, 2008, J PHYSIOL-LONDON, V586, P779, DOI 10.1113/jphysiol.2007.147017; CHAPMAN B, 1986, NATURE, V324, P154, DOI 10.1038/324154a0; DEWS PB, 1970, J PHYSIOL-LONDON, V206, P437, DOI 10.1113/jphysiol.1970.sp009023; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; FRIEDLANDER MJ, 1989, J PHYSIOL-LONDON, V416, P183, DOI 10.1113/jphysiol.1989.sp017756; FRIEDLANDER MJ, 1991, J NEUROSCI, V11, P3268; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144; Hardingham NR, 2007, J NEUROPHYSIOL, V97, P2965, DOI 10.1152/jn.01352.2006; Hirsch JA, 2006, CURR OPIN NEUROBIOL, V16, P377, DOI 10.1016/j.conb.2006.06.014; Ismailov I, 2004, J NEUROSCI, V24, P9847, DOI 10.1523/JNEUROSCI.0738-04.2004; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; Kara P, 2009, NATURE, V458, P627, DOI 10.1038/nature07721; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Kirkwood A, 1999, J NEUROSCI, V19, P1599; Kuhlman SJ, 2013, NATURE, V501, P543, DOI 10.1038/nature12485; LARKMAN A, 1992, NATURE, V360, P70, DOI 10.1038/360070a0; Lefort S, 2013, P NATL ACAD SCI USA, V110, pE4540, DOI 10.1073/pnas.1319571110; Li W, 2008, NEURON, V57, P442, DOI 10.1016/j.neuron.2007.12.011; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Martin KAC, 2002, CURR OPIN NEUROBIOL, V12, P418, DOI 10.1016/S0959-4388(02)00343-4; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Owens DF, 1996, J NEUROSCI, V16, P6414; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Rossner MJ, 2006, J NEUROSCI, V26, P9956, DOI 10.1523/JNEUROSCI.0468-06.2006; Rozas C, 2001, DEV INHIBITORY GATE; Saez I, 2009, J NEUROSCI, V29, P15286, DOI 10.1523/JNEUROSCI.2980-09.2009; Saez I, 2009, J NEUROSCI, V29, P4930, DOI 10.1523/JNEUROSCI.0046-09.2009; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Wang L, 2014, J NEUROSCI, V34, P1083, DOI 10.1523/JNEUROSCI.4711-13.2014; Wang L, 2012, J NEUROSCI, V32, P10562, DOI 10.1523/JNEUROSCI.0622-12.2012	45	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147642	10.1371/journal.pone.0147642	http://dx.doi.org/10.1371/journal.pone.0147642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841221	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200051
J	Hu, J; Juan, W; Sahyoun, NR				Hu, Jing; Juan, WenYen; Sahyoun, Nadine R.			Intake and Biomarkers of Folate and Risk of Cancer Morbidity in Older Adults, NHANES 1999-2002 with Medicare Linkage	PLOS ONE			English	Article							FOLIC-ACID; MULTIVITAMIN USE; COLON-CANCER; CLAIMS DATA; FORTIFICATION; ACCURACY; DEFICIENCY; PREVENTION; REDUCTASE; PROSTATE	Background After the 1998 mandatory folic acid fortification of enriched cereal-grain products in the U.S., safety concerns were raised that excess consumption of folic acid and high blood folate biomarkers detected in adults may increase the risk of certain types of cancer. Methods Baseline data from about 1400 participants in the National Health and Nutrition Examination Survey (NHANES) 1999-2002, aged >= 57 years were linked to Medicare and mortality files through December 31, 2007. Using cox proportional hazards regression models, we assessed associations between dietary folate equivalents, folate biomarkers, the presence of unmetabolized folic acid and, overall cancer incidence. Results With 8,114 person-years of follow-up (median follow-up, 6.3 years), about 125 cancer cases were identified. After adjusting for confounders, the hazard ratios of the highest quartile versus the second quartile of RBC folate and dietary folate equivalents were 0.54 (95% CI: 0.31-0.93) and 0.54 (95% CI: 0.30-0.95), respectively. Additionally, serum and RBC folate as continuous variables were inversely and significantly associated with cancer incidence (p<0.01). No significant associations were observed between the presence of unmetabolized folic acid, intake of naturally-occurring food folate or folic acid separately, and cancer incidence. Conclusions High total folate intake and biomarkers in older adults appear to be protective against cancer in post-folic acid fortification years. This study does not show a negative impact of current level of folic acid fortification on cancer risk. As this is one of the few studies to examine the association between unmetabolized folic acid and cancer outcome, a study including a larger nationwide representative sample of the U.S. population is needed.	[Hu, Jing; Sahyoun, Nadine R.] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Juan, WenYen] US FDA, Off Nutr Labeling & Dietary Supplements, Ctr Food Safety & Appl Nutr, College Pk, MD USA	University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA)	Sahyoun, NR (corresponding author), Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA.	nsahyoun@umd.edu		Sahyoun, Nadine/0000-0003-2309-1868	Maryland Agricultural Experiment Station (MAES) [MD-HNFS-7307]	Maryland Agricultural Experiment Station (MAES)	This work was fully supported by a grant from the Maryland Agricultural Experiment Station (MAES), MD-HNFS-7307. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bailey RL, 2012, FOOD NUTR RES, V56; Bailey SW, 2009, P NATL ACAD SCI USA, V106, P15424, DOI 10.1073/pnas.0902072106; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; *CDCP, NHANES 2001 2002 PUB; Centers for Disease Control and Prevention, NHANES 1999 2000 PUB; Centers for Disease Control and Prevention, DESCR NCHS CMS MED L; Cho E, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv260; Choumenkovitch SF, 2002, J NUTR, V132, P2792, DOI 10.1093/jn/132.9.2792; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Cooper GS, 1999, MED CARE, V37, P436, DOI 10.1097/00005650-199905000-00003; Dietrich M, 2005, J AM COLL NUTR, V24, P266, DOI 10.1080/07315724.2005.10719474; DOLNICK BJ, 1978, J BIOL CHEM, V253, P3563; Duthie SJ, 1999, BRIT MED BULL, V55, P578, DOI 10.1258/0007142991902646; Figueiredo JC, 2009, JNCI-J NATL CANCER I, V101, P432, DOI 10.1093/jnci/djp019; Fuchs CS, 2002, CANCER EPIDEM BIOMAR, V11, P227; Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002; Hirsch S, 2009, EUR J GASTROEN HEPAT, V21, P346, DOI 10.1097/MEG.0b013e328306ccdb; HSIA DC, 1992, JAMA-J AM MED ASSOC, V268, P896, DOI 10.1001/jama.268.7.896; HSIA DC, 1988, NEW ENGL J MED, V318, P352, DOI 10.1056/NEJM198802113180604; Hu J, 2016, CRIT REV FOOD SCI, V56, P1325, DOI 10.1080/10408398.2013.807221; Mason JB, 2007, CANCER EPIDEM BIOMAR, V16, P1325, DOI 10.1158/1055-9965.EPI-07-0329; MATTHEWS RG, 1980, BIOCHEMISTRY-US, V19, P2040, DOI 10.1021/bi00551a005; National Center for Health Statistics, NAT HLTH NUTR EX SUR; Pfeiffer CM, 2012, J NUTR, V142, P886, DOI 10.3945/jn.111.156919; Pitkin RM, 2007, AM J CLIN NUTR, V85, p285S, DOI 10.1093/ajcn/85.1.285S; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Stevens VL, 2010, AM J CLIN NUTR, V91, P1708, DOI 10.3945/ajcn.2009.28553; Stolzenberg-Solomon RZ, 2006, AM J CLIN NUTR, V83, P895, DOI 10.1093/ajcn/83.4.895; Suitor CW, 2000, J AM DIET ASSOC, V100, P88, DOI 10.1016/S0002-8223(00)00027-4; Troen AM, 2006, J NUTR, V136, P189, DOI 10.1093/jn/136.1.189; Ulrich CM, 2007, AM J CLIN NUTR, V86, P271, DOI 10.1093/ajcn/86.2.271; Vollset SE, 2013, LANCET, V381, P1029, DOI 10.1016/S0140-6736(12)62001-7; WHITTLE J, 1991, MED CARE, V29, P1226, DOI 10.1097/00005650-199112000-00005; Wu K, 2009, AM J CLIN NUTR, V90, P1623, DOI 10.3945/ajcn.2009.28319	34	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148697	10.1371/journal.pone.0148697	http://dx.doi.org/10.1371/journal.pone.0148697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862893	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600098
J	Jayakumaran, JS; Aaron, E; Gracely, EJ; Schriver, E; Szep, Z				Jayakumaran, Jenani Sarah; Aaron, Erika; Gracely, Ed J.; Schriver, Emily; Szep, Zsofia			Knowledge, Attitudes, and Acceptability of Pre-Exposure Prophylaxis among Individuals Living with HIV in an Urban HIV Clinic	PLOS ONE			English	Article							ANTIRETROVIRAL PROPHYLAXIS; PREVENTION; MEN; INFECTION; PREP; CARE; SEX	Introduction Pre-exposure prophylaxis (PrEP) is an effective tool to reduce HIV transmission. The primary objective of this study was to assess awareness of PrEP by individuals living with HIV (HIV+) and acceptance of its use for their HIV negative (HIV-) partners. Methods A cross sectional survey was conducted among individuals living with HIV who received care at an urban HIV clinic between January 2013 and June 2013. The survey examined knowledge, attitudes, and acceptability of PrEP, and perception of transmission risk of HIV. Chi-Square test and Fisher's Exact test were used to compare proportions. Results Among 206 subjects living with HIV, 15.3% (32) had heard of PrEP. Men who have sex with men (MSM) were more likely to be aware of PrEP than all others (p = 0.003). Once educated about PrEP those who believed PrEP would reduce their partner's risk for HIV were more likely to recommend PrEP to their partner (p<0.001) .92% of all respondents said they would be "extremely likely/likely" to discuss PrEP use with their provider. Of 159 subjects whose main partner was HIV-, MSM (p = 0.007), male participants (p = 0.044), and those who were consistently taking meds (p = 0.049) were more likely to be aware of PrEP. Those who perceived they were at risk of transmitting HIV (p<0.001) and those who were consistently taking meds (0.049) were more likely to agree that PrEP could reduce the risk of HIV to their partners. Conclusion This study illustrates a low awareness of PrEP but once educated the willingness of a cohort of individuals living with HIV to recommend PrEP to their partners. Our findings demonstrate the importance of providers informing their patients living with HIV about PrEP, as these persons are an underutilized link to support the uptake of PrEP by their HIV-partners.	[Jayakumaran, Jenani Sarah] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA; [Aaron, Erika; Szep, Zsofia] Drexel Univ, Coll Med, Dept Infect Dis & HIV Med, Philadelphia, PA 19104 USA; [Gracely, Ed J.; Schriver, Emily] Drexel Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Schriver, Emily] Drexel Univ, Sch Publ Hlth, AJ Drexel Autism Inst, Philadelphia, PA 19104 USA	Drexel University; Drexel University; Drexel University; Drexel University	Jayakumaran, JS (corresponding author), Drexel Univ, Coll Med, Philadelphia, PA 19104 USA.	Jsj43@drexel.edu	Gracely, Ed/B-7188-2014	Gracely, Ed/0000-0002-8344-3223; Schriver, Emily/0000-0003-4522-1029				Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bekker LG, 2015, HPTN 067 ADAPT CAPE; Campbell JD, 2013, AM J PREV MED, V44, pS63, DOI 10.1016/j.amepre.2012.09.045; Denning Paul H., 2011, Morbidity and Mortality Weekly Report, V60, P1045; Dombrowski JC, 2010, AIDS PATIENT CARE ST, V24, P747, DOI 10.1089/apc.2010.0198; Gamarel KE, 2014, ANN BEHAV MED, V47, pS18, DOI 10.1007/s12160-014-9646-3; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hoff CC, 2015, AIDS PATIENT CARE ST, V29, P408, DOI 10.1089/apc.2014.0315; Johnson MO, 2012, AIDS BEHAV, V16, P1511, DOI 10.1007/s10461-011-0021-0; Kelesidis Theodoros, 2011, Curr HIV/AIDS Rep, V8, P94, DOI 10.1007/s11904-011-0078-4; Krakower D, 2014, AIDS BEHAV, V18, P1712, DOI 10.1007/s10461-014-0839-3; Krosnick JA, 1999, ANNU REV PSYCHOL, V50, P537, DOI 10.1146/annurev.psych.50.1.537; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McCormack S, 2015, PRAGMATIC OPEN LABEL; Mimiaga MJ, 2014, ARCH SEX BEHAV, V43, P99, DOI 10.1007/s10508-013-0208-8; Molina JM CC, 2015, DEM PREP WTIH OR TDF; Oldenburg CE, 2015, AIDS, V29, P837, DOI 10.1097/QAD.0000000000000622; Rawlings KM R., 2013, STATUS TRUVADA TVD H; Smith DK, 2012, AIDS EDUC PREV, V24, P408, DOI 10.1521/aeap.2012.24.5.408; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7; Young I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064038	25	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0145670	10.1371/journal.pone.0145670	http://dx.doi.org/10.1371/journal.pone.0145670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26862744	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600007
J	Bourdel-Marchasson, I; Diallo, A; Bellera, C; Blanc-Bisson, C; Durrieu, J; Germain, C; Mathoulin-Pelissier, S; Soubeyran, P; Rainfray, M; Fonck, M; Doussau, A				Bourdel-Marchasson, Isabelle; Diallo, Abou; Bellera, Carine; Blanc-Bisson, Christelle; Durrieu, Jessica; Germain, Christine; Mathoulin-Pelissier, Simone; Soubeyran, Pierre; Rainfray, Muriel; Fonck, Mariane; Doussau, Adelaide			One-Year Mortality in Older Patients with Cancer: Development and External Validation of an MNA-Based Prognostic Score	PLOS ONE			English	Article							MINI NUTRITIONAL ASSESSMENT; SUBJECTIVE GLOBAL ASSESSMENT; ELDERLY-PATIENTS; WEIGHT-LOSS; CHEMOTHERAPY; SURVIVAL; RISK; INFLAMMATION; CACHEXIA; INDEX	Purpose The MNA (Mini Nutritional Assessment) is known as a prognosis factor in older population. We analyzed the prognostic value for one-year mortality of MNA items in older patients with cancer treated with chemotherapy as the basis of a simplified prognostic score. Methods The prospective derivation cohort included 606 patients older than 70 years with an indication of chemotherapy for cancers. The endpoint to predict was one-year mortality. The 18 items of the Full MNA, age, gender, weight loss, cancer origin, TNM, performance status and lymphocyte count were considered to construct the prognostic model. MNA items were analyzed with a backward step-by-step multivariate logistic regression and other items were added in a forward step-by-step regression. External validation was performed on an independent cohort of 229 patients. Results At one year 266 deaths had occurred. Decreased dietary intake (p = 0.0002), decreased protein-rich food intake (p = 0.025), 3 or more prescribed drugs (p = 0.023), calf circumference <31 cm (p = 0.0002), tumor origin (p<0.0001), metastatic status (p = 0.0007) and lymphocyte count <1500/mm(3) (0.029) were found to be associated with 1-year mortality in the final model and were used to construct a prognostic score. The area under curve (AUC) of the score was 0.793, which was higher than the Full MNA AUC (0.706). The AUC of the score in validation cohort (229 subjects, 137 deaths) was 0.698. Conclusion Key predictors of one-year mortality included cancer cachexia clinical features, comorbidities, the origin and the advanced status of the tumor. The prognostic value of this model combining a subset of MNA items and cancer related items was better than the full MNA, thus providing a simple score to predict 1-year mortality in older patients with an indication of chemotherapy.	[Bourdel-Marchasson, Isabelle; Blanc-Bisson, Christelle; Durrieu, Jessica; Rainfray, Muriel] CHU Bordeaux, Clin Gerontol Dept, Bordeaux, France; [Bourdel-Marchasson, Isabelle] CNRS, RMSB, UMR 5536, Bordeaux, France; [Bourdel-Marchasson, Isabelle] Bordeaux Univ, RMSB, UMR 5536, Bordeaux, France; [Diallo, Abou; Germain, Christine; Doussau, Adelaide] CHU Bordeaux, Clin Epidemiol Unit, Bordeaux, France; [Bellera, Carine; Mathoulin-Pelissier, Simone; Doussau, Adelaide] INSERM, CIC 14 01, Bordeaux, France; [Bellera, Carine; Mathoulin-Pelissier, Simone] Inst Bergonie, Clin Res & Clin Epidemiol Unit, Bordeaux, France; [Soubeyran, Pierre; Fonck, Mariane] Inst Bergonie, Dept Med Oncol, Bordeaux, France; [Soubeyran, Pierre; Rainfray, Muriel] Bordeaux Univ, Bordeaux, France	CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Bergonie; UNICANCER; Institut Bergonie	Bourdel-Marchasson, I (corresponding author), CHU Bordeaux, Clin Gerontol Dept, Bordeaux, France.; Bourdel-Marchasson, I (corresponding author), CNRS, RMSB, UMR 5536, Bordeaux, France.; Bourdel-Marchasson, I (corresponding author), Bordeaux Univ, RMSB, UMR 5536, Bordeaux, France.	isabelle.bourdel-marchasson@chu-bordeaux.fr	MATHOULIN-PELISSIER, Simone/T-2385-2019; Rainfray, Muriel/T-4880-2019; Soubeyran, Pierre-Louis/F-4523-2012	Soubeyran, Pierre-Louis/0000-0003-3244-7299; Bellera, Carine/0000-0001-7926-4671; doussau, adelaide/0000-0003-2622-5948; blanc-bisson, christelle/0000-0001-7982-8801	National Hospital Program of Clinical Research (Programme Hospitalier de Recherche Clinique); La Ligue contre le cancer; AMGEN; university hospital of Bordeaux (CHU Bordeaux)	National Hospital Program of Clinical Research (Programme Hospitalier de Recherche Clinique); La Ligue contre le cancer(Ligue nationale contre le cancer); AMGEN(Amgen); university hospital of Bordeaux (CHU Bordeaux)	This work was supported by the National Hospital Program of Clinical Research (Programme Hospitalier de Recherche Clinique 2006) (46%), La Ligue contre le cancer (52%) and AMGEN (2%) and sponsored by the university hospital of Bordeaux (CHU Bordeaux). The sponsor and the funding sources had no role in the design, methods, subject recruitment, data collections, analysis, preparation of the paper or decision to publish.	Aaldriks AA, 2011, CRIT REV ONCOL HEMAT, V79, P205, DOI 10.1016/j.critrevonc.2010.05.009; Aaldriks A, 2016, ACTA ONCOL, V55, P15, DOI 10.3109/0284186X.2015.1068446; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Blanc-Bisson C, 2008, CRIT REV ONCOL HEMAT, V67, P243, DOI 10.1016/j.critrevonc.2008.04.005; Bosaeus I, 2001, INT J CANCER, V93, P380, DOI 10.1002/ijc.1332; Bourdel-Marchasson I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108687; Cohen LM, 2010, CLIN J AM SOC NEPHRO, V5, P72, DOI 10.2215/CJN.03860609; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Dharma-Wardene M, 2004, QUAL LIFE RES, V13, P1209, DOI 10.1023/B:QURE.0000037481.36604.eb; Dy SM, 2008, J CLIN ONCOL, V26, P3886, DOI 10.1200/JCO.2007.15.9525; Extermann M, 2005, CRIT REV ONCOL HEMAT, V55, P241, DOI 10.1016/j.critrevonc.2005.06.003; Extermann M, 2012, CANCER-AM CANCER SOC, V118, P3377, DOI 10.1002/cncr.26646; Fearon KC, 2006, AM J CLIN NUTR, V83, P1345, DOI 10.1093/ajcn/83.6.1345; Fiteni F, 2016, EUR J CANCER, V52, P120, DOI 10.1016/j.ejca.2015.10.004; Gioulbasanis I, 2011, LUNG CANCER, V74, P516, DOI 10.1016/j.lungcan.2011.05.009; Guigoz Y, 2002, CLIN GERIATR MED, V18, P737, DOI 10.1016/S0749-0690(02)00059-9; Hiramatsu M, 2012, CONTRIB NEPHROL, V177, P48, DOI 10.1159/000336935; Hutton JL, 2006, AM J CLIN NUTR, V84, P1163, DOI 10.1093/ajcn/84.5.1163; Kaiser MJ, 2009, J NUTR HEALTH AGING, V13, P782, DOI 10.1007/s12603-009-0214-7; Lealdini V, 2015, J GERIATR ONCOL, V6, P479, DOI 10.1016/j.jgo.2015.09.001; Libby AM, 2013, CLIN THER, V35, P385, DOI 10.1016/j.clinthera.2013.02.019; Liu M, 2012, EUR J HEART FAIL, V14, P39, DOI 10.1093/eurjhf/hfr154; Martin L, 2010, J CLIN ONCOL, V28, P4376, DOI 10.1200/JCO.2009.27.1916; McMillan DC, 2008, P NUTR SOC, V67, P257, DOI 10.1017/S0029665108007131; Newson RS, 2010, AGE, V32, P521, DOI 10.1007/s11357-010-9154-8; Ostenfeld Eva Bjerre, 2013, Clin Epidemiol, V5, P65, DOI 10.2147/CLEP.S47154; Pentheroudakis G, 2008, CRIT REV ONCOL HEMAT, V66, P237, DOI 10.1016/j.critrevonc.2007.12.003; Persson CR, 2002, NUTR CANCER, V42, P48, DOI 10.1207/S15327914NC421_7; Pirovano M, 1999, J PAIN SYMPTOM MANAG, V17, P231, DOI 10.1016/S0885-3924(98)00145-6; Reuben DB, 2002, J AM GERIATR SOC, V50, P638, DOI 10.1046/j.1532-5415.2002.50157.x; Rodrigues CS, 2015, NUTRITION, V31, P1372, DOI 10.1016/j.nut.2015.06.001; Rolland Y, 2003, J AM GERIATR SOC, V51, P1120, DOI 10.1046/j.1532-5415.2003.51362.x; Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6; Senesse P, 2014, DIGEST LIVER DIS, V46, P667, DOI 10.1016/j.dld.2014.01.160; Sogaard Mette, 2013, Clin Epidemiol, V5, P3, DOI 10.2147/CLEP.S47150; Soubeyran P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115060; Soubeyran P, 2012, J CLIN ONCOL, V30, P1829, DOI 10.1200/JCO.2011.35.7442; Suh SY, 2010, SUPPORT CARE CANCER, V18, P151, DOI 10.1007/s00520-009-0639-x; Tassinari D, 2008, SUPPORT CARE CANCER, V16, P359, DOI 10.1007/s00520-007-0302-3; Tsai AC, 2010, J NUTR HEALTH AGING, V14, P183, DOI 10.1007/s12603-010-0046-5; van der Meij BS, 2013, BRIT J NUTR, V109, P2231, DOI 10.1017/S0007114512004527; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2987, DOI 10.1001/jama.285.23.2987; Yun YH, 2001, ONCOL REP, V8, P795	44	41	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148523	10.1371/journal.pone.0148523	http://dx.doi.org/10.1371/journal.pone.0148523			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859298	Green Published, gold			2022-12-27	WOS:000370038400048
J	Duprat, JP; Brechtbulh, ER; de Sa, BC; Enokihara, M; Fregnani, JH; Landman, G; Maia, M; Riccardi, F; Belfort, FA; Wainstein, A; Moredo, LF; Steck, H; Brandao, M; Moreno, M; Miranda, E; Santos, IDD				Duprat, Joao Pedreira; Brechtbuelh, Eduard Rene; de Sa, Bianca Costa; Enokihara, Mauro; Fregnani, Jose Humberto; Landman, Gilles; Maia, Marcus; Riccardi, Felice; Belfort, Francisco Alberto; Wainstein, Alberto; Moredo, Luciana F.; Steck, Higino; Brandao, Miguel; Moreno, Marcelo; Miranda, Eduardo; de Oliveira Santos, Ivan Dunshee			Absence of Tumor-Infiltrating Lymphocyte Is a Reproducible Predictive Factor for Sentinel Lymph Node Metastasis: A Multicenter Database Study by the Brazilian Melanoma Group	PLOS ONE			English	Article							PRIMARY CUTANEOUS MELANOMA; MALIGNANT-MELANOMA; BIOPSY; REGRESSION; SURVIVAL; POSITIVITY; EXCISION; THERAPY; GRADE; RISK	Aims The aim of this study is to confirm the function of tumor-infiltrating lymphocytes (TILs) in sentinel lymph node (SLN) metastasis. Materials and Methods This retrospective study included 633 patients with invasive melanoma who underwent sentinel lymph node biopsy in 7 referral centers certified by the Brazilian Melanoma Group. Independent risk factors of sentinel node metastasis (SNL) were identified by multiple logistic regression. Results SLN metastasis was detected in 101 of 633 cases (16.1%) and in 93 of 428 patients (21.7%) when melanomas <= 1mm were excluded. By multiple logistic regression, the absence of TILs was as an independent risk factor of SLN metastasis (OR = 1.8; 95% CI: 1.1-3.0), in addition to Breslow index (greater than 2.00 mm), lymph vascular invasion, and presence of mitosis. Conclusion SLNB can identify patients who might benefit from immunotherapy, and the determination of predictors of SLNB positivity can help select the proper population for this type of therapy. The absence of TILs is a reproducible parameter that can predict SLNB positivity in melanoma patients, since this study was made with several centers with different dermatopathologists.	[Duprat, Joao Pedreira; Brechtbuelh, Eduard Rene; de Sa, Bianca Costa; Moredo, Luciana F.] AC Camargo Canc Ctr, Sao Paulo, Brazil; [Enokihara, Mauro; Landman, Gilles; de Oliveira Santos, Ivan Dunshee] Univ Fed Sao Paulo, Sch Med, Sao Paulo, Brazil; [Fregnani, Jose Humberto] Barretos Canc Hosp, Barretos, Brazil; [Maia, Marcus] Santa Casa Misericordia, Sao Paulo, Brazil; [Riccardi, Felice] Santa Rita Hosp, Porto Alegre, RS, Brazil; [Belfort, Francisco Alberto] Sao Jose Hosp, Oswaldo Cruz Hosp, Sirio Libanes Hosp, Sao Paulo, Brazil; [Wainstein, Alberto] Minas Gerais Sch Med, Belo Horizonte, MG, Brazil; [Steck, Higino] Mario Gatti Hosp, Campinas, SP, Brazil; [Brandao, Miguel] AMO Clin, Salvador, BA, Brazil; [Moreno, Marcelo] Community Univ Chapeco Reg, Sch Med, Chapeco, Brazil; [Miranda, Eduardo] Univ Pernambuco, Dept Oncol, Recife, PE, Brazil	A.C.Camargo Cancer Center; Universidade Federal de Sao Paulo (UNIFESP); Hospital de Cancer de Barretos; Hospital Sirio Libanes; Universidade Comunitaria Regional de Chapeco; Universidade de Pernambuco (UPE)	Duprat, JP (corresponding author), AC Camargo Canc Ctr, Sao Paulo, Brazil.	joao.duprat@accarmargo.org.br	Moredo, Luciana/M-1299-2016; Soares de Sá, Bianca/B-4479-2015; Moreno, Marcelo/GWZ-5373-2022; LANDMAN, GILLES/D-5071-2012; Duprat, Joao P/I-4198-2015; Enokihara, Mauro Y/M-9126-2017; Fregnani, José H/H-4238-2012	Moreno, Marcelo/0000-0003-0244-9138; LANDMAN, GILLES/0000-0001-7441-3068; Duprat, Joao P/0000-0001-8968-4506; Fregnani, José H/0000-0002-5235-6469				Australian Cancer Network and N. Z. G. Group, CLIN PRACT GUID MAN; Azimi F, 2012, J CLIN ONCOL, V30, P2678, DOI 10.1200/JCO.2011.37.8539; Bakos L, 2002, INT J DERMATOL, V41, P557, DOI 10.1046/j.1365-4362.2002.01412.x; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Burton AL, 2011, AM SURGEON, V77, P1009; Coit DG, 2013, J NATL COMPR CANC NE, V11, P395, DOI 10.6004/jnccn.2013.0055; DAY CL, 1981, ANN SURG, V193, P436, DOI 10.1097/00000658-198104000-00007; de Vries M, 2009, ANN SURG ONCOL, V16, P2840, DOI 10.1245/s10434-009-0602-6; Duprat JP, 2005, PLAST RECONSTR SURG, V115, P1944, DOI 10.1097/01.PRs.0000165279.99067.79; Fontaine D, 2003, AM J DERMATOPATH, V25, P371, DOI 10.1097/00000372-200310000-00002; Garbe C, 2008, J DTSCH DERMATOL GES, V6, pS9, DOI 10.1111/j.1610-0387.2008.06711.x; Han D, 2012, ANN SURG ONCOL, V19, P3335, DOI 10.1245/s10434-012-2469-1; Kaur C, 2008, J CLIN PATHOL, V61, P297, DOI 10.1136/jcp.2007.049411; Kretschmer L, 2008, MELANOMA RES, V18, P16, DOI 10.1097/CMR.0b013e3282f2017d; Kruper LL, 2006, CANCER-AM CANCER SOC, V107, P2436, DOI 10.1002/cncr.22295; Kunte C, 2010, MELANOMA RES, V20, P330, DOI 10.1097/CMR.0b013e32833ba9ff; Landman G, 2003, ACTA ONCOL BRAS, V23, P7; Mihm MC, 1996, LAB INVEST, V74, P43; Morris KT, 2008, ANN SURG ONCOL, V15, P316, DOI 10.1245/s10434-007-9675-2; Morton DL, 2014, NEW ENGL J MED, V370, P599, DOI 10.1056/NEJMoa1310460; Murali R, 2012, ANN SURG ONCOL, V19, P1782, DOI 10.1245/s10434-012-2265-y; Murali R, 2012, ANN SURG, V255, P128, DOI 10.1097/SLA.0b013e3182306c72; Neves R. I, 2003, ACTA ONCOL BRAS, V23, P499; Olah J, 2003, BRIT J DERMATOL, V149, P662, DOI 10.1046/j.1365-2133.2003.05502.x; Pasquali S, 2013, ANN SURG, V258, P152, DOI 10.1097/SLA.0b013e31828421e1; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Pflugfelder A, 2013, J DTSCH DERMATOL GES, V11, P1, DOI 10.1111/ddg.12113_suppl; Requena C, 2009, ACTAS DERMO-SIFILOGR, V100, P759; Roach BA, 2010, AM J SURG, V200, P759, DOI 10.1016/j.amjsurg.2010.07.037; Schatton T, 2014, METHODS MOL BIOL, V1102, P287, DOI 10.1007/978-1-62703-727-3_16; Taylor RC, 2007, J CLIN ONCOL, V25, P869, DOI 10.1200/JCO.2006.08.9755; Thomas JM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f675; Thomas NE, 2013, J CLIN ONCOL, V31, P4252, DOI 10.1200/JCO.2013.51.3002; White RL, 2011, ANN SURG ONCOL, V18, P3593, DOI 10.1245/s10434-011-1826-9; Wong SL, 2012, ANN SURG ONCOL, V19, P3313, DOI 10.1245/s10434-012-2475-3; Wu R, 2012, CANCER J, V18, P160, DOI 10.1097/PPO.0b013e31824d4465	36	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148160	10.1371/journal.pone.0148160	http://dx.doi.org/10.1371/journal.pone.0148160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859408	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400022
J	Endo, T; Kimura, O; Ohta, C; Koga, N; Kato, Y; Fujii, Y; Haraguchi, K				Endo, Tetsuya; Kimura, Osamu; Ohta, Chiho; Koga, Nobuyuki; Kato, Yoshihisa; Fujii, Yukiko; Haraguchi, Koichi			Metal Concentrations in the Liver and Stable Isotope Ratios of Carbon and Nitrogen in the Muscle of Silvertip Shark (Carcharhinus albimarginatus) Culled off Ishigaki Island, Japan: Changes with Growth	PLOS ONE			English	Article							GALEOCERDO-CUVIER; COASTAL WATERS; TRACE-ELEMENTS; NORTHERN AREA; TOTAL MERCURY; HEAVY-METALS; TIGER SHARK; WHALES; SELENIUM; AGE	We analyzed Hg, Cd, Zn, Cu and Fe concentrations in liver samples as well as the Hg concentration and stable isotope ratios of carbon and nitrogen (delta C-13 and delta N-15) in muscle samples from silvertip sharks (Carcharhinus albimarginatus) in Japan. Muscular and hepatic Hg concentrations increased with increased body length. However, these increases were more prominent in the liver than in the muscle samples, and appeared to occur after maturation. Hepatic Zn and Cu concentrations decreased during the growth stage, and then increased concomitantly thereafter with increases in Cd burden. Hepatic Fe concentration from males increased proportionally with increases in body length, whereas no increase was observed in samples from females, probably due to the mother-to-embryo transfer of Fe. The delta C-13 values tended to decrease with increases in body length, whereas no decrease in the delta N-15 values was observed.	[Endo, Tetsuya; Kimura, Osamu] Hlth Sci Univ Hokkaido, Sch Pharmaceut Sci, 1757 Kanazawa, Ishikari, Hokkaido 0610293, Japan; [Ohta, Chiho; Koga, Nobuyuki] Nakamura Gakuen Univ, Fac Nutr Sci, Jonan Ku, 5-7-1 Befu, Fukuoka 8140198, Japan; [Kato, Yoshihisa] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, 1314-1 Shido, Sanuki, Kagawa 7692193, Japan; [Fujii, Yukiko; Haraguchi, Koichi] Daiichi Coll Pharmaceut Sci, Minami Ku, 22-1 Tamagawa Cho, Fukuoka 8158511, Japan	Health Sciences University of Hokkaido; Tokushima Bunri University	Endo, T (corresponding author), Hlth Sci Univ Hokkaido, Sch Pharmaceut Sci, 1757 Kanazawa, Ishikari, Hokkaido 0610293, Japan.	endotty@hoku-iryo-u.ac.jp	Fujii, Yukiko/E-4406-2017	Fujii, Yukiko/0000-0001-6218-3453; Endo, Tetsuya/0000-0003-4278-5689; Kato, Yoshihisa/0000-0003-3980-1115; Fujii, Yukiko/0000-0003-2349-4907	Japan Society for the Promotion of Science [24614012, 26614012, 25303011]; Grants-in-Aid for Scientific Research [26881008] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by a Grant-in-Aid for Scientific Research (C) (No. 24614012 O.K. and No. 26614012 Y.F.) and a Grant-in-Aid for Scientific Research (B) (No. 25303011 K.H.) from Japan Society for the Promotion of Science.	Adams DH, 1999, FISH B-NOAA, V97, P372; Barrera-Garcia A, 2013, COMP BIOCHEM PHYS A, V165, P483, DOI 10.1016/j.cbpa.2013.01.024; Bisi TL, 2012, ECOL INDIC, V18, P291, DOI 10.1016/j.ecolind.2011.11.015; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bourg BL, 2014, J FISH BIOL, V84, P1574, DOI [10.1111/jfb.12357, DOI 10.1111/JFB.12357]; Branco V, 2007, ENVIRON POLLUT, V150, P373, DOI 10.1016/j.envpol.2007.01.040; Bustamante P, 1998, SCI TOTAL ENVIRON, V220, P71, DOI 10.1016/S0048-9697(98)00250-2; Campbell LM, 2005, SCI TOTAL ENVIRON, V351, P247, DOI 10.1016/j.scitotenv.2005.02.043; Compagno L, 2005, SHARKS WORLD, p[77, 289]; Cortes Enric, 2000, Reviews in Fisheries Science, V8, P299, DOI 10.1080/10641260008951115; Das K, 2000, CELL MOL BIOL, V46, P283; de Pinho AP, 2002, ENVIRON RES, V89, P250, DOI 10.1006/enrs.2002.4365; Endo T, 2002, SCI TOTAL ENVIRON, V300, P15, DOI 10.1016/S0048-9697(02)00137-7; Endo T, 2008, MAR POLLUT BULL, V56, P1774, DOI 10.1016/j.marpolbul.2008.06.003; Endo T, 2008, SCI TOTAL ENVIRON, V401, P73, DOI 10.1016/j.scitotenv.2008.04.006; Endo T, 2007, CHEMOSPHERE, V67, P51, DOI 10.1016/j.chemosphere.2006.09.086; Endo T, 2006, ENVIRON POLLUT, V144, P145, DOI 10.1016/j.envpol.2005.12.035; Endo T, 2015, ECOL INDIC, V55, P86, DOI 10.1016/j.ecolind.2015.03.008; Endo T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128149; Endo T, 2013, ARCH ENVIRON CON TOX, V64, P467, DOI 10.1007/s00244-012-9858-0; Endo T, 2012, ECOTOX ENVIRON SAFE, V79, P35, DOI 10.1016/j.ecoenv.2012.01.020; Endo T, 2009, CHEMOSPHERE, V77, P1333, DOI 10.1016/j.chemosphere.2009.09.041; Hisamichi Y, 2012, ARCH ENVIRON CON TOX, V62, P296, DOI 10.1007/s00244-011-9696-5; HONDA K, 1983, AGR BIOL CHEM TOKYO, V47, P1219, DOI 10.1080/00021369.1983.10863383; Honda K, 1978, ARCH ENV CONTAM TOXI, V16, P209; HORNUNG H, 1993, MAR BIOL, V115, P331, DOI 10.1007/BF00346351; Karimi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074695; KETCHEN KS, 1975, J FISH RES BOARD CAN, V32, P43, DOI 10.1139/f75-006; Kneebone J, 2008, MAR BIOL, V154, P423, DOI 10.1007/s00227-008-0934-y; Lailson-Brito J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042162; Last PR, 2009, SHARKS RAYS AUSTR, P248; Logan JM, 2008, RAPID COMMUN MASS SP, V22, P1081, DOI 10.1002/rcm.3471; LYLE JM, 1984, AUST J MAR FRESH RES, V35, P441, DOI 10.1071/MF9840441; McMeans BC, 2009, J FISH BIOL, V75, P2464, DOI 10.1111/j.1095-8649.2009.02402.x; Meyer CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084799; Pethybridge H, 2010, MAR ENVIRON RES, V69, P18, DOI 10.1016/j.marenvres.2009.07.006; Rumbold D, 2014, ARCH ENVIRON CON TOX, V67, P402, DOI 10.1007/s00244-014-0050-6; Storelli MM, 2002, B ENVIRON CONTAM TOX, V69, P516, DOI 10.1007/s00128-002-0092-8; Storelli MM, 2000, B ENVIRON CONTAM TOX, V64, P333, DOI 10.1007/s001280000004; TAGUCHI M, 1979, MAR ENVIRON RES, V2, P239, DOI 10.1016/0141-1136(79)90021-7; Taguchi M, 1980, JAP J CHEM, V34, P44; Tayasu I, 2011, LIMNOLOGY, V12, P261, DOI 10.1007/s10201-011-0345-5; VAS P, 1991, MAR POLLUT BULL, V22, P67, DOI 10.1016/0025-326X(91)90138-I; Vaudo JJ, 2010, J FISH BIOL, V77, P1724, DOI 10.1111/j.1095-8649.2010.02813.x; Whitney NM, 2007, MAR BIOL, V151, P63, DOI 10.1007/s00227-006-0476-0; Zhang L, 2005, AQUAT TOXICOL, V73, P353, DOI 10.1016/j.aquatox.2005.04.001; Zhou JL, 2001, SCI TOTAL ENVIRON, V273, P61, DOI 10.1016/S0048-9697(00)00844-5	47	20	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0147797	10.1371/journal.pone.0147797	http://dx.doi.org/10.1371/journal.pone.0147797			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859569	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400015
J	Baril, JG; Angel, JB; Gill, MJ; Gathe, J; Cahn, P; van Wyk, J; Walmsley, S				Baril, Jean-Guy; Angel, Jonathan B.; Gill, M. John; Gathe, Joseph; Cahn, Pedro; van Wyk, Jean; Walmsley, Sharon			Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; CHRONIC KIDNEY-DISEASE; NUCLEOSIDE-SPARING REGIMEN; GLOMERULAR-FILTRATION-RATE; RANDOMIZED-TRIAL; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; PROTEASE INHIBITOR	Objective We reviewed the current literature regarding antiretroviral (ARV)-sparing therapy strategies to determine whether these novel regimens can be considered appropriate alternatives to standard regimens for the initial treatment of ARV-naive patients or as switch therapy for those patients with virologically suppressed HIV infection. Methods A search for studies related to HIV dual therapy published from January 2000 through April 2014 was performed using Biosis, Derwent Drug File, Embase, International Pharmaceutical Abstracts, Medline, Pascal, SciSearch, and TOXNET databases; seven major trial registries, and the abstracts of major conferences. Using predetermined criteria for inclusion, an expert review committee critically reviewed and qualitatively evaluated all identified trials for efficacy and safety results and potential limitations. Results Sixteen studies of dual therapy regimens were critiqued for the ARV-naive population. Studies of a protease inhibitor/ritonavir in combination with the integrase inhibitor raltegravir or the nucleoside reverse transcriptase inhibitor lamivudine provided the most definitive evidence supporting a role for dual therapy. In particular, lopinavir/ritonavir or darunavir/ritonavir combined with raltegravir and lopinavir/ritonavir combined with lamivudine demonstrated noninferiority to standard of care triple therapy after 48 weeks of treatment. Thirteen trials were critiqued in ARV-experienced, virologically suppressed patients. The virologic efficacy outcomes were mixed. Although overall data regarding toxicity are limited, when compared with standard triple therapy, certain dual therapy regimens may offer advantages in renal function, bone mineral density, and limb fat changes; however, some dual combinations may elevate lipid or bilirubin levels. Conclusions The potential benefits of dual therapy regimens include reduced toxicity, improved tolerability and adherence, and reduced cost. Although the data reviewed here provide valuable insights into the effectiveness and tolerability of dual therapy regimens, it remains unclear whether these potential benefits can be maintained long-term. Appropriately powered studies with longer follow-up periods are needed to more definitively assess potential toxicity reduction advantages with dual therapy.	[Baril, Jean-Guy] Clin Med Quartier Latin, Montreal, PQ, Canada; [Angel, Jonathan B.] Univ Ottawa, Div Infect Dis, Ottawa, ON, Canada; [Angel, Jonathan B.] Ottawa Hosp, Ottawa, ON, Canada; [Gill, M. John] Univ Calgary, Dept Med, Calgary, AB, Canada; [Gathe, Joseph] Therapeut Concepts, Houston, TX USA; [Cahn, Pedro] Fdn Huesped, Buenos Aires, DF, Argentina; [van Wyk, Jean] AbbVie Inc, N Chicago, IL USA; [Walmsley, Sharon] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Walmsley, Sharon] Univ Toronto, Toronto, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Calgary; AbbVie; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto	Baril, JG (corresponding author), Clin Med Quartier Latin, Montreal, PQ, Canada.	jgbaril@videotron.ca	Dodsley, Maria/G-7083-2016; Gill, Michael John/G-7083-2016	Dodsley, Maria/0000-0001-7587-558X; Gill, Michael John/0000-0002-8546-8790; Angel, Jonathan B/0000-0003-3102-4462; Walmsley, Sharon/0000-0002-3959-5692	AbbVie, Inc.; AbbVie Inc.	AbbVie, Inc.(AbbVie); AbbVie Inc.(AbbVie)	This study was funded by AbbVie, Inc. One of the authors is an employee of AbbVie; therefore, the funders contributed to the data collection and analysis, decision to publish, and preparation of the manuscript.; We thank Sandra Blitz for her review of the data searches and summaries. Medical editing support was provided by John E. Fincke, PhD, and Daniel McCallus, PhD, at Complete Publication Solutions, LLC; this support was sponsored by AbbVie Inc.	Achhra AC, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/246280; Andrade R, 2011, 6 INT AIDS SOC C HIV; Bavinger C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059551; Bedimo R, 2013, 7 IAS C HIV PATH TRE; Bedimo R, 2011, 6 INT AIDS SOC C HIV; Bowman V, 2011, 6 INT AIDS SOC C HIV; Burgos J, 2012, J ANTIMICROB CHEMOTH, V67, P1453, DOI 10.1093/jac/dks057; Cahn P, 2014, LANCET INFECT DIS, V14, P572, DOI 10.1016/S1473-3099(14)70736-4; Calin R, 2013, 7 IAS C HIV PATH TRE; Calza L, 2013, 14 EUR AIDS CLIN SOC; Capetti AF, 2009, JAIDS-J ACQ IMM DEF, V50, P233, DOI 10.1097/QAI.0b013e31818c7e8e; Carr A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001240; Choi AI, 2011, AIDS, V25, P1289, DOI 10.1097/QAD.0b013e328347fa16; COHEN C, 2012, J INT AIDS SOC S4, V15, P18279; Cotte L, 2013, 7 IAS C HIV PATH TRE; Cruciani M, 2011, AIDS, V25, P1993, DOI 10.1097/QAD.0b013e328349c6ee; Cunningham J, 2004, AM J KIDNEY DIS, V43, P566, DOI 10.1053/j.ajkd.2003.12.004; Dazo C, 2011, 18 C RETR OPP INF FE; De Luca A, 2011, 6 INT AIDS SOC C HIV; Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, 2015, GUIDELINES USE ANTIR; Desai M, 2015, CLIN INFECT DIS, V61, P445, DOI 10.1093/cid/civ316; Di Angelantonio E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4986; Ding X, 2012, JAIDS-J ACQ IMM DEF, V61, P441, DOI 10.1097/QAI.0b013e31826f993c; European AIDS Clinical Society, 2014, GUID CLIN MAN TREATM; Fabbiani M, 2012, 19 INT AIDS C JUL 22; Fabbiani M, 2011, 6 INT AIDS SOC C HIV; Figueroa MI, 2015, 15 EUR AIDS C OCT 21; Fischl MA, 2007, AIDS, V21, P325, DOI 10.1097/QAD.0b013e328011ddfa; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Glanville JM, 2006, J MED LIBR ASSOC, V94, P130; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Hall AM, 2011, AM J KIDNEY DIS, V57, P773, DOI 10.1053/j.ajkd.2011.01.022; Harris M, 2009, JAIDS-J ACQ IMM DEF, V50, P335, DOI 10.1097/QAI.0b013e3181938fc9; Harris VW, 2012, J INFECT DIS, V205, pS391, DOI 10.1093/infdis/jis199; Haubrich RH, 2009, AIDS, V23, P1109, DOI 10.1097/QAD.0b013e32832b4377; Havlir DV, 1998, NEW ENGL J MED, V339, P1261, DOI 10.1056/NEJM199810293391801; Katlama C, 2013, 20 C RETR OPP INF MA; Katlama C, 2014, J ANTIMICROB CHEMOTH, V69, P1648, DOI 10.1093/jac/dkt536; Kirk O, 2010, 17 C RETR OPP INF FE; Kozal MJ, 2012, HIV CLIN TRIALS, V13, P119, DOI 10.1310/hct1303-119; Lee M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4249; Lundgren JD, 2008, AIDS, V22, pF17, DOI 10.1097/QAD.0b013e32830fe35e; Margolis D, 2015, C RETR OPP INF FEBR; Mathis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022003; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; McCutchan JA, 2007, AIDS, V21, P1109, DOI 10.1097/QAD.0b013e3280ef6acd; Mills A, 2012, 19 INT AIDS C JUL 22; Mills A, 2011, 6 IAS C HIV PATH TRE; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Monforte AD, 2012, 19 C RETR OPP INF MA; National Institutes of Health, 2011, WHAT AR COR HEART DI; Negredo E, 2005, JAIDS-J ACQ IMM DEF, V38, P47, DOI 10.1097/00126334-200501010-00009; Nishijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073639; Nozza S, 2012, J INT AIDS SOC, V15, P145, DOI 10.7448/IAS.15.6.18232; Nozza S, 2011, 6 INT AIDS SOC C HIV; Ofotokun I, 2012, AIDS RES HUM RETROV, V28, P1196, DOI 10.1089/aid.2011.0336; Peluso MJ, 2014, CURR HIV-AIDS REP, V11, P353, DOI 10.1007/s11904-014-0223-y; Perez-Molina JA, 2013, 14 EUR AIDS CLIN SOC; Pialoux G, 1998, NEW ENGL J MED, V339, P1269, DOI 10.1056/NEJM199810293391802; Portsmouth S, 2011, 6 INT AIDS SOC C HIV; Qaqish R, 2011, 6 INT AIDS SOC C HIV; Raffi F, 2014, 21 C RETR OPP INF MA; Reijers MHE, 1998, LANCET, V352, P185, DOI 10.1016/S0140-6736(98)06193-5; Reliquet V, 2014, ANTIVIR THER, V19, P117, DOI 10.3851/IMP2691; Reynes J, 2013, AIDS RES HUM RETROV, V29, P256, DOI [10.1089/aid.2011.0275, 10.1089/AID.2011.0275]; Reynes J, 2011, HIV CLIN TRIALS, V12, P255, DOI 10.1310/hct1205-255; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Ruane PJ, 2010, INT C ANT AG CHEM SE; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Salter ML, 2011, CLIN INFECT DIS, V53, P1256, DOI 10.1093/cid/cir673; SELZENTRY (maraviroc), 2015, SELZENTRY MAR FULL P; Spudich Serena S, 2013, Top Antivir Med, V21, P100; Stellbrink HJ, 2014, 20 INT AIDS C JUL 20; Taiwo B, 2012, 19 INT AIDS C JUL 22; Taiwo B, 2011, AIDS, V25, P2113, DOI 10.1097/QAD.0b013e32834bbaa9; Tebas P, 2007, JAIDS-J ACQ IMM DEF, V45, P193, DOI 10.1097/QAI.0b013e318042e204; van Vonderen MGA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005647; van Wyk J, 2011, 13 EUR AIDS C OCT 12; Vella S, 2012, AIDS, V26, P1231, DOI 10.1097/QAD.0b013e32835521a3; VIRAMUNE (nevirapine), 2014, VIRAMUNE NEV FULL PR; Ward D, 2006, 45 ANN INT C ANT AG; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Yin MT, 2012, J CLIN ENDOCR METAB, V97, P554, DOI 10.1210/jc.2011-2197	85	67	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148231	10.1371/journal.pone.0148231	http://dx.doi.org/10.1371/journal.pone.0148231			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849060	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000054
J	Bosman, RC; Borg, C; de Jong, PJ				Bosman, Renske C.; Borg, Charmaine; de Jong, Peter J.			Optimising Extinction of Conditioned Disgust	PLOS ONE			English	Article							THREAT-RELEVANT STIMULI; SPIDER PHOBIA; FEAR; SENSITIVITY; AVOIDANCE; EXPOSURE; REINSTATEMENT; RESPONSES; ANXIETY; DECLINE	Maladaptive disgust responses are tenacious and resistant to exposure-based interventions. In a similar vein, laboratory studies have shown that conditioned disgust is relatively insensitive to Conditioned Stimulus (CS)-only extinction procedures. The relatively strong resistance to extinction might be explained by disgust's adaptive function to motivate avoidance from contamination threats (pathogens) that cannot be readily detected and are invisible to the naked eye. Therefore, the mere visual presentation of unreinforced disgust eliciting stimuli might not be sufficient to correct a previously acquired threat value of the CS +. Following this, the current study tested whether the efficacy of CS-only exposure can be improved by providing additional safety information about the CS+. For the CSs we included two neutral items a pea soup and a sausage roll, whereas for the Unconditioned Stimulus (US) we used one video clip of a woman vomiting and a neutral one about glass blowing. The additional safety information was conveyed by allowing actual contact with the CS+ or by observing an actress eating the food items representing the CS+. When additional safety information was provided via allowing direct contact with the CS+, there was a relatively strong post-extinction increase in participants' willingness-to-eat the CS+. This beneficial effect was still evident at one-week follow up. Also self-reported disgust was lower at one-week follow up when additional safety information was provided. The current findings help explain why disgust is relatively insensitive to CS-only extinction procedures, and provide helpful starting points to improve interventions that are aimed to reduce distress in disgust-related psychopathology.	[Bosman, Renske C.; Borg, Charmaine; de Jong, Peter J.] Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands; [Bosman, Renske C.] VU Univ Med Ctr Amsterdam, Dept Psychiat, Amsterdam, Netherlands; [Bosman, Renske C.] GGZ InGeest, Amsterdam, Netherlands	University of Groningen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Borg, C (corresponding author), Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands.	c.borg@rug.nl	de Jong, Peter/E-9095-2014; Bosman, R.C./K-6519-2019; de Jong, Peter/ABB-1750-2020	de Jong, Peter/0000-0002-3512-3663; Bosman, R.C./0000-0002-3143-9345; de Jong, Peter/0000-0002-3512-3663; Borg, Charmaine/0000-0002-0122-1118				Armstrong T, 2014, EMOTION, V14, P95, DOI 10.1037/a0034558; Borg C, 2016, COGNITION EMOTION, V30, P669, DOI 10.1080/02699931.2015.1022512; Borg C, 2010, J SEX MED, V7, P2149, DOI 10.1111/j.1743-6109.2010.01800.x; Curtis V, 2011, PHILOS T R SOC B, V366, P389, DOI 10.1098/rstb.2010.0117; Davey GCL, 2009, CLIN PSYCHOL PSYCHOT, V16, P268, DOI 10.1002/cpp.623; de Jong PJ, 2013, CHANGING EMOTIONS, P74; de Jong PJ, 2000, BEHAV RES THER, V38, P1055, DOI 10.1016/S0005-7967(99)00135-7; de Jong PJ, 2002, J ANXIETY DISORD, V16, P477, DOI 10.1016/S0887-6185(02)00167-6; Dirikx T, 2007, J BEHAV THER EXP PSY, V38, P237, DOI 10.1016/j.jbtep.2006.04.001; Emmelkamp PMG, 2014, INT J METH PSYCH RES, V23, P58, DOI 10.1002/mpr.1411; Engelhard IM, 2014, BEHAV THER, V45, P708, DOI 10.1016/j.beth.2014.04.003; Engelhard IM, 2011, J ANXIETY DISORD, V25, P58, DOI 10.1016/j.janxdis.2010.08.003; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Geres JH, 2012, GEDRAGSTHERAPIE, P315; GRAND S, 1968, J EXP PSYCHOL, V77, P31, DOI 10.1037/h0025759; Hermans D, 2005, BEHAV RES THER, V43, P533, DOI 10.1016/j.brat.2004.03.013; Hermans D, 2006, BIOL PSYCHIAT, V60, P361, DOI 10.1016/j.biopsych.2005.10.006; Mason EC, 2012, CLIN PSYCHOL-SCI PR, V19, P180, DOI 10.1111/j.1468-2850.2012.01282.x; Mason EC, 2010, J ANXIETY DISORD, V24, P63, DOI 10.1016/j.janxdis.2009.08.007; MATCHETT G, 1991, BEHAV RES THER, V29, P91, DOI 10.1016/S0005-7967(09)80011-9; McCambridge J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039116; Moretz MW, 2008, J ANXIETY DISORD, V22, P707, DOI 10.1016/j.janxdis.2007.07.004; Oaten M, 2009, PSYCHOL BULL, V135, P303, DOI 10.1037/a0014823; Olatunji BO, 2009, DISORDERS DISGUST AS; Olatunji BO, 2007, J ANXIETY DISORD, V21, P820, DOI 10.1016/j.janxdis.2006.11.004; Olatunji BO, 2007, J ANXIETY DISORD, V21, P445, DOI 10.1016/j.janxdis.2006.05.001; Olatunji BO, 2009, J ANXIETY DISORD, V23, P118, DOI 10.1016/j.janxdis.2008.04.006; Peterman JS, 2015, COGN BEHAV PRACT, V22, P379, DOI 10.1016/j.cbpra.2014.02.003; ROZIN P, 1987, PSYCHOL REV, V94, P23, DOI 10.1037/0033-295X.94.1.23; Ruiter J, 2013, APHYS EMG ANAL PROGR; Sawchuk CN, 2000, BEHAV RES THER, V38, P753, DOI 10.1016/S0005-7967(99)00093-5; Schienle A, 2001, LEARN MOTIV, V32, P65, DOI 10.1006/lmot.2000.1067; Smits JAJ, 2002, BEHAV RES THER, V40, P1243, DOI 10.1016/S0005-7967(01)00094-8; Thordarson DS, 2004, BEHAV RES THER, V42, P1289, DOI 10.1016/j.brat.2003.08.007; van Overveld M, 2008, J ANXIETY DISORD, V22, P524, DOI 10.1016/j.janxdis.2007.04.001; van Overveld WJM, 2006, PERS INDIV DIFFER, V41, P1241, DOI 10.1016/j.paid.2006.04.021; Vrana S.R., 2009, DISGUST ITS DISORDER, P123; VRANA SR, 1993, PSYCHOPHYSIOLOGY, V30, P279, DOI 10.1111/j.1469-8986.1993.tb03354.x; Wolf K, 2005, SCAND J PSYCHOL, V46, P403, DOI 10.1111/j.1467-9450.2005.00471.x	39	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148626	10.1371/journal.pone.0148626	http://dx.doi.org/10.1371/journal.pone.0148626			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26849211	gold, Green Published			2022-12-27	WOS:000369554000140
J	Gupta, S; Termini, JM; Issac, B; Guirado, E; Stone, GW				Gupta, Sachin; Termini, James M.; Issac, Biju; Guirado, Elizabeth; Stone, Geoffrey W.			Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NF-KAPPA-B; PRIMARY HUMAN MACROPHAGES; PLACEBO-CONTROLLED TRIAL; YELLOW-FEVER VACCINE; CHRONIC HEPATITIS-C; RIG-I; ALPHA-INTERFERON; T-CELLS; ANTIVIRAL RESPONSE	Type I interferon is known to inhibit HIV-1 replication through the induction of interferon stimulated genes (ISG), including a number of HIV-1 restriction factors. To better understand interferon-mediated HIV-1 restriction, we constructed a constitutively active form of the RIG-I adapter protein MAVS. Constitutive MAVS was generated by fusion of full length MAVS to a truncated form of the Epstein Barr virus protein LMP1 (Delta LMP1). Supernatant from Delta LMP1-MAVS-transfected 293T cells contained high levels of type I interferons and inhibited HIV replication in both TZM-bl and primary human CD4+ T cells. Supernatant from Delta LMP1-MAVS-transfected 293T cells also inhibited replication of VSV-G pseudotyped single cycle SIV in TZM-bl cells, suggesting restriction was post-entry and common to both HIV and SIV. Gene array analysis of Delta LMP1-MAVS-transfected 293T cells and trans-activated CD4+ T cells showed significant upregulation of ISG, including previously characterized HIV restriction factors Viperin, Tetherin, MxB, and ISG56. Interferon blockade studies implicated interferon-beta in this response. In addition to direct viral inhibition, Delta LMP1-MAVS markedly enhanced secretion of IFN-beta and IL-12p70 by dendritic cells and the activation and maturation of dendritic cells. Based on this immunostimulatory activity, an adenoviral vector (Ad5) expressing Delta LMP1-MAVS was tested as a molecular adjuvant in an HIV vaccine mouse model. Ad5-Gag antigen combined with Ad5-Delta LMP1-MAVS enhanced control of vaccinia-gag replication in a mouse challenge model, with 4/5 animals showing undetectable virus following challenge. Overall, Delta LMP1-MAVS is a promising reagent to inhibit HIV-1 replication in infected tissues and enhance vaccine-mediated immune responses, while avoiding toxicity associated with systemic type I interferon administration.	[Gupta, Sachin; Termini, James M.; Guirado, Elizabeth; Stone, Geoffrey W.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami Ctr AIDS Res, Miami, FL 33136 USA; [Gupta, Sachin; Termini, James M.; Guirado, Elizabeth; Stone, Geoffrey W.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Issac, Biju] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Div Bioinformat Biostat & Bioinformat Core, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Stone, GW (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami Ctr AIDS Res, Miami, FL 33136 USA.; Stone, GW (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.	gstone@med.miami.edu		Issac, Biju/0000-0002-7311-678X	National Institutes of Health (NIH), National Institutes of Allergies and Infectious Diseases (NIAID) [R21AI093294]; Florida Department of Health James and Esther King Biomedical Research Technology Transfer Feasibility (TTF) Award [4KF03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI093294, P30AI073961] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institutes of Allergies and Infectious Diseases (NIAID); Florida Department of Health James and Esther King Biomedical Research Technology Transfer Feasibility (TTF) Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the following: National Institutes of Health (NIH), National Institutes of Allergies and Infectious Diseases (NIAID) grant R21AI093294 to GWS, http://grants.nih.gov/grants/guide/contacts/parent_R21.html; and Florida Department of Health James and Esther King Biomedical Research Technology Transfer Feasibility (TTF) Award 4KF03 to GWS, http://www.floridahealth.gov/provider-and-partner-resources/research/FINAL-FY-15-16-King-Program-FOA1.pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Berg RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029291; Brandt SM, 2002, J BIOL CHEM, V277, P17291, DOI 10.1074/jbc.M108232200; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; DEWIT R, 1988, LANCET, V2, P1214; DIBISCEGLIE AM, 1989, NEW ENGL J MED, V321, P1506, DOI 10.1056/NEJM198911303212204; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; FERNIE BF, 1991, J VIROL, V65, P3968, DOI 10.1128/JVI.65.7.3968-3971.1991; Frentzen A, 2015, J VIROL; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; GENDELMAN HE, 1990, AIDS RES HUM RETROV, V6, P1045, DOI 10.1089/aid.1990.6.1045; Geonnotti AR, 2010, AIDS RES HUM RETROV, V26, P279, DOI 10.1089/aid.2009.0186; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Goujon C, 2010, J VIROL, V84, P9254, DOI 10.1128/JVI.00854-10; Gupta S, 2014, J VIROL, V88, P1492, DOI 10.1128/JVI.02229-13; Gupta S, 2011, J LEUKOCYTE BIOL, V90, P389, DOI 10.1189/jlb.0211068; Gupta S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-39; HARTSHORN KL, 1987, AIDS RES HUM RETROV, V3, P125, DOI 10.1089/aid.1987.3.125; Hatzivassiliou E, 1998, J IMMUNOL, V160, P1116; HO DD, 1985, LANCET, V1, P602; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kobiyama K, 2009, J IMMUNOL, V182, P1593, DOI 10.4049/jimmunol.182.3.1593; LANE HC, 1990, ANN INTERN MED, V112, P805, DOI 10.7326/0003-4819-112-11-805; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Liu L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-94; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Maurais E, 2009, VIROLOGY, V385, P227, DOI 10.1016/j.virol.2008.11.033; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; MEYLAN PRA, 1993, VIROLOGY, V193, P138, DOI 10.1006/viro.1993.1110; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Olagnier D, 2014, J VIROL, V88, P4180, DOI 10.1128/JVI.03114-13; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; PITHA PM, 1994, ANTIVIR RES, V24, P205, DOI 10.1016/0166-3542(94)90068-X; POLI G, 1989, SCIENCE, V244, P575, DOI 10.1126/science.2470148; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rempel H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001967; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Scherer E, 2008, CLIN EXP IMMUNOL, V154, P6, DOI 10.1111/j.1365-2249.2008.03750.x; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; SHIRAZI Y, 1992, J VIROL, V66, P1321, DOI 10.1128/JVI.66.3.1321-1328.1992; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Soni V, 2006, J VIROL, V80, P10787, DOI 10.1128/JVI.01214-06; Stone GW, 2009, J THORAC ONCOL, V4, P802, DOI 10.1097/JTO.0b013e3181a8634d; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Verweij FJ, 2011, EMBO J, V30, P2115, DOI 10.1038/emboj.2011.123; Wang YM, 2012, CELL HOST MICROBE, V11, P631, DOI 10.1016/j.chom.2012.05.003; Wang YZ, 2013, J LEUKOCYTE BIOL, V94, P337, DOI 10.1189/jlb.0313158; Welsch C, 2014, J HEPATOL; Woelk CH, 2004, AIDS RES HUM RETROV, V20, P1210, DOI 10.1089/aid.2004.20.1210; Xiao HY, 2013, J IMMUNOL, V190, P5866, DOI 10.4049/jimmunol.1203470; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; YAMAMOTO JK, 1986, J INTERFERON RES, V6, P143, DOI 10.1089/jir.1986.6.143; Yasui T, 2004, P NATL ACAD SCI USA, V101, P278, DOI 10.1073/pnas.2237224100; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang J, 2004, J BIOL CHEM, V279, P46335, DOI 10.1074/jbc.M403966200	75	8	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148929	10.1371/journal.pone.0148929	http://dx.doi.org/10.1371/journal.pone.0148929			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849062	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000186
J	Keranen, T; Hommo, T; Hamalainen, M; Moilanen, E; Korhonen, R				Keranen, Tiina; Hommo, Tuija; Hamalainen, Mari; Moilanen, Eeva; Korhonen, Riku			Anti-Inflammatory Effects of beta(2)-Receptor Agonists Salbutamol and Terbutaline Are Mediated by MKP-1	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DUAL-SPECIFICITY PHOSPHATASES; P38 MAPK; TYROSINE-PHOSPHATASE; GENE-EXPRESSION; INHIBITION; CAMP; DEXAMETHASONE; INFLAMMATION; ROFLUMILAST	Mitogen-activated protein kinase phosphatase 1 (MKP-1) expression is induced by inflammatory factors, and it is an endogenous suppressor of inflammatory response. MKP-1 expression is increased by PDE4 inhibitor rolipram suggesting that it is regulated by cAMP-enhancing compounds. Therefore, we investigated the effect of beta(2)-receptor agonists on MKP-1 expression and inflammatory response. We found that beta(2)-receptor agonists salbutamol and terbutaline, as well as 8-Br-cAMP, increased MKP-1 expression. Salbutamol and terbutaline also inhibited p38 MAPK phosphorylation and TNF production in J774 mouse macrophages. Interestingly, salbutamol suppressed carrageenan-induced paw inflammation in wild-type mice, but the effect was attenuated in MKP-1(-/-) mice. In conclusion, these data show that beta(2)-receptor agonists increase MKP-1 expression, which seems to mediate, at least partly, the observed anti-inflammatory effects of beta(2)-receptor agonists.	[Korhonen, Riku] Univ Tampere, Immunopharmacol Res Grp, Sch Med, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland	Tampere University; Tampere University; Tampere University Hospital	Korhonen, R (corresponding author), Univ Tampere, Immunopharmacol Res Grp, Sch Med, FIN-33101 Tampere, Finland.	riku.korhonen@staff.uta.fi		Hamalainen, Mari/0000-0002-6409-3758; Korhonen, Riku/0000-0002-7264-517X	Academy of Finland; Pirkanmaa Hospital District, Finland; Tampere Tuberculosis Foundation	Academy of Finland(Academy of Finland); Pirkanmaa Hospital District, Finland; Tampere Tuberculosis Foundation	This work was financially supported by grants from The Academy of Finland, from the Competitive Research Funding of the Pirkanmaa Hospital District, Finland, and from Tampere Tuberculosis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; Badger AM, 2000, OSTEOARTHR CARTILAGE, V8, P434, DOI 10.1053/joca.1999.0319; Baouz S, 2005, INT IMMUNOL, V17, P1473, DOI 10.1093/intimm/dxh325; Bateman ED, 2011, EUR RESPIR J, V38, P553, DOI 10.1183/09031936.00178710; Bobick Brent E., 2008, Birth Defects Research, V84, P131, DOI 10.1002/bdrc.20126; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Brion L, 2011, ENDOCRINOLOGY, V152, P2665, DOI 10.1210/en.2011-0021; Burnette BL, 2009, PHARMACOLOGY, V84, P42, DOI 10.1159/000227286; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Cazzola M, 2013, AM J RESP CRIT CARE, V187, P690, DOI 10.1164/rccm.201209-1739PP; Cazzola M, 2012, PHARMACOL REV, V64, P450, DOI 10.1124/pr.111.004580; Chen KH, 2007, BIOCHEM PHARMACOL, V73, P215, DOI 10.1016/j.bcp.2006.09.018; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Deupi X, 2007, ADV PROTEIN CHEM, V74, P137, DOI 10.1016/S0065-3231(07)74004-4; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fabbri LM, 2009, LANCET, V374, P695, DOI 10.1016/S0140-6736(09)61252-6; Frazier WJ, 2009, J IMMUNOL, V183, P7411, DOI 10.4049/jimmunol.0804343; Grimshaw MJ, 2001, EUR J IMMUNOL, V31, P480, DOI 10.1002/1521-4141(200102)31:2<480::AID-IMMU480>3.0.CO;2-L; Huang GH, 2011, IMMUNITY, V35, P45, DOI 10.1016/j.immuni.2011.05.014; Huang X, 2003, TOXICOL APPL PHARM, V191, P40, DOI 10.1016/S0041-008X(03)00194-7; Kaur M, 2008, AM J PHYSIOL-LUNG C, V295, pL505, DOI 10.1152/ajplung.00046.2008; Korhonen R, 2014, BASIC CLIN PHARMACOL, V114, P24, DOI 10.1111/bcpt.12141; Korhonen R, 2013, BRIT J PHARMACOL, V169, P1525, DOI 10.1111/bph.12189; Korhonen R, 2012, MOL IMMUNOL, V51, P219, DOI 10.1016/j.molimm.2012.03.019; Korhonen R, 2011, MOL IMMUNOL, V48, P2059, DOI 10.1016/j.molimm.2011.06.439; KWAK SP, 1994, J BIOL CHEM, V269, P3596; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lee J, 2012, J BIOL CHEM, V287, P22799, DOI 10.1074/jbc.M111.337378; Liang L, 2013, RESPIROLOGY, V18, P20, DOI 10.1111/resp.12189; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Manetsch M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059635; Mortaz E, 2008, J MOL MED, V86, P1045, DOI 10.1007/s00109-008-0360-0; Nieminen R, 2010, ARTHRITIS RHEUM-US, V62, P1650, DOI 10.1002/art.27409; NOGUCHI T, 1993, MOL CELL BIOL, V13, P5195, DOI 10.1128/MCB.13.9.5195; Patel BS, 2014, AM J RESPIR CELL MOL; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Saleh TSF, 1996, BRIT J PHARMACOL, V118, P811, DOI 10.1111/j.1476-5381.1996.tb15472.x; Salojin K, 2007, J LEUKOCYTE BIOL, V81, P860, DOI 10.1189/jlb.1006639; Shipp LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013754; Theron AJ, 2013, DRUG DES DEV THER, V7, P1387, DOI 10.2147/DDDT.S50995; Turpeinen T, 2010, J PHARMACOL EXP THER, V333, P310, DOI 10.1124/jpet.109.157438; Underwood DC, 2000, AM J PHYSIOL-LUNG C, V279, pL895, DOI 10.1152/ajplung.2000.279.5.L895; Uzkeser H, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/438912; Vida G, 2011, FASEB J, V25, P4476, DOI 10.1096/fj.11-191007; Wancket LM, 2012, LIFE SCI, V90, P237, DOI 10.1016/j.lfs.2011.11.017; Zarrindast MR, 2002, PHARMACOL BIOCHEM BE, V72, P203, DOI 10.1016/S0091-3057(01)00749-3; Zhang J, 2008, CELL DEATH DIFFER, V15, P1654, DOI 10.1038/cdd.2008.87; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	52	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148144	10.1371/journal.pone.0148144	http://dx.doi.org/10.1371/journal.pone.0148144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849227	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000044
J	Kong, XJ; Jiang, HZ; Yang, Z; Xu, ZZ; Xia, F; Tolba, A				Kong, Xiangjie; Jiang, Huizhen; Yang, Zhuo; Xu, Zhenzhen; Xia, Feng; Tolba, Amr			Exploiting Publication Contents and Collaboration Networks for Collaborator Recommendation	PLOS ONE			English	Article								Thanks to the proliferation of online social networks, it has become conventional for researchers to communicate and collaborate with each other. Meanwhile, one critical challenge arises, that is, how to find the most relevant and potential collaborators for each researcher? In this work, we propose a novel collaborator recommendation model called CCRec, which combines the information on researchers' publications and collaboration network to generate better recommendation. In order to effectively identify the most potential collaborators for researchers, we adopt a topic clustering model to identify the academic domains, as well as a random walk model to compute researchers' feature vectors. Using DBLP datasets, we conduct benchmarking experiments to examine the performance of CCRec. The experimental results show that CCRec outperforms other state-of-the-art methods in terms of precision, recall and F1 score.	[Kong, Xiangjie; Jiang, Huizhen; Yang, Zhuo; Xu, Zhenzhen; Xia, Feng] Dalian Univ Technol, Sch Software, Dalian, Peoples R China; [Tolba, Amr] King Saud Univ, Riyadh Community Coll, Riyadh, Saudi Arabia; [Tolba, Amr] Menoufia Univ, Fac Sci, Math & Comp Sci Dept, Menoufia, Egypt	Dalian University of Technology; King Saud University; Egyptian Knowledge Bank (EKB); Menofia University	Xu, ZZ (corresponding author), Dalian Univ Technol, Sch Software, Dalian, Peoples R China.	xzz@dlut.edu.cn	Tolba, Amr/O-8464-2016; Xia, Feng/Y-2859-2019; Kong, Xiangjie/B-8809-2016	Tolba, Amr/0000-0003-3439-6413; Xia, Feng/0000-0002-8324-1859; Kong, Xiangjie/0000-0003-2698-3319	National Natural Science Foundation of China [61203165, 51209036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China under Grants No. 61203165 (XK) and 51209036 (ZX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Cao Ziqiang, 2015, 29 AAAI C ART INT; Chaiwanarom P, 2014, KNOWLEDGE BASED SYST; Chen H.-H., 2012, PROC 27 ANN ACM S AP, P138; Chen Hung-Hsuan, 2011, P 11 ANN INT ACM IEE, P231, DOI DOI 10.1145/1998076.1998121; Chen JL, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P201, DOI 10.1145/1518701.1518735; Cohen S, 2013, PROCEEDINGS OF THE 22ND INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'13 COMPANION), P959; DiMicco J, 2008, CSCW: 2008 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, CONFERENCE PROCEEDINGS, P711; Goldberg Y., 2014, WORD2VEC EXPLAINED D, V1402, P3722; Gollapalli S.D., 2012, P 12 ACM IEEE CS JOI, P167, DOI DOI 10.1145/2232817.2232849; Hofmann T, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P50, DOI 10.1145/312624.312649; Kim HN, 2010, ELECTRON COMMER R A, V9, P73, DOI 10.1016/j.elerap.2009.08.004; Lee D.H., 2011, PROC PROC ASIST ANN, V48, P1, DOI [10.1002/meet.2011.14504801025, DOI 10.1002/MEET.2011.14504801025, DOI 10.1002/meet.2011.14504801025]; Lee S, 2005, SOC STUD SCI, V35, P673, DOI 10.1177/0306312705052359; Ley M, 2009, PROC VLDB ENDOW, V2, P1493, DOI 10.14778/1687553.1687577; Li C. Y., 2014, ELECT J DIFFERENTIAL, V2014, P1, DOI DOI 10.1016/J.RSE.2014.04.020; Li J, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P1209, DOI 10.1145/2567948.2579034; Lichtenwalter R.N., 2010, P 16 ACM SIGKDD INT, P243; Lopes GR, 2010, LECT NOTES COMPUT SC, V6413, P190, DOI 10.1007/978-3-642-16385-2_24; Ma Hao, 2011, ACM WSDM, P287; Petertonkoker J, 2014, RECOMMENDER SYSTEMS, P283, DOI DOI 10.1007/978-1-4939-0530-0; Shani G, 2011, RECOMMENDER SYSTEMS HANDBOOK, P257, DOI 10.1007/978-0-387-85820-3_8; Sun YZ, 2011, 2011 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2011), P121, DOI 10.1109/ASONAM.2011.112; Tang J., 2012, P 18 ACM SIGKDD INT, P1285, DOI DOI 10.1145/2339530.2339730; Huynh T, 2013, LECT NOTES ARTIF INT, V8083, P11; Xia F, 2014, IEEE T EMERG TOP COM, V2, P364, DOI 10.1109/TETC.2014.2356505; Xia F, 2017, IEEE SYST J, V11, P2255, DOI 10.1109/JSYST.2014.2342375	27	42	46	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148492	10.1371/journal.pone.0148492	http://dx.doi.org/10.1371/journal.pone.0148492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849682	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000108
J	Schluter, N				Schlueter, Nils			Ecophenotypic Variation and Developmental Instability in the Late Cretaceous Echinoid Micraster brevis (Irregularia; Spatangoida)	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; GENE-EXPRESSION; EVOLUTION; ENVIRONMENTS; VARIABILITY; SHAPE	The Late Cretaceous echinoid genus Micraster (irregular echinoids, Spatangoida) is one of the most famous examples of a continuous evolutionary lineage in invertebrate palaeontology. The influence of the environment on the phenotype, however, was not tested so far. This study analyses differences in phenotypical variations within three populations of Micraster (Gibbaster) brevis from the early Coniacian, two from the Munsterland Cretaceous Basin (Germany) and one from the North Cantabrian Basin (Spain). The environments of the Spanish and the German sites differed by their sedimentary characteristics, which are generally a crucial factor for morphological adaptations in echinoids. Most of the major phenotypical variations (position of the ambitus, periproct and development of the subanal fasciole) among the populations can be linked to differences in their host sediments. These phenotypic variations are presumed to be an expression of phenotpic plasticiy, which has not been considered in Micraster in previous studies. Two populations (Erwitte area, Germany; Liencres area, Spain) were tested for stochastic variation (fluctuating asymmetry) due to developmental instability, which was present in all studied traits. However, differences in the amount of fluctuating asymmetry between both populations were recognised only in one trait (amount of pore pairs in the anterior paired petals). The results strengthen previous assumptions on ecophenotypic variations in Micraster.	[Schlueter, Nils] Univ Gottingen, Geosci Ctr, Dept Geobiol, Goldschmidtstr 3, D-37077 Gottingen, Germany	University of Gottingen	Schluter, N (corresponding author), Univ Gottingen, Geosci Ctr, Dept Geobiol, Goldschmidtstr 3, D-37077 Gottingen, Germany.	nils.schluter@gmail.com		Schluter, Nils/0000-0002-5699-3684	German Research Foundation; Gottingen University; SYNTHESYS Project - European Community [FR-TAF-4917]	German Research Foundation(German Research Foundation (DFG)); Gottingen University; SYNTHESYS Project - European Community	The author acknowledges support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University. This research received in parts support from the SYNTHESYS Project, http://www.synthesys.info/, which is financed by European Community Research Infrastructure Action under the FP7, Capacities" Program (FR-TAF-4917). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur W, 2000, EVOL DEV, V2, P49, DOI 10.1046/j.1525-142x.2000.00028.x; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Braendle C, 2006, BIOESSAYS, V28, P868, DOI 10.1002/bies.20456; Chalancon G, 2012, TRENDS GENET, V28, P221, DOI 10.1016/j.tig.2012.01.006; Chauffe KM, 1995, PALAEONTOLOGY, V38, P875; Chenuil A, 2003, ECHINODERM RES 2001, P15; Cunningham JA, 2009, BIOL LETTERS, V5, P647, DOI 10.1098/rsbl.2009.0302; DAVID B, 1984, GEOBIOS-LYON, V17, P447, DOI 10.1016/S0016-6995(84)80019-4; De Baets K, 2015, TOP GEOBIOL, V43, P359, DOI 10.1007/978-94-017-9630-9_9; De Ridder C, 1982, ECHINODERM NUTR, P97; DeWitt T.J., 2004, PHENOTYPIC PLASTICIT; Drummond PVO, 1983, GEOLOGIE MEDITERRANE, V10, P177; Egea E, 2016, MOL PHYLOGENET EVOL, V94, P207, DOI 10.1016/j.ympev.2015.07.023; Ernst G., 1970, Mitt. geol. St. Inst., Hamb., V39, P117; Ernst G., 1972, Geologisches Jb (A), VNo. 4, P63; Ernst G., 1977, CONCEPTS METHODS BIO, P541; Falkingham PL, 2012, PALAEONTOL ELECTRON, V15; Fouray M., 1981, Annales de Paleontologie Invertebres, V67, P81; Francois E, 2006, GEOBIOS-LYON, V39, P355, DOI 10.1016/j.geobios.2005.01.002; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; HIGGINS RC, 1974, J ZOOL, V173, P451; Hunt G, 2004, PALEOBIOLOGY, V30, P426, DOI 10.1666/0094-8373(2004)030<0426:PVIFSM>2.0.CO;2; Jablonski D, 1999, SCIENCE, V284, P2114, DOI 10.1126/science.284.5423.2114; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KANAZAWA K, 1992, PALAEONTOLOGY, V35, P733; Kaplan U, 1998, BOCHUMER GEOL GEOTEC, V48, P184; Kaplan U., 1994, GEOLOGIE PALAONTOLOG, V31, P1; Karvonen E, 2003, OIKOS, V100, P507, DOI 10.1034/j.1600-0706.2003.11851.x; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg Christian Peter, 2003, P14; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1999, EVOLUTION, V53, P358, DOI [10.2307/2640773, 10.1111/j.1558-5646.1999.tb03772.x]; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Lambert J., 1909, ESSAI NOMENCLATURE R; Lawrence JM, 1998, INVERTEBR BIOL, V117, P94, DOI 10.2307/3226855; Mallison H., 2014, J PALEONTOL TECHN, V12, P1; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; McKinney ML, 1991, EVOLUTION ONTOGENY; MCNAMARA KJ, 1980, ALCHERINGA, V4, P47, DOI 10.1080/03115518008558980; MCNAMARA KJ, 1987, PALEOBIOLOGY, V13, P312; Moller AP, 1997, ASYMMETRY DEV STABIL; Neraudeau D, 1998, LETHAIA, V31, P323; Neraudeau Didier, 2001, Biosystema, V19, P93; NICHOLS D, 1959, PHILOS T ROY SOC B, V242, P347, DOI 10.1098/rstb.1959.0007; Olszewska-Nejbert D, 2007, ACTA GEOL POL, V57, P1; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer A. Richard, 2003, P279; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Pigliucci M, 1998, CURR OPIN PLANT BIOL, V1, P87, DOI 10.1016/S1369-5266(98)80133-7; Polak M, 1997, AM NAT, V149, P955, DOI 10.1086/286032; Rowe A., 1899, Quarterly Journal of the Geological Society, Vlv, P494; Saitoh M, 2012, ZOOSYMPOSIA, V7, P255, DOI 10.11646/zoosymposia.7.1.24; Saucede T, 2006, BIOL J LINN SOC, V88, P165, DOI 10.1111/j.1095-8312.2006.00603.x; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seibertz E., 1979, AUFSCHLUSS SONDERBAN, V29, P85; Smith A. B., 2012, Monograph of the Palaeontographical Society, P635; Smith A.B., 1980, Palaeontology (Oxford), V23, P39; Smith A.B., 1984, ECHINOID PALAEOBIOLO; Stige LC, 2006, J EVOLUTION BIOL, V19, P492, DOI 10.1111/j.1420-9101.2005.01011.x; STOKES R B, 1975, Memoires du Museum National d'Histoire Naturelle Serie C Sciences de la Terre, V31, P1; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888; SWAIN DP, 1987, AM NAT, V129, P761, DOI 10.1086/284671; Troger K.-A., 1974, Freiberger Forschungshefte, VNo. C298, P109; VANVALEN L, 1962, EVOLUTION, V16, P125; Villier L, 2001, ECHINODERMS 2000, P563; Voigt S, 2003, INT J EARTH SCI, V92, P285, DOI 10.1007/s00531-003-0315-1; Walker Danielle E., 2014, Journal of Marine Biology, P297631; West-Eberhard Mary Jane, 2003, pi; Wiese F, 2002, GEOBIOS-LYON, V35, P65, DOI 10.1016/S0016-6995(02)00010-4; Wiese F, 1997, BERLINER GEOWISSENSC, V24, P1; Willmore KE, 2007, EVOL BIOL, V34, P99, DOI 10.1007/s11692-007-9008-1; Willmore KE, 2005, VARIATION CENTRAL CO, P191; ZAGHBIBTURKI D, 1990, ECHINODERM RESEARCH, P49; Ziegler P.A, 1988, AAPG MEMOIR, V43	76	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148341	10.1371/journal.pone.0148341	http://dx.doi.org/10.1371/journal.pone.0148341			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849648	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000072
J	Ubiali, T; Sanfins, MD; Borges, LR; Colella-Santos, MF				Ubiali, Thalita; Sanfins, Milaine Dominici; Borges, Leticia Reis; Colella-Santos, Maria Francisca			Contralateral Noise Stimulation Delays P300 Latency in School-Aged Children	PLOS ONE			English	Article							MEDIAL OLIVOCOCHLEAR SYSTEM; AUDITORY-EVOKED POTENTIALS; OTOACOUSTIC EMISSION; COCHLEAR SENSITIVITY; INFERIOR COLLICULUS; SOUND LOCALIZATION; NORMAL-HEARING; BRAIN-STEM; MODULATION; CORTEX	Background and Objective The auditory cortex modulates auditory afferents through the olivocochlear system, which innervates the outer hair cells and the afferent neurons under the inner hair cells in the cochlea. Most of the studies that investigated the efferent activity in humans focused on evaluating the suppression of the otoacoustic emissions by stimulating the contralateral ear with noise, which assesses the activation of the medial olivocochlear bundle. The neurophysiology and the mechanisms involving efferent activity on higher regions of the auditory pathway, however, are still unknown. Also, the lack of studies investigating the effects of noise on human auditory cortex, especially in peadiatric population, points to the need for recording the late auditory potentials in noise conditions. Assessing the auditory efferents in schoolaged children is highly important due to some of its attributed functions such as selective attention and signal detection in noise, which are important abilities related to the development of language and academic skills. For this reason, the aim of the present study was to evaluate the effects of noise on P300 responses of children with normal hearing. Methods P300 was recorded in 27 children aged from 8 to 14 years with normal hearing in two conditions: with and whitout contralateral white noise stimulation. Results P300 latencies were significantly longer at the presence of contralateral noise. No significant changes were observed for the amplitude values. Conclusion Contralateral white noise stimulation delayed P300 latency in a group of school-aged children with normal hearing. These results suggest a possible influence of the medial olivocochlear activation on P300 responses under noise condition.	[Ubiali, Thalita; Sanfins, Milaine Dominici; Borges, Leticia Reis; Colella-Santos, Maria Francisca] Univ Estadual Campinas, Fac Med Sci, Campinas, SP, Brazil	Universidade Estadual de Campinas	Ubiali, T (corresponding author), Univ Estadual Campinas, Fac Med Sci, Campinas, SP, Brazil.	thalita.ubiali@gmail.com	Colella-Santos, Maria Francisca/AAC-6110-2021; Colella-Santos, Maria Francisca/A-6008-2013; Ubiali, Thalita/B-4858-2019; Sanfins, Milaine Dominici/K-2262-2012	Colella-Santos, Maria Francisca/0000-0002-7456-9502; Ubiali, Thalita/0000-0003-1723-0614; Sanfins, Milaine Dominici/0000-0002-3647-3999	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/14944-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2013/14944-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andeol G, 2011, J NEUROSCI, V31, P6759, DOI 10.1523/JNEUROSCI.0248-11.2011; ANDERSEN RA, 1980, J COMP NEUROL, V191, P479, DOI 10.1002/cne.901910310; Bajo VM, 2007, CEREB CORTEX, V17, P475, DOI 10.1093/cercor/bhj164; Bidelman GM, 2015, NEUROREPORT, V26, P483, DOI 10.1097/WNR.0000000000000376; Canale A, 2014, INT J PEDIATR OTORHI, V78, P455, DOI 10.1016/j.ijporl.2013.12.016; CASSEDAY JH, 1976, J COMP NEUROL, V166, P303, DOI 10.1002/cne.901660304; Chaubet J, 2014, INT ARCH OTORHINOLAR, V18, P146, DOI 10.1055/s-0033-1363465; COLLET L, 1990, HEARING RES, V43, P251, DOI 10.1016/0378-5955(90)90232-E; de Boer J, 2008, J NEUROSCI, V28, P4929, DOI 10.1523/JNEUROSCI.0902-08.2008; de Boer J, 2012, J NEUROPHYSIOL, V107, P1301, DOI 10.1152/jn.00222.2011; Delano PH, 2007, J NEUROSCI, V27, P4146, DOI 10.1523/JNEUROSCI.3702-06.2007; Dragicevic CD, 2015, JARO-J ASSOC RES OTO, V16, P223, DOI 10.1007/s10162-015-0509-9; Frizzo ACF, 2012, INT ARCH OTORHINOLAR, V16, P335, DOI 10.7162/S1809-97772012000300006; Guinan JJ, 2006, EAR HEARING, V27, P589, DOI 10.1097/01.aud.0000240507.83072.e7; Guinan JJ, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00142; Guinan JJ, 2010, CURR OPIN OTOLARYNGO, V18, P447, DOI 10.1097/MOO.0b013e32833e05d6; Irving S, 2011, J NEUROSCI, V31, P2493, DOI 10.1523/JNEUROSCI.2679-10.2011; Jager K, 2015, HEARING RES, V332, P61; JERGER J, 1970, ARCHIV OTOLARYNGOL, V92, P311; KARNISKI W, 1989, ELECTROEN CLIN NEURO, V72, P373, DOI 10.1016/0013-4694(89)90043-6; Keefe DH, 2010, HEARING RES, V263, P52, DOI 10.1016/j.heares.2009.09.008; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kouni SN, 2013, AM J OTOLARYNG, V34, P646, DOI 10.1016/j.amjoto.2013.07.004; Kraus D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100486; Krishnamurti S., 2001, CONTEM ISSUES COMMUN, V28, P40; Lauer AM, 2011, JARO-J ASSOC RES OTO, V12, P329, DOI 10.1007/s10162-011-0262-7; Leon A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036203; Lopez L, 2003, ANN NY ACAD SCI, V999, P124, DOI 10.1196/annals.1284.013; Matas Carla Gentile, 2011, Rev. soc. bras. fonoaudiol., V16, P37, DOI 10.1590/S1516-80342011000100008; McPherson DL, 1996, EVOKED POTENCIAL SER; Wiemes GRM, 2012, BRAZ J OTORHINOLAR, V78, P91, DOI 10.1590/S1808-86942012000300016; Mishra SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085756; Northern J, 2005, AUDICAO NA INFANCIA, P129; OATMAN LC, 1971, EXP NEUROL, V32, P341, DOI 10.1016/0014-4886(71)90003-3; OLIVER DL, 1978, J COMP NEUROL, V182, P459, DOI 10.1002/cne.901820306; Perez-Villa YE, 2014, ACTA OTORRINOLAR ESP, V65, P332, DOI 10.1016/j.otorri.2014.02.010; Perrot X, 2006, CEREB CORTEX, V16, P941, DOI 10.1093/cercor/bhj035; Perrot X, 2014, HEARING RES, V308, P27, DOI 10.1016/j.heares.2013.08.010; POLICH J, 1985, BIOL PSYCHOL, V21, P309, DOI 10.1016/0301-0511(85)90185-1; Rabbitt RD, 2011, CURR OPIN OTOLARYNGO, V19, P376, DOI 10.1097/MOO.0b013e32834a5be1; Rabelo CM, 2015, BRAZ J OTORHINOLAR, V81, P63, DOI 10.1016/j.bjorl.2014.11.003; RASMUSSEN GL, 1946, J COMP NEUROL, V84, P141, DOI 10.1002/cne.900840204; Reis Ana Cláudia Mirândola Barbosa, 2014, Audiol., Commun. Res., V19, P293, DOI 10.1590/S2317-643120140003000014; Ryugo DK, 2011, SPRINGER HANDB AUDIT, V38, P1, DOI 10.1007/978-1-4419-7070-1_1; Saldana E, 2015, CEREBELLUM, V14, P584, DOI 10.1007/s12311-015-0694-4; Salisbury DF, 2002, PSYCHOPHYSIOLOGY, V39, P111, DOI 10.1017/S0048577201020030; Salo SK, 2003, J PSYCHOPHYSIOL, V17, P189, DOI 10.1027/0269-8803.17.4.189; Sandman CA, 2000, CLIN NEUROPHYSIOL, V111, P1427, DOI 10.1016/S1388-2457(00)00320-5; Schochat E, 2012, ACTA NEUROBIOL EXP, V72, P296; Schofield BR, 2006, HEARING RES, V216, P81, DOI 10.1016/j.heares.2006.01.004; Terreros G, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00134; Tervaniemi M, 2006, NEUROREPORT, V17, P1225, DOI 10.1097/01.wnr.0000230510.55596.8b; Tokgoz-Yilmaz S, 2013, AURIS NASUS LARYNX, V40, P521, DOI 10.1016/j.anl.2013.04.003; Ungan P, 2013, NEUROL SCI, V34, P25, DOI 10.1007/s10072-012-0961-9; Urnau D, 2012, BRAZ J OTORHINOLAR, V78, P87, DOI 10.1590/S1808-86942012000100014; van Dinteren R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087347; Weihing J, 2008, J AM ACAD AUDIOL, V19, P481, DOI 10.3766/jaaa.19.6.4; Wersinger E, 2011, HEARING RES, V279, P1, DOI 10.1016/j.heares.2010.12.018; Winer JA, 1998, J COMP NEUROL, V400, P147; Wittekindt A, 2014, J NEUROSCI, V34, P9995, DOI 10.1523/JNEUROSCI.4861-13.2014; Wolpert S, 2014, AUDIOL NEURO-OTOL, V19, P31, DOI 10.1159/000354913; Xiao ZJ, 2002, NAT NEUROSCI, V5, P57, DOI 10.1038/nn786; Zhao W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018725	63	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148360	10.1371/journal.pone.0148360	http://dx.doi.org/10.1371/journal.pone.0148360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849224	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000080
J	Kiely, B; Migdal, TR; Vettam, S; Adesman, A				Kiely, Bridget; Migdal, Talia R.; Vettam, Sujit; Adesman, Andrew			Prevalence and Correlates of Elopement in a Nationally Representative Sample of Children with Developmental Disabilities in the United States	PLOS ONE			English	Article							BEHAVIOR QUESTIONNAIRE CSBQ; INTELLECTUAL DISABILITY; AUTISM	Despite increased awareness and concern about children with developmental disabilities wandering away from adult supervision, there is a paucity of research about elopement. This is the first study to examine and report the prevalence and correlates of elopement in a nationally representative sample of school-age children in the United States with an autism spectrum disorder (ASD) and/or cognitive impairment. Data were obtained from the CDC's "Pathways" Survey, a follow-up telephone survey of the parents of 4,032 children with a developmental condition. 3,518 children that had ASD, intellectual disability (ID), and/or developmental delay (DD) at the time of survey administration were included for analysis. Children were divided into three condition groups: ASD-only; ID/DD-only; ASD+ID/DD. Logistic regression analyses were used to compare the prevalence of elopement and rates of preventive measure use (barriers and/or electronic devices) across condition groups, and to examine the clinical and demographic correlates of elopement. T-tests were also performed to compare scores on the Children's Social Behavior Questionnaire (CSBQ) between wanderers and non-wanderers. Overall, 26.7% of children had reportedly eloped within the previous year, most commonly from public places. Children with ASD-only and ASD+ID/DD were more likely to have eloped than those with ID/DD-only. Across all groups, wanderers scored higher than non-wanderers on five out of six CSBQ subscales; they were more likely not to realize when there is danger, to have difficulty distinguishing between strangers and familiar people, to show sudden mood changes, to over-react to everything/everyone, to get angry quickly, to get lost easily, and to panic in new situations or if change occurs. Even after controlling for elopement history, parents of children in the ASD+ID/DD group were more likely than those in the other condition groups to report using physical or electronic measures to prevent wandering.	[Kiely, Bridget; Migdal, Talia R.; Vettam, Sujit; Adesman, Andrew] Steven & Alexandra Cohen Childrens Med Ctr New Yo, Dept Pediat, Div Dev & Behav Pediat, New Hyde Pk, NY USA	Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York	Adesman, A (corresponding author), Steven & Alexandra Cohen Childrens Med Ctr New Yo, Dept Pediat, Div Dev & Behav Pediat, New Hyde Pk, NY USA.	AAdesman@Northwell.edu						Anderson C, 2012, PEDIATRICS, V130, P870, DOI 10.1542/peds.2012-0762; [Anonymous], MMWR; [Anonymous], MMWR; [Anonymous], 2009, MMWR; Bertrand J, 2001, PEDIATRICS, V108, P1155, DOI 10.1542/peds.108.5.1155; Boyle CA, 2011, PEDIATRICS, V127, P1034, DOI 10.1542/peds.2010-2989; CDC, 2014, MMWR, V63; de Bildt A, 2009, J AUTISM DEV DISORD, V39, P1350, DOI 10.1007/s10803-009-0749-9; Hartman CA, 2006, J AUTISM DEV DISORD, V36, P325, DOI 10.1007/s10803-005-0072-z; La Malfa G, 2004, J INTELL DISABIL RES, V48, P262, DOI 10.1111/j.1365-2788.2003.00567.x; Matson JL, 2009, RES DEV DISABIL, V30, P1107, DOI 10.1016/j.ridd.2009.06.003; McIlwain L, 2010, INT AUT COORD COMM M; Rice C, 2012, NAT C HLTH STAT AUG; Yeargin-Allsopp M, 2003, JAMA-J AM MED ASSOC, V289, P49, DOI 10.1001/jama.289.1.49	14	21	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148337	10.1371/journal.pone.0148337	http://dx.doi.org/10.1371/journal.pone.0148337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PF	26845701	Green Submitted, Green Published, gold			2022-12-27	WOS:000369552800047
J	Saviolli, JY; Cunha, MPV; Guerra, MFL; Irino, K; Catao-Dias, JL; de Carvalho, VM				Saviolli, Juliana Yuri; Vieira Cunha, Marcos Paulo; Lopes Guerra, Maria Flavia; Irino, Kinue; Catao-Dias, Jose Luiz; de Carvalho, Vania Maria			Free-Ranging Frigates (Fregata magnificens) of the Southeast Coast of Brazil Harbor Extraintestinal Pathogenic Escherichia coli Resistant to Antimicrobials	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ANTIBIOTIC-RESISTANCE; VIRULENCE GENOTYPES; WILD BIRDS; STRAINS; INFECTIONS; BACTERIA; HUMANS; IDENTIFICATION; MENINGITIS	Seabirds may be responsible for the spread of pathogenic/resistant organisms over great distances, playing a relevant role within the context of the One World, One Health concept. Diarrheagenic E. coli strains, known as STEC (shiga toxin-producing E. coli), and the extra-intestinal pathogenic E. coli (ExPEC and the subpathotype APEC), are among the E. coli pathotypes with zoonotic potential associated with the birds. In order to identify health threats carried by frigates and to evaluate the anthropic influence on the southern coast of Brazil, the aim of this work was to characterize E. coli isolated from free-ranging frigates in relation to virulence genotypes, serotypes, phylogenetic groups and antimicrobial resistance. Cloacal and choanal swabs were sampled from 38 Fregata magnificens from two oceanic islands and one rescue center. Forty-three E. coli strains were recovered from 33 out of the 38 birds (86.8%); 88.4% of strains showed some of the virulence genes (VGs) searched, 48.8% contained three or more VGs. None of the strains presented VGs related to EPEC/STEC. Some of the isolates showed virulence genotypes, phylogenetic groups and serotypes of classical human ExPEC or APEC (O2:H7, O1:H6, ONT:H7, O25:H4). Regarding antimicrobial susceptibility, 62.8% showed resistance, and 11.6% (5/43) were multidrug-resistant. The E. coli present in the intestines of the frigates may reflect the environmental human impact on southeast coast of Brazil; they may also represent an unexplored threat for seabird species, especially considering the overlap of pathogenic potential and antimicrobial resistance present in these strains.	[Saviolli, Juliana Yuri; Vieira Cunha, Marcos Paulo; Lopes Guerra, Maria Flavia; Catao-Dias, Jose Luiz; de Carvalho, Vania Maria] Univ Sao Paulo, Fac Med Vet, Dept Pathol, Sao Paulo, SP, Brazil; [Irino, Kinue] Adolfo Lutz Inst, Enterobacteriacea Lab, Sao Paulo, SP, Brazil; [Saviolli, Juliana Yuri] Projeto Albatroz, Santos, SP, Brazil	Universidade de Sao Paulo; Instituto Adolfo Lutz	de Carvalho, VM (corresponding author), Univ Sao Paulo, Fac Med Vet, Dept Pathol, Sao Paulo, SP, Brazil.	vaniamc@uol.com.br	Cunha, Marcos Paulo Vieira/J-4832-2014; CATÃO-DIAS, JOSE LUIZ/C-4897-2012	Cunha, Marcos Paulo Vieira/0000-0002-8545-1518; CATÃO-DIAS, JOSE LUIZ/0000-0003-2999-3395	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; VMC [2010/51943-4]; MPVC [2010/20706-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); VMC; MPVC	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br); VMC, Grant #2010/51943-4; MPVC, Grant # 2010/20706-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Barbieri NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072322; Barbieri NL, 2015, FOODBORNE PATHOG DIS, V12, P74, DOI 10.1089/fpd.2014.1815; Bonnedahl J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005958; Carroll D, 2015, ZOONOSES PUBLIC HLTH, V62, P534, DOI 10.1111/zph.12182; Carvalho VM, 2012, J VET DIAGN INVEST, V24, P1014, DOI 10.1177/1040638712453576; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clinical and Laboratory Standards Institute (CLSI), 2020, PERFORMANCE STANDARD, V5th; CLSI, 2013, VET01S2 CLSI; CLSI, 2013, PERFORMANCE STANDARD; Cunha MPV, 2014, SCI WORLD J, DOI 10.1155/2014/289024; da Costa PM, 2013, INT J ENV RES PUB HE, V10, P278, DOI 10.3390/ijerph10010278; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; GANNON VPJ, 1993, J CLIN MICROBIOL, V31, P1268, DOI 10.1128/JCM.31.5.1268-1274.1993; Germon P, 2005, MICROBIOL-SGM, V151, P1179, DOI 10.1099/mic.0.27809-0; Gordon DM, 2003, MICROBIOL-SGM, V149, P3575, DOI 10.1099/mic.0.26486-0; Iovine R, 2015, BRAZILIAN J IN PRESS; Johnson JR, 2005, INT J MED MICROBIOL, V295, P383, DOI 10.1016/j.ijmm.2005.07.005; Johnson JR, 2003, J CLIN MICROBIOL, V41, P337, DOI 10.1128/JCM.41.1.337-345.2003; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Maluta RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105016; Mellata M, 2013, FOODBORNE PATHOG DIS, V10, P916, DOI 10.1089/fpd.2013.1533; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0018318, 10.1371/journal.pone.0021326]; Mora Azucena, 2013, Vet Microbiol, V167, P506, DOI 10.1016/j.vetmic.2013.08.007; Mora A, 2012, APPL ENVIRON MICROB, V78, P2578, DOI 10.1128/AEM.07520-11; Moura A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00419; Muscat Edelcio, 2014, Check List, V10, P729; Olsvik Orjan, 1993, P271; Osugui L, 2014, VET MICROBIOL, V171, P242, DOI 10.1016/j.vetmic.2014.03.027; Pesapane R, 2013, ECOHEALTH, V10, P115, DOI 10.1007/s10393-013-0838-2; POLLARD DR, 1990, J CLIN MICROBIOL, V28, P540, DOI 10.1128/JCM.28.3.540-545.1990; Radhouani H, 2009, VET REC, V165, P138, DOI 10.1136/vr.165.5.138; Radhouani H, 2012, J MED MICROBIOL, V61, P837, DOI 10.1099/jmm.0.038364-0; Riley LW, 2014, CLIN MICROBIOL INFEC, V20, P380, DOI 10.1111/1469-0691.12646; Rodriguez-Siek KE, 2005, VET RES, V36, P241, DOI 10.1051/vetres:2004057; Schwarz S, 2010, VET MICROBIOL, V141, P1, DOI 10.1016/j.vetmic.2009.12.013; Smith JL, 2007, FOODBORNE PATHOG DIS, V4, P134, DOI 10.1089/fpd.2007.0087; Smith S, 2014, IRISH VET J, V67, DOI 10.1186/2046-0481-67-8; Steele CM, 2005, J WILDLIFE DIS, V41, P735, DOI 10.7589/0090-3558-41.4.735; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Tivendale KA, 2010, INFECT IMMUN, V78, P3412, DOI 10.1128/IAI.00347-10; Tsiodras S, 2008, J INFECTION, V56, P83, DOI 10.1016/j.jinf.2007.11.001; YAMAMOTO S, 1995, MICROBIOL IMMUNOL, V39, P401, DOI 10.1111/j.1348-0421.1995.tb02219.x	45	9	10	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148624	10.1371/journal.pone.0148624	http://dx.doi.org/10.1371/journal.pone.0148624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845679	gold, Green Published, Green Submitted			2022-12-27	WOS:000369552800077
J	Chua, SK; Wang, BW; Lien, LM; Lo, HM; Chiu, CZ; Shyu, KG				Chua, Su-Kiat; Wang, Bao-Wei; Lien, Li-Ming; Lo, Huey-Ming; Chiu, Chiung-Zuan; Shyu, Kou-Gi			Mechanical Stretch Inhibits MicroRNA499 via p53 to Regulate Calcineurin-A Expression in Rat Cardiomyocytes	PLOS ONE			English	Article							DYNAMIN-RELATED PROTEIN-1; INDUCED HEART-FAILURE; MITOCHONDRIAL FISSION; GROWTH-FACTOR; MYOCYTE APOPTOSIS; VOLUME-OVERLOAD; DRP1; DEPHOSPHORYLATION; ACTIVATION; ALPHA	Background MicroRNAs play an important role in cardiac remodeling. MicroRNA 499 (miR499) is highly enriched in cardiomyocytes and targets the gene for Calcineurin A (CnA), which is associated with mitochondrial fission and apoptosis. The mechanism regulating miR499 in stretched cardiomyocytes and in volume overloaded heart is unclear. We sought to investigate the mechanism regulating miR499 and CnA in stretched cardiomyocytes and in volume overload-induced heart failure. Methods & Results Rat cardiomyocytes grown on a flexible membrane base were stretched via vacuum to 20% of maximum elongation at 60 cycles/min. An in vivo model of volume overload with aortacaval shunt in adult rats was used to study miR499 expression. Mechanical stretch downregulated miR499 expression, and enhanced the expression of CnA protein and mRNA after 12 hours of stretch. Expression of CnA and calcineurin activity was suppressed with miR499 overexpression; whereas, expression of dephosphorylated dynamin-related protein 1 (Drp1) was suppressed with miR499 overexpression and CnA siRNA. Adding p53 siRNA reversed the downregulation of miR499 when stretched. A gel shift assay and promoter-activity assay demonstrated that stretch increased p53 DNA binding activity but decreased miR499 promoter activity. When the miR499 promoter p53-binding site was mutated, the inhibition of miR499 promoter activity with stretch was reversed. The in vivo aorta-caval shunt also showed downregulated myocardial miR499 and overexpression of miR499 suppressed CnA and cellular apoptosis. Conclusion The miR499-controlled apoptotic pathway involving CnA and Drp1 in stretched cardiomyocytes may be regulated by p53 through the transcriptional regulation of miR499.	[Chua, Su-Kiat; Shyu, Kou-Gi] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Chua, Su-Kiat; Wang, Bao-Wei; Lo, Huey-Ming; Chiu, Chiung-Zuan; Shyu, Kou-Gi] Shin Kong Wu Ho Su Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Chua, Su-Kiat; Wang, Bao-Wei; Lo, Huey-Ming; Chiu, Chiung-Zuan] Fu Jen Catholic Univ, Sch Med, Taipei, Taipei County, Taiwan; [Lien, Li-Ming] Taipei Med Univ, Sch Med, Coll Med, Taipei, Taiwan; [Lien, Li-Ming] Shin Kong Wu Ho Su Mem Hosp, Dept Neurol, Taipei, Taiwan	Taipei Medical University; Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; Taipei Medical University; Shin Kong Wu Ho Su Memorial Hospital	Shyu, KG (corresponding author), Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.; Shyu, KG (corresponding author), Shin Kong Wu Ho Su Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan.	shyukg@ms12.hinet.net			National Science Council, Taiwan; Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan	This work was supported by The National Science Council, Taiwan, and Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.	Amorim PA, 2010, J THORAC CARDIOV SUR, V140, P1160, DOI 10.1016/j.jtcvs.2010.08.003; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basson M, 2007, NAT MED, V13, P541, DOI 10.1038/nm0507-541; Bell ML, 2010, MOL CELL BIOL, V30, P1937, DOI 10.1128/MCB.01370-09; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; Bugger H, 2010, CARDIOVASC RES, V85, P376, DOI 10.1093/cvr/cvp344; Cai Q, 1998, CARDIOVASC DRUG THER, V12, P499, DOI 10.1023/A:1007745814463; Callis TE, 2008, TRENDS MOL MED, V14, P254, DOI 10.1016/j.molmed.2008.03.006; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Cheng WP, 2012, CARDIOVASC RES, V93, P181, DOI 10.1093/cvr/cvr280; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; de Frutos S, 2007, J BIOL CHEM, V282, P15081, DOI 10.1074/jbc.M702679200; De Rosa S, 2011, CIRCULATION, V124, P1936, DOI 10.1161/CIRCULATIONAHA.111.037572; Diniz GP, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0504-7; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Elrod JW, 2013, CIRC J, V77, P1111, DOI 10.1253/circj.CJ-13-0321; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Leri A, 2000, AM J PATHOL, V157, P843, DOI 10.1016/S0002-9440(10)64598-1; Leychenko A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029055; Li PF, 2010, J CARDIOVASC TRANSL, V3, P219, DOI 10.1007/s12265-010-9175-9; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liao XD, 2004, CELL RES, V14, P16, DOI 10.1038/sj.cr.7290198; Lim HW, 1999, NAT MED, V5, P246, DOI 10.1038/6430; McCarthy JJ, 2009, PHYSIOL GENOMICS, V39, P219, DOI 10.1152/physiolgenomics.00042.2009; Nantajit D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012341; Osorio JC, 2002, CIRCULATION, V106, P606, DOI 10.1161/01.CIR.0000023531.22727.C1; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Seqqat R, 2012, J MOL CELL CARDIOL, V53, P240, DOI 10.1016/j.yjmcc.2012.05.004; Shyu KG, 2005, J CARD FAIL, V11, P152, DOI 10.1016/j.cardfail.2004.06.433; Shyu KG, 2001, J MOL CELL CARDIOL, V33, P691, DOI 10.1006/jmcc.2000.1333; Shyu KG, 2013, EUR J HEART FAIL, V15, P36, DOI 10.1093/eurjhf/hfs143; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Swietach P, 2010, CARDIOVASC RES, V85, P729, DOI 10.1093/cvr/cvp343; Talmadge RJ, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-28; Tan WQ, 2008, CIRCULATION, V118, P2268, DOI 10.1161/CIRCULATIONAHA.107.750869; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Todd LR, 2010, MOL BIOL CELL, V21, P1225, DOI 10.1091/mbc.E09-11-0937; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang JJ, 2014, RNA BIOL, V11, P339, DOI 10.4161/rna.28300; Wang JX, 2011, NAT MED, V17, P71, DOI 10.1038/nm.2282; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zheng B, 2015, J MOL CELL CARDIOL, V82, P201, DOI 10.1016/j.yjmcc.2015.03.011	44	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148683	10.1371/journal.pone.0148683	http://dx.doi.org/10.1371/journal.pone.0148683			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859150	Green Published, gold			2022-12-27	WOS:000370038400065
J	Geng, RS; Noda, T; Mulvaney, JF; Lin, VYW; Edge, ASB; Dabdoub, A				Geng, Ruishuang; Noda, Teppei; Mulvaney, Joanna F.; Lin, Vincent Y. W.; Edge, Albert S. B.; Dabdoub, Alain			Comprehensive Expression of Wnt Signaling Pathway Genes during Development and Maturation of the Mouse Cochlea	PLOS ONE			English	Article							BETA-CATENIN; INNER-EAR; REGENERATION; CELLS	Background In the inner ear Wnt signaling is necessary for proliferation, cell fate determination, growth of the cochlear duct, polarized orientation of stereociliary bundles, differentiation of the periotic mesenchyme, and homeostasis of the stria vascularis. In neonatal tissue Wnt signaling can drive proliferation of cells in the sensory region, suggesting that Wnt signaling could be used to regenerate the sensory epithelium in the damaged adult inner ear. Manipulation of Wnt signaling for regeneration will require an understanding of the dynamics of Wnt pathway gene expression in the ear. We present a comprehensive screen for 84 Wnt signaling related genes across four developmental and postnatal time points. Results We identified 72 Wnt related genes expressed in the inner ear on embryonic day (E) 12.5, postnatal day (P) 0, P6 and P30. These genes included secreted Wnts, Wnt antagonists, intracellular components of canonical signaling and components of non-canonical signaling/planar cell polarity. Conclusion A large number of Wnt signaling molecules were dynamically expressed during cochlear development and in the early postnatal period, suggesting complex regulation of Wnt transduction. The data revealed several potential key regulators for further study.	[Geng, Ruishuang; Noda, Teppei; Mulvaney, Joanna F.; Lin, Vincent Y. W.; Dabdoub, Alain] Sunnybrook Res Inst, Biol Sci, Toronto, ON, Canada; [Lin, Vincent Y. W.; Dabdoub, Alain] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada; [Edge, Albert S. B.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; [Dabdoub, Alain] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Harvard University; Harvard Medical School; University of Toronto	Dabdoub, A (corresponding author), Sunnybrook Res Inst, Biol Sci, Toronto, ON, Canada.; Dabdoub, A (corresponding author), Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada.; Dabdoub, A (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	alain.dabdoub@sri.utoroto.ca	Edge, Albert/Q-5448-2019; Geng, Ruishuang/F-8255-2013	Mulvaney, Joanna/0000-0002-8014-4535; Dabdoub, Alain/0000-0002-4259-2425	Hearing Health Foundation; Sunnybrook Hearing Regeneration Initiative; Hearing Health Foundation's Hearing Restoration Project; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014089] Funding Source: NIH RePORTER	Hearing Health Foundation; Sunnybrook Hearing Regeneration Initiative; Hearing Health Foundation's Hearing Restoration Project; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding for this work came from the Hearing Health Foundation (AD and AE) (http://hearinghealthfoundation.org/) and the Sunnybrook Hearing Regeneration Initiative (AD).; We thank Drs. Stricker and De Robertis for providing Dkk3 and Sfrp3 plasmids respectively. We also thank Dr. D. Sweetman for providing comments on an earlier version of the manuscript. Funding for this study was provided by the Hearing Health Foundation's Hearing Restoration Project (AE, AD) and the Sunnybrook Hearing Regeneration Initiative.	Atkinson PJ, 2015, DEVELOPMENT, V142, P1561, DOI 10.1242/dev.114926; Belluoccio D, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058154, DOI 10.1371/J0URNAL.P0NE.0058154]; Berschneider B, 2011, INT J BIOCHEM CELL B, V43, P306, DOI 10.1016/j.biocel.2010.11.013; Brown AS, 2015, DEV BIOL, V399, P177, DOI 10.1016/j.ydbio.2015.01.001; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Huang MQ, 2011, CELL CYCLE, V10, P337, DOI 10.4161/cc.10.2.14640; Huyghe A, 2015, CELL REP, V13, P31, DOI 10.1016/j.celrep.2015.08.054; Jacques BE, 2012, DEVELOPMENT, V139, P4395, DOI 10.1242/dev.080358; Jansson L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00066; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Malinauskas T, 2014, CURR OPIN STRUC BIOL, V29, P77, DOI 10.1016/j.sbi.2014.10.003; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Mulvaney JF, 2013, DEV DYNAM, V242, P179, DOI 10.1002/dvdy.23908; Noda T, 2012, DEV BIOL, V362, P83, DOI 10.1016/j.ydbio.2011.11.019; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Riccomagno MM, 2005, GENE DEV, V19, P1612, DOI 10.1101/gad.1303905; Shi FX, 2014, J NEUROSCI, V34, P6470, DOI 10.1523/JNEUROSCI.4305-13.2014; Shi FX, 2013, P NATL ACAD SCI USA, V110, P13851, DOI 10.1073/pnas.1219952110; Sienknecht UJ, 2008, J COMP NEUROL, V510, P378, DOI 10.1002/cne.21791; Swain Rajeeb Kumar, 2005, Cell Commun Signal, V3, P12, DOI 10.1186/1478-811X-3-12; Uysal-Onganer P, 2012, ACTA PHYSIOL, V204, P52, DOI 10.1111/j.1748-1716.2011.02297.x; Waldhaus J, 2015, CELL REP, V11, P1385, DOI 10.1016/j.celrep.2015.04.062; Witte F, 2009, GENE EXPR PATTERNS, V9, P215, DOI 10.1016/j.gep.2008.12.009; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yu HM, 2010, DEVELOPMENT, V137, P3707, DOI 10.1242/dev.052001	28	28	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148339	10.1371/journal.pone.0148339	http://dx.doi.org/10.1371/journal.pone.0148339			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859490	Green Published, gold, Green Submitted			2022-12-27	WOS:000370038400032
J	Price, GR; Fuchs, LS				Price, Gavin R.; Fuchs, Lynn S.			The Mediating Relation between Symbolic and Nonsymbolic Foundations of Math Competence	PLOS ONE			English	Article							APPROXIMATE NUMBER SYSTEM; INDIVIDUAL-DIFFERENCES; MATHEMATICS; ACUITY; PRESCHOOLERS; ASSOCIATION; PREDICTORS; ABILITY; SENSE	This study investigated the relation between symbolic and nonsymbolic magnitude processing abilities with 2 standardized measures of math competence (WRAT Arithmetic and Key-Math Numeration) in 150 3rd-grade children (mean age 9.01 years). Participants compared sets of dots and pairs of Arabic digits with numerosities 1-9 for relative numerical magnitude. In line with previous studies, performance on both symbolic and nonsymbolic magnitude processing was related to math ability. Performance metrics combining reaction and accuracy, as well as weber fractions, were entered into mediation models with standardized math test scores. Results showed that symbolic magnitude processing ability fully mediates the relation between nonsymbolic magnitude processing and math ability, regardless of the performance metric or standardized test.	[Price, Gavin R.] Vanderbilt Univ, Peabody Coll, Dept Psychol & Human Dev, 230 Appleton Pl, Nashville, TN 37203 USA; [Fuchs, Lynn S.] Vanderbilt Univ, Peabody Coll, Dept Special Educ, 230 Appleton Pl, Nashville, TN 37203 USA	Vanderbilt University; Vanderbilt University Peabody College; Vanderbilt University; Vanderbilt University Peabody College	Price, GR (corresponding author), Vanderbilt Univ, Peabody Coll, Dept Psychol & Human Dev, 230 Appleton Pl, Nashville, TN 37203 USA.	gavin.price@vanderbilt.edu	Fuchs, Lynn/AAV-3828-2021; Price, Gavin R/C-5477-2009	Fuchs, Lynn/0000-0003-2099-5247; 	Eunice Kennedy Shriver National Institute of Child Health & Human Development [R01 HD053714, HD15052]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053714, P30HD015052, U54HD083211] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by R01 HD053714 and Core Grant #HD15052 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development to Vanderbilt University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health.; This research was supported by R01 HD053714 and Core Grant #HD15052 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development to Vanderbilt University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health. Thanks to Kris Preacher for advice and instruction on mediation analysis, and Eric D. Wilkey for assistance with calculating weber fractions.	ASHCRAFT MH, 1982, DEV REV, V2, P213, DOI 10.1016/0273-2297(82)90012-0; Bugden S, 2012, DEV COGN NEUROS-NETH, V2, P448, DOI 10.1016/j.dcn.2012.04.001; Bugden S, 2011, COGNITION, V118, P32, DOI 10.1016/j.cognition.2010.09.005; Bynner J., 1997, DOES NUMERACY MATTER; Cantlon JF, 2006, PSYCHOL SCI, V17, P401, DOI 10.1111/j.1467-9280.2006.01719.x; Chen QX, 2014, ACTA PSYCHOL, V148, P163, DOI 10.1016/j.actpsy.2014.01.016; Connolly AJ, 2011, J PSYCHOEDUC ASSESS, V29, P94; De Smedt B, 2013, TRENDS NEUROSCI EDUC, V2, P48, DOI 10.1016/j.tine.2013.06.001; Dumontheil I, 2012, CEREB CORTEX, V22, P1078, DOI 10.1093/cercor/bhr175; Fazio LK, 2014, J EXP CHILD PSYCHOL, V123, P53, DOI 10.1016/j.jecp.2014.01.013; Fuchs LS, 2013, J EDUC PSYCHOL, V105, P58, DOI 10.1037/a0030127; Fuhs MW, 2013, DEVELOPMENTAL SCI, V16, P136, DOI 10.1111/desc.12013; Gilmore C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067374; Gilmore C, 2011, Q J EXP PSYCHOL, V64, P2099, DOI 10.1080/17470218.2011.574710; Goodman M., 2014, PROBLEM SOLVING TECH; Gross J., 2009, LONG TERM COSTS NUME; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Inglis M, 2014, ACTA PSYCHOL, V145, P147, DOI 10.1016/j.actpsy.2013.11.009; Jordan NC, 2009, DEV PSYCHOL, V45, P850, DOI 10.1037/a0014939; LeFevre JA, 2010, CHILD DEV, V81, P1753, DOI 10.1111/j.1467-8624.2010.01508.x; Libertus ME, 2011, DEVELOPMENTAL SCI, V14, P1292, DOI 10.1111/j.1467-7687.2011.01080.x; Lipton JS, 2004, INFANCY, V5, P271, DOI 10.1207/s15327078in0503_2; Lyons IM, 2014, DEVELOPMENTAL SCI, V17, P714, DOI 10.1111/desc.12152; Lyons IM, 2011, COGNITION, V121, P256, DOI 10.1016/j.cognition.2011.07.009; Mazzocco MMM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023749; Mundy E, 2009, J EXP CHILD PSYCHOL, V103, P490, DOI 10.1016/j.jecp.2009.02.003; Mussolin C, 2015, DEV REV, P1; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; Parsons S., 2005, DOES NUMERACY MATTER; Piazza M, 2010, COGNITION; Piazza M, 2013, PSYCHOL SCI, V24, P1037, DOI 10.1177/0956797612464057; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Price GR, 2007, CURR BIOL, V17, pR1042, DOI 10.1016/j.cub.2007.10.013; Price GR, 2012, ACTA PSYCHOL, V140, P50, DOI 10.1016/j.actpsy.2012.02.008; Raghubar KP, 2010, LEARN INDIVID DIFFER, V20, P110, DOI 10.1016/j.lindif.2009.10.005; Rykhlevskaia E, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.051.2009; Sasanguie D, 2012, BRIT J DEV PSYCHOL, V30, P344, DOI 10.1111/j.2044-835X.2011.02048.x; Schneider M, DEVELOPMENTAL SCI, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]; STARKEY P, 1980, SCIENCE, V210, P1033, DOI 10.1126/science.7434014; vanMarle K, 2014, DEVELOPMENTAL SCI, V17, P492, DOI 10.1111/desc.12143; Wynn K, 2002, COGNITION, V83, pB55, DOI 10.1016/S0010-0277(02)00008-2; Wynn K, 1998, TRENDS COGN SCI, V2, P296, DOI 10.1016/S1364-6613(98)01203-0; WYNN K, 1992, COGNITIVE PSYCHOL, V24, P220, DOI 10.1016/0010-0285(92)90008-P; WYNN K, 1990, COGNITION, V36, P155, DOI 10.1016/0010-0277(90)90003-3; Xu F, 2005, DEVELOPMENTAL SCI, V8, P88, DOI 10.1111/j.1467-7687.2005.00395.x	47	21	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148981	10.1371/journal.pone.0148981	http://dx.doi.org/10.1371/journal.pone.0148981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859564	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400114
J	Reinecke, H; Breithardt, G; Engelbertz, C; Schmieder, RE; Fobker, M; Pinnschmidt, HO; Schmitz, B; Bruland, P; Wegscheider, K; Pavenstadt, H; Brand, E				Reinecke, Holger; Breithardt, Guenter; Engelbertz, Christiane; Schmieder, Roland E.; Fobker, Manfred; Pinnschmidt, Hans O.; Schmitz, Boris; Bruland, Philipp; Wegscheider, Karl; Pavenstaedt, Hermann; Brand, Eva			Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry)	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ELEVATION MYOCARDIAL-INFARCTION; GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR RISK; HEART-FAILURE; CLINICAL CARDIOLOGY; ATRIAL-FIBRILLATION; OUTCOMES; DESIGN; EPIDEMIOLOGY	Background Chronic kidney disease (CKD) is strongly associated with coronary artery disease (CAD). We established a prospective observational nationwide multicenter registry to evaluate current treatment and outcomes in patients with both CKD and angiographically documented CAD. Methods In 32 cardiological centers 3,352 CAD patients with >= 50% stenosis in at least one coronary artery were enrolled and classified according to their estimated glomerular filtration rate and proteinuria into one of five stages of CKD or as a control group. Results 2,723 (81.2%) consecutively enrolled patients suffered from CKD. Compared to controls, CKD patients had a higher prevalence of diabetes, hypertension, peripheral artery diseases, heart failure, and valvular heart disease (each p<0.001). Myocardial infarctions (p = 0.02), coronary bypass grafting, valve replacements and pacemaker implantations had been recorded more frequently (each p<0.001). With advanced CKD, the number of diseased coronary vessels and the proportion of patients with reduced left ventricular ejection fraction (LVEF) increased significantly (both p<0.001). Percutaneous coronary interventions were performed less frequently (p<0.001) while coronary bypass grafting was recommendedmore often (p = 0.04) with advanced CKD. With regard to standard drugs in CAD treatment, prescriptions were higher in our registry than in previous reports, but beta-blockers (p = 0.008), and angiotensin-converting-enzyme inhibitors and/or angiotensin-receptor blockers (p<0.001) were given less often in higher CKD stages. In contrast, in the subgroup of patients with moderately to severely reduced LVEF the prescription rates did not differ between CKD stages. In-hospital mortality increased stepwise with each CKD stage (p = 0.02). Conclusions In line with other studies comprising CKD cohorts, patients' morbidity and in-hospital mortality increased with the degree of renal impairment. Although cardiologists' drug prescription rates in CAD-REF were higher than in previous studies, they were still lower especially in advanced CKD stages compared to cohorts treated by nephrologists.	[Reinecke, Holger; Breithardt, Guenter; Engelbertz, Christiane] Univ Hosp Muenster, Dept Cardiovasc Med, Div Vasc Med, Munster, Germany; [Engelbertz, Christiane; Pavenstaedt, Hermann; Brand, Eva] Univ Hosp Muenster, Dept Nephrol Hypertens & Rheumatol, Munster, Germany; [Schmieder, Roland E.] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany; [Fobker, Manfred] Univ Hosp Muenster, Inst Clin Chem & Lab Med, Munster, Germany; [Pinnschmidt, Hans O.; Wegscheider, Karl] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Schmitz, Boris] Univ Hosp Muenster, Inst Sports Med Mol Genet Cardiovasc Dis, Munster, Germany; [Bruland, Philipp] Univ Munster, Inst Med Informat, Munster, Germany	University of Munster; University of Munster; University of Erlangen Nuremberg; University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; University of Munster	Brand, E (corresponding author), Univ Hosp Muenster, Dept Nephrol Hypertens & Rheumatol, Munster, Germany.	eva.brand@ukmuenster.de	Schmitz, Boris/M-3205-2019; Bruland, Philipp/A-8701-2013	Schmitz, Boris/0000-0001-7041-7424; Bruland, Philipp/0000-0001-6939-7630	German Ministry of Education and Research (BMBF) [01GI0701]; KfH Foundation for Preventive Medicine; Amgen GmbH, Munich; AstraZeneca GmbH, Wedel; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein; Sanofi-Aventis Deutschland GmbH, Frankfurt; German Cardiac Society (DGK); German Society of Nephrology (DGFN); University of Muenster	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); KfH Foundation for Preventive Medicine; Amgen GmbH, Munich(Amgen); AstraZeneca GmbH, Wedel(AstraZeneca); Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein(Boehringer Ingelheim); Sanofi-Aventis Deutschland GmbH, Frankfurt; German Cardiac Society (DGK); German Society of Nephrology (DGFN); University of Muenster	The CAD-REF Registry was funded by grants from the German Ministry of Education and Research (BMBF) (http://www.gesundheitsforschungbmbf.de/_media/NL_36.pdf; grant number 01GI0701) and the KfH Foundation for Preventive Medicine (http://www.kfhstiftungpraeventivmedizin.de/content/foerderprogramm). Commercial sources of funding include Research grants by Amgen GmbH, Munich (https://www.amgen.de/), AstraZeneca GmbH, Wedel (http://www.astrazeneca.de/willkommen), Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein (http://www.boehringer-ingelheim.de/), and Sanofi-Aventis Deutschland GmbH, Frankfurt (http://www.sanofi.de/l/de/de/index.jsp). The CAD-REF Registry is conducted under the auspices of the German Cardiac Society (DGK) (http://dgk.org) and the German Society of Nephrology (DGFN) (http://www.dgfn.eu). We acknowledge support by Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Bello AK, 2011, CLIN J AM SOC NEPHRO, V6, P1418, DOI 10.2215/CJN.09741110; Berger AK, 2003, J AM COLL CARDIOL, V42, P201, DOI 10.1016/S0735-1097(03)00572-2; Brand E, 2013, AM HEART J, V166, P449, DOI 10.1016/j.ahj.2013.06.010; Dasari TW, 2014, AM J CARDIOL, V113, P621, DOI 10.1016/j.amjcard.2013.11.006; Ding Z, 2012, EUR J INTERN MED, V23, P716, DOI 10.1016/j.ejim.2012.07.003; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Eckardt KU, 2012, NEPHROL DIAL TRANSPL, V27, P1454, DOI 10.1093/ndt/gfr456; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ezekowitz J, 2004, J AM COLL CARDIOL, V44, P1587, DOI 10.1016/j.jacc.2004.06.072; Feldman HI, 2003, J AM SOC NEPHROL, V14, pS148, DOI 10.1097/01.ASN.0000070149.78399.CE; Flynn MR, 2005, EUR HEART J, V26, P308, DOI 10.1093/eurheartj/ehi079; Fox CS, 2010, CIRCULATION, V121, P357, DOI 10.1161/CIRCULATIONAHA.109.865352; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Ghali WA, 2000, CAN J CARDIOL, V16, P1225; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Herzog CA, 2011, KIDNEY INT, V80, P572, DOI 10.1038/ki.2011.223; Imai E, 2008, HYPERTENS RES, V31, P1101, DOI 10.1291/hypres.31.1101; Imai E, 2010, CLIN EXP NEPHROL, V14, P558, DOI 10.1007/s10157-010-0328-6; Kalra PR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102335; Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group, 2012, KIDNEY INT S, V5, P337, DOI DOI 10.1038/KISUP.2012.46; Kiyosue A, 2010, CIRC J, V74, P786, DOI 10.1253/circj.CJ-09-0715; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Martinez-Castelao A, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-53; Muntner P, 2010, AM J KIDNEY DIS, V55, P441, DOI 10.1053/j.ajkd.2009.09.014; Reinecke H, 2003, KIDNEY INT, V63, P696, DOI 10.1046/j.1523-1755.2003.00784.x; Reinecke H, 2015, KIDNEY INT, V87, P200, DOI 10.1038/ki.2014.195; Reinecke H, 2009, J AM SOC NEPHROL, V20, P705, DOI 10.1681/ASN.2007111207; Ritz E, 2003, HEART, V89, P963, DOI 10.1136/heart.89.9.963; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Szummer K, 2009, CIRCULATION, V120, P851, DOI 10.1161/CIRCULATIONAHA.108.838169; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zamora E, 2012, J AM COLL CARDIOL, V59, P1709, DOI 10.1016/j.jacc.2011.11.066	36	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148057	10.1371/journal.pone.0148057	http://dx.doi.org/10.1371/journal.pone.0148057			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859890	Green Published, gold			2022-12-27	WOS:000370038400019
J	Winters, K; Netscher, S				Winters, Kristi; Netscher, Sebastian			Proposed Standards for Variable Harmonization Documentation and Referencing: A Case Study Using QuickCharmStats 1.1	PLOS ONE			English	Article							REPLICATION; SCIENCE	Comparative statistical analyses often require data harmonization, yet the social sciences do not have clear operationalization frameworks that guide and homogenize variable coding decisions across disciplines. When faced with a need to harmonize variables researchers often look for guidance from various international studies that employ output harmonization, such as the Comparative Survey of Election Studies, which offer recoding structures for the same variable (e.g. marital status). More problematically there are no agreed documentation standards or journal requirements for reporting variable harmonization to facilitate a transparent replication process. We propose a conceptual and data-driven digital solution that creates harmonization documentation standards for publication and scholarly citation: QuickCharmStats 1.1. It is free and open-source software that allows for the organizing, documenting and publishing of data harmonization projects. QuickCharmStats starts at the conceptual level and its workflow ends with a variable recording syntax. It is therefore flexible enough to reflect a variety of theoretical justifications for variable harmonization. Using the socio-demographic variable 'marital status', we demonstrate how the CharmStats workflow collates metadata while being guided by the scientific standards of transparency and replication. It encourages researchers to publish their harmonization work by providing researchers who complete the peer review process a permanent identifier. Those who contribute original data harmonization work to their discipline can now be credited through citations. Finally, we propose peer-review standards for harmonization documentation, describe a route to online publishing, and provide a referencing format to cite harmonization projects. Although CharmStats products are designed for social scientists our adherence to the scientific method ensures our products can be used by researchers across the sciences.	[Winters, Kristi; Netscher, Sebastian] GESIS Leibniz Inst Social Sci, Int Data Infrastruct, Cologne, Nordrhein Westf, Germany	Leibniz Institut fur Sozialwissenschaften (GESIS)	Winters, K (corresponding author), GESIS Leibniz Inst Social Sci, Int Data Infrastruct, Cologne, Nordrhein Westf, Germany.	kristi.winters@gesis.org						[Anonymous], 2015, FREE DICT LEGAL DICT; [Anonymous], 2015, FREE DICT MARITAL ST; Borrillo D, 2005, YALE J LAW FEMINISM, V17, P89; Busenitz LW, 2003, J MANAGE, V29, P285, DOI 10.1016/S0149-2063(03)00013-8; Clarke H, 2005, TECHNICAL REPORTS PR; Clarke H, 2010, 2010 BES CSES DATA; Doiron D, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-12; FOWLER LI, 1995, PS, V28, P478, DOI 10.2307/420312; Freese J, 2007, SOCIOL METHOD RES, V36, P153, DOI 10.1177/0049124107306659; Gherghina S, 2013, EUR POLIT SCI, V12, P333, DOI 10.1057/eps.2013.8; Harkness J.A., 2010, SURVEY METHODS MULTI; King G, 2006, PS-POLIT SCI POLIT, V39, P119; Moravcsik A, 2014, PS-POLIT SCI POLIT, V47, P48, DOI 10.1017/S1049096513001789; Sanders D, 2007, POLIT ANAL, V15, P257, DOI 10.1093/pan/mpl010; Schrama W, 1999, INT J LAW POLICY FAM, V13, P315; Scudder G. D., 1998, Journal of Operations Management, V16, P91, DOI 10.1016/S0272-6963(97)00008-9; The Comparative Study of Electoral Systems, 2013, CSES MOD 3 FULL REL; Winters K, 2015, QUICKCHARMSTATS PC U; Winters K, 2015, MARITAL STATUS COMP	19	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0147795	10.1371/journal.pone.0147795	http://dx.doi.org/10.1371/journal.pone.0147795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859494	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400014
J	Wu, GC; Johnson, SK; Bornman, JF; Bennett, SJ; Singh, V; Simic, A; Fang, ZX				Wu, Gangcheng; Johnson, Stuart K.; Bornman, Janet F.; Bennett, Sarita J.; Singh, Vijaya; Simic, Azra; Fang, Zhongxiang			Effects of Genotype and Growth Temperature on the Contents of Tannin, Phytate and In Vitro Iron Availability of Sorghum Grains	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; CEREALS; ZINC; FERMENTATION; IMPACT	Background It has been predicted that the global temperature will rise in the future, which means crops including sorghum will likely be grown under higher temperatures, and consequently may affect the nutritional properties. Methods The effects of two growth temperatures (OT, day/night 32/21 degrees C; HT 38/21 degrees C) on tannin, phytate, mineral, and in vitro iron availability of raw and cooked grains (as porridge) of six sorghum genotypes were investigated. Results Tannin content significantly decreased across all sorghum genotypes under high growth temperature (P <= 0.05), while the phytate and mineral contents maintained the same level, increased or decreased significantly, depending on the genotype. The in vitro iron availability in most sorghum genotypes was also significantly reduced under high temperature, except for Ai4, which showed a pronounced increase (P <= 0.05). The cooking process significantly reduced tannin content in all sorghum genotypes (P <= 0.05), while the phytate content and in vitro iron availability were not significantly affected. Conclusions This research provides some new information on sorghum grain nutritional properties when grown under predicted future higher temperatures, which could be important for humans where sorghum grains are consumed as staple food.	[Wu, Gangcheng; Johnson, Stuart K.; Fang, Zhongxiang] Curtin Univ, Food Sci & Technol Program, Sch Publ Hlth, Perth, WA 6845, Australia; [Bornman, Janet F.] Curtin Univ, IIAFS, POB U1987, Perth, WA 6845, Australia; [Bennett, Sarita J.] Curtin Univ, Sch Sci, Dept Environm & Agr, Perth, WA 6845, Australia; [Singh, Vijaya] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld 4072, Australia; [Simic, Azra] Natl Measurement Inst, Perth, WA 6151, Australia; [Fang, Zhongxiang] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3010, Australia	Curtin University; Curtin University; Curtin University; University of Queensland; National Measurement Institute Australia - NMI; University of Melbourne	Fang, ZX (corresponding author), Curtin Univ, Food Sci & Technol Program, Sch Publ Hlth, Perth, WA 6845, Australia.; Fang, ZX (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3010, Australia.	zhongxiang.fang@unimelb.edu.au	Fang, Zhongxiang/A-8988-2019; Johnson, Stuart/B-5174-2012	Fang, Zhongxiang/0000-0002-9902-3426; Johnson, Stuart/0000-0001-8357-797X	Curtin International Postgraduate Research Scholarships (CIPRS)	Curtin International Postgraduate Research Scholarships (CIPRS)	Financial support was provided by Curtin International Postgraduate Research Scholarships (CIPRS).	Afify AMR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025512; BRUNE M, 1989, EUR J CLIN NUTR, V43, P547; Cohen SD, 2010, CRIT REV FOOD SCI, V50, P620, DOI 10.1080/10408390802603441; Dlamini NR, 2007, FOOD CHEM, V105, P1412, DOI 10.1016/j.foodchem.2007.05.017; Duodu KG, 1999, FOOD CHEM, V66, P21, DOI 10.1016/S0308-8146(98)00070-3; Dykes L, 2007, CEREAL FOOD WORLD, V52, P105, DOI 10.1094/CFW-52-3-0105; Dykes L, 2005, J AGR FOOD CHEM, V53, P6813, DOI 10.1021/jf050419e; Dykes L, 2006, J CEREAL SCI, V44, P236, DOI 10.1016/j.jcs.2006.06.007; Gibson RS, 2010, FOOD NUTR BULL, V31, pS134, DOI 10.1177/15648265100312S206; GLENNIE CW, 1981, J AGR FOOD CHEM, V29, P965, DOI 10.1021/jf00107a020; Hassan A. B., 2009, Pakistan Journal of Nutrition, V8, P167, DOI 10.3923/pjn.2009.167.171; HAUG W, 1983, J SCI FOOD AGR, V34, P1423, DOI 10.1002/jsfa.2740341217; Hemalatha S, 2007, J TRACE ELEM MED BIO, V21, P1, DOI 10.1016/j.jtemb.2006.10.002; Horvatic M, 1996, J AGRON CROP SCI, V176, P73, DOI 10.1111/j.1439-037X.1996.tb00448.x; Idris WH, 2006, INT J FOOD SCI TECH, V41, P1229, DOI 10.1111/j.1365-2621.2006.01190.x; IPCC, 2007, IPCC 4 ASS REP AR4, V11, P17; Kayode APP, 2007, LWT-FOOD SCI TECHNOL, V40, P834, DOI 10.1016/j.lwt.2006.04.001; Kayode APP, 2006, J AGR FOOD CHEM, V54, P256, DOI 10.1021/jf0521404; Kruger J, 2012, FOOD CHEM, V131, P220, DOI 10.1016/j.foodchem.2011.08.063; Li EP, 2013, CEREAL CHEM, V90, P223, DOI 10.1094/CCHEM-09-12-0113-R; Lopez MAA, 2004, INT J FOOD SCI NUTR, V55, P597, DOI 10.1080/09637480500085820; Luten J, 1996, J SCI FOOD AGR, V72, P415, DOI [10.1002/(SICI)1097-0010(199612)72:4<415::AID-JSFA675>3.3.CO;2-O, 10.1002/(SICI)1097-0010(199612)72:4&lt;415::AID-JSFA675&gt;3.0.CO;2-X]; Martinez-Navarrete N, 2002, FOOD RES INT, V35, P225, DOI 10.1016/S0963-9969(01)00189-2; Matuschek E, 2001, J AGR FOOD CHEM, V49, P5630, DOI 10.1021/jf0108157; Nguyen CT, 2013, FUNCT PLANT BIOL, V40, P439, DOI 10.1071/FP12264; Nyachoti CM, 1997, WORLD POULTRY SCI J, V53, P5, DOI 10.1079/WPS19970002; PRICE ML, 1978, J AGR FOOD CHEM, V26, P1214, DOI 10.1021/jf60219a031; Proietti I, 2013, INT J FOOD SCI TECH, V48, P1526, DOI 10.1111/ijfs.12121; RADHAKRISHNAN MR, 1980, J AGR FOOD CHEM, V28, P55, DOI 10.1021/jf60227a038; Singh V, 2015, FIELD CROP RES, V171, P32, DOI 10.1016/j.fcr.2014.11.003; Towo E, 2006, FOOD CHEM, V94, P369, DOI 10.1016/j.foodchem.2004.11.027; WANISKA RD, 1989, J CEREAL SCI, V10, P217, DOI 10.1016/S0733-5210(89)80051-7; Wedad H., 2008, PAKISTAN J NUTR, V7, P335, DOI DOI 10.3923/PJN.2008.335.341	33	29	29	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148712	10.1371/journal.pone.0148712	http://dx.doi.org/10.1371/journal.pone.0148712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859483	Green Published, gold			2022-12-27	WOS:000370038400068
J	Bose, B; Reed, SE; Besprozvannaya, M; Burton, BM				Bose, Baundauna; Reed, Sydney E.; Besprozvannaya, Marina; Burton, Briana M.			Missense Mutations Allow a Sequence-Blind Mutant of SpoIIIE to Successfully Translocate Chromosomes during Sporulation	PLOS ONE			English	Article							BACILLUS-SUBTILIS SPOIIIE; DNA TRANSLOCATION; GENE-EXPRESSION; MEMBRANE FISSION; CELL-DIVISION; STRANDED-DNA; FTSK; PROTEIN; SEGREGATION; MECHANISM	SpoIIIE directionally pumps DNA across membranes during Bacillus subtilis sporulation and vegetative growth. The sequence-reading domain (gamma domain) is required for directional DNA transport, and its deletion severely impairs sporulation. We selected suppressors of the spoIIIE Delta gamma sporulation defect. Unexpectedly, many suppressors were intragenic missense mutants, and some restore sporulation to near-wild-type levels. The mutant proteins are likely not more abundant, faster at translocating DNA, or sequence-sensitive, and rescue does not involve the SpoIIIE homolog SftA. Some mutants behave differently when co-expressed with spoIIIE Delta gamma, consistent with the idea that some, but not all, variants may form mixed oligomers. In full-length spoIIIE, these mutations do not affect sporulation, and yet the corresponding residues are rarely found in other SpoIIIE/FtsK family members. The suppressors do not rescue chromosome translocation defects during vegetative growth, indicating that the role of the. domain cannot be fully replaced by these mutations. We present two models consistent with our findings: that the suppressors commit to transport in one arbitrarily-determined direction or delay spore development. It is surprising that missense mutations somehow rescue loss of an entire domain with a complex function, and this raises new questions about the mechanism by which SpoIIIE pumps DNA and the roles SpoIIIE plays in vivo.	[Bose, Baundauna; Reed, Sydney E.; Besprozvannaya, Marina; Burton, Briana M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Bose, Baundauna] Evelo Biosci, Cambridge, MA USA; [Besprozvannaya, Marina] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	Harvard University; University of California System; University of California Davis	Burton, BM (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	briana.burton@wisc.edu			Massachusetts Life Science Foundation; NSF GRFP fellowship [DGE-1144152]; Molecules, Cells, and Organisms Training Grant [GM-07598]	Massachusetts Life Science Foundation; NSF GRFP fellowship(National Science Foundation (NSF)NSF - Office of the Director (OD)); Molecules, Cells, and Organisms Training Grant	This work was supported in part by the Massachusetts Life Science Foundation (to BMB). MB was supported by NSF GRFP fellowship (DGE-1144152) and by Molecules, Cells, and Organisms Training Grant (GM-07598). The authors declare no conflict of interest in this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; Ben-Yehuda S, 2003, SCIENCE, V299, P532, DOI 10.1126/science.1079914; Besprozvannaya M, 2014, J BACTERIOL, V196, P2481, DOI 10.1128/JB.01725-14; Besprozvannaya M, 2013, J BIOL CHEM, V288, P28962, DOI 10.1074/jbc.M113.484055; Bigot S, 2005, EMBO J, V24, P3770, DOI 10.1038/sj.emboj.7600835; Bigot S, 2007, MOL MICROBIOL, V64, P1434, DOI 10.1111/j.1365-2958.2007.05755.x; Biller SJ, 2009, MOL MICROBIOL, V74, P790, DOI 10.1111/j.1365-2958.2009.06893.x; Britton RA, 1999, J BACTERIOL, V181, P5860, DOI 10.1128/JB.181.18.5860-5864.1999; Burton B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000406; Burton BM, 2007, CELL, V131, P1301, DOI 10.1016/j.cell.2007.11.009; Cattoni DI, 2014, NUCLEIC ACIDS RES, V42, P2624, DOI 10.1093/nar/gkt1231; Cattoni DI, 2013, EMBO REP, V14, P473, DOI 10.1038/embor.2013.39; Doan T, 2013, GENE DEV, V27, P322, DOI 10.1101/gad.209049.112; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Fiche JB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001557; Fleming TC, 2010, GENE DEV, V24, P1160, DOI 10.1101/gad.1925210; FOULGER D, 1989, MOL MICROBIOL, V3, P1247, DOI 10.1111/j.1365-2958.1989.tb00275.x; Harwood CR, 1990, MOL BIOL METHODS BAC, pxxxv; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Kaimer C, 2011, CURR OPIN MICROBIOL, V14, P719, DOI 10.1016/j.mib.2011.10.004; Levy O, 2005, P NATL ACAD SCI USA, V102, P17618, DOI 10.1073/pnas.0508932102; Liu NJL, 2006, MOL MICROBIOL, V59, P1097, DOI 10.1111/j.1365-2958.2005.05004.x; Lowe J, 2008, MOL CELL, V31, P498, DOI 10.1016/j.molcel.2008.05.027; Marquis KA, 2008, GENE DEV, V22, P1786, DOI 10.1101/gad.1684008; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; Nolivos S, 2012, NUCLEIC ACIDS RES, V40, P5535, DOI 10.1093/nar/gks171; Pogliano J, 2002, J BACTERIOL, V184, P1743, DOI 10.1128/JB.184.4.1743-1749.2002; Pogliano K, 1997, J BACTERIOL, V179, P3331, DOI 10.1128/jb.179.10.3331-3341.1997; Ptacin JL, 2008, NAT STRUCT MOL BIOL, V15, P485, DOI 10.1038/nsmb.1412; Ptacin JL, 2006, NAT STRUCT MOL BIOL, V13, P1023, DOI 10.1038/nsmb1157; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sciochetti SA, 2001, J BACTERIOL, V183, P1058, DOI 10.1128/JB.183.3.1058-1068.2001; Sharp MD, 2002, SCIENCE, V295, P137, DOI 10.1126/science.1066274; Sharp MD, 2003, J BACTERIOL, V185, P2005, DOI 10.1128/JB.185.6.2005-2008.2003; SHARPE ME, 1995, P NATL ACAD SCI USA, V92, P8630, DOI 10.1073/pnas.92.19.8630; Sivanathan V, 2006, NAT STRUCT MOL BIOL, V13, P965, DOI 10.1038/nsmb1158; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; Sullivan NL, 2009, CELL, V137, P697, DOI 10.1016/j.cell.2009.04.044; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1; WU LJ, 1995, GENE DEV, V9, P1316, DOI 10.1101/gad.9.11.1316; Wu LJ, 1998, MOL MICROBIOL, V27, P777, DOI 10.1046/j.1365-2958.1998.00724.x; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 1997, EMBO J, V16, P2161, DOI 10.1093/emboj/16.8.2161; Yates J, 2006, MOL MICROBIOL, V59, P1754, DOI 10.1111/j.1365-2958.2005.05033.x	50	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148365	10.1371/journal.pone.0148365	http://dx.doi.org/10.1371/journal.pone.0148365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849443	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000082
J	Busset, N; De Felice, A; Chaintreuil, C; Gully, D; Fardoux, J; Romdhane, S; Molinaro, A; Silipo, A; Giraud, E				Busset, Nicolas; De Felice, Antonia; Chaintreuil, Clemence; Gully, Djamel; Fardoux, Joel; Romdhane, Sana; Molinaro, Antonio; Silipo, Alba; Giraud, Eric			The LPS O-Antigen in Photosynthetic Bradyrhizobium Strains Is Dispensable for the Establishment of a Successful Symbiosis with Aeschynomene Legumes	PLOS ONE			English	Article							NOD FACTORS; LIPOPOLYSACCHARIDE; INFECTION; BACTERIA; PLANTS; MONOSACCHARIDE; MUTAGENESIS; GENETICS; INDICA; MUTANT	The photosynthetic bradyrhizobia are able to use a Nod-factor independent process to induce nitrogen-fixing nodules on some semi-aquatic Aeschynomene species. These bacteria display a unique LPS O-antigen composed of a new sugar, the bradyrhizose that is regarded as a key symbiotic factor due to its non-immunogenic character. In this study, to check this hypothesis, we isolated mutants affected in the O-antigen synthesis by screening a transposon mutant library of the ORS285 strain for clones altered in colony morphology. Over the 10,000 mutants screened, five were selected and found to be mutated in two genes, rfaL, encoding for a putative O-antigen ligase and gdh encoding for a putative dTDP-glucose 4,6-dehydratase. Biochemical analysis confirmed that the LPS of these mutants completely lack the O-antigen region. However, no effect of the mutations could be detected on the symbiotic properties of the mutants indicating that the O-antigen region of photosynthetic Bradyrhizobium strains is not required for the establishment of symbiosis with Aeschynomene.	[Busset, Nicolas; Chaintreuil, Clemence; Gully, Djamel; Fardoux, Joel; Romdhane, Sana; Giraud, Eric] UMR IRD SupAgro INRA UM2 CIRAD, IRD, Lab Symbioses Trop & Mediterraneennes, Campus Int Baillarguet,TA A-82-J, F-34398 Montpellier 5, France; [De Felice, Antonia; Molinaro, Antonio; Silipo, Alba] Univ Naples Federico II, Dipartimento Sci Chim, Complesso Univ Monte St Angelo, Via Cintia 4, I-80126 Naples, Italy	CIRAD; INRAE; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Naples Federico II	Giraud, E (corresponding author), UMR IRD SupAgro INRA UM2 CIRAD, IRD, Lab Symbioses Trop & Mediterraneennes, Campus Int Baillarguet,TA A-82-J, F-34398 Montpellier 5, France.	eric.giraud@ird.fr	Romdhane, sana/J-6359-2019; Silipo, Alba/L-5929-2014	GULLY, Djamel/0000-0003-1695-5744	French national research agency [ANR-BugsInaCell-13-BSV7-0013]	French national research agency(French National Research Agency (ANR))	This work was supported by the French national research agency (ANR-BugsInaCell-13-BSV7-0013).	Arrighi JF, 2012, MOL PLANT MICROBE IN, V25, P851, DOI 10.1094/MPMI-02-12-0045-TA; Berry MC, 2009, FEMS MICROBIOL LETT, V291, P80, DOI 10.1111/j.1574-6968.2008.01438.x; Bonaldi K, 2011, MOL PLANT MICROBE IN, V24, P1359, DOI 10.1094/MPMI-04-11-0093; Bonaldi K, 2010, MOL PLANT MICROBE IN, V23, P760, DOI 10.1094/MPMI-23-6-0760; Carlson RW, 2010, SUBCELL BIOCHEM, V53, P339, DOI 10.1007/978-90-481-9078-2_16; CARLSON RW, 1987, J BACTERIOL, V169, P4923, DOI 10.1128/jb.169.11.4923-4928.1987; CAVA JR, 1989, J BACTERIOL, V171, P8, DOI 10.1128/jb.171.1.8-15.1989; De Castro C, 2010, METHOD ENZYMOL, V480, P89, DOI 10.1016/S0076-6879(10)80005-9; EHRHARDT DW, 1992, SCIENCE, V256, P998, DOI 10.1126/science.10744524; Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x; Gao MS, 2001, MOL PLANT MICROBE IN, V14, P857, DOI 10.1094/MPMI.2001.14.7.857; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Giraud E, 2010, METHOD ENZYMOL, V471, P135, DOI 10.1016/S0076-6879(10)71009-0; Gourion B, 2015, TRENDS PLANT SCI, V20, P186, DOI 10.1016/j.tplants.2014.11.008; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jaubert M, 2009, PHOTOSYNTH RES, V100, P97, DOI 10.1007/s11120-009-9433-3; Kawaharada Y, 2015, NATURE, V523, P308, DOI 10.1038/nature14611; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; Li W, 2015, CHEM COMMUN, V51, P6964, DOI 10.1039/c5cc00752f; Liang Y, 2013, SCIENCE, V341, P1384, DOI 10.1126/science.1242736; Molouba F, 1999, APPL ENVIRON MICROB, V65, P3084; Noel KD, 2000, J BACTERIOL, V182, P5317, DOI 10.1128/JB.182.19.5317-5324.2000; Noh JG, 2015, INT J MOL SCI, V16, P16778, DOI 10.3390/ijms160816778; Okazaki S, 2016, ISME J, V10, P64, DOI 10.1038/ismej.2015.103; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Podlesakova K, 2013, MOL PLANT MICROBE IN, V26, P1232, DOI 10.1094/MPMI-03-13-0076-R; Reeve WG, 1999, MICROBIOL-SGM, V145, P1307, DOI 10.1099/13500872-145-6-1307; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Silipo A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6106; Silipo A, 2011, ANGEW CHEM INT EDIT, V50, P12610, DOI 10.1002/anie.201106548; Vincent J. M., 1970, HANDBOOK, V15; Xu LL, 2010, ARCH MICROBIOL, V192, P1039, DOI 10.1007/s00203-010-0635-z	33	2	2	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148884	10.1371/journal.pone.0148884	http://dx.doi.org/10.1371/journal.pone.0148884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849805	Green Published, gold			2022-12-27	WOS:000369554000181
J	de Castro, AP; da Silva, MRSS; Quirino, BF; Bustamante, MMD; Kruger, RH				de Castro, Alinne Pereira; Silveira Sartori da Silva, Maria Regina; Quirino, Betania Ferraz; da Cunha Bustamante, Mercedes Maria; Krueger, Ricardo Henrique			Microbial Diversity in Cerrado Biome (Neotropical Savanna) Soils	PLOS ONE			English	Article							FUNGAL COMMUNITIES; BACTERIAL COMMUNITIES; MICROORGANISMS; INCREASES; RESPONSES; DYNAMICS; PATTERNS; RESOURCE; GRADIENT; RAINFALL	The Cerrado, the largest savanna region in South America, is located in central Brazil. Cerrado physiognomies, which range from savanna grasslands to forest formations, combined with the highly weathered, acidic clay Cerrado soils form a unique ecoregion. In this study, high-throughput sequencing of ribosomal RNA genes was combined with shotgun metagenomic analysis to explore the taxonomic composition and potential functions of soil microbial communities in four different vegetation physiognomies during both dry and rainy seasons. Our results showed that changes in bacterial, archaeal, and fungal community structures in cerrado denso, cerrado sensu stricto, campo sujo, and gallery forest soils strongly correlated with seasonal patterns of soil water uptake. The relative abundance of AD3, WPS-2, Planctomycetes, Thermoprotei, and Glomeromycota typically decreased in the rainy season, whereas the relative abundance of Proteobacteria and Ascomycota increased. In addition, analysis of shotgun metagenomic data revealed a significant increase in the relative abundance of genes associated with iron acquisition and metabolism, dormancy, and sporulation during the dry season, and an increase in the relative abundance of genes related to respiration and DNA and protein metabolism during the rainy season. These gene functional categories are associated with adaptation to water stress. Our results further the understanding of how tropical savanna soil microbial communities may be influenced by vegetation covering and temporal variations in soil moisture.	[de Castro, Alinne Pereira; Krueger, Ricardo Henrique] Univ Brasilia, Enzymol Lab, Dept Biol Celular, Brasilia, DF, Brazil; [de Castro, Alinne Pereira] Univ Catolica Dom Bosco, Biotechnol Program, Campo Grande, MS, Brazil; [Silveira Sartori da Silva, Maria Regina; da Cunha Bustamante, Mercedes Maria] Univ Brasilia, Lab Ecol Ecossistemas, Dept Ecol, Inst Ciencias Biol, Brasilia, DF, Brazil; [Quirino, Betania Ferraz] Embrapa Agroenergy, Brasilia, DF, Brazil; [Quirino, Betania Ferraz] Univ Catolica Brasilia, Genom Sci & Biotechnol Program, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade Catolica Dom Bosco (UCDB); Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Catolica de Brasilia	Kruger, RH (corresponding author), Univ Brasilia, Enzymol Lab, Dept Biol Celular, Brasilia, DF, Brazil.	kruger@unb.br	Bustamante, Mercedes MC/H-7597-2015; Bustamante, Mercedes/GQZ-8625-2022; Quirino, Betania F/H-8835-2013; Bustamante, Mercedes/AAQ-7231-2020; Castro, Alinne/F-5101-2019; Kruger, Ricardo/Y-9595-2019	Bustamante, Mercedes MC/0000-0003-1008-452X; Bustamante, Mercedes/0000-0003-1008-452X; Castro, Alinne/0000-0002-9703-0577; Quirino, Betania/0000-0002-7578-6314; Kruger, Ricardo/0000-0002-8443-9402	National Council for Scientific and Technological Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	The authors thank the National Council for Scientific and Technological Development (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF) for financial support.; The authors acknowledge grant support from the following Brazilian government agencies: National Council for Scientific and Technological Development (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF). The authors declare no competing financial interests.	Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Andrew DR, 2012, APPL ENVIRON MICROB, V78, P7527, DOI 10.1128/AEM.01459-12; Angel R, 2012, ISME J, V6, P847, DOI 10.1038/ismej.2011.141; Araujo JF, 2012, MICROB ECOL, V64, P760, DOI 10.1007/s00248-012-0057-3; Armougom F., 2009, J COMPUT SCI SYST BI, V2, P74, DOI DOI 10.4172/JCSB.1000019; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bouskill NJ, 2013, ISME J, V7, P384, DOI 10.1038/ismej.2012.113; Bruce T, 2012, ADV MICROB ECOL, DOI [10.1007/978-1-4614-2182-5_13, DOI 10.1007/978-1-4614-2182-5_]; Bruce T, 2010, MICROB ECOL, V60, P840, DOI 10.1007/s00248-010-9750-2; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Chu HY, 2011, SOIL SCI SOC AM J, V75, P1756, DOI 10.2136/sssaj2011.0057; Clark J, 2009, MICROB ECOL, V57, P248, DOI 10.1007/s00248-008-9475-7; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cruz-Martinez K, 2009, ISME J, V3, P738, DOI 10.1038/ismej.2009.16; de Castro AP, 2008, ARCH MICROBIOL, V190, P129, DOI 10.1007/s00203-008-0374-6; de Castro AP, 2011, BIOTECHNOL LETT, V33, P2169, DOI 10.1007/s10529-011-0693-6; Dimitriu PA, 2010, MICROB ECOL, V59, P563, DOI 10.1007/s00248-009-9590-0; Emerson D, 2010, ANNU REV MICROBIOL, V64, P561, DOI 10.1146/annurev.micro.112408.134208; Faoro H, 2010, APPL ENVIRON MICROB, V76, P4744, DOI 10.1128/AEM.03025-09; Fierer N., 2012, P NATL ACAD SCI USA, V109, P21390, DOI [10.1073/pnas.1215210110., DOI 10.1073/pnas.1215210110]; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Grandy AS, 2008, SCI TOTAL ENVIRON, V404, P297, DOI 10.1016/j.scitotenv.2007.11.013; Gray SB, 2011, SOIL SCI SOC AM J, V75, P2217, DOI 10.2136/sssaj2011.0135; Grossman JM, 2010, MICROB ECOL, V60, P192, DOI 10.1007/s00248-010-9689-3; Hannula SE, 2010, SOIL BIOL BIOCHEM, V42, P2211, DOI 10.1016/j.soilbio.2010.08.020; Hawksworth DL, 2012, BIODIVERS CONSERV, V21, P2425, DOI 10.1007/s10531-012-0335-x; Lau JA, 2012, P NATL ACAD SCI USA, V109, P14058, DOI 10.1073/pnas.1202319109; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lentendu G, 2011, FUNGAL DIVERS, V49, P113, DOI 10.1007/s13225-011-0101-5; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; McGuire KL, 2012, MICROB ECOL, V63, P804, DOI 10.1007/s00248-011-9973-x; Mendonca R.C., 2008, CERRADO ECOLOGIA FLO, P423; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Millard P, 2010, NUTR CYCL AGROECOSYS, V88, P147, DOI 10.1007/s10705-009-9314-3; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Nielsen UN, 2010, J BIOGEOGR, V37, P1317, DOI 10.1111/j.1365-2699.2010.02281.x; Oliveira PS, 2002, CERRADOS BRAZIL ECOL; Oliveira-Filho A., 2002, CERRADOS BRAZIL, P91, DOI [10.1590/1519-6984.02016, DOI 10.7312/OLIV12042-007]; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Placella SA, 2012, P NATL ACAD SCI USA, V109, P10931, DOI 10.1073/pnas.1204306109; Porras-Alfaro A, 2011, MYCOLOGIA, V103, P10, DOI 10.3852/09-297; Quirino BF, 2009, MICROBIOL RES, V164, P59, DOI 10.1016/j.micres.2006.12.001; Rasche F, 2011, ISME J, V5, P389, DOI 10.1038/ismej.2010.138; Ratter J. A., 2003, Edinburgh Journal of Botany, V60, P57, DOI 10.1017/S0960428603000064; Ribeiro JF, 1998, CERRADO AMBIENTE FLO, P89; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Shary S, 2007, APPL ENVIRON MICROB, V73, P6691, DOI 10.1128/AEM.01361-07; Smit E, 1999, APPL ENVIRON MICROB, V65, P2614; Sugiyama M, 2010, P NATL ACAD SCI USA, V107, P571, DOI 10.1073/pnas.0903186107; Valentini AMC, 2008, J GEOPHYS RES, V113, P10; Van der Putten WH, 2012, ANNU REV ECOL EVOL S, V43, P365, DOI 10.1146/annurev-ecolsys-110411-160423; Wallenstein MD, 2007, FEMS MICROBIOL ECOL, V59, P428, DOI 10.1111/j.1574-6941.2006.00260.x; Wang JJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00064; Ward NL, 2009, APPL ENVIRON MICROB, V75, P2046, DOI 10.1128/AEM.02294-08; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Zhang XF, 2013, J APPL MICROBIOL, V114, P1054, DOI 10.1111/jam.12106; [No title captured]; [No title captured]	61	44	45	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148785	10.1371/journal.pone.0148785	http://dx.doi.org/10.1371/journal.pone.0148785			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849674	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000169
J	Ito, T				Ito, Tatsuya			Differences in Investigator-Initiated Trials between Japan and Other Countries: Analyses of Clinical Trials Sponsored by Academia and Government in the ClinicalTrials.gov Registry and in the Three Japanese Registries	PLOS ONE			English	Article								Background Following the amendment of the Pharmaceutical Affairs Law in Japan in 2003 researchers were permitted to begin investigator-initiated trials (IITs). In subsequent years, however, the number of IITs remained low. In other countries in Asia as well as in Europe, North America, and South Africa, the number of IITs has increased over the past decade. The differences in the characteristics of IITs between Japan and other countries are unknown. Some studies have analyzed the characteristics of all clinical trials according to registry databases, but there has been less research focusing on IITs. Aims The purpose of this study is to analyze the characteristics of IITs in the ClinicalTrials.gov registry and in the three Japanese registries, to identify differences in IITs between Japan and other countries. Methods Using Thomson Reuters Pharma T, trials sponsored by academia and government as IITs in 2010 and registered in ClinicalTrials.gov were identified. IITs from 2004 to 2012 in Japan were identified in the three Japanese registries: the University Hospital Medical Information Network Clinical Trials Registry, the Japan Pharmaceutical Information Center Clinical Trials Information, and the Japan Medical Association Center for Clinical Trials, Clinical Trials Registry. Characterization was made of the trial purposes, phases, participants, masking, arms, design, controls, and other data. Results New and revised IITs registered in ClinicalTrials.gov during 2010 averaged about 40% of all sponsor-identified trials. IITs were nearly all early-phase studies with small numbers of participants. A total of 56 Japanese IITs were found over a period of 8 years, and these were also almost nearly all early-phase studies with small numbers of participants. Conclusion There appear to be no great differences between Japan and other countries in terms of characteristics of IITs. These results should prompt a new review of the IIT environment in Japan.	[Ito, Tatsuya] Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Dept Expt Therapeut, Kyoto 606, Japan	Kyoto University	Ito, T (corresponding author), Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Dept Expt Therapeut, Kyoto 606, Japan.	taito@kuhp.kyoto-u.ac.jp			Ministry of Health, Labor, Welfare [H22-Medicine-Young researcher-019]	Ministry of Health, Labor, Welfare(Ministry of Health, Labour and Welfare, Japan)	The funder is the Ministry of Health, Labor, Welfare. The grant name is "Health and Labour Sciences Research Grant of the Ministry of Health, Labour and Welfare," and grant number is " H22-Medicine-Young researcher-019." The funder had no role in study design, data collection and analysis, decision to publish.	Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; Japan Medical Association Center for Clinical Trials, 2015, IIT CURR REP CLIN TR; Kobayashi F, 2013, PHARM MED DEVICE REG, V44, P827; Ministry of Education Culture Sports Science and Technology, 2015, TRANSL RES NETW PROG; Ministry of Health Labour and Welfare, 2015, PROJ CLIN RES HOSP; Ministry of Health Labour and Welfare, 2015, EARL EXPL CLIN TRIAL; Shiokawa Tomonori, 2009, J Evid Based Med, V2, P41, DOI 10.1111/j.1756-5391.2009.01013.x; Sinha G, 2010, J NATL CANCER I, V102, P148, DOI 10.1093/jnci/djq017; The Ministry of Health Labour and Welfare, 2003, ETH GUID CLIN RES; University Hospital Medical Information Network Clinical Trials Registry, 2015, SEARCH CLIN TRIALS R; Yamamoto M., 2011, Journal of the National Institute of Public Health, V60, P8; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	13	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148455	10.1371/journal.pone.0148455	http://dx.doi.org/10.1371/journal.pone.0148455			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848574	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000098
J	Li, H; Xu, LY; Wu, FZ; Yang, WQ; Ni, XY; He, J; Tan, B; Hu, Y				Li, Han; Xu, Liya; Wu, Fuzhong; Yang, Wanqin; Ni, Xiangyin; He, Jie; Tan, Bo; Hu, Yi			Forest Gaps Alter the Total Phenol Dynamics in Decomposing Litter in an Alpine Fir Forest	PLOS ONE			English	Article							LEAF-LITTER; NITROGEN; BIODEGRADATION; TEMPERATURE; PATTERNS; LEAVES; CARBON; SEASON; PLANTS; WINTER	The total phenol content in decomposing litter not only acts as a crucial litter quality indicator, but is also closely related to litter humification due to its tight absorption to clay particles. However, limited attention has been focused on the total phenol dynamics in foliar litter in relation to forest gaps. Here, the foliar litter of six representative tree species was incubated on the forest floor from the gap center to the closed canopy of an alpine Minjiang fir (Abies faxoniana) forest in the upper reaches of the Yangtze River and eastern Tibetan Plateau. The dynamics of total phenol concentration in the incubated litter was measured from November 2012 to October 2014. Over two-year incubation, 78.22% to 94.06% of total phenols were lost from the foliar litter, but 52.08% to 86.41% of this occurred in the first year. Forest gaps accelerated the loss of total phenols in the foliar litter in the winter, although they inhibited the loss of total phenols during the growing season in the first year. In comparison with the effects of forest gaps, the variations of litter quality among different species were much stronger on the dynamics of total phenols in the second year. Overall, the loss of total phenols in the foliar litter was slightly higher in both the canopy gap and the expanded gap than in the gap center and under the closed canopy. The results suggest that the predicted decline in snow cover resulting from winter warming or vanishing gaps caused by forest regeneration will retard the loss of total phenol content in the foliar litter of alpine forest ecosystems, especially in the first decomposition year.	[Li, Han; Xu, Liya; Wu, Fuzhong; Yang, Wanqin; Ni, Xiangyin; He, Jie; Tan, Bo; Hu, Yi] Sichuan Agr Univ, Inst Ecol & Forestry, Long Term Res Stn Alpine Forest Ecosyst, Chengdu 611130, Peoples R China; [Wu, Fuzhong; Yang, Wanqin; Tan, Bo] Collaborat Innovat Ctr Ecol Secur Upper Reaches Y, Chengdu 611130, Peoples R China; [Xu, Liya] Sichuan Technol & Business Univ, Int Business Sch, 9 Min River Eastern Sect, Meishan City, Peoples R China	Sichuan Agricultural University	Yang, WQ (corresponding author), Sichuan Agr Univ, Inst Ecol & Forestry, Long Term Res Stn Alpine Forest Ecosyst, Chengdu 611130, Peoples R China.; Yang, WQ (corresponding author), Collaborat Innovat Ctr Ecol Secur Upper Reaches Y, Chengdu 611130, Peoples R China.	scyangwq@163.com		Ni, Xiangyin/0000-0002-2507-3463	National Natural Science Foundation of China [31270498, 31570445, 31500509]; China Postdoctoral Science Foundation [2012T50782]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This project was supported by the National Natural Science Foundation of China (31270498, 31570445, 31500509) and the China Postdoctoral Science Foundation Special Funding (2012T50782).	Balasundram N, 2006, FOOD CHEM, V99, P191, DOI 10.1016/j.foodchem.2005.07.042; Baptist F, 2010, PLANT SOIL, V328, P397, DOI 10.1007/s11104-009-0119-6; BEART JE, 1985, J CHEM SOC PERK T 2, P1439, DOI 10.1039/p29850001439; Bending GD, 1996, SOIL BIOL BIOCHEM, V28, P1603, DOI 10.1016/S0038-0717(96)00258-1; Berg B., 2008, PLANT LITTER; Bokhorst S, 2013, SOIL BIOL BIOCHEM, V62, P157, DOI 10.1016/j.soilbio.2013.03.016; Cornelissen JHC, 2004, FUNCT ECOL, V18, P779, DOI 10.1111/j.0269-8463.2004.00900.x; De Marco A, 2012, SOIL BIOL BIOCHEM, V51, P1, DOI 10.1016/j.soilbio.2012.03.025; GALLARDO A, 1992, BIOGEOCHEMISTRY, V15, P213; GALLET C, 1995, SOIL BIOL BIOCHEM, V27, P157, DOI 10.1016/0038-0717(94)00167-Y; Gupta G, 1998, J ENVIRON SCI HEAL A, V33, P83, DOI 10.1080/10934529809376719; Hattenschwiler S, 2000, TRENDS ECOL EVOL, V15, P238, DOI 10.1016/S0169-5347(00)01861-9; He J., 2015, SCI REP-UK, V4, P1; He W., 2015, 2015 IEEE International Vacuum Electronics Conference (IVEC), P1, DOI 10.1109/IVEC.2015.7223785; Isaac SR, 2005, SOIL BIOL BIOCHEM, V37, P1656, DOI 10.1016/j.soilbio.2005.02.002; Kennedy J, 1996, EUR J SOIL SCI, V47, P615, DOI 10.1111/j.1365-2389.1996.tb01860.x; Konestabo HS, 2007, APPL SOIL ECOL, V36, P136, DOI 10.1016/j.apsoil.2007.01.003; KUITERS AT, 1990, ACTA BOT NEERL, V39, P329, DOI 10.1111/j.1438-8677.1990.tb01412.x; KUITERS AT, 1986, SOIL BIOL BIOCHEM, V18, P475, DOI 10.1016/0038-0717(86)90003-9; Lu R., 1999, SOIL AGROCHEMICAL AN, P146; Mallik AU, 2014, FOREST ECOL MANAG, V312, P117, DOI 10.1016/j.foreco.2013.10.015; Ni XY, 2015, GEODERMA, V241, P136, DOI 10.1016/j.geoderma.2014.11.018; Ni XY, 2014, CAN J SOIL SCI, V94, P453, DOI 10.4141/CJSS2013-121; Olsson PQ, 2003, ARCT ANTARCT ALP RES, V35, P74, DOI 10.1657/1523-0430(2003)035[0074:FSOTAA]2.0.CO;2; PALM CA, 1990, BIOTROPICA, V22, P330, DOI 10.2307/2388550; Preston CM, 2009, ECOSYSTEMS, V12, P1078, DOI 10.1007/s10021-009-9267-z; Preston CM, 2009, ECOSYSTEMS, V12, P1053, DOI 10.1007/s10021-009-9266-0; Ritter E, 2005, FOREST ECOL MANAG, V206, P15, DOI 10.1016/j.foreco.2004.08.011; SCALBERT A, 1991, PHYTOCHEMISTRY, V30, P3875, DOI 10.1016/0031-9422(91)83426-L; Scharenbroch BC, 2007, PLANT SOIL, V294, P219, DOI 10.1007/s11104-007-9248-y; Schliemann SA, 2011, FOREST ECOL MANAG, V261, P1143, DOI 10.1016/j.foreco.2011.01.011; Schofield JA, 1998, J CHEM ECOL, V24, P1409, DOI 10.1023/A:1021287018787; SLAPOKAS T, 1991, BIOL FERT SOILS, V10, P241, DOI 10.1007/BF00337374; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Tan Bo, 2011, Yingyong Shengtai Xuebao, V22, P2553; Tan B, 2011, ACTA AGR SCAND B-S P, V61, P670, DOI 10.1080/09064710.2010.541489; TORTI SD, 1995, J CHEM ECOL, V21, P117, DOI 10.1007/BF02036646; Vanderbilt KL, 2008, J ARID ENVIRON, V72, P696, DOI 10.1016/j.jaridenv.2007.10.010; VANSOEST PJ, 1968, J ASSOC OFF ANA CHEM, V51, P780; WHITMORE TC, 1989, ECOLOGY, V70, P536, DOI 10.2307/1940195; Wu F, 2014, BIOGEOSCI DISCUSS, V11, P9539, DOI DOI 10.5194/BGD-11-9539-2014; Wu FZ, 2010, ACTA OECOL, V36, P135, DOI 10.1016/j.actao.2009.11.002; Wu QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097112; Zhu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062073	44	4	6	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148426	10.1371/journal.pone.0148426	http://dx.doi.org/10.1371/journal.pone.0148426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849120	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000091
J	Miller, R; Laskowski, KL; Schiestl, M; Bugnyar, T; Schwab, C				Miller, Rachael; Laskowski, Kate L.; Schiestl, Martina; Bugnyar, Thomas; Schwab, Christine			Socially Driven Consistent Behavioural Differences during Development in Common Ravens and Carrion Crows	PLOS ONE			English	Article							PERSONALITY; EXPLORATION; PLASTICITY; ONTOGENY; ECOLOGY	Consistent individual differences in behaviour, or 'personality', are likely to be influenced by development, social context, and species ecology, though few comparative, longitudinal studies exist. Here, we investigated the role of development and social context on personality variation in two identically reared, social corvids: common ravens and carrion crows. We repeatedly presented subjects with a variety of novel food and objects, while alone and in a primarily sibling subgroup, from fledging to sub-adulthood. We predicted that consistent individual differences would emerge later in development, and that conspecific presence would facilitate behavioural similarities. In contrast to our predictions, we found that individuals of both species were highly inconsistent in their behavioural responses throughout the development period. In line with our predictions, though in the ravens only, conspecific presence promoted behavioural similarities as individuals were strongly shaped by their subgroup, and it is likely that these effects were driven by social context rather than relatedness. We discuss these findings in relation to developmental steps and the role of social relations in these species. Overall, our findings highlight that these two species are highly adaptable in their behaviour, and the ravens in particular are strongly influenced by their social environment, which may facilitate cooperation and social learning.	[Miller, Rachael; Schiestl, Martina; Bugnyar, Thomas; Schwab, Christine] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Miller, Rachael; Schiestl, Martina; Bugnyar, Thomas] Univ Vienna, Haidlhof Res Stn, Bad Voslau, Austria; [Miller, Rachael; Schiestl, Martina; Bugnyar, Thomas] Univ Vet Med, Bad Voslau, Austria; [Laskowski, Kate L.] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany; [Schwab, Christine] Med Univ Vienna, Messerli Res Inst, Univ Vet Med Vienna, Vienna, Austria; [Schwab, Christine] Univ Vienna, Vienna, Austria	University of Vienna; University of Vienna; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Miller, R (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.; Miller, R (corresponding author), Univ Vienna, Haidlhof Res Stn, Bad Voslau, Austria.; Miller, R (corresponding author), Univ Vet Med, Bad Voslau, Austria.	rachael.miller@univie.ac.at		Miller (Harrison), Rachael/0000-0003-2996-9571; Laskowski, Kate/0000-0003-1523-9340	Vienna Science and Technology Fund [CS11-008]; Austrian Science Fund [Y366-B17, W1234]; Leibniz Competition [SAW-2013-IGB-2]	Vienna Science and Technology Fund; Austrian Science Fund(Austrian Science Fund (FWF)); Leibniz Competition	RM was supported by the Vienna Science and Technology Fund through project CS11-008 to CS and by the Austrian Science Fund through project Y366-B17 and W1234 to TB. KLL was supported by the Leibniz Competition (SAW-2013-IGB-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen R. H., 2008, ANAL LINGUISTIC DATA; Baglione V, 2003, SCIENCE, V300, P1947, DOI 10.1126/science.1082429; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Braun A, 2012, J ORNITHOL, V153, pS97, DOI 10.1007/s10336-011-0810-2; Caspi A, 2005, ANNU REV PSYCHOL, V56, P453, DOI 10.1146/annurev.psych.55.090902.141913; Chiarati E, 2012, ANIM BEHAV, V83, P103, DOI 10.1016/j.anbehav.2011.10.012; de Knijff P, 2014, SCIENCE, V344, P1345, DOI 10.1126/science.1255744; Dingemanse NJ, 2013, ANIM BEHAV, V85, P1031, DOI 10.1016/j.anbehav.2012.12.032; Fraser ON, 2010, ANIM BEHAV, V79, P927, DOI 10.1016/j.anbehav.2010.01.008; Gabor CR, 2008, BEHAV ECOL, V19, P871, DOI 10.1093/beheco/arn043; Glutz Von Blotzheim U.N., 1993, HDB VOGEL MITTELEURO; GOODWIN D, 1976, CROWS OF THE WORLD; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Groothuis TGG, 2011, DEV PSYCHOBIOL, V53, P641, DOI 10.1002/dev.20574; Guenther A, 2014, ANIM BEHAV, V90, P131, DOI 10.1016/j.anbehav.2014.01.032; Gyuris E, 2012, ANIM BEHAV, V84, P103, DOI 10.1016/j.anbehav.2012.04.014; HEINRICH B, 1991, BEHAV ECOL SOCIOBIOL, V28, P13; HEINRICH B, 1995, ANIM BEHAV, V50, P695, DOI 10.1016/0003-3472(95)80130-8; Kilham L, 1991, AM CROW COMMON RAVEN; King AJ, 2015, ANIM BEHAV, V99, P25, DOI 10.1016/j.anbehav.2014.10.016; Koski SE, 2015, SCI REP-UK, V5, DOI 10.1038/srep08878; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Massen JJM, 2014, EVOL HUM BEHAV, V35, P1, DOI 10.1016/j.evolhumbehav.2013.08.008; Miller R, 2015, BEHAV ECOL SOCIOBIOL, V69, P1209, DOI 10.1007/s00265-015-1935-8; Miller R, 2014, ETHOLOGY, V120, P1248, DOI 10.1111/eth.12298; Modlmeier AP, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0419; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Niemela PT, 2012, BEHAV ECOL SOCIOBIOL, V66, P645, DOI 10.1007/s00265-011-1312-1; Poole A., 2002, BIRDS N AM; Range F, 2008, ACTA ETHOL, V11, P34, DOI 10.1007/s10211-008-0039-0; Ratcliffe D, 2010, THE RAVEN; Reale D, 2001, ANIMAL PERSONALITY; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Riemer S., 2014, J VET BEHAV, V9, pe10, DOI [10.1016/j.jveb.2014.09.035, DOI 10.1016/J.JVEB.2014.09.035]; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; Rodel HG, 2011, DEV PSYCHOBIOL, V53, P601, DOI 10.1002/dev.20522; Schwab C, 2008, ANIM BEHAV, V75, P501, DOI 10.1016/j.anbehav.2007.06.006; Sih A, 2012, PHILOS T R SOC B, V367, P2762, DOI 10.1098/rstb.2012.0216; Sinn DL, 2008, ANIM BEHAV, V75, P433, DOI 10.1016/j.anbehav.2007.05.008; Snow D.W., 1998, BIRDS W PALEARCTIC; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Stamps JA, 2010, PHILOS T R SOC B, V365, P4029, DOI 10.1098/rstb.2010.0218; Templeton CN, 2012, BEHAV ECOL, V23, P141, DOI 10.1093/beheco/arr167; Westneat D.F., 2010, EVOLUTIONARY BEHAV E	45	10	10	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148822	10.1371/journal.pone.0148822	http://dx.doi.org/10.1371/journal.pone.0148822			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848954	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000173
J	Souverein, D; Houtman, P; Euser, SM; Herpers, BL; Kluytmans, J; Den Boer, JW				Souverein, Dennis; Houtman, Patricia; Euser, Sjoerd M.; Herpers, Bjorn L.; Kluytmans, Jan; Den Boer, Jeroen W.			Costs and Benefits Associated with the MRSA Search and Destroy Policy in a Hospital in the Region Kennemerland, The Netherlands	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANCE; BACTEREMIA; MORTALITY	Objective The objective of this study was to analyze the costs and benefits of the MRSA Search and Destroy (S&D) policy between 2008 and 2013 in the Kennemer Gasthuis, a 400 bed teaching hospital in the region Kennemerland, the Netherlands. Methods A patient registration database was used to retrospectively calculate costs, including screening, isolation, follow-up, contact tracing, cleaning, treatment, deployment of extra healthcare workers, salary for an infection control practitioner (ICP) and service of isolation rooms. The estimated benefits (costs and lives when no MRSA S&D was applied) were based on a varying MRSA prevalence rate (up to 50%). Results When no MRSA S&D policy was applied, the additional costs and deaths due to MRSA bacteraemia were estimated to be (sic) 1,388,907 and 33 respectively (at a MRSA prevalence rate of 50%). Currently, the total costs were estimated to be (sic) 290,672 ((sic) 48,445 annually) and a MRSA prevalence rate of 17.3% was considered as break-even point. Between 2008 and 2013, a total of 576 high risk patients were screened for MRSA carriage, of whom 19 (3.3%) were found to be MRSA positive. Forty-nine patients (72.1%) were found unexpectedly. Conclusions Application of the MRSA S&D policy saves lives and money, although the high rate of unexpected MRSA cases is alarming.	[Souverein, Dennis; Euser, Sjoerd M.; Herpers, Bjorn L.; Den Boer, Jeroen W.] Reg Publ Hlth Lab Kennemerland, Dept Epidemiol & Infect Prevent, Haarlem, Netherlands; [Houtman, Patricia] Kennemer Gasthuis, Dept Infect Control, Haarlem, Netherlands; [Kluytmans, Jan] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Kluytmans, Jan] Univ Med Ctr, Utrecht, Netherlands	Spaarne Hospital; Amphia Hospital; Utrecht University; Utrecht University Medical Center	Souverein, D (corresponding author), Reg Publ Hlth Lab Kennemerland, Dept Epidemiol & Infect Prevent, Haarlem, Netherlands.	d.souverein@streeklabhaarlem.nl						[Anonymous], 2005, METH RES STAPH AUR M; Bootsma MCJ, 2006, P NATL ACAD SCI USA, V103, P5620, DOI 10.1073/pnas.0510077103; CDC, 2006, MAN MULT RES ORG HEA; College bouw ziekenhuisvoorzieningen, 2003, 0113 COLL BOUW ZIEK; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; ECDC, 2012, SUMM LAT DAT ANT RES; Filice GA, 2010, INFECT CONT HOSP EP, V31, P365, DOI 10.1086/651094; Kramer A, 2010, GMS HYG INFECT CONTR, V5, DOI 10.3205/dgkh000144; Nulens E, 2008, J HOSP INFECT, V68, P301, DOI 10.1016/j.jhin.2008.01.018; NVMM, 2013, GUID LAB DET HIGHL R; Pan A, 2013, INFECTION, V41, P783, DOI 10.1007/s15010-013-0454-7; Stefani S, 2012, INT J ANTIMICROB AG, V39, P273, DOI 10.1016/j.ijantimicag.2011.09.030; Stichting Werkgroep Antibiotica Beleid, SWAB RICHTL BEH MRSA; van der Zee A, 2013, AM J INFECT CONTROL, V41, P204, DOI 10.1016/j.ajic.2012.02.033; van Rijen MML, 2009, EUR J CLIN MICROBIOL, V28, P1245, DOI 10.1007/s10096-009-0775-8; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672; Vriens M, 2002, EUR J CLIN MICROBIOL, V21, P782, DOI 10.1007/s10096-002-0811-4; Wassenberg Marjan W M, 2010, Ned Tijdschr Geneeskd, V154, pA2575; Wassenberg MWM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011562; Werkgroep Infectie Preventie, 2013, BIJZ RES MICR BRMO; Werkgroep Infectie Preventie, 2012, MET RES STAPH AUR; Wyllie DH, 2006, BRIT MED J, V333, P281, DOI 10.1136/bmj.38834.421713.2F	22	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148175	10.1371/journal.pone.0148175	http://dx.doi.org/10.1371/journal.pone.0148175			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849655	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000048
J	Stumpf, M; den Hertog, J				Stumpf, Miriam; den Hertog, Jeroen			Differential Requirement for Pten Lipid and Protein Phosphatase Activity during Zebrafish Embryonic Development	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PTEN; ENDOTHELIAL GROWTH-FACTOR; HEMATOPOIETIC STEM-CELLS; GLIOMA-CELLS; TYROSINE PHOSPHATASES; GERMLINE MUTATIONS; GLIOBLASTOMA CELLS; SIGNALING PATHWAY; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN	The lipid- and protein phosphatase PTEN is one of the most frequently mutated tumor suppressor genes in human cancers and many mutations found in tumor samples directly affect PTEN phosphatase activity. In order to understand the functional consequences of these mutations in vivo, the aim of our study was to dissect the role of Pten phosphatase activities during zebrafish embryonic development. As in other model organisms, zebrafish mutants lacking functional Pten are embryonically lethal. Zebrafish have two pten genes and pten double homozygous zebrafish embryos develop a severe pleiotropic phenotype around 4 days post fertilization, which can be largely rescued by re-introduction of pten mRNA at the one-cell stage. We used this assay to characterize the rescue-capacity of Pten and variants with mutations that disrupt lipid, protein or both phosphatase activities. The pleiotropic phenotype at 4dpf could only be rescued by wild type Pten, indicating that both phosphatase activities are required for normal zebrafish embryonic development. An earlier aspect of the phenotype, hyperbranching of intersegmental vessels, however, was rescued by Pten that retained lipid phosphatase activity, independent of protein phosphatase activity. Lipid phosphatase activity was also required for moderating pAkt levels at 4 dpf. We propose that the role of Pten during angiogenesis mainly consists of suppressing PI3K signaling via its lipid phosphatase activity, whereas the complex process of embryonic development requires lipid and protein phosphatase of Pten.	[Stumpf, Miriam; den Hertog, Jeroen] Koninklijke Nederlandse Akad Wetenschappen, Hubrecht Inst, Utrecht, Netherlands; [Stumpf, Miriam; den Hertog, Jeroen] Univ Med Ctr Utrecht, Utrecht, Netherlands; [den Hertog, Jeroen] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University - Excl LUMC	den Hertog, J (corresponding author), Koninklijke Nederlandse Akad Wetenschappen, Hubrecht Inst, Utrecht, Netherlands.	j.denhertog@hubrecht.eu						BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Buxbaum JD, 2007, AM J MED GENET B, V144B, P484, DOI 10.1002/ajmg.b.30493; Cheney IW, 1998, CANCER RES, V58, P2331; Chi SG, 1998, GASTROENTEROLOGY, V115, P1084, DOI 10.1016/S0016-5085(98)70078-2; Choorapoikayil S, 2014, BLOOD, V123, P184, DOI 10.1182/blood-2013-05-501544; Choorapoikayil S, 2013, DIS MODEL MECH, V6, P1159, DOI 10.1242/dmm.012377; Choorapoikayil S, 2012, DIS MODEL MECH, V5, P241, DOI 10.1242/dmm.008326; Covassin LD, 2009, DEV BIOL, V329, P212, DOI 10.1016/j.ydbio.2009.02.031; Croushore JA, 2005, DEV DYNAM, V234, P911, DOI 10.1002/dvdy.20576; Davidson L, 2010, ONCOGENE, V29, P687, DOI 10.1038/onc.2009.384; Davies MA, 1998, CANCER RES, V58, P5285; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Errafiy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083318; Faucherre A, 2008, ONCOGENE, V27, P1079, DOI 10.1038/sj.onc.1210730; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; Furnari FB, 1998, CANCER RES, V58, P5002; Gildea JJ, 2004, ONCOGENE, V23, P6788, DOI 10.1038/sj.onc.1207599; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Goffin A, 2001, AM J MED GENET, V105, P521, DOI 10.1002/ajmg.1477; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; Huang JH, 2002, J BIOL CHEM, V277, P10760, DOI 10.1074/jbc.M110219200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kolmodin K, 2001, FEBS LETT, V498, P208, DOI 10.1016/S0014-5793(01)02479-6; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Leslie NR, 2009, ADV ENZYME REGUL, V49, P190, DOI 10.1016/j.advenzreg.2008.12.002; Leslie NR, 2001, BIOCHEM J, V357, P427, DOI 10.1042/0264-6021:3570427; Leslie NR, 2000, BIOCHEM J, V346, P827, DOI 10.1042/0264-6021:3460827; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lyu JW, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0114-1; Ma DD, 2011, BLOOD, V118, P289, DOI 10.1182/blood-2010-12-327403; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Mihaylova VT, 1999, P NATL ACAD SCI USA, V96, P7427, DOI 10.1073/pnas.96.13.7427; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Newton RH, 2015, BLOOD, V125, P852, DOI 10.1182/blood-2014-04-571372; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; Park MJ, 2002, CANCER RES, V62, P6318; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stumpf M, 2015, METHODS, V77-78, P191, DOI 10.1016/j.ymeth.2014.11.002; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Thakker GD, 1999, J BIOL CHEM, V274, P10002, DOI 10.1074/jbc.274.15.10002; Tibarewal P, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002138; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Wang H, 2010, P NATL ACAD SCI USA, V107, P5142, DOI 10.1073/pnas.0912524107; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Zhang XC, 2012, BIOCHEM J, V444, P457, DOI 10.1042/BJ20120098; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109; Zhou YJ, 2004, WORLD J GASTROENTERO, V10, P3225	57	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148508	10.1371/journal.pone.0148508	http://dx.doi.org/10.1371/journal.pone.0148508			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848951	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000113
J	Chen, GW; Kuo, SM; Yang, SL; Gong, YN; Hsiao, MR; Liu, YC; Shih, SR; Tsao, KC				Chen, Guang-Wu; Kuo, Shu-Ming; Yang, Shu-Li; Gong, Yu-Nong; Hsiao, Mei-Ren; Liu, Yi-Chun; Shih, Shin-Ru; Tsao, Kuo-Chien			Genomic Signatures for Avian H7N9 Viruses Adapting to Humans	PLOS ONE			English	Article							INFLUENZA-A VIRUS; AMINO-ACID; INCREASED VIRULENCE; POLYMERASE-ACTIVITY; POSITION 627; PB2 PROTEIN; PATHOGENICITY; TRANSMISSION; MUTATION; FERRETS	An avian influenza A H7N9 virus emerged in March 2013 and caused a remarkable number of human fatalities. Genome variability in these viruses may provide insights into host adaptability. We scanned over 140 genomes of the H7N9 viruses isolated from humans and identified 104 positions that exhibited seven or more amino acid substitutions. Approximately half of these substitutions were identified in the influenza ribonucleoprotein (RNP) complex. Although PB2 627K of the avian virus promotes replication in humans, 45 of the 147 investigated PB2 sequences retained the E signature at this position, which is an avian characteristic. We discovered 10 PB2 substitutions that covaried with K627E. An RNP activity assay showed that Q591K, D701N, and M535L restored the polymerase activity in human cells when 627K transformed to an avian-like E. Genomic analysis of the human-isolated avian influenza virus is crucial in assessing genome variability, because relationships between position-specific variations can be observed and explored. In this study, we observed alternative positions that can potentially compensate for PB2 627K, a well-known marker for cross-species infection. An RNP assay suggested Q591K, D701N, and M535L as potential markers for an H7N9 virus capable of infecting humans.	[Chen, Guang-Wu] Chang Gung Univ, Sch Elect & Comp Engn, Dept Comp Sci & Informat Engn, Coll Engn, Taoyuan, Taiwan; [Chen, Guang-Wu; Kuo, Shu-Ming; Shih, Shin-Ru; Tsao, Kuo-Chien] Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan; [Yang, Shu-Li; Gong, Yu-Nong; Hsiao, Mei-Ren; Liu, Yi-Chun; Shih, Shin-Ru; Tsao, Kuo-Chien] Linkou Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan; [Hsiao, Mei-Ren; Tsao, Kuo-Chien] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chen, GW (corresponding author), Chang Gung Univ, Sch Elect & Comp Engn, Dept Comp Sci & Informat Engn, Coll Engn, Taoyuan, Taiwan.; Chen, GW; Tsao, KC (corresponding author), Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan.; Tsao, KC (corresponding author), Linkou Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan.; Tsao, KC (corresponding author), Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Taoyuan, Taiwan.	gwchen@mail.cgu.edu.tw; kctsao@cgmh.org.tw	liu, yi/GXE-9662-2022; Shih, Shin-Ru/M-9711-2016; Kuo, Shu-Ming/I-6350-2016; Chen, Guang-Wu/M-6768-2016	Kuo, Shu-Ming/0000-0002-4437-689X; Gong, Yu-Nong/0000-0002-6799-1561; Shih, Shin-Ru/0000-0003-4874-401X; Chen, Guang-Wu/0000-0002-5322-4839	Ministry of Science and Technology, Taipei, Taiwan [MOST 100-2221-E-182-056-MY3, MOST 103-2221-E-182-022, MOST 104-2221-E-182-064, MOST 101-2321-B-182-016-MY2]; Ministry of Health and Welfare, Taipei, Taiwan [MOHW-TD-B-111-D005]; Chang Gung Memorial Hospital, Linkou, Taiwan [BMRP 832, CMRPD1A0083, CLRPG3B0043, CMRPG3C0731-2]	Ministry of Science and Technology, Taipei, Taiwan; Ministry of Health and Welfare, Taipei, Taiwan; Chang Gung Memorial Hospital, Linkou, Taiwan(Chang Gung Memorial Hospital)	This work was supported by grants from the Ministry of Science and Technology, Taipei, Taiwan (MOST 100-2221-E-182-056-MY3, MOST 103-2221-E-182-022, MOST 104-2221-E-182-064, MOST 101-2321-B-182-016-MY2, http://www.most.gov.tw/); Ministry of Health and Welfare, Taipei, Taiwan (MOHW-TD-B-111-D005, http://www.mohw.gov.tw/); and Chang Gung Memorial Hospital, Linkou, Taiwan (BMRP 832, CMRPD1A0083, CLRPG3B0043, CMRPG3C0731-2, https://www.cgmh.org.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Bogner P, 2006, NATURE, V442, P981, DOI 10.1038/442981a; Boivin S, 2011, J BIOL CHEM, V286, P10439, DOI 10.1074/jbc.M110.182964; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Carr SM, 2006, VIROLOGY, V344, P492, DOI 10.1016/j.virol.2005.08.041; Chang SY, 2013, LANCET, V381, P1621, DOI 10.1016/S0140-6736(13)60943-5; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen Guang-Wu, 2014, Biomed J, V37, P1, DOI 10.4103/2319-4170.125882; Chen GW, 2013, J FORMOS MED ASSOC, V112, P312, DOI 10.1016/j.jfma.2013.04.015; Chen GW, 2009, EMERG INFECT DIS, V15, P1897, DOI 10.3201/eid1512.090845; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Huang CH, 2013, J INFECT DIS, V208, P1898, DOI 10.1093/infdis/jit381; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Lam WY, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-528; Li JE, 2013, SCI CHINA LIFE SCI, V56, P619, DOI 10.1007/s11427-013-4504-2; Li JW, 2009, VIRUS RES, V144, P123, DOI 10.1016/j.virusres.2009.04.008; Lin PH, 2014, CLIN INFECT DIS, V58, P242, DOI 10.1093/cid/cit638; Lo YC, 2013, EURO SURVEILL, V18; Lutz A, 2005, J VIROL METHODS, V126, P13, DOI 10.1016/j.jviromet.2005.01.016; McAuley JL, 2010, J VIROL, V84, P558, DOI 10.1128/JVI.01785-09; Mehle A, 2012, J VIROL, V86, P1750, DOI 10.1128/JVI.06203-11; Min JY, 2013, J VIROL, V87, P10884, DOI 10.1128/JVI.01016-13; Mok CKP, 2014, J VIROL, V88, P3568, DOI 10.1128/JVI.02740-13; Mok CK, 2013, JOURNAL OF MICROBIOL; Moncorge O, 2013, J VIROL, V87, P384, DOI 10.1128/JVI.01633-12; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Simonetti FL, 2013, NUCLEIC ACIDS RES, V41, pW8, DOI 10.1093/nar/gkt427; Song WJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6509; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Sun HL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00073; Sun YP, 2011, P NATL ACAD SCI USA, V108, P4164, DOI 10.1073/pnas.1019109108; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tharakaraman K, 2013, CELL, V153, P1486, DOI 10.1016/j.cell.2013.05.034; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034; Yamamoto N, 2013, VIRUS RES, V178, P404, DOI 10.1016/j.virusres.2013.09.012; Zhang H, 2014, J GEN VIROL, V95, P779, DOI 10.1099/vir.0.061721-0; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Zhou B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067616; Zhou HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006277; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	53	20	21	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148432	10.1371/journal.pone.0148432	http://dx.doi.org/10.1371/journal.pone.0148432			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845764	Green Published, Green Submitted, gold			2022-12-27	WOS:000369552800058
J	Frydlova, J; Prikryl, P; Truksa, J; Falke, LL; Du, X; Gurieva, I; Vokurka, M; Krijt, J				Frydlova, Jana; Prikryl, Petr; Truksa, Jaroslav; Falke, Lucas L.; Du, Xin; Gurieva, Iuliia; Vokurka, Martin; Krijt, Jan			Effect of Erythropoietin, Iron Deficiency and Iron Overload on Liver Matriptase-2 (TMPRSS6) Protein Content in Mice and Rats	PLOS ONE			English	Article							HEPCIDIN EXPRESSION; SERINE-PROTEASE; GENE-EXPRESSION; DIETARY IRON; ORAL IRON; HEMOJUVELIN; HOMEOSTASIS; REGULATOR; ANEMIA; BMP6	Matriptase-2 (TMPRSS6) is an important negative regulator of hepcidin expression; however, the effects of iron overload or accelerated erythropoiesis on liver TMPRSS6 protein content in vivo are largely unknown. We determined TMPRSS6 protein content in plasma membrane-enriched fractions of liver homogenates by immunoblotting, using a commercial antibody raised against the catalytic domain of TMPRSS6. Plasma membrane-enriched fractions were obtained by centrifugation at 3000 g and washing. TMPRSS6 was detected in the 3000 g fraction as a 120 kDa full-length protein in both mice and rats. Feeding of iron-deficient diet as well as erythropoietin treatment increased TMPRSS6 protein content in rats and mice by a posttranscriptional mechanism; the increase in TMPRSS6 protein by erythropoietin was also observed in Bmp6-mutant mice. Administration of high doses of iron to mice (200, 350 and 700 mg/kg) decreased TMPRSS6 protein content. Hemojuvelin was detected in the plasma membrane-enriched fractions of control animals as a full length protein of approximately 52 kDa; in iron deficient animals, the full length protein was partially cleaved at the N-terminus, resulting in an additional weak band of approximately 47 kDa. In livers from hemojuvelin-mutant mice, TMPRSS6 protein content was strongly decreased, suggesting that intact hemojuvelin is necessary for stable TMPRSS6 expression in the membrane. Overall, the results demonstrate posttranscriptional regulation of liver TMPRSS6 protein by iron status and erythropoietin administration, and provide support for the interaction of TMPRSS6 and hemojuvelin proteins in vivo.	[Frydlova, Jana; Prikryl, Petr; Gurieva, Iuliia; Vokurka, Martin; Krijt, Jan] Charles Univ Prague, Fac Med 1, Inst Pathophysiol, Prague, Czech Republic; [Truksa, Jaroslav] Acad Sci Czech Republic, Inst Biotechnol, Lab Tumour Resistance, Prague, Czech Republic; [Falke, Lucas L.] Univ Med Ctr Utrecht, Dept Pathol, Kidney Grp, Utrecht, Netherlands; [Du, Xin] Univ Calif San Diego, Dept Med, Div Med Genet, La Jolla, CA 92093 USA	Charles University Prague; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Utrecht University; Utrecht University Medical Center; University of California System; University of California San Diego	Krijt, J (corresponding author), Charles Univ Prague, Fac Med 1, Inst Pathophysiol, Prague, Czech Republic.	jan.krijt@lf1.cuni.cz	Frydlova, Jana/H-8878-2017; Krijt, Jan/B-2359-2009; Truksa, Jaroslav/G-9454-2014; Falke, Lucas L/D-5288-2017; Truksa, Jaroslav/AAB-5089-2020; Gurieva, Iuliia/I-4575-2017; Prikryl, Petr/B-1359-2008; Vokurka, Martin/F-7533-2017	Frydlova, Jana/0000-0001-9725-9526; Truksa, Jaroslav/0000-0002-8967-7354; Falke, Lucas L/0000-0003-0020-433X; Truksa, Jaroslav/0000-0002-8967-7354; Gurieva, Iuliia/0000-0003-1269-1083; Prikryl, Petr/0000-0001-6167-2853; Vokurka, Martin/0000-0001-5943-5939	Czech Science Foundation [15-16803S, 13-28830S]; Charles University [PRVOUK P24/LF1/3, SVV 260157]; European Regional Development Fund [BIOCEV CZ.1.05/1.1.00/02.0109]; Netherlands Institute for Regenerative Medicine [FES0908]	Czech Science Foundation(Grant Agency of the Czech Republic); Charles University; European Regional Development Fund(European Commission); Netherlands Institute for Regenerative Medicine	The study was supported by the Czech Science Foundation (http://gacr.cz/en/), grants 15-16803S to JK and 13-28830S to JT; by Charles University (https://www.cuni.cz/), grants PRVOUK P24/LF1/3 and SVV 260157, to MV; by the European Regional Development Fund, grant BIOCEV CZ.1.05/1.1.00/02.0109, to JT; and by the Netherlands Institute for Regenerative Medicine (www.nirmresearch.nl), grant FES0908 to LLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Bothwell, 1980, METHODS HEMATOLOGY, V1, P90; Corradini E, 2011, HEPATOLOGY, V54, P273, DOI 10.1002/hep.24359; Daba A, 2013, J MOL MED, V91, P95, DOI 10.1007/s00109-012-0937-5; Dendooven A, 2011, AM J PATHOL, V178, P1069, DOI 10.1016/j.ajpath.2010.12.005; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Enns CA, 2012, J BIOL CHEM, V287, P35104, DOI 10.1074/jbc.M112.363937; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2009, SEMIN HEMATOL, V46, P378, DOI 10.1053/j.seminhematol.2009.06.006; FINCH C, 1994, BLOOD, V84, P1697; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Frydlova J, 2013, PHYSIOL RES, V62, P405, DOI 10.33549/physiolres.932455; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Guillem F, 2008, BLOOD, V112, P2089, DOI 10.1182/blood-2008-05-154740; Jiang J, 2014, J BIOL CHEM, V289, P19500, DOI 10.1074/jbc.M114.555110; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Keel SB, 2015, EXP HEMATOL, V43, P469, DOI 10.1016/j.exphem.2015.03.001; Krijt J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037391; Krijt J, 2011, BLOOD CELL MOL DIS, V47, P133, DOI 10.1016/j.bcmd.2011.04.009; Krijt J, 2010, BLOOD CELL MOL DIS, V44, P257, DOI 10.1016/j.bcmd.2010.02.012; Lakhal S, 2011, J BIOL CHEM, V286, P4090, DOI 10.1074/jbc.M110.173096; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Lee P, 2012, BRIT J HAEMATOL, V156, P415, DOI 10.1111/j.1365-2141.2011.09006.x; Lehmberg K, 2013, ANN HEMATOL, V92, P387, DOI 10.1007/s00277-012-1618-8; Maurer E, 2012, BIOL CHEM, V393, P535, DOI 10.1515/hsz-2011-0221; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; McDonald CJ, 2014, AM J PHYSIOL-GASTR L, V306, pG132, DOI 10.1152/ajpgi.00256.2013; Melis MA, 2008, HAEMATOL-HEMATOL J, V93, P1473, DOI 10.3324/haematol.13342; Meynard D, 2011, BLOOD, V118, P747, DOI 10.1182/blood-2011-04-348698; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nai A, 2012, BLOOD, V119, P5021, DOI 10.1182/blood-2012-01-401885; Nicolas G, 2002, BLOOD CELL MOL DIS, V29, P327, DOI 10.1006/bcmd.2002.0573; Nicolas G, 2011, BRIT J HAEMATOL, V152, P498, DOI 10.1111/j.1365-2141.2010.08473.x; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Nili M, 2010, J BIOL CHEM, V285, P24783, DOI 10.1074/jbc.M110.130286; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Ramsay AJ, 2009, HAEMATOL-HEMATOL J, V94, P840, DOI 10.3324/haematol.2008.001867; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Truksa J, 2009, BRIT J HAEMATOL, V147, P571, DOI 10.1111/j.1365-2141.2009.07873.x; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Willemetz A, 2014, BLOOD, V124, P441, DOI 10.1182/blood-2014-01-551150; Wisniewski Jacek R., 2009, V528, P127, DOI 10.1007/978-1-60327-310-7_9; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zhao NN, 2015, J BIOL CHEM, V290, P4432, DOI 10.1074/jbc.M114.611913	47	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148540	10.1371/journal.pone.0148540	http://dx.doi.org/10.1371/journal.pone.0148540			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845567	Green Submitted, Green Published, gold			2022-12-27	WOS:000369552800066
J	Kohata, Y; Fujiwara, Y; Watanabe, T; Kobayashi, M; Takemoto, Y; Kamata, N; Yamagami, H; Tanigawa, T; Shiba, M; Watanabe, T; Tominaga, K; Shuto, T; Arakawa, T				Kohata, Yukie; Fujiwara, Yasuhiro; Watanabe, Takanori; Kobayashi, Masanori; Takemoto, Yasuhiko; Kamata, Noriko; Yamagami, Hirokazu; Tanigawa, Tetsuya; Shiba, Masatsugu; Watanabe, Toshio; Tominaga, Kazunari; Shuto, Taichi; Arakawa, Tetsuo			Long-Term Benefits of Smoking Cessation on Gastroesophageal Reflux Disease and Health-Related Quality of Life	PLOS ONE			English	Article							CIGARETTE-SMOKING; STYLE MEASURES; RISK-FACTORS; POPULATION; IMPACT; GERD	Objective Smoking is associated with gastroesophageal reflux disease (GERD). Varenicline, a nicotinic receptor partial agonist, is used to aid smoking cessation. The purpose of this study was to prospectively examine the long-term benefits of smoking cessation on GERD and health-related quality of life (HR-QOL). Methods Patients treated with varenicline were asked to fill out a self-report questionnaire about their smoking habits, gastrointestinal symptoms, and HR-QOL before and 1 year after smoking cessation. The prevalence of GERD, frequency of symptoms, and HR-QOL scores were compared. We also investigated associations between clinical factors and newly-developed GERD. Results A total of 141 patients achieved smoking cessation (success group) and 50 did not (failure group) at 1 year after the treatment. The GERD improvement in the success group (43.9%) was significantly higher than that in the failure group (18.2%). The frequency of reflux symptoms significantly decreased only in the success group. There were no significant associations between newly developed GERD and clinical factors including increased body mass index and successful smoking cessation. HR-QOL significantly improved only in the success group. Conclusions Smoking cessation improved both GERD and HR-QOL. Smoking cessation should be recommended for GERD patients.	[Kohata, Yukie; Fujiwara, Yasuhiro; Kamata, Noriko; Yamagami, Hirokazu; Tanigawa, Tetsuya; Shiba, Masatsugu; Watanabe, Toshio; Tominaga, Kazunari; Arakawa, Tetsuo] Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka 558, Japan; [Watanabe, Takanori] Uehonmachi Watanabe Clin, Osaka, Japan; [Kobayashi, Masanori; Takemoto, Yasuhiko; Shuto, Taichi] Osaka City Univ, Grad Sch Med, Dept Med Educ & Gen Practice, Osaka 558, Japan	Osaka Metropolitan University; Osaka Metropolitan University	Fujiwara, Y (corresponding author), Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka 558, Japan.	yasu@med.osaka-cu.ac.jp	Tanigawa, Tetsuya/J-6131-2019	Tanigawa, Tetsuya/0000-0002-9305-1637	Otsuka; Eisai; Astellas; Abbott Japan, Takeda; Dainippon Sumitomo; Daiichi Sankyo	Otsuka(Otsuka Pharmaceutical); Eisai(Eisai Co Ltd); Astellas(Astellas Pharmaceuticals); Abbott Japan, Takeda; Dainippon Sumitomo(Dainippon Sumitomo Pharma Co., Ltd.); Daiichi Sankyo(Daiichi Sankyo Company Limited)	Prof. Arakawa received lecture fees from Otsuka and Eisai and research grants from Otsuka, Eisai, Astellas, Abbott Japan, Takeda, Dainippon Sumitomo, and Daiichi Sankyo. The remaining authors have no conflicts to disclose. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	DENNISH GW, 1971, NEW ENGL J MED, V284, P1136, DOI 10.1056/NEJM197105202842007; DIMENAS E, 1993, SCAND J GASTROENTERO, V28, P18, DOI 10.3109/00365529309098350; Fujiwara Y, 2011, INTERNAL MED, V50, P2443, DOI 10.2169/internalmedicine.50.6012; Fujiwara Y, 2009, J GASTROENTEROL, V44, P518, DOI 10.1007/s00535-009-0047-5; Fukuhara S., 2004, MANUAL SF 8 JAPANESE; Hallan A, 2015, AM J GASTROENTEROL, V110, P393, DOI 10.1038/ajg.2015.18; Hays JT, 2012, EUR J PUBLIC HEALTH, V22, P224, DOI 10.1093/eurpub/ckq137; KADAKIA SC, 1995, AM J GASTROENTEROL, V90, P1785; KAHRILAS PJ, 1989, J LAB CLIN MED, V114, P431; KAHRILAS PJ, 1990, GUT, V31, P4, DOI 10.1136/gut.31.1.4; Kaltenbach T, 2006, ARCH INTERN MED, V166, P965, DOI 10.1001/archinte.166.9.965; Kang JHE, 2015, THER ADV CHRONIC DIS, V6, P51, DOI 10.1177/2040622315569501; Kinoshita Y, 2009, AM J GASTROENTEROL, V104, P1106, DOI 10.1038/ajg.2009.77; Kusano M, 2004, J GASTROENTEROL, V39, P888, DOI 10.1007/s00535-004-1417-7; Matsuki N, 2013, J GASTROENTEROL, V48, P340, DOI 10.1007/s00535-012-0649-1; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Ness-Jensen E, 2016, CLIN GASTROENTEROL H, V14, P175, DOI 10.1016/j.cgh.2015.04.176; Ness-Jensen E, 2014, AM J GASTROENTEROL, V109, P171, DOI 10.1038/ajg.2013.414; Nilsson M, 2004, GUT, V53, P1730, DOI 10.1136/gut.2004.043265; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Piper ME, 2012, ANN BEHAV MED, V43, P262, DOI 10.1007/s12160-011-9329-2; SCHINDLBECK NE, 1987, GASTROENTEROLOGY, V92, P1994, DOI 10.1016/0016-5085(87)90634-2; Trudgill NJ, 1998, SCAND J GASTROENTERO, V33, P568; Ware J, 1994, SF 36 PHYS MENTAL SU; WARING JP, 1989, AM J GASTROENTEROL, V84, P1076; Watanabe Y, 2003, SCAND J GASTROENTERO, V38, P807, DOI 10.1080/00365520310004506	26	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147860	10.1371/journal.pone.0147860	http://dx.doi.org/10.1371/journal.pone.0147860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845761	gold, Green Published, Green Submitted			2022-12-27	WOS:000369552800018
J	Li, L; Liu, JC; Lai, FN; Liu, HQ; Zhang, XF; Dyce, PW; Shen, W; Chen, H				Li, Lan; Liu, Jing-Cai; Lai, Fang-Nong; Liu, Huan-Qi; Zhang, Xi-Feng; Dyce, Paul W.; Shen, Wei; Chen, Hong			Di (2-ethylhexyl) Phthalate Exposure Impairs Growth of Antral Follicle in Mice	PLOS ONE			English	Article							DI(2-ETHYLHEXYL) PHTHALATE; DIETHYLHEXYL PHTHALATE; OXIDATIVE STRESS; ESTROUS CYCLICITY; HORMONE-RECEPTOR; OVARIAN-FUNCTION; GENE-EXPRESSION; MOUSE; DEHP; OOCYTES	Di (2-ethylhexyl) phthalate (DEHP) is a widely used plastic additive. As an environmental endocrine disruptor, it has been shown to be harmful to the mammalian reproductive system. Previous studies indicated that DEHP inhibited the development of mouse ovarian follicles. However, the mechanisms by which DEHP affects ovarian antral follicle development during the pre-puberty stage are poorly understand. Thus, we investigated the effects of direct DEHP exposure on antral follicle growth in pre-pubescent mice by use of intraperitoneal injection. Our results demonstrated that the percentage of large antral follicles was significantly reduced when mice were exposed to 20 or 40 mu g/kg DEHP every 5 days from postnatal day 0 (0 dpp) to 15 dpp. In 20 dpp, we performed microarray of these ovaries. The microarray results indicated that mRNA levels of apoptosis related genes were increased. The mRNA levels of the apoptosis and cell proliferation (negative) related genes Apoe, Agt, Glo1 and Grina were increased after DEHP exposure. DEHP induced the differential gene expression of Hsp90ab1, Rhoa, Grina and Xdh which may play an important role in this process. In addition, TUNEL staining and immunofluorescence showed that DEHP exposure significantly increased the number of TUNEL, Caspase3 and.H2AX positive ovarian somatic cells within the mouse ovaries. Flow cytometer analyses of redox-sensitive probes showed that DEHP caused the accumulation of reactive oxygen species. Moreover, the mRNA expression of ovarian somatic cell antioxidative enzymes was down-regulated both in vivo and in vitro. In conclusion, our data here demonstrated that DEHP exposure induced oxidative stress and ovarian somatic cell apoptosis, and thus may impact antral follicle enlargement during the pre-pubertal stage in mice.	[Li, Lan; Chen, Hong] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Peoples R China; [Liu, Jing-Cai; Lai, Fang-Nong] Qingdao Agr Univ, Coll Life Sci, Qingdao 266109, Peoples R China; [Liu, Jing-Cai; Lai, Fang-Nong; Liu, Huan-Qi; Zhang, Xi-Feng; Shen, Wei] Qingdao Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Reprod & Germplasm Enhancement Univ, Inst Reprod Sci, Qingdao 266109, Peoples R China; [Dyce, Paul W.] Auburn Univ, Dept Anim Sci, Auburn, AL 36849 USA	Northwest A&F University - China; Qingdao Agricultural University; Qingdao Agricultural University; Auburn University System; Auburn University	Chen, H (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Peoples R China.	chenhong1212@263.net		Dyce, Paul/0000-0002-4574-3321	National Nature Science Foundation of China [31572225, 31471346, 31201120]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by National Nature Science Foundation of China, Number: 31572225, Recipient: Lan Li; National Nature Science Foundation of China, Number: 31471346, Recipient: Wei Shen; National Nature Science Foundation of China, Number: 31201120, Recipient: Xi-Feng Zhang.	Abd-Ellah MF, 2016, HUM EXP TOXICOL, V35, P232, DOI 10.1177/0960327115580602; Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Alvarez-Quilon A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4347; Ambruosi B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027452; Barry JA, 2014, J SEX MED, V11, P1882, DOI 10.1111/jsm.12503; Bauer MJ, 1997, SCI TOTAL ENVIRON, V208, P49, DOI 10.1016/S0048-9697(97)00272-6; Chao HH, 2012, HISTOCHEM CELL BIOL, V137, P249, DOI 10.1007/s00418-011-0894-z; Craig ZR, 2014, REPROD TOXICOL, V45, P45, DOI 10.1016/j.reprotox.2014.01.002; Craig ZR, 2011, REPRODUCTION, V142, P633, DOI 10.1530/REP-11-0136; Dalman A, 2008, BIOFACTORS, V33, P149, DOI 10.1002/biof.5520330207; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Edwards JL, 1997, MOL REPROD DEV, V46, P138, DOI 10.1002/(SICI)1098-2795(199702)46:2&lt;138::AID-MRD4&gt;3.0.CO;2-R; Engel SM, 2013, ANNU REV PUBL HEALTH, V34, P139, DOI 10.1146/annurev-publhealth-031811-124556; Forand A, 2004, BIOL REPROD, V71, P643, DOI 10.1095/biolreprod.104.027466; Fridstrom M, 1999, ACTA OBSTET GYN SCAN, V78, P212, DOI 10.1034/j.1600-0412.1999.780308.x; Hai L, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.129072; Hannon PR, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.129148; Hannon PR, 2015, TOXICOL APPL PHARM, V284, P42, DOI 10.1016/j.taap.2015.02.010; Hannon PR, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.119032; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43, DOI 10.1016/s0074-7696(08)61524-7; Hoeger KM, 2014, SEMIN REPROD MED, V32, P157, DOI 10.1055/s-0034-1371086; Kambia K, 2004, INT J ARTIF ORGANS, V27, P971, DOI 10.1177/039139880402701110; Kim SY, 2015, ENDOCRINOLOGY, V156, P1464, DOI 10.1210/en.2014-1926; Li L, 2015, HISTOCHEM CELL BIOL, V144, P389, DOI 10.1007/s00418-015-1348-9; Li L, 2014, MOL BIOL REP, V41, P1227, DOI 10.1007/s11033-013-2967-7; Liu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106412; Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Mu XY, 2015, J HAZARD MATER, V298, P232, DOI 10.1016/j.jhazmat.2015.05.052; Pierre A, 2013, HUM REPROD, V28, P762, DOI 10.1093/humrep/des460; Qin XS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127551; Rockville, 2014, SAF ASS DI 2 ETH PHT; Ruder EH, 2008, HUM REPROD UPDATE, V14, P345, DOI 10.1093/humupd/dmn011; Sampson J, 2011, TRANSFUSION MED, V21, P73, DOI 10.1111/j.1365-3148.2010.01056.x; Sircar D, 2008, J CHROMATOGR SCI, V46, P627, DOI 10.1093/chromsci/46.7.627; Tesfaye D, 2009, REPROD FERT DEVELOP, V21, P451, DOI 10.1071/RD08190; Thomas TA, 2010, REV EXPOSURE DATA AS; Turinetto V, 2015, NUCLEIC ACIDS RES, V43, P2489, DOI 10.1093/nar/gkv061; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; Wang W, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102467; Wang W, 2012, TOXICOL APPL PHARM, V258, P288, DOI 10.1016/j.taap.2011.11.008; Yodoi R, 2009, ENDOCRINOLOGY, V150, P3345, DOI 10.1210/en.2008-1449; Yuan FL, 2015, BONE, V75, P128, DOI 10.1016/j.bone.2015.02.017; Zhang HQ, 2012, MOL BIOL REP, V39, P5651, DOI 10.1007/s11033-011-1372-3; Zhang JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086589; Zhang T, 2014, ENVIRON MOL MUTAGEN, V55, P343, DOI 10.1002/em.21847; Zhang XF, 2015, REPROD FERT DEVELOP, V27, P1213, DOI 10.1071/RD14113; Zhang XF, 2013, ENVIRON MOL MUTAGEN, V54, P354, DOI 10.1002/em.21776	49	26	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148350	10.1371/journal.pone.0148350	http://dx.doi.org/10.1371/journal.pone.0148350			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845775	Green Published, gold			2022-12-27	WOS:000369552800048
J	Mikkelsen, KB; Bach, LA				Mikkelsen, Kaare B.; Bach, Lars A.			Threshold Games and Cooperation on Multiplayer Graphs	PLOS ONE			English	Article							SNOWDRIFT GAMES; EVOLUTIONARY DYNAMICS; DILEMMA; MODEL; DEFECTION; SIZE	Objective The study investigates the effect on cooperation in multiplayer games, when the population from which all individuals are drawn is structured-i.e. when a given individual is only competing with a small subset of the entire population. Method To optimize the focus on multiplayer effects, a class of games were chosen for which the payoff depends nonlinearly on the number of cooperators-this ensures that the game cannot be represented as a sum of pair-wise interactions, and increases the likelihood of observing behaviour different from that seen in two-player games. The chosen class of games are named "threshold games", and are defined by a threshold, M > 0, which describes the minimal number of cooperators in a given match required for all the participants to receive a benefit. The model was studied primarily through numerical simulations of large populations of individuals, each with interaction neighbourhoods described by various classes of networks. Results When comparing the level of cooperation in a structured population to the mean-field model, we find that most types of structure lead to a decrease in cooperation. This is both interesting and novel, simply due to the generality and breadth of relevance of the model-it is likely that any model with similar payoff structure exhibits related behaviour. More importantly, we find that the details of the behaviour depends to a large extent on the size of the immediate neighbourhoods of the individuals, as dictated by the network structure. In effect, the players behave as if they are part of a much smaller, fully mixed, population, which we suggest an expression for. Highlights Observed behaviour depends on the size of each player's immediate interaction neighbourhood. When the number of players is much larger than the number of required cooperators, average payoff decreases. Most network structures lead to a decrease in cooperation compared to the fully mixed case.	[Mikkelsen, Kaare B.] Aarhus Univ, Interacting Minds Ctr, DK-8000 Aarhus C, Denmark; [Mikkelsen, Kaare B.; Bach, Lars A.] Aarhus Univ, Dept Engn, DK-8000 Aarhus C, Denmark; [Bach, Lars A.] Aarhus Univ, ICOA, DK-8210 Aarhus V, Denmark	Aarhus University; Aarhus University; Aarhus University	Mikkelsen, KB (corresponding author), Aarhus Univ, Interacting Minds Ctr, DK-8000 Aarhus C, Denmark.; Mikkelsen, KB (corresponding author), Aarhus Univ, Dept Engn, DK-8000 Aarhus C, Denmark.	mikkelsen.kaare@gmail.com	Mikkelsen, Kaare/J-2217-2018	Mikkelsen, Kaare/0000-0002-7360-8629	Interacting Minds Centre, Aarhus University	Interacting Minds Centre, Aarhus University	This project has been supported by the seed funding program from the Interacting Minds Centre, Aarhus University.	Archetti M, 2011, EVOLUTION, V65, P1140, DOI 10.1111/j.1558-5646.2010.01185.x; Archetti M, 2009, J THEOR BIOL, V261, P475, DOI 10.1016/j.jtbi.2009.08.018; Bach LA, 2006, J THEOR BIOL, V238, P426, DOI 10.1016/j.jtbi.2005.06.007; Bach LA, 2001, EUR J CANCER, V37, P2116, DOI 10.1016/S0959-8049(01)00246-5; Bastian M., 2009, 3 INT AAAI C WEBL SO; Broom M, 1997, B MATH BIOL, V59, P931; Broom M, 2013, CHAPMAN HALL CRC MAT; Chen XJ, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/38003; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; EWENS WJ, 1982, THEOR POPUL BIOL, V21, P373, DOI 10.1016/0040-5809(82)90024-7; Gillespie JH, 2001, EVOLUTION, V55, P2161; Gokhale CS, 2014, DYN GAMES APPL, V4, P468, DOI 10.1007/s13235-014-0106-2; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Hummert S, 2014, MOL BIOSYST, V10, P3044, DOI 10.1039/c3mb70602h; Latane B, 1972, UNRESPONSIVE BYSTAND, V1; Li AM, 2015, J THEOR BIOL, V377, P57, DOI 10.1016/j.jtbi.2015.04.008; MOTRO U, 1991, J THEOR BIOL, V151, P145, DOI 10.1016/S0022-5193(05)80358-3; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pena J, 2014, J THEOR BIOL, V346, P23, DOI 10.1016/j.jtbi.2013.12.016; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos MD, 2012, J THEOR BIOL, V315, P81, DOI 10.1016/j.jtbi.2012.09.001; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Souza MO, 2009, J THEOR BIOL, V260, P581, DOI 10.1016/j.jtbi.2009.07.010; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; Szolnoki A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026104; Toivonen R, 2006, PHYSICA A, V371, P851, DOI 10.1016/j.physa.2006.03.050; Traulsen A, 2007, J THEOR BIOL, V246, P522, DOI 10.1016/j.jtbi.2007.01.002; Wang Z, 2015, PHYS LIFE REV, V14, P1, DOI 10.1016/j.plrev.2015.04.033; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WEESIE J, 1993, J CONFLICT RESOLUT, V37, P569, DOI 10.1177/0022002793037003008; WRIGHT S., 1938, Science (Washington), V87, P430; Zhang JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09098; Zhang YL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02021; Zheng DF, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/18002	37	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147207	10.1371/journal.pone.0147207	http://dx.doi.org/10.1371/journal.pone.0147207			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844547	Green Submitted, Green Published, gold			2022-12-27	WOS:000369552800009
J	Nagasawa, K; Sarropoulou, E; Edvardsen, V; Fernandes, JMO				Nagasawa, Kazue; Sarropoulou, Elena; Edvardsen, Vigdis; Fernandes, Jorge M. O.			Substantial Downregulation of Myogenic Transcripts in Skeletal Muscle of Atlantic Cod during the Spawning Period	PLOS ONE			English	Article							GADUS-MORHUA L; EXTRAOCULAR-MUSCLE; EXPRESSION; GENE; GROWTH; FISH; L.; MATURATION; PROTEASES; PROTEINS	Gonadal maturation is an extremely energy consuming process for batch spawners and it is associated with a significant decrease in growth and seasonal deterioration in flesh quality. Our knowledge about the molecular mechanisms linking sexual maturation and muscle growth is still limited. In the present study, we performed RNA-Seq using 454 GS-FLX pyro-sequencing in fast skeletal muscle sampled from two-year-old Atlantic cod (Gadus morhua) at representative time points throughout the reproductive cycle (August, March and May). In total, 126,937 good quality reads were obtained, with 546 nucleotide length and 52% GC content on average. RNA-Seq analysis using the CLC Genomics Workbench with the Atlantic cod reference UniGene cDNA data revealed 59,581 (46.9%) uniquely annotated reads. Pairwise comparison for expression levels identified 153 differentially expressed UniGenes between time points. Notably, we found a significant suppression of myh13 and myofibrillar gene isoforms in fast skeletal muscle during the spawning season. This study uncovered a large number of differentially expressed genes that may be influenced by gonadal maturation, thus representing a significant contribution to our limited understanding of the molecular mechanisms regulating muscle wasting and regeneration in batch spawners during their reproductive cycle.	[Nagasawa, Kazue; Edvardsen, Vigdis; Fernandes, Jorge M. O.] Nord Univ, Fac Biosci & Aquaculture, Marine Genom Grp, N-8049 Bodo, Norway; [Sarropoulou, Elena] Hellen Ctr Marine Res, Inst Marine Biol Biotechnol & Aquaculture, Iraklion 71003, Greece	Nord University; Hellenic Centre for Marine Research	Fernandes, JMO (corresponding author), Nord Univ, Fac Biosci & Aquaculture, Marine Genom Grp, N-8049 Bodo, Norway.	jorge.m.fernandes@nord.no	Fernandes, Jorge/AAC-4632-2022; Fernandes, Jorge MO/A-3526-2013; Nagasawa, Kazue/ABH-6117-2020	Fernandes, Jorge/0000-0002-2550-1640; Fernandes, Jorge MO/0000-0002-2550-1640; Nagasawa, Kazue/0000-0003-2819-3302	Research Council of Norway [190350/S40]	Research Council of Norway(Research Council of Norway)	This work was financed by the Research Council of Norway (grant 190350/S40, http://www.forskningsradet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolkar DB, 2010, J EXP BIOL, V213, P137, DOI 10.1242/jeb.030759; Bagenal T.B., 1978, P75; Bertola LD, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-166; BRADFORD RG, 1993, J FISH BIOL, V43, P811, DOI 10.1111/j.1095-8649.1993.tb01157.x; Briggs MM, 2002, J EXP BIOL, V205, P3133; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de la Serrana DG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-181; Freiburg A, 2000, CIRC RES, V86, P1114; Georgiou S, 2016, CELL TISSUE RES, V363, P541, DOI 10.1007/s00441-015-2254-0; Godo O.R., 1999, Journal of Northwest Atlantic Fishery Science, V25, P115, DOI 10.2960/J.v25.a10; Hagen O, 2008, J AGR FOOD CHEM, V56, P5953, DOI 10.1021/jf801215b; Hansen T, 2001, AQUACULTURE, V203, P51, DOI 10.1016/S0044-8486(01)00610-X; Hemre GI, 2004, AQUAC RES, V35, P683, DOI 10.1111/j.1365-2109.2004.01069.x; Imai JI, 1997, J EXP BIOL, V200, P27; Johnston IA, 2003, J EXP BIOL, V206, P1337, DOI 10.1242/jeb.00262; KARLSEN O, 1995, AQUACULTURE, V133, P159, DOI 10.1016/0044-8486(94)00399-9; Kiessling A, 1995, FISH PHYSIOL BIOCHEM, V14, P439, DOI 10.1007/BF00004344; Koshiba-Takeuchi K, 2006, NAT GENET, V38, P175, DOI 10.1038/ng1707; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; LUQUET P, 1986, FISH PHYSIOL BIOCHEM, V2, P121, DOI 10.1007/BF02264080; Nagasawa K, 2014, J MOL ENDOCRINOL, V52, P357, DOI 10.1530/JME-13-0187; Nagasawa K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036908; Palstra AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053171; Ricker W.E., 1979, BIOENERGETICS GROWTH, VVIII, P677, DOI DOI 10.1016/S1546-5098(08)60034-5; Salem M., 2013, PHYS REP, V1, P1; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Sarropoulou E, 2012, MAR BIOTECHNOL, V14, P634, DOI 10.1007/s10126-012-9466-z; Seeley M, 2007, CIRC RES, V100, P238, DOI 10.1161/01.RES.0000255758.69821.b5; Socquet-Juglard D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054196; Solberg C, 2008, AQUAC RES, V39, P619, DOI 10.1111/j.1365-2109.2008.01918.x; SPARGO E, 1979, J ROY SOC MED, V72, P921; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; TOYOHARA H, 1991, COMP BIOCHEM PHYS B, V99, P419, DOI 10.1016/0305-0491(91)90064-K; Wang DK, 2011, INT J BIOL SCI, V7, P440, DOI 10.7150/ijbs.7.440; Wang PA, 2009, FOOD CHEM, V115, P1228, DOI 10.1016/j.foodchem.2009.01.031; Winters LM, 1998, GENOMICS, V54, P188, DOI 10.1006/geno.1998.5558	38	0	0	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148374	10.1371/journal.pone.0148374	http://dx.doi.org/10.1371/journal.pone.0148374			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844771	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000369552800050
J	Zheng, H; Dirlam, J				Zheng, Hui; Dirlam, Jonathan			The Body Mass Index-Mortality Link across the Life Course: Two Selection Biases and Their Effects	PLOS ONE			English	Article							OBESITY PARADOX; HEART-FAILURE; WEIGHT CHANGE; RE OBESITY; RISK; AGE; HETEROGENEITY; ASSOCIATION; TIME; EXPECTANCY	In this study, we investigated two selection biases that may affect the obesity-mortality link over the life course: mortality selection and healthy participant effects. If these selection mechanisms are stronger among obese adults than among non-obese adults, they may contribute to the weakening obesity-mortality link over the life course. We used data from the National Health and Nutrition Examination Survey 1988-2010 with linked mortality files from 1988-2011. We employed weighted Cox models to test and adjust for these two selection biases. We also used complementary log-log models, adjusted for a normal distribution of frailty, to test for mortality selection effects; accelerated failure-time models to mitigate the mortality selection effect; and ordinary least squares regression to test for healthy participant effects. The link between class II/III obesity and mortality weakens at older ages. We did not find evidence for significant mortality selection or healthy participant effects. Also, even if the healthy participant effects were stronger among obese adults, they are not strong enough to produce a weakening association between obesity and morbidity at higher ages at the time of the survey. Therefore, neither of these selection biases explains the diminishing effect of class II/III obesity on mortality over the life course.	[Zheng, Hui; Dirlam, Jonathan] Ohio State Univ, Dept Sociol, Inst Populat Res, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Zheng, H (corresponding author), Ohio State Univ, Dept Sociol, Inst Populat Res, Columbus, OH 43210 USA.	zheng.64@osu.edu	Zheng, Hui/K-3735-2012	Zheng, Hui/0000-0003-3085-4560	Institute for Population Research at the Ohio State University, Eunice Kennedy Shriver National Institute for Child Health and Human Development [R24-HD058484]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD058484, R24HD058484] Funding Source: NIH RePORTER	Institute for Population Research at the Ohio State University, Eunice Kennedy Shriver National Institute for Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Support for this project is provided by a seed grant from the Institute for Population Research at the Ohio State University which is supported by a grant from the Eunice Kennedy Shriver National Institute for Child Health and Human Development (R24-HD058484).	Abhyankar S, 2012, CRIT CARE, V16, DOI 10.1186/cc11903; Adams KF, 2014, AM J EPIDEMIOL, V179, P135, DOI 10.1093/aje/kwt254; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Bender R, 1999, JAMA-J AM MED ASSOC, V281, P1498, DOI 10.1001/jama.281.16.1498; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Casas-Vara A, 2012, NUTRITION, V28, P616, DOI 10.1016/j.nut.2011.10.006; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Chapman IM, 2010, INTERD T GERONT GERI, V37, P20, DOI 10.1159/000319992; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flicker L, 2010, J AM GERIATR SOC, V58, P234, DOI 10.1111/j.1532-5415.2009.02677.x; Flinn C.J., 1982, SOCIOL METHODOL, V13, P99; Fonarow GC, 2007, AM HEART J, V153, P74, DOI 10.1016/j.ahj.2006.09.007; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Freedman DM, 2006, INT J OBESITY, V30, P822, DOI 10.1038/sj.ijo.0803193; Heckman JJ, 1982, ADV ECONOMETRICS, P39; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; HOUGAARD P, 1994, BIOMETRICS, V50, P1178, DOI 10.2307/2533456; Hutagalung R, 2011, INTENS CARE MED, V37, P1793, DOI 10.1007/s00134-011-2321-2; Keiding N, 1997, STAT MED, V16, P215; Kim BJ, 2012, NEUROLOGY, V79, P856, DOI 10.1212/WNL.0b013e318266fad1; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Kuk JL, 2009, J AM GERIATR SOC, V57, P2077, DOI 10.1111/j.1532-5415.2009.02486.x; Lantz PM, 2010, SOC SCI MED, V70, P1558, DOI 10.1016/j.socscimed.2010.02.003; Masters RK, 2013, AM J EPIDEMIOL, V177, P431, DOI 10.1093/aje/kws325; McAuley PA, 2010, MAYO CLIN PROC, V85, P115, DOI 10.4065/mcp.2009.0562; Mehta NK, 2013, AM J EPIDEMIOL, V178, P320, DOI 10.1093/aje/kwt117; Mehta NK, 2011, POPUL DEV REV, V37, P435, DOI 10.1111/j.1728-4457.2011.00429.x; Mehta NK, 2009, DEMOGRAPHY, V46, P851, DOI 10.1353/dem.0.0077; Mokdad AH, 2005, JAMA-J AM MED ASSOC, V293, P293, DOI 10.1001/jama.293.3.293; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Myrskyla M, 2009, EPIDEMIOLOGY, V20, P840, DOI 10.1097/EDE.0b013e3181b5f520; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Preston SH, 2014, EPIDEMIOLOGY, V25, P454, DOI 10.1097/EDE.0000000000000075; Reynolds SL, 2005, GERONTOLOGIST, V45, P438, DOI 10.1093/geront/45.4.438; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Stallard E., 2010, POP ASS AM 2010 ANN; Stevens June, 1998, New England Journal of Medicine, V338, P1, DOI 10.1056/NEJM199801013380101; Stewart Susan T, 2009, N Engl J Med, V361, P2252, DOI 10.1056/NEJMsa0900459; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Wang ZQ, 2014, AM J EPIDEMIOL, V179, P529, DOI 10.1093/aje/kwt329; Zheng H, 2013, AM J EPIDEMIOL, V178, P1591, DOI 10.1093/aje/kwt179; Zheng H, 2012, SOC SCI MED, V75, P990, DOI 10.1016/j.socscimed.2012.05.013	44	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148178	10.1371/journal.pone.0148178	http://dx.doi.org/10.1371/journal.pone.0148178			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841215	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200090
J	Hu, Q; Wang, XY; Kang, LK; Wei, HM; Xu, CM; Wang, T; Wen, ZH				Hu, Qiao; Wang, Xiao-Yan; Kang, Li-Ke; Wei, Hai-Ming; Xu, Chun-Mei; Wang, Tao; Wen, Zong-Hua			RGD-Targeted Ultrasound Contrast Agent for Longitudinal Assessment of Hep-2 Tumor Angiogenesis In Vivo	PLOS ONE			English	Article							MICROBUBBLES; EXPRESSION; US; INFLAMMATION; FEASIBILITY	Objective To prepare arginine-glycine-aspartate (RGD)-targeted ultrasound contrast microbubbles (MBs) and explore the feasibility of their use in assessing dynamic changes in alpha v beta 3 integrin expression in a murine model of tumor angiogenesis. Methods RGD peptides were conjugated to the surfaces of microbubbles via biotin-avidin linkage. Microbubbles bearing RADfK peptides were prepared as controls. The RGD-MBs were characterized using an Accusizer 780 and optical microscopy. The binding specificity of the RGD-MBs for alpha v beta 3-expressing endothelial cells (bEnd.3) was demonstrated in vitro by a competitive inhibition experiment. In an in vivo study, mice bearing tumors of three different stages were intravenously injected with RGD-MBs and subjected to targeted, contrast-enhanced, high-frequency ultrasound. Subsequently, tumors were harvested and sectioned for immunofluorescence analysis of alpha v beta 3 expression. Results The mean size of the RGD-MBs was 2.36 +/- 1.7 mu m. The RGD-MBs showed significantly higher adhesion levels to bEnd.3 cells compared to control MBs (P < 0.01). There was rarely binding of RGD-MBs to alpha v beta 3-negative MCF-7 cells. Adhesion of the RGD-MBs to the bEnd.3 cells was significantly inhibited following treatment with anti-alpha(v) antibodies. The quantitative acoustic video intensity for high-frequency, contrast-enhanced ultrasound imaging of subcutaneous human laryngeal carcinoma (Hep-2) tumor xenografts was significantly higher in small tumors (19.89 +/- 2.49) than in medium tumors (11.25 +/- 2.23) and large tumors (3.38 +/- 0.67) (P < 0.01). Conclusions RGD-MBs enable noninvasive in vivo visualization of changes in tumor angiogenesis during tumor growth in subcutaneous cancer xenografts.	[Hu, Qiao; Wang, Xiao-Yan; Kang, Li-Ke; Xu, Chun-Mei] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Diagnost Ultrasound, Nanning, Peoples R China; [Wei, Hai-Ming; Wen, Zong-Hua] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Pathol, Nanning, Peoples R China; [Wang, Tao] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Otolaryngol Head & Neck Surg, Nanning, Peoples R China		Hu, Q (corresponding author), Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Diagnost Ultrasound, Nanning, Peoples R China.	xyyxyhq@163.com			National Natural Science Foundation of China [81260223]; Guangxi Natural Science Foundation [2012GXNSFBA053083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This study was supported by the National Natural Science Foundation of China (No. 81260223) and Guangxi Natural Science Foundation project (2012GXNSFBA053083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CR, 2011, INVEST RADIOL, V46, P215, DOI 10.1097/RLI.0b013e3182034fed; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Chai LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061136; Deshpande N, 2011, RADIOLOGY, V258, P804, DOI 10.1148/radiol.10101079; Deshpande N, 2010, ANGIOGENESIS, V13, P175, DOI 10.1007/s10456-010-9175-z; Ellegala DB, 2003, CIRCULATION, V108, P336, DOI 10.1161/01.CIR.0000080326.15367.0C; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Golestani R, 2015, J NUCL CARDIOL, V22, P1179, DOI 10.1007/s12350-014-0061-8; Hauff P, 2004, RADIOLOGY, V231, P667, DOI 10.1148/radiol.2313030425; Hillen F, 2007, CANCER METAST REV, V26, P489, DOI 10.1007/s10555-007-9094-7; Kaufmann BA, 2007, CURR OPIN BIOTECH, V18, P11, DOI [10.1016/j.copbio.2007.01.004, 10.1159/000203128]; Kaufmann BA, 2009, CARDIOVASC RES, V83, P617, DOI 10.1093/cvr/cvp179; Lindner JR, 2009, CARDIOVASC RES, V84, P182, DOI 10.1093/cvr/cvp302; Liu S, 2006, MOL PHARMACEUT, V3, P472, DOI 10.1021/mp060049x; Lucidarme O, 2006, RADIOLOGY, V239, P730, DOI 10.1148/radiol.2392040986; Lyshchik A, 2007, J ULTRAS MED, V26, P1575, DOI 10.7863/jum.2007.26.11.1575; Needles A, 2010, ULTRASOUND MED BIOL, V36, P2097, DOI 10.1016/j.ultrasmedbio.2010.08.012; Rashidi LH, 2016, PHOTODIAGN PHOTODYN, V13, P244, DOI 10.1016/j.pdpdt.2015.08.001; Razavian M, 2011, ARTERIOSCL THROM VAS, V31, P2820, DOI 10.1161/ATVBAHA.111.231654; Schnell O, 2009, NEURO-ONCOLOGY, V11, P861, DOI 10.1215/15228517-2009-024; Sorace AG, 2012, J ULTRAS MED, V31, P1543; Streeter JE, 2011, MOL IMAGING, V10, P460, DOI 10.2310/7290.2011.00015; Wei SP, 2014, ULTRASOUND MED BIOL, V40, P1250, DOI 10.1016/j.ultrasmedbio.2013.12.001; Willmann JK, 2008, RADIOLOGY, V246, P508, DOI 10.1148/radiol.2462070536; Willmann JK, 2010, J NUCL MED, V51, P433, DOI 10.2967/jnumed.109.068007; Wu WL, 2013, INVEST RADIOL, V48, P803, DOI 10.1097/RLI.0b013e318298652d; Yan F, 2012, ULTRASOUND MED BIOL, V38, P670, DOI 10.1016/j.ultrasmedbio.2011.12.025	27	15	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149075	10.1371/journal.pone.0149075	http://dx.doi.org/10.1371/journal.pone.0149075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862757	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600151
J	Jagodzinski, AM; Ziolkowski, J; Warnkowska, A; Prais, H				Jagodzinski, Andrzej M.; Ziolkowski, Jedrzej; Warnkowska, Aleksandra; Prais, Hubert			Tree Age Effects on Fine Root Biomass and Morphology over Chronosequences of Fagus sylvatica, Quercus robur and Alnus glutinosa Stands	PLOS ONE			English	Article							SCOTS PINE STANDS; NORWAY SPRUCE FOREST; PICEA-ABIES L.; SILVER BIRCH; BOREAL FORESTS; SYLVESTRIS L.; VERTICAL-DISTRIBUTION; ABOVEGROUND BIOMASS; PLANTATION FORESTS; TEMPERATE FORESTS	There are few data on fine root biomass and morphology change in relation to stand age. Based on chronosequences for beech (9-140 years old), oak (11-140 years) and alder (476 years old) we aimed to examine how stand age affects fine root biomass and morphology. Soil cores from depths of 0-15 cm and 16-30 cm were used for the study. In contrast to previously published studies that suggested that maximum fine root biomass is reached at the canopy closure stage of stand development, we found almost linear increases of fine root biomass over stand age within the chronosequences. We did not observe any fine root biomass peak in the canopy closure stage. However, we found statistically significant increases of mean fine root biomass for the average individual tree in each chronosequence. Mean fine root biomass (0-30 cm) differed significantly among tree species chronosequences studied and was 4.32 Mg ha(-1), 3.71 Mg ha(-1) and 1.53 Mg ha(-1), for beech, oak and alder stands, respectively. The highest fine root length, surface area, volume and number of fine root tips (0-30 cm soil depth), expressed on a stand area basis, occurred in beech stands, with medium values for oak stands and the lowest for alder stands. In the alder chronosequence all these values increased with stand age, in the beech chronosequence they decreased and in the oak chronosequence they increased until ca. 50 year old stands and then reached steady-state. Our study has proved statistically significant negative relationships between stand age and specific root length (SRL) in 0-30 cm soil depth for beech and oak chronosequences. Mean SRLs for each chronosequence were not significantly different among species for either soil depth studied. The results of this study indicate high fine root plasticity. Although only limited datasets are currently available, these data have provided valuable insight into fine root biomass and morphology of beech, oak and alder stands.	[Jagodzinski, Andrzej M.] Polish Acad Sci, Inst Dendrol, Parkowa 5, PL-62035 Kornik, Poland; [Jagodzinski, Andrzej M.; Ziolkowski, Jedrzej; Warnkowska, Aleksandra; Prais, Hubert] Poznan Univ Life Sci, Dept Game Management & Forest Protect, Fac Forestry, Wojska Polskiego 71c, PL-60625 Poznan, Poland	Polish Academy of Sciences; Poznan University of Life Sciences	Jagodzinski, AM (corresponding author), Polish Acad Sci, Inst Dendrol, Parkowa 5, PL-62035 Kornik, Poland.; Jagodzinski, AM (corresponding author), Poznan Univ Life Sci, Dept Game Management & Forest Protect, Fac Forestry, Wojska Polskiego 71c, PL-60625 Poznan, Poland.	amj@man.poznan.pl	Jagodziński, Andrzej M./AAA-2537-2021	Jagodziński, Andrzej M./0000-0001-6899-0985	General Directorate of State Forests, Warsaw, Poland	General Directorate of State Forests, Warsaw, Poland	This study was supported by General Directorate of State Forests, Warsaw, Poland (research projects: Carbon balance of the major forest-forming tree species in Poland' (2007-2011) and 'Environmental and genetic factors affecting productivity of forest ecosystems on forest and postindustrial habitats' (2011-2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by General Directorate of State Forests, Warsaw, Poland (research projects: 'Carbon balance of the major forest-forming tree species in Poland' (2007-2011) and 'Environmental and genetic factors affecting productivity of forest ecosystems on forest and post-industrial habitats' (2011-2015)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank Dr. Lee E. Frelich (University of Minnesota, USA) for valuable suggestions and linguistic revision of the manuscript and Dr. Jan Bocianowski (Department of Mathematical and Statistical Methods, Poznan University of Life Sciences, Poland) for statistical advice. We are also grateful to Marcin Dyderski for preparation of figures and valuable comments to the earlier version of the manuscript. Before we established the study sites, the approvals were obtained for each location from the respective local forest district managers (Andrzej Wawrzyniak-Piaski Forest District, Dr. Roman Bartol-Trzcianka Forest District, Roman Wojcik-Gryfino Forest District) that represent the State Forests National Forest Holding.	[Anonymous], 2014, R LANG ENV STAT COMP; Aosaar J, 2013, EUR J FOREST RES, V132, P737, DOI 10.1007/s10342-013-0706-1; Bakker MR, 2008, J FOREST RES-JPN, V13, P176, DOI 10.1007/s10310-008-0068-6; Bauhus J, 1999, CAN J FOREST RES, V29, P260, DOI 10.1139/cjfr-29-2-260; Bauhus J, 1999, AGRON J, V91, P142, DOI 10.2134/agronj1999.00021962009100010022x; Berg B., 2008, PLANT LITTER DECOMPO, DOI [DOI 10.1007/978-3-662-05349-2, 10.1007/978-3-662-05349-2]; Borja I, 2008, TREE PHYSIOL, V28, P773, DOI 10.1093/treephys/28.5.773; Brassard BW, 2009, CRIT REV PLANT SCI, V28, P179, DOI 10.1080/07352680902776572; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; Chang RY, 2012, ECOL RES, V27, P827, DOI 10.1007/s11284-012-0958-0; Chen WJ, 2004, PLANT SOIL, V265, P31, DOI 10.1007/s11104-005-8503-3; Claessens H, 2010, FORESTRY, V83, P163, DOI 10.1093/forestry/cpp038; Claus A, 2005, CAN J FOREST RES, V35, P1617, DOI 10.1139/x05-079; Comas LH, 2002, OECOLOGIA, V132, P34, DOI 10.1007/s00442-002-0922-8; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; DAWSON JO, 1981, FOREST SCI, V27, P239; Di Iorio A, 2013, TREES-STRUCT FUNCT, V27, P1503, DOI 10.1007/s00468-013-0897-6; EISSENSTAT DM, 1991, NEW PHYTOL, V118, P63, DOI 10.1111/j.1469-8137.1991.tb00565.x; Eissenstat DM, 1997, ADV ECOL RES, V27, P1, DOI 10.1016/S0065-2504(08)60005-7; Finer L, 2007, PLANT BIOSYST, V141, P394, DOI 10.1080/11263500701625897; Finer L, 1997, CAN J FOREST RES, V27, P304, DOI 10.1139/x96-170; Finer L, 2011, FOREST ECOL MANAG, V262, P2008, DOI 10.1016/j.foreco.2011.08.042; Finer L, 2011, FOREST ECOL MANAG, V261, P265, DOI 10.1016/j.foreco.2010.10.016; Fujimaki R, 2007, J FOREST RES-JPN, V12, P96, DOI 10.1007/s10310-006-0256-1; Goebel M, 2011, ECOL MONOGR, V81, P89, DOI 10.1890/09-2390.1; Gower S. T., 1994, ECOL BULL, P115; Hartmann P, 2014, CAN J FOREST RES, V44, P71, DOI 10.1139/cjfr-2013-0357; Helmisaari HS, 2007, TREE PHYSIOL, V27, P1493, DOI 10.1093/treephys/27.10.1493; Helmisaari HS, 2002, FOREST ECOL MANAG, V165, P317, DOI 10.1016/S0378-1127(01)00648-X; Hertel D, 2013, J ECOL, V101, DOI 10.1111/1365-2745.12124; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Idol TW, 2000, FOREST ECOL MANAG, V127, P153, DOI 10.1016/S0378-1127(99)00127-9; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Jagodzinski AM, 2008, DENDROBIOLOGY, V59, P57; Jagodzinski AM, 2011, DENDROBIOLOGY, V66, P71; Jagodzinski AM, 2010, DENDROBIOLOGY, V64, P19; Jagodzinski AM, 2009, SYLWAN, V153, P147; Kalliokoski T, 2010, PLANT SOIL, V330, P73, DOI 10.1007/s11104-009-0177-9; Konopka B, 2005, PLANT SOIL, V276, P33, DOI 10.1007/s11104-004-2976-3; Leuschner C, 2003, PROG BOT, V64, P405; Leuschner C, 2004, PLANT SOIL, V258, P43, DOI 10.1023/B:PLSO.0000016508.20173.80; Litton CM, 2003, CAN J FOREST RES, V33, P351, DOI 10.1139/X02-181; LOHMUS K, 1989, PLANT SOIL, V119, P245, DOI 10.1007/BF02370415; Lohmus Krista, 2002, Archiv fuer Hydrobiologie Supplement, V141, P321; Makkonen K, 2001, TREE PHYSIOL, V21, P193, DOI 10.1093/treephys/21.2-3.193; McCormack ML, 2015, NEW PHYTOL, V207, P505, DOI 10.1111/nph.13363; Mei L, 2010, J FOREST RES-JPN, V15, P194, DOI 10.1007/s10310-009-0176-y; Meinen C, 2009, ECOSYSTEMS, V12, P1103, DOI 10.1007/s10021-009-9271-3; Meinen C, 2009, OECOLOGIA, V161, P99, DOI 10.1007/s00442-009-1352-7; Mund M, 2002, FOREST ECOL MANAG, V171, P275, DOI 10.1016/S0378-1127(01)00788-5; Noguchi K, 2007, J FOREST RES-JPN, V12, P83, DOI 10.1007/s10310-006-0262-3; Ostonen I, 2007, PLANT BIOSYST, V141, P426, DOI 10.1080/11263500701626069; Ostonen I, 2006, OIL SHALE, V23, P187; Ostonen I, 2005, FOREST ECOL MANAG, V212, P264, DOI 10.1016/j.foreco.2005.03.064; Ostonen I, 2007, TREE PHYSIOL, V27, P1627, DOI 10.1093/treephys/27.11.1627; Peichl M, 2006, AGR FOREST METEOROL, V140, P51, DOI 10.1016/j.agrformet.2006.08.004; PERSSON HA, 1983, PLANT SOIL, V71, P87, DOI 10.1007/BF02182644; Persson HA, 2010, PLANT SOIL, V330, P329, DOI 10.1007/s11104-009-0206-8; Persson HA, 2009, PLANT SOIL, V318, P1, DOI 10.1007/s11104-008-9811-1; Rosenvald K, 2013, EUR J FOREST RES, V132, P219, DOI 10.1007/s10342-012-0669-7; Rosenvald K, 2011, ECOL ENG, V37, P1027, DOI 10.1016/j.ecoleng.2010.05.011; SAINJU UM, 1993, PLANT SOIL, V150, P87, DOI 10.1007/BF00779179; Schenk HJ, 2005, PROG BOT, V66, P341; Schmid I, 2002, FOREST ECOL MANAG, V159, P37, DOI 10.1016/S0378-1127(01)00708-3; Vanninen P, 1999, TREE PHYSIOL, V19, P823; Vanninen P, 1996, TREES-STRUCT FUNCT, V10, P231, DOI 10.1007/BF02185674; Vares A, 2004, OIL SHALE, V21, P43; Vogt K.A., 1991, TECHNIQUES APPROACHE, P477; Vogt KA, 1996, PLANT SOIL, V187, P159, DOI 10.1007/BF00017088; VOGT KA, 1987, J ECOL, V75, P857, DOI 10.2307/2260210; Withington JM, 2006, ECOL MONOGR, V76, P381, DOI 10.1890/0012-9615(2006)076[0381:COSALS]2.0.CO;2; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Xiao CW, 2003, TREE PHYSIOL, V23, P505, DOI 10.1093/treephys/23.8.505; Yuan ZY, 2012, FUNCT ECOL, V26, P991, DOI 10.1111/j.1365-2435.2012.02007.x; Yuan ZY, 2010, CRIT REV PLANT SCI, V29, P204, DOI 10.1080/07352689.2010.483579; Yuste JC, 2005, TREE PHYSIOL, V25, P701, DOI 10.1093/treephys/25.6.701; Zadworny M, 2015, TREE PHYSIOL, V35, P644, DOI 10.1093/treephys/tpv018; Zadworny M, 2011, NEW PHYTOL, V190, P213, DOI 10.1111/j.1469-8137.2010.03598.x; Zhou ZC, 2007, PLANT SOIL, V291, P119, DOI 10.1007/s11104-006-9179-z	80	37	39	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148668	10.1371/journal.pone.0148668	http://dx.doi.org/10.1371/journal.pone.0148668			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859755	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400062
J	Omer, S; Golden, E; Priebe, S				Omer, Serif; Golden, Eoin; Priebe, Stefan			Exploring the Mechanisms of a Patient-Centred Assessment with a Solution Focused Approach (DIALOG plus ) in the Community Treatment of Patients with Psychosis: A Process Evaluation within a Cluster-Randomised Controlled Trial	PLOS ONE			English	Article							MENTAL-HEALTH-SERVICES; RESEARCH-COUNCIL GUIDANCE; COMPLEX INTERVENTIONS; CLINICIAN COMMUNICATION; REPORTED OUTCOMES; SCHIZOPHRENIA; CARE; DEPRESSION; DISORDERS; THERAPY	Background DIALOG+ is a new intervention to make routine community mental health meetings therapeutically effective. It involves a structured assessment of patient concerns and a solution-focused approach to address them. In a randomised controlled trial, DIALOG+ was associated with better subjective quality of life and other outcomes in patients with psychosis, but it was not clear how this was achieved. This study explored the possible mechanisms. Methods This was a mixed-methods process evaluation within a cluster-randomised controlled trial. Focus groups and interviews were conducted with patients and clinicians who experienced DIALOG+ and were analysed using thematic analysis. The content of DIALOG+ sessions was recorded and analysed according to (i) the type of actions agreed during sessions and (ii) the domains discussed. The subjective quality of life measure was analysed with mixed-effects models to explore whether the effect of DIALOG+ was limited to life domains that had been addressed in sessions or consistent across all domains. Results Four qualitative themes emerged regarding the mechanisms of DIALOG+: (1) a comprehensive structure; (2) self-reflection; (3) therapeutic self-expression; and (4) empowerment. Patients took responsibility for the majority of actions agreed during sessions (65%). The treatment effect on subjective quality of life was largest for living situation (accommodation and people that the patient lives with) and mental health. Two of these domains were among the three most commonly discussed in DIALOG+ sessions (accommodation, mental health, and physical health). Conclusion DIALOG+ initiates positive, domain-specific change in the areas that are addressed in sessions. It provides a comprehensive and solution-focused structure to routine meetings, encourages self-reflection and expression, and empowers patients. Future research should strengthen and monitor these factors.	[Omer, Serif; Golden, Eoin; Priebe, Stefan] Queen Mary Univ London, WHO Collaborating Ctr Mental Hlth Serv Dev, Unit Social & Community Psychiat, London, England	University of London; Queen Mary University London; World Health Organization	Priebe, S (corresponding author), Queen Mary Univ London, WHO Collaborating Ctr Mental Hlth Serv Dev, Unit Social & Community Psychiat, London, England.	s.priebe@qmul.ac.uk		Priebe, Stefan/0000-0001-9864-3394	National Institute for Health Research under its Programme Grants for Applied Research Programme [RP-PG-0108-10023]; National Institute for Health Research [RP-PG-0108-10023] Funding Source: researchfish	National Institute for Health Research under its Programme Grants for Applied Research Programme; National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research funded by the National Institute for Health Research (http://www.nihr.ac.uk) under its Programme Grants for Applied Research Programme (Grant Reference Number RP-PG-0108-10023). The views expressed are those of the authors, and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JR, 2007, PSYCHIAT SERV, V58, P1219, DOI 10.1176/appi.ps.58.9.1219; Arnau RC, 2007, J PERS, V75, P43, DOI 10.1111/j.1467-6494.2006.00432.x; Becker EM, 2013, BEHAV THER, V44, P614, DOI 10.1016/j.beth.2013.05.002; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bridle D, 2013, PSYCHOSIS, V5, P154, DOI 10.1080/17522439.2012.683036; Clarke E, 2015, ACTA PSYCHIAT SCAND, V131, P369, DOI 10.1111/acps.12365; Collins K, 2006, LEARN DISABIL-MULTI, DOI DOI 10.1177/1558689807299526; Corrigan PW, 1999, SCHIZOPHR RES, V38, P77, DOI 10.1016/S0920-9964(98)00180-7; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Craske MG, 2009, DEPRESS ANXIETY, V26, P235, DOI 10.1002/da.20542; De Hert M, 2011, WORLD PSYCHIATRY, V10, P138; Gilbody SM, 2001, BRIT MED J, V322, P406, DOI 10.1136/bmj.322.7283.406; Gilburt H, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-167; Grant A, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-15; Hamann J, 2008, J NERV MENT DIS, V196, P329, DOI 10.1097/NMD.0b013e31816a62a0; HANSSON L, 1992, SCAND J SOC MED, V20, P45, DOI 10.1177/140349489202000109; Hemming L., 2016, WHO ARE EXPERTS EXPE; Kennedy C, 2001, NURS RES, V50, P184, DOI 10.1097/00006199-200105000-00010; Krippendorff K., 2018, CONTENT ANAL INTRO I, V4th ed.; McCabe R, 2007, BRIT J PSYCHIAT, V191, pS21, DOI 10.1192/bjp.191.50.s21; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; Pfammatter M, 2006, SCHIZOPHRENIA BULL, V32, pS64, DOI 10.1093/schbul/sbl030; Priebe S, 2006, ACTA PSYCHIAT SCAND, V113, P69, DOI 10.1111/j.1600-0447.2005.00721.x; Priebe S, 1999, INT J SOC PSYCHIATR, V45, P7, DOI 10.1177/002076409904500102; Priebe S, 2011, EUR PSYCHIAT, V26, P403, DOI 10.1016/j.eurpsy.2010.07.010; Priebe S, PSYCHOTHER PSYCHOSOM; Priebe S, 2007, BRIT J PSYCHIAT, V191, P420, DOI 10.1192/bjp.bp.107.036939; Priebe S, 2014, BRIT J PSYCHIAT, V204, P256, DOI 10.1192/bjp.bp.113.135038; Priebe S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-173; Reininghaus U, 2011, PSYCHOL MED, V41, P277, DOI 10.1017/S0033291710000784; Schrank B, 2014, EPIDEMIOL PSYCH SCI, V23, P271, DOI 10.1017/S2045796013000322; Slade M, 2006, BRIT J PSYCHIAT, V189, P330, DOI 10.1192/bjp.bp.105.015412; Van Os J, 2004, BRIT J PSYCHIAT, V184, P79, DOI 10.1192/bjp.184.1.79; Warner R, 2009, CURR OPIN PSYCHIATR, V22, P374, DOI 10.1097/YCO.0b013e32832c920b; Watson J. C., 2001, REV GEN PSYCHOL, V5, P187, DOI DOI 10.1037/1089-2680.5.3.187; World Health Organization, 2013, MENT HLTH ACT PLAN 2; Wykes T, 2008, SCHIZOPHRENIA BULL, V34, P523, DOI 10.1093/schbul/sbm114	37	18	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148415	10.1371/journal.pone.0148415	http://dx.doi.org/10.1371/journal.pone.0148415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859388	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400040
J	Dogan, C; De Antonio, M; Hamroun, D; Varet, H; Fabbro, M; Rougier, F; Amarof, K; Bes, MCA; Bedat-Millet, AL; Behin, A; Bellance, R; Bouhour, F; Boutte, C; Boyer, F; Campana-Salort, E; Chapon, F; Cintas, P; Desnuelle, C; Deschamps, R; Drouin-Garraud, V; Ferrer, X; Gervais-Bernard, H; Ghorab, K; Laforet, P; Magot, A; Magy, L; Menard, D; Minot, MC; Nadaj-Pakleza, A; Pellieux, S; Pereon, Y; Preudhomme, M; Pouget, J; Sacconi, S; Sole, G; Stojkovich, T; Tiffreau, V; Urtizberea, A; Vial, C; Zagnoli, F; Caranhac, G; Bourlier, C; Riviere, G; Geille, A; Gherardi, RK; Eymard, B; Puymirat, J; Katsahian, S; Bassez, G				Dogan, Celine; De Antonio, Marie; Hamroun, Dalil; Varet, Hugo; Fabbro, Marianne; Rougier, Felix; Amarof, Khadija; Bes, Marie-Christine Arne; Bedat-Millet, Anne-Laure; Behin, Anthony; Bellance, Remi; Bouhour, Francoise; Boutte, Celia; Boyer, Francois; Campana-Salort, Emmanuelle; Chapon, Francoise; Cintas, Pascal; Desnuelle, Claude; Deschamps, Romain; Drouin-Garraud, Valerie; Ferrer, Xavier; Gervais-Bernard, Helene; Ghorab, Karima; Laforet, Pascal; Magot, Armelle; Magy, Laurent; Menard, Dominique; Minot, Marie-Christine; Nadaj-Pakleza, Aleksandra; Pellieux, Sybille; Pereon, Yann; Preudhomme, Marguerite; Pouget, Jean; Sacconi, Sabrina; Sole, Guilhem; Stojkovich, Tanya; Tiffreau, Vincent; Urtizberea, Andoni; Vial, Christophe; Zagnoli, Fabien; Caranhac, Gilbert; Bourlier, Claude; Riviere, Gerard; Geille, Alain; Gherardi, Romain K.; Eymard, Bruno; Puymirat, Jack; Katsahian, Sandrine; Bassez, Guillaume			Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study	PLOS ONE			English	Article							CTG REPEAT EXPANSION; SOMATIC INSTABILITY; TRIPLET REPEAT; DISEASE; REGION; MANIFESTATIONS; AMPLIFICATION; ANTICIPATION; IMPAIRMENT; PREDICTION	Background Myotonic Dystrophy type 1 (DM1) is one of the most heterogeneous hereditary disease in terms of age of onset, clinical manifestations, and severity, challenging both medical management and clinical trials. The CTG expansion size is the main factor determining the age of onset although no factor can finely predict phenotype and prognosis. Differences between males and females have not been specifically reported. Our aim is to study gender impact on DM1 phenotype and severity. Methods We first performed cross-sectional analysis of main multiorgan clinical parameters in 1409 adult DM1 patients (> 18y) from the DM-Scope nationwide registry and observed different patterns in males and females. Then, we assessed gender impact on social and economic domains using the AFM-Telethon DM1 survey (n = 970), and morbidity and mortality using the French National Health Service Database (n = 3301). Results Men more frequently had (1) severe muscular disability with marked myotonia, muscle weakness, cardiac, and respiratory involvement; (2) developmental abnormalities with facial dysmorphism and cognitive impairment inferred from low educational levels and work in specialized environments; and (3) lonely life. Alternatively, women more frequently had cataracts, dysphagia, digestive tract dysfunction, incontinence, thyroid disorder and obesity. Most differences were out of proportion to those observed in the general population. Compared to women, males were more affected in their social and economic life. In addition, they were more frequently hospitalized for cardiac problems, and had a higher mortality rate. Conclusion Gender is a previously unrecognized factor influencing DM1 clinical profile and severity of the disease, with worse socio-economic consequences of the disease and higher morbidity and mortality in males. Gender should be considered in the design of both stratified medical management and clinical trials.	[Dogan, Celine; De Antonio, Marie; Varet, Hugo; Fabbro, Marianne; Rougier, Felix; Gherardi, Romain K.; Bassez, Guillaume] GH Henri Mondor, AP HP, Neuromuscular Reference Ctr, Creteil, France; [Dogan, Celine; De Antonio, Marie; Varet, Hugo; Fabbro, Marianne; Rougier, Felix; Gherardi, Romain K.; Bassez, Guillaume] UPEC Univ, INSERM U955, Creteil, France; [De Antonio, Marie; Katsahian, Sandrine] UPMC Univ, Paris Descartes Univ, Ctr Rech Cordeliers, INSERM U1138, Paris, France; [Hamroun, Dalil] CHU Montpellier, Direct Rech & Innovat, Montpellier, France; [Amarof, Khadija; Bellance, Remi; Deschamps, Romain] CHU Fort de France, Neuromuscular Reference Ctr, Fort De France, France; [Bes, Marie-Christine Arne; Cintas, Pascal] CHU Toulouse, Neuromuscular Reference Ctr, Toulouse, France; [Bedat-Millet, Anne-Laure; Drouin-Garraud, Valerie] CHU Rouen, Neuromuscular Competence Ctr, Rouen, France; [Behin, Anthony; Laforet, Pascal; Eymard, Bruno] GH Pitie Salpetriere, AP HP, Neuromuscular Reference Ctr, Paris, France; [Bouhour, Francoise; Gervais-Bernard, Helene; Vial, Christophe] HCL, GH Est, Neuromuscular Reference Ctr, Bron, France; [Boutte, Celia] CHU Grenoble, Neuromuscular Reference Ctr, F-38043 Grenoble, France; [Boyer, Francois] CHU Reims, Neuromuscular Reference Ctr, Reims, France; [Campana-Salort, Emmanuelle; Pouget, Jean] GH Timone, AP HM, Neuromuscular Reference Ctr, Marseille, France; [Chapon, Francoise] CHU Caen, Neuromuscular Competence Ctr, F-14000 Caen, France; [Desnuelle, Claude; Sacconi, Sabrina] CHU Nice, Neuromuscular Reference Ctr, F-06202 Nice, France; [Ferrer, Xavier; Sole, Guilhem] CHU Bordeaux, Neuromuscular Reference Ctr, Bordeaux, France; [Ghorab, Karima; Magy, Laurent] CHU Limoges, Neuromuscular Reference Ctr, Limoges, France; [Magot, Armelle; Pereon, Yann] CHU Nantes, Neuromuscular Reference Ctr, F-44035 Nantes 01, France; [Menard, Dominique; Minot, Marie-Christine] CHU Rennes, Neuromuscular Competence Ctr, Rennes, France; [Nadaj-Pakleza, Aleksandra] CHU Angers, Neuromuscular Reference Ctr, Angers, France; [Pellieux, Sybille] CHU Tours, Neuromuscular Competence Ctr, Tours, France; [Preudhomme, Marguerite; Tiffreau, Vincent] CHRU Lille, Neuromuscular Reference Ctr, F-59037 Lille, France; [Urtizberea, Andoni] Hop Marin, AP HP, Neuromuscular Reference Ctr, Hendaye, France; [Zagnoli, Fabien] HIA Clermont Tonnerre, Neuromuscular Competence Ctr, Brest, France; [Caranhac, Gilbert] Hox Com Analyt Paris, PMSI Div, Paris, France; [Bourlier, Claude; Riviere, Gerard; Geille, Alain] AFM Telethon, Patients Grp DM1, CoPil, Evry, France; [Puymirat, Jack] CHU Laval, Human Genet Res Unit, Laval, PQ, Canada	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier; CHU Martinique; CHU de Toulouse; CHU de Rouen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Lyon; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU de Reims; Universite de Reims Champagne-Ardenne; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU Nice; CHU Bordeaux; CHU Limoges; Nantes Universite; CHU de Nantes; CHU Rennes; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Tours; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Marin de Hendaye - APHP; Laval University	Bassez, G (corresponding author), GH Henri Mondor, AP HP, Neuromuscular Reference Ctr, Creteil, France.; Bassez, G (corresponding author), UPEC Univ, INSERM U955, Creteil, France.	guillaume.bassez@hmn.aphp.fr	Boyer, François Constant/P-4544-2016; BELLANCE, Remi/H-3721-2019; Dalil, Hamroun/A-8382-2008; Bassez, Guillaume/AAD-3033-2022; SACCONI, Sabrina/AFT-1096-2022	Boyer, François Constant/0000-0003-1035-9108; Dalil, Hamroun/0000-0002-4853-8227; SACCONI, Sabrina/0000-0002-0246-1455; Bassez, Guillaume/0000-0002-2044-1052; KATSAHIAN, Sandrine/0000-0002-7261-0671; Behin, Anthony/0000-0001-7179-5152; Magy, Laurent/0000-0003-1784-2901; DE ANTONIO, Marie/0000-0001-5114-0546; pascal, cintas/0000-0002-0242-4849	AFM-Telethon	AFM-Telethon(Association Francaise contre les Myopathies)	The study has been funded by AFM-Telethon, http://www.afm-telethon.fr/, GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHIZAWA T, 1992, NEUROLOGY, V42, P1877; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BRAIS B, 1995, HUM MOL GENET, V4, P429, DOI 10.1093/hmg/4.3.429; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; DAMIAN MS, 1994, NEUROREPORT, V5, P2549, DOI 10.1097/00001756-199412000-00036; Dean NL, 2006, FERTIL STERIL, V86, P98, DOI 10.1016/j.fertnstert.2005.12.025; Eguchi I, 1994, Rinsho Shinkeigaku, V34, P118; Eschwege E, 2012, ENQUETE EPIDEMIOLOGI; Estaquio C, MALADIES THYROIDIENN; Fagot-Campagna A, PREVALENCE INCIDENCE; Fialho D, 2008, NEUROMUSCULAR DISORD, V18, P869, DOI 10.1016/j.nmd.2008.07.004; Finsterer J, 2007, INT J CARDIOL, V119, P176, DOI 10.1016/j.ijcard.2006.07.121; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Garcia-Gomez T, 1999, REV NEUROLOGIA, V29, P499, DOI 10.33588/rn.2906.99252; Gennarelli M, 1996, AM J MED GENET, V65, P342, DOI 10.1002/(SICI)1096-8628(19961111)65:4<342::AID-AJMG18>3.0.CO;2-U; Gharehbaghi-Schnell EB, 1998, CLIN GENET, V53, P20, DOI 10.1034/j.1399-0004.1998.531530105.x; GREEN HJ, 1984, J NEUROL SCI, V65, P323, DOI 10.1016/0022-510X(84)90095-9; Groh WJ, 2011, MUSCLE NERVE, V43, P648, DOI 10.1002/mus.21934; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Harper P.S., 2001, MAJOR PROBLEMS NEURO; HARPER PS, 1992, AM J HUM GENET, V51, P10; Hermans MCE, 2011, J PERIPHER NERV SYST, V16, P24, DOI 10.1111/j.1529-8027.2011.00313.x; Heydemann A, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-26; Higham CF, 2012, HUM MOL GENET, V21, P2450, DOI 10.1093/hmg/dds059; Hsiao KM, 2003, NEUROEPIDEMIOLOGY, V22, P283, DOI 10.1159/000071191; HUNTER A, 1992, J MED GENET, V29, P774, DOI 10.1136/jmg.29.11.774; JASPERT A, 1995, J NEUROL, V242, P99, DOI 10.1007/BF00887824; Kaminsky P, 2011, MEDICINE, V90, P262, DOI 10.1097/MD.0b013e318226046b; Ke Q, 2013, MUSCLE NERVE, V47, P41, DOI 10.1002/mus.23460; KOCH MC, 1991, AM J HUM GENET, V48, P1084; Kuo HC, 2008, ACTA NEUROL SCAND, V117, P101, DOI 10.1111/j.1600-0404.2007.00911.x; LAVEDAN C, 1993, AM J HUM GENET, V52, P875; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Marchini C, 2000, CLIN GENET, V57, P74, DOI 10.1034/j.1399-0004.2000.570112.x; Marcon M, 1998, ITAL J NEUROL SCI, V19, P75, DOI 10.1007/BF02427560; Martorell L, 1997, HUM MOL GENET, V6, P877, DOI 10.1093/hmg/6.6.877; MASTROGIACOMO I, 1994, J ENDOCRINOL INVEST, V17, P381, DOI 10.1007/BF03349005; Mathieu J, 2001, NEUROLOGY, V56, P336, DOI 10.1212/WNL.56.3.336; MATHIEU J, 1990, NEUROLOGY, V40, P839, DOI 10.1212/WNL.40.5.839; Minghetti L, 2013, J MATERN-FETAL NEO M, V26, P259, DOI 10.3109/14767058.2012.733751; Morales F, 2012, HUM MOL GENET, V21, P3558, DOI 10.1093/hmg/dds185; Muscle Study Grp, 2002, NEUROLOGY, V58, P334; NOVELLI G, 1993, BIOCHEM MED METAB B, V50, P85, DOI 10.1006/bmmb.1993.1049; Osanai R, 2007, ACTA OTO-LARYNGOL, V127, P78, DOI 10.1080/03655230701597192; Perini GI, 1999, BIOL PSYCHIAT, V46, P425, DOI 10.1016/S0006-3223(99)00016-5; PINESSI L, 1982, ITAL J NEUROL SCI, V3, P207, DOI 10.1007/BF02043311; Straface Elisabetta, 2012, Handb Exp Pharmacol, P49, DOI 10.1007/978-3-642-30726-3_3; Tawil R, 2001, NEUROLOGY, V57, P1566; Utsugisawa K, 1997, Nihon Rinsho, V55, P3214; Welle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001385	50	85	86	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148264	10.1371/journal.pone.0148264	http://dx.doi.org/10.1371/journal.pone.0148264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849574	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000059
J	Jones, JW; Singh, P; Govind, CK				Jones, Jeffery W.; Singh, Priyanka; Govind, Chhabi K.			Recruitment of Saccharomyces cerevisiae Cmr1/Ydl156w to Coding Regions Promotes Transcription Genome Wide	PLOS ONE			English	Article							POL II CTD; PAF1 COMPLEX; HISTONE MODIFICATIONS; TERMINAL DOMAIN; RNA; METHYLATION; GCN4P; DEACETYLATION; CHROMATIN; BINDING	Cmr1 (changed mutation rate 1) is a largely uncharacterized nuclear protein that has recently emerged in several global genetic interaction and protein localization studies. It clusters with proteins involved in DNA damage and replication stress response, suggesting a role in maintaining genome integrity. Under conditions of proteasome inhibition or replication stress, this protein localizes to distinct sub-nuclear foci termed as intranuclear quality control (INQ) compartments, which sequester proteins for their subsequent degradation. Interestingly, it also interacts with histones, chromatin remodelers and modifiers, as well as with proteins involved in transcription including subunits of RNA Pol I and Pol III, but not with those of Pol II. It is not known whether Cmr1 plays a role in regulating transcription of Pol II target genes. Here, we show that Cmr1 is recruited to the coding regions of transcribed genes of S. cerevisiae. Cmr1 occupancy correlates with the Pol II occupancy genome-wide, indicating that it is recruited to coding sequences in a transcription-dependent manner. Cmr1-enriched genes include Gcn4 targets and ribosomal protein genes. Furthermore, our results show that Cmr1 recruitment to coding sequences is stimulated by Pol II CTD kinase, Kin28, and the histone deacetylases, Rpd3 and Hos2. Finally, our genome-wide analyses implicate Cmr1 in regulating Pol II occupancy at transcribed coding sequences. However, it is dispensable for maintaining co-transcriptional histone occupancy and histone modification (acetylation and methylation). Collectively, our results show that Cmr1 facilitates transcription by directly engaging with transcribed coding regions.	[Jones, Jeffery W.; Singh, Priyanka; Govind, Chhabi K.] Oakland Univ, Dept Biol Sci, Rochester, MI 48309 USA	Oakland University	Govind, CK (corresponding author), Oakland Univ, Dept Biol Sci, Rochester, MI 48309 USA.	govind@oakland.edu			National Institutes of Health [GM095514]; Center for Biomedical Sciences, Oakland University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Biomedical Sciences, Oakland University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health, GM095514, and Center for Biomedical Sciences, Oakland University.	Abu-Jamous B, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0990; Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Bataille AR, 2012, MOL CELL, V45, P158, DOI 10.1016/j.molcel.2011.11.024; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Buratowski S, 1994, Genet Eng (N Y), V16, P1; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Burugula BB, 2014, MOL CELL BIOL, V34, P4115, DOI 10.1128/MCB.00695-14; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Choi DH, 2012, J MICROBIOL, V50, P112, DOI 10.1007/s12275-012-1597-4; Coulombe C, 2014, NUCLEIC ACIDS RES, V42, pW485, DOI 10.1093/nar/gku302; Drouin S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001173; Dutta A, 2014, GENE DEV, V28, P2314, DOI 10.1101/gad.243584.114; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Gallina I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7533; Ghosh A, 2011, MOL CELL, V43, P299, DOI 10.1016/j.molcel.2011.06.001; Gilmore JM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011544; Ginsburg DS, 2009, MOL CELL BIOL, V29, P6473, DOI 10.1128/MCB.01033-09; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Govind CK, 2012, METHODS MOL BIOL, V833, P15, DOI 10.1007/978-1-61779-477-3_2; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hellauer K, 2005, MOL PHARMACOL, V68, P1365, DOI 10.1124/mol.105.012963; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jeronimo C, 2014, NAT STRUCT MOL BIOL, V21, P449, DOI 10.1038/nsmb.2810; Joo YJ, 2011, EMBO J, V30, P859, DOI 10.1038/emboj.2010.332; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim T, 2012, CELL, V150, P1158, DOI 10.1016/j.cell.2012.08.016; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Natarajan K, 1999, MOL CELL, V4, P657, DOI 10.1016/S1097-2765(00)80217-8; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Patterson AV, 1998, ANTI-CANCER DRUG DES, V13, P541; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Polo SE, 2015, J MOL BIOL, V427, P626, DOI 10.1016/j.jmb.2014.05.025; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schwer B, 2011, MOL CELL, V43, P311, DOI 10.1016/j.molcel.2011.05.024; Spain MM, 2014, MOL CELL, V56, P653, DOI 10.1016/j.molcel.2014.10.002; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Struhl K, 1995, ANNU REV GENET, V29, P651, DOI 10.1146/annurev.ge.29.120195.003251; Swanson MJ, 2003, MOL CELL BIOL, V23, P2800, DOI 10.1128/MCB.23.8.2800-2820.2003; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Tomson BN, 2013, BBA-GENE REGUL MECH, V1829, P116, DOI 10.1016/j.bbagrm.2012.08.011; Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941; Wong CM, 2007, MOL CELL BIOL, V27, P6520, DOI 10.1128/MCB.00733-07; Wong KH, 2014, MOL CELL, V15, P00257; Wu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043005	58	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148897	10.1371/journal.pone.0148897	http://dx.doi.org/10.1371/journal.pone.0148897			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848854	gold, Green Published			2022-12-27	WOS:000369554000184
J	Chen, XJ; Li, WN; Hiett, SC; Obukhov, AG				Chen, Xingjuan; Li, Wennan; Hiett, S. Christopher; Obukhov, Alexander G.			Novel Roles for K(v)7 Channels in Shaping Histamine-Induced Contractions and Bradykinin-Dependent Relaxations in Pig Coronary Arteries	PLOS ONE			English	Article							KCNQ POTASSIUM CHANNELS; SMOOTH-MUSCLE-CELLS; METABOLIC SYNDROME; BLOOD-FLOW; DOWN-REGULATION; KV7 CHANNELS; ACTIVATION; EXPRESSION; VASODILATION; RETIGABINE	Voltage-gated K(v)7 channels are inhibited by agonists of G(q)-protein-coupled receptors, such as histamine. Recent works have provided evidence that inhibition of vascular K(v)7 channels may trigger vessel contractions. In this study, we investigated how K(v)7 activity modulates the histamine-induced contractions in "healthy" and metabolic syndrome (MetS) pig right coronary arteries (CAs). We performed isometric tension and immunohistochemical studies with domestic, lean Ossabaw, and MetS Ossabaw pig CAs. We found that neither the K(v)7.2/K(v)7.4/K(v)7.5 activator ML213 nor the general K(v)7 inhibitor XE991 altered the tension of CA rings under preload, indicating that vascular K(v)7 channels are likely inactive in the preloaded rings. Conversely, ML213 potently dilated histamine-pre-contracted CAs, suggesting that K(v)7 channels are activated during histamine applications and yet partially inhibited by histamine. Immunohistochemistry analysis revealed strong K(v)7.4 immunostaining in the medial and intimal layers of the CA wall, whereas K(v)7.5 immunostaining intensity was strong in the intimal but weak in the medial layers. The medial K(v)7 immunostaining was significantly weaker in MetS Ossabaw CAs as compared to lean Ossabaw or domestic CAs. Consistently, histamine-pre-contracted MetS Ossabaw CAs exhibited attenuated ML213-dependent dilations. In domestic pig CAs, where medial K(v)7 immunostaining intensity was stronger, histamine-induced contractions spontaneously decayed to similar to 31% of the peak amplitude within 4 minutes. Oppositely, in Ossabaw CAs, where K(v)7 immunostaining intensity was weaker, the histamine-induced contractions were more sustained. XE991 pretreatment significantly slowed the decay rate of histamine-induced contractions in domestic CAs, supporting the hypothesis that increased K(v)7 activity correlates with a faster rate of histamine-induced contraction decay. Alternatively, XE991 significantly decreased the amplitude of bradykinin-dependent dilations in pre-contracted CAs. We propose that in CAs, a decreased expression or a loss of function of K(v)7 channels may lead to sustained histamine-induced contractions and reduced endothelium-dependent relaxation, both risk factors for coronary spasm.	[Chen, Xingjuan; Li, Wennan; Hiett, S. Christopher; Obukhov, Alexander G.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Obukhov, AG (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA.	aobukhov@iu.edu	Obukhov, Alexander G/C-7246-2008; chen, xingjuan/V-4064-2019	Obukhov, Alexander G/0000-0002-3862-6004; chen, xingjuan/0000-0002-7380-8399	NIH [R01HL115140]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097512] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by a grant from the NIH (R01HL115140 to AGO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alevizos M, 2014, ANN ALLERG ASTHMA IM, V112, P309, DOI 10.1016/j.anai.2013.09.017; Beech DJ, 2013, CIRC J, V77, P570, DOI 10.1253/circj.CJ-13-0154; Berwick ZC, 2012, J MOL CELL CARDIOL, V52, P912, DOI 10.1016/j.yjmcc.2011.07.004; Borbouse L, 2010, AM J PHYSIOL-HEART C, V298, pH966, DOI 10.1152/ajpheart.00876.2009; Brueggemann LI, 2011, MOL PHARMACOL, V79, P10, DOI 10.1124/mol.110.067496; Brueggemann LI, 2014, MOL PHARMACOL, V86, P330, DOI 10.1124/mol.114.093799; Bubolz AH, 2005, AM J PHYSIOL-HEART C, V289, pH1873, DOI 10.1152/ajpheart.00357.2005; Chakraborty S, 2011, J PHARMACOL EXP THER, V339, P329, DOI 10.1124/jpet.111.183673; Dupuis DS, 2002, EUR J PHARMACOL, V437, P129, DOI 10.1016/S0014-2999(02)01287-6; Edwards JM, 2010, CARDIOVASC RES, V85, P631, DOI 10.1093/cvr/cvp308; GINSBURG R, 1984, CIRCULATION, V69, P430, DOI 10.1161/01.CIR.69.2.430; Greenwood IA, 2009, BRIT J PHARMACOL, V156, P1196, DOI 10.1111/j.1476-5381.2009.00131.x; Hedegaard ER, 2014, BRIT J PHARMACOL, V171, P69, DOI 10.1111/bph.12424; Hiett SC, 2014, CARDIOVASC RES, V103, P607, DOI 10.1093/cvr/cvu152; Jepps TA, 2011, CIRCULATION, V124, P602, DOI 10.1161/CIRCULATIONAHA.111.032136; Jeziorska M, 1997, J PATHOL, V182, P115, DOI 10.1002/(SICI)1096-9896(199705)182:1<115::AID-PATH806>3.0.CO;2-9; Joshi S, 2009, J PHARMACOL EXP THER, V329, P368, DOI 10.1124/jpet.108.147785; KEITOKU M, 1990, CARDIOVASC RES, V24, P614, DOI 10.1093/cvr/24.8.614; LECLERC G, 1992, CIRCULATION, V85, P543, DOI 10.1161/01.CIR.85.2.543; Liu BY, 2008, AM J PHYSIOL-CELL PH, V295, pC81, DOI 10.1152/ajpcell.00028.2008; Liu YP, 2001, CIRC RES, V89, P146, DOI 10.1161/hh1401.093294; Mackie AR, 2008, J PHARMACOL EXP THER, V325, P475, DOI 10.1124/jpet.107.135764; Milionis HJ, 2007, CORONARY ARTERY DIS, V18, P247, DOI 10.1097/MCA.0b013e328035f8c4; Moiseeva EP, 2001, CARDIOVASC RES, V52, P372, DOI 10.1016/S0008-6363(01)00399-6; Morales-Cano D, 2015, CARDIOVASC RES, V106, P98, DOI 10.1093/cvr/cvv020; Ng FL, 2011, BRIT J PHARMACOL, V162, P42, DOI 10.1111/j.1476-5381.2010.01027.x; Ohya S, 2003, CIRC RES, V92, P1016, DOI 10.1161/01.RES.0000070880.20955.F4; Saarinen K, 1998, HUM MUTAT, V11, P158, DOI 10.1002/(SICI)1098-1004(1998)11:2<158::AID-HUMU9>3.0.CO;2-F; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Setty S, 2003, BASIC RES CARDIOL, V98, P416, DOI 10.1007/s00395-003-0418-7; Soh H, 2010, MOL PHARMACOL, V78, P1088, DOI 10.1124/mol.110.066100; Stott JB, 2015, HYPERTENSION, V65, P676, DOI 10.1161/HYPERTENSIONAHA.114.04373; Stott JB, 2014, DRUG DISCOV TODAY, V19, P413, DOI 10.1016/j.drudis.2013.12.003; Su CC, 2006, BIOCHEM BIOPH RES CO, V348, P295, DOI 10.1016/j.bbrc.2006.07.053; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; TODA N, 1987, CIRC RES, V61, P280, DOI 10.1161/01.RES.61.2.280; Turhan H, 2004, AM HEART J, V148, P789, DOI 10.1016/j.ahj.2004.05.016; Van d V, 1994, EUR J PHARMACOL, V271, P17; van Heuven-Nolsen D, 1990, BR J CLIN PHARM S1, V30, p156S; Wang HS, 2000, MOL PHARMACOL, V57, P1218; WOLFF AA, 1986, CIRC RES, V58, P1; Yeung SYM, 2008, BRIT J PHARMACOL, V155, P62, DOI 10.1038/bjp.2008.231; Yeung SYM, 2005, BRIT J PHARMACOL, V146, P585, DOI 10.1038/sj.bjp.0706342; Yu H., 2010, PROBE REPORTS NIH MO; Zdravkovic V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/315709	45	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148569	10.1371/journal.pone.0148569	http://dx.doi.org/10.1371/journal.pone.0148569			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844882	Green Submitted, gold, Green Published			2022-12-27	WOS:000369552800071
J	Gascuel, Q; Bordat, A; Sallet, E; Pouilly, N; Carrere, S; Roux, F; Vincourt, P; Godiard, L				Gascuel, Quentin; Bordat, Amandine; Sallet, Erika; Pouilly, Nicolas; Carrere, Sebastien; Roux, Fabrice; Vincourt, Patrick; Godiard, Laurence			Effector Polymorphisms of the Sunflower Downy Mildew Pathogen Plasmopara halstedii and Their Use to Identify Pathotypes from Field Isolates	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; HELIANTHUS-ANNUUS L; MULTIPLE INTRODUCTIONS; DISEASE RESISTANCE; RXLR EFFECTORS; PHYTOPHTHORA; SEQUENCE; VIRULENCE; EVOLUTION; REVEALS	The obligate biotroph oomycete Plasmopara halstedii causes downy mildew on sunflower crop, Helianthus annuus. The breakdown of several Pl resistance genes used in sunflower hybrids over the last 25 years came along with the appearance of new Pl. halstedii isolates showing modified virulence profiles. In oomycetes, two classes of effector proteins, key players of pathogen virulence, are translocated into the host: RXLR and CRN effectors. We identified 54 putative CRN or RXLR effector genes from transcriptomic data and analyzed their genetic diversity in seven Pl. halstedii pathotypes representative of the species variability. Pl. halstedii effector genes were on average more polymorphic at both the nucleic and protein levels than random non-effector genes, suggesting a potential adaptive dynamics of pathogen virulence over the last 25 years. Twenty-two KASP (Competitive Allele Specific PCR) markers designed on polymorphic effector genes were genotyped on 35 isolates belonging to 14 Pl. halstedii pathotypes. Polymorphism analysis based on eight KASP markers aims at proposing a determination key suitable to classify the eight multi-isolate pathotypes into six groups. This is the first report of a molecular marker set able to discriminate Pl. halstedii pathotypes based on the polymorphism of pathogenicity effectors. Compared to phenotypic tests handling living spores used until now to discriminate Pl. halstedii pathotypes, this set of molecular markers constitutes a first step in faster pathotype diagnosis of Pl. halstedii isolates. Hence, emerging sunflower downy mildew isolates could be more rapidly characterized and thus, assessment of plant resistance breakdown under field conditions should be improved.	[Gascuel, Quentin; Bordat, Amandine; Sallet, Erika; Pouilly, Nicolas; Carrere, Sebastien; Roux, Fabrice; Vincourt, Patrick; Godiard, Laurence] INRA, Lab Interact Plantes Microorganismes LIPM, Unite Mixte Recherches UMR441, F-31326 Castanet Tolosan, France; [Gascuel, Quentin; Bordat, Amandine; Sallet, Erika; Pouilly, Nicolas; Carrere, Sebastien; Roux, Fabrice; Vincourt, Patrick; Godiard, Laurence] CNRS, Lab Interact Plantes Microorganismes LIPM, Unite Mixte Recherches UMR2594, F-31326 Castanet Tolosan, France; [Bordat, Amandine] INRA, Unite Mixte Recherches UMR1332 BFP, Biol Fruit & Pathol, CS20032, F-33882 Villenave Dornon, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Godiard, L (corresponding author), INRA, Lab Interact Plantes Microorganismes LIPM, Unite Mixte Recherches UMR441, F-31326 Castanet Tolosan, France.; Godiard, L (corresponding author), CNRS, Lab Interact Plantes Microorganismes LIPM, Unite Mixte Recherches UMR2594, F-31326 Castanet Tolosan, France.	Laurence.Godiard@toulouse.inra.fr		Sallet, Erika/0000-0003-4637-473X; Carrere, Sebastien/0000-0002-2348-0778; Fabrice, Roux/0000-0001-8059-5638	French INRA Project "Bioressources"; CETIOM; French Laboratory of Excellence project "TULIP" [ANR-10-LABX-41, ANR-11-IDEX-0002-02]	French INRA Project "Bioressources"; CETIOM; French Laboratory of Excellence project "TULIP"	This work was supported by the French INRA Project "Bioressources 2009", the CETIOM, and the French Laboratory of Excellence project "TULIP" (Toward a unified theory of biotic interactions: role of environmental perturbations) (ANR-10-LABX-41; ANR-11-IDEX-0002-02).	Ahmed S, 2012, FUNGAL GENET BIOL, V49, P847, DOI 10.1016/j.fgb.2012.06.012; Allen RL, 2008, MOL PLANT PATHOL, V9, P511, DOI 10.1111/J.1364-3703.2008.00481.X; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; As-sadi F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-498; Bailey K, 2011, MOL PLANT MICROBE IN, V24, P827, DOI 10.1094/MPMI-12-10-0278; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Birch PRJ, 2009, J EXP BOT, V60, P1133, DOI 10.1093/jxb/ern353; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Boutemy LS, 2011, J BIOL CHEM, V286, P35834, DOI 10.1074/jbc.M111.262303; Bozkurt TO, 2012, CURR OPIN PLANT BIOL, V15, P483, DOI 10.1016/j.pbi.2012.03.008; Caillaud MC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001732; Cooke DEL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002940; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Delmotte F, 2008, INFECT GENET EVOL, V8, P534, DOI 10.1016/j.meegid.2008.02.012; Dillmann C, 1997, THEOR APPL GENET, V95, P92, DOI 10.1007/s001220050536; Fabro G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002348; Gascuel Q, 2015, MOL PLANT PATHOL, V16, P109, DOI 10.1111/mpp.12164; Giedroc DP, 2009, VIRUS RES, V139, P193, DOI 10.1016/j.virusres.2008.06.008; Gilroy EM, 2011, NEW PHYTOL, V191, P763, DOI 10.1111/j.1469-8137.2011.03736.x; Gulya TJ, 1998, ISA: SYMPOSIUM III: SUNFLOWER DOWNY MILDEW, P130; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Lindeberg M, 2012, TRENDS MICROBIOL, V20, P199, DOI 10.1016/j.tim.2012.01.003; Links MG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-503; Liu TL, 2011, PLANT PHYSIOL, V155, P490, DOI 10.1104/pp.110.166470; Mestre P, 2016, PLANT PATHOL, V65, P767, DOI 10.1111/ppa.12469; Michelmore RW, 2013, ANNU REV PHYTOPATHOL, V51, P291, DOI 10.1146/annurev-phyto-082712-102334; MOINARD J, 2006, PHYTOMA DEFENSE VEGE, V589, P34; MOUZEYAR S, 1995, THEOR APPL GENET, V91, P733, DOI 10.1007/BF00220951; MOUZEYAR S, 1993, J PHYTOPATHOL, V139, P289, DOI 10.1111/j.1439-0434.1993.tb01430.x; MOUZEYAR S, 1994, J PHYTOPATHOL, V141, P249, DOI 10.1111/j.1439-0434.1994.tb01468.x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NISHIMURA M., 1922, Journal of the College of Agriculture, Hokkaido Imperial University, V11, P185; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Pais M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-211; Pedersen C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-694; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Saunders DGO, 2012, PLANT CELL, V24, P3420, DOI 10.1105/tpc.112.099861; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Schornack S, 2009, MOL PLANT PATHOL, V10, P795, DOI 10.1111/j.1364-3703.2009.00593.x; Sharma V, 2011, MOL BIOL EVOL, V28, P3195, DOI 10.1093/molbev/msr155; Stam R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059517; Stassen JHM, 2012, MOL PLANT PATHOL, V13, P719, DOI 10.1111/j.1364-3703.2011.00780.x; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Tian MY, 2011, MOL PLANT MICROBE IN, V24, P543, DOI 10.1094/MPMI-08-10-0185; Tourvieille de Labrouhe D, 2012, P 18 INT SUNFL C MAR, P322; van Damme M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002875; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Wawra S, 2012, CURR OPIN MICROBIOL, V15, P685, DOI 10.1016/j.mib.2012.10.008; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203	51	15	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148513	10.1371/journal.pone.0148513	http://dx.doi.org/10.1371/journal.pone.0148513			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845339	Green Published, Green Submitted, gold			2022-12-27	WOS:000369552800064
J	Kosulic, O; Michalko, R; Hula, V				Kosulic, Ondrej; Michalko, Radek; Hula, Vladimir			Impact of Canopy Openness on Spider Communities: Implications for Conservation Management of Formerly Coppiced Oak Forests	PLOS ONE			English	Article							SPECIES COMPOSITION; OPEN WOODLANDS; HABITAT; DIVERSITY; BIODIVERSITY; SUCCESSION; ARANEAE; INVERTEBRATES; ASSEMBLAGES; VEGETATION	Traditional woodland management created a mosaic of differently aged patches providing favorable conditions for a variety of arthropods. After abandonment of historical ownership patterns and traditional management and the deliberate transformation to high forest after World War II, large forest areas became darker and more homogeneous. This had significant negative consequences for biodiversity. An important question is whether even small-scale habitat structures maintained by different levels of canopy openness in abandoned coppiced forest may constitute conditions suitable for forest as well as open habitat specialists. We investigated the effect of canopy openness in former traditionally coppiced woodlands on the species richness, functional diversity, activity density, conservation value, and degree of rareness of epigeic spiders. In each of the eight studied locations, 60-m-long transect was established consisting of five pitfall traps placed at regular 15 m intervals along the gradient. Spiders were collected from May to July 2012. We recorded 90 spider species, including high proportions of xeric specialists (40%) and red-listed threatened species (26%). The peaks of conservation indicators, as well as spider community abundance, were shifted toward more open canopies. On the other hand, functional diversity peaked at more closed canopies followed by a rapid decrease with increasing canopy openness. Species richness was highest in the middle of the canopy openness gradient, suggesting an ecotone effect. Ordinations revealed that species of conservation concern tended to be associated with sparse and partly opened canopy. The results show that the various components of biodiversity peaked at different levels of canopy openness. Therefore, the restoration and suitable forest management of such conditions will retain important diversification of habitats in formerly coppiced oak forest stands. We indicate that permanent presence of small-scale improvements could be suitable conservation tools to prevent the general decline of woodland biodiversity in the intensified landscape of Central Europe.	[Kosulic, Ondrej] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Protect & Wildlife Management, Brno, Czech Republic; [Michalko, Radek] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Ecol, Brno, Czech Republic; [Michalko, Radek] Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic; [Hula, Vladimir] Mendel Univ Brno, Fac Agron, Dept Zool Fisheries Hydrobiol & Apiculture, Brno, Czech Republic	Mendel University in Brno; Mendel University in Brno; Masaryk University Brno; Mendel University in Brno	Kosulic, O (corresponding author), Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Protect & Wildlife Management, Brno, Czech Republic.	ondra.kosulic@seznam.cz	Ondrej, Kosulic/B-9736-2014; Michalko, Radek/Q-2349-2016; Michalko, Radek/AAT-2529-2021; Hula, Vladimir/B-9726-2014; Hula, Vladimir/ABG-9500-2020	Michalko, Radek/0000-0003-0831-0823; Michalko, Radek/0000-0003-0831-0823; Hula, Vladimir/0000-0001-7023-7087; Kosulic, Ondrej/0000-0003-2199-1694	Internal Grant Agency of Mendel University [LDF_VT_2015012/2015]; Masaryk University [MUNI/A/1484/2014]	Internal Grant Agency of Mendel University; Masaryk University	The study was funded by the Internal Grant Agency of Mendel University (Reg. No. LDF_VT_2015012/2015) as well as by student grant no. MUNI/A/1484/2014 provided by Masaryk University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadjiev S, 2001, ATLAS DISTRIBUTION B; Altman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055770; Auguie B, 2017, GRIDEXTRA MISCELLANE; Ausden M., 2007, HABITAT MANAGEMENT C; Basset Y, 2001, J APPL ECOL, V38, P1045, DOI 10.1046/j.1365-2664.2001.00660.x; Benes J, 2006, FOREST ECOL MANAG, V237, P353, DOI 10.1016/j.foreco.2006.09.058; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Bicknell JE, 2014, CURR BIOL, V24, pR1119, DOI 10.1016/j.cub.2014.10.067; Brunet Jorg, 2010, Ecological Bulletins, V53, P77; Buchar J., 1993, ACTA U CAROLINAE BIO, V36, P383; Buckley G.P., 1992, ECOLOGY MANAGEMENT C; Cardoso P, 2015, METHODS ECOL EVOL, V6, P232, DOI 10.1111/2041-210X.12310; Cardoso P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021710; Currylow AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040473; Denno R.F., 2005, ECOLOGY PREDATOR PRE; Entling W, 2007, GLOBAL ECOL BIOGEOGR, V16, P440, DOI 10.1111/j.1466-8238.2006.00305.x; Fartmann T, 2013, BIOL CONSERV, V159, P396, DOI 10.1016/j.biocon.2012.11.024; Samu F, 2014, J ARACHNOL, V42, P135, DOI 10.1636/CP13-75.1; Frazer GW, 1999, GAP LIGHT ANAL GLA V; FULLER R. J., 1990, COPPICED WOODLANDS T; Gonsamo A, 2013, OIKOS, V122, P1283, DOI 10.1111/j.1600-0706.2013.00369.x; GREENSTONE MH, 1984, OECOLOGIA, V62, P299, DOI 10.1007/BF00384260; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; HANSEN AJ, 1991, BIOSCIENCE, V41, P382, DOI 10.2307/1311745; Hansson L, 2010, BIODIVERS CONSERV, V10, P1865; Hedl R, 2010, DIVERS DISTRIB, V16, P267, DOI 10.1111/j.1472-4642.2010.00637.x; Heimer S., 1991, SPINNEN MITTELEUROPA; Hermy M, 2007, ECOL RES, V22, P361, DOI 10.1007/s11284-007-0354-3; HILL D, 1990, BIOL CONSERV, V51, P167, DOI 10.1016/0006-3207(90)90149-J; Horak J, 2014, FOREST ECOL MANAG, V315, P80, DOI 10.1016/j.foreco.2013.12.018; Horak J, 2013, J INSECT CONSERV, V17, P307, DOI 10.1007/s10841-012-9511-2; Horvath R., 2002, Web Ecology, V3, P43; Jimenez-Valverde A, 2007, ECOL ENTOMOL, V32, P113, DOI 10.1111/j.1365-2311.2006.00848.x; Kasal P, ARACHNOBASE CZECH SP; Klessmann C, 2011, ENERG POLICY, V39, P7637, DOI 10.1016/j.enpol.2011.08.038; Konvicka M., 2004, OHROZENY HMYZ NIZINN; Konvicka M, 2008, J INSECT CONSERV, V12, P549, DOI 10.1007/s10841-007-9087-4; Kosulic O, 2014, ECOL ENG, V68, P133, DOI 10.1016/j.ecoleng.2014.03.030; Krauss J, 2009, J APPL ECOL, V46, P194, DOI 10.1111/j.1365-2664.2008.01582.x; Kurka A, 2015, SPIDERS CZECH REPUBL; Larrivee M, 2008, FOREST ECOL MANAG, V255, P1434, DOI 10.1016/j.foreco.2007.10.062; Mackovcin P, 2007, PROTECTED AREAS CZEC, VIX; MCIVER JD, 1992, CAN J FOREST RES, V22, P984, DOI 10.1139/x92-132; McNett BJ, 2000, ECOL ENTOMOL, V25, P423, DOI 10.1046/j.1365-2311.2000.00279.x; Miklin J, 2014, J NAT CONSERV, V22, P35, DOI 10.1016/j.jnc.2013.08.002; Mullerova J, 2015, FOREST ECOL MANAG, V343, P88, DOI 10.1016/j.foreco.2015.02.003; Mullerova J, 2014, FOREST ECOL MANAG, V331, P104, DOI 10.1016/j.foreco.2014.07.032; Muff P, 2009, INSECT CONSERV DIVER, V2, P36, DOI 10.1111/j.1752-4598.2008.00037.x; Mupepele AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086571; Nentwig W, SPINNEN MITTELEUROPA; New TR., 2009, INSECT CONSERVATION; Niemela J, 1996, ECOGRAPHY, V19, P352, DOI 10.1111/j.1600-0587.1996.tb01264.x; NYFFELER M, 1987, J APPL ENTOMOL, V103, P321, DOI 10.1111/j.1439-0418.1987.tb00992.x; Oxbrough AG, 2005, FOREST ECOL MANAG, V212, P171, DOI 10.1016/j.foreco.2005.03.040; Oxbrough AG, 2006, FOREST ECOL MANAG, V237, P404, DOI 10.1016/j.foreco.2006.09.063; Paletto A, 2009, EUR J FOREST RES, V128, P265, DOI 10.1007/s10342-009-0262-x; Pearce JL, 2006, ECOL INDIC, V6, P780, DOI 10.1016/j.ecolind.2005.03.005; Pearce JL, 2004, BIODIVERS CONSERV, V13, P1305, DOI 10.1023/B:BIOC.0000019403.26948.55; Pekar S, 2012, MODERN ANAL BIOL DAT, P2; Pekar S., 2009, MODERN ANAL BIOL DAT; Purchart L, 2013, FOREST ECOL MANAG, V306, P42, DOI 10.1016/j.foreco.2013.06.012; Quitt E., 1971, STUD GEOGR BRNO, V16, P1; Rancka B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120085; Rezac M, 2015, BIOLOGIA, V70, P645, DOI 10.1515/biolog-2015-0079; Rezac M, 2014, J INSECT CONSERV, V18, P523, DOI 10.1007/s10841-014-9668-y; Roberts M.J., 1995, COLLINS FIELD GUIDE; RUZICKA V., 2008, SBORNIK OBLASTNIHO M, V29, P3; Ruzicka V, 2002, CATALOGUE SPIDERS CZ; Sanders D, 2015, J ANIM ECOL, V84, P134, DOI 10.1111/1365-2656.12271; Schuldt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022905; Sebek P, 2015, FOREST ECOL MANAG, V358, P80, DOI 10.1016/j.foreco.2015.09.008; Sebek P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060456; Settele Josef, 2009, P353; Silbernagel J, 2001, FOREST ECOL MANAG, V149, P217, DOI 10.1016/S0378-1127(00)00556-9; SMILAUER P, 2014, MULTIVARIETE ANAL EC; Spitzer L, 2008, BIOL CONSERV, V141, P827, DOI 10.1016/j.biocon.2008.01.005; Swenson N., 2014, PHYLOGENETIC FUNCTIO; TERBRAAK CJF, 2012, CANNOCO 5 SOFTWARE M; Thomas CD, 2000, P ROY SOC B-BIOL SCI, V267, P139, DOI 10.1098/rspb.2000.0978; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Tropek R, 2014, ECOL ENG, V73, P45, DOI 10.1016/j.ecoleng.2014.09.011; Tropek R, 2010, J APPL ECOL, V47, P139, DOI 10.1111/j.1365-2664.2009.01746.x; Ugurlu E, 2012, APPL VEG SCI, V15, P590, DOI 10.1111/j.1654-109X.2012.01192.x; Vacik R, 2009, SILVA BALCANICA, V10, P35; Van Calster H, 2008, FOREST ECOL MANAG, V256, P519, DOI 10.1016/j.foreco.2008.04.042; Vera FWM, 2000, GRAZING ECOLOGY FORE; Vodka S, 2013, FOREST ECOL MANAG, V304, P33, DOI 10.1016/j.foreco.2013.04.007; Vodka S, 2009, J INSECT CONSERV, V13, P553, DOI 10.1007/s10841-008-9202-1; VRSKA T., 2006, DYNAMIKA VYVOJE PRAL; Vrska T, 2006, DEV DYNAMICS VIRGIN; Wagner JD, 2003, J ARACHNOL, V31, P28, DOI 10.1636/0161-8202(2003)031[0028:SSILDB]2.0.CO;2; Warren M. S., 1991, The conservation of insects and their habitats., P155; WARREN MS, 1987, J APPL ECOL, V24, P499, DOI 10.2307/2403889; Wise DH, 1999, OECOLOGIA, V121, P129, DOI 10.1007/s004420050914; Wise DH, 1993, SPIDERS ECOLOGICAL W; Ziesche TM, 2008, FOREST ECOL MANAG, V255, P738, DOI 10.1016/j.foreco.2007.09.060	96	53	56	6	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148585	10.1371/journal.pone.0148585	http://dx.doi.org/10.1371/journal.pone.0148585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845431	Green Published, gold, Green Submitted			2022-12-27	WOS:000369552800075
J	Gainey, MA; Wolfe, R; Pourzia, O; Feldman, DE				Gainey, Melanie A.; Wolfe, Renna; Pourzia, Olivia; Feldman, Daniel E.			Whisker Deprivation Drives Two Phases of Inhibitory Synapse Weakening in Layer 4 of Rat Somatosensory Cortex	PLOS ONE			English	Article							CORTICAL MAP PLASTICITY; MOUSE VISUAL-CORTEX; BARREL CORTEX; CRITICAL PERIOD; IN-VIVO; SENSORY DEPRIVATION; GABAERGIC TRANSMISSION; DEPENDENT MATURATION; EXPERIENCE; NEURONS	Inhibitory synapse development in sensory neocortex is experience-dependent, with sustained sensory deprivation yielding fewer and weaker inhibitory synapses. Whether this represents arrest of synapse maturation, or a more complex set of processes, is unclear. To test this, we measured the dynamics of inhibitory synapse development in layer 4 of rat somatosensory cortex (S1) during continuous whisker deprivation from postnatal day 7, and in age-matched controls. In deprived columns, spontaneous miniature inhibitory postsynaptic currents (mIPSCs) and evoked IPSCs developed normally until P15, when IPSC amplitude transiently decreased, recovering by P16 despite ongoing deprivation. IPSCs remained normal until P22, when a second, sustained phase of weakening began. Delaying deprivation onset by 5 days prevented the P15 weakening. Both early and late phase weakening involved measurable reduction in IPSC amplitude relative to prior time points. Thus, deprivation appears to drive two distinct phases of active IPSC weakening, rather than simple arrest of synapse maturation.	[Feldman, Daniel E.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Feldman, DE (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA.	dfeldman@berkeley.edu		Gainey, Melanie/0000-0002-4782-9647	National Institute of Health Ruth L. Kirschstein National Research Service Award (NRSA) [1F32NS087893-01A1]; National Science Foundation; National Institute of Health [1R01NS073912]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073912, F32NS087893] Funding Source: NIH RePORTER	National Institute of Health Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by: National Institute of Health (http://www.nih.gov/) Ruth L. Kirschstein National Research Service Award (NRSA) 1F32NS087893-01A1 to MG; National Science Foundation (http://www.nsf.gov/) Graduate Research Fellowship to RW; National Institute of Health (http://www.nih.gov/) 1R01NS073912 to DF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; BLUE ME, 1983, J NEUROCYTOL, V12, P599, DOI 10.1007/BF01181526; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chittajallu R, 2010, NAT NEUROSCI, V13, P1240, DOI 10.1038/nn.2639; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; DeFelipe J, 1997, CEREB CORTEX, V7, P619, DOI 10.1093/cercor/7.7.619; Drew PJ, 2009, CEREB CORTEX, V19, P331, DOI 10.1093/cercor/bhn085; Erzurumlu RS, 2012, EUR J NEUROSCI, V35, P1540, DOI 10.1111/j.1460-9568.2012.08075.x; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; FOX K, 1992, J NEUROSCI, V12, P1826; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Jiang B, 2010, J NEUROSCI, V30, P14261, DOI 10.1523/JNEUROSCI.2979-10.2010; Jiao YY, 2006, J NEUROSCI, V26, P8691, DOI 10.1523/JNEUROSCI.2478-06.2006; Jiao YY, 2011, P NATL ACAD SCI USA, V108, P12131, DOI 10.1073/pnas.1105296108; Kreczko A, 2009, NEURAL PLAST, V2009, DOI 10.1155/2009/415135; Landers M, 2006, SOMATOSENS MOT RES, V23, P1, DOI 10.1080/08990220600700768; Lee SH, 2007, J NEUROPHYSIOL, V97, P4380, DOI 10.1152/jn.01217.2006; Lefort S, 2013, P NATL ACAD SCI USA, V110, pE4540, DOI 10.1073/pnas.1319571110; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; LI XR, 1995, J COMP NEUROL, V357, P465, DOI 10.1002/cne.903570310; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Maffei A, 2010, J NEUROSCI, V30, P3304, DOI 10.1523/JNEUROSCI.5340-09.2010; MICHEVA KD, 1995, EUR J NEUROSCI, V7, P419, DOI 10.1111/j.1460-9568.1995.tb00338.x; MILLER MW, 1986, DEV BRAIN RES, V25, P271, DOI 10.1016/0165-3806(86)90217-8; Minlebaev M, 2011, SCIENCE, V334, P226, DOI 10.1126/science.1210574; Morales B, 2002, J NEUROSCI, V22, P8084; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Sadaka Y, 2003, J COMP NEUROL, V457, P75, DOI 10.1002/cne.10518; Shoykhet M, 2005, J NEUROPHYSIOL, V94, P3987, DOI 10.1152/jn.00569.2005; SIMONS DJ, 1984, J COMP NEUROL, V230, P119, DOI 10.1002/cne.902300111; Smit-Rigter LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005167; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Stief F, 2007, EUR J NEUROSCI, V25, P519, DOI 10.1111/j.1460-9568.2006.05296.x; Sun QQ, 2009, J NEUROPHYSIOL, V102, P2955, DOI 10.1152/jn.00562.2009; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; Zhang Z, 2011, NEUROSCIENCE, V174, P10, DOI 10.1016/j.neuroscience.2010.11.045; Zhang Z, 2011, INT REV NEUROBIOL, V97, P305, DOI 10.1016/B978-0-12-385198-7.00012-6; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	47	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148227	10.1371/journal.pone.0148227	http://dx.doi.org/10.1371/journal.pone.0148227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840956	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200102
J	Singer, BH; Newstead, MW; Zeng, XY; Cooke, CL; Thompson, RC; Singer, K; Ghantasala, R; Parent, JM; Murphy, GG; Iwashyna, TJ; Standiford, TJ				Singer, Benjamin H.; Newstead, Michael W.; Zeng, Xianying; Cooke, Christopher L.; Thompson, Robert C.; Singer, Kanakadurga; Ghantasala, Ramya; Parent, Jack M.; Murphy, Geoffrey G.; Iwashyna, Theodore J.; Standiford, Theodore J.			Cecal Ligation and Puncture Results in Long-Term Central Nervous System Myeloid Inflammation	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; POSTTRAUMATIC-STRESS-DISORDER; NECROSIS-FACTOR-ALPHA; COGNITIVE IMPAIRMENT; MICROGLIAL ACTIVATION; MACROPHAGE POLARIZATION; SEVERE SEPSIS; LUNG INJURY; EXPRESSION; FEAR	Survivors of sepsis often experience long-term cognitive and functional decline. Previous studies utilizing lipopolysaccharide injection and cecal ligation and puncture in rodent models of sepsis have demonstrated changes in depressive-like behavior and learning and memory after sepsis, as well as evidence of myeloid inflammation and cytokine expression in the brain, but the long-term course of neuroinflammation after sepsis remains unclear. Here, we utilize cecal ligation and puncture with greater than 80% survival as a model of sepsis. We found that sepsis survivor mice demonstrate deficits in extinction of conditioned fear, but no acquisition of fear conditioning, nearly two months after sepsis. These cognitive changes occur in the absence of neuronal loss or changes in synaptic density in the hippocampus. Sepsis also resulted in infiltration of monocytes and neutrophils into the CNS at least two weeks after sepsis in a CCR2 independent manner. Cellular inflammation is accompanied by long-term expression of pro-inflammatory cytokine and chemokine genes, including TNFa and CCR2 ligands, in whole brain homogenates. Gene expression analysis of microglia revealed that while microglia do express anti-microbial genes and damage-associated molecular pattern molecules of the S100A family of genes at least 2 weeks after sepsis, they do not express the cytokines observed in whole brain homogenates. Our results indicate that in a naturalistic model of infection, sepsis results in long-term neuroinflammation, and that this sustained inflammation is likely due to interactions among multiple cell types, including resident microglia and peripherally derived myeloid cells.	[Singer, Benjamin H.; Newstead, Michael W.; Zeng, Xianying; Ghantasala, Ramya; Iwashyna, Theodore J.; Standiford, Theodore J.] Univ Michigan, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI USA; [Cooke, Christopher L.; Thompson, Robert C.; Murphy, Geoffrey G.] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Singer, Kanakadurga] Univ Michigan, Sch Med, Dept Pediat, Div Endocrinol & Metab, Ann Arbor, MI USA; [Parent, Jack M.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI USA; [Murphy, Geoffrey G.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Iwashyna, Theodore J.] VA Ann Arbor Hlth Syst, Ctr Clin Management Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Singer, BH (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI USA.	singerb@med.umich.edu	Singer, Benjamin/J-6330-2019	Singer, Benjamin/0000-0002-4721-6920; Singer, Kanakadurga/0000-0001-8278-3800	National Heart Lungs and Blood Institute [T32 HL007749, R01 HL123515]; University of Michigan Depression Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123515, T32HL007749] Funding Source: NIH RePORTER	National Heart Lungs and Blood Institute; University of Michigan Depression Center(University of Michigan System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	BHS is supported by National Heart Lungs and Blood Institute T32 HL007749. This work was supported by National Heart Lungs and Blood Institute R01 HL123515 to TJS and a Strategic Translational Research Award from the University of Michigan Depression Center to BHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Aguliar-Valles A, 2014, MOL PSYCHIATR, V19, P599, DOI 10.1038/mp.2013.137; Anderson ST, 2015, BRAIN BEHAV IMMUN, V43, P98, DOI 10.1016/j.bbi.2014.07.007; Anderson ST, 2013, LONG LASTING ACUTE E; Araujo CV, 2012, MICROVASC RES, V84, P218, DOI 10.1016/j.mvr.2012.05.006; Ballinger MN, 2012, J IMMUNOL, V189, P356, DOI 10.4049/jimmunol.1103124; Bard F, 2012, EXP NEUROL, V238, P38, DOI 10.1016/j.expneurol.2012.07.022; Barichello T, 2007, BRAZ J MED BIOL RES, V40, P831, DOI 10.1590/S0100-879X2007000600013; Barichello T, 2005, CRIT CARE MED, V33, P1671, DOI 10.1097/01.CCM.0000170192.54682.C1; Barichello T, 2005, CRIT CARE MED, V33, P221, DOI 10.1097/01.CCM.0000150741.12906.BD; Bienvenu OJ, 2013, PSYCHOL MED, V43, P2657, DOI 10.1017/S0033291713000214; Boer KR, 2007, CRIT CARE, V11, DOI 10.1186/cc5710; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Calsavara AC, 2015, METAB BRAIN DIS, V30, P669, DOI 10.1007/s11011-014-9610-8; Calsavara AC, 2013, NEUROTOX RES, V24, P103, DOI 10.1007/s12640-012-9364-1; Catlow BJ, 2013, EXP BRAIN RES, V228, P481, DOI 10.1007/s00221-013-3579-0; Cazareth J, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-132; Chavan SS, 2012, MOL MED, V18, P930, DOI 10.2119/molmed.2012.00195; Chen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115828; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Comim CM, 2011, INTENS CARE MED, V37, P711, DOI 10.1007/s00134-011-2151-2; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donzis EJ, 2014, NEUROBIOL LEARN MEM, V115, P68, DOI 10.1016/j.nlm.2014.08.008; Drevets DA, 2010, BRAIN BEHAV IMMUN, V24, P919, DOI 10.1016/j.bbi.2010.02.011; Erickson MA, 2011, BRAIN BEHAV IMMUN, V25, P1637, DOI 10.1016/j.bbi.2011.06.006; Frank MG, 2006, J NEUROSCI METH, V151, P121, DOI 10.1016/j.jneumeth.2005.06.026; Fu HQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106331; Gallaher ZR, 2012, NEUROSCI LETT, V513, P31, DOI 10.1016/j.neulet.2012.01.079; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Guyon A, 2009, NEUROSCIENCE, V162, P1072, DOI 10.1016/j.neuroscience.2009.05.048; Harkness KA, 2003, J NEUROIMMUNOL, V142, P1, DOI 10.1016/S0165-5728(03)00251-0; Hofer S, 2008, J SURG RES, V146, P276, DOI 10.1016/j.jss.2007.07.021; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwashyna TJ, 2012, J AM GERIATR SOC, V60, P1070, DOI 10.1111/j.1532-5415.2012.03989.x; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jackson JC, 2007, CRIT CARE, V11, DOI 10.1186/cc5707; Jackson JC, 2010, AM J RESP CRIT CARE, V182, P183, DOI 10.1164/rccm.200903-0442OC; Karrer M, 2015, BRAIN BEHAV IMMUN, V47, P186, DOI 10.1016/j.bbi.2014.11.008; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kondo S, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-27; Kutlu MG, 2014, BEHAV BRAIN RES, V263, P133, DOI 10.1016/j.bbr.2014.01.031; Laflamme N, 1999, J NEUROSCI, V19, P10923, DOI 10.1523/JNEUROSCI.19-24-10923.1999; Larochelle A, 2015, BRAIN BEHAV IMMUN, V46, P221, DOI 10.1016/j.bbi.2015.02.019; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Lu SM, 2015, BRAIN BEHAV IMMUN, V44, P221, DOI 10.1016/j.bbi.2014.10.011; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Michels M, 2015, BRAIN BEHAV IMMUN, V43, P54, DOI 10.1016/j.bbi.2014.07.002; Misane I, 2005, HIPPOCAMPUS, V15, P418, DOI 10.1002/hipo.20067; Moore BB, 2001, J IMMUNOL, V167, P4368, DOI 10.4049/jimmunol.167.8.4368; Moraes CA, 2015, MOL NEUROBIOL, V52, P653, DOI 10.1007/s12035-014-8868-5; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Morris MC, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00680; Nakajima A, 2004, J NEUROSCI, V24, P2212, DOI 10.1523/JNEUROSCI.4847-03.2004; Norden DM, 2016, GLIA, V64, P300, DOI 10.1002/glia.22930; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Ponnusamy R, 2005, LEARN MEMORY, V12, P399, DOI 10.1101/lm.96605; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Sade-Feldman M, 2013, IMMUNITY, V38, P541, DOI 10.1016/j.immuni.2013.02.007; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; SEITZ RJ, 1985, ACTA NEUROPATHOL, V68, P15, DOI 10.1007/BF00688950; Semmler A, 2005, J CHEM NEUROANAT, V30, P144, DOI 10.1016/j.jchemneu.2005.07.003; Semmler A, 2007, EXP NEUROL, V204, P733, DOI 10.1016/j.expneurol.2007.01.003; Semmler A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-38; Shah FA, 2013, AM J RESP CRIT CARE, V188, P586, DOI 10.1164/rccm.201212-2154OC; Sierra-Filardi E, 2014, J IMMUNOL, V192, P3858, DOI 10.4049/jimmunol.1302821; Singer BH, 2011, P NATL ACAD SCI USA, V108, P5437, DOI 10.1073/pnas.1015425108; Skelly DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069123; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Starickova EA, 2011, B EXP BIOL MED+, V150, P446, DOI 10.1007/s10517-011-1165-7; Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013; Tuon L, 2008, INTENS CARE MED, V34, P1724, DOI 10.1007/s00134-008-1129-1; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wache C, 2015, J INFECT DIS, V212, P247, DOI 10.1093/infdis/jiv028; Wakida N, 2014, J PHARMACOL SCI, V125, P68, DOI 10.1254/jphs.14032FP; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; Weberpals M, 2009, J NEUROSCI, V29, P14177, DOI 10.1523/JNEUROSCI.3238-09.2009; Woolley CS, 1997, J NEUROSCI, V17, P1848	78	56	57	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149136	10.1371/journal.pone.0149136	http://dx.doi.org/10.1371/journal.pone.0149136			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862765	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600160
J	de Oliveira, ACM; Spraggon, JM; Denny, MJ				de Oliveira, Angela C. M.; Spraggon, John M.; Denny, Matthew J.			Instrumenting Beliefs in Threshold Public Goods	PLOS ONE			English	Article							SOCIAL INFORMATION; VOLUNTARY PROVISION; ELICITING BELIEFS; REBATE RULES; GAME; IMPACT; COOPERATION	Understanding the causal impact of beliefs on contributions in Threshold Public Goods (TPGs) is particularly important since the social optimum can be supported as a Nash Equilibrium and best-response contributions are a function of beliefs. Unfortunately, investigations of the impact of beliefs on behavior are plagued with endogeneity concerns. We create a set of instruments by cleanly and exogenously manipulating beliefs without deception. Tests indicate that the instruments are valid and relevant. Perhaps surprisingly, we fail to find evidence that beliefs are endogenous in either the one-shot or repeated-decision settings. TPG allocations are determined by a base contribution and beliefs in a one shot-setting. In the repeated-decision environment, once we instrument for first-round allocations, we find that second-round allocations are driven equally by beliefs and history. Moreover, we find that failing to instrument prior decisions overstates their importance.	[de Oliveira, Angela C. M.; Spraggon, John M.] Univ Massachusetts, Dept Resource Econ, 80 Campus Ctr Way, Amherst, MA 01003 USA; [Denny, Matthew J.] Penn State Univ, Dept Polit Sci, University Pk, PA 16801 USA	University of Massachusetts System; University of Massachusetts Amherst; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Spraggon, JM (corresponding author), Univ Massachusetts, Dept Resource Econ, 80 Campus Ctr Way, Amherst, MA 01003 USA.	jmspragg@resecon.umass.edu			University of Massachusetts Amherst Social and Behavioral Science Undergraduate Student Research Grant	University of Massachusetts Amherst Social and Behavioral Science Undergraduate Student Research Grant	Funding for this project was provided by a University of Massachusetts Amherst Social and Behavioral Science Undergraduate Student Research Grant to Matthew Denny.; We would like to thank Alexander Smith, Emily Wang, participants at the Society for the Advancement of Behavioral Economics 2014 Annual Meetings, the 2015 Biennial Social Dilemmas Conference at Brown, the 2015 Annual Meetings of the Canadian Economics Association, and the 2015 Western Massachusetts Experimental Economics Workshop for their helpful comments. Funding for this project was provided by a University of Massachusetts Amherst Social and Behavioral Science Undergraduate Student Research Grant.	Amir O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031461; Armantier O, 2013, EUR ECON REV, V62, P17, DOI 10.1016/j.euroecorev.2013.03.008; Bechtel MM, 2015, PREPRINT; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Cadsby CB, 1999, J PUBLIC ECON, V71, P53, DOI 10.1016/S0047-2727(98)00049-8; Cameron C., 2005, MICROECONOMETRICS US, P1056; Chaudhuri A, 2011, EXP ECON, V14, P47, DOI 10.1007/s10683-010-9257-1; Chen MH, 2015, APPL MATH COMPUT, V251, P192, DOI 10.1016/j.amc.2014.11.052; Costa-Gomes MA, 2014, GAME ECON BEHAV, V88, P298, DOI 10.1016/j.geb.2014.10.006; Croson R, 2008, EXP ECON, V11, P221, DOI 10.1007/s10683-007-9191-z; Croson R, 2009, NONPROFIT MANAG LEAD, V19, P467, DOI 10.1002/nml.232; Croson RTA, 2007, ECON INQ, V45, P199, DOI 10.1111/j.1465-7295.2006.00006.x; Croson RTA, 2000, EXP ECON, V2, P239, DOI 10.1007/BF01669198; Croson RTA, 2000, J ECON BEHAV ORGAN, V41, P299, DOI 10.1016/S0167-2681(99)00078-5; Dal Bo P, 2010, AM ECON REV, V100, P2205, DOI 10.1257/aer.100.5.2205; Di Stefano A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140646; Fischbacher U, 2010, AM ECON REV, V100, P541, DOI 10.1257/aer.100.1.541; Gachter S, 2010, EXP ECON, V13, P364, DOI 10.1007/s10683-010-9246-4; Gee LK, 2015, PREPRINT; Goodman JK, 2013, J BEHAV DECIS MAKING, V26, P213, DOI 10.1002/bdm.1753; Ham JC, 2005, J ECONOMETRICS, V125, P175, DOI 10.1016/j.jeconom.2004.04.008; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; ISAAC RM, 1989, PUBLIC CHOICE, V62, P217, DOI 10.1007/BF02337743; Marks M, 1998, J PUBLIC ECON, V67, P195, DOI 10.1016/S0047-2727(97)00067-4; MULLEN B, 1985, J EXP SOC PSYCHOL, V21, P262, DOI 10.1016/0022-1031(85)90020-4; Nikiforakis N, 2010, GAME ECON BEHAV, V68, P689, DOI 10.1016/j.geb.2009.09.004; Offerman T, 1996, ECON J, V106, P817, DOI 10.2307/2235360; Offerman T, 2001, ECON INQ, V39, P250, DOI 10.1093/ei/39.2.250; Palfrey TR, 2009, J ECON BEHAV ORGAN, V71, P98, DOI 10.1016/j.jebo.2009.03.025; Rutstrom EE, 2009, GAME ECON BEHAV, V67, P616, DOI 10.1016/j.geb.2009.04.001; Shang J, 2009, ECON J, V119, P1422, DOI 10.1111/j.1468-0297.2009.02267.x; Smith A, 2013, EXP ECON, V16, P414, DOI 10.1007/s10683-012-9345-5; Spencer MA, 2009, J PUBLIC ECON, V93, P798, DOI 10.1016/j.jpubeco.2009.01.005; Stock, 2005, IDENTIFICATION INFER; Wang SW, 2011, ECON LETT, V111, P30, DOI 10.1016/j.econlet.2010.11.045; Yuan WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091012; Zhu CJ, 2014, PHYSICA A, V406, P145, DOI 10.1016/j.physa.2014.03.035	37	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0147043	10.1371/journal.pone.0147043	http://dx.doi.org/10.1371/journal.pone.0147043			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859492	Green Published, gold			2022-12-27	WOS:000370038400005
J	Ku, LJE; Pai, MC; Shih, PY				Ku, Li-Jung Elizabeth; Pai, Ming-Chyi; Shih, Pei-Yu			Economic Impact of Dementia by Disease Severity: Exploring the Relationship between Stage of Dementia and Cost of Care in Taiwan	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; INFORMAL CARE; ASIAN COUNTRY; MILD	Objective Given the shortage of cost-of-illness studies in dementia outside of the Western population, the current study estimated the annual cost of dementia in Taiwan and assessed whether different categories of care costs vary by severity using multiple disease-severity measures. Methods This study included 231 dementia patient-caregiver dyads in a dementia clinic at a national university hospital in southern Taiwan. Three disease measures including cognitive, functional, and behavioral disturbances were obtained from patients based on medical history. A societal perspective was used to estimate the total costs of dementia according to three cost sub-categories. The association between dementia severity and cost of care was examined through bivariate and multivariate analyses. Results Total costs of care for moderate dementia patient were 1.4 times the costs for mild dementia and doubled from mild to severe dementia among our community-dwelling dementia sample. Multivariate analysis indicated that functional declines had a greater impact on all cost outcomes as compared to behavioral disturbance, which showed no impact on any costs. Informal care costs accounted for the greatest share in total cost of care for both mild (42%) and severe (43%) dementia patients. Conclusions Since the total costs of dementia increased with severity, providing care to delay disease progression, with a focus on maintaining patient physical function, may reduce the overall cost of dementia. The greater contribution of informal care to total costs as opposed to social care also suggests a need for more publicly-funded long-term care services to assist family caregivers of dementia patients in Taiwan.	[Ku, Li-Jung Elizabeth; Shih, Pei-Yu] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Publ Hlth, Tainan 70101, Taiwan; [Pai, Ming-Chyi] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Div Behav Neurol,Dept Neurol, Tainan 70101, Taiwan; [Pai, Ming-Chyi] Natl Cheng Kung Univ Hosp, Alzheimers Dis Res Ctr, Tainan 70428, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Ku, LJE (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Publ Hlth, Tainan 70101, Taiwan.	eljku@mail.ncku.edu.tw		Ku, Li-Jung Elizabeth/0000-0002-4644-8439	National Science Council [NSC 102-2410-H-006 -001 -SS2]	National Science Council(Ministry of Science and Technology, Taiwan)	This research was supported by grants from the National Science Council (NSC 102-2410-H-006 -001 -SS2). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Benaim C., 2005, Annales de Readaptation et de Medecine Physique, V48, P336, DOI 10.1016/j.annrmp.2005.04.005; Bureau of National Health Insurance, 2013, REIMB RUL DRUGS ACT; Chan SWC, 2010, DEMENT GERIATR COGN, V30, P469, DOI 10.1159/000322086; Chong MS, 2013, INT PSYCHOGERIATR, V25, P1475, DOI 10.1017/S1041610213000707; Chou LF, 2000, NATIL CHENGCHI U J, V82, P1; Chuo LJ, 2007, DEMENT GERIATR COGN, V23, P251, DOI 10.1159/000100021; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Fuh Jong-Ling, 2008, Acta Neurol Taiwan, V17, P153; Gerves C, 2014, HEALTH POLICY, V116, P114, DOI 10.1016/j.healthpol.2014.01.001; Hill J, 2006, PHARMACOECONOMICS, V24, P265, DOI 10.2165/00019053-200624030-00006; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; International Monetary Fund, WORLD EC OUTL DAT 20; Jonsson L, 2006, INT J GERIATR PSYCH, V21, P449, DOI 10.1002/gps.1489; Jonsson L, 2009, PHARMACOECONOMICS, V27, P391, DOI 10.2165/00019053-200927050-00004; Kuo YC, 2010, ARCH GERONTOL GERIAT, V51, P159, DOI 10.1016/j.archger.2009.10.001; Lafortune L, 2009, MED CARE, V47, P286, DOI 10.1097/MLR.0b013e3181894293; Leicht H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070018; Lim J, 2012, INT PSYCHOGERIATR, V24, P1571, DOI 10.1017/S1041610212000919; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Mauskopf J, 2010, J NUTR HEALTH AGING, V14, P655, DOI 10.1007/s12603-010-0312-6; Ministry of Health and Welfare, 2014, SOC WELF SUBS IT SCH; Neubauer S, 2008, INT PSYCHOGERIATR, V20, P1160, DOI 10.1017/S1041610208007564; Quentin W, 2010, ACTA PSYCHIAT SCAND, V121, P243, DOI 10.1111/j.1600-0447.2009.01461.x; Rapp T, 2012, VALUE HEALTH, V15, P412, DOI 10.1016/j.jval.2012.02.003; Schaller S, 2015, INT J GERIATR PSYCH, V30, P111, DOI 10.1002/gps.4198; Schwarzkopf L, 2011, VALUE HEALTH, V14, P827, DOI 10.1016/j.jval.2011.04.005; Small GW, 2002, J AM GERIATR SOC, V50, P321, DOI 10.1046/j.1532-5415.2002.50065.x; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100303; Thomas P, 2006, INT J GERIATR PSYCH, V21, P50, DOI 10.1002/gps.1422; Wimo A, 2010, WORLD ALZHEIMER REPO; Wimo A., 2015, WORLD ALZHEIMER REPO; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P429, DOI 10.1016/j.jalz.2012.06.008; Zhu CW, 2008, DEMENT GERIATR COGN, V26, P416, DOI 10.1159/000164797	35	27	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148779	10.1371/journal.pone.0148779	http://dx.doi.org/10.1371/journal.pone.0148779			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859891	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400082
J	Nakayama-Imaohji, H; Hirota, K; Yamasaki, H; Yoneda, S; Nariya, H; Suzuki, M; Secher, T; Miyake, Y; Oswald, E; Hayashi, T; Kuwahara, T				Nakayama-Imaohji, Haruyuki; Hirota, Katsuhiko; Yamasaki, Hisashi; Yoneda, Saori; Nariya, Hirofumi; Suzuki, Motoo; Secher, Thomas; Miyake, Yoichiro; Oswald, Eric; Hayashi, Tetsuya; Kuwahara, Tomomi			DNA Inversion Regulates Outer Membrane Vesicle Production in Bacteroides fragilis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; COMMENSAL BACTERIUM; SYMBIOTIC BACTERIA; GENE-EXPRESSION; PHASE VARIATION; SALMONELLA; MICROBIOTA; VIRULENCE; RNA; COLONIZATION	Phase changes in Bacteroides fragilis, a member of the human colonic microbiota, mediate variations in a vast array of cell surface molecules, such as capsular polysaccharides and outer membrane proteins through DNA inversion. The results of the present study show that outer membrane vesicle (OMV) formation in this anaerobe is also controlled by DNA inversions at two distantly localized promoters, IVp-I and IVp-II that are associated with extracellular polysaccharide biosynthesis and the expression of outer membrane proteins. These promoter inversions are mediated by a single tyrosine recombinase encoded by BF2766 (orthologous to tsr19 in strain NCTC9343) in B. fragilis YCH46, which is located near IVp-I. A series of BF2766 mutants were constructed in which the two promoters were locked in different configurations (IVp-I/IVp-II = ON/ON, OFF/OFF, ON/OFF or OFF/ON). ON/ON B. fragilis mutants exhibited hypervesiculating, whereas the other mutants formed only a trace amount of OMVs. The hypervesiculating ON/ON mutants showed higher resistance to treatment with bile, LL-37, and human beta-defensin 2. Incubation of wild-type cells with 5% bile increased the population of cells with the ON/ON genotype. These results indicate that B. fragilis regulates the formation of OMVs through DNA inversions at two distantly related promoter regions in response to membrane stress, although the mechanism underlying the interplay between the two regions controlled by the invertible promoters remains unknown.	[Nakayama-Imaohji, Haruyuki; Yoneda, Saori; Nariya, Hirofumi; Suzuki, Motoo; Kuwahara, Tomomi] Kagawa Univ, Fac Med, Dept Microbiol, 1750-1 Miki, Kagawa 7610793, Japan; [Hirota, Katsuhiko; Miyake, Yoichiro] Univ Tokushima, Inst Biomed Sci, Dept Oral Microbiol, Grad Sch, Tokushima 7708503, Japan; [Yamasaki, Hisashi] Wakayama Med Univ, Grad Sch Med, Dept Cellular & Mol Med, Wakayama 6418509, Japan; [Secher, Thomas; Oswald, Eric] Inserm UMR1043, Toulouse, France; [Secher, Thomas; Oswald, Eric] INRA USC 1360 Toulouse, Toulouse, France; [Secher, Thomas; Oswald, Eric] CNRS UMR5282 Toulouse, Toulouse, France; [Secher, Thomas; Oswald, Eric] Univ Toulouse, UPS, CPTP, Toulouse, France; [Oswald, Eric] CHU Toulouse, Hop Purpan, Serv Bacteriol Hyg, Toulouse, France; [Hayashi, Tetsuya] Kyushu Univ, Dept Bacteriol, Fac Med Sci, Fukuoka 8128582, Japan	Kagawa University; Tokushima University; Wakayama Medical University; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Kyushu University	Kuwahara, T (corresponding author), Kagawa Univ, Fac Med, Dept Microbiol, 1750-1 Miki, Kagawa 7610793, Japan.	tomomi@med.kagawa-u.ac.jp	Hayashi, Tetsuya/ABA-1074-2020; SECHER, Thomas/P-4795-2016	Oswald, Eric/0000-0002-3017-0081	KAKENHI [15K00822, 26460530]; Grants-in-Aid for Scientific Research [25460535] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-aid for Scientific Research (KAKENHI, www.jsps.go.jp/) to HNI (15K00822) and TK (26460530).	ARANDA CMA, 1992, P NATL ACAD SCI USA, V89, P10079, DOI 10.1073/pnas.89.21.10079; Bayley DP, 2000, FEMS MICROBIOL LETT, V193, P149, DOI 10.1111/j.1574-6968.2000.tb09417.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Chatzidaki-Livanis M, 2008, J BACTERIOL, V190, P1020, DOI 10.1128/JB.01519-07; Coyne MJ, 2003, P NATL ACAD SCI USA, V100, P10446, DOI 10.1073/pnas.1832655100; Coyne MJ, 2001, INFECT IMMUN, V69, P4342, DOI 10.1128/IAI.69.7.4342-4350.2001; Elhenawy W, 2014, MBIO, V5, DOI 10.1128/mBio.00909-14; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Goedhart J, 1999, BIOCHEMISTRY-US, V38, P10898, DOI 10.1021/bi990714q; Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0; Ichimura M, 2014, J BASIC MICROB, V54, P558, DOI 10.1002/jobm.201200763; Ichimura M, 2010, APPL ENVIRON MICROB, V76, P3325, DOI 10.1128/AEM.02420-09; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Kitagawa R, 2010, J BACTERIOL, V192, P5645, DOI 10.1128/JB.00590-10; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; KUTSUKAKE K, 1980, NATURE, V284, P479, DOI 10.1038/284479a0; Kuwahara T, 2004, P NATL ACAD SCI USA, V101, P14919, DOI 10.1073/pnas.0404172101; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Nakayama-Imaohji H, 2009, J BACTERIOL, V191, P6003, DOI 10.1128/JB.00687-09; PATRICK S, 1983, J MED MICROBIOL, V16, P239, DOI 10.1099/00222615-16-2-239; Prouty AM, 2004, MICROBIOL-SGM, V150, P775, DOI 10.1099/mic.0.26769-0; Pumbwe L, 2007, MICROB PATHOGENESIS, V43, P78, DOI 10.1016/j.micpath.2007.04.002; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ramasundara M, 2009, J GASTROEN HEPATOL, V24, P202, DOI 10.1111/j.1440-1746.2008.05772.x; Rocha ER, 1997, J BACTERIOL, V179, P7033, DOI 10.1128/jb.179.22.7033-7039.1997; Roche-Hakansson H, 2007, J BACTERIOL, V189, P2119, DOI 10.1128/JB.01362-06; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Salyers AA, 1999, METHOD MICROBIOL, V29, P229; Sanchez B, 2005, J BACTERIOL, V187, P5799, DOI 10.1128/JB.187.16.5799-5808.2005; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; SILVERMAN M, 1980, CELL, V19, P845, DOI 10.1016/0092-8674(80)90075-6; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; VALENTINE PJ, 1988, J BACTERIOL, V170, P1319, DOI 10.1128/jb.170.3.1319-1324.1988; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Wakimoto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053829; Wehkamp J, 2007, CURR OPIN GASTROEN, V23, P370, DOI 10.1097/MOG.0b013e328136c580; Weinacht KG, 2004, MOL MICROBIOL, V53, P1319, DOI 10.1111/j.1365-2958.2004.04219.x; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	48	12	12	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148887	10.1371/journal.pone.0148887	http://dx.doi.org/10.1371/journal.pone.0148887			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859882	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400100
J	Sun, HL; Tsai, WC; Li, BY; Tao, W; Chen, PS; Rubart, M				Sun, Hong-Li; Tsai, Wen-Chin; Li, Bai-Yan; Tao, Wen; Chen, Peng-Sheng; Rubart, Michael			Voltage-Induced Ca2+ Release in Postganglionic Sympathetic Neurons in Adult Mice	PLOS ONE			English	Article							2-AMINOETHOXYDIPHENYL BORATE; DIHYDROPYRIDINE RECEPTORS; RYANODINE RECEPTORS; CALCIUM-CHANNELS; RAT; EXCITATION; ACTIVATION; CADMIUM; SIGNAL; STORE	Recent studies have provided evidence that depolarization in the absence of extracellular Ca2+ can trigger Ca2+ release from internal stores in a variety of neuron subtypes. Here we examine whether postganglionic sympathetic neurons are able to mobilize Ca2+ from intracellular stores in response to depolarization, independent of Ca2+ influx. We measured changes in cytosolic Delta F/F-0 in individual fluo-4-loaded sympathetic ganglion neurons in response to maintained K+ depolarization in the presence (2 mM) and absence of extracellular Ca2+ ([Ca2+](e)). Progressive elevations in extracellular [K+](e) caused increasing membrane depolarizations that were of similar magnitude in 0 and 2 mM [Ca2+](e). Peak amplitude of Delta F/F-0 transients in 2 mM [Ca2+](e) increased in a linear fashion as the membrane become more depolarized. Peak elevations of Delta F/F-0 in 0 mM [Ca2+](e) were similar to 5-10% of those evoked at the same membrane potential in 2 mM [Ca2+](e) and exhibited an inverse U-shaped dependence on voltage. Both the rise and decay of Delta F/F-0 transients in 0 mM [Ca2+](e) were slower than those of Delta F/F-0 transients evoked in 2 mM [Ca2+](e). Rises in Delta F/F-0 evoked by high [K+](e) in the absence of extracellular Ca2+ were blocked by thapsigargin, an inhibitor of endoplasmic reticulum Ca2+ ATPase, or the inositol 1,4,5-triphosphate (IP3) receptor antagonists 2-aminoethoxydiphenyl borate and xestospongin C, but not by extracellular Cd2+, the dihydropyridine antagonist nifedipine, or by ryanodine at concentrations that caused depletion of ryanodine-sensitive Ca2+ stores. These results support the notion that postganglionic sympathetic neurons possess the ability to release Ca2+ from IP3-sensitive internal stores in response to membrane depolarization, independent of Ca2+ influx.	[Sun, Hong-Li; Tao, Wen; Rubart, Michael] Indiana Univ Sch Med, Riley Heart Res Ctr, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Sun, Hong-Li] Harbin Med Univ Daqing, Dept Pharmacol, Daqing, Heilongjiang, Peoples R China; [Tsai, Wen-Chin; Chen, Peng-Sheng] Indiana Univ Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; [Tsai, Wen-Chin; Chen, Peng-Sheng] Indiana Univ Sch Med, Div Cardiol, Dept Med, Indianapolis, IN 46202 USA; [Tsai, Wen-Chin] Hualein Tzu Chi Gen Hosp, Dept Med, Div Cardiol, Hualein, Taiwan; [Li, Bai-Yan] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Harbin Medical University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Buddhist Tzu Chi General Hospital; Indiana University System; Indiana University-Purdue University Indianapolis	Rubart, M (corresponding author), Indiana Univ Sch Med, Riley Heart Res Ctr, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.	mrubartv@iu.edu	Tsai, WEN-CHIN/AGY-3079-2022		National Natural Science Foundation of China [81202509]; National Heart, Lung and Blood Institute [R01HL07165]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078931] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Natural Science Foundation of China (81202509, http://www.nsfc.gov.cn/) to HS and the National Heart, Lung and Blood Institute (R01HL07165, http://www.nhlbi.nih.gov/) to MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita T, 2000, J GEN PHYSIOL, V116, P697, DOI 10.1085/jgp.116.5.697; Albrecht MA, 2001, J GEN PHYSIOL, V118, P83, DOI 10.1085/jgp.118.1.83; Araya R, 2003, J GEN PHYSIOL, V121, P3, DOI 10.1085/jgp.20028671; Bannister RA, 2009, J GEN PHYSIOL, V133, P79, DOI 10.1085/jgp.200810105; Beam KG, 2010, J GEN PHYSIOL, V136, P7, DOI 10.1085/jgp.201010461; BELLUZZI O, 1989, J PHYSIOL-LONDON, V412, P493, DOI 10.1113/jphysiol.1989.sp017628; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Blumenstein Y, 2004, J PHYSIOL-LONDON, V556, P121, DOI 10.1113/jphysiol.2003.056168; Bofill-Cardona E, 2000, MOL PHARMACOL, V57, P1165; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; De Crescenzo V, 2006, J NEUROSCI, V26, P7565, DOI 10.1523/JNEUROSCI.1512-06.2006; Eltit JM, 2004, BIOPHYS J, V86, P3042, DOI 10.1016/S0006-3495(04)74353-2; Esteve E, 2010, J GEN PHYSIOL, V135, P619, DOI 10.1085/jgp.200910328; FRIEL DD, 1992, J PHYSIOL-LONDON, V450, P217, DOI 10.1113/jphysiol.1992.sp019125; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HINKLE PM, 1992, J BIOL CHEM, V267, P25553; Kim S, 2007, J BIOL CHEM, V282, P32877, DOI 10.1074/jbc.M701418200; Kukwa W, 1998, J AUTONOM NERV SYST, V74, P143, DOI 10.1016/S0165-1838(98)00154-4; Li BY, 2007, J NEUROSCI METH, V164, P75, DOI 10.1016/j.jneumeth.2007.04.003; Martinez-Pinna J, 2002, BRAIN RES, V951, P227, DOI 10.1016/S0006-8993(02)03165-7; Namkung Y, 1998, P NATL ACAD SCI USA, V95, P12010, DOI 10.1073/pnas.95.20.12010; Nimmrich V, 2012, BRIT J PHARMACOL, V167, P741, DOI 10.1111/j.1476-5381.2012.02069.x; Okamura Y, 2009, J PHYSIOL-LONDON, V587, P513, DOI 10.1113/jphysiol.2008.163097; Ouardouz M, 2003, NEURON, V40, P53, DOI 10.1016/j.neuron.2003.08.016; Parri HR, 1998, J NEUROSCI, V18, P854; PoloParada L, 1997, J GEN PHYSIOL, V109, P693, DOI 10.1085/jgp.109.6.693; Ryglewski S, 2007, PLOS BIOL, V5, P818, DOI 10.1371/journal.pbio.0050066; Satoh H, 1996, BIOPHYS J, V70, P1494, DOI 10.1016/S0006-3495(96)79711-4; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; THAYER SA, 1988, MOL PHARMACOL, V34, P664; Usai C, 1999, J NEUROCHEM, V72, P2154, DOI 10.1046/j.1471-4159.1999.0722154.x; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Xu SZ, 2005, BRIT J PHARMACOL, V145, P405, DOI 10.1038/sj.bjp.0706197	34	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148962	10.1371/journal.pone.0148962	http://dx.doi.org/10.1371/journal.pone.0148962			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859144	Green Published, gold			2022-12-27	WOS:000370038400110
J	Yu, YP; Pan, G; Gong, YY; Xu, KD; Zheng, NG; Hua, WD; Zheng, XX; Wu, ZH				Yu, Yipeng; Pan, Gang; Gong, Yongyue; Xu, Kedi; Zheng, Nenggan; Hua, Weidong; Zheng, Xiaoxiang; Wu, Zhaohui			Intelligence-Augmented Rat Cyborgs in Maze Solving	PLOS ONE			English	Article							REMOTE-CONTROL; BRAIN; NAVIGATION; REPRESENTATION; DIRECTION; MACHINE; ROBOTS	Cyborg intelligence is an emerging kind of intelligence paradigm. It aims to deeply integrate machine intelligence with biological intelligence by connecting machines and living beings via neural interfaces, enhancing strength by combining the biological cognition capability with the machine computational capability. Cyborg intelligence is considered to be a new way to augment living beings with machine intelligence. In this paper, we build rat cyborgs to demonstrate how they can expedite the maze escape task with integration of machine intelligence. We compare the performance of maze solving by computer, by individual rats, and by computer-aided rats (i.e. rat cyborgs). They were asked to find their way from a constant entrance to a constant exit in fourteen diverse mazes. Performance of maze solving was measured by steps, coverage rates, and time spent. The experimental results with six rats and their intelligence-augmented rat cyborgs show that rat cyborgs have the best performance in escaping from mazes. These results provide a proof-of-principle demonstration for cyborg intelligence. In addition, our novel cyborg intelligent system (rat cyborg) has great potential in various applications, such as search and rescue in complex terrains.	[Yu, Yipeng; Pan, Gang; Gong, Yongyue; Hua, Weidong; Wu, Zhaohui] Zhejiang Univ, Coll Comp Sci & Technol, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Kedi; Zheng, Nenggan; Zheng, Xiaoxiang] Qiushi Acad Adv Studies, Zhejiang Univ, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Pan, G (corresponding author), Zhejiang Univ, Coll Comp Sci & Technol, Hangzhou 310003, Zhejiang, Peoples R China.	gpan@zju.edu.cn	Pan, Gang/B-5978-2013	Pan, Gang/0000-0002-4049-6181	National Key Basic Research Program of China [2013CB329504]; Zhejiang Provincial Natural Science Foundation of China [LR15F020001]; Program for New Century Excellent Talents in University [NCET-13-0521]	National Key Basic Research Program of China(National Basic Research Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work has been supported by National Key Basic Research Program of China (2013CB329504) (http://www.973.gov.cn/English/Index.aspx), Zhejiang Provincial Natural Science Foundation of China (LR15F020001) (http://www.zjnsf.gov.cn/), and Program for New Century Excellent Talents in University (NCET-13-0521) (http://www.moe.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by National Key Basic Research Program of China (2013CB329504), Zhejiang Provincial Natural Science Foundation of China (LR15F020001), and Program for New Century Excellent Talents in University (NCET-13-0521). The authors are grateful to the editor and reviewers for their insightful comments. They also are pleased to thank Liqiang Gao, Liujing Zhuang, Shengzhang Lai for technical support and Chaonan Yu for the rat surgery.	Abelson H., 1981, TURTLE GEOMETRY; [Anonymous], 2004, BEHAV LAB RAT HDB TE; Beauchamp GK, 2003, BIOCHEM SOC T, V31, P147; Berger TW, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046017; Bozkurt A, 2009, IEEE T BIO-MED ENG, V56, P2304, DOI 10.1109/TBME.2009.2022551; Chen N, 1996, PROC FRONT EDUC CONF, P1057, DOI 10.1109/FIE.1996.567748; Crenshaw DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117973; Cully A, 2015, NATURE, V521, P503, DOI 10.1038/nature14422; DiGiovanna J, 2009, IEEE T BIO-MED ENG, V56, P54, DOI 10.1109/TBME.2008.926699; Ejaz N, 2011, JOVE-J VIS EXP, V10, P218; Etienne S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096275; Feng ZY, 2007, J ZHEJIANG UNIV-SC A, V8, P323, DOI 10.1631/jzus.2007.A0323; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; HART PE, 1968, IEEE T SYST SCI CYB, VSSC4, P100, DOI 10.1109/TSSC.1968.300136; Holzer R., 1997, Proceedings of the 1997 IEEE/RSJ International Conference on Intelligent Robot and Systems. Innovative Robotics for Real-World Applications. IROS '97 (Cat. No.97CH36108), P1514, DOI 10.1109/IROS.1997.656559; Julia M, 2012, AUTON ROBOT, V33, P427, DOI 10.1007/s10514-012-9298-8; Khan AG, 2012, NATURE COMMUNICATION, V3, P23; Lee MG, 2010, BEHAV PROCESS, V84, P715, DOI 10.1016/j.beproc.2010.04.007; MATHER JG, 1981, NATURE, V291, P152, DOI 10.1038/291152a0; Milford MJ, 2008, IEEE T ROBOT, V24, P1038, DOI 10.1109/TRO.2008.2004520; Muheim R, 2006, LEARN BEHAV, V34, P366, DOI 10.3758/BF03193201; Nicolelis M. A. L., 2013, NATURE COMMUN, V4, P66; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; OLDS J, 1958, SCIENCE, V127, P315, DOI 10.1126/science.127.3294.315; Phillips JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073112; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Sadik A. M. J., 2010, 2010 International Conference on Artificial Intelligence and Computational Intelligence (AICI 2010), P52, DOI 10.1109/AICI.2010.18; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Sato H, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.024.2009; Sun C, 2013, J BIONIC ENG, V10, P46, DOI 10.1016/S1672-6529(13)60198-5; SUTHERLAND RJ, 1983, BEHAV BRAIN RES, V7, P133, DOI 10.1016/0166-4328(83)90188-2; Talwar SK, 2002, NATURE, V417, P37, DOI 10.1038/417037a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Thrun S, 1996, PROCEEDINGS OF THE THIRTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE EIGHTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE, VOLS 1 AND 2, P944; Vasile C, 2010, IFAC P; Wallace DG, 2002, BEHAV BRAIN RES, V131, P185, DOI 10.1016/S0166-4328(01)00384-9; Wang YM, 2015, IEEE COMPUT INTELL M, V10, P42, DOI 10.1109/MCI.2015.2405318; Wen Y, 2015, MAGN RESON IMAGING, V33, P465, DOI 10.1016/j.mri.2015.01.013; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Wu ZH, 2013, IEEE INTELL SYST, V28, P28, DOI 10.1109/MIS.2013.137; Xu Dongrong, 2012, Int J Virtual Real, V11, P63; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001; Zhang SW, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00088; Zhang SW, 2000, LEARN MEMORY, V7, P363, DOI 10.1101/lm.32900	44	18	18	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0147754	10.1371/journal.pone.0147754	http://dx.doi.org/10.1371/journal.pone.0147754			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859299	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400012
J	Frommlet, F; Nuel, G				Frommlet, Florian; Nuel, Gregory			An Adaptive Ridge Procedure for L-0 Regularization	PLOS ONE			English	Article							NONCONCAVE PENALIZED LIKELIHOOD; VARIABLE SELECTION; MODEL SELECTION; REGRESSION; DECONVOLUTION; ASSOCIATION; LASSO	Penalized selection criteria like AIC or BIC are among the most popular methods for variable selection. Their theoretical properties have been studied intensively and are well understood, but making use of them in case of high-dimensional data is difficult due to the non-convex optimization problem induced by L-0 penalties. In this paper we introduce an adaptive ridge procedure (AR), where iteratively weighted ridge problems are solved whose weights are updated in such a way that the procedure converges towards selection with L-0 penalties. After introducing AR its specific shrinkage properties are studied in the particular case of orthogonal linear regression. Based on extensive simulations for the non-orthogonal case as well as for Poisson regression the performance of AR is studied and compared with SCAD and adaptive LASSO. Furthermore an efficient implementation of AR in the context of least-squares segmentation is presented. The paper ends with an illustrative example of applying AR to analyze GWAS data.	[Frommlet, Florian] Med Univ Vienna, Dept Med Stat CEMSIIS, Spitalgasse 23, A-1090 Vienna, Austria; [Nuel, Gregory] Univ Paris 06, LPMA UMR CNRS 7599, Stochast & Biol Grp PSB, Natl Inst Math Sci INSMI,CNRS, 4 Pl Jussieu, F-75005 Paris, France	Medical University of Vienna; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Frommlet, F (corresponding author), Med Univ Vienna, Dept Med Stat CEMSIIS, Spitalgasse 23, A-1090 Vienna, Austria.	Florian.Frommlet@meduniwien.ac.at	Frommlet, Florian/H-7097-2019	Frommlet, Florian/0000-0003-4104-1768	WWTF, the Vienna Science and Technology Fund [MA09-007a]; ANR, the French National Research Agency [ANR-13-MONU-0013]; WWTF; ANR	WWTF, the Vienna Science and Technology Fund; ANR, the French National Research Agency(French National Research Agency (ANR)); WWTF; ANR(French National Research Agency (ANR))	This research has been funded by WWTF, the Vienna Science and Technology Fund (http://www.wwtf.at/) through project MA09-007a and by ANR, the French National Research Agency, through Project SAMOGWAS (http://www.agence-nationale-recherche.fr/?Project=ANR-13-MONU-0013). Florian Frommlet received funding from WWTF and Gregory Nuel from ANR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bogdan M, 2004, GENETICS, V167, P989, DOI 10.1534/genetics.103.021683; Bogdan M, 2008, QUAL RELIAB ENG INT, V24, P627, DOI 10.1002/qre.936; Breheny P, 2011, ANN APPL STAT, V5, P232, DOI 10.1214/10-AOAS388; Breiman L, 1996, ANN STAT, V24, P2350; Broman KW, 2002, J R STAT SOC B, V64, P641, DOI 10.1111/1467-9868.00354; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Buhlmann P, 2008, ANN STAT, V36, P1534, DOI 10.1214/07-AOS0316A; Buhlmann P, 2011, SPRINGER SER STAT, P1, DOI 10.1007/978-3-642-20192-9; Candes EJ, 2008, J FOURIER ANAL APPL, V14, P877, DOI 10.1007/s00041-008-9045-x; Chen JH, 2008, BIOMETRIKA, V95, P759, DOI 10.1093/biomet/asn034; Chen YQ, 2014, WIRES COMPUT STAT, V6, P1, DOI 10.1002/wics.1284; Cleynen A, 2012, ARXIV12045564; de Rooi J, 2011, ANAL CHIM ACTA, V705, P218, DOI 10.1016/j.aca.2011.05.030; de Rooi JJ, 2014, ANAL CHEM, V86, P6291, DOI 10.1021/ac500260h; Dicker L, 2013, STAT SINICA, V23, P929, DOI 10.5705/ss.2011.074; Dolejsi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103322; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; FRANK IE, 1993, TECHNOMETRICS, V35, P109, DOI 10.2307/1269656; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Frommlet F, 2011, ARXIV PREPRINT ARXIV; Frommlet F, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1793; Frommlet F, 2012, COMPUT STAT DATA AN, V56, P1038, DOI 10.1016/j.csda.2011.05.005; FURNIVAL GM, 1974, TECHNOMETRICS, V16, P499, DOI 10.2307/1267601; Grandvalet Y, 1999, ADV NEUR IN, V11, P445; Grandvalet Y., 1998, ICANN 98. Proceedings of the 8th International Conference on Artificial Neural Networks, P201; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Kim J, 2008, J COMPUT GRAPH STAT, V17, P994, DOI 10.1198/106186008X386210; Liu YF, 2007, J COMPUT GRAPH STAT, V16, P782, DOI 10.1198/106186007X255676; Mazumder R, 2011, J AM STAT ASSOC, V106, P1125, DOI 10.1198/jasa.2011.tm09738; Rigaill G., 2010, 10040887 ARXIV; Rippe RCA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038230; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; ULBRICHT J., 2010, VARIABLE SELECTION G; Wu TT, 2008, ANN APPL STAT, V2, P224, DOI 10.1214/07-AOAS147; Yang YH, 2005, BIOMETRIKA, V92, P937, DOI 10.1093/biomet/92.4.937; Zhan HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044173; Zhang CH, 2010, ANN STAT, V38, P894, DOI 10.1214/09-AOS729; Zhao P, 2006, J MACH LEARN RES, V7, P2541; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	43	29	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148620	10.1371/journal.pone.0148620	http://dx.doi.org/10.1371/journal.pone.0148620			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849123	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000139
J	Peng, Z; Sun, YF; Lv, XL; Zhang, HY; Liu, CM; Dai, SM				Peng, Zheng; Sun, Yifan; Lv, Xiaolan; Zhang, Hongyu; Liu, Chunming; Dai, Shengming			Interleukin-6 Levels in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INSULIN-RESISTANCE; SYNDROME PCOS; RISK MARKERS; CHRONIC INFLAMMATION; METFORMIN; OBESITY; PIOGLITAZONE; CYTOKINES; DISEASE	Background The change of serum interleukin-6(IL-6) levels in women with polycystic ovary syndrome (PCOS), as well as the relations between IL-6 levels and body mass index (BMI), insulin resistance(IR) and androgen status of PCOS patients, are not fully understood. Methods A literature search was performed in October 2015 using PubMed, Embase and the Cochrane Library databases to identify studies. Random-effects model was used to estimate the standardized mean differences (SMDs) with 95% confidence intervals (CIs). Results Twenty articles with 25 case-control studies included 1618 women (922 PCOS patients and 696 controls) were included in this study. IL-6 levels in controls were significantly lower than that of PCOS patients (SMD = 0.78, 95% CI = 0.41-1.16, P<0.001), with significant heterogeneity across studies (I-2 = 91% and P<0.001). Meta-regression analysis model indicated IR status was the main source of heterogeneity (P = 0.005). Results from group analysis suggested that high IL-6 levels in PCOS were significantly associated with Homeostasis Model Assessment of Insulin Resistance (HOMA2-IR) ratio and total testosterone ratio (T ratio), and was found in both lean and obese women with PCOS. Cumulative meta-analysis results indicated the total effect size (SMD) had tend to be stable since 2012(0.79 to 0.92). Conclusions A high IL-6 level is not an intrinsic characteristic of PCOS, but may be a useful monitoring biomarker for the treatment of PCOS.	[Peng, Zheng; Dai, Shengming] Guangxi Med Univ, Affiliated Hosp 4, Dept Clin Lab, Liuzhou, Guangxi, Peoples R China; [Sun, Yifan; Zhang, Hongyu; Liu, Chunming] Liuzhou Hosp Tradit Chinese Med, Dept Clin Lab, Liuzhou, Guangxi, Peoples R China; [Lv, Xiaolan] Liuzhou Maternal & Child Hlth Care Hosp, Dept Clin Lab, Liuzhou, Guangxi, Peoples R China	Guangxi Medical University	Dai, SM (corresponding author), Guangxi Med Univ, Affiliated Hosp 4, Dept Clin Lab, Liuzhou, Guangxi, Peoples R China.; Liu, CM (corresponding author), Liuzhou Hosp Tradit Chinese Med, Dept Clin Lab, Liuzhou, Guangxi, Peoples R China.	zyyliuchunming@126.com; daishm@sina.com	Peng, Zheng/G-6511-2016; Peng, Zheng/ABH-3205-2021	Peng, Zheng/0000-0001-9117-840X; Peng, Zheng/0000-0001-9117-840X				Benson S, 2008, BRAIN BEHAV IMMUN, V22, P177, DOI 10.1016/j.bbi.2007.07.003; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Ciaraldi TP, 2013, METABOLISM, V62, P1587, DOI 10.1016/j.metabol.2013.07.004; Escobar-Morreale Hector F, 2011, Fertil Steril, V95, P1048, DOI 10.1016/j.fertnstert.2010.11.036; Escobar-Morreale HF, 2003, DIABETOLOGIA, V46, P625, DOI 10.1007/s00125-003-1090-z; Gen R, 2009, GYNECOL ENDOCRINOL, V25, P241, DOI 10.1080/09513590802585613; Glintborg D, 2008, DIABETES CARE, V31, P328, DOI 10.2337/dc07-1424; Gozdemir E, 2013, GYNECOL OBSTET INVES, V75, P196, DOI 10.1159/000348497; Guldiken B, 2008, ANGIOLOGY; Heutling D, 2008, J CLIN ENDOCRINOLOGY; Jakubowska J, 2008, GYNECOL ENDOCRINOL, V24, P378, DOI 10.1080/09513590802128968; Kelly CCJ, 2001, J CLIN ENDOCR METAB, V86, P2453, DOI 10.1210/jc.86.6.2453; Kucuk M, 2014, GYNECOL ENDOCRINOL, V30, P423, DOI 10.3109/09513590.2014.895981; Li Xin, 2009, Zhonghua Yi Xue Za Zhi, V89, P2607; Lin YS, 2011, AM J REPROD IMMUNOL, V66, P527, DOI 10.1111/j.1600-0897.2011.01059.x; Luque-Ramirez M, 2010, HORM METAB RES, V42, P815, DOI 10.1055/s-0030-1262855; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mohlig M, 2004, EUR J ENDOCRINOL, V150, P525, DOI 10.1530/eje.0.1500525; Moran LJ, 2007, J CLIN ENDOCR METAB, V92, P2944, DOI 10.1210/jc.2006-2336; Nikolajuk A, 2010, DIABETES, V59, P1026, DOI 10.2337/db09-1316; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Olszanecka-Glinianowicz M, 2007, EUR J OBSTET GYN R B, V133, P197, DOI 10.1016/j.ejogrb.2006.10.037; Ozcaka O, 2012, J PERIODONTOL, V83, P1529, DOI 10.1902/jop.2012.110588; Phelan N, 2013, CLIN ENDOCRINOL, V78, P107, DOI 10.1111/j.1365-2265.2012.04454.x; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Roytblat L, 2000, OBES RES, V8, P673, DOI 10.1038/oby.2000.86; Samy N, 2009, DIS MARKERS, V26, P163, DOI [10.3233/DMA-2009-0627, 10.1155/2009/465203]; Soares GM, 2009, CLIN ENDOCRINOL, V71, P406, DOI 10.1111/j.1365-2265.2008.03506.x; STITH RD, 1994, CIRC SHOCK, V44, P210; Tarkun Ilhan, 2006, Metabolic Syndrome and Related Disorders, V4, P122, DOI 10.1089/met.2006.4.122; Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461; Toulis KA, 2011, HUM REPROD UPDATE, V17, P741, DOI 10.1093/humupd/dmr025; Tsilchorozidou T, 2009, HORM RES, V71, P148, DOI 10.1159/000197871; Vgontzas AN, 2006, METABOLISM, V55, P1076, DOI 10.1016/j.metabol.2006.04.002; Victor VM, 2011, J CLIN ENDOCR METAB, V96, P3115, DOI 10.1210/jc.2011-0651; Wells G, 2000, NEWCASTLE OTTAWA SCA; Xu XH, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-93; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Zawadzki J, 1992, POLYCYSTIC OVARY SYN, P377	40	52	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148531	10.1371/journal.pone.0148531	http://dx.doi.org/10.1371/journal.pone.0148531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849353	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000117
J	Ruano, J; Suarez-Farinas, M; Shemer, A; Oliva, M; Guttman-Yassky, E; Krueger, JG				Ruano, Juan; Suarez-Farinas, Mayte; Shemer, Avner; Oliva, Margeaux; Guttman-Yassky, Emma; Krueger, James G.			Molecular and Cellular Profiling of Scalp Psoriasis Reveals Differences and Similarities Compared to Skin Psoriasis	PLOS ONE			English	Article							SEVERE PLAQUE PSORIASIS; DOUBLE-BLIND; T-CELLS; EXPRESSION; KERATINOCYTES; PATHOGENESIS; INVOLVEMENT; MICROARRAY; EPILYSIN; RECEPTOR	Scalp psoriasis shows a variable clinical spectrum and in many cases poses a great therapeutic challenge. However, it remains unknown whether the immune response of scalp psoriasis differs from understood pathomechanisms of psoriasis in other skin areas. We sought to determine the cellular and molecular phenotype of scalp psoriasis by performing a comparative analysis of scalp and skin using lesional and nonlesional samples from 20 Caucasian subjects with untreated moderate to severe psoriasis and significant scalp involvement and 10 control subjects without psoriasis. Our results suggest that even in the scalp, psoriasis is a disease of the inter-follicular skin. The immune mechanisms that mediate scalp psoriasis were found to be similar to those involved in skin psoriasis. However, the magnitude of dysregulation, number of differentially expressed genes, and enrichment of the psoriatic genomic fingerprint were more prominent in skin lesions. Furthermore, the scalp transcriptome showed increased modulation of several gene-sets, particularly those induced by interferon-gamma, compared with that of skin psoriasis, which was mainly associated with activation of TNF alpha/L-17/IL-22-induced keratinocyte response genes. We also detected differences in expression of gene-sets involving negative regulation, epigenetic regulation, epidermal differentiation, and dendritic cell or Th1/Th17/Th22-related T-cell processes.	[Ruano, Juan] Reina Sofia Univ Hosp, Dept Dermatol, Cordoba, Spain; [Ruano, Juan] Univ Cordoba, Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain; [Suarez-Farinas, Mayte; Guttman-Yassky, Emma] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA; [Suarez-Farinas, Mayte] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Suarez-Farinas, Mayte] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Shemer, Avner] Tel Hashomer Hosp, Dept Dermatol, Tel Aviv, Israel; [Shemer, Avner] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Oliva, Margeaux] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Suarez-Farinas, Mayte; Guttman-Yassky, Emma; Krueger, James G.] Rockefeller Univ, Invest Dermatol Lab, 1230 York Ave, New York, NY 10021 USA	Hospital Universitario Reina Sofia - Cordoba; Universidad de Cordoba; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Tel Aviv University; Icahn School of Medicine at Mount Sinai; Rockefeller University	Ruano, J (corresponding author), Reina Sofia Univ Hosp, Dept Dermatol, Cordoba, Spain.; Ruano, J (corresponding author), Univ Cordoba, Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain.	juan.ruano@imibic.org	Ruano, Juan/T-1991-2018	Ruano, Juan/0000-0002-0286-4107	National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program [UL1 TR000043]; Plan Propio de movilidad para investigadores del Instituto Maimonides de Investigacion Biomedica de Cordoba [PP13/009]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Plan Propio de movilidad para investigadores del Instituto Maimonides de Investigacion Biomedica de Cordoba; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	MSF was supported by grant #UL1 TR000043 from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program. JGK was supported by grant #UL1 TR000043 from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program. JR was supported by grant #PP13/009 of the Plan Propio de movilidad para investigadores del Instituto Maimonides de Investigacion Biomedica de Cordoba.	Austin LM, 1999, J INVEST DERMATOL, V113, P752, DOI 10.1046/j.1523-1747.1999.00749.x; Bagel J, 2012, J AM ACAD DERMATOL, V67, P86, DOI 10.1016/j.jaad.2011.07.034; Chan CS, 2009, J AM ACAD DERMATOL, V60, P962, DOI 10.1016/j.jaad.2008.11.890; Chiricozzi A, 2013, EXPERT OPIN INV DRUG, V22, P993, DOI 10.1517/13543784.2013.806483; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; FARBER EM, 1992, CUTIS, V49, P396; Gudjonsson JE, 2007, J INVEST DERMATOL, V127, P1292, DOI 10.1038/sj.jid.5700807; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1849, DOI 10.1038/jid.2010.67; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1420, DOI 10.1016/j.jaci.2011.01.054; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; He XH, 2014, J INVEST DERMATOL, V134, P975, DOI 10.1038/jid.2013.459; Jiang S, 2015, GENOM PROTEOM BIOINF, V13, P224, DOI 10.1016/j.gpb.2015.04.002; Johnson-Huang LM, 2009, J CLIN IMMUNOL, V29, P247, DOI 10.1007/s10875-009-9278-8; Kamata M, 2012, CLIN EXP DERMATOL, V37, P296, DOI 10.1111/j.1365-2230.2011.04265.x; Khattri S, 2014, J ALLERGY CLIN IMMUN, V133, P1626, DOI 10.1016/j.jaci.2014.03.003; Komatsu N, 2007, BRIT J DERMATOL, V156, P875, DOI 10.1111/j.1365-2133.2006.07743.x; Krell J, 2008, J AM ACAD DERMATOL, V58, P609, DOI 10.1016/j.jaad.2007.12.031; LEIGH IM, 1995, BRIT J DERMATOL, V133, P501, DOI 10.1111/j.1365-2133.1995.tb02696.x; Lohi J, 2001, J BIOL CHEM, V276, P10134, DOI 10.1074/jbc.M001599200; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Mattozzi C, 2013, DERMATOLOGY, V227, P134, DOI 10.1159/000353398; Mee JB, 2007, AM J PATHOL, V171, P32, DOI 10.2353/ajpath.2007.061067; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Ortonne JP, 2009, J EUR ACAD DERMATOL, V23, P1435, DOI 10.1111/j.1468-3083.2009.03372.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ramot Y, 2013, PEERJ, V1, DOI 10.7717/peerj.40; Reischl J, 2007, J INVEST DERMATOL, V127, P163, DOI 10.1038/sj.jid.5700488; Romani J, 2013, ARCH DERMATOL RES, V305, P105, DOI 10.1007/s00403-012-1306-5; Saarialho-Kere U, 2002, J INVEST DERMATOL, V119, P14, DOI 10.1046/j.1523-1747.2002.01790.x; Shen F, 2008, CYTOKINE, V41, P92, DOI 10.1016/j.cyto.2007.11.013; Suarez-Farinas M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-294; Suarez-Farinas M, 2011, J INVEST DERMATOL, V131, P391, DOI 10.1038/jid.2010.280; Suarez-Farinas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010247; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Swindell WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018266; Tian SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044274; Tyring S, 2013, J EUR ACAD DERMATOL, V27, P125, DOI 10.1111/j.1468-3083.2011.04394.x; Weitz JE, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0377-4; Zaba LC, 2010, J ALLERGY CLIN IMMUN, V125, P1261, DOI 10.1016/j.jaci.2010.03.018; Zaba LC, 2009, J ALLERGY CLIN IMMUN, V124, P1022, DOI 10.1016/j.jaci.2009.08.046	42	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148450	10.1371/journal.pone.0148450	http://dx.doi.org/10.1371/journal.pone.0148450			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849645	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000096
J	Schultheiss, M; Schnichels, S; Hermann, T; Hurst, J; Feldkaemper, M; Arango-Gonzalez, B; Ueffing, M; Bartz-Schmidt, KU; Zeck, G; Spitzer, MS				Schultheiss, Maximilian; Schnichels, Sven; Hermann, Thoralf; Hurst, Jose; Feldkaemper, Marita; Arango-Gonzalez, Blanca; Ueffing, Marius; Bartz-Schmidt, Karl U.; Zeck, Guenther; Spitzer, Martin S.			Hypothermia Protects and Prolongs the Tolerance Time of Retinal Ganglion Cells against Ischemia	PLOS ONE			English	Article							LOCAL INTRAARTERIAL FIBRINOLYSIS; TISSUE-PLASMINOGEN ACTIVATOR; ARTERY-OCCLUSION; STROKE; RECOVERY; DAMAGE; TRIAL	Purpose Hypothermia has been shown to be neuroprotective in the therapy of ischemic stroke in the brain. To date no studies exist on the level of the inner retina and it is unclear if hypothermia would prolong the ischemic tolerance time of retinal ganglion cells, which are decisive in many ischemic retinopathies. Methods Bovine eyes were enucleated and stored either at 21 degrees C or 37 degrees C for 100 or 340 minutes, respectively. Afterwards the globes were dissected, the retina was prepared and either the spontaneous ganglion cell responses were measured or the retina was incubated as an organotypic culture for additional 24 hours. After incubation the retina was either processed for histology (H& E and DAPI staining) or real-time PCR (Thy-1 expression) was performed. Results Hypothermia prolonged ganglion cell survival up to 340 minutes under ischemic conditions. In contrast to eyes kept at 37 degrees C the eyes stored at 21 degrees C still showed spontaneous ganglion cell spiking (56.8% versus 0%), a 5.8 fold higher Thy-1 mRNA expression (not significant, but a trend) and a preserved retinal structure after 340 minutes of ischemia. Conclusion Hypothermia protects retinal ganglion cells against ischemia and prolongs their ischemic tolerance time.	[Schultheiss, Maximilian; Schnichels, Sven; Hurst, Jose; Bartz-Schmidt, Karl U.; Spitzer, Martin S.] Univ Eye Hosp Tubingen, Ctr Ophthalmol, Tubingen, Germany; [Hermann, Thoralf; Zeck, Guenther] Univ Tubingen, Nat & Med Sci Inst, Reutlingen, Germany; [Feldkaemper, Marita; Arango-Gonzalez, Blanca; Ueffing, Marius] Univ Tubingen, Inst Ophthalm Res, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schnichels, S (corresponding author), Univ Eye Hosp Tubingen, Ctr Ophthalmol, Tubingen, Germany.	sven.schnichels@med.uni-tuebingen.de	Zeck, Günther/H-7419-2013; Arango-Gonzalez, Blanca/AAR-7427-2021	Zeck, Günther/0000-0003-3998-9883; Arango-Gonzalez, Blanca/0000-0002-9045-182X; Schnichels, Sven/0000-0002-2385-5517; Hurst, Jose/0000-0002-8697-2569; Feldkaemper, Marita Pauline/0000-0001-6938-3714				Aldrich EM, 2008, STROKE, V39, P1746, DOI 10.1161/STROKEAHA.107.505404; ASTRUP J, 1977, STROKE, V8, P51, DOI 10.1161/01.STR.8.1.51; Baltmr A, 2010, EXP EYE RES, V91, P554, DOI 10.1016/j.exer.2010.08.009; Beatty S, 2000, BRIT J OPHTHALMOL, V84, P914, DOI 10.1136/bjo.84.8.914; Brandt SK, 2010, NEUROSCIENCE; Chen CS, 2011, STROKE, V42, P2229, DOI 10.1161/STROKEAHA.111.613653; Gumbinger C, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3429; Hattenrach LO, 2008, AM J OPHTHALMOL, V146, P700, DOI 10.1016/j.ajo.2008.06.016; Hayreh SS, 2004, EXP EYE RES, V78, P723, DOI 10.1016/S0014-4835(03)00214-8; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nash MS, 1999, INVEST OPHTH VIS SCI, V40, P1293; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quinones-Hinojosa A, 2003, NEUROSURGERY, V52, P1178, DOI 10.1227/01.NEU.0000057836.64972.A0; Salido EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061656; Schumacher M, 2010, OPHTHALMOLOGY, V117, P1367, DOI 10.1016/j.ophtha.2010.03.061; Stevens WD, 2002, STROKE, V33, P1107, DOI 10.1161/01.STR.0000014204.05597.0C; Stutzki H, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00038; Tamai K, 1997, BRIT J OPHTHALMOL, V81, P789, DOI 10.1136/bjo.81.9.789; Terao Y, 2009, NEUROSCI RES, V64, P75, DOI 10.1016/j.neures.2009.01.017; Wang XD, 2002, NEUROL RES, V24, P730, DOI 10.1179/016164102101200663; Wu TC, 2013, LANCET NEUROL, V12, P275, DOI 10.1016/S1474-4422(13)70013-9; Zeitler R, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3672224	23	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148616	10.1371/journal.pone.0148616	http://dx.doi.org/10.1371/journal.pone.0148616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848953	Green Submitted, gold, Green Published			2022-12-27	WOS:000369554000137
J	Schwanz, LE; Robert, KA				Schwanz, Lisa E.; Robert, Kylie A.			Costs of Rearing the Wrong Sex: Cross-Fostering to Manipulate Offspring Sex in Tammar Wallabies	PLOS ONE			English	Article							LOCAL RESOURCE COMPETITION; MATERNAL INVESTMENT; MACROPUS-EUGENII; POUCH YOUNG; FACULTATIVE ADJUSTMENT; RATIO; ALLOCATION; LACTATION; SELECTION; TRIVERS	Sex allocation theory assumes that offspring sex (son vs. daughter) has consequences for maternal fitness. The most compelling experiment to test this theory would involve manipulating offspring sex and measuring the fitness consequences of having the "wrong" sex. Unfortunately, the logistical challenges of such an experiment limit its application. In tammar wallabies (Macropus eugenii), previous evidence suggests that mothers in good body condition are more likely to produce sons compared to mothers in poor condition, in support of the Trivers-Willard Hypothesis (TW) of condition-dependent sex allocation. More recently, we have found in our population of tammar wallabies that females with seemingly poor access to resources (based on condition loss over the dry summer) are more likely to produce sons, consistent with predictions from the Local Resource Competition (LRC) hypothesis, which proposes that production of sons or daughters is driven by the level of potential competition between mothers and philopatric daughters. We conducted a cross-fostering experiment in free-ranging tammar wallabies to disassociate the effects of rearing and birthing offspring of each sex. This allowed us to test the prediction of the LRC hypothesis that rearing daughters reduces the future direct fitness of mothers post-weaning and the prediction of the TW hypothesis that rearing sons requires more energy during lactation. Overall, we found limited costs to the mother of rearing the "wrong" sex, with switching of offspring sex only reducing the likelihood of a mother having a pouch young the following year. Thus, we found some support for both hypotheses in that rearing an unexpected son or an unexpected daughter both lead to reduced future maternal fitness. The study suggests that there may be context-specific costs associated with rearing the "wrong" sex.	[Schwanz, Lisa E.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Schwanz, Lisa E.] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; [Robert, Kylie A.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Robert, Kylie A.] La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic, Australia; [Schwanz, Lisa E.] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia	James Cook University; University of Canberra; University of Western Australia; La Trobe University; University of New South Wales Sydney	Schwanz, LE (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	Lisa.Schwanz@gmail.com	Robert, Kylie/C-5181-2009	Robert, Kylie/0000-0002-8554-8440	U.S. National Science Foundation International Research Fellowship [NSF IRFP 0754299]; University of Western Australia Postdoctoral Research Fellowship; University of Western Australia Research Grants Scheme; Australian Department of Defence	U.S. National Science Foundation International Research Fellowship(National Science Foundation (NSF)); University of Western Australia Postdoctoral Research Fellowship; University of Western Australia Research Grants Scheme; Australian Department of Defence(Australian Government)	The research was funded by an U.S. National Science Foundation International Research Fellowship (LES; NSF IRFP 0754299), a University of Western Australia Postdoctoral Research Fellowship (KAR), University of Western Australia Research Grants Scheme (KAR), and the Australian Department of Defence (KAR and LES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks SC, 2008, J ANIM ECOL, V77, P1250, DOI 10.1111/j.1365-2656.2008.01448.x; Blumstein DT, 1999, ANIM BEHAV, V58, P351, DOI 10.1006/anbe.1999.1156; Blumstein DT, 2002, ETHOLOGY, V108, P815, DOI 10.1046/j.1439-0310.2002.00813.x; Blumstein DT, 2002, ETHOLOGY, V108, P937, DOI 10.1046/j.1439-0310.2002.00823.x; Cameron EZ, 2008, P ROY SOC B-BIOL SCI, V275, P323, DOI 10.1098/rspb.2007.1401; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; Chambers BK, 2009, THESIS U W AUSTR; Charnov EL, 1982, THEORY SEX ALLOCATIO; CLARK AB, 1978, SCIENCE, V201, P163, DOI 10.1126/science.201.4351.163; CLUTTONBROCK TH, 1986, ANIM BEHAV, V34, P460, DOI 10.1016/S0003-3472(86)80115-4; COCKBURN A, 1985, OECOLOGIA, V66, P427, DOI 10.1007/BF00378310; CORK SJ, 1991, J ZOOL, V225, P567, DOI 10.1111/j.1469-7998.1991.tb04325.x; CORK SJ, 1989, J ZOOL, V219, P399, DOI 10.1111/j.1469-7998.1989.tb02588.x; Cripps JK, 2011, BIOL LETTERS, V7, P859, DOI 10.1098/rsbl.2011.0526; CROFT DB, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P505; DICKMAN CR, 1988, AM NAT, V132, P289, DOI 10.1086/284851; Dusek A, 2011, BEHAV ECOL SOCIOBIOL, V65, P2209, DOI 10.1007/s00265-011-1229-8; EMLEN ST, 1986, AM NAT, V127, P1, DOI 10.1086/284463; Findlay L., 1984, Symposia of the Zoological Society of London, P403; Gardner DK, 2010, MOL HUM REPROD, V16, P539, DOI 10.1093/molehr/gaq042; Gelin U, 2015, J ANIM ECOL, V84, P239, DOI 10.1111/1365-2656.12266; Gelin U, 2013, ANIM BEHAV, V86, P885, DOI 10.1016/j.anbehav.2013.08.016; Goltsman M, 2005, BEHAV ECOL SOCIOBIOL, V59, P198, DOI 10.1007/s00265-005-0025-8; GOWATY PA, 1985, AM NAT, V126, P347, DOI 10.1086/284421; GREEN B, 1988, AUST J ZOOL, V36, P217, DOI 10.1071/ZO9880217; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; HIRAIWAHASEGAWA M, 1993, TRENDS ECOL EVOL, V8, P395, DOI 10.1016/0169-5347(93)90040-V; Hynes EF, 2005, REPRODUCTION, V130, P123, DOI 10.1530/rep.1.00624; Inns R.W, 1980, ECOLOGY KANGAROO ISL; Isaac JL, 2005, J ANIM ECOL, V74, P552, DOI 10.1111/j.1365-2656.2005.00954.x; JOHNSON CN, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P593; Johnson CN, 2001, P ROY SOC B-BIOL SCI, V268, P2001, DOI 10.1098/rspb.2001.1723; Julliard R, 2000, BEHAV ECOL, V11, P421, DOI 10.1093/beheco/11.4.421; King WJ, 2015, ECOL EVOL, V5, P2084, DOI 10.1002/ece3.1498; Komdeur J, 1997, NATURE, V385, P522, DOI 10.1038/385522a0; Koskela E, 2009, J ANIM ECOL, V78, P1007, DOI 10.1111/j.1365-2656.2009.01574.x; Le Gall-Payne C, 2015, BEHAV ECOL SOCIOBIOL, V69, P795, DOI 10.1007/s00265-015-1896-y; MacDonald AJ, 2013, HEREDITY, V2013, P1; Martin JGA, 2011, ECOLOGY, V92, P441, DOI 10.1890/09-2413.1; Miller EJ, 2010, MACROPODS: THE BIOLOGY OF KANGAROOS, WALLABIES AND RAT-KANGAROOS, P77; Moore EPB, 2015, J MAMMAL, V96, P1203, DOI 10.1093/jmammal/gyv129; MYERS JH, 1978, AM NAT, V112, P381, DOI 10.1086/283280; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; Nager RG, 2000, BEHAV ECOL SOCIOBIOL, V48, P452, DOI 10.1007/s002650000262; Pelletier F, 2007, EVOLUTION, V61, P1969, DOI 10.1111/j.1558-5646.2007.00160.x; Pike TW, 2006, P ROY SOC B-BIOL SCI, V273, P1093, DOI 10.1098/rspb.2005.3422; Poole WE, 1991, TABLES AGE DETERMINA; Radersma R, 2011, ANIM BEHAV, V81, P69, DOI 10.1016/j.anbehav.2010.09.007; Robert KA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1745; Robert KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051099; Robert KA, 2011, MAMMAL REV, V41, P1, DOI 10.1111/j.1365-2907.2010.00168.x; Robert KA, 2010, BIOL LETTERS, V6, P242, DOI 10.1098/rsbl.2009.0774; RUDD CD, 1994, J ZOOL, V232, P151, DOI 10.1111/j.1469-7998.1994.tb01565.x; Rutkowska J, 2011, P ROY SOC B-BIOL SCI, V278, P2962, DOI 10.1098/rspb.2010.2654; Schwanz LE, 2006, AM NAT, V168, P521, DOI 10.1086/507993; Schwanz LE, 2014, BEHAV ECOL SOCIOBIOL, V68, P1085, DOI 10.1007/s00265-014-1720-0; Schwanz LE, 2012, AUST J ZOOL, V60, P111, DOI 10.1071/ZO12024; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; SILK JB, 1983, AM NAT, V121, P56, DOI 10.1086/284039; Silk JB, 2008, P ROY SOC B-BIOL SCI, V275, P1761, DOI 10.1098/rspb.2008.0340; Sunnucks P, 1997, AUST J ZOOL, V45, P573, DOI 10.1071/ZO97038; Taggart D, 2002, ANZCCART NEWS, V15, P1; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Trott JF, 2003, BIOL REPROD, V68, P929, DOI 10.1095/biolreprod.102.005934; Tyndale-Biscoe H., 1987, REPROD PHYSL MARSUPI; West SA, 2009, MONOGR POPUL BIOL, V44, P162; Wild G, 2007, AM NAT, V170, pE112, DOI 10.1086/522057; Wild G, 2006, EVOLUTION, V60, P2012, DOI 10.1111/j.0014-3820.2006.tb01839.x; WILLIAMS GC, 1979, PROC R SOC SER B-BIO, V205, P567, DOI 10.1098/rspb.1979.0085; Windley HR, 2013, OECOLOGIA, V173, P203, DOI 10.1007/s00442-013-2616-9	70	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0146011	10.1371/journal.pone.0146011	http://dx.doi.org/10.1371/journal.pone.0146011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849128	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000369554000007
J	Shi, HB; Zhang, GD; Zhou, M; Cheng, L; Yang, HX; Wang, J; Sun, J; Wang, ZZ				Shi, Hongbo; Zhang, Guangde; Zhou, Meng; Cheng, Liang; Yang, Haixiu; Wang, Jing; Sun, Jie; Wang, Zhenzhen			Integration of Multiple Genomic and Phenotype Data to Infer Novel miRNA-Disease Associations	PLOS ONE			English	Article							MICRORNA TARGET PREDICTION; NETWORK; SIMILARITY; WALKING; PRIORITIZATION; IDENTIFICATION; INTERACTOME; EXPRESSION; RESOURCE; GENES	MicroRNAs (miRNAs) play an important role in the development and progression of human diseases. The identification of disease-associated miRNAs will be helpful for understanding the molecular mechanisms of diseases at the post-transcriptional level. Based on different types of genomic data sources, computational methods for miRNA-disease association prediction have been proposed. However, individual source of genomic data tends to be incomplete and noisy; therefore, the integration of various types of genomic data for inferring reliable miRNA-disease associations is urgently needed. In this study, we present a computational framework, CHNmiRD, for identifying miRNA-disease associations by integrating multiple genomic and phenotype data, including protein-protein interaction data, gene ontology data, experimentally verified miRNA-target relationships, disease phenotype information and known miRNA-disease connections. The performance of CHNmiRD was evaluated by experimentally verified miRNA-disease associations, which achieved an area under the ROC curve (AUC) of 0.834 for 5-fold cross-validation. In particular, CHNmiRD displayed excellent performance for diseases without any known related miRNAs. The results of case studies for three human diseases (glioblastoma, myocardial infarction and type 1 diabetes) showed that all of the top 10 ranked miRNAs having no known associations with these three diseases in existing miRNA-disease databases were directly or indirectly confirmed by our latest literature mining. All these results demonstrated the reliability and efficiency of CHNmiRD, and it is anticipated that CHNmiRD will serve as a powerful bioinformatics method for mining novel disease-related miRNAs and providing a new perspective into molecular mechanisms underlying human diseases at the post-transcriptional level. CHNmiRD is freely available at http://www.bio-bigdata.com/CHNmiRD.	[Shi, Hongbo; Zhou, Meng; Cheng, Liang; Yang, Haixiu; Wang, Jing; Sun, Jie; Wang, Zhenzhen] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Heilongjiang, Peoples R China; [Zhang, Guangde] Harbin Med Univ, Affiliated Hosp 4, Dept Cardiol, Harbin 150001, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Shi, HB; Sun, J; Wang, ZZ (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Heilongjiang, Peoples R China.	shihongbo@ems.hrbmu.edu.cn; suncarajie@hotmail.com; wangzz@ems.hrbmu.edu.cn	Zhou, Meng/G-7674-2011; Cheng, Liang/ABY-7421-2022	Zhou, Meng/0000-0001-9987-9024; Sun, Jie/0000-0002-0932-7195; Cheng, Liang/0000-0002-6665-6710	National Natural Science Foundation of China [31500675]; Postdoctoral Foundation of Heilongjiang Province [LBH-Z15162]; Natural Science Foundation of Heilongjiang Province [QC2013C019]; Science Foundation of Heilongjiang Provincial Health Department [2013126]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Foundation of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Science Foundation of Heilongjiang Provincial Health Department	This work was supported in part by the National Natural Science Foundation of China (Grant Nos. 31500675), the Postdoctoral Foundation of Heilongjiang Province (Grant No. LBH-Z15162), the Natural Science Foundation of Heilongjiang Province (Grant No. QC2013C019) and the Science Foundation of Heilongjiang Provincial Health Department (Grant Nos. 2013126). There was no additional external funding received for this study.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bandyopadhyay S, 2009, BIOINFORMATICS, V25, P2625, DOI 10.1093/bioinformatics/btp503; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chakraborty C, 2014, WIRES RNA, V5, P697, DOI 10.1002/wrna.1240; Chen HL, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-12; Chen X, 2014, SCI REP-UK, V4, DOI 10.1038/srep05501; Chen X, 2012, MOL BIOSYST, V8, P2792, DOI 10.1039/c2mb25180a; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Jiang QH, 2013, INT J DATA MIN BIOIN, V8, P282, DOI 10.1504/IJDMB.2013.056078; Jiang QH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S2; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Jiang R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S2; Kim AH, 2012, SCHIZOPHR RES, V141, P60, DOI 10.1016/j.schres.2012.06.038; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Li SF, 2014, J MOL CELL CARDIOL, V75, P49, DOI 10.1016/j.yjmcc.2014.06.017; Li Y, 2014, NUCLEIC ACIDS RES, V42, pD1070, DOI 10.1093/nar/gkt1023; Li YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S27; Li YJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S20; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lv SL, 2012, J R SOC INTERFACE, V9, P1063, DOI 10.1098/rsif.2011.0551; Macropol K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-283; Mork S, 2014, BIOINFORMATICS, V30, P392, DOI 10.1093/bioinformatics/btt677; Parekh Vanisha, 2011, Nat Rev Neurol, V7, P304, DOI 10.1038/nrneurol.2011.68; Shi HB, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-101; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Spinetti G, 2013, CIRC RES, V112, DOI 10.1161/CIRCRESAHA.111.300418; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Sun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069719; Szeto CC, 2012, DIS MARKERS, V33, P137, DOI 10.1155/2012/842764; Taurino C, 2010, CLIN SCI, V119, P335, DOI 10.1042/CS20100043; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Wang D, 2010, BIOINFORMATICS, V26, P1644, DOI 10.1093/bioinformatics/btq241; Wang QH, 2011, BIOINFORMATICS, V27, P1521, DOI 10.1093/bioinformatics/btr154; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu J, 2011, MOL CANCER THER, V10, P1857, DOI 10.1158/1535-7163.MCT-11-0055; Xuan P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070204, 10.1371/annotation/a076115e-dd8c-4da7-989d-c1174a8cd31e]; Yang Z, 2014, ACTA DIABETOL; Zitman-Gal T, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-8	49	19	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148521	10.1371/journal.pone.0148521	http://dx.doi.org/10.1371/journal.pone.0148521			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849207	Green Published, gold			2022-12-27	WOS:000369554000116
J	Macintosh, AA; Pinhasi, R; Stock, JT				Macintosh, Alison A.; Pinhasi, Ron; Stock, Jay T.			Early Life Conditions and Physiological Stress following the Transition to Farming in Central/Southeast Europe: Skeletal Growth Impairment and 6000 Years of Gradual Recovery	PLOS ONE			English	Article							BODY-MASS ESTIMATION; CATCH-UP GROWTH; HUMAN-POPULATIONS; SEX-DIFFERENCES; SECULAR CHANGE; AMERICAN-BORN; LONG BONES; ENVIRONMENTAL-INFLUENCES; SIMILAR-TO-6150 YEARS; NEOLITHIC SETTLEMENT	Early life conditions play an important role in determining adult body size. In particular, childhood malnutrition and disease can elicit growth delays and affect adult body size if severe or prolonged enough. In the earliest stages of farming, skeletal growth impairment and small adult body size are often documented relative to hunter-gatherer groups, though this pattern is regionally variable. In Central/Southeast Europe, it is unclear how early life stress, growth history, and adult body size were impacted by the introduction of agriculture and ensuing long-term demographic, social, and behavioral change. The current study assesses this impact through the reconstruction and analysis of mean stature, body mass, limb proportion indices, and sexual dimorphism among 407 skeletally mature men and women from foraging and farming populations spanning the Late Mesolithic through Early Medieval periods in Central/Southeast Europe (similar to 7100 calBC to 850 AD). Results document significantly reduced mean stature, body mass, and crural index in Neolithic agriculturalists relative both to Late Mesolithic hunter-gatherer-fishers and to later farming populations. This indication of relative growth impairment in the Neolithic, particularly among women, is supported by existing evidence of high developmental stress, intensive physical activity, and variable access to animal protein in these early agricultural populations. Among subsequent agriculturalists, temporal increases in mean stature, body mass, and crural index were more pronounced among Central European women, driving declines in the magnitude of sexual dimorphism through time. Overall, results suggest that the transition to agriculture in Central/Southeast Europe was challenging for early farming populations, but was followed by gradual amelioration across thousands of years, particularly among Central European women. This sex difference may be indicative, in part, of greater temporal variation in the social status afforded to young girls, in their access to resources during growth, and/or in their health status than was experienced by men.	[Macintosh, Alison A.; Stock, Jay T.] Univ Cambridge, Dept Archaeol & Anthropol, Div Biol Anthropol, PAVE Res Grp, Cambridge, England; [Pinhasi, Ron] Univ Coll Dublin, Earth Inst & Sch Archaeol, Newman Bldg, Dublin 2, Ireland	University of Cambridge; University College Dublin	Macintosh, AA (corresponding author), Univ Cambridge, Dept Archaeol & Anthropol, Div Biol Anthropol, PAVE Res Grp, Cambridge, England.	am2028@cam.ac.uk	Stock, Jay T/B-6453-2011; Pinhasi, Ron/AAT-1531-2020	Stock, Jay T/0000-0003-0147-8631; Pinhasi, Ron/0000-0003-1629-8131; Murray, Alison/0000-0003-2914-5206	Cambridge Commonwealth, European and International Trust; Social Sciences and Humanities Research Council of Canada; European Research Council (ERC) [ERC-2010-StG263441]; Natural Environment Research Council (NERC) [NE/M/S/2003/00069]	Cambridge Commonwealth, European and International Trust; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); European Research Council (ERC)(European Research Council (ERC)European Commission); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by funding from the Cambridge Commonwealth, European and International Trust (AAPM), the Social Sciences and Humanities Research Council of Canada (AAPM), the European Research Council (RP; ERC Starting Grant, ERC-2010-StG263441), and the Natural Environment Research Council (JTS; NERC Grant Number NE/M/S/2003/00069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 1999, J NUTR, V129, P1140, DOI 10.1093/jn/129.6.1140; ALBERMAN E, 1991, ANN HUM BIOL, V18, P127, DOI 10.1080/03014469100001472; Alfonso MP, 2007, ANCIENT HLTH SKELETA, P113; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Ameen S, 2005, SKELETAL RADIOL, V34, P279, DOI 10.1007/s00256-004-0841-3; Angel, 1984, PALEOPATHOLOGY ORIGI, P51; Auerbach BM, 2011, AM J PHYS ANTHROPOL, V144, P382, DOI 10.1002/ajpa.21418; Auerbach BM, 2006, J HUM EVOL, V50, P203, DOI 10.1016/j.jhevol.2005.09.004; Auerbach BM, 2004, AM J PHYS ANTHROPOL, V125, P331, DOI 10.1002/ajpa.20032; Bakker JA, 1999, ANTIQUITY, V73, P778, DOI 10.1017/S0003598X00065522; Banffy E., 2010, NEOLITHISIERUNG MITT, P255; Banner J, 1956, DIE PECELER KULTUR; Bartelheim Martin, 2009, STUDIES HONOUR BARBA, V169, P3446; Bass S, 2000, J PEDIATR-US, V136, P149, DOI 10.1016/S0022-3476(00)70094-1; Bentley RA, 2012, P NATL ACAD SCI USA, V109, P9326, DOI 10.1073/pnas.1113710109; Bentley RA, 2013, 1 FARMERS CENTRAL EU, P251; Berner M, 2012, AM J PHYS ANTHROPOL, V147, P98; Bickle Penny, 2013, 1 FARMERS CENTRAL EU, P101; Bigoni L, 2013, AM J PHYS ANTHROPOL, V150, P349, DOI 10.1002/ajpa.22210; Bocquet-Appel JP, 2009, J ARCHAEOL SCI, V36, P807, DOI 10.1016/j.jas.2008.11.004; Bogin B, 2003, COMP BIOCHEM PHYS A, V136, P71, DOI 10.1016/S1095-6433(02)00294-5; Bogin B, 2002, AM J HUM BIOL, V14, P753, DOI 10.1002/ajhb.10092; Bonsall C, 2004, RADIOCARBON, V46, P293, DOI 10.1017/S0033822200039606; Bonsall C., 2000, DOC PRAEHIST, V27, P119; Bonsall C., 1997, J EUROPEAN ARCHAEOLO, V5, P50, DOI DOI 10.1179/096576697800703575; Bonsall C, 2015, RADIOCARBON, V57, P33, DOI 10.2458/azu_rc.57.18188; Boric D, 2002, ANTIQUITY, V76, P1026, DOI 10.1017/S0003598X00091833; Boric D., 2004, EUR J ARCHAEOL, V7, P221, DOI DOI 10.1177/1461957104056500; Boric D., 2007, STARINAR, V57, P9; Boric D., 2007, DOCUMENTA PRAEHISTOR, V34, P53, DOI DOI 10.4312/DP.34.5; Boric D, 2006, CULTURAL CONTINUTIES; Boric D., 2011, BEGINNINGS NEW RES A, P157; Boric D, 2014, J FIELD ARCHAEOL, V39, P4, DOI 10.1179/0093469013Z.00000000070; Boric Dusan., 2009, METALS SOC STUDIES H, P191; BOTTEMA S, 1982, J ARCHAEOL SCI, V9, P221, DOI 10.1016/0305-4403(82)90020-6; Buikstra JE, 1994, ARKANSAS ARACHEOLOGI, V44; Cavelaars AEJM, 2000, ANN HUM BIOL, V27, P407, DOI 10.1080/03014460050044883; CHAKRABORTY R, 1982, AM J PHYS ANTHROPOL, V59, P295, DOI 10.1002/ajpa.1330590309; Cizmarova J, 2006, DOSSIERS ARAHCEOLOGI, P26; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coles J.M, 1979, BRONZE AGE EUROPE IN; Constantini N. W., 1997, Medicine and Science in Sports and Exercise, V29, pS150; Cook DC, 1984, PALEOPATHOLOGY ORIGI, P235; Cutler GB, 1997, J STEROID BIOCHEM, V61, P3; Dani J, 2001, BRONZEZEITLICHE KULT, P93; Dezso G, 1966, ANTHROPOL HUNG, VVII, P36; Drozdova E, 2011, RESULTS ANTHR SURVEY; Dubois L, 2007, TWIN RES HUM GENET, V10, P479, DOI 10.1375/twin.10.3.479; Dziegielewski K., 2010, MIGRATION BRONZE EAR, V63, P121; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Eveleth PB, 1990, WORLDWIDE VARIATION; Fischl KP., 2013, 1600 KULTURELLER UMB, P355; Frayer D. W., 2004, ANTHROPOLOGIE, V42, P71; Freedman DS, 2000, ARCH PEDIAT ADOL MED, V154, P155, DOI 10.1001/archpedi.154.2.155; Frelat MA, 2011, AM J HUM BIOL, V23, P796, DOI 10.1002/ajhb.21217; Frey Otto-Herman, 2004, P ROY IRISH ACAD, V104C, P104; Friesinger H, 1972, ARCHA, V51, P113; Frisancho A. Roberto, 2001, Acta Medica Auxologica (Milan), V33, P47; Galvani AP, 2005, MICROBES INFECT, V7, P302, DOI 10.1016/j.micinf.2004.12.006; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Garasanin M, 2001, ANTIQUITY, V75, P118, DOI 10.1017/S0003598X00052819; GOLDEN MHN, 1994, EUR J CLIN NUTR, V48, pS58; Greenfield HJ, 2001, ENCY PREHISTORY, V4, P124; GREULICH WW, 1957, AM J PHYS ANTHROPOL, V15, P489, DOI 10.1002/ajpa.1330150403; GREULICH WW, 1976, AM J PHYS ANTHROPOL, V45, P553, DOI 10.1002/ajpa.1330450320; Gronkiewicz L, 2001, PRZEGLAD ATHR ANTHR, V64, P73; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Haapasalo H, 1996, J BONE MINER RES, V11, P864; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; Harding A, 2002, EUROPEAN PREHISTORY, P271; Havelkova P, 2011, INT J OSTEOARCHAEOL, V21, P487, DOI 10.1002/oa.1164; Herold M, 2008, THESIS U WIEN; Hofmann, 2009, CREATING COMMUNITIES, P142; Holden C, 2009, HUM BIOL, V81, P597, DOI 10.3378/027.081.0609; Holliday TW, 2010, AM J PHYS ANTHROPOL, V142, P287, DOI 10.1002/ajpa.21226; Holliday TW, 1997, AM J PHYS ANTHROPOL, V104, P245, DOI 10.1002/(SICI)1096-8644(199710)104:2<245::AID-AJPA10>3.3.CO;2-8; Holliday TW, 1997, J HUM EVOL, V32, P423, DOI 10.1006/jhev.1996.0111; Holliday TW, 2001, AM J PHYS ANTHROPOL, V116, P26, DOI 10.1002/ajpa.1098; Holliday TW, 1999, J HUM EVOL, V36, P549, DOI 10.1006/jhev.1998.0289; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; JANSSON JO, 1983, AM J PHYSIOL, V244, pE135, DOI 10.1152/ajpendo.1983.244.2.E135; Jantz LM, 1999, AM J PHYS ANTHROPOL, V110, P57, DOI 10.1002/(SICI)1096-8644(199909)110:1<57::AID-AJPA5>3.0.CO;2-1; Jarosova I, 2008, ANTHROPOL-INT J HUM, V46, P175; Jelenkovic A, 2011, AM J HUM BIOL, V23, P764, DOI 10.1002/ajhb.21208; JENKINS CL, 1981, AM J PHYS ANTHROPOL, V56, P169, DOI 10.1002/ajpa.1330560208; Jeunesse C., 1997, PRATIQUES FUNERAIRES; Jochim M, 2002, EUROPEAN PREHISTORY, P115; Kala J, 2008, ACTA ARCHAEOLOGICA O, P61; Kalicz N, 1976, SOV ARCHEOL, V2, P106; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Katzmarzyk PT, 1998, AM J PHYS ANTHROPOL, V106, P483, DOI 10.1002/(SICI)1096-8644(199808)106:4<483::AID-AJPA4>3.0.CO;2-K; KUH DL, 1991, INT J EPIDEMIOL, V20, P1001, DOI 10.1093/ije/20.4.1001; Kujanova M, 2008, INT J OSTEOARCHAEOL, V18, P476, DOI 10.1002/oa.958; Kuster H, 1992, BAUERN BAYERN ANFANG, P137; LARSEN CS, 1995, ANNU REV ANTHROPOL, V24, P185, DOI 10.1146/annurev.an.24.100195.001153; Lasker GW, 1946, AM J PHYS ANTHROP-NE, V4, P273, DOI 10.1002/ajpa.1330040310; Le Huray JD, 2005, J ANTHROPOL ARCHAEOL, V24, P135, DOI 10.1016/j.jaa.2004.09.002; Le Huray Jonathan D, 2009, Acta Univ Carol Med Monogr, V156, P145; Leonard WR, 2000, AM J HUM BIOL, V12, P825, DOI 10.1002/1520-6300(200011/12)12:6<825::AID-AJHB10>3.3.CO;2-5; Li L, 2004, AM J CLIN NUTR, V80, P185; Lillie M, 2008, ANTHROPOL-INT J HUM, V46, P135; LINDHOLM C, 1994, ACTA OBSTET GYN SCAN, V73, P269, DOI 10.3109/00016349409023452; Livshits G, 2002, ANN HUM BIOL, V29, P271, DOI 10.1080/03014460110085322; Macintosh AA, 2014, J ARCHAEOL SCI, V52, P376, DOI 10.1016/j.jas.2014.09.001; Macintosh AA, 2015, AM J PHYS ANTHROPOL, V157, P260, DOI 10.1002/ajpa.22710; Macintosh AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112116; Macklin, 2002, FARMING, V3, P1, DOI [10.3828/bfarm.2002.3-4.2, DOI 10.3828/BFARM.2002.3-4.2]; Martin R., 1928, LEHRBUCH ANTHR; Martin R, 1957, LEHBRBUCH ANTHR SYST; MARTORELL R, 1988, HUM BIOL, V60, P205; Mascie-Taylor CGN, 2010, SOC ST HUM, V49, P239; Mathieson I, 2015, BIORXIV; Mauras N, 1996, HORM RES, V45, P74, DOI 10.1159/000184763; MEADOWS L, 1995, J FORENSIC SCI, V40, P762; Meiklejohn C., 1984, PALEOPATHOLOGY ORIGI, P75; Meiklejohn C, 1991, BAR INT SERIES, V567, P129; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Milasinovic L, 2009, REV POSSIBILITY SOCI, P65; Milisauskas S, 2002, EUROPEAN PREHISTORY, P143; Morris DH, 2012, AM J HUM BIOL, V24, P22, DOI 10.1002/ajhb.21230; Muller HH, 1964, HAUSTIERE MITTELDEUT; Mummert A, 2011, ECON HUM BIOL, V9, P284, DOI 10.1016/j.ehb.2011.03.004; Nemejcova-Pavukova V, 1973, S ENTST CHRON BAD KU, P297; NICKENS PR, 1976, J ARCHAEOL SCI, V3, P31, DOI 10.1016/0305-4403(76)90029-7; Nikitovic D, 2014, AM J HUM BIOL, V26, P117, DOI 10.1002/ajhb.22492; Olalde I, 2015, MODERN HUMANS PALEOG, V1; Pankowska A, 2009, ANTHROPOL-INT J HUM, V47, P215; Peng Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-15; Pettitt P, 2008, ANTHROPOL-INT J HUM, V46, P125; Pinhasi R, 2005, AM J HUM BIOL, V17, P470, DOI 10.1002/ajhb.20406; Pinhasi R, 2008, ADV HUMAN PALAEOPATH, P31; Pinhasi R, 2011, HUMAN BIOARCHAEOLOGY OF THE TRANSITION TO AGRICULTURE, P177; Piontek J., 2012, INTERDISCIPLINARIA A, V3, P23, DOI DOI 10.24916/IANSA.2012.1.2; Podborsky V., 1993, PRAVEKE DEJINY MORAV, V3rd; PRADER A, 1963, J PEDIATR-US, V62, P646, DOI 10.1016/S0022-3476(63)80035-9; Price T., 2003, FUNDBERICHTE BADEN W, P23; Raczky P, 2009, INTERACTIONS DIFFERE, P31; Radovanovic I, 1996, ARCHAEOLOGICAL SERIE, V11; Rathbun TA, 1984, PALEOPATHOLOGY ORIGI, P137; RELETHFORD JH, 1985, AM J PHYS ANTHROPOL, V66, P55, DOI 10.1002/ajpa.1330660105; Richards MP, 2008, ANTHROPOL-INT J HUM, V46, P185; Rosch M, 2008, VEG HIST ARCHAEOBOT, V17, pS225, DOI 10.1007/s00334-008-0184-4; Roksandic M, 2012, ADV ANTHR, V2, P117; Rolle R, 1989, WORLD SCYTHIANS; Ruff C, 2002, ANNU REV ANTHROPOL, V31, P211, DOI 10.1146/annurev.anthro.31.040402.085407; RUFF CB, 1991, J HUM EVOL, V21, P81, DOI 10.1016/0047-2484(91)90001-C; RUFF CB, 1984, AM J PHYS ANTHROPOL, V64, P125, DOI 10.1002/ajpa.1330640205; RUFF CB, 1981, HUM BIOL, V53, P69; Ruff Christopher B., 1994, Yearbook of Physical Anthropology, V37, P65; Ruff CB, 2012, AM J PHYS ANTHROPOL, V148, P601, DOI 10.1002/ajpa.22087; Scheeres M, 2014, AM J PHYS ANTHROPOL, V155, P496, DOI 10.1002/ajpa.22597; Schutkowski H, 1999, J ARCHAEOL SCI, V26, P675, DOI 10.1006/jasc.1998.0384; Schutkowski H., 1995, FGR HUM EVOL, V10, P119, DOI DOI 10.1007/BF02437535; Sherratt A., 2006, PREMIERS CHARIOTS PR, V29, p329 ; Shin DH, 2012, AM J PHYS ANTHROPOL, V147, P433, DOI 10.1002/ajpa.22011; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Silventoinen K, 2000, AM J PUBLIC HEALTH, V90, P627, DOI 10.2105/AJPH.90.4.627; Silventoinen K, 2007, TWIN RES HUM GENET, V10, P354, DOI 10.1375/twin.10.2.354; Smrcka V, 2008, STUDIEN BURGWALL MIK, VVIII, P169; Smrcka V, 2007, SLUZBACH ARCHEOLOGIE, V2, P110; Smrcka V, 2006, SLUZBACH ARCHEOLOGIE, V7, P329; Smrcka V, 2005, ANTHROPOL-INT J HUM, V43, P315; Sosna D, 2007, 1621 FLOR STAT U; Larsen CS, 2006, QUATERN INT, V150, P12, DOI 10.1016/j.quaint.2006.01.004; Srejovic D, 1978, SERBIAN ACAD SCI ART, V5; Starling AP, 2007, AM J PHYS ANTHROPOL, V134, P520, DOI 10.1002/ajpa.20700; STINI WA, 1969, AM J PHYS ANTHROPOL, V31, P417, DOI 10.1002/ajpa.1330310316; STINSON S, 1985, YEARB PHYS ANTHROPOL, V28, P123, DOI 10.1002/ajpa.1330280507; Stinson S., 2012, HUMAN BIOL EVOLUTION, P587, DOI [10.1002/9781118108062.ch12, DOI 10.1002/9781118108062.CH12]; Stock JT, 2011, HUMAN BIOARCHAEOLOGY OF THE TRANSITION TO AGRICULTURE, P347; Stranska P, 2015, ARCH ORAL BIOL, V60, P62, DOI 10.1016/j.archoralbio.2014.08.002; TANNER JM, 1982, ANN HUM BIOL, V9, P411, DOI 10.1080/03014468200005951; Tanner JM, 1989, OETUS MAN PHYS GROWT; Tasic N, 2003, STARINAR, V53-54, P25; Tasic N., 1972, ARCHAEOLOGIA IUGOSLA, V13, P27; Tasic N, 2004, BALCANICA, VXXXV, P5; Temple DH, 2011, AM J PHYS ANTHROPOL, V145, P415, DOI 10.1002/ajpa.21515; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Toomay Douglas Michele, 2007, ANCIENT HLTH SKELETA, P300; Trotter M, 1952, AM J PHYS ANTHROP-NE, V10, P463, DOI 10.1002/ajpa.1330100407; Trotter M, 1951, AM J PHYS ANTHROP-NE, V9, P427, DOI 10.1002/ajpa.1330090404; TUPMAN GS, 1962, J BONE JOINT SURG BR, V44, P42, DOI 10.1302/0301-620X.44B1.42; Tveit-Milligan P, 1993, SPORTS MED TRAIN REH, V4, P47; Ubelaker DH, 1998, INT J OSTEOARCHAEOL, V8, P231, DOI 10.1002/(SICI)1099-1212(199807/08)8:4<231::AID-OA423>3.3.CO;2-2; Ubelaker DH, 1996, ANN HIST NAT MUS HUN, V88, P271; VANZEIST W, 1975, J ARCHAEOL SCI, V2, P315, DOI 10.1016/0305-4403(75)90004-7; Vercellotti G, 2012, AM J PHYS ANTHROPOL, V147, P113, DOI 10.1002/ajpa.21636; Vercellotti G, 2011, AM J PHYS ANTHROPOL, V145, P203, DOI 10.1002/ajpa.21486; Wadsworth MEJ, 2002, INT J EPIDEMIOL, V31, P383, DOI 10.1093/ije/31.2.383; Wallduck RJ, 2013, THESIS U CAMBRIDGE; Wells PS, 2002, EUROPEAN PREHISTORY, P335; Welte B, 2010, FUNDBERICHTE BADEN W, V31, P7; Whittle A., 1996, EUROPE NEOLITHIC CRE; Whittle A, 2013, 1 FARMERS CENTRAL EU, P49; Zakrzewski SR, 2007, AM J PHYS ANTHROPOL, V132, P501, DOI 10.1002/ajpa.20569; Zelditch Miriam Leah, 2005, P249, DOI 10.1016/B978-012088777-4/50014-4; Zoffmann ZK, 2011, RAD MUZEJA VOJVODINE, V53, P93; Zvelebil M, 2013, J ANTHROPOL ARCHAEOL, V32, P313, DOI 10.1016/j.jaa.2012.01.011; Zvelebil M, 2008, ANTHROPOL-INT J HUM, V46, P195	202	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148468	10.1371/journal.pone.0148468	http://dx.doi.org/10.1371/journal.pone.0148468			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PF	26844892	Green Published, gold, Green Submitted			2022-12-27	WOS:000369552800061
J	Lamichhane, JR; Bartoli, C; Varvaro, L				Lamichhane, Jay Ram; Bartoli, Claudia; Varvaro, Leonardo			Extensive Field Survey, Laboratory and Greenhouse Studies Reveal Complex Nature of Pseudomonas syringae-Associated Hazelnut Decline in Central Italy	PLOS ONE			English	Article							BACTERIUM CAUSING CANKER; PV AVELLANAE; CORYLUS-AVELLANA; LEAF-SPOT; DISEASE; NOV; EVOLUTION; OUTBREAK; TREES	Pseudomonas avellanae (Pav) has been reported as the causal agent of bacterial decline and bacterial canker of hazelnut in Italy and Greece, respectively. Both hazelnut diseases were reported to be similar in terms of symptoms, severity and persistence. In this study, we found that both symptomatic and asymptomatic trees in the field were colonized by Pav. Multilocus Sequence Typing (MLST) analysis showed that Pav strains isolated during this study in Italy belong to the P. syringae phylogroup 1 and they are closely related to Pav strains previously isolated in Greece from hazelnut bacterial canker. On the other hand, strains isolated in earlier studies from hazelnut decline in Italy belong to both phylogroup 1 and 2 of P. syringae. Both phylogroup 1 strains of P. syringae from Greece and Italy are different than strains isolated in this study in terms of their capacity to excrete fluorescent pigments on different media. Despite the same plant genotype and cropping practices adopted, the incidence of hazelnut decline ranged from nearly 0 to 91% across our study sites. No disease developed on plants inoculated with Pav through wounding while leaf scar inoculations produced only mild disease symptoms. Based on our results and the previously reported correlation between pedo-climatic conditions and hazelnut decline, we conclude that hazelnut decline in central Italy could be incited by a combination of predisposing (adverse pedo-climatic conditions) and contributing factors (Pav). Because this is a true decline different from "bacterial canker" described in Greece, we refer to it as hazelnut decline (HD).	[Lamichhane, Jay Ram; Bartoli, Claudia; Varvaro, Leonardo] Univ Tuscia, Dept Sci & Technol Agr Forestry Nat & Energy DAFN, Viterbo, Italy; [Lamichhane, Jay Ram; Varvaro, Leonardo] Hazelnut Res Ctr, Viterbo, Italy; [Lamichhane, Jay Ram] INRA, UAR Ecoinnov 1240, BP 01, F-78850 Thiverval Grignon, France; [Bartoli, Claudia] INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France; [Bartoli, Claudia] CNRS, LIPM, UMR2594, Castanet Tolosan, France	Tuscia University; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse	Lamichhane, JR (corresponding author), Univ Tuscia, Dept Sci & Technol Agr Forestry Nat & Energy DAFN, Viterbo, Italy.; Lamichhane, JR (corresponding author), Hazelnut Res Ctr, Viterbo, Italy.; Lamichhane, JR (corresponding author), INRA, UAR Ecoinnov 1240, BP 01, F-78850 Thiverval Grignon, France.	jayram.lamichhane@gmail.com	Bartoli, Claudia/F-4961-2017	Bartoli, Claudia/0000-0003-1461-2983; Lamichhane, Jay Ram/0000-0001-9780-0941				Aloj B, 1987, INF AGRARIO, V26, P55; Aloj B., 1994, INFORM AGRARIO, V10, P65; Araujo WL, 2002, APPL ENVIRON MICROB, V68, P4906, DOI 10.1128/AEM.68.10.4906-4914.2002; Bartoli C, 2015, MOL PLANT PATHOL, V16, P137, DOI 10.1111/mpp.12167; Berge O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105547; CROSSE JE, 1966, ANN APPL BIOL, V58, P31, DOI 10.1111/j.1744-7348.1966.tb05068.x; Destefano SAL, 2010, PLANT PATHOL, V59, P1162, DOI 10.1111/j.1365-3059.2010.02357.x; Fabi A, 2005, ACTA HORTIC, P427, DOI 10.17660/ActaHortic.2005.686.59; Fabi A, 2009, ACTA HORTIC, V845, P507, DOI 10.17660/ActaHortic.2009.845.78; Fabi A, 2003, J PLANT PATHOL, V85, P282; GOTO M, 1983, INT J SYST BACTERIOL, V33, P546, DOI 10.1099/00207713-33-3-546; HUTCHINSON P. B., 1949, NEW ZEALAND JOUR SCI AND TECHNOL, V30, P274; Janse JD, 1996, SYST APPL MICROBIOL, V19, P589, DOI 10.1016/S0723-2020(96)80030-0; KING EO, 1954, J LAB CLIN MED, V44, P301; KOVACS N, 1956, NATURE, V178, P703, DOI 10.1038/178703a0; Lamichhane JR, 2013, PLANT PATHOL, V62, P624, DOI 10.1111/j.1365-3059.2012.02670.x; Lamichhane JR, 2014, ADV AGRON, V126, P235, DOI 10.1016/B978-0-12-800132-5.00004-3; Lamichhane JR, 2014, PHYTOPATHOLOGY, V104, P387, DOI 10.1094/PHYTO-05-13-0136-R; Lamichhane JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056298; Lelliot R.A., 1987, METHODS PLANT PATHOL, V2; Lindow S.E, 1990, METHODS PHYTOBACTERI, P428; Loreti S, 2009, J PLANT PATHOL, V91, P365; LUISETTI J, 1972, Annales de Phytopathologie, V4, P295; Marcelletti S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131112; Me G, 2006, PETRIA, V16, P7; Mertelik J, 2013, FOREST PATHOL, V43, P165, DOI 10.1111/efp.12021; Mirik M, 2005, PLANT PATHOL, V54, P238, DOI 10.1111/j.1365-3059.2005.01134.x; O'Brien HE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-141; PSALLIDAS PG, 1979, PHYTOPATHOL Z, V94, P103; PSALLIDAS PG, 1993, PLANT PATHOL, V42, P358, DOI 10.1111/j.1365-3059.1993.tb01512.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakamoto Y., 1999, J FOR RES, V4, P281; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Scortichini M., 1999, Journal of Plant Pathology, V81, P55; Scortichini M, 1996, J PHYTOPATHOL, V144, P215, DOI 10.1111/j.1439-0434.1996.tb01517.x; SCORTICHINI M, 1994, J PHYTOPATHOL, V140, P65, DOI 10.1111/j.1439-0434.1994.tb00177.x; Scortichini M, 2012, MOL PLANT PATHOL, V13, P631, DOI 10.1111/j.1364-3703.2012.00788.x; SEEM RC, 1984, ANNU REV PHYTOPATHOL, V22, P133, DOI 10.1146/annurev.py.22.090184.001025; Tacconi R, 1991, FRUTTICOLTURA, V7, P41; Varvaro L., 1994, Acta Horticulturae, P559; Varvaro L, 1993, INF FITOPATOL, V2, P54; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Wang PW, 2007, MICROBIOL-SGM, V153, P2067, DOI 10.1099/mic.0.2006/001545-0; WHITBREAD R, 1967, ANN APPL BIOL, V59, P123, DOI 10.1111/j.1744-7348.1967.tb04423.x; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064	45	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147584	10.1371/journal.pone.0147584	http://dx.doi.org/10.1371/journal.pone.0147584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840951	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200048
J	Heirali, A; McKeon, S; Purighalla, S; Storey, DG; Rossi, L; Costilhes, G; Drews, SJ; Rabin, HR; Surette, MG; Parkins, MD				Heirali, Alya; McKeon, Suzanne; Purighalla, Swathi; Storey, Douglas G.; Rossi, Laura; Costilhes, Geoffrey; Drews, Steven J.; Rabin, Harvey R.; Surette, Michael G.; Parkins, Michael D.			Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; PSEUDOMONAS-AERUGINOSA COLONIZATION; FIELD GEL-ELECTROPHORESIS; BURKHOLDERIA-CEPACIA; POLYMICROBIAL NATURE; IDENTIFICATION; STRAINS; DIFFERENTIATION; COMMUNITIES; RESISTANT	Introduction Cystic fibrosis (CF) airways are colonized by a polymicrobial community of organisms, termed the CF microbiota. We sought to define the microbial constituents of the home environment of individuals with CF and determine if it may serve as a latent reservoir for infection. Methods Six patients with newly identified CF pathogens were included. An investigator collected repeat sputum and multiple environmental samples from their homes. Bacteria were cultured under both aerobic and anaerobic conditions. Morphologically distinct colonies were selected, purified and identified to the genus and species level through 16S rRNA gene sequencing. When concordant organisms were identified in sputum and environment, pulsed-field gel electrophoresis (PFGE) was performed to determine relatedness. Culture-independent bacterial profiling of each sample was carried out by Illumina sequencing of the V3 region of the 16s RNA gene. Results New respiratory pathogens prompting investigation included: Mycobacterium abscessus (2), Stenotrophomonas maltophilia(3), Pseudomonas aeruginosa(3), Pseudomonas fluorescens (1), Nocardia spp.(1), and Achromobacter xylosoxidans(1). A median 25 organisms/patient were cultured from sputum. A median 125 organisms/home were cultured from environmental sites. Several organisms commonly found in the CF lung microbiome were identified within the home environments of these patients. Concordant species included members of the following genera: Brevibacterium(1), Microbacterium(1), Staphylococcus (3), Stenotrophomonas(2), Streptococcus(2), Sphingomonas(1), and Pseudomonas(4). PFGE confirmed related strains (one episode each of Sphinogomonas and P. aeruginosa) from the environment and airways were identified in two patients. Culture-independent assessment confirmed that many organisms were not identified using culture-dependent techniques. Conclusions Members of the CF microbiota can be found as constituents of the home environment in individuals with CF. While the majority of isolates from the home environment were not genetically related to those isolated from the lower airways of individuals with CF suggesting alternate sources of infection were more common, a few genetically related isolates were indeed identified. As such, the home environment may rarely serve as either the source of infection or a persistent reservoir for re-infection after clearance.	[Heirali, Alya; McKeon, Suzanne; Purighalla, Swathi; Storey, Douglas G.; Costilhes, Geoffrey; Rabin, Harvey R.; Surette, Michael G.; Parkins, Michael D.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Heirali, Alya; Storey, Douglas G.] Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada; [Rabin, Harvey R.; Parkins, Michael D.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Rossi, Laura; Surette, Michael G.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Drews, Steven J.] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada	University of Calgary; University of Calgary; University of Calgary; McMaster University; University of Alberta	Parkins, MD (corresponding author), Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada.; Parkins, MD (corresponding author), Univ Calgary, Dept Med, Calgary, AB, Canada.	mdparkin@ucalgary.ca	Storey, Doug/AFM-0647-2022; Surette, Michael G/AAE-8825-2020; Storey, Doug/AAH-3066-2022	Storey, Douglas/0000-0001-8927-0493				Aaron SD, 2010, JAMA-J AM MED ASSOC, V304, P2145, DOI 10.1001/jama.2010.1665; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Canton R, 2003, PEDIATR PULM, V35, P99, DOI 10.1002/ppul.10216; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC; Chen LH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088886, 10.1371/journal.pone.0101544, 10.1371/journal.pone.0099645]; Clifton Ian J, 2010, Expert Rev Respir Med, V4, P519, DOI 10.1586/ers.10.42; Conway Steven P, 2009, Expert Rev Respir Med, V3, P349, DOI 10.1586/ers.09.26; Crago B, 2014, J HOSP INFECT, V87, P59, DOI 10.1016/j.jhin.2014.03.002; De Baets F, 2007, J CYST FIBROS, V6, P75, DOI 10.1016/j.jcf.2006.05.011; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doring G, 1996, PEDIATR PULM, V21, P90, DOI 10.1002/(SICI)1099-0496(199602)21:2<90::AID-PPUL5>3.0.CO;2-T; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Frederiksen B, 1997, PEDIATR PULM, V23, P330, DOI 10.1002/(SICI)1099-0496(199705)23:5<330::AID-PPUL4>3.0.CO;2-O; Gibson RL, 2003, AM J RESP CRIT CARE, V167, P841, DOI 10.1164/rccm.200208-855OC; Griese M, 2002, EUR J MED RES, V7, P79; Hampton TH, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-14; Hewer SCL, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004197.pub4; Hoppe-Seyler TS, 2007, SYST APPL MICROBIOL, V30, P50, DOI 10.1016/j.syapm.2006.02.008; Hoppe-Seyler TS, 2003, SYST APPL MICROBIOL, V26, P438, DOI 10.1078/072320203322497473; Hutchinson GR, 1996, J CLIN MICROBIOL, V34, P584, DOI 10.1128/JCM.34.3.584-587.1996; Kidd TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044199; Lambiase A, 2011, EUR J CLIN MICROBIOL, V30, P973, DOI 10.1007/s10096-011-1182-5; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Lynch SV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009738; Maragalkis LL, 2009, EMERG INFECT DIS, V15, P12, DOI 10.3201/eid1501.081054; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Munck A, 2001, PEDIATR PULM, V32, P288, DOI 10.1002/ppul.1121; Parkins MD, 2015, J CYST FIBROS, V14, P293, DOI 10.1016/j.jcf.2015.03.012; Parkins MD, 2014, J CLIN MICROBIOL, V52, P1127, DOI 10.1128/JCM.03218-13; Purdy-Gibson ME, 2015, J CYST FIBROS, V14, P341, DOI 10.1016/j.jcf.2014.10.008; Ratjen F, 2010, THORAX, V65, P286, DOI 10.1136/thx.2009.121657; Scales BS, 2015, GENOME ANNO IN PRESS, P3; Schelstraete P, 2008, EUR RESPIR J, V31, P822, DOI 10.1183/09031936.00088907; Sibley CD, 2012, EUR J CLIN MICROBIOL, V31, P2679, DOI 10.1007/s10096-012-1614-x; Sibley CD, 2006, FUTURE MICROBIOL, V1, P53, DOI 10.2217/17460913.1.1.53; Sibley CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022702; Sibley CD, 2011, CAN J MICROBIOL, V57, P69, DOI [10.1139/W10-105, 10.1139/w10-105]; Sibley CD, 2010, J CLIN MICROBIOL, V48, P2592, DOI 10.1128/JCM.00414-10; Sibley CD, 2010, J MED MICROBIOL, V59, P534, DOI 10.1099/jmm.0.016592-0; Sibley CD, 2009, CURR OPIN INVEST DR, V10, P787; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Spicuzza L, 2009, EUR J CLIN MICROBIOL, V28, P191, DOI 10.1007/s10096-008-0605-4; Stressmann FA, 2011, J CLIN MICROBIOL, V49, P281, DOI 10.1128/JCM.01650-10; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tewari D, 2011, J VET DIAGN INVEST, V23, P1104, DOI 10.1177/1040638711425583; TUMMLER B, 1991, J CLIN MICROBIOL, V29, P1265; VALERIUS NH, 1991, LANCET, V338, P725, DOI 10.1016/0140-6736(91)91446-2; Vanlaere E, 2008, INT J SYST EVOL MICR, V58, P1580, DOI 10.1099/ijs.0.65634-0; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Waters V, 2013, J CYST FIBROS, V12, P482, DOI 10.1016/j.jcf.2012.12.006; Whelan Fiona J, 2014, Ann Am Thorac Soc, V11, P513, DOI 10.1513/AnnalsATS.201310-351OC; WILLEMS A, 1993, INT J SYST BACTERIOL, V43, P305, DOI 10.1099/00207713-43-2-305; Workentine ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060225; Ye Y, 2011, P IEEE INT C BIOINFO, V2010, P153, DOI DOI 10.1109/BIBM.2010.5706555	61	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148534	10.1371/journal.pone.0148534	http://dx.doi.org/10.1371/journal.pone.0148534			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859493	Green Published, gold, Green Submitted			2022-12-27	WOS:000370038400050
J	Sarkar, S; Vaddavalli, PK; Bharadwaj, SR				Sarkar, Samrat; Vaddavalli, Pravin Krishna; Bharadwaj, Shrikant R.			Image Quality Analysis of Eyes Undergoing LASER Refractive Surgery	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; HIGHER-ORDER ABERRATIONS; WAVE-FRONT ABERRATIONS; SECONDARY SPHERICAL-ABERRATION; ASPHERIC INTRAOCULAR LENSES; PREDICT VISUAL PERFORMANCE; DEPTH-OF-FIELD; CONTRAST SENSITIVITY; OPTICAL ABERRATIONS; OCULAR ABERRATIONS	Laser refractive surgery for myopia increases the eye's higher-order wavefront aberrations (HOA's). However, little is known about the impact of such optical degradation on post-operative image quality (IQ) of these eyes. This study determined the relation between HOA's and IQ parameters (peak IQ, dioptric focus that maximized IQ and depth of focus) derived from psychophysical (logMAR acuity) and computational (logVSOTF) through-focus curves in 45 subjects (18 to 31yrs) before and 1-month after refractive surgery and in 40 age-matched emmetropic controls. Computationally derived peak IQ and its best focus were negatively correlated with the RMS deviation of all HOA's (HORMS) (r >=-0.5; p<0.001 for all). Computational depth of focus was positively correlated with HORMS (r >= 0.55; p<0.001 for all) and negatively correlated with peak IQ (r >=-0.8; p<0.001 for all). All IQ parameters related to logMAR acuity were poorly correlated with HORMS (r <=vertical bar 0.16 vertical bar; p>0.16 for all). Increase in HOA's after refractive surgery is therefore associated with a decline in peak IQ and a persistence of this sub-standard IQ over a larger dioptric range, vis-a-vis, before surgery and in age-matched controls. This optical deterioration however does not appear to significantly alter psychophysical IQ, suggesting minimal impact of refractive surgery on the subject's ability to resolve spatial details and their tolerance to blur.	[Sarkar, Samrat; Bharadwaj, Shrikant R.] Hyderabad Eye Res Fdn, LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Hyderabad 500034, Telangana, India; [Vaddavalli, Pravin Krishna] LV Prasad Eye Inst, Cornea & Anterior Segment Serv, Hyderabad 500034, Telangana, India; [Bharadwaj, Shrikant R.] LV Prasad Eye Inst, Bausch & Lomb Sch Optometry, Hyderabad 500034, Telangana, India	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; Bausch Health; Bausch + Lomb; L. V. Prasad Eye Institute	Bharadwaj, SR (corresponding author), Hyderabad Eye Res Fdn, LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Hyderabad 500034, Telangana, India.; Bharadwaj, SR (corresponding author), LV Prasad Eye Inst, Bausch & Lomb Sch Optometry, Hyderabad 500034, Telangana, India.	bharadwaj@lvpei.org	SARKAR, SAMRAT/AAW-4944-2020	SARKAR, SAMRAT/0000-0003-0134-7498	Ramalingaswami Fellowship from the Department of Biotechnology, Govt. of India; Champalimaud Foundation, Portugal	Ramalingaswami Fellowship from the Department of Biotechnology, Govt. of India; Champalimaud Foundation, Portugal	This study was funded by the Ramalingaswami Fellowship from the Department of Biotechnology, Govt. of India to Dr. Shrikant Bharadwaj and a core grant from the Champalimaud Foundation, Portugal to the Prof. Brien Holden Eye Research Centre, Hyderabad Eye Research Foundation.	Applegate RA, 2003, J CATARACT REFR SURG, V29, P1487, DOI 10.1016/S0886-3350(03)00334-1; Applegate RA, 2000, J REFRACT SURG, V16, P507; Applegate RA, 1998, J REFRACT SURG, V14, P397, DOI 10.3928/1081-597X-19980701-05; Applegate RA, 2006, OPTOMETRY VISION SCI, V83, P635, DOI 10.1097/01.opx.0000232842.60932.af; Artal P, 2004, J VISION, V4, P281, DOI 10.1167/4.4.4; Atchison DA, 2005, VISION RES, V45, P1967, DOI 10.1016/j.visres.2005.01.022; BAILEY IL, 1991, INVEST OPHTH VIS SCI, V32, P422; Bailey MD, 2004, OPTOMETRY VISION SCI, V81, P362, DOI 10.1097/01.opx.0000134910.28898.ce; Benard Y, 2011, VISION RES, V51, P2471, DOI 10.1016/j.visres.2011.10.003; Benito A, 2011, OPHTHAL PHYSL OPT, V31, P421, DOI 10.1111/j.1475-1313.2011.00854.x; Buehren T, 2006, VISION RES, V46, P1633, DOI 10.1016/j.visres.2005.06.009; Buehren T, 2005, VISION RES, V45, P1297, DOI 10.1016/j.visres.2004.10.026; Campbell CE, 2003, J OPT SOC AM A, V20, P209, DOI 10.1364/JOSAA.20.000209; Cheng X, 2004, J VISION, V4, P310, DOI 10.1167/4.4.7; Cheng X, 2010, OPTOMETRY VISION SCI, V87, P300, DOI 10.1097/OPX.0b013e3181d95217; Gambra E, 2009, J VISION, V9, DOI 10.1167/9.6.4; Gatinel D., 2007, REFRACTIVE SURGERY, P183; He JC, 2002, VISION RES, V42, P1063, DOI 10.1016/S0042-6989(02)00035-4; Hong X, 2000, J REFRACT SURG, V16, pS647; Howland HC, 2002, OPHTHAL PHYSL OPT, V22, P434, DOI 10.1046/j.1475-1313.2002.00072.x; Iskander D Robert, 2000, Clin Exp Optom, V83, P315; Jansonius NM, 1998, OPHTHAL PHYSL OPT, V18, P504, DOI 10.1016/S0275-5408(98)00022-2; Keir NJ, 2009, J REFRACT SURG, V25, P524, DOI 10.3928/1081597X-20090512-06; Laidlaw DAH, 2008, BRIT J OPHTHALMOL, V92, P241, DOI 10.1136/bjo.2007.121715; Li J, 2009, J CATARACT REFR SURG, V35, P1389, DOI 10.1016/j.jcrs.2009.03.033; Liou HL, 1998, ACTA OPHTHALMOL SCAN, V76, P325, DOI 10.1034/j.1600-0420.1998.760314.x; Marcos S, 2005, J REFRACT SURG, V21, P223; Marcos S, 1999, VISION RES, V39, P2039, DOI 10.1016/S0042-6989(98)00317-4; Marcos S, 2001, J REFRACT SURG, V17, pS596; Marsack JD, 2004, J VISION, V4, P322, DOI 10.1167/4.4.8; Martin J, 2011, VISION RES, V51, P1932, DOI 10.1016/j.visres.2011.07.006; Moreno-Barriuso E, 2001, INVEST OPHTH VIS SCI, V42, P1396; Oshika T, 2006, INVEST OPHTH VIS SCI, V47, P1334, DOI 10.1167/iovs.05-1154; Perez-Straziota CE, 2009, J CATARACT REFR SURG, V35, P256, DOI 10.1016/j.jcrs.2008.10.047; Pesudovs K, 2005, J REFRACT SURG, V21, P144; Piers PA, 2007, J REFRACT SURG, V23, P374; Plainis S, 2005, J VISION, V5, P466, DOI 10.1167/5.5.7; Poothullil AM, 2007, REFRACTIVE SURG, P1; Ravikumar A, 2013, J VISION, V13, DOI 10.1167/13.13.28; Ravikumar S, 2008, J OPT SOC AM A, V25, P2395, DOI 10.1364/JOSAA.25.002395; Rocha KM, 2007, OPHTHALMOLOGY, V114, P2050, DOI 10.1016/j.ophtha.2007.01.024; Rocha KM, 2009, J CATARACT REFR SURG, V35, P1885, DOI 10.1016/j.jcrs.2009.05.059; Rosenfield M, 1999, OPTOMETRY VISION SCI, V76, P303, DOI 10.1097/00006324-199905000-00018; Salchow DJ, 1999, J CATARACT REFR SURG, V25, P827, DOI 10.1016/S0886-3350(99)00033-4; Salmon TO, 2006, J CATARACT REFR SURG, V32, P2064, DOI 10.1016/j.jcrs.2006.07.022; Schoneveld P, 2009, CLIN EXP OPTOM, V92, P289, DOI 10.1111/j.1444-0938.2009.00372.x; Smadja D, 2013, J REFRACT SURG, V29, P42, DOI 10.3928/1081597X-20121210-03; Smadja D, 2012, J REFRACT SURG, V28, P224, DOI 10.3928/1081597X-20120217-01; Thibos LN, 2013, OPHTHAL PHYSL OPT, V33, P482, DOI 10.1111/opo.12047; Thibos LN, 2004, J VISION, V4, P329, DOI 10.1167/4.4.9; Thibos LN, 2002, J OPT SOC AM A, V19, P2329, DOI 10.1364/JOSAA.19.002329; Thibos LN, 2002, OPHTHAL PHYSL OPT, V22, P427, DOI 10.1046/j.1475-1313.2002.00059.x; Villegas EA, 2014, AM J OPHTHALMOL, V157, P142, DOI 10.1016/j.ajo.2013.08.009; Visser N, 2011, INVEST OPHTH VIS SCI, V52, P1302, DOI 10.1167/iovs.10-5841; Xu RF, 2015, OPHTHAL PHYSL OPT, V35, P28, DOI 10.1111/opo.12185; Xu RF, 2013, OPHTHAL PHYSL OPT, V33, P444, DOI 10.1111/opo.12072; Yamane N, 2004, INVEST OPHTH VIS SCI, V45, P3986, DOI 10.1167/iovs.04-0629; Yi F, 2011, VISION RES, V51, P1648, DOI 10.1016/j.visres.2011.05.006; Yi F, 2010, J VISION, V10, DOI 10.1167/10.4.3	59	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148085	10.1371/journal.pone.0148085	http://dx.doi.org/10.1371/journal.pone.0148085			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859302	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400021
J	Zhang, ZB; Nie, CS; Jia, YX; Jiang, RS; Xia, HJ; Lv, XZ; Chen, Y; Li, JY; Li, XY; Ning, ZH; Xu, GY; Chen, JL; Yang, N; Qu, LJ				Zhang, Zebin; Nie, Changsheng; Jia, Yaxiong; Jiang, Runshen; Xia, Haijian; Lv, Xueze; Chen, Yu; Li, Junying; Li, Xianyao; Ning, Zhonghua; Xu, Guiyun; Chen, Jilan; Yang, Ning; Qu, Lujiang			Parallel Evolution of Polydactyly Traits in Chinese and European Chickens	PLOS ONE			English	Article							RANGE SHH ENHANCER; TRIPHALANGEAL THUMB; POLARIZING ACTIVITY; MNX1 MUTATIONS; LMBR1 GENE; LIMB; EXPRESSION; MOUSE; ZRS; SEQUENCE	Polydactyly is one of the most common hereditary congenital limb malformations in chickens and other vertebrates. The zone of polarizing activity regulatory sequence (ZRS) is critical for the development of polydactyly. The causative mutation of polydactyly in the Silkie chicken has been mapped to the ZRS; however, the causative mutations of other chicken breeds are yet to be established. To understand whether the same mutation decides the polydactyly phenotype in other chicken breeds, we detected the single-nucleotide polymorphism in 26 different chicken breeds, specifically, 24 Chinese indigenous breeds and 2 European breeds. The mutation was found to have fully penetrated chickens with polydactyly in China, indicating that it is causative for polydactyly in Chinese indigenous chickens. In comparison, the mutation showed no association with polydactyly in Houdan chickens, which originate from France, Europe. Based on the different morphology of polydactyly in Chinese and European breeds, we assumed that the trait might be attributable to different genetic foundations. Therefore, we subsequently performed genome-wide association analysis (GWAS) to locate the region associated with polydactyly. As a result, a similar to 0.39 Mb genomic region on GGA2p was identified. The region contains six candidate genes, with the causative mutation found in Chinese indigenous breeds also being located in this region. Our results demonstrate that polydactyly in chickens from China and Europe is caused by two independent mutation events that are closely located in the chicken genome.	[Zhang, Zebin; Nie, Changsheng; Xia, Haijian; Li, Junying; Ning, Zhonghua; Xu, Guiyun; Yang, Ning; Qu, Lujiang] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Dept Anim Genet & Breeding, Beijing 100193, Peoples R China; [Jia, Yaxiong; Lv, Xueze; Chen, Yu] Beijing Municipal Gen Stn Anim Sci, Beijing 100107, Peoples R China; [Jiang, Runshen] Anhui Agr Univ, Coll Anim Sci & Technol, Hefei 230036, Peoples R China; [Li, Xianyao] Shandong Agr Univ, Coll Anim Sci, Tai An 271018, Shandong, Peoples R China; [Chen, Jilan] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China	China Agricultural University; Anhui Agricultural University; Shandong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Qu, LJ (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Dept Anim Genet & Breeding, Beijing 100193, Peoples R China.	quluj@163.com	Zhang, Zebin/AAE-4976-2019	Zhang, Zebin/0000-0002-9828-4245; Yang, Ning/0000-0001-5772-3320	earmarked fund for the Beijing Innovation Team of the Modern Agro-industry Technology Research System; New Star project in science and technology of Beijing Agriculture Municipal Bureau [20150304034219]; National Scientific Supporting Projects of China [2015BAD03B03]	earmarked fund for the Beijing Innovation Team of the Modern Agro-industry Technology Research System; New Star project in science and technology of Beijing Agriculture Municipal Bureau; National Scientific Supporting Projects of China	This work was funded in part by the earmarked fund for the Beijing Innovation Team of the Modern Agro-industry Technology Research System (http://219.232.192.143/bpm/main.jsp), New Star project in science and technology of Beijing Agriculture Municipal Bureau (20150304034219, http://www.bjny.gov.cn/) and National Scientific Supporting Projects of China (2015BAD03B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054454; Albuisson J, 2011, CLIN GENET, V79, P371, DOI 10.1111/j.1399-0004.2010.01465.x; American Poultry Association, 1998, AM STAND PERF; Anderson E, 2014, DEVELOPMENT, V141, P3934, DOI 10.1242/dev.108480; ASHCRAFT KW, 1974, J PEDIATR SURG, V9, P691, DOI 10.1016/0022-3468(74)90107-9; Babbs C, 2008, MECH DEVELOP, V125, P517, DOI 10.1016/j.mod.2008.01.001; Beasley TM, 2009, BEHAV GENET, V39, P580, DOI 10.1007/s10519-009-9281-0; Belloni E, 2000, AM J HUM GENET, V66, P312, DOI 10.1086/302723; Bouldin CM, 2009, DEV BIOL, V334, P133, DOI 10.1016/j.ydbio.2009.07.009; Britton NF, 2003, ESSENTIAL MATH BIOL, P117; China National Commission of Animal Genetic Resources, 2010, AN GEN RES CHIN POUL; Clark RM, 2000, GENOMICS, V67, P19, DOI 10.1006/geno.2000.6225; Dodgson Jerry B, 2004, Curr Protoc Hum Genet, VChapter 15, DOI 10.1002/0471142905.hg1505s40; Dorshorst B, 2010, J HERED, V101, P339, DOI 10.1093/jhered/esp120; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Dunn IC, 2011, DEV DYNAM, V240, P1163, DOI 10.1002/dvdy.22623; Elgar G, 1996, TRENDS GENET, V12, P145, DOI 10.1016/0168-9525(96)10018-4; Fang MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000341; Flanagan SE, 2014, CELL METAB, V19, P146, DOI 10.1016/j.cmet.2013.11.021; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Girisha KM, 2014, AM J MED GENET A, V164, P898, DOI 10.1002/ajmg.a.36367; Gopal M, 2007, EUR J PEDIATR SURG, V17, P214, DOI 10.1055/s-2007-965121; Gurnett CA, 2007, AM J MED GENET A, V143A, P27, DOI 10.1002/ajmg.a.31563; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Huang YQ, 2006, GENE, V374, P10, DOI 10.1016/j.gene.2005.07.047; Ianakiev P, 2001, AM J HUM GENET, V68, P38, DOI 10.1086/316955; Johnson EJ, 2014, DEV BIOL, V392, P209, DOI 10.1016/j.ydbio.2014.05.025; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Li H, 2009, EUR J HUM GENET, V17, P604, DOI 10.1038/ejhg.2008.240; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Lohan S, 2014, CLIN GENET, V86, P318, DOI 10.1111/cge.12352; Maas SA, 2004, DEV DYNAM, V229, P520, DOI 10.1002/dvdy.10502; MARIGO V, 1995, GENOMICS, V28, P44, DOI 10.1006/geno.1995.1104; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Merello E, 2013, EUR J MED GENET, V56, P648, DOI 10.1016/j.ejmg.2013.09.011; Qu LJ, 2006, SCI CHINA SER C, V49, P332, DOI 10.1007/s11427-006-2001-6; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Sagai T, 2009, DEVELOPMENT, V136, P1665, DOI 10.1242/dev.032714; Sheng XH, 2015, GENE, V568, P176, DOI 10.1016/j.gene.2015.05.049; Sun YF, 2014, G3-GENES GENOM GENET, V4, P1167, DOI 10.1534/g3.114.011338; VanderMeer JE, 2014, HUM MUTAT, V35, P945, DOI 10.1002/humu.22581; Wang ZP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003183; Wang ZQ, 2007, BIOCHEM BIOPH RES CO, V355, P312, DOI 10.1016/j.bbrc.2007.01.129; Warren DC, 1944, GENETICS, V29, P217; Wragg D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071393; Yan YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104652; Yang K, 2013, ANIM GENET, V44, P118, DOI 10.1111/j.1365-2052.2012.02369.x; Yang Y, 1998, DEVELOPMENT, V125, P3123; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zguricas J, 1999, J MED GENET, V36, P32; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	57	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0149010	10.1371/journal.pone.0149010	http://dx.doi.org/10.1371/journal.pone.0149010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859147	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400119
J	Chan, BKK; Wang, TW; Chen, PC; Lin, CW; Chan, TY; Tsang, LM				Chan, Benny Kwok Kan; Wang, Teng-Wei; Chen, Pin-Chen; Lin, Chia-Wei; Chan, Tin-Yam; Tsang, Ling Ming			Community Structure of Macrobiota and Environmental Parameters in Shallow Water Hydrothermal Vents off Kueishan Island, Taiwan	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; NE-TAIWAN; OCEAN ACIDIFICATION; DEEP-SEA; PACIFIC; CRAB; DIVERSITY; BRACHYURA; GRADIENT; BEHAVIOR	Hydrothermal vents represent a unique habitat in the marine ecosystem characterized with high water temperature and toxic acidic chemistry. Vents are distributed at depths ranging from a few meters to several thousand meters. The biological communities of shallow-water vents have, however, been insufficiently studied in most biogeographic areas. We attempted to characterize the macrofauna and macroflora community inhabiting the shallow-water vents off Kueishan Island, Taiwan, to identify the main abiotic factors shaping the community structure and the species distribution. We determined that positively buoyant vent fluid exhibits a more pronounced negative impact to species on the surface water than on the bottom layer. Species richness increased with horizontal distance from the vent, and continuing for a distance of 2000 m, indicating that the vent fluid may exert a negative impact over several kilometers. The community structure off Kueishan Island displayed numerous transitions along the horizontal gradient, which were broadly congruent with changes in environmental conditions. Combination of variation in Ca2+, Cl-, temperature, pH and depth were revealed to show the strongest correlation with the change in benthic community structure, suggesting multiple factors of vent fluid were influencing the associated fauna. Only the vent crabs of Kueishan Island may have an obligated relationship with vents and inhabit the vent mouths because other fauna found nearby are opportunistic taxa that are more tolerant to acidic and toxic environments.	[Chan, Benny Kwok Kan; Wang, Teng-Wei] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Chen, Pin-Chen] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Lin, Chia-Wei] Natl Museum Marine Biol & Aquarium, Dept Exhibit, Pingtung 944, Taiwan; [Chan, Tin-Yam; Tsang, Ling Ming] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan; [Chan, Tin-Yam; Tsang, Ling Ming] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan	Academia Sinica - Taiwan; Tunghai University; National Museum of Marine Biology & Aquarium; National Taiwan Ocean University; National Taiwan Ocean University	Tsang, LM (corresponding author), Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan.; Tsang, LM (corresponding author), Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan.	lmtsang@mail.ntou.edu.tw	Tsang, Ling Ming/Q-7628-2018	Tsang, Ling Ming/0000-0002-5029-5690; Chan, Benny/0000-0001-9479-024X	Center of Excellence for the Oceans, National Taiwan Ocean University, Taiwan; Ministry of Science and Technology, Taiwan, R.O.C.	Center of Excellence for the Oceans, National Taiwan Ocean University, Taiwan; Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This research is supported by funding from the Center of Excellence for the Oceans, National Taiwan Ocean University, Taiwan. This work is also supported by research grants from the Ministry of Science and Technology, Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Chan IN, 2012, ZOOL STUD, V51, P1319; Chen CTA, 2005, CHEM GEOL, V224, P69, DOI 10.1016/j.chemgeo.2005.07.022; Chen CTA, 2005, ACTA OCEANOL SIN, V24, P125; Chen YJ, 2015, BIOGEOSCIENCES, V12, P2631, DOI 10.5194/bg-12-2631-2015; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Dahms HU, 2013, J MAR SCI TECH-TAIW, V21, P711, DOI 10.6119/JMST-012-1128-1; Dai C, 2009, SCLERACTINIA FAUNA T; Dando PR, 2010, TOP GEOBIOL, V33, P333, DOI 10.1007/978-90-481-9572-5_11; Desbruyeres D., 2006, HDB DEEP SEA HYDROTH; FRICKE H, 1989, MAR BIOL, V102, P425, DOI 10.1007/BF00428495; Gorley C.K., 2006, GETTING STARTED PRIM; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hebbinghaus R, 2000, B I OCEANOGRAPHIQUE, V20, P355; Ho TW, 2015, MAR BIOL, V162, P1787, DOI 10.1007/s00227-015-2711-z; Hu MYA, 2012, AQUAT BIOL, V15, P11, DOI 10.3354/ab00396; Hurd CL, 2009, J PHYCOL, V45, P1236, DOI 10.1111/j.1529-8817.2009.00768.x; Jeng MS, 2004, NATURE, V432, P969, DOI 10.1038/432969a; Karlen DJ, 2010, PAC SCI, V64, P391, DOI 10.2984/64.3.391; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Li GX, 2006, CONT SHELF RES, V26, P1954, DOI 10.1016/j.csr.2006.06.008; Melwani AR, 2008, ACTA OECOL, V33, P162, DOI 10.1016/j.actao.2007.10.008; Merck KGaA Darmstadt, 1999, TEST KITS PHOT METH; Miyake S., 1982, MACRUCA ANOMURA STOM, VI, P1; Miyake S, 1983, BRACHYURA CRABS, V2; Morton B, 2006, J MAR BIOL ASSOC UK, V86, P141, DOI 10.1017/S0025315406012951; Ng NK, 2014, P BIOL SOC WASH, V127, P391, DOI 10.2988/0006-324X-127.2.391; Nisbet EG, 2001, NATURE, V409, P1083, DOI 10.1038/35059210; Okutani T., MARINE MOLLUSKS JAPA; Segawa S, 1962, COLOURED ILLUSTRATIO; Takeda M., 1993, NATURE ENV SCI RES, V6, P59; Tang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072958; Tarasov VG, 2006, ADV MAR BIOL, V50, P267, DOI 10.1016/S0065-2881(05)50004-X; Tarasov VG, 1999, CONT SHELF RES, V19, P79, DOI 10.1016/S0278-4343(98)00073-9; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; Thiermann F, 1997, MAR BIOL, V128, P149, DOI 10.1007/s002270050078; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Vermeij MJA, 2005, CORAL REEFS, V24, P442, DOI 10.1007/s00338-005-0489-z; Wang TW, 2014, MAR BIOL, V161, P2447, DOI 10.1007/s00227-014-2479-6; Wang TW, 2013, B MAR SCI, V89, P505, DOI 10.5343/bms.2012.1036; Yang LY, 2012, MAR CHEM, V128, P64, DOI 10.1016/j.marchem.2011.10.003; Zeng ZG, 2011, J ASIAN EARTH SCI, V40, P661, DOI 10.1016/j.jseaes.2010.10.019; Zeppilli D, 2009, AQUAT BIOL, V5, P75, DOI 10.3354/ab00140; Zhang YL, 2009, WATER RES, V43, P4685, DOI 10.1016/j.watres.2009.07.024	47	24	24	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148675	10.1371/journal.pone.0148675	http://dx.doi.org/10.1371/journal.pone.0148675			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849440	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000154
J	Czaikoski, PG; Mota, JM; Nascimento, DC; Sonego, F; Castanheira, FVES; Melo, PH; Scortegagna, GT; Silva, RL; Barroso-Sousa, R; Souto, FO; Pazin, A; Figueiredo, F; Alves, JC; Cunha, FQ				Czaikoski, Paula Giselle; Mota, Jose Mauricio; Nascimento, Daniele Carvalho; Sonego, Fabiane; Vargas e Silva Castanheira, Fernanda; Melo, Paulo Henrique; Scortegagna, Gabriela Trentin; Silva, Rangel Leal; Barroso-Sousa, Romualdo; Souto, Fabricio Oliveira; Pazin-Filho, Antonio; Figueiredo, Florencio; Alves-Filho, Jose Carlos; Cunha, Fernando Queiroz			Neutrophil Extracellular Traps Induce Organ Damage during Experimental and Clinical Sepsis	PLOS ONE			English	Article							POLYMICROBIAL SEPSIS; NETTING NEUTROPHILS; KIDNEY INJURY; HISTONES; LUNG; PATHOPHYSIOLOGY; CONTRIBUTE; MIGRATION; FAILURE; NETOSIS	Organ dysfunction is a major concern in sepsis pathophysiology and contributes to its high mortality rate. Neutrophil extracellular traps (NETs) have been implicated in endothelial damage and take part in the pathogenesis of organ dysfunction in several conditions. NETs also have an important role in counteracting invading microorganisms during infection. The aim of this study was to evaluate systemic NETs formation, their participation in host bacterial clearance and their contribution to organ dysfunction in sepsis. C57Bl/6 mice were subjected to endotoxic shock or a polymicrobial sepsis model induced by cecal ligation and puncture (CLP). The involvement of cf-DNA/NETs in the physiopathology of sepsis was evaluated through NETs degradation by rhDNase. This treatment was also associated with a broad-spectrum antibiotic treatment (ertapenem) in mice after CLP. CLP or endotoxin administration induced a significant increase in the serum concentrations of NETs. The increase in CLP-induced NETs was sustained over a period of 3 to 24 h after surgery in mice and was not inhibited by the antibiotic treatment. Systemic rhDNase treatment reduced serum NETs and increased the bacterial load in non-antibiotic-treated septic mice. rhDNase plus antibiotics attenuated sepsis-induced organ damage and improved the survival rate. The correlation between the presence of NETs in peripheral blood and organ dysfunction was evaluated in 31 septic patients. Higher cf-DNA concentrations were detected in septic patients in comparison with healthy controls, and levels were correlated with sepsis severity and organ dysfunction. In conclusion, cf-DNA/NETs are formed during sepsis and are associated with sepsis severity. In the experimental setting, the degradation of NETs by rhDNase attenuates organ damage only when combined with antibiotics, confirming that NETs take part in sepsis pathogenesis. Altogether, our results suggest that NETs are important for host bacterial control and are relevant actors in the pathogenesis of sepsis.	[Czaikoski, Paula Giselle; Sonego, Fabiane; Vargas e Silva Castanheira, Fernanda; Silva, Rangel Leal; Alves-Filho, Jose Carlos; Cunha, Fernando Queiroz] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, BR-14049 Ribeirao Preto, Brazil; [Mota, Jose Mauricio; Barroso-Sousa, Romualdo; Pazin-Filho, Antonio] Univ Sao Paulo, Dept Clin, Ribeirao Preto Med Sch, BR-14049 Ribeirao Preto, Brazil; [Nascimento, Daniele Carvalho; Melo, Paulo Henrique; Scortegagna, Gabriela Trentin; Souto, Fabricio Oliveira] Univ Sao Paulo, Dept Biochem & Immunol, Ribeirao Preto Med Sch, BR-14049 Ribeirao Preto, Brazil; [Figueiredo, Florencio] Univ Brasilia, Dept Pathol, Sch Med, Brasilia, DF, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Brasilia	Cunha, FQ (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, BR-14049 Ribeirao Preto, Brazil.	fdqcunha@fmrp.usp.br	Cunha, Fernando Q/M-3090-2014; Souto, Fabricio/AAS-7671-2020; Barroso-Sousa, Romualdo/G-2244-2014; Alves-Filho, Jose Carlos/B-5814-2008; BARROSO-SOUSA, ROMUALDO/T-6405-2019; Silva, Rangel Leal/G-2009-2016; Pazin Filho, Antonio/E-9495-2010; Mota, Jose Mauricio/O-5577-2015; Souto, Fabricio/AAX-8668-2021; SCORTEGAGNA, GABRIELA/GPK-6327-2022	Barroso-Sousa, Romualdo/0000-0002-1825-9876; Alves-Filho, Jose Carlos/0000-0002-9918-8714; BARROSO-SOUSA, ROMUALDO/0000-0002-1825-9876; Silva, Rangel Leal/0000-0002-1322-7808; Pazin Filho, Antonio/0000-0001-5242-329X; Mota, Jose Mauricio/0000-0001-9510-6956; Souto, Fabricio/0000-0002-2392-8499; Castanheira, Fernanda/0000-0002-2024-7858; Cunha, Fernando Queiroz/0000-0003-4755-1670; De Melo, Paulo/0000-0001-8911-1142	European Union [HEALTH-F4-2011-281608]; Sao Paulo Research Foundation (FAPESP) [2011/19670-0, 2013/08216-2]; University of Sao Paulo NAP-DIN [11.1.21625.01.0]	European Union(European Commission); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); University of Sao Paulo NAP-DIN	The authors have received financial support from European Union Seventh Framework Programme (FP7-2007-2013) under grant agreement number HEALTH-F4-2011-281608 (TIMER), from Sao Paulo Research Foundation (FAPESP - http://www.fapesp.br/en/) under grant agreements number 2011/19670-0 (projeto tematico) and 2013/08216-2 (Center for Research in Inflammatory Disease), and from University of Sao Paulo NAP-DIN under grant agreement number 11.1.21625.01.0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Allam R, 2012, J AM SOC NEPHROL, V23, P1375, DOI 10.1681/ASN.2011111077; Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Bianchi M, 2011, J ALLERGY CLIN IMMUN, V127, P1243, DOI 10.1016/j.jaci.2011.01.021; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Canetti C, 2001, BRIT J PHARMACOL, V134, P1619, DOI 10.1038/sj.bjp.0704403; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; CUNHA FQ, 1994, IMMUNOLOGY, V81, P211; Fattahi F, 2015, IMMUNOL RES, V61, P177, DOI 10.1007/s12026-015-8628-2; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gao X, 2015, J SURG RES, V195, P211, DOI 10.1016/j.jss.2014.12.019; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006; Gustot T, 2011, CURR OPIN CRIT CARE, V17, P153, DOI 10.1097/MCC.0b013e328344b446; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Hamaguchi S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/614518; Hashiba M, 2015, J SURG RES, V194, P248, DOI 10.1016/j.jss.2014.09.033; Hoesel LM, 2005, SHOCK, V24, P40, DOI 10.1097/01.shk.0000170353.80318.d5; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Lassalle P, 1996, J BIOL CHEM, V271, P20458, DOI 10.1074/jbc.271.34.20458; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lopes JA, 2008, CRIT CARE, V12, DOI 10.1186/cc6997; Luo LT, 2014, AM J PHYSIOL-LUNG C, V307, pL586, DOI 10.1152/ajplung.00365.2013; Margraf S, 2008, SHOCK, V30, P352, DOI 10.1097/SHK.0b013e31816a6bb1; Martinod K, 2015, BLOOD, V125, P1948, DOI 10.1182/blood-2014-07-587709; Meng W, 2012, CRIT CARE, V16, DOI 10.1186/cc11442; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Tanaka K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111888; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Young RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023637	47	195	210	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148142	10.1371/journal.pone.0148142	http://dx.doi.org/10.1371/journal.pone.0148142			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849138	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000043
J	Holter, JC; Ueland, T; Jenum, PA; Muller, F; Brunborg, C; Froland, SS; Aukrust, P; Husebye, E; Heggelund, L				Holter, Jan C.; Ueland, Thor; Jenum, Pal A.; Muller, Fredrik; Brunborg, Cathrine; Froland, Stig S.; Aukrust, Pal; Husebye, Einar; Heggelund, Lars			Risk Factors for Long-Term Mortality after Hospitalization for Community-Acquired Pneumonia: A 5-Year Prospective Follow-Up Study	PLOS ONE			English	Article							1-YEAR MORTALITY; IMMUNE-RESPONSE; PROGNOSIS; SURVIVAL; SEVERITY; PREDICTION; ETIOLOGY; OUTCOMES; MARKERS; ADULTS	Background Contributors to long-term mortality in patients with community-acquired pneumonia (CAP) remain unclear, with little attention paid to pneumonia etiology. We examined long-term survival, causes of death, and risk factors for long-term mortality in adult patients who had been hospitalized for CAP, with emphasis on demographic, clinical, laboratory, and microbiological characteristics. Methods Two hundred and sixty-seven consecutive patients admitted in 2008-2011 to a general hospital with CAP were prospectively recruited and followed up. Patients who died during hospital stay were excluded. Demographic, clinical, and laboratory data were collected within 48 hours of admission. Extensive microbiological work-up was performed to establish the etiology of CAP in 63% of patients. Mortality data were obtained from the Norwegian Cause of Death Registry. Cox regression models were used to identify independent risk factors for all-cause mortality. Results Of 259 hospital survivors of CAP (median age 66 years), 79 (30.5%) died over a median of 1,804 days (range 1-2,520 days). Cumulative 5-year survival rate was 72.9% (95% CI 67.4-78.4%). Standardized mortality ratio was 2.90 for men and 2.05 for women. The main causes of death were chronic obstructive pulmonary disease (COPD), vascular diseases, and malignancy. Independent risk factors for death were the following (hazard ratio, 95% CI): age (1.83 per decade, 1.47-2.28), cardiovascular disease (2.63, 1.61-4.32), COPD (2.09, 1.27-3.45), immunocompromization (1.98, 1.17-3.37), and low serum albumin level at admission (0.75 per 5g/L higher, 0.58-0.96), whereas active smoking was protective (0.32, 0.14-0.74); active smokers were younger than non-smokers (P < 0.001). Microbial etiology did not predict mortality. Conclusions Results largely confirm substantial comorbidity-related 5-year mortality after hospitalization for CAP and the impact of several well-known risk factors for death, and extend previous findings on the prognostic value of serum albumin level at hospital admission. Pneumonia etiology had no prognostic value, but this remains to be substantiated by further studies using extensive diagnostic microbiological methods in the identification of causative agents of CAP.	[Holter, Jan C.; Husebye, Einar; Heggelund, Lars] Vestre Viken Hlth Trust, Dept Internal Med, Drammen Hosp, Drammen, Norway; [Holter, Jan C.; Ueland, Thor; Froland, Stig S.; Aukrust, Pal] Univ Oslo, Rikshosp, Internal Med Res Inst, Oslo Univ Hosp, N-0027 Oslo, Norway; [Holter, Jan C.; Ueland, Thor; Jenum, Pal A.; Froland, Stig S.; Aukrust, Pal; Husebye, Einar; Heggelund, Lars] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Ueland, Thor; Aukrust, Pal] Univ Oslo, KG Jebsen Inflammatory Res Ctr, Oslo, Norway; [Jenum, Pal A.] Vestre Viken Hlth Trust, Dept Med Microbiol, Drammen Hosp, Drammen, Norway; [Muller, Fredrik] Univ Oslo, Rikshosp, Dept Microbiol, Oslo Univ Hosp, N-0027 Oslo, Norway; [Brunborg, Cathrine] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Res Support Serv, Oslo, Norway; [Froland, Stig S.; Aukrust, Pal] Univ Oslo, Rikshosp, Sect Clin Immunol & Infect Dis, Oslo Univ Hosp, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway	Holter, JC (corresponding author), Vestre Viken Hlth Trust, Dept Internal Med, Drammen Hosp, Drammen, Norway.	jancho@mail.uio.no	Heggelund, Lars/GSN-0026-2022		Vestre Viken Health Trust	Vestre Viken Health Trust	This study was funded by Vestre Viken Health Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamuz J, 2014, J INFECTION, V68, P534, DOI 10.1016/j.jinf.2014.02.006; Alan M, 2015, J INTERN MED, V278, P174, DOI 10.1111/joim.12341; Bordon J, 2010, CHEST, V138, P279, DOI 10.1378/chest.09-2702; Bruns AHW, 2011, CLIN MICROBIOL INFEC, V17, P763, DOI 10.1111/j.1469-0691.2010.03296.x; Bruns AHW, 2013, CLIN INFECT DIS, V57, P1370, DOI 10.1093/cid/cit507; Cangemi R, 2015, AM J CARDIOL, V116, P647, DOI 10.1016/j.amjcard.2015.05.028; Cecere LM, 2010, RESPIRATION, V79, P128, DOI 10.1159/000255764; Corrales-Medina VF, 2015, JAMA-J AM MED ASSOC, V313, P264, DOI 10.1001/jama.2014.18229; de Roux A, 2006, CHEST, V129, P1219, DOI 10.1378/chest.129.5.1219; Eurich DT, 2015, AM J RESP CRIT CARE, V192, P597, DOI 10.1164/rccm.201501-0140OC; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Guertler C, 2011, EUR RESPIR J, V37, P1439, DOI 10.1183/09031936.00121510; HEDLUND JU, 1993, THORAX, V48, P785, DOI 10.1136/thx.48.8.785; Holter JC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0803-5; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; Johnstone J, 2008, MEDICINE, V87, P329, DOI 10.1097/MD.0b013e318190f444; Kaplan V, 2003, ARCH INTERN MED, V163, P317, DOI 10.1001/archinte.163.3.317; Karhu J, 2011, ACTA ANAESTH SCAND, V55, P1254, DOI 10.1111/j.1399-6576.2011.02535.x; Katz MH., 2011, MULTIVARIABLE ANAL A; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Koivula I, 1999, ARCH INTERN MED, V159, P1550, DOI 10.1001/archinte.159.14.1550; Koskela HO, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005715; Kruger S, 2010, AM J RESP CRIT CARE, V182, P1426, DOI 10.1164/rccm.201003-0415OC; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lu TH, 2003, J EPIDEMIOL COMMUN H, V57, P470, DOI 10.1136/jech.57.6.470; Mortensen EM, 2012, SEMIN RESP CRIT CARE, V33, P319, DOI 10.1055/s-0032-1315644; Murugan R, 2010, KIDNEY INT, V77, P527, DOI 10.1038/ki.2009.502; Ramirez J, 2008, CLIN INFECT DIS, V47, P182, DOI 10.1086/589246; Restrepo MI, 2013, CURR OPIN INFECT DIS, V26, P151, DOI 10.1097/QCO.0b013e32835ebc6d; Sandvall B, 2013, CLIN INFECT DIS, V56, P1145, DOI 10.1093/cid/cis1207; Sington JD, 2002, J CLIN PATHOL, V55, P499, DOI 10.1136/jcp.55.7.499; Sligl WI, 2011, CHEST, V139, P88, DOI 10.1378/chest.10-1054; Sligl WI, 2010, CRIT CARE MED, V38, P2126, DOI 10.1097/CCM.0b013e3181eedaeb; Statistics Norway, STATBANK NORW DEATHS; Viasus D, 2013, EXPERT REV ANTI-INFE, V11, P917, DOI 10.1586/14787210.2013.825442; Viasus D, 2013, J INFECTION, V66, P415, DOI 10.1016/j.jinf.2012.12.007; Vincent JL, 2014, CRIT CARE, V18, DOI 10.1186/cc13991; Waterer GW, 2004, AM J RESP CRIT CARE, V169, P910, DOI 10.1164/rccm.200310-1448OC; Wesemann T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0730-x; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC; Yende S, 2007, J AM GERIATR SOC, V55, P518, DOI 10.1111/j.1532-5415.2007.01100.x; Yende S, 2013, CHEST, V144, P1008, DOI 10.1378/chest.12-2818; Yende S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022847; Yende S, 2010, THORAX, V65, P870, DOI 10.1136/thx.2010.136317	45	42	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148741	10.1371/journal.pone.0148741	http://dx.doi.org/10.1371/journal.pone.0148741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849359	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000165
J	Ko, M; Yeo, J; Lee, J; Lee, U; Jang, YJ				Ko, Minsam; Yeo, Jaeryong; Lee, Juyeong; Lee, Uichin; Jang, Young Jae			What Makes Sports Fans Interactive? Identifying Factors Affecting Chat Interactions in Online Sports Viewing	PLOS ONE			English	Article							BASEBALL; OPTIMIZATION	Sports fans are able to watch games from many locations using TV services while interacting with other fans online. In this paper, we identify the factors that affect sports viewers' online interactions. Using a large-scale dataset of more than 25 million chat messages from a popular social TV site for baseball, we extract various game-related factors, and investigate the relationships between these factors and fans' interactions using a series of multiple regression analyses. As a result, we identify several factors that are significantly related to viewer interactions. In addition, we determine that the influence of these factors varies according to the user group; i.e., active vs. less active users, and loyal vs. non-loyal users.	[Ko, Minsam; Lee, Uichin] Korea Adv Inst Sci & Technol, Dept Knowledge Serv Engn, Daejeon, South Korea; [Yeo, Jaeryong; Lee, Juyeong; Jang, Young Jae] Korea Adv Inst Sci & Technol, Dept Ind & Syst Engn, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Lee, U (corresponding author), Korea Adv Inst Sci & Technol, Dept Knowledge Serv Engn, Daejeon, South Korea.	uclee@kaist.ac.kr	Lee, Uichin/C-1827-2011; Jang, Young Jae/C-1837-2011	Jang, Young Jae/0000-0002-2342-1444	Institute for Information & communications Technology Promotion (IITP) - Korea government (MSIP) [10041313, B0101-15-1272]	Institute for Information & communications Technology Promotion (IITP) - Korea government (MSIP)	This work was partly supported by Institute for Information & communications Technology Promotion (IITP) grant funded by the Korea government (MSIP) (No. 10041313, UX-oriented Mobile SW Platform); (No. B0101-15-1272, Development of Device Collaborative Giga-Level Smart Cloudlet Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler I, 2002, INTERFACES, V32, P12, DOI 10.1287/inte.32.2.12.67; Alamar B, 2011, ANAL MAGAZINE, P33; [Anonymous], 1989, APPL LINEAR REGRESSI; [Anonymous], 1998, MEDIASPORT; Bao P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076027; Bennett J, 1998, STAT SPORT, P25; Benton, 2012, P ADKDD 2012, P4; Bukiet B, 1997, OPER RES, V45, P14, DOI 10.1287/opre.45.1.14; Chiu W, 2015, EMERGING TRENDS INNO; Cho HJ, 2011, KOR IND ENG ANN C ST; Coppens T, 2004, P EUROITV 2004; Corbin K, 2014, NFLS CIO TACKLES BIG; Dezfuli Niloofar, 2011, P 9 INT INT C INT TE, P21, DOI DOI 10.1145/2000119.2000123; Eastman S. T., 1997, Journal of Sport and Social Issues, V21, P156, DOI 10.1177/019372397021002004; Fan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110184; Geerts Cesar P, 2008, P 1 INT C DES INT US, P7180, DOI [10.1145/1453805.1453822, DOI 10.1145/1453805.1453822]; Geerts D, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P311; Geerts D, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P595; Hair J.F., 1998, MULTIVARIATE DATA AN, V5, P207; Hannon John, 2011, IUI, P335, DOI DOI 10.1145/1943403.1943459; Harboe G., 2008, COMPUTERS ENTERTAINM, V6, P1, DOI DOI 10.1145/1350843.1350851; Hirotsu N, 2011, J QUANT ANAL SPORTS, V7, DOI 10.2202/1559-0410.1332; Hirotsu N, 2016, IMA J MANAG MATH, V27, P297, DOI 10.1093/imaman/dpu024; Jang YJ, 2012, PCT/KR2012/010370, Patent No. 2012010370; Jiang W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141185; Kennedy P, 1995, GUIDE ECONOMETRICS; Kirton Andrew., 2013, DIGITAL MEDIA SPORT; Kleinberg J. M., 2014, ICWSM; Ko M, 2015, WHAT MAKES SPORTS FA, DOI DOI 10.5281/ZENODO.34939; Lee M. J., 1985, Journal of Sport Behavior, V8, P210; Lewis M., 2003, MONEYBALL ART WINNIN; LINDSEY GR, 1959, OPER RES, V7, P197, DOI 10.1287/opre.7.2.197; Marcus A, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P227; MARQUARDT DW, 1970, TECHNOMETRICS, V12, P591, DOI 10.2307/1267205; Moon HW, 2013, KOREAN J APPL STAT, V26, P649, DOI 10.5351/KJAS.2013.26.4.649; Nam KK, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P779; NATHAN M., 2008, P 1 INT C DES INT US, V1, P85, DOI DOI 10.1145/1453805.1453824; Nichols J., 2012, P 2012 ACM INT C INT, P189, DOI DOI 10.1145/2166966.2166999; Olsen D. R., 2011, P EUROITV 2011, P115; Park S, 2013, J MED INTERNET RES, V15, P163, DOI 10.2196/jmir.2718; PERFORM, 2014, PERFORM GLOB SPORTS; Qu Y., 2011, P ACM 2011 C COMP SU, P25, DOI DOI 10.1145/1958824.1958830; Raney A. A., 2006, HDB SPORTS MEDIA, P313; Ribeiro CC, 2004, OR MS TODAY, V31, P50; Robinson SJ, 2013, INT J COMPUTER SCI S, V12; RUSSELL RA, 1994, OPER RES, V42, P614, DOI 10.1287/opre.42.4.614; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Shirazi AS, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P307; Smith G. J., 1988, Journal of Sport and Social Issues, V12, P54, DOI 10.1177/019372358801200105; Sokol JS, 2003, J HEURISTICS, V9, P353, DOI 10.1023/A:1025657820328; Tang A., 2012, P SIGCHI C HUMAN FAC, DOI [10.1145/2207676.2208622, DOI 10.1145/2207676.2208622]; Thomay CD, 2014, THESIS; Tobin J, 2015, PRO SPORTS ANAL IS P; Wakamiya S, 2011, P ICUIMC 2011; Weisz JD, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P877; Yoon SJ, 2005, J BRAND MANAG, V12, P191, DOI 10.1057/palgrave.bm.2540215; Yu Y, 2015, COMPUT HUM BEHAV, V48, P392, DOI 10.1016/j.chb.2015.01.075; Zhao J., 2012, P 18 ACM SIGKDD INT, P1528, DOI DOI 10.1145/2339530.2339772	58	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148377	10.1371/journal.pone.0148377	http://dx.doi.org/10.1371/journal.pone.0148377			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849568	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000083
J	Mair, JL; Nevill, AM; De Vito, G; Boreham, CA				Mair, Jacqueline L.; Nevill, Alan M.; De Vito, Giuseppe; Boreham, Colin A.			Personalised Prescription of Scalable High Intensity Interval Training to Inactive Female Adults of Different Ages	PLOS ONE			English	Article							RESTING METABOLIC-RATE; PHYSICAL-ACTIVITY; HEART-RATE; ENERGY-COST; EXERCISE; YOUNG; INTERVENTION; MORTALITY; MODERATE; PROGRAM	Stepping is a convenient form of scalable high-intensity interval training (HIIT) that may lead to health benefits. However, the accurate personalised prescription of stepping is hampered by a lack of evidence on optimal stepping cadences and step heights for various populations. This study examined the acute physiological responses to stepping exercise at various heights and cadences in young (n = 14) and middle-aged (n = 14) females in order to develop an equation that facilitates prescription of stepping at targeted intensities. Participants completed a step test protocol consisting of randomised three-minute bouts at different step cadences (80, 90, 100, 110 steps.min(-1)) and step heights (17, 25, 30, 34 cm). Aerobic demand and heart rate values were measured throughout. Resting metabolic rate was measured in order to develop female specific metabolic equivalents (METs) for stepping. Results revealed significant differences between age groups for METs and heart rate reserve, and within-group differences for METs, heart rate, and metabolic cost, at different step heights and cadences. At a given step height and cadence, middle-aged females were required to work at an intensity on average 1.9 +/- 0.26 METs greater than the younger females. A prescriptive equation was developed to assess energy cost in METs using multilevel regression analysis with factors of step height, step cadence and age. Considering recent evidence supporting accumulated bouts of HIIT exercise for health benefits, this equation, which allows HIIT to be personally prescribed to inactive and sedentary women, has potential impact as a public health exercise prescription tool.	[Mair, Jacqueline L.; De Vito, Giuseppe; Boreham, Colin A.] Univ Coll Dublin, UCD Inst Sport & Hlth, Newstead, Dublin 2, Dublin, Ireland; [Nevill, Alan M.] Wolverhampton Univ, Sch Sport Performing Arts & Leisure, Wolverhampton WV1 1DJ, W Midlands, England; [Mair, Jacqueline L.] Univ Ulster, Sch Sport, Shore Rd, Newtownabbey, Antrim, North Ireland	University College Dublin; University of Wolverhampton; Ulster University	Mair, JL (corresponding author), Univ Coll Dublin, UCD Inst Sport & Hlth, Newstead, Dublin 2, Dublin, Ireland.	j.mair@ulster.ac.uk	Nevill, Alan/Q-1010-2019; Mair, Jacqueline Louise/D-3829-2013; De Vito, Giuseppe/J-4499-2012	Nevill, Alan/0000-0003-0506-3652; Mair, Jacqueline Louise/0000-0002-1466-8680; De Vito, Giuseppe/0000-0002-6855-9180				Adams J., 2002, HLTH ED J, V61, DOI [10.1177/001789690206100308, DOI 10.1177/001789690206100308]; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; American College., 2006, ACSMS GUID EX TEST P; Babraj JA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-3; Balke B, 1960, MED PHYS, P50; Bartlett JD, 2011, J SPORT SCI, V29, P547, DOI 10.1080/02640414.2010.545427; Bassett DR, 1997, MED SCI SPORT EXER, V29, P1250, DOI 10.1097/00005768-199709000-00019; Betik AC, 2008, APPL PHYSIOL NUTR ME, V33, P130, DOI 10.1139/H07-174; Boreham CAG, 2000, PREV MED, V30, P277, DOI 10.1006/pmed.2000.0634; Bouchard C., 1990, EXERCISE FITNESS HLT; Buford TW, 2013, SPORTS MED, V43, P157, DOI 10.1007/s40279-013-0018-0; Byrne NM, 2005, J APPL PHYSIOL, V99, P1112, DOI 10.1152/japplphysiol.00023.2004; Cohen J.E., 1988, STAT POWER ANAL BEHA; Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009; Department of Health, 2011, START ACT STAY ACT R; Doheny EP, 2013, ANN BIOMED ENG, V41, P1748, DOI 10.1007/s10439-013-0804-8; Engbers LH, 2007, PREV MED, V44, P356, DOI 10.1016/j.ypmed.2006.11.005; FARDY PS, 1975, MED SCI SPORT EXER, V7, P91; GREIG CA, 1994, AGE AGEING, V23, P185, DOI 10.1093/ageing/23.3.185; Grier TD, 2002, J STRENGTH COND RES, V16, P242; Gulati M, 2010, CIRCULATION, V122, P130, DOI 10.1161/CIRCULATIONAHA.110.939249; Hall EE, 2002, BRIT J HEALTH PSYCH, V7, P47, DOI 10.1348/135910702169358; HEMENWAY D, 1994, ACCIDENT ANAL PREV, V26, P675, DOI 10.1016/0001-4575(94)90029-9; Higgins TP, 2015, CLIN HEMORHEOL MICRO, V59, P365, DOI 10.3233/CH-141857; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; Horner NK, 2001, J NUTR, V131, P2215, DOI 10.1093/jn/131.8.2215; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Jung ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114541; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; Kennedy RA, 2007, J SPORT SCI MED, V6, P448; LAKATTA EG, 1990, EUR HEART J, V11, P22, DOI 10.1093/eurheartj/11.suppl_C.22; Lee IM, 1998, STROKE, V29, P2049, DOI 10.1161/01.STR.29.10.2049; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Mair JL, 2014, CLIN PHYSIOL FUNCT I, V34, P10, DOI 10.1111/cpf.12056; Mair JL, 2014, EUR J APPL PHYSIOL, V114, P983, DOI 10.1007/s00421-014-2826-9; Myers J, 2004, AM J MED, V117, P912, DOI 10.1016/j.amjmed.2004.06.047; Nevill AM, 1998, J APPL PHYSIOL, V84, P963, DOI 10.1152/jappl.1998.84.3.963; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; ScharffOlson MR, 1996, RES Q EXERCISE SPORT, V67, P465, DOI 10.1080/02701367.1996.10607979; Sergi G, 2010, CLIN NUTR, V29, P84, DOI 10.1016/j.clnu.2009.07.010; Shenassa ED, 2008, INT J OBESITY, V32, P490, DOI 10.1038/sj.ijo.0803755; STUDENSKI S, 1994, J AM GERIATR SOC, V42, P297, DOI 10.1111/j.1532-5415.1994.tb01755.x; Teh KC, 2002, MED SCI SPORT EXER, V34, P695, DOI 10.1097/00005768-200204000-00021; Yu S, 2003, HEART, V89, P502, DOI 10.1136/heart.89.5.502; Zaletel P, 2009, KINESIOLOGY, V41, P97	45	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148702	10.1371/journal.pone.0148702	http://dx.doi.org/10.1371/journal.pone.0148702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848956	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000161
J	Li, HY; Lin, HA; Nien, FJ; Wu, VC; Jiang, YD; Chang, TJ; Kao, HL; Lin, MS; Wei, JN; Lin, CH; Shih, SR; Hung, CS; Chuang, LM				Li, Hung-Yuan; Lin, Hung-An; Nien, Feng-Jung; Wu, Vin-Cent; Jiang, Yi-Der; Chang, Tien-Jyun; Kao, Hsien-Li; Lin, Mao-Shin; Wei, Jung-Nan; Lin, Cheng-Hsin; Shih, Shyang-Rong; Hung, Chi-Sheng; Chuang, Lee-Ming			Serum Vascular Adhesion Protein-1 Predicts End-Stage Renal Disease in Patients with Type 2 Diabetes	PLOS ONE			English	Article							SENSITIVE AMINE OXIDASE; CHRONIC KIDNEY-DISEASE; RISK-FACTORS; COMPLICATIONS; MORTALITY; INFLAMMATION; DIALYSIS; MARKERS; PEOPLE; TAIWAN	Background Diabetes is the leading cause of end-stage renal disease (ESRD) worldwide. Vascular adhesion protein-1 (VAP-1) participates in inflammation and catalyzes the deamination of primary amines into aldehydes, hydrogen peroxide, and ammonia, both of which are involved in the pathogenesis of diabetic complications. We have shown that serum VAP-1 is higher in patients with diabetes and in patients with chronic kidney disease (CKD), and can predict cardiovascular mortality in subjects with diabetes. In this study, we investigated if serum VAP-1 can predict ESRD in diabetic subjects. Methods In this prospective cohort study, a total of 604 type 2 diabetic subjects were enrolled between 1996 to 2003 at National Taiwan University Hospital, Taiwan, and were followed for a median of 12.36 years. The development of ESRD was ascertained by linking our database with the nationally comprehensive Taiwan Society Nephrology registry. Serum VAP-1 concentrations at enrollment were measured by time-resolved immunofluorometric assay. Results Subjects with serum VAP-1 in the highest tertile had the highest incidence of ESRD (p<0.001). Every 1-SD increase in serum VAP-1 was associated with a hazard ratio of 1.55 (95% CI 1.12-2.14, p<0.01) for the risk of ESRD, adjusted for smoking, history of cardiovascular disease, body mass index, hypertension, HbA1c, duration of diabetes, total cholesterol, use of statins, ankle-brachial index, estimated GFR, and proteinuria. We developed a risk score comprising serum VAP-1, HbA1c, estimated GFR, and proteinuria, which could predict ESRD with good performance (area under the ROC curve = 0.9406, 95% CI 0.8871-0.9941, sensitivity = 77.3%, and specificity = 92.8%). We also developed an algorithm based on the stage of CKD and a risk score including serum VAP-1, which can stratify these subjects into 3 categories with an ESRD risk of 0.101%/year, 0.131%/year, and 2.427%/year, respectively. Conclusions In conclusion, serum VAP-1 can predict ESRD and is a useful biomarker to improve risk stratification in type 2 diabetic subjects.	[Li, Hung-Yuan; Wu, Vin-Cent; Jiang, Yi-Der; Chang, Tien-Jyun; Kao, Hsien-Li; Lin, Mao-Shin; Shih, Shyang-Rong; Hung, Chi-Sheng; Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lin, Hung-An] Minist Hlth & Welf, Lo Sheng Sanat & Hosp, Taipei, Taiwan; [Nien, Feng-Jung] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Internal Med, Yunlin, Taiwan; [Lin, Mao-Shin; Chuang, Lee-Ming] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Wei, Jung-Nan] Chia Nan Univ Pharm & Sci, Tainan, Taiwan; [Lin, Cheng-Hsin] Taipei Med Univ, Wan Fang Hosp, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ, Sch Publ Hlth, Grad Inst Prevent Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chia Nan University of Pharmacy & Science; Taipei Medical University; Taipei Municipal WanFang Hospital; National Taiwan University	Chuang, LM (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.; Chuang, LM (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan.; Chuang, LM (corresponding author), Natl Taiwan Univ, Sch Publ Hlth, Grad Inst Prevent Med, Taipei 10764, Taiwan.	leeming@ntu.edu.tw	Chuang, Lee-Ming/AAF-3324-2019	Li, Hung-Yuan/0000-0001-9644-2855; WU, VIN-CENT/0000-0001-7935-0991; SHIH, SHYANG-RONG/0000-0001-7424-1358; KAO, HSIEN-LI/0000-0002-5278-3540; CHUANG, LEE-MING/0000-0003-0978-2662; JIANG, YI-DER/0000-0002-4276-5461; CHANG, TIEN-JYUN/0000-0001-9437-5847	National Science Council, Taiwan [NSC 101-2314-B-002-069-MY3]; Diabetes Research Fund of National Taiwan University Hospital, Taipei, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Diabetes Research Fund of National Taiwan University Hospital, Taipei, Taiwan	This work is supported in part by a grant (NSC 101-2314-B-002-069-MY3) from the National Science Council, Taiwan, and by the Diabetes Research Fund (to LMC) of National Taiwan University Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto K, 2012, ARTERIOSCL THROM VAS, V32, P523, DOI 10.1161/ATVBAHA.111.238030; Abella A, 2004, DIABETOLOGIA, V47, P429, DOI 10.1007/s00125-004-1346-2; Boomsma F, 2003, BBA-PROTEINS PROTEOM, V1647, P48, DOI 10.1016/S1570-9639(03)00047-5; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Clark N, 2003, DIABETES CARE, V26, P3333; Dalla Vestra M, 2005, J AM SOC NEPHROL, V16, pS78, DOI 10.1681/ASN.2004110961; Dunkel P, 2008, CURR MED CHEM, V15, P1827, DOI 10.2174/092986708785133022; Fernandes-Freitas I, 2015, CURR OPIN PHARMACOL, V25, P30, DOI 10.1016/j.coph.2015.09.014; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Guariguata L, 2012, DIABETES RES CLIN PR, V98, P524, DOI 10.1016/j.diabres.2012.11.006; Huang YY, 2012, J FORMOS MED ASSOC, V111, P637, DOI 10.1016/j.jfma.2012.09.006; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Jalkanen S, 2008, ARTERIOSCL THROM VAS, V28, P18, DOI 10.1161/ATVBAHA.107.153130; Kendrick J, 2011, J AM SOC NEPHROL, V22, P1913, DOI 10.1681/ASN.2010121224; Kohavi R, 1995, P 14 INT JOINT C ART, V2, P1137; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Lee MJ, 2015, DIABETES METAB J, V39, P230, DOI 10.4093/dmj.2015.39.3.230; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LEWINSOHN R, 1981, J PHARM PHARMACOL, V33, P569, DOI 10.1111/j.2042-7158.1981.tb13868.x; Li HY, 2012, J FORMOS MED ASSOC, V111, P645, DOI 10.1016/j.jfma.2012.09.013; Li HY, 2011, DIABETES, V60, P993, DOI 10.2337/db10-0607; Li HY, 2009, CLIN CHIM ACTA, V404, P149, DOI 10.1016/j.cca.2009.03.041; Li HY, 2009, CLIN CHIM ACTA, V403, P97, DOI 10.1016/j.cca.2009.01.027; Lin MS, 2008, CLIN BIOCHEM, V41, P1362, DOI 10.1016/j.clinbiochem.2008.06.019; Murata M, 2012, INVEST OPHTH VIS SCI, V53, P4055, DOI 10.1167/iovs.12-9857; Narita T, 2006, DIABETES CARE, V29, P142, DOI 10.2337/diacare.29.1.142; Pannecoeck R, 2015, CRIT REV CL LAB SCI, V52, P284, DOI 10.3109/10408363.2015.1050714; Sallisalmi M, 2012, ACTA ANAESTH SCAND, V56, P316, DOI 10.1111/j.1399-6576.2011.02578.x; SALMI M, 1993, J EXP MED, V178, P2255, DOI 10.1084/jem.178.6.2255; Schnedl C, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/358086; Stolen CM, 2004, FASEB J, V18, P702, DOI 10.1096/fj.03-0562fje; Stolen CM, 2004, CIRC RES, V95, P50, DOI 10.1161/01.RES.0000134630.68877.2F; Streja D, 2003, J DIABETES COMPLICAT, V17, P120, DOI 10.1016/S1056-8727(02)00204-0; Taal MW, 2014, CURR OPIN NEPHROL HY, V23, P519, DOI 10.1097/MNH.0000000000000072; Venugopal SK, 2002, CIRCULATION, V106, P1439, DOI 10.1161/01.CIR.0000033116.22237.F9; Wang C, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-9; Wu VC, 2011, KIDNEY INT, V80, P1222, DOI 10.1038/ki.2011.259; Yu PH, 1998, ATHEROSCLEROSIS, V140, P357, DOI 10.1016/S0021-9150(98)00142-7; Yu PH, 1997, DIABETOLOGIA, V40, P1243, DOI 10.1007/s001250050816	40	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147981	10.1371/journal.pone.0147981	http://dx.doi.org/10.1371/journal.pone.0147981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845338	gold, Green Published, Green Submitted			2022-12-27	WOS:000369552800024
J	Maiden, SL; Petrova, YI; Gumbiner, BM				Maiden, Stephanie L.; Petrova, Yuliya I.; Gumbiner, Barry M.			Microtubules Inhibit E-Cadherin Adhesive Activity by Maintaining Phosphorylated p120-Catenin in a Colon Carcinoma Cell Model	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SNAIL; ARMADILLO REPEAT REGION; TYROSINE KINASE FER; ALPHA-CATENIN; BETA-CATENIN; CYTOPLASMIC DOMAIN; MOLECULE UVOMORULIN; P120 CATENIN; C-CADHERIN; F-ACTIN	Tight regulation of cadherin-mediated intercellular adhesions is critical to both tissue morphogenesis during development and tissue homeostasis in adults. Cell surface expression of the cadherin-catenin complex is often directly correlated with the level of adhesion, however, examples exist where cadherin appears to be inactive and cells are completely non-adhesive. The state of p120-catenin phosphorylation has been implicated in regulating the adhesive activity of E-cadherin but the mechanism is currently unclear. We have found that destabilization of the microtubule cytoskeleton, independent of microtubule plus-end dynamics, dephosphorylates p120-catenin and activates E-cadherin adhesion in Colo 205 cells. Through chemical screening, we have also identified several kinases as potential regulators of E-cadherin adhesive activity. Analysis of several p120-catenin phosphomutants suggests that gross dephosphorylation of p120-catenin rather than that of specific amino acids may trigger E-cadherin adhesion. Uncoupling p120-catenin binding to E-cadherin at the membrane causes constitutive adhesion in Colo 205 cells, further supporting an inhibitory role of phosphorylated p120-catenin on E-cadherin activity.	[Maiden, Stephanie L.; Petrova, Yuliya I.; Gumbiner, Barry M.] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Maiden, Stephanie L.] Truman State Univ, Dept Biol, Kirksville, MO USA; [Gumbiner, Barry M.] Seattle Childrens Res Inst, Seattle, WA USA; [Gumbiner, Barry M.] Univ Washington, Sch Med, Seattle, WA USA	University of Virginia; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Gumbiner, BM (corresponding author), Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA.; Gumbiner, BM (corresponding author), Seattle Childrens Res Inst, Seattle, WA USA.; Gumbiner, BM (corresponding author), Univ Washington, Sch Med, Seattle, WA USA.	gumbiner@uw.edu		Maiden, Stephanie/0000-0002-5144-386X	National Institutes of Health [R01GM106659, 5T32DK007769]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health (http://www.nih.gov/) grant R01GM106659 to BMG. National Institutes of Health (http://www.nih.gov/) postdoctoral training grant 5T32DK007769 to SLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERLE H, 1994, J CELL SCI, V107, P3655; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Aono S, 1999, J CELL BIOL, V145, P551, DOI 10.1083/jcb.145.3.551; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cheung PY, 2004, J BIOL CHEM, V279, P45308, DOI 10.1074/jbc.C400333200; Ferrarese A, 2007, BIOCHEMISTRY-US, V46, P11902, DOI 10.1021/bi701674z; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Franke WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003061; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huber O, 1997, J CELL SCI, V110, P1759; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ikeda K, 2011, MOL BIOL CELL, V22, P1321, DOI 10.1091/mbc.E10-09-0741; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Kaufmann U, 2000, J CELL SCI, V113, P4121; KIM L, 1995, MOL CELL BIOL, V15, P4553; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Koeberle SC, 2012, NAT CHEM BIOL, V8, P141, DOI 10.1038/nchembio.761; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; LEE CH, 1995, DEV BIOL, V171, P363, DOI 10.1006/dbio.1995.1288; Mariner DJ, 2001, J BIOL CHEM, V276, P28006, DOI 10.1074/jbc.M102443200; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Miyashita Y, 2007, J BIOL CHEM, V282, P11540, DOI 10.1074/jbc.M608351200; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Nieset JE, 1997, J CELL SCI, V110, P1013; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Ohkubo T, 1999, J BIOL CHEM, V274, P21409, DOI 10.1074/jbc.274.30.21409; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Pappas DJ, 2006, CELL COMMUN ADHES, V13, P151, DOI 10.1080/15419060600726142; Petrova YI, 2012, MOL BIOL CELL, V23, P2092, DOI 10.1091/mbc.E11-12-1060; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; REYNOLDS AB, 1992, ONCOGENE, V7, P2439; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Risco Ana, 2012, J Signal Transduct, V2012, P520289, DOI 10.1155/2012/520289; Rosato R, 1998, MOL CELL BIOL, V18, P5762, DOI 10.1128/MCB.18.10.5762; Seldin DC, 2005, MOL CELL BIOCHEM, V274, P63, DOI 10.1007/s11010-005-3078-0; Shanware NP, 2009, BMB REP, V42, P142, DOI 10.5483/BMBRep.2009.42.3.142; Shashikanth N, 2015, J BIOL CHEM, V290, P21749, DOI 10.1074/jbc.M115.657098; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; Stehbens SJ, 2006, J CELL SCI, V119, P1801, DOI 10.1242/jcs.02903; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; VESTWEBER D, 1987, DEV BIOL, V124, P451, DOI 10.1016/0012-1606(87)90498-2; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Xia XB, 2003, BIOCHEMISTRY-US, V42, P9195, DOI 10.1021/bi034597h; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Zhong Y, 1999, J CELL BIOL, V144, P351, DOI 10.1083/jcb.144.2.351	61	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148574	10.1371/journal.pone.0148574	http://dx.doi.org/10.1371/journal.pone.0148574			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845024	Green Published, gold			2022-12-27	WOS:000369552800072
J	Owen, HE; Halberstadt, J; Carr, EW; Winkielman, P				Owen, Helen E.; Halberstadt, Jamin; Carr, Evan W.; Winkielman, Piotr			Johnny Depp, Reconsidered: How Category-Relative Processing Fluency Determines the Appeal of Gender Ambiguity	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; PERCEPTUAL FLUENCY; FACES; ATTRACTIVENESS; TYPICALITY; EVOLUTION; DOMINANCE; ATTENTION; MEMORY; EYES	Individuals that combine features of both genders-gender blends-are sometimes appealing and sometimes not. Heretofore, this difference was explained entirely in terms of sexual selection. In contrast, we propose that part of individuals' preference for gender blends is due to the cognitive effort required to classify them, and that such effort depends on the context in which a blend is judged. In two studies, participants judged the attractiveness of male-female morphs. Participants did so after classifying each face in terms of its gender, which was selectively more effortful for gender blends, or classifying faces on a gender-irrelevant dimension, which was equally effortful for gender blends. In both studies, gender blends were disliked when, and only when, the faces were first classified by gender, despite an overall preference for feminine features in all conditions. Critically, the preferences were mediated by the effort of stimulus classification. The results suggest that the variation in attractiveness of gender-ambiguous faces may derive from context-dependent requirements to determine gender membership. More generally, the results show that the difficulty of resolving social category membership-not just attitudes toward a social category-feed into perceivers' overall evaluations toward category members.	[Owen, Helen E.; Halberstadt, Jamin] Univ Otago, Dept Psychol, Dunedin, New Zealand; [Carr, Evan W.; Winkielman, Piotr] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; [Winkielman, Piotr] Univ Warwick, Warwick Business Sch, Behav Sci Grp, Coventry CV4 7AL, W Midlands, England; [Winkielman, Piotr] Univ Social Sci & Humanities, Dept Psychol, Warsaw, Poland	University of Otago; University of California System; University of California San Diego; University of Warwick; SWPS University of Social Sciences & Humanities	Halberstadt, J (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.; Winkielman, P (corresponding author), Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA.; Winkielman, P (corresponding author), Univ Warwick, Warwick Business Sch, Behav Sci Grp, Coventry CV4 7AL, W Midlands, England.; Winkielman, P (corresponding author), Univ Social Sci & Humanities, Dept Psychol, Warsaw, Poland.	jhalbers@psy.otago.ac.pz; pwinkielman@ucsd.edu	Winkielman, Piotr/AAT-6275-2020	Winkielman, Piotr/0000-0003-2330-1802				Allan K, 2012, EVOL HUM BEHAV, V33, P193, DOI 10.1016/j.evolhumbehav.2011.09.002; Alter AL, 2006, P NATL ACAD SCI USA, V103, P9369, DOI 10.1073/pnas.0601071103; Anderson US, 2010, J EXP SOC PSYCHOL, V46, P804, DOI 10.1016/j.jesp.2010.04.015; [Anonymous], 2003, POP COMMUN, DOI DOI 10.1207/S15405710PC0102_2; [Anonymous], 2009, MORPH PHOT SUIT; ARMSTRONG SL, 1983, COGNITION, V13, P263, DOI 10.1016/0010-0277(83)90012-4; BARSALOU LW, 1985, J EXP PSYCHOL LEARN, V11, P629, DOI 10.1037/0278-7393.11.1-4.629; Budgeon S, 2014, SOCIOLOGY, V48, P317, DOI 10.1177/0038038513490358; Causey K., 2009, JOHNNY DEPP EFFECT E; Cunningham M. R., 1997, EVOLUTIONARY SOCIAL, P109; DeBruine L. M., 2010, P ROYAL SOC B; DUNKLE JH, 1990, SEX ROLES, V23, P157, DOI 10.1007/BF00289863; Eagly AH, 2002, PSYCHOL REV, V109, P573, DOI 10.1037//0033-295X.109.3.573; Fiske S. T., 1982, AFFECT COGNITION, P55; Gangestad SW, 1998, P ROY SOC B-BIOL SCI, V265, P927, DOI 10.1098/rspb.1998.0380; Gangestad SW, 2000, BEHAV BRAIN SCI, V23, P573, DOI 10.1017/S0140525X0000337X; Garber Marjorie, 1997, VESTED INTERESTS CRO; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Halberstadt J., 2013, PSYCHOL SCI; Halberstadt J, 2014, J EXP SOC PSYCHOL, V50, P175, DOI 10.1016/j.jesp.2013.08.004; Halberstadt J, 2013, EXPERIENCE OF THINKING: HOW THE FLUENCY OF MENTAL PROCESSES INFLUENCES COGNITION AND BEHAVIOR, P133; Hayes A. F., 2012, PROCESS VERSATILE CO; Ito TA, 2003, J PERS SOC PSYCHOL, V85, P616, DOI 10.1037/0022-3514.85.4.616; Lee AY, 2004, J MARKETING RES, V41, P151, DOI 10.1509/jmkr.41.2.151.28665; Meadow T, 2010, GENDER SOC, V24, P814, DOI 10.1177/0891243210385918; Meyer DA, 1999, NATURE, V397, P661, DOI 10.1038/17720; Oppenheimer DM, 2006, APPL COGNITIVE PSYCH, V20, P139, DOI 10.1002/acp.1178; Penton-Voak IS, 2004, EVOL HUM BEHAV, V25, P355, DOI 10.1016/j.evolhumbehav.2004.06.002; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; POSNER MI, 1968, J EXP PSYCHOL, V77, P353, DOI 10.1037/h0025953; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Reber R, 1998, PSYCHOL SCI, V9, P45, DOI 10.1111/1467-9280.00008; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2005, SOC COGNITION, V23, P205, DOI 10.1521/soco.2005.23.3.205; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Rhodes G, 2000, BRIT J PSYCHOL, V91, P125, DOI 10.1348/000712600161718; Sczesny S, 2006, SWISS J PSYCHOL, V65, P15, DOI 10.1024/1421-0185.65.1.15; Smith D, 2013, MEM COGNITION, V41, P850, DOI 10.3758/s13421-013-0301-1; STANGOR C, 1992, J PERS SOC PSYCHOL, V62, P207, DOI 10.1037/0022-3514.62.2.207; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; von Stockhausen L, 2013, EXP PSYCHOL, V60, P444, DOI 10.1027/1618-3169/a000217; Watkins CD, 2012, EUR J PERSONALITY, V26, P79, DOI 10.1002/per.837; Watkins CD, 2010, PERS INDIV DIFFER, V49, P967, DOI 10.1016/j.paid.2010.08.006; Watkins CD, 2010, BEHAV ECOL, V21, P943, DOI 10.1093/beheco/arq091; Weber P., 2014, CONFUSED ALL NEW FAC; Winkielman P, 2003, PSYCHOLOGY OF EVALUATION, P189; Winkielman P, 2001, J PERS SOC PSYCHOL, V81, P989, DOI 10.1037//0022-3514.81.6.989; Winkielman P, 2006, PSYCHOL SCI, V17, P799, DOI 10.1111/j.1467-9280.2006.01785.x; Winkielman P, 2015, EMOTION, V15, P232, DOI 10.1037/emo0000036	50	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0146328	10.1371/journal.pone.0146328	http://dx.doi.org/10.1371/journal.pone.0146328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PF	26845341	Green Published, gold, Green Submitted			2022-12-27	WOS:000369552800004
J	Sako, H; Yada, K; Suzuki, K				Sako, Hiroaki; Yada, Koichi; Suzuki, Katsuhiko			Genome-Wide Analysis of Acute Endurance Exercise-Induced Translational Regulation in Mouse Skeletal Muscle	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; PROTEIN-SYNTHESIS; RESISTANCE EXERCISE; IN-VIVO; MECHANISMS; BREAKDOWN; TARGET	Exercise dynamically changes skeletal muscle protein synthesis to respond and adapt to the external and internal stimuli. Many studies have focused on overall protein synthesis to understand how exercise regulates the muscular adaptation. However, despite the probability that each gene transcript may have its own unique translational characteristics and would be differentially regulated at translational level, little attention has been paid to how exercise affects translational regulation of individual genes at a genome-wide scale. Here, we conducted a genome-wide translational analysis using ribosome profiling to investigate the effect of a single bout of treadmill running (20 m/min for 60 min) on mouse gastrocnemius. Global translational profiles largely differed from those in transcription even at a basal resting condition as well as immediately after exercise. As for individual gene, Slc25a25 (Solute carrier family 25, member 25), localized in mitochondrial inner membrane and maintaining ATP homeostasis and endurance performance, showed significant up-regulation at translational level. However, multiple regression analysis suggests that Slc25a25 protein degradation may also have a role in mediating Slc25a25 protein abundance in the basal and early stages after acute endurance exercise.	[Sako, Hiroaki] Waseda Univ, Grad Sch Sport Sci, Saitama 3591192, Japan; [Yada, Koichi; Suzuki, Katsuhiko] Waseda Univ, Fac Sport Sci, Saitama 3591192, Japan	Waseda University; Waseda University	Sako, H (corresponding author), Waseda Univ, Grad Sch Sport Sci, Saitama 3591192, Japan.	h.sako@kurenai.waseda.jp	Suzuki, Katsuhiko/AAI-2197-2019	Suzuki, Katsuhiko/0000-0002-6572-5809; SAKO, Hiroaki/0000-0002-5812-655X	Ministry of Education, Culture, Sports Science and Technology of Japan [26560370]; Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan [S1511017]; Grants-in-Aid for Scientific Research [15H01833] Funding Source: KAKEN	Ministry of Education, Culture, Sports Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ministry of Education, Culture, Sports Science and Technology of Japan, a Grant-in-Aid for the Global COE Program "Sport Science for the Promotion of Active Life", Challenging Exploratory Research 26560370, and the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology (S1511017) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anunciado-Koza RP, 2011, J BIOL CHEM, V286, P11659, DOI 10.1074/jbc.M110.203000; Carmeli E, 2005, EXP PHYSIOL, V90, P613, DOI 10.1113/expphysiol.2004.029462; Chinkes D, 1996, AM J PHYSIOL-ENDOC M, V270, pE67, DOI 10.1152/ajpendo.1996.270.1.E67; Freeberg MA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r13; Fyfe JJ, 2014, SPORTS MED, V44, P743, DOI 10.1007/s40279-014-0162-1; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gautsch TA, 1998, AM J PHYSIOL-CELL PH, V274, pC406, DOI 10.1152/ajpcell.1998.274.2.C406; Glover EI, 2008, J PHYSIOL-LONDON, V586, P6049, DOI 10.1113/jphysiol.2008.160333; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jobling RK, 2015, BRAIN, V138, P1505, DOI 10.1093/brain/awv057; Jung T, 2014, REDOX BIOL, V2, P388, DOI 10.1016/j.redox.2013.12.029; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Kumar V, 2009, J APPL PHYSIOL, V106, P2026, DOI 10.1152/japplphysiol.91481.2008; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; Lu B, 2008, BIOL REPROD, V78, P601, DOI 10.1095/biolreprod.107.065987; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Miller BF, 2015, J APPL PHYSIOL, V118, P655, DOI 10.1152/japplphysiol.00987.2014; Muthusamy VR, 2012, FREE RADICAL BIO MED, V52, P366, DOI 10.1016/j.freeradbiomed.2011.10.440; Ogasawara R, 2014, AM J PHYSIOL-ENDOC M, V306, pE1155, DOI 10.1152/ajpendo.00647.2013; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Pickering AM, 2012, J BIOL CHEM, V287, P10021, DOI 10.1074/jbc.M111.277145; RENNIE MJ, 1982, CLIN SCI, V63, P519, DOI 10.1042/cs0630519; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sako H, 2014, EXERC IMMUNOL REV, V20, P55; Scalzo RL, 2014, FASEB J, V28, P2705, DOI 10.1096/fj.13-246595; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Wang WJ, 2002, CIRCULATION, V106, P1543, DOI 10.1161/01.CIR.0000028818.33488.7B; Williamson DL, 2006, J PHYSIOL-LONDON, V573, P497, DOI 10.1113/jphysiol.2005.103481	36	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148311	10.1371/journal.pone.0148311	http://dx.doi.org/10.1371/journal.pone.0148311			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845575	gold, Green Published, Green Submitted			2022-12-27	WOS:000369552800046
J	Ho, J; Theg, SM				Ho, Jonathan; Theg, Steven M.			The Formation of Stromules In Vitro from Chloroplasts Isolated from Nicotiana benthamiana	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; PLASTID STROMULES; MEMBRANE; MOVEMENT; MICROFILAMENTS; PROTRUSIONS; EXPRESSION; TUBULATION; MORPHOLOGY; INDUCTION	Stromules are stroma-containing tubules that have been observed to emanate from the main plastidic body in vivo. These structures have been shown to require cytoskeletal components for movement. Though numerous studies have shown a close association with the endoplasmic reticulum, nucleus, mitochondria, and other plastids, the mechanism of formation and their overall function remain unknown. A limiting factor in studying these structures has been the lack of a reconstituted system for in vitro stromule formation. In this study, stromule formation was induced in vitro by adding a plant extract fraction that is greater than 100 kDa to a population of isolated chloroplasts. Kinetic measurements show that stromule formation occurs within similar to 10 seconds after the addition of the plant extract fraction. Heat inactivation and apyrase treatment reveal that the stromule stimulating compound found in the extract fraction is a protein or protein complex 100 kDa or greater. The formation of the stromules in vitro with isolated chloroplasts and a concentrated fraction of cell extract opens an avenue for the biochemical dissection of this process that has heretofore been studied only in vivo.	[Ho, Jonathan; Theg, Steven M.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Theg, SM (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.	smtheg@ucdavis.edu			National Science Foundation [MCB-1330321]	National Science Foundation(National Science Foundation (NSF))	This work was supported by MCB-1330321 from the National Science Foundation (http://www.nsf.gov/bio/mcb/about.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MX, 2007, J BIOL CHEM, V282, P1170, DOI 10.1074/jbc.M608124200; Arimura S, 2004, PLANT CELL PHYSIOL, V45, P236, DOI 10.1093/pcp/pch024; Breuers FKH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00007; Brunkard JO, 2015, P NATL ACAD SCI USA, V112, P10044, DOI 10.1073/pnas.1511570112; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; Caplan JL, 2015, DEV CELL, V34, P45, DOI 10.1016/j.devcel.2015.05.011; Gray JC, 2001, PLANT BIOLOGY, V3, P223, DOI 10.1055/s-2001-15204; Gray JC, 2012, PLANT J, V69, P387, DOI 10.1111/j.1365-313X.2011.04800.x; Gunning BES, 2005, PROTOPLASMA, V225, P33, DOI 10.1007/s00709-004-0073-3; Hanson MR, 2011, PLANT PHYSIOL, V155, P1486, DOI 10.1104/pp.110.170852; Hayward A, 2011, METHODS MOL BIOL, V678, P55, DOI 10.1007/978-1-60761-682-5_5; Holzinger A, 2007, PROTOPLASMA, V230, P23, DOI 10.1007/s00709-006-0222-y; Kohler RH, 1997, SCIENCE, V276, P2039, DOI 10.1126/science.276.5321.2039; Kohler RH, 2000, J CELL SCI, V113, P81; Krenz B, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00291; Kwok Ernest Y., 2004, BMC Plant Biology, V4, P2, DOI 10.1186/1471-2229-4-2; Kwok EY, 2003, PLANT J, V35, P16, DOI 10.1046/j.1365-313X.2003.01777.x; Kwok EY, 2004, PLANT CELL REP, V23, P188, DOI 10.1007/s00299-004-0824-9; Lo SM, 2011, METHODS MOL BIOL, V684, P139, DOI [10.1007/978.1.60761.925.3_13, 10.1007/978-1-60761-925-3_13]; Machettira AB, 2012, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00118; MENZEL D, 1994, PROTOPLASMA, V179, P166, DOI 10.1007/BF01403955; Natesan SKA, 2009, MOL PLANT, V2, P1262, DOI 10.1093/mp/ssp078; Oikawa K, 2008, PLANT PHYSIOL, V148, P829, DOI 10.1104/pp.108.123075; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Pyke KA, 2002, ANN BOT-LONDON, V90, P559, DOI 10.1093/aob/mcf235; Schattat M, 2011, PLANT PHYSIOL, V155, P1667, DOI 10.1104/pp.110.170480; Schattat MH, 2015, PROTOPLASMA, V252, P359, DOI 10.1007/s00709-014-0666-4; Senn G., 1908, GESTALTS UND LAGEVER; Singh ND, 2008, PLANT CELL, V20, P3405, DOI 10.1105/tpc.108.063172; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Stachowiak JC, 2010, P NATL ACAD SCI USA, V107, P7781, DOI 10.1073/pnas.0913306107; Tominaga M, 2003, EMBO J, V22, P1263, DOI 10.1093/emboj/cdg130; Usami H, 2012, PLANTA, V236, P1889, DOI 10.1007/s00425-012-1735-6; Wada M, 2003, ANNU REV PLANT BIOL, V54, P455, DOI 10.1016/j.plantsci.2013.05.016; Walley J, 2015, P NATL ACAD SCI USA, V112, P6212, DOI 10.1073/pnas.1504828112; Wang WM, 2013, PLANT CELL, V25, P4242, DOI 10.1105/tpc.113.117226; Waters MT, 2004, PLANT J, V39, P655, DOI 10.1111/j.1365-313X.2004.02164.x; Xiao YM, 2012, CELL, V149, P1525, DOI 10.1016/j.cell.2012.04.038	39	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146489	10.1371/journal.pone.0146489	http://dx.doi.org/10.1371/journal.pone.0146489			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840974	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200010
J	Bhagwandin, VJ; Bishop, JM; Wright, WE; Shay, JW				Bhagwandin, Vikash J.; Bishop, J. Michael; Wright, Woodring E.; Shay, Jerry W.			The Metastatic Potential and Chemoresistance of Human Pancreatic Cancer Stem Cells	PLOS ONE			English	Article							SIDE POPULATION CELLS; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER-1; DRUG EFFLUX CAPACITY; MULTIDRUG-RESISTANCE; MESENCHYMAL TRANSITION; P-GLYCOPROTEIN; MELANOMA-CELLS; IN-VITRO; GEMCITABINE; LINES	Cancer stem cells (CSCs) typically have the capacity to evade chemotherapy and may be the principal source of metastases. CSCs for human pancreatic ductal carcinoma (PDAC) have been identified, but neither the metastatic potential nor the chemoresistance of these cells has been adequately evaluated. We have addressed these issues by examining sidepopulation (SP) cells isolated from the Panc-1 and BxPC3 lines of human PDAC cells, the oncogenotypes of which differ. SP cells could be isolated from monolayers of Panc-1, but only from spheroids of BxPC3. Using orthotopic xenografts into the severely immunocompromised NSG mouse, we found that SP cells isolated from both cell lines produced tumors that were highly metastatic, in contrast to previous experience with PDAC cell lines. SP cells derived from both cell lines expressed the ABCG2 transporter, which was demonstrably responsible for the SP phenotype. SP cells gave rise to non-SP (NSP) cells in vitro and in vivo, a transition that was apparently due to posttranslational inhibition of the ABCG2 transporter. Twenty-two other lines of PDAC cells also expressed ABCG2. The sensitivity of PDAC SP cells to the vinca alkaloid vincristine could be greatly increased by verapamil, a general inhibitor of transporters. In contrast, verapamil had no effect on the killing of PDAC cells by gemcitabine, the current first-line therapeutic for PDAC. We conclude that the isolation of SP cells can be a convenient and effective tool for the study of PDAC CSCs; that CSCs may be the principal progenitors of metastasis by human PDAC; that the ABCG2 transporter is responsible for the SP phenotype in human PDAC cells, and may be a ubiquitous source of drug-resistance in PDAC, but does not confer resistance to gemcitabine; and that inhibition of ABCG2 might offer a useful adjunct in a therapeutic attack on the CSCs of PDAC.	[Bhagwandin, Vikash J.; Wright, Woodring E.; Shay, Jerry W.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Bhagwandin, Vikash J.; Bishop, J. Michael] Univ Calif San Francisco, GW Hooper Res Fdn, San Francisco, CA 94143 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco	Bhagwandin, VJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.; Bhagwandin, VJ (corresponding author), Univ Calif San Francisco, GW Hooper Res Fdn, San Francisco, CA 94143 USA.	vikash.bhagwandin@va.gov			National Aeronautics and Space Administration-Specialized Center of Research [NNJ05HD36G]; National Institute of Health, Ruth L. Kirschstein National Research Service Award, Institutional Training Grant (T32) [CA09043]; NATIONAL CANCER INSTITUTE [T32CA009043] Funding Source: NIH RePORTER	National Aeronautics and Space Administration-Specialized Center of Research; National Institute of Health, Ruth L. Kirschstein National Research Service Award, Institutional Training Grant (T32)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by: 1. National Aeronautics and Space Administration-Specialized Center of Research: NNJ05HD36G (VJB, WEW, JWS), and 2. National Institute of Health, Ruth L. Kirschstein National Research Service Award, Institutional Training Grant (T32) for The G.W. Hooper Research Foundation: CA09043 (VJB, JMB).	BATES SE, 1991, J CLIN ENDOCR METAB, V73, P18, DOI 10.1210/jcem-73-1-18; Bello-Reuss E, 2000, AM J PHYSIOL-CELL PH, V278, pC1256, DOI 10.1152/ajpcell.2000.278.6.C1256; Bhagwandin VJ, 2009, BBA-MOL BASIS DIS, V1792, P248, DOI 10.1016/j.bbadis.2009.02.007; Bold RJ, 1999, ANN SURG ONCOL, V6, P279, DOI 10.1007/s10434-999-0279-x; Chow EKH, 2012, HEPATOLOGY, V56, P1331, DOI 10.1002/hep.25776; Du ZY, 2011, DIGEST DIS SCI, V56, P741, DOI 10.1007/s10620-010-1340-0; Giovannetti E, 2006, ANN ONCOL, V17, pV17, DOI 10.1093/annonc/mdj943; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; Giovannetti E, 2006, MOL CANCER THER, V5, P1387, DOI 10.1158/1535-7163.MCT-06-0004; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Griffiths M, 1997, NAT MED, V3, P89, DOI 10.1038/nm0197-89; Gysin S, 2005, GENE CHROMOSOME CANC, V44, P37, DOI 10.1002/gcc.20216; Gysin S, 2012, MOL CANCER RES, V10, P1607, DOI 10.1158/1541-7786.MCR-12-0188; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Kabashima A, 2009, INT J CANCER, V124, P2771, DOI 10.1002/ijc.24349; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; MECHETNER EB, 1992, P NATL ACAD SCI USA, V89, P5824, DOI 10.1073/pnas.89.13.5824; Miranda-Lorenzo I, 2014, NAT METHODS, V11, P1161, DOI [10.1038/NMETH.3112, 10.1038/nmeth.3112]; Mitsutake N, 2007, ENDOCRINOLOGY, V148, P1797, DOI 10.1210/en.2006-1553; Nakanishi T, 2006, BLOOD, V108, P678, DOI 10.1182/blood-2005-10-4020; Okazaki T, 2010, CLIN CANCER RES, V16, P320, DOI 10.1158/1078-0432.CCR-09-1555; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sennino B, 2012, CANCER DISCOV, V2, P270, DOI 10.1158/2159-8290.CD-11-0240; SHEN DW, 1986, SCIENCE, V232, P643, DOI 10.1126/science.3457471; Shi X, 2002, ONCOLOGY-BASEL, V62, P354, DOI 10.1159/000065068; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Spratlin J, 2004, CLIN CANCER RES, V10, P6956, DOI 10.1158/1078-0432.CCR-04-0224; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Takada T, 2005, DRUG METAB DISPOS, V33, P905, DOI 10.1124/dmd.104.003228; Wang F, 2010, BRIT J CANCER, V103, P567, DOI 10.1038/sj.bjc.6605724; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Wang YH, 2009, NEOPLASMA, V56, P371, DOI 10.4149/neo_2009_05_371; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Xu ZW, 2001, INT J CANCER, V94, P268, DOI 10.1002/ijc.1447; Yao J, 2010, ONCOL REP, V23, P1375, DOI 10.3892/or_00000774; Yin LQ, 2008, CANCER RES, V68, P800, DOI 10.1158/0008-5472.CAN-07-2545; Yin T, 2011, INT J MOL SCI, V12, P1595, DOI 10.3390/ijms12031595; Zhou J, 2008, WORLD J GASTROENTERO, V14, P925, DOI 10.3748/wjg.14.925	50	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148807	10.1371/journal.pone.0148807	http://dx.doi.org/10.1371/journal.pone.0148807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859746	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400089
J	Lei, R; Zhang, K; Wei, YX; Chen, M; Weinstein, LS; Hong, Y; Zhu, MY; Li, HC; Li, HS				Lei, Run; Zhang, Ke; Wei, Yanxia; Chen, Min; Weinstein, Lee S.; Hong, Yang; Zhu, Minyan; Li, Hongchang; Li, Huashun			G-Protein alpha-Subunit Gs alpha Is Required for Craniofacial Morphogenesis	PLOS ONE			English	Article							STIMULATORY G-PROTEIN; ELEMENT-BINDING PROTEIN; CRANIAL NEURAL CREST; PARATHYROID-HORMONE REQUIRES; EPIDERMAL-GROWTH-FACTOR; PIERRE-ROBIN SEQUENCE; INDIAN-HEDGEHOG; BONE-FORMATION; OSTEOBLASTIC CELLS; CLEFT-PALATE	The heterotrimeric G protein subunit Gs alpha couples receptors to activate adenylyl cyclase and is required for the intracellular cAMP response and protein kinase A (PKA) activation. Gs alpha is ubiquitously expressed in many cell types; however, the role of Gs alpha in neural crest cells (NCCs) remains unclear. Here we report that NCCs-specific Gs alpha knockout mice die within hours after birth and exhibit dramatic craniofacial malformations, including hypoplastic maxilla and mandible, cleft palate and craniofacial skeleton defects. Histological and anatomical analysis reveal that the cleft palate in Gs alpha knockout mice is a secondary defect resulting from craniofacial skeleton deficiencies. In Gs alpha knockout mice, the morphologies of NCCs-derived cranial nerves are normal, but the development of dorsal root and sympathetic ganglia are impaired. Furthermore, loss of Gs alpha in NCCs does not affect cranial NCCs migration or cell proliferation, but significantly accelerate osteochondrogenic differentiation. Taken together, our study suggests that Gs alpha is required for neural crest cells-derived craniofacial development.	[Lei, Run; Zhang, Ke; Wei, Yanxia; Li, Huashun] Sichuan Univ, West China Dev & Stem Cell Inst, West China Second Hosp, Chengdu 610064, Sichuan, Peoples R China; [Lei, Run; Zhang, Ke; Wei, Yanxia; Li, Huashun] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Lei, Run; Zhang, Ke; Li, Hongchang] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen Key Lab Mol Biol Neural Dev, Lab Dev & Regenerat Biol,Inst Biomed & Biotechnol, Shenzhen, Guangdong, Peoples R China; [Lei, Run; Zhang, Ke; Zhu, Minyan; Li, Huashun] Chinese Acad Sci, Tongji Univ, SARITEX Ctr Stem Cell Engn Translat Med, Shanghai East Hosp,Sch Med, Shanghai, Peoples R China; [Chen, Min; Weinstein, Lee S.] Natl Inst Diabet & Digest & Kidney Dis, Metab Dis Branch, NIH, Bethesda, MD USA; [Hong, Yang] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA USA	Sichuan University; Sichuan University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; Tongji University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Li, HS (corresponding author), Sichuan Univ, West China Dev & Stem Cell Inst, West China Second Hosp, Chengdu 610064, Sichuan, Peoples R China.; Li, HS (corresponding author), Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu 610064, Sichuan, Peoples R China.; Li, HC (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen Key Lab Mol Biol Neural Dev, Lab Dev & Regenerat Biol,Inst Biomed & Biotechnol, Shenzhen, Guangdong, Peoples R China.; Li, HS (corresponding author), Chinese Acad Sci, Tongji Univ, SARITEX Ctr Stem Cell Engn Translat Med, Shanghai East Hosp,Sch Med, Shanghai, Peoples R China.	hc.li@siat.ac.cn; huashunli@tongji.edu.cn	Li, Hongchang/GQO-9662-2022	Weinstein, Lee/0000-0002-1899-5152	Ministry of Science & Technology-China [2014CB964600, 2012CB966800, 2013ZX09509104, 2007CB947202, 2009CB941402, 2010CB945600, 2011CB965100, 2009R0002]; National Science Foundation of China [31301125, 30771102, 31071283, 81370457, 81271498]; Shenzhen Peacock Plan [KQCX20130628112914292]; Shenzhen Key Laboratory for Molecular Biology of Neural Development [ZDSY20120617112838879]; faculty development support (West China Women's & Children Hospital & Shenzhen Institutes of Advanced Technology-CAS & Tongji University Shanghai East Hospital); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043313] Funding Source: NIH RePORTER	Ministry of Science & Technology-China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Peacock Plan; Shenzhen Key Laboratory for Molecular Biology of Neural Development; faculty development support (West China Women's & Children Hospital & Shenzhen Institutes of Advanced Technology-CAS & Tongji University Shanghai East Hospital); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partially supported by grants from the Ministry of Science & Technology-China (2014CB964600, 2012CB966800,2013ZX09509104, 2007CB947202,2009CB941402, 2010CB945600, 2011CB965100, 2013ZX09509104, and 2009R0002), National Science Foundation of China (31301125, 30771102, 31071283,81370457, 81271498), Shenzhen Peacock Plan (No. KQCX20130628112914292), and faculty development support (West China Women's & Children Hospital & Shenzhen Institutes of Advanced Technology-CAS & Tongji University Shanghai East Hospital) and Shenzhen Key Laboratory for Molecular Biology of Neural Development (ZDSY20120617112838879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano K, 2014, J BIOL CHEM, V289, P24898, DOI 10.1074/jbc.M114.570507; Bastepe M, 2004, P NATL ACAD SCI USA, V101, P14794, DOI 10.1073/pnas.0405091101; BELLOWS CG, 1990, ENDOCRINOLOGY, V127, P3111, DOI 10.1210/endo-127-6-3111; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Brault V, 2001, DEVELOPMENT, V128, P1253; BRUNET CL, 1995, INT J DEV BIOL, V39, P345; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Chai Y, 1998, INT J DEV BIOL, V42, P87; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Chung U, 2000, IN VIVO FUNCTION STI, pS175; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Connerney J, 2006, DEV DYNAM, V235, P1345, DOI 10.1002/dvdy.20717; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Dettlaff-Swiercz DA, 2005, DEV BIOL, V282, P174, DOI 10.1016/j.ydbio.2005.03.006; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; Farlie Peter G, 2004, Birth Defects Res C Embryo Today, V72, P173, DOI 10.1002/bdrc.20013; Funato N, 2009, DEVELOPMENT, V136, P615, DOI 10.1242/dev.029355; Gammill LS, 2003, NAT REV NEUROSCI, V4, P795, DOI 10.1038/nrn1219; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; Graul-Neumann LM, 2009, AM J MED GENET A, V149A, P1487, DOI 10.1002/ajmg.a.32889; Guo J, 2002, DEV CELL, V3, P183, DOI 10.1016/S1534-5807(02)00218-6; HALL BK, 1980, J EMBRYOL EXP MORPH, V56, P71; Helms JA, 2005, DEVELOPMENT, V132, P851, DOI 10.1242/dev.01705; HOGAN B, 1986, MANIPULATING MOUSE E; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Ivey K, 2003, DEV BIOL, V255, P230, DOI 10.1016/S0012-1606(02)00097-0; Iwata J, 2010, J BIOL CHEM, V285, P4975, DOI 10.1074/jbc.M109.035105; Jobert AS, 1998, J CLIN INVEST, V102, P34, DOI 10.1172/JCI2918; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kim TH, 2012, ANAT CELL BIOL, V45, P193, DOI 10.5115/acb.2012.45.3.193; Knecht AK, 2002, NAT REV GENET; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Le Douarin N, 1999, NEURAL CREST, Vxxiii; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; MARK M, 1993, DEVELOPMENT, V119, P319; Mayor R, 2013, DEVELOPMENT, V140, P2247, DOI 10.1242/dev.091751; Miao DS, 2002, J CLIN INVEST, V109, P1173, DOI 10.1172/JCI200214817; Miao DS, 2004, ENDOCRINOLOGY, V145, P2046, DOI 10.1210/en.2003-1097; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; Nanes M, 1995, OLIGONUCLEOTIDES ANT, P62; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; PATTEN JL, 1990, NEW ENGL J MED, V322, P1412, DOI 10.1056/NEJM199005173222002; Pearman AT, 1996, J BIOL CHEM, V271, P25715, DOI 10.1074/jbc.271.41.25715; Qin L, 2005, J CELL BIOCHEM, V96, P632, DOI 10.1002/jcb.20550; Ramaesh T, 2003, J ANAT, V203, P213, DOI 10.1046/j.1469-7580.2003.00210.x; Regard JB, 2011, P NATL ACAD SCI USA, V108, P20101, DOI 10.1073/pnas.1114656108; Ricks JE, 2002, TERATOLOGY, V65, P116, DOI 10.1002/tera.10022; ROSEN V, 1994, J BONE MINER RES, V9, P1759; Ruest LB, 2004, DEVELOPMENT, V131, P4413, DOI 10.1242/dev.01291; Ruest LB, 2009, DEV BIOL, V328, P94, DOI 10.1016/j.ydbio.2009.01.005; Sakamoto A, 2005, J BIOL CHEM, V280, P21369, DOI 10.1074/jbc.M500346200; Sakamoto A, 2005, J BONE MINER RES, V20, P663, DOI 10.1359/JBMR.041210; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; SEEGMILLER RE, 1977, J EMBRYOL EXP MORPH, V38, P227; SHENKER A, 1993, J PEDIATR-US, V123, P509, DOI 10.1016/S0022-3476(05)80943-6; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stewart K, 2013, DEVELOPMENT, V140, P3413, DOI 10.1242/dev.094532; Swarthout JT, 2002, J BONE MINER RES, V17, P1401, DOI 10.1359/jbmr.2002.17.8.1401; Tataria M, 2006, J PEDIATR SURG, V41, P624, DOI 10.1016/j.jpedsurg.2005.12.001; Taya Y, 1999, DEVELOPMENT, V126, P3869; Tintut Y, 1999, J BIOL CHEM, V274, P28875, DOI 10.1074/jbc.274.41.28875; Trainor PA, 2005, SEMIN CELL DEV BIOL, V16, P683, DOI 10.1016/j.semcdb.2005.06.007; TURKSEN K, 1990, J CELL PHYSIOL, V142, P61, DOI 10.1002/jcp.1041420109; Tyson DR, 1999, ENDOCRINOLOGY, V140, P1255, DOI 10.1210/en.140.3.1255; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Weinstein L, 1996, PRINCIPLES BONE BIOL, V2, P1165; Weinstein LS, 2006, TRENDS PHARMACOL SCI, V27, P260, DOI 10.1016/j.tips.2006.03.005; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wu JY, 2011, J CLIN INVEST, V121, P3492, DOI 10.1172/JCI46406; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; Yin TT, 2000, CIRCULATION, V102, P2636, DOI 10.1161/01.cir.102.21.2636; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715; Zhang RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020780; Zhang YP, 2012, DEV DYNAM, V241, P924, DOI 10.1002/dvdy.23776; Zhen XC, 2001, J BIOL CHEM, V276, P4879, DOI 10.1074/jbc.M004990200; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016	87	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0147535	10.1371/journal.pone.0147535	http://dx.doi.org/10.1371/journal.pone.0147535			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859889	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000370038400010
J	Pawlowski, CS; Andersen, HB; Troelsen, J; Schipperijn, J				Pawlowski, Charlotte Skau; Andersen, Henriette Bondo; Troelsen, Jens; Schipperijn, Jasper			Children's Physical Activity Behavior during School Recess: A Pilot Study Using GPS, Accelerometer, Participant Observation, and Go-Along Interview	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; ENVIRONMENTS; PLAY; INTERVENTIONS; DETERMINANT; ADOLESCENTS; PLAYGROUNDS; FACILITIES; BARRIERS; DESIGN	Schoolyards are recognized as important settings for physical activity interventions during recess. However, varying results have been reported. This pilot study was conducted to gain in-depth knowledge of children's physical activity behavior during recess using a mixed-methods approach combining quantitative GPS and accelerometer measurements with qualitative go-along group interviews and participant observations. Data were collected during three weekdays in a public school in Denmark. Eighty-one children (47 girls) wore an accelerometer (ActiGraph GT3X) and GPS (QStarz BT-Q1000xt), sixteen children participated in go-along group interviews, and recess behavior was observed using an ethnographical participant observation approach. All data were analyzed separated systematically answering the Five W Questions. Children were categorized into Low, Middle and High physical activity groups and these groups were predominantly staying in three different locations during recess: school building, schoolyard and field, respectively. Mostly girls were in the building remaining in there because of a perceived lack of attractive outdoor play facilities. The children in the schoolyard were predominantly girls who preferred the schoolyard over the field to avoid the competitive soccer games on the field whereas boys dominated the field playing soccer. Using a mixed-methods approach to investigate children's physical activity behavior during recess helped gain in-depth knowledge that can aid development of future interventions in the school environment.	[Pawlowski, Charlotte Skau; Andersen, Henriette Bondo; Troelsen, Jens; Schipperijn, Jasper] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Res Unit Act Living, Campusvej 55, DK-5230 Odense M, Denmark; [Pawlowski, Charlotte Skau; Andersen, Henriette Bondo; Troelsen, Jens; Schipperijn, Jasper] Univ Southern Denmark, Ctr Intervent Res Hlth Promot & Dis Prevent, Natl Inst Publ Hlth, Oster Farimagsgade 5a, DK-1353 Copenhagen K, Denmark	University of Southern Denmark; University of Southern Denmark	Pawlowski, CS (corresponding author), Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Res Unit Act Living, Campusvej 55, DK-5230 Odense M, Denmark.; Pawlowski, CS (corresponding author), Univ Southern Denmark, Ctr Intervent Res Hlth Promot & Dis Prevent, Natl Inst Publ Hlth, Oster Farimagsgade 5a, DK-1353 Copenhagen K, Denmark.	cspawlowski@health.sdu.dk		Schipperijn, Jasper/0000-0002-6558-7610; Troelsen, Jens/0000-0001-8105-0349	Danish Cancer Society	Danish Cancer Society(Danish Cancer Society)	This study was funded by The Danish Cancer Society.	Adams MA, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-49; Andersen HB, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1828-9; Andersen HB, 2015, LANDSCAPE URBAN PLAN, V134, P83, DOI 10.1016/j.landurbplan.2014.10.005; Andersen Lars Bo, 2004, Int J Behav Nutr Phys Act, V1, P6, DOI 10.1186/1479-5868-1-6; [Anonymous], 2011, PETER LISTENING YOUN; Anthamatten P, 2014, J PHYS ACT HEALTH, V11, P564, DOI 10.1123/jpah.2012-0064; Anthamatten P, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-27; Bailey DP, 2012, EUR J PEDIATR, V171, P1805, DOI 10.1007/s00431-012-1827-0; Blatchford P, 2003, BRIT J DEV PSYCHOL, V21, P481, DOI 10.1348/026151003322535183; BLATCHFORD P, 1996, J RES CHILDHOOD ED, V11, P14, DOI DOI 10.1080/02568549609594692; Boyle DE, 2003, AM BEHAV SCI, V46, P1326, DOI 10.1177/0002764203046010004; Brink LA, 2010, AM J PUBLIC HEALTH, V100, P1672, DOI 10.2105/AJPH.2009.178939; Carpiano RM, 2009, HEALTH PLACE, V15, P263, DOI 10.1016/j.healthplace.2008.05.003; Colabianchi N, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-32; Cook H., 2013, ED STUD BOD TAK PHYS; Darbyshire P, 2005, QUALITATIVE RES, V5, P417, DOI DOI 10.1177/1468794105056921; Dessing D, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-97; Dobbins M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651.pub2; Dyment JE, 2009, CHILD GEOGR, V7, P261, DOI 10.1080/14733280903024423; Emerson R, 2011, WRITING ETHNOGRAPHIC; Escalante Y, 2014, HEALTH EDUC BEHAV, V41, P138, DOI 10.1177/1090198113490725; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Fairclough SJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-406; Fjortoft I, 2010, SCAND J PUBLIC HEALT, V38, P28, DOI 10.1177/1403494810384909; Fjortoft I, 2009, LANDSCAPE URBAN PLAN, V93, P210, DOI 10.1016/j.landurbplan.2009.07.008; Flyvbjerg B, 2006, QUAL INQ, V12, P219, DOI 10.1177/1077800405284363; Hammersley Martin, 2007, ETHNOGRAPHY; Haug E, 2010, HEALTH EDUC RES, V25, P248, DOI 10.1093/her/cyn050; Hornby-Turner YC, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-74; Horner SD, 2000, RES NURS HLTH, V23; Huberty JL, 2011, J PHYS ACT HEALTH, V8, pS249, DOI 10.1123/jpah.8.s2.s249; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Johnson RB, 2007, J MIX METHOD RES, V1, P112, DOI 10.1177/1558689806298224; Knowles ZR, 2013, J PHYS ACT HEALTH, V10, P406, DOI 10.1123/jpah.10.3.406; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Krueger RA, 2002, FOCUS GROUPS PRACTIC; Kusenbach M, 2003, ETHNOGRAPHY, V4, P455, DOI DOI 10.1177/146613810343007; MacDougall C., 2004, EARLY CHILD DEV CARE, V174, P369, DOI [10.1080/0300443032000153426, DOI 10.1080/0300443032000153426]; de Rezende LFM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131342; McKenzie TL, 2010, J SCHOOL HEALTH, V80, P470, DOI 10.1111/j.1746-1561.2010.00530.x; Metcalf B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5888; Morgan A, 2012, HLTH BEHAV SCH AGED; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Nielsen G, 2012, J PHYS ACT HEALTH, V9, P104, DOI 10.1123/jpah.9.1.104; Nielsen G, 2010, J PHYS ACT HEALTH, V7, P490, DOI 10.1123/jpah.7.4.490; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Ozdemir A, 2008, J ENVIRON PSYCHOL, V28, P287, DOI 10.1016/j.jenvp.2008.02.004; Parrish AM, 2013, SPORTS MED, V43, P287, DOI 10.1007/s40279-013-0024-2; Parrish AM, 2012, HEALTH EDUC RES, V27, P269, DOI 10.1093/her/cyr049; Pawlowski CS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-639; Pawlowski CS, 2014, EUR PHYS ED REV; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Ridgers ND, 2006, SPORTS MED, V36, P359, DOI 10.2165/00007256-200636040-00005; Ridgers ND, 2005, PREV MED, V41, P102, DOI 10.1016/j.ypmed.2004.10.023; Ridgers ND, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-74; Ridgers ND, 2012, AM J PREV MED, V43, P320, DOI 10.1016/j.amepre.2012.05.019; Ridgers ND, 2011, HEALTH EDUC RES, V26, P586, DOI 10.1093/her/cyr014; Rowlands AV, 2007, PEDIATR EXERC SCI, V19, P252, DOI 10.1123/pes.19.3.252; Sallis JF, 2001, AM J PUBLIC HEALTH, V91, P618, DOI 10.2105/AJPH.91.4.618; Santelli John S, 2003, J Adolesc Health, V33, P396; Schipperijn J, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00021; Spradley J. P., 2016, PARTICIPANT OBSERVAT; Stanley RM, 2012, J SCI MED SPORT, V15, P44, DOI 10.1016/j.jsams.2011.08.002; Swain J, 2006, SPORT EDUC SOC, V11, P317, DOI 10.1080/13573320600924841; Taylor RW, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-38; Thorne B., 1993, GENDER PLAY GIRLS BO; Toftager M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099369; Troelsen J, 2013, NEIGHBOURHOOD STRUCT, P249; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; Willenberg LJ, 2010, J SCI MED SPORT, V13, P210, DOI 10.1016/j.jsams.2009.02.011; Wolcott HF., 1994, TRANSFORMING QUALITA; Wood C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108701; Yin RK., 2013, CASE STUDY RES DESIG, V5th ed; Yirmiya N, 2010, J CHILD PSYCHOL PSYC, V51, P1297, DOI 10.1111/j.1469-7610.2010.02344.x; Zask A, 2001, PREV MED, V33, P402, DOI 10.1006/pmed.2001.0905	77	43	43	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148786	10.1371/journal.pone.0148786	http://dx.doi.org/10.1371/journal.pone.0148786			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859288	Green Published, gold			2022-12-27	WOS:000370038400084
J	Quarto, T; Blasi, G; Maddalena, C; Viscanti, G; Lanciano, T; Soleti, E; Mangiulli, I; Taurisano, P; Fazio, L; Bertolino, A; Curci, A				Quarto, Tiziana; Blasi, Giuseppe; Maddalena, Chiara; Viscanti, Giovanna; Lanciano, Tiziana; Soleti, Emanuela; Mangiulli, Ivan; Taurisano, Paolo; Fazio, Leonardo; Bertolino, Alessandro; Curci, Antonietta			Association between Ability Emotional Intelligence and Left Insula during Social Judgment of Facial Emotions	PLOS ONE			English	Article							SOMATIC MARKER HYPOTHESIS; NEURAL CIRCUITRY; BRAIN ACTIVITY; TRAIT; RESPONSES; CONNECTIVITY; EXPRESSIONS; AGGRESSION; PREDICTS; VALIDITY	The human ability of identifying, processing and regulating emotions from social stimuli is generally referred as Emotional Intelligence (EI). Within EI, Ability EI identifies a performance measure assessing individual skills at perceiving, using, understanding and managing emotions. Previous models suggest that a brain "somatic marker circuitry" (SMC) sustains emotional sub-processes included in EI. Three primary brain regions are included: the amygdala, the insula and the ventromedial prefrontal cortex (vmPFC). Here, our aim was to investigate the relationship between Ability EI scores and SMC activity during social judgment of emotional faces. Sixty-three healthy subjects completed a test measuring Ability EI and underwent fMRI during a social decision task (i.e. approach or avoid) about emotional faces with different facial expressions. Imaging data revealed that EI scores are associated with left insula activity during social judgment of emotional faces as a function of facial expression. Specifically, higher EI scores are associated with greater left insula activity during social judgment of fearful faces but also with lower activity of this region during social judgment of angry faces. These findings indicate that the association between Ability EI and the SMC activity during social behavior is region- and emotionspecific.	[Quarto, Tiziana; Blasi, Giuseppe; Viscanti, Giovanna; Taurisano, Paolo; Fazio, Leonardo; Bertolino, Alessandro] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Psychiat Neurosci Grp, Bari, Italy; [Quarto, Tiziana] Univ Helsinki, Cognit Brain Res Unit, Inst Behav Sci, Helsinki, Finland; [Maddalena, Chiara; Lanciano, Tiziana; Soleti, Emanuela; Mangiulli, Ivan; Curci, Antonietta] Univ Bari Aldo Moro, Dept Educ Sci Psychol & Commun Sci, Bari, Italy; [Bertolino, Alessandro] F Hoffmann La Roche & Co Ltd, pRED, NORD DTA, CH-4002 Basel, Switzerland	Universita degli Studi di Bari Aldo Moro; University of Helsinki; Universita degli Studi di Bari Aldo Moro; Roche Holding	Curci, A (corresponding author), Univ Bari Aldo Moro, Dept Educ Sci Psychol & Commun Sci, Bari, Italy.	antonietta.curci@uniba.it	Taurisano, Paolo/U-1828-2017; Blasi, Giuseppe/HHS-5404-2022; Mangiulli, Ivan/GQA-5584-2022; Bertolino, Alessandro/O-6352-2016; Taurisano, Paolo/AID-5342-2022	Taurisano, Paolo/0000-0001-6140-9326; Bertolino, Alessandro/0000-0002-1251-1380; Taurisano, Paolo/0000-0001-6140-9326; Mangiulli, Ivan/0000-0002-5409-7325; Blasi, Giuseppe/0000-0003-0878-1131; Fazio, Leonardo/0000-0003-4000-974X; Lanciano, Tiziana/0000-0001-6533-1052; Curci, Antonietta/0000-0002-0932-7152	European Community's Seventh Framework Programme [602450]	European Community's Seventh Framework Programme(European Commission)	The author Tiziana Quarto has been financially supported by the European Community's Seventh Framework Programme (project number 602450; URL: http://ec.europa.eu/research/health/medical-research/brain-research/projects/imagemend_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin EJ, 2005, PERS INDIV DIFFER, V39, P403, DOI 10.1016/j.paid.2005.01.017; Bar-On R, 2003, BRAIN, V126, P1790, DOI 10.1093/brain/awg177; Bar-On R., 1997, BAR ON EM QUOT INV E; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Bechara A, 1999, NERVENHEILKUNDE, V18, P54; Bertolino A, 2006, J NEUROSCI, V26, P3918, DOI 10.1523/JNEUROSCI.4975-05.2006; Blasi G, 2011, P NATL ACAD SCI USA, V108, P1158, DOI 10.1073/pnas.1013535108; Blasi G, 2009, J NEUROSCI, V29, P14812, DOI 10.1523/JNEUROSCI.3609-09.2009; Blasi G, 2009, BIOL PSYCHIAT, V66, P847, DOI 10.1016/j.biopsych.2009.06.017; Calder AJ, 2011, PHILOS T R SOC B, V366, P1684, DOI 10.1098/rstb.2010.0362; Castillo R, 2013, J ADOLESCENCE, V36, P883, DOI 10.1016/j.adolescence.2013.07.001; Castro-Schilo L, 2010, BRAIN COGNITION, V73, P62, DOI 10.1016/j.bandc.2010.03.003; Coccaro EF, 2007, BIOL PSYCHIAT, V62, P168, DOI 10.1016/j.biopsych.2006.08.024; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; D'Amico A, 2011, TRADUZIONE ADATTAMEN; Damasio A.R., 2005, DESCARTES ERROR EMOT; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Damasio AR, 1979, CLIN NEUROPSYCHOLOGY, P360; Davis SK, 2012, J ADOLESCENCE, V35, P1369, DOI 10.1016/j.adolescence.2012.05.007; Dawda D, 2000, PERS INDIV DIFFER, V28, P797, DOI 10.1016/S0191-8869(99)00139-7; Duerden EG, 2013, NEUROIMAGE, V78, P159, DOI 10.1016/j.neuroimage.2013.04.014; Elfenbein HA, 2002, WISDOM FEELING PSYCH; Ewbank MP, 2009, NEUROIMAGE, V44, P1144, DOI 10.1016/j.neuroimage.2008.09.056; Fridlund A.J., 1994, HUMAN FACIAL EXPRESS; Hermans EJ, 2008, BIOL PSYCHIAT, V63, P263, DOI 10.1016/j.biopsych.2007.05.013; Hertel J, 2009, J CLIN PSYCHOL, V65, P942, DOI 10.1002/jclp.20597; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Hollingshead AB, 2011, YALE J SOCIOLOGY, V8; Killgore WDS, 2007, COGN AFFECT BEHAV NE, V7, P140, DOI 10.3758/CABN.7.2.140; Killgore WDS, 2013, SOC NEUROSCI-UK, V8, P334, DOI 10.1080/17470919.2013.807300; Killgore WDS, 2012, NEUROREPORT, V23, P551, DOI 10.1097/WNR.0b013e32835446f7; Koven NS, 2011, SOC COGN AFFECT NEUR, V6, P582, DOI 10.1093/scan/nsq084; Kragel PA, 2013, EMOTION, V13, P681, DOI 10.1037/a0031820; Kreifelts B, 2010, HUM BRAIN MAPP, V31, P979, DOI 10.1002/hbm.20913; Lanciano T, 2014, HLTH COMMUN; Lanciano T, 2014, AM J PSYCHOL, V127, P447, DOI 10.5406/amerjpsyc.127.4.0447; Lanciano T, 2012, PERS INDIV DIFFER, V53, P753, DOI 10.1016/j.paid.2012.05.027; Lizeretti NP, 2011, PSYCHIAT QUART, V82, P253, DOI 10.1007/s11126-011-9167-1; Lo Bianco L, 2013, PSYCHOL MED, V43, P279, DOI 10.1017/S0033291712001134; Lopes PN, 2006, PSICOTHEMA, V18, P132; Lopes PN, 2005, EMOTION, V5, P113, DOI 10.1037/1528-3542.5.1.113; Lutz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001897; MacCann C, 2014, EMOTION, V14, P358, DOI 10.1037/a0034755; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Martins A, 2010, PERS INDIV DIFFER, V49, P554, DOI 10.1016/j.paid.2010.05.029; Mayer J., 2002, MAYER SALOVEY CARUSO; Mayer J. D., 1997, EMOTIONAL DEV EMOTIO, P3, DOI DOI 10.1177/1066480710387486; Mayer JD, 2008, ANNU REV PSYCHOL, V59, P507, DOI 10.1146/annurev.psych.59.103006.093646; O'Boyle EH, 2010, RELATION EMOTIONAL I; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Reis DL, 2007, NEUROIMAGE, V35, P1385, DOI 10.1016/j.neuroimage.2006.12.045; Rudebeck PH, 2008, COGN AFFECT BEHAV NE, V8, P485, DOI 10.3758/CABN.8.4.485; Ruiz-Aranda D, 2012, J ADOLESCENT HEALTH, V51, P462, DOI 10.1016/j.jadohealth.2012.02.003; Sambataro F, 2006, EUR J NEUROSCI, V24, P2355, DOI 10.1111/j.1460-9568.2006.05120.x; Silverstein RG, 2011, PSYCHOSOM MED, V73, P817, DOI 10.1097/PSY.0b013e318234e628; Takeuchi H, 2013, NEUROIMAGE, V83, P318, DOI 10.1016/j.neuroimage.2013.06.044; Tarasuik JC, 2009, SPRINGER SER HUM EXC, P307, DOI 10.1007/978-0-387-88370-0_16; Taurisano P, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00235; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006	60	27	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148621	10.1371/journal.pone.0148621	http://dx.doi.org/10.1371/journal.pone.0148621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859495	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400059
J	Romero, AC; Bergamaschi, CT; de Souza, DN; Nogueira, FN				Romero, Ana Carolina; Bergamaschi, Cassia Toledo; de Souza, Douglas Nesadal; Nogueira, Fernando Neves			Salivary Alterations in Rats with Experimental Chronic Kidney Disease	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; OXIDATIVE STRESS; WHOLE SALIVA; GLAND; SECRETION; EXCRETION; PROTEIN; HYPERTENSION; PEROXIDASE; MECHANISMS	Objective This study aimed to analyze changes in saliva composition and salivary secretion process of rats with chronic kidney disease induced by 5/6 nephrectomy to set the foundation for salivary studies related to CKD. Methods CKD was induced in Wistar rats via 5/6 nephrectomy. Blood and saliva samples were collected from Control, Sham and CKD groups at 8 and 12 weeks after the surgery. Salivation was stimulated via intraperitoneal injections of pilocarpine (1.0 mg/Kg body weight) or isoproterenol (5.0 mg/Kg body weight). Saliva was collected and immediately stored at -80 degrees C until analysis. The salivary flow rate, total protein, amylase and peroxidase activities, and urea concentrations were measured. The blood urea nitrogen (BUN) and serum creatinine concentrations were also evaluated. Results Increases in BUN and serum creatinine concentrations were observed in the CKD groups. Amylase activity was significantly reduced in response to both stimuli in the CKD groups at 8 weeks and increased in the CKD groups at 12 weeks in response to isoproterenol stimulus. The peroxidase activities of the CKD groups were significantly reduced in response to isoproterenol stimulation and were increased at 12 weeks in response to pilocarpine stimulation. Salivary urea was significantly increased in the CKD groups at 8 weeks in response to the isoproterenol stimuli and at 12 weeks in response to both salivary agonists. Conclusions The pattern of alterations observed in this experimental model is similar to those observed in patients and clearly demonstrates the viability of 5/6 nephrectomy as an experimental model in future studies to understand the alterations in salivary compositions and in salivary glands that are elicited by CKD.	[Romero, Ana Carolina; de Souza, Douglas Nesadal; Nogueira, Fernando Neves] Univ Sao Paulo, Dept Biomat & Biol Oral, Fac Odontol, Sao Paulo, Brazil; [Bergamaschi, Cassia Toledo] Escola Paulista Med UNIFESP, Dept Fisiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Nogueira, FN (corresponding author), Univ Sao Paulo, Dept Biomat & Biol Oral, Fac Odontol, Sao Paulo, Brazil.	fnn@usp.br	Bergamaschi, Cassia/AAZ-9441-2020; Nogueira, Fernando/I-7549-2015	Nogueira, Fernando/0000-0002-6595-9154; Bergamaschi, Cassia/0000-0002-5741-6993	FAPESP (the Research Council for the State of Sao Paulo) [2013/18609-1]	FAPESP (the Research Council for the State of Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (the Research Council for the State of Sao Paulo) (2013/18609-1).	ALHASHIMI I, 1989, ARCH ORAL BIOL, V34, P289, DOI 10.1016/0003-9969(89)90070-8; Amano O, 2012, ACTA HISTOCHEM CYTOC, V45, P241, DOI 10.1267/ahc.12013; ANDERSON LC, 1986, ARCH ORAL BIOL, V31, P501, DOI 10.1016/0003-9969(86)90027-0; Ashby MT, 2008, J DENT RES, V87, P900, DOI 10.1177/154405910808701003; Augustyniak RA, 2002, J HYPERTENS, V20, P3, DOI 10.1097/00004872-200201000-00002; BASSECHES PJ, 1982, ARCH INT PHARMACOD T, V257, P180; Bergamaschi CT, 1997, MED SCI SPORT EXER, V29, P169, DOI 10.1097/00005768-199702000-00001; Bossola M, 2012, NAT REV NEPHROL, V8, P176, DOI 10.1038/nrneph.2011.218; CAMPESE VM, 1981, KIDNEY INT, V20, P246, DOI 10.1038/ki.1981.127; Cardoso EML, 2009, SCAND J CLIN LAB INV, V69, P330, DOI 10.1080/00365510802588076; CHANDRA T, 1977, EUR J BIOCHEM, V72, P259, DOI 10.1111/j.1432-1033.1977.tb11248.x; Chanutin A, 1932, ARCH INTERN MED, V49, P767, DOI 10.1001/archinte.1932.00150120057006; Davidovich E, 2011, NEPHROL DIAL TRANSPL, V26, P1541, DOI 10.1093/ndt/gfq587; Davidovich E, 2009, NEPHROL DIAL TRANSPL, V24, P2439, DOI 10.1093/ndt/gfp101; DAWES C, 1970, J DENT RES, V49, P1263, DOI 10.1177/00220345700490061501; DAWES C, 1984, J PHYSIOL-LONDON, V346, P579, DOI 10.1113/jphysiol.1984.sp015042; DEMUNIZ BR, 1983, ARCH ORAL BIOL, V28, P575, DOI 10.1016/0003-9969(83)90004-3; Ding GH, 1998, J PHARMACOL EXP THER, V287, P31; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Ersson C, 2011, ORAL SURG ORAL MED O, V112, P209, DOI 10.1016/j.tripleo.2011.03.016; Eyre S, 2008, J RENAL NUTR, V18, P269, DOI 10.1053/j.jrn.2007.11.013; FISHER EH, 1961, BIOCHEM PREP, V8, P27; Fregoneze AP, 2013, SPEC CARE DENT, V33, P118, DOI 10.1111/scd.12008; HEINTZE U, 1983, SWED DENT J, V7, P227; Hostetter TH, 2001, J CLIN INVEST, V107, P161, DOI 10.1172/JCI12066; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Kao CH, 2000, AM J KIDNEY DIS, V36, P1110, DOI 10.1053/ajkd.2000.19810; Kho HS, 1999, ORAL SURG ORAL MED O, V88, P316, DOI 10.1016/S1079-2104(99)70035-1; Klassen Judith T, 2002, J Can Dent Assoc, V68, P34; KUMANO K, 1986, KIDNEY INT, V30, P433, DOI 10.1038/ki.1986.203; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martins C, 2006, SPEC CARE DENT, V26, P205, DOI 10.1111/j.1754-4505.2006.tb01439.x; Martins C, 2012, PEDIATR NEPHROL, V27, P1961, DOI 10.1007/s00467-012-2194-9; Naugle K, 1998, Ann Periodontol, V3, P197, DOI 10.1902/annals.1998.3.1.197; OBRY F, 1987, J DENT CHILD, V54, P429; Pedersen AM, 2002, ORAL DIS, V8, P117, DOI 10.1034/j.1601-0825.2002.02851.x; Peng CH, 2013, CLIN BIOCHEM, V46, P275, DOI 10.1016/j.clinbiochem.2012.10.029; Postorino M, 2003, AM J KIDNEY DIS, V42, P722, DOI 10.1016/S0272-6386(03)00908-9; Ribeiro DA, 2009, EUR J CLIN INVEST, V39, P289, DOI 10.1111/j.1365-2362.2009.02100.x; Romero AC, 2012, ARCH ORAL BIOL, V57, P1189, DOI 10.1016/j.archoralbio.2012.02.016; Savica V, 2008, CLIN NEPHROL, V69, P229; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161, DOI 10.1177/10454411950060020501; SHANNON IL, 1966, ARCH ORAL BIOL, V11, P451, DOI 10.1016/0003-9969(66)90109-9; Sviglerova J, 2010, PHYSIOL RES, V59, pS81, DOI 10.33549/physiolres.932003; Tomas I, 2008, ARCH ORAL BIOL, V53, P528, DOI 10.1016/j.archoralbio.2008.01.006; TSIANOS EV, 1994, INT J PANCREATOL, V15, P105; Turner RJ, 2002, ORAL DIS, V8, P3, DOI 10.1034/j.1601-0825.2002.10815.x; Vaziri ND, 2004, CURR HYPERTENS REP, V6, P314, DOI 10.1007/s11906-004-0027-3; Vaziri ND, 2004, SEMIN NEPHROL, V24, P469, DOI 10.1016/j.semnephrol.2004.06.026; Vesterinen M, 2007, QUINTESSENCE INT, V38, P211; Weiner DE, 2007, J MANAGE CARE PHARM, V13, pS1; Yu XF, 2012, RENAL FAILURE, V34, P907, DOI 10.3109/0886022X.2012.691012	53	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148742	10.1371/journal.pone.0148742	http://dx.doi.org/10.1371/journal.pone.0148742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859883	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400073
J	Sarian, FD; Rahman, DY; Schepers, O; van der Maarel, MJEC				Sarian, Fean Davisunjaya; Rahman, Delicia Yunita; Schepers, Otto; van der Maarel, Marc Jos Elise Cornelis			Effects of Oxygen Limitation on the Biosynthesis of Photo Pigments in the Red Microalgae Galdieria sulphuraria Strain 074G	PLOS ONE			English	Article							COPROPORPHYRINOGEN-III OXIDASE; TETRAPYRROLE BIOSYNTHESIS; HEME; GLUCOSE	As a consequence of the inhibition of one of the steps in the biosynthesis of the photopigments chlorophyll and phycobilin, the red microalga Galdieria partita excretes coproporphyrinogen III in the medium when growing on glucose. No coproporphyrinogen III was found when the closely related red microalgae G. sulphuraria strain 074G was grown on glucose and excessive amounts of oxygen. When under the same conditions oxygen was limiting, coproporphyrinogen III was present in the medium. We conclude that not glucose but the amount of oxygen in the medium results in the accumulation of coproporphyrinogen III. This is explained by the inactivition of the oxygen-dependent coproporphyrinogen III oxidase that converts coproporhyrinogen III to protoporphyrinogen IX, one of the intermediate steps in the biosynthesis of chlorophyl and phycobilin.	[Sarian, Fean Davisunjaya] Inst Teknol Bandung, Fac Math & Nat Sci, Div Biochem Res, Bandung, Indonesia; [Sarian, Fean Davisunjaya; Rahman, Delicia Yunita; Schepers, Otto; van der Maarel, Marc Jos Elise Cornelis] Univ Groningen, Engn & Technol Inst ENTEG, Aquat Biotechnol & Bioprod Engn, Groningen, Netherlands	Institute Technology of Bandung; University of Groningen	van der Maarel, MJEC (corresponding author), Univ Groningen, Engn & Technol Inst ENTEG, Aquat Biotechnol & Bioprod Engn, Groningen, Netherlands.	m.j.e.c.van.der.maarel@rug.nl		rahman, delicia/0000-0002-8170-3247; Sarian, Fean Davisunjaya/0000-0001-7540-8746				ALLEN MB, 1959, ARCH MIKROBIOL, V32, P270, DOI 10.1007/BF00409348; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; BATLLE AMD, 1965, BIOCHEM J, V97, P731, DOI 10.1042/bj0970731; Battersby AR, 2000, NAT PROD REP, V17, P507, DOI 10.1039/b002635m; Breckau D, 2003, J BIOL CHEM, V278, P46625, DOI 10.1074/jbc.M308553200; Brzezowski P, 2015, BBA-BIOENERGETICS, V1847, P968, DOI 10.1016/j.bbabio.2015.05.007; Cozzolino S, 2000, HYDROBIOLOGIA, V433, P145, DOI 10.1023/A:1004035224715; FALK JE, 1953, NATURE, V172, P292, DOI 10.1038/172292a0; FALK JE, 1964, BIOCHEM J, V90, P66, DOI 10.1042/bj0900066; Falk JE, 1975, PORPHYRINS METALLOPO; Goto T, 2010, PLANT CELL PHYSIOL, V51, P650, DOI 10.1093/pcp/pcq023; GROSS W, 1995, PLANT CELL PHYSIOL, V36, P633; HENDRY GAF, 1980, J MED GENET, V17, P1, DOI 10.1136/jmg.17.1.1; Ishikawa A, 2001, PLANT J, V27, P89, DOI 10.1046/j.1365-313x.2001.01058.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Komatsu Y, 2015, INT J ASTROBIOL, V14, P505, DOI 10.1017/S147355041400072X; KRUSE E, 1995, PLANTA, V196, P796, DOI 10.1007/BF01106776; Layer G, 2010, PROTEIN SCI, V19, P1137, DOI 10.1002/pro.405; McDonald AG, 2008, NUCLEIC ACIDS RES, V37, P593; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Panek H, 2002, MICROBIOL-SGM, V148, P2273, DOI 10.1099/00221287-148-8-2273; Papenbrock J, 2001, PLANTA, V213, P667, DOI 10.1007/s004250100593; POULSON R, 1974, J BIOL CHEM, V249, P6367; REINBOTHE S, 1991, PLANT PHYSIOL BIOCH, V29, P297; Sloth JK, 2006, ENZYME MICROB TECH, V38, P168, DOI 10.1016/j.enzmictec.2005.05.010; Stadnichuk I, 1998, PLANT SCI, V136, P11, DOI 10.1016/S0168-9452(98)00088-0; STEINMULLER K, 1984, PLANT PHYSIOL, V76, P935, DOI 10.1104/pp.76.4.935; XU KP, 1993, J BACTERIOL, V175, P4990, DOI 10.1128/JB.175.16.4990-4999.1993	28	7	7	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148358	10.1371/journal.pone.0148358	http://dx.doi.org/10.1371/journal.pone.0148358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859750	Green Published, gold, Green Submitted			2022-12-27	WOS:000370038400035
J	van Leeuwen, N; Lingsma, HF; Vanrolleghem, AM; Sturkenboom, MCJM; van Doorn, PA; Steyerberg, EW; Jacobs, BC				van Leeuwen, Nikki; Lingsma, Hester F.; Vanrolleghem, Ann M.; Sturkenboom, Miriam C. J. M.; van Doorn, Pieter A.; Steyerberg, Ewout W.; Jacobs, Bart C.			Hospital Admissions, Transfers and Costs of Guillain-Barre Syndrome	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS	Background Guillain-Barre syndrome (GBS) has a highly variable clinical course, leading to frequent transfers within and between hospitals and high associated costs. We defined the current admissions, transfers and costs in relation to disease severity of GBS. Methods Dutch neurologists were requested to report patients diagnosed with GBS between November 2009 and November 2010. Information regarding clinical course and transfers was obtained via neurologists and general practitioners. Results 87 GBS patients were included with maximal GBS disability score of 1 or 2 (28%), 3 or 4 (53%), 5 (18%) and 6 (1%). Four mildly affected GBS patients were not hospital admitted. Of the 83 hospitalized patients 68 (82%) were initially admitted at a neurology department, 4 (5%) at an ICU, 4 (5%) at pediatrics, 4 (5%) at pediatrics neurology and 3 (4%) at internal medicine. Median hospital stay was 17 days (IQR 11-26 days, absolute range 1-133 days). Transfers between departments or hospitals occurred in 33 (40%) patients and 25 (30%) were transferred 2 times or more. From a cost-effectiveness perspective 21 (25%) of the admissions was suboptimal. Median costs for hospital admission of GBS patients were 15,060 Euro (IQR 11,226-23,683). Maximal GBS disability score was significantly correlated with total length of stay, number of transfers, ICU admission and costs. Conclusions Hospital admissions for GBS patients are highly heterogeneous, with frequent transfers and higher costs for those with more severe disease. Future research should aim to develop prediction models to early identify the most cost-effective allocation in individual patients.	[van Leeuwen, Nikki; Lingsma, Hester F.; Steyerberg, Ewout W.] Erasmus MC, Ctr Med Decis Making, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Vanrolleghem, Ann M.; Sturkenboom, Miriam C. J. M.] Erasmus MC, Dept Med Informat, POB 2040, NL-3000 CA Rotterdam, Netherlands; [van Doorn, Pieter A.; Jacobs, Bart C.] Erasmus MC, Dept Neurol, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Jacobs, Bart C.] Erasmus MC, Dept Immunol, POB 2040, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van Leeuwen, N (corresponding author), Erasmus MC, Ctr Med Decis Making, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	n.vanleeuwen.1@erasmusmc.nl	Jacobs, Bart/ABE-2210-2021	Sturkenboom, Miriam/0000-0003-1360-2388				[Anonymous], HANDLEIDING KOSTENON; Barratt H, 2012, CRIT CARE, V16, DOI 10.1186/cc11662; de Wit Marie-Claire Y, 2011, Ned Tijdschr Geneeskd, V155, pA3808; Dieleman J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3908; Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285; Frenzen PD, 2008, NEUROLOGY, V71, P21, DOI 10.1212/01.wnl.0000316393.54258.d1; Havelaar AH, 2000, EPIDEMIOL INFECT, V125, P505, DOI 10.1017/S0950268800004933; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 1997, J INFECT DIS, V176, pS92, DOI 10.1086/513793; Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004; Ligtenberg JJM, 2005, CRIT CARE, V9, pR446, DOI 10.1186/cc3749; Mehndiratta M M, 2001, J Assoc Physicians India, V49, P459; Nagpal S, 1999, J CLIN APHERESIS, V14, P107, DOI 10.1002/(SICI)1098-1101(1999)14:3<107::AID-JCA1>3.0.CO;2-3; Roodbol J, 2011, NEUROLOGY, V76, P807, DOI 10.1212/WNL.0b013e31820e7b62; Ruts L, 2005, NEUROLOGY, V65, P138, DOI 10.1212/01.wnl.0000167549.09664.b8; Ruts L, 2010, NEUROLOGY, V75, P1439, DOI 10.1212/WNL.0b013e3181f88345; Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003; Van Koningsveld R, 2001, NEUROLOGY, V56, P564, DOI 10.1212/WNL.56.4.564; VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705; Walgaard C, 2011, NEUROLOGY, V76, P968, DOI 10.1212/WNL.0b013e3182104407; Walgaard C, 2010, ANN NEUROL, V67, P781, DOI 10.1002/ana.21976; Winters JL, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-101	22	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0143837	10.1371/journal.pone.0143837	http://dx.doi.org/10.1371/journal.pone.0143837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859880	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400001
J	Choudhry, P				Choudhry, Priya			High-Throughput Method for Automated Colony and Cell Counting by Digital Image Analysis Based on Edge Detection	PLOS ONE			English	Article							IN-VITRO; HEART MORPHOLOGY; EPITHELIAL-CELLS; LEAF MORPHOLOGY; STEM-CELLS; CULTURE; TOXICITY; LEUKEMIA; MODELS; GENE	Counting cells and colonies is an integral part of high-throughput screens and quantitative cellular assays. Due to its subjective and time-intensive nature, manual counting has hindered the adoption of cellular assays such as tumor spheroid formation in high-throughput screens. The objective of this study was to develop an automated method for quick and reliable counting of cells and colonies from digital images. For this purpose, I developed an ImageJ macro Cell Colony Edge and a CellProfiler Pipeline Cell Colony Counting, and compared them to other open-source digital methods and manual counts. The ImageJ macro Cell Colony Edge is valuable in counting cells and colonies, and measuring their area, volume, morphology, and intensity. In this study, I demonstrate that Cell Colony Edge is superior to other open-source methods, in speed, accuracy and applicability to diverse cellular assays. It can fulfill the need to automate colony/cell counting in high-throughput screens, colony forming assays, and cellular assays.	[Choudhry, Priya] CALTECH, Dept Chem, Pasadena, CA 91125 USA	California Institute of Technology	Choudhry, P (corresponding author), CALTECH, Dept Chem, Pasadena, CA 91125 USA.	docpriya21@gmail.com	Choudhry, Priya/F-7576-2014	Choudhry, Priya/0000-0002-4438-1576				Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; ALVESGOMES JA, 1995, MOL BIOL EVOL, V12, P298; Anderson Melisa, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P205, DOI 10.1016/S2221-1691(11)60028-2; Azari H, 2011, JOVE-J VIS EXP, DOI 10.3791/2639; Bewes JM, 2008, PHYS MED BIOL, V53, P5991, DOI 10.1088/0031-9155/53/21/007; Brugger SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033695; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Arroyo ECJ, 2013, NAT REV MICROBIOL, V11, P648, DOI 10.1038/nrmicro3090; Cai ZL, 2011, INT J RADIAT BIOL, V87, P1135, DOI 10.3109/09553002.2011.622033; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chang EH, 2015, SCI REP-UK, V5, DOI 10.1038/srep07695; Cheng CM, 2011, MOL CELL BIOL, V31, P983, DOI 10.1128/MCB.00137-10; Choudhry P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058145; Choudhry P, 2011, DEV BIOL, V349, P483, DOI 10.1016/j.ydbio.2010.11.006; Clarke ML, 2010, CYTOM PART A, V77A, P790, DOI 10.1002/cyto.a.20864; Eskiocak U, 2010, RADIAT RES, V174, P27, DOI 10.1667/RR2155.1; Fidanza V, 1996, CANCER RES, V56, P1179; Galli Rossella, 2013, Methods Mol Biol, V986, P267, DOI 10.1007/978-1-62703-311-4_17; Geissmann Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054072; GRAY TE, 1983, IN VITRO CELL DEV B, V19, P559; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Hamer PCDW, 2008, ONCOGENE, V27, P2091, DOI 10.1038/sj.onc.1210850; Hebert EM, 2010, INT J RADIAT BIOL, V86, P692, DOI 10.3109/09553001003746067; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Ho WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044640; Horie M, 2010, J BIOCHEM, V148, P289, DOI 10.1093/jb/mvq068; Ivanov DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103817; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Kim S, 2014, BIOTECHNOL LETT, V36, P481, DOI 10.1007/s10529-013-1393-1; KOTOURA Y, 1985, ARCH ORTHOP TRAUM SU, V104, P15, DOI 10.1007/BF00449950; Krastev DB, 2011, NAT CELL BIOL, V13, P809, DOI 10.1038/ncb2264; LI Y, 1994, BRIT J HAEMATOL, V87, P471, DOI 10.1111/j.1365-2141.1994.tb08300.x; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Lopez V, 2008, BIOL TRACE ELEM RES, V122, P238, DOI 10.1007/s12011-007-8079-2; Martinon-Torres M, 2006, J HUM EVOL, V50, P523, DOI 10.1016/j.jhevol.2005.12.004; Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045; Neame PB, 1997, AM J HEMATOL, V56, P131, DOI 10.1002/(SICI)1096-8652(199711)56:3<131::AID-AJH1>3.0.CO;2-Z; Niyazi M, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-4; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Park SK, 2010, BREAST CANCER RES TR, V124, P361, DOI 10.1007/s10549-010-0786-2; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Rac M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08882; Ridges S, 2012, BLOOD, V119, P5621, DOI 10.1182/blood-2011-12-398818; RUDIN M, 1991, BASIC RES CARDIOL, V86, P165, DOI 10.1007/BF02190549; Ruusuvuori P, 2014, BIOTECHNIQUES, V56, P18, DOI 10.2144/000114123; Sieuwerts S, 2008, LETT APPL MICROBIOL, V47, P275, DOI 10.1111/j.1472-765X.2008.02417.x; So JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107616; Treloar KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067389; Vieira FCS, 2005, MICROBIOL RES, V160, P197, DOI 10.1016/j.micres.2005.01.004; Vokes Martha S, 2008, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1417s82; Wang Yue J, 2013, Methods Mol Biol, V980, P281, DOI 10.1007/978-1-62703-287-2_15; Williams TF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01317; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zhang F, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0368-4; Zhang G, 2012, MOL MED REP, V6, P519, DOI 10.3892/mmr.2012.939	57	70	73	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148469	10.1371/journal.pone.0148469	http://dx.doi.org/10.1371/journal.pone.0148469			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848849	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000369554000100
J	Farino, ZJ; Morgenstern, TJ; Vallaghe, J; Gregor, N; Donthamsetti, P; Harris, PE; Pierre, N; Freyberg, R; Charrier-Savournin, F; Javitch, JA; Freyberg, Z				Farino, Zachary J.; Morgenstern, Travis J.; Vallaghe, Julie; Gregor, Nathalie; Donthamsetti, Prashant; Harris, Paul E.; Pierre, Nicolas; Freyberg, Robin; Charrier-Savournin, Fabienne; Javitch, Jonathan A.; Freyberg, Zachary			Development of a Rapid Insulin Assay by Homogenous Time-Resolved Fluorescence	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; DOPAMINE-RECEPTORS; GLUCOSE-TOLERANCE; OBESE SUBJECTS; ISLET SIZE; BROMOCRIPTINE; SECRETION; RATS; IMMUNOASSAY; ACTIVATION	Direct measurement of insulin is critical for basic and clinical studies of insulin secretion. However, current methods are expensive and time-consuming. We developed an insulin assay based on homogenous time-resolved fluorescence that is significantly more rapid and cost-effective than current commonly used approaches. This assay was applied effectively to an insulin secreting cell line, INS-1E cells, as well as pancreatic islets, allowing us to validate the assay by elucidating mechanisms by which dopamine regulates insulin release. We found that dopamine functioned as a significant negative modulator of glucose-stimulated insulin secretion. Further, we showed that bromocriptine, a known dopamine D2/D3 receptor agonist and newly approved drug used for treatment of type II diabetes mellitus, also decreased glucose-stimulated insulin secretion in islets to levels comparable to those caused by dopamine treatment.	[Farino, Zachary J.; Morgenstern, Travis J.; Donthamsetti, Prashant; Javitch, Jonathan A.; Freyberg, Zachary] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Farino, Zachary J.; Morgenstern, Travis J.; Donthamsetti, Prashant; Javitch, Jonathan A.; Freyberg, Zachary] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Vallaghe, Julie; Gregor, Nathalie; Pierre, Nicolas; Charrier-Savournin, Fabienne] Cisbio Bioassays, Res Dept, Codolet, France; [Donthamsetti, Prashant; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY USA; [Harris, Paul E.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Endocrinol, New York, NY USA; [Freyberg, Robin] Yeshiva Univ, Stern Coll Women, Dept Psychol, New York, NY 10033 USA	Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University; Yeshiva University	Freyberg, Z (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA.; Freyberg, Z (corresponding author), New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA.	zf2101@cumc.columbia.edu	Freyberg, Zachary/L-4927-2018	Freyberg, Zachary/0000-0001-6460-0118; HARRIS, PAUL/0000-0003-4806-8242; Javitch, Jonathan/0000-0001-7395-2967	Louis V. Gerstner Jr., Scholars Program (Columbia University); Cisbio Bioassays; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077493, R01DK104740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K08DA031241, K05DA022413] Funding Source: NIH RePORTER	Louis V. Gerstner Jr., Scholars Program (Columbia University); Cisbio Bioassays; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Louis V. Gerstner Jr., Scholars Program (Columbia University) - Z.F. Cisbio Bioassays - J.V., N.G., N.P., F.C.S. The funder Cisbio Bioassays provided support in the form of salaries for authors J.V., N.G., N.P., F.C.S.; Columbia University provided salary support for Z.F. Neither funder had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ARMBRUSTER DA, 1994, CLIN CHEM, V40, P1233; Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Ayoub MA, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00094; Burns SM, 2015, CELL METAB, V21, P126, DOI 10.1016/j.cmet.2014.12.010; Burns SM V A, 2012, HIGH THROUGHPUT SCRE; Carter JD, 2009, BIOL PROCED ONLINE, V11, P3, DOI 10.1007/s12575-009-9021-0; Chen Y, 2014, CELL TISSUE RES, V357, P597, DOI 10.1007/s00441-014-1894-9; Cheung AT, 2000, SCIENCE, V290, P1959, DOI 10.1126/science.290.5498.1959; CINCOTTA AH, 1993, AM J PHYSIOL, V264, pE285, DOI 10.1152/ajpendo.1993.264.2.E285; Cincotta AH, 1997, LIFE SCI, V61, P951, DOI 10.1016/S0024-3205(97)00599-7; Cincotta AH, 1996, DIABETES CARE, V19, P667, DOI 10.2337/diacare.19.6.667; CINCOTTA AH, 1991, METABOLISM, V40, P639, DOI 10.1016/0026-0495(91)90057-4; Claret EJ, 2004, HIGH THROUGHPUT HTRF; COLELLA RM, 1985, LIFE SCI, V37, P1059, DOI 10.1016/0024-3205(85)90597-1; Daijo JE, 1999, J PHARMACEUT BIOMED, V19, P335, DOI 10.1016/S0731-7085(98)00126-5; Degorce Francois, 2009, Curr Chem Genomics, V3, P22, DOI 10.2174/1875397300903010022; Doucet J, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/290670; Drummond GB, 2010, EXP PHYSIOL, V95, P841, DOI 10.1113/expphysiol.2010.053785; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Duvillie B, 1997, P NATL ACAD SCI USA, V94, P5137, DOI 10.1073/pnas.94.10.5137; Eglen Richard M, 2008, Curr Chem Genomics, V1, P2, DOI 10.2174/1875397300801010002; Ezrokhi M, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-104; Garcia-Tornadu I, 2010, ENDOCRINOLOGY, V151, P1441, DOI 10.1210/en.2009-0996; Granata R, 2007, ENDOCRINOLOGY, V148, P512, DOI 10.1210/en.2006-0266; Granata R, 2014, DIABETES, V63, P2380, DOI 10.2337/db13-1522; Hiram-Bab S, 2012, PANCREAS, V41, P238, DOI 10.1097/MPA.0b013e3182277e56; Holt RIG, 2010, DIABETES OBES METAB, V12, P1048, DOI 10.1111/j.1463-1326.2010.01304.x; HOPCROFT DW, 1985, HORM METAB RES, V17, P559, DOI 10.1055/s-2007-1013606; Imai S, 2014, ANAL BIOCH; JAHR H, 1978, ACTA BIOL MED GER, V37, P659; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kalra S, 2011, RECENT PATENTS ENDOC, V5, P61, DOI 10.2174/187221411794351842; Kawasaki E, 2000, FRONT BIOSCI, V5, pE181, DOI 10.2741/kawasaki; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kok P, 2006, AM J PHYSIOL-ENDOC M, V291, pE1038, DOI 10.1152/ajpendo.00567.2005; KRATZSCH J, 1990, EXP CLIN ENDOCRINOL, V95, P229, DOI 10.1055/s-0029-1210957; LANCRANJAN I, 1981, J NEURAL TRANSM, V51, P61, DOI 10.1007/BF01664005; LEAHY JL, 1993, DIABETES, V42, P22, DOI 10.2337/diabetes.42.1.22; Mahajan R, 2009, INDIAN J PHARMACOL, V41, P197, DOI 10.4103/0253-7613.56070; Mathis G, 1999, J BIOMOL SCREEN, V4, P309, DOI 10.1177/108705719900400605; MEIER AH, 1992, EXPERIENTIA, V48, P248, DOI 10.1007/BF01930467; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Mikhail N, 2011, CURR DRUG DELIV, V8, P511, DOI 10.2174/156720111796642255; Pijl H, 2000, DIABETES CARE, V23, P1154, DOI 10.2337/diacare.23.8.1154; REAVEN EP, 1981, HORM METAB RES, V13, P673, DOI 10.1055/s-2007-1019372; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Rubi B, 2005, J BIOL CHEM, V280, P36824, DOI 10.1074/jbc.M505560200; SEEMAN P, 1993, CURR OPIN NEUROL NEU, V6, P602; Simpson N, 2012, MOL ENDOCRINOL, V26, P1757, DOI 10.1210/me.2012-1101; Ustione A, 2012, MOL ENDOCRINOL, V26, P1928, DOI 10.1210/me.2012-1226; Valiquette G, 2011, CARDIOL REV, V19, P272, DOI 10.1097/CRD.0b013e318229d2d2; van Weenen JED, 2010, BIOCHEM PHARMACOL, V79, P1827, DOI 10.1016/j.bcp.2010.01.029; Vuojola J, 2014, METHODS APPL FLUORES, V2, DOI 10.1088/2050-6120/2/1/012001; YALOW RS, 1960, J CLIN INVEST, V39, P1157, DOI 10.1172/JCI104130; Yan D, 2015, LIFE SCI; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Y, 2015, PANCREAS, V44, P925, DOI 10.1097/MPA.0000000000000357; Zhang ZY, 2010, FASEB J, V24, P1497, DOI 10.1096/fj.09-136572	58	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148684	10.1371/journal.pone.0148684	http://dx.doi.org/10.1371/journal.pone.0148684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849707	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000157
J	Gardini, S; Cheli, S; Baroni, S; Di Lascio, G; Mangiavacchi, G; Micheletti, N; Monaco, CL; Savini, L; Alocci, D; Mangani, S; Niccolai, N				Gardini, Simone; Cheli, Sara; Baroni, Silvia; Di Lascio, Gabriele; Mangiavacchi, Guido; Micheletti, Nicholas; Monaco, Carmen Luigia; Savini, Lorenzo; Alocci, Davide; Mangani, Stefano; Niccolai, Neri			On Nature's Strategy for Assigning Genetic Code Multiplicity	PLOS ONE			English	Article							ATOM DEPTH; EVOLUTION; ORIGIN; USAGE; PATHWAYS; PROTEINS; MUTATION; ERROR; MODEL; DNA	Genetic code redundancy would yield, on the average, the assignment of three codons for each of the natural amino acids. The fact that this number is observed only for incorporating Ile and to stop RNA translation still waits for an overall explanation. Through a Structural Bioinformatics approach, the wealth of information stored in the Protein Data Bank has been used here to look for unambiguous clues to decipher the rationale of standard genetic code (SGC) in assigning from one to six different codons for amino acid translation. Leu and Arg, both protected from translational errors by six codons, offer the clearest clue by appearing as the most abundant amino acids in protein-protein and protein-nucleic acid interfaces. Other SGC hidden messages have been sought by analyzing, in a protein structure framework, the roles of over-and under-protected amino acids.	[Gardini, Simone; Cheli, Sara; Baroni, Silvia; Di Lascio, Gabriele; Mangiavacchi, Guido; Micheletti, Nicholas; Monaco, Carmen Luigia; Savini, Lorenzo; Alocci, Davide; Mangani, Stefano; Niccolai, Neri] Univ Siena, Dept Biotechnol Chem & Pharm, Via Laterina 8, I-53100 Siena, Italy	University of Siena	Niccolai, N (corresponding author), Univ Siena, Dept Biotechnol Chem & Pharm, Via Laterina 8, I-53100 Siena, Italy.	neri.niccolai@unisi.it						Alocci D, 2013, BIOCHEM BIOPH RES CO, V436, P725, DOI 10.1016/j.bbrc.2013.06.024; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Buhrman H, 2013, J MOL EVOL, V77, P170, DOI 10.1007/s00239-013-9571-2; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Di Giulio M, 2005, BIOSYSTEMS, V80, P175, DOI 10.1016/j.biosystems.2004.11.005; Di Giulio M, 2000, TRENDS BIOCHEM SCI, V25, P44, DOI 10.1016/S0968-0004(99)01522-4; Freeland SJ, 2000, MOL BIOL EVOL, V17, P511, DOI 10.1093/oxfordjournals.molbev.a026331; Freeland SJ, 1999, SCIENCE, V286, P690, DOI 10.1126/science.286.5440.690; Freeland SJ, 1998, J MOL EVOL, V47, P238, DOI 10.1007/PL00006381; Freeland SJ, 2000, TRENDS BIOCHEM SCI, V25, P44, DOI 10.1016/S0968-0004(99)01531-5; GOLDBERG AL, 1966, SCIENCE, V153, P420, DOI 10.1126/science.153.3734.420; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; Higgs PG, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-16; Kay L. E., 2000, WHO WROTE BOOK LIFE; Knight RD, 2000, CELL, V101, P569, DOI 10.1016/S0092-8674(00)80866-1; Knight RD, 1999, TRENDS BIOCHEM SCI, V24, P241, DOI 10.1016/S0968-0004(99)01392-4; Koonin EV, 2009, IUBMB LIFE, V61, P99, DOI 10.1002/iub.146; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Lenstra R, 2014, J THEOR BIOL, V347, P95, DOI 10.1016/j.jtbi.2014.01.002; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; Marquez R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r91; NIRENBERG MW, 1963, SCI AM, V208, P80, DOI 10.1038/scientificamerican0363-80; Santos J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-56; Sengupta S, 2015, J MOL EVOL, V80, P229, DOI 10.1007/s00239-015-9686-8; SHIELDS DC, 1990, J MOL EVOL, V31, P71, DOI 10.1007/BF02109476; Varrazzo D, 2005, BIOINFORMATICS, V21, P2856, DOI 10.1093/bioinformatics/bti444; WOESE CR, 1966, P NATL ACAD SCI USA, V55, P966, DOI 10.1073/pnas.55.4.966; WOESE CR, 1964, SCIENCE, V144, P1030, DOI 10.1126/science.144.3621.1030; Zhu CT, 2003, J MOL EVOL, V57, P533, DOI 10.1007/s00239-003-2505-7	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148174	10.1371/journal.pone.0148174	http://dx.doi.org/10.1371/journal.pone.0148174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849571	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000047
J	Harrison, MF; Anderson, PJ; Johnson, JB; Richert, M; Miller, AD; Johnson, BD				Harrison, Michael F.; Anderson, Paul J.; Johnson, Jacob B.; Richert, Maile; Miller, Andrew D.; Johnson, Bruce D.			Acute Mountain Sickness Symptom Severity at the South Pole: The Influence of Self-Selected Prophylaxis with Acetazolamide	PLOS ONE			English	Article							HIGH-ALTITUDE; DOUBLE-BLIND; SLEEP; PREVENTION; DEXAMETHASONE; TRIAL; IBUPROFEN; PLACEBO; ILLNESS; BLOOD	Introduction Acetazolamide, a carbonic anhydrase inhibitor, remains the only FDA approved pharmaceutical prophylaxis for acute mountain sickness (AMS) though its effectiveness after rapid transport in real world conditions is less clear. Methods Over 2 years, 248 healthy adults traveled by airplane from sea level (SL) to the South Pole (ALT, similar to 3200m) and 226 participants provided Lake Louise Symptom Scores (LLSS) on a daily basis for 1 week; vital signs, blood samples, and urine samples were collected at SL and at ALT. Acetazolamide was available to any participant desiring prophylaxis. Comparisons were made between the acetazolamide with AMS (ACZ/AMS) (n = 42), acetazolamide without AMS (ACZ/No AMS)(n = 49), no acetazolamide with AMS (No ACZ/AMS) (n = 56), and the no acetazolamide without AMS (No ACZ/No AMS) (n = 79) groups. Statistical analysis included Chisquared and one-way ANOVA with Bonferroni post-hoc tests. Significance was p <= 0.05. Results No significant differences were found for between-group characteristics or incidence of AMS between ACZ and No ACZ groups. ACZ/AMS reported greater LLSS, BMI, and red cell distribution width. ACZ/No AMS had the highest oxygen saturation (O(2)Sat) at ALT. No significant differences were found in serum electrolyte concentrations or PFT results. Discussion Acetazolamide during rapid ascent provided no apparent protection from AMS based on LLSS. However, it is unclear if this lack of effect was directly associated with the drug or if perhaps there was some selection bias with individuals taking ACZ more likely to have symptoms or if there may have been more of perceptual phenomenon related to a constellation of side effects.	[Harrison, Michael F.; Johnson, Jacob B.; Richert, Maile; Miller, Andrew D.; Johnson, Bruce D.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Harrison, Michael F.] Henry Ford Hosp, Dept Emergency Med, Detroit, MI 48202 USA; [Anderson, Paul J.] Mayo Clin, Div Prevent Occupat & Aerosp Med, Rochester, MN USA	Mayo Clinic; Henry Ford Health System; Henry Ford Hospital; Mayo Clinic	Johnson, BD (corresponding author), Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA.	Johnson.bruce@mayo.edu	Harrison, Michael/GYD-8608-2022		National Science Foundation; Mayo Clinic Center for Translational Science Activity (CTSA), Clinical Research Unit [1 UL1 RR024150];  [B-179-M]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Mayo Clinic Center for Translational Science Activity (CTSA), Clinical Research Unit; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Support was provided by National Science Foundation, B-179-M, and Mayo Clinic Center for Translational Science Activity (CTSA), Clinical Research Unit, Grant Number 1 UL1 RR024150. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PJ, 2011, CLIN MED INSIGHTS-CI, V5, P27, DOI 10.4137/CCRPM.S6882; ANHOLM JD, 1992, AM REV RESPIR DIS, V145, P817, DOI 10.1164/ajrccm/145.4_Pt_1.817; Bailey DM, 2009, CELL MOL LIFE SCI, V66, P3583, DOI 10.1007/s00018-009-0145-9; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Bernhard WN, 1998, AVIAT SPACE ENVIR MD, V69, P883; Burgess KR, 2004, RESPIROLOGY, V9, P485, DOI 10.1111/j.1440-1843.2004.00625.x; Burtscher M, 2014, INT J CLIN EXP MED, V7, P4378; CAIN SM, 1966, J APPL PHYSIOL, V21, P1195, DOI 10.1152/jappl.1966.21.4.1195; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; ELLSWORTH AJ, 1987, AM J MED, V83, P1024, DOI 10.1016/0002-9343(87)90937-5; ELLSWORTH AJ, 1991, WESTERN J MED, V154, P289; Faoro V, 2007, J APPL PHYSIOL, V103, P1161, DOI 10.1152/japplphysiol.00180.2007; Fischer R, 2004, EUR RESPIR J, V23, P47, DOI 10.1183/09031936.03.00113102; Gertsch JH, 2010, WILD ENVIRON MED, V21, P236, DOI 10.1016/j.wem.2010.06.009; GREENE MK, 1981, BRIT MED J, V283, P811, DOI 10.1136/bmj.283.6295.811; GRISSOM CK, 1992, ANN INTERN MED, V116, P461, DOI 10.7326/0003-4819-116-6-461; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Harrison MF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003064; Kayser B, 2012, HIGH ALT MED BIOL, V13, P82, DOI 10.1089/ham.2011.1084; Lalande S, 2011, EUR J APPL PHYSIOL, V111, P2221, DOI 10.1007/s00421-011-1864-9; Leaf DE, 2007, J APPL PHYSIOL, V102, P1313, DOI 10.1152/japplphysiol.01572.2005; Lipman GS, 2012, ANN EMERG MED, V59, P484, DOI 10.1016/j.annemergmed.2012.01.019; Low EV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6779; Luks AM, 2014, WILDERNESS ENV MED, V21, P146; Ritchie ND, 2012, J TRAVEL MED, V19, P298, DOI 10.1111/j.1708-8305.2012.00629.x; Roach RC, 2001, J EXP BIOL, V204, P3161; Roeggla G, 1996, J ROY SOC MED, V89, P141, DOI 10.1177/014107689608900307; Schoonman GG, 2008, J CEREBR BLOOD F MET, V28, P198, DOI 10.1038/sj.jcbfm.9600513; Sokucu SN, 2012, J CLIN SLEEP MED, V8, P521, DOI 10.5664/jcsm.2146; SWENSON ER, 1991, RESP PHYSIOL, V86, P333, DOI 10.1016/0034-5687(91)90104-Q; Swenson ER, 1998, EUR RESPIR J, V12, P1242, DOI 10.1183/09031936.98.12061242; Swenson ER, 2007, J APPL PHYSIOL, V102, P1305, DOI 10.1152/japplphysiol.01407.2006; Teppema LJ, 2007, AM J RESP CRIT CARE, V175, P277, DOI 10.1164/rccm.200608-1199OC; Waeber B, 2015, HIGH ALT MED BIOL, V16, P204, DOI 10.1089/ham.2015.0022; Wilson MH, 2008, NEUROSURGERY, V63, P970, DOI 10.1227/01.NEU.0000327885.15132.CA	35	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148206	10.1371/journal.pone.0148206	http://dx.doi.org/10.1371/journal.pone.0148206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848757	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000051
J	Haulsee, DE; Fox, DA; Breece, MW; Clauss, TM; Oliver, MJ				Haulsee, Danielle E.; Fox, Dewayne A.; Breece, Matthew W.; Clauss, Tonya M.; Oliver, Matthew J.			Implantation and Recovery of Long-Term Archival Transceivers in a Migratory Shark with High Site Fidelity	PLOS ONE			English	Article							TIGERS CARCHARIAS-TAURUS; SAND TIGER; MOVEMENT PATTERNS; EAST-COAST; ATLANTIC; BEHAVIOR; GROWTH; FISH; ABUNDANCE; SURVIVAL	We developed a long-term tagging method that can be used to understand species assemblages and social groupings associated with large marine fishes such as the Sand Tiger shark Carcharias taurus. We deployed internally implanted archival VEMCO Mobile Transceivers (VMTs; VEMCO Ltd. Nova Scotia, Canada) in 20 adult Sand Tigers, of which two tags were successfully recovered (10%). The recovered VMTs recorded 29,646 and 44,210 detections of telemetered animals respectively. To our knowledge, this is the first study to demonstrate a method for long-term (similar to 1 year) archival acoustic transceiver tag implantation, retention, and recovery in a highly migratory marine fish. Results show low presumed mortality (n = 1, 5%), high VMT retention, and that non-lethal recovery after almost a year at liberty can be achieved for archival acoustic transceivers. This method can be applied to study the social interactions and behavioral ecology of large marine fishes.	[Haulsee, Danielle E.; Breece, Matthew W.; Oliver, Matthew J.] Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA; [Fox, Dewayne A.] Delaware State Univ, Dept Agr & Nat Resources, Dover, DE USA; [Clauss, Tonya M.] Georgia Aquarium, Atlanta, GA USA	University of Delaware; Delaware State University	Haulsee, DE (corresponding author), Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA.	dhaulsee@udel.edu	Haulsee, Danielle/W-7513-2019	Haulsee, Danielle/0000-0003-0691-0278	Robertson's Fund; NOAA-NMFS Proactive Species Conservation Program; The Georgia Aquarium	Robertson's Fund; NOAA-NMFS Proactive Species Conservation Program; The Georgia Aquarium	This work was supported by the generous support of The Robertson's Fund and the NOAA-NMFS Proactive Species Conservation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Georgia Aquarium provided support in the form of salary for author TMC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BRANSTETTER S, 1994, T AM FISH SOC, V123, P242, DOI 10.1577/1548-8659(1994)123<0242:AAGEFT>2.3.CO;2; Chiaramonte G., 2007, IUCN RED LIST THREAT; Compagno L, 1984, FAO SPECIES CATALO 1, V4; Cooke SJ, 2003, J FISH BIOL, V62, P1366, DOI 10.1046/j.1095-8649.2003.00119.x; Cooke SJ, 2011, REV FISH BIOL FISHER, V21, P127, DOI 10.1007/s11160-010-9193-3; Croft DP, 2005, OECOLOGIA, V143, P211, DOI 10.1007/s00442-004-1796-8; Dicken ML, 2006, AFR J MAR SCI, V28, P589, DOI 10.2989/18142320609504209; Dicken ML, 2006, ICES J MAR SCI, V63, P1640, DOI 10.1016/j.icesjms.2006.06.009; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Driggers WB, 2014, J EXP MAR BIOL ECOL, V459, P61, DOI 10.1016/j.jembe.2014.05.006; Fox DA, 2015, CONSERVATION SAND TI; Goldman KJ, 2006, ENVIRON BIOL FISH, V77, P241, DOI 10.1007/s10641-006-9128-y; Gurshin CWD, 2004, J FISH BIOL, V65, P973, DOI 10.1111/j.0022-1112.2004.00501.x; Guttridge TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009324; Hammerschlag N, 2014, METHODS ECOL EVOL, V5, P1147, DOI 10.1111/2041-210X.12248; Harms CA, 2005, LAB ANIMAL, V34, P28, DOI 10.1038/laban0105-28; Hayes SA, 2013, ENVIRON BIOL FISH, V96, P189, DOI 10.1007/s10641-011-9940-x; Heupel MR, 2002, CAN J FISH AQUAT SCI, V59, P624, DOI 10.1139/F02-036; Holland Kim N., 2010, Endangered Species Research, V10, P287; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Jacoby DMP, 2010, BEHAV ECOL, V21, P808, DOI 10.1093/beheco/arq061; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Kilfoil J., 2014, THESIS DELAWARE STAT; KLIMLEY AP, 1984, BEHAV ECOL SOCIOBIOL, V15, P45, DOI 10.1007/BF00310214; Kneebone J, 2014, MAR BIOL, V161, P1149, DOI 10.1007/s00227-014-2407-9; Kneebone J, 2013, FISH RES, V147, P103, DOI 10.1016/j.fishres.2013.04.009; Kneebone J, 2012, MAR ECOL PROG SER, V471, P165, DOI 10.3354/meps09989; Kynard B, 1997, REJECTION INTERNAL T, P58; Lidgard DC, 2014, MAR ECOL PROG SER, V501, P157, DOI 10.3354/meps10670; Lidgard DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048962; Lucifora LO, 2009, ANIM CONSERV, V12, P291, DOI 10.1111/j.1469-1795.2009.00247.x; Lucifora LO, 2002, ICES J MAR SCI, V59, P553, DOI 10.1006/jmsc.2002.1183; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; McAuley, 2003, IUCN RED LIST THREAT; McCandless Camilla T., 2007, V50, P45; MCKIBBEN JN, 1986, B MAR SCI, V38, P89; Meyer CG, 2007, AQUAT LIVING RESOUR, V20, P291, DOI 10.1051/alr:2008002; Mourier J, 2012, ANIM BEHAV, V83, P389, DOI 10.1016/j.anbehav.2011.11.008; Pollard D., 2009, IUCN RED LIST THREAT; Pratt HL, 2001, ENVIRON BIOL FISH, V60, P157; Ripley W. E., 1946, California Fish and Game Commission Fish Bulletin, V64, P1; Sibert J., 2001, ELECT TAGGING TRACKI; Teter SM, 2015, MAR FRESHWATER RES, V66, P158, DOI 10.1071/MF14129; WATSKY MA, 1990, FISH PHYSIOL BIOCHEM, V8, P207, DOI 10.1007/BF00004459; Whitney Nicholas M., 2010, Endangered Species Research, V10, P71, DOI 10.3354/esr00247; Wilson SG, 2005, MAR BIOL, V146, P409, DOI 10.1007/s00227-004-1445-0; Winter J.D., 1983, P371	47	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148617	10.1371/journal.pone.0148617	http://dx.doi.org/10.1371/journal.pone.0148617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849043	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000138
J	Juge, L; Pong, AC; Bongers, A; Sinkus, R; Bilston, LE; Cheng, S				Juge, Lauriane; Pong, Alice C.; Bongers, Andre; Sinkus, Ralph; Bilston, Lynne E.; Cheng, Shaokoon			Changes in Rat Brain Tissue Microstructure and Stiffness during the Development of Experimental Obstructive Hydrocephalus	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; KAOLIN-INDUCED HYDROCEPHALUS; CEREBRAL WHITE-MATTER; MR ELASTOGRAPHY; IN-VIVO; INFANTILE HYDROCEPHALUS; VISCOELASTIC PROPERTIES; BREAST-LESIONS; IMMATURE RATS; DIFFUSION	Understanding neural injury in hydrocephalus and how the brain changes during the course of the disease in-vivo remain unclear. This study describes brain deformation, microstructural and mechanical properties changes during obstructive hydrocephalus development in a rat model using multimodal magnetic resonance (MR) imaging. Hydrocephalus was induced in eight Sprague-Dawley rats (4 weeks old) by injecting a kaolin suspension into the cisterna magna. Six sham-injected rats were used as controls. MR imaging (9.4T, Bruker) was performed 1 day before, and at 3, 7 and 16 days post injection. T2-weighted MR images were collected to quantify brain deformation. MR elastography was used to measure brain stiffness, and diffusion tensor imaging (DTI) was conducted to observe brain tissue microstructure. Results showed that the enlargement of the ventricular system was associated with a decrease in the cortical gray matter thickness and caudate-putamen cross-sectional area (P < 0.001, for both), an alteration of the corpus callosum and periventricular white matter microstructure (CC+ PVWM) and rearrangement of the cortical gray matter microstructure (P < 0.001, for both), while compression without gross microstructural alteration was evident in the caudate-putamen and ventral internal capsule (P < 0.001, for both). During hydrocephalus development, increased space between the white matter tracts was observed in the CC+ PVWM (P < 0.001), while a decrease in space was observed for the ventral internal capsule (P < 0.001). For the cortical gray matter, an increase in extracellular tissue water was significantly associated with a decrease in tissue stiffness (P = 0.001). To conclude, this study characterizes the temporal changes in tissue microstructure, water content and stiffness in different brain regions and their association with ventricular enlargement. In summary, whilst diffusion changes were larger and statistically significant for majority of the brain regions studied, the changes in mechanical properties were modest. Moreover, the effect of ventricular enlargement is not limited to the CC+ PVWM and ventral internal capsule, the extent of microstructural changes vary between brain regions, and there is regional and temporal variation in brain tissue stiffness during hydrocephalus development.	[Juge, Lauriane; Pong, Alice C.; Bilston, Lynne E.; Cheng, Shaokoon] Neurosci Res Australia, Margarete Ainsworth Bldg, Randwick, NSW, Australia; [Juge, Lauriane] Univ New S Wales, Sch Med Sci, Wallace Wurth Bldg, Kensington, NSW, Australia; [Bongers, Andre] Univ New S Wales, Biol Resources Imaging Lab, Lowy Canc Res Ctr, POB 1, Kensington, NSW 2033, Australia; [Sinkus, Ralph] Kings Coll London, Imaging Sci & Biomed Engn Div Kings Coll, St Thomas Hosp, Biomed Engn, London WC2R 2LS, England; [Bilston, Lynne E.] Univ New S Wales, Prince Wales Clin Sch, Edmund Blacket Bldg, Kensington, NSW 2033, Australia; [Cheng, Shaokoon] Macquarie Univ, Fac Sci, Dept Engn, Sydney, NSW 2109, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of New South Wales Sydney; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of New South Wales Sydney; Macquarie University	Cheng, S (corresponding author), Neurosci Res Australia, Margarete Ainsworth Bldg, Randwick, NSW, Australia.; Cheng, S (corresponding author), Macquarie Univ, Fac Sci, Dept Engn, Sydney, NSW 2109, Australia.	shaokoon.cheng@mq.edu.au	Jugé, Lauriane/F-7085-2014; Bilston, Lynne/C-9665-2011	Jugé, Lauriane/0000-0002-4136-8069; Sinkus, Ralph/0000-0002-6093-1654; Cheng, Shaokoon/0000-0002-2057-4605; Bilston, Lynne/0000-0001-8250-9019	National Health and Medical Research Council of Australia [APP1027684, 568610]; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London(General Electric); King's College Hospital NHS Foundation Trust	This project was supported by a project grant (APP1027684) from the National Health and Medical Research Council of Australia [https://www.nhmrc.gov.au/]. L.E. Bilston was supported by a Senior Research Fellowship (#568610) from the National Health and Medical Research Council of Australia [https://www.nhmrc.gov.au/]. The authors also acknowledge financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. No individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish.	Assaf Y, 2006, AM J NEURORADIOL, V27, P1717; Atay SM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2899575; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bilston LE, 2011, STUD MECHANOBIOL TIS, V3, P1, DOI 10.1007/978-3-642-13890-4; Bilston LE, 2014, 7 WORLD C BIOM BOST; Bourne RM, 2014, MAGN RESON MED, V72, P1418, DOI 10.1002/mrm.25032; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; CLARK RG, 1970, J NEUROSURG, V32, P400, DOI 10.3171/jns.1970.32.4.0400; Clarke EC, 2011, J BIOMECH, V44, P2461, DOI 10.1016/j.jbiomech.2011.06.023; Clayton EH, 2011, PHYS MED BIOL, V56, P2391, DOI 10.1088/0031-9155/56/8/005; Czosnyka M, 2001, J NEUROSURG, V94, P482, DOI 10.3171/jns.2001.94.3.0482; DE SN, 1950, J PATHOL BACTERIOL, V62, P197, DOI 10.1002/path.1700620207; Del Bigio MR, 2003, ANN NEUROL, V53, P337, DOI 10.1002/ana.10453; Del Bigio MR, 1998, EXP NEUROL, V154, P157, DOI 10.1006/exnr.1998.6922; DelBigio MR, 1997, J NEUROPATH EXP NEUR, V56, P1053, DOI 10.1097/00005072-199709000-00010; DelBigio MR, 1997, EXP NEUROL, V148, P256, DOI 10.1006/exnr.1997.6644; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; DIGGS J, 1986, INVEST RADIOL, V21, P118, DOI 10.1097/00004424-198602000-00006; Diguet E, 2009, P INT SOC MAG RESON, P17; ELGAMMAL T, 1987, AM J ROENTGENOL, V149, P807, DOI 10.2214/ajr.149.4.807; EPSTEIN F, 1974, DEV MED CHILD NEUROL, V16, P49; Eskandari R, 2014, CHILD NERV SYST, V30, P1651, DOI 10.1007/s00381-014-2500-x; FLETCHER JM, 1992, ARCH NEUROL-CHICAGO, V49, P818, DOI 10.1001/archneur.1992.00530320042010; Fletcher JM, 1996, ARCH NEUROL-CHICAGO, V53, P549, DOI 10.1001/archneur.1996.00550060093022; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Hakim S, 1976, Surg Neurol, V5, P187; HANIGAN WC, 1991, NEUROSURGERY, V29, P701, DOI 10.1227/00006123-199111000-00010; Harris NG, 1996, EXP NEUROL, V141, P269, DOI 10.1006/exnr.1996.0161; Herring Susan W., 2008, V12, P41, DOI 10.1159/000115031; Ho ML, 2012, AM J ROENTGENOL, V199, pW258, DOI 10.2214/AJR.11.8081; HOCHWALD GM, 1981, Z KINDERCHIR, V34, P403; HOCHWALD GM, 1972, ARCH NEUROL-CHICAGO, V26, P120, DOI 10.1001/archneur.1972.00490080038003; Hoehn-Berlage M, 1999, NMR BIOMED, V12, P45, DOI 10.1002/(SICI)1099-1492(199902)12:1<45::AID-NBM545>3.0.CO;2-6; Hwang YS, 2011, J NEUROSURG-PEDIATR, V7, P401, DOI 10.3171/2011.1.PEDS10182; Juge L, 2012, RADIOLOGY, V264, P436, DOI 10.1148/radiol.12111548; Klatt D, 2006, INVEST RADIOL, V41, P841, DOI 10.1097/01.rli.0000244341.16372.08; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; Mcalexander J. H., 2015, J NEUROSURG, P1; MILHORAT TH, 1970, ARCH NEUROL-CHICAGO, V22, P397, DOI 10.1001/archneur.1970.00480230015002; Miller Janet M, 2007, Cerebrospinal Fluid Res, V4, P5, DOI 10.1186/1743-8454-4-5; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Olopade FE, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-19; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; PAGE RB, 1975, J NEUROSURG, V42, P646, DOI 10.3171/jns.1975.42.6.0646; PANG DL, 1994, NEUROSURGERY, V35, P643, DOI 10.1227/00006123-199410000-00010; Pena A, 2002, ACT NEUR S, V81, P59; PENN RD, 1984, NEUROSURGERY, V14, P670, DOI 10.1227/00006123-198406000-00004; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Pong AC, 2014, 7 WORLD C BIOM BOST; Qin EC, 2014, RADIOLOGY, V273, P726, DOI 10.1148/radiol.14132661; RUBIN RC, 1972, DEV MED CHILD NEUROL, V14, P117; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; SAHAR A, 1969, ARCH NEUROL-CHICAGO, V21, P638, DOI 10.1001/archneur.1969.00480180094009; Schregel K, 2012, P NATL ACAD SCI USA, V109, P6650, DOI 10.1073/pnas.1200151109; SCHURR PH, 1953, J NEUROSURG, V10, P515, DOI 10.3171/jns.1953.10.5.0515; Shulyakov AV, 2012, NEUROSURGERY, V71, P1032, DOI 10.1227/NEU.0b013e3182690a0c; Sinkus R, 2000, PHYS MED BIOL, V45, P1649, DOI 10.1088/0031-9155/45/6/317; Sinkus R, 2005, MAGN RESON IMAGING, V23, P159, DOI 10.1016/j.mri.2004.11.060; Sinkus R, 2007, MAGN RESON MED, V58, P1135, DOI 10.1002/mrm.21404; SKLAR FH, 1980, J NEUROSURG, V53, P173, DOI 10.3171/jns.1980.53.2.0173; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Tan K, 2013, J BIOMECH, V46, P1060, DOI 10.1016/j.jbiomech.2013.01.028; Tu TW, 2014, J NEUROPATH EXP NEUR, V73, P1152, DOI 10.1097/NEN.0000000000000140; Vappou J, 2008, J BIOMECH, V41, P2954, DOI 10.1016/j.jbiomech.2008.07.034; Vinchon M, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-18; WELLER RO, 1972, J NEUROSURG, V36, P255, DOI 10.3171/jns.1972.36.3.0255; Williams MA, 2007, J NEUROSURG, V107, P345, DOI 10.3171/PED-07/11/345; Williams MA, 2007, J NEUROSURG, V107, P21, DOI 10.3171/JNS-07/07/0021; WILLS KE, 1993, J CLIN CHILD PSYCHOL, V22, P247, DOI 10.1207/s15374424jccp2202_11; YAMADA H, 1992, J NEUROSURG, V76, P856, DOI 10.3171/jns.1992.76.5.0856; Yuan W, 2009, AM J NEURORADIOL, V30, P1792, DOI 10.3174/ajnr.A1663; Yuan WH, 2012, CHILD NERV SYST, V28, P47, DOI 10.1007/s00381-011-1590-y; Yuan WH, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-19	78	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148652	10.1371/journal.pone.0148652	http://dx.doi.org/10.1371/journal.pone.0148652			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848844	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000148
J	Khan, J; Khan, I; Amin, I				Khan, Jehangir; Khan, Inamullah; Amin, Ibne			A Comprehensive Entomological, Serological and Molecular Study of 2013 Dengue Outbreak of Swat, Khyber Pakhtunkhwa, Pakistan	PLOS ONE			English	Article							NATURAL VERTICAL TRANSMISSION; AEDES-ALBOPICTUS DIPTERA; VIRUS TRANSMISSION; AEGYPTI DIPTERA; CULICIDAE; MOSQUITOS; VECTOR; THAILAND; URBAN; MULTICOUNTRY	Background Aedes aegypti and Aedes albopictus play a fundamental role in transmission of dengue virus to humans. A single infected Aedes mosquito is capable to act as a reservoir/amplifier host for dengue virus and may cause epidemics via horizontal and vertical modes of dengue virus (DENV) transmission. The present and future dengue development can be clarified by understanding the elements which help the dissemination of dengue transmission. The current study deals with molecular surveillance of dengue in addition to ecological and social context of 2013 dengue epidemics in Swat, Pakistan. Methods Herein, we reported dengue vectors surveillance in domestic and peridomistic containers in public and private places in 7 dengue epidemic-prone sites in District Swat, Pakistan from July to November 2013. Using the Flaviviruses genus-specific reverse transcriptase (RT) semi nested-PCR assay, we screened blood samples (N = 500) of dengue positive patients, 150 adult mosquito pools and 25 larval pools. Results The 34 adult and 7 larval mosquito pools were found positive. The adult positive pools comprised 30 pools of Ae. aegypti and 4 pools of Ae. albopictus, while among the 7 larval pools, 5 pools of Ae. aegypti and 2 pools of Ae. albopictus were positive. The detected putative genomes of dengue virus were of DENV-2 (35% in 14 mosquito pools & 39% in serum) and DENV-3 (65% in 27 mosquito pools & 61% in serum). The higher vector density and dengue transmission rate was recorded in July and August (due to favorable conditions for vector growth). About 37% of Ae. aegpti and 34% Ae. albopictus mosquitoes were collected from stagnant water in drums, followed by drinking water tanks (23% & 26%), tires (20% & 18%) and discarded containers (10% & 6%). Among the surveyed areas, Saidu was heavily affected (26%) by dengue followed by Kanju (20% and Landikas (12%). The maximum infection was observed in the age group of <15 (40%) followed by 15-45 (35%) and >45 (25%) years and was more in males (55.3%) as compare to females (44.7%). The increase in vector mosquito density and the subsequent viral transmission was determined by a complex interplay of ecological, biological and social factors. Conclusion The suitable environmental conditions and discriminable role of Aedes through trans-ovarial transmission of DENV is indispensable in the recent geographic increase of dengue in Pakistan. Climate change affects the survival and dispersion of vectors as well as the transmission rates of dengue. Control of Aedes mosquitoes (vectors) and elimination of breeding sources must be emphasized and prioritized. Such actions may not only reduce the risk of dengue transmission during epidemics, but also minimize the chances of dengue viruses establishment in new (non endemic) areas of the region.	[Khan, Jehangir; Amin, Ibne] Abdul Wali Khan Univ Mardan, Dept Zool, Khyber Pakhtunkhwa, Kpk, Pakistan; [Khan, Inamullah] Nucl Inst Food & Agr, Tarnab Peshawar, Pakistan	Nuclear Institute for Food & Agriculture - Pakistan	Khan, J (corresponding author), Abdul Wali Khan Univ Mardan, Dept Zool, Bunir Campus, Khyber Pakhtunkhwa, Kpk, Pakistan.	abu_amna2013@hotmail.com	Khan, Jehangir/HIR-2247-2022; Khan, Inamullah/C-2836-2015; Khan, Inamullah/H-3258-2019	Khan, Jehangir/0000-0003-4328-5459; Khan, Inamullah/0000-0002-4290-4070				Abdalmagid M. S., 2008, SUDANESE J PUBLIC HL, V3, P77; Adams B, 2010, EPIDEMICS-NETH, V2, P1, DOI 10.1016/j.epidem.2010.01.001; Ali A, 2013, BIOHELIKON IMMU AND, V1, pa6; Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421; Angel Bennet, 2008, Journal of Vector Borne Diseases, V45, P56; [Anonymous], [No title captured]; Arredondo-Jimenez JI, 2006, ANN TROP MED PARASIT, V100, pS17, DOI 10.1179/136485906X105480; Arunachalam N, 2008, INDIAN J MED RES, V127, P395; Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892; Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338; Buckner EA, 2013, J MED ENTOMOL, V50, P1291, DOI 10.1603/ME13047; Pamplona LDC, 2009, TROP MED INT HEALTH, V14, P1347, DOI 10.1111/j.1365-3156.2009.02377.x; Cecilio AB, 2009, BRAZ J BIOL, V69, P123, DOI 10.1590/S1519-69842009000100015; Chaves LF, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-3; Chen MJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040659, 10.1371/journal.pone.0034651]; Crans WJ, 2009, AEDES ALBOPICTUS GLO; Cruz EI, 2008, DENGUE B, V32, P167; de Figueiredo MLG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-152; Dieng Hamady, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P228, DOI 10.1016/S2221-1691(12)60047-1; Dieng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011790; El-Badry A. A., 2010, Journal of Entomology, V7, P80, DOI 10.3923/je.2010.80.88; Ergunay K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003028; Espinosa M, 2014, REV INST MED TROP SP, V56, P165, DOI 10.1590/S0036-46652014000200013; Fan J, 2013, EPIDEMIOL INFECT, V142, P1; Farjana T, 2012, MED VET ENTOMOL, V26, P210, DOI 10.1111/j.1365-2915.2011.00971.x; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; Higa Y, 2010, J AM MOSQUITO CONTR, V26, P1, DOI 10.2987/09-5945.1; Huber K, 2008, AM J TROP MED HYG, V79, P218, DOI 10.4269/ajtmh.2008.79.218; Idrees M., 2012, AM J BIOMED SCI, V4, P307, DOI [10.5099/aj120400307, DOI 10.5099/AJ120400307]; Idrees S, 2012, GENET VACCINES THER, V10, P6, DOI DOI 10.1186/1479-0556-10-6; Isaacs N., 2006, Indian Journal of Community Medicine, V31, P187; Jahan Nusrat, 2014, Biologia (Lahore), V60, P169; Jamil B, 2007, EMERG INFECT DIS, V13, P182, DOI 10.3201/eid1301.060376; Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158; Kanthong N, 2008, DEV COMP IMMUNOL, V32, P1063, DOI 10.1016/j.dci.2008.02.008; Khan A, 2014, J MED SCI, V22, P92; Khan E, 2008, J CLIN VIROL, V43, P176, DOI 10.1016/j.jcv.2008.06.003; Khan J., 2015, IMMUNITY DIS, V3, pa11, DOI DOI 10.5281/ZEN0D0.816342; Khan J, 2013, J MED PLANTS STUD, V2, P1; Khan MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056391; Kittayapong P, 2006, J AM MOSQUITO CONTR, V22, P538, DOI 10.2987/8756-971X(2006)22[538:CPAATF]2.0.CO;2; Koo C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-275; Kow CY, 2001, J MED ENTOMOL, V38, P475, DOI 10.1603/0022-2585-38.4.475; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Le Goff G, 2011, PARASITE, V18, P277, DOI 10.1051/parasite/2011183277; Leopoldo MR, 2004, ZOOTAXA, V589, P60; Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P799, DOI 10.1590/S0074-02762002000600009; Luo L, 2012, J VECTOR ECOL, V37, P230, DOI 10.1111/j.1948-7134.2012.00221.x; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; Micieli MV, 2003, MEM I OSWALDO CRUZ, V98, P659, DOI 10.1590/S0074-02762003000500013; Mukhtar M, 2011, DENG BULL, V35; Mulyatno KC, 2012, JPN J INFECT DIS, V65, P274, DOI 10.7883/yoken.65.274; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; Martins VEP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041386; Pham HV, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-172; Quintero J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-38; Raheel U, 2011, J INFECT DEV COUNTR, V5, P239, DOI 10.3855/jidc.1017; Rahman GMS, 2010, J AM MOSQUITO CONTR, V26, P373; Rasheed SB, 2013, PUBLIC HEALTH, V127, P11, DOI 10.1016/j.puhe.2012.09.006; Raza FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089868; Sang SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102755; SAVAGE HM, 1993, AM J TROP MED HYG, V49, P38, DOI 10.4269/ajtmh.1993.49.38; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Sharma KD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-341; Thenmozhi V, 2007, JPN J INFECT DIS, V60, P245; Tsuda Y, 2006, J AM MOSQUITO CONTR, V22, P222, DOI 10.2987/8756-971X(2006)22[222:DSDOAA]2.0.CO;2; Urdaneta Ludmel, 2005, Infection Genetics and Evolution, V5, P177, DOI 10.1016/j.meegid.2004.09.004; Vilela APP, 2010, EMERG INFECT DIS, V16, P989, DOI 10.3201/eid1606.091000; Wai KT, 2012, PATHOG GLOB HEALTH, V106, P436, DOI 10.1179/2047773212Y.0000000063; Wang CG, 2014, ASIA-PAC J PUBLIC HE, V26, P48, DOI 10.1177/1010539513490195; Warraich H, 2011, B WORLD HEALTH ORGAN, V89, P236, DOI 10.2471/BLT.10.083386; Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7; Wu PC, 2009, SCI TOTAL ENVIRON, V407, P2224, DOI 10.1016/j.scitotenv.2008.11.034; Zeidler JD, 2008, REV SAUDE PUBL, V42, P986	76	28	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147416	10.1371/journal.pone.0147416	http://dx.doi.org/10.1371/journal.pone.0147416			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848847	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000016
J	Kim, SW; Jung, HW; Kim, CH; Kim, KI; Chin, HJ; Lee, H				Kim, Sun-wook; Jung, Hee-Won; Kim, Cheol-Ho; Kim, Kwang-Il; Chin, Ho Jun; Lee, Hajeong			A New Equation to Estimate Muscle Mass from Creatinine and Cystatin C	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; BIOELECTRICAL-IMPEDANCE ANALYSIS; SERUM CREATININE; BODY-COMPOSITION; URINARY CREATININE; KIDNEY-FUNCTION; RENAL-FUNCTION; HEALTH; SARCOPENIA; PREVALENCE	Background With evaluation for physical performance, measuring muscle mass is an important step in detecting sarcopenia. However, there are no methods to estimate muscle mass from blood sampling. Methods To develop a new equation to estimate total-body muscle mass with serum creatinine and cystatin C level, we designed a cross-sectional study with separate derivation and validation cohorts. Total body muscle mass and fat mass were measured using dual-energy x-ray absorptiometry (DXA) in 214 adults aged 25 to 84 years who underwent physical checkups from 2010 to 2013 in a single tertiary hospital. Serum creatinine and cystatin C levels were also examined. Results Serum creatinine was correlated with muscle mass (P < .001), and serum cystatin C was correlated with body fat mass (P < .001) after adjusting glomerular filtration rate (GFR). After eliminating GFR, an equation to estimate total-body muscle mass was generated and coefficients were calculated in the derivation cohort. There was an agreement between muscle mass calculated by the novel equation and measured by DXA in both the derivation and validation cohort (P < .001, adjusted R-2 = 0.829, beta = 0.95, P < .001, adjusted R-2 = 0.856, beta = 1.03, respectively). Conclusion The new equation based on serum creatinine and cystatin C levels can be used to estimate total-body muscle mass.	[Kim, Sun-wook; Jung, Hee-Won; Kim, Cheol-Ho; Kim, Kwang-Il; Chin, Ho Jun] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Kim, Sun-wook; Kim, Cheol-Ho; Kim, Kwang-Il; Chin, Ho Jun; Lee, Hajeong] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Jung, Hee-Won] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Lee, Hajeong] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University Hospital	Lee, H (corresponding author), Seoul Natl Univ, Coll Med, Seoul, South Korea.; Lee, H (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.	mdhjlee@gmail.com	Kim, Kwang-il/AAP-7315-2021; Jung, Hee-Won/B-4269-2015; Kim, Kwang-il/D-8024-2012	Kim, Kwang-il/0000-0002-6658-047X; Jung, Hee-Won/0000-0002-2583-3354; Kim, Kwang-il/0000-0002-6658-047X				Baxmann AC, 2008, CLIN J AM SOC NEPHRO, V3, P348, DOI 10.2215/CJN.02870707; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cawthon PM, 2007, J AM GERIATR SOC, V55, P1216, DOI 10.1111/j.1532-5415.2007.01259.x; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Chew-Harris JSC, 2013, ANN CLIN BIOCHEM, V50, P39, DOI 10.1258/acb.2012.011241; Chien MY, 2008, J AM GERIATR SOC, V56, P1710, DOI 10.1111/j.1532-5415.2008.01854.x; Coll E, 2000, AM J KIDNEY DIS, V36, P29, DOI 10.1053/ajkd.2000.8237; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; ENGSTROM CM, 1991, J ANAT, V176, P139; Frazee EN, 2014, CRIT CARE, V18, DOI 10.1186/cc13899; GOLDBERG TH, 1987, ARCH INTERN MED, V147, P1430, DOI 10.1001/archinte.147.8.1430; Hart A, 2013, J AM GERIATR SOC, V61, P1530, DOI 10.1111/jgs.12413; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Horber FF, 1997, NUTRITION, V13, P524, DOI 10.1016/S0899-9007(97)00031-2; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Inouye SK, 2007, J AM GERIATR SOC, V55, P780, DOI 10.1111/j.1532-5415.2007.01156.x; Janssen I, 2000, J APPL PHYSIOL, V89, P465, DOI 10.1152/jappl.2000.89.2.465; Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Kottgen A, 2008, AM J KIDNEY DIS, V51, P385, DOI 10.1053/j.ajkd.2007.11.019; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; LAKE KD, 1985, PHARMACOTHERAPY, V5, P340; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115, DOI 10.1152/jappl.1998.85.1.115; Muntner P, 2008, AM J MED, V121, P341, DOI 10.1016/j.amjmed.2008.01.003; Naour N, 2009, OBESITY, V17, P2121, DOI 10.1038/oby.2009.96; Odden MC, 2006, AM J EPIDEMIOL, V164, P1180, DOI 10.1093/aje/kwj333; Oterdoom LH, 2009, ATHEROSCLEROSIS, V207, P534, DOI 10.1016/j.atherosclerosis.2009.05.010; Proctor DN, 1999, AM J PHYSIOL-ENDOC M, V277, pE489, DOI 10.1152/ajpendo.1999.277.3.E489; Schaeffner ES, 2012, ANN INTERN MED, V157, P471, DOI 10.7326/0003-4819-157-7-201210020-00003; Shlipak MG, 2006, J AM SOC NEPHROL, V17, P254, DOI 10.1681/ASN.2005050545; Srikanthan P, 2014, AM J MED, V127, P547, DOI 10.1016/j.amjmed.2014.02.007; Stevens LA, 2009, KIDNEY INT, V75, P652, DOI 10.1038/ki.2008.638; Trutschnigg B, 2008, APPL PHYSIOL NUTR ME, V33, P1232, DOI 10.1139/H08-122; Wasen E, 2003, AM J KIDNEY DIS, V42, P36, DOI 10.1016/S0272-6386(03)00406-2	38	32	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148495	10.1371/journal.pone.0148495	http://dx.doi.org/10.1371/journal.pone.0148495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849842	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000109
J	Thormann, B; Ahrens, D; Armijos, DM; Peters, MK; Wagner, T; Wagele, JW				Thormann, Birthe; Ahrens, Dirk; Armijos, Diego Marin; Peters, Marcell K.; Wagner, Thomas; Waegele, Johann W.			Exploring the Leaf Beetle Fauna (Coleoptera: Chrysomelidae) of an Ecuadorian Mountain Forest Using DNA Barcoding	PLOS ONE			English	Article							SPECIES DELIMITATION; BIOLOGICAL IDENTIFICATIONS; BIODIVERSITY ASSESSMENT; INSECT HERBIVORES; TROPICAL FORESTS; RAIN-FOREST; DIVERSITY; RICHNESS; TAXONOMY; PHYLOGENY	Background Tropical mountain forests are hotspots of biodiversity hosting a huge but little known diversity of insects that is endangered by habitat destruction and climate change. Therefore, rapid assessment approaches of insect diversity are urgently needed to complement slower traditional taxonomic approaches. We empirically compare different DNA-based species delimitation approaches for a rapid biodiversity assessment of hyperdiverse leaf beetle assemblages along an elevational gradient in southern Ecuador and explore their effect on species richness estimates. Methodology/Principal Findings Based on a COI barcode data set of 674 leaf beetle specimens (Coleoptera: Chrysomelidae) of 266 morphospecies from three sample sites in the Podocarpus National Park, we employed statistical parsimony analysis, distance-based clustering, GMYC- and PTP-modelling to delimit species-like units and compared themtomorphology-based (parataxonomic) species identifications. The four different approaches for DNA-based species delimitation revealed highly similar numbers of molecular operational taxonomic units (MOTUs) (n = 284-289). Estimated total species richness was considerably higher than the sampled amount, 414 for morphospecies (Chao2) and 469-481 for the different MOTU types. Assemblages at different elevational levels (1000 vs. 2000 m) had similar species numbers but a very distinct species composition for all delimitation methods. Most species were found only at one elevation while this turnover pattern was even more pronounced for DNA-based delimitation. Conclusions/Significance Given the high congruence of DNA-based delimitation results, probably due to the sampling structure, our study suggests that when applied to species communities on a regionally limited level with high amount of rare species (i.e. similar to 50% singletons), the choice of species delimitation method can be of minor relevance for assessing species numbers and turnover in tropical insect communities. Therefore, DNA-based species delimitation is confirmed as a valuable tool for evaluating biodiversity of hyperdiverse insect communities, especially when exact taxonomic identifications are missing.	[Thormann, Birthe; Ahrens, Dirk; Waegele, Johann W.] Zool Res Museum Alexander Koenig, Bonn, Germany; [Armijos, Diego Marin] Univ Tecn Particular Loja, Dept Ciencias Nat, Museo Colecc Biol MUTPL, Loja, Ecuador; [Peters, Marcell K.] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr, D-97070 Wurzburg, Germany; [Wagner, Thomas] Univ Koblenz Landau, Abt Biol, Inst Integrierte Nat Wissensch, Koblenz, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Universidad Tecnica Particular de Loja; University of Wurzburg; University of Koblenz & Landau	Thormann, B (corresponding author), Zool Res Museum Alexander Koenig, Bonn, Germany.	birthe.thormann.zfmk@uni-bonn.de	Ahrens, Dirk/AAR-1310-2021; Wagner, Thomas/S-9370-2019	Peters, Marcell/0000-0002-1262-0827; Marin-Armijos, Diego/0000-0001-7138-3916	German Science Foundation (DFG) [WA 530/46-1]; Leibniz Association	German Science Foundation (DFG)(German Research Foundation (DFG)); Leibniz Association	Funding for this study was provided by grants of the German Science Foundation (DFG) to J.W.W. (WA 530/46-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The publication of this article was funded by the Open Access fund of the Leibniz Association.	Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Ahrens D, 2007, MOL PHYLOGENET EVOL, V44, P436, DOI 10.1016/j.ympev.2007.02.024; Andrew NR, 2004, ECOL ENTOMOL, V29, P527, DOI 10.1111/j.0307-6946.2004.00639.x; Astrin JJ, 2012, MOL PHYLOGENET EVOL, V63, P1, DOI 10.1016/j.ympev.2011.11.018; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Basset Y, 2004, J APPL ECOL, V41, P163, DOI 10.1111/j.1365-2664.2004.00878.x; Basset Y, 2001, BIOL J LINN SOC, V72, P585, DOI 10.1111/j.1095-8312.2001.tb01340.x; Basset Y, 2001, OECOLOGIA, V129, P253, DOI 10.1007/s004420100724; Basset Y, 2007, B I R SC N B ENTOMOL, V77; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; Beck EH, 2008, BASIC APPL ECOL, V9, P1, DOI 10.1016/j.baae.2007.06.017; Bendix J, 2006, INT J BIOMETEOROL, V50, P370, DOI 10.1007/s00484-006-0029-8; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Blackwelder RE, 1947, B US NATL MUSEUM, V185; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Borowiec Lech, 2000, Genus (Wroclaw), V11, P229; Borowiec Lech, 2000, Genus (Wroclaw), V11, P49; Borowiec Lech, 1998, Genus (Wroclaw), V9, P155; Bradshaw CJA, 2009, FRONT ECOL ENVIRON, V7, P79, DOI 10.1890/070193; Brehm G, 2003, J BIOGEOGR, V30, P431, DOI 10.1046/j.1365-2699.2003.00832.x; Brehm G, 2007, GLOBAL ECOL BIOGEOGR, V16, P205, DOI 10.1111/j.1466-8238.2006.00281.x; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Brummitt N, 2003, CONSERV BIOL, V17, P1442, DOI 10.1046/j.1523-1739.2003.02344.x; Cabrera N, 2001, PHYSIS A B C, V58, pC47; Cardoso A, 2005, MOL ECOL, V14, P3531, DOI 10.1111/j.1365-294X.2005.02679.x; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Chaboo CS, 2007, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2007)305[1:BAPOTC]2.0.CO;2; Chamorro ML, 2011, ZOOKEYS, P43, DOI 10.3897/zookeys.78.980; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Charles E, 2005, J TROP ECOL, V21, P329, DOI 10.1017/S0266467405002300; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coddington JA, 2009, J ANIM ECOL, V78, P573, DOI 10.1111/j.1365-2656.2009.01525.x; Cognato AI, 2006, J ECON ENTOMOL, V99, P1037, DOI 10.1603/0022-0493-99.4.1037; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Costa C, 2000, PROYECTO IBEROAMERIC; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Descampe A, 2008, ENVIRON ENTOMOL, V37, P224, DOI 10.1603/0046-225X(2008)37[224:PARFNO]2.0.CO;2; Didham Raphael K., 2003, Weta, V26, P1; Donoso DA, 2009, ANN SOC ENTOMOL FR, V45, P487, DOI 10.1080/00379271.2009.10697631; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; FAO, 2020, GLOBAL FOREST RESOUR; Farrell B.D., 1988, Series Entomologica (Dordrecht), V42, P73; Flowers RW, 2009, ZOOTAXA, P65, DOI 10.11646/zootaxa.2132.1.4; Flowers RW, 2009, ZOOTAXA, P65; Flowers RW, 2003, SPECIAL TOPICS LEAF, P25; Flowers Wills, 2009, Insecta Mundi, V0095, P1; Fontaneto D, 2011, HYDROBIOLOGIA, V662, P27, DOI 10.1007/s10750-010-0481-7; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Furth David G., 2003, International Congress of Entomology Proceedings, V21, P1; Furth David G., 1996, Insecta Mundi, V10, P45; Garcia-Lopez A, 2013, J BIOGEOGR, V40, P2134, DOI 10.1111/jbi.12148; Garcia-Robledo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052967; Gomez-Zurita J, 2008, CLADISTICS, V24, P34, DOI 10.1111/j.1096-0031.2007.00167.x; Gomez-Zurita J, 2014, SYST ENTOMOL, V39, P111, DOI 10.1111/syen.12038; Gotelli Nicholas J., 2011, P39; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Homeier J., 2008, V198, P87; Homeier J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047128; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Sanchez-Reyes UJ, 2014, ZOOKEYS, P103, DOI 10.3897/zookeys.417.7551; Jolivet P, 1988, BIOL CHRYSOMELIDAE; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Kanzaki N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043865; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Linzmeier AM, 2012, J NAT HIST, V46, P1921, DOI 10.1080/00222933.2012.707237; Linzmeier AM, 2013, BIOTA NEOTROP, V13, P153, DOI 10.1590/S1676-06032013000100018; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; Markmann M, 2005, PHILOS T R SOC B, V360, P1917, DOI 10.1098/rstb.2005.1723; May RM, 2010, SCIENCE, V329, P41, DOI 10.1126/science.1191058; Mayden R. L., 1997, V54, P381; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Monaghan MT, 2005, PHILOS T R SOC B, V360, P1925, DOI 10.1098/rstb.2005.1724; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Mosandl R., 2008, V198, P37; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Novotny V, 2000, OIKOS, V89, P564, DOI 10.1034/j.1600-0706.2000.890316.x; Odegaard F, 2000, BIOL J LINN SOC, V71, P583, DOI 10.1006/bijl.2000.0468; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Oliver I, 1996, ECOL APPL, V6, P594, DOI 10.2307/2269394; Papadopoulou A, 2013, ZOOL J LINN SOC-LOND, V168, P473, DOI 10.1111/zoj.12039; Papadopoulou A, 2011, AM NAT, V178, P241, DOI 10.1086/660828; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Rodriguez-Castaneda G, 2010, ECOL LETT, V13, P1348, DOI 10.1111/j.1461-0248.2010.01525.x; Sekerka L, 2012, ANN ZOOL, V62, P669, DOI 10.3161/000345412X659722; Sheffield CS, 2009, MOL ECOL RESOUR, V9, P196, DOI 10.1111/j.1755-0998.2009.02645.x; Smith MA, 2009, MOL ECOL RESOUR, V9, P208, DOI 10.1111/j.1755-0998.2009.02646.x; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Staines C.L., 2012, Insecta Mundi, V0232, P1; Staines CL, 2002, P ENTOMOL SOC WASH, V104, P721; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strutzenberger P, 2011, INSECT SCI, V18, P349, DOI 10.1111/j.1744-7917.2010.01366.x; Swietojanska Jolanta, 2000, Genus (Wroclaw), V11, P607; Tanzler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028832; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tang CQ, 2014, METHODS ECOL EVOL, V5, P1086, DOI 10.1111/2041-210X.12246; TEMPLETON AR, 1992, GENETICS, V132, P619; Templeton AR, 2001, MOL ECOL, V10, P779, DOI 10.1046/j.1365-294x.2001.01199.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Wagner T, 2000, BIOTROPICA, V32, P502, DOI 10.1111/j.1744-7429.2000.tb00496.x; Walther BA, 1998, PARASITOLOGY, V116, P395, DOI 10.1017/S0031182097002230; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	121	17	17	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148268	10.1371/journal.pone.0148268	http://dx.doi.org/10.1371/journal.pone.0148268			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849826	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000061
J	Tiptiri-Kourpeti, A; Spyridopoulou, K; Santarmaki, V; Aindelis, G; Tompoulidou, E; Lamprianidou, EE; Saxami, G; Ypsilantis, P; Lampri, ES; Simopoulos, C; Kotsianidis, I; Galanis, A; Kourkoutas, Y; Dimitrellou, D; Chlichlia, K				Tiptiri-Kourpeti, Angeliki; Spyridopoulou, Katerina; Santarmaki, Valentina; Aindelis, Georgios; Tompoulidou, Evgenia; Lamprianidou, Eleftheria E.; Saxami, Georgia; Ypsilantis, Petros; Lampri, Evangeli S.; Simopoulos, Constantinos; Kotsianidis, Ioannis; Galanis, Alex; Kourkoutas, Yiannis; Dimitrellou, Dimitra; Chlichlia, Katerina			Lactobacillus casei Exerts Anti-Proliferative Effects Accompanied by Apoptotic Cell Death and Up-Regulation of TRAIL in Colon Carcinoma Cells	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; SUPPRESSES TUMOR-GROWTH; GUT MICROBIOTA; COLORECTAL-CANCER; RHAMNOSUS-GG; PROBIOTIC BACTERIA; HT-29 CELLS; ANNEXIN-V; IN-VITRO; ATCC 393	Probiotic microorganisms such as lactic acid bacteria (LAB) exert a number of strain-specific health-promoting activities attributed to their immunomodulatory, anti-inflammatory and anti-carcinogenic properties. Despite recent attention, our understanding of the biological processes involved in the beneficial effects of LAB strains is still limited. To this end, the present study investigated the growth-inhibitory effects of Lactobacillus casei ATCC 393 against experimental colon cancer. Administration of live Lactobacillus casei (as well as bacterial components thereof) on murine (CT26) and human (HT29) colon carcinoma cell lines raised a significant concentration-and time-dependent anti-proliferative effect, determined by cell viability assays. Specifically, a dramatic decrease in viability of colon cancer cells co-incubated with 10(9) CFU/mL L. casei for 24 hours was detected (78% for HT29 and 52% for CT26 cells). In addition, live L. casei induced apoptotic cell death in both cell lines as revealed by annexin V and propidium iodide staining. The significance of the in vitro anti-proliferative effects was further confirmed in an experimental tumor model. Oral daily administration of 10(9) CFU live L. casei for 13 days significantly inhibited in vivo growth of colon carcinoma cells, resulting in approximately 80% reduction in tumor volume of treated mice. Tumor growth inhibition was accompanied by L. casei-driven up-regulation of the TNF-related apoptosis-inducing ligand TRAIL and down-regulation of Survivin. Taken together, these findings provide evidence for beneficial tumor-inhibitory, anti-proliferative and proapoptotic effects driven by this probiotic LAB strain.	[Tiptiri-Kourpeti, Angeliki; Spyridopoulou, Katerina; Santarmaki, Valentina; Aindelis, Georgios; Tompoulidou, Evgenia; Saxami, Georgia; Galanis, Alex; Kourkoutas, Yiannis; Dimitrellou, Dimitra; Chlichlia, Katerina] Democritus Univ Thrace, Sch Hlth Sci, Dept Mol Biol & Genet, Univ Campus Dragana, Alexandroupolis 68100, Greece; [Lamprianidou, Eleftheria E.; Kotsianidis, Ioannis] Democritus Univ Thrace, Sch Hlth Sci, Dept Hematol, Univ Campus Dragana, Alexandroupolis 68100, Greece; [Ypsilantis, Petros; Simopoulos, Constantinos] Democritus Univ Thrace, Sch Hlth Sci, Lab Expt Surg & Surg Res, Alexandroupolis 68100, Greece; [Lampri, Evangeli S.] Univ Ioannina, Sch Med, Dept Pathol, GR-45110 Ioannina, Greece	Democritus University of Thrace; Democritus University of Thrace; Democritus University of Thrace; University of Ioannina	Chlichlia, K (corresponding author), Democritus Univ Thrace, Sch Hlth Sci, Dept Mol Biol & Genet, Univ Campus Dragana, Alexandroupolis 68100, Greece.	achlichl@mbg.duth.gr	Dimitrellou, Dimitra/M-1242-2019; Chlichlia, Katerina/Q-3948-2019; Kotsianidis, Ioannis/AGH-1791-2022; Ypsilantis, Petros/AAO-8216-2021; Spyridopoulou, Katerina/AAJ-1631-2021; KOTSIANIDIS, IOANNIS/ABH-1436-2021; Ypsilantis, Petros/ABH-2143-2021; Galanis, Alex/ABF-4762-2020; Kourkoutas, Yiannis/AAM-8253-2021	Spyridopoulou, Katerina/0000-0003-4905-9567; KOTSIANIDIS, IOANNIS/0000-0001-7668-0186; Galanis, Alex/0000-0001-9991-3173; Simopoulos, Konstantinos/0000-0002-7994-3583; Chlichlia, Katerina/0000-0003-4952-0675; Dimitrellou, Dimitra/0000-0002-8120-7585	European Social Fund (ESF); Greek State	European Social Fund (ESF)(European Social Fund (ESF)); Greek State	The research project was implemented within the framework of the Action "Supporting Postdoctoral Researchers" of the Operational Program "Education and Lifelong Learning" (Action's Beneficiary: General Secretariat for Research and Technology), and was co-financed by the European Social Fund (ESF) and the Greek State.	Baldwin C, 2010, NUTR CANCER, V62, P371, DOI 10.1080/01635580903407197; Bianchi MA, 2004, LETT APPL MICROBIOL, V39, P301, DOI 10.1111/j.1472-765X.2004.01589.x; Castle JC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-190; Chen CC, 2012, BRIT J NUTR, V107, P1623, DOI 10.1017/S0007114511004934; Choi SS, 2006, LETT APPL MICROBIOL, V42, P452, DOI 10.1111/j.1472-765X.2006.01913.x; Cicenia A, 2014, J CLIN GASTROENTEROL, V48, pS18, DOI 10.1097/MCG.0000000000000231; Clarke RG, 2000, CYTOMETRY, V39, P141, DOI 10.1002/(SICI)1097-0320(20000201)39:2<141::AID-CYTO7>3.3.CO;2-F; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; CORBETT TH, 1975, CANCER RES, V35, P2434; de LeBlanc AD, 2014, WORLD J GASTROENTERO, V20, P16518, DOI 10.3748/wjg.v20.i44.16518; Di Luccia B, 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0069102; Diao ZJ, 2013, CANCER IMMUNOL IMMUN, V62, P653, DOI 10.1007/s00262-012-1370-x; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Escamilla J, 2012, NUTR CANCER, V64, P871, DOI 10.1080/01635581.2012.700758; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Fang J, 2014, J PHARM SCI-US, V103, P3235, DOI 10.1002/jps.24083; Fogh J, 1975, HUMAN TUMOR CELLS IN; Galligan L, 2005, MOL CANCER THER, V4, P2026, DOI 10.1158/1535-7163.MCT-05-0262; Gianotti L, 2010, WORLD J GASTROENTERO, V16, P167, DOI 10.3748/wjg.v16.i2.167; Hirayama K, 2000, MICROBES INFECT, V2, P681, DOI 10.1016/S1286-4579(00)00357-9; Horinaka M, 2010, FEBS LETT, V584, P577, DOI 10.1016/j.febslet.2009.12.004; Ishii M, 2007, CANCER LETT, V245, P134, DOI 10.1016/j.canlet.2005.12.040; Ishikawa H, 2005, INT J CANCER, V116, P762, DOI 10.1002/ijc.21115; Iyer C, 2008, CELL MICROBIOL, V10, P1442, DOI 10.1111/j.1462-5822.2008.01137.x; KATO I, 1994, INT J IMMUNOPHARMACO, V16, P29, DOI 10.1016/0192-0561(94)90116-3; KATO I, 1981, GANN, V72, P517; Khazaie K, 2012, P NATL ACAD SCI USA, V109, P10462, DOI 10.1073/pnas.1207230109; Kim JE, 2007, J MICROBIOL BIOTECHN, V17, P1227; Kim Y, 2010, LETT APPL MICROBIOL, V51, P123, DOI 10.1111/j.1472-765X.2010.02859.x; Kodaikkal V., 2012, INT J APPL ANIMAL SC, V1, P01; Kourkoutas Y, 2006, J DAIRY SCI, V89, P1439, DOI 10.3168/jds.S0022-0302(06)72212-3; Kumar M, 2010, INT J FOOD SCI NUTR, V61, P473, DOI 10.3109/09637480903455971; Lan A, 2007, APOPTOSIS, V12, P573, DOI 10.1007/s10495-006-0010-3; Lee Jung-Woo, 2004, J Vet Sci, V5, P41; Liu CT, 2011, MUTAT RES-GEN TOX EN, V721, P157, DOI 10.1016/j.mrgentox.2011.01.005; Marco ML, 2006, CURR OPIN BIOTECH, V17, P204, DOI 10.1016/j.copbio.2006.02.005; MATSUZAKI T, 1985, CANCER IMMUNOL IMMUN, V20, P18; Neish AS, 2011, J CLIN GASTROENTEROL, V45, P571, DOI 10.1097/MCG.0b013e318219221d; Oelschlaeger TA, 2010, INT J MED MICROBIOL, V300, P57, DOI 10.1016/j.ijmm.2009.08.005; Orlando A, 2012, NUTR CANCER, V64, P1103, DOI 10.1080/01635581.2012.717676; Pagnini C, 2011, J CLIN GASTROENTEROL, V45, P602, DOI 10.1097/MCG.0b013e31820abf29; Pagnini C, 2010, P NATL ACAD SCI USA, V107, P454, DOI 10.1073/pnas.0910307107; Rafter J, 2004, NUTR RES REV, V17, P277, DOI 10.1079/NRR200484; Rauch M, 2010, GUT MICROBES, V1, P335, DOI 10.4161/gmic.1.5.13169; Raviv Z, 2011, BRIT J PHARMACOL, V164, P1422; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seow SW, 2010, CANCER SCI, V101, P751, DOI 10.1111/j.1349-7006.2009.01426.x; Serban DE, 2014, CANCER LETT, V345, P258, DOI 10.1016/j.canlet.2013.08.013; Shida K, 2011, GUT MICROBES, V2, P109, DOI 10.4161/gmic.2.2.15661; Sidira M, 2014, MEAT SCI, V96, P948, DOI 10.1016/j.meatsci.2013.09.013; Sidira M, 2013, J DAIRY SCI, V96, P3369, DOI 10.3168/jds.2012-6343; Sidira M, 2010, J MOL MICROB BIOTECH, V19, P224, DOI 10.1159/000321115; Stolfi C, 2011, MOL CANCER THER, V10, P1969, DOI 10.1158/1535-7163.MCT-11-0316; Sung BK, 2010, J BIOL CHEM, V285, P35418, DOI 10.1074/jbc.M110.172767; Tsilingiri K, 2013, BENEF MICROBES, V4, P101, DOI 10.3920/BM2012.0046; Tuo YF, 2010, J DAIRY SCI, V93, P2362, DOI 10.3168/jds.2010-3069; Uccello M, 2012, BMC SURG, V12, DOI 10.1186/1471-2482-12-S1-S35; van Geelen CMM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-39; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Walsh CJ, 2014, FEBS LETT, V588, P4120, DOI 10.1016/j.febslet.2014.03.035; Wan Y, 2014, ONCOL LETT, V7, P1738, DOI 10.3892/ol.2014.1959; Wang K, 2014, INT J BIOL MACROMOL, V63, P133, DOI 10.1016/j.ijbiomac.2013.10.036; Wang SM, 2014, RES MICROBIOL, V165, P202, DOI 10.1016/j.resmic.2014.02.004; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031; Zhong L, 2014, WORLD J GASTROENTERO, V20, P7878, DOI 10.3748/wjg.v20.i24.7878; Zhu YM, 2011, CANCER LETT, V309, P119, DOI 10.1016/j.canlet.2011.06.004	68	139	144	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147960	10.1371/journal.pone.0147960	http://dx.doi.org/10.1371/journal.pone.0147960			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849051	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000030
J	Wei, CH; Chen, JJ; Kuang, HH				Wei, Chunhua; Chen, Jiongjiong; Kuang, Hanhui			Dramatic Number Variation of R Genes in Solanaceae Species Accounted for by a Few R Gene Subfamilies	PLOS ONE			English	Article							DISEASE RESISTANCE GENES; NUCLEOTIDE-BINDING SITE; REPEAT-ENCODING GENES; GENOME-WIDE ANALYSIS; PROVIDES INSIGHTS; EVOLUTIONARY PATTERNS; TOMATO; SOLANUM; FAMILY; SEQUENCE	Most disease resistance genes encode nucleotide-binding-site (NBS) and leucine-rich-repeat (LRR) domains, and the NBS-LRR encoding genes are often referred to as R genes. Using newly developed approach, 478, 485, 1,194, 1,665, 2,042 and 374 R genes were identified from the genomes of tomato Heinz1706, wild tomato LA716, potato DM1-3, pepper Zunla-1 and wild pepper Chiltepin and tobacco TN90, respectively. The majority of R genes from Solanaceae were grouped into 87 subfamilies, including 16 TIR-NBS-LRR (TNL) and 71 non-TNL subfamilies. Each subfamily was annotated manually, including identification of intron/exon structure and intron phase. Interestingly, TNL subfamilies have similar intron phase patterns, while the non-TNL subfamilies have diverse intron phase due to frequent gain of introns. Prevalent presence/absence polymorphic R gene loci were found among Solanaceae species, and an integrated map with 427 R loci was constructed. The pepper genome (2,042 in Chiltepin) has at least four times of R genes as in tomato (478 in Heinz1706). The high number of R genes in pepper genome is due to the amplification of R genes in a few subfamilies, such as the Rpi-blb2 and BS2 subfamilies. The mechanism underlying the variation of R gene number among different plant genomes is discussed.	[Wei, Chunhua; Chen, Jiongjiong; Kuang, Hanhui] Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, MOA,Coll Hort & Forestry Sci, Wuhan 430070, Peoples R China; [Wei, Chunhua; Chen, Jiongjiong; Kuang, Hanhui] Huazhong Agr Univ, Key Lab Hort Crop Biol & Genet Improvement Cent R, MOA, Coll Hort & Forestry Sci, Wuhan 430070, Peoples R China; [Wei, Chunhua] Northwest A&F Univ, Coll Hort, Yangling 712100, Shanxi, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Northwest A&F University - China	Chen, JJ (corresponding author), Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, MOA,Coll Hort & Forestry Sci, Wuhan 430070, Peoples R China.; Chen, JJ (corresponding author), Huazhong Agr Univ, Key Lab Hort Crop Biol & Genet Improvement Cent R, MOA, Coll Hort & Forestry Sci, Wuhan 430070, Peoples R China.	jjchen@mail.hzau.edu.cn			National Natural Science Foundation of China [31221062, 31272030]; "973" National Key Basic Research Program [2009CB119000]; Natural Science Foundation of Hubei Province of China [2013CFB204]; Fundamental Research Funds for the Central Universities [2014PY031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973" National Key Basic Research Program(National Basic Research Program of China); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China: No. [31221062] and [31272030]; "973" National Key Basic Research Program: no. 2009CB119000; Natural Science Foundation of Hubei Province of China: NO. [2013CFB204]; The Fundamental Research Funds for the Central Universities: No.[2014PY031].	Andolfo G, 2013, NEW PHYTOL, V197, P223, DOI 10.1111/j.1469-8137.2012.04380.x; Andolfo G, 2014, MOL BREEDING; Arya P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107987; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bolger A, 2014, NAT GENET, V46, P1034, DOI 10.1038/ng.3046; Denoeud F, 2014, SCIENCE, V345, P1181, DOI 10.1126/science.1255274; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ernst K, 2002, PLANT J, V31, P127, DOI 10.1046/j.1365-313X.2002.01341.x; Gu L, 2014, MOL GENET GENOMICS; Guo YL, 2011, PLANT PHYSIOL, V157, P757, DOI 10.1104/pp.111.181990; He LM, 2004, MOL PLANT MICROBE IN, V17, P1234, DOI 10.1094/MPMI.2004.17.11.1234; Hirakawa H, 2014, DNA RES; Jinling Liu, 2007, Journal of Genetics and Genomics, V34, P765, DOI 10.1016/S1673-8527(07)60087-3; Jupe F, 2013, PLANT J, V76, P530, DOI 10.1111/tpj.12307; Jupe F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-75; Kim Seungill, 2014, Nat Genet, V46, P270, DOI 10.1038/ng.2877; Kuang H, 2004, PLANT CELL, V16, P2870, DOI 10.1105/tpc.104.025502; Lin X, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-335; Lozano R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1554-9; Lozano R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034775; Luo S, 2012, PLANT PHYSIOL, V159, P197, DOI 10.1104/pp.111.192062; Luo S, 2011, MOL BIOL EVOL, V28, P313, DOI 10.1093/molbev/msq216; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Meyers BC, 2005, CURR OPIN PLANT BIOL, V8, P129, DOI 10.1016/j.pbi.2005.01.002; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Nguyen HD, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-69; Park TH, 2005, MOL PLANT MICROBE IN, V18, P722, DOI 10.1094/MPMI-18-0722; Porter BW, 2009, MOL GENET GENOMICS, V281, P609, DOI 10.1007/s00438-009-0434-x; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Richly E, 2002, MOL BIOL EVOL, V19, P76, DOI 10.1093/oxfordjournals.molbev.a003984; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Shao ZQ, 2014, PLANT PHYSIOL, V166, P217, DOI 10.1104/pp.114.243626; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; Sierro N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4833; Simons G, 1998, PLANT CELL, V10, P1055, DOI 10.1105/tpc.10.6.1055; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan SL, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/418208; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wei CH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-743; Wei Hengling, 2013, PLoS One, V8, pe68435, DOI 10.1371/journal.pone.0068435; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Yang SH, 2013, P NATL ACAD SCI USA, V110, P18572, DOI 10.1073/pnas.1318211110	49	26	30	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148708	10.1371/journal.pone.0148708	http://dx.doi.org/10.1371/journal.pone.0148708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849045	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000162
J	Lampert, A; Tlusty, T				Lampert, Adam; Tlusty, Tsvi			Where Two Are Fighting, the Third Wins: Stronger Selection Facilitates Greater Polymorphism in Traits Conferring Competition-Dispersal Tradeoffs	PLOS ONE			English	Article							EVOLUTION; COOPERATION; DYNAMICS; SIZE; GERMINATION; STRATEGIES; STABILITY; RESOURCE; GROWTH	A major conundrum in evolution is that, despite natural selection, polymorphism is still omnipresent in nature: Numerous species exhibit multiple morphs, namely several abundant values of an important trait. Polymorphism is particularly prevalent in asymmetric traits, which are beneficial to their carrier in disruptive competitive interference but at the same time bear disadvantages in other aspects, such as greater mortality or lower fecundity. Here we focus on asymmetric traits in which a better competitor disperses fewer offspring in the absence of competition. We report a general pattern in which polymorphic populations emerge when disruptive selection increases: The stronger the selection, the greater the number of morphs that evolve. This pattern is general and is insensitive to the form of the fitness function. The pattern is somewhat counterintuitive since directional selection is excepted to sharpen the trait distribution and thereby reduce its diversity (but note that similar patterns were suggested in studies that demonstrated increased biodiversity as local selection increases in ecological communities). We explain the underlying mechanism in which stronger selection drives the population towards more competitive values of the trait, which in turn reduces the population density, thereby enabling lesser competitors to stably persist with reduced need to directly compete. Thus, we believe that the pattern is more general and may apply to asymmetric traits more broadly. This robust pattern suggests a comparative, unified explanation to a variety of polymorphic traits in nature.	[Lampert, Adam] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Lampert, Adam] Arizona State Univ, Math Computat & Modeling Sci Ctr, Tempe, AZ 85287 USA; [Tlusty, Tsvi] Inst Adv Study, Simons Ctr Syst Biol, Olden Lane, Princeton, NJ 08540 USA; [Tlusty, Tsvi] Inst Adv Study, Sch Nat Sci, Olden Lane, Princeton, NJ 08540 USA; [Tlusty, Tsvi] UNIST, IBS, Dept Phys, UNIST Gil 50, Ulsan 689798, South Korea; [Tlusty, Tsvi] UNIST, IBS, Ctr Soft & Living Matter, UNIST Gil 50, Ulsan 689798, South Korea	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Institute for Advanced Study - USA; Institute for Advanced Study - USA; Institute for Basic Science - Korea (IBS); Ulsan National Institute of Science & Technology (UNIST); Institute for Basic Science - Korea (IBS); Ulsan National Institute of Science & Technology (UNIST)	Lampert, A (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA.; Lampert, A (corresponding author), Arizona State Univ, Math Computat & Modeling Sci Ctr, Tempe, AZ 85287 USA.	adam.lampert@asu.edu	Tlusty, Tsvi/A-9880-2008	Tlusty, Tsvi/0000-0002-9662-3725	School of Human Evolution and Social Change, Arizona State University; Institute for Basic Science [IBS-R020-D1]; Simons Center for Systems Biology at the Institute for Advanced Study	School of Human Evolution and Social Change, Arizona State University; Institute for Basic Science; Simons Center for Systems Biology at the Institute for Advanced Study	We thank Jon Wilkins, Tamar Fridlander, Rami Pugatch, Gyuri Barabas and another (anonymous) reviewer for helpful comments on the manuscript. A.L. is supported by the School of Human Evolution and Social Change, Arizona State University. T.T. has been partly supported by the Institute for Basic Science (IBS-R020-D1) and the Simons Center for Systems Biology at the Institute for Advanced Study.	Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067; ATKINSON WD, 1981, J ANIM ECOL, V50, P461, DOI 10.2307/4067; Barabas G, 2013, THEOR ECOL-NETH, V6, P1, DOI 10.1007/s12080-011-0151-z; Burger R, 2010, THEOR POPUL BIOL, V78, P123, DOI 10.1016/j.tpb.2010.06.002; Burger R, 2005, J MATH BIOL, V50, P355, DOI 10.1007/s00285-004-0294-2; CHRISTIANSEN FB, 1980, THEOR POPUL BIOL, V18, P297, DOI 10.1016/0040-5809(80)90056-8; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dieckmann U, 1996, J MATH BIOL, V34, P579, DOI 10.1007/BF02409751; Doebeli M, 2004, SCIENCE, V306, P859, DOI 10.1126/science.1101456; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Emlen DJ, 2000, BIOSCIENCE, V50, P403, DOI 10.1641/0006-3568(2000)050[0403:IDWEAC]2.0.CO;2; Eshel I, 1996, J MATH BIOL, V34, P485; FLINT SD, 1978, OECOLOGIA, V36, P33, DOI 10.1007/BF00344569; Gavrilets S, 2003, EVOLUTION, V57, P2197; Gavrilets S, 2004, FITNESS LANDSCAPES O; Geritz SAH, 2000, P ROY SOC B-BIOL SCI, V267, P1671, DOI 10.1098/rspb.2000.1194; Geritz SAH, 1999, THEOR POPUL BIOL, V55, P324, DOI 10.1006/tpbi.1998.1409; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hanski I., 1999, METAPOPULATION ECOLO; HASTINGS A, 1980, THEOR POPUL BIOL, V18, P363, DOI 10.1016/0040-5809(80)90059-3; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Jansen VAA, 1999, ECOL LETT, V2, P379; Johnson C.G., 1969, MIGRATION DISPERSAL; Johnson TC, 1996, SCIENCE, V273, P1091, DOI 10.1126/science.273.5278.1091; KHAN MA, 1984, AM J BOT, V71, P481, DOI 10.2307/2443323; Kinzig AP, 1999, AM NAT, V153, P371, DOI 10.1086/303182; Kisdi E, 1999, J THEOR BIOL, V197, P149, DOI 10.1006/jtbi.1998.0864; Kondrashov AS, 1999, NATURE, V400, P351, DOI 10.1038/22514; Lampert A, 2014, ECOL COMPLEX, V19, P80, DOI 10.1016/j.ecocom.2014.05.002; Lampert A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0559; Lampert A, 2013, P NATL ACAD SCI USA, V110, P205, DOI 10.1073/pnas.1211761110; Lampert A, 2011, EVOLUTION, V65, P2750, DOI 10.1111/j.1558-5646.2011.01364.x; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; MAY RM, 1994, J THEOR BIOL, V170, P95, DOI 10.1006/jtbi.1994.1171; Maynard Smith J., 1982, pi; Nagylaki T, 2007, THEOR POPUL BIOL, V72, P21, DOI 10.1016/j.tpb.2007.02.005; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pillai P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033566; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Ross-Gillespie A, 2009, EVOLUTION, V63, P2315, DOI 10.1111/j.1558-5646.2009.00723.x; Rowland JM, 2009, SCIENCE, V323, P773, DOI 10.1126/science.1167345; RYAN MJ, 1992, AM NAT, V139, P21, DOI 10.1086/285311; Schliewen UK, 1994, NATURE, V400, P351; Schneider KA, 2007, THEOR POPUL BIOL, V71, P342, DOI 10.1016/j.tpb.2006.11.003; SHORROCKS B, 1979, J ANIM ECOL, V48, P899, DOI 10.2307/4202; SHUSTER SM, 1991, NATURE, V350, P608, DOI 10.1038/350608a0; TAYLOR LR, 1975, J ANIM ECOL, V44, P135, DOI 10.2307/3855; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143	52	0	0	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147970	10.1371/journal.pone.0147970	http://dx.doi.org/10.1371/journal.pone.0147970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845157	Green Submitted, Green Published, gold			2022-12-27	WOS:000369552800023
J	Jurets, A; Le Bras, M; Staffler, G; Stein, G; Leitner, L; Neuhofer, A; Tardelli, M; Turkof, E; Zeyda, M; Stulnig, TM				Juerets, Alexander; Le Bras, Marie; Staffler, Guenther; Stein, Gesine; Leitner, Lukas; Neuhofer, Angelika; Tardelli, Matteo; Turkof, Edvin; Zeyda, Maximilian; Stulnig, Thomas M.			Inhibition of Cellular Adhesion by Immunological Targeting of Osteopontin Neoepitopes Generated through Matrix Metalloproteinase and Thrombin Cleavage	PLOS ONE			English	Article							CRYPTIC EPITOPE SLAYGLR; RHEUMATOID-ARTHRITIS; ADIPOSE-TISSUE; LIGAND INTERACTION; PROTEOLYTIC FRAGMENTS; INSULIN-RESISTANCE; TERMINAL FRAGMENT; INTEGRIN; EXPRESSION; OBESITY	Osteopontin (OPN), a secreted protein involved in inflammatory processes and cancer, induces cell adhesion, migration, and activation of inflammatory pathways in various cell types. Cells bind OPN via integrins at a canonical RGD region in the full length form as well as to a contiguous cryptic site that some have shown is unmasked upon thrombin or matrix metalloproteinase cleavage. Thus, the adhesive capacity of osteopontin is enhanced by proteolytic cleavage that may occur in inflammatory conditions such as obesity, atherosclerosis, rheumatoid arthritis, tumor growth and metastasis. Our aim was to inhibit cellular adhesion to recombinant truncated proteins that correspond to the N-terminal cleavage products of thrombin-or matrix metalloproteinase-cleaved OPN in vitro. We specifically targeted the cryptic integrin binding site with monoclonal antibodies and antisera induced by peptide immunization of mice. HEK 293 cells adhered markedly stronger to truncated OPN proteins than to full length OPN. Without affecting cell binding to the full length form, the raised monoclonal antibodies specifically impeded cellular adhesion to the OPN fragments. Moreover, we show that the peptides used for immunization were able to induce antisera, which impeded adhesion either to all OPN forms, including the full-length form, or selectively to the corresponding truncated recombinant proteins. In conclusion, we developed immunological tools to selectively target functional properties of protease-cleaved OPN forms, which could find applications in treatment and prevention of various inflammatory diseases and cancers.	[Juerets, Alexander; Stein, Gesine; Leitner, Lukas; Neuhofer, Angelika; Tardelli, Matteo; Zeyda, Maximilian; Stulnig, Thomas M.] Med Univ Vienna, Christian Doppler Lab Cardiometab Immunotherapy, Vienna, Austria; [Juerets, Alexander; Stein, Gesine; Leitner, Lukas; Neuhofer, Angelika; Tardelli, Matteo; Zeyda, Maximilian; Stulnig, Thomas M.] Med Univ Vienna, Dept Med 3, Clin Div Endocrinol & Metab, Vienna, Austria; [Le Bras, Marie; Staffler, Guenther] AFFiRiS AG, A-1030 Vienna, Austria; [Turkof, Edvin] Med Univ Vienna, Dept Plast & Reconstruct Surg, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Stulnig, TM (corresponding author), Med Univ Vienna, Christian Doppler Lab Cardiometab Immunotherapy, Vienna, Austria.	thomas.stulnig@meduniwien.ac.at	Tardelli, Matteo/U-3834-2019; Jürets, Alexander/K-3469-2019	Tardelli, Matteo/0000-0003-2232-7779; Neuhofer, Angelika/0000-0002-8989-6207; Stulnig, Thomas/0000-0003-3300-6161; Zeyda, Maximilian/0000-0001-5000-1974	Austrian Federal Ministry of Science, Research and Economy; National Foundation for Research, Technology and Development; AFFiRiS AG	Austrian Federal Ministry of Science, Research and Economy; National Foundation for Research, Technology and Development; AFFiRiS AG	This study was funded by the Austrian Federal Ministry of Science, Research and Economy and the National Foundation for Research, Technology and Development (to TMS). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. AFFiRiS AG provided support in the form of salaries for authors MLB and GS, but did not have any additional role in the study design, data collection and analysis, or decision to publish.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Bachmann MF, 2013, VACCINE, V31, P1777, DOI 10.1016/j.vaccine.2013.02.001; Barry ST, 2000, EXP CELL RES, V258, P342, DOI 10.1006/excr.2000.4941; Barry ST, 2000, BIOCHEM BIOPH RES CO, V267, P764, DOI 10.1006/bbrc.1999.2032; Bayless KJ, 1998, J CELL SCI, V111, P1165; Boumans MJH, 2012, ANN RHEUM DIS, V71, P180, DOI 10.1136/annrheumdis-2011-200298; Breyne J, 2010, ATHEROSCLEROSIS, V213, P369, DOI 10.1016/j.atherosclerosis.2010.07.047; BROWN LF, 1994, AM J PATHOL, V145, P610; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Christensen B, 2014, J DAIRY SCI, V97, P136, DOI 10.3168/jds.2013-7223; Christensen B, 2010, J BIOL CHEM, V285, P7929, DOI 10.1074/jbc.M109.075010; Denda S, 1998, MOL BIOL CELL, V9, P1425, DOI 10.1091/mbc.9.6.1425; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Gabazza EC, 1999, LUNG, V177, P253, DOI 10.1007/PL00007645; Galabova G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114469; Gao YA, 2004, MATRIX BIOL, V23, P457, DOI 10.1016/j.matbio.2004.09.003; GIACHELLI CM, 1995, ANN NY ACAD SCI, V760, P109, DOI 10.1111/j.1749-6632.1995.tb44624.x; Gravallese EM, 2003, J CLIN INVEST, V112, P147, DOI 10.1172/JCI200310109; Hamamoto S, 2011, J BONE MINER RES, V26, P2967, DOI 10.1002/jbmr.495; Hasegawa M, 2009, J RHEUMATOL, V36, P240, DOI 10.3899/jrheum.080753; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hoshino M, 1998, J ALLERGY CLIN IMMUN, V102, P783, DOI 10.1016/S0091-6749(98)70018-1; HU DD, 1995, J BIOL CHEM, V270, P26232, DOI 10.1074/jbc.270.44.26232; Hui T, 2015, MATRIX BIOL, V41, P19, DOI 10.1016/j.matbio.2014.11.005; Ito K, 2009, MATRIX BIOL, V28, P11, DOI 10.1016/j.matbio.2008.10.002; Kahles F, 2014, MOL METAB, V3, P384, DOI 10.1016/j.molmet.2014.03.004; Kessenbrock K, 2015, MATRIX BIOL, V44-46, P184, DOI 10.1016/j.matbio.2015.01.022; Kiefer FW, 2010, DIABETES, V59, P935, DOI 10.2337/db09-0404; Kon S, 2002, J CELL BIOCHEM, V84, P420, DOI 10.1002/jcb.10039; Konno S, 2011, CLIN EXP ALLERGY, V41, P1360, DOI 10.1111/j.1365-2222.2011.03775.x; Leitner L, 2015, OBESITY, V23, P779, DOI 10.1002/oby.21024; Madden HL, 2000, AM J RESP CRIT CARE, V162, P1553, DOI 10.1164/ajrccm.162.4.2001015; Maquoi E, 2002, DIABETES, V51, P1093, DOI 10.2337/diabetes.51.4.1093; Mas-Moruno C, 2010, ANTI-CANCER AGENT ME, V10, P753, DOI 10.2174/187152010794728639; Megaptche AP, 2014, IMMUNOL CELL BIOL, V92, P709, DOI 10.1038/icb.2014.47; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Overstreet MG, 2013, NAT IMMUNOL, V14, P949, DOI 10.1038/ni.2682; Petrow PK, 2000, ARTHRITIS RHEUM, V43, P1597, DOI 10.1002/1529-0131(200007)43:7<1597::AID-ANR25>3.0.CO;2-0; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Platzer G, 2011, BIOCHEMISTRY-US, V50, P6113, DOI 10.1021/bi200291e; Schack L, 2009, J IMMUNOL, V182, P6943, DOI 10.4049/jimmunol.0900065; SENGER DR, 1989, BIOCHIM BIOPHYS ACTA, V996, P43, DOI 10.1016/0167-4838(89)90092-7; Shao ZF, 2014, J BIOL CHEM, V289, P27146, DOI 10.1074/jbc.M114.572172; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; Smith LL, 1999, J CELL BIOCHEM, V73, P20, DOI 10.1002/(SICI)1097-4644(19990401)73:1<20::AID-JCB3>3.0.CO;2-3; Vacek TP, 2015, VASC HEALTH RISK MAN, V11, P173, DOI 10.2147/VHRM.S68415; Wang MY, 2015, P NATL ACAD SCI USA, V112, P2503, DOI 10.1073/pnas.1424934112; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Weetall M, 2001, ANAL BIOCHEM, V293, P277, DOI 10.1006/abio.2001.5140; Weis SM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006478; Yamamoto N, 2003, J CLIN INVEST, V112, P181, DOI 10.1172/JCI200317778; Yamamoto N, 2007, INT IMMUNOPHARMACOL, V7, P1460, DOI 10.1016/j.intimp.2007.06.009; Yokosaki Y, 2005, MATRIX BIOL, V24, P418, DOI 10.1016/j.matbio.2005.05.005; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Zeyda M, 2011, ENDOCRINOLOGY, V152, P2219, DOI 10.1210/en.2010-1328; Zhang FJ, 2015, RHEUMATOL INT, V35, P589, DOI 10.1007/s00296-014-3122-z	57	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148333	10.1371/journal.pone.0148333	http://dx.doi.org/10.1371/journal.pone.0148333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840958	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200127
J	Ramos, A; Petit, O; Longour, P; Pasquaretta, C; Sueur, C				Ramos, Amandine; Petit, Odile; Longour, Patrice; Pasquaretta, Cristian; Sueur, Cedric			Space Use and Movement Patterns in a Semi-Free-Ranging Herd of European Bison (Bison bonasus)	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; FLIGHT SEARCH PATTERNS; SEXUAL SEGREGATION; ACTIVITY BUDGETS; DECISION-MAKING; HOME-RANGE; LEVY; CONSERVATION; DENSITY; BEHAVIOR	The successful reintroduction and restocking of the European Bison demands a reliable knowledge of the biology of this species. Yet little is known to date about the European bison, and empirical data remains insufficient to set up a reliable plan ensuring the reintroduction, maintenance and survival of populations in habitats that have been largely modified by human activity. Studies of the ecology, social behaviour and management of bison are therefore crucial to the conservation of this species and its cohabitation with humans. To meet these challenges, we focused on movement patterns and space use in a semi-free-ranging herd of European bison living in the Reserve Biologique des Monts-d'Azur (France). Bison spend over 80% of their time foraging and resting; foraging mainly occurs around the artificial feeding sites (i.e., hay racks) or in meadows. The time of day and the presence of snow have no influence on the time budget allocated to each activity. Animals, however, spend more time at the food racks in winter. Bison also spend most of their time in small groups of individuals, confirming the occurrence of both fission-fusion dynamics and sexual segregation in this species. Bison seem to follow a Levy walk pattern of movement, which is probably related to the geographical distribution and size of food patches in the reserve. The conclusions of this study provide a better understanding of the sociality, life habits and habitat use of bison, and also describe how the provision of hay affects all these behaviours. These results could be useful in the development of tools to select the most suitable habitats for the reintroduction, management and conservation of bison populations.	[Ramos, Amandine; Petit, Odile; Pasquaretta, Cristian; Sueur, Cedric] Ctr Natl Rech Sci, Dept Ecol Physiol & Ethol, Strasbourg, France; [Ramos, Amandine; Petit, Odile; Pasquaretta, Cristian; Sueur, Cedric] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Longour, Patrice] Domaine Haut Thorenc, Reserve Biol Monts dAzur, Thorenc, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sueur, C (corresponding author), Ctr Natl Rech Sci, Dept Ecol Physiol & Ethol, Strasbourg, France.; Sueur, C (corresponding author), Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France.	cedric.sueur@iphc.cnrs.fr	Pasquaretta, Cristian/AAA-3364-2021; Sueur, Cédric/A-4020-2011	Pasquaretta, Cristian/0000-0001-8308-9968; Sueur, Cédric/0000-0001-8206-2739	Fyssen Foundation	Fyssen Foundation	The authors thank Baptiste Vivinus for his help during bison observations. C.S. gratefully acknowledges the support of the Fyssen Foundation.	Aldezabal A, 2010, PIRINEOS, V153, P145; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Balciauskas Linas, 1999, Acta Zoologica Lituanica, V9, P3; Benecke N, 2015, ANTROPOLOGIA ARKEOLO, V57, P421; Bocherens H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115090; Bon R, 1996, BEHAV PROCESS, V38, P131, DOI 10.1016/S0376-6357(96)00029-0; Bowyer RT, 2004, J MAMMAL, V85, P1039, DOI 10.1644/BBL-002.1; CABONRACZYNSKA K, 1983, ACTA THERIOL, V28, P273, DOI 10.4098/AT.arch.83-22; CABONRACZYNSKA K, 1987, ACTA THERIOL, V32, P335, DOI 10.4098/AT.arch.87-24; Caro T, 2013, ANIM BEHAV, V85, P305, DOI 10.1016/j.anbehav.2012.11.007; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Couzin ID, 2009, CURR BIOL, V19, pR633, DOI 10.1016/j.cub.2009.05.034; DANELL K, 1994, J MAMMAL, V75, P833, DOI 10.2307/1382465; Edwards AM, 2008, J ANIM ECOL, V77, P1212, DOI 10.1111/j.1365-2656.2008.01428.x; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; ERRIKSSON LO, 1981, OECOLOGIA, V48, P64, DOI 10.1007/BF00346989; Fersterer P, 2001, URSUS-SERIES, V12, P51; Fieberg J, 2007, ECOLOGY, V88, P1059, DOI 10.1890/06-0930; Focardi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006587; Fortin D, 2009, ANIM BEHAV, V78, P887, DOI 10.1016/j.anbehav.2009.06.026; Hastings A, 2007, ECOL LETT, V10, P153, DOI 10.1111/j.1461-0248.2006.00997.x; Hoffman TS, 2012, ECOL SOC, V17, DOI 10.5751/ES-04882-170313; Hofman-Kaminska E, 2012, ENVIRON MANAGE, V50, P530, DOI 10.1007/s00267-012-9913-7; HOLM S, 1979, SCAND J STAT, V6, P65; Hudson RJ, 2006, J RANGE MANAGEMENT A, V54, P218; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Jacobs A, 2010, BEHAV PROCESS, V84, P678, DOI 10.1016/j.beproc.2010.03.004; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Kaplan BS, 2011, INT J PRIMATOL, V32, P1397, DOI 10.1007/s10764-011-9541-8; Kerley GIH, 2012, ECOGRAPHY, V35, P519, DOI 10.1111/j.1600-0587.2011.07146.x; Kowalczyk R, 2013, ACTA THERIOL, V58, P391, DOI 10.1007/s13364-013-0136-y; Kozlo P, 2011, EUROPEAN BISON CONSE, V4, P37; KRASINSKA M, 1995, ACTA THERIOL, V40, P1; Krasinska M, 2000, ACTA THERIOL, V45, P321, DOI 10.4098/AT.arch.00-32; Kuemmerle T, 2011, ECOL APPL, V21, P830, DOI 10.1890/10-0073.1; Kuemmerle T, 2010, BIOL CONSERV, V143, P908, DOI 10.1016/j.biocon.2009.12.038; Kuijper DPJ, 2010, J VEG SCI, V21, P1082, DOI 10.1111/j.1654-1103.2010.01217.x; Landman M, 2014, BIOTROPICA, V46, P42, DOI 10.1111/btp.12066; McHugh T, 1958, SOCIAL BEHAV AM BUFF; Mendoza M, 2008, J ZOOL, V274, P134, DOI 10.1111/j.1469-7998.2007.00365.x; Merkle JA, 2015, ECOL LETT, V18, P799, DOI 10.1111/ele.12457; Merkle JA, 2015, ECOLOGY, V96, P1793, DOI 10.1890/14-0805.1; Mooring MS, 2005, BEHAVIOUR, V142, P897, DOI 10.1163/1568539055010110; Mysterud A, 2007, ANIM CONSERV, V10, P77, DOI 10.1111/j.1469-1795.2006.00075.x; Neuhaus P, 2002, CAN J ZOOL, V80, P1437, DOI 10.1139/Z02-126; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Parnikoza I., 2009, EUROPEAN BISON CONSE, V2, P5; Pays O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034678; Perzanowski K, 2007, WILDLIFE BIOL, V13, P108, DOI 10.2981/0909-6396(2007)13[108:AFFEBB]2.0.CO;2; Prins HHT, 1996, ECOLOGY BEHAV AFRICA; Pyziel AM, 2011, J PARASITOL, V97, P737, DOI 10.1645/GE-2567.1; Radwan J, 2010, BIOL CONSERV, V143, P2049, DOI 10.1016/j.biocon.2010.05.012; Ramseyer A, 2009, ANIMAL, V3, P1319, DOI 10.1017/S1751731109004790; ROBITAILLE JF, 1993, ZOO BIOL, V12, P367, DOI 10.1002/zoo.1430120407; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; Sahlsten J, 2010, WILDLIFE BIOL, V16, P85, DOI 10.2981/08-085; Selva N, 2003, ECOSCIENCE, V10, P303, DOI 10.1080/11956860.2003.11682778; Shakun V, 2012, EUROPEAN BISON CONSE, V5, P95; Sueur C, 2011, OIKOS, V120, P1608, DOI 10.1111/j.1600-0706.2011.19685.x; Sueur C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026788; Sueur C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016131; Sutherland WJ, 1998, ANIM BEHAV, V56, P801, DOI 10.1006/anbe.1998.0896; Tokarska M, 2011, MAMMAL REV, V41, P151, DOI 10.1111/j.1365-2907.2010.00178.x; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Zdzislaw Pucek, 2004, EUROPEAN BISON BISON; Ziolkowska E, 2012, BIOL CONSERV, V146, P188, DOI 10.1016/j.biocon.2011.12.017	67	12	13	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147404	10.1371/journal.pone.0147404	http://dx.doi.org/10.1371/journal.pone.0147404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841107	Green Published, gold			2022-12-27	WOS:000369550200038
J	Gogoi-Tiwari, J; Williams, V; Waryah, CB; Mathavan, S; Tiwari, HK; Costantino, P; Mukkur, T				Gogoi-Tiwari, Jully; Williams, Vincent; Waryah, Charlene Babra; Mathavan, Sangeetha; Tiwari, Harish Kumar; Costantino, Paul; Mukkur, Trilochan			Intramammary Immunization of Pregnant Mice with Staphylococcal Protein A Reduces the Post-Challenge Mammary Gland Bacterial Load but Not Pathology	PLOS ONE			English	Article							AUREUS MASTITIS; BINDING-PROTEIN; IMMUNE EVASION; DAIRY-COWS; VACCINE; ANTIBODY; INFECTION; PERSISTENCE; BIOFILMS; EFFICACY	Protein A, encoded by the spa gene, is one of the major immune evading MSCRAMM of S. aureus, demonstrated to be prevalent in a significant percentage of clinical bovine mastitis isolates in Australia. Given its' reported significance in biofilm formation and the superior performance of S. aureus biofilm versus planktonic vaccine in the mouse mastitis model, it was of interest to determine the immunogenicity and protective potential of Protein A as a potential vaccine candidate against bovine mastitis using the mouse mastitis model. Pregnant Balb/c mice were immunised with Protein A emulsified in an alum-based adjuvant by subcutaneous (s/c) or intramammary (i/mam) routes. While humoral immune response of mice post-immunization were determined using indirect ELISA, cell-mediated immune response was assessed by estimation of interferon-gamma (IFN-gamma) produced by protein A-stimulated splenocyte supernatants. Protective potential of Protein A against experimental mastitis was determined by challenge of immunized versus sham-vaccinated mice by i/mam route, based upon manifestation of clinical symptoms, total bacterial load and histopathological damage to mammary glands. Significantly (p<0.05) higher levels of IgG1 iso-type were produced in mice immunized by the s/c route. In contrast, significantly higher levels of the antibody isotype IgG2a were produced in mice immunized by the i/mam route (p<0.05). There was significant reduction (p<0.05) in bacterial loads of the mammary glands of mice immunized by Protein A regardless of the route of immunization, with medium level of clinical symptoms observed up to day 3 post-challenge. However, Protein A vaccine failed to protect immunized mice post-challenge with biofilm producing encapsulated S. aureus via i/mam route, regardless of the route of immunization, as measured by the level of mammary tissue damage. It was concluded that, Protein A in its' native state was apparently not a suitable candidate for inclusion in a cell-free vaccine formulation against mastitis.	[Gogoi-Tiwari, Jully; Williams, Vincent; Waryah, Charlene Babra; Mathavan, Sangeetha; Costantino, Paul; Mukkur, Trilochan] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA 6102, Australia; [Gogoi-Tiwari, Jully] Cent Agr Univ, Coll Vet Sci & Anim Husb, Aizawl 796014, Mizoram, India; [Waryah, Charlene Babra] Albert Einstein Coll Med, Dept Med & Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Tiwari, Harish Kumar] Murdoch Univ, Sch Vet & Life Sci, Perth, WA 6150, Australia	Curtin University; Yeshiva University; Albert Einstein College of Medicine; Murdoch University	Mukkur, T (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA 6102, Australia.	tk_mukkur@hotmail.com	Tiwari, Harish/AAU-9372-2021	Tiwari, Harish/0000-0002-6950-8422; Tiwari, Harish/0000-0002-2911-9895; Waryah, Charlene/0000-0002-1295-320X	Curtin University; Australian Postgraduate Award	Curtin University; Australian Postgraduate Award(Australian Government)	Curtin University provided the International Postgraduate Research Scholarship and the Australian Postgraduate Award to JG-T in support of her doctoral studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AC, 2014, EXPERT REV VACCINES, V13, P1253, DOI 10.1586/14760584.2014.936391; ANDERSON JC, 1975, J COMP PATHOL, V85, P499, DOI 10.1016/0021-9975(75)90117-6; Atkins KL, 2008, MOL IMMUNOL, V45, P1600, DOI 10.1016/j.molimm.2007.10.021; Babra C, 2013, FOLIA MICROBIOL, V58, P469, DOI 10.1007/s12223-013-0232-z; Barkema HW, 2006, J DAIRY SCI, V89, P1877, DOI 10.3168/jds.S0022-0302(06)72256-1; BJORK I, 1972, European Journal of Biochemistry, V29, P579, DOI 10.1111/j.1432-1033.1972.tb02024.x; Buzzola FR, 2006, INFECT IMMUN, V74, P3498, DOI 10.1128/IAI.01507-05; DOSSETT JH, 1969, J IMMUNOL, V103, P1405; Dutta GN, 2001, INDIAN J MED RES, V113, P11; El-Din ANMN, 2006, VACCINE, V24, P1997, DOI 10.1016/j.vaccine.2005.11.033; Falugi F, 2013, MBIO, V4, DOI 10.1128/mBio.00575-13; FORSGREN A, 1970, Infection and Immunity, V2, P672; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fry SR, 2008, J MED MICROBIOL, V57, P28, DOI 10.1099/jmm.0.47527-0; Gamble M., 2008, THEORY PRACTICE HIST, V6th, P121, DOI DOI 10.1016/B978-0-443-10279-0.50016-6; Gogoi-Tiwari J, 2015, Aust Vet J, V93, P278, DOI 10.1111/avj.12349; Gogoi-Tiwari J, 2015, BIOFOULING, V31, P543, DOI 10.1080/08927014.2015.1074681; Gogoi-Tiwari J, 2015, VIRULENCE, V6, P419, DOI 10.1080/21505594.2015.1043508; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; GREENBERG DP, 1989, INFECT IMMUN, V57, P1113, DOI 10.1128/IAI.57.4.1113-1118.1989; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hartleib J, 2000, BLOOD, V96, P2149; Kim HK, 2012, INFECT IMMUN, V80, P3460, DOI 10.1128/IAI.00230-12; Kim HK, 2010, J EXP MED, V207, P1863, DOI 10.1084/jem.20092514; Kobayashi SD, 2013, MBIO, V4, DOI 10.1128/mBio.00764-13; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; LEE JC, 1988, J INFECT DIS, V157, P723, DOI 10.1093/infdis/157.4.723; Lee JW, 2005, CAN J VET RES, V69, P11; Leitner G, 2000, RES VET SCI, V69, P181, DOI 10.1053/rvsc.2000.0409; Leitner G, 2003, VET IMMUNOL IMMUNOP, V93, P153, DOI 10.1016/S0165-2427(03)00062-X; Maira-Litran T, 2004, VACCINE, V22, P872, DOI 10.1016/j.vaccine.2003.11.033; MAMO W, 1994, VACCINE, V12, P988, DOI 10.1016/0264-410X(94)90333-6; McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523; Melchior MB, 2006, VET J, V171, P398, DOI 10.1016/j.tvjl.2005.01.006; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Middleton JR, 2008, EXPERT REV VACCINES, V7, P805, DOI 10.1586/14760584.7.6.805; MOKS T, 1986, EUR J BIOCHEM, V156, P637, DOI 10.1111/j.1432-1033.1986.tb09625.x; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; OLLETT WS, 1947, J PATHOL BACTERIOL, V59, P357; PANKEY JW, 1985, J DAIRY SCI, V68, P726, DOI 10.3168/jds.S0022-0302(85)80879-1; Pauli NT, 2014, J EXP MED, V211, P2331, DOI 10.1084/jem.20141404; Pozzi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046648; ROSS S, 1974, JAMA-J AM MED ASSOC, V229, P1075, DOI 10.1001/jama.229.8.1075; SJODAHL J, 1977, EUR J BIOCHEM, V73, P343, DOI 10.1111/j.1432-1033.1977.tb11324.x; SPIKA JS, 1981, INFECT IMMUN, V34, P455, DOI 10.1128/IAI.34.2.455-460.1981; Tenhagen BA, 2001, J VET MED A, V48, P601, DOI 10.1046/j.1439-0442.2001.00397.x; Thammavongsa V, 2015, VACCINE, V33, P523, DOI 10.1016/j.vaccine.2014.11.051; Tiwari J. G., 2013, Journal of Vaccines and Vaccination, V4, P1000176; TWORT Frederick W., 1924, Journal of State Medicine, V32, P351; UHLEN M, 1984, J BACTERIOL, V159, P713; Watson DL, 1996, AUST VET J, V74, P447, DOI 10.1111/j.1751-0813.1996.tb07567.x	51	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148383	10.1371/journal.pone.0148383	http://dx.doi.org/10.1371/journal.pone.0148383			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862761	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600061
J	Johnson, DT; Hooker, E; Luong, R; Yu, EJ; He, YF; Gonzalgo, ML; Sun, ZJ				Johnson, Daniel T.; Hooker, Erika; Luong, Richard; Yu, Eun-Jeong; He, Yongfeng; Gonzalgo, Mark L.; Sun, Zijie			Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice	PLOS ONE			English	Article							PROSTATE; TUMORIGENESIS; PROGRESSION; METASTASIS; CARCINOMA; ESTROGEN	Bladder cancer represents a significant human tumor burden, accounting for about 7.7% and 2.4% of all cancer cases in males and females, respectively. While men have a higher risk of developing bladder cancer, women tend to present at a later stage of disease and with more aggressive tumors. Previous studies have suggested a promotional role of androgen signaling in enhancing bladder cancer development. To directly assess the role of androgens in bladder tumorigenesis, we have developed a novel transgenic mouse strain, R26hAR(LoxP/+):Upk3a(GCE/+), in which the human AR transgene is conditionally expressed in bladder urothelium. Intriguingly, both male and female R26hAR(LoxP/+):Upk3a(GCE/+) mice display a higher incidence of urothelial cell carcinoma (UCC) than the age and sex matched control littermates in response to the carcinogen, N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN). We detect expression of the human AR transgene in CK5-positive and p63-positive basal cells in bladder urothelium. Further analyses of UCC tissues from R26hAR(LoxP/+):Upk3a(GCE/+) mice showed that the majority of tumor cells are of urothelial basal cell origin. Positive immunostaining of transgenic AR protein was observed in the majority of tumor cells of the transgenic mice, providing a link between transgenic AR expression and oncogenic transformation. We observed an increase in Ki67 positive cells within the UCC lesions of transgenic AR mice. Manipulating endogenous androgen levels by castration and androgen supplementation directly affected bladder tumor development in male and female R26hAR(LoxP/+):Upk3a(GCE/+) mice, respectively. Taken together, our data demonstrate for the first time that conditional activation of transgenic AR expression in bladder urothelium enhances carciongen-induced bladder tumor formation in mice. This new AR transgenic mouse line mimics certain features of human bladder cancer and can be used to study bladder tumorigenesis and for drug development.	[Johnson, Daniel T.; Hooker, Erika; Yu, Eun-Jeong; He, Yongfeng; Sun, Zijie] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Luong, Richard] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA; [Gonzalgo, Mark L.] Univ Miami, Miller Sch Med, Dept Urol, Miami, FL 33136 USA	Stanford University; Stanford University; University of Miami	Sun, ZJ (corresponding author), Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA.	zsun@stanford.edu	He, Yongfeng/AAR-8257-2020	Johnson, Daniel/0000-0003-4669-037X; Hooker, Erika/0000-0002-4515-4041	National Institute of Health [R01CA070297, R01CA151623, R01CA166894, R21CA190021, R01DK104941]; NATIONAL CANCER INSTITUTE [R01CA070297, R01CA166894, R21CA190021, R01CA151623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104941] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Health grants R01CA070297, R01CA151623, R01CA166894, R21CA190021, and R01DK104941.	Ahmad I, 2012, DIS MODEL MECH, V5, P323, DOI 10.1242/dmm.008888; [Anonymous], 2010, UPK3A GCE ALL CHAR; Baffa R, 2008, CARCINOGENESIS, V29, P846, DOI 10.1093/carcin/bgn006; Culig Z, 2003, UROLOGY, V62, P21, DOI 10.1016/S0090-4295(03)00698-8; DEWINTER JAR, 1991, J HISTOCHEM CYTOCHEM, V39, P927, DOI 10.1177/39.7.1865110; Gakis G, 2013, SCAND J UROL, V47, P173, DOI 10.3109/00365599.2012.756929; Gandhi D, 2013, DEV CELL, V26, P469, DOI 10.1016/j.devcel.2013.07.017; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Howlader N, 2010, J NATL CANCER I, V102, P1584, DOI 10.1093/jnci/djq366; Hsu JW, 2013, AM J PATHOL, V182, P1811, DOI 10.1016/j.ajpath.2013.01.018; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Huggins C, 2002, J UROLOGY, V168, P9, DOI 10.1016/S0022-5347(05)64820-3; Izumi K, 2014, ANDROGEN DEPRIVATION; Jenster G, 1999, SEMIN ONCOL, V26, P407; Kobayashi T, 2015, NAT REV CANCER, V15, P42, DOI 10.1038/nrc3858; KYPRIANOU N, 1988, ENDOCRINOLOGY, V122, P552, DOI 10.1210/endo-122-2-552; Li Y, 2013, ENDOCR-RELAT CANCER, V20, P293, DOI 10.1530/ERC-12-0328; Lin CX, 2013, CANCER RES, V73, P5914, DOI 10.1158/0008-5472.CAN-12-4198; Lobban ED, 1998, AM J PATHOL, V153, P1957, DOI 10.1016/S0002-9440(10)65709-4; Lubet RA, 2005, CARCINOGENESIS, V26, P571, DOI 10.1093/carcin/bgh352; Matsumoto T, 2013, ANNU REV PHYSIOL, V75, P201, DOI 10.1146/annurev-physiol-030212-183656; Mir C, 2011, BJU INT, V108, P24, DOI 10.1111/j.1464-410X.2010.09834.x; Miyamoto H, 2007, J NATL CANCER I, V99, P558, DOI 10.1093/jnci/djk113; Miyamoto H, 2012, BJU INT, V109, P1716, DOI 10.1111/j.1464-410X.2011.10706.x; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; NORONHA RFX, 1986, UROLOGY, V28, P401, DOI 10.1016/0090-4295(86)90073-7; Overdevest JB, 2012, P NATL ACAD SCI USA, V109, pE3588, DOI 10.1073/pnas.1113960109; Overdevest JB, 2011, CANCER RES, V71, P3802, DOI 10.1158/0008-5472.CAN-11-0519; SCHAAFSMA HE, 1990, AM J PATHOL, V136, P329; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; SUGIMURA Y, 1986, BIOL REPROD, V34, P961, DOI 10.1095/biolreprod34.5.961; Van Batavia J, 2014, NAT CELL BIOL, V16, P982, DOI 10.1038/ncb3038; WU XR, 1994, J BIOL CHEM, V269, P13716; Zhu CF, 2011, J BIOL CHEM, V286, P33478, DOI 10.1074/jbc.M111.269894	36	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148851	10.1371/journal.pone.0148851	http://dx.doi.org/10.1371/journal.pone.0148851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862755	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600115
J	Petrosino, JM; Heiss, VJ; Maurya, SK; Kalyanasundaram, A; Periasamy, M; LaFountain, RA; Wilson, JM; Simonetti, OP; Ziouzenkova, O				Petrosino, Jennifer M.; Heiss, Valerie J.; Maurya, Santosh K.; Kalyanasundaram, Anuradha; Periasamy, Muthu; LaFountain, Richard A.; Wilson, Jacob M.; Simonetti, Orlando P.; Ziouzenkova, Ouliana			Graded Maximal Exercise Testing to Assess Mouse Cardio-Metabolic Phenotypes	PLOS ONE			English	Article							HIGH-FAT DIET; HEART-FAILURE; ANAEROBIC THRESHOLD; GAS-EXCHANGE; MITOCHONDRIAL DYSFUNCTION; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; ENDURANCE EXERCISE; MODERATE EXERCISE	Functional assessments of cardiovascular fitness (CVF) are needed to establish animal models of dysfunction, test the effects of novel therapeutics, and establish the cardio-metabolic phenotype ofmice. In humans, the graded maximal exercise test (GXT) is a standardized diagnostic for assessing CVF and mortality risk. These tests, which consist of concurrent staged increases in running speed and inclination, provide diagnostic cardio-metabolic parameters, such as, VO2max, anaerobic threshold, and metabolic crossover. Unlike the human-GXT, published mouse treadmill tests have set, not staged, increases in inclination as speed progress until exhaustion (PXT). Additionally, they often lack multiple cardio-metabolic parameters. Here, we developed a mouse-GXT with the intent of improving mouse-exercise testing sensitivity and developing translatable parameters to assess CVF in healthy and dysfunctional mice. The mouse-GXT, like the human-GXT, incorporated staged increases in inclination, speed, and intensity; and, was designed by considering imitations of the PXT and differences between human and mouse physiology. The mouse-GXT and PXTs were both tested in healthy mice (C57BL/6J, FVBN/J) to determine their ability to identify cardio-metabolic parameters (anaerobic threshold, VO2max, metabolic crossover) observed in human-GXTs. Next, theses assays were tested on established diet-induced (obese-C57BL/6J) and genetic (cardiac isoform Casq2(-/-)) models of cardiovascular dysfunction. Results showed that both tests reported VO2max and provided reproducible data about performance. Only the mouse-GXT reproducibly identified anaerobic threshold, metabolic crossover, and detected impaired CVF in dysfunctional models. Our findings demonstrated that the mouse-GXT is a sensitive, non-invasive, and cost-effective method for assessing CVF inmice. This new test can be used as a functional assessment to determine the cardio-metabolic phenotype of various animalmodels or the effects of novel therapeutics.	[Petrosino, Jennifer M.; Heiss, Valerie J.; LaFountain, Richard A.; Ziouzenkova, Ouliana] Ohio State Univ, Coll Educ & Human Ecol, Dept Human Sci, Columbus, OH 43210 USA; [Maurya, Santosh K.; Periasamy, Muthu] Sanford Burnham Med Res Inst Lake Nona, Cardiovasc Pathobiol Program, Orland, FL USA; [Kalyanasundaram, Anuradha] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Wilson, Jacob M.] Univ Tampa, Dept Human Performance, Tampa, FL 33606 USA; [Simonetti, Orlando P.] Ohio State Univ, Coll Med, Dept Radiol, Columbus, OH 43210 USA; [Simonetti, Orlando P.] Ohio State Univ, Coll Med, Dept Cardiovasc Med, Columbus, OH 43210 USA; [Petrosino, Jennifer M.] Ohio State Univ, Coll Med, Program Biomed Sci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Tampa; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ziouzenkova, O (corresponding author), Ohio State Univ, Coll Educ & Human Ecol, Dept Human Sci, Columbus, OH 43210 USA.	ziouzenkova.1@osu.edu	Maurya, Santosh/O-9066-2017; Ziouzenkova, Ouliana/B-3690-2012; Ziouzenkova, Ouliana/AAM-1971-2020	Maurya, Santosh/0000-0002-7610-2463; Ziouzenkova, Ouliana/0000-0003-2449-2591; Petrosino, Jennifer M/0000-0002-5951-8942	American Egg Board [20020728]; Novo Nordisk Pharmaceuticals [10040042]; Food Innovation Center; National Center for Research Resources - Office of the Director (OD), National Institutes of Health [R21OD017244, UL1TR001070, UL1RR025755, NCI P30CA16058]; NIH Roadmap for Medical Research; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068412] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R21OD017244] Funding Source: NIH RePORTER	American Egg Board; Novo Nordisk Pharmaceuticals(Novo Nordisk); Food Innovation Center; National Center for Research Resources - Office of the Director (OD), National Institutes of Health; NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by Award Number 20020728 from American Egg Board and Award Number 10040042 from Novo Nordisk Pharmaceuticals, as well as by the Food Innovation Center (OZ, JMP). The project described was supported by Award Number R21OD017244 (OZ), UL1TR001070 (CCTS), UL1RR025755 and NCI P30CA16058 (OSUCCC) from the National Center for Research Resources, funded by the Office of the Director (OD), National Institutes of Health and supported by the NIH Roadmap for Medical Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health.	Abdurrachim D, 2015, CARDIOVASC RES, V106, P194, DOI 10.1093/cvr/cvv105; Allen JM, 2015, J APPL PHYSIOL, V118, P1059, DOI 10.1152/japplphysiol.01077.2014; Aoi W, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0067-x; Aoyagi T, 2015, AM J PHYSIOL-HEART C, V308, pH1530, DOI 10.1152/ajpheart.00008.2015; Appukutty M, 2015, BENEF MICROBES, V6, P491, DOI 10.3920/BM2014.0129; Aschar-Sobbi R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7018; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; Barrett EJ, 2009, DIABETOLOGIA, V52, P752, DOI 10.1007/s00125-009-1313-z; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Booth FW, 2010, J APPL PHYSIOL, V108, P219, DOI 10.1152/japplphysiol.00125.2009; Breckenridge R, 2010, DIS MODEL MECH, V3, P138, DOI 10.1242/dmm.005017; Brooks GA, 1998, COMP BIOCHEM PHYS B, V120, P89, DOI 10.1016/S0305-0491(98)00025-X; BROOKS GA, 1994, J APPL PHYSIOL, V76, P2253, DOI 10.1152/jappl.1994.76.6.2253; BRUCE RA, 1973, AM HEART J, V85, P546, DOI 10.1016/0002-8703(73)90502-4; CAIOZZO VJ, 1982, J APPL PHYSIOL, V53, P1184, DOI 10.1152/jappl.1982.53.5.1184; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; CHALMERS RJ, 1976, EUR J APPL PHYSIOL O, V35, P261, DOI 10.1007/BF00423285; Cho J, 2015, MED SCI SPORT EXER, V47, P1814, DOI 10.1249/MSS.0000000000000612; Chu GX, 2002, J CARD FAIL, V8, pS432, DOI 10.1054/jcaf.2002.129284; Courtney SM, 2012, PHYSIOL GENOMICS, V44, P948, DOI 10.1152/physiolgenomics.00051.2012; Darrow MD, 1999, AM FAM PHYSICIAN, V59, P401; Desai KH, 1997, AM J PHYSIOL-HEART C, V272, pH1053, DOI 10.1152/ajpheart.1997.272.2.H1053; Doevendans PA, 1998, CARDIOVASC RES, V39, P34, DOI 10.1016/S0008-6363(98)00073-X; Ehrman JK, 2010, ACSMS RESOURCE MANUA; Ericsson M, 2010, J APPL PHYSIOL, V108, P1311, DOI 10.1152/japplphysiol.01133.2009; Fentz J, 2015, FASEB J, V29, P1725, DOI 10.1096/fj.14-266650; Ferreira JCB, 2007, CLIN EXP PHARMACOL P, V34, P760, DOI 10.1111/j.1440-1681.2007.04635.x; Fiedler LR, 2014, CURR TOP DEV BIOL, V109, P171, DOI 10.1016/B978-0-12-397920-9.00002-0; Fletcher GF, 2013, CIRCULATION, V128, P873, DOI 10.1161/CIR.0b013e31829b5b44; Francis J, 2005, HEART RHYTHM, V2, P550, DOI 10.1016/j.hrthm.2005.01.024; Fueger PT, 2005, J PHYSIOL-LONDON, V566, P533, DOI 10.1113/jphysiol.2005.085043; Garcia-Pelagio KP, 2015, AM J PHYSIOL-CELL PH, V308, pC448, DOI 10.1152/ajpcell.00331.2014; Giacomello E, 2015, AM J PHYSIOL-CELL PH, V308, pC123, DOI 10.1152/ajpcell.00090.2014; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Glukhov AV, 2015, EUR HEART J, V36, P686, DOI 10.1093/eurheartj/eht452; Gupta S, 2011, CIRCULATION, V123, P1377, DOI 10.1161/CIRCULATIONAHA.110.003236; Han YQ, 2001, ENDOCR J, V48, P551, DOI 10.1507/endocrj.48.551; Henderson KK, 2002, J APPL PHYSIOL, V93, P1265, DOI 10.1152/japplphysiol.00809.2001; Hernandez OM, 2005, J BIOL CHEM, V280, P37183, DOI 10.1074/jbc.M508114200; Jawien J, 2004, J PHYSIOL PHARMACOL, V55, P503; Jordy AB, 2015, AM J PHYSIOL-ENDOC M, V308, pE778, DOI 10.1152/ajpendo.00547.2014; Kadoguchi T, 2015, EXP PHYSIOL, V100, P312, DOI 10.1113/expphysiol.2014.084095; Kalyanasundaram A, 2012, AM J PHYSIOL-HEART C, V302, pH253, DOI 10.1152/ajpheart.00578.2011; Kemi OJ, 2002, J APPL PHYSIOL, V93, P1301, DOI 10.1152/japplphysiol.00231.2002; Kim DS, 2015, BIOCHEM BIOPH RES CO, V459, P534, DOI 10.1016/j.bbrc.2015.02.144; Knollmann BC, 2006, J CLIN INVEST, V116, P2510, DOI 10.1172/JCI29128; Knudsen JG, 2015, MOL CELL BIOCHEM, V403, P209, DOI 10.1007/s11010-015-2351-0; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Krahwinkel W, 1997, EUR HEART J, V18, pD9; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Lerman I, 2002, J APPL PHYSIOL, V92, P2245, DOI 10.1152/japplphysiol.01045.2001; Li YH, 2008, J VASC RES, V45, P205, DOI 10.1159/000112133; Lin TW, 2015, NEUROBIOL LEARN MEM, V118, P189, DOI 10.1016/j.nlm.2014.12.005; Lujan HL, 2013, AM J PHYSIOL-REG I, V304, pR286, DOI 10.1152/ajpregu.00517.2012; Lund J, 2015, AM J PHYSIOL-HEART C, V308, pH823, DOI 10.1152/ajpheart.00734.2014; Macpherson REK, 2015, MED SCI SPORT EXER, V47, P2034, DOI 10.1249/MSS.0000000000000660; Marchon C, 2015, CELL PHYSIOL BIOCHEM, V35, P397, DOI 10.1159/000369705; MEAD WF, 1979, J FAM PRACTICE, V9, P479; Meek TH, 2010, INT J OBESITY, V34, P960, DOI 10.1038/ijo.2010.25; Myers J, 1996, ESSENTIALS OF CARDIO, Vxiii; Ostler JE, 2014, AM J PHYSIOL-ENDOC M, V306, pE592, DOI 10.1152/ajpendo.00277.2013; Pate KM, 2015, J APPL PHYSIOL, V118, P760, DOI 10.1152/japplphysiol.00112.2014; Pescatello LS, 2014, ACSMS GUIDELINES EXE, VNinth; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Piguet AC, 2015, J HEPATOL, V62, P1296, DOI 10.1016/j.jhep.2015.01.017; Pincu Y, 2015, CYTOKINE, V73, P23, DOI 10.1016/j.cyto.2015.01.013; Platt C, 2015, CELL METAB, V21, P227, DOI 10.1016/j.cmet.2015.01.014; Podolin DA, 1999, J APPL PHYSIOL, V86, P1374, DOI 10.1152/jappl.1999.86.4.1374; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Pollock ML, 2000, CIRCULATION, V101, P828, DOI 10.1161/01.CIR.101.7.828; Postma AV, 2002, CIRC RES, V91, pE21, DOI 10.1161/01.RES.0000038886.18992.6B; PUTMAN CT, 1995, AM J PHYSIOL-ENDOC M, V269, pE458, DOI 10.1152/ajpendo.1995.269.3.E458; Rank MM, 2015, J PHYSIOL-LONDON, V593, P331, DOI 10.1113/jphysiol.2014.282640; Rezende EL, 2006, J EXP BIOL, V209, P115, DOI 10.1242/jeb.01883; Rezende EL, 2005, J EXP BIOL, V208, P2447, DOI 10.1242/jeb.01631; Rezende EL, 2006, J APPL PHYSIOL, V101, P477, DOI 10.1152/japplphysiol.00042.2006; Roberts TJ, 1996, J EXP BIOL, V199, P1651; Rocco AB, 2014, MUSCLE NERVE, V50, P541, DOI 10.1002/mus.24184; ROSTON WL, 1987, AM REV RESPIR DIS, V135, P1080; Russell LK, 2005, J MOL CELL CARDIOL, V38, P81, DOI 10.1016/j.yjmcc.2004.10.010; Sashindranath M, 2015, BEHAV BRAIN RES, V286, P33, DOI 10.1016/j.bbr.2015.02.038; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Sommer W, 2015, J THORAC CARDIOV SUR, V149, P330, DOI 10.1016/j.jtcvs.2014.10.029; Stolen TO, 2009, CIRC RES, V105, P527, DOI 10.1161/CIRCRESAHA.109.199810; Swain DP., 2014, ACSMS RESOURCE MANUA; Uchiyama M, 2015, TRANSPL INT, V28, P352, DOI 10.1111/tri.12491; Vogel J, 2015, J PHYSIOL-LONDON, V593, P2145, DOI 10.1113/jphysiol.2014.284901; Wallace IJ, 2015, J ANAT, V226, P224, DOI 10.1111/joa.12277; Wallace IJ, 2015, BONE, V72, P1, DOI 10.1016/j.bone.2014.11.013; WASSERMAN K, 1994, Z KARDIOL, V83, P1; WASSERMAN K, 1964, AM J CARDIOL, V14, P844, DOI 10.1016/0002-9149(64)90012-8; WASSERMAN K, 1984, CLIN CHEST MED, V5, P77; WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236, DOI 10.1152/jappl.1973.35.2.236; WASSERMAN K, 1967, J APPL PHYSIOL, V22, P71, DOI 10.1152/jappl.1967.22.1.71; WASSERMAN K, 1967, CAN MED ASSOC J, V96, P775; Wessels A, 2003, PHYSIOL GENOMICS, V15, P165, DOI 10.1152/physiolgenomics.00033.2003; WIELAND OH, 1982, REV PHYSIOL BIOCH P, V96, P123, DOI 10.1007/BFb0031008; Wiesmann F, 2001, CIRC RES, V88, P563, DOI 10.1161/01.RES.88.6.563; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wisloff U, 2001, AM J PHYSIOL-HEART C, V280, pH1301, DOI 10.1152/ajpheart.2001.280.3.H1301; Wood LK, 2016, J ORTHOP RES, V34, P346, DOI 10.1002/jor.22824; Zeng H, 2015, J CELL MOL MED, V19, P1847, DOI 10.1111/jcmm.12556; Zheng DM, 2015, BIOCHEM BIOPH RES CO, V456, P519, DOI 10.1016/j.bbrc.2014.11.118; Zou K, 2015, MED SCI SPORT EXER, V47, P315, DOI 10.1249/MSS.0000000000000405	104	43	43	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148010	10.1371/journal.pone.0148010	http://dx.doi.org/10.1371/journal.pone.0148010			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859763	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400017
J	Wales, K; Clemson, L; Lannin, N; Cameron, I				Wales, Kylie; Clemson, Lindy; Lannin, Natasha; Cameron, Ian			Functional Assessments Used by Occupational Therapists with Older Adults at Risk of Activity and Participation Limitations: A Systematic Review	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; EARLY SUPPORTED DISCHARGE; QUALITY-OF-LIFE; FALL-PREVENTION PROGRAM; STROKE UNIT SERVICE; BARTHEL INDEX; HIP FRACTURE; HOME REHABILITATION; PHYSICAL FUNCTION; INSTRUMENTAL ACTIVITIES	Introduction The use of functional assessments to evaluate patient change is complicated by a lack of consensus as to which assessment is most suitable for use with older adults. Objective: To identify and appraise the properties of assessments used to evaluate functional abilities in older adults. Methods A systematic review of randomised controlled trials of occupational therapy interventions was conducted up to 2012 to identify assessments used to measure function. Two authors screened and extracted data independently. A second search then identified papers investigating measurement properties of each assessment. Studies from the second search were included if: i) published in English, ii) the assessment was not modified from its original published form, iii) study aim was to evaluate the quality of the tool, iv) and was original research. Translated versions of assessments were excluded. Measurement quality was rated using the COSMIN checklist and Terwee criteria. Results Twenty-eight assessments were identified from the systematic search of occupational therapy interventions provided to older adults. Assessments were of varied measurement quality and many had been adapted (although still evaluated as though the original tool had been administered) potentially altering the conclusions drawn about measurement quality. Synthesis of best evidence established 15 functional assessments have not been tested in an older adult population. Conclusions The Functional Autonomy Measurement System (SMAF) appears to be a promising assessment for use with older adults. Only two tools (the SMAF and the Assessment of Motor and Process Skills (AMPS)) were deemed to be responsive to change when applied to older adults. Health professionals should use functional assessments that have been validated with their population and in their setting. There are reliable and valid assessments to capture the functional performance of older adults in community and hospital settings, although further refinement of these assessments may be necessary.	[Wales, Kylie; Clemson, Lindy] Univ Sydney, Fac Hlth Sci, Ageing Work & Hlth Res Unit, Lidcombe, NSW, Australia; [Wales, Kylie; Clemson, Lindy] Univ Sydney, Fac Hlth Sci, Ctr Excellence Populat Ageing Res, Lidcombe, NSW, Australia; [Lannin, Natasha] La Trobe Univ, Sch Allied Hlth, Melbourne, Vic, Australia; [Lannin, Natasha] Alfred Hlth, Occupat Therapy Dept, Melbourne, Vic, Australia; [Cameron, Ian] Univ Sydney, Sydney Med Sch Northern, John Walsh Ctr Rehabil Res, St Leonards, NSW, Australia; [Clemson, Lindy] Univ Sydney, Ageing Work & Hlth Res Unit, Lidcombe, NSW, Australia; [Lannin, Natasha] Alfred Hlth, Dept Occupat Therapy, Commercial Rd, Melbourne, Vic, Australia; [Cameron, Ian] Royal N Shore Hosp, John Walsh Ctr Rehabil Res, Kolling Inst, St Leonards, NSW 2065, Australia	University of Sydney; University of Sydney; La Trobe University; University of Sydney; University of Sydney; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Wales, K (corresponding author), Univ Sydney, Fac Hlth Sci, Ageing Work & Hlth Res Unit, Lidcombe, NSW, Australia.; Wales, K (corresponding author), Univ Sydney, Fac Hlth Sci, Ctr Excellence Populat Ageing Res, Lidcombe, NSW, Australia.	kylie.wales@sydney.edu.au	Lannin, Natasha A/A-4195-2013	Lannin, Natasha A/0000-0002-2066-8345	Australian Post-Graduate Award; Centre of Excellence in Population Ageing Research Postgraduate scholarship; NHMRC	Australian Post-Graduate Award(Australian Government); Centre of Excellence in Population Ageing Research Postgraduate scholarship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The authors received no grant funding for this work. Kylie Wales was supported with an Australian Post-Graduate Award and a Centre of Excellence in Population Ageing Research Postgraduate scholarship. Lindy Clemson is a recipient of an NHMRC Career Development Research Fellowship and Ian Cameron is a recipient of an NHMRC Practitioner Fellowship.	Abizanda P, 2011, MATURITAS, V69, P273, DOI 10.1016/j.maturitas.2011.04.001; Albert SM, 2006, J GERONTOL A-BIOL, V61, P826, DOI 10.1093/gerona/61.8.826; Anderson C, 2000, STROKE, V31, P1024, DOI 10.1161/01.STR.31.5.1024; [Anonymous], 2013, WHAT DOES 2011 CENS; Askim T, 2004, CLIN REHABIL, V18, P238, DOI 10.1191/0269215504cr752oa; Australian Bureau of Statistics, 2012, CULTURAL DIVERSITY A; Avlund K., 2002, SCAND J OCCUP THER, V9, P17; Barer DH, 1993, CLIN REHABIL, V7, P271; Bautz-Holter E, 2002, DISABIL REHABIL, V24, P348, DOI 10.1080/09638280110093677; Berggren M, 2008, OSTEOPOROSIS INT, V19, P801, DOI 10.1007/s00198-007-0507-9; Bond MJ, 1998, CLIN REHABIL, V12, P228, DOI 10.1191/026921598676962688; Bowman J, 2006, BRIT J OCCUP THER, V69, P464, DOI DOI 10.1177/030802260606901005; Bredart A, 2015, PSYCHO-ONCOLOGY, V24, P382, DOI 10.1002/pon.3661; Burton LJ, 2013, DISABIL REHABIL, V35, P828, DOI 10.3109/09638288.2012.709305; Buurman BM, 2011, J CLIN EPIDEMIOL, V64, P619, DOI 10.1016/j.jclinepi.2010.07.005; Carswell A, 2002, CANADIAN J OCCUPATIO, V69, P84; Carter J, 1997, CLIN REHABIL, V11, P131, DOI 10.1177/026921559701100206; Clare L, 2010, AM J GERIAT PSYCHIAT, V18, P928, DOI 10.1097/JGP.0b013e3181d5792a; Clark F, 2001, J GERONTOL B-PSYCHOL, V56, pP60, DOI 10.1093/geronb/56.1.P60; Clark F, 1997, JAMA-J AM MED ASSOC, V278, P1321, DOI 10.1001/jama.278.16.1321; CLARK MS, 1995, AGING-CLIN EXP RES, V7, P174, DOI 10.1007/BF03324332; Clarke CE, 2009, J NEUROL NEUROSUR PS, V80, P976, DOI 10.1136/jnnp.2007.138586; Clemson L, 2010, AUST OCCUP THER J, V57, P42, DOI 10.1111/j.1440-1630.2009.00848.x; Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4; Collin C, 1988, Int Disabil Stud, V10, P61; Commonwealth of Australia, 2015, MEAS REC AUSTR SPEC; Conroy S, 2010, AGE AGEING, V39, P704, DOI 10.1093/ageing/afq096; Corr S, 1995, CLIN REHABIL, V9, P291; Crotty M, 2003, ARCH PHYS MED REHAB, V84, P1237, DOI 10.1016/S0003-9993(03)00141-2; Crotty M, 2002, CLIN REHABIL, V16, P406, DOI 10.1191/0269215502cr518oa; Crotty M, 2008, AGE AGEING, V37, P628, DOI 10.1093/ageing/afn141; Cunliffe AL, 2004, AGE AGEING, V33, P246, DOI 10.1093/ageing/afh076; de Craen AJM, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010002; de Morton NA, 2008, ARCH PHYS MED REHAB, V89, P641, DOI 10.1016/j.apmr.2007.10.021; de Vet HCW., 2018, MEASUREMENT MED, V10th; Demers L, 2010, ARCH PHYS MED REHAB, V91, P233, DOI 10.1016/j.apmr.2009.10.007; Dennis M, 2000, J NEUROL NEUROSUR PS, V68, P47, DOI 10.1136/jnnp.68.1.47; Desrosiers J, 2003, ARCH GERONTOL GERIAT, V37, P157, DOI 10.1016/S0167-4943(03)00044-X; Doble S E, 1997, Int Psychogeriatr, V9, P25, DOI 10.1017/S1041610297004171; Doble S E, 1999, Int Psychogeriatr, V11, P399, DOI 10.1017/S1041610299006018; Doble SE, 1999, OCCUP THER J RES, V19, P203, DOI 10.1177/153944929901900303; Dobson F, 2012, OSTEOARTHR CARTILAGE, V20, P1548, DOI 10.1016/j.joca.2012.08.015; Duncan EAS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-96; Eklund K, 2008, SCAND J OCCUP THER, V15, P68, DOI 10.1080/11038120701442963; Eyres L, 2005, AUST OCCUP THER J, V52, P218, DOI DOI 10.1111/J.1440-1630.2005.00498.X; Fagerberg B, 2000, STROKE, V31, P2578, DOI 10.1161/01.STR.31.11.2578; Fawcett AJL., 2007, PRINCIPLES ASSESSMEN; Fioravanti AM, 2012, CAN J OCCUP THER, V79, P167, DOI 10.2182/cjot.2012.79.3.6; Fjaertoft H, 2004, CLIN REHABIL, V18, P580, DOI 10.1191/0269215504cr773oa; Fjaertoft H, 2003, STROKE, V34, P2687, DOI 10.1161/01.STR.0000095189.21659.4F; Fjaertoft H, 2011, STROKE, V42, P1707, DOI 10.1161/STROKEAHA.110.601153; Fleming SA, 2004, AGE AGEING, V33, P384, DOI 10.1093/ageing/afh126; Fricke J, 1996, AUST OCCUP THER J, V44, P22; Fricke J, 1998, SCANDINAVIAN J OCCUP, V5, P180, DOI DOI 10.3109/11038129809035744; Gitlin LN, 2008, J GERONTOL A-BIOL, V63, P745, DOI 10.1093/gerona/63.7.745; Gitlin LN, 2006, J AM GERIATR SOC, V54, P809, DOI 10.1111/j.1532-5415.2006.00703.x; Gitlin LN, 2005, J AGING HEALTH, V17, P148, DOI 10.1177/0898264304274184; Gitlin LN, 2001, GERONTOLOGIST, V41, P4, DOI 10.1093/geront/41.1.4; GLADMAN JRF, 1993, AGE AGEING, V22, P419, DOI 10.1093/ageing/22.6.419; Graff MJL, 2006, BMJ-BRIT MED J, V333, P1196, DOI 10.1136/bmj.39001.688843.BE; Hagsten B, 2006, ACTA ORTHOP, V77, P114, DOI 10.1080/17453670610045786; Hagsten B, 2004, ACTA ORTHOP SCAND, V75, P177, DOI 10.1080/00016470412331294435; Hall K.M., 1993, J HEAD TRAUMA REHAB, DOI [10.1097/00001199-199308020-00008, DOI 10.1097/00001199-199308020-00008]; Harwood RH, 2000, CLIN REHABIL, V14, P527, DOI 10.1191/0269215500cr346oa; HEBERT R, 1988, AGE AGEING, V17, P293, DOI 10.1093/ageing/17.5.293; Hebert R, 1997, ARCH PHYS MED REHAB, V78, P1305, DOI 10.1016/S0003-9993(97)90301-4; Hebert R, 2002, FUNCTIONAL AUTONOMY; Hemmingsson H, 2005, AM J OCCUP THER, V59, P569, DOI 10.5014/ajot.59.5.569; Hendriks MRC, 2008, J AM GERIATR SOC, V56, P1390, DOI 10.1111/j.1532-5415.2008.01803.x; Hendriksen H, 2001, J ADV NURS, V36, P727, DOI 10.1046/j.1365-2648.2001.02038.x; Hinkka K, 2007, J REHABIL MED, V39, P473, DOI 10.2340/16501977-0078; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Indredavik B, 2000, STROKE, V31, P2989, DOI 10.1161/01.STR.31.12.2989; Jette DU, 2005, ARCH PHYS MED REHAB, V86, P1089, DOI 10.1016/j.apmr.2004.11.018; Lannin NA, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-42; Latham Trombly CA., 2008, CONCEPTUAL FDN PRACT; LAW M, 1989, AM J OCCUP THER, V43, P522, DOI 10.5014/ajot.43.8.522; Liddle J, 1996, AUST NZ J PUBL HEAL, V20, P574, DOI 10.1111/j.1467-842X.1996.tb01068.x; Lincoln NB, 2004, CLIN REHABIL, V18, P40, DOI 10.1191/0269215504cr700oa; Logan PA, 2005, BRIT MED J, V330, P137; Logan PA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2102; Mahoney RI, 1965, VISITING PROFESSOR N, P1; Mayo N, 1993, CANADIAN J REHABILIT, V7, P81; Mercier L, 2001, STROKE, V32, P2602, DOI 10.1161/hs1101.098154; Mokkink LB., 2012, COSMIN CHECKLIST MAN; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Newson RS, 2005, J GERONTOL B-PSYCHOL, V60, pP113, DOI 10.1093/geronb/60.3.P113; Nikolaus T, 1999, AGE AGEING, V28, P543, DOI 10.1093/ageing/28.6.543; Ollonqvist K, 2008, HEALTH SOC CARE COMM, V16, P115, DOI 10.1111/j.1365-2524.2007.00733.x; Pardessus V, 2002, AM J PHYS MED REHAB, V81, P247, DOI 10.1097/00002060-200204000-00002; Parker CJ, 2001, CLIN REHABIL, V15, P42, DOI 10.1191/026921501666968247; Pitkala K, 1998, J AM GERIATR SOC, V46, P1086, DOI 10.1111/j.1532-5415.1998.tb06645.x; REUBEN DB, 1995, J AM GERIATR SOC, V43, P17, DOI 10.1111/j.1532-5415.1995.tb06236.x; Richards SH, 1998, BRIT MED J, V316, P1796, DOI 10.1136/bmj.316.7147.1796; Roderick P, 2001, AGE AGEING, V30, P303, DOI 10.1093/ageing/30.4.303; Rodgers H, 1997, CLIN REHABIL, V11, P280, DOI 10.1177/026921559701100403; Ronning OM, 1998, STROKE, V29, P779, DOI 10.1161/01.STR.29.4.779; Rudd AG, 1998, BRIT MED J, V316, P435; Rudd AG, 1997, BMJ-BRIT MED J, V315, P1039, DOI 10.1136/bmj.315.7115.1039; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Shepperd S, 1998, BRIT MED J, V316, P1786, DOI 10.1136/bmj.316.7147.1786; Stamm TA, 2006, AUSTR OCCUPATIONAL T, V53, P9, DOI [10.1111/j.1440-1630.2005.00513.x, DOI 10.1111/J.1440-1630.2005.00513.X]; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; TUCKER MA, 1984, BRIT MED J, V289, P1209, DOI 10.1136/bmj.289.6453.1209; U.S. Department of Health and Human Services, 2013, PROF OLD AM 2013; Unsworth C., 2000, AUST OCCUP THER J, V47, P147, DOI [DOI 10.1046/J.1440-1630.2000.00239.X, 10.1046/j.1440-1630.2000.00239.x]; Van Peppen RPS, 2008, PHYSIOTHER RES INT, V13, P255, DOI 10.1002/pri.417; Vass M, 2005, J AM GERIATR SOC, V53, P563, DOI 10.1111/j.1532-5415.2005.53201.x; Vergauwen K, 2015, DISABIL REHABIL, V37, P1706, DOI 10.3109/09638288.2014.978507; Wales K, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-45; Wilkinson PR, 1997, QUAL HEALTH CARE, V6, P125, DOI 10.1136/qshc.6.3.125; World Health Organization, 2002, COMMON LANGUAGE FUNC; Wright J, 1998, PHYSIOTHERAPY, V84, P216, DOI DOI 10.1016/S0031-9406(05)65552-6; Yohannes AM, 1998, AGE AGEING, V27, P369, DOI 10.1093/ageing/27.3.369; Ziden L, 2008, CLIN REHABIL, V22, P1019, DOI 10.1177/0269215508096183; Zwakhalen Sandra M G, 2006, BMC Geriatr, V6, P3, DOI 10.1186/1471-2318-6-3	116	35	35	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0147980	10.1371/journal.pone.0147980	http://dx.doi.org/10.1371/journal.pone.0147980			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859678	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400016
J	Boire, N; Zhang, S; Khuvis, J; Lee, R; Rivers, J; Crandall, P; Keel, MK; Parrish, N				Boire, Nicholas; Zhang, Sean; Khuvis, Joshua; Lee, Rick; Rivers, Jennifer; Crandall, Philip; Keel, M. Kevin; Parrish, Nicole			Potent Inhibition of Pseudogymnoascus destructans, the Causative Agent of White-Nose Syndrome in Bats, by Cold-Pressed, Terpeneless, Valencia Orange Oil	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; IN-VITRO; AGRICULTURE; MORTALITY; PATHOGEN	The causative agent of White-nose Syndrome (WNS), Pseudogymnoascus destructans, has been shown to be fatal to several species of bats in North America. To date, no compounds or chemical control measures have been developed which eliminates the growth of the fungus in the environment or in affected animals. In the current study, we evaluated the activity of cold-pressed, terpeneless orange oil (CPT) against multiple isolates of P. destructans in vitro. For all assays, a modified Kirby-Bauer disk diffusion assay was used. Standardized spore suspensions were prepared, adjusted to a specific optical density, and used to plate fungal lawns. Plates were incubated at either 15 degrees C or 4 degrees C for up to 6 months and checked at regular intervals for growth. Once controls had grown, zones of inhibition were measured (mm) on test plates and compared to those obtained using current antifungal drugs. All P. destructans isolates were completely inhibited by 100% CPT (10 mu L) at 1 month of incubation regardless of temperature (4 degrees C and 15 degrees C). Complete inhibition persisted up to 6 months following a single exposure at this concentration. Of the standard anti-fungals, only amphotericin B demonstrated any activity, resulting in zone diameters ranging from 58 mm to 74 mm. CPT, at the highest concentration tested (100%), had no significant effect against a variety of other environmental organisms including various filamentous fungi, bacteria and aerobic actinomycetes. Given that CPT is relatively non-toxic, the possibility exists that the all-natural, mixture could be used as an environmental pre-treatment to eradicate P. destructans from bat habitats. Additional studies are needed to assess any undesirable effects of CPT on bat behavior and health and overall impacts on other members of the interconnected ecosystem(s).	[Boire, Nicholas; Zhang, Sean; Khuvis, Joshua; Lee, Rick; Parrish, Nicole] Johns Hopkins Sch Med, Baltimore, MD USA; [Rivers, Jennifer] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Crandall, Philip] Univ Arkansas, Fayetteville, AR 72701 USA; [Keel, M. Kevin] UC Davis Sch Vet Med, Davis, CA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Arkansas System; University of Arkansas Fayetteville; University of California System; University of California Davis	Parrish, N (corresponding author), Johns Hopkins Sch Med, Baltimore, MD USA.	nicholasboire@gmail.com		Crandall, Phil/0000-0002-5180-3204				Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Blehert DS, 2011, MICROBE, V6, P267; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Boyles JG, 2010, FRONT ECOL ENVIRON, V8, P92, DOI 10.1890/080187; Brooks RT, 2011, BIODIVERS CONSERV, V20, P2537, DOI 10.1007/s10531-011-9996-0; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Chaturvedi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017032; Clinical and Laboratory Standards Institute, 2010, M51A CLSI; Cornelison CT, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0246-y; Cox SD, 1998, LETT APPL MICROBIOL, V26, P355, DOI 10.1046/j.1472-765X.1998.00348.x; Crandall PG, 2012, J ENVIRON SCI HEAL B, V47, P736, DOI 10.1080/03601234.2012.669331; Cryan PM, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-47; Dzal Y, 2011, BIOL LETTERS, V7, P392, DOI 10.1098/rsbl.2010.0859; Fisher K, 2006, J APPL MICROBIOL, V101, P1232, DOI 10.1111/j.1365-2672.2006.03035.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Hill J., 1992, BATS NATURAL HIST; Isman MB, 2011, PHYTOCHEM REV, V10, P197, DOI 10.1007/s11101-010-9170-4; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Muthaiyan A, 2012, J APPL MICROBIOL, V112, P1020, DOI 10.1111/j.1365-2672.2012.05270.x; Muthaiyan A, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-125; Rasooli I, 2006, INT J INFECT DIS, V10, P236, DOI 10.1016/j.ijid.2005.05.006; Turner Gregory G., 2011, Bat Research News, V52, P13; U.S. Fish and Wildlife Service, WHIT NOS SYNDR IS IT; United States Subcommittee on Fisheries Wildlife Oceans and Insular Affairs, 2011, WHY WE SHOULD CAR BA; Warnecke L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0177; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Willis CKR, 2011, INTEGR COMP BIOL, V51, P364, DOI 10.1093/icb/icr076	28	13	14	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148473	10.1371/journal.pone.0148473	http://dx.doi.org/10.1371/journal.pone.0148473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849057	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000102
J	Brennan-Ing, M; Seidel, L; Rodgers, L; Ernst, J; Wirth, D; Tietz, D; Morretti, A; Karpiak, SE				Brennan-Ing, Mark; Seidel, Liz; Rodgers, Leslie; Ernst, Jerome; Wirth, Doug; Tietz, Daniel; Morretti, Antonio; Karpiak, Stephen E.			The Impact of Comprehensive Case Management on HIV Client Outcomes	PLOS ONE			English	Article							UNITED-STATES; ANTIRETROVIRAL ADHERENCE; OLDER-ADULTS; CARE; ASSOCIATION; PROGRAM; ACCESS	In 1990, New York State instituted Comprehensive Medicaid Case Management, also known as Target Case Management (TCM), for people dealing with multiple comorbid conditions, including HIV. The goal of TCM is to assist clients in navigating the health care system to increase care engagement and treatment adherence for individuals with complex needs. HIV-positive individuals engaged in care are more likely to be virally suppressed, improving clinical outcomes and decreasing chances of HIV transmission. The purpose of this study was to understand the impact of TCM management on outcomes for people with HIV. Data were obtained from Amida Care, which operates not-for-profit managed care Medicaid and Medicare Special Needs Plans (SNPs) for HIV clients. Changes in clinical, cost, as well as medical and pharmacy utilization data among TCM clients were examined between January 2011 through September 2012 from the start of case management enrollment through the end of the study period (i. e., up to 6 months after disenrollment). Additionally, CD4 counts were compared between Amida Care TCM clients and non-TCM clients. Notable findings include increased CD4 counts for TCM clients over the one-year study period, achieving parity with non-TCM clients (i. e., Mean CD4 count > 500). When looking exclusively at TCM clients, there were increases in medication costs over time, which were concomitant with increased care engagement. Current findings demonstrate that TCM is able to achieve its goals of improving care engagement and treatment adherence. Subsequent policy changes resulting from the Affordable Care Act and the New York State Medicaid Redesign have made the Health Home the administrator of TCM services. Government entities charged with securing and managing TCM and care coordination for people with HIV should provide thoughtful and reasonable guidance and oversight in order to maintain optimal clinical outcomes for TCM clients and reduce the transmission of HIV.	[Brennan-Ing, Mark; Seidel, Liz; Ernst, Jerome; Karpiak, Stephen E.] ACRIA, Ctr HIV & Aging, New York, NY USA; [Brennan-Ing, Mark; Karpiak, Stephen E.] NYU, Coll Nursing, New York, NY USA; [Seidel, Liz] Fordham Univ, Grad Sch Social Serv, New York, NY 10023 USA; [Rodgers, Leslie] BOOM Hlth, Bronx, NY USA; [Ernst, Jerome; Wirth, Doug] Amida Care Inc, New York, NY USA; [Tietz, Daniel] City New York, Human Resources Adm, New York, NY USA; [Morretti, Antonio] Columbia Univ, New York, NY USA	New York University; Fordham University; Columbia University	Brennan-Ing, M (corresponding author), ACRIA, Ctr HIV & Aging, New York, NY USA.; Brennan-Ing, M (corresponding author), NYU, Coll Nursing, New York, NY USA.	mbrennan@acria.org						AIDS.gov, 2015, HIV AIDS CAR CONT; Allen G, 2014, DELIVERY SYSTEM REFO; Brennan M, 2010, HIV AIDS-MED SOC PSY, P1; Brennan-Ing M, 2014, P 18 US C AIDS OCT 2; Brennan-Ing M, 2014, J HOMOSEXUAL, V61, P166, DOI 10.1080/00918369.2013.835608; Brennan-Ing M, 2014, J HOMOSEXUAL, V61, P21, DOI 10.1080/00918369.2013.835235; Broaddus MR, 2015, AIDS CARE; Cahill SR, 2015, AM J PUBLIC HEALTH, V105, P1078, DOI 10.2105/AJPH.2014.302442; Freedman J, 2003, HIST AIDS SOCIAL WOR, P59; Gursansky D., 2020, CASE MANAGEMENT POLI, DOI [10.4324/9781003115113, DOI 10.4324/9781003115113]; Hajewski CJ, 2014, J NURS ADMIN, V44, P577, DOI 10.1097/NNA.0000000000000129; Havlik RJ, 2011, SEX HEALTH, V8, P551, DOI 10.1071/SH11017; Hirschhorna LR, 2009, GROUND BUILDING COMP; Irvine MK, 2015, CLIN INFECT DIS, V60, P298, DOI 10.1093/cid/ciu783; Kates J., 2011, MEDICAID HIV NATL AN; Kates Jennifer, 2013, Top Antivir Med, V21, P138; Kim JJ, 2014, AIDS EDUC PREV, V26, P429, DOI 10.1521/aeap.2014.26.5.429; Kushel MB, 2006, CLIN INFECT DIS, V43, P234, DOI 10.1086/505212; Lehrman SE, 2001, AIDS CARE, V13, P481, DOI 10.1080/09540120120058012; Mallory R, 2011, COBRA MED OUTCOMES E; McColl WD, 2013, HIV SPECIALIST, V5, P2; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; New York City Department of Health, 2010, NEW YORK CIT ANN HIV; New York State Department of Health AIDS Institute: Office of Medicaid Policy and Programs, 2013, NEW YORK STAT MED RE; OPTUM, 2015, IMP PRO HLTH CAR AN; Pecoraro A, 2013, AIDS CARE, V25, P1399, DOI 10.1080/09540121.2013.772273; Sood N, 2014, HEALTH AFFAIR, V33, P394, DOI 10.1377/hlthaff.2013.1297; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Wagner EH, 2014, MED CARE, V52, pS33, DOI 10.1097/MLR.0000000000000197; World Health Organization, 2015, CONS STRAT INF GUID	30	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148865	10.1371/journal.pone.0148865	http://dx.doi.org/10.1371/journal.pone.0148865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26849561	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000179
J	Mathot, S; Melmi, JB; van der Linden, L; van der Stigchel, S				Mathot, Sebastiaan; Melmi, Jean-Baptiste; van der Linden, Lotje; van der Stigchel, Stefan			The Mind-Writing Pupil: A Human-Computer Interface Based on Decoding of Covert Attention through Pupillometry	PLOS ONE			English	Article							LIGHT RESPONSE; BRAIN; COMMUNICATION; BCI; EYE	We present a new human-computer interface that is based on decoding of attention through pupillometry. Our method builds on the recent finding that covert visual attention affects the pupillary light response: Your pupil constricts when you covertly (without looking at it) attend to a bright, compared to a dark, stimulus. In our method, participants covertly attend to one of several letters with oscillating brightness. Pupil size reflects the brightness of the selected letter, which allows us-with high accuracy and in real time-to determine which letter the participant intends to select. The performance of our method is comparable to the best covert-attention brain-computer interfaces to date, and has several advantages: no movement other than pupil-size change is required; no physical contact is required (i.e. no electrodes); it is easy to use; and it is reliable. Potential applications include: communication with totally locked-in patients, training of sustained attention, and ultra-secure password input.	[Mathot, Sebastiaan; Melmi, Jean-Baptiste; van der Linden, Lotje] Aix Marseille Univ, CNRS, LPC UMR 7290, Marseille, France; [van der Stigchel, Stefan] Univ Utrecht, Dept Expt Psychol, Helmholtz Inst, Utrecht, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Utrecht University	Mathot, S (corresponding author), Aix Marseille Univ, CNRS, LPC UMR 7290, Marseille, France.	s.mathot@cogsci.nl		Mathot, Sebastiaan/0000-0003-3379-8584; van der Stigchel, Stefan/0000-0002-5918-3521	People Programme (Marie Curie Actions) of European Union's Seventh Framework Programme under REA [622738]; VIDI Grant from Netherlands Organization for Scientific Research [452-13-008]	People Programme (Marie Curie Actions) of European Union's Seventh Framework Programme under REA; VIDI Grant from Netherlands Organization for Scientific Research	The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement no 622738 awarded to Sebastiaan Mathot (http://cordis.europa.eu/project/rcn/187709_en.html). In addition, this research was funded by a VIDI Grant 452-13-008 from the Netherlands Organization for Scientific Research to Stefan Van der Stigchel (http://www.nwo.nl/en/research-andresults/programmes/Talent+Scheme/awards/vidi+awards/vidi+awards+2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement no 622738 awarded to Sebastiaan Mathot (http://cordis.europa.eu/project/rcn/187709_en.html). In addition, this research was funded by a VIDI Grant 452-13-008 from the Netherlands Organization for Scientific Research to Stefan Van der Stigchel (http://www.nwo.nl/en/research-and-results/programmes/Talent+Scheme/awards/vidi+awards/vidi+awards+2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acqualagna L, 2013, CLIN NEUROPHYSIOL, V124, P901, DOI 10.1016/j.clinph.2012.12.050; Astrand E, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00144; Bates D., 2015, LME4 LINEAR MIXED EF; BAUER G, 1979, J NEUROL, V221, P77, DOI 10.1007/BF00313105; Binda P, 2013, J NEUROSCI, V33, P2199, DOI 10.1523/JNEUROSCI.3440-12.2013; Birbaumer N, 2006, PSYCHOPHYSIOLOGY, V43, P517, DOI 10.1111/j.1469-8986.2006.00456.x; Blankertz B., 2006, P 3 INT BRAIN COMP I; Brunner P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056013; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Dalmaijer E., 2014, PEERJ PREPRINTS, DOI DOI 10.7287/PEERJ.PREPRINTS.585V1; Dalmaijer ES, 2014, BEHAV RES METHODS, V46, P913, DOI 10.3758/s13428-013-0422-2; Donoghue JP, 2008, NEURON, V60, P511, DOI 10.1016/j.neuron.2008.10.037; Duvinage M, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-56; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fazel-Rezai Reza, 2012, Front Neuroeng, V5, P14, DOI 10.3389/fneng.2012.00014; Feinberg Richard, 1965, LATENCY PUPILLARY RE; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Gilja V, 2015, NAT MED, V21, P1142, DOI 10.1038/nm.3953; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Kuznetsova A., 2015, LMERTEST TESTS LINEA; Laeng B, 2014, PSYCHOL SCI, V25, P188, DOI 10.1177/0956797613503556; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Majaranta Paivi, 2006, UNIVERSAL ACCESS INF, V5, P199, DOI [10.1007/s10209-006-0034-z, DOI 10.1007/S10209-006-0034-Z]; Marchetti M, 2013, NEUROREHAB NEURAL RE, V27, P430, DOI 10.1177/1545968312471903; Mathot S, 2015, CURR DIR PSYCHOL SCI, V24, P374, DOI 10.1177/0963721415593725; Mathot S, 2015, PEERJ, V3, DOI 10.7717/peerj.1150; Mathot S, 2014, J VISION, V14, DOI 10.1167/14.14.7; Mathot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078168; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Naber M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00919; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; R Core Team, 2014, LANG ENV STAT COMP; Riccio A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045001; SLOOTER J, 1980, INVEST OPHTH VIS SCI, V19, P105; Stoll J, 2013, CURR BIOL, V23, pR647, DOI 10.1016/j.cub.2013.06.011; Treder MS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066003; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; UKAI K, 1985, J OPT SOC AM A, V2, P1094, DOI 10.1364/JOSAA.2.001094; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yuan P, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026014	41	28	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148805	10.1371/journal.pone.0148805	http://dx.doi.org/10.1371/journal.pone.0148805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848745	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000171
J	Moon, YW; Kim, HJ; Ahn, HS; Lee, DH				Moon, Young-Wan; Kim, Hyun-Jung; Ahn, Hyeong-Sik; Lee, Dae-Hee			Serial Changes of Quadriceps and Hamstring Muscle Strength Following Total Knee Arthroplasty: A Meta-Analysis	PLOS ONE			English	Article							WEAKNESS	This meta-analysis was performed to analyze serial changes in thigh muscles, including quadriceps and hamstring muscles, from before to one year after total knee arthroplasty (TKA). All studies sequentially comparing isokinetic quadriceps and hamstring muscle strengths between the TKA side and the contralateral uninjured limb were included in this meta-analysis. Five studies with 7 cohorts were included in this meta-analysis. The mean differences in the strengths of quadriceps and hamstring muscles between the TKA and uninjured sides were greatest three months after surgery (26.8 N.m, 12.8 N.m, P<0.001), but were similar to preoperative level at six months (18.4 N.m, 7.4 N.m P<0.001) and were maintained for up to one year (15.9 N.m, 4.1 N.m P<0.001). The pooled mean differences in changes in quadriceps and hamstring strengths relative to preoperative levels were 9.2 N.m and 4.9 N.m, respectively, three months postoperatively (P = 0.041), but were no longer significant after six months and one year. During the year after TKA, quadriceps and hamstring muscle strengths were lowest after 3 months, recovering to preoperative level after six months, but not reaching the muscle strength on the contralateral side. Relative to preoperative levels, the difference in muscle strength between the TKA and contralateral knees was only significant at three months. Because decrease of strength of the quadriceps was significantly greater than decrease in hamstring muscle strength at postoperative three months, early rehabilitation after TKA should focus on recovery of quadriceps muscle strength.	[Moon, Young-Wan; Lee, Dae-Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, Seoul, South Korea; [Kim, Hyun-Jung; Ahn, Hyeong-Sik] Korea Univ, Coll Med, Dept Prevent Med, Seoul 136705, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Korea University; Korea University Medicine (KU Medicine)	Lee, DH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, Seoul, South Korea.	eoak22@empal.com	lee, dae hee/I-9390-2017					Anchuela J, 2001, INT ORTHOP, V25, P253, DOI 10.1007/s002640100234; BERMAN AT, 1991, CLIN ORTHOP RELAT R, P106; Daines BK, 2014, CLIN ORTHOP SURG, V6, P1, DOI 10.4055/cios.2014.6.1.1; Farquhar S, 2010, CLIN ORTHOP RELAT R, V468, P37, DOI 10.1007/s11999-009-0892-9; Kim Seok Jin, 2015, Knee Surg Relat Res, V27, P24, DOI 10.5792/ksrr.2015.27.1.24; Lauermann SP, 2014, J ELECTROMYOGR KINES, V24, P285, DOI 10.1016/j.jelekin.2013.10.018; Lee DC, 1999, J KOREAN ORTHOP ASS, V34, P931; Lorentzen JS, 1999, ACTA ORTHOP SCAND, V70, P176, DOI 10.3109/17453679909011258; Maffiuletti NA, 2010, CLIN ORTHOP RELAT R, V468, P191, DOI 10.1007/s11999-009-0978-4; Mizner RL, 2005, J ORTHOP RES, V23, P1083, DOI 10.1016/j.orthres.2005.01.021; Mizner RL, 2005, J RHEUMATOL, V32, P1533; Mizner RL, 2005, J ORTHOP SPORT PHYS, V35, P424, DOI 10.2519/jospt.2005.35.7.424; Mizner RL, 2005, J BONE JOINT SURG AM, V87A, P1047, DOI 10.2106/JBJS.D.01992; O'Reilly SC, 1998, ANN RHEUM DIS, V57, P588, DOI 10.1136/ard.57.10.588; Pua Y-H, 2015, J ARTHROPLASTY; Rossi MD, 2006, AM J PHYS MED REHAB, V85, P737, DOI 10.1097/01.phm.0000233178.22621.a5; Rossi Mark D, 2011, Am J Orthop (Belle Mead NJ), V40, P29; Schache MB, 2014, KNEE, V21, P12, DOI 10.1016/j.knee.2013.08.002; Schroer WC, 2010, J ARTHROPLASTY, V25, P274, DOI 10.1016/j.arth.2008.09.017; Stevens-Lapsley JE, 2010, CLIN ORTHOP RELAT R, V468, P2460, DOI 10.1007/s11999-009-1219-6; Thomas AC, 2014, KNEE, V21, P1115, DOI 10.1016/j.knee.2014.08.001; Valtonen A, 2009, PHYS THER, V89, P1072, DOI 10.2522/ptj.20070295; Walsh M, 1998, PHYS THER, V78, P248, DOI 10.1093/ptj/78.3.248; Wells GA, 2015, NEWCASTLE OTTAWA SCA, DOI DOI 10.13105/WJMA.V5.I4.80	24	23	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148193	10.1371/journal.pone.0148193	http://dx.doi.org/10.1371/journal.pone.0148193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849808	gold, Green Submitted, Green Published			2022-12-27	WOS:000369554000049
J	Sobolevsky, S; Sitko, I; des Combes, RT; Hawelka, B; Arias, JM; Ratti, C				Sobolevsky, Stanislav; Sitko, Izabela; Tachet des Combes, Remi; Hawelka, Bartosz; Murillo Arias, Juan; Ratti, Carlo			Cities through the Prism of People's Spending Behavior	PLOS ONE			English	Article							HUMAN MOBILITY; PATTERNS; PROXY; LIFE	Scientific studies of society increasingly rely on digital traces produced by various aspects of human activity. In this paper, we exploit a relatively unexplored source of data-anonymized records of bank card transactions collected in Spain by a big European bank, and propose a new classification scheme of cities based on the economic behavior of their residents. First, we study how individual spending behavior is qualitatively and quantitatively affected by various factors such as customer's age, gender, and size of his/her home city. We show that, similar to other socioeconomic urban quantities, individual spending activity exhibits a statistically significant superlinear scaling with city size. With respect to the general trends, we quantify the distinctive signature of each city in terms of residents' spending behavior, independently from the effects of scale and demographic heterogeneity. Based on the comparison of city signatures, we build a novel classification of cities across Spain in three categories. That classification exhibits a substantial stability over different city definitions and connects with a meaningful socioeconomic interpretation. Furthermore, it corresponds with the ability of cities to attract foreign visitors, which is a particularly remarkable finding given that the classification was based exclusively on the behavioral patterns of city residents. This highlights the far-reaching applicability of the presented classification approach and its ability to discover patterns that go beyond the quantities directly involved in it.	[Sobolevsky, Stanislav] NYU, Ctr Urban Sci & Progress, Brooklyn, NY USA; [Sobolevsky, Stanislav; Tachet des Combes, Remi; Ratti, Carlo] MIT, Senseable City Lab, Cambridge, MA 02139 USA; [Sitko, Izabela; Hawelka, Bartosz] Salzburg Univ, Dept Geoinformat Z GIS, A-5020 Salzburg, Austria; [Murillo Arias, Juan] Data & Analyt BBVA, Madrid, Spain	New York University; Massachusetts Institute of Technology (MIT); Salzburg University	Sobolevsky, S (corresponding author), NYU, Ctr Urban Sci & Progress, Brooklyn, NY USA.	sobolevsky@nyu.edu	Sobolevsky, Stanislav/ABH-7108-2020	Sobolevsky, Stanislav/0000-0001-6281-0656	Austrian Science Fund (FWF) through the Doctoral College GIScience at the University of Salzburg [DK W 1237-N23]; SENSEable city lab consortium; Austrian Science Fund (FWF) through the Doctoral College GIScience [DK W 1237-N23]	Austrian Science Fund (FWF) through the Doctoral College GIScience at the University of Salzburg(Austrian Science Fund (FWF)); SENSEable city lab consortium; Austrian Science Fund (FWF) through the Doctoral College GIScience(Austrian Science Fund (FWF))	IS and BH are receiving financial support from Austrian Science Fund (FWF, https://www.fwf.ac.at/en/) through the Doctoral College GIScience at the University of Salzburg (DK W 1237-N23). This research has been funded through the SENSEable city lab consortium, where BBVA acted as one of the sponsors. One of the authors of the paper (JMA) is BBVA's employee. The funder provided support in the form of salaries for the specified author as well as funding for the SENSEable city lab where other authors (SS, RTC, CR) are employed, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.; The authors would like to thank BBVA for providing the dataset for this research. Special thanks to Assaf Biderman, Marco Bressan, Elena Alfaro Martinez, Maria Hernandez Rubio and Heribert Valero for organizational support of the project and stimulating discussions. We further thank the BBVA, MIT SMART Program, Center for Complex Engineering Systems (CCES) at KACST and MIT, Accenture, Air Liquide, The Coca Cola Company, Emirates Integrated Telecommunications Company, The ENELfoundation, Ericsson, Expo 2015, Ferrovial, Liberty Mutual, The Regional Municipality of Wood Buffalo, Volkswagen Electronics Research Lab, UBER and all the members of the MIT Senseable City Lab Consortium for supporting the research. IS and BH acknowledge the support of the Austrian Science Fund (FWF) through the Doctoral College GIScience (DK W 1237-N23).	Amini A, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds31; [Anonymous], 2007, FINAL REPORT; Arcaute E, 2014, PREPRINT; Arribas-Bel D, 2013, CITIES, V31, P248, DOI 10.1016/j.cities.2012.06.019; Bagchi M, 2005, TRANSP POLICY, V12, P464, DOI 10.1016/j.tranpol.2005.06.008; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Bhatnagar A, 2000, COMMUN ACM, V43, P98, DOI 10.1145/353360.353371; Borzekowski R, 2008, J MONEY CREDIT BANK, V40, P149, DOI 10.1111/j.1538-4616.2008.00107.x; Bounie D, 2006, SSRN SCHOLARLY PAPER; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Chan PK, 1999, IEEE INTELL SYST APP, V14, P67, DOI 10.1109/5254.809570; Childers TL, 2001, J RETAILING, V77, P511, DOI 10.1016/S0022-4359(01)00056-2; Dholakia R. R., 1999, INT J RETAIL DISTRIB, V27, P154, DOI [DOI 10.1108/09590559910268499, 10.1108/09590559910268499]; Frank MR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02625; Girardin F, 2008, IEEE PERVAS COMPUT, V7, P36, DOI 10.1109/MPRV.2008.71; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Grauwin S, 2015, GEOTECH ENVIRON, V13, P363, DOI 10.1007/978-3-319-11469-9_15; Hawelka B, 2014, CARTOGR GEOGR INF SC, V41, P260, DOI 10.1080/15230406.2014.890072; Hayhoe CR, 2008, JOURNAL OF CONSUMER, V34, P113, DOI [10.1111/j.1745-, DOI 10.1111/J.1745-]; Hui T.-K., 2007, INT J CONSUM STUD, V31, P310, DOI [10.1111/j.1470-6431.2006.00554.x, DOI 10.1111/J.1470-6431.2006.00554.X]; Krumme C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01645; Kung KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096180; Lathia Neal, 2012, Pervasive Computing. Proceedings of the 10th International Conference, Pervasive 2012, P91, DOI 10.1007/978-3-642-31205-2_6; Lenormand M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10075; LLOYD R, 1978, ECON GEOGR, V54, P157, DOI 10.2307/142850; Louail T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05276; MacQueen J.B., 1967, STATISTICS, VI; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Paldino S, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0043-3; Pei T, 2014, INT J GEOGR INF SCI, V28, P1988, DOI 10.1080/13658816.2014.913794; Pennacchioli D, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds/s13688-014-0033-x; Quercia Daniele, 2010, Proceedings 2010 10th IEEE International Conference on Data Mining (ICDM 2010), P971, DOI 10.1109/ICDM.2010.152; Ratti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014248; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rysman M, 2007, J IND ECON, V55, P1, DOI 10.1111/j.1467-6451.2007.00301.x; Santi P, 2014, P NATL ACAD SCI USA, V111, P13290, DOI 10.1073/pnas.1403657111; Schlapfer M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0789; Sobolevsky S, 2014, BIG DATA SCIENCE AND; Sobolevsky S, 2015, PREPRTINT ARXIV 1504; Sobolevsky S, 2014, IEEE INT CONGR BIG, P136, DOI 10.1109/BigData.Congress.2014.28; Sobolevsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081707; Szell M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089052; World Factbook (The), MOTHERS MEAN AGE AT	46	22	22	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0146291	10.1371/journal.pone.0146291	http://dx.doi.org/10.1371/journal.pone.0146291			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26849218	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000008
J	Song, MS; Choi, SY; Ryu, PD; Lee, SY				Song, Min Seok; Choi, Seon Young; Ryu, Pan Dong; Lee, So Yeong			Voltage-Gated K+ Channel, K(v)3.3 Is Involved in Hemin-Induced K562 Differentiation	PLOS ONE			English	Article							KV3.3 POTASSIUM CHANNELS; CELL-PROLIFERATION; MEGAKARYOCYTIC DIFFERENTIATION; ERYTHROID-DIFFERENTIATION; HEMOGLOBIN-SYNTHESIS; MOLECULAR DIVERSITY; ION CHANNELS; ACTIVATION; EXPRESSION; LINE	Voltage-gated K+ (K-v) channels are well known to be involved in cell proliferation. However, even though cell proliferation is closely related to cell differentiation, the relationship between K-v channels and cell differentiation remains poorly investigated. This study demonstrates that K(v)3.3 is involved in K562 cell erythroid differentiation. Down-regulation of K(v)3.3 using siRNA-K(v)3.3 increased hemin-induced K562 erythroid differentiation through decreased activation of signal molecules such as p38, cAMP response element-binding protein, and c-fos. Down-regulation of K(v)3.3 also enhanced cell adhesion by increasing integrin beta 3 and this effect was amplified when the cells were cultured with fibronectin. The K-v channels, or at least K(v)3.3, appear to be associated with cell differentiation; therefore, understanding the mechanisms of K-v channel regulation of cell differentiation would provide important information regarding vital cellular processes.	[Lee, So Yeong] Seoul Natl Univ, Coll Vet Med, Lab Vet Pharmacol, Seoul, South Korea; Seoul Natl Univ, Res Inst Vet Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lee, SY (corresponding author), Seoul Natl Univ, Coll Vet Med, Lab Vet Pharmacol, Seoul, South Korea.	leeso@snu.ac.kr	Ryu, Pan Dong/AGX-5700-2022	Ryu, Pan Dong/0000-0003-4130-2251	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2011-0014514, NRF-2014R1A1A3A04052757]; BK21 PLUS program for Creative Veterinary Science Research; Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2011-0014514, NRF-2014R1A1A3A04052757]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; BK21 PLUS program for Creative Veterinary Science Research; Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2011-0014514, NRF-2014R1A1A3A04052757) and BK21 PLUS program for Creative Veterinary Science Research.; This research was supported by Basic Science Research Program through National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2011-0014514, NRF-2014R1A1A3A04052757).	Akel S, 2007, PLATELETS, V18, P566, DOI 10.1080/09537100701549546; Arcangeli A, 2004, BIOCHEM SOC T, V32, P826, DOI 10.1042/BST0320826; Bardou O, 2009, AM J PHYSIOL-LUNG C, V296, pL145, DOI 10.1152/ajplung.90525.2008; DANEN EHJ, 1995, J BIOL CHEM, V270, P21612, DOI 10.1074/jbc.270.37.21612; de Nigris F, 2003, TRENDS MOL MED, V9, P351, DOI 10.1016/S1471-4914(03)00139-4; Di Pietro R, 2007, J CELL BIOCHEM, V100, P1070, DOI 10.1002/jcb.21106; Fernandez FR, 2003, J BIOL CHEM, V278, P40890, DOI 10.1074/jbc.M304235200; GOLDING B, 1988, J IMMUNOL, V141, P2564; Guidetti Gianni F., 2015, Advances in Biological Regulation, V59, P36, DOI 10.1016/j.jbior.2015.06.001; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hocking JC, 2012, MECH DEVELOP, V129, P125, DOI 10.1016/j.mod.2012.05.003; Huang HM, 2004, BIOCHEM BIOPH RES CO, V320, P1247, DOI 10.1016/j.bbrc.2004.06.083; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Ida C, 2009, BIOSCI BIOTECH BIOCH, V73, P79, DOI 10.1271/bbb.80483; Jang SH, 2011, J VET SCI, V12, P35, DOI 10.4142/jvs.2011.12.1.35; Jang SH, 2011, EUR J PHARMACOL, V651, P26, DOI 10.1016/j.ejphar.2010.10.066; Jang SH, 2009, BIOCHEM BIOPH RES CO, V384, P180, DOI 10.1016/j.bbrc.2009.04.108; JARVINEN M, 1993, CELL BIOL INT, V17, P399, DOI 10.1006/cbir.1993.1078; Kim SJ, 2012, CELL DEATH DIFFER, V19, P333, DOI 10.1038/cdd.2011.102; KOEFFLER HP, 1980, BLOOD, V56, P344; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Lang F, 2005, J MEMBRANE BIOL, V205, P147, DOI 10.1007/s00232-005-0780-5; LANGDON SP, 1988, LEUKEMIA RES, V12, P211, DOI 10.1016/0145-2126(88)90138-5; Leung YM, 2012, PHARMACOL THERAPEUT, V133, P151, DOI 10.1016/j.pharmthera.2011.10.005; Limb JK, 2009, CELL MOL LIFE SCI, V66, P1962, DOI 10.1007/s00018-009-8775-5; Liu K, 2010, BLOOD CELL MOL DIS, V45, P269, DOI 10.1016/j.bcmd.2010.09.004; Liu QH, 2002, J EXP MED, V196, P897, DOI 10.1084/jem.20020381; Liu YP, 2002, CLIN EXP PHARMACOL P, V29, P305, DOI 10.1046/j.1440-1681.2002.03649.x; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; O'Grady SM, 2005, INT J BIOCHEM CELL B, V37, P1578, DOI 10.1016/j.biocel.2005.04.002; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; Pardo LA, 2008, EXPERT OPIN THER TAR, V12, P837, DOI 10.1517/14728222.12.7.837 ; Patel AJ, 2001, EUR RESPIR J, V18, P221, DOI 10.1183/09031936.01.00204001; Pettiford SM, 2003, LEUKEMIA, V17, P366, DOI 10.1038/sj.leu.2402767; Pillozzi S, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/217910; Rae JL, 2000, EXP EYE RES, V70, P339, DOI 10.1006/exer.1999.0796; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; RUTHERFORD TR, 1979, NATURE, V280, P164, DOI 10.1038/280164a0; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Sangerman J, 2006, BLOOD, V108, P3590, DOI 10.1182/blood-2006-01-023713; Tong HX, 2010, J PHYSIOL-LONDON, V588, P1451, DOI 10.1113/jphysiol.2009.186676; VEGA-SAENZ DE MIERA E, 1992, BIOCHEM BIOPH RES CO, V186, P1681; VOLPI N, 1994, EXP CELL RES, V215, P119, DOI 10.1006/excr.1994.1323; Wang HZ, 2002, CANCER RES, V62, P4843; Wang ZG, 2004, PFLUG ARCH EUR J PHY, V448, P274, DOI 10.1007/s00424-004-1258-5; Witt O, 2000, BLOOD, V95, P2391, DOI 10.1182/blood.V95.7.2391.007k21_2391_2396; Yang GH, 2009, J CELL BIOCHEM, V107, P548, DOI 10.1002/jcb.22156; Yi ZC, 2004, ACTA PHARMACOL SIN, V25, P231; You MH, 2013, ACTA PHARMACOL SIN, V34, P129, DOI 10.1038/aps.2012.142; Zeller KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064897; Zhang DZ, 2007, CELL RES, V17, P804, DOI 10.1038/cr.2007.72	53	2	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148633	10.1371/journal.pone.0148633	http://dx.doi.org/10.1371/journal.pone.0148633			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849432	Green Published, gold			2022-12-27	WOS:000369554000142
J	Suh, DH; Jung, ES; Park, HM; Kim, SH; Lee, S; Jo, YH; Lee, MK; Jung, G; Do, SG; Lee, CH				Suh, Dong Ho; Jung, Eun Sung; Park, Hye Min; Kim, Seung Hyung; Lee, Sarah; Jo, Yang Hee; Lee, Mi Kyeong; Jung, Gayoung; Do, Seon-Gil; Lee, Choong Hwan			Comparison of Metabolites Variation and Antiobesity Effects of Fermented versus Nonfermented Mixtures of Cudrania tricuspidata, Lonicera caerulea, and Soybean According to Fermentation In Vitro and In Vivo	PLOS ONE			English	Article							HIGH-FAT DIET; ISOFLAVONE GLYCOSIDES; ANTIOXIDANT ACTIVITY; HYDROLYSIS; PLASMA; URINE; SERUM	We used ultra-performance-liquid-chromatography with quadrupole-time-of-flight mass spectrometry to study the changes in metabolites in the mixture of Cudrania tricuspidata, Lonicera caerulea, and soybean (CLM) during fermentation. Additionally, the antiobesity effects of CLM and fermented-CLM (FCLM) were studied based on the analysis of plasma from high-fat diet (HFD)-fed mice. The levels of cyanidin and the glycosides of luteolin, quercetin, and cyanidin derived from L. caerulea were decreased, whereas the levels of luteolin and quercetin were increased during fermentation. Isoflavone glycosides and soyasaponins originating from the soybean were decreased, whereas their aglycones such as daidzein, glycitein, and genistein were increased. As for prenylated flavonoids from C. tricuspidata, these metabolites were decreased at the early stage of fermentation, and were increased at end of the fermentation. In terms of the functional food product, various metabolites derived from diverse natural products in CLM had complementary effects and demonstrated higher antioxidant and pancreatic lipase inhibition activities after fermentation; these activities were closely related to flavonoid aglycones including genistein, daidzein, glycitein, luteolin, and quercetin. In an in vivo experiment, several clinical parameters affected by HFD were improved by the administration of either CLM or FCLM, but there was a difference in the antiobesity effects. The levels of lysoPCs with C20:4, C16:0, and C22:6 were significantly attenuated by CLM administration, while the attenuated levels of lysoPCs with C20:4 and C18:2 were significantly restored by FCLM administration. These metabolites may explain the above-mentioned differences in antiobesity effects. Although only the changes in plasma lysophospholipids could not fully explain antiobesity effects between non-fermented and fermented plant mixtures from our results, we suggest that metabolomics approach could provide a way to reveal the metabolite alterations in the complex fermentation process and understand the differences or changes in bioactivity according to fermentation.	[Suh, Dong Ho; Jung, Eun Sung; Park, Hye Min; Lee, Choong Hwan] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Kim, Seung Hyung] Daejeon Univ, Inst Tradit Med & Biosci, Daejon, South Korea; [Lee, Sarah] Natl Inst Biol Resources, Inchon, South Korea; [Jo, Yang Hee; Lee, Mi Kyeong] Chungbuk Natl Univ, Coll Pharm, Cheongju, South Korea; [Jung, Gayoung; Do, Seon-Gil] Univera Inc, Wellness R&D Ctr, Seoul, South Korea	Konkuk University; Daejeon University; National Institute of Biological Resources; Chungbuk National University	Lee, CH (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea.	chlee123@konkuk.ac.kr	Kim, Seung-Hyung/AAA-4707-2020	Kim, Seung-Hyung/0000-0002-4598-1733	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2014R1A2A1A11050884]; "Cooperative Research Program for Agricultural Science & Technology Development", Rural Department Administration, Republic of Korea [PJ00982603]; Univera, Inc.	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korean government (MSIP); "Cooperative Research Program for Agricultural Science & Technology Development", Rural Department Administration, Republic of Korea; Univera, Inc.	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. NRF-2014R1A2A1A11050884) and carried out with the support of "Cooperative Research Program for Agricultural Science & Technology Development" (Project No. PJ00982603), Rural Department Administration, Republic of Korea. Univera, Inc. provided support in the form of salaries for authors GJ and SGD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahn JH, 2012, BIOORG MED CHEM LETT, V22, P2760, DOI 10.1016/j.bmcl.2012.02.088; Bajpai VK, 2013, FOOD CONTROL, V32, P582, DOI 10.1016/j.foodcont.2013.01.032; Barber MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041456; Birari RB, 2007, DRUG DISCOV TODAY, V12, P879, DOI 10.1016/j.drudis.2007.07.024; Chandrasekara A, 2012, J FUNCT FOODS, V4, P226, DOI 10.1016/j.jff.2011.11.001; Choi HK, 2008, FOOD CHEM, V106, P564, DOI 10.1016/j.foodchem.2007.06.024; Choi JY, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-35; Faithong N, 2010, FOOD CHEM, V119, P133, DOI 10.1016/j.foodchem.2009.06.056; Harbaum B, 2008, J AGR FOOD CHEM, V56, P148, DOI 10.1021/jf072428o; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; Hugas M, 2002, FOOD MICROBIOL, V19, P519, DOI 10.1006/fmic.2002.0497; Hur SJ, 2014, FOOD CHEM, V160, P346, DOI 10.1016/j.foodchem.2014.03.112; John KMM, 2013, FOOD RES INT, V54, P487, DOI 10.1016/j.foodres.2013.07.045; Kawakami Y, 2005, J NUTR BIOCHEM, V16, P205, DOI 10.1016/j.jnutbio.2004.11.005; Kim HY, 2015, MOLECULES, V20, P3107, DOI 10.3390/molecules20023107; Kim HY, 2014, NUTRITION, V30, P1433, DOI 10.1016/j.nut.2014.04.013; Kim JY, 2010, J PROTEOME RES, V9, P4368, DOI 10.1021/pr100101p; Kim J, 2013, MOL NUTR FOOD RES, V57, P1886, DOI 10.1002/mnfr.201200700; Kuo LC, 2006, APPL MICROBIOL BIOT, V73, P314, DOI 10.1007/s00253-006-0474-7; Lew BW, 2006, BIOSCI BIOTECH BIOCH, V70, P427, DOI 10.1271/bbb.70.427; Palikova I, 2008, J AGR FOOD CHEM, V56, P11883, DOI 10.1021/jf8026233; Park KH, 2006, BIOORG MED CHEM LETT, V16, P5580, DOI 10.1016/j.bmcl.2006.08.032; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Richelle M, 2002, J NUTR, V132, P2587, DOI 10.1093/jn/132.9.2587; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Siro I, 2008, APPETITE, V51, P456, DOI 10.1016/j.appet.2008.05.060; Svarcova Irena, 2007, Biomedical Papers (Olomouc), V151, P163; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Wu CH, 2009, J AGR FOOD CHEM, V57, P10695, DOI 10.1021/jf902752t	29	25	27	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0149022	10.1371/journal.pone.0149022	http://dx.doi.org/10.1371/journal.pone.0149022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848749	Green Published, gold			2022-12-27	WOS:000369554000195
J	Wang, L; Wang, YC; Cao, HL; Hao, XY; Zeng, JM; Yang, YJ; Wang, XC				Wang, Lu; Wang, Yuchun; Cao, Hongli; Hao, Xinyuan; Zeng, Jianming; Yang, Yajun; Wang, Xinchao			Transcriptome Analysis of an Anthracnose-Resistant Tea Plant Cultivar Reveals Genes Associated with Resistance to Colletotrichum camelliae	PLOS ONE			English	Article							APOPLASTIC OXIDATIVE BURST; CINNAMOYL-COA REDUCTASE; NBS-LRR PROTEINS; ELSINOE-AMPELINA; WINTER DORMANCY; EXPRESSION; SINENSIS; ARABIDOPSIS; METABOLISM; IDENTIFICATION	Tea plant breeding is a topic of great economic importance. However, disease remains a major cause of yield and quality losses. In this study, an anthracnose-resistant cultivar, ZC108, was developed. An infection assay revealed different responses to Colletotrichum sp. infection between ZC108 and its parent cultivar LJ43. ZC108 had greater resistance than LJ43 to Colletotrichum camelliae. Additionally, ZC108 exhibited earlier sprouting in the spring, as well as different leaf shape and plant architecture. Microarray data revealed that the genes that are differentially expressed between LJ43 and ZC108 mapped to secondary metabolism-related pathways, including phenylpropanoid biosynthesis, phenylalanine metabolism, and flavonoid biosynthesis pathways. In addition, genes involved in plant hormone biosynthesis and signaling as well as plant-pathogen interaction pathways were also changed. Quantitative real-time PCR was used to examine the expression of 27 selected genes in infected and uninfected tea plant leaves. Genes encoding a MADS-box transcription factor, NBS-LRR disease-resistance protein, and phenylpropanoid metabolism pathway components (CAD, CCR, POD, beta-glucosidase, ALDH and PAL) were among those differentially expressed in ZC108.	[Wang, Lu; Wang, Yuchun; Cao, Hongli; Hao, Xinyuan; Zeng, Jianming; Yang, Yajun; Wang, Xinchao] Chinese Acad Agr Sci, Natl Ctr Tea Plant Improvement, Tea Res Inst, Hangzhou, Zhejiang, Peoples R China; [Wang, Lu; Hao, Xinyuan; Zeng, Jianming; Yang, Yajun; Wang, Xinchao] Minist Agr, Key Lab Tea Biol & Resources Utilizat, Hangzhou, Zhejiang, Peoples R China; [Wang, Yuchun] Northwest Agr & Forestry Univ, Coll Hort, Yangling 712100, Shaanxi, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Yang, YJ; Wang, XC (corresponding author), Chinese Acad Agr Sci, Natl Ctr Tea Plant Improvement, Tea Res Inst, Hangzhou, Zhejiang, Peoples R China.; Yang, YJ; Wang, XC (corresponding author), Minist Agr, Key Lab Tea Biol & Resources Utilizat, Hangzhou, Zhejiang, Peoples R China.	yjyang@tricaas.com; wangxinchao@caas.cn	Hao, Xinyuan/AAF-6386-2021; Wang, Xinchao/I-5745-2019; Wang, Lu/AGT-2034-2022	Hao, Xinyuan/0000-0001-8300-7491; Wang, Xinchao/0000-0002-5224-6286; Yang, Yajun/0000-0003-0552-5730	Earmarked Fund for China Agriculture Research System [CARS-23]; Major Project for New Agricultural Varieties Breeding of Zhejiang Province [2012C2905-3]; Chinese Academy of Agricultural Sciences through an Innovation Project for Agricultural Sciences and Technology (CAAS-ASTIP-TRICAAS)	Earmarked Fund for China Agriculture Research System; Major Project for New Agricultural Varieties Breeding of Zhejiang Province; Chinese Academy of Agricultural Sciences through an Innovation Project for Agricultural Sciences and Technology (CAAS-ASTIP-TRICAAS)	This work was supported by the Earmarked Fund for China Agriculture Research System (CARS-23), the Major Project for New Agricultural Varieties Breeding of Zhejiang Province (2012C2905-3) and the Chinese Academy of Agricultural Sciences through an Innovation Project for Agricultural Sciences and Technology (CAAS-ASTIP-2014-TRICAAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Araujo L, 2015, PLANT DIS, V99, P447, DOI 10.1094/PDIS-08-14-0788-RE; Arvind Gulati, 1993, Indian Phytopathology, V46, P155; Baxter HL, 2013, BIOFUELS-UK, V4, P635, DOI [10.4155/BFS.13.56, 10.4155/bfs.13.56]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; BOWLES DJ, 1990, ANNU REV BIOCHEM, V59, P873, DOI 10.1146/annurev.bi.59.070190.004301; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen Jin, 2005, Genetic Resources and Crop Evolution, V52, P41, DOI 10.1007/s10722-005-0285-1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Dauwe R, 2007, PLANT J, V52, P263, DOI 10.1111/j.1365-313X.2007.03233.x; Deng WW, 2013, J PLANT PHYSIOL, V170, P272, DOI 10.1016/j.jplph.2012.10.010; Derikvand MM, 2008, PLANTA, V227, P943, DOI 10.1007/s00425-007-0669-x; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Finlayson SA, 2010, PLANT PHYSIOL, V152, P1914, DOI 10.1104/pp.109.148833; Fornale S, 2010, PLANT J, V64, P633, DOI 10.1111/j.1365-313X.2010.04363.x; Gallavotti A, 2013, J EXP BOT, V64, P2593, DOI 10.1093/jxb/ert141; Gao M, 2012, PLANT PHYSIOL BIOCH, V58, P253, DOI 10.1016/j.plaphy.2012.07.009; Hao XY, 2014, INT J MOL SCI, V15, P22155, DOI 10.3390/ijms151222155; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kavousi HR., 2009, PLANT PATHOLOGY J, V8, P127, DOI [10.3923/ppj.2009.127.132, DOI 10.3923/PPJ.2009.127.132]; Kim DS, 2014, J EXP BOT, V65, P2295, DOI 10.1093/jxb/eru109; La Camera S, 2004, IMMUNOL REV, V198, P267, DOI 10.1111/j.0105-2896.2004.0129.x; Lacombe E, 1997, PLANT J, V11, P429, DOI 10.1046/j.1365-313X.1997.11030429.x; Lauvergeat V, 2001, PHYTOCHEMISTRY, V57, P1187, DOI 10.1016/S0031-9422(01)00053-X; Leple JC, 2007, PLANT CELL, V19, P3669, DOI 10.1105/tpc.107.054148; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louime C, 2011, INT J MOL SCI, V12, P3473, DOI 10.3390/ijms12063473; MacDonald MJ, 2007, BIOCHEM CELL BIOL, V85, P273, DOI 10.1139/O07-018; MATTIACCI L, 1995, P NATL ACAD SCI USA, V92, P2036, DOI 10.1073/pnas.92.6.2036; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Nagar PK, 2000, ACTA PHYSIOL PLANT, V22, P439, DOI 10.1007/s11738-000-0086-2; Nagar PK, 2006, ACTA PHYSIOL PLANT, V28, P165, DOI 10.1007/s11738-006-0043-9; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ongaro V, 2008, J EXP BOT, V59, P67, DOI 10.1093/jxb/erm134; Pallas JA, 1996, PLANT J, V10, P281, DOI 10.1046/j.1365-313X.1996.10020281.x; Payyavula RS, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-39; Pedras MSC, 2012, MOL PLANT PATHOL, V13, P483, DOI 10.1111/j.1364-3703.2011.00765.x; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Powell L. E., 1987, Plant hormones and their role in plant growth and development., P539; Prashant S, 2011, PLANT CELL REP, V30, P2215, DOI 10.1007/s00299-011-1127-6; Prom L. K., 2015, American Journal of Experimental Agriculture, V6, P242, DOI 10.9734/AJEA/2015/14589; Saravanakumar D, 2007, CROP PROT, V26, P556, DOI 10.1016/j.cropro.2006.05.007; Sirisha VL, 2012, PLANT GROWTH REGUL, V66, P239, DOI 10.1007/s10725-011-9647-1; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; Tan LQ, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0914-6; Teichmann T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00233; Vanstraelen M, 2012, ANNU REV CELL DEV BI, V28, P463, DOI 10.1146/annurev-cellbio-101011-155741; Vasanthaiah HKN, 2010, PLANT GROWTH REGUL, V61, P127, DOI 10.1007/s10725-010-9458-9; Wachira F, 2001, J HORTIC SCI BIOTECH, V76, P557; Wang HA, 2010, J PHOTOCH PHOTOBIO B, V99, P150, DOI 10.1016/j.jphotobiol.2010.03.011; Wang L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0352-x; Wang L, 2014, SCI HORTIC-AMSTERDAM, V174, P133, DOI 10.1016/j.scienta.2014.05.024; Wang XC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-415; Wen YQ, 2012, PLANTA, V236, P525, DOI 10.1007/s00425-012-1624-z; Xu W, 2015, RADIAT RES, V183, P511, DOI 10.1667/RR13909.1; Yang Y., 2003, CHINA TEA, V25, P12; Yoshida K, 2006, JARQ-JPN AGR RES Q, V40, P379, DOI 10.6090/jarq.40.379	62	36	40	7	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148535	10.1371/journal.pone.0148535	http://dx.doi.org/10.1371/journal.pone.0148535			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849553	gold, Green Submitted, Green Published			2022-12-27	WOS:000369554000119
J	Lafortune, L; Martin, S; Kelly, S; Kuhn, I; Remes, O; Cowan, A; Brayne, C				Lafortune, Louise; Martin, Steven; Kelly, Sarah; Kuhn, Isla; Remes, Olivia; Cowan, Andy; Brayne, Carol			Behavioural Risk Factors in Mid-Life Associated with Successful Ageing, Disability, Dementia and Frailty in Later Life: A Rapid Systematic Review	PLOS ONE			English	Article							MIDDLE-AGED MEN; CORONARY-HEART-DISEASE; TIME PHYSICAL-ACTIVITY; ALL-CAUSE MORTALITY; ELDERLY JAPANESE MEN; BODY-MASS INDEX; TYPE-2 DIABETES-MELLITUS; 10-YEAR FOLLOW-UP; LONG-TERM RISK; LEISURE-TIME	Background Smoking, alcohol consumption, poor diet and low levels of physical activity significantly contribute to the burden of illness in developed countries. Whilst the links between specific and multiple risk behaviours and individual chronic conditions are well documented, the impact of these behaviours in mid-life across a range of later life outcomes has yet to be comprehensively assessed. This review aimed to provide an overview of behavioural risk factors in mid-life that are associated with successful ageing and the primary prevention or delay of disability, dementia, frailty and non-communicable chronic conditions. Methods A literature search was conducted to identify cohort studies published in English since 2000 up to Dec 2014. Multivariate analyses and a minimum follow-up of five years were required for inclusion. Two reviewers screened titles, abstracts and papers independently. Studies were assessed for quality. Evidence was synthesised by mid-life behavioural risk for a range of late life outcomes. Findings This search located 10,338 individual references, of which 164 are included in this review. Follow-up data ranged from five years to 36 years. Outcomes include dementia, frailty, disability and cardiovascular disease. There is consistent evidence of beneficial associations between mid-life physical activity, healthy ageing and disease outcomes. Across all populations studied there is consistent evidence that mid-life smoking has a detrimental effect on health. Evidence specific to alcohol consumption was mixed. Limited, but supportive, evidence was available relating specifically to mid-life diet, leisure and social activities or health inequalities. Conclusions There is consistent evidence of associations between mid-life behaviours and a range of late life outcomes. The promotion of physical activity, healthy diet and smoking cessation in all mid-life populations should be encouraged for successful ageing and the prevention of disability and chronic disease.	[Lafortune, Louise; Martin, Steven; Kelly, Sarah; Remes, Olivia; Cowan, Andy; Brayne, Carol] Univ Cambridge, Sch Clin Med, Forvie Site, Inst Publ Hlth, Cambridge Biomed Campus, Cambridge, England; [Kuhn, Isla] Univ Cambridge, Univ Cambridge Med Lib, Sch Clin Med, Cambridge Biomed Campus, Cambridge, England	University of Cambridge; University of Cambridge	Lafortune, L (corresponding author), Univ Cambridge, Sch Clin Med, Forvie Site, Inst Publ Hlth, Cambridge Biomed Campus, Cambridge, England.	ll394@medschl.cam.ac.uk	Brayne, Carol/AAA-4285-2020; Kuhn, Isla L/J-6753-2012; Lafortune, Louise/AAJ-9257-2020	Brayne, Carol/0000-0001-5307-663X; Lafortune, Louise/0000-0002-9018-1217; Kuhn, Isla/0000-0002-2879-4020; Kelly, Sarah/0000-0002-1114-2456; Cowan, Andy/0000-0002-8981-5673; Remes, Olivia/0000-0001-9065-1429	National Institute for Health and Care Excellence (NICE) [DDER 42013]; National Institute for Health Research School for Public Health Research; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish	National Institute for Health and Care Excellence (NICE); National Institute for Health Research School for Public Health Research; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the National Institute for Health and Care Excellence (NICE), invitation to tender reference DDER 42013, and supported by the National Institute for Health Research School for Public Health Research. The scope of the work was defined by NICE and the protocol was agreed with NICE prior to the start of work. The funders had no role in data analysis, preparation of the manuscript or decision to publish.	Agahi N, 2013, PREV MED, V57, P107, DOI 10.1016/j.ypmed.2013.04.016; Agrigoroaei S, 2011, J GERONTOL B-PSYCHOL, V66, P130, DOI 10.1093/geronb/gbr017; Ahmed N, 2007, AM J MED, V120, P748, DOI 10.1016/j.amjmed.2006.10.018; Akbaraly T, 2013, AM J MED, V126, P411, DOI 10.1016/j.amjmed.2012.10.028; Alonso A, 2009, J NEUROL NEUROSUR PS, V80, P1194, DOI 10.1136/jnnp.2009.176818; Andel R, 2008, J GERONTOL A-BIOL, V63, P62, DOI 10.1093/gerona/63.1.62; Andrew MK, 2008, AM J MED, V121, pE21, DOI 10.1016/j.amjmed.2007.09.017; Angevaren M, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005381.pub3, 10.1002/14651858.CD005381.pub2]; Anttila T, 2004, BMJ-BRIT MED J, V329, P539, DOI 10.1136/bmj.38181.418958.BE; Baba S, 2006, EUR J CARDIOV PREV R, V13, P207, DOI 10.1097/01.hjr.0000194417.16638.3d; Baker PRA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008366.pub3; Beckett MW, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0007-2; Benzein EG, 2005, PALLIATIVE MED, V19, P234, DOI 10.1191/0269216305pm1003oa; Beulens JWJ, 2007, J AM COLL CARDIOL, V50, P14, DOI 10.1016/j.jacc.2007.02.068; Bielak AAM, 2012, PSYCHOL AGING, V27, P219, DOI 10.1037/a0024667; Blanco-Cedres L, 2002, AM J EPIDEMIOL, V155, P354, DOI 10.1093/aje/155.4.354; Blane D., 2006, SOCIAL DETERMINANTS, P54; Boudik F, 2006, ATHEROSCLEROSIS, V184, P86, DOI 10.1016/j.atherosclerosis.2005.02.011; Brand DA, 2007, PLOS MED, V4, P752, DOI 10.1371/journal.pmed.0040151; Brayne C, 2006, PLOS MED, V3, P1922, DOI 10.1371/journal.pmed.0030397; Britton A, 2008, J AM GERIATR SOC, V56, P1098, DOI 10.1111/j.1532-5415.2008.01740.x; Carlson MC, 2008, ALZHEIMERS DEMENT, V4, P324, DOI 10.1016/j.jalz.2008.07.002; Champagne CM, 2009, CURR DIABETES REP, V9, P389, DOI 10.1007/s11892-009-0060-3; Chang M, 2013, J AM GERIATR SOC, V61, P237, DOI 10.1111/jgs.12077; Chang ML, 2010, J GERONTOL A-BIOL, V65, P1369, DOI 10.1093/gerona/glq152; Christensen U, 2006, SCAND J MED SCI SPOR, V16, P245, DOI 10.1111/j.1600-0838.2005.00459.x; Debette S, 2011, NEUROLOGY, V77, P461, DOI 10.1212/WNL.0b013e318227b227; Desroches Sophie, 2013, Cochrane Database Syst Rev, pCD008722, DOI 10.1002/14651858.CD008722.pub2; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dudas KA, 2007, EUR J CARDIOV PREV R, V14, P122, DOI 10.1097/01.hjr.0000209814.82701.3f; Echouffo-Tcheugui Justin B, 2013, PLoS One, V8, pe67370, DOI 10.1371/journal.pone.0067370; Ekelund U, 2005, DIABETES CARE, V28, P1195, DOI 10.2337/diacare.28.5.1195; Elwood P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081877; Emberson JR, 2005, AM J EPIDEMIOL, V161, P856, DOI 10.1093/aje/kwi111; Englund U, 2013, OSTEOPOROSIS INT, V24, P533, DOI 10.1007/s00198-012-1988-8; Englund U, 2011, OSTEOPOROSIS INT, V22, P499, DOI 10.1007/s00198-010-1234-1; Eskelinen MH, 2008, INT J GERIATR PSYCH, V23, P741, DOI 10.1002/gps.1969; Eskelinen MH, 2009, J ALZHEIMERS DIS, V16, P85, DOI 10.3233/JAD-2009-0920; Eskelinen MH, 2009, ALZHEIMERS DEMENT, V5, P284; Field AE, 2009, ARCH INTERN MED, V169, P881, DOI 10.1001/archinternmed.2009.67; Flood A, 2008, AM J CLIN NUTR, V88, P176, DOI 10.1093/ajcn/88.1.176; Fogelholm M, 2000, OBES RES, V8, P367, DOI 10.1038/oby.2000.44; Friedland RP, 2001, P NATL ACAD SCI USA, V98, P3440, DOI 10.1073/pnas.061002998; Gerber Y, 2012, AM J EPIDEMIOL, V175, P1006, DOI 10.1093/aje/kwr466; Guallar-Castillon P, 2012, NUTR METAB CARDIOVAS, V22, P192, DOI 10.1016/j.numecd.2010.06.004; Haapanen-Niemi N, 2000, INT J OBESITY, V24, P1465, DOI 10.1038/sj.ijo.0801426; Halperin RO, AM J HYPERTENSION, V21, P148; Hamer M, 2014, BRIT J SPORT MED, V48, P239, DOI 10.1136/bjsports-2013-092993; Happonen P, 2004, J NUTR, V134, P2381, DOI 10.1093/jn/134.9.2381; Hara M, 2002, JPN J CANCER RES, V93, P6, DOI 10.1111/j.1349-7006.2002.tb01194.x; Harmsen P, 2006, STROKE, V37, P1663, DOI 10.1161/01.STR.0000226604.10877.fc; Harrison SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114431; He K, 2004, INT J OBESITY, V28, P1569, DOI 10.1038/sj.ijo.0802795; Hillsdon M, 2005, Cochrane Database Syst Rev, pCD003180; Hodge AM, 2014, J NUTR HEALTH AGING, V18, P221, DOI 10.1007/s12603-013-0405-0; Hodge A, 2013, INT PSYCHOGERIATR, V25, P456, DOI 10.1017/S1041610212001986; Holmberg AH, 2006, OSTEOPOROSIS INT, V17, P1065, DOI 10.1007/s00198-006-0137-7; Holme I, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-154; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Holtermann A, 2009, SCAND J WORK ENV HEA, V35, P466, DOI 10.5271/sjweh.1357; Holtzman RE, 2004, J GERONTOL B-PSYCHOL, V59, pP278, DOI 10.1093/geronb/59.6.P278; Hu G, 2004, EUR HEART J, V25, P2212, DOI 10.1016/j.ehj.2004.10.020; Hu G, 2005, INT J OBESITY, V29, P894, DOI 10.1038/sj.ijo.0802870; Hu G, 2003, DIABETOLOGIA, V46, P322, DOI 10.1007/s00125-003-1031-x; Hu G, 2007, ATHEROSCLEROSIS, V194, P490, DOI 10.1016/j.atherosclerosis.2006.08.051; Hughes TF, 2010, AM J GERIAT PSYCHIAT, V18, P413, DOI 10.1097/JGP.0b013e3181c65250; Humphries SE, 2001, LANCET, V358, P115, DOI 10.1016/S0140-6736(01)05330-2; Inoue M, 2004, PREV MED, V38, P516, DOI 10.1016/j.ypmed.2003.11.026; Iso H, 2004, STROKE, V35, P1124, DOI 10.1161/01.STR.0000124459.33597.00; Janzon E, 2004, J INTERN MED, V256, P111, DOI 10.1111/j.1365-2796.2004.01346.x; Kareholt I, 2011, INT J GERIATR PSYCH, V26, P65, DOI 10.1002/gps.2490; Kato M, 2009, ENDOCR J, V56, P459, DOI 10.1507/endocrj.K09E-003; Kesse-Guyot E, 2012, J NUTR, V142, P909, DOI 10.3945/jn.111.156257; Khalili P, 2002, J HYPERTENS, V20, P1759, DOI 10.1097/00004872-200209000-00019; Khaw Kay-Tee, 2008, PLoS Med, V5, pe12, DOI 10.1371/journal.pmed.0050012; Kimm H, 2011, ARCH GERONTOL GERIAT, V52, pE117, DOI 10.1016/j.archger.2010.09.004; King DE, 2007, AM J MED, V120, P598, DOI 10.1016/j.amjmed.2006.09.020; Knopman D, 2001, NEUROLOGY, V56, P42, DOI 10.1212/WNL.56.1.42; Kuh D, 2007, J GERONTOL A-BIOL, V62, P717, DOI 10.1093/gerona/62.7.717; Lahti J, 2010, PREV MED, V50, P246, DOI 10.1016/j.ypmed.2010.02.007; Laitala VS, 2009, AM J CLIN NUTR, V90, P640, DOI 10.3945/ajcn.2009.27660; Laitinen MH, 2006, DEMENT GERIATR COGN, V22, P99, DOI 10.1159/000093478; Lajous M, 2013, AM J EPIDEMIOL, V178, P382, DOI 10.1093/aje/kws478; Lang IA, 2007, J AM GERIATR SOC, V55, P1836, DOI 10.1111/j.1532-5415.2007.01426.x; Langlois JA, 2001, OSTEOPOROSIS INT, V12, P763, DOI 10.1007/s001980170053; Laurin D, 2004, AM J EPIDEMIOL, V159, P959, DOI 10.1093/aje/kwh124; Lavie CJ, 2009, J AM COLL CARDIOL, V54, P585, DOI 10.1016/j.jacc.2009.02.084; Lehto SM, 2013, J AFFECT DISORDERS, V150, P682, DOI 10.1016/j.jad.2013.03.027; Leosdottir M, 2007, EUR J CARDIOV PREV R, V14, P701, DOI 10.1097/HJR.0b013e3282a56c45; Levitan EB, 2009, EUR HEART J, V30, P1495, DOI 10.1093/eurheartj/ehp111; Lim SH, 2013, TOB CONTROL, V22, P235, DOI 10.1136/tobaccocontrol-2011-050106; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin YS, 2005, ANN EPIDEMIOL, V15, P590, DOI 10.1016/j.annepidem.2004.10.010; Liu SM, 2003, AM J CLIN NUTR, V78, P920, DOI 10.1093/ajcn/78.5.920; Malmberg JJ, 2006, J AGING PHYS ACTIV, V14, P133, DOI 10.1123/japa.14.2.133; Mannami T, 2004, STROKE, V35, P1248, DOI 10.1161/01.STR.0000128794.30660.e8; Masaki Motofumi, 2003, Asian Pac J Cancer Prev, V4, P61; Matthews F, 2005, PLOS MED, V2, P1047, DOI 10.1371/journal.pmed.0020389; Meisinger C, 2007, EUR J CARDIOV PREV R, V14, P788, DOI 10.1097/HJR.0b013e32828641be; Menotti A, 2012, NUTR METAB CARDIOVAS, V22, P369, DOI 10.1016/j.numecd.2010.08.002; Menotti A, 2006, AGING CLIN EXP RES, V18, P394; Miura K, 2004, AM J EPIDEMIOL, V159, P572, DOI 10.1093/aje/kwh085; Moayyeri A, 2009, EUR J EPIDEMIOL, V24, P259, DOI 10.1007/s10654-009-9337-8; Morgan GS, 2012, J ALZHEIMERS DIS, V31, P569, DOI 10.3233/JAD-2012-112171; Mostofsky E, 2010, CIRC-HEART FAIL, V3, P612, DOI 10.1161/CIRCHEARTFAILURE.110.944025; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Mursu J, 2008, BRIT J NUTR, V100, P890, DOI 10.1017/S0007114508945694; Myint PK, 2011, AGE AGEING, V40, P589, DOI 10.1093/ageing/afr058; Nafziger AN, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-108; Nakamura Y, 2009, GERONTOLOGY, V55, P707, DOI 10.1159/000235906; Nakayama T, 2000, NEUROEPIDEMIOLOGY, V19, P217, DOI 10.1159/000026259; National Institute for Clinical Excellence, 2012, METH DEV NICE PUBL H; Newman AB, 2011, AGING-US, V3, P63, DOI 10.18632/aging.100242; Noborisaka Y, 2013, ENVIRON HEALTH PREV, V18, P24, DOI 10.1007/s12199-012-0285-7; Nokes NR, 2012, AM J HEALTH PROMOT, V26, P341, DOI 10.4278/ajhp.100622-QUAN-208; Nooyens ACJ, 2011, BRIT J NUTR, V106, P752, DOI 10.1017/S0007114511001024; Nooyens ACJ, 2008, AM J PUBLIC HEALTH, V98, P2244, DOI 10.2105/AJPH.2007.130294; Osler M, 2003, J CLIN EPIDEMIOL, V56, P274, DOI 10.1016/S0895-4356(02)00600-5; Ostbye T, 2002, PREV MED, V34, P334, DOI 10.1006/pmed.2001.0991; Ostenson CG, 2012, SCAND J PUBLIC HEALT, V40, P730, DOI 10.1177/1403494812459814; Otani T, 2003, CANCER EPIDEM BIOMAR, V12, P1492; Panel NHLBI Obesity Education Initiative Expert, 2000, CLIN GUID ID EV TREA; Patel KV, 2006, AM J PREV MED, V31, P217, DOI 10.1016/j.amepre.2006.05.005; Patja K, 2005, J INTERN MED, V258, P356, DOI 10.1111/j.1365-2796.2005.01545.x; Pelkonen M, 2000, THORAX, V55, P746, DOI 10.1136/thorax.55.9.746; Pelkonen M, 2006, CHEST, V130, P1129, DOI 10.1378/chest.130.4.1129; Peto R, 1996, BRIT MED BULL, V52, P12, DOI 10.1093/oxfordjournals.bmb.a011519; Pi-Sunyer FX, 2007, NUTR REV, V65, P101, DOI [10.1301/nr.2007.mar.101-110, 10.1111/j.1753-4887.2007.tb00287.x]; Pisinger C, 2007, NICOTINE TOB RES, V9, P631, DOI 10.1080/14622200701365327; Pitsavos C, 2004, J HUM HYPERTENS, V18, P495, DOI 10.1038/sj.jhh.1001692; Plassman BL, 2010, ANN INTERN MED, V153, P182, DOI 10.7326/0003-4819-153-3-201008030-00258; Preis SR, 2010, AM J CLIN NUTR, V92, P1265, DOI 10.3945/ajcn.2010.29626; Qiao Q, 2000, EUR HEART J, V21, P1621, DOI 10.1053/euhj.2000.2151; Qiu DM, 2003, J EPIDEMIOL, V13, P149, DOI 10.2188/jea.13.149; Raikkonen K, 2001, HYPERTENSION, V38, P798, DOI 10.1161/hyp.38.4.798; Ravona-Springer Ramit, 2013, Neurology, V80, P1677, DOI 10.1212/WNL.0b013e3182904cee; Ream E, 1996, INT J NURS STUD, V33, P519, DOI 10.1016/0020-7489(96)00004-1; Riserus U, 2007, DIABETES CARE, V30, P2928, DOI 10.2337/dc07-0360; Rodgers A, 2004, PLOS MED, V1, P44, DOI 10.1371/journal.pmed.0010027; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Rovio S, 2007, INT J GERIATR PSYCH, V22, P874, DOI 10.1002/gps.1755; Ruder EH, 2011, AM J CLIN NUTR, V94, P1607, DOI 10.3945/ajcn.111.020701; Rusanen M, 2011, ARCH INTERN MED, V171, P333, DOI 10.1001/archinternmed.2010.393; Ruusunen A, 2010, PUBLIC HEALTH NUTR, V13, P1215, DOI 10.1017/S1368980010000509; Sabia S, 2008, ARCH INTERN MED, V168, P1165, DOI 10.1001/archinte.168.11.1165; Sabia S, 2012, CAN MED ASSOC J, V184, P1985, DOI 10.1503/cmaj.121080; Sabia S, 2011, ADDICTION, V106, P93, DOI 10.1111/j.1360-0443.2010.03106.x; Sabia S, 2009, AM J EPIDEMIOL, V170, P428, DOI 10.1093/aje/kwp161; Sairenchi T, 2004, AM J EPIDEMIOL, V160, P158, DOI 10.1093/aje/kwh183; Samieri C, 2013, ANN INTERN MED, V159, P584, DOI 10.7326/0003-4819-159-9-201311050-00004; Satoh H, 2006, INTERNAL MED, V45, P235, DOI 10.2169/internalmedicine.45.1532; Seccareccia F, 2003, ANN EPIDEMIOL, V13, P424, DOI 10.1016/S1047-2797(02)00457-X; Shaper AG, 2003, INT J EPIDEMIOL, V32, P802, DOI 10.1093/ije/dyg206; Singh-Manoux A, 2011, ANN NEUROL, V70, P296, DOI 10.1002/ana.22391; Skogen JC, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0020-5; Smart NA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007957.pub2; Sobue T, 2002, INT J CANCER, V99, P245, DOI 10.1002/ijc.10308; Song Y, 2004, DIABETES CARE, V27, P2108, DOI 10.2337/diacare.27.9.2108; Song YQ, 2006, AM J CARDIOL, V98, P1616, DOI 10.1016/j.amjcard.2006.07.040; Stevens RJ, 2009, INT J CANCER, V124, P2400, DOI 10.1002/ijc.24196; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; Strand BH, 2013, J NEUROL SCI, V324, P124, DOI 10.1016/j.jns.2012.10.018; Strandberg AY, 2008, ARCH INTERN MED, V168, P1968, DOI 10.1001/archinte.168.18.1968; Strandberg TE, 2007, LANCET, V369, P1328, DOI 10.1016/S0140-6736(12)62167-9; Strandhagen E, 2000, EUR J CLIN NUTR, V54, P337, DOI 10.1038/sj.ejcn.1600959; Sun Q, 2010, ARCH INTERN MED, V170, P194, DOI 10.1001/archinternmed.2009.503; Szoeke CEI, 2006, BONE, V39, P1149, DOI 10.1016/j.bone.2006.05.016; Tabak C, 2001, EPIDEMIOLOGY, V12, P239, DOI 10.1097/00001648-200103000-00018; Tsugane S, 2004, BRIT J CANCER, V90, P128, DOI 10.1038/sj.bjc.6601511; Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213; Tyas SL, 2003, NEUROBIOL AGING, V24, P589, DOI 10.1016/S0197-4580(02)00156-2; Villegas R, 2011, AM J CLIN NUTR, V94, P543, DOI 10.3945/ajcn.111.013193; Villegas R, 2010, INT J EPIDEMIOL, V39, P889, DOI 10.1093/ije/dyq008; Virta JJ, 2013, EUR J EPIDEMIOL, V28, P405, DOI 10.1007/s10654-013-9794-y; Virta JJ, 2010, J ALZHEIMERS DIS, V22, P939, DOI 10.3233/JAD-2010-100870; Waki K, 2005, DIABETIC MED, V22, P323, DOI 10.1111/j.1464-5491.2004.01403.x; Walda IC, 2002, EUR J CLIN NUTR, V56, P638, DOI 10.1038/sj.ejcn.1601370; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076357; Wang L, 2008, HYPERTENSION, V51, P1073, DOI 10.1161/HYPERTENSIONAHA.107.107821; Wang L, 2012, AM J HYPERTENS, V25, P180, DOI 10.1038/ajh.2011.186; Wang L, 2010, HYPERTENSION, V56, P598, DOI 10.1161/HYPERTENSIONAHA.110.154187; Wang L, 2010, ARCH INTERN MED, V170, P453, DOI 10.1001/archinternmed.2009.527; Wang L, 2009, AM J CLIN NUTR, V89, P905, DOI 10.3945/ajcn.2008.26913; Wannamethee SG, 2001, BRIT J CANCER, V85, P1311, DOI 10.1054/bjoc.2001.2096; Wannamethee SG, 2002, HEART, V87, P32, DOI 10.1136/heart.87.1.32; Wannamethee SG, 2003, AM J CLIN NUTR, V77, P1312, DOI 10.1093/ajcn/77.5.1312; Waring ME, 2010, AM J EPIDEMIOL, V171, P550, DOI 10.1093/aje/kwp433; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; WHO, 2002, RED RISKS PROM HLTH; Wiles NJ, 2007, AM J EPIDEMIOL, V165, P946, DOI 10.1093/aje/kwk070; Willcox BJ, 2006, JAMA-J AM MED ASSOC, V296, P2343, DOI 10.1001/jama.296.19.2343; Wills AK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000440; World Health Organisation, 1999, GLOB STAT REP ALC; Xu QY, 2010, HEALTH CARE WOMEN IN, V31, P1082, DOI 10.1080/07399332.2010.486096; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703; Yu Shu, 2003, J Nurs Res, V11, P65	199	80	81	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0144405	10.1371/journal.pone.0144405	http://dx.doi.org/10.1371/journal.pone.0144405			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PF	26845035	Green Published, gold			2022-12-27	WOS:000369552800002
J	Sauerwald, A; Niggl, M; Puppe, J; Prescher, A; Scaal, M; Noe, GK; Schiermeier, S; Warm, M; Eichler, C				Sauerwald, A.; Niggl, M.; Puppe, J.; Prescher, A.; Scaal, M.; Noe, G. K.; Schiermeier, S.; Warm, M.; Eichler, C.			Laparoscopic Pectopexy: A Biomechanical Analysis	PLOS ONE			English	Article							FIXED-ANGLE PLATE; TRANSVERSE PATELLA FRACTURES; IN-VIVO; SACROCOLPOPEXY; FIXATION; PROLAPSE; MESH; LIGAMENT; CADAVER	Introduction Pectopexy, a laparoscopic method for prolapse surgery, showed promising results in recent literature. Further improving this approach by reducing surgical time may decrease complication rates and patient morbidity. Since laparoscopic suturing is a time consuming task, we propose a single suture /mesh ileo-pectineal ligament fixation as opposed to the commonly used continues approach. Methods Evaluation was performed on human non-embalmed, fresh cadaver pelves. A total of 33 trials was performed. Eight female pelves with an average age of 75, were used. This resulted in 16 available ligaments. Recorded parameters were ultimate load, displacement at failure and stiffness. Results The ultimate load for the mesh + simplified single "interrupted" suture (MIS) group was 35 (+/- 12) N and 48 (+/- 7) N for the mesh + continuous suture (MCS) group. There was no significant difference in the ultimate load between both groups (p>0.05). This was also true for displacement at failure measured at 37 (+/- 12) mm and 36 (+/-5) mm respectively. There was also no significant difference in stiffness and failure modes. Conclusion Given the data above we must conclude that a continuous suture is not necessary in laparoscopic mesh /ileo-pectineal ligament fixation during pectopexy. Ultimate load and displacement at failure results clearly indicate that a single suture is not inferior to a continuous approach. The use of two single sutures may improve ligamental fixation. However, overall stability should not benefit since the surgical mesh remains the limiting factor.	[Sauerwald, A.] Hosp Duren GmbH, Dept Gynecol & Obstet, Duren, Germany; [Niggl, M.; Warm, M.; Eichler, C.] Municipal Hosp Holweide, Breast Canc Ctr, Cologne, Germany; [Niggl, M.; Eichler, C.] Municipal Hosp Holweide, Dept Gynecol & Obstet, Cologne, Germany; [Puppe, J.; Warm, M.] Univ Cologne, Dept Gynecol & Obstet, D-50931 Cologne, Germany; [Prescher, A.] Rhein Westfal TH Aachen, Dept Anat, Aachen, Germany; [Scaal, M.] Univ Cologne, Dept Anat 2, D-50931 Cologne, Germany; [Noe, G. K.] Fac Univ Witten Herdecke, Dept Ob Gyn Hosp Rhein Kreis Neuss, Witten, Germany; [Schiermeier, S.] Dept Ob Gyn Marienhosp Witten, Witten, Germany	University of Cologne; RWTH Aachen University; University of Cologne	Eichler, C (corresponding author), Municipal Hosp Holweide, Breast Canc Ctr, Cologne, Germany.; Eichler, C (corresponding author), Municipal Hosp Holweide, Dept Gynecol & Obstet, Cologne, Germany.	ceichler@gmail.com	Noé, Guenter Karl/AAF-4928-2021	Noé, Guenter Karl/0000-0001-5673-9689; Sauerwald, Axel/0000-0002-9451-7726				Alkatout I, 2014, JSLS-J SOC LAPAROEND, V18, P89, DOI 10.4293/108680813X13693422520846; Banerjee C, 2011, ARCH GYNECOL OBSTET, V284, P631, DOI 10.1007/s00404-010-1687-7; BURCH JC, 1961, AM J OBSTET GYNECOL, V81, P281, DOI 10.1016/S0002-9378(16)36367-0; Cosson M, 2003, EUR J OBSTET GYN R B, V109, P80, DOI 10.1016/S0301-2115(02)00487-6; Endo M, 2014, INT UROGYNECOL J, V25, P737, DOI 10.1007/s00192-013-2293-6; Huber SA, 2014, INT UROGYNECOL J; Lee RK, 2014, EUR UROL, V65, P1128, DOI 10.1016/j.eururo.2013.12.064; Maher C, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004014.PUB2, 10.1002/14651858.CD004014.pub2]; Noe KG, 2013, ARCH GYNECOL OBSTET, V287, P275, DOI 10.1007/s00404-012-2536-7; Noe KG, 2014, J ENDOUROL; Nygaard IE, 2004, OBSTET GYNECOL, V104, P805, DOI 10.1097/01.AOG.0000139514.90897.07; Siddiqui NY, 2015, OBSTET GYNECOL, V125, P44, DOI 10.1097/AOG.0000000000000570; Thelen S, 2013, ORTHOPEDICS, V36, pE1437, DOI 10.3928/01477447-20131021-29; Thelen S, 2013, KNEE SURG SPORT TR A, V21, P311, DOI 10.1007/s00167-012-1999-1; Thelen S, 2012, INJURY, V43, P1290, DOI 10.1016/j.injury.2012.04.020; Wild M, 2011, EUR J MED RES, V16, P41, DOI 10.1186/2047-783X-16-1-41; Wild M, 2010, CLIN BIOMECH, V25, P341, DOI 10.1016/j.clinbiomech.2009.12.010; Zimkowski MM, 2014, J BIOMED MATER RES B, V102, P1093, DOI 10.1002/jbm.b.33091; Zimkowski MM, 2013, J BIOMED MATER RES A, V101, P2613, DOI 10.1002/jbm.a.34556	19	8	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0144143	10.1371/journal.pone.0144143	http://dx.doi.org/10.1371/journal.pone.0144143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844890	Green Published, gold			2022-12-27	WOS:000369552800001
J	Fiorentino, M; Sophonneary, P; Laillou, A; Whitney, S; de Groot, R; Perignon, M; Kuong, K; Berger, J; Wieringa, FT				Fiorentino, Marion; Sophonneary, Prak; Laillou, Arnaud; Whitney, Sophie; de Groot, Richard; Perignon, Marlene; Kuong, Khov; Berger, Jacques; Wieringa, Frank T.			Current MUAC Cut-Offs to Screen for Acute Malnutrition Need to Be Adapted to Gender and Age: The Example of Cambodia	PLOS ONE			English	Article							UPPER-ARM CIRCUMFERENCE; WEIGHT-FOR-HEIGHT; NUTRITIONAL-STATUS; LOW-INCOME; HIGH-RISK; Z SCORES; CHILDREN; MORTALITY; FAT	Background Early identification of children <5 yrs with acute malnutrition is a priority. Acute malnutrition is defined by the World Health Organization as a mid-upper-arm circumference (MUAC) <12.5 cm or a weight-for-height Z-score (WHZ) <-2. MUAC is a simple and low-cost indicator to screen for acute malnutrition in communities, but MUAC cut-offs currently recommended by WHO do not identify the majority of children with weight-for-height Z-score (<-2 (moderate malnourished) or r<-3 (severe malnourished). Also, no cut-offs for MUAC are established for children >5 yrs. Therefore, this study aimed at defining gender and age-specific cut-offs to improve sensitivity of MUAC as an indicator of acute malnutrition. Methods To establish new age and gender-specific MUAC cut-offs, pooled data was obtained for 14,173 children from 5 surveys in Cambodia (2011-2013). Sensitivity, false positive rates, and areas under receiver-operator characteristic curves (AUC) were calculated using wasting for children <5yrs and thinness for children >= 5yrs as gold standards. Among the highest values of AUC, the cut-off with the highest sensitivity and a false positive rate <= 33% was selected as the optimal cut-off. Results Optimal cut-off values increased with age. Boys had higher cut-offs than girls, except in the 8-10.9 yrs age range. In children <2yrs, the cut-off was lower for stunted children compared to non stunted children. Sensitivity of MUAC to identify WHZ<-2 and <-3 z-scores increased from 24.3% and 8.1% to >80% with the new cut-offs in comparison with the current WHO cut-offs. Conclusion Gender and age specific MUAC cut-offs drastically increased sensitivity to identify children with WHZ-score <-2 z-scores. International reference of MUAC cut-offs by age group and gender should be established to screen for acute malnutrition at the community level.	[Fiorentino, Marion; Perignon, Marlene; Berger, Jacques; Wieringa, Frank T.] Inst Rech Dev, IRD SupAgro Nutripass Montpellier1 Montpellier2, UMR 204, Montpellier, France; [Sophonneary, Prak] Maternal & Child Hlth Ctr, Natl Nutr Program, Phnom Penh, Cambodia; [Laillou, Arnaud] UNICEF, Maternal Child Hlth & Nutr Sect, Phnom Penh, Cambodia; [Whitney, Sophie] World Food Program, Phnom Penh, Cambodia; [Kuong, Khov] FiA Adm DFPTQ, Minist Agr Forestry & Fisheries, Phnom Penh, Cambodia	Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Fiorentino, M (corresponding author), Inst Rech Dev, IRD SupAgro Nutripass Montpellier1 Montpellier2, UMR 204, Montpellier, France.	marionfiorentino@hotmail.com	Wieringa, Frank Tammo/K-7565-2017	Wieringa, Frank Tammo/0000-0002-6010-355X; fiorentino, marion/0000-0002-1615-4579; PERIGNON, Marlene/0000-0003-2862-9030	UNICEF; WHO; WFP; World Vision; International Relief and Development; Institut de Recherche pour le Developpement	UNICEF; WHO(World Health Organization); WFP; World Vision; International Relief and Development; Institut de Recherche pour le Developpement	Data were obtained from studies funded by UNICEF, WHO, WFP, World Vision, International Relief and Development, and Institut de Recherche pour le Developpement.	Berkley J, 2005, JAMA-J AM MED ASSOC, V294, P591, DOI 10.1001/jama.294.5.591; Best C, 2010, FOOD NUTR BULL, V31, P400, DOI 10.1177/156482651003100303; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; BRIEND A, 1987, LANCET, V2, P725; Briend A, 2012, MATERN CHILD NUTR, V8, P130, DOI 10.1111/j.1740-8709.2011.00340.x; Cogill B, 2003, ANTHROPOMETRIC INDIC; De Onis M, 1997, WHO B OMS, V75, P11; Fernandez MAL, 2010, PEDIATRICS, V126, pE195, DOI 10.1542/peds.2009-2175; Clemente APG, 2011, J PEDIAT-BRAZIL, V87, P138, DOI 10.2223/JPED.2071; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; HALL G, 1993, LANCET, V341, P1481, DOI 10.1016/0140-6736(93)90927-9; Hop le T, 1998, Asia Pac J Clin Nutr, V7, P65; Jelliffe D B, 1966, Monogr Ser World Health Organ, V53, P3; Laillou A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101159; Malina R., 1999, HLTH WEIGHT J, V13; Martins PA, 2004, BRIT J NUTR, V92, P819, DOI 10.1079/BJN20041274; MCLAREN DS, 1974, AM J CLIN NUTR, V27, P105, DOI 10.1093/ajcn/27.2.105-a; Mwangome MK, 2014, MATERN CHILD NUTR, V10, P474, DOI 10.1111/mcn.12124; Myatt M, 2009, ANN HUM BIOL, V36, P5, DOI 10.1080/03014460802471205; National Institute of Statistics, 2011, CAMB DEM HLTH SURV 2; VANDENBROECK J, 1993, LANCET, V341, P1491, DOI 10.1016/0140-6736(93)90632-Q; VELLA V, 1993, AM J PUBLIC HEALTH, V83, P1616, DOI 10.2105/AJPH.83.11.1616; WHO, 2013, GUID UPD MAN SEV AC; WHO, 2006, WHO CHILD GROWTH STA; World Health Organization, 1995, PHYS STAT US INT ANT; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	27	30	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146442	10.1371/journal.pone.0146442	http://dx.doi.org/10.1371/journal.pone.0146442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840899	Green Submitted, gold, Green Published			2022-12-27	WOS:000369550200009
J	Cassel, R; Ducreux, S; Alam, MR; Dingreville, F; Berle, C; Burda-Jacob, K; Chauvin, A; Chikh, K; Paita, L; Al-Mawla, R; Da Silva, CC; Rieusset, J; Thivolet, C; Van Coppenolle, F; Madec, AM				Cassel, R.; Ducreux, S.; Alam, M. R.; Dingreville, F.; Berle, C.; Burda-Jacob, K.; Chauvin, A.; Chikh, K.; Paita, L.; Al-Mawla, R.; Da Silva, C. Crola; Rieusset, J.; Thivolet, C.; Van Coppenolle, F.; Madec, A. M.			Protection of Human Pancreatic Islets from Lipotoxicity by Modulation of the Translocon	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; BETA-CELL DYSFUNCTION; SATURATED FATTY-ACID; INSULIN-RESISTANCE; CALCIUM LEAK; ER STRESS; KAPPA-B; MECHANISMS; PALMITATE	Type 2 diabetes is characterized by peripheral insulin resistance and pancreatic beta cell dysfunction. Elevated free fatty acids (FFAs) may impair beta cell function and mass (lipotoxicity). Altered calcium homeostasis may be involved in defective insulin release. The endoplasmic reticulum (ER) is the major intracellular calcium store. Lipotoxicity induces ER stress and in parallel an ER calcium depletion through unknown ER calcium leak channels. The main purposes of this study is first to identify one of these channels and secondly, to check the opportunity to restore beta cells function (i.e., insulin secretion) after pharmacological inhibition of ER calcium store depletion. We investigated the functionality of translocon, an ER calcium leak channel and its involvement on FFAs-induced alterations in MIN6B1 cells and in human pancreatic islets. We evidenced that translocon acts as a functional ER calcium leak channel in human beta cells using anisomycin and puromycin (antibiotics), respectively blocker and opener of this channel. Puromycin induced a significant ER calcium release, inhibited by anisomycin pretreatment. Palmitate treatment was used as FFA model to induce a mild lipotoxic effect: ER calcium content was reduced, ER stress but not apoptosis were induced and glucose induced insulin secretion was decreased in our beta cells. Interestingly, translocon inhibition by chronic anisomycin treatment prevented dysfunctions induced by palmitate, avoiding reticular calcium depletion, ER stress and restoring insulin secretion. Our results provide for the first time compelling evidence that translocon actively participates to the palmitate-induced ER calcium leak and insulin secretion decrease in beta cells. Its inhibition reduces these lipotoxic effects. Taken together, our data indicate that TLC may be a new potential target for the treatment of type 2 diabetes.	[Cassel, R.; Dingreville, F.; Berle, C.; Burda-Jacob, K.; Chauvin, A.; Chikh, K.; Rieusset, J.; Thivolet, C.; Madec, A. M.] Univ Lyon 1, Fac Med Charles Merieux Lyon Sud, CarMeN Lab, INSA Lyon,INRA,Inserm,UMR U1060,U1235, F-69003 Lyon, France; [Ducreux, S.; Alam, M. R.; Paita, L.; Al-Mawla, R.; Da Silva, C. Crola; Van Coppenolle, F.] Univ Lyon 1, Fac Med Rockefeller, CarMeN Lab, INSA Lyon,INRA,Inserm,UMR U1060,U1235, F-69003 Lyon, France; [Thivolet, C.] Hop Lyon Sud, Hosp Civils Lyon, Serv Endocrinol Diabetol & Nutr, F-69310 Pierre Benite, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Madec, AM (corresponding author), Univ Lyon 1, Fac Med Charles Merieux Lyon Sud, CarMeN Lab, INSA Lyon,INRA,Inserm,UMR U1060,U1235, F-69003 Lyon, France.	anne-marie.coquelet-madec@univ-lyon1.fr	Rieusset, Jennifer/F-1595-2018; Carmen, Team2/Y-7383-2019; Carmen, Team1/Y-7382-2019; DUCREUX, SYLVIE/D-6257-2013; Alam, Muhammad Rizwan/AAE-2266-2019; Carmen, Team3/Y-7384-2019	Rieusset, Jennifer/0000-0002-1587-2253; Carmen, Team2/0000-0001-9867-5724; Carmen, Team1/0000-0003-4234-1746; DUCREUX, SYLVIE/0000-0003-3207-9537; Alam, Muhammad Rizwan/0000-0002-1578-5723; Carmen, Team3/0000-0002-3614-0924; BERGER, Marie-Agnes/0000-0003-4189-6029; Lab, Carmen/0000-0002-5935-3236; CHIKH, Karim/0000-0002-1217-4193	INSERM (Institut national de la sante et la recherche Medical) (FR); Universite Claude bernard Lyon1 (FR); JDRF award (ECIT Islet for Basic Research program) from the Geneva University Hospital [31-2008-413]	INSERM (Institut national de la sante et la recherche Medical) (FR); Universite Claude bernard Lyon1 (FR); JDRF award (ECIT Islet for Basic Research program) from the Geneva University Hospital	This work was supported by INSERM (Institut national de la sante et la recherche Medical) (FR) and Universite Claude bernard Lyon1 (FR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Human islets were provided through the JDRF award 31-2008-413 (ECIT Islet for Basic Research program; T. Berney, D. Bosco) from the Geneva University Hospital. We thank the genomic platform (E. Meugnier, E. Loizon, S. Pesanti) from INSERM UMR-1060 CARMEN and A. Durand and C. Durand (INSERM UMR-1060) for technical assistance in cell culture. We thank Prof Dr. Roger Tsien (UCSD, San Diego, USA) for ER Ca2+ sensors. MIN6B1 cell line was provided by Dr. Jun-ichi Miyazaki, OUMS, Osaka, Japan [55].	Akerfeldt MC, 2008, DIABETES, V57, P3034, DOI 10.2337/db07-1802; Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; [Anonymous], 2014, LANCET DIABETES ENDO; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Charles MA, 1997, DIABETOLOGIA, V40, P1101, DOI 10.1007/s001250050793; Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x; Cnop M, 2008, BIOCHEM SOC T, V36, P348, DOI 10.1042/BST0360348; Cnop M, 2014, DIABETES, V63, P1978, DOI 10.2337/db13-1383; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Dey D, 2007, MOL CELL BIOCHEM, V300, P149, DOI 10.1007/s11010-006-9378-1; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Erdmann F, 2010, BIOCHEM BIOPH RES CO, V396, P714, DOI 10.1016/j.bbrc.2010.04.168; Flourakis M, 2006, FASEB J, V20, P1215, DOI 10.1096/fj.05-5254fje; Fonseca SG, 2001, TRENDS ENDOCRIN MET, V22, P266; Giaccia A, 2010, AM J PHYSIOL-ENDOC M, V200, pE255; Gilon P, 2014, CELL CALCIUM, V14, P136; Giunti R, 2007, ARCH BIOCHEM BIOPHYS, V462, P115, DOI 10.1016/j.abb.2007.03.039; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Halban PA, 2014, J CLIN ENDOCR METAB, V99, P1983, DOI 10.1210/jc.2014-1425; Hammadi M, 2013, FASEB J, V27, P1600, DOI 10.1096/fj.12-218875; Hara T, 2014, ENDOCRINOLOGY, V155, P758, DOI 10.1210/en.2013-1519; Hommelberg PPH, 2009, AM J PHYSIOL-ENDOC M, V296, pE114, DOI 10.1152/ajpendo.00436.2007; Hoppa MB, 2009, CELL METAB, V10, P455, DOI 10.1016/j.cmet.2009.09.011; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kaufman RJ, ANN REV BIOCH, V20, P767; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kusminski CM, 2009, APOPTOSIS, V14, P1484, DOI 10.1007/s10495-009-0352-8; Langenberg C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001647; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lloyd DJ, 2010, DIABETES, V59, P460, DOI 10.2337/db08-1362; Lomax RB, 2002, J BIOL CHEM, V277, P26479, DOI 10.1074/jbc.M201845200; Madec AM, 2013, FASEB J, V27, P5122, DOI 10.1096/fj.13-234104; Martino L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036188; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Papa FR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007666; Paredes RM, 2013, CELL CALCIUM, V53, P286, DOI 10.1016/j.ceca.2013.01.002; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Schauble N, 2012, EMBO J, V31, P3282, DOI 10.1038/emboj.2012.189; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Swanton E, 2003, MOL MEMBR BIOL, V20, P99, DOI 10.1080/0968768031000069241; Van Coppenolle F, 2004, J CELL SCI, V117, P4135, DOI 10.1242/jcs.01274; Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433	54	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148686	10.1371/journal.pone.0148686	http://dx.doi.org/10.1371/journal.pone.0148686			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862742	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600097
J	McKay, PF; King, DFL; Mann, JFS; Barinaga, G; Carter, D; Shattock, RJ				McKay, Paul F.; King, Deborah F. L.; Mann, Jamie F. S.; Barinaga, Guillermo; Carter, Darrick; Shattock, Robin J.			TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN Routes	PLOS ONE			English	Article							DENDRITIC CELLS; IMMUNIZATION; EXPRESSION; RESPONSES; MUCOSAL; MACROPHAGES; LIGAND; PROTECTION; SECRETION; PATHWAYS	The induction of high levels of systemic and mucosal humoral immunity is a key goal for many prophylactic vaccines. However, adjuvant strategies developed in mice have often performed poorly in the clinic. Due to their closer similarity to humans, minipigs may provide a more accurate picture of adjuvant performance. Based on their complementary signalling pathways, we assessed humoral immune responses to model antigens after co-administration with the toll-like receptor 4 (TLR4) stimulator glucopyranosyl lipid adjuvant (GLA-AF) or the TLR7/8 agonist resiquimod (R848) (alone and in combination) via the intradermal (ID), intranasal (IN) or combined routes in the Gottingen minipig animal model. Surprisingly, we discovered that while GLA-AF additively enhanced the adjuvant effect of R848 when injected ID, it abrogated the adjuvant activity of R848 after IN inoculation. We then performed a route comparison study using a CN54 gp140 HIV Envelope model antigen adjuvanted with R848 + GLA-AF (ID) or R848 alone (IN). Animals receiving priming inoculations via one route were then boosted by the alternate route. Although differences were observed in the priming phase (IN or ID), responses converged upon boosting by the alternative route with no observable impact resultant from the order of administration (ID/IN vs IN/ID). Specific IgG responses were measured at a distal mucosal site (vaginal), although there was no evidence of mucosal linkage as these closely reflected serum antibody levels. These data indicate that the complex in vivo cross-talk between innate pathways are likely tissue specific and cannot be predicted by simple in vitro models.	[McKay, Paul F.; King, Deborah F. L.; Mann, Jamie F. S.; Barinaga, Guillermo; Shattock, Robin J.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, Div Med, Norfolk Pl, London W2 1PG, England; [Carter, Darrick] Infect Dis Res Inst, Seattle, WA 98102 USA	Imperial College London	McKay, PF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, Div Med, Norfolk Pl, London W2 1PG, England.	p.mckay@imperial.ac.uk	; Carter, Darrick/N-3304-2016	McKay, Paul/0000-0001-5195-6254; Carter, Darrick/0000-0001-5901-3402; Mann, Jamie/0000-0001-7037-1286	Center for HIV/AIDS Vaccine Immunology (CHAVI) [U19 AI067854-05]; Dormeur Investment Service Ltd; Sir Joseph Hotung Trust Fellowship; Bill and Melinda Gates Foundation [42387, OPP1055855]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854] Funding Source: NIH RePORTER	Center for HIV/AIDS Vaccine Immunology (CHAVI); Dormeur Investment Service Ltd; Sir Joseph Hotung Trust Fellowship; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a grant to RJS by the Center for HIV/AIDS Vaccine Immunology (CHAVI) # U19 AI067854-05. We gratefully acknowledge Dormeur Investment Service Ltd for providing funds to purchase equipment used in these studies. PM was supported by a Sir Joseph Hotung Trust Fellowship. DC was also supported with funding from the Bill and Melinda Gates Foundation, grants #42387 and OPP1055855. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Alving CR, 2012, CURR OPIN IMMUNOL, V24, P310, DOI 10.1016/j.coi.2012.03.008; Anderson RC, 2010, COLLOID SURFACE B, V75, P123, DOI 10.1016/j.colsurfb.2009.08.022; Arias MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041144; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Baldwin SL, 2009, VACCINE, V27, P5956, DOI 10.1016/j.vaccine.2009.07.081; Baz M, 2012, CLIN VACCINE IMMUNOL, V19, P209, DOI 10.1128/CVI.05441-11; Bode G, 2010, J PHARMACOL TOX MET, V62, P196, DOI 10.1016/j.vascn.2010.05.009; Bohnenkamp HR, 2007, CELL IMMUNOL, V247, P72, DOI 10.1016/j.cellimm.2007.07.008; Brandtzaeg P, 2011, AM J RESP CRIT CARE, V183, P1595, DOI 10.1164/rccm.201011-1783OC; Brekke K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112556; Buffa V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050529; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Fang Y, 2013, MUCOSAL IMMUNOL, V6, P1168, DOI 10.1038/mi.2013.16; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Habibi M, 2015, MOL IMMUNOL, V64, P285, DOI 10.1016/j.molimm.2014.12.008; Harandi AM, 2010, VACCINE, V28, P2363, DOI 10.1016/j.vaccine.2009.12.084; Heine SJ, 2014, J IMMUNOL, V192, P1630, DOI 10.4049/jimmunol.1302743; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kapetanovic R, 2012, J IMMUNOL, V188, P3382, DOI 10.4049/jimmunol.1102649; Krejci J, 2013, RES VET SCI, V94, P73, DOI 10.1016/j.rvsc.2012.07.021; Liu ZX, 2012, ANAT REC, V295, P686, DOI 10.1002/ar.21534; Lombardi V, 2009, J IMMUNOL, V182, P3372, DOI 10.4049/jimmunol.0801969; Makela SM, 2009, J LEUKOCYTE BIOL, V85, P664, DOI 10.1189/jlb.0808503; Mann JFS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067412; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; McCluskie MJ, 2002, FEMS IMMUNOL MED MIC, V32, P179, DOI 10.1016/S0928-8244(01)00305-4; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Milpied PJ, 2013, NAT IMMUNOL, V14, P313, DOI 10.1038/ni.2567; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Petricevic B, 2009, SHOCK, V32, P484, DOI 10.1097/SHK.0b013e3181a5ac8a; Ploemen IHJ, 2014, COMPARATIVE MED, V64, P50; Schroder K, 2012, P NATL ACAD SCI USA, V109, pE944, DOI 10.1073/pnas.1110156109; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Summerfield A, 2009, DEV COMP IMMUNOL, V33, P299, DOI 10.1016/j.dci.2008.05.005; Tan RST, 2014, INT REV IMMUNOL, V33, P443, DOI 10.3109/08830185.2014.921164; Uenishi H, 2009, DEV COMP IMMUNOL, V33, P353, DOI 10.1016/j.dci.2008.06.001; Vaure C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00316; Villadangos JA, 2010, J EXP MED, V207, P1131, DOI 10.1084/jem.20100985; Wu HY, 2000, INFECT IMMUN, V68, P5539, DOI 10.1128/IAI.68.10.5539-5545.2000; Zhu JZ, 2008, MOL IMMUNOL, V45, P3238, DOI 10.1016/j.molimm.2008.02.028	44	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148984	10.1371/journal.pone.0148984	http://dx.doi.org/10.1371/journal.pone.0148984			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862758	gold, Green Published			2022-12-27	WOS:000370046600133
J	Rios-Diaz, AJ; Lam, J; Ramos, MS; Moscoso, AV; Vaughn, P; Zogg, CK; Caterson, EJ				Rios-Diaz, Arturo J.; Lam, Jimmy; Ramos, Margarita S.; Moscoso, Andrea V.; Vaughn, Patrick; Zogg, Cheryl K.; Caterson, Edward J.			Global Patterns of QALY and DALY Use in Surgical Cost-Utility Analyses: A Systematic Review	PLOS ONE			English	Review							SURGERY; DISEASE; BURDEN; HEALTH	Background Surgical interventions are being increasingly recognized as cost-effective global priorities, the utility of which are frequently measured using either quality-adjusted (QALY) or disability-adjusted (DALY) life years. The objectives of this study were to: (1) identify surgical cost-effectiveness studies that utilized a formulation of the QALY or DALY as a summary measure, (2) report on global patterns of QALY and DALY use in surgery and the income characteristics of the countries and/or regions involved, and (3) assess for possible associations between national/regional-income levels and the relative prominence of either measure. Study Design PRISMA-guided systematic review of surgical cost-effectiveness studies indexed in PubMed or EMBASE prior to December 15, 2014, that used the DALY and/or QALY as a summary measure. National locations were used to classify publications based on the 2014 World Bank income stratification scheme into: low-, lower-middle-, upper-middle-, or high-income countries. Differences in QALY/DALY use were considered by income level as well as for differences in geographic location and year using descriptive statistics (two-sided Chi-squared tests, Fischer's exact tests in cell counts <5). Results A total of 540 publications from 128 countries met inclusion criteria, representing 825 "national studies" (regional publications included data from multiple countries). Data for 69.0% (569/825) were reported using QALYs (2.1% low-, 1.2% lower-middle-, 4.4% upper-middle-, and 92.3% high-income countries), compared to 31.0% (256/825) reported using DALYs (46.9% low-, 31.6% lower-middle-, 16.8% upper-middle-, and 4.7% high-income countries) (p<0.001). Studies from the US and the UK dominated the total number of QALY studies (49.9%) and were themselves almost exclusively QALY-based. DALY use, in contrast, was the most common in Africa and Asia. While prominent published use of QALYs (1990s) in surgical cost-effectiveness studies began approximately 10 years earlier than DALYs (2000s), the use of both measures continues to increase. Conclusion As global prioritization of surgical interventions gains prominence, it will be important to consider the comparative implications of summary measure use. The results of this study demonstrate significant income-and geographic-based differences in the preferential utilization of the QALY and DALY for surgical cost-effectiveness studies. Such regional variation holds important implications for efforts to interpret and utilize global health policy research. PROSPERO registration number: CRD42015015991	[Rios-Diaz, Arturo J.; Lam, Jimmy; Moscoso, Andrea V.; Vaughn, Patrick; Zogg, Cheryl K.; Caterson, Edward J.] Harvard Univ, Sch Med, Ctr Surg & Publ Hlth, Boston, MA USA; [Rios-Diaz, Arturo J.; Lam, Jimmy; Moscoso, Andrea V.; Vaughn, Patrick; Zogg, Cheryl K.; Caterson, Edward J.] Harvard Univ, Sch Publ Hlth, Dept Surg, Brigham & Womens Hosp, 665 Huntington Ave, Boston, MA 02115 USA; [Lam, Jimmy] Boston Univ, Sch Med, Boston, MA 02118 USA; [Ramos, Margarita S.] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Vaughn, Patrick] Harvard Univ, Sch Dent Med, 188 Longwood Ave, Boston, MA 02115 USA; [Caterson, Edward J.] Brigham & Womens Hosp, Dept Surg, Div Plast & Reconstruct Surg, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard School of Dental Medicine; Harvard University; Brigham & Women's Hospital	Rios-Diaz, AJ (corresponding author), Harvard Univ, Sch Med, Ctr Surg & Publ Hlth, Boston, MA USA.; Rios-Diaz, AJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Surg, Brigham & Womens Hosp, 665 Huntington Ave, Boston, MA 02115 USA.	ecaterson@partners.org		Zogg, Cheryl/0000-0003-4461-746X				Airoldi M, 2009, HEALTH ECON, V18, P1237, DOI 10.1002/hec.1424; Chao TE, 2014, LANCET GLOB HEALTH, V2, pE334, DOI 10.1016/S2214-109X(14)70213-X; Colantonio L, 2011, VALUE HLTH, V14; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Gold MR, 1996, COST EFFECTIVENESS H; Gosselin R, 2013, WORLD J SURG, V37, P2507, DOI 10.1007/s00268-013-2182-7; Gosselin RA, 2011, WORLD J SURG, V35, P258, DOI 10.1007/s00268-010-0863-z; Grimes CE, 2014, WORLD J SURG, V38, P252, DOI 10.1007/s00268-013-2243-y; Groom Z, 2014, ISPOR 6 AS PAC C BEI; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; KLARMAN HE, 1968, MED CARE, V6, P48, DOI 10.1097/00005650-196801000-00005; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Marseille E, 1996, B WORLD HEALTH ORGAN, V74, P319; Meara JG, 2015, LANCET; Mock C, 2010, WORLD J SURG, V34, P381, DOI 10.1007/s00268-009-0263-4; Mock CN, 2015, LANCET; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9; Petroze RT, 2013, WORLD J SURG, V37, P1500, DOI 10.1007/s00268-012-1769-8; ROBBERSTAD B, 2005, NORSK EPIDEMIOLOGI, V15, P183; Rose J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089693; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Sassi F, 2006, HEALTH POLICY PLANN, V21, P402, DOI 10.1093/heapol/czl018; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Weinstein MC, 2009, VALUE HEALTH, V12, pS5, DOI 10.1111/j.1524-4733.2009.00515.x; WILLIAMS A, 1985, BRIT MED J, V291, P326, DOI 10.1136/bmj.291.6491.326; World Bank, 2014, UPD INC CLASS; World Health Organisation, 2003, MAK CHOIC HLTH WHO G; World Health Organization, 1996, INV HLTH RES DEV GEN; ZECKHAUSER R, 1976, LAW CONTEMP PROBL, V40, P5, DOI 10.2307/1191310	33	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148304	10.1371/journal.pone.0148304	http://dx.doi.org/10.1371/journal.pone.0148304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26862894	Green Published, gold			2022-12-27	WOS:000370046600053
J	Ntiri, ES; Calatayud, PA; Van den Berg, J; Schulthess, F; Le Ru, BP				Ntiri, Eric Siaw; Calatayud, Paul-Andre; Van den Berg, Johnnie; Schulthess, Fritz; Le Ru, Bruno Pierre			Influence of Temperature on Intra- and Interspecific Resource Utilization within a Community of Lepidopteran Maize Stemborers	PLOS ONE			English	Article							ELDANA-SACCHARINA LEPIDOPTERA; PARTELLUS SWINHOE LEPIDOPTERA; BUSSEOLA-FUSCA LEPIDOPTERA; STEM-BORERS; CHILO-PARTELLUS; CLIMATE-CHANGE; HOST PLANTS; DEPENDENT COMPETITION; PHYTOPHAGOUS INSECTS; SPECIES INTERACTIONS	Competition or facilitation characterises intra-and interspecific interactions within communities of species that utilize the same resources. Temperature is an important factor influencing those interactions and eventual outcomes. The noctuid stemborers, Busseola fusca and Sesamia calamistis and the crambid Chilo partellus attack maize in sub-Saharan Africa. They often occur as a community of interacting species in the same field and plant at all elevations. The influence of temperature on the intra-and interspecific interactions among larvae of these species, was studied using potted maize plants exposed to varying temperatures in a greenhouse and artificial stems kept at different constant temperatures (15 degrees C, 20 degrees C, 25 degrees C and 30 degrees C) in an incubator. The experiments involved single-and multispecies infestation treatments. Survival and relative growth rates of each species were assessed. Both intra-and interspecific competitions were observed among all three species. Interspecific competition was stronger between the noctuids and the crambid than between the two noctuids. Temperature affected both survival and relative growth rates of the three species. Particularly at high temperatures, C. partellus was superior in interspecific interactions shown by higher larval survival and relative growth rates. In contrast, low temperatures favoured survival of B. fusca and S. calamistis but affected the relative growth rates of all three species. Survival and relative growth rates of B. fusca and S. calamistis in interspecific interactions did not differ significantly across temperatures. Temperature increase caused by future climate change is likely to confer an advantage on C. partellus over the noctuids in the utilization of resources (crops).	[Ntiri, Eric Siaw; Calatayud, Paul-Andre; Le Ru, Bruno Pierre] Int Ctr Insect Physiol & Ecol, POB 30772, Nairobi, Kenya; [Ntiri, Eric Siaw; Van den Berg, Johnnie] North West Univ, Unit Environm Sci & Management, Potchefstroom, South Africa; [Calatayud, Paul-Andre; Le Ru, Bruno Pierre] CNRS, UMR 247, IRD, Lab Evolut Genomes Comportement & Ecol Diversite, Gif Sur Yvette, France; [Calatayud, Paul-Andre; Le Ru, Bruno Pierre] Univ Paris 11, Orsay, France; [Schulthess, Fritz] 4 Postfach 508, Chur, Switzerland	International Centre of Insect Physiology & Ecology (ICIPE); North West University - South Africa; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Ntiri, ES (corresponding author), Int Ctr Insect Physiol & Ecol, POB 30772, Nairobi, Kenya.; Ntiri, ES (corresponding author), North West Univ, Unit Environm Sci & Management, Potchefstroom, South Africa.	ensiaw@gmail.com	Paul-André, Calatayud/K-3282-2019; Van den Berg, Johnnie/M-7256-2013; Calatayud, Paul-andre/AAG-8117-2020; Le Ru, bruno/K-3480-2016; Ntiri, Eric Siaw/AFO-6189-2022; LE RU, BRUNO/C-5862-2011	Van den Berg, Johnnie/0000-0002-6831-3180; Calatayud, Paul-andre/0000-0002-9482-4646; Le Ru, bruno/0000-0002-4208-3727; Ntiri, Eric Siaw/0000-0002-8598-1201; 	Swedish International Development Cooperation Agency through the CAPACITY BUILDING FOR SCIENCE EDUCATION AND RESEARCH COOPERATION IN AFRICA (CB-SERCA) PROJECT of the CB & ID Programme of icipe [75000529]; Ministry of Foreign Affairs of Finland through the Climate Change Impacts of Ecosystem Services and Food Security in Eastern Africa (CHIESA) project	Swedish International Development Cooperation Agency through the CAPACITY BUILDING FOR SCIENCE EDUCATION AND RESEARCH COOPERATION IN AFRICA (CB-SERCA) PROJECT of the CB & ID Programme of icipe; Ministry of Foreign Affairs of Finland through the Climate Change Impacts of Ecosystem Services and Food Security in Eastern Africa (CHIESA) project	This work was supported by the Swedish International Development Cooperation Agency [Contribution no. 75000529] through the CAPACITY BUILDING FOR SCIENCE EDUCATION AND RESEARCH COOPERATION IN AFRICA (CB-SERCA) PROJECT of the CB & ID Programme of icipe. It was also supported by the Ministry of Foreign Affairs of Finland sponsorship through the Climate Change Impacts of Ecosystem Services and Food Security in Eastern Africa (CHIESA) project.	Agnew P, 2002, ECOL ENTOMOL, V27, P396, DOI 10.1046/j.1365-2311.2002.00430.x; Agrawal AA, 2005, ENTOMOL EXP APPL, V115, P97, DOI 10.1111/j.1570-7458.2005.00294.x; Alexandrou MA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1745; Applebaum SW, 1999, ANNU REV ENTOMOL, V44, P317, DOI 10.1146/annurev.ento.44.1.317; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; BERGER A, 1989, ENTOMOL EXP APPL, V50, P125, DOI 10.1007/BF00365396; Best RJ, 2013, ECOL LETT, V16, P72, DOI 10.1111/ele.12016; Bezemer TM, 1998, OECOLOGIA, V116, P128, DOI 10.1007/s004420050571; Breeuwer A, 2008, OECOLOGIA, V156, P155, DOI 10.1007/s00442-008-0963-8; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Buse A, 1999, FUNCT ECOL, V13, P74, DOI 10.1046/j.1365-2435.1999.00010.x; CAMMELL ME, 1992, ADV ECOL RES, V22, P117, DOI 10.1016/S0065-2504(08)60135-X; Carmona-Catot G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054734; CONNELL JH, 1983, AM NAT, V122, P661, DOI 10.1086/284165; Craig TP, 2000, ECOL ENTOMOL, V25, P7, DOI 10.1046/j.1365-2311.2000.00226.x; Damos Petros, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/123405; Dangles O, 2008, ECOL APPL, V18, P1795, DOI 10.1890/07-1638.1; Davis AJ, 1998, J ANIM ECOL, V67, P600, DOI 10.1046/j.1365-2656.1998.00223.x; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Gounou S, 2004, AFR ENTOMOL, V12, P171; Guofa Zhou, 2001, Insect Science and its Application, V21, P395; GUREVITCH J, 1992, AM NAT, V140, P539, DOI 10.1086/285428; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; HOWE RW, 1967, ANNU REV ENTOMOL, V12, P15, DOI 10.1146/annurev.en.12.010167.000311; INBAR M, 1995, ECOLOGY, V76, P1506, DOI 10.2307/1938152; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Jiang L, 2004, J ANIM ECOL, V73, P569, DOI 10.1111/j.0021-8790.2004.00830.x; Jiang NQ, 2006, ANN SOC ENTOMOL FR, V42, P381, DOI 10.1080/00379271.2006.10697470; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; KARBAN R, 1986, ECOLOGY, V67, P1063, DOI 10.2307/1939829; KAUFMANN T, 1983, J GEORGIA ENTOMOL SO, V18, P259; Kfir R, 1997, ANN ENTOMOL SOC AM, V90, P619, DOI 10.1093/aesa/90.5.619; Kfir R, 2002, ANNU REV ENTOMOL, V47, P701, DOI 10.1146/annurev.ento.47.091201.145254; Khadioli N, 2014, ANN APPL BIOL, V165, P373, DOI 10.1111/aab.12157; Khadioli N, 2014, B ENTOMOL RES, V104, P809, DOI 10.1017/S0007485314000601; Krueger W., 2008, South African Journal of Plant and Soil, V25, P144; Kutywayo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073432; LACTIN DJ, 1995, ENVIRON ENTOMOL, V24, P68, DOI 10.1093/ee/24.1.68; Laws AN, 2010, ENVIRON ENTOMOL, V39, P312, DOI 10.1603/EN09294; LEIBOLD MA, 1995, ECOLOGY, V76, P1371, DOI 10.2307/1938141; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Masters GJ, 1998, ECOL ENTOMOL, V23, P45, DOI 10.1046/j.1365-2311.1998.00109.x; Matama-Kauma T., 2001, Insect Science and its Application, V21, P317; Moya-Larano J, 2007, BIOLOGY LETT, V3, P475, DOI 10.1098/rsbl.2007.0300; Ndemah R, 2003, ENVIRON ENTOMOL, V32, P51, DOI 10.1603/0046-225X-32.1.51; Nooten SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085987; Ofomata VC, 2000, ANN ENTOMOL SOC AM, V93, P492, DOI 10.1603/0013-8746(2000)093[0492:CSOTFE]2.0.CO;2; Ofomata VC, 1999, ENTOMOL EXP APPL, V93, P141, DOI 10.1023/A:1003844318375; Ojeda-Avila T, 2003, J INSECT PHYSIOL, V49, P293, DOI 10.1016/S0022-1910(03)00003-9; Ong'amo GO, 2006, ANN SOC ENTOMOL FR, V42, P363, DOI 10.1080/00379271.2006.10697468; Ong'amo GO, 2006, ANN SOC ENTOMOL FR, V42, P171, DOI 10.1080/00379271.2006.10700620; ONYANGO FO, 1994, ENTOMOL EXP APPL, V73, P139, DOI 10.1007/BF02383419; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Pascual S, 2004, B ENTOMOL RES, V94, P369, DOI 10.1079/BER2003307; R Development Team, 2014, R LANG ENV STAT COMP; Ranum P, 2014, ANN NY ACAD SCI, V1312, P105, DOI 10.1111/nyas.12396; Rebe M, 2004, AFR ENTOMOL, V12, P187; Rensburg J. B. J. van, 1987, South African Journal of Plant and Soil, V4, P183; Rwomushana I, 2009, ENTOMOL EXP APPL, V133, P27, DOI 10.1111/j.1570-7458.2009.00897.x; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Scherber C, 2013, ECOL EVOL, V3, P1449, DOI 10.1002/ece3.564; Schoonhoven L. M., 2005, Insect-plant biology; Seshu Reddy K. V., 1998, P25; SHANOWER TG, 1993, B ENTOMOL RES, V83, P237, DOI 10.1017/S0007485300034726; Shiojiri K, 2002, ECOL LETT, V5, P186, DOI 10.1046/j.1461-0248.2002.00292.x; Speight M.R., 2008, ECOLOGY INSECTS CONC, V2nd ed.; Sporleder M, 2004, ENVIRON ENTOMOL, V33, P477, DOI 10.1603/0046-225X-33.3.477; STILING PD, 1983, ECOLOGY, V64, P770, DOI 10.2307/1937200; Stokes K, 2015, ENTOMOL EXP APPL, V154, P23, DOI 10.1111/eea.12251; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Tadele Tefera, 2004, Tropical Science, V44, P128, DOI 10.1002/ts.153; Taniguchi Y, 1998, CAN J FISH AQUAT SCI, V55, P1894, DOI 10.1139/cjfas-55-8-1894; Taniguchi Y, 2000, ECOLOGY, V81, P2027, DOI 10.2307/177290; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; VANDENBERG J, 1991, B ENTOMOL RES, V81, P137, DOI 10.1017/S0007485300051191; Venail PA, 2014, J ECOL, V102, P1288, DOI 10.1111/1365-2745.12271; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; Wang HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098761; WILSON DS, 1984, ECOL ENTOMOL, V9, P205, DOI 10.1111/j.1365-2311.1984.tb00716.x; Yang X B, 2001, GLOB CHANGE HUM HLTH, V2, P90, DOI [10.1023/A:1015086831467, DOI 10.1023/A:1015086831467]; Zilli A, 2005, NOCTUIDAE EUROPAEAE, V8	86	25	26	6	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148735	10.1371/journal.pone.0148735	http://dx.doi.org/10.1371/journal.pone.0148735			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859748	gold, Green Published			2022-12-27	WOS:000370038400071
J	Phang, CW; Karsani, SA; Sethi, G; Abd Malek, SN				Phang, Chung-Weng; Karsani, Saiful Anuar; Sethi, Gautam; Abd Malek, Sri Nurestri			Flavokawain C Inhibits Cell Cycle and Promotes Apoptosis, Associated with Endoplasmic Reticulum Stress and Regulation of MAPKs and Akt Signaling Pathways in HCT 116 Human Colon Carcinoma Cells	PLOS ONE			English	Article							ANTIOXIDATIVE ACTIVITY; PIPER-METHYSTICUM; MAMMALIAN-CELLS; CASPASE CASCADE; CANCER-THERAPY; TUMOR-GROWTH; DEATH; MITOCHONDRIA; ACTIVATION; PROTEIN	Flavokawain C (FKC) is a naturally occurring chalcone which can be found in Kava (Piper methysticum Forst) root. The present study evaluated the effect of FKC on the growth of various human cancer cell lines and the underlying associated mechanisms. FKC showed higher cytotoxic activity against HCT 116 cells in a time- and dose-dependent manner in comparison to other cell lines (MCF-7, HT-29, A549 and CaSki), with minimal toxicity on normal human colon cells. The apoptosis-inducing capability of FKC on HCT 116 cells was evidenced by cell shrinkage, chromatin condensation, DNA fragmentation and increased phosphatidylserine externalization. FKC was found to disrupt mitochondrial membrane potential, resulting in the release of Smac/DIABLO, AIF and cytochrome c into the cytoplasm. Our results also revealed that FKC induced intrinsic and extrinsic apoptosis via upregulation of the levels of pro-apoptotic proteins (Bak) and death receptors (DR5), while downregulation of the levels of anti-apoptotic proteins (XIAP, cIAP-1, c-FlipL, Bcl-xL and survivin), resulting in the activation of caspase-3, -8 and -9 and cleavage of poly(ADPribose) polymerase (PARP). FKC was also found to cause endoplasmic reticulum (ER) stress, as suggested by the elevation of GADD153 protein after FKC treatment. After the cells were exposed to FKC (60 mu M) over 18hrs, there was a substantial increase in the phosphorylation of ERK 1/2. The expression of phosphorylated Akt was also reduced. FKC also caused cell cycle arrest in the S phase in HCT 116 cells in a time- and dose-dependent manner and with accumulation of cells in the sub-G1 phase. This was accompanied by the downregulation of cyclin-dependent kinases (CDK2 and CDK4), consistent with the upregulation of CDK inhibitors (p21(Cip1) and p27(Kip1)), and hypophosphorylation of Rb.	[Phang, Chung-Weng; Karsani, Saiful Anuar; Abd Malek, Sri Nurestri] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Sethi, Gautam] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117600, Singapore	Universiti Malaya; National University of Singapore	Abd Malek, SN (corresponding author), Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia.	srimalek@um.edu.my	Phang, Chung Weng/AAK-6217-2020; Malek, Sri Nurestri/W-8556-2019; Malek, Sri Nurestri Abd/B-9834-2010; SA, karsani/B-9667-2010; Sethi, Gautam/F-2372-2011	Malek, Sri Nurestri/0000-0001-6278-8559; Malek, Sri Nurestri Abd/0000-0001-6278-8559; SA, karsani/0000-0003-1617-9554; Sethi, Gautam/0000-0002-8677-8475	High Impact Research MoE Grant from the Ministry of Education Malaysia [UM.C/625/1/HIR/MoE/SC/02]	High Impact Research MoE Grant from the Ministry of Education Malaysia	This research is supported by High Impact Research MoE Grant UM.C/625/1/HIR/MoE/SC/02 from the Ministry of Education Malaysia. This grant was awarded to SNAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu N, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-102; Agarwal ML, 1998, P NATL ACAD SCI USA, V95, P14775, DOI 10.1073/pnas.95.25.14775; Aizat AAA, 2011, ASIAN PAC J CANCER P, V12, P2909; Berthelet Jean, 2013, Cells, V2, P163, DOI 10.3390/cells2010163; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chen SP, 2006, VIROLOGY, V347, P379, DOI 10.1016/j.virol.2005.11.052; Cote CS, 2004, BIOCHEM BIOPH RES CO, V322, P147, DOI 10.1016/j.bbrc.2004.07.093; Darzynkiewicz Z, 2008, METHODS, V44, P250, DOI 10.1016/j.ymeth.2007.11.008; Dharmaratne HRW, 2002, PHYTOCHEMISTRY, V59, P429; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Guicciardi ME, 2011, EXP CELL RES, V317, P107, DOI 10.1016/j.yexcr.2010.10.005; Han CR, 2012, BIOORG MED CHEM LETT, V22, P945, DOI 10.1016/j.bmcl.2011.12.023; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Ho YF, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/857257; Houghton P, 2007, METHODS, V42, P377, DOI 10.1016/j.ymeth.2007.01.003; Hu W, 2003, LANCET ONCOL, V4, P721, DOI 10.1016/S1470-2045(03)01277-4; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Indran IR, 2011, BBA-BIOENERGETICS, V1807, P735, DOI 10.1016/j.bbabio.2011.03.010; Itoh N, 2002, CANCER, V94, P3127, DOI 10.1002/cncr.10591; Jain MV, 2013, J CELL MOL MED, V17, P12, DOI 10.1111/jcmm.12001; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jin HR, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.169; Johnson ME, 2004, VET PATHOL, V41, P599, DOI 10.1354/vp.41-6-599; Johnson TL, 2010, EVID-BASED COMPL ALT, V7, P351, DOI 10.1093/ecam/nen011; Karmakar S, 2007, APOPTOSIS, V12, P671, DOI 10.1007/s10495-006-0024-x; Kawada M, 1997, ONCOGENE, V15, P629, DOI 10.1038/sj.onc.1201228; Klamt F, 2005, J BIOL CHEM, V280, P21346, DOI 10.1074/jbc.M501170200; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Kuo YF, 2010, FREE RADICAL BIO MED, V49, P214, DOI 10.1016/j.freeradbiomed.2010.04.005; Lee ER, 2006, BBA-MOL CELL RES, V1763, P958, DOI 10.1016/j.bbamcr.2006.06.006; Lenferink AEG, 2001, CANCER RES, V61, P6583; Li N, 2008, J AGR FOOD CHEM, V56, P3876, DOI 10.1021/jf073520n; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lin FM, 2008, CANCER RES, V68, P6634, DOI 10.1158/0008-5472.CAN-08-0635; Lindsay J, 2011, BBA-MOL CELL RES, V1813, P532, DOI 10.1016/j.bbamcr.2010.10.017; Majors BS, 2007, METAB ENG, V9, P317, DOI 10.1016/j.ymben.2007.05.003; Malek NA, 2011, MOLECULES, V16, P583, DOI 10.3390/molecules16010583; McGuckin MA, 2010, AM J PHYSIOL-GASTR L, V298, pG820, DOI 10.1152/ajpgi.00063.2010; Munoz-Alonso MJ, 2005, J BIOL CHEM, V280, P18120, DOI 10.1074/jbc.M500758200; Ng SC, 2013, BRIT MED BULL, V105, P29, DOI 10.1093/bmb/lds040; Novak B, 2003, BIOCHEM SOC T, V31, P1526; Parrish AB, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008672; Puteh SEW, 2013, ASIA-PAC PSYCHIAT, V5, P110, DOI 10.1111/appy.12055; Rahman SNSA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/257108; Selimovic D, 2011, CARCINOGENESIS, V32, P1268, DOI 10.1093/carcin/bgr112; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tamm I, 2001, LANCET ONCOL, V2, P33, DOI 10.1016/S1470-2045(00)00193-5; Tzifi Flora, 2012, Adv Hematol, V2012, P524308, DOI 10.1155/2012/524308; van den Brink MRM, 1999, J BIOL CHEM, V274, P11178, DOI 10.1074/jbc.274.16.11178; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vogel S, 2008, BIOORGAN MED CHEM, V16, P4286, DOI 10.1016/j.bmc.2008.02.079; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Weiss J, 2005, DRUG METAB DISPOS, V33, P1580, DOI 10.1124/dmd.105.005892; Whitton PA, 2003, PHYTOCHEMISTRY, V64, P673, DOI 10.1016/S0031-9422(03)00381-9; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Xu Y, 2014, MOL CLIN ONCOL, V2, P3, DOI 10.3892/mco.2013.202; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Zeestraten Eliane C M, 2013, Biomark Cancer, V5, P13, DOI 10.4137/BIC.S11475; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zi XL, 2005, CANCER RES, V65, P3479, DOI 10.1158/0008-5472.CAN-04-3803	65	30	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148775	10.1371/journal.pone.0148775	http://dx.doi.org/10.1371/journal.pone.0148775			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859847	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400081
J	Chu, C; Bottaro, DP; Betenbaugh, MJ; Shiloach, J				Chu, Chia; Bottaro, Donald P.; Betenbaugh, Michael J.; Shiloach, Joseph			Stable Ectopic Expression of ST6GALNAC5 Induces Autocrine MET Activation and Anchorage-Independence in MDCK Cells	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; PROTEIN-FREE CULTURE; SCATTER FACTOR; CANCER PROGRESSION; CHO-CELLS; C-MET; MATRIX METALLOPROTEINASES; KINASE ACTIVATION; SIGNALING PATHWAY	The epithelial-mesenchymal transition (EMT) is a complex cancer progression that can boost the metastatic potential of transformed cells by inducing migration, loss of cell adhesion, and promoting proliferation under anchorage-independent conditions. A DNA microarray analysis was performed comparing parental anchorage-dependent MDCK cells and anchorage-independent MDCK cells that were engineered to express human siat7e (ST6GALNAC5). The comparison identified several genes involved in the EMT process that were differentially expressed between the anchorage-dependent and the anchorage-independent MDCK cell lines. The hepatocyte growth factor gene (hgf) was found to be over-expressed in the engineered MDCK-siat7e cells at both transcription and protein expression levels. Phosphorylation analysis of the MET receptor tyrosine kinase confirmed the activation of an autocrine loop of the HGF/MET signaling pathway in the MDCK-siat7e cells. When MET activities were suppressed by using the small-molecular inhibitor drug PF-02341066 (Crizotinib), the anchorage-independent MDCK-siat7e cells reverted to the cellular morphology of the parental anchorage-dependent MDCK cells. These observations indicate that the MET receptor plays a central role in the growth properties of the MDCK cells and its phosphorylation status is likely dependent on sialylation. Further investigation of the downstream signaling targets in the MET network showed that the degree of MDCK cell adhesion correlated with secretion levels of a matrix metalloproteinase, MMP1, suggesting a role of metalloproteinases in the EMT process. These results demonstrate that in addition to its application in biotechnology processes, MDCK-siat7e may serve as a model cell for metastasis studies to decipher the sequence of events leading up to the activation of EMT.	[Chu, Chia; Shiloach, Joseph] NIDDK, Biotechnol Core Lab, NIH, Bethesda, MD 20892 USA; [Chu, Chia; Betenbaugh, Michael J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Bottaro, Donald P.] NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Chu, Chia] Pfizer Inc, Bioproc Res & Dev, Chesterfield, MO USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pfizer	Shiloach, J (corresponding author), NIDDK, Biotechnol Core Lab, NIH, Bethesda, MD 20892 USA.	Josephs@niddk.nih.gov	Bottaro, Donald P/AAF-3853-2020; Bottaro, Donald P/F-8550-2010	Bottaro, Donald P/0000-0002-5057-5334; Bottaro, Donald P/0000-0002-5057-5334	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075080] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the Intramural program at the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.	Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057; Astley K, 2008, APPL MICROBIOL BIOT, V78, P391, DOI 10.1007/s00253-007-1320-2; Astley K, 2007, J BIOTECHNOL, V130, P282, DOI 10.1016/j.jbiotec.2007.04.012; Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Cecchi F, 2010, EUR J CANCER, V46, P1260, DOI 10.1016/j.ejca.2010.02.028; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chacon-Heszele MF, 2014, AM J PHYSIOL-RENAL, V306, pF1047, DOI 10.1152/ajprenal.00589.2013; Christensen JG, 2007, MOL CANCER THER, V6, P3314, DOI 10.1158/1535-7163.MCT-07-0365; Christiansen MN, 2014, PROTEOMICS, V14, P525, DOI 10.1002/pmic.201300387; Chu C, VACCINE; Chu C, 2009, P NATL ACAD SCI USA, V106, P14802, DOI 10.1073/pnas.0905912106; Chu SH, 2007, J NEURO-ONCOL, V85, P33, DOI 10.1007/s11060-007-9387-2; DENNIS J, 1982, NATURE, V300, P274, DOI 10.1038/300274a0; Duca L, 2007, J BIOL CHEM, V282, P12484, DOI 10.1074/jbc.M609505200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fukuta K, 2005, BIOCHEM J, V388, P555, DOI 10.1042/BJ20041698; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; GHERARDI E, 1989, P NATL ACAD SCI USA, V86, P5844, DOI 10.1073/pnas.86.15.5844; Gomes C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066737; GRAZIANI A, 1991, J BIOL CHEM, V266, P22087; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hellman NE, 2008, J BIOL CHEM, V283, P4272, DOI 10.1074/jbc.M708027200; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Hu WS, 1997, CURR OPIN BIOTECH, V8, P148, DOI 10.1016/S0958-1669(97)80093-6; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ikehara Y, 1999, FEBS LETT, V463, P92, DOI 10.1016/S0014-5793(99)01605-1; Jaluria P, 2007, METAB ENG, V9, P241, DOI 10.1016/j.ymben.2006.12.001; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Kurcon T, 2015, P NATL ACAD SCI USA, V112, P7327, DOI 10.1073/pnas.1502076112; Kuystermans D, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-25; Lau KM, 2011, EXP CELL RES, V317, P539, DOI 10.1016/j.yexcr.2010.12.005; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lesko E, 2008, FRONT BIOSCI-LANDMRK, V13, P1271, DOI 10.2741/2760; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mathias RA, 2009, J PROTEOME RES, V8, P2827, DOI 10.1021/pr8010974; Moon SK, 2004, J BIOL CHEM, V279, P33063, DOI 10.1074/jbc.M313462200; Nakashiro K, 2004, AM J PATHOL, V165, P533, DOI 10.1016/S0002-9440(10)63318-4; Okajima T, 1999, J BIOL CHEM, V274, P30557, DOI 10.1074/jbc.274.43.30557; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Parrott JA, 2000, ENDOCRINOLOGY, V141, P2532, DOI 10.1210/en.141.7.2532; Qian J, 2009, ACTA PHARMACOL SIN, V30, P1039, DOI 10.1038/aps.2009.84; RENNER WA, 1995, BIOTECHNOL BIOENG, V47, P476, DOI 10.1002/bit.260470409; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; STOKER M, 1989, J CELL PHYSIOL, V139, P565, DOI 10.1002/jcp.1041390316; Takashima S, 2008, BIOSCI BIOTECH BIOCH, V72, P1155, DOI 10.1271/bbb.80025; UEHARA Y, 1992, J CELL BIOL, V117, P889, DOI 10.1083/jcb.117.4.889; Vadnais J, 2002, J BIOL CHEM, V277, P48342, DOI 10.1074/jbc.M209481200; Yamazaki S, 2008, DRUG METAB DISPOS, V36, P1267, DOI 10.1124/dmd.107.019711; Yang JW, 2005, J AM SOC NEPHROL, V16, P68, DOI 10.1681/ASN.2003090795; Ye M, 2008, INVEST OPHTH VIS SCI, V49, P497, DOI 10.1167/iovs.07-0975; YOGEESWARAN G, 1981, SCIENCE, V212, P1514, DOI 10.1126/science.7233237; Zhang AH, 2006, AM J PHYSIOL-RENAL, V291, pF1323, DOI 10.1152/ajprenal.00480.2005; Zhao XH, 2011, BIOTECHNOL LETT, V33, P1293, DOI 10.1007/s10529-011-0577-9; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	64	3	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148075	10.1371/journal.pone.0148075	http://dx.doi.org/10.1371/journal.pone.0148075			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848584	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000038
J	Desmarais, MJ; Beauregard, F; Cabana, T; Pflieger, JF				Desmarais, Marie-Josee; Beauregard, France; Cabana, Therese; Pflieger, Jean-Francois			Facial Mechanosensory Influence on Forelimb Movement in Newborn Opossums, Monodelphis domestica	PLOS ONE			English	Article							MERKEL CELLS; SPINAL-CORD; DEVELOPMENTAL ORIGINS; NERVOUS-SYSTEM; BRAIN-STEM; LOCOMOTION; RAT; NEURONS; GRAY; DIFFERENTIATION	The opossum, Monodelphis domestica, is born very immature but crawls, unaided, with its forelimbs (FL) from the mother's birth canal to a nipple where it attaches to pursue its development. What sensory cues guide the newborn to the nipple and trigger its attachment to it? Previous experiments showed that low intensity electrical stimulation of the trigeminal ganglion induces FL movement in in vitro preparations and that trigeminal innervation of the facial skin is well developed in the newborn. The skin does not contain Vater-Pacini or Meissner touch corpuscles at this age, but it contains cells which appear to be Merkel cells (MC). We sought to determine if touch perceived by MC could exert an influence on FL movements. Application of the fluorescent dye AM1-43, which labels sensory cells such as MC, revealed the presence of a large number of labeled cells in the facial epidermis, especially in the snout skin, in newborn opossums. Moreover, calibrated pressure applied to the snout induced bilateral and simultaneous electromyographic responses of the triceps muscle in in vitro preparations of the neuraxis and FL from newborn. These responses increase with stimulation intensity and tend to decrease over time. Removing the facial skin nearly abolished these responses. Metabotropic glutamate 1 receptors being involved in MC neurotransmission, an antagonist of these receptors was applied to the bath, which decreased the EMG responses in a reversible manner. Likewise, bath application of the purinergic type 2 receptors, used by AM1-43 to penetrate sensory cells, also decreased the triceps EMG responses. The combined results support a strong influence of facial mechanosensation on FL movement in newborn opossums, and suggest that this influence could be exerted via MC.	[Desmarais, Marie-Josee; Beauregard, France; Cabana, Therese; Pflieger, Jean-Francois] Univ Montreal, Dept Sci Biol, CP 6128, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Pflieger, JF (corresponding author), Univ Montreal, Dept Sci Biol, CP 6128, Montreal, PQ H3C 3J7, Canada.	jf.pflieger@umontreal.ca		Pflieger, Jean-Francois/0000-0002-6533-6416	Natural Sciences and Engineering Research Council of Canada [3595, 312015]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada, Discovery Grants #3595 (TC) and #312015 (JFP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adadja T, 2013, NEUROSCIENCE, V228, P259, DOI 10.1016/j.neuroscience.2012.10.029; AOKI M, 1981, BRAIN RES, V214, P424, DOI 10.1016/0006-8993(81)91206-3; Ashwell KW, 2015, SOMATOSENS MOT RES, V3, P1; Beiriger A, 2014, J EXP ZOOL PART B, V322, P221, DOI 10.1002/jez.b.22556; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; Boulais N, 2007, J AM ACAD DERMATOL, V57, P147, DOI 10.1016/j.jaad.2007.02.009; Burnstock G, 2000, BRIT J ANAESTH, V84, P476, DOI 10.1093/oxfordjournals.bja.a013473; Burnstock G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00227; Cahusac PMB, 2009, NEUROSCIENCE, V163, P933, DOI 10.1016/j.neuroscience.2009.07.015; CASSIDY G, 1994, BRAIN BEHAV EVOLUT, V43, P244, DOI 10.1159/000113638; Crumling MA, 2009, NEUROSCIENCE, V161, P1144, DOI 10.1016/j.neuroscience.2009.02.076; Di Prisco GV, 2000, J NEUROSCI, V20, P8169; DiPrisco GV, 1997, SCIENCE, V278, P1122, DOI 10.1126/science.278.5340.1122; ERZURUMLU RS, 1992, J NEUROSCI, V12, P3946; FADEM BH, 1982, LAB ANIM SCI, V32, P405; Frappell PB, 2006, RESP PHYSIOL NEUROBI, V154, P252, DOI 10.1016/j.resp.2006.05.001; GEMMELL RT, 1988, ANAT EMBRYOL, V177, P403, DOI 10.1007/BF00304737; HUGHES RL, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P377; JONES TE, 1985, SOMATOSENS MOT RES, V3, P169, DOI 10.3109/07367228509144582; Keyte AL, 2010, DEVELOPMENT, V137, P4283, DOI 10.1242/dev.049445; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; KRAUS DB, 1987, LAB ANIM SCI, V37, P478; Lavallee A, 2009, BRAIN RES, V1282, P1, DOI 10.1016/j.brainres.2009.05.068; Liu Xue Jun, 2005, Curr Opin Investig Drugs, V6, P65; Lucarz A, 2007, EUR J CELL BIOL, V86, P243, DOI 10.1016/j.ejcb.2007.02.001; Marasco PD, 2006, P NATL ACAD SCI USA, V103, P9339, DOI 10.1073/pnas.0603229103; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; Meyers JR, 2003, J NEUROSCI, V23, P4054; Nagarajan R, 2010, NEUROINFORMATICS, V8, P201, DOI 10.1007/s12021-010-9081-y; Nakatsuka T, 2001, J NEUROSCI, V21, P6522, DOI 10.1523/JNEUROSCI.21-17-06522.2001; NICHOLLS JG, 1990, J EXP BIOL, V152, P1; NOGA BR, 1988, J NEUROSCI, V8, P2074; NOGA BR, 1991, J NEUROSCI, V11, P1691; Petruska JC, 2000, J CHEM NEUROANAT, V20, P141, DOI 10.1016/S0891-0618(00)00080-6; Pflieger JF, 1996, BEHAV BRAIN RES, V80, P137, DOI 10.1016/0166-4328(96)00028-9; Puzzolo E, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-8; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Ruan HZ, 2004, HISTOCHEM CELL BIOL, V122, P539, DOI 10.1007/s00418-004-0714-9; Smith KK, 2006, DEV DYNAM, V235, P1181, DOI 10.1002/dvdy.20676; Staikopoulos V, 2007, NEUROSCIENCE, V144, P208, DOI 10.1016/j.neuroscience.2006.09.035; STEWART RR, 1991, J EXP BIOL, V161, P25; Tachibana Tamiko, 2002, Anatomical Science International, V77, P26, DOI 10.1046/j.0022-7722.2002.00008.x; Vandeberg J. L., 2010, The UFAW handbook on the care and management of laboratory and other research animals, P246, DOI 10.1002/9781444318777.ch19; VINAY L, 1995, EUR J NEUROSCI, V7, P143, DOI 10.1111/j.1460-9568.1995.tb01028.x; Waite PME, 2000, EUR J NEUROSCI, V12, P2781, DOI 10.1046/j.1460-9568.2000.00161.x; WAITE PME, 1994, J COMP NEUROL, V350, P75, DOI 10.1002/cne.903500106; Woo SH, 2015, TRENDS CELL BIOL, V25, P74, DOI 10.1016/j.tcb.2014.10.003	47	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148352	10.1371/journal.pone.0148352	http://dx.doi.org/10.1371/journal.pone.0148352			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848758	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000075
J	Mlunde, LB; Sunguya, BF; Mbwambo, JK; Ubuguyu, OS; Shibanuma, A; Yasuoka, J; Jimba, M				Mlunde, Linda Beatrice; Sunguya, Bruno Fokas; Mbwambo, Jessie Kazeni; Ubuguyu, Omary Said; Shibanuma, Akira; Yasuoka, Junko; Jimba, Masamine			A Mismatch between High-Risk Behaviors and Screening of Infectious Diseases among People Who Inject Drugs in Dar es Salaam, Tanzania	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; HEPATITIS-C VIRUS; HIV PREVENTION; PUBLIC-HEALTH; USERS; TUBERCULOSIS; METAANALYSIS; PREVALENCE; OPPORTUNITIES; INTEGRATION	Background People who inject drugs are at risk of various infectious diseases. Despite such a risk, evidence is limited which studied the utilization of screening services for common infectious diseases among people who inject drugs in Tanzania. We aimed to examine their high-risk behaviors; utilization of screening services for HIV infection, hepatitis B/C, any other sexually transmitted infection, and tuberculosis; and their associated factors in Dar es Salaam, Tanzania. Methods We conducted a baseline cross-sectional study as part of a prospective cohort study of people who inject drugs. We included 578 participants comprising of new enrollees of the integrated methadone-assisted treatment program and those who were selected from the communities but not enrolled in the program. We interviewed new enrollees preceding their enrollment and receipt of services from the program. We measured participants' high-risk behaviors and their utilization of screening services. We analyzed the data descriptively and used multiple logistic regressions to identify the factors associated with ever being screened for infectious diseases. Results Of 578 participants, 14.2% shared injection needles. Of 547 sexually active participants, 37.5% had multiple sexual partners and only 17.4% used a condom. Of all participants, however, only 36.0% had ever been screened for HIV infection, 18.5% for tuberculosis, 11.8% for any other sexually transmitted infection, and 11.6% for hepatitis B/C. They were more likely to have ever been screened for HIV infection if they had education levels above primary education (adjusted odds ratio [AOR]: 2.54, 95% CI: 1.54-4.20), had a history of transactional sex (OR: 2.63, 95% CI: 1.01-6.84), and were new enrollees of the program (AOR: 7.41, 95% CI: 4.41-12.86). Conclusions People who inject drugs practice high-risk behaviors but their utilization of screening services for infectious diseases is poor in Dar es Salaam, Tanzania. It is crucial to increase the coverage of screening services for them and strengthen the counseling of safer sexual practices.	[Mlunde, Linda Beatrice; Shibanuma, Akira; Yasuoka, Junko; Jimba, Masamine] Univ Tokyo, Dept Community & Global Hlth, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Sunguya, Bruno Fokas] Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth & Social Sci, Dept Community Hlth, POB 65015, Dar Es Salaam, Tanzania; [Mbwambo, Jessie Kazeni; Ubuguyu, Omary Said] Muhimbili Natl Hosp, Dept Psychiat & Mental Hlth, POB 65000, Dar Es Salaam, Tanzania	University of Tokyo; Muhimbili University of Health & Allied Sciences	Jimba, M (corresponding author), Univ Tokyo, Dept Community & Global Hlth, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mjimba@m.u-tokyo.ac.jp	Jimba, Masamine/AAF-5630-2020; Yasuoka, Junko/GVT-8950-2022; Shibanuma, Akira/C-7652-2016	Shibanuma, Akira/0000-0003-2058-1722; Sunguya, Bruno/0000-0003-3625-0725	Department of Community and Global Health, The University of Tokyo, Japan	Department of Community and Global Health, The University of Tokyo, Japan	The authors received no specific funding for this work. However, the work was supported by the Department of Community and Global Health, The University of Tokyo, Japan.	Altice FL, 2010, LANCET, V376, P367, DOI 10.1016/S0140-6736(10)60829-X; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Backmund M, 2005, CLIN INFECT DIS, V40, pS330, DOI 10.1086/427475; Barocas JA, 2014, HARM REDUCT J, V11, DOI 10.1186/1477-7517-11-1; Bernstein E, 2012, ACAD EMERG MED, V19, P386, DOI 10.1111/j.1553-2712.2012.01314.x; Bobashev GV, 2009, J URBAN HEALTH, V86, pS32, DOI 10.1007/s11524-009-9368-1; Bowring AL, 2013, INT J DRUG POLICY, V24, P78, DOI 10.1016/j.drugpo.2012.08.005; Bruce RD, 2014, INT J DRUG POLICY, V25, P22, DOI 10.1016/j.drugpo.2013.09.005; CHITWOOD DD, 1995, AM J PUBLIC HEALTH, V85, P1538, DOI 10.2105/AJPH.85.11.1538; Deng LP, 2009, WORLD J GASTROENTERO, V15, P996, DOI 10.3748/wjg.15.996; Du J, 2012, INT J INFECT DIS, V16, pE498, DOI 10.1016/j.ijid.2012.02.013; Dutta A., 2014, CONSENSUS ESTIMATES; Flanigan TP, 2010, JAIDS-J ACQ IMM DEF, V55, pS78, DOI 10.1097/QAI.0b013e3181fbc94f; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Francis SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101221; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Gupta A, 2014, INT J TUBERC LUNG D, V18, P793, DOI 10.5588/ijtld.13.0208; Hahn RA, 2015, INT J HLTH SERV; Jarlais DCD, 2004, JAIDS-J ACQ IMM DEF, V35, P158, DOI 10.1097/00126334-200402010-00010; Lambdin BH, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19936; Lambdin BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067062; Mahanta J, 2008, AIDS, V22, pS59, DOI 10.1097/01.aids.0000343764.62455.9e; MARKOWITZ N, 1993, ANN INTERN MED, V119, P185, DOI 10.7326/0003-4819-119-3-199308010-00002; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Matovu JKB, 2007, TROP MED INT HEALTH, V12, P1315, DOI 10.1111/j.1365-3156.2007.01923.x; Mbwambo J, 2012, SAHARA J-J SOC ASP H, V9, P154, DOI 10.1080/17290376.2012.743832; McCurdy SA, 2005, AIDS CARE, V17, pS65, DOI 10.1080/09540120500120930; McCurdy SA, 2010, ADDICTION, V105, P1062, DOI 10.1111/j.1360-0443.2010.02908.x; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Ministry of Health and Social Welfare (MoHSW), 2008, SEX TRANSM REPR TRAC; Ministry of Health and Social Welfare (MoHSW), 2009, STAND OP PROC HIV TE; Ministry of Health and Social Welfare (MoHSW), 2007, NAT GUID MAN SEX TRA; Mmbaga EJ, 2008, SEX TRANSM INFECT, V84, P224, DOI 10.1136/sti.2007.029488; Mmbaga Elia J, 2006, Afr J AIDS Res, V5, P281, DOI 10.2989/16085900609490390; MORENO S, 1993, ANN INTERN MED, V119, P194, DOI 10.7326/0003-4819-119-3-199308010-00003; NBS, TANZ DEM HLTH SURV 2; Niccolai LM, 2010, AIDS BEHAV, V14, P932, DOI 10.1007/s10461-008-9469-y; Platt L, 2009, SEX TRANSM INFECT, V85, P17, DOI 10.1136/sti.2008.034090; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Sandra T, 2006, AFRICAN J DRUG ALCOH, V5, P158; Seal KH, 2000, WESTERN J MED, V172, P16, DOI 10.1136/ewjm.172.1.16; Senyimba C, 2005, BMJ-BRIT MED J, V331, P778, DOI 10.1136/bmj.331.7519.778-b; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Urassa W, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-159; van Beek I, 1998, BMJ-BRIT MED J, V317, P433, DOI 10.1136/bmj.317.7156.433; World Health Organization, 2014, POL BRIEF CONS GUID	46	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148598	10.1371/journal.pone.0148598	http://dx.doi.org/10.1371/journal.pone.0148598			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26849802	gold, Green Published			2022-12-27	WOS:000369554000133
J	Nawaz, MS; Giarda, E; Bedogni, F; La Montanara, P; Ricciardi, S; Ciceri, D; Alberio, T; Landsberger, N; Rusconi, L; Kilstrup-Nielsen, C				Nawaz, Mohammad Sarfaraz; Giarda, Elisa; Bedogni, Francesco; La Montanara, Paolo; Ricciardi, Sara; Ciceri, Dalila; Alberio, Tiziana; Landsberger, Nicoletta; Rusconi, Laura; Kilstrup-Nielsen, Charlotte			CDKL5 and Shootin1 Interact and Concur in Regulating Neuronal Polarization	PLOS ONE			English	Article							AXON OUTGROWTH; RETT-SYNDROME; KINASE; POLARITY; SIGNAL; GENE	In the last years, the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene has been associated with epileptic encephalopathies characterized by the early onset of intractable epilepsy, severe developmental delay, autistic features, and often the development of Rett syndrome-like features. Still, the role of CDKL5 in neuronal functions is not fully understood. By way of a yeast two hybrid screening we identified the interaction of CDKL5 with shootin1, a brain specific protein acting as a determinant of axon formation during neuronal polarization. We found evidence that CDKL5 is involved, at least in part, in regulating neuronal polarization through its interaction with shootin1. Indeed, the two proteins interact in vivo and both are localized in the distal tip of outgrowing axons. By using primary hippocampal neurons as model system we find that adequate CDKL5 levels are required for axon specification. In fact, a significant number of neurons overexpressing CDKL5 is characterized by supernumerary axons, while the silencing of CDKL5 disrupts neuronal polarization. Interestingly, shootin1 phosphorylation is reduced in neurons silenced for CDKL5 suggesting that the kinase affects, directly or indirectly, the post-translational modification of shootin1. Finally, we find that the capacity of CDKL5 to generate surplus axons is attenuated in neurons with reduced shootin1 levels, in agreement with the notion that two proteins act in a common pathway. Altogether, these results point to a role of CDKL5 in the early steps of neuronal differentiation that can be explained, at least in part, by its association with shootin1.	[Nawaz, Mohammad Sarfaraz; Giarda, Elisa; La Montanara, Paolo; Ciceri, Dalila; Rusconi, Laura; Kilstrup-Nielsen, Charlotte] Univ Insubria, Dept Biotechnol & Life Sci, Ctr Neurosci, Lab Genet & Epigenet Control Gene Express, I-21052 Busto Arsizio, Italy; [Bedogni, Francesco; Landsberger, Nicoletta] San Raffaele Sci Insitute, Div Neurosci, San Raffaele Rett Res Unit, I-20132 Milan, Italy; [Ricciardi, Sara] Fdn Ist Nazl Genet Mol INGM, Mol Histol & Cell Growth Unit, I-20122 Milan, Italy; [Alberio, Tiziana] Univ Insubria, Dept Sci & High Technol, Ctr Neurosci, Lab Biochem & Funct Prote, I-21052 Busto Arsizio, Italy; [Landsberger, Nicoletta] Univ Milan, Dept Med Biotechnol & Translat Medicin, I-20090 Segrate, Italy	University of Insubria; University of Insubria; University of Milan	Rusconi, L; Kilstrup-Nielsen, C (corresponding author), Univ Insubria, Dept Biotechnol & Life Sci, Ctr Neurosci, Lab Genet & Epigenet Control Gene Express, I-21052 Busto Arsizio, Italy.	laura.rusconi@uninsubria.it; c.kilstrup-nielsen@uninsubria.it	Ciceri, Dalila/K-9766-2017; Ricciardi, Sara/I-6308-2018; Alberio, Tiziana/I-5398-2018	Ricciardi, Sara/0000-0001-8124-432X; Alberio, Tiziana/0000-0002-6065-6699; Landsberger, Nicoletta/0000-0003-0820-3155; Kilstrup-Nielsen, Charlotte/0000-0003-4977-4077; bedogni, francesco/0000-0002-6651-0041; Ciceri, Dalila/0000-0003-4688-406X; La Montanara, Paolo/0000-0002-5146-9269	Telethon Foundation [GGP10032]; Ministero della Salute Foundation; Cariplo Foundation [2010-0724]; EU Initial Training Network program [238242]; Jerome Lejeune Foundation; Italian parents' association L'Albero di Greta; Italian parents' association ProRett Ricerca	Telethon Foundation(Fondazione Telethon); Ministero della Salute Foundation; Cariplo Foundation(Fondazione Cariplo); EU Initial Training Network program; Jerome Lejeune Foundation; Italian parents' association L'Albero di Greta; Italian parents' association ProRett Ricerca	This work was supported by Telethon (GGP10032), Ministero della Salute (Ricerca finalizzata 2008 - Bando Malattie Rare) and Cariplo (2010-0724) Foundations (to NL) and by the EU Initial Training Network program (no. 238242 "DisChrom") and the Jerome Lejeune Foundation (to CKN), and the Italian parents' associations L'Albero di Greta and ProRett Ricerca.	Amendola E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091613; Baj G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00018; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Bedogni F, 2010, GENE EXPR PATTERNS, V10, P9, DOI 10.1016/j.gep.2009.11.005; Bertani I, 2006, J BIOL CHEM, V281, P32048, DOI 10.1074/jbc.M606325200; Chen QA, 2010, J NEUROSCI, V30, P12777, DOI 10.1523/JNEUROSCI.1102-10.2010; Cheng PL, 2012, ANNU REV NEUROSCI, V35, P181, DOI 10.1146/annurev-neuro-061010-113618; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Fehr S, 2013, EUR J HUM GENET, V21, P266, DOI 10.1038/ejhg.2012.156; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fuchs C, 2014, NEUROBIOL DIS, V70, P53, DOI 10.1016/j.nbd.2014.06.006; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Kameshita I, 2008, BIOCHEM BIOPH RES CO, V377, P1162, DOI 10.1016/j.bbrc.2008.10.113; Kilstrup-Nielsen C, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/728267; Mari F, 2005, HUM MOL GENET, V14, P1935, DOI 10.1093/hmg/ddi198; Montini E, 1998, GENOMICS, V51, P427, DOI 10.1006/geno.1998.5391; Ricciardi S, 2012, NAT CELL BIOL, V14, P911, DOI 10.1038/ncb2566; Rusconi L, 2008, J BIOL CHEM, V283, P30101, DOI 10.1074/jbc.M804613200; Rusconi L, 2011, J BIOL CHEM, V286, P36550, DOI 10.1074/jbc.M111.235630; Sapir T, 2013, J NEUROSCI, V33, P11932, DOI 10.1523/JNEUROSCI.5425-12.2013; Shimada T, 2008, J CELL BIOL, V181, P817, DOI 10.1083/jcb.200712138; Szafranski P, 2014, EUR J HUM GENET, P217; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Toriyama M, 2013, CURR BIOL, V23, P529, DOI 10.1016/j.cub.2013.02.017; Wang ITJ, 2012, P NATL ACAD SCI USA, V109, P21516, DOI 10.1073/pnas.1216988110; Williamson SL, 2012, HUM GENET, V131, P187, DOI 10.1007/s00439-011-1058-x; Zhu YC, 2013, P NATL ACAD SCI USA, V110, P9118, DOI 10.1073/pnas.1300003110	29	32	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148634	10.1371/journal.pone.0148634	http://dx.doi.org/10.1371/journal.pone.0148634			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849555	Green Published, Green Accepted, gold			2022-12-27	WOS:000369554000143
J	Rapp, AE; Bindl, R; Recknagel, S; Erbacher, A; Muller, I; Schrezenmeier, H; Ehrnthaller, C; Gebhard, F; Ignatius, A				Rapp, Anna E.; Bindl, Ronny; Recknagel, Stefan; Erbacher, Annika; Mueller, Ingo; Schrezenmeier, Hubert; Ehrnthaller, Christian; Gebhard, Florian; Ignatius, Anita			Fracture Healing Is Delayed in Immunodeficient NOD/scid-IL2R gamma(null)(c) Mice	PLOS ONE			English	Article							CELL-DEVELOPMENT; GAMMA-CHAIN; BONE; INFLAMMATION; OSTEOIMMUNOLOGY; INTERLEUKIN-15; MACROPHAGES; CYTOKINES; HEMATOMA; CALLUS	Following bone fracture, the repair process starts with an inflammatory reaction at the fracture site. Fracture healing is disturbed when the initial inflammation is increased or prolonged, whereby, a balanced inflammatory response is anticipated to be crucial for fracture healing, because it may induce down-stream responses leading to tissue repair. However, the impact of the immune response on fracture healing remains poorly understood. Here, we investigated bone healing in NOD/scid-IL2R gamma(null)(c) mice, which exhibit severe defects in innate and adaptive immunity, by biomechanical testing, histomorphometry and micro-computed tomography. We demonstrated that NOD/scid-IL2R gamma(null)(c) mice exhibited normal skeletal anatomy and a mild bone phenotype with a slightly reduced bone mass in the trabecular compartment in comparison to immunocompetent Balb/c mice. Fracture healing was impaired in immunodeficient NOD/scid-IL2R gamma(null)(c) mice. Callus bone content was unaffected during the early healing stage, whereas it was significantly reduced during the later healing period. Concomitantly, the amount of cartilage was significantly increased, indicating delayed endochondral ossification, most likely due to the decreased osteoclast activity observed in cells isolated from NOD/scid-IL2R gamma(null)(c) mice. Our results suggest that-under aseptic, uncomplicated conditions-the immediate immune response after fracture is nonessential for the initiation of bone formation. However, an intact immune system in general is important for successful bone healing, because endochondral ossification is delayed in immunodeficient NOD/scid-IL2R gamma(null)(c) mice.	[Rapp, Anna E.; Bindl, Ronny; Recknagel, Stefan; Ignatius, Anita] Univ Ulm, Inst Orthopaed Res & Biomech, D-89069 Ulm, Germany; [Erbacher, Annika] Univ Childrens Hosp Tubingen, Dept Gen Paediat Haematol & Oncol, Tubingen, Germany; [Mueller, Ingo] Univ Med Ctr Hamburg Eppendorf, Bone Marrow Transplantat Unit, Clin Paediat Haematol & Oncol, Hamburg, Germany; [Schrezenmeier, Hubert] German Red Cross Blood Transfus Serv, Inst Clin Transfus Med & Immunogenet, Ulm, Germany; [Schrezenmeier, Hubert] Univ Hosp Ulm, Ulm, Germany; [Schrezenmeier, Hubert] Univ Ulm, Inst Transfus Med, D-89069 Ulm, Germany; [Ehrnthaller, Christian; Gebhard, Florian] Univ Ulm, Ctr Surg, Dept Traumatol Hand Plast & Reconstruct Surg, D-89069 Ulm, Germany	Ulm University; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; Ulm University; Ulm University	Rapp, AE (corresponding author), Univ Ulm, Inst Orthopaed Res & Biomech, D-89069 Ulm, Germany.	anna.rapp@uni-ulm.de	Müller, Ingo/AAW-9025-2021; Ignatius, Anita/M-6012-2013; Rapp, Anna/L-8807-2016	Müller, Ingo/0000-0002-7477-6632; Ignatius, Anita/0000-0002-4782-1979; Rapp, Anna/0000-0001-5122-765X; Erbacher, Annika/0000-0002-6367-3769	European Commission [241879]; German Research Foundation (DFG) in the framework of the Collaborative Research Center 1149 (CRC1149)	European Commission(European CommissionEuropean Commission Joint Research Centre); German Research Foundation (DFG) in the framework of the Collaborative Research Center 1149 (CRC1149)(German Research Foundation (DFG))	This study was funded by the 7th Framework Programme (FP7) of the European Commission through the REBORNE Project, grant no. 241879 and the German Research Foundation (DFG) in the framework of the Collaborative Research Center 1149 (CRC1149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Bhandari M, 2003, J ORTHOP TRAUMA, V17, P353, DOI 10.1097/00005131-200305000-00006; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bozlar M, 2005, SAUDI MED J, V26, P1250; Bunn R. J., 2005, BONE JOINT J, V87, P265; Butterfield TA, 2006, J ATHL TRAINING, V41, P457; Chan JK, 2015, EMBO MOL MED, V7, P547, DOI 10.15252/emmm.201404487; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Danks L, 2013, J BIOCHEM, V154, P29, DOI 10.1093/jb/mvt049; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Djaafar S, 2010, ARTHRITIS RHEUM-US, V62, P3300, DOI 10.1002/art.27645; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Heilmann A, 2013, J ORTHOP RES, V31, P1845, DOI 10.1002/jor.22426; Hernandez RK, 2012, ACTA ORTHOP, V83, P653, DOI 10.3109/17453674.2012.747054; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Karladani AH, 2001, ARCH ORTHOP TRAUM SU, V121, P325, DOI 10.1007/s004020000252; Konnecke I, 2014, BONE, V64, P155, DOI 10.1016/j.bone.2014.03.052; Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI 10.1089/ten.TEB.2009.0687; Kolar P, 2011, CLIN ORTHOP RELAT R, V469, P3118, DOI 10.1007/s11999-011-1865-3; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Lee SH, 2008, BMB REP, V41, P495, DOI 10.5483/BMBRep.2008.41.7.495; Lee Y, 2011, BIOMOL THER, V19, P141, DOI 10.4062/biomolther.2011.19.2.141; Li X, 2001, BONE, V29, P134, DOI 10.1016/S8756-3282(01)00497-5; Manigrasso MB, 2008, CALCIFIED TISSUE INT, V82, P465, DOI 10.1007/s00223-008-9144-3; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Marusic A, 2000, LAB INVEST, V80, P1761, DOI 10.1038/labinvest.3780186; Mori G, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/720504; Nakashima T, 2009, J CLIN IMMUNOL, V29, P555, DOI 10.1007/s10875-009-9316-6; Niikura T, 2014, J ORTHOP SCI, V19, P120, DOI 10.1007/s00776-013-0472-4; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Pacifici R, 2010, BONE, V47, P461, DOI 10.1016/j.bone.2010.04.611; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Raggatt LJ, 2014, AM J PATHOL, V184, P3192, DOI 10.1016/j.ajpath.2014.08.017; Reinke S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004754; Rontgen V, 2010, J ORTHOP RES, V28, P1456, DOI 10.1002/jor.21148; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Schmidt-Bleek K, 2015, TISSUE ENG PART B-RE, V21, P354, DOI [10.1089/ten.teb.2014.0677, 10.1089/ten.TEB.2014.0677]; Schmidt-Bleek K, 2009, J ORTHOP RES, V27, P1147, DOI 10.1002/jor.20901; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Takayanagi H, 2010, ANN NY ACAD SCI, V1192, P117, DOI 10.1111/j.1749-6632.2009.05303.x; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Toben D, 2011, J BONE MINER RES, V26, P113, DOI 10.1002/jbmr.185; Wu Andy C, 2013, Bonekey Rep, V2, P373, DOI 10.1038/bonekey.2013.107	45	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147465	10.1371/journal.pone.0147465	http://dx.doi.org/10.1371/journal.pone.0147465			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849055	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000018
J	Sonoda, R; Tanaka, K; Kikuchi, T; Onishi, Y; Takao, T; Tahara, T; Yoshida, Y; Suzawa, N; Kawazu, S; Iwamoto, Y; Kushiyama, A				Sonoda, Remi; Tanaka, Kentaro; Kikuchi, Takako; Onishi, Yukiko; Takao, Toshiko; Tahara, Tazu; Yoshida, Yoko; Suzawa, Naoki; Kawazu, Shoji; Iwamoto, Yasuhiko; Kushiyama, Akifumi			C-Peptide Level in Fasting Plasma and Pooled Urine Predicts HbA1c after Hospitalization in Patients with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							BETA-CELL FUNCTION; BODY-MASS INDEX; GLYCEMIC CONTROL; INTRAVENOUS GLUCAGON; INSULIN-SECRETION; JAPANESE PATIENTS; AFTER-DISCHARGE; RISK-FACTORS; ASSOCIATION; MANAGEMENT	In this study, we investigate how measures of insulin secretion and other clinical information affect long-term glycemic control in patients with type 2 diabetes mellitus. Between October 2012 and June 2014, we monitored 202 diabetes patients who were admitted to the hospital of Asahi Life Foundation for glycemic control, as well as for training and education in diabetes management. We measured glycated hemoglobin (HbA1c) six months after discharge to assess disease management. In univariate analysis, fasting plasma C-peptide immunoreactivity (F-CPR) and pooled urine CPR (U-CPR) were significantly associated with HbA1c, in contrast to.CPR and C-peptide index (CPI). This association was strongly independent of most other patient variables. In exploratory factor analysis, five underlying factors, namely insulin resistance, aging, sex differences, insulin secretion, and glycemic control, represented patient characteristics. In particular, insulin secretion and resistance strongly influenced F-CPR, while insulin secretion affected U-CPR. In conclusion, the data indicate that among patients with type 2 diabetes mellitus, F-CPR and U-CPR may predict improved glycemic control six months after hospitalization.	[Sonoda, Remi; Tanaka, Kentaro; Kikuchi, Takako; Onishi, Yukiko; Takao, Toshiko; Tahara, Tazu; Yoshida, Yoko; Suzawa, Naoki; Kawazu, Shoji; Iwamoto, Yasuhiko; Kushiyama, Akifumi] Asahi Life Fdn, Inst Adult Dis, Div Diabet & Metab, Chuo Ku, Tokyo, Japan	Asahi Life Foundation	Kushiyama, A (corresponding author), Asahi Life Fdn, Inst Adult Dis, Div Diabet & Metab, Chuo Ku, Tokyo, Japan.	kusiyaa-tky@umin.ac.jp	Onishi, Yukiko/AAU-9057-2021; Kushiyama, Akifumi/W-5988-2019; Kushiyama, Akifumi/A-6386-2011	Onishi, Yukiko/0000-0003-1180-5982; Kushiyama, Akifumi/0000-0003-1385-7487; Kushiyama, Akifumi/0000-0003-1385-7487				Aarts EO, 2013, OBES SURG, V23, P867, DOI 10.1007/s11695-013-0872-8; Ayyagari P, 2011, INT J HEALTH CARE FI, V11, P35, DOI 10.1007/s10754-010-9087-x; Chan WB, 2000, QJM-MON J ASSOC PHYS, V93, P183, DOI 10.1093/qjmed/93.3.183; Chen PC, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0160-4; Dungan Kathleen M, 2012, J Diabetes Sci Technol, V6, P1045; FABER O K, 1986, Diabetes Metabolism Reviews, V2, P331; FRIER BM, 1977, DIABETES, V26, P369; Funakoshi S, 2011, J DIABETES INVEST, V2, P429, DOI 10.1111/j.2040-1124.2011.00126.x; Funakoshi S, 2011, J DIABETES INVEST, V2, P297, DOI 10.1111/j.2040-1124.2010.00096.x; Funakoshi S, 2008, DIABETES RES CLIN PR, V82, P353, DOI 10.1016/j.diabres.2008.09.010; Gomez-Huelgas R, 2014, ACTA DIABETOL, V51, P377, DOI 10.1007/s00592-013-0520-8; Goto A, 2010, ENDOCR J, V57, P237, DOI 10.1507/endocrj.K09E-279; Haneda Masakazu, 2013, Nihon Naika Gakkai Zasshi, V102, P2291; Healy SJ, 2013, DIABETES CARE, V36, P2960, DOI 10.2337/dc13-0108; HENDRIKSEN C, 1977, DIABETOLOGIA, V13, P615, DOI 10.1007/BF01236316; Incalzi Raffaele Antonelli, 2002, BMC Geriatr, V2, P4, DOI 10.1186/1471-2318-2-4; Koproski J, 1997, DIABETES CARE, V20, P1553, DOI 10.2337/diacare.20.10.1553; MADSBAD S, 1981, ACTA MED SCAND, V210, P153; Moss SE, 1999, ARCH INTERN MED, V159, P2053, DOI 10.1001/archinte.159.17.2053; Murai K, 2014, DRUGS R&D, V14, P301, DOI 10.1007/s40268-014-0072-6; Murea M, 2012, AM J NEPHROL, V36, P488, DOI 10.1159/000343920; Saisho Y, 2013, ENDOCR J, V60, P517; Scheen AJ, 1996, DIABETES METAB, V22, P397; Shim WS, 2006, EUR J ENDOCRINOL, V155, P615, DOI 10.1530/eje.1.02249; SMITH DM, 1987, J GEN INTERN MED, V2, P168, DOI 10.1007/BF02596146; Taverna MJ, 2001, DIABETIC MED, V18, P584, DOI 10.1046/j.1464-5491.2001.00534.x; The Japan Diabetes Society, 2013, EV BAS PRACT GUID TR; TURNER RC, 1995, DIABETES, V44, P1249; Usui R, 2015, J DIABETES COMPLICAT, V29, P1203, DOI 10.1016/j.jdiacomp.2015.07.020; Wei NJ, 2012, ENDOCR PRACT, V18, P456, DOI 10.4158/EP11309.OR; Wexler DJ, 2012, DIABETES RES CLIN PR, V98, P249, DOI 10.1016/j.diabres.2012.09.016; Yamada Y, 2006, DIABETES RES CLIN PR, V74, P222, DOI 10.1016/j.diabres.2006.03.030	32	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147303	10.1371/journal.pone.0147303	http://dx.doi.org/10.1371/journal.pone.0147303			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849676	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000013
J	Su, HY; Waldron, RT; Gong, R; Ramanujan, VK; Pandol, SJ; Lugea, A				Su, Hsin-Yuan; Waldron, Richard T.; Gong, Raymond; Ramanujan, V. Krishnan; Pandol, Stephen J.; Lugea, Aurelia			The Unfolded Protein Response Plays a Predominant Homeostatic Role in Response to Mitochondrial Stress in Pancreatic Stellate Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ROTTLERIN INDUCES AUTOPHAGY; DELTA-INDEPENDENT PATHWAY; BREAST-CANCER CELLS; SIGNALING PATHWAY; ER-STRESS; GENE-EXPRESSION; STEM-CELLS; APOPTOSIS; DEATH	Activated pancreatic stellate cells (PaSC) are key participants in the stroma of pancreatic cancer, secreting extracellular matrix proteins and inflammatory mediators. Tumors are poorly vascularized, creating metabolic stress conditions in cancer and stromal cells that necessitate adaptive homeostatic cellular programs. Activation of autophagy and the endoplasmic reticulum unfolded protein response (UPR) have been described in hepatic stellate cells, but the role of these processes in PaSC responses to metabolic stress is unknown. We reported that the PI3K/mTOR pathway, which AMPK can regulate through multiple inputs, modulates PaSC activation and fibrogenic potential. Here, using primary and immortalized mouse PaSC, we assess the relative contributions of AMPK/mTOR signaling, autophagy and the UPR to cell fate responses during metabolic stress induced by mitochondrial dysfunction. The mitochondrial uncoupler rottlerin at low doses (0.5-2.5 mu M) was added to cells cultured in 10% FBS complete media. Mitochondria rapidly depolarized, followed by altered mitochondrial dynamics and decreased cellular ATP levels. This mitochondrial dysfunction elicited rapid, sustained AMPK activation, mTOR pathway inhibition, and blockade of autophagic flux. Rottlerin treatment also induced rapid, sustained PERK/CHOP UPR signaling. Subsequently, high doses (> 5 mu M) induced loss of cell viability and cell death. Interestingly, AMPK knock-down using siRNA did not prevent rottlerin-induced mTOR inhibition, autophagy, or CHOP upregulation, suggesting that AMPK is dispensable for these responses. Moreover, CHOP genetic deletion, but not AMPK knock-down, prevented rottlerin-induced apoptosis and supported cell survival, suggesting that UPR signaling is a major modulator of cell fate in PaSC during metabolic stress. Further, short-term rottlerin treatment reduced both PaSC fibrogenic potential and IL-6 mRNA expression. In contrast, expression levels of the angiogenic factors HGF and VEGF alpha were unaffected, and the immune modulator IL-4 was markedly upregulated. These data imply that metabolic stress-induced PaSC reprogramming differentially modulates neighboring cells in the tumor microenvironment.	[Su, Hsin-Yuan; Waldron, Richard T.; Gong, Raymond; Pandol, Stephen J.; Lugea, Aurelia] Cedars Sinai Med Ctr, Dept Med, Pancreat Res Grp, Los Angeles, CA 90048 USA; [Waldron, Richard T.; Ramanujan, V. Krishnan; Pandol, Stephen J.; Lugea, Aurelia] UCLA VA Greater Los Angeles Hlth Sci Ctr, Dept Med, David Geffen Sch Med, Los Angeles, CA USA; [Ramanujan, V. Krishnan] Cedars Sinai Med Ctr, Metab Photon Lab, Dept Surg, Los Angeles, CA 90048 USA; [Ramanujan, V. Krishnan] Cedars Sinai Med Ctr, Metab Photon Lab, Dept Biomed Sci, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Lugea, A (corresponding author), Cedars Sinai Med Ctr, Dept Med, Pancreat Res Grp, Los Angeles, CA 90048 USA.; Lugea, A (corresponding author), UCLA VA Greater Los Angeles Hlth Sci Ctr, Dept Med, David Geffen Sch Med, Los Angeles, CA USA.	Aurelia.Lugea@cshs.org	Waldron, Richard Taliesin/ABF-2773-2020	Waldron, Richard Taliesin/0000-0003-3151-6002	National Institutes of Health [R01 AA019954, P01CA163200, P01DK098108, P50 AA011999]; NATIONAL CANCER INSTITUTE [P01CA163200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK098108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019954, P50AA011999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Support was provided by the National Institutes of Health R01 AA019954 (to AL), P01CA163200 (to SP), P01DK098108 (to SP and AL), P50 AA011999 (to SP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman BJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008763; Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Apte MV, 2013, GASTROENTEROLOGY, V144, P1210, DOI 10.1053/j.gastro.2012.11.037; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; B'chir W, 2014, CELL SIGNAL, V26, P1385, DOI 10.1016/j.cellsig.2014.03.009; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Gholamin S, 2014, CURR DRUG TARGETS, V15, P1302, DOI 10.2174/1389450115666141107105456; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; He K, 2015, ONCOGENE; Hernandez-Gea V, 2013, J HEPATOL, V59, P98, DOI 10.1016/j.jhep.2013.02.016; Hernandez-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kojima K, 2008, BIOCHEM BIOPH RES CO, V376, P434, DOI 10.1016/j.bbrc.2008.09.007; Kumar D, 2014, CANCER LETT, V343, P179, DOI 10.1016/j.canlet.2013.10.003; Kumar D, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-171; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Lim JH, 2008, APOPTOSIS, V13, P1378, DOI 10.1007/s10495-008-0264-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Lu QY, 2013, J CHROMATOGR SEP TEC, V4, P1; Lu WY, 2014, CELL SIGNAL, V26, P1303, DOI 10.1016/j.cellsig.2014.02.018; Lugea A, 2006, GASTROENTEROLOGY, V131, P885, DOI 10.1053/j.gastro.2006.06.023; MAIOLI E, 2012, THESCIENTIFICWORLDJO, V2012, DOI DOI 10.1100/2012/350826; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Miller BW, 2012, MOL CELL BIOCHEM, V367, P31, DOI 10.1007/s11010-012-1316-9; Ming M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114573; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Ohno I, 2010, AM J PHYSIOL-GASTR L, V298, pG63, DOI 10.1152/ajpgi.00257.2009; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Pandol S, 2012, J GASTROEN HEPATOL, V27, P127, DOI 10.1111/j.1440-1746.2011.07013.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Patel MB, 2014, CARCINOGENESIS, V35, P1891, DOI 10.1093/carcin/bgu122; Paulo JA, 2011, J PROTEOME RES, V10, P4835, DOI 10.1021/pr2006318; De Obanos MP, 2006, J CELL PHYSIOL, V209, P580, DOI 10.1002/jcp.20790; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Song KS, 2008, AUTOPHAGY, V4, P650, DOI 10.4161/auto.6057; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Suhane S, 2011, BIOCHEM BIOPH RES CO, V414, P73, DOI 10.1016/j.bbrc.2011.09.024; Valencia T, 2014, CANCER CELL, V26, P121, DOI 10.1016/j.ccr.2014.05.004; Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014; Wu YS, 2015, NAT CELL BIOL, V17, P715, DOI 10.1038/ncb3172; Xue J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8158; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	61	23	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148999	10.1371/journal.pone.0148999	http://dx.doi.org/10.1371/journal.pone.0148999			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849807	Green Published, gold			2022-12-27	WOS:000369554000193
J	Hirooka, M; Koizumi, Y; Imai, Y; Miyake, T; Watanabe, T; Yoshida, O; Takeshita, E; Tokumoto, Y; Abe, M; Hiasa, Y				Hirooka, Masashi; Koizumi, Yohei; Imai, Yusuke; Miyake, Teruki; Watanabe, Takao; Yoshida, Osamu; Takeshita, Eiji; Tokumoto, Yoshio; Abe, Masanori; Hiasa, Yoichi			Usefulness of a New Three-Dimensional Simulator System for Radiofrequency Ablation	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; THERMAL ABLATION; EX-VIVO; IN-VIVO; LIVER; PROGRESSION; ELECTRODES; MONOPOLAR; RESECTION; BIOPSY	Multipuncture radiofrequency ablation is expected to produce a large ablated area and reduce intrahepatic recurrence of hepatocellular carcinoma; however, it requires considerable skill. This study evaluated the utility of a new simulator system for multipuncture radiofrequency ablation. To understand positioning of multipuncture electrodes on three-dimensional images, we developed a new technology by expanding real-time virtual ultrasonography. We performed 21 experimental punctures in phantoms. Electrode insertion directions and positions were confirmed on computed tomography, and accuracy and utility of the simulator system were evaluated by measuring angles and intersections for each electrode. Moreover, to appropriately assess placement of the three electrodes, puncture procedures with or without the simulator were performed by experts and non-experts. Technical success was defined as maximum angle and distance ratio, as calculated by maximum and minimum distances between electrodes. In punctures using 2 electrodes, correlations between angles on each imaging modality were strong (ultrasound vs. simulator: r = 0.991, p<0.001, simulator vs. computed tomography: r = 0.991, p<0.001, ultrasound vs. computed tomography: r = 0.999, p<0.001). Correlations between distances in each imaging modality were also strong (ultrasound vs. simulator: r = 0.993, p<0.001; simulator vs. computed tomography: r = 0.994, p<0.001; ultrasound vs. computed tomography: r = 0.994, p<0.001). In cases with 3 electrodes, distances between each electrode correlated strongly (yellow-labeled vs. red-labeled: r = 0.980, p<0.001; red-labeled vs. blue-labeled: r = 0.953, p<0.001; yellow-labeled vs. blue-labeled: r = 0.953, p<0.001). Both angle and distance ratio (expert with simulator vs. without simulator; p = 0.03, p = 0.02) were significantly smaller in procedures performed by experts using the simulator system. The new simulator system appears to accurately guide electrode positioning. This simulator system could allow multipuncture radiofrequency ablation to be performed more effectively and comfortably.	[Hirooka, Masashi; Koizumi, Yohei; Imai, Yusuke; Miyake, Teruki; Watanabe, Takao; Yoshida, Osamu; Takeshita, Eiji; Tokumoto, Yoshio; Abe, Masanori; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan	Ehime University	Hiasa, Y (corresponding author), Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan.	hiasa@m.ehime-u.ac.jp	Hiasa, Yoichi/ABD-2759-2021	Hiasa, Yoichi/0000-0003-4117-339X; Miyake, Teruki/0000-0002-9905-5356	Japanese Ministry of Education, Culture, Sports, Science and Technology [JSPS KAKENHI 15K09006, JSPS KAKENHI 15K09960]; Japanese Ministry of Health, Labor and Welfare	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in the role of data collection by a Grant-in-Aid for Scientific Research (JSPS KAKENHI 15K09006 to YH and JSPS KAKENHI 15K09960 to MH) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, as well as a Grant-in-Aid for Scientific Research and Development from the Japanese Ministry of Health, Labor and Welfare (to YH) (https://www.jsps.go.jp/j-grantsinaid/).	Cady B, 1998, ANN SURG, V227, P566, DOI 10.1097/00000658-199804000-00019; Chapoutot C, 1999, GASTROEN CLIN BIOL, V23, P552; Clasen S, 2006, RADIOLOGY, V238, P881, DOI 10.1148/radiol.2382050571; Dodd GD, 2001, AM J ROENTGENOL, V177, P777, DOI 10.2214/ajr.177.4.1770777; Elias D, 1998, EUR J SURG ONCOL, V24, P174, DOI 10.1016/S0748-7983(98)92878-5; Frericks BB, 2005, RADIOLOGY, V237, P1056, DOI 10.1148/radiol.2373041104; Hirooka M, 2009, AM J ROENTGENOL, V193, pW149, DOI 10.2214/AJR.08.1817; Kang TW, 2015, INVEST RADIOL, V50, P81, DOI 10.1097/RLI.0000000000000103; Lencioni R, 2001, ABDOM IMAGING, V26, P345, DOI 10.1007/s002610000194; Matsuda M, 2014, JPN J RADIOL, V32, P405, DOI 10.1007/s11604-014-0323-z; Nakazawa T, 2007, AM J ROENTGENOL, V188, P480, DOI 10.2214/AJR.05.2079; Osaki Y, 2013, J GASTROENTEROL, V48, P874, DOI 10.1007/s00535-012-0685-x; Seror O, 2008, RADIOLOGY, V248, P288, DOI 10.1148/radiol.2481071101; Seror O, 2014, J VASC INTERV RADIOL, V25, P599, DOI 10.1016/j.jvir.2013.11.025; Takamori R, 2000, LIVER TRANSPLANT, V6, P67, DOI 10.1002/lt.500060103; Woo S, 2013, RADIOLOGY, V268, P589, DOI 10.1148/radiol.13121736; Yu SCH, 2004, AM J ROENTGENOL, V183, P383, DOI 10.2214/ajr.183.2.1830383	17	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148298	10.1371/journal.pone.0148298	http://dx.doi.org/10.1371/journal.pone.0148298			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845038	gold, Green Published			2022-12-27	WOS:000369552800042
J	Jamalian, S; Davis, MJ; Zawieja, DC; Moore, JE				Jamalian, Samira; Davis, Michael J.; Zawieja, David C.; Moore, James E., Jr.			Network Scale Modeling of Lymph Transport and Its Effective Pumping Parameters	PLOS ONE			English	Article							CONTRACTILE ACTIVITY; VESSELS; COORDINATION; FLOW; PRESSURE; ANATOMY; SYSTEM	The lymphatic system is an open-ended network of vessels that run in parallel to the blood circulation system. These vessels are present in almost all of the tissues of the body to remove excess fluid. Similar to blood vessels, lymphatic vessels are found in branched arrangements. Due to the complexity of experiments on lymphatic networks and the difficulty to control the important functional parameters in these setups, computational modeling becomes an effective and essential means of understanding lymphatic network pumping dynamics. Here we aimed to determine the effect of pumping coordination in branched network structures on the regulation of lymph flow. Lymphatic vessel networks were created by building upon our previous lumped-parameter model of lymphangions in series. In our network model, each vessel is itself divided into multiple lymphangions by lymphatic valves that help maintain forward flow. Vessel junctions are modeled by equating the pressures and balancing mass flows. Our results demonstrated that a 1.5 s rest-period between contractions optimizes the flow rate. A time delay between contractions of lymphangions at the junction of branches provided an advantage over synchronous pumping, but additional time delays within individual vessels only increased the flow rate for adverse pressure differences greater than 10.5 cmH(2)O. Additionally, we quantified the pumping capability of the system under increasing levels of steady transmural pressure and outflow pressure for different network sizes. We observed that peak flow rates normally occurred under transmural pressures between 2 to 4 cmH(2)O (for multiple pressure differences and network sizes). Networks with 10 lymphangions per vessel had the highest pumping capability under a wide range of adverse pressure differences. For favorable pressure differences, pumping was more efficient with fewer lymphangions. These findings are valuable for translating experimental measurements from the single lymphangion level to tissue and organ scales.	[Jamalian, Samira; Moore, James E., Jr.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, S Kensington Campus, London, England; [Davis, Michael J.] Univ Missouri, Sch Med, Dept Physiol & Pharmacol, Columbia, MO USA; [Zawieja, David C.] Texas A&M Hlth Sci Ctr, Dept Syst Biol & Translat Med, Temple, TX USA	Imperial College London; University of Missouri System; University of Missouri Columbia; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Moore, JE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, S Kensington Campus, London, England.	james.moore.jr@imperial.ac.uk	Jamalian, Samira/N-1259-2013; Moore, James/D-1326-2013	Jamalian, Samira/0000-0003-2265-5502; Moore, James/0000-0003-1604-158X; Zawieja, David/0000-0002-2644-6524	National Institutes of Health [U01 HL-123420, R01 HL-120867]; Royal Society; Royal Academy of Engineering; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120867, R01HL125608, U01HL123420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); Royal Academy of Engineering(Royal Academy of Engineering - UK); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by National Institutes of Health U01 HL-123420 (DCZ, JEM) and R01 HL-120867 (MJD). JEM gratefully acknowledges the support of The Royal Society and The Royal Academy of Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram CD, 2014, COMPUT METHOD BIOMEC, V17, P1519, DOI 10.1080/10255842.2012.753066; Bertram CD, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4002799; Bertram CD, 2015, AM J PHYSL IN PRESS; Bertram CD, 2013, BIOMECH MODEL MECHAN, P1, DOI 10.1007/s10237-013-0505-0; Crowe MJ, 1997, J PHYSIOL-LONDON, V500, P235, DOI 10.1113/jphysiol.1997.sp022013; Davis Michael J., 2006, Lymphatic Research and Biology, V4, P3, DOI 10.1089/lrb.2006.4.3; Davis MJ, 2011, AM J PHYSIOL-HEART C, V301, pH48, DOI 10.1152/ajpheart.00133.2011; Dixon JB, 2006, MICROCIRCULATION, V13, P597, DOI 10.1080/10739680600893909; EISENHOFFER J, 1995, MICROVASC RES, V49, P97, DOI 10.1006/mvre.1995.1008; Gashev AA, 2004, MICROCIRCULATION, V11, P477, DOI 10.1080/10739680490476033; Gashev AA, 2002, ANN NY ACAD SCI, V979, P178, DOI 10.1111/j.1749-6632.2002.tb04878.x; Jamalian S, 2013, PARAMETER SENSITIVIT; Jamalian S, 2015, P SB3C 2015 SUMM BIO; Macdonald AJ, 2008, AM J PHYSIOL-HEART C, V295, pH305, DOI 10.1152/ajpheart.00004.2008; Margaris KN, 2012, J R SOC INTERFACE, V9, P601, DOI 10.1098/rsif.2011.0751; MCHALE NG, 1992, J PHYSIOL-LONDON, V450, P503, DOI 10.1113/jphysiol.1992.sp019139; MCHALE NG, 1976, J PHYSIOL-LONDON, V261, P255, DOI 10.1113/jphysiol.1976.sp011557; Mislin H., 1966, PROGR LYMPH P INT S, P87; Munn LL, 2015, SEMIN CELL DEV BIOL, V38, P67, DOI 10.1016/j.semcdb.2015.01.010; REDDY NP, 1977, COMPUT BIOL MED, V7, P181, DOI 10.1016/0010-4825(77)90023-3; SCHMIDSCHONBEIN GW, 1990, PHYSIOL REV, V70, P987, DOI 10.1152/physrev.1990.70.4.987; STAPLES LD, 1982, J REPROD FERTIL, V64, P409; Suami H, 2008, ANN SURG ONCOL, V15, P863, DOI 10.1245/s10434-007-9709-9; Venugopal AM, 2007, AM J PHYSIOL-HEART C, V293, pH1183, DOI 10.1152/ajpheart.01340.2006; ZAWIEJA DC, 1993, AM J PHYSIOL, V264, pH1283, DOI 10.1152/ajpheart.1993.264.4.H1283	25	28	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148384	10.1371/journal.pone.0148384	http://dx.doi.org/10.1371/journal.pone.0148384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845031	Green Published, Green Submitted, gold			2022-12-27	WOS:000369552800052
J	Katz, ML; Viney, TJ; Nikolic, K				Katz, Matthew L.; Viney, Tim J.; Nikolic, Konstantin			Receptive Field Vectors of Genetically-Identified Retinal Ganglion Cells Reveal Cell-Type-Dependent Visual Functions	PLOS ONE			English	Article							MORPHOLOGICAL CLASSIFICATION; NEURAL RESPONSES; NATURAL SCENES; MOUSE; ORGANIZATION; MELANOPSIN; DIVERSITY; POPULATIONS; STATISTICS; PARALLEL	Sensory stimuli are encoded by diverse kinds of neurons but the identities of the recorded neurons that are studied are often unknown. We explored in detail the firing patterns of eight previously defined genetically-identified retinal ganglion cell (RGC) types from a single transgenic mouse line. We first introduce a new technique of deriving receptive field vectors (RFVs) which utilises a modified form of mutual information ("Quadratic Mutual Information"). We analysed the firing patterns of RGCs during presentation of short duration (similar to 10 second) complex visual scenes (natural movies). We probed the high dimensional space formed by the visual input for a much smaller dimensional subspace of RFVs that give the most information about the response of each cell. The new technique is very efficient and fast and the derivation of novel types of RFVs formed by the natural scene visual input was possible even with limited numbers of spikes per cell. This approach enabled us to estimate the 'visual memory' of each cell type and the corresponding receptive field area by calculating Mutual Information as a function of the number of frames and radius. Finally, we made predictions of biologically relevant functions based on the RFVs of each cell type. RGC class analysis was complemented with results for the cells' response to simple visual input in the form of black and white spot stimulation, and their classification on several key physiological metrics. Thus RFVs lead to predictions of biological roles based on limited data and facilitate analysis of sensory-evoked spiking data from defined cell types.	[Katz, Matthew L.; Nikolic, Konstantin] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, Dept Elect & Elect Engn, Ctr Bioinspired Technol, Bessemer Bldg, London SW7 2AZ, England; [Viney, Tim J.] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, CH-4058 Basel, Switzerland; [Viney, Tim J.] Univ Basel, CH-4003 Basel, Switzerland; [Viney, Tim J.] Univ Oxford, Dept Pharmacol, MRC Brain Network Dynam Unit, Mansfield Rd, Oxford OX1 3TH, England	Imperial College London; Friedrich Miescher Institute for Biomedical Research; University of Basel; University of Oxford	Nikolic, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, Dept Elect & Elect Engn, Ctr Bioinspired Technol, Bessemer Bldg, London SW7 2AZ, England.	k.nikolic@imperial.ac.uk		Viney, Tim/0000-0001-6444-1188; Nikolic, Konstantin/0000-0002-6551-2977	European Union [270324]; UK Biotechnology and Biological Sciences Research Council [BB/L018268/1]; UK Engineering and Physical Sciences Research Council [EP/N002474/1]; Biotechnology and Biological Sciences Research Council [BB/L018268/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H024581/1, EP/N002474/1] Funding Source: researchfish; BBSRC [BB/L018268/1] Funding Source: UKRI; EPSRC [EP/N002474/1, EP/H024581/1] Funding Source: UKRI	European Union(European Commission); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the European Union Framework Programme 7 project "SeeBetter" (270324), http://fp7-pp.publicdata.eu/page/resource/project/270324 to MLK and KN; UK Biotechnology and Biological Sciences Research Council (BB/L018268/1) http://www.bbsrc.ac.uk/home/home.aspx to KN; and UK Engineering and Physical Sciences Research Council (EP/N002474/1) http://www.epsrc.ac.uk to KN.	BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; Betsch BY, 2004, BIOL CYBERN, V90, P41, DOI 10.1007/s00422-003-0434-6; Bomash I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053363; Brenner N, 2000, NEURAL COMPUT, V12, P1531, DOI 10.1162/089976600300015259; Chan YC, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.13; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; da Silveira RA, 2011, CURR OPIN NEUROBIOL, V21, P664, DOI 10.1016/j.conb.2011.05.007; Dayan P, 2001, COMPUTATIONAL NEUROS; Dimitrov AG, 2011, J COMPUT NEUROSCI, V30, P1, DOI 10.1007/s10827-011-0314-3; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Elstrott J, 2009, CURR OPIN NEUROBIOL, V19, P293, DOI 10.1016/j.conb.2009.03.004; Famiglietti EV, 2005, J COMP NEUROL, V484, P357, DOI 10.1002/cne.20433; Farrow K, 2013, NEURON, V78, P325, DOI 10.1016/j.neuron.2013.02.014; Farrow K, 2011, J NEUROPHYSIOL, V105, P1516, DOI 10.1152/jn.00331.2010; Fitzgerald JD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002249; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Greschner M, 2011, J PHYSIOL-LONDON, V589, P75, DOI 10.1113/jphysiol.2010.193888; Grimes WN, 2014, NEURON, V82, P460, DOI 10.1016/j.neuron.2014.02.037; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kapur J. N., 1994, MEASURES INFORM THEI; Kayser C, 2003, J NEUROPHYSIOL, V90, P1910, DOI 10.1152/jn.00195.2003; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Kim TJ, 2006, INVEST OPHTH VIS SCI, V47, P2757, DOI 10.1167/iovs.05-1442; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Kouh M, 2009, NETWORK-COMP NEURAL, V20, P49, DOI 10.1080/09548980902950891; Lee ES, 2010, NEUROSCI RES, V66, P141, DOI 10.1016/j.neures.2009.10.008; MacKay D. J. C., 2003, INFORM THEORY INFERE; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Nirenberg S, 2012, P NATL ACAD SCI USA, V109, P15012, DOI 10.1073/pnas.1207035109; Nishimori Y, 2005, NEUROCOMPUTING, V67, P106, DOI 10.1016/j.neucom.2004.11.035; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; Paninski L, 2003, NETWORK-COMP NEURAL, V14, P437, DOI 10.1088/0954-898X/14/3/304; Paninski L, 2007, PROG BRAIN RES, V165, P493, DOI 10.1016/S0079-6123(06)65031-0; Panzeri S, 2007, J NEUROPHYSIOL, V98, P1064, DOI 10.1152/jn.00559.2007; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Pillow JW, 2006, J VISION, V6; Principe J.C., 2000, UNSUPERVISED ADAPTIV, P265; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Rajan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071959; REMTULLA S, 1985, VISION RES, V25, P21, DOI 10.1016/0042-6989(85)90076-8; Renyi A., 1961, MEASURES ENTROPY INF, VVolume 1; Rockhill RL, 2002, J NEUROSCI, V22, P3831; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Roska B, 2003, NAT NEUROSCI, V6, P600, DOI 10.1038/nn1061; Rowekamp RJ, 2011, NETWORK-COMP NEURAL, V22, P45, DOI 10.3109/0954898X.2011.566303; Schmidt TM, 2014, NEURON, V82, P781, DOI 10.1016/j.neuron.2014.03.022; Schwartz G, 2011, J GEN PHYSIOL, V138, P283, DOI 10.1085/jgp.201110629; Schwartz GW, 2012, NAT NEUROSCI, V15, P1572, DOI 10.1038/nn.3225; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Smyth D, 2003, J NEUROSCI, V23, P4746; Soo FS, 2011, J NEUROSCI, V31, P2145, DOI 10.1523/JNEUROSCI.5129-10.2011; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Trong PK, 2008, NAT NEUROSCI, V11, P1343, DOI 10.1038/nn.2199; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; VANSTEVENINCK RD, 1995, PHILOS T R SOC B, V348, P321; Victor JD, 2005, NAT NEUROSCI, V8, P1651, DOI 10.1038/nn1607; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Wen Z, 2010, FEASIBLE METHOD OPTI, P1; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Wu MCK, 2006, ANNU REV NEUROSCI, V29, P477, DOI 10.1146/annurev.neuro.29.051605.113024; Xu DX, 2010, INFORM SCI STAT, P47, DOI 10.1007/978-1-4419-1570-2_2; Yonehara K, 2013, NEURON, V79, P1078, DOI 10.1016/j.neuron.2013.08.005; Zeck GM, 2007, EUR J NEUROSCI, V26, P367, DOI 10.1111/j.1460-9568.2007.05670.x; Zhang Y, 2012, P NATL ACAD SCI; Zhu YL, 2014, J NEUROSCI, V34, P7845, DOI 10.1523/JNEUROSCI.2960-13.2014	78	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147738	10.1371/journal.pone.0147738	http://dx.doi.org/10.1371/journal.pone.0147738			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845435	Green Published, gold, Green Submitted			2022-12-27	WOS:000369552800015
J	Matsumoto, YK; Okanoya, K				Matsumoto, Yui K.; Okanoya, Kazuo			Phase-Specific Vocalizations of Male Mice at the Initial Encounter during the Courtship Sequence	PLOS ONE			English	Article							ULTRASONIC VOCALIZATIONS; HOUSE MICE; UNUSUAL REPERTOIRE; MUS-MUSCULUS; BEHAVIOR; URINE; SEX; EXPERIENCE	Mice produce ultrasonic vocalizations featuring a variety of syllables. Vocalizations are observed during social interactions. In particular, males produce numerous syllables during courtship. Previous studies have shown that vocalizations change according to sexual behavior, suggesting that males vary their vocalizations depending on the phase of the courtship sequence. To examine this process, we recorded large sets of mouse vocalizations during male-female interactions and acoustically categorized these sounds into 12 vocal types. We found that males emitted predominantly short syllables during the first minute of interaction, more long syllables in the later phases, and mainly harmonic sounds during mounting. These context-and time-dependent changes in vocalization indicate that vocal communication during courtship in mice consists of at least three stages and imply that each vocalization type has a specific role in a phase of the courtship sequence. Our findings suggest that recording for a sufficiently long time and taking the phase of courtship into consideration could provide more insights into the role of vocalization in mouse courtship behavior in future study.	[Matsumoto, Yui K.; Okanoya, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan	University of Tokyo	Okanoya, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	cokanoya@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science Research Fellowships for Young Scientists [259181]; Ministry of Education, Culture, Sports, Science and Technology of Japan [3118003]; Japan Science and Technology Agency, ERATO, Okanoya Emotional Information Project; Grants-in-Aid for Scientific Research [13J09181] Funding Source: KAKEN	Japan Society for the Promotion of Science Research Fellowships for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency, ERATO, Okanoya Emotional Information Project; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by Japan Society for the Promotion of Science Research Fellowships for Young Scientists (259181; DC1) to YM and Grant-in-Aid for Scientific Research on Innovative Areas (3118003; Adolescent Mind & Self-Regulation) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Japan Science and Technology Agency, ERATO, Okanoya Emotional Information Project to KO.	Asaba A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00231; Asaba A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087186; Chabout J, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3389/fnbeh.2015.00076, 10.3389/fnbh.2015.00076]; Chabout J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029401; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Hammerschmidt K, 2009, BIOL LETTERS, V5, P589, DOI 10.1098/rsbl.2009.0317; Hammerschmidt K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041133; Hanson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040782; Holfoth DP, 2014, J ACOUST SOC AM, V136, P3401, DOI 10.1121/1.4900564; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Kikusui T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017721; Mahrt EJ, 2013, J NEUROSCI, V33, P5573, DOI 10.1523/JNEUROSCI.5054-12.2013; Matsumoto YK, 2012, NEUROREPORT, V23, P676, DOI 10.1097/WNR.0b013e3283557eea; Neilans EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085405; Neunuebel JP, 2015, ELIFE, V4, DOI 10.7554/eLife.06203; NYBY J, 1983, BEHAV NEURAL BIOL, V39, P128, DOI 10.1016/S0163-1047(83)90722-7; NYBY J, 1980, PHYSIOL BEHAV, V24, P737, DOI 10.1016/0031-9384(80)90405-9; POMERANTZ SM, 1983, PHYSIOL BEHAV, V31, P91, DOI 10.1016/0031-9384(83)90101-4; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Roullet FI, 2011, BEHAV BRAIN RES, V216, P19, DOI 10.1016/j.bbr.2010.06.004; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; SIPOS ML, 1992, BEHAV NEURAL BIOL, V58, P138, DOI 10.1016/0163-1047(92)90375-E; Sugimoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022093; Wang HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001893; White NR, 1998, PHYSIOL BEHAV, V63, P467, DOI 10.1016/S0031-9384(97)00484-8	26	50	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147102	10.1371/journal.pone.0147102	http://dx.doi.org/10.1371/journal.pone.0147102			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841117	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200025
J	Ban, JJ; Yang, S; Im, W; Kim, M				Ban, Jae-Jun; Yang, Seungwon; Im, Wooseok; Kim, Manho			Neurogenic Effects of Cell-Free Extracts of Adipose Stem Cells	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; MAMMALIAN NEURAL STEM; STROMAL CELLS; REGENERATIVE MEDICINE; SUBVENTRICULAR ZONE; NEUROTROPHIC FACTOR; NEURITE OUTGROWTH; IN-VIVO; TISSUE; GROWTH	Stem-cell-based therapies are regarded as promising treatments for neurological disorders, and adipose-derived stem cells (ASCs) are a feasible source of clinical application of stem cell. Recent studies have shown that stem cells have a therapeutic potential for use in the treatment of various illnesses through paracrine action. To examine the effects of cell components of ASCs on neural stem cells (NSCs), we treated cell-free extracts of ASCs (CFE-ASCs) containing various components with brain-derived NSCs. To elucidate the effects of CFE-ASCs in NSC proliferation, we treated mouse subventricular zone-derived cultured NSCs with various doses of CFE-ASCs. As a result, CFE-ASCs were found to induce the proliferation of NSCs under conditions of growth factor deprivation in a dose-dependent manner (p<0.01). CFE-ASCs increase the expression of neuron and astrocyte differentiation markers including Tuj-1 (p<0.05) and glial fibrillary acidic protein (p<0.01) without altering the cell's fate in differentiating NSCs. In addition, treatment with CFE-ASCs induces an increase in neurite numbers (p<0.01) and lengths of NSCs (p<0.05). Furthermore, CFE-ASCs rescue the hydrogen peroxide-induced reduction of NSCs' viability (p<0.05) and neurite branching (p<0.01). Findings from our study indicate that CFE-ASCs support the survival, proliferation and differentiation of NSCs accompanied with neurite outgrowth, suggesting that CFE-ASCs can modulate neurogenesis in the central nervous system.	[Ban, Jae-Jun; Im, Wooseok; Kim, Manho] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea; [Yang, Seungwon] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Kim, Manho] Seoul Natl Univ, Coll Med, Prot Metab Med Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; University of Chicago; Seoul National University (SNU)	Im, W; Kim, M (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea.; Kim, M (corresponding author), Seoul Natl Univ, Coll Med, Prot Metab Med Res Ctr, Seoul, South Korea.	imwooseok@gmail.com; kimmanho@snu.ac.kr	Yang, Seungwon/AAM-7585-2021		National Research Foundation of Korea (NRF) [2014R1A2A1A11051520]; Korea Health 21 R & D Project by the Ministry of Health & Welfare, Republic of Korea [HI14C2348]; National Research Foundation of Korea [2015R1D1A1A01060056]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea Health 21 R & D Project by the Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) (2014R1A2A1A11051520), Korea Health 21 R & D Project (HI14C2348) by the Ministry of Health & Welfare, Republic of Korea, and National Research Foundation of Korea (2015R1D1A1A01060056).	Atsma DE, 2007, CURR OPIN LIPIDOL, V18, P645, DOI 10.1097/MOL.0b013e3282f0dd1f; Banks WA, 2001, CURR PHARM DESIGN, V7, P125, DOI 10.2174/1381612013398310; Brown Larry R, 2005, Expert Opin Drug Deliv, V2, P29, DOI 10.1517/17425247.2.1.29; Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135; Choi YS, 2012, BIOMATERIALS, V33, P6943, DOI 10.1016/j.biomaterials.2012.06.057; Deleyrolle Loic P., 2009, V549, P91, DOI 10.1007/978-1-60327-931-4_7; Deshpande RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137918; Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Faigle R, 2013, BBA-GEN SUBJECTS, V1830, P2435, DOI 10.1016/j.bbagen.2012.09.002; Fraser JK, 2006, NAT CLIN PRACT CA S1, V3, P33, DOI DOI 10.1038/ncpcardio0444; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Hrvoj-Mihic B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00707; Huri PY, 2014, CELL MOL BIOENG, V7, P497, DOI 10.1007/s12195-014-0362-7; Im W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059438; Jacqueline GA, 2006, NEURAL STEM CELL CUL; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kim WS, 2009, J DERMATOL SCI, V53, P96, DOI 10.1016/j.jdermsci.2008.08.007; Kishino A, 2001, NEUROREPORT, V12, P1067, DOI 10.1097/00001756-200104170-00040; Lee EY, 2009, WOUND REPAIR REGEN, V17, P540, DOI 10.1111/j.1524-475X.2009.00499.x; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; McGinn MJ, 2012, J NEUROSCI RES, V90, P1159, DOI 10.1002/jnr.23012; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d; Pan WH, 2000, NEUROENDOCRINOLOGY, V72, P171, DOI 10.1159/000054584; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Rasmussen P, 2009, EXP PHYSIOL, V94, P1062, DOI 10.1113/expphysiol.2009.048512; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Safford KM, 2004, EXP NEUROL, V187, P319, DOI 10.1016/j.expneurol.2004.01.027; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; Schiwy N, 2009, EUR J NEUROSCI, V30, P1544, DOI 10.1111/j.1460-9568.2009.06929.x; Skaper SD, 2005, ANN NY ACAD SCI, V1053, P376, DOI 10.1196/annals.1344.032; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Winner B, 2011, EUR J NEUROSCI, V33, P1139, DOI 10.1111/j.1460-9568.2011.07613.x; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Young DA, 2013, BIOMATERIALS, V34, P8581, DOI 10.1016/j.biomaterials.2013.07.103; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	41	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148691	10.1371/journal.pone.0148691	http://dx.doi.org/10.1371/journal.pone.0148691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859291	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400066
J	do Prado, C; Guinsburg, R; de Almeida, MFB; Mascaretti, RS; Vale, LA; Haddad, LB; Rebello, CM				do Prado, Cristiane; Guinsburg, Ruth; Branco de Almeida, Maria Fernanda; Mascaretti, Renata Suman; Vale, Luciana Assis; Haddad, Luciana Branco; Rebello, Celso Moura			Manual Ventilation and Sustained Lung Inflation in an Experimental Model: Influence of Equipment Type and Operator's Training	PLOS ONE			English	Article							FUNCTIONAL RESIDUAL CAPACITY; END-EXPIRATORY PRESSURE; T-PIECE RESUSCITATOR; NEONATAL RESUSCITATION; TIDAL VOLUME; PRETERM INFANTS; MASK VENTILATION; AIRWAY PRESSURE; BIRTH; DEVICES	Aim To compare the influence of devices for manual ventilation and individual experience on the applied respiratory mechanics and sustained lung inflation. Methods A total of 114 instructors and non-instructors from the Neonatal Resuscitation Program of the Brazilian Society of Pediatrics participated in this study. Participants ventilated an intubated manikin. To evaluate respiratory mechanics and sustained lung inflation parameters, a direct comparison was made between the self-inflating bag and the T-shaped resuscitator (T-piece), followed by an analysis of the effectiveness of the equipment according to the participants' education and training. Results A difference between equipment types was observed for the tidal volume, with a median (interquartile range) of 28.5 mL (12.6) for the self-inflating bag and 20.1 mL (8.4) for the T-piece in the instructor group and 31.6 mL (14) for the self-inflating bag and 22.3 mL (8.8) for the T-piece in the non-instructor group. Higher inspiratory time values were observed with the T-piece in both groups of professionals, with no significant difference between them. The operator's ability to maintain the target pressure over the 10 seconds of sustained lung inflation was evaluated using the area under the pressure-time curve and was 1.7-fold higher with the use of the T-piece. Inspiratory pressure and mean airway pressure applied during sustained lung inflation were greater with the self-inflating bag, as evaluated between the beginning and the end of the procedure. Conclusion The T-piece resulted in lower tidal volume and higher inspiratory time values, irrespective of the operator's experience, and increased the ease of performing the sustained lung inflation maneuver, as demonstrated by the maintenance of target pressure for the desired period and a higher mean airway pressure than that obtained using the self-inflating bag.	[do Prado, Cristiane; Rebello, Celso Moura] Univ Sao Paulo, Sch Med, Dept Pediat, Sao Paulo, SP, Brazil; [Guinsburg, Ruth; Branco de Almeida, Maria Fernanda] Brazilian Soc Pediat, Neonatal Resuscitat Program, Sao Paulo, SP, Brazil; [Mascaretti, Renata Suman] Hosp Vila Santa Catarina, Dept Pediat, Sao Paulo, SP, Brazil; [do Prado, Cristiane; Vale, Luciana Assis; Haddad, Luciana Branco; Rebello, Celso Moura] Hosp Israelita Albert Einstein, Dept Pediat, Sao Paulo, SP, Brazil; [Guinsburg, Ruth; Branco de Almeida, Maria Fernanda] Univ Fed Sao Paulo, Paulista Sch Med, Dept Pediat, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Hospital Israelita Albert Einstein; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	do Prado, C (corresponding author), Univ Sao Paulo, Sch Med, Dept Pediat, Sao Paulo, SP, Brazil.; do Prado, C (corresponding author), Hosp Israelita Albert Einstein, Dept Pediat, Sao Paulo, SP, Brazil.	crisprado@einstein.br	Guinsburg, Ruth/F-1984-2013; Rebello, Celso M/E-9400-2013	Guinsburg, Ruth/0000-0003-1967-9861; Rebello, Celso/0000-0002-4637-6295	Brazilian Society of Pediatrics	Brazilian Society of Pediatrics	The authors gratefully acknowledge Dr. Eduardo da Silva Vaz, Chair of the Brazilian Society of Pediatrics for his generous support.	Attar Mohammad Ali, 2002, Semin Neonatol, V7, P353, DOI 10.1053/siny.2002.0129; Bennett S, 2005, RESUSCITATION, V67, P113, DOI 10.1016/j.resuscitation.2005.02.016; Dawson JA, 2011, J PAEDIATR CHILD H, V47, P698, DOI 10.1111/j.1440-1754.2011.02036.x; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; Ersdal HL, 2012, RESUSCITATION, V83, P869, DOI 10.1016/j.resuscitation.2011.12.011; Hawkes CP, 2012, RESUSCITATION, V83, P797, DOI 10.1016/j.resuscitation.2011.12.020; Hillman NH, 2012, PEDIATR RES, V72, P593, DOI 10.1038/pr.2012.135; Hussey SG, 2004, ARCH DIS CHILD-FETAL, V89, pF490, DOI 10.1136/adc.2003.047712; Jobe AH, 2008, NEONATOLOGY, V94, P190, DOI 10.1159/000143721; Klingenberg C, 2011, NEONATOLOGY, V100, P78, DOI 10.1159/000322983; Lista G, 2015, PEDIATRICS, V135, pE457, DOI 10.1542/peds.2014-1692; McHale S, 2008, RESUSCITATION, V79, P230, DOI 10.1016/j.resuscitation.2008.06.024; Murthy V, 2012, ARCH DIS CHILD-FETAL, V97, pF249, DOI 10.1136/archdischild-2011-300117; O'Donnell CPF, 2012, CLIN PERINATOL, V39, P857, DOI 10.1016/j.clp.2012.09.010; O'Reilly M, 2013, CRIT CARE RES PRACT, V2013, P1; Oddie S, 2005, RESUSCITATION, V67, P109, DOI 10.1016/j.resuscitation.2005.05.004; Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127; Polglase GR, 2008, PEDIATR RES, V64, P517, DOI 10.1203/PDR.0b013e3181841363; Polglase GR, 2009, PEDIATR RES, V65, P67, DOI 10.1203/PDR.0b013e318189487e; Roehr CC, 2010, AM J PERINAT, V27, P753, DOI 10.1055/s-0030-1254236; Roehr CC, 2010, RESUSCITATION, V81, P202, DOI 10.1016/j.resuscitation.2009.10.008; Schmolzer GM, 2010, ARCH DIS CHILD-FETAL, V95, pF393, DOI 10.1136/adc.2009.174003; Szyld E, 2014, J PEDIATR-US, V165, P234, DOI 10.1016/j.jpeds.2014.02.035; te Pas AB, 2009, PEDIATR RES, V66, P295, DOI 10.1203/PDR.0b013e3181b1bca4; te Pas AB, 2009, PEDIATR RES, V65, P537, DOI 10.1203/PDR.0b013e31819da21b; Thio M, 2014, ARCH DIS CHILD-FETAL, V99, pF274, DOI 10.1136/archdischild-2013-305239	26	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148475	10.1371/journal.pone.0148475	http://dx.doi.org/10.1371/journal.pone.0148475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859896	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400046
J	Gohari, IM; Kropinski, AM; Weese, SJ; Parreira, VR; Whitehead, AE; Boerlin, P; Prescott, JF				Gohari, Iman Mehdizadeh; Kropinski, Andrew M.; Weese, Scott J.; Parreira, Valeria R.; Whitehead, Ashley E.; Boerlin, Patrick; Prescott, John F.			Plasmid Characterization and Chromosome Analysis of Two netF plus Clostridium perfringens Isolates Associated with Foal and Canine Necrotizing Enteritis	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE PLASMID; GENOME SEQUENCE; ENCODING PLASMIDS; TOXIN PLASMIDS; ENTEROTOXIN; PCW3; GENE; IDENTIFICATION; ORGANIZATION; CONJUGATION	The recent discovery of a novel beta-pore-forming toxin, NetF, which is strongly associated with canine and foal necrotizing enteritis should improve our understanding of the role of type A Clostridium perfringens associated disease in these animals. The current study presents the complete genome sequence of two netF-positive strains, JFP55 and JFP838, which were recovered from cases of foal necrotizing enteritis and canine hemorrhagic gastroenteritis, respectively. Genome sequencing was done using Single Molecule, Real-Time (SMRT) technology-PacBio and Illumina Hiseq2000. The JFP55 and JFP838 genomes include a single 3.34 Mb and 3.53 Mb chromosome, respectively, and both genomes include five circular plasmids. Plasmid annotation revealed that three plasmids were shared by the two newly sequenced genomes, including a NetF/NetE toxins-encoding tcp-conjugative plasmid, a CPE/CPB2 toxins-encoding tcp-conjugative plasmid and a putative bacteriocin-encoding plasmid. The putative beta-pore-forming toxin genes, netF, netE and netG, were located in unique pathogenicity loci on tcp-conjugative plasmids. The C. perfringens JFP55 chromosome carries 2,825 protein-coding genes whereas the chromosome of JFP838 contains 3,014 protein-encoding genes. Comparison of these two chromosomes with three available reference C. perfringens chromosome sequences identified 48 (similar to 247 kb) and 81 (similar to 430 kb) regions unique to JFP55 and JFP838, respectively. Some of these divergent genomic regions in both chromosomes are phage-and plasmid-related segments. Sixteen of these unique chromosomal regions (similar to 69 kb) were shared between the two isolates. Five of these shared regions formed a mosaic of plasmid-integrated segments, suggesting that these elements were acquired early in a clonal lineage of netF-positive C. perfringens strains. These results provide significant insight into the basis of canine and foal necrotizing enteritis and are the first to demonstrate that netF resides on a large and unique plasmid-encoded locus.	[Gohari, Iman Mehdizadeh; Kropinski, Andrew M.; Weese, Scott J.; Parreira, Valeria R.; Boerlin, Patrick; Prescott, John F.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Whitehead, Ashley E.] Univ Calgary, Dept Vet Clin & Diagnost Sci, Calgary, AB CSB 101E, Canada	University of Guelph; University of Calgary	Prescott, JF (corresponding author), Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada.	prescott@uoguelph.ca		Whitehead, Ashley/0000-0002-3165-6809	Natural Sciences and Engineering Discovery Grant	Natural Sciences and Engineering Discovery Grant	Funding was provided from Natural Sciences and Engineering Discovery Grant.	ABRAHAM LJ, 1985, PLASMID, V14, P37, DOI 10.1016/0147-619X(85)90030-7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bannam TL, 2006, J BACTERIOL, V188, P4942, DOI 10.1128/JB.00298-06; Bannam TL, 2011, MBIO, V2, DOI 10.1128/mBio.00190-11; Bantwal R, 2012, PLASMID, V67, P139, DOI 10.1016/j.plasmid.2011.12.016; Barbara AJ, 2008, VET MICROBIOL, V126, P377, DOI 10.1016/j.vetmic.2007.07.019; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Brynestad S, 2001, INFECT IMMUN, V69, P3483, DOI 10.1128/IAI.69.5.3483-3487.2001; Chalmers G, 2008, J CLIN MICROBIOL, V46, P3957, DOI 10.1128/JCM.01548-08; Cheung JK, 2010, INFECT IMMUN, V78, P3064, DOI 10.1128/IAI.00123-10; Cheung JK, 2004, J BACTERIOL, V186, P3321, DOI 10.1128/JB.186.11.3321-3330.2004; CORNILLOT E, 1995, MOL MICROBIOL, V15, P639, DOI 10.1111/j.1365-2958.1995.tb02373.x; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; Gohari IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122684; Govind R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002727; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Hassan KA, 2015, RES MICROBIOL, V166, P255, DOI 10.1016/j.resmic.2014.10.003; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Hosomi K, 2014, MOL GENET GENOMICS, V289, P1267, DOI 10.1007/s00438-014-0887-4; Hughes ML, 2007, J BACTERIOL, V189, P7531, DOI 10.1128/JB.00767-07; Iacobino A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071324; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; Lepp D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010795; Li JH, 2013, MICROBIOL MOL BIOL R, V77, P208, DOI 10.1128/MMBR.00062-12; Li JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010932; Lindstrom M, 2011, FOOD MICROBIOL, V28, P192, DOI 10.1016/j.fm.2010.03.020; McClane B.A., 2006, PROKARYOTES, V3rd ed., P688; McClane BA, 1996, TOXICON, V34, P1335, DOI 10.1016/S0041-0101(96)00101-8; Miyamoto K, 2006, J BACTERIOL, V188, P1585, DOI 10.1128/JB.188.4.1585-1598.2006; Miyamoto K, 2002, INFECT IMMUN, V70, P4261, DOI 10.1128/IAI.70.8.4261-4272.2002; Miyamoto K, 2008, J BACTERIOL, V190, P7178, DOI 10.1128/JB.00939-08; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Nakjang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030287; Nowell VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032271; Ohtani K, 2010, ANAEROBE, V16, P258, DOI 10.1016/j.anaerobe.2009.10.003; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Parreira VR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049753; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; Porter CJ, 2012, MOL MICROBIOL, V83, P275, DOI 10.1111/j.1365-2958.2011.07930.x; POSPIECH A, 1995, TRENDS GENET, V11, P217, DOI 10.1016/S0168-9525(00)89052-6; ROOD JI, 1978, PLASMID, V1, P563, DOI 10.1016/0147-619X(78)90013-6; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; Sparks SG, 2001, J CLIN MICROBIOL, V39, P883, DOI 10.1128/JCM.39.3.883-888.2001; Spraggon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010919; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; TAGG JR, 1976, BACTERIOL REV, V40, P722, DOI 10.1128/MMBR.40.3.722-756.1976; Uzal F A, 2010, Open Toxinology J, V2, P24; Uzal FA, 2014, FUTURE MICROBIOL, V9, P361, DOI 10.2217/fmb.13.168; Yonogi S, 2014, INFECT IMMUN, V82, P2390, DOI 10.1128/IAI.01759-14; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	56	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148344	10.1371/journal.pone.0148344	http://dx.doi.org/10.1371/journal.pone.0148344			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859667	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400034
J	Hertzog, LR; Meyer, ST; Weisser, WW; Ebeling, A				Hertzog, Lionel R.; Meyer, Sebastian T.; Weisser, Wolfgang W.; Ebeling, Anne			Experimental Manipulation of Grassland Plant Diversity Induces Complex Shifts in Aboveground Arthropod Diversity	PLOS ONE			English	Article							BOTTOM-UP; SPECIES-DIVERSITY; TOP-DOWN; MULTITROPHIC INTERACTIONS; BIODIVERSITY; COMMUNITIES; RICHNESS; HERBIVORY; EXTRAPOLATION; RAREFACTION	Changes in producer diversity cause multiple changes in consumer communities through various mechanisms. However, past analyses investigating the relationship between plant diversity and arthropod consumers focused only on few aspects of arthropod diversity, e.g. species richness and abundance. Yet, shifts in understudied facets of arthropod diversity like relative abundances or species dominance may have strong effects on arthropod-mediated ecosystem functions. Here we analyze the relationship between plant species richness and arthropod diversity using four complementary diversity indices, namely: abundance, species richness, evenness (equitability of the abundance distribution) and dominance (relative abundance of the dominant species). Along an experimental gradient of plant species richness (1, 2, 4, 8, 16 and 60 plant species), we sampled herbivorous and carnivorous arthropods using pitfall traps and suction sampling during a whole vegetation period. We tested whether plant species richness affects consumer diversity directly (i), or indirectly through increased productivity (ii). Further, we tested the impact of plant community composition on arthropod diversity by testing for the effects of plant functional groups (iii). Abundance and species richness of both herbivores and carnivores increased with increasing plant species richness, but the underlying mechanisms differed between the two trophic groups. While higher species richness in herbivores was caused by an increase in resource diversity, carnivore richness was driven by plant productivity. Evenness of herbivore communities did not change along the gradient in plant species richness, whereas evenness of carnivores declined. The abundance of dominant herbivore species showed no response to changes in plant species richness, but the dominant carnivores were more abundant in species-rich plant communities. The functional composition of plant communities had small impacts on herbivore communities, whereas carnivore communities were affected by forbs of small stature, grasses and legumes. Contrasting patterns in the abundance of dominant species imply different levels of resource specialization for dominant herbivores (narrow food spectrum) and carnivores (broad food spectrum). That in turn could heavily affect ecosystem functions mediated by herbivorous and carnivorous arthropods, such as herbivory or biological pest control.	[Hertzog, Lionel R.; Meyer, Sebastian T.; Weisser, Wolfgang W.] Tech Univ Munich, Dept Ecol & Ecosyst Management, Ctr Food & Life Sci Weihenstephan, Freising Weihenstephan, Germany; [Ebeling, Anne] Univ Jena, Inst Ecol, Jena, Germany	Technical University of Munich; Friedrich Schiller University of Jena	Ebeling, A (corresponding author), Univ Jena, Inst Ecol, Jena, Germany.	anne.ebeling@uni-jena.de	Meyer, Sebastian Tobias/AAH-3856-2021; Weisser, Wolfgang W/B-9718-2014	Meyer, Sebastian Tobias/0000-0003-0833-1472; Weisser, Wolfgang W/0000-0002-2757-8959; Hertzog, Lionel/0000-0003-0869-9672	German Science Foundation (Deutsche Forschungsgemeinschaft) [WWW: FOR 1451, WE 401 1381/15-2, WE 1381/17-2]; Deutsche Forschungsgemeinschaft [WE 1381/17-2, FOR 1451, WE 1381/15-2]	German Science Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was funded by the German Science Foundation (Deutsche Forschungsgemeinschaft), grant numbers WWW: FOR 1451, WE 401 1381/15-2, WE 1381/17-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by the Deutsche Forschungsgemeinschaft (FOR 1451, WE 1381/15-2, WE 1381/17-2). We thank the gardener team and the technical assistants in particular Gerlinde Kratzsch for maintaining the field site. Further, we acknowledge numerous student assistants, who helped weeding the experimental plots. Ilka Wolf, Silke Schroeck and Sylvia Creutzburg are greatly acknowledged for helping in data collection, and Alexandra Weigelt and Enrica de Luca for providing biomass data.	Abbas M, 2014, BASIC APPL ECOL, V15, P169, DOI 10.1016/j.baae.2014.02.001; [Anonymous], 2014, R LANG ENV STAT COMP; Borer ET, 2012, ECOL LETT, V15, P1457, DOI 10.1111/ele.12006; Boyer AG, 2003, OECOLOGIA, V136, P309, DOI 10.1007/s00442-003-1272-x; Brose U, 2003, OECOLOGIA, V135, P407, DOI 10.1007/s00442-003-1222-7; BRUST GE, 1986, AGR ECOSYST ENVIRON, V18, P145, DOI 10.1016/0167-8809(86)90137-4; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chalcraft DR, 2009, BIODIVERS CONSERV, V18, P91, DOI 10.1007/s10531-008-9457-6; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Denno RF, 2003, ECOLOGY, V84, P2522, DOI 10.1890/02-0370; Dinnage R, 2012, ECOL LETT, V15, P1308, DOI 10.1111/j.1461-0248.2012.01854.x; Ebeling A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106529; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; FAHNESTOCK JT, 1993, INT J PLANT SCI, V154, P432, DOI 10.1086/297126; Gagic V, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2620; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; HSIEH T.C., 2014, INEXT INTERPOLATION; Joern A, 2013, ANNU REV ENTOMOL, V58, P19, DOI 10.1146/annurev-ento-120811-153540; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Langellotto GA, 2004, OECOLOGIA, V139, P1, DOI 10.1007/s00442-004-1497-3; MacArthur R. H., 1984, GEOGRAPHICAL ECOLOGY; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; MATSON PA, 1992, ECOLOGY, V73, P723, DOI 10.2307/1940151; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Milcu A, 2013, ECOLOGY, V94, P1878, DOI 10.1890/12-1936.1; Nitschke N, 2014, OIKOS; Randlkofer B, 2010, BASIC APPL ECOL, V11, P383, DOI 10.1016/j.baae.2010.03.003; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Rzanny M, 2013, OIKOS, V122, P967, DOI 10.1111/j.1600-0706.2012.00114.x; Rzanny M, 2012, J ANIM ECOL, V81, P614, DOI 10.1111/j.1365-2656.2012.01951.x; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Tilman D, 2014, ANNU REV ECOL EVOL S, V45, P471, DOI 10.1146/annurev-ecolsys-120213-091917; WILLIAMS SL, 1993, ECOLOGY, V74, P904, DOI 10.2307/1940815; Wilsey BJ, 2005, ECOLOGY, V86, P1178, DOI 10.1890/04-0394; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109	44	31	31	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148768	10.1371/journal.pone.0148768	http://dx.doi.org/10.1371/journal.pone.0148768			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859496	Green Published, gold, Green Submitted			2022-12-27	WOS:000370038400077
J	Correa-Martin, L; Parraga, E; Sanchez-Margallo, FM; Latorre, R; Lopez-Albors, O; Wise, R; Malbrain, MLNG; Castellanos, G				Correa-Martin, L.; Parraga, E.; Sanchez-Margallo, F. M.; Latorre, R.; Lopez-Albors, O.; Wise, R.; Malbrain, M. L. N. G.; Castellanos, G.			Mechanical Intestinal Obstruction in a Porcine Model: Effects of Intra-Abdominal Hypertension. A Preliminary Study	PLOS ONE			English	Article							ABDOMINAL COMPARTMENT SYNDROME; PULSE PRESSURE VARIATION; STROKE VOLUME VARIATION; CRITICALLY-ILL PATIENTS; BOWEL OBSTRUCTION; BLOOD-FLOW; RAT MODEL; INTERNATIONAL-CONFERENCE; DISTRESS SYNDROME; TRANSLOCATION	Introduction Mechanical intestinal obstruction is a disorder associated with intra-abdominal hypertension and abdominal compartment syndrome. As the large intestine intraluminal and intra-abdominal pressures are increased, so the patient's risk for intestinal ischaemia. Previous studies have focused on hypoperfusion and bacterial translocation without considering the concomitant effect of intra-abdominal hypertension. The objective of this study was to design and evaluate a mechanical intestinal obstruction model in pigs similar to the human pathophysiology. Materials and Methods Fifteen pigs were divided into three groups: a control group (n = 5) and two groups of 5 pigs with intra-abdominal hypertension induced by mechanical intestinal obstruction. The intra-abdominal pressures of 20 mmHg were maintained for 2 and 5 hours respectively. Hemodynamic, respiratory and gastric intramucosal pH values, as well as blood tests were recorded every 30 min. Results Significant differences between the control and mechanical intestinal obstruction groups were noted. The mean arterial pressure, cardiac index, dynamic pulmonary compliance and abdominal perfusion pressure decreased. The systemic vascular resistance index, central venous pressure, pulse pressure variation, airway resistance and lactate increased within 2 hours from starting intra-abdominal hypertension (p<0.05). In addition, we observed increased values for the peak and plateau airway pressures, and low values of gastric intramucosal pH in the mechanical intestinal obstruction groups that were significant after 3 hours. Conclusion The mechanical intestinal obstruction model appears to adequately simulate the pathophysiology of intestinal obstruction that occurs in humans. Monitoring abdominal perfusion pressure, dynamic pulmonary compliance, gastric intramucosal pH and lactate values may provide insight in predicting the effects on endorgan function in patients with mechanical intestinal obstruction.	[Correa-Martin, L.; Sanchez-Margallo, F. M.] Jesus Uson Minimally Invas Surg Ctr, Laparoscopy Dept, Caceres, Spain; [Parraga, E.; Latorre, R.; Lopez-Albors, O.] Univ Murcia, Fac Vet, Dept Anat & Comparat Pathol, Murcia, Spain; [Wise, R.] Edendale Hosp, Crit Care Unit, Pietermaritzburg, South Africa; [Wise, R.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Perioperat Res Grp, Dept Anaesthet & Crit Care, Durban, South Africa; [Malbrain, M. L. N. G.] Ziekenhuis Netwerk Antwerpen, Med & Surg ICU & High Care Burn Unit, Antwerp, Belgium; [Castellanos, G.] Virgen Arrixaca Gen Univ Hosp, Dept Gen Surg, Murcia, Spain	University of Murcia; University of Kwazulu Natal; Hospital Clinico Universitario Virgen de la Arrixaca	Correa-Martin, L (corresponding author), Jesus Uson Minimally Invas Surg Ctr, Laparoscopy Dept, Caceres, Spain.	lcorrea@ccmijesususon.com	Latorre, Rafael/L-1184-2014; Sánchez Margallo, Francisco Miguel Miguel/I-5605-2019; Malbrain, Manu LNG/B-3680-2017; Albors, Octavio Lopez/D-8612-2015; PARRAGA, EDUARDO/ABB-9054-2021	Latorre, Rafael/0000-0002-3609-2790; Sánchez Margallo, Francisco Miguel Miguel/0000-0003-2138-988X; Malbrain, Manu LNG/0000-0002-1816-5255; Albors, Octavio Lopez/0000-0002-1410-1668; Correa Martin, Laura/0000-0003-4470-7924	Extremadura Regional Government through the Plan Regional de Investigacion de Extremadura [PRI09A161]	Extremadura Regional Government through the Plan Regional de Investigacion de Extremadura	This work was supported by one grant from Extremadura Regional Government through the Plan Regional de Investigacion de Extremadura (PRI09A161 to Minimally Invasive Surgery Center Jesus Uson). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameloot K, 2012, SURG CLIN N AM, V92, P207, DOI 10.1016/j.suc.2012.01.009; [Anonymous], GUID EUTH AN; Baigorri-Gonzalez F, 2005, OXIGENACION TISULAR, V29; Balogh Z, 2003, ARCH SURG-CHICAGO, V138, P637, DOI 10.1001/archsurg.138.6.637; Cheatham ML, 2007, ACTA CLIN BELG, V62, P98, DOI 10.1179/acb.2007.62.s1.013; Cheatham ML, 2007, INTENS CARE MED, V33, P951, DOI 10.1007/s00134-007-0592-4; Cheatham ML, 2000, J TRAUMA, V49, P621, DOI 10.1097/00005373-200010000-00008; Correa-Martin L, 2013, ACTAS UROL ESP, V37, P273, DOI 10.1016/j.acuro.2012.06.001; Correa-Martin L, 2014, GASTROENT HEPAT-BARC, V37, P51, DOI 10.1016/j.gastrohep.2013.08.002; Correa-Martin L, 2013, J SURG RES, V184, P1028, DOI 10.1016/j.jss.2013.04.041; de Laet I E, 2007, Med Intensiva, V31, P88; de Tomas J TF, 2001, CIR ESPAN, P129; Deenichin GP, 2008, SURG TODAY, V38, P5, DOI 10.1007/s00595-007-3573-x; Diaz F DA, 2012, CONSECUENCIAS HEMODI, V83, P454; DIEBEL L, 1992, AM SURGEON, V58, P573; DIEBEL LN, 1992, J TRAUMA, V33, P279, DOI 10.1097/00005373-199208000-00019; Duperret S, 2007, INTENS CARE MED, V33, P163, DOI 10.1007/s00134-006-0412-2; El-Awady SI, 2009, ACTA CIR BRAS, V24, P98, DOI 10.1590/S0102-86502009000200005; Fauci B, 2008, MED INTERNA; Giardino R., 1993, Bollettino Societa Italiana Biologia Sperimentale, V69, P625; Gudmundsson FF, 2001, SURG ENDOSC, V15, P854, DOI 10.1007/s004640090090; Holodinsky JK, 2013, CRIT CARE, V17, DOI 10.1186/cc13075; Jacques D, 2011, CRIT CARE, V15, DOI 10.1186/cc9980; Kaussen T, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-S1-S17; Ke L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033125; Kirkpatrick AW, 2013, INTENS CARE MED, V39, P1190, DOI 10.1007/s00134-013-2906-z; Kucuk HF, 2010, ULUS TRAVMA ACIL CER, V16, P349; Laurell H, 2006, ANTICANCER RES, V26, P3675; Lee RK, 2012, CRIT CARE NURSE, V32, P19, DOI 10.4037/ccn2012662; Leite R, 2010, ACTA CIR BRAS, V25, P2, DOI 10.1590/S0102-86502010000100003; Lopez-Kostner F, 1997, SURG CLIN N AM, V77, P1265, DOI 10.1016/S0039-6109(05)70617-4; Madl C, 2003, BEST PRACT RES CL GA, V17, P445, DOI 10.1016/S1521-6918(03)00022-2; Makinen MT, 2001, CAN J ANAESTH, V48, P121; Malbrain M, 2009, F1000 MED REP, V1; Malbrain MLNG, 2008, MINERVA ANESTESIOL, V74, P657; Malbrain MLNG, 2014, MINERVA ANESTESIOL, V80, P293; Malbrain MLNG, 2006, INTENS CARE MED, V32, P1722, DOI 10.1007/s00134-006-0349-5; Malbrain MLNG, 2009, CLIN CHEST MED, V30, P45, DOI 10.1016/j.ccm.2008.09.003; Malbrain MLNG, 2009, CRIT CARE MED, V37, P781, DOI 10.1097/CCM.0b013e318194c397; Malbrain ML, 2002, ABDOMINAL PERFUSION; Malbrain MLNG, 2005, CRIT CARE MED, V33, P315, DOI 10.1097/01.CCM.0000153408.09806.1B; Malbrain MLNG, 2004, INTENS CARE MED, V30, P357, DOI 10.1007/s00134-003-2107-2; Markogiannakis H, 2007, WORLD J GASTROENTERO, V13, P432, DOI 10.3748/wjg.v13.i3.432; Vivas AM, 2008, ENFERM INTENSIV, V19, P132, DOI 10.1016/S1130-2399(08)72755-X; Otto J, 2010, SHOCK, V33, P639, DOI 10.1097/SHK.0b013e3181cb8be0; PATTILLO JC, 2004, REV CHIL MED INTENSI, V19, P7; Pelosi P, 2007, ACTA CLIN BELG, V62, P78, DOI 10.1179/acb.2007.62.s1.011; Piacentini E, 2010, ENFERM INFEC MICR CL, V28, P2, DOI 10.1016/S0213-005X(10)70024-0; Pittner A, 2002, ANESTH ANALG, V94, P1510, DOI 10.1097/00000539-200206000-00025; Renner J, 2009, CRIT CARE MED, V37, P650, DOI 10.1097/CCM.0b013e3181959864; Sanchez-Miralles A, 2013, MED INTENSIVA, V37, P99, DOI 10.1016/j.medin.2011.11.019; Schachtrupp A, 2007, ACTA CLIN BELG, V62, P225, DOI 10.1179/acb.2007.62.s1.031; Schachtrupp A, 2002, J SURG RES, V106, P37, DOI 10.1006/jsre.2002.6421; Sugrue M, 1996, WORLD J SURG, V20, P988, DOI 10.1007/s002689900149; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Swindle MM, 1998, SACAND J LAB ANIM SC, V25; Toens C, 2002, SHOCK, V18, P316, DOI 10.1097/00024382-200210000-00005; van Noord D, 2011, DIGEST DIS SCI, V56, P506, DOI 10.1007/s10620-010-1303-5; Walters Eric M, 2013, Mo Med, V110, P212; Wu CC, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-39; Yuan ML, 2013, WORLD J GASTROENTERO, V19, P692, DOI 10.3748/wjg.v19.i5.692; Zanoni FL, 2009, CLINICS, V64, P911, DOI 10.1590/S1807-59322009000900013	63	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148058	10.1371/journal.pone.0148058	http://dx.doi.org/10.1371/journal.pone.0148058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849559	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000035
J	Davillas, A; Benzeval, M; Kumari, M				Davillas, Apostolos; Benzeval, Michaela; Kumari, Meena			Association of Adiposity and Mental Health Functioning across the Lifespan: Findings from Understanding Society (The UK Household Longitudinal Study)	PLOS ONE			English	Article							BODY-MASS INDEX; QUALITY-OF-LIFE; GENERAL-POPULATION; JOLLY FAT; OBESITY; DEPRESSION; OVERWEIGHT; METAANALYSIS; ADULTS; DISORDERS	Background Evidence on the adiposity-mental health associations is mixed, with studies finding positive, negative or no associations, and less is known about how these associations may vary by age. Objective To examine the association of adiposity -body mass index (BMI), waist circumference (WC) and percentage body fat (BF%)-with mental health functioning across the adult lifespan. Methods Data from 11,257 participants (aged 18+) of Understanding Society: the UK Household Longitudinal Study (waves 2 and 3, 5/2010-7/2013) were employed. Regressions of mental health functioning, assessed by the Mental Component Summary (MCS-12) and the General Health Questionnaire (GHQ-12), on adiposity measures (continuous or dichotomous indicators) were estimated adjusted for covariates. Polynomial age-adiposity interactions were estimated. Results Higher adiposity was associated with poorer mental health functioning. This emerged in the 30s, increased up to mid-40s (all central adiposity and obesity-BF% measures) or early 50s (all BMI measures) and then decreased with age. Underlying physical health generally accounted for these associations except for central adiposity, where associations remained statistically significant from the mid-30s to50s. Cardiovascular, followed by arthritis and endocrine, conditions played the greatest role in attenuating the associations under investigation. Conclusions We found strong age-specific patterns in the adiposity-mental health functioning association that varied across adiposity measures. Underlying physical health had the dominant role in attenuating these associations. Policy makers and health professionals should target increased adiposity, mainly central adiposity, as it is a risk factor for poor mental health functioning in those aged between mid-30s to 50 years.	[Davillas, Apostolos; Benzeval, Michaela; Kumari, Meena] Univ Essex, ISER, Colchester CO4 3SQ, Essex, England; [Benzeval, Michaela] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Kumari, Meena] UCL, Dept Epidemiol & Publ Hlth, London, England	University of Essex; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of London; University College London	Kumari, M (corresponding author), Univ Essex, ISER, Colchester CO4 3SQ, Essex, England.; Kumari, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	mkumari@essex.ac.uk	Benzeval, Michaela/J-3163-2015	Benzeval, Michaela/0000-0002-0372-2098; Kumari, Meena/0000-0001-9716-1035; Davillas, Apostolos/0000-0002-6607-274X	Economic and Social Research Council; University of Essex; ESRC [ES/L009153/1, ES/N00812X/1, ES/K005146/1] Funding Source: UKRI; Economic and Social Research Council [ES/K005146/1, ES/L009153/1, ES/N00812X/1] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); University of Essex; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	MB is funded by Economic and Social Research Council and the University of Essex, MK and AD are funded by the University of Essex. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; Atlantis E, 2008, INT J OBESITY, V32, P881, DOI 10.1038/ijo.2008.54; Atlantis E, 2008, INT J OBESITY, V32, P715, DOI 10.1038/sj.ijo.0803762; BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; Bjerkeset O, 2008, AM J EPIDEMIOL, V167, P193, DOI 10.1093/aje/kwm280; Bowling A., 1991, MEASURING HLTH REV Q; Cash TF., 2004, BODY IMAGE, V1, P363, DOI [10.1016/j.bodyim.2004.10.001, DOI 10.1016/J.B0DYIM.2004.10.001, DOI 10.1016/J.BODYIM.2004.10.001]; Clarke LH, 2011, CAN J AGING, V30, P495, DOI 10.1017/S0714980811000274; CRISP AH, 1976, BRIT MED J, V1, P7, DOI 10.1136/bmj.1.6000.7; Dalal DK, 2012, ORGAN RES METHODS, V15, P339, DOI 10.1177/1094428111430540; de Wit L, 2010, PSYCHIAT RES, V178, P230, DOI 10.1016/j.psychres.2009.04.015; Doll HA, 2000, OBES RES, V8, P160, DOI 10.1038/oby.2000.17; Epel ES, 2000, PSYCHOSOM MED, V62, P623, DOI 10.1097/00006842-200009000-00005; Faith MS, 2002, J PSYCHOSOM RES, V53, P935, DOI 10.1016/S0022-3999(02)00308-2; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Han TS, 1998, AM J PUBLIC HEALTH, V88, P1814, DOI 10.2105/AJPH.88.12.1814; He Y, 2008, PSYCHOL MED, V38, P1639, DOI 10.1017/S0033291707002474; Heo M, 2006, INT J OBESITY, V30, P513, DOI 10.1038/sj.ijo.0803122; Joynt KE, 2003, BIOL PSYCHIAT, V54, P248, DOI 10.1016/S0006-3223(03)00568-7; Knies G., 2014, UNDERSTANDING SOC UK; Larsson U, 2002, INT J OBESITY, V26, P417, DOI 10.1038/sj.ijo.0801919; Linke SE, 2009, ARCH GEN PSYCHIAT, V66, P499, DOI 10.1001/archgenpsychiatry.2009.27; Lynn P., 2012, UNDERSTANDING SOC WO; Magallares A, 2014, APPL RES QUAL LIFE, V9, P295, DOI 10.1007/s11482-013-9226-x; Marijnissen RM, 2011, J AM GERIATR SOC, V59, P67, DOI 10.1111/j.1532-5415.2010.03228.x; Mcdowell I., 2006, MEASURING HLTH GUIDE, V3, P37, DOI [DOI 10.1093/ACPROF:OSO/9780195165678.001.0001, 10.1093/acprof:oso/9780195165678.001.0001]; McFall S., 2014, UNDERSTANDING SOC UK; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Oswald A., 2007, ECON J, DOI DOI 10.1111/J.1468-0297.2007.02077_1.X; Palinkas LA, 1996, J PSYCHOSOM RES, V40, P59, DOI 10.1016/0022-3999(95)00542-0; Panel NOEIE, 1998, CLIN GUIDELINES IDEN; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Propper C, 2005, SOC SCI MED, V61, P2065, DOI 10.1016/j.socscimed.2005.04.013; Puhl RM, 2008, INT J OBESITY, V32, P992, DOI 10.1038/ijo.2008.22; Rivenes AC, 2009, J PSYCHOSOM RES, V66, P269, DOI 10.1016/j.jpsychores.2008.07.012; Rogol AD, 2002, J ADOLESCENT HEALTH, V31, P192, DOI 10.1016/S1054-139X(02)00485-8; ROSS CE, 1994, J HEALTH SOC BEHAV, V35, P63, DOI 10.2307/2137335; Stata Corp, 2013, STAT STAT SOFTW REL; Sturm R, 2002, HEALTH AFFAIR, V21, P245, DOI 10.1377/hlthaff.21.2.245; Ul-Haq Z, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-153; Ul-Haq Z, 2014, J EPIDEMIOL COMMUN H, V68, P340, DOI 10.1136/jech-2013-203077; Ul-Haq Z, 2013, OBESITY, V21, pE322, DOI 10.1002/oby.20107; University of Essex. Institute for Social and Economic Research and National Centre for Social Research. Understanding Society, 2014, UND SOC WAV 2 3 NURS; University of Essex. Institute for Social and Economic Research and National Centre for Social Research. Understanding Society, 2009, UND SOC WAV 1 5, P1; Ware J. E. J., 2002, SCORE VERSION 2 SF 1; WHO, 2000, OB PREV MAN GLOB EP; World Health Organization, 2003, INV MENT HLTH; Xu QY, 2011, OBES RES CLIN PRACT, V5, pE267, DOI 10.1016/j.orcp.2011.04.007	50	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148561	10.1371/journal.pone.0148561	http://dx.doi.org/10.1371/journal.pone.0148561			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26849046	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000369554000126
J	Shen, LY; Chen, L; Zhang, SH; Du, JJ; Bai, L; Zhang, Y; Jiang, YZ; Li, XW; Wang, JY; Zhu, L				Shen, Linyuan; Chen, Lei; Zhang, Shunhua; Du, Jingjing; Bai, Lin; Zhang, Yi; Jiang, Yanzhi; Li, Xuewei; Wang, Jinyong; Zhu, Li			MicroRNA-27b Regulates Mitochondria Biogenesis in Myocytes	PLOS ONE			English	Article							MUSCLE FIBER-TYPE; SKELETAL-MUSCLE; OVEREXPRESSION; PGC-1-ALPHA; ACTIVATION; MEF2C; RNA	MicroRNAs (miRNAs) are small, non-coding RNAs that affect the post-transcriptional regulation of various biological pathways. To date, it is not fully understood how miRNAs regulate mitochondrial biogenesis. This study aimed at the identification of the role of miRNA-27b in mitochondria biogenesis. The mitochondria content in C2C12 cells was significantly increased during myogenic differentiation and accompanied by a marked decrease of miRNA-27b expression. Furthermore, the expression of the predicted target gene of miRNA-27b, forkhead box j3 (Foxj3), was also increased during myogenic differentiation. Luciferase activity assays confirmed that miRNA-27b directly targets the 3'-untranslated region (3'-UTR) of Foxj3. Overexpression of miRNA-27b provoked a decrease of mitochondria content and diminished expression of related mitochondrial genes and Foxj3 both at mRNA and protein levels. The expression levels of downstream genes of Foxj3, such as Mef2c, PGC1 alpha, NRF1 and mtTFA, were also decreased in C2C12 cells upon overexpression of miRNA-27b. These results suggested that miRNA-27b may affect mitochondria biogenesis by down-regulation of Foxj3 during myocyte differentiation.	[Shen, Linyuan; Zhang, Shunhua; Du, Jingjing; Bai, Lin; Li, Xuewei; Zhu, Li] Sichuan Agr Univ, Coll Anim Sci & Technol, Chengdu 611130, Sichuan, Peoples R China; [Chen, Lei; Wang, Jinyong] Chongqing Acad Anim Sci, Chongqing 402460, Peoples R China; [Zhang, Yi] Xichang Coll, Dept Anim Sci, Xichang 615000, Sichuan, Peoples R China; [Jiang, Yanzhi] Sichuan Agr Univ, Dept Biol, Coll Life & Sci, Chengdu 611130, Sichuan, Peoples R China	Sichuan Agricultural University; Xichang College; Sichuan Agricultural University	Zhu, L (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Chengdu 611130, Sichuan, Peoples R China.; Wang, JY (corresponding author), Chongqing Acad Anim Sci, Chongqing 402460, Peoples R China.	kingyou@vip.sina.com; zhuli7508@163.com	Du, Jingjing/X-4006-2019	Shen, Linyuan/0000-0001-6072-3268	Sichuan Sci & Tech Support Program [2013NZ0041, 2013NZ0056]; earmarked fund for China Agriculture Research System [CARS-36-05B]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13083]	Sichuan Sci & Tech Support Program; earmarked fund for China Agriculture Research System; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	The study was supported by the Sichuan Sci & Tech Support Program (No. 2013NZ0041 and 2013NZ0056), the earmarked fund for China Agriculture Research System (No. CARS-36-05B), and Program for Changjiang Scholars and Innovative Research Team in University (No. IRT13083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MS, 2010, DEV BIOL, V337, P396, DOI 10.1016/j.ydbio.2009.11.015; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Chinchilla A, 2010, CARDIOVASC RES; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Gao YR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082782, 10.1371/journal.pone.0075065]; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Hou Ning, 2012, Yichuan, V34, P326, DOI 10.3724/SP.J.1005.2012.00326; Kang T, 2013, J BIOL CHEM, V288, P34394, DOI 10.1074/jbc.M113.514372; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu YK, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; May-Panloup P, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-65; Menshikova EV, 2005, AM J PHYSIOL-ENDOC M, V288, pE818, DOI 10.1152/ajpendo.00322.2004; Menzies FM, 2002, NEUROCHEM INT, V40, P543, DOI 10.1016/S0197-0186(01)00125-5; Ngamsiri P, 2014, MITOCHONDRION, V14, P54, DOI 10.1016/j.mito.2013.11.003; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Russell AP, 2014, BBA-GEN SUBJECTS, V1840, P1276, DOI 10.1016/j.bbagen.2013.11.016; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Shum AMY, 2012, AGING-US, V4, P133, DOI 10.18632/aging.100436; Sierra V, 2013, RECENT PATENTS ENDOC, V7, P120, DOI 10.2174/1872214811307020005; Singh K, 2013, FEBS J, V280, P3991, DOI 10.1111/febs.12188; Tak H, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.73; Wang J, 2012, CELL RES, V22, P516, DOI 10.1038/cr.2011.132; Wang K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1770; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamamoto H, 2012, AM J PHYSIOL-ENDOC M, V303, pE1419, DOI 10.1152/ajpendo.00097.2012; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	34	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148532	10.1371/journal.pone.0148532	http://dx.doi.org/10.1371/journal.pone.0148532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849429	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000118
J	Bosch, M; Tavender, EJ; Brennan, SE; Knott, J; Gruen, RL; Green, SE				Bosch, Marije; Tavender, Emma J.; Brennan, Sue E.; Knott, Jonathan; Gruen, Russell L.; Green, Sally E.			The Many Organisational Factors Relevant to Planning Change in Emergency Care Departments: A Qualitative Study to Inform a Cluster Randomised Controlled Trial Aiming to Improve the Management of Patients with Mild Traumatic Brain Injuries	PLOS ONE			English	Article							HEALTH-CARE; KNOWLEDGE TRANSLATION; PROMOTING ACTION; IMPLEMENTATION; FRAMEWORK; GUIDELINES; INNOVATION; DIFFUSION; SERVICES; PROFESSIONALS	Background The Neurotrauma Evidence Translation (NET) Trial aims to design and evaluate the effectiveness of a targeted theory-and evidence-informed intervention to increase the uptake of evidence-based recommended practices for the management of patients who present to an emergency department (ED) with mild head injuries. When designing interventions to bring about change in organisational settings such as the ED, it is important to understand the impact of the context to ensure successful implementation of practice change. Few studies explicitly use organisational theory to study which factors are likely to be most important to address when planning change processes in the ED. Yet, this setting may have a unique set of organisational pressures that need to be taken into account when implementing new clinical practices. This paper aims to provide an in depth analysis of the organisational context in which ED management of mild head injuries and implementation of new practices occurs, drawing upon organisational level theory. Methods Semi-structured interviews were conducted with ED staff in Australia. The interviews explored the organisational context in relation to change and organisational factors influencing the management of patients presenting with mild head injuries. Two researchers coded the interview transcripts using thematic content analysis. The "model of diffusion in service organisations" was used to guide analyses and organisation of the results. Results Nine directors, 20 doctors and 13 nurses of 13 hospitals were interviewed. With regard to characteristics of the innovation (i.e. the recommended practices) the most important factor was whether they were perceived as being in line with values and needs. Tension for change (the degree to which stakeholders perceive the current situation as intolerable or needing change) was relatively low for managing acute mild head injury symptoms, and mixed for managing longer-term symptoms (higher change commitment, but relatively low change efficacy). Regarding implementation processes, the importance of (visible) senior leadership for all professions involved was identified as a critical factor. An unpredictable and hectic environment brings challenges in creating an environment in which team-based and organisational learning can thrive (system antecedents for innovation). In addition, the position of the ED as the entry-point of the hospital points to the relevance of securing buy-in from other units. Conclusions We identified several organisational factors relevant to realising change in ED management of patients who present with mild head injuries. These factors will inform the intervention design and process evaluation in a trial evaluating the effectiveness of our implementation intervention.	[Bosch, Marije; Tavender, Emma J.; Gruen, Russell L.] Monash Univ, Cent Clin Sch, Dept Surg, Melbourne, Vic 3004, Australia; [Bosch, Marije; Tavender, Emma J.; Gruen, Russell L.] Monash Univ, Natl Trauma Res Inst, Alfred, Melbourne, Vic 3004, Australia; [Brennan, Sue E.; Green, Sally E.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Knott, Jonathan] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic, Australia; [Knott, Jonathan] Royal Melbourne Hosp, Dept Emergency Med, Melbourne, Vic, Australia; [Gruen, Russell L.] Alfred Hosp, Alfred Trauma Serv, Melbourne, Vic, Australia; [Gruen, Russell L.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore	Monash University; Monash University; Monash University; University of Melbourne; Royal Melbourne Hospital; Florey Institute of Neuroscience & Mental Health; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Bosch, M (corresponding author), Monash Univ, Cent Clin Sch, Dept Surg, Melbourne, Vic 3004, Australia.; Bosch, M (corresponding author), Monash Univ, Natl Trauma Res Inst, Alfred, Melbourne, Vic 3004, Australia.	marije.bosch@monash.edu		Green, Sally Elizabeth/0000-0002-9564-9050; Tavender, Emma/0000-0002-7230-712X; Brennan, Sue/0000-0003-1789-8809	Transport Accident Commission (TAC), Australia [D166]; Australian Postgraduate Award	Transport Accident Commission (TAC), Australia; Australian Postgraduate Award(Australian Government)	The NET Program is funded by the Transport Accident Commission (TAC), Australia (grant number D166, RLG, SEG, JK); https://www.tac.vic.gov.au/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EJT is supported by an Australian Postgraduate Award.	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Alves W, 1993, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Anderson NR, 1998, J ORGAN BEHAV, V19, P235, DOI 10.1002/(SICI)1099-1379(199805)19:3<235::AID-JOB837>3.3.CO;2-3; Angus D, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-4; [Anonymous], FACTORS THEORIES BEH; Armenakis AA, 1999, RES ORGAN C, V12, P97; Ashford AJ, 1998, BEHAV CHANGE PROFESS; Australian Bureau of Statistics, 2011, 1216 0 AUSTR STAT GE; Baker DP, 2006, HEALTH SERV RES, V41, P1576, DOI 10.1111/j.1475-6773.2006.00566.x; Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bosch M, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-281; Boudreaux ED, 2009, ACAD EMERG MED, V16, P1120, DOI 10.1111/j.1553-2712.2009.00543.x; Buetow S, 2010, J HEALTH SERV RES PO, V15, P123, DOI 10.1258/jhsrp.2009.009081; Casalino L, 2003, JAMA-J AM MED ASSOC, V289, P434, DOI 10.1001/jama.289.4.434; Chaix-Couturier C, 2000, INT J QUAL HEALTH C, V12, P133, DOI 10.1093/intqhc/12.2.133; Chassin MR, 2010, NEW ENGL J MED, V363, P683, DOI 10.1056/NEJMsb1002320; Compton S, 2007, ACAD EMERG MED, V14, P991, DOI 10.1197/j.aem.2007.06.031; Croskerry P, 2000, ACAD EMERG MED, V7, P1232, DOI 10.1111/j.1553-2712.2000.tb00468.x; Curran J, 2007, COCHRANE DB SYST REV; Dalrymple PW, 2010, HEALTH INFORM J, V16, P177, DOI 10.1177/1460458210377469; DAMANPOUR F, 1991, ACAD MANAGE J, V34, P555, DOI 10.2307/256406; Ferlie E, 2005, ACAD MANAGE J, V48, P117, DOI [10.5465/amj.2005.15993150, 10.2307/20159644]; Ferlie EB, 2001, MILBANK Q, V79, P281, DOI 10.1111/1468-0009.00206; Flodgren G, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000125.pub4, 10.1002/14651858.CD000125]; Foy R, 2002, J CLIN EPIDEMIOL, V55, P717, DOI 10.1016/S0895-4356(02)00403-1; Foy R, 2011, BMJ QUAL SAF, V20, P453, DOI 10.1136/bmjqs.2010.047993; Frambach RT, 2002, J BUS RES, V55, P163, DOI 10.1016/S0148-2963(00)00152-1; Francis JJ, 2009, PSYCHOL HEALTH, V22, P1; French B, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-28; Garavelli AC, 2002, TECHNOVATION, V22, P269, DOI 10.1016/S0166-4972(01)00009-8; Gershon RRM, 2004, J NURS ADMIN, V34, P33, DOI 10.1097/00005110-200401000-00008; Green SE, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-74; Greenfield D, 2011, BMJ QUAL SAF, V20, P332, DOI 10.1136/bmjqs.2010.044545; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; GRILLI R, 1994, MED CARE, V32, P202, DOI 10.1097/00005650-199403000-00002; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Gruen RL, 2012, BRIT J SURG, V99, P97, DOI 10.1002/bjs.7754; Ham C, 2003, LANCET, V361, P1978, DOI 10.1016/S0140-6736(03)13593-3; Helfrich CD, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-82; Helfrich CD, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-38; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Holroyd BR, 2007, ACAD EMERG MED, V14, P942, DOI 10.1197/j.aem.2007.06.023; Holt DT, 2010, J GEN INTERN MED, V25, P50, DOI 10.1007/s11606-009-1112-8; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kitson A, 1998, QUAL HEALTH CARE, V7, P149, DOI 10.1136/qshc.7.3.149; Kitson AL, 2009, J ADV NURS, V65, P217, DOI 10.1111/j.1365-2648.2008.04864.x; Klein KJ, 1996, ACAD MANAGE REV, V21, P1055, DOI 10.2307/259164; Kuper A, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1035; Lemieux-Charles L, 2006, MED CARE RES REV, V63, P263, DOI 10.1177/1077558706287003; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Makowsky MJ, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-109; McDonald R, 2005, QUAL SAF HEALTH CARE, V14, P290, DOI 10.1136/qshc.2005.013912; McMullen H, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0755-5; Meurer WJ, 2011, BMC EMERG MED, P11; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Muntlin A, 2010, J EMERG NURS, V36, P317, DOI 10.1016/j.jen.2009.09.003; Murray E, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-63; Musacchio NS, 2009, J ADOLESCENT HEALTH, V44, P81, DOI 10.1016/j.jadohealth.2008.05.011; NEVIS EC, 1995, SLOAN MANAGE REV, V36, P73; Nilsen P, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0242-0; Nugus P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5201; Ortenblad A, 2002, MANAGE LEARN, V33, P213, DOI 10.1177/1350507602332004; Ovretveit J, 2008, INT J CLIN LEADER, V16, P9; Ovretveit J., 2009, LEADING IMPROVEMENT; Pham JC, 2007, ACAD EMERG MED, V14, P856, DOI 10.1197/j.aem.2007.06.035; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Quiros D, 2007, HEART LUNG, V36, P287, DOI 10.1016/j.hrtlng.2006.08.005; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Rousseau V, 2006, SMALL GR RES, V37, P540, DOI 10.1177/1046496406293125; Roy PM, 2006, ANN INTERN MED, V144, P157, DOI 10.7326/0003-4819-144-3-200602070-00003; Rycroft-Malone J, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-28; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P42, DOI 10.1017/S0317167100006296; Sandelowski M, 2000, RES NURS HEALTH, V23, P246, DOI 10.1002/1098-240X(200006)23:3<246::AID-NUR9>3.0.CO;2-H; Scott SD, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-65; Scott Tim, 2003, J Health Serv Res Policy, V8, P105, DOI 10.1258/135581903321466085; Scott W R, 1990, Med Care Rev, V47, P165, DOI 10.1177/107755879004700203; Stetler CB, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-30; Stuart B, 2012, J EMERG NURS, V38, P435, DOI 10.1016/j.jen.2011.04.006; Tavender EJ, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0264-7; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Weiner BJ, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-78; West E, 1999, SOC SCI MED, V48, P633, DOI 10.1016/S0277-9536(98)00361-X; West E, 2005, CAN J NURS RES, V37, P132; Yang B., 2004, HRDQ, V15, P23; Zwarenstein M, 2006, J CONTIN EDUC HEALTH, V26, P46, DOI 10.1002/chp.50	88	9	9	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148091	10.1371/journal.pone.0148091	http://dx.doi.org/10.1371/journal.pone.0148091			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PF	26845772	Green Published, gold			2022-12-27	WOS:000369552800028
J	Contreras, M; Riveros, ME; Quispe, M; Sanchez, C; Perdomo, G; Torrealba, F; Valdes, JL				Contreras, Marco; Riveros, Maria E.; Quispe, Maricel; Sanchez, Cristian; Perdomo, Guayec; Torrealba, Fernando; Valdes, Jose L.			The Histaminergic Tuberomamillary Nucleus Is Involved in Appetite for Sex, Water and Amphetamine	PLOS ONE			English	Article							TUBEROMAMMILLARY NUCLEUS; HYPOTHALAMIC NEURONS; HISTIDINE-DECARBOXYLASE; NERVOUS-SYSTEM; MECHANISMS; BEHAVIOR; MICE; H-1; RESPONSES; INSIGHTS	The histaminergic system is one component of the ascending arousal system which is involved in wakefulness, neuroendocrine control, cognition, psychiatric disorders and motivation. During the appetitive phase of motivated behaviors the arousal state rises to an optimal level, thus giving proper intensity to the behavior. Previous studies have demonstrated that the histaminergic neurons show an earlier activation during the appetitive phase of feeding, compared to other ascending arousal system nuclei, paralleled with a high increase in arousal state. Lesions restricted to the histaminergic neurons in rats reduced their motivation to get food even after 24h of food deprivation, compared with intact or sham lesioned rats. Taken together, these findings indicate that the histaminergic system is important for appetitive behavior related to feeding. However, its role in other goal-directed behaviors remains unexplored. In the present work, male rats rendered motivated to obtain water, sex, or amphetamine showed an increase in Fos-ir of histaminergic neurons in appetitive behaviors directed to get those reinforcers. However, during appetitive tests to obtain sex, or drug in amphetamine-conditioned rats, Fos expression increased in most other ascending arousal system nuclei, including the orexin neurons in the lateral hypothalamus, dorsal raphe, locus coeruleus and laterodorsal tegmental neurons, but not in the ventral tegmental area, which showed no Fos-ir increase in any of the 3 conditions. Importantly, all these appetitive behaviors were drastically reduced after histaminergic cell-specific lesion, suggesting a critical contribution of histamine on the intensity component of several appetitive behaviors.	[Contreras, Marco; Riveros, Maria E.; Quispe, Maricel; Perdomo, Guayec; Torrealba, Fernando] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ciencias Fisiol, Alameda 340, Santiago, Chile; [Sanchez, Cristian; Valdes, Jose L.] Univ Chile, Fac Med, Programa Disciplinario Fisiol & Biofis, BNI,Biomedical Neurosci Inst,ICBM, Independencia 1027, Santiago 7, Chile; [Riveros, Maria E.] Clin Alemana Univ Desarrollo, Fac Med, Ctr Fisiol Celular Integrat, Santiago, Chile; [Valdes, Jose L.] Univ Chile, Fac Med, ICBM, Programa Disciplinario Fisiol & Biofis, Independencia 1027, Santiago 7, Chile	Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad del Desarrollo; Universidad de Chile	Valdes, JL (corresponding author), Univ Chile, Fac Med, Programa Disciplinario Fisiol & Biofis, BNI,Biomedical Neurosci Inst,ICBM, Independencia 1027, Santiago 7, Chile.; Valdes, JL (corresponding author), Univ Chile, Fac Med, ICBM, Programa Disciplinario Fisiol & Biofis, Independencia 1027, Santiago 7, Chile.	jlvaldes@med.uchile.cl		Perdomo Martin, Guayec/0000-0001-7783-9160; Valdes, Jose L/0000-0002-9178-2743; riveros, maria/0000-0002-0926-8535	Fondecyt [1130042]; Programa de Investigacion Asociativa, Anillos [ACT_66]; Iniciativa Cientifica Milenio, Ministerio de Economia [ICM-P10-063-F, ICM-P10-001-F]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa de Investigacion Asociativa, Anillos; Iniciativa Cientifica Milenio, Ministerio de Economia	This work was supported by: Fondecyt grant number 1130042, http://www.conicyt.cl/fondecyt/ (FT); Programa de Investigacion Asociativa, Anillos grant number ACT_66 (JLV, FT), http://www.conicyt.cl/pia/; Iniciativa Cientifica Milenio, Ministerio de Economia, grant number ICM-P10-063-F & ICM-P10-001-F, http://www.iniciativamilenio.cl/ (FT & JLV respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aston-Jones G, 2000, PROG BRAIN RES, V126, P165; ASTONJONES G, 1986, SCIENCE, V234, P734, DOI 10.1126/science.3775363; Ball GF, 2008, HORM BEHAV, V53, P307, DOI 10.1016/j.yhbeh.2007.09.023; Berlucchi G, 1997, ARCH ITAL BIOL, V135, P5; Brabant C, 2010, PROG NEUROBIOL, V92, P421, DOI 10.1016/j.pneurobio.2010.07.002; Contreras M, 2007, SCIENCE, V318, P655, DOI 10.1126/science.1145590; Craig W, 1917, P NATL ACAD SCI USA, V3, P685, DOI 10.1073/pnas.3.12.685; Dere E, 2004, REV NEUROSCIENCE, V15, P231; DONOSO AO, 1979, PSYCHOPHARMACOLOGY, V66, P251, DOI 10.1007/BF00428315; DUFORT RH, 1966, PSYCHOL REP, V18, P148, DOI 10.2466/pr0.1966.18.1.148; Dupre C, 2010, P NATL ACAD SCI USA, V107, P12311, DOI 10.1073/pnas.1006049107; Gerashchenko D, 2004, SLEEP, V27, P1275, DOI 10.1093/sleep/27.7.1275; HEBB DO, 1955, PSYCHOL REV, V62, P243, DOI 10.1037/h0041823; Inoue I, 1996, P NATL ACAD SCI USA, V93, P13316, DOI 10.1073/pnas.93.23.13316; Inzunza O, 2000, NEUROSCI LETT, V293, P139, DOI 10.1016/S0304-3940(00)01516-0; LEIBOWITZ SF, 1973, BRAIN RES, V63, P440; LEPETIT P, 1988, NEUROENDOCRINOLOGY, V48, P271, DOI 10.1159/000125022; Valdes JL, 2010, EUR J NEUROSCI, V31, P2073, DOI 10.1111/j.1460-9568.2010.07241.x; Magrani J, 2005, PHYSIOL BEHAV, V84, P233, DOI 10.1016/j.physbeh.2004.11.010; Magrani J, 2004, PHARMACOL BIOCHEM BE, V79, P189, DOI 10.1016/j.pbb.2004.07.004; Mahia J, 2006, EUR J NEUROSCI, V23, P1321, DOI 10.1111/j.1460-9568.2006.04644.x; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Nielsen BL, 2013, PHYSIOL BEHAV, V120, P150, DOI 10.1016/j.physbeh.2013.07.012; Orihuela PA, 1999, BIOL REPROD, V60, P908, DOI 10.1095/biolreprod60.4.908; Panula P, 2011, J PHARMACOL EXP THER, V336, P9, DOI 10.1124/jpet.110.170928; Parmentier R, 2002, J NEUROSCI, V22, P7695; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pfaff D, 2008, ANN NY ACAD SCI, V1129, P11, DOI 10.1196/annals.1417.019; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; Robbins Trevor W., 1995, P703; Rowland NE, 1998, NEUROSCI BIOBEHAV R, V23, P49, DOI 10.1016/S0149-7634(97)00068-7; SENBA E, 1985, J NEUROSCI, V5, P3393; Sherrington C.S., 1906, INTEGRATIVE ACTION N, Vfirst, DOI 10.1037/13798-000; Toth LA, 2000, CONTEMP TOP LAB ANIM, V39, P9; Valdes JL, 2005, EUR J NEUROSCI, V21, P1931, DOI 10.1111/j.1460-9568.2005.04013.x; Zhou J, 2007, J NEUROPHYSIOL, V98, P3143, DOI 10.1152/jn.00337.2007	36	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148484	10.1371/journal.pone.0148484	http://dx.doi.org/10.1371/journal.pone.0148484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845170	Green Published, gold			2022-12-27	WOS:000369552800063
J	Salazar, RD; Montgomery, RA; Thresher, SE; Macdonald, DW				Salazar, Rosie D.; Montgomery, Robert A.; Thresher, Sarah E.; Macdonald, David W.			Mapping the Relative Probability of Common Toad Occurrence in Terrestrial Lowland Farm Habitat in the United Kingdom	PLOS ONE			English	Article							RESOURCE SELECTION FUNCTIONS; BUFO-BUFO; BODY CONDITION; LANDSCAPE CHARACTERISTICS; AMPHIBIAN POPULATIONS; GENETIC DIVERSITY; HIBERNATION SITES; SPECIES RICHNESS; ANAXYRUS-BOREAS; POND OCCUPANCY	Introduction The common toad (Bufo bufo) is of increasing conservation concern in the United Kingdom (UK) due to dramatic population declines occurring in the past century. Many of these population declines coincided with reductions in both terrestrial and aquatic habitat availability and quality and have been primarily attributed to the effect of agricultural land conversion (of natural and semi-natural habitats to arable and pasture fields) and pond drainage. However, there is little evidence available to link habitat availability with common toad population declines, especially when examined at a broad landscape scale. Assessing such patterns of population declines at the landscape scale, for instance, require an understanding of how this species uses terrestrial habitat. Methods We intensively studied the terrestrial resource selection of a large population of common toads in Oxfordshire, England, UK. Adult common toads were fitted with passive integrated transponder (PIT) tags to allow detection in the terrestrial environment using a portable PIT antenna once toads left the pond and before going into hibernation (April/May-October 2012 and 2013). We developed a population-level resource selection function (RSF) to assess the relative probability of toad occurrence in the terrestrial environment by collecting location data for 90 recaptured toads. Results The predicted relative probability of toad occurrence for this population was greatest in wooded habitat near to water bodies; relative probability of occurrence declined dramatically >50 m from these habitats. Toads also tended to select habitat near to their breeding pond and toad occurrence was negatively related to urban environments.	[Salazar, Rosie D.; Montgomery, Robert A.; Thresher, Sarah E.; Macdonald, David W.] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit WildCRU, Tubney House,Abingdon Rd, Tubney OX13 5QL, Oxon, England; [Montgomery, Robert A.] Michigan State Univ, Dept Fisheries & Wildlife, 480 Wilson Rd,Room 13,Nat Resources Bldg, E Lansing, MI 48824 USA	University of Oxford; Michigan State University	Salazar, RD (corresponding author), Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit WildCRU, Tubney House,Abingdon Rd, Tubney OX13 5QL, Oxon, England.	rosie.salazar@zoo.ox.ac.uk	Montgomery, Robert A./C-5541-2019	Montgomery, Robert A./0000-0001-5894-0589	Patsy Wood Trust	Patsy Wood Trust	RDS received funding for tuition fees, stipend, employment costs, and college fees from Ms. Sarianne Durie (individual donor). Operational costs for fieldwork were met by the Patsy Wood Trust (www.patsywoodtrust.com). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews Kimberly M., 2008, P121; Atauri JA, 2001, LANDSCAPE ECOL, V16, P147, DOI 10.1023/A:1011115921050; Baillie J. E. M., 2004, 2004 IUCN RED LIST T; Baker J., 2011, AMPHIBIAN HABITAT MA; Bancila RI, 2010, AMPHIBIA-REPTILIA, V31, P558, DOI 10.1163/017353710X518405; BEEBEE TJC, 1981, BIOL CONSERV, V21, P127, DOI 10.1016/0006-3207(81)90075-6; Beebee TJC., 1985, FROGS TOADS; Beebee TJC, 2014, J HERPETOL, V48, P2, DOI 10.1670/12-263; Blaxter K., 1995, DEARTH PLENTY MODERN; Bonardi A, 2011, BIOL CONSERV, V144, P2328, DOI 10.1016/j.biocon.2011.06.011; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Brown LJ, 1997, J HERPETOL, V31, P410, DOI 10.2307/1565670; Browne CL, 2010, HERPETOL CONSERV BIO, V5, P49; Browne CL, 2010, HERPETOLOGICA, V66, P250, DOI 10.1655/08-071.1; Carrier JA, 2003, BIOL CONSERV, V111, P395, DOI 10.1016/S0006-3207(02)00308-7; Connette GM, 2012, WILDLIFE RES, V39, P1, DOI 10.1071/WR11055; Cucherousset J, 2005, N AM J FISH MANAGE, V25, P270, DOI 10.1577/M04-053.1; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Daversa DR, 2012, J HERPETOL, V46, P658, DOI 10.1670/11-012; Denton Jonathan S., 1992, Amphibia-Reptilia, V13, P365, DOI 10.1163/156853892X00067; DENTON JS, 1994, OECOLOGIA, V97, P390, DOI 10.1007/BF00317330; Dzialak MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026273; Elzanowski A, 2009, EUR J WILDLIFE RES, V55, P33, DOI 10.1007/s10344-008-0211-x; Findlay CS, 1997, CONSERV BIOL, V11, P1000, DOI 10.1046/j.1523-1739.1997.96144.x; Gervasi V, 2013, ECOL APPL, V23, P1722, DOI 10.1890/12-1615.1; Gibbons JW, 2004, BIOSCIENCE, V54, P447, DOI 10.1641/0006-3568(2004)054[0447:PTSTAI]2.0.CO;2; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Hartel T, 2008, APPL HERPETOL, V5, P1, DOI 10.1163/157075408783489248; Hebblewhite M, 2011, BIOL CONSERV, V144, P2403, DOI 10.1016/j.biocon.2011.03.020; HEUSSER H, 1969, Revue Suisse de Zoologie, V76, P443; HEUSSER H, 1968, Revue Suisse de Zoologie, V75, P927; Heusser H., 1958, Behaviour, V13, P208; Hitchings SP, 1998, J EVOLUTION BIOL, V11, P269, DOI 10.1046/j.1420-9101.1998.11030269.x; Hof AR, 2010, AGR ECOSYST ENVIRON, V139, P280, DOI 10.1016/j.agee.2010.08.014; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Houlahan JE, 2004, LANDSCAPE ECOL, V19, P677, DOI 10.1023/B:LAND.0000042912.87067.35; Indermaur L, 2009, ECOLOGY, V90, P3430, DOI 10.1890/08-0886.1; Janin A, 2011, BIOL CONSERV, V144, P1008, DOI 10.1016/j.biocon.2010.12.009; Janin A, 2009, J APPL ECOL, V46, P833, DOI 10.1111/j.1365-2664.2009.01665.x; Jehle R, 1998, HERPETOL J, V8, P181; Kovar R, 2009, AMPHIBIA-REPTILIA, V30, P367, DOI 10.1163/156853809788795236; Latham DM, 1997, TERRESTRIAL HABITAT; Long RA, 2009, WILDLIFE BIOL, V15, P288, DOI 10.2981/09-003; Macdonald D.W., 2000, P357; Madison DM, 2010, AMPHIBIAN ECOLOGY CO; Manly BF, 1992, RESOURCE SELECTION A; Marczak LB, 2010, ECOL APPL, V20, P126, DOI 10.1890/08-2064.1; Mazerolle MJ, 2005, ECOL APPL, V15, P824, DOI 10.1890/04-0502; Meatherby A., 2010, 707 NERC CTR EC HYDR; Millspaugh JJ, POPULATION IN PRESS; Muths E, 2014, BIOL CONSERV, V172, P200, DOI 10.1016/j.biocon.2014.02.034; Piha H, 2007, ECOL APPL, V17, P2298, DOI 10.1890/06-1509.1; Pyke Graham H., 2005, Herpetological Review, V36, P281; READING CJ, 1991, J ZOOL, V225, P201, DOI 10.1111/j.1469-7998.1991.tb03811.x; Romero J, 1996, ECOGRAPHY, V19, P305, DOI 10.1111/j.1600-0587.1996.tb01258.x; Salazar RD, 2014, DISTRIBUTION DISPERS; Scribner KT, 2001, BIOL CONSERV, V98, P201, DOI 10.1016/S0006-3207(00)00155-5; SINSCH U, 1988, OECOLOGIA, V76, P390, DOI 10.1007/BF00377034; Smith MA, 2005, ECOGRAPHY, V28, P110; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sztatecsny M, 2005, CAN J ZOOL, V83, P788, DOI [10.1139/Z05-071, 10.1139/z05-071]; Van Buskirk J, 2005, ECOLOGY, V86, P1936, DOI 10.1890/04-1237; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; WAKE DB, 1991, SCIENCE, V253, P860, DOI 10.1126/science.253.5022.860; Zanini F, 2008, CAN J ZOOL, V86, P692, DOI 10.1139/Z08-048	67	16	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148269	10.1371/journal.pone.0148269	http://dx.doi.org/10.1371/journal.pone.0148269			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841108	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200115
J	Fu, R; Noguchi, H				Fu, Rong; Noguchi, Haruko			Does Marriage Make Us Healthier? Inter-Country Comparative Evidence from China, Japan, and Korea	PLOS ONE			English	Article							URBAN CHINA; AGE 50; DISPARITIES; EDUCATION; COHORT; MEN	Objectives This study focuses on East Asian countries and investigates the difference in the marriage premium on the health-marriage protection effect (MPE) between younger and older generations and the intra-couple education concordance effect (ECE) on the health of married individuals. This study used inter-country comparative data from China, Japan, and Korea. Methods This study focused on individuals (n = 7,938) in China, Japan, and Korea who were sampled from the 2010 East Asian Social Survey. To investigate MPE and ECE, four health indicators were utilized: a physical and mental components summary (PCS and MCS), self-rated health status (Dself), and happiness level (Dhappy). Ordinary least squares regression was conducted by country-and gender-specific subsamples. Results We found that the MPE on PCS, MCS, and Dself was more significant for the older generation than for the younger generation in both China and Japan, whereas the results were inconclusive in Korea. With regard to the ECE on happiness (Dhappy), for both men and women, couples tend to be happier when both the husband and the wife are well educated ("higher balanced marriage") compared to couples with a lower level of educational achievement ("lower balanced marriage"). Significant benefits from a "higher balanced marriage" on MCS and Dself were observed for women only. In contrast, no statistically significant differences in health status were observed between "higher balanced marriage" couples and couples with different levels of educational achievements ("upward marriage" or "downward marriage"). Conclusions This study found that (1) the MPE was more significant for the older generation, and (2) the health gap, particularly the happiness gap, between higher-and lower-balanced married couples was significant. The inter-country comparative findings are useful to explain how the role of marriage (and therefore of family) on health has been diluted due to the progress of industrialization and modernization.	[Fu, Rong] Waseda Univ, Grad Sch Econ, Tokyo, Japan; [Fu, Rong] Univ Tsukuba, Fac Med, Ibaraki, Japan; [Noguchi, Haruko] Waseda Univ, Fac Polit Sci & Econ, Tokyo, Japan	Waseda University; University of Tsukuba; Waseda University	Fu, R (corresponding author), Waseda Univ, Grad Sch Econ, Tokyo, Japan.; Fu, R (corresponding author), Univ Tsukuba, Fac Med, Ibaraki, Japan.	nataliefu1988@fuji.waseda.jp	Noguchi, Haruko/ABF-3059-2020; FU, Rong/O-7293-2018	Noguchi, Haruko/0000-0002-4437-8238; FU, Rong/0000-0002-2850-1697				ANTONUCCI TC, 1987, SEX ROLES, V17, P737, DOI 10.1007/BF00287685; Bumpass Larry L., 2004, MARRIAGE WORK FAMILY, P19; Chang Kyung-Sup, 2010, S ASIAN J TOURISM HE, P1; Chang Yun-Shik, 2006, TRANSFORMATION 20 CE, P345; Cheng H, 2003, PERS INDIV DIFFER, V34, P921, DOI 10.1016/S0191-8869(02)00078-8; Chung W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104868; Dufouil C, 2000, J CLIN EPIDEMIOL, V53, P589, DOI 10.1016/S0895-4356(99)00189-4; Goldstein JR, 2001, AM SOCIOL REV, V66, P506, DOI 10.2307/3088920; GOVE WR, 1972, SOC FORCES, V51, P34, DOI 10.2307/2576129; Groot W., 2002, J HAPPINESS STUD, V3, P153, DOI [DOI 10.1023/A:1019673927286, 10.1023/A:1019673927286]; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Lantz PM, 2001, SOC SCI MED, V53, P29, DOI 10.1016/S0277-9536(00)00319-1; LILLARD LA, 1995, AM J SOCIOL, V100, P1131, DOI 10.1086/230634; MASON KO, 1976, AM SOCIOL REV, V41, P573, DOI 10.2307/2094837; National Bureau of Statistics of China, 2010, 2010 POP CENS PEOPL; Noddings N, 2003, HAPPINESS ED, P97; Perreira KM, 2002, ADDICTION, V97, P301, DOI 10.1046/j.1360-0443.2002.00067.x; Pimentel EF, 2000, J MARRIAGE FAM, V62, P32, DOI 10.1111/j.1741-3737.2000.00032.x; Retherford RD, 2001, POPUL DEV REV, V27, P65, DOI 10.1111/j.1728-4457.2001.00065.x; Retherford RD, 1996, POP STUD-J DEMOG, V50, P5, DOI 10.1080/0032472031000149016; ROSS CE, 1990, J MARRIAGE FAM, V52, P1059, DOI 10.2307/353319; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; SCHAFER RB, 1990, J SOC PSYCHOL, V130, P657, DOI 10.1080/00224545.1990.9922958; Tiffin PA, 2005, J EPIDEMIOL COMMUN H, V59, P870, DOI 10.1136/jech.2005.035246; WINKLEBY MA, 1990, PREV MED, V19, P1, DOI 10.1016/0091-7435(90)90001-Z; Zuo JP, 2001, J MARRIAGE FAM, V63, P1122, DOI 10.1111/j.1741-3737.2001.01122.x	26	20	21	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148990	10.1371/journal.pone.0148990	http://dx.doi.org/10.1371/journal.pone.0148990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26862896	Green Submitted, gold, Green Published			2022-12-27	WOS:000370046600134
J	Nolet, BA; Gyimesi, A; van Krimpen, RRD; de Boer, WF; Stillman, RA				Nolet, Bart A.; Gyimesi, Abel; van Krimpen, Roderick R. D.; de Boer, Willem F.; Stillman, Richard A.			Predicting Effects of Water Regime Changes on Waterbirds: Insights from Staging Swans	PLOS ONE			English	Article							DERIVING POPULATION PARAMETERS; CYGNUS-COLUMBIANUS-BEWICKII; INDIVIDUAL-BASED MODEL; FUNCTIONAL-RESPONSES; ABDOMINAL PROFILES; FORAGING BEHAVIOR; MIGRATORY SWANS; WHITE SEA; PATCH USE; COMPETITION	Predicting the environmental impact of a proposed development is notoriously difficult, especially when future conditions fall outside the current range of conditions. Individual-based approaches have been developed and applied to predict the impact of environmental changes on wintering and staging coastal bird populations. How many birds make use of staging sites is mostly determined by food availability and accessibility, which in the case of many waterbirds in turn is affected by water level. Many water systems are regulated and water levels are maintained at target levels, set by management authorities. We used an individual-based modelling framework (MORPH) to analyse how different target water levels affect the number of migratory Bewick's swans Cygnus columbianus bewickii staging at a shallow freshwater lake (Lauwersmeer, the Netherlands) in autumn. As an emerging property of the model, we found strong non-linear responses of swan usage to changes in water level, with a sudden drop in peak numbers as well as bird-days with a 0.20 m rise above the current target water level. Such strong non-linear responses are probably common and should be taken into account in environmental impact assessments.	[Nolet, Bart A.; Gyimesi, Abel; van Krimpen, Roderick R. D.] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [van Krimpen, Roderick R. D.; de Boer, Willem F.] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Stillman, Richard A.] Bournemouth Univ, Dept Life & Environm Sci, Fac Sci & Technol, Talbot Campus, Poole BH12 5BB, Dorset, England; [Nolet, Bart A.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Sci, Computat Geoecol, Ge Amsterdam, Netherlands; [Gyimesi, Abel] Bur Waardenburg, Dept Bird Ecol, Culemborg, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; Bournemouth University; University of Amsterdam	Nolet, BA (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands.; Nolet, BA (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Sci, Computat Geoecol, Ge Amsterdam, Netherlands.	b.nolet@nioo.knaw.nl	Nolet, Bart A/C-1416-2008; KNAW, NIOO-KNAW/A-4320-2012	Nolet, Bart A/0000-0002-7437-4879; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organisation for Scientific Research, NWO [814.01.008]	Netherlands Organisation for Scientific Research, NWO(Netherlands Organization for Scientific Research (NWO))	This work was funded by the Netherlands Organisation for Scientific Research (http://www.nwo.nl), NWO grant 814.01.008 to BAN.	ALATALO RV, 1987, ECOLOGY, V68, P284, DOI 10.2307/1939259; Amano T, 2006, ECOL MONOGR, V76, P601, DOI 10.1890/0012-9615(2006)076[0601:DIGFWI]2.0.CO;2; ANHOLT BR, 1990, ECOLOGY, V71, P1483, DOI 10.2307/1938285; Beekman J. H., 1996, Gibier Faune Sauvage, V13, P157; Beekman Jan H., 1991, Wildfowl, P238; Beekman JH, 2002, ARDEA, V90, P437; BOWLER JM, 1994, ARDEA, V82, P241; Brouwer G. A., 1939, Limosa, V12, P1; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Caldow RWG, 1999, J ANIM ECOL, V68, P869, DOI 10.1046/j.1365-2656.1999.00334.x; Clausen P, 2000, WILDLIFE BIOL, V6, P75, DOI 10.2981/wlb.2000.003; deLeeuw JJ, 1996, CAN J ZOOL, V74, P2131, DOI 10.1139/z96-242; Ellis EC, 2015, ECOL MONOGR, V85, P287, DOI 10.1890/14-2274.1; Evans M.E., 1978, Wildfowl, V29, P118; Gawlik DE, 2002, ECOL MONOGR, V72, P329, DOI 10.1890/0012-9615(2002)072[0329:TEOPAO]2.0.CO;2; Goss-Custard JD, 2004, P ROY SOC B-BIOL SCI, V271, P233, DOI 10.1098/rspb.2003.2602; GOSSCUSTARD JD, 1995, J ANIM ECOL, V64, P265, DOI 10.2307/5761; GOSSCUSTARD JD, 1995, J ANIM ECOL, V64, P277, DOI 10.2307/5762; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Gyimesi A, 2012, ARDEA, V100, P55, DOI 10.5253/078.100.0109; Gyimesi A, 2012, WETLANDS, V32, P119, DOI 10.1007/s13157-011-0256-6; Gyimesi A, 2011, AQUAT BOT, V94, P24, DOI 10.1016/j.aquabot.2010.10.002; Gyimesi A, 2010, ANIM BEHAV, V80, P791, DOI 10.1016/j.anbehav.2010.07.006; Gyimesi A, 2010, BEHAV ECOL SOCIOBIOL, V64, P1897, DOI 10.1007/s00265-010-1001-5; Hidding B, 2012, BASIC APPL ECOL, V13, P50, DOI 10.1016/j.baae.2011.11.002; Hidding B, 2010, OECOLOGIA, V162, P199, DOI 10.1007/s00442-009-1450-6; Holling C. S., 1959, Canadian Entomologist, V91, P385; Hornman M., 2011, 201103 SOVON; Karanek AR, 2008, NAT RESOUR MODEL, V21, P93; Klaassen RHG, 2006, ECOLOGY, V87, P2244, DOI 10.1890/0012-9658(2006)87[2244:MOFTSE]2.0.CO;2; Leirs H, 1997, NATURE, V389, P176, DOI 10.1038/38271; Logemann D, 2003, BEHEER INRICHTRINGSP; LOVVORN JR, 1994, HYDROBIOLOGIA, V279, P223, DOI 10.1007/BF00027856; Madsen J, 2006, J AVIAN BIOL, V37, P283, DOI 10.1111/j.2006.0908-8857.03555.x; Mori Y, 2004, ECOLOGY, V85, P398, DOI 10.1890/03-4005; Nolet BA, 2006, OIKOS, V112, P353, DOI 10.1111/j.0030-1299.2006.13463.x; Nolet BA, 1998, J AVIAN BIOL, V29, P574, DOI 10.2307/3677178; Nolet BA, 2002, J ANIM ECOL, V71, P979, DOI 10.1046/j.1365-2656.2002.00662.x; Nolet BA, 2005, OIKOS, V111, P302, DOI 10.1111/j.0030-1299.2005.14043.x; Nolet BA, 2002, J ANIM ECOL, V71, P451, DOI 10.1046/j.1365-2656.2002.00610.x; Nolet BA, 2001, ECOLOGY, V82, P1655, DOI 10.1890/0012-9658(2001)082[1655:SVITDB]2.0.CO;2; Nolet BA, 2001, IBIS, V143, P63, DOI 10.1111/j.1474-919X.2001.tb04170.x; Nolet BA, 2006, J ANIM ECOL, V75, P1285, DOI 10.1111/j.1365-2656.2006.01150.x; Nolet BA, 2013, J ORNITHOL, V154, P695, DOI 10.1007/s10336-013-0934-7; Nolet BA, 2009, OIKOS, V118, P431, DOI 10.1111/j.1600-0706.2008.16857.x; Norberg Ulla M., 1996, P199; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; POT R, 1984, ACTA BOT NEERL, V33, P361; SCHEFFER M, 1995, ECOL MODEL, V80, P161, DOI 10.1016/0304-3800(94)00055-M; Stillman RA, 2015, ECOSPHERE, V6, DOI 10.1890/ES1400455.1; Stillman RA, 2001, J APPL ECOL, V38, P857, DOI 10.1046/j.1365-2664.2001.00644.x; Stillman RA, 2008, ECOL MODEL, V216, P265, DOI 10.1016/j.ecolmodel.2008.04.014; Stillman RA, 2015, BIOSCIENCE, V65, P140, DOI 10.1093/biosci/biu192; Stillman RA, 2010, BIOL REV, V85, P413, DOI 10.1111/j.1469-185X.2009.00106.x; van Eerden M.R., 1997, PATCHWORK, P187; van Eerden M.R., 1997, PATCHWORK PATCH USE, P283; van Gils JA, 2006, ECOLOGY, V87, P1189, DOI 10.1890/0012-9658(2006)87[1189:FIATSE]2.0.CO;2; VANWIJK RJ, 1988, AQUAT BOT, V31, P211, DOI 10.1016/0304-3770(88)90015-0; Williams Christopher K., 2014, Wildfowl, P407	59	8	8	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147340	10.1371/journal.pone.0147340	http://dx.doi.org/10.1371/journal.pone.0147340			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862895	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600026
J	Zenker, MM; Rougerie, R; Teston, JA; Laguerre, M; Pie, MR; Freitas, AVL				Zenker, Mauricio M.; Rougerie, Rodolphe; Teston, Jose A.; Laguerre, Michel; Pie, Marcio R.; Freitas, Andre V. L.			Fast Census of Moth Diversity in the Neotropics: A Comparison of Field-Assigned Morphospecies and DNA Barcoding in Tiger Moths	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; NOMENCLATURAL CHANGES; NATURAL-HISTORY; MTDNA VARIATION; LEPIDOPTERA; COMPLEX; BIODIVERSITY; MITOCHONDRIAL; HYMENOPTERA; INTEGRATION	The morphological species delimitations (i.e. morphospecies) have long been the best way to avoid the taxonomic impediment and compare insect taxa biodiversity in highly diverse tropical and subtropical regions. The development of DNA barcoding, however, has shown great potential to replace (or at least complement) the morphospecies approach, with the advantage of relying on automated methods implemented in computer programs or even online rather than in often subjective morphological features. We sampled moths extensively for two years using light traps in a patch of the highly endangered Atlantic Forest of Brazil to produce a nearly complete census of arctiines (Noctuoidea: Erebidae), whose species richness was compared using different morphological and molecular approaches (DNA barcoding). A total of 1,075 barcode sequences of 286 morphospecies were analyzed. Based on the clustering method Barcode Index Number (BIN) we found a taxonomic bias of approximately 30% in our initial morphological assessment. However, a morphological reassessment revealed that the correspondence between morphospecies and molecular operational taxonomic units (MOTUs) can be up to 94% if differences in genitalia morphology are evaluated in individuals of different MOTUs originated from the same morphospecies (putative cases of cryptic species), and by recording if individuals of different genders in different morphospecies merge together in the same MOTU (putative cases of sexual dimorphism). The results of two other clustering methods (i.e. Automatic Barcode Gap Discovery and 2% threshold) were very similar to those of the BIN approach. Using empirical data we have shown that DNA barcoding performed substantially better than the morphospecies approach, based on superficial morphology, to delimit species of a highly diverse moth taxon, and thus should be used in species inventories.	[Zenker, Mauricio M.; Freitas, Andre V. L.] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Campinas, SP, Brazil; [Rougerie, Rodolphe; Laguerre, Michel] UPMC, Univ Paris 04, Museum Natl Hist Nat, Inst Systemat Evolut Biodivers ISYEB,CNRS,EPHE,UM, Paris, France; [Teston, Jose A.] Univ Fed Oeste Para, Lab Estudos Lepidopteros Neotropicais, Santarem, PA, Brazil; [Teston, Jose A.] Univ Fed Oeste Para, Programa Posgrad Recursos Nat Amazonia, Santarem, PA, Brazil; [Pie, Marcio R.] Univ Fed Parana, Dept Zool, BR-80060000 Curitiba, PR, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Universidade Federal do Oeste do Para; Universidade Federal do Oeste do Para; Universidade Federal do Parana	Zenker, MM (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Campinas, SP, Brazil.	maurizenker@gmail.com	Rougerie, Rodolphe/D-2930-2009; Fapesp, Biota/F-8655-2017; Freitas, André V. L./B-7513-2013; Teston, Jose Augusto/F-7443-2014	Rougerie, Rodolphe/0000-0003-0937-2815; Fapesp, Biota/0000-0002-9887-8449; Freitas, André V. L./0000-0002-5763-4990; Teston, Jose Augusto/0000-0003-0741-0347	Biodiversity Institute of Ontario (BIO)	Biodiversity Institute of Ontario (BIO)	This research was supported by funding to the National Council of Scientific and Technological Development of Brazil (CNPq), The State of Sao Paulo Research Foundation (FAPESP), and by the Biodiversity Institute of Ontario (BIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeodato S, 2008, HORIZONTE GEOGRAFICO, V119, P71; Allen CE, 2011, ANNU REV ENTOMOL, V56, P445, DOI 10.1146/annurev-ento-120709-144828; [Anonymous], 2014, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0101975; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P832, DOI 10.1111/1755-0998.12131; Ashton LA, 2015, INSECT CONSERV DIVER, V8, P132, DOI 10.1111/icad.12090; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Brehm G, 2005, J BIOGEOGR, V32, P1621, DOI 10.1111/j.1365-2699.2005.01304.x; Clare EL, 2011, MOL ECOL, V20, P1772, DOI 10.1111/j.1365-294X.2011.05040.x; Dewaard JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018290; deWaard JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014280; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Douris V, 2006, ADV VIRUS RES, V68, P113, DOI 10.1016/S0065-3527(06)68004-4; Duarte M, 2012, INSETOS BRASIL DIVER, P625; Dufour L, 1844, ANN SCI NAT, V1, P2445; EISNER T, 1991, Psyche (Cambridge), V98, P111, DOI 10.1155/1991/95350; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; FROST SW, 1957, J ECON ENTOMOL, V50, P287, DOI 10.1093/jee/50.3.287; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Huemer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115774; Intachat J, 1999, B ENTOMOL RES, V89, P153, DOI 10.1017/S0007485399000243; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Janzen DH, 2005, PHILOS NAVIGATION US; Kent RJ, 2006, MED VET ENTOMOL, V20, P459, DOI 10.1111/j.1365-2915.2006.00646.x; Krell FT, 2004, BIODIVERS CONSERV, V13, P795, DOI 10.1023/B:BIOC.0000011727.53780.63; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Linares MC, 2009, MOL PHYLOGENET EVOL, V50, P485, DOI 10.1016/j.ympev.2008.11.008; Mende MB, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-83; Moscardi F, 1999, ANNU REV ENTOMOL, V44, P257, DOI 10.1146/annurev.ento.44.1.257; Mutanen M, 2007, SYST ENTOMOL, V32, P371, DOI 10.1111/j.1365-3113.2006.00372.x; OLIVER I, 1993, CONSERV BIOL, V7, P562, DOI 10.1046/j.1523-1739.1993.07030562.x; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Powell JR, 2012, METHODS ECOL EVOL, V3, P1, DOI 10.1111/j.2041-210X.2011.00122.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Quinzin MC, 2014, MOL PHYLOGENET EVOL, V78, P14, DOI 10.1016/j.ympev.2014.05.003; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Ritter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078107; Rougerie R, 2012, INVERTEBR SYST, V26, P445, DOI 10.1071/IS12029; Rougerie R, 2010, ANN SOC ENTOMOL FR, V46, P477, DOI 10.1080/00379271.2010.10697684; Roy HE, 2012, UNDERSTANDING CITIZE; Schaefer H, 2008, MOL PHYLOGENET EVOL, V47, P799, DOI 10.1016/j.ympev.2008.01.030; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Schmidt BC, 2008, SYST ENTOMOL, V33, P613, DOI 10.1111/J.1365-3113.2008.00433.x; SCOBLE M. J., 1992, LEPIDOPTERA FORM FUN; Sengun A, 1944, REV FS ISTANBUL B, V9, P2395; SHAPIRO AM, 1989, ANNU REV ENTOMOL, V34, P231, DOI 10.1146/annurev.en.34.010189.001311; Sheffield CS, 2009, MOL ECOL RESOUR, V9, P196, DOI 10.1111/j.1755-0998.2009.02645.x; Silva-Brandao KL, 2009, NEOTROP ENTOMOL, V38, P441, DOI 10.1590/S1519-566X2009000400001; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036514; Specht A, 2005, REV BRAS ENTOMOL, V49, P130, DOI 10.1590/S0085-56262005000100015; Specht Alexandre, 2002, Rev. Bras. Zool., V19, P281, DOI 10.1590/S0101-81752002000500022; Strutzenberger P, 2011, INSECT SCI, V18, P349, DOI 10.1111/j.1744-7917.2010.01366.x; Tanzler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028832; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; Teston JA, 2003, THESIS PONTIFICIA U; The Barcode of Life Data Systems, 2014, HANDBOOK; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; VANEWRIGHT RI, 1975, J ZOOL, V177, P329; Vesterinen EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082168; Vincent B, 2014, ZOOSYSTEMA, V36, P137, DOI 10.5252/z2014n2a1; Vincent B, 2013, ZOOSYSTEMA, V35, P425, DOI 10.5252/z2013n3a5; Vincent Benoit, 2010, Bulletin de la Societe Entomologique de France, V115, P175; Voda R, 2015, ECOGRAPHY, V38, P405, DOI 10.1111/ecog.00762; Wahlberg N, 2003, SYST ENTOMOL, V28, P257, DOI 10.1046/j.1365-3113.2003.00212.x; Weller SJ, 1999, BIOL J LINN SOC, V68, P557, DOI 10.1111/j.1095-8312.1999.tb01188.x; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Zahiri R, 2012, SYST ENTOMOL, V37, P102, DOI 10.1111/j.1365-3113.2011.00607.x; Zenker MM, 2015, J INSECT CONSERV, V19, P129, DOI 10.1007/s10841-015-9753-x; Zenker MM, 2013, THESIS U FEDERAL PAR	79	17	17	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148423	10.1371/journal.pone.0148423	http://dx.doi.org/10.1371/journal.pone.0148423			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859488	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400041
J	Kim, MB; Shim, HY; Jin, SH; Kang, S; Woo, J; Han, JC; Lee, JY; Kim, M; Cho, YS; Moon, IJ; Hong, SH				Kim, Min-Beom; Shim, Hyun-Yong; Jin, Sun Hwa; Kang, Soojin; Woo, Jihwan; Han, Jong Chul; Lee, Ji Young; Kim, Martha; Cho, Yang-Sun; Moon, Il Joon; Hong, Sung Hwa			Cross-Modal and Intra-Modal Characteristics of Visual Function and Speech Perception Performance in Postlingually Deafened, Cochlear Implant Users	PLOS ONE			English	Article							ACTIVATE AUDITORY-CORTEX; PUPILLARY RESPONSES; CONGENITALLY DEAF; SPATIAL-DISTRIBUTION; PLASTICITY; ATTENTION; HEARING; LANGUAGE; NEUROPLASTICITY; DEPRIVATION	Evidence of visual-auditory cross-modal plasticity in deaf individuals has been widely reported. Superior visual abilities of deaf individuals have been shown to result in enhanced reactivity to visual events and/or enhanced peripheral spatial attention. The goal of this study was to investigate the association between visual-auditory cross-modal plasticity and speech perception in post-lingually deafened, adult cochlear implant (CI) users. Post-lingually deafened adults with CIs (N = 14) and a group of normal hearing, adult controls (N = 12) participated in this study. The CI participants were divided into a good performer group (good CI, N = 7) and a poor performer group (poor CI, N = 7) based on word recognition scores. Visual evoked potentials (VEP) were recorded from the temporal and occipital cortex to assess reactivity. Visual field (VF) testing was used to assess spatial attention and Goldmann perimetry measures were analyzed to identify differences across groups in the VF. The association of the amplitude of the P1 VEP response over the right temporal or occipital cortex among three groups (control, good CI, poor CI) was analyzed. In addition, the association between VF by different stimuli and word perception score was evaluated. The P1 VEP amplitude recorded from the right temporal cortex was larger in the group of poorly performing CI users than the group of good performers. The P1 amplitude recorded from electrodes near the occipital cortex was smaller for the poor performing group. P1 VEP amplitude in right temporal lobe was negatively correlated with speech perception outcomes for the CI participants (r = -0.736, P = 0.003). However, P1 VEP amplitude measures recorded from near the occipital cortex had a positive correlation with speech perception outcome in the CI participants (r = 0.775, P = 0.001). In VF analysis, CI users showed narrowed central VF (VF to low intensity stimuli). However, their far peripheral VF (VF to high intensity stimuli) was not different from the controls. In addition, the extent of their central VF was positively correlated with speech perception outcome (r = 0.669, P = 0.009). Persistent visual activation in right temporal cortex even after CI causes negative effect on outcome in post-lingual deaf adults. We interpret these results to suggest that insufficient intra-modal (visual) compensation by the occipital cortex may cause negative effects on outcome. Based on our results, it appears that a narrowed central VF could help identify CI users with poor outcomes with their device.	[Kim, Min-Beom] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Shim, Hyun-Yong; Jin, Sun Hwa; Kang, Soojin; Cho, Yang-Sun; Moon, Il Joon; Hong, Sung Hwa] Samsung Med Ctr, Hearing Lab, Seoul, South Korea; [Woo, Jihwan] Univ Ulsan, Sch Elect Engn, Biomed Engn, Ulsan 680749, South Korea; [Han, Jong Chul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Lee, Ji Young] Catholic Univ Daegu, Dept Audiol & Speech Language Pathol, Daegu, South Korea; [Kim, Martha] Dongguk Univ, Coll Med, Dept Ophthalmol, Ilsan Hosp, Goyang, South Korea; [Cho, Yang-Sun; Moon, Il Joon; Hong, Sung Hwa] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Ulsan; Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Daegu; Dongguk University; NHIS Ilsan Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center	Moon, IJ; Hong, SH (corresponding author), Samsung Med Ctr, Hearing Lab, Seoul, South Korea.; Moon, IJ; Hong, SH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	moonij@skku.edu; hongsh@skku.edu	Cho, Yang Sun/F-4611-2014		IN-SUNG Foundation [CB14011]	IN-SUNG Foundation	This work was supported by the IN-SUNG Foundation, grant number CB14011 (SHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHERN S, 1979, SCIENCE, V205, P1289, DOI 10.1126/science.472746; Arnal LH, 2009, J NEUROSCI, V29, P13445, DOI 10.1523/JNEUROSCI.3194-09.2009; Auer ET, 2007, NEUROREPORT, V18, P645, DOI 10.1097/WNR.0b013e3280d943b9; Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bavelier D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0001.2000; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; BLAMEY PJ, 1992, ANN OTO RHINOL LARYN, V101, P342, DOI 10.1177/000348949210100410; BLUMHARDT LD, 1982, ANN NY ACAD SCI, V388, P264, DOI 10.1111/j.1749-6632.1982.tb50796.x; Bosworth RG, 2002, BRAIN COGNITION, V49, P152, DOI 10.1006/brcg.2001.1497; BRYDEN MP, 1983, BRAIN LANG, V18, P236, DOI 10.1016/0093-934X(83)90018-4; Buckley D, 2010, VISION RES, V50, P548, DOI 10.1016/j.visres.2009.11.018; Buckley KA, 2011, EAR HEARING, V32, P2, DOI 10.1097/AUD.0b013e3181fa41bb; Cammann R, 1985, Zentralbl Neurochir, V46, P52; Campbell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090594; Capek CM, 2008, NEUROPSYCHOLOGIA, V46, P1233, DOI 10.1016/j.neuropsychologia.2007.11.026; Chen Q, 2006, BRAIN RES, V1109, P117, DOI 10.1016/j.brainres.2006.06.043; Codina C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020417; Codina C, 2011, DEVELOPMENTAL SCI, V14, P725, DOI 10.1111/j.1467-7687.2010.01017.x; Dewey RS, 2015, HEARING RES, V325, P55, DOI 10.1016/j.heares.2015.03.007; Doucet ME, 2006, BRAIN, V129, P3376, DOI 10.1093/brain/awl264; Dye MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005640; Fine I, 2005, J COGNITIVE NEUROSCI, V17, P1621, DOI 10.1162/089892905774597173; Finney EM, 2003, NEUROREPORT, V14, P1425, DOI 10.1097/00001756-200308060-00004; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Friederici AD, 2004, BRAIN LANG, V89, P267, DOI 10.1016/S0093-934X(03)00351-1; GANTZ BJ, 1993, ANN OTO RHINOL LARYN, V102, P909, DOI 10.1177/000348949310201201; Giraud AL, 2001, NEURON, V30, P657, DOI 10.1016/S0896-6273(01)00318-X; Granholm E, 1996, PSYCHOPHYSIOLOGY, V33, P457, DOI 10.1111/j.1469-8986.1996.tb01071.x; HOEKS B, 1993, BEHAV RES METH INSTR, V25, P16, DOI 10.3758/BF03204445; Holden LK, 2013, EAR HEARING, V34, P342, DOI 10.1097/AUD.0b013e3182741aa7; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Koelewijn T, 2014, HEARING RES, V312, P114, DOI 10.1016/j.heares.2014.03.010; Kral A, 2001, AUDIOL NEURO-OTOL, V6, P346, DOI 10.1159/000046845; Kral A, 2002, CEREB CORTEX, V12, P797, DOI 10.1093/cercor/12.8.797; Lambertz N, 2005, COGNITIVE BRAIN RES, V25, P884, DOI 10.1016/j.cogbrainres.2005.09.010; Lazard DS, 2010, ACTA OTO-LARYNGOL, V130, P1267, DOI 10.3109/00016481003769972; Lee DS, 2001, NATURE, V409, P149, DOI 10.1038/35051653; Lee JS, 2003, J NUCL MED, V44, P1435; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; McIntosh AR, 1999, SCIENCE, V284, P1531, DOI 10.1126/science.284.5419.1531; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Meyer M, 2002, HUM BRAIN MAPP, V17, P73, DOI 10.1002/hbm.10042; Neville H, 2002, PROG BRAIN RES, V138, P177, DOI 10.1016/S0079-6123(02)38078-6; PARASNIS I, 1985, BRAIN COGNITION, V4, P313, DOI 10.1016/0278-2626(85)90024-7; Pavani F., 2011, NEURAL BASES MULTISE; Petitto LA, 2000, P NATL ACAD SCI USA, V97, P13961, DOI 10.1073/pnas.97.25.13961; Porter G, 2007, Q J EXP PSYCHOL, V60, P211, DOI 10.1080/17470210600673818; Proksch J, 2002, J COGNITIVE NEUROSCI, V14, P687, DOI 10.1162/08989290260138591; Rauschecker JP, 2002, SCIENCE, V295, P1025, DOI 10.1126/science.1067796; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; Roder B, 2004, CURR BIOL, V14, P121, DOI 10.1016/j.cub.2003.12.054; Sandmann P, 2012, BRAIN, V135, P555, DOI 10.1093/brain/awr329; Shams L, 2001, NEUROREPORT, V12, P3849, DOI 10.1097/00001756-200112040-00049; Stevens C, 2006, J COGNITIVE NEUROSCI, V18, P701, DOI 10.1162/jocn.2006.18.5.701; Strelnikov K, 2013, BRAIN, V136, P3682, DOI 10.1093/brain/awt274; Tyler RS, 1997, J ACOUST SOC AM, V102, P508, DOI 10.1121/1.419724; Valimaa TT, 2000, SCAND AUDIOL, V29, P276, DOI 10.1080/010503900750022916; Verney SP, 2004, INT J PSYCHOPHYSIOL, V52, P23, DOI 10.1016/j.ijpsycho.2003.12.003; Zrenner E, 2002, SCIENCE, V295, P1022, DOI 10.1126/science.1067996	61	82	85	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148466	10.1371/journal.pone.0148466	http://dx.doi.org/10.1371/journal.pone.0148466			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848755	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000099
J	Mizuno, S; Ogishima, S; Kitatani, K; Kikuchi, M; Tanaka, H; Yaegashi, N; Nakaya, J				Mizuno, Satoshi; Ogishima, Soichi; Kitatani, Kazuyuki; Kikuchi, Masataka; Tanaka, Hiroshi; Yaegashi, Nobuo; Nakaya, Jun			Network Analysis of a Comprehensive Knowledge Repository Reveals a Dual Role for Ceramide in Alzheimer's Disease	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SIGNALING PATHWAYS; INFLAMMATION; MAP; SPHINGOLIPIDS; ACCUMULATION; GANGLIOSIDES; METABOLISM; TARGET; BRAINS	Alzheimer's disease (AD) is the most common cause of senile dementia. Many inflammatory factors such as amyloid-beta and pro-inflammatory cytokines are known to contribute to the inflammatory response in the AD brain. Sphingolipids are widely known to have roles in the pathogenesis of inflammatory diseases, where the precise roles for sphingolipids in inflammation-associated pathogenesis of AD are not well understood. Here we performed a network analysis to clarify the importance of sphingolipids and to model relationships among inflammatory factors and sphingolipids in AD. In this study, we have updated sphingolipid signaling and metabolic cascades in a map of AD signaling networks that we named "AlzPathway," a comprehensive knowledge repository of signaling pathways in AD. Our network analysis of the updated AlzPathway indicates that the pathways related to ceramide are one of the primary pathways and that ceramide is one of the important players in the pathogenesis of AD. The results of our analysis suggest the following two prospects about inflammation in AD: (1) ceramide could play important roles in both inflammatory and anti-inflammatory pathways of AD, and (2) several factors such as Sphingomyelinase and Siglec-11 may be associated with ceramide related inflammation and anti-inflammation pathways in AD. In this study, network analysis of comprehensive knowledge repository reveals a dual role for ceramide in AD. This result provides a clue to clarify sphingolipids related inflammatory and anti-inflammatory pathways in AD.	[Mizuno, Satoshi; Nakaya, Jun] Tohoku Univ, Grad Sch Med, Dept Clin Informat, Sendai, Miyagi 980, Japan; [Mizuno, Satoshi; Ogishima, Soichi; Tanaka, Hiroshi] Tohoku Univ, Tohoku Med Megabank Org, Dept Clin Record Informat, Sendai, Miyagi 980, Japan; [Kitatani, Kazuyuki; Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Dept Gynecol & Obstet, Sendai, Miyagi 980, Japan; [Kikuchi, Masataka] Osaka Univ, Grad Sch Med, Dept Genome Informat, Suita, Osaka, Japan	Tohoku University; Tohoku University; Tohoku University; Osaka University	Mizuno, S (corresponding author), Tohoku Univ, Grad Sch Med, Dept Clin Informat, Sendai, Miyagi 980, Japan.; Mizuno, S; Ogishima, S (corresponding author), Tohoku Univ, Tohoku Med Megabank Org, Dept Clin Record Informat, Sendai, Miyagi 980, Japan.	samizuno@med.tohoku.ac.jp; ogishima@sysmedbio.org	Kitatani, Kazuyuki/H-7100-2019	Kitatani, Kazuyuki/0000-0002-8516-6135	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25330333]; Grants-in-Aid for Scientific Research [26240044] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Grant number : 25330333, URL : https://kaken.nii.ac.jp/d/p/25330333.en.html. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Caberlotto L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078919; Cai ZY, 2012, NEUROMOL MED, V14, P1, DOI 10.1007/s12017-012-8173-2; Calzone L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.7; Car H, 2012, POSTEP HIG MED DOSW, V66, P295, DOI 10.5604/17322693.999024; Colell A, 2009, J BIOENERG BIOMEMBR, V41, P417, DOI 10.1007/s10863-009-9242-6; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Fernandes A, 2014, CELL MOL LIFE SCI, V71, P3969, DOI 10.1007/s00018-014-1670-8; Filippov V, 2012, J ALZHEIMERS DIS, V29, P537, DOI 10.3233/JAD-2011-111202; Fujita KA, 2014, MOL NEUROBIOL, V49, P88, DOI 10.1007/s12035-013-8489-4; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Han XL, 2003, J LIPID RES, V44, P1071, DOI 10.1194/jlr.R300004-JLR200; Hartmann T, 2006, NEURODEGENER DIS, V3, P305, DOI 10.1159/000095271; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; He XX, 2010, NEUROBIOL AGING, V31, P398, DOI 10.1016/j.neurobiolaging.2008.05.010; Horres CR, 2012, NEUROCHEM RES, V37, P1137, DOI 10.1007/s11064-011-0692-y; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Kwak JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096456; Lukiw WJ, 2010, MOL NEUROBIOL, V42, P10, DOI 10.1007/s12035-010-8126-4; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Malhotra A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13634; Matsuzaki K, 2007, BBA-BIOMEMBRANES, V1768, P1935, DOI 10.1016/j.bbamem.2007.02.009; Matsuzaki K, 2010, BBA-MOL CELL BIOL L, V1801, P868, DOI 10.1016/j.bbalip.2010.01.008; McGeer PL, 2013, ACTA NEUROPATHOL, V126, P479, DOI 10.1007/s00401-013-1177-7; Mielke MM, 2012, CLIN LIPIDOL, V7, P525, DOI 10.2217/CLP.12.59; Mielke MM, 2010, NEUROMOL MED, V12, P331, DOI 10.1007/s12017-010-8121-y; Mizuno S, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-52; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Ogishima S, 2013, CLIN PHARMACOL THER, V93, P399, DOI 10.1038/clpt.2013.37; Patil S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-137; Pernber Z, 2012, DEMENT GERIATR COGN, V33, P174, DOI 10.1159/000338181; Potapov Anatolij P, 2005, Genome Inform, V16, P270; Rubio-Perez Jose Miguel, 2012, ScientificWorldJournal, V2012, P756357, DOI 10.1100/2012/756357; Salminen A, 2009, J MOL MED, V87, P697, DOI 10.1007/s00109-009-0472-1; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soreghan M, 2003, ADV DRUG DELIVER REV, V55, P1515, DOI 10.1016/j.addr.2003.07.007; Taki T, 2012, BIOL PHARM BULL, V35, P1642, DOI 10.1248/bpb.b12-00400; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Terrill-Usery SE, 2014, BBA-MOL BASIS DIS, V1842, P2276, DOI 10.1016/j.bbadis.2014.08.001; Tessarz AAS, 2008, IMMUNOL LETT, V116, P111, DOI 10.1016/j.imlet.2007.11.021; Van Dooren T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/167024; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Voronkov M, 2011, FUTURE MED CHEM, V3, P821, DOI [10.4155/FMC.11.47, 10.4155/fmc.11.47]; Wong ML, 2000, P NATL ACAD SCI USA, V97, P8681, DOI 10.1073/pnas.150098097; Wu CK, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S3-S2; Yu RK, 2012, NEUROCHEM RES, V37, P1230, DOI 10.1007/s11064-012-0744-y; Yuyama K, 2014, BBA-MOL CELL BIOL L, V1841, P793, DOI 10.1016/j.bbalip.2013.08.002	54	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148431	10.1371/journal.pone.0148431	http://dx.doi.org/10.1371/journal.pone.0148431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849355	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000093
J	Debelak, R; Tran, US				Debelak, Rudolf; Tran, Ulrich S.			Comparing the Effects of Different Smoothing Algorithms on the Assessment of Dimensionality of Ordered Categorical Items with Parallel Analysis	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; CORRELATION MATRIX; DETERMINING NUMBER; COMPONENTS; CRITERION; VARIANCE; ACCURACY; RULES	The analysis of polychoric correlations via principal component analysis and exploratory factor analysis are well-known approaches to determine the dimensionality of ordered categorical items. However, the application of these approaches has been considered as critical due to the possible indefiniteness of the polychoric correlation matrix. A possible solution to this problem is the application of smoothing algorithms. This study compared the effects of three smoothing algorithms, based on the Frobenius norm, the adaption of the eigenvalues and eigenvectors, and on minimum-trace factor analysis, on the accuracy of various variations of parallel analysis by the means of a simulation study. We simulated different datasets which varied with respect to the size of the respondent sample, the size of the item set, the underlying factor model, the skewness of the response distributions and the number of response categories in each item. We found that a parallel analysis and principal component analysis of smoothed polychoric and Pearson correlations led to the most accurate results in detecting the number of major factors in simulated datasets when compared to the other methods we investigated. Of the methods used for smoothing polychoric correlation matrices, we recommend the algorithm based on minimum trace factor analysis.	[Debelak, Rudolf] SCHUHFRIED GmbH, Modling, Austria; [Debelak, Rudolf] Univ Zurich, Zurich, Switzerland; [Tran, Ulrich S.] Univ Vienna, Vienna, Austria	University of Zurich; University of Vienna	Tran, US (corresponding author), Univ Vienna, Vienna, Austria.	ulrich.tran@univie.ac.at		Debelak, Rudolf/0000-0001-8900-2106; Tran, Ulrich/0000-0002-6589-3167	Open Access Publishing Fund of the University of Vienna	Open Access Publishing Fund of the University of Vienna	This article was supported by the Open Access Publishing Fund of the University of Vienna.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; BABAKUS E, 1987, J MARKETING RES, V24, P222, DOI 10.2307/3151512; Bates D, 2011, MATRIX SPARSE DENSE; Beauducel A, 2006, STRUCT EQU MODELING, V13, P186, DOI 10.1207/s15328007sem1302_2; Bentler PM, 2011, PSYCHOMETRIKA, V76, P119, DOI 10.1007/s11336-010-9191-3; Bravo HC, 2010, RCSDP R INTERFACE CS; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cho SJ, 2009, EDUC PSYCHOL MEAS, V69, P748, DOI 10.1177/0013164409332229; Crawford AV, 2010, EDUC PSYCHOL MEAS, V70, P885, DOI 10.1177/0013164410379332; Debelak R, 2013, EDUC PSYCHOL MEAS, V73, P63, DOI 10.1177/0013164412457366; Garrido LE, 2013, PSYCHOL METHODS, V18, P454, DOI 10.1037/a0030005; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Flora DB, 2004, PSYCHOL METHODS, V9, P466, DOI 10.1037/1082-989X.9.4.466; GLORFELD LW, 1995, EDUC PSYCHOL MEAS, V55, P377, DOI 10.1177/0013164495055003002; Gorsuch R., 1983, FACTOR ANAL; Green SB, 2015, EDUC PSYCHOL MEAS, V75, P428, DOI 10.1177/0013164414546566; Green SB, 2012, EDUC PSYCHOL MEAS, V72, P357, DOI 10.1177/0013164411422252; Green SB, 2015, ED PSYCHOL MEAS; Harlow LL, 2013, MULTIVAR BEHAV RES, V48, P749, DOI 10.1080/00273171.2013.822784; Higham NJ, 2002, IMA J NUMER ANAL, V22, P329, DOI 10.1093/imanum/22.3.329; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; HUMPHREY.LG, 1969, EDUC PSYCHOL MEAS, V29, P571, DOI 10.1177/001316446902900303; HUMPHREYS LG, 1975, MULTIVAR BEHAV RES, V10, P193, DOI 10.1207/s15327906mbr1002_5; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; KNOL DL, 1989, PSYCHOMETRIKA, V54, P53, DOI 10.1007/BF02294448; KNOL DL, 1991, MULTIVAR BEHAV RES, V26, P457, DOI 10.1207/s15327906mbr2603_5; Ledesma RD, 2007, PRACT ASSESS RES EVA, V12, P1, DOI [https://doi.org/10.7275/wjnc-nm63, DOI 10.7275/WJNC-NM63]; Lord F.M., 1980, APPL ITEM RESPONSE T; Lord F. M., 1968, STAT THEORIES MENTAL; Lorenzo-Seva U, 2015, FACTOR VERS 10 3 01; Lorenzo-Seva U, 2011, MULTIVAR BEHAV RES, V46, P340, DOI 10.1080/00273171.2011.564527; Maechler M, 2014, SFSMISC UT SEM FUER; Mulaik S., 2010, FDN FACTOR ANAL, V2nd; OLSSON U, 1979, MULTIVAR BEHAV RES, V14, P485, DOI 10.1207/s15327906mbr1404_7; OLSSON U, 1979, PSYCHOMETRIKA, V44, P443, DOI 10.1007/BF02296207; Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reckase MD, 2009, THEORY; Revelle W., 2014, PSYCH PROCEDURES PER; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Steger MF, 2006, J PERS ASSESS, V86, P263, DOI 10.1207/s15327752jpa8603_03; TENBERGE JMF, 1977, PSYCHOMETRIKA, V42, P593, DOI 10.1007/BF02295981; Timmerman ME, 2011, PSYCHOL METHODS, V16, P209, DOI 10.1037/a0023353; Tran US, 2009, EDUC PSYCHOL MEAS, V69, P50, DOI 10.1177/0013164408318761; TUCKER LR, 1969, PSYCHOMETRIKA, V34, P421, DOI 10.1007/BF02290601; Turner NE, 1998, EDUC PSYCHOL MEAS, V58, P541, DOI 10.1177/0013164498058004001; VELICER WF, 1976, PSYCHOMETRIKA, V41, P321, DOI 10.1007/BF02293557; Weng LJ, 2005, EDUC PSYCHOL MEAS, V65, P791, DOI 10.1177/0013164404273941; Yuan KH, 2011, BRIT J MATH STAT PSY, V64, P107, DOI 10.1348/000711010X497442; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	50	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148143	10.1371/journal.pone.0148143	http://dx.doi.org/10.1371/journal.pone.0148143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845032	Green Published, gold, Green Submitted			2022-12-27	WOS:000369552800032
J	Han, B; Liu, HB; Zhai, GJ; Wang, Q; Liang, J; Zhang, MC; Cui, K; Shen, FH; Yi, HB; Li, YT; Zhai, YH; Sheng, Y; Chen, J				Han, Bing; Liu, Hongbo; Zhai, Guojiang; Wang, Qun; Liang, Jie; Zhang, Mengcang; Cui, Kai; Shen, Fuhai; Yi, Hongbo; Li, Yuting; Zhai, Yuhan; Sheng, Yang; Chen, Jie			Estimates and Predictions of Coal Workers' Pneumoconiosis Cases among Redeployed Coal Workers of the Fuxin Mining Industry Group in China: A Historical Cohort Study	PLOS ONE			English	Article							REGION	This research was aimed at estimating possible Coal workers' pneumoconiosis (CWP) cases as of 2012, and predicting future CWP cases among redeployed coal workers from the Fuxin Mining Industry Group. This study provided the scientific basis for regulations on CWP screening and diagnosis and labor insurance policies for redeployed coal workers of resource-exhausted mines. The study cohort included 19,116 coal workers. The cumulative incidence of CWP was calculated by the life-table method. Possible CWP cases by occupational category were estimated through the average annual incidence rate of CWP and males' life expectancy. It was estimated that 141 redeployed coal workers might have suffered from CWP as of 2012, and 221 redeployed coal workers could suffer from CWP in the future. It is crucial to establish a set of feasible and affordable regulations on CWP screening and diagnosis as well as labor insurance policies for redeployed coal workers of resource-exhausted coal mines in China.	[Han, Bing; Liu, Hongbo; Cui, Kai; Shen, Fuhai; Chen, Jie] China Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Shenyang 110122, Liaoning, Peoples R China; [Han, Bing; Liu, Hongbo; Li, Yuting; Zhai, Yuhan; Sheng, Yang] China Med Univ, Sch Publ Hlth, Dept Hlth Stat, Shenyang 110122, Liaoning, Peoples R China; [Zhai, Guojiang; Wang, Qun; Yi, Hongbo] Fuxin Min Area Social Secur Adm Ctr, Fuxing 123000, Liaoning, Peoples R China; [Liang, Jie; Zhang, Mengcang] Inst Occupat Dis Prevent & Treatment, Fuxin Min Ind Grp, Fuxing 123000, Liaoning, Peoples R China	China Medical University; China Medical University	Chen, J (corresponding author), China Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Shenyang 110122, Liaoning, Peoples R China.	chenjie@mail.cmu.edu.cn			National Natural Science Foundation of China [71073176]; Program for Liaoning Innovative Research Team in University [LT2015028]; General Program of Scientific Research of the Educational Department of Liaoning Province [L2015573]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Liaoning Innovative Research Team in University; General Program of Scientific Research of the Educational Department of Liaoning Province	This study was funded by the National Natural Science Foundation of China (no. 71073176) to HL; the Program for Liaoning Innovative Research Team in University (no. LT2015028) to Jie Chen; and the General Program of Scientific Research of the Educational Department of Liaoning Province (no. L2015573) to Bing Han. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaan MR, 1998, OCCUPATIONAL ENV MED, P435; BRADBURY J, 1984, INT J URBAN REGIONAL, V8, P311, DOI 10.1111/j.1468-2427.1984.tb00613.x; Bradbury J., 1988, RESOURCE COMMUNITIES, P3; Chinese Center for disease control and prevention, NAT OCC DIS CONTR PR; Chong S, 2006, RADIOGRAPHICS, V26, P59, DOI 10.1148/rg.261055070; De Vuyst P, 2000, Curr Opin Pulm Med, V6, P151, DOI 10.1097/00063198-200003000-00012; Farzaneh MR, 2010, INT J OCCUP ENV MED, V1, P11; Han XW, 2005, OCCUP HLTH EMERG RES, V23, P110; LANE E, 1977, SOUTHERN MED J, V70, P53, DOI 10.1097/00007611-197701000-00023; Laney AS, 2014, AM J PUBLIC HEALTH, V104, P165, DOI 10.2105/AJPH.2012.301051; Laney AS, 2012, CLIN CHEST MED, V33, P745, DOI 10.1016/j.ccm.2012.08.005; Laney AS, 2010, OCCUP ENVIRON MED, V67, P652, DOI 10.1136/oem.2009.047126; Leng YJ, 2011, J LIAONING TU SOCIAL, V13, P169; Liu FD, 2007, HEALTH PHYS, V93, P127, DOI 10.1097/01.HP.0000261600.29366.b4; LOU JZ, 1989, AM J PUBLIC HEALTH, V79, P1613, DOI 10.2105/AJPH.79.12.1613; Lou JZ, 1998, CHINESE J HLTH STAT, V15, P22; National Health and Family Planning Commission of the People's Republic of China, 702009 GBZ NAT HLTH; National Health and Family Planning Commission of the People's Republic of China, NAT OCC DIS REP 2012; National Institute for Occupational Safety and Health Division of Respiratory Disease Studies, 2008, WORKR LUNG DIS SURV, P27; Ringshausen FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082005; Scarisbrick DA., 2002, ANN OCCUP HYG     S1, V46, P254; Shen FH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130958; Shen FH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082181; Sun YF, 2010, HLJ FOREIGN EC RELAT, V187, P109, DOI DOI 10.3969/J.ISSN.2095-3283.2010.01.041; The Central People's Government of the People's Republic of China, NAT RES BAS CIT SUST; Thomas CR, 2010, ENVIRON HEALTH INSIG, V4, P21; Xie ZY, 2014, ADV MATER RES-SWITZ, V869-870, P226, DOI 10.4028/www.scientific.net/AMR.869-870.226; Ying Hua, 2014, Applied Mechanics and Materials, V448-453, P4215, DOI 10.4028/www.scientific.net/AMM.448-453.4215; Zhao G, 2011, ANAL SOCIAL EC IMPAC, P55	29	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148179	10.1371/journal.pone.0148179	http://dx.doi.org/10.1371/journal.pone.0148179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845337	gold, Green Published, Green Submitted			2022-12-27	WOS:000369552800034
J	Nguyen, A; Hulleman, JD				Nguyen, Annie; Hulleman, John D.			Evidence of Alternative Cystatin C Signal Sequence Cleavage Which Is Influenced by the A25T Polymorphism	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; GENE G73A POLYMORPHISM; AMYLOID ANGIOPATHY; CEREBRAL-HEMORRHAGE; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; CST3 GENE; ASSOCIATION; VARIANT; PROTEIN	Cystatin C (Cys C) is a small, potent, cysteine protease inhibitor. An Ala25Thr (A25T) polymorphism in Cys C has been associated with both macular degeneration and late-onset Alzheimer's disease. Previously, studies have suggested that this polymorphism may compromise the secretion of Cys C. Interestingly, we found that untagged A25T, A25T tagged C-terminally with FLAG, or A25T FLAG followed by green fluorescent protein (GFP), were all secreted as efficiently from immortalized human cells as their wild-type (WT) counterparts (e.g., 112%, 100%, and 88% of WT levels from HEK-293T cells, respectively). Supporting these observations, WT and A25T Cys C variants also showed similar intracellular steady state levels. Furthermore, A25T Cys C did not activate the unfolded protein response and followed the same canonical endoplasmic reticulum (ER)-Golgi trafficking pathway as WT Cys C. WT Cys C has been shown to undergo signal sequence cleavage between residues Gly26 and Ser27. While the A25T polymorphism did not affect Cys C secretion, we hypothesized that it may alter where the Cys C signal sequence is preferentially cleaved. Under normal conditions, WT and A25T Cys C have the same signal sequence cleavage site after Gly26 (referred to as 'site 2' cleavage). However, in particular circumstances when the residues around site 2 are modified (such as by the presence of an N-terminal FLAG tag immediately after Gly26, or by a Gly26Lys (G26K) mutation), A25T has a significantly higher likelihood than WT Cys C of alternative signal sequence cleavage after Ala20 ('site 1') or even earlier in the Cys C sequence. Overall, our results indicate that the A25T polymorphism does not cause a significant reduction in Cys C secretion, but instead predisposes the protein to be cleaved at an alternative signal sequence cleavage site if site 2 is hindered. Additional N-terminal amino acids resulting from alternative signal sequence cleavage may, in turn, affect the protease inhibition function of Cys C.	[Nguyen, Annie; Hulleman, John D.] Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA; [Hulleman, John D.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hulleman, JD (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA.; Hulleman, JD (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	John.Hulleman@UTSouthwestern.edu	Hulleman, John D./AAV-8242-2020	Hulleman, John/0000-0001-8149-656X	Roger and Dorothy Hirl Research Fund; National Eye Institute Visual Science Core Grant [EY020799]; Research to Prevent Blindness; Career Development Award from Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY020799] Funding Source: NIH RePORTER	Roger and Dorothy Hirl Research Fund; National Eye Institute Visual Science Core Grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Career Development Award from Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded in part by an endowment from the Roger and Dorothy Hirl Research Fund (JDH), a National Eye Institute Visual Science Core Grant (EY020799), an unrestricted grant from Research to Prevent Blindness, and a Career Development Award from Research to Prevent Blindness (JDH).	ABRAHAMSON M, 1991, BIOCHEM J, V273, P621, DOI 10.1042/bj2730621; ABRAHAMSON M, 1990, BIOCHEM J, V268, P287, DOI 10.1042/bj2680287; ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; ALDRED AR, 1995, COMP BIOCHEM PHYS B, V111, P1, DOI 10.1016/0305-0491(94)00229-N; Nguyen A, 2015, EXP EYE RES, V130, P66, DOI 10.1016/j.exer.2014.12.002; Bai G, 2011, NEURON, V72, P9, DOI 10.1016/j.neuron.2011.09.012; BARRETT AJ, 1984, BIOCHEM BIOPH RES CO, V120, P631, DOI 10.1016/0006-291X(84)91302-0; Benussi L, 2003, NEUROBIOL DIS, V13, P15, DOI 10.1016/S0969-9961(03)00012-3; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bjarnadottir M, 1998, J CLIN PATHOL-MOL PA, V51, P317, DOI 10.1136/mp.51.6.317; Bjarnadottir M, 2001, AMYLOID, V8, P1, DOI 10.3109/13506120108993809; Butler JM, 2015, HUM GENET, V134, P705, DOI 10.1007/s00439-015-1552-7; Chuo LJ, 2007, DEMENT GERIATR COGN, V23, P251, DOI 10.1159/000100021; Crawford FC, 2000, NEUROLOGY, V55, P763, DOI 10.1212/WNL.55.6.763; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Finckh U, 2000, ARCH NEUROL-CHICAGO, V57, P1579, DOI 10.1001/archneur.57.11.1579; HARRIS RJ, 1995, J CHROMATOGR A, V705, P129, DOI 10.1016/0021-9673(94)01255-D; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Helisalmi S, 2009, DEMENT GERIATR COGN, V27, P318, DOI 10.1159/000209278; Hua Y, 2012, INT J NEUROSCI, V122, P431, DOI 10.3109/00207454.2012.672502; Huh CG, 1999, J CLIN PATHOL-MOL PA, V52, P332, DOI 10.1136/mp.52.6.332; Hulleman JD, 2015, FASEB J, V29, P565, DOI 10.1096/fj.14-255414; Hulleman JD, 2013, J BIOMOL SCREEN, V18, P647, DOI 10.1177/1087057112469405; Hulleman JD, 2011, MOL BIOL CELL, V22, P4765, DOI 10.1091/mbc.E11-08-0695; JENSSON O, 1987, ACTA NEUROL SCAND, V76, P102, DOI 10.1111/j.1600-0404.1987.tb03553.x; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Levy E, 2006, BRAIN PATHOL, V16, P60, DOI 10.1111/j.1750-3639.2006.tb00562.x; LEVY E, 1989, J EXP MED, V169, P1771, DOI 10.1084/jem.169.5.1771; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Maetzler W, 2010, J ALZHEIMERS DIS, V19, P937, DOI 10.3233/JAD-2010-1289; Maruyama H, 2001, NEUROLOGY, V57, P337, DOI 10.1212/WNL.57.2.337; Monastero R, 2005, J ALZHEIMERS DIS, V7, P291; Nacmias B, 2006, NEUROSCI LETT, V392, P110, DOI 10.1016/j.neulet.2005.09.006; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nilsson J, 2009, NAT METHODS, V6, P809, DOI [10.1038/NMETH.1392, 10.1038/nmeth.1392]; Noto D, 2005, INT J CARDIOL, V101, P213, DOI 10.1016/j.ijcard.2004.03.018; Palsdottir A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000099; Paraoan L, 2004, TRAFFIC, V5, P884, DOI 10.1111/j.1600-0854.2004.00230.x; Paraoan L, 2000, INT J BIOCHEM CELL B, V32, P417, DOI 10.1016/S1357-2725(99)00143-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ratnayaka A, 2007, EXP EYE RES, V84, P1135, DOI 10.1016/j.exer.2006.01.030; Roks G, 2001, NEUROLOGY, V57, P366, DOI 10.1212/WNL.57.2.366-a; Ryan CM, 2010, J AM SOC MASS SPECTR, V21, P908, DOI 10.1016/j.jasms.2010.01.025; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; SUN Q, 1989, EXP CELL RES, V180, P150, DOI 10.1016/0014-4827(89)90219-X; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; VONHEIJNE G, 1982, J MOL BIOL, V159, P537, DOI 10.1016/0022-2836(82)90300-X; Wallin H, 2013, J BIOL CHEM, V288, P17019, DOI 10.1074/jbc.M113.453449; Wang BB, 2008, DEMENT GERIATR COGN, V25, P461, DOI 10.1159/000125670; Wei LH, 1998, J BIOL CHEM, V273, P11806, DOI 10.1074/jbc.273.19.11806; Yamamoto-Watanabe Y, 2010, BRAIN RES, V1361, P140, DOI 10.1016/j.brainres.2010.09.033; Zhang ZM, 2004, PROTEIN SCI, V13, P2819, DOI 10.1110/ps.04682504; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015; Zurdel J, 2002, BRIT J OPHTHALMOL, V86, P214, DOI 10.1136/bjo.86.2.214	61	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147684	10.1371/journal.pone.0147684	http://dx.doi.org/10.1371/journal.pone.0147684			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845025	Green Submitted, gold, Green Published			2022-12-27	WOS:000369552800012
J	Scheffer, HJ; Vogel, JA; van den Bos, W; Neal, RE; van Lienden, KP; Besselink, MGH; van Gemert, MJC; van der Geld, CWM; Meijerink, MR; Klaessens, JH; Verdaasdonk, RM				Scheffer, Hester J.; Vogel, Jantien A.; van den Bos, Willemien; Neal, Robert E., II; van Lienden, Krijn P.; Besselink, Marc G. H.; van Gemert, Martin J. C.; van der Geld, Cees W. M.; Meijerink, Martijn R.; Klaessens, John H.; Verdaasdonk, Rudolf M.			The Influence of a Metal Stent on the Distribution of Thermal Energy during Irreversible Electroporation	PLOS ONE			English	Article							TISSUE ABLATION; LIVER	Purpose Irreversible electroporation (IRE) uses short duration, high-voltage electrical pulses to induce cell death via nanoscale defects resulting from altered transmembrane potential. The technique is gaining interest for ablations in unresectable pancreatic and hepatobiliary cancer. Metal stents are often used for palliative biliary drainage in these patients, but are currently seen as an absolute contraindication for IRE due to the perceived risk of direct heating of the metal and its surroundings. This study investigates the thermal and tissue viability changes due to a metal stent during IRE. Methods IRE was performed in a homogeneous tissue model (polyacrylamide gel), without and with a metal stent placed perpendicular and parallel to the electrodes, delivering 90 and 270 pulses (15-35 A, 90 mu sec, 1.5 cm active tip exposure, 1.5 cm interelectrode distance, 1000-1500 V/cm, 90 pulses/min), and in-vivo in a porcine liver (4 ablations). Temperature changes were measured with an infrared thermal camera and with fiber-optic probes. Tissue viability after in-vivo IRE was investigated macroscopically using 5-triphenyltetrazolium chloride (TTC) vitality staining. Results In the gel, direct stent-heating was not observed. Contrarily, the presence of a stent between the electrodes caused a higher increase in median temperature near the electrodes (23.2 vs 13.3 degrees C [90 pulses]; p = 0.021, and 33.1 vs 24.8 degrees C [270 pulses]; p = 0.242). In-vivo, no temperature difference was observed for ablations with and without a stent. Tissue examination showed white coagulation 1mm around the electrodes only. A rim of vital tissue remained around the stent, whereas ablation without stent resulted in complete tissue avitality. Conclusion IRE in the vicinity of a metal stent does not cause notable direct heating of the metal, but results in higher temperatures around the electrodes and remnant viable tissue. Future studies should determine for which clinical indications IRE in the presence of metal stents is safe and effective.	[Scheffer, Hester J.; Meijerink, Martijn R.] Vrije Univ Amsterdam, Dept Radiol & Nucl Med, Med Ctr, Amsterdam, Netherlands; [Vogel, Jantien A.; Besselink, Marc G. H.] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [van den Bos, Willemien] Univ Amsterdam, Acad Med Ctr, Dept Urol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Neal, Robert E., II] Monash Univ, Alfred Hosp, Dept Radiol, Melbourne, Vic 3181, Australia; [van Lienden, Krijn P.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [van Gemert, Martin J. C.; Verdaasdonk, Rudolf M.] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [van der Geld, Cees W. M.] Eindhoven Univ Technol, Dept Mech Engn, NL-5600 MB Eindhoven, Netherlands; [Klaessens, John H.] Vrije Univ Amsterdam, Med Ctr, Dept Phys & Med Technol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Florey Institute of Neuroscience & Mental Health; Monash University; University of Amsterdam; University of Amsterdam; Eindhoven University of Technology; Vrije Universiteit Amsterdam	Scheffer, HJ (corresponding author), Vrije Univ Amsterdam, Dept Radiol & Nucl Med, Med Ctr, Amsterdam, Netherlands.	hj.scheffer@vumc.nl	Besselink, Marc/H-3294-2019; Besselink, Marc G/R-4268-2019	Besselink, Marc G/0000-0003-2650-9350; Klaessens, John/0000-0002-2798-2206; Meijerink, Martijn/0000-0002-1500-7294; Verdaasdonk, Rudolf/0000-0002-3115-637X	AngioDynamics	AngioDynamics	Robert E Neal recently began employment with AngioDynamics. Martijn R Meijerink and Krijn P van Lienden are paid consultants for AngioDynamics.	Al-Sakere B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001135; Ben-David E, 2013, RADIOLOGY, V269, P738, DOI 10.1148/radiol.13122590; Davalos RV, 2008, INT J HEAT MASS TRAN, V51, P5617, DOI 10.1016/j.ijheatmasstransfer.2008.04.046; Davalos RV, 2015, PROSTATE, V75, P1114, DOI 10.1002/pros.22986; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Dunki-Jacobs EM, 2014, BRIT J SURG, V101, P1113, DOI 10.1002/bjs.9536; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; Faroja M, 2013, RADIOLOGY, V266, P462, DOI 10.1148/radiol.12120609; FISHBEIN MC, 1981, AM HEART J, V101, P593, DOI 10.1016/0002-8703(81)90226-X; Garcia PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103083; Kamalski DMA, 2014, EUR ARCH OTO-RHINO-L, V271, P1477, DOI 10.1007/s00405-013-2624-8; Lee EW, 2012, J VASC INTERV RADIOL, V23, P107, DOI 10.1016/j.jvir.2011.09.020; Lee EW, 2010, GUT LIVER, V4, pS99, DOI 10.5009/gnl.2010.4.S1.S99; Lee YJ, 2012, INVEST RADIOL, V47, P671, DOI 10.1097/RLI.0b013e318274b0df; Mansson C, 2014, ACTA RADIOL OPEN, V3, DOI 10.1177/2047981614556409; Maor E, 2007, TECHNOL CANCER RES T, V6, P307, DOI 10.1177/153303460700600407; Melenhorst MCAM, 2016, CARDIOVASC INTER RAD, V39, P117, DOI 10.1007/s00270-015-1126-z; Miller L, 2005, TECHNOL CANCER RES T, V4, P699, DOI 10.1177/153303460500400615; Narayanan G, 2014, CARDIOVASC INTER RAD, V37, P1523, DOI 10.1007/s00270-014-0988-9; Neal RE, 2013, CARDIOVASC INTER RAD, V36, P1638, DOI 10.1007/s00270-013-0704-1; Pavlin M, 2005, BIOPHYS J, V88, P4378, DOI 10.1529/biophysj.104.048975; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Sawas T, 2015, GASTROINTEST ENDOSC, V82, P256, DOI 10.1016/j.gie.2015.03.1980; Scheffer HJ, 2014, EUR RADIOL, V24, P2467, DOI 10.1007/s00330-014-3259-x; Scheffer HJ, 2015, ACTA RADIOL OPEN, V4, DOI 10.1177/2058460115584111; Tol JA, 2015, GUT; van den Bos W, 2016, J VASC INTERV RADIOL, V27, P433, DOI 10.1016/j.jvir.2015.10.020; van Gemert MJC, 2015, PROSTATE, V75, P332, DOI 10.1002/pros.22913; Verdaasdonk RM, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2338817; Wagstaff PGK, 2015, UROL ONCOL, V33, p168e1	30	20	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148457	10.1371/journal.pone.0148457	http://dx.doi.org/10.1371/journal.pone.0148457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844550	Green Published, gold, Green Submitted			2022-12-27	WOS:000369552800059
J	Imamura, K; Kawakami, N; Inoue, A; Shimazu, A; Tsutsumi, A; Takahashi, M; Totsuzaki, T				Imamura, Kotaro; Kawakami, Norito; Inoue, Akiomi; Shimazu, Akihito; Tsutsumi, Akizumi; Takahashi, Masaya; Totsuzaki, Takafumi			Work Engagement as a Predictor of Onset of Major Depressive Episode (MDE) among Workers, Independent of Psychological Distress: A 3-Year Prospective Cohort Study	PLOS ONE			English	Article							JAPANESE VERSION; DISORDERS; WORKAHOLISM; PERFORMANCE; VALIDATION; ANXIETY; FUTURE	Objective This study investigated work engagement as a baseline predictor of onset of major depressive episode (MDE). Methods The study used a prospective cohort design, conforming to the STROBE checklist. Participants were recruited from the employee population of a private think tank company (N = 4,270), and 1,058 (24.8%) of them completed a baseline survey, of whom 929 were included in this study. Work engagement and psychological distress at baseline were assessed as predictor variables. MDE was measured at baseline and at each of the follow-ups as the outcome, using the web-based, self-administered version of the Japanese WHO-CIDI 3.0 depression section based upon DSM-IV-TR/DSM-5 criteria. Cox discrete-time hazards analyses were conducted to estimate hazard ratios (95% confidence intervals CIs). Results Follow-up rates of participants (N = 929) were 78.4%, 67.2%, and 51.6% at 1-, 2-, and 3-year follow-ups, respectively. The association between work engagement at baseline and the onset of MDE was U-shaped. Compared with a group with low work engagement scores, groups with the middle and high scores showed significantly (HR = 0.19, 95% CI = 0.05 to 0.64; p = 0.007) and marginally significantly (HR = 0.48, 95% CI = 0.20 to 1.15, p = 0.099) lower risks of MDE, respectively, over the follow-ups, after adjusting for covariates. The pattern remained the same after additionally adjusting for psychological distress. Conclusions The present study first demonstrated work engagement as an important predictor of the onset of MDE diagnosed according to an internationally standard diagnostic criteria of mental disorders.	[Imamura, Kotaro; Kawakami, Norito; Shimazu, Akihito] Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Tokyo, Japan; [Inoue, Akiomi] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Mental Hlth, Kitakyushu, Fukuoka 807, Japan; [Tsutsumi, Akizumi] Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa 228, Japan; [Takahashi, Masaya] Natl Inst Occupat Safety & Hlth, Hlth Adm & Psychosocial Factor Res Grp, Kawasaki, Kanagawa, Japan; [Totsuzaki, Takafumi] Mizuho Hlth Insurance Soc, Uchisaiwaicho Med Ctr, Tokyo, Japan	University of Tokyo; University of Occupational & Environmental Health - Japan; Kitasato University	Kawakami, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Tokyo, Japan.	nkawakami@m.u-tokyo.ac.jp		Shimazu, Akihito/0000-0002-7172-0043	Ministry of Education, Culture, Sports, Science and Technology, Japan [4102-21119001]; KAKENHI from the Japan Society for the Promotion of Science [26253042, 26860433]; Ministry of Health, Labour and Welfare, Japan [H27-Rodo-Ippan-004]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	The present study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Research Area) 2009-2013 (No. 4102-21119001) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm), The KAKENHI Grant Number 26253042 & 26860433 from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/jgrantsinaid/), and the Health and Labor Sciences Research Grant 2015-2017 (H27-Rodo-Ippan-004) from the Ministry of Health, Labour and Welfare, Japan. (http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Bakker AB, 2010, WORK ENGAGEMENT: A HANDBOOK OF ESSENTIAL THEORY AND RESEARCH, P181; Cuijpers P, 2004, ACTA PSYCHIAT SCAND, V109, P325, DOI 10.1111/j.1600-0447.2004.00301.x; de Beer LT, 2016, STRESS HEALTH, V32, P36, DOI 10.1002/smi.2576; Eguchi H, 2014, INT ARCH OCC ENV HEA, P1; Ehlert U, 2001, BIOL PSYCHOL, V57, P141, DOI 10.1016/S0301-0511(01)00092-8; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Hakanen JJ, 2012, J AFFECT DISORDERS, V141, P415, DOI 10.1016/j.jad.2012.02.043; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Innstrand ST, 2012, STRESS HEALTH, V28, P1, DOI 10.1002/smi.1395; Inoue A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091583; Inoue A, 2013, J OCCUP HEALTH, V55, P47, DOI 10.1539/joh.12-0131-OA; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Kendler KS, 2006, AM J PSYCHIAT, V163, P115, DOI 10.1176/appi.ajp.163.1.115; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2012, PSYCHIAT CLIN N AM, V35, P1, DOI 10.1016/j.psc.2011.11.005; Langelaan S, 2006, SCAND J WORK ENV HEA, V32, P339, DOI 10.5271/sjweh.1029; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Peters L, 1998, PSYCHOL MED, V28, P893, DOI 10.1017/S0033291798006655; RUBINSTEIN LV, 1981, J CHRON DIS, V34, P469, DOI 10.1016/0021-9681(81)90007-2; Saarni SI, 2007, BRIT J PSYCHIAT, V190, P326, DOI 10.1192/bjp.bp.106.025106; Schaufeli W.B., 2003, UWES UTRECHT W UNPUB; Schaufeli W.B., 2002, J HAPPINESS STUD, V3, P72, DOI [10.1023/A:1015630930326, DOI 10.1023/A:1015630930326]; Schaufeli WB, 2004, APPL PSYCHOL-INT REV, V53, P502, DOI 10.1111/j.1464-0597.2004.00184.x; Shimazu A, 2008, APPL PSYCHOL-INT REV, V57, P510, DOI 10.1111/j.1464-0597.2008.00333.x; Shimazu A, 2015, INT J BEHAV MED, V22, P18, DOI 10.1007/s12529-014-9410-x; Shimazu A, 2012, IND HEALTH, V50, P316, DOI 10.2486/indhealth.MS1355; Shimazu A, 2010, BIOPSYCHOSOC MED, V4, DOI 10.1186/1751-0759-4-17; Shimoda H, 2014, INT J METH PSYCH RES, V2014, DOI [10.1002/mpr.437, 10.1002/mpr.1437, DOI 10.1002/MPR.437]; Wang JL, 2013, J AFFECT DISORDERS, V151, P39, DOI 10.1016/j.jad.2013.05.045	32	24	27	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148157	10.1371/journal.pone.0148157	http://dx.doi.org/10.1371/journal.pone.0148157			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26841020	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200088
J	Connor, DO; Zantow, J; Hust, M; Bier, FF; von Nickisch-Rosenegk, M				Connor, Daniel O.; Zantow, Jonas; Hust, Michael; Bier, Frank F.; von Nickisch-Rosenegk, Markus			Identification of Novel Immunogenic Proteins of Neisseria gonorrhoeae by Phage Display	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; VACCINE ANTIGENS; GENE-EXPRESSION; MYCOBACTERIUM-TUBERCULOSIS; ANTIMICROBIAL RESISTANCE; RECOMBINANT ANTIBODIES; SALMONELLA-TYPHIMURIUM; UNTREATABLE GONORRHEA; MULTIDRUG-RESISTANT; ESCHERICHIA-COLI	Neisseria gonorrhoeae is one of the most prevalent sexually transmitted diseases worldwide with more than 100 million new infections per year. A lack of intense research over the last decades and increasing resistances to the recommended antibiotics call for a better understanding of gonococcal infection, fast diagnostics and therapeutic measures against N. gonorrhoeae. Therefore, the aim of this work was to identify novel immunogenic proteins as a first step to advance those unresolved problems. For the identification of immunogenic proteins, pHORF oligopeptide phage display libraries of the entire N. gonorrhoeae genome were constructed. Several immunogenic oligopeptides were identified using polyclonal rabbit antibodies against N. gonorrhoeae. Corresponding full-length proteins of the identified oligopeptides were expressed and their immunogenic character was verified by ELISA. The immunogenic character of six proteins was identified for the first time. Additional 13 proteins were verified as immunogenic proteins in N. gonorrhoeae.	[Connor, Daniel O.; von Nickisch-Rosenegk, Markus] Fraunhofer Inst Cell Therapy & Immunol, Branch Bioanalyt & Bioproc IZI BB, Dept Bioanalyt & Biosensor, Potsdam, Germany; [Zantow, Jonas; Hust, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, D-38106 Braunschweig, Germany; [Bier, Frank F.] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Bier, Frank F.] Fraunhofer Inst Cell Therapy & Immunol, Branch Bioanalyt & Bioproc IZI BB, Dept Biosyst Integrat & Automat, Potsdam, Germany	Fraunhofer Gesellschaft; Braunschweig University of Technology; University of Potsdam; Fraunhofer Gesellschaft	Connor, DO (corresponding author), Fraunhofer Inst Cell Therapy & Immunol, Branch Bioanalyt & Bioproc IZI BB, Dept Bioanalyt & Biosensor, Potsdam, Germany.	Daniel.Connor@izi-bb.fraunhofer.de	Bier, Frank/AAN-2532-2020	Bier, Frank/0000-0003-0375-9832; Hust, Michael/0000-0003-3418-6045	German Federal Ministry of Education and Research [03IS2201A]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by grant 03IS2201A of the German Federal Ministry of Education and Research (www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlaAldeen DAA, 1996, J MED MICROBIOL, V45, P419, DOI 10.1099/00222615-45-6-419; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bae JE, 2002, VET MICROBIOL, V88, P189, DOI 10.1016/S0378-1135(02)00101-3; Barbee LA, 2013, INFECT DIS CLIN N AM, V27, P723, DOI 10.1016/j.idc.2013.08.001; Becker M, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0167-3; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Bennett JE, 2015, MANDELL DOUGLAS BENN; Beranova-Giorgianni S, 2003, TRAC-TREND ANAL CHEM, V22, P273, DOI 10.1016/S0165-9936(03)00508-9; BLACK JR, 1985, J INFECT DIS, V151, P650, DOI 10.1093/infdis/151.4.650; Burlak C, 2007, CELL MICROBIOL, V9, P1172, DOI 10.1111/j.1462-5822.2006.00858.x; CANNON JG, 1989, CLIN MICROBIOL REV, V2, pS1, DOI 10.1128/CMR.2.Suppl.S1-S4.1989; Christodoulides M, 2014, EXPERT REV PROTEOMIC, V11, P573, DOI 10.1586/14789450.2014.938640; Cole MJ, 2014, EUROSURVEILLANCE, V19, P17, DOI 10.2807/1560-7917.ES2014.19.45.20955; Danckert L, 2014, MICROCHIM ACTA, V181, P1707, DOI 10.1007/s00604-014-1197-6; Dennehy R, 2012, CURR PROTEIN PEPT SC, V13, P807, DOI 10.2174/138920312804871184; Dietrich M, 2009, FEBS J, V276, P5507, DOI 10.1111/j.1742-4658.2009.07234.x; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Dobrindt U, 2002, INFECT IMMUN, V70, P6365, DOI 10.1128/IAI.70.11.6365-6372.2002; Dorman CJ, 2003, CURR OPIN GENET DEV, V13, P179, DOI 10.1016/S0959-437X(03)00025-X; Dubel S, 2010, TRENDS BIOTECHNOL, V28, P333, DOI 10.1016/j.tibtech.2010.05.001; Fantappie L, 2009, INFECT IMMUN, V77, P1842, DOI 10.1128/IAI.01216-08; Ferrari G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/pmic.200500164; Gil J, 2009, HUM VACCINES, V5, P347, DOI 10.4161/hv.5.5.7367; Grifantini R, 2002, ANN NY ACAD SCI, V975, P202, DOI 10.1111/j.1749-6632.2002.tb05953.x; HAGBLOM P, 1985, NATURE, V315, P156, DOI 10.1038/315156a0; HANDSFIELD HH, 1974, NEW ENGL J MED, V290, P117, DOI 10.1056/NEJM197401172900301; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; Holmes KK, 2008, SEXUALLY TRANSMITTED, V4th; HOOGENBOOM HR, 1992, J MOL BIOL, V227, P381, DOI 10.1016/0022-2836(92)90894-P; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Hoppe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065837; Hsu CA, 2008, PROTEOMICS, V8, P2115, DOI 10.1002/pmic.200700574; Hubalek M, 2003, J CHROMATOGR B, V787, P149, DOI 10.1016/S1570-0232(02)00730-4; Hust Michael, 2007, V408, P243, DOI 10.1007/978-1-59745-547-3_14; Hust M, 2006, BIOTECHNIQUES, V41, P335, DOI 10.2144/000112225; Jacobsson Karin, 2003, Biological Procedures Online, V5, P123, DOI 10.1251/bpo54; JANOSI L, 1994, P NATL ACAD SCI USA, V91, P4249, DOI 10.1073/pnas.91.10.4249; JOHN J, 1978, BRIT J VENER DIS, V54, P322; Kelly DF, 2005, ADV EXP MED BIOL, V568, P217; Knaust A, 2007, J BACTERIOL, V189, P3246, DOI 10.1128/JB.01966-06; Kovach AR, 2014, RNA, V20, P1548, DOI 10.1261/rna.044032.113; Kugler J, 2008, APPL MICROBIOL BIOT, V80, P447, DOI 10.1007/s00253-008-1576-1; Kugler J, 2013, VIRUSES-BASEL, V5, P2531, DOI 10.3390/v5102531; Kurz S, 2003, VACCINE, V21, P768, DOI 10.1016/S0264-410X(02)00596-0; Kwiatek A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00712; LaFrentz BR, 2011, J FISH DIS, V34, P823, DOI 10.1111/j.1365-2761.2011.01297.x; Mendum TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005940; Meyer T, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-29; MILLER HI, 1981, P NATL ACAD SCI-BIOL, V78, P6754, DOI 10.1073/pnas.78.11.6754; MULKS MH, 1978, NEW ENGL J MED, V299, P973, DOI 10.1056/NEJM197811022991802; Naseem S, 2010, VET MICROBIOL, V142, P285, DOI 10.1016/j.vetmic.2009.09.071; Nowalk AJ, 2006, INFECT IMMUN, V74, P3864, DOI 10.1128/IAI.00189-06; Ohnishi M, 2011, ANTIMICROB AGENTS CH, V55, P3538, DOI 10.1128/AAC.00325-11; PANNEKOEK Y, 1995, MOL MICROBIOL, V15, P277, DOI 10.1111/j.1365-2958.1995.tb02242.x; Papp JR, 2014, MMWR RECOMM REP, V63, P1; Pawlik MC, 2012, J BACTERIOL, V194, P6594, DOI 10.1128/JB.01091-12; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piekarowicz A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-66; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Qamra R, 2005, TUBERCULOSIS, V85, P385, DOI 10.1016/j.tube.2005.08.014; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; Rondot S, 2001, NAT BIOTECHNOL, V19, P75, DOI 10.1038/83567; Rotman E, 2014, ANNU REV GENET, V48, P405, DOI 10.1146/annurev-genet-120213-092007; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sambrook J., 2001, MOL CLONING LAB MANU; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Soltes G, 2007, J BIOTECHNOL, V127, P626, DOI 10.1016/j.jbiotec.2006.08.015; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Spence JM, 2002, MICROB PATHOGENESIS, V32, P117, DOI 10.1006/mpat.2001.0484; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; SVENSSON L, 1980, AM J OBSTET GYNECOL, V138, P1017, DOI 10.1016/0002-9378(80)91099-6; SWANSON J, 1982, INFECT IMMUN, V38, P668, DOI 10.1128/IAI.38.2.668-672.1982; Tapsall John W, 2009, Expert Rev Anti Infect Ther, V7, P821, DOI 10.1586/eri.09.63; Tsolakos N, 2014, J PROTEOMICS, V101, P63, DOI 10.1016/j.jprot.2014.02.013; Tureci O, 1997, MOL MED TODAY, V3, P342, DOI 10.1016/S1357-4310(97)01081-2; Unemo M, 2012, FUTURE MICROBIOL, V7, P1401, DOI [10.2217/FMB.12.117, 10.2217/fmb.12.117]; Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010, ORAL CEPHALOSPORINS; Urquhart BL, 1998, BIOCHEM BIOPH RES CO, V253, P70, DOI 10.1006/bbrc.1998.9709; Vaughan TE, 2006, VACCINE, V24, P5277, DOI 10.1016/j.vaccine.2006.03.013; WALLIN J, 1975, BRIT J VENER DIS, V51, P41; Weng JW, 2009, BIOPHYS J, V96, P1918, DOI 10.1016/j.bpj.2008.11.035; WHO, 2012, WHO GLOB ACT PLAN CO; Williams JN, 2007, INFECT IMMUN, V75, P1364, DOI 10.1128/IAI.01424-06; Williams JN, 2014, VACCINE, V32, P1280, DOI 10.1016/j.vaccine.2013.12.070; Williams JN, 2009, INFECT IMMUN, V77, P5080, DOI 10.1128/IAI.00701-09; Workowski KA, 2008, ANN INTERN MED, V148, P606, DOI 10.7326/0003-4819-148-8-200804150-00005; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhu H, 2006, P NATL ACAD SCI USA, V103, P4011, DOI 10.1073/pnas.0510921103	96	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148986	10.1371/journal.pone.0148986	http://dx.doi.org/10.1371/journal.pone.0148986			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859666	Green Published, gold, Green Submitted			2022-12-27	WOS:000370038400115
J	Kavlashvili, T; Jia, YC; Dai, DH; Meng, XB; Thiel, KW; Leslie, KK; Yang, SJ				Kavlashvili, Tamar; Jia, Yichen; Dai, Donghai; Meng, Xiangbing; Thiel, Kristina W.; Leslie, Kimberly K.; Yang, Shujie			Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer	PLOS ONE			English	Article							BREAST-CANCER; EXPRESSION; ESTROGEN; RESPONSIVENESS; MECHANISMS; INHIBITORS; PROMOTERS; CARCINOMA; CELLS; WOMEN	Endometrial cancer, the most common gynecologic malignancy, is a hormonally-regulated disease. Response to progestin therapy positively correlates with hormone receptor expression, in particular progesterone receptor (PR). However, many advanced tumors lose PR expression. We recently reported that the efficacy of progestin therapy can be significantly enhanced by combining progestin with epigenetic modulators, which we term "molecularly enhanced progestin therapy." What remained unclear was the mechanism of action and if estrogen receptor alpha (ER alpha), the principle inducer of PR, is necessary to restore functional expression of PR via molecularly enhanced progestin therapy. Therefore, we modeled advanced endometrial tumors that have lost both ER alpha and PR expression by generating ER alpha-null endometrial cancer cell lines. CRISPR-Cas9 technology was used to delete ER alpha at the genomic level. Our data demonstrate that treatment with a histone deacetylase inhibitor (HDACi) was sufficient to restore functional PR expression, even in cells devoid of ER alpha. Our studies also revealed that HDACi treatment results in marked downregulation of the oncogene Myc. We established that PR is a negative transcriptional regulator of Myc in endometrial cancer in the presence or absence of ER alpha, which is in contrast to studies in breast cancer cells. First, estrogen stimulation augmented PR expression and decreased Myc in endometrial cancer cell lines. Second, progesterone increased PR activity yet blunted Myc mRNA and protein expression. Finally, overexpression of PR by adenoviral transduction in ER alpha-null endometrial cancer cells significantly decreased expression of Myc and Myc-regulated genes. Analysis of the Cancer Genome Atlas (TCGA) database of endometrial tumors identified an inverse correlation between PR and Myc mRNA levels, with a corresponding inverse correlation between PR and Myc downstream transcriptional targets SRD5A1, CDK2 and CCNB1. Together, these data reveal a previously unanticipated inverse relationship between the tumor suppressor PR and the oncogene Myc in endometrial cancer.	[Kavlashvili, Tamar; Jia, Yichen; Dai, Donghai; Meng, Xiangbing; Thiel, Kristina W.; Leslie, Kimberly K.; Yang, Shujie] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; [Meng, Xiangbing; Leslie, Kimberly K.; Yang, Shujie] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA; [Jia, Yichen] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA	University of Iowa; University of Iowa; University of Washington; University of Washington Seattle	Yang, SJ (corresponding author), Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA.; Yang, SJ (corresponding author), Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA.	Shujie-yang@uiowa.edu		Dai, Donghai/0000-0002-9670-7822; Leslie, Kimberly/0000-0002-2704-8990; meng, xiangbing/0000-0002-9612-6438; Jia, Yichen/0000-0002-9127-5610; Thiel, Kristina/0000-0001-8295-864X; Yang, Shujie/0000-0003-1753-3068	American Cancer Society Institutional Research Grant; NIH [R01CA99908, R01CA184101]; Department of Obstetrics and Gynecology Research Development Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD063117] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA099908, P30CA086862, R01CA184101] Funding Source: NIH RePORTER	American Cancer Society Institutional Research Grant(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Obstetrics and Gynecology Research Development Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the American Cancer Society Institutional Research Grant (SY), and the NIH R01CA99908 and R01CA184101 (KKL), the Department of Obstetrics and Gynecology Research Development Fund (KKL). The funders did not play a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2015, CANC FACTS FIG; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Diep CH, 2015, J MOL ENDOCRINOL, V54, pR31, DOI 10.1530/JME-14-0252; DUBIK D, 1987, CANCER RES, V47, P6517; Gabay M, 2014, COLD SPRING HARB PER, V4; Giulianelli S, 2012, CANCER RES, V72, P2416, DOI 10.1158/0008-5472.CAN-11-3290; Hunter DJ, 2010, CANCER EPIDEM BIOMAR, V19, P2496, DOI 10.1158/1055-9965.EPI-10-0747; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Lee JH, 2012, ADV CANCER RES, V116, P39, DOI 10.1016/B978-0-12-394387-3.00002-1; Leslie KK, 2005, GYNECOL ONCOL, V96, P32, DOI 10.1016/j.ygyno.2004.09.057; Li CI, 2012, CANCER RES, V72, P2028, DOI 10.1158/0008-5472.CAN-11-4064; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McEwan MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049160; McKeown MR, 2014, COLD SPRING HARB PER, V4; Moore MR, 1997, J STEROID BIOCHEM, V62, P243, DOI 10.1016/S0960-0760(97)00036-8; Nishida Masato, 2002, Hum Cell, V15, P104, DOI 10.1111/j.1749-0774.2002.tb00105.x; Prystowsky MB, 2009, J PATHOL, V218, P467, DOI 10.1002/path.2554; Raeder MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054873; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Singh M, 2007, GYNECOL ONCOL, V106, P325, DOI 10.1016/j.ygyno.2007.03.042; Tansey WP, 2014, N J SCI, V2014, P27; Wargon V, 2015, INT J CANCER, V136, P2680, DOI 10.1002/ijc.29304; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Yang S, 2013, CURR PHARM DES; Yang SJ, 2014, ONCOTARGET, V5, P9783, DOI 10.18632/oncotarget.2392; Yang SJ, 2011, DISCOV MED, V12, P205; Yang S, 2011, TRENDS ENDOCRIN MET, V22, P145, DOI 10.1016/j.tem.2011.01.005	27	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148912	10.1371/journal.pone.0148912	http://dx.doi.org/10.1371/journal.pone.0148912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859414	gold, Green Published			2022-12-27	WOS:000370038400103
J	Val, S; Burgett, K; Brown, KJ; Preciado, D				Val, Stephanie; Burgett, Katelyn; Brown, Kristy J.; Preciado, Diego			SuperSILAC Quantitative Proteome Profiling of Murine Middle Ear Epithelial Cell Remodeling with NTHi	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; EXPRESSION; METAPLASIA; EFFUSION; PHOSPHORYLATION; PROLIFERATION; MANAGEMENT; INDUCTION; DIAGNOSIS; PATHOLOGY	Background Chronic Otitis Media with effusion (COME) develops after sustained inflammation and is characterized by secretory middle ear epithelial metaplasia and effusion, most frequently mucoid. Non-typeable Haemophilus influenzae (NTHi), the most common acute Otitis Media (OM) pathogen, is postulated to promote middle ear epithelial remodeling in the progression of OM from acute to chronic. The goals of this study were to examine histopathological and quantitative proteomic epithelial effects of NTHi challenge in a murine middle ear epithelial cell line. Methods NTHi lysates were generated and used to stimulate murine epithelial cells (mMEEC) cultured at air-liquid interface over 48 hours-1 week. Conditional quantitative Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) of cell lysates was performed to interrogate the global protein production in the cells, using the SuperSILAC technique. Histology of the epithelium over time was done to measure bacterial dependent remodeling. Results Mass spectrometry analysis identified 2,565 proteins across samples, of which 74 exhibited differential enrichment or depletion in cell lysates (+/-2.0 fold-change; p value<0.05). The key molecular functions regulated by NTHi lysates exposure were related to cell proliferation, death, migration, adhesion and inflammation. Finally, chronic exposure induced significant epithelial thickening of cells grown at air liquid interface. Conclusions NTHi lysates drive pathways responsible of cell remodeling in murine middle ear epithelium which likely contributes to observed epithelial hyperplasia in vitro. Further elucidation of these mediators will be critical in understanding the progression of OM from acute to chronic at the molecular level.	[Val, Stephanie; Burgett, Katelyn; Preciado, Diego] Childrens Natl Hlth Syst, Sheikh Zayed Ctr Pediat Surg Innovat, Washington, DC USA; [Brown, Kristy J.] Childrens Natl Hlth Syst, Med Genet Res Ctr, Washington, DC USA; [Preciado, Diego] Childrens Natl Hlth Syst, Div Pediat Otolaryngol, Washington, DC USA	Children's National Health System; Children's National Health System; Children's National Health System	Preciado, D (corresponding author), Childrens Natl Hlth Syst, Sheikh Zayed Ctr Pediat Surg Innovat, Washington, DC USA.; Preciado, D (corresponding author), Childrens Natl Hlth Syst, Div Pediat Otolaryngol, Washington, DC USA.	dpreciad@cnmc.org			NIDCD [R01DC012377]; National Institute of Health (NIH) [P30HD040677]; NIH [2R24HD050846-06, NICHD 5P30HD040677, UL1TR000075]; CRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677, R24HD050846] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012377] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by R01DC012377 from the NIDCD. Microscopic analysis was carried out at the Children's Research Institute (CRI) Light Microscopy and Image Analysis Core supported by CRI and National Institute of Health (NIH) grant P30HD040677. This work was partially supported by NIH core grants 2R24HD050846-06 (National Center for Medical Rehabilitation Research), NICHD 5P30HD040677 (Intellectual and Developmental Disabilities Research Center) and UL1TR000075 (NIH National Center for Advancing Translational Sciences). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2014, LARYNGOSCOPE, V124, P301, DOI 10.1002/lary.24190; Bluestone C.D, 1996, PEDIAT OTOLARYNGOLOG; Brown KJ, 1834, BIOCHIM BIOPHYS ACTA, P2454; Casey JR, 2004, PEDIATR INFECT DIS J, V23, P824, DOI 10.1097/01.inf.0000136871.51792.19; Caye-Thomasen P, 2002, INT J PEDIATR OTORHI, V63, P99, DOI 10.1016/S0165-5876(01)00641-3; Cherry Donald K, 2002, Adv Data, P1; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; He JS, 2014, J BREAST CANCER, V17, P200, DOI 10.4048/jbc.2014.17.3.200; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Klein JO, 2002, PEDIATR ANN, V31, P777, DOI 10.3928/0090-4481-20021201-06; Koch PJ, 2004, J INVEST DERMATOL, V123, pX, DOI 10.1111/j.0022-202X.2004.23495.x; Lee HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-87; LEUBE RE, 1991, VIRCHOWS ARCH B, V61, P227; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; LIM DJ, 1971, ANN OTO RHINOL LARYN, V80, P838, DOI 10.1177/000348947108000611; Maeda K, 2004, LARYNGOSCOPE, V114, P1967, DOI 10.1097/01.mlg.0000147930.29261.51; Mazzalupo S, 2003, DEV DYNAM, V226, P356, DOI 10.1002/dvdy.10245; Moghaddam SJ, 2008, AM J RESP CELL MOL, V38, P629, DOI 10.1165/rcmb.2007-0366OC; MOLL R, 1989, VIRCHOWS ARCH B, V58, P129, DOI 10.1007/BF02890064; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Ninkina NN, 1999, EXP CELL RES, V246, P308, DOI 10.1006/excr.1998.4292; Paramio JM, 1999, EUR J CELL BIOL, V78, P33, DOI 10.1016/S0171-9335(99)80005-3; Preciado D PM, 2015, INT J PEDIA IN PRESS; Preciado D, 2008, LARYNGOSCOPE, V118, P464, DOI 10.1097/MLG.0b013e31815aedc7; Preciado D, 2013, LARYNGOSCOPE, V123, pE66, DOI 10.1002/lary.24097; Preciado D, 2010, PEDIATR RES, V68, P231, DOI 10.1203/00006450-201011001-00451; Rosenfeld RM, 2004, PEDIATRICS, V113, P1412, DOI 10.1542/peds.113.5.1412; Rosenfeld RM, 2001, OTOLARYNG HEAD NECK, V125, P440, DOI 10.1067/mhn.2001.119326; Ruhrberg C, 1997, CURR OPIN GENET DEV, V7, P392, DOI 10.1016/S0959-437X(97)80154-2; RYAN AF, 1993, ACTA OTO-LARYNGOL, V113, P68, DOI 10.3109/00016489309135769; Ryan AF, 2005, ANN OTO RHINOL LARYN, V114, P42, DOI 10.1177/00034894051140S106; Sevilla LM, 2007, J CELL BIOL, V179, P1599, DOI 10.1083/jcb.200706187; Storck Sebastien, 2007, Subcell Biochem, V41, P125; STOSIEK P, 1992, VIRCHOWS ARCH A, V421, P133, DOI 10.1007/BF01607046; TOS M, 1977, ANN OTO RHINOL LARYN, V86, P209, DOI 10.1177/000348947708600212; Tsuboi Y, 2002, ACTA OTO-LARYNGOL, V122, P153, DOI 10.1080/00016480252814153; Tsuchiya K, 2005, ACTA OTO-LARYNGOL, V125, P823, DOI 10.1080/00016480510031533; Val S, 2015, J INVEST MED, V63, P258, DOI 10.1097/JIM.0000000000000127; Waseem A, 1999, J INVEST DERMATOL, V112, P362, DOI 10.1046/j.1523-1747.1999.00535.x; Wu XF, 2011, AM J RESP CELL MOL, V45, P525, DOI 10.1165/rcmb.2010-0133OC; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148612	10.1371/journal.pone.0148612	http://dx.doi.org/10.1371/journal.pone.0148612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859300	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400057
J	Vives-Cases, C; Goicolea, I; Hernandez, A; Sanz-Barbero, B; Gill, AK; Baldry, AC; Schrottle, M; Stoeckl, H				Vives-Cases, Carmen; Goicolea, Isabel; Hernandez, Alison; Sanz-Barbero, Belen; Gill, Aisha K.; Baldry, Anna Costanza; Schroettle, Monika; Stoeckl, Heidi			Expert Opinions on Improving Femicide Data Collection across Europe: A Concept Mapping Study	PLOS ONE			English	Article							HUMAN-DEVELOPMENT INDEX; INTIMATE PARTNER HOMICIDE; VIOLENCE; HEALTH; WOMEN; COUNTRIES; MORTALITY; INDIA	Femicide, defined as the killings of females by males because they are females, is becoming recognized worldwide as an important ongoing manifestation of gender inequality. Despite its high prevalence or widespread prevalence, only a few countries have specific registries about this issue. This study aims to assemble expert opinion regarding the strategies which might feasibly be employed to promote, develop and implement an integrated and differentiated femicide data collection system in Europe at both the national and international levels. Concept mapping methodology was followed, involving 28 experts from 16 countries in generating strategies, sorting and rating them with respect to relevance and feasibility. The experts involved were all members of the EU-Cost-Action on femicide, which is a scientific network of experts on femicide and violence against women across Europe. As a result, a conceptual map emerged, consisting of 69 strategies organized in 10 clusters, which fit into two domains: "Political action" and "Technical steps". There was consensus among participants regarding the high relevance of strategies to institutionalize national databases and raise public awareness through different stakeholders, while strategies to promote media involvement were identified as the most feasible. Differences in perceived priorities according to the level of human development index of the experts' countries were also observed.	[Vives-Cases, Carmen] Univ Alicante, Dept Community Nursing Publ Hlth & Prevent Med &, E-03080 Alicante, Spain; [Vives-Cases, Carmen; Sanz-Barbero, Belen] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Vives-Cases, Carmen; Goicolea, Isabel] Univ Alicante, Publ Hlth Res Grp, E-03080 Alicante, Spain; [Goicolea, Isabel; Hernandez, Alison] Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth Unit, Umea, Sweden; [Sanz-Barbero, Belen] Inst Salud Carlos III, Escuela Nacl Sanidad, Madrid, Spain; [Gill, Aisha K.] Univ Roehampton, Dept Social Sci, London, England; [Baldry, Anna Costanza] Univ Naples 2, Dept Psychol, Naples, Italy; [Schroettle, Monika] Tech Univ Dortmund, Dept Rehabil Sci, Dormund, Germany; [Stoeckl, Heidi] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England	Universitat d'Alacant; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universitat d'Alacant; Umea University; Instituto de Salud Carlos III; Escuela Nacional de Sanidad (ENS); Roehampton University; Universita della Campania Vanvitelli; Dortmund University of Technology; University of London; London School of Hygiene & Tropical Medicine	Vives-Cases, C (corresponding author), Univ Alicante, Dept Community Nursing Publ Hlth & Prevent Med &, E-03080 Alicante, Spain.; Vives-Cases, C (corresponding author), CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain.; Vives-Cases, C (corresponding author), Univ Alicante, Publ Hlth Res Grp, E-03080 Alicante, Spain.	carmen.vives@ua.es	SANZ BARBERO, BELEN/F-2383-2016; Vives-Cases, Carmen/ABC-5170-2021	SANZ BARBERO, BELEN/0000-0001-6030-061X; Vives-Cases, Carmen/0000-0002-6797-5051; Goicolea, Isabel/0000-0002-8114-4705; Hernandez, Alison/0000-0001-7250-9891; Stockl, Heidi/0000-0002-0907-8483; Baldry, Anna Costanza/0000-0003-3520-0048	Umea Center for Global Health Research - FORTE, the Swedish Council for Working Life and Social Research [2006-1512]	Umea Center for Global Health Research - FORTE, the Swedish Council for Working Life and Social Research	This study received funding from Umea Center for Global Health Research, funded by FORTE, the Swedish Council for Working Life and Social Research (grant no. 2006-1512). With this funding it was possible to do the data collection and analyses with the appropriate software. The authors didn't receive any other funding for the study design and preparation of the manuscript.	Banks E, 2006, LANCET, V367, P1835, DOI 10.1016/S0140-6736(06)68805-3; Burke JG, 2005, QUAL HEALTH RES, V15, P1392, DOI 10.1177/1049732305278876; Castillo-Salgado C, 2002, MODULOS PRINCIPIOS E, P52; Concept Systems Incorporated, 2013, CONC SYST SOFTW; Corradi C, 2014, EUR J CRIMINOL, V11, P601, DOI 10.1177/1477370814539438; Cost European Cooperation in Science and Technology, COST COST; Cost European Cooperation in Science and Technology, FEM EUR COST ACT IS; Dawson M., 1998, HOMICIDE STUD, V2, P378, DOI DOI 10.1177/1088767998002004003; Dobash RP, 2012, VIOLENCE AGAINST WOM, V18, P662, DOI 10.1177/1077801212453984; Doiron D, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-12; Dumith SC, 2011, PREV MED, V53, P24, DOI 10.1016/j.ypmed.2011.02.017; Eurostat, DEATH DUE HOM ASS SE; George SM, 2006, PRENATAL DIAG, V26, P604, DOI 10.1002/pd.1475; Heidi Stockl CV-C, ISSUES MEAS IN PRESS; Holder Y., 2001, INJURY SURVEILLANCE; Hu QD, 2013, WORLD J GASTROENTERO, V19, P5261, DOI 10.3748/wjg.v19.i32.5261; Kane M, 2007, CONCEPT MAPPING PLAN; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Kubai A, 2013, ETHNIC HEALTH, V18, P469, DOI 10.1080/13557858.2013.832012; Laurent C, 2013, GLOBAL ISSUE DEMANDS; Manjoo MR, 2011, FEMICIDE FEMINICIDE; Nasrullah M, 2009, EUR J PUBLIC HEALTH, V19, P193, DOI 10.1093/eurpub/ckp021; Oliveira Mirella Gondim Ozias Aquino de, 2013, Rev Bras Epidemiol, V16, P178, DOI 10.1590/S1415-790X2013000100017; Porter T, 2010, TRAUMA VIOLENCE ABUS, V11, P99, DOI 10.1177/1524838010371950; Rastogi M, 2006, TRAUMA VIOLENCE ABUS, V7, P66, DOI 10.1177/1524838005283927; Rodrigues-Júnior Antonio Luiz, 2014, Rev. bras. epidemiol., V17, P204, DOI 10.1590/1809-4503201400060017; Rodriguez-Morales AJ, 2012, INT J INFECT DIS, V16, pE704, DOI 10.1016/j.ijid.2012.04.011; Roy A, 2015, HEART, V101, P279, DOI 10.1136/heartjnl-2014-306389; Russell D.E.H., 2001, FEMICIDE GLOBAL PERS; Russell Diana, 1992, FEMICIDE POLITICS WO; Secretariat GD, 2011, GLOB BURD ARM VIOL 2; Shah A, 2010, INT PSYCHOGERIATR, V22, P727, DOI 10.1017/S1041610210001110; Stockl H, 2013, LANCET, V382, P859, DOI 10.1016/S0140-6736(13)61030-2; Trochim William M K, 2004, Health Promot Pract, V5, P8, DOI 10.1177/1524839903258020; UN/ ACUN, 2014, FEM GLOB ISS DEM ACT; United Nations Development Programme, HUM DEV REP; Walby S., 2009, COST DOMESTIC VIOLEN; Waltz T.J., 2015, IMPLEMENT SCI, V10, pA44, DOI [10.1186/1748-5908-10-S1-A44, DOI 10.1186/1748-5908-10-S1-A44]; Westra BL, 2015, J AM MED INFORM ASSN, V22, P600, DOI 10.1093/jamia/ocu011; WHO, 2011, COUNTR HLTH INF SYST; WHO Pan American Health Organization, 2012, UND ADDR VIOL WOM; Witkin B. R., 1997, INT J LISTENING, V11, P69, DOI [10.1207/s1932586xijl1101_5, DOI 10.1207/S1932586XIJL1101_5]; World Health Organization, 2011, MON EV REV NAT HLTH	43	21	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148364	10.1371/journal.pone.0148364	http://dx.doi.org/10.1371/journal.pone.0148364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859885	gold, Green Published, Green Accepted			2022-12-27	WOS:000370038400037
J	Chaw, L; Kamigaki, T; Burmaa, A; Urtnasan, C; Od, I; Nyamaa, G; Nymadawa, P; Oshitani, H				Chaw, Liling; Kamigaki, Taro; Burmaa, Alexanderyn; Urtnasan, Chuluunbatiin; Od, Ishiin; Nyamaa, Gunregjaviin; Nymadawa, Pagbajabyn; Oshitani, Hitoshi			Burden of Influenza and Respiratory Syncytial Virus Infection in Pregnant Women and Infants Under 6 Months in Mongolia: A Prospective Cohort Study	PLOS ONE			English	Article							ANTIBODY-RESPONSES; TRACT INFECTIONS; ILLNESS; HOSPITALIZATIONS; VACCINE; IMMUNIZATION; CHILDREN; PROTECTION; IMPACT; RECOMMENDATIONS	Background Pregnant women and infants under 6 months are at risk of influenza-related complications. Limited information exists on their community burden of respiratory viruses. Methods and Findings This prospective, observational open cohort study was conducted in Baganuur district, Ulaanbaatar, Mongolia during 2013/14 and 2014/15 influenza seasons. Influenza-like illness (ILI) and severe acute respiratory infection (sARI) were identified by follow-up calls twice a week. For those identified, influenza and respiratory syncytical virus (RSV) were tested by point-of-care test kits. We calculated overall and stratified (by trimester or age group) incidence rates (IR) and used Cox proportional hazard regression for risk factor analyses. Among 1260 unvaccinated pregnant women enrolled, overall IRs for ILI, sARI and influenza A were 11.8 (95% confidence interval (C.I): 11.2-12.4), 0.1 (95% C.I: 0.0-0.4), and 1.7 (95% C.I: 1.5-1.9) per 1,000person-days, respectively. One sARI case was influenza A positive. IRs and adjusted hazard ratios (Adj.HR) for ILI and influenza A were lowest in the third trimester. Those with co-morbidity were 1.4 times more likely to develop ILI [Adj.HR: 1.4 (95% C.I: 1.1-1.9)]. Among 1304 infants enrolled, overall ILI and sARI IRs were 15.2 (95% C.I: 14.5-15.8) and 20.5 (95% C.I: 19.7-21.3) per 1,000person-days, respectively. From the tested ILI (77.6%) and sARI (30.6%) cases, the overall positivity rates were 6.3% (influenza A), 1.1% (influenza B) and 9.3% (RSV). Positivity rates of influenza A and RSV tend to increase with age. sARI cases were 1.4 times more likely to be male [Adj.HR: 1.4 (95% C.I: 1.1-1.8)]. Among all influenza A and RSV positive infants, 11.8% and 68.0% were respectively identified among sARI hospitalized cases. Conclusion We observed low overall influenza A burden in both groups, though underestimation was likely due to point-of-care tests used. For infants, RSV burden was more significant than influenza A. These findings would be useful for establishing control strategies for both viruses in Mongolia.	[Chaw, Liling; Kamigaki, Taro; Oshitani, Hitoshi] Tohoku Univ, Dept Virol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Burmaa, Alexanderyn; Urtnasan, Chuluunbatiin; Nyamaa, Gunregjaviin; Nymadawa, Pagbajabyn] Natl Ctr Communicable Dis, Natl Influenza Ctr, Ulaanbaatar, Mongolia; [Nymadawa, Pagbajabyn] Mongolian Acad Med Sci, Ulaanbaatar, Mongolia	Tohoku University; National Center for Communicable Diseases of Mongolia; Mongolian Academy of Sciences	Kamigaki, T (corresponding author), Tohoku Univ, Dept Virol, Grad Sch Med, Sendai, Miyagi 980, Japan.	kamigakit@med.tohoku.ac.jp	Nymadawa, Pagbajab/AAE-7344-2019; Oshitani, Hitoshi/AAE-4349-2019; Chaw, Liling/R-1591-2019	Nymadawa, Pagbajab/0000-0002-3189-2772; Chaw, Liling/0000-0003-3301-7565	Japan Society for the Promotion of Science (KAKENHI) [24249041]; MEXT Monbukagakusho scholarship program	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT Monbukagakusho scholarship program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI) [Grant no. 24249041]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to express their gratitude to the following for their valuable support in this study: All personnel involved in the primary healthcare clinics and district hospital in Baganuur; personnel in National Influenza Center (NIC) and National Center for Communicable Diseases (NCCD) in Ulanbataar, Mongolia; Denka Seiken Co. Ltd, Japan who kindly donated point-of- care test kits in the 2014/15 season; and Dr. Mayuko Saito for her useful advice on the risk factor analyses. LC would also like to thank the MEXT Monbukagakusho scholarship program for financial support during her graduate study in Japan.	Anderson LJ, 2013, VACCINE S2, V31; [Anonymous], 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.1.009, 10.5365/WPSAR.2013.4.1.009]; [Anonymous], 2013, Obstet Gynecol, V122, P1139, DOI 10.1097/01.AOG.0000437385.88715.4a; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], 2015, SOC EC SIT MONG PREL; [Anonymous], 2014, R LANG ENV STAT COMP; Baigalmaa J, 2012, WEST PAC SURVEILL RE, V3, DOI [10.5365/wpsar.2010.1.1.006, 10.5365/WPSAR.2010.1.1.006]; Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309; Black SB, 2004, AM J PERINAT, V21, P333, DOI 10.1055/s-2004-831888; Blanchard-Rohner G, 2011, VACCINE, V29, P7542, DOI 10.1016/j.vaccine.2011.08.013; Brandenburg AH, 1997, J MED VIROL, V52, P97, DOI 10.1002/(SICI)1096-9071(199705)52:1&lt;97::AID-JMV16&gt;3.0.CO;2-Y; Burmaa A, 2014, INFLUENZA OTHER RESP, V8, P530, DOI 10.1111/irv.12268; Central Intelligence Agency (CIA), WORLD FACTB MONG; Chartrand C, 2012, ANN INTERN MED, V156, P500, DOI 10.7326/0003-4819-156-7-201204030-00403; Chu HY, 2014, J INFECT DIS, V210, P1582, DOI 10.1093/infdis/jiu316; Chu HY, 2014, CLIN INFECT DIS, V59, P560, DOI 10.1093/cid/ciu327; Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; Eick A, 2008, PEDIATR INFECT DIS J, V27, P207, DOI 10.1097/INF.0b013e31815ac585; Eick AA, 2011, ARCH PEDIAT ADOL MED, V165, P104, DOI 10.1001/archpediatrics.2010.192; ENGLUND JA, 1993, J INFECT DIS, V168, P647, DOI 10.1093/infdis/168.3.647; Evenson KR, 2010, PREV MED, V50, P123, DOI 10.1016/j.ypmed.2009.12.015; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Goodnight William H, 2005, Crit Care Med, V33, pS390, DOI 10.1097/01.CCM.0000182483.24836.66; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hall CB, 2001, CLIN INFECT DIS, V33, P792, DOI 10.1086/322657; Harper Scott A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Hartert TV, 2003, AM J OBSTET GYNECOL, V189, P1705, DOI 10.1016/S0002-9378(03)00857-3; Hasan R, 2014, PEDIATR INFECT DIS J, V33, pE45, DOI 10.1097/INF.0000000000000062; Hoo AF, 2002, AM J RESP CRIT CARE, V165, P1084, DOI 10.1164/ajrccm.165.8.2103035; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jedrychowski W, 2005, EUR J EPIDEMIOL, V20, P775, DOI 10.1007/s10654-005-1048-1; Jones M, 2000, AM J RESP CRIT CARE, V161, P353, DOI 10.1164/ajrccm.161.2.9903026; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566; Kraus TA, 2012, J CLIN IMMUNOL, V32, P300, DOI 10.1007/s10875-011-9627-2; Lindsay L, 2006, AM J EPIDEMIOL, V163, P838, DOI 10.1093/aje/kwj095; Lu PJ, 2008, VACCINE, V26, P1786, DOI 10.1016/j.vaccine.2008.01.040; MACFARLANE JT, 1993, LANCET, V341, P511, DOI 10.1016/0140-6736(93)90275-L; Martin A, 2013, MATERN CHILD HLTH J, V17, P1325, DOI 10.1007/s10995-012-1135-3; Meng J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004016; MULLOOLY JP, 1986, PUBLIC HEALTH REP, V101, P205; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; National Statistical Office of Mongolia, 2014, SOC EC SIT MONG PREL; Nethery E, 2009, J EXPO SCI ENV EPID, V19, P317, DOI 10.1038/jes.2008.24; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Nolan T, 2015, CLIN INFECT DIS, V60, pE80, DOI 10.1093/cid/civ065; Nukiwa N, 2011, WEST PAC SURVEILL RE, V2, P16, DOI [10.5365/wpsar.2010.1.1.004, 10.5365/WPSAR.2010.1.1.004]; Ochola R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008088; Ortiz JR, 2011, VACCINE, V29, P4439, DOI 10.1016/j.vaccine.2011.04.048; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Poehling KA, 2011, AM J OBSTET GYNECOL, V204, pS141, DOI 10.1016/j.ajog.2011.02.042; PUCK JM, 1980, J INFECT DIS, V142, P844, DOI 10.1093/infdis/142.6.844; Rasmussen SA, 2012, AM J OBSTET GYNECOL, V207, pS3, DOI 10.1016/j.ajog.2012.06.068; REUMAN PD, 1987, PEDIATR INFECT DIS J, V6, P398, DOI 10.1097/00006454-198704000-00011; Robinson DP, 2012, HORM BEHAV, V62, P263, DOI 10.1016/j.yhbeh.2012.02.023; Sande CJ, 2014, VACCINE, V32, P4726, DOI 10.1016/j.vaccine.2014.05.038; Schanzer DL, 2007, J OBSTET GYNAECOL CA, V29, P622, DOI 10.1016/S1701-2163(16)32559-2; Simoes EAF, 2003, J PEDIATR-US, V143, pS118, DOI 10.1067/S0022-3476(03)00511-0; Spong CY, 2013, JAMA-J AM MED ASSOC, V309, P2445, DOI 10.1001/jama.2013.6235; Steinhoff MC, 2014, LANCET, V383, P1611, DOI 10.1016/S0140-6736(14)60583-3; Steinhoff MC, 2010, NEW ENGL J MED, V362, P1644, DOI 10.1056/NEJMc0912599; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; *WHO, 2005, MOD IMCI HDB INT MAN; World Health Organization, 2015, WHO REC COMP INFL VI; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	69	25	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148421	10.1371/journal.pone.0148421	http://dx.doi.org/10.1371/journal.pone.0148421			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849042	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000090
J	Mezzenga, E; D'Errico, V; Sarnelli, A; Strigari, L; Menghi, E; Marcocci, F; Bianchini, D; Benassi, M				Mezzenga, Emilio; D'Errico, Vincenzo; Sarnelli, Anna; Strigari, Lidia; Menghi, Enrico; Marcocci, Francesco; Bianchini, David; Benassi, Marcello			Preliminary Retrospective Analysis of Daily Tomotherapy Output Constancy Checks Using Statistical Process Control	PLOS ONE			English	Article							CONTROL CHARTS; BREAST-CANCER; QA; RADIOTHERAPY	The purpose of this study was to retrospectively evaluate the results from a Helical TomoTherapy Hi-Art treatment system relating to quality controls based on daily static and dynamic output checks using statistical process control methods. Individual value X-charts, exponentially weighted moving average charts, and process capability and acceptability indices were used to monitor the treatment system performance. Daily output values measured from January 2014 to January 2015 were considered. The results obtained showed that, although the process was in control, there was an out-of-control situation in the principal maintenance intervention for the treatment system. In particular, process capability indices showed a decreasing percentage of points in control which was, however, acceptable according to AAPM TG148 guidelines. Our findings underline the importance of restricting the acceptable range of daily output checks and suggest a future line of investigation for a detailed process control of daily output checks for the Helical TomoTherapy Hi-Art treatment system.	[Mezzenga, Emilio; D'Errico, Vincenzo; Sarnelli, Anna; Menghi, Enrico; Marcocci, Francesco; Bianchini, David; Benassi, Marcello] IRCCS, Dept Med Phys, Ist Sci Romagnolo Studio & Cura Tumori IRST, Meldola, FC, Italy; [Strigari, Lidia] Regina Elena Inst Canc Res, Lab Med Phys & Expert Syst, Rome, Italy	IRCCS Meldola (IRST); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Mezzenga, E (corresponding author), IRCCS, Dept Med Phys, Ist Sci Romagnolo Studio & Cura Tumori IRST, Meldola, FC, Italy.	emilio.mezzenga@irst.emr.it	Bianchini, David/K-7205-2016; Strigari, Lidia/B-9352-2017; Sarnelli, Anna/V-4284-2018; Strigari, Lidia/J-3541-2012; Mezzenga, Emilio/Q-1018-2018	Bianchini, David/0000-0001-5927-7483; Strigari, Lidia/0000-0003-4293-2298; Sarnelli, Anna/0000-0001-5986-3845; Mezzenga, Emilio/0000-0002-0150-7757				Abbas N, 2011, QUAL RELIAB ENG INT, V27, P821, DOI 10.1002/qre.1175; [Anonymous], 2011, J STAT MODELING ANAL, DOI DOI 10.1515/BILE-2015-0008; Breen SL, 2008, MED PHYS, V35, P4417, DOI 10.1118/1.2975144; Carey R.G., 2003, IMPROVING HEALTHCARE; CHAMP CW, 1987, TECHNOMETRICS, V29, P393, DOI 10.2307/1269449; Cisar P, 2011, ACTA POLYTECH HUNG, V8, P73; DAVIS RB, 1988, J QUAL TECHNOL, V20, P260, DOI 10.1080/00224065.1988.11979118; Dettmer H. W., 1997, GOLDRATTS THEORY CON; Gerard K, 2009, MED PHYS, V36, P1275, DOI 10.1118/1.3089793; Holli K, 1999, INT J RADIAT ONCOL, V44, P827, DOI 10.1016/S0360-3016(99)00078-4; KANE VE, 1986, J QUAL TECHNOL, V18, P41, DOI 10.1080/00224065.1986.11978984; Kelly DL, 1999, USE CONTROL CHARTS H; Langen KM, 2010, MED PHYS, V37, P4817, DOI 10.1118/1.3462971; Montgomery DC, 2009, INTRO STAT QUALITY C, P179; Palaniswaamy G, 2012, MED PHYS, V39, P7560, DOI 10.1118/1.4768161; Pawlicki T, 2008, RADIOTHER ONCOL, V89, P330, DOI 10.1016/j.radonc.2008.07.002; Pitkanen MA, 2001, ACTA ONCOL, V40, P50; RYAN T, 2000, STAT METHODS QUALITY; Sanghangthum T, 2013, J APPL CLIN MED PHYS, V14, P147, DOI 10.1120/jacmp.v14i1.4032; Wheeler DJ, 1992, UNDERSTANDING STAT P, V2nd; Woodall WH, 2000, J QUAL TECHNOL, V32, P341	21	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147936	10.1371/journal.pone.0147936	http://dx.doi.org/10.1371/journal.pone.0147936			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848962	Green Submitted, gold, Green Published			2022-12-27	WOS:000369554000029
J	Moorhouse, AJ; Rennison, C; Raza, M; Lilic, D; Gow, NAR				Moorhouse, Alexander J.; Rennison, Claire; Raza, Muhammad; Lilic, Desa; Gow, Neil A. R.			Clonal Strain Persistence of Candida albicans Isolates from Chronic Mucocutaneous Candidiasis Patients	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; POPULATION-STRUCTURE; AZOLE RESISTANCE; IL-17 IMMUNITY; SUSCEPTIBILITY; RECOMBINATION; MECHANISMS; REVEALS; RELATEDNESS; FLUCONAZOLE	Chronic mucocutaneous candidiasis (CMC) is a primary immunodeficiency disorder characterised by susceptibility to chronic Candida and fungal dermatophyte infections of the skin, nails and mucous membranes. Molecular epidemiology studies of CMC infection are limited in number and scope and it is not clear whether single or multiple strains inducing CMC persist stably or are exchanged and replaced. We subjected 42 C. albicans individual single colony isolates from 6 unrelated CMC patients to multilocus sequence typing (MLST). Multiple colonies were typed from swabs taken from multiple body sites across multiple time points over a 17-month period. Among isolates from each individual patient, our data show clonal and persistent diploid sequence types (DSTs) that were stable over time, identical between multiple infection sites and exhibit azole resistant phenotypes. No shared origin or common source of infection was identified among isolates from these patients. Additionally, we performed C. albicans MLST SNP genotype frequency analysis to identify signatures of past loss of heterozygosity (LOH) events among persistent and azole resistant isolates retrieved from patients with autoimmune disorders including CMC.	[Moorhouse, Alexander J.; Gow, Neil A. R.] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen Fungal Grp, Aberdeen, Scotland; [Rennison, Claire; Raza, Muhammad; Lilic, Desa] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Aberdeen; Newcastle University - UK	Gow, NAR (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen Fungal Grp, Aberdeen, Scotland.	n.gow@abdn.ac.uk	GOW, Neil/AAS-5323-2021	GOW, Neil/0000-0002-2776-5850; Moorhouse, Alexander/0000-0002-1626-6087	MRC; Wellcome Trust [086827, 075470, 097377, 101873]	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	The study was supported by the MRC for a PhD studentship for AM and the Wellcome Trust for funding (086827, 075470, 097377 & 101873).	Badoc C, 2002, FEMS MICROBIOL LETT, V209, P249, DOI 10.1111/j.1574-6968.2002.tb11139.x; Balloux F, 2003, GENETICS, V164, P1635; Bougnoux ME, 2004, INFECT GENET EVOL, V4, P243, DOI 10.1016/j.meegid.2004.06.002; Bougnoux ME, 2003, J CLIN MICROBIOL, V41, P5265, DOI 10.1128/JCM.41.11.5265-5266.2003; Magri MMC, 2013, J CLIN MICROBIOL, V51, P268, DOI 10.1128/JCM.02366-12; Chen KW, 2009, INFECT GENET EVOL, V9, P912, DOI 10.1016/j.meegid.2009.06.011; Chen KW, 2005, J MED MICROBIOL, V54, P249, DOI 10.1099/jmm.0.45829-0; CLSI, 2008, M27A3 CLSI; Coleman D, 1997, Oral Dis, V3 Suppl 1, pS96; Coste A, 2006, GENETICS, V172, P2139, DOI 10.1534/genetics.105.054767; Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07; Coste AT, 2004, EUKARYOT CELL, V3, P1639, DOI 10.1128/EC.3.6.1639-1652.2004; Da Matta DA, 2010, J CLIN MICROBIOL, V48, P3062, DOI 10.1128/JCM.00262-10; De Meeus T, 2006, INFECT GENET EVOL, V6, P163, DOI 10.1016/j.meegid.2005.02.004; Dodgson AR, 2005, FUNGAL GENET BIOL, V42, P233, DOI 10.1016/j.fgb.2004.11.010; Dodgson AR, 2003, J CLIN MICROBIOL, V41, P5709, DOI 10.1128/JCM.41.12.5709-5717.2003; Dunkel N, 2008, MOL MICROBIOL, V69, P827, DOI 10.1111/j.1365-2958.2008.06309.x; Dunkel N, 2011, EUKARYOT CELL, V10, P54, DOI 10.1128/EC.00281-10; Farrer RA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003703; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Forche A, 2011, MBIO, V2, DOI 10.1128/mBio.00129-11; Forche A, 1999, FUNGAL GENET BIOL, V28, P107, DOI 10.1006/fgbi.1999.1164; Ford CB, 2015, ELIFE, V4, DOI 10.7554/eLife.00662; Gammelsrud KW, 2012, MED MYCOL, V50, P619, DOI 10.3109/13693786.2012.675088; Ge SH, 2012, FUNGAL GENET BIOL, V49, P86, DOI 10.1016/j.fgb.2011.10.006; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Hickman MA, 2015, GENETICS, V200, P781, DOI 10.1534/genetics.115.178020; Hickman MA, 2013, NATURE, V494, P55, DOI 10.1038/nature11865; Huppler AR, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3893; Jacobsen MD, 2008, MED MYCOL, V46, P647, DOI 10.1080/13693780801986631; Jacobsen MD, 2008, FEMS YEAST RES, V8, P1334, DOI 10.1111/j.1567-1364.2008.00438.x; Jacobsen MD, 2007, J CLIN MICROBIOL, V45, P317, DOI 10.1128/JCM.01549-06; Jarmula A, 2011, POSTEP HIG MED DOSW, V65, P216, DOI 10.5604/17322693.937011; Jeffares DC, 2015, NAT GENET, V47, P235, DOI 10.1038/ng.3215; L'Ollivier C, 2012, INFECT GENET EVOL, V12, P1949, DOI 10.1016/j.meegid.2012.07.025; Laverdiere M, 2006, J ANTIMICROB CHEMOTH, V57, P705, DOI 10.1093/jac/dkl022; Lilic D, 2012, CURR OPIN MICROBIOL, V15, P420, DOI 10.1016/j.mib.2012.06.003; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Lott TJ, 2012, MED MYCOL, V50, P136, DOI 10.3109/13693786.2011.592153; Lott TJ, 2010, EUKARYOT CELL, V9, P619, DOI 10.1128/EC.00002-10; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; Marco F, 1999, J CLIN MICROBIOL, V37, P2817, DOI 10.1128/JCM.37.9.2817-2828.1999; McManus BA, 2008, J CLIN MICROBIOL, V46, P652, DOI 10.1128/JCM.01574-07; McManus BA, 2014, INFECT GENET EVOL, V21, P166, DOI 10.1016/j.meegid.2013.11.008; McManus BA, 2012, J CLIN MICROBIOL, V50, P3335, DOI 10.1128/JCM.01532-12; McManus BA, 2011, J CLIN MICROBIOL, V49, P1879, DOI 10.1128/JCM.00026-11; Noel T, 2012, J MYCOL MED, V22, P173, DOI 10.1016/j.mycmed.2012.04.004; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Odds FC, 2009, FEMS YEAST RES, V9, P1091, DOI 10.1111/j.1567-1364.2009.00577.x; Puel A, 2012, CURR OPIN ALLERGY CL, V12, P616, DOI 10.1097/ACI.0b013e328358cc0b; Puel A, 2010, CURR OPIN IMMUNOL, V22, P467, DOI 10.1016/j.coi.2010.06.009; Pujol C, 1997, J CLIN MICROBIOL, V35, P2348, DOI 10.1128/JCM.35.9.2348-2358.1997; REAGAN DR, 1995, DIAGN MICR INFEC DIS, V21, P191, DOI 10.1016/0732-8893(95)00048-F; REDDING S, 1994, CLIN INFECT DIS, V18, P240, DOI 10.1093/clinids/18.2.240; Sampaio P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010155; SCHMID J, 1990, J CLIN MICROBIOL, V28, P1236, DOI 10.1128/JCM.28.6.1236-1243.1990; Shin JH, 2007, J CLIN MICROBIOL, V45, P2385, DOI 10.1128/JCM.00381-07; Siikala E, 2010, J ANTIMICROB CHEMOTH, V65, P2505, DOI 10.1093/jac/dkq354; Smeekens SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029248; Soll DR, 2003, FEMS IMMUNOL MED MIC, V39, P1, DOI 10.1016/S0928-8244(03)00242-6; Takezaki S, 2012, J IMMUNOL, V189, P1521, DOI 10.4049/jimmunol.1200926; Tavanti A, 2005, J CLIN MICROBIOL, V43, P5593, DOI 10.1128/JCM.43.11.5593-5600.2005; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; Tavanti A, 2003, J CLIN MICROBIOL, V41, P3765, DOI 10.1128/JCM.41.8.3765-3776.2003; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047767	67	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0145888	10.1371/journal.pone.0145888	http://dx.doi.org/10.1371/journal.pone.0145888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849050	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000006
J	Viiard, E; Bessmeltseva, M; Simm, J; Talve, T; Aaspollu, A; Paalme, T; Sarand, I				Viiard, Ene; Bessmeltseva, Marianna; Simm, Jaak; Talve, Tiina; Aaspollu, Anu; Paalme, Toomas; Sarand, Inga			Diversity and Stability of Lactic Acid Bacteria in Rye Sourdoughs of Four Bakeries with Different Propagation Parameters	PLOS ONE			English	Article							FERMENTATION PROCESSES; POPULATION-DYNAMICS; SP-NOV.; LACTOBACILLUS; GROWTH; AMPLIFICATION; BIODIVERSITY; MICROFLORA; COMPLEX; YEASTS	We identified the lactic acid bacteria within rye sourdoughs and starters from four bakeries with different propagation parameters and tracked their dynamics for between 5-28 months after renewal. Evaluation of bacterial communities was performed using plating, denaturing gradient gel electrophoresis, and pyrosequencing of 16S rRNA gene amplicons. Lactobacillus amylovorus and Lactobacillus frumenti or Lactobacillus helveticus, Lactobacillus pontis and Lactobacillus panis prevailed in sourdoughs propagated at higher temperature, while ambient temperature combined with a short fermentation cycle selected for Lactobacillus sanfranciscensis, Lactobacillus pontis, and Lactobacillus zymae or Lactobacillus helveticus, Lactobacillus pontis and Lactobacillus zymae. The ratio of species in bakeries employing room-temperature propagation displayed a seasonal dependence. Introduction of different and controlled propagation parameters at one bakery (higher fermentation temperature, reduced inoculum size, and extended fermentation time) resulted in stabilization of the microbial community with an increased proportion of L. helveticus and L. pontis. Despite these new propagation parameters no new species were detected.	[Viiard, Ene; Bessmeltseva, Marianna; Talve, Tiina; Paalme, Toomas; Sarand, Inga] Competence Ctr Food & Fermentat Technol, Tallinn, Estonia; [Viiard, Ene; Bessmeltseva, Marianna; Paalme, Toomas; Sarand, Inga] Tallinn Univ Technol, Food Proc Dept, EE-19086 Tallinn, Estonia; [Simm, Jaak; Aaspollu, Anu] Tallinn Univ Technol, Ctr Biol Integrated Syst, EE-19086 Tallinn, Estonia; [Sarand, Inga] Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia	Tallinn University of Technology; Tallinn University of Technology; Tallinn University of Technology	Viiard, E (corresponding author), Competence Ctr Food & Fermentat Technol, Tallinn, Estonia.; Viiard, E (corresponding author), Tallinn Univ Technol, Food Proc Dept, EE-19086 Tallinn, Estonia.	ene@tftak.eu	Talve, Tiina/AAZ-3494-2020; Sarand, Inga/AAK-1871-2020	Talve, Tiina/0000-0002-8659-5759; Sarand, Inga/0000-0002-9517-8965	European Regional Development Fund [EU29994]; Estonian Research Council [ETF9417]; Ministry of Education and Research [IUT19-27]; European Social Fund Doctoral Studies and Internationalization Programme DoRa; graduate school "Functional materials and technologies" - European Social Fund in Estonia [1.2.0401.09-0079]	European Regional Development Fund(European Commission); Estonian Research Council(Estonian Research Council); Ministry of Education and Research; European Social Fund Doctoral Studies and Internationalization Programme DoRa; graduate school "Functional materials and technologies" - European Social Fund in Estonia	Financial support was provided by the European Regional Development Fund (http://www.struktuurifondid.ee/euroopa-regionaalarengu-fond/) project EU29994 (EV, MB, TT, IS) together with funds from Estonian Research Council (http://www.etag.ee/rahastamine/etf-grandid/) research grant ETF9417 (IS), Ministry of Education and Research (http://www.etag.ee/rahastamine/institutsionaalne-uurimistoetus/) research grant IUT19-27 (TP, IS) and the European Social Fund Doctoral Studies and Internationalization Programme DoRa (http://adm.archimedes.ee/stipendiumid/programm-dora/) administered by SA Archimedes (EV, MB). This work has been partially supported by graduate school "Functional materials and technologies" receiving funding from the European Social Fund (http://www.struktuurifondid.ee/euroopa-sotsiaalfond-2/) under project 1.2.0401.09-0079 in Estonia (EV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armougom F., 2009, J COMPUT SCI SYST BI, V2, P74, DOI DOI 10.4172/JCSB.1000019; Bocker G., 1995, GETR MEHL BROT, V49, P370; De Vuyst L, 2005, TRENDS FOOD SCI TECH, V16, P43, DOI 10.1016/j.tifs.2004.02.012; De Vuyst L, 2014, FOOD MICROBIOL, V37, P11, DOI 10.1016/j.fm.2013.06.002; De Vuyst L, 2004, INT J FOOD MICROBIOL, V90, P93, DOI 10.1016/S0168-1605(03)00298-8; De Vuyst L, 2002, APPL ENVIRON MICROB, V68, P6059, DOI 10.1128/AEM.68.12.6059-6069.2002; Ehrmann MA, 2007, INT J SYST EVOL MICR, V57, P745, DOI 10.1099/ijs.0.64700-0; Ercolini D, 2013, APPL ENVIRON MICROB, V79, P3148, DOI 10.1128/AEM.00256-13; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gafan GP, 2005, FEMS MICROBIOL LETT, V253, P303, DOI 10.1016/j.femsle.2005.09.048; Ganzle MG, 1998, APPL ENVIRON MICROB, V64, P2616; GOBBETTI M, 1994, WORLD J MICROB BIOT, V10, P275, DOI 10.1007/BF00414862; Hammes W.P., 1998, MICROBIOLOGY FERMENT, V1, P199, DOI [10.1007/978-1-4613-0309-1_8, DOI 10.1007/978-1-4613-0309-1_8]; Hansen AS, 2004, HDB FOOD BEVERAGE FE, P840; KLINE L, 1971, APPL MICROBIOL, V21, P459, DOI 10.1128/AEM.21.3.459-465.1971; Kurtzman CP, 2005, J CLIN MICROBIOL, V43, P101, DOI 10.1128/JCM.43.1.101-111.2005; Leroy F, 2006, INT J FOOD MICROBIOL, V112, P102, DOI 10.1016/j.ijfoodmicro.2006.05.016; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Meroth CB, 2003, APPL ENVIRON MICROB, V69, P7453, DOI 10.1128/AEM.69.12.7453-7461.2003; Meroth CB, 2003, APPL ENVIRON MICROB, V69, P475, DOI 10.1128/AEM.69.1.475-482.2003; Mihhalevski A, 2011, J APPL MICROBIOL, V110, P529, DOI 10.1111/j.1365-2672.2010.04904.x; Minervini F, 2014, INT J FOOD MICROBIOL, V171, P136, DOI 10.1016/j.ijfoodmicro.2013.11.021; Minervini F, 2012, APPL ENVIRON MICROB, V78, P5328, DOI 10.1128/AEM.00572-12; Muller MRA, 2001, FOOD MICROBIOL, V18, P217, DOI 10.1006/fmic.2000.0394; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rosenquist H, 2000, FOOD MICROBIOL, V17, P241, DOI 10.1006/fmic.1999.0313; Scheirlinck I, 2009, J APPL MICROBIOL, V106, P1081, DOI 10.1111/j.1365-2672.2008.04094.x; Scheirlinck I, 2007, APPL ENVIRON MICROB, V73, P6262, DOI 10.1128/aem.00894-07; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siragusa S, 2009, APPL ENVIRON MICROB, V75, P1099, DOI 10.1128/AEM.01524-08; Stolz Peter, 1996, Advances in Food Sciences, V18, P234; Valjakka TT, 2003, HDB DOUGH FERMENTATI, P269; Vancanneyt M, 2005, INT J SYST EVOL MICR, V55, P615, DOI 10.1099/ijs.0.63274-0; Vera A, 2009, FOOD MICROBIOL, V26, P728, DOI 10.1016/j.fm.2009.07.010; Viiard E, 2013, J APPL MICROBIOL, V114, P404, DOI 10.1111/jam.12045; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	38	24	25	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148325	10.1371/journal.pone.0148325	http://dx.doi.org/10.1371/journal.pone.0148325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849134	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000067
J	Werbowy, O; Kaczorowski, T				Werbowy, Olesia; Kaczorowski, Tadeusz			Plasmid pEC156, a Naturally Occurring Escherichia coli Genetic Element That Carries Genes of the EcoVIII Restriction-Modification System, Is Mobilizable among Enterobacteria	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; CLONING VEHICLES; F-PLASMID; TRANSFORMATION; DNA; BACTERIAL; EVOLUTION; MAINTENANCE; REGION; CER	Type II restriction-modification systems are ubiquitous in prokaryotes. Some of them are present in naturally occurring plasmids, which may facilitate the spread of these systems in bacterial populations by horizontal gene transfer. However, little is known about the routes of their dissemination. As a model to study this, we have chosen an Escherichia coli natural plasmid pEC156 that carries the EcoVIII restriction modification system. The presence of this system as well as the cis-acting cer site involved in resolution of plasmid multimers determines the stable maintenance of pEC156 not only in Escherichia coli but also in other enterobacteria. We have shown that due to the presence of oriT-type F and oriT-type R64 loci it is possible to mobilize pEC156 by conjugative plasmids (F and R64, respectively). The highest mobilization frequency was observed when pEC156-derivatives were transferred between Escherichia coli strains, Enterobacter cloacae and Citrobacter freundii representing coliform bacteria. We found that a pEC156-derivative with a functional EcoVIII restriction-modification system was mobilized in enterobacteria at a frequency lower than a plasmid lacking this system. In addition, we found that bacteria that possess the EcoVIII restriction-modification system can efficiently release plasmid content to the environment. We have shown that E. coli cells can be naturally transformed with pEC156-derivatives, however, with low efficiency. The transformation protocol employed neither involved chemical agents (e.g. CaCl2) nor temperature shift which could induce plasmid DNA uptake.	[Werbowy, Olesia; Kaczorowski, Tadeusz] Univ Gdansk, Dept Microbiol, Wita Stwosza 59, PL-80952 Gdansk, Poland	Fahrenheit Universities; University of Gdansk	Kaczorowski, T (corresponding author), Univ Gdansk, Dept Microbiol, Wita Stwosza 59, PL-80952 Gdansk, Poland.	tadeusz.kaczorowski@biol.ug.edu.pl	Kaczorowski, Tadeusz/AAX-2027-2020	Werbowy, Olesia/0000-0002-0194-0673	National Science Centre [N302 654240]	National Science Centre(National Science Centre, Poland)	This work was supported by grant N302 654240 from the National Science Centre.	Aas FE, 2002, MOL MICROBIOL, V46, P749, DOI 10.1046/j.1365-2958.2002.03193.x; Ahmer BMM, 1999, J BACTERIOL, V181, P1364, DOI 10.1128/JB.181.4.1364-1368.1999; Bartosik D, 2002, MICROBIOL-SGM, V148, P2847, DOI 10.1099/00221287-148-9-2847; Baur B, 1996, APPL ENVIRON MICROB, V62, P3673, DOI 10.1128/AEM.62.10.3673-3678.1996; BLAKELY G, 1993, CELL, V75, P351, DOI 10.1016/0092-8674(93)80076-Q; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; BOYD AC, 1989, MOL GEN GENET, V217, P488; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Claus H, 2000, J BACTERIOL, V182, P1296, DOI 10.1128/JB.182.5.1296-1303.2000; COLLOMS SD, 1990, J BACTERIOL, V172, P6973, DOI 10.1128/jb.172.12.6973-6980.1990; Corvaglia AR, 2010, P NATL ACAD SCI USA, V107, P11954, DOI 10.1073/pnas.1000489107; Das T, 2013, ENV MICROBIOL REP, V5, P778, DOI 10.1111/1758-2229.12085; Davison J, 1999, PLASMID, V42, P73, DOI 10.1006/plas.1999.1421; Dziewit L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00596; ENGLEBERG NC, 1988, PLASMID, V20, P83, DOI 10.1016/0147-619X(88)90010-8; Ershova AS, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1373, DOI 10.1134/S0006297915100193; Eutsey RA, 2015, MBIO, V6, DOI 10.1128/mBio.00173-15; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; FROST LS, 1994, MICROBIOL REV, V58, P162, DOI 10.1128/MMBR.58.2.162-210.1994; Furuya N, 1997, J BACTERIOL, V179, P7291, DOI 10.1128/jb.179.23.7291-7297.1997; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Handa N, 2000, J BACTERIOL, V182, P2218, DOI 10.1128/JB.182.8.2218-2229.2000; Handa N, 1999, BIOCHIMIE, V81, P931; HANISH J, 1988, GENE ANAL TECH, V5, P105, DOI 10.1016/0735-0651(88)90005-2; Harr B, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-80; Heuer H, 2012, FEMS MICROBIOL REV, V36, P1083, DOI 10.1111/j.1574-6976.2012.00337.x; Ichige A, 2005, J BACTERIOL, V187, P6612, DOI 10.1128/JB.187.19.6612-6621.2005; ISHIAI M, 1994, P NATL ACAD SCI USA, V91, P3839, DOI 10.1073/pnas.91.9.3839; Jeltsch A, 1996, J MOL EVOL, V42, P91, DOI 10.1007/BF02198833; Jeltsch A, 2003, GENE, V317, P13, DOI 10.1016/S0378-1119(03)00652-8; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; KACZOROWSKI T, 1993, BIOTECHNIQUES, V14, P900; Kong HM, 2000, NUCLEIC ACIDS RES, V28, P3216, DOI 10.1093/nar/28.17.3216; Kong Y, 2013, GENOME BIOL EVOL, V5, P1611, DOI 10.1093/gbe/evt116; KUES U, 1989, MICROBIOL REV, V53, P491; Lawley T, 2004, PLASMID BIOLOGY, P203; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; LORENZ MG, 1991, ARCH MICROBIOL, V156, P319, DOI 10.1007/BF00263005; Maeda S, 2004, FEMS MICROBIOL LETT, V236, P61, DOI 10.1111/j.1574-6968.2004.tb09627.x; MCKANE M, 1995, GENETICS, V139, P35; Mell JC, 2014, J BACTERIOL, V196, P1471, DOI 10.1128/JB.01293-13; Milewska K, 2015, PLASMID, V81, P42, DOI 10.1016/j.plasmid.2015.07.001; Milkman R, 1999, GENETICS, V153, P539; Mruk I, 2003, MICROBIOL-SGM, V149, P3331, DOI 10.1099/mic.0.26562-0; Mruk I, 2003, APPL ENVIRON MICROB, V69, P2638, DOI 10.1128/AEM.69.5.2638-2650.2003; Mruk I, 2001, PLASMID, V46, P128, DOI 10.1006/plas.2001.1534; Mruk I, 2014, NUCLEIC ACIDS RES, V42, P70, DOI 10.1093/nar/gkt711; Oliveira PH, 2014, NUCLEIC ACIDS RES, V42, P10618, DOI 10.1093/nar/gku734; ORSKOV I, 1973, ACTA PATH MICRO IM B, VB 81, P59; Paradis S, 2005, INT J SYST EVOL MICR, V55, P2013, DOI 10.1099/ijs.0.63539-0; Pleska M, 2016, CURR BIOL, V26, P404, DOI 10.1016/j.cub.2015.12.041; Podgorska B, 2012, ACTA BIOCHIM POL, V59, P669; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; REECE KS, 1995, GENE, V165, P141, DOI 10.1016/0378-1119(95)00529-F; Rehel N, 1996, PLASMID, V36, P183, DOI 10.1006/plas.1996.0045; Roer L, 2015, J BACTERIOL, V197, P337, DOI 10.1128/JB.02418-14; Rychlik I, 2006, VET MICROBIOL, V112, P1, DOI 10.1016/j.vetmic.2005.10.030; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCOTT JR, 1984, MICROBIOL REV, V48, P1; Seitz P, 2013, P NATL ACAD SCI USA, V110, P17987, DOI 10.1073/pnas.1315647110; SHAPIRO JA, 1977, DNA INSERTION ELEMEN, P601; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Stanisich V.A., 1988, METHOD MICROBIOL, V21, P11; STIRLING CJ, 1989, EMBO J, V8, P1623, DOI 10.1002/j.1460-2075.1989.tb03547.x; STIRLING CJ, 1988, EMBO J, V7, P4389, DOI 10.1002/j.1460-2075.1988.tb03338.x; STIRLING CJ, 1988, MOL GEN GENET, V214, P80, DOI 10.1007/BF00340183; SUMMERS DK, 1984, CELL, V36, P1097, DOI 10.1016/0092-8674(84)90060-6; Sun DC, 2006, FEMS MICROBIOL LETT, V265, P249, DOI 10.1111/j.1574-6968.2006.00503.x; Suzuki H, 2010, J BACTERIOL, V192, P6045, DOI 10.1128/JB.00277-10; Tock MR, 2005, CURR OPIN MICROBIOL, V8, P466, DOI 10.1016/j.mib.2005.06.003; TWIGG AJ, 1980, NATURE, V283, P216, DOI 10.1038/283216a0; van Elsas JD, 2002, FEMS MICROBIOL ECOL, V42, P187, DOI 10.1111/j.1574-6941.2002.tb01008.x; Vasu K, 2013, MICROBIOL MOL BIOL R, V77, P53, DOI 10.1128/MMBR.00044-12; Veiga H, 2009, APPL ENVIRON MICROB, V75, P3034, DOI 10.1128/AEM.01862-08; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; Werbowy O, 2015, PLASMID, V77, P39, DOI 10.1016/j.plasmid.2014.12.002; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; WILLETTS N, 1980, MOL GEN GENET, V180, P213, DOI 10.1007/BF00267372; Woegerbauer M, 2002, APPL ENVIRON MICROB, V68, P440, DOI 10.1128/AEM.68.1.440-443.2002; Zakharova MV, 2002, MOL GENET GENOMICS, V267, P171, DOI 10.1007/s00438-002-0644-y; Zhong ZP, 2005, PLASMID, V54, P48, DOI 10.1016/j.plasmid.2004.11.001	82	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148355	10.1371/journal.pone.0148355	http://dx.doi.org/10.1371/journal.pone.0148355			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848973	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000077
J	Arif, R; Farag, M; Gertner, V; Szabo, G; Weymann, A; Veres, G; Ruhparwar, A; Bekeredjian, R; Bruckner, T; Karck, M; Kallenbach, K; Beller, CJ				Arif, Rawa; Farag, Mina; Gertner, Victor; Szabo, Gabor; Weymann, Alexander; Veres, Gabor; Ruhparwar, Arjang; Bekeredjian, Raffi; Bruckner, Tom; Karck, Matthias; Kallenbach, Klaus; Beller, Carsten J.			Female Gender and Differences in Outcome after Isolated Coronary Artery Bypass Graft Surgery: Does Age Play a Role?	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; LONG-TERM OUTCOMES; CARDIAC-SURGERY; SEX-DIFFERENCES; HEART-DISEASE; INDEPENDENT PREDICTORS; SINGLE-CENTER; RISK-FACTORS; WOMEN; MEN	Introduction Female gender is a known risk factor for early and late mortality after coronary artery bypass graft surgery (CABG). Higher age of women at operation may influence outcome, since age per se is also an important risk factor. The purpose of our study was to analyze possible gender differences in outcome after isolated CABG in different age groups to delineate the impact of female gender and age. Methods All patients over 60 years of age undergoing isolated CABG at our department during 2001 and 2011 were included and categorized by age into sexagenarians (2266, 16.6% women), septuagenarians (2332, 25.4% women) and octogenarians (374, 32% women) and assessed by gender for 30-day and 180-day mortality. Results Thirty-day mortality was significantly higher in women only amongst septuagenarians (7.1 vs. 4.7%, p = 0.033). Same differences apply for 180-day mortality (12.3 vs. 8.2%, p = 0.033) and estimated one-year survival (81.6 +/- 4.2 vs. 86.9 +/- 2.2%, p = 0.001). Predictive factors for 30-day mortality of septuagenarian were logistic EuroSCORE (ES) (p = 0.003), perioperative myocardial infarction (MI) (p<0.001), pneumonia (p<0.001), abnormal LV-function (p<0.04) and use of LIMA graft (p<0.001), but not female gender. However, female gender was found to be an independent predictor for 180-day mortality (HR 1.632, p = 0.001) in addition to ES, use of LIMA graft, perioperative MI, pneumonia and abnormal LV function (HR 1.013, p = 0.004; HR 0.523, p<0.001; HR 2.710, p<0.001; HR 3.238, p<0.001; HR 2.013, p<0.001). Conclusion Women have a higher observed probability of early death after CABG in septuagenarians. However, female gender was not found to be an independent risk factor for 30-day, but for 180-day survival. Therefore, reduction of high impact risk factors such as perioperative MI and enhancement of LIMA use should be future goals. In view of our findings, decision for surgical revascularization should not be based on gender.	[Arif, Rawa; Farag, Mina; Gertner, Victor; Szabo, Gabor; Weymann, Alexander; Veres, Gabor; Ruhparwar, Arjang; Karck, Matthias; Kallenbach, Klaus; Beller, Carsten J.] Univ Heidelberg Hosp, Heart Ctr Heidelberg, Dept Cardiac Surg, Heidelberg, Germany; [Bekeredjian, Raffi] Univ Heidelberg Hosp, Heart Ctr Heidelberg, Dept Cardiol Angiol & Pneumol, Heidelberg, Germany; [Bruckner, Tom] Heidelberg Univ, Heart Ctr Heidelberg, Inst Med Biometry & Informat, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Arif, R (corresponding author), Univ Heidelberg Hosp, Heart Ctr Heidelberg, Dept Cardiac Surg, Heidelberg, Germany.	rawa.arif@med.uni-heidelberg.de	Weymann, Alexander/AAQ-5115-2021	Szabo, Gabor/0000-0001-6038-9968				Al-Alao BS, 2012, GEN THORAC CARDIOVAS, V60, P417, DOI 10.1007/s11748-012-0082-7; Aldea GS, 1999, ANN THORAC SURG, V67, P1097, DOI 10.1016/S0003-4975(99)00055-7; BARBIR M, 1994, BRIT HEART J, V71, P408; BARRETTCONNOR E, 1991, JAMA-J AM MED ASSOC, V265, P1861, DOI 10.1001/jama.265.14.1861; Blankstein R, 2005, CIRCULATION, V112, pI323, DOI 10.1161/CIRCULATIONAHA.104.525139; Bradshaw PJ, 2002, HEART, V88, P488, DOI 10.1136/heart.88.5.488; BrandrupWognsen G, 1996, EUR HEART J, V17, P1426; Bukkapatnam RN, 2010, AM J CARDIOL, V105, P339, DOI 10.1016/j.amjcard.2009.09.035; COWLEY MJ, 1985, CIRCULATION, V71, P90, DOI 10.1161/01.CIR.71.1.90; Edwards FH, 1998, ANN THORAC SURG, V66, P125, DOI 10.1016/S0003-4975(98)00358-0; Ennker Ina C, 2009, Asian Cardiovasc Thorac Ann, V17, P253, DOI 10.1177/0218492309104746; Ergunes K, 2014, J CARDIOVASC THORAC, V6, P105, DOI 10.5681/jcvtr.2014.023; Fukui T, 2010, CIRC J, V74, P2103, DOI 10.1253/circj.CJ-10-0275; Gulbins H, 2010, THORAC CARDIOV SURG, V58, P403, DOI 10.1055/s-0030-1249924; Guru V, 2004, J THORAC CARDIOV SUR, V127, P1158, DOI 10.1016/j.jtcvs.2003.12.008; Hammar N, 1997, J AM COLL CARDIOL, V29, P659, DOI 10.1016/S0735-1097(96)00531-1; Hannan EL, 2011, JACC-CARDIOVASC INTE, V4, P569, DOI 10.1016/j.jcin.2011.01.010; Hassan A, 2005, CAN J CARDIOL, V21, P757; Hogue CW, 2001, CIRCULATION, V103, P2133; Kim SG, 2004, CLIN CARDIOL, V27, P291, DOI 10.1002/clc.4960270511; Koch CG, 2003, J THORAC CARDIOV SUR, V126, P2032, DOI 10.1016/S0022-5223(03)00950-4; Kotting J, 2014, THORAC CARDIOV SURG, V62, P276, DOI 10.1055/s-0033-1364193; Leavitt BJ, 2001, CIRCULATION, V103, P507, DOI 10.1161/01.CIR.103.4.507; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Mehilli J, 2000, JAMA-J AM MED ASSOC, V284, P1799, DOI 10.1001/jama.284.14.1799; Miskowiec DL, 2015, KARDIOL POL, V73, P109, DOI 10.5603/KP.a2014.0166; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Norheim A, 2011, SCAND CARDIOVASC J, V45, P247, DOI 10.3109/14017431.2011.582139; RAHIMTOOLA SH, 1993, CIRCULATION, V88, P71; Regitz-Zagrosek V, 2004, J AM COLL CARDIOL, V44, P2413, DOI 10.1016/j.jacc.2004.09.031; Ried M, 2011, GENDER MED, V8, P252, DOI 10.1016/j.genm.2011.05.003; Roques F, 1999, EUR J CARDIO-THORAC, V15, P816, DOI 10.1016/S1010-7940(99)00106-2; Solimene MC, 2010, CLINICS, V65, P99, DOI 10.1590/S1807-59322010000100015; Toumpoulis IK, 2006, J THORAC CARDIOV SUR, V131, P343, DOI 10.1016/j.jtcvs.2005.08.056; Vaccarino V, 2002, CIRCULATION, V105, P1176, DOI 10.1161/hc1002.105133; Yang Felix, 2006, J Interv Cardiol, V19, P340, DOI 10.1111/j.1540-8183.2006.00157.x; Zimmermann S, 2009, CLIN RES CARDIOL, V98, P709, DOI 10.1007/s00392-009-0055-8	37	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0145371	10.1371/journal.pone.0145371	http://dx.doi.org/10.1371/journal.pone.0145371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845158	Green Published, gold, Green Submitted			2022-12-27	WOS:000369552800003
J	Harari, S; Madotto, F; Caminati, A; Conti, S; Cesana, G				Harari, Sergio; Madotto, Fabiana; Caminati, Antonella; Conti, Sara; Cesana, Giancarlo			Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASES; MORTALITY; PREVALENCE; DIAGNOSIS; IPF	Background Idiopathic pulmonary fibrosis (IPF) is the most common and severe form of idiopathic interstitial pneumonia. Despite its clinical relevance, few studies have examined the epidemiology of IPF and temporal variation in disease incidence and prevalence. Aim of the study was to investigate the prevalence, incidence and trends of IPF in Lombardy, a region with nearly 10 million inhabitants, during 2005-2010. Methods For the identification of IPF patients, we used healthcare administrative databases of Lombardy Healthcare System and adopted three algorithms: generic, broad and narrow case definition (GCD, BCD, NCD). IPF cases were identified according to diagnoses reported in inpatient and outpatient claims occurred during 2000-2010. We estimated age-and sex-adjusted annual prevalence and incidence rates from 2005 to 2010, thus allowing for a 5-year washout period. Results The mean annual incidence rate was estimated at 2.3 and 5.3 per 100,000 person-years using NCD and GCD, respectively. IPF incidence was higher among males, and increased with age. Trend remained stable over the years. The estimated annual prevalence rate was 35.5, 22.4, and 12.6 per 100,000 person-years using GCD, BCD and NCD, respectively, and increased with age. Moreover, we observed a positive trend over the years. Using BCD and NCD, prevalence was higher among males. Conclusions The results of this study, which is one of the largest population-based survey ever conducted according to strict criteria, indicated that prevalence of IPF increased across the years while incidence remained stable, thus suggesting that survival with IPF has improved.	[Harari, Sergio; Caminati, Antonella] Osped San Giuseppe MultiMed IRCCS, Serv Fisiopatol Resp & Emodinam Polmonare, Unita Operat Pneumol & Terapia Semiintens Resp, Milan, Italy; [Madotto, Fabiana; Conti, Sara] Univ Milano Bicocca, Dept Med & Surg, Res Ctr Publ Hlth, Milan, Italy	University of Milano-Bicocca	Harari, S (corresponding author), Osped San Giuseppe MultiMed IRCCS, Serv Fisiopatol Resp & Emodinam Polmonare, Unita Operat Pneumol & Terapia Semiintens Resp, Milan, Italy.	sharari@hotmail.it	Madotto, Fabiana/AAA-9802-2019; Caminati, Antonella/L-8743-2019; Conti, Sara/J-4891-2019	Madotto, Fabiana/0000-0002-8829-9160; Conti, Sara/0000-0002-5774-3740; Harari, Sergio/0000-0001-8629-7391	InterMune s.r.l.	InterMune s.r.l.	This study was funded by InterMune s.r.l. The sponsor approved the study design but played no role in development of the research and manuscript.	Agabiti N, 2014, SARCOIDOSIS VASC DIF, V31, P191; Agostini C, 2001, Monaldi Arch Chest Dis, V56, P364; Caminati A, 2015, EUR RESPIR REV, V24, P436, DOI 10.1183/16000617.0040-2015; Caminati A, 2010, RESP MED, V104, pS2, DOI 10.1016/j.rmed.2010.03.012; COULTAS DB, 1994, AM J RESP CRIT CARE, V150, P967, DOI 10.1164/ajrccm.150.4.7921471; COULTAS DB, 2004, IDIOPATHIC PULMONARY, P1; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; Fernandez-Perez ER, 2010, CHEST, V137, P242, DOI [10.1378/chest.09-1002, 10.1378/chest.09-1871]; Fornari C, 2008, EPIDEMIOL PREV, V32, P79; Gordis L., 2004, EPIDEMIOLOGY; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; Harari S, 2005, ALLERGY, V60, P421, DOI 10.1111/j.1398-9995.2005.00719.x; Hubbard R, 1996, THORAX, V51, P711, DOI 10.1136/thx.51.7.711; Hutchinson John P, 2014, Ann Am Thorac Soc, V11, P1176, DOI 10.1513/AnnalsATS.201404-145OC; Hyldgaard C, 2014, RESP MED, V108, P793, DOI 10.1016/j.rmed.2013.09.002; JOHNSTON I, 1990, BRIT MED J, V301, P1017, DOI 10.1136/bmj.301.6759.1017; Karakatsani A, 2009, RESP MED, V103, P1122, DOI 10.1016/j.rmed.2009.03.001; Kaunisto J, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-53; Lai CC, 2012, RESP MED, V106, P1566, DOI 10.1016/j.rmed.2012.07.012; Ley Brett, 2013, Clin Epidemiol, V5, P483, DOI 10.2147/CLEP.S54815; Lumley T., 2004, BIOSTATISTICS METHOD, V519; Madotto F, 2013, EPIDEMIOL BIOSTAT PU, V10, DOI 10.2427/8840; Mannino DM, 1996, AM J RESP CRIT CARE, V153, P1548, DOI 10.1164/ajrccm.153.5.8630600; Meltzer EB, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-8; Nalysnyk L, 2012, EUR RESPIR REV, V21, P355, DOI 10.1183/09059180.00002512; Natsuizaka M, 2014, AM J RESP CRIT CARE, V190, P773, DOI 10.1164/rccm.201403-0566OC; Navaratnam V, 2011, THORAX, V66, P462, DOI 10.1136/thx.2010.148031; Ohno S, 2008, RESPIROLOGY, V13, P926, DOI 10.1111/j.1440-1843.2008.01349.x; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; PANOS RJ, 1990, AM J MED, V88, P396, DOI 10.1016/0002-9343(90)90495-Y; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Raghu G, 2014, LANCET RESP MED, V2, P566, DOI 10.1016/S2213-2600(14)70101-8; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Tinelli C, 2005, SARCOIDOSIS VASC DIF, V22, pS4	34	49	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147072	10.1371/journal.pone.0147072	http://dx.doi.org/10.1371/journal.pone.0147072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841042	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200024
J	Hegdahl, HK; Fylkesnes, KM; Sandoy, IF				Hegdahl, Hanne K.; Fylkesnes, Knut M.; Sandoy, Ingvild F.			Sex Differences in HIV Prevalence Persist over Time: Evidence from 18 Countries in Sub-Saharan Africa	PLOS ONE			English	Article							AGE-DIFFERENCES; YOUNG-PEOPLE; INFECTION; RISK; TRENDS; WOMEN; SURVEILLANCE; ASSOCIATION; BEHAVIOR; ZAMBIA	Objective The aim of this study was to examine changes over time in the female: male HIV prevalence ratio in 18 countries in Sub-Saharan Africa, overall and when stratified by area of residence, educational attainment and marital status. Methodology We used data from the Demographic and Health Surveys, which are nationally representative household surveys. By using data from 18 countries with at least two survey rounds with HIV testing, and dividing the countries into three regions (Western/Central, Eastern and Southern) we were able to examine cross-country and regional changes in the female: male HIV prevalence ratio over time. Logistic regression was used to estimate female: male HIV prevalence ratios in urban versus rural areas and for different categories of education and marital status. To assess changes over time, we compared the confidence intervals of the prevalence ratios. Results The female: male HIV prevalence ratio was above one in all countries in at least one survey round for both ages 15-24 years and 25-49 years. In 13 out of 18 countries the prevalence ratio was higher for the younger age group compared to the age group 25-49 years (3 significant) and this difference in prevalence ratios between the age groups did not change over time. Overall, there was a higher frequency of increasing than decreasing prevalence ratios. The gender disparity was greater among those who were married/living together than among the never-married, and over time, the ratio was more stable among the married/living together. The study found no clear differential changes by education. Conclusion Women continue to carry the greater burden of HIV in Sub-Saharan Africa and there is no clear pattern of change in the gap between men and women as the direction and magnitude of change in the prevalence ratios varied greatly.	[Hegdahl, Hanne K.; Fylkesnes, Knut M.; Sandoy, Ingvild F.] Univ Bergen, Ctr Int Hlth, Bergen, Norway	University of Bergen	Hegdahl, HK (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.	hannekeyserhegdahl@gmail.com	Sandøy, Ingvild Fossgard/ABD-3557-2020	Sandoy, Ingvild/0000-0001-5567-4588	Medical Student Research Programme at The Faculty of Medicine and Dentistry at the University of Bergen	Medical Student Research Programme at The Faculty of Medicine and Dentistry at the University of Bergen	The Medical Student Research Programme at The Faculty of Medicine and Dentistry (HKH, IFS) at the University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agence Nationale de la Statistique et de la Demographie (ANSD) [Senegal] ICF International, 2012, ENQ DEM SANT IND MUL; [Anonymous], 2013, 2012 TANZ POP HOUS C; [Anonymous], 2014, ENQ DEM SANT REP DEM; Camlin CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011539; Cellule de Planification et de Statistique du Ministere de la Sante (CPS/MS) Direction Nationale de la Statistique et de l'Informatique (DNSI) et ORC Macro, 2002, ENQ DEM SANT MAL 200; Central Statistical Office (CSO) [Zambia] Central Board of Health [Zambia] and ORC Macro, 2003, ZAMB DEM HLTH SURV 2; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; CPS/SSDSPF, 2014, ENQ DEM SANT MAL 201; CSO MOH TDRC University of Zambia, 2009, ZAMB DEM HLTH SURV 2; de Walque D, 2005, TROP MED INT HEALTH, V10, P993, DOI 10.1111/j.1365-3156.2005.01475.x; [DNdlSedlIdMrdlEc Cellule de Planification et de Statistique du Ministere de la Sante (CPS/MS)], 2007, ENQ DEM SANT MAL 200; Druyts E, 2013, AIDS, V27, P417, DOI 10.1097/QAD.0b013e328359b89b; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Fortson JG, 2008, DEMOGRAPHY, V45, P303, DOI 10.1353/dem.0.0006; Fylkesnes K, 1998, AIDS, V12, P1227, DOI 10.1097/00002030-199810000-00015; Garcia-Calleja JM, 2006, SEX TRANSM INFECT, V82, pIII64, DOI 10.1136/sti.2006.019901; Gregson S, 2010, INT J EPIDEMIOL, V39, P1311, DOI 10.1093/ije/dyq055; Hajizadeh M, 2014, INT J EQUITY HEALTH, V13, DOI [10.1186/s12939-014-0120-4, 10.1186/1475-9276-13-18]; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Hargreaves JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121775; Hargreaves JR, 2010, AIDS, V24, P754, DOI 10.1097/QAD.0b013e328336672e; ICF INdlSIe, 2012, ENQ DEM SANT IND MUL; Inc CSOCZaMI, 2007, ZIMB DEM HLTH SURV 2; Inc INdlSIeMI, 2007, ENQ DEM SANT IND MUL; International CSAEaI, 2012, ETH DEM HLTH SURV 20; International INdlSedlDmlel, 2012, ENQ DEM SANT IND MUL; International INdlSIeI, 2012, ENQ DEM SANT IND MUL; International INdlSlel, 2013, ENQ DEM SANT IND MUL; International MrdPeM, 2008, ENQ DEM SANT REP DEM; International SSLSaI, 2014, SIERR LEON DEM HLTH; International ZNSAZaI, 2012, ZIMB DEM HLTH SURV 2; Kayeyi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064881; Kayeyi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033652; Kelly RJ, 2003, JAIDS-J ACQ IMM DEF, V32, P446, DOI 10.1097/00126334-200304010-00016; Kembo J, 2013, SAHARA J-J SOC ASP H, V10, P150, DOI 10.1080/17290376.2014.903620; Kenya National Bureau of Statistics; Ministry of Health; National AIDS Control Council; The DHS Program ICF International KDHS, 2003, KEN DEM HLTH SURV 20; Kimanga DO, 2014, JAIDS-J ACQ IMM DEF, V66, pS13, DOI 10.1097/QAI.0000000000000124; Kuate S, 2009, JAIDS-J ACQ IMM DEF, V52, P258, DOI 10.1097/QAI.0b013e3181ab6d2e; Langen Tabitha T, 2005, Afr Health Sci, V5, P188; Liberia Institute of Statistics and Geo-Information Services (LISGIS) Ministry of Health and Social Welfare [Liberia] National AIDS Control Program [Liberia] & ICF International, 2014, LIB DEM HLTH SURV 20; Liberia Institute of Statistics and Geo-Information Services (LISGIS) Ministry of Health and Social Welfare National AIDS Control Program Macro International Inc, 2008, LIB DEM HLTH SURV 20; Macro and NSONaI, 2011, MAL DEM HLTH SURV 20; Macro CSAEaO, 2006, ETH DEM HLTH SURV 20; Macro DNdlSDGeeO, 2006, ENQ DEM SANT GUIN 20; Macro INdlSdRIaO, 2006, RWAND DEM HLTH SURV; Macro INdlSedlDmIeO, 2004, ENQ DEM SANT BURK FA; Macro INdlSIeMrdlLclSCtdIeO, 2006, ENQ IND SID COT IV 2; Macro INdlSIeO, 2004, ENQ DEM SANT CAM 200; Macro KNBoSKaI, 2010, KEN DEM HLTH SURV 20; Macro SSLSaI, 2009, SIERR LEON DEM HLTH; Magadi MA, 2013, ANN AM ACAD POLIT SS, V648, P136, DOI 10.1177/0002716213482440; Magadi MA, 2011, SOCIOL HEALTH ILL, V33, P522, DOI 10.1111/j.1467-9566.2010.01304.x; Maughan-Brown B, 2014, AIDS BEHAV, V18, P2469, DOI 10.1007/s10461-014-0828-6; McGrath N, 2013, AIDS, V27, P2461, DOI 10.1097/01.aids.0000432473.69250.19; Michelo C, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-279; [MoHaSWMLaI Macro], 2010, LES DEM HLTH SURV 20; MoHSW, 2005, LES DEM HLTH SURV 20; Montana LS, 2008, SEX TRANSM INFECT, V84, pI78, DOI 10.1136/sti.2008.030106; Mugisha V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085774; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Mutasa-Apollo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086305; Nalugoda F, 2014, JAIDS-J ACQ IMM DEF, V65, P91, DOI 10.1097/QAI.0b013e3182a7f08a; National Institute of Statistics of Rwanda (NISR) MoHMR ICF International, 2012, RWAND DEM HLTH SURV; Ndiaye S, 2006, ENQUETE DEMOGRAPHIQU; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; NSO ICF, 2005, MAL DEM HLTH SURV 20; Shannon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028739; Sia D, 2013, HLTH POLICY PLANNING; Smith J, 1999, INT J STD AIDS; TACAIDS/Tanzania ZAC/Tanzania NBS/Tanzania OCGS/Tanzania and Macro International, 2008, TANZ HIV AIDS MAL IN; Tanzania Commission for AIDS (TACAIDS) National Bureau of Statistics (NBS) [Tanzania] & ORC Macro, 2005, TANZ HIV AIDS IND SU; Tenkorang EY, 2014, INT HEALTH, V6, P46, DOI 10.1093/inthealth/ihu003; UNAIDS, 2013, GAP REP; UNAIDS, 2013, GLOB REP 2013; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4; Wyrod R, 2011, AIDS BEHAV, V15, P1275, DOI 10.1007/s10461-010-9800-2; Zambia Statistics Agency Ministry of Health Zambia ICF., 2019, ZAMB DEM HLTH SURV 2	77	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148502	10.1371/journal.pone.0148502	http://dx.doi.org/10.1371/journal.pone.0148502			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26841112	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200142
J	Figueroa-Montiel, A; Ramos, MA; Mares, RE; Duenas, S; Pimienta, G; Ortiz, E; Possani, LD; Licea-Navarro, AF				Figueroa-Montiel, Andrea; Ramos, Marco A.; Mares, Rosa E.; Duenas, Salvador; Pimienta, Genaro; Ortiz, Ernesto; Possani, Lourival D.; Licea-Navarro, Alexei F.			In Silico Identification of Protein Disulfide Isomerase Gene Families in the De Novo Assembled Transcriptomes of Four Different Species of the Genus Conus	PLOS ONE			English	Article							RNA-SEQ DATA; DIVERSITY; REVEALS; CONOTOXINS; PLATFORM; BINDING; DOMAIN; LENGTH	Small peptides isolated from the venom of the marine snails belonging to the genus Conus have been largely studied because of their therapeutic value. These peptides can be classified in two groups. The largest one is composed by peptides rich in disulfide bonds, and referred to as conotoxins. Despite the importance of conotoxins given their pharmacology value, little is known about the protein disulfide isomerase (PDI) enzymes that are required to catalyze their correct folding. To discover the PDIs that may participate in the folding and structural maturation of conotoxins, the transcriptomes of the venom duct of four different species of Conus from the peninsula of Baja California (Mexico) were assembled. Complementary DNA (cDNA) libraries were constructed for each species and sequenced using a Genome Analyzer Illumina platform. The raw RNA-seq data was converted into transcript sequences using Trinity, a de novo assembler that allows the grouping of reads into contigs without a reference genome. An N50 value of 605 was established as a reference for future assemblies of Conus transcriptomes using this software. Transdecoder was used to extract likely coding sequences from Trinity transcripts, and PDI-specific sequence motif "APWCGHCK" was used to capture potential PDIs. An in silico analysis was performed to characterize the group of PDI protein sequences encoded by the duct-transcriptome of each species. The computational approach entailed a structural homology characterization, based on the presence of functional Thioredoxin-like domains. Four different PDI families were characterized, which are constituted by a total of 41 different gene sequences. The sequences had an average of 65% identity with other PDIs. Using MODELLER 9.14, the homology-based three-dimensional structure prediction of a subset of the sequences reported, showed the expected thioredoxin fold which was confirmed by a "simulated annealing" method.	[Figueroa-Montiel, Andrea; Duenas, Salvador; Pimienta, Genaro; Licea-Navarro, Alexei F.] Ctr Invest & Estudios Super Ensenada CICESE, Dept Innovac Biomed, Ensenada, Baja California, Mexico; [Ramos, Marco A.; Mares, Rosa E.] Univ Autonoma Baja California, Fac Ciencias Quim & Ingn, Tijuana, Baja California, Mexico; [Possani, Lourival D.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico	Universidad Autonoma de Baja California; Universidad Nacional Autonoma de Mexico	Licea-Navarro, AF (corresponding author), Ctr Invest & Estudios Super Ensenada CICESE, Dept Innovac Biomed, Ensenada, Baja California, Mexico.	alicea@cicese.mx	Navaro, Alexei Fedorovish Licea/B-4106-2016; Ramos-Ibarra, Marco A./D-5438-2012; Mares, Rosa E/D-2451-2016; Ortiz, Ernesto/E-4592-2013	Navaro, Alexei Fedorovish Licea/0000-0003-4022-7405; Ramos-Ibarra, Marco A./0000-0002-8950-2079; Mares, Rosa E/0000-0001-6102-6966; Ortiz, Ernesto/0000-0002-8713-0224; Duenas, Salvador/0000-0002-0818-820X	Centro de Investigacion Cientifica y Educacion Superior de Ensenada	Centro de Investigacion Cientifica y Educacion Superior de Ensenada	This work was supported by Centro de Investigacion Cientifica y Educacion Superior de Ensenada, Internal Project for AFLN.	Akondi KB, 2014, CHEM REV, V114, P5815, DOI 10.1021/cr400401e; Biggs JS, 2010, MOL PHYLOGENET EVOL, V56, P1, DOI 10.1016/j.ympev.2010.03.029; Bulaj G, 2003, P NATL ACAD SCI USA, V100, P14562, DOI 10.1073/pnas.2335845100; d'Aloisio E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-101; Darby NJ, 1999, FEBS LETT, V448, P167, DOI 10.1016/S0014-5793(99)00374-9; DENECKE J, 1992, EMBO J, V11, P2345, DOI 10.1002/j.1460-2075.1992.tb05294.x; Dutertre S, 2013, MOL CELL PROTEOMICS, V12, P312, DOI 10.1074/mcp.M112.021469; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Elliger CA, 2011, TOXICON, V57, P311, DOI 10.1016/j.toxicon.2010.12.008; Galligan JJ, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-6; Gowd KH, 2007, MOL BIOSYST, V3, P554, DOI 10.1039/b705382g; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Interests CF, 2011, INT GEN VIEW, V29, P24, DOI [10.1038/nbt0111-24, DOI 10.1038/NBT0111-24]; Kaas Q, 2010, TOXICON, V55, P1491, DOI 10.1016/j.toxicon.2010.03.002; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kemmink J, 1997, CURR BIOL, V7, P239, DOI 10.1016/S0960-9822(06)00119-9; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Knodler LA, 1999, J BIOL CHEM, V274, P29805, DOI 10.1074/jbc.274.42.29805; Langmead B, 2012, NATURE METHODS, V29, P997, DOI [10.1016/j.biotechadv.2011.08.021.Secreted, DOI 10.1016/J.BIOTECHADV.2011.08.021.SECRETED]; Lavergne V, 2015, P NATL ACAD SCI USA, V112, pE3782, DOI 10.1073/pnas.1501334112; Lucero HA, 1999, J BIOL CHEM, V274, P3243, DOI 10.1074/jbc.274.5.3243; Neves J, 2013, MAR DRUGS, V11, P2203, DOI 10.3390/md11062203; Norton RS, 2006, TOXICON, V48, P780, DOI 10.1016/j.toxicon.2006.07.022; Ramos MA, 2005, MOL BIOCHEM PARASIT, V143, P236, DOI 10.1016/j.molbiopara.2005.04.013; Rendon-anaya M, 2013, TOXINOLOGY, P1, DOI [10.1007/978-94-007-6647-1, DOI 10.1007/978-94-007-6647-1]; Robinson SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087648; Safavi-Hemami H, 2012, J BIOL CHEM, V287, P34288, DOI 10.1074/jbc.M112.366781; Safavi-Hemami H, 2011, J PROTEOME RES, V10, P3904, DOI 10.1021/pr1012976; TACHIKAWA H, 1995, FEBS LETT, V369, P212, DOI 10.1016/0014-5793(95)00750-4; Wang XJ, 2013, BIOINFORMATICS, V29, P3235, DOI 10.1093/bioinformatics/btt543; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Winnebeck EC, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14119	34	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148390	10.1371/journal.pone.0148390	http://dx.doi.org/10.1371/journal.pone.0148390			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859138	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400038
J	Omori, K; Hattori, N; Senoo, T; Takayama, Y; Masuda, T; Nakashima, T; Iwamoto, H; Fujitaka, K; Hamada, H; Kohno, N				Omori, Keitaro; Hattori, Noboru; Senoo, Tadashi; Takayama, Yusuke; Masuda, Takeshi; Nakashima, Taku; Iwamoto, Hiroshi; Fujitaka, Kazunori; Hamada, Hironobu; Kohno, Nobuoki			Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-beta-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; TGF-BETA; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; LUNG COLLAGEN; CELLS; MICE; VITRONECTIN; INTEGRINS; BINDING	Transforming growth factor-beta (TGF-beta) is central during the pathogenesis of pulmonary fibrosis, in which the plasminogen activator inhibitor-1 (PAI-1) also has an established role. TGF-beta is also known to be the strongest inducer of PAI-1. To investigate the link between PAI-1 and TGF-beta in fibrotic processes, we evaluated the effect of SK-216, a PAI-1-specific inhibitor, in TGF-beta-dependent epithelial-mesenchymal transition (EMT) and fibroblast to myofibroblast differentiation. In human alveolar epithelial A549 cells, treatment with TGF-beta induced EMT, whereas co-treatment with SK-216 attenuated the occurrence of EMT. The inhibition of TGF-beta-induced EMT by SK-216 was also confirmed in the experiment using murine epithelial LA-4 cells. Blocking EMT by SK-216 inhibited TGF-beta-induced endogenous production of PAI-1 and TGF-beta in A549 cells as well. These effects of SK-216 were not likely mediated by suppressing either Smad or ERK pathways. Using human lung fibroblast MRC-5 cells, we demonstrated that SK-216 inhibited TGF-beta-dependent differentiation of fibroblasts to myofibroblasts. We also observed this inhibition by SK-216 in human primary lung fibroblasts. Following these in vitro results, we tested oral administration of SK-216 into mice injected intratracheally with bleomycin. We found that SK-216 reduced the degree of bleomycin-induced pulmonary fibrosis in mice. Although the precise mechanisms underlying the link between TGF-beta and PAI-1 regarding fibrotic process were not determined, PAI-1 seems to act as a potent downstream effector on the pro-fibrotic property of TGF-beta. In addition, inhibition of PAI-1 activity by a PAI-1 inhibitor exerts an antifibrotic effect even in vivo. These data suggest that targeting PAI-1 as a downstream effector of TGF-beta could be a promising therapeutic strategy for pulmonary fibrosis.	[Omori, Keitaro; Hattori, Noboru; Senoo, Tadashi; Takayama, Yusuke; Masuda, Takeshi; Nakashima, Taku; Iwamoto, Hiroshi; Fujitaka, Kazunori; Kohno, Nobuoki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol & Internal Med, Hiroshima, Japan; [Hamada, Hironobu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Phys Anal & Therapeut Sci, Hiroshima, Japan	Hiroshima University; Hiroshima University	Hattori, N (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol & Internal Med, Hiroshima, Japan.	nhattori@hiroshima-u.ac.jp	Hamada, Hironobu/A-6489-2018; Hiyama, Eiso/A-2013-2019; Nakashima, Taku/D-1517-2011	Hamada, Hironobu/0000-0002-7979-0708; Hiyama, Eiso/0000-0001-9179-5037; Nakashima, Taku/0000-0002-0035-674X; Iwamoto, Hiroshi/0000-0003-4922-5334	Ministry of Education, Culture, Sports, Science and Technology of Japan [22390165]; ministry of Health, Labour and Welfare, Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/a_menu/shinkou/hojyo/03041519.htm no. 22390165 to NH) and a grant to the Diffuse Lung Diseases Research Group from the ministry of Health, Labour and Welfare, Japan. These funders had a role in study design, data collection and analysis.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; ALBO D, 1994, BIOCHEM BIOPH RES CO, V203, P857, DOI 10.1006/bbrc.1994.2262; Courey AJ, 2011, BLOOD, V118, P2313, DOI 10.1182/blood-2010-12-324574; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; GIRI SN, 1993, THORAX, V48, P959, DOI 10.1136/thx.48.10.959; Hattori N, 2000, J CLIN INVEST, V106, P1341, DOI 10.1172/JCI10531; Huang WT, 2012, AM J RESP CELL MOL, V46, P87, DOI 10.1165/rcmb.2011-0139OC; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; Kim JY, 2007, LASER SURG MED, P1; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; KUHN C, 1991, AM J PATHOL, V138, P1257; Loskutoff DJ, 1999, APMIS, P107; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Nicholas SB, 2005, KIDNEY INT, V67, P1297, DOI 10.1111/j.1523-1755.2005.00207.x; OLMAN MA, 1995, J CLIN INVEST, V96, P1621, DOI 10.1172/JCI118201; Piek E, 1999, J CELL SCI, V112, P4557; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Samarakoon R, 2005, J CELL PHYSIOL, V204, P236, DOI 10.1002/jcp.20279; Scaffidi AK, 2001, J CELL SCI, V114, P3507; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Senoo T, 2010, THORAX, V65, P334, DOI 10.1136/thx.2009.119974; Seo JY, 2009, AM J NEPHROL, V30, P481, DOI 10.1159/000242477; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Taylor MA, 2010, J MAMMARY GLAND BIOL, V15, P169, DOI 10.1007/s10911-010-9181-1; Vial D, 2008, J CELL SCI, V121, P1661, DOI 10.1242/jcs.020149; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; ZHANG K, 1994, AM J PATHOL, V145, P114; Zhang YP, 2013, THROMB RES, V131, P64, DOI 10.1016/j.thromres.2012.09.003	35	50	52	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148969	10.1371/journal.pone.0148969	http://dx.doi.org/10.1371/journal.pone.0148969			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859294	gold, Green Submitted, Green Published			2022-12-27	WOS:000370038400111
J	Kikuchi, M; Koyasu, S; Shinohara, S; Imai, Y; Hino, M; Naito, Y				Kikuchi, Masahiro; Koyasu, Sho; Shinohara, Shogo; Imai, Yukihiro; Hino, Megumu; Naito, Yasushi			Preoperative Diagnostic Strategy for Parotid Gland Tumors Using Diffusion-Weighted MRI and Technetium-99m Pertechnetate Scintigraphy: A Prospective Study	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; BILATERAL WARTHIN TUMOR; ECHO-PLANAR; SALIVARY-GLANDS; FROZEN-SECTION; LESIONS; BIOPSY; HEAD; NECK; COEFFICIENT	Objective Fine needle aspiration cytology (FNAC) for diagnosis of a parotid gland tumor is widely used but its sensitivity is low and non-diagnostic rate is relatively high. In contrast, core needle biopsy (CNB) has a higher sensitivity and lower rate of sampling errors but has a higher risk of injury to adjacent organs such as facial nerve than FNAC. Screening of patients with parotid gland tumors to identify cases of pleomorphic adenoma (PA) and Warthin tumor (WT) may allow CNB to be confined to patients without PA and WT. We established an algorithm for preoperative diagnosis and management of parotid gland tumor using diffusion-weighted MRI and Tc-99m pertechnetate scintigraphy. This algorithm was developed with the goal of maximal reduction of the number of patients in whom CNB is required. The purpose of the study is to validate our algorithm prospectively. Methods A prospective study was conducted in 71 cases who were newly diagnosed with parotid gland tumor and 53 cases were enrolled in the study. In the algorithm, PA (high apparent diffusion coefficient (ADC) (mean)>= 1.5x10(-3) mm(2)/s) and non-PA (low ADC(mean)< 1.5x10(-3) mm(2)/s) cases are first distinguished based on the ADC(mean) on diffusion-weighed MRI. Second, among suspected non-PA cases, WT and non-WT are distinguished using technetium-99m pertechnetate scintigraphy. CNB is then performed only in probable non-PA and non-WT cases. Results CNB was only required in 40% (21/53) of all cases, we made a preoperative histopathological diagnosis with an accuracy of 87% (46/53) and we correctly diagnosed whether a tumor was benign or malignant with an accuracy of 96% (51/53). Preoperative surgical planning had to be changed during surgery in only one case (2%) Conclusions Our algorithm is valuable in terms of clinical practice with highly potential for preoperative diagnosis and with less risk of CNB procedure.	[Kikuchi, Masahiro; Shinohara, Shogo; Naito, Yasushi] Kobe City Med Ctr Gen Hosp, Dept Otolaryngol Head & Neck Surg, Kobe, Hyogo, Japan; [Koyasu, Sho; Hino, Megumu] Kobe City Med Ctr Gen Hosp, Dept Radiol, Kobe, Hyogo, Japan; [Imai, Yukihiro] Kobe City Med Ctr Gen Hosp, Dept Clin Pathol, Kobe, Hyogo, Japan; [Koyasu, Sho] Kyoto Univ, Dept Diagnost Imaging & Nucl Med, Grad Sch Med, Kyoto, Japan	Kobe City Medical Center General Hospital; Kobe City Medical Center General Hospital; Kobe City Medical Center General Hospital; Kyoto University	Kikuchi, M (corresponding author), Kobe City Med Ctr Gen Hosp, Dept Otolaryngol Head & Neck Surg, Kobe, Hyogo, Japan.	kikuchan0414@gmail.com	Kikuchi, Masahiro/AAQ-5569-2020; Koyasu, Sho/I-5747-2019; Shinohara, Shogo/H-8976-2019	Kikuchi, Masahiro/0000-0002-0711-468X; Shinohara, Shogo/0000-0002-1794-2091; Koyasu, Sho/0000-0002-6690-7460	Kasahara Fund for Promotion of Cancer Research	Kasahara Fund for Promotion of Cancer Research	This study was supported by the Kasahara Fund for Promotion of Cancer Research and MK. received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Celebi I, 2013, CLIN IMAG, V37, P232, DOI 10.1016/j.clinimag.2012.04.025; CHAPNIK JS, 1983, LARYNGOSCOPE, V93, P695; Cho HW, 2011, AM J ROENTGENOL, V196, P1160, DOI 10.2214/AJR.10.4256; Chuang CC, 2012, J NEUROSURG, V117, P63, DOI 10.3171/2012.7.GKS121003; Douville NJ, 2013, HEAD NECK-J SCI SPEC, V35, P1657, DOI 10.1002/hed.23193; Eida S, 2007, AM J NEURORADIOL, V28, P116; Habermann CR, 2009, AM J NEURORADIOL, V30, P591, DOI 10.3174/ajnr.A1412; Haldar S, 2015, INT J ORAL MAX SURG, V44, P151, DOI 10.1016/j.ijom.2014.09.025; Heaton CM, 2013, LARYNGOSCOPE, V123, P3056, DOI 10.1002/lary.24247; IBI A, 1981, J ORAL SURG, V39, P362; Ichihara T, 2014, ACTA OTO-LARYNGOL, V134, P1185, DOI 10.3109/00016489.2014.914246; Ikeda M, 2004, AM J NEURORADIOL, V25, P1256; Juan CJ, 2009, RADIOLOGY, V253, P144, DOI 10.1148/radiol.2531082228; Kikuchi Masahiro, 2010, Nihon Jibiinkoka Gakkai Kaiho, V113, P441; Klussmann JP, 2006, ACTA OTO-LARYNGOL, V126, P1213, DOI 10.1080/00016480600740605; Koyasu S, 2014, EUR RADIOL, V24, P3088, DOI 10.1007/s00330-014-3369-5; Maeda M, 2008, J NEURORADIOLOGY, V35, P71, DOI 10.1016/j.neurad.2008.01.080; Miyake H, 2001, EUR RADIOL, V11, P2472, DOI 10.1007/s003300100839; Motoori K, 2005, J COMPUT ASSIST TOMO, V29, P506, DOI 10.1097/01.rct.0000164672.34261.33; Pfeiffer J, 2012, INT J ORAL MAX SURG, V41, P437, DOI 10.1016/j.ijom.2011.12.005; Sasaki M, 2011, AM J NEURORADIOL, V32, P1100, DOI 10.3174/ajnr.A2434; Schmidt RL, 2011, AM J CLIN PATHOL, V136, P45, DOI 10.1309/AJCPOIE0CZNAT6SQ; Seethala RR, 2005, HEAD NECK-J SCI SPEC, V27, P217, DOI 10.1002/hed.20142; Srinivasan A, 2008, AM J NEURORADIOL, V29, P40, DOI 10.3174/ajnr.A0743; Suh SI, 2005, J COMPUT ASSIST TOMO, V29, P121, DOI 10.1097/01.rct.0000150141.14113.ab; Vories AA, 1997, SOUTHERN MED J, V90, P416, DOI 10.1097/00007611-199704000-00011; WEINSTEIN GS, 1994, J NUCL MED, V35, P179; Witt BL, 2014, LARYNGOSCOPE, V124, P695, DOI 10.1002/lary.24339; Wu EH, 2013, KOREAN J RADIOL, V14, P299, DOI 10.3348/kjr.2013.14.2.299; Yabuuchi H, 2008, RADIOLOGY, V249, P909, DOI 10.1148/radiol.2493072045; Yerli H, 2007, ACTA RADIOL, V48, P980, DOI 10.1080/02841850701501717; Yoshino N, 2001, RADIOLOGY, V221, P837, DOI 10.1148/radiol.2213010131; Zaghi S, 2014, AM J OTOLARYNG, V35, P713, DOI 10.1016/j.amjoto.2014.07.013; Zbaren P, 2004, CANCER-AM CANCER SOC, V100, P1876, DOI 10.1002/cncr.20186	34	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148973	10.1371/journal.pone.0148973	http://dx.doi.org/10.1371/journal.pone.0148973			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849569	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000191
J	Lasda, E; Parker, R				Lasda, Erika; Parker, Roy			Circular RNAs Co-Precipitate with Extracellular Vesicles: A Possible Mechanism for circRNA Clearance	PLOS ONE			English	Article							EXOSOMES; ABUNDANT	Backspliced circular RNAs (circRNAs) are prevalent in many eukaryotic systems and are spliced from thousands of different genes. Where examined, circRNAs are often highly stable and the mechanisms by which cells degrade and/or clear circRNAs from the cells are unknown. Here we investigated the possibility that cells can eliminate circRNAs into extracellular space, possibly within released vesicles such as exosomes and microvesicles. From three different cell lines and examining multiple circRNAs, we show that extracellular vesicle (EVs) preparations recovered from cell culture conditioned media contain established circRNAs. Moreover, these circRNAs are enriched over their linear counterparts within EV preparations when compared to the producing cells. This supports the idea that expulsion from cells into extracellular space, as by EVs release, can be a mechanism by which cells clear circRNAs. Moreover, since EVs can be taken up by other cells, excreted circRNAs could contribute to cell to cell communication.	[Lasda, Erika] Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA; Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Lasda, E (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	erika.lasda@colorado.edu			Howard Hughes Medical Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by funds from the Howard Hughes Medical Institute.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Ghosh S, 2010, WIRES RNA, V1, P351, DOI 10.1002/wrna.25; Glazar P, 2014, RNA, V20, P1666, DOI 10.1261/rna.043687.113; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Jeppesen DK, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.25011; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Li Y, 2015, CELL RES, V25, P981, DOI 10.1038/cr.2015.82; Liang DM, 2014, GENE DEV, V28, P2233, DOI 10.1101/gad.251926.114; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Taylor DD, 2015, METHODS, V87, P3, DOI 10.1016/j.ymeth.2015.02.019; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Van Deun J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24858; Westholm JO, 2014, CELL REP, V9, P1966, DOI 10.1016/j.celrep.2014.10.062	24	255	277	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148407	10.1371/journal.pone.0148407	http://dx.doi.org/10.1371/journal.pone.0148407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848835	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000088
J	Lorem, GF; Schirmer, H; Emaus, N				Lorem, Geir Fagerjord; Schirmer, Henrik; Emaus, Nina			Health Impact Index. Development and Validation of a Method for Classifying Comorbid Disease Measured against Self-Reported Health	PLOS ONE			English	Article							QUALITY-OF-LIFE; RATED HEALTH; OLDER-ADULTS; MORTALITY; RISK; MORBIDITY; STRESS; COHORT; SF-36	The objective of this study was to develop a method of classifying comorbid conditions that accounts for both the severity and joint effects of the diseases. The Tromso Study is a cohort study with a longitudinal design utilizing a survey approach with physical examinations in the Tromso municipality from 1974 to 2008, where in total 40051 subjects participated. We used Tromso 4 as reference population and the Norwegian Institute of Public Health (FHI) panel as validation population. Ordinal regression was used to assess the effect of comorbid disease on Self-Reported Health (SRH). The model is controlled for interaction between diseases, mental health, age, and gender. The health impact index estimated levels of SRH. The comparison of predicted and observed SRH showed no significant differences. Spearman's correlation showed that increasing levels of comorbidity were related to lower levels of SRH (RS = -0.36, p <.001). The Charlson Comorbidity Index (CCI) was also associated with SRH (r = -.25, p <.001). When focusing on only individuals with a comorbid disease, the relation between SRH and the Health Impact Index (HII) was strengthened (r = -.42, p <.001), while the association between SRH and CCI was attenuated (r = -.14, p <.001). CCI was designed to control for comorbid conditions when survival/mortality is the outcome of interest but is inaccurate when the outcome is SRH. We conclude that HII should be used when SRH is not available, and well-being or quality of survival/life is the outcome of interest.	[Lorem, Geir Fagerjord; Emaus, Nina] Arctic Univ Norway, Dept Caring & Hlth Sci, Fac Hlth Sci, Tromso, Norway; [Schirmer, Henrik] Arctic Univ Norway, Dept Clin Med, Fac Hlth Sci, Tromso, Norway; [Schirmer, Henrik] Univ Hosp Northern Norway, Div Cardiothorac & Resp Med, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Lorem, GF (corresponding author), Arctic Univ Norway, Dept Caring & Hlth Sci, Fac Hlth Sci, Tromso, Norway.	Geir.lorem@uit.no			UiT The Arctic University of Norway	UiT The Arctic University of Norway	UiT The Arctic University of Norway funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benyamini Y, 2011, PSYCHOL HEALTH, V26, P1407, DOI 10.1080/08870446.2011.621703; Bishop F, 2010, PSYCHOL HEALTH, V25, P271, DOI 10.1080/08870440802609980; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Charlson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112479; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Craigs CL, 2014, ARCH GERONTOL GERIAT, V59, P211, DOI 10.1016/j.archger.2014.06.009; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; DHoore W, 1996, J CLIN EPIDEMIOL, V49, P1429, DOI 10.1016/S0895-4356(96)00271-5; Eriksson I, 2001, INT J EPIDEMIOL, V30, P326, DOI 10.1093/ije/30.2.326; Franks P, 2003, SOC SCI MED, V56, P2505, DOI 10.1016/S0277-9536(02)00281-2; Ganna A, 2015, LANCET; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Halford C, 2003, J PSYCHOSOM RES, V55, P317, DOI 10.1016/S0022-3999(02)00634-7; Halford C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001353; Halford C, 2010, UPSALA J MED SCI, V115, P266, DOI 10.3109/03009734.2010.496910; Hardy MA, 2014, J HEALTH SOC BEHAV, V55, P320, DOI 10.1177/0022146514541446; Haring R, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-103; Hirve S, 2014, SOC INDIC RES, V117, P105, DOI 10.1007/s11205-013-0334-7; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Jylha M, 1998, J GERONTOL B-PSYCHOL, V53, pS144, DOI 10.1093/geronb/53B.3.S144; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kaplan GA, 1996, INT J EPIDEMIOL, V25, P259, DOI 10.1093/ije/25.2.259; Kvamme JM, 2010, EUR J EPIDEMIOL, V25, P183, DOI 10.1007/s10654-009-9422-z; Lehmann EL., 1998, NONPARAMETRICS STAT, V292, P23; Mavaddat N, 2014, BMC FAM PRACT, V15, DOI 10.1186/s12875-014-0185-6; Mavaddat N, 2011, J EPIDEMIOL COMMUN H, V65, P800, DOI 10.1136/jech.2009.090845; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Miilunpalo S, 1997, J CLIN EPIDEMIOL, V50, P517, DOI 10.1016/S0895-4356(97)00045-0; Mikolajczyk RT, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-215; MOEN P, 1992, AM J SOCIOL, V97, P1612, DOI 10.1086/229941; Mukherjee S., 2012, J POSTGRAD MED ED RE, V46, P112, DOI [10.5005/jp-journals-10028-1025, DOI 10.5005/JP-JOURNALS-10028-1025]; Needham DM, 2005, J CRIT CARE, V20, P12, DOI 10.1016/j.jcrc.2004.09.007; OConnell A. A., 2006, LOGISTIC REGRESSION, DOI [10.4135/9781412984812, DOI 10.4135/9781412984812]; Pentakota SR, 2012, DIABETES CARE, V35, P1285, DOI 10.2337/dc11-1569; Shetterly SM, 1996, AM J PUBLIC HEALTH, V86, P1798, DOI 10.2105/AJPH.86.12.1798; Sogaard AJ, 2003, NOR EPIDEMIOL, V13, P279, DOI DOI 10.5324/NJE.V13I2.296; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; Vingilis ER, 2002, CAN J PUBLIC HEALTH, V93, P193, DOI 10.1007/BF03404999; Weiss NS, 2014, EUR J EPIDEMIOL, V29, P147, DOI 10.1007/s10654-014-9899-y	41	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148830	10.1371/journal.pone.0148830	http://dx.doi.org/10.1371/journal.pone.0148830			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26849044	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000174
J	Mir, RA; Weppelmann, TA; Elzo, M; Ahn, S; Driver, JD; Jeong, KC				Mir, Raies A.; Weppelmann, Thomas A.; Elzo, Mauricio; Ahn, Soohyoun; Driver, J. Danny; Jeong, KwangCheol Casey			Colonization of Beef Cattle by Shiga Toxin-Producing Escherichia coli during the First Year of Life: A Cohort Study	PLOS ONE			English	Article							O157H7 STRAINS; UNITED-STATES; INFECTIONS; PREVALENCE; DIVERSITY; CALVES; GENES	Each year Shiga toxin-producing Escherichia coli (STEC) are responsible for 2.8 million acute illnesses around the world and > 250,000 cases in the US. Lowering the prevalence of this pathogen in animal reservoirs has the potential to reduce STEC outbreaks in humans by controlling its entrance into the food chain. However, factors that modulate the colonization and persistence of STEC in beef cattle remain largely unidentified. This study evaluated if animal physiological factors such as age, breed, sex, and weight gain influenced the shedding of STEC in beef cattle. A cohort of beef calves (n = 260) from a multi-breed beef calf population was sampled every three months after birth to measure prevalence and concentration of STEC during the first year of life. Metagenomic analysis was also used to understand the association between the STEC colonization and the composition of gut microflora. This study identified that beef calves were more likely to shed STEC during the first 6 months and that STEC shedding decreased as the animal matured. Animal breed group, sex of the calf, and average weight gain were not significantly associated with STEC colonization. The meta-genomic analysis revealed for the first time that STEC colonization was correlated with a lower diversity of gut microflora, which increases as the cattle matured. Given these findings, intervention strategies that segregate younger animals, more likely to be colonized by STEC from older animals that are ready to be harvested, could be investigated as a method to reduce zoonotic transmission of STEC from cattle to humans.	[Mir, Raies A.; Elzo, Mauricio; Driver, J. Danny; Jeong, KwangCheol Casey] Univ Florida, Inst Food & Agr Sci, Dept Anim Sci, Gainesville, FL 32611 USA; [Mir, Raies A.; Weppelmann, Thomas A.; Jeong, KwangCheol Casey] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Weppelmann, Thomas A.] Univ Florida, Dept Environm & Global Hlth, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Ahn, Soohyoun] Univ Florida, Inst Food & Agr Sci, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Jeong, KC (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Anim Sci, Gainesville, FL 32611 USA.; Jeong, KC (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.	kcjeong@ufl.edu			National Institute of Food and Agriculture, U.S. Department of Agriculture [2014-67021-21597, 2015-68003-22971]	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This material is based upon work that is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under awad number 2014-67021-21597 and 2015-68003-22971 to KCJ.	[Anonymous], 2010, R LANG ENV STAT COMP; Bai JF, 2010, J MICROBIOL METH, V82, P85, DOI 10.1016/j.mimet.2010.05.003; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Cobbold R, 2000, VET MICROBIOL, V71, P125, DOI 10.1016/S0378-1135(99)00173-X; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Durso LM, 2010, APPL ENVIRON MICROB, V76, P4858, DOI 10.1128/AEM.00207-10; Farfan MJ, 2012, INFECT IMMUN, V80, P903, DOI 10.1128/IAI.05907-11; Frey KG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-96; Frohlich J, 2009, APPL ENVIRON MICROB, V75, P3695, DOI 10.1128/AEM.02869-08; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Jeon SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055728; LeJeune JT, 2007, J ANIM SCI, V85, pE73, DOI 10.2527/jas.2006-612; Li K, 2012, PLOS ONE, V7; Lima FS, 2015, APPL ENVIRON MICROB, V81, P1327, DOI 10.1128/AEM.03138-14; Majowicz SE, 2014, FOODBORNE PATHOG DIS, V11, P447, DOI 10.1089/fpd.2013.1704; Matthews L, 2013, P NATL ACAD SCI USA, V110, P16265, DOI 10.1073/pnas.1304978110; Mir RA, 2014, VET MICROBIOL; Monaghan I, 2011, APPL ENVIRON MICROB, V77, P8662, DOI 10.1128/AEM.06190-11; Park D, 2013, APPL ENVIRON MICROB, V79, P1563, DOI 10.1128/AEM.03158-12; Rantsiou K, 2012, INT J FOOD MICROBIOL, V154, P37, DOI 10.1016/j.ijfoodmicro.2011.12.010; Reiland HA, 2014, ADV MICROBIOL, V4, P390, DOI DOI 10.4236/aim.2014.47046; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Siegler RL, 2003, PEDIATR NEPHROL, V18, P92, DOI 10.1007/s00467-002-1035-7; Slanec T, 2009, APPL ENVIRON MICROB, V75, P6187, DOI 10.1128/AEM.00874-09; Stanton E, 2014, MICROBIOL-SGM, V160, P502, DOI 10.1099/mic.0.073437-0; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; Zhang YX, 2010, APPL ENVIRON MICROB, V76, P474, DOI 10.1128/AEM.01288-09; Zhao L, 2014, FOODBORNE PATHOG DIS, V11, P55, DOI 10.1089/fpd.2013.1587	32	29	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148518	10.1371/journal.pone.0148518	http://dx.doi.org/10.1371/journal.pone.0148518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849041	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000114
J	Nakatsukasa, K; Kamura, T				Nakatsukasa, Kunio; Kamura, Takumi			Subcellular Fractionation Analysis of the Extraction of Ubiquitinated Polytopic Membrane Substrate during ER-Associated Degradation	PLOS ONE			English	Article							RETICULUM-ASSOCIATED DEGRADATION; PROTEIN-QUALITY CONTROL; STEROL-INDUCED DISLOCATION; MAMMALIAN 20S PROTEASOMES; COENZYME-A REDUCTASE; HMG-COA REDUCTASE; ENDOPLASMIC-RETICULUM; MISFOLDED PROTEINS; SACCHAROMYCES-CEREVISIAE; LIGASE	During ER-associated degradation (ERAD), misfolded polytopic membrane proteins are ubiquitinated and retrotranslocated to the cytosol for proteasomal degradation. However, our understanding as to how polytopic membrane proteins are extracted from the ER to the cytosol remains largely unclear. To better define the localization and physical properties of ubiquitinated polytopic membrane substrates in vivo, we performed subcellular fractionation analysis of Ste6*, a twelve transmembrane protein that is ubiquitinated primarily by Doa10 E3 ligase in yeast. Consistent with previous in vitro studies, ubiquitinated Ste6* was extracted from P20 (20,000 g pellet) fraction to S20 (20,000 g supernatant) fraction in a Cdc48/p97-dependent manner. Similarly, Ubx2p, which recruits Cdc48/p97 to the ER, facilitated the extraction of Ste6*. By contrast, lipid droplet formation, which was suggested to be dispensable for the degradation of Hrd1-substrates in yeast, was not required for the degradation of Ste6*. Intriguingly, we found that ubiquitinated Ste6* in the S20 fraction could be enriched by further centrifugation at 100,000 g. Although it is currently uncertain whether ubiquitinated Ste6* in P100 fraction is completely free from any lipids, membrane flotation analysis suggested the existence of two distinct populations of ubiquitinated Ste6* with different states of membrane association. Together, these results imply that ubiquitinated Ste6* may be sequestered into a putative quality control sub-structure by Cdc48/p97. Fractionation assays developed in the present study provide a means to further dissect the ill-defined post-ubiquitination step during ERAD of polytopic membrane substrates.	[Nakatsukasa, Kunio; Kamura, Takumi] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Nakatsukasa, K; Kamura, T (corresponding author), Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	z47875a@cc.nagoya-u.ac.jp; z47617a@nucc.cc.nagoya-u.ac.jp			JSPS KAKENHI [15K18503, 15K14474]; MEXT KAKENHI [24112006]; Grants-in-Aid for Scientific Research [24112006] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding provided by JSPS KAKENHI Grant Number 15K18503 to K. N. and 15K14474 to T. K. and MEXT KAKENHI Grant Number 24112006 to T. K. https://www.jsps.go.jp/english/index.html.	Aridor M, 2007, ADV DRUG DELIVER REV, V59, P759, DOI 10.1016/j.addr.2007.06.002; Baek GH, 2011, P NATL ACAD SCI USA, V108, P13558, DOI 10.1073/pnas.1104051108; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chartron JW, 2011, J BIOL CHEM, V286, P34325, DOI 10.1074/jbc.M111.277798; Elsabrouty R, 2013, MOL BIOL CELL, V24, P3300, DOI 10.1091/mbc.E13-03-0157; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Foresti O, 2014, SCIENCE, V346, P751, DOI 10.1126/science.1255638; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; Habeck G, 2015, J CELL BIOL, V209, P261, DOI 10.1083/jcb.201408088; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015; Huyer G, 2004, MOL BIOL CELL, V15, P908, DOI 10.1091/mbc.E03-07-0546; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jo Y, 2013, MOL BIOL CELL, V24, P169, DOI 10.1091/mbc.E12-07-0564; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kawahara H, 2013, J BIOCHEM, V153, P147, DOI 10.1093/jb/mvs149; Khmelinskii A, 2014, NATURE, V516, P410, DOI 10.1038/nature14096; Klemm EJ, 2011, J BIOL CHEM, V286, P37602, DOI 10.1074/jbc.M111.284794; Kohl C, 2011, BIOL CHEM, V392, P601, DOI 10.1515/BC.2011.066; KOLLING R, 1994, EMBO J, V13, P3261, DOI 10.1002/j.1460-2075.1994.tb06627.x; Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100; Leichner GS, 2009, MOL BIOL CELL, V20, P3330, DOI 10.1091/mbc.E08-09-0953; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Metzger MB, 2008, J BIOL CHEM, V283, P32302, DOI 10.1074/jbc.M806424200; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nakatsukasa K, 2015, CRIT REV BIOCHEM MOL, V50, P489, DOI 10.3109/10409238.2015.1081869; Nakatsukasa K, 2015, MOL CELL, V59, P22, DOI 10.1016/j.molcel.2015.04.013; Nakatsukasa K, 2013, MOL BIOL CELL, V24, P1765, DOI 10.1091/mbc.E12-12-0907; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Ng WY, 2007, J CELL SCI, V120, P682, DOI 10.1242/jcs.03351; Olzmann JA, 2011, J BIOL CHEM, V286, P27872, DOI 10.1074/jbc.C111.266452; Pagant S, 2007, MOL BIOL CELL, V18, P3398, DOI 10.1091/mbc.E07-01-0046; Palmer EA, 2003, J CELL SCI, V116, P2361, DOI 10.1242/jcs.00439; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Rieder S E, 2001, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0307s07; Rodrigo-Brenni MC, 2012, DEV CELL, V23, P896, DOI 10.1016/j.devcel.2012.10.012; Rubenstein EM, 2012, J CELL BIOL, V197, P761, DOI 10.1083/jcb.201203061; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Scott CM, 2007, MOL BIOL CELL, V18, P3776, DOI 10.1091/mbc.E07-01-0034; Sorger D, 2004, J BIOL CHEM, V279, P31190, DOI 10.1074/jbc.M403251200; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; Stolz A, 2013, P NATL ACAD SCI USA, V110, P15271, DOI 10.1073/pnas.1304928110; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Wunderley L, 2014, J CELL SCI, V127, P4728, DOI 10.1242/jcs.155648; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; Xu Y, 2012, CELL REP, V2, P1633, DOI 10.1016/j.celrep.2012.11.010; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	80	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148327	10.1371/journal.pone.0148327	http://dx.doi.org/10.1371/journal.pone.0148327			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849222	Green Published, gold			2022-12-27	WOS:000369554000068
J	Ramo, A; Quilez, J; Monteagudo, L; Del Cacho, E; Sanchez-Acedo, C				Ramo, Ana; Quilez, Joaquin; Monteagudo, Luis; Del Cacho, Emilio; Sanchez-Acedo, Caridad			Intra-Species Diversity and Panmictic Structure of Cryptosporidium parvum Populations in Cattle Farms in Northern Spain	PLOS ONE			English	Article							INFECTING DOMESTIC RUMINANTS; GENETIC DIVERSITY; UNITED-STATES; DAIRY CALVES; HOMINIS; SUBTYPE; GENOTYPES; RECOMBINATION; PREVALENCE; CHILDREN	The intra-herd and intra-host genetic variability of 123 Cryptosporidium parvum isolates was investigated using a multilocus fragment typing approach with eleven variable-number tandem-repeat (VNTR) loci and the GP60 gene. Isolates were collected from intensively farmed diarrheic pre-weaned calves originating from 31 dairy farms in three adjoining regions in northern Spain (Pais Vasco, Cantabria and Asturias). The multilocus tool demonstrated an acceptable typeability, with 104/123 samples amplifying at all twelve loci. The ML2, TP14, GP60 and the previously un-described minisatellite at locus cgd2_3850 were the most discriminatory markers, while others may be dismissed as monomorphic (MSB) or less informative (CP47, ML1 and the novel minisatellites at loci Cgd1_3670 and Cgd6_3940). The 12-satellite typing tool provided a Hunter-Gaston index (HGDI) of 0.987 (95% CI, 0.982-0.992), and differentiated a total of 70 multilocus subtypes (MLTs). The inclusion of only the four most discriminatory markers dramatically reduced the number of MLTs (n: 44) but hardly reduced the HGDI value. A total of 54 MLTs were distinctive for individual farms, indicating that cryptosporidiosis is an endemic condition on most cattle farms. However, a high rate of mixed infections was detected, suggesting frequent meiotic recombination. Namely, multiple MLTs were seen in most farms where several specimens were analyzed (90.5%), with up to 9 MLTs being found on one farm, and individual specimens with mixed populations being reported on 11/29 farms. Bayesian Structure analysis showed that over 35% of isolates had mixed ancestry and analysis of evolutionary descent using the eBURST algorithm detected a high rate (21.4%) of MLTs appearing as singletons, indicating a high degree of genetic divergence. Linkage analysis found evidence of linkage equilibrium and an overall panmictic structure within the C. parvum population in this discrete geographical area.	[Ramo, Ana; Quilez, Joaquin; Del Cacho, Emilio; Sanchez-Acedo, Caridad] Univ Zaragoza, Fac Vet Sci, Dept Anim Pathol, Zaragoza, Spain; [Monteagudo, Luis] Univ Zaragoza, Fac Vet Sci, Dept Anat Embriol & Genet, Zaragoza, Spain	University of Zaragoza; University of Zaragoza	Quilez, J (corresponding author), Univ Zaragoza, Fac Vet Sci, Dept Anim Pathol, Zaragoza, Spain.	jquilez@unizar.es	; Quilez Cinca, Joaquin/Q-7194-2017	Ramo, Ana/0000-0002-0308-1390; Quilez Cinca, Joaquin/0000-0001-7831-2483	European Social Fund; Spanish and regional research programs [AGL2012-32138, DGA-B82]	European Social Fund(European Social Fund (ESF)); Spanish and regional research programs	This work was supported by funds from Spanish (AGL2012-32138) and regional (DGA-B82) research programs, and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brook EJ, 2009, VET J, V179, P378, DOI 10.1016/j.tvjl.2007.10.023; Caccio SM, 2015, INFECT GENET EVOL, V31, P245, DOI 10.1016/j.meegid.2015.02.008; Castro-Hermida JA, 2002, VET PARASITOL, V106, P1, DOI 10.1016/S0304-4017(02)00036-5; Castro-Hermida JA, 2002, VET PARASITOL, V106, P11, DOI 10.1016/S0304-4017(02)00038-9; Chalmers RM, 2013, TRENDS PARASITOL, V29, P237, DOI 10.1016/j.pt.2013.03.001; Chalmers RM, 2005, INT J PARASITOL, V35, P397, DOI 10.1016/j.ijpara.2005.01.001; COCKERHAM CC, 1993, EVOLUTION, V47, P855, DOI 10.1111/j.1558-5646.1993.tb01239.x; De Waele V, 2013, APPL ENVIRON MICROB, V79, P2534, DOI 10.1128/AEM.03613-12; Diaz P, 2012, VET PARASITOL, V186, P188, DOI 10.1016/j.vetpar.2011.11.039; Drumo R, 2012, APPL ENVIRON MICROB, V78, P3523, DOI 10.1128/AEM.07686-11; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feng YY, 2014, J CLIN MICROBIOL, V52, P524, DOI 10.1128/JCM.02973-13; Feng YY, 2013, INT J PARASITOL, V43, P1141, DOI 10.1016/j.ijpara.2013.09.002; Garcia A, 2000, COMP IMMUNOL MICROB, V23, P175, DOI 10.1016/S0147-9571(99)00071-5; Gatei W, 2007, INFECT GENET EVOL, V7, P197, DOI 10.1016/j.meegid.2006.08.006; Grinberg A, 2013, INFECT GENET EVOL, V15, P18, DOI 10.1016/j.meegid.2012.08.017; Guo YQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1517-1; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Herges GR, 2012, APPL ENVIRON MICROB, V78, P8096, DOI 10.1128/AEM.02105-12; Hotchkiss EJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1107-8; Hunter PR, 2007, EMERG INFECT DIS, V13, P82, DOI 10.3201/eid1301.060481; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Li N, 2013, EMERG INFECT DIS, V19, P1573, DOI 10.3201/eid1910.121361; Mallon M, 2003, J MOL EVOL, V56, P407, DOI 10.1007/s00239-002-2412-3; Mallon ME, 2003, INFECT GENET EVOL, V3, P207, DOI 10.1016/S1567-1348(03)00089-3; Mercado R, 2015, PARASITOL RES, V114, P1985, DOI 10.1007/s00436-015-4364-8; Morrison LJ, 2008, INFECT GENET EVOL, V8, P121, DOI 10.1016/j.meegid.2007.10.010; Ng J, 2010, EXP PARASITOL, V125, P348, DOI 10.1016/j.exppara.2010.02.017; Peng MM, 2003, PARASITOL RES, V90, P175, DOI 10.1007/s00436-003-0834-5; Pritchard JK, 2000, GENETICS, V155, P945; Quilez J, 2008, PARASITOLOGY, V135, P1613, DOI 10.1017/S0031182008005088; Quilez J, 2014, PARASITOL RES, V113, P1821, DOI 10.1007/s00436-014-3828-6; Quilez J, 2013, APPL ENVIRON MICROB, V79, P5363, DOI 10.1128/AEM.01168-13; Quilez J, 2011, APPL ENVIRON MICROB, V77, P7779, DOI 10.1128/AEM.00751-11; Ramo A, 2015, INFECT GENET EVOL, V31, P190, DOI 10.1016/j.meegid.2015.01.023; Ramo A, 2014, VET PARASITOL, V205, P466, DOI 10.1016/j.vetpar.2014.08.025; Robinson G, 2012, EXP PARASITOL, V132, P200, DOI 10.1016/j.exppara.2012.06.016; Ryan U, 2014, PARASITOLOGY, V141, P1667, DOI 10.1017/S0031182014001085; Tanriverdi S, 2006, APPL ENVIRON MICROB, V72, P2507, DOI 10.1128/AEM.72.4.2507-2513.2006; Tanriverdi S, 2006, INFECT GENET EVOL, V6, P113, DOI 10.1016/j.meegid.2005.02.002; Tanriverdi S, 2008, APPL ENVIRON MICROB, V74, P7227, DOI 10.1128/AEM.01576-08; Tanriverdi S, 2007, MOL MICROBIOL, V63, P1432, DOI 10.1111/j.1365-2958.2007.05594.x; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Waldron LS, 2011, INFECT GENET EVOL, V11, P1388, DOI 10.1016/j.meegid.2011.05.008; Wang RJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04208; Widmer G, 2012, PARASITE IMMUNOL, V34, P61, DOI 10.1111/j.1365-3024.2011.01301.x	46	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148811	10.1371/journal.pone.0148811	http://dx.doi.org/10.1371/journal.pone.0148811			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848837	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000172
J	Takayama, Y; Kida, YS				Takayama, Yuzo; Kida, Yasuyuki S.			In Vitro Reconstruction of Neuronal Networks Derived from Human iPS Cells Using Microfabricated Devices	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; DIRECTED DIFFERENTIATION; HUMAN FIBROBLASTS; NERVOUS-SYSTEM; GENERATION; INDUCTION	Morphology and function of the nervous system is maintained via well-coordinated processes both in central and peripheral nervous tissues, which govern the homeostasis of organs/tissues. Impairments of the nervous system induce neuronal disorders such as peripheral neuropathy or cardiac arrhythmia. Although further investigation is warranted to reveal the molecular mechanisms of progression in such diseases, appropriate model systems mimicking the patient-specific communication between neurons and organs are not established yet. In this study, we reconstructed the neuronal network in vitro either between neurons of the human induced pluripotent stem(iPS) cell derived peripheral nervous system (PNS) and central nervous system (CNS), or between PNS neurons and cardiac cells in a morphologically and functionally compartmentalized manner. Networks were constructed in photolithographically microfabricated devices with two culture compartments connected by 20 microtunnels. We confirmed that PNS and CNS neurons connected via synapses and formed a network. Additionally, calcium-imaging experiments showed that the bundles originating from the PNS neurons were functionally active and responded reproducibly to external stimuli. Next, we confirmed that CNS neurons showed an increase in calcium activity during electrical stimulation of networked bundles from PNS neurons in order to demonstrate the formation of functional cell-cell interactions. We also confirmed the formation of synapses between PNS neurons and mature cardiac cells. These results indicate that compartmentalized culture devices are promising tools for reconstructing network-wide connections between PNS neurons and various organs, and might help to understand patient-specific molecular and functional mechanisms under normal and pathological conditions.	[Takayama, Yuzo; Kida, Yasuyuki S.] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Takayama, Y; Kida, YS (corresponding author), Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Tsukuba, Ibaraki, Japan.	yuzo-takayama@aist.go.jp; y-kida@aist.go.jp	kida, yasuyuki S/J-1718-2018; Takayama, Yuzo/L-5072-2018	kida, yasuyuki S/0000-0002-9972-293X; Takayama, Yuzo/0000-0002-6382-8767	Japan Society for the Promotion of Science (JSPS) [26702015]; Uehara Memorial Foundation; Ono Medical Research Foundation; Grants-in-Aid for Scientific Research [26702015] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Ono Medical Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by a Grant-in-Aid for Young Scientists (A) (#26702015) from Japan Society for the Promotion of Science (JSPS) to YT. Funding was also provided by the Uehara Memorial Foundation and the Ono Medical Research Foundation to YSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchard JW, 2015, NAT NEUROSCI, V18, P25, DOI 10.1038/nn.3887; Bloch J, 2001, EXP NEUROL, V172, P425, DOI 10.1006/exnr.2001.7778; Buckner RL, 2013, TRENDS COGN SCI, V17, P648, DOI 10.1016/j.tics.2013.09.017; Burnett Mark G, 2004, Neurosurg Focus, V16, pE1, DOI 10.3171/foc.2004.16.5.2; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Downes JH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002522; Florea VG, 2014, CIRC RES, V114, P1815, DOI 10.1161/CIRCRESAHA.114.302589; HORAN PK, 1989, NATURE, V340, P167, DOI 10.1038/340167a0; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003; Kanagasabapathi TT, 2013, J NEUROSCI METH, V214, P1, DOI 10.1016/j.jneumeth.2012.12.019; Kempf H, 2014, STEM CELL REP, V3, P1132, DOI 10.1016/j.stemcr.2014.09.017; Kim Ju-Yeon, 2012, World J Stem Cells, V4, P110, DOI 10.4252/wjsc.v4.i11.110; Kreitzer FR, 2013, AM J STEM CELLS, V2, P119; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Liu QY, 2012, STEM CELL TRANSL MED, V1, P266, DOI 10.5966/sctm.2011-0042; Mata A, 2005, BIOMED MICRODEVICES, V7, P281, DOI 10.1007/s10544-005-6070-2; Menendez L, 2013, NAT PROTOC, V8, P203, DOI 10.1038/nprot.2012.156; Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025; Millet Larry J., 2012, Yale Journal of Biology and Medicine, V85, P501; Mooren OL, 2014, MOL BIOL CELL, V25, P4115, DOI 10.1091/mbc.E14-05-0976; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Parati G, 2012, EUR HEART J, V33, P1058, DOI 10.1093/eurheartj/ehs041; Pfister Bryan J., 2011, Critical Reviews in Biomedical Engineering, V39, P81, DOI 10.1615/CritRevBiomedEng.v39.i2.20; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Qu QH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4449; Slaugenhaupt SA, 2002, CURR OPIN GENET DEV, V12, P307, DOI 10.1016/S0959-437X(02)00303-9; Takayama Y, 2012, BIOSYSTEMS, V107, P1, DOI 10.1016/j.biosystems.2011.08.001; Takeuchi A, 2011, LAB CHIP, V11, P2268, DOI 10.1039/c0lc00327a; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Van Dam PS, 2013, EUR J PHARMACOL, V719, P180, DOI 10.1016/j.ejphar.2013.07.017; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002	37	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148559	10.1371/journal.pone.0148559	http://dx.doi.org/10.1371/journal.pone.0148559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848955	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000125
J	Troelstra, SA; Bosdriesz, JR; De Boer, MR; Kunst, AE				Troelstra, Sigrid A.; Bosdriesz, Jizzo R.; De Boer, Michiel R.; Kunst, Anton E.			Effect of Tobacco Control Policies on Information Seeking for Smoking Cessation in the Netherlands: A Google Trends Study	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; FREE LEGISLATION; IMPACT; CONSUMPTION; PREVALENCE; LAW	Background The impact of tobacco control policies on measures of smoking cessation behaviour has often been studied, yet there is little information on their precise magnitude and duration. This study aims to measure the magnitude and timing of the impact of Dutch tobacco control policies on the rate of searching for information on smoking cessation, using Google Trends search query data. Methods An interrupted time series analysis was used to examine the effect of two types of policies (smoke-free legislation and reimbursement of smoking cessation support (SCS)) on Google searches for 'quit smoking'. Google Trends data were seasonally adjusted and analysed using autoregressive integrated moving average (ARIMA) modelling. Multiple effect periods were modelled as dummy variables and analysed simultaneously to examine the magnitude and duration of the effect of each intervention. The same analysis was repeated with Belgian search query data as a control group, since Belgium is the country most comparable to the Netherlands in terms of geography, language, history and culture. Results A significant increase in relative search volume (RSV) was found from one to four weeks (21-41%) after the introduction of the smoking ban in restaurants and bars in the Netherlands in 2008. The introduction of SCS reimbursement in 2011 was associated with a significant increase of RSV (16-22%) in the Netherlands after 3 to 52 weeks. The reintroduction of SCS in 2013 was associated with a significant increase of RSV (9-21%) in the Netherlands from 3 to 32 weeks after the intervention. No effects were found in the Belgian control group for the smoking ban and the reintroduction of SCS in 2013, but there was a significant increase in RSV shortly before and after the introduction of SCS in 2011. Conclusions These findings suggest that these tobacco control policies have short-term or medium-term effects on the rate of searching for information on smoking cessation, and therefore potentially on smoking cessation rates.	[Troelstra, Sigrid A.; Bosdriesz, Jizzo R.; Kunst, Anton E.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [De Boer, Michiel R.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hlth Sci, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam	Troelstra, SA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	sigrid_troelstra@hotmail.com	Bosdriesz, Jizzo/Q-6250-2016; Troelstra, Sigrid/C-1288-2018	Bosdriesz, Jizzo/0000-0002-1038-7814; Troelstra, Sigrid/0000-0003-1738-4752; de Boer, Michiel/0000-0001-9240-0199; Kunst, Anton/0000-0002-3313-5273	European Commission, Directorate-General for Research and Innovation [278273]	European Commission, Directorate-General for Research and Innovation	This work was supported by the European Commission, Directorate-General for Research and Innovation, under the FP7-Health-2011 program, with grant agreement number 278273; http://ec.europa.eu/research/fp7/index_en.cfm. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers AB, 2007, TOB CONTROL, V16, P101, DOI 10.1136/tc.2006.017426; Ayers JW, 2014, NICOTINE TOB RES, V16, P576, DOI 10.1093/ntr/ntt186; Ayers JW, 2012, J AFFECT DISORDERS, V142, P323, DOI 10.1016/j.jad.2012.05.005; Ayers JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016777; Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007; Blanke DD, 2004, TOOLS ADV TOBACCO CO; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; Cavazos-Rehg PA, 2015, TOB CONTROL, V24, P249, DOI 10.1136/tobaccocontrol-2013-051276; Chandran A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087482; Cook T.C., 1979, QUASIEXPERIMENTATION; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Edwards R, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.020347; European Union, 2015, EUR DAT; Google Support, 2014, TRENDS HELP; Hackshaw L, 2010, TOB CONTROL, V19, P160, DOI 10.1136/tc.2009.032656; Hanbury A, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-130; HU TW, 1995, AM J PUBLIC HEALTH, V85, P1218, DOI 10.2105/AJPH.85.9.1218; IBM Corp, 2012, SPSS; Jo CL, 2015, TOB CONTROL, V24, P395, DOI 10.1136/tobaccocontrol-2013-051261; Joossens L, 2007, PROGR TOBACCO CONTRO; Joossens L, 2014, TOBACCO CONTROL SCAL; McAfee TA, 2008, AM J PREV MED, V35, P103, DOI 10.1016/j.amepre.2008.04.017; Ministry of Health WaS, 1990, TOB ACT; Nagelhout GE, 2015, TOB CONTROL, V24, P455, DOI 10.1136/tobaccocontrol-2013-051430; Nagelhout GE, 2013, HEALTH EDUC RES, V28, P83, DOI 10.1093/her/cys101; Nagelhout GE, 2012, NICOTINE TOB RES, V14, P1474, DOI 10.1093/ntr/nts081; Nagelhout GE, 2012, EUR J PUBLIC HEALTH, V22, P4, DOI 10.1093/eurpub/ckr203; Nagelhout GE, 2012, ADDICTION, V107, P407, DOI 10.1111/j.1360-0443.2011.03642.x; Nagelhout GE, 2011, ADDICTION, V106, P816, DOI 10.1111/j.1360-0443.2010.03247.x; Nelson BK, 1998, ACAD EMERG MED, V5, P739, DOI 10.1111/j.1553-2712.1998.tb02493.x; PEKURINEN M, 1987, SOC SCI MED, V25, P875, DOI 10.1016/0277-9536(87)90256-5; PEW Research Center's Internet & American Life Project, 2014, INT US DEM; Seifter A, 2010, GEOSPATIAL HEALTH, V4, P135, DOI 10.4081/gh.2010.195; Shadish WR, 2009, ANNU REV PSYCHOL, V60, P607, DOI 10.1146/annurev.psych.60.110707.163544; STIVORO, 2013, KERNC ROK NED 2012 O; Szatkowski L, 2011, ADDICTION, V106, P1827, DOI 10.1111/j.1360-0443.2011.03494.x; Tabachnick B. G., 2001, USING MULTIVARIATE S; Thomas L, 1997, CONSERV BIOL, V11, P276, DOI 10.1046/j.1523-1739.1997.96102.x; Thyrian JR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-2; Wakefield MA, 2000, BRIT MED J, V321, P333, DOI 10.1136/bmj.321.7257.333; Wakefield MA, 2014, B WORLD HEALTH ORGAN, V92, P413, DOI 10.2471/BLT.13.118448; Warner KE, 2010, NICOTINE TOB RES, V12, P876, DOI 10.1093/ntr/ntq125; Willems RA, 2012, EVALUATIE ECHT STOPP; Wilson N, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-75; Yang AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013728; Zhang F, 2011, J CLIN EPIDEMIOL, V64, P1252, DOI 10.1016/j.jclinepi.2011.02.007; Zhang XY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088075, 10.1371/journal.pone.0101532]	47	20	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148489	10.1371/journal.pone.0148489	http://dx.doi.org/10.1371/journal.pone.0148489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26849567	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000107
J	Bonaventura, P; Lamboux, A; Albarede, F; Miossec, P				Bonaventura, Paola; Lamboux, Aline; Albarede, Francis; Miossec, Pierre			A Feedback Loop between Inflammation and Zn Uptake	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; ZINC; HOMEOSTASIS; CONTRIBUTES; JOINT; BONE	Objective Zinc (Zn) has major effects on the immune system and inflammation is associated with systemic Zn deficiency. The aim of this work was to investigate how inflammation modifies Zn metabolism at the cellular level. Rheumatoid arthritis (RA) synoviocytes exposed to cytokines were used as a model of chronic inflammation. Osteoarthritis (OA) synoviocytes were used as control. Methods Zn levels were measured in medium and inside cells by Induced Coupled Plasma-Mass Spectrometry (ICP-MS), in the presence of minute quantities of stable spike Zn-70 isotope and the addition or not of the pro-inflammatory cytokines interleukin-17 (IL-17) and tumor necrosis factor alpha (TNF-alpha). Gene expression of ZIP-8 importer, ZnT1 exporter and the homeostasis regulators metallothioneins (MTs) was evaluated after pre-exposure to cytokines, with or without exogenous Zn addition at increasing concentrations. IL-6 production was used as a marker of inflammation and measured by ELISA. Results Exposure to IL-17 and TNF-alpha enhanced expression of the Zn-importer ZIP-8, regardless of the concentration of Zn in the culture medium. In contrast, the expression of the Zn-exporter ZnT1 and of the MTs was primarily dependent on Zn levels. Addition of Zn also increased the production of IL-6, thus further stimulating the inflammatory response. Conclusion IL-17/TNF-mediated inflammation enhanced the intracellular Zn uptake by synoviocytes, further increasing inflammation. These observations document the existence of a feedback loop between inflammation and Zn uptake. Based on these results, a mathematical model was developed to represent the cytokine-mediated Zn homeostasis alterations.	[Bonaventura, Paola; Miossec, Pierre] Univ Lyon, Edouard Herriot Hosp, Dept Immunol & Rheumatol, Dept Immunol & Rheumatol,Immunogen & Inflammat Re, F-69437 Lyon, France; [Lamboux, Aline; Albarede, Francis] Ecole Normale Super Lyon, Geol Lab, Dept Earth Sci, F-69364 Lyon, France; [Lamboux, Aline; Albarede, Francis] CNRS Lyon, F-69364 Lyon, France	CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS)	Miossec, P (corresponding author), Univ Lyon, Edouard Herriot Hosp, Dept Immunol & Rheumatol, Dept Immunol & Rheumatol,Immunogen & Inflammat Re, F-69437 Lyon, France.	pierre.miossec@univ-lyon1.fr	Albarede, Francis/A-8871-2011	Albarede, Francis/0000-0003-1994-1428	7th Framework program of the EU, SP3-People, support for training and career development for researchers (Marie Curie), Network for Initial Training (ITN), FP7-PEOPLE-ITN, under the Marie Sklodowska-Curie grant [289903]; IHU prometteur OPERA; "Cluster 1 region Rhone-Alpes"; "Institut universitaire de France"	7th Framework program of the EU, SP3-People, support for training and career development for researchers (Marie Curie), Network for Initial Training (ITN), FP7-PEOPLE-ITN, under the Marie Sklodowska-Curie grant; IHU prometteur OPERA; "Cluster 1 region Rhone-Alpes"(Region Auvergne-Rhone-Alpes); "Institut universitaire de France"	This project and PB have received funding from the 7th Framework program of the EU, SP3-People, support for training and career development for researchers (Marie Curie), Network for Initial Training (ITN), FP7-PEOPLE-2011-ITN, under the Marie Sklodowska-Curie grant agreement No 289903. This work has been supported in part by grants from the IHU prometteur OPERA and the "Cluster 1 region Rhone-Alpes." PM is a senior member of and supported by the "Institut universitaire de France."	Afridi HI, 2012, CLIN LAB, V58, P705, DOI 10.7754/Clin.Lab.2011.110525; Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bonaventura P, 2015, AUTOIMMUN REV, V14, P277, DOI 10.1016/j.autrev.2014.11.008; Chabaud M, 2001, ARTHRITIS RES, V3, P168, DOI 10.1186/ar294; Colvin RA, 2008, AM J PHYSIOL-CELL PH, V294, pC726, DOI 10.1152/ajpcell.00541.2007; Colvin RA, 2010, METALLOMICS, V2, P306, DOI 10.1039/b926662c; DOLLERY CM, 1995, CIRC RES, V77, P863, DOI 10.1161/01.RES.77.5.863; Eljaafari A, 2012, ARTHRITIS RHEUM-US, V64, P2147, DOI 10.1002/art.34391; Flavell SJ, 2008, BRIT J PHARMACOL, V153, pS241, DOI 10.1038/sj.bjp.0707487; Gumulec J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085346; JORDANA M, 1994, EUR RESPIR J, V7, P2212, DOI 10.1183/09031936.94.07122212; Kim JH, 2014, CELL, V156, P730, DOI 10.1016/j.cell.2014.01.007; Kim MH, 2014, EUR J PHARMACOL, V738, P31, DOI 10.1016/j.ejphar.2014.05.030; Krebs NF, 2001, BIOMETALS, V14, P397, DOI 10.1023/A:1012942409274; Li S, 2015, J BIOL CHEM, V290, P2368, DOI 10.1074/jbc.M114.618454; Li YX, 2015, MEDCHEMCOMM, V6, P613, DOI 10.1039/c4md00401a; LIGNERE GC, 1984, J INT MED RES, V12, P193, DOI 10.1177/030006058401200311; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; Menghini R, 2013, ATHEROSCLEROSIS, V228, P12, DOI 10.1016/j.atherosclerosis.2013.01.024; Mertens K, 2015, BR J ANAESTH; Plum LM, 2010, INT J ENV RES PUB HE, V7, P1342, DOI 10.3390/ijerph7041342; PRASAD AS, 1995, NUTRITION, V11, P93; Simpkins CO, 2000, CELL MOL BIOL, V46, P465; Sokolove J, 2013, THER ADV MUSCULOSKEL, V5, P77, DOI 10.1177/1759720X12467868; Sutherland DEK, 2011, METALLOMICS, V3, P444, DOI 10.1039/c0mt00102c; Thevenod F, 2010, BIOMETALS, V23, P857, DOI 10.1007/s10534-010-9309-1; Yoshida Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/698313; Zrioual S, 2008, J IMMUNOL, V180, P655, DOI 10.4049/jimmunol.180.1.655; Zrioual S, 2009, J IMMUNOL, V182, P3112, DOI 10.4049/jimmunol.0801967	31	20	22	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147146	10.1371/journal.pone.0147146	http://dx.doi.org/10.1371/journal.pone.0147146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845700	Green Published, gold, Green Submitted			2022-12-27	WOS:000369552800007
J	Kahl, P; Baroni, P; Noirez, L				Kahl, Philipp; Baroni, Patrick; Noirez, Laurence			Bringing to Light Hidden Elasticity in the Liquid State Using In-Situ Pretransitional Liquid Crystal Swarms	PLOS ONE			English	Article							ISOTROPIC-PHASE; TRANSITION	The present work reveals that at the sub-millimeter length-scale, molecules in the liquid state are not dynamically free but elastically correlated. It is possible to "visualize" these hidden elastic correlations by using the birefringent properties of pretransitional swarms persistent in liquids presenting a weak first order transition. The strategy consists in observing the optical response of the isotropic phase of mesogenic fluids to a weak (low energy) mechanical excitation. We show that a synchronized optical response is observable at frequencies as low as 0.01Hz and at temperatures far away from any phase transition (up to at least 15 degrees C above the transition). The observation of a synchronized optical signal at very low frequencies points out a collective response and supports the existence of long-range elastic (solid-like) correlations existing at the sub-millimeter length-scale in agreement to weak solid-like responses already identified in various liquids including liquid water. This concept of elastically linked molecules differs deeply with the academic view of molecules moving freely in the liquid state and has profound consequences on the mechanisms governing collective effects as glass formation, gelation and transport, or synchronized processes in physiological media.	[Kahl, Philipp; Baroni, Patrick; Noirez, Laurence] CEA Saclay, Lab Leon Brillouin CEA CNRS, F-91191 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Noirez, L (corresponding author), CEA Saclay, Lab Leon Brillouin CEA CNRS, F-91191 Gif Sur Yvette, France.	laurence.noirez@cea.fr						ASTARITA G, 1974, POLYM ENG SCI, V14, P730, DOI 10.1002/pen.760141012; Bailey C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.237803; Baroni P, 2005, Patent PCT, Patent No. 0510988; Dabrowski R, 2013, CRYSTALS, V3, P443, DOI 10.3390/cryst3030443; Droulias S, 2010, LIQ CRYST, V37, P969, DOI 10.1080/02678292.2010.488819; Farrand L.D., 2008, Merck Patent GmbH, Patent No. [EP1690917 B1, 1690917]; GALLANI JL, 1994, PHYS REV LETT, V72, P2109, DOI 10.1103/PhysRevLett.72.2109; Granato AV, 2009, MAT SCI ENG A-STRUCT, V521-22, P6, DOI 10.1016/j.msea.2008.09.147; Guenza M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.025901; HESS S, 1976, Z NATURFORSCH A, V31, P1507; Humbert C, 1998, COLLOID POLYM SCI, V276, P160, DOI 10.1007/s003960050224; Ibar JP, 2013, J MACROMOLECULAR S B, V52, P1; Kahl P, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.050501; Marrucci G., 1993, ADV CHEM PHYS, V86, P331; Mendil H, 2006, EUR PHYS J E, V19, P77, DOI 10.1140/epje/e2006-00011-x; Mendil H, 2005, EUROPHYS LETT, V72, P983, DOI 10.1209/epl/i2004-10552-3; Mukherjee PK, 2001, EUR PHYS J E, V4, P293, DOI 10.1007/s101890170111; Noirez L, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051701; Noirez L, 2010, J MOL STRUCT, V972, P16, DOI 10.1016/j.molstruc.2010.02.013; Noirez L, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/37/372101; OLMSTED PD, 1990, PHYS REV A, V41, P4578, DOI 10.1103/PhysRevA.41.4578; Prost J., 1993, PHYS LIQUID CRYSTALS; Pujolle-Robic C, 2001, NATURE, V409, P167, DOI 10.1038/35051537; REITER G, 1994, J CHEM PHYS, V101, P2606, DOI 10.1063/1.467633; REYS V, 1988, PHYS REV LETT, V61, P2340, DOI 10.1103/PhysRevLett.61.2340; Rzoska SJ, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/24/245105; Sadron C, 1936, J PHYS-PARIS, V7, P263, DOI 10.1051/jphysrad:0193600706026300; SCHOEN M, 1995, PHYS REV E, V52, P2587, DOI 10.1103/PhysRevE.52.2587; Volino F, 1997, ANN PHYS, V22, P18; Zvetkov V, 1944, ACTA PHYSICOCHIM URS, V19, P86	30	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147914	10.1371/journal.pone.0147914	http://dx.doi.org/10.1371/journal.pone.0147914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844881	gold, Green Published, Green Submitted			2022-12-27	WOS:000369552800021
J	Mathupala, SP; Kiousis, S; Szerlip, NJ				Mathupala, Saroj P.; Kiousis, Sam; Szerlip, Nicholas J.			A Lab Assembled Microcontroller-Based Sensor Module for Continuous Oxygen Measurement in Portable Hypoxia Chambers	PLOS ONE			English	Article							TUMOR HYPOXIA; BRAIN-TUMORS; CANCER	Background Hypoxia-based cell culture experiments are routine and essential components of in vitro cancer research. Most laboratories use low-cost portable modular chambers to achieve hypoxic conditions for cell cultures, where the sealed chambers are purged with a gas mixture of preset O-2 concentration. Studies are conducted under the assumption that hypoxia remains unaltered throughout the 48 to 72 hour duration of such experiments. Since these chambers lack any sensor or detection system to monitor gas-phase O-2, the cell-based data tend to be non-uniform due to the ad hoc nature of the experimental setup. Methodology With the availability of low-cost open-source microcontroller-based electronic project kits, it is now possible for researchers to program these with easy-to-use software, link them to sensors, and place them in basic scientific apparatus to monitor and record experimental parameters. We report here the design and construction of a small-footprint kit for continuous measurement and recording of O-2 concentration in modular hypoxia chambers. The low-cost assembly (US$135) consists of an Arduino-based microcontroller, data-logging freeware, and a factory pre-calibrated miniature O-2 sensor. A small, intuitive software program was written by the authors to control the data input and output. The basic nature of the kit will enable any student in biology with minimal experience in hobby-electronics to assemble the system and edit the program parameters to suit individual experimental conditions. Results/Conclusions We show the kit's utility and stability of data output via a series of hypoxia experiments. The studies also demonstrated the critical need to monitor and adjust gas-phase O-2 concentration during hypoxia-based experiments to prevent experimental errors or failure due to partial loss of hypoxia. Thus, incorporating the sensor-microcontroller module to a portable hypoxia chamber provides a researcher a capability that was previously available only to labs with access to sophisticated (and expensive) cell culture incubators.	[Mathupala, Saroj P.; Kiousis, Sam] Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI USA; [Mathupala, Saroj P.; Kiousis, Sam] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI USA; [Szerlip, Nicholas J.] Univ Michigan, Sch Med, Dept Neurosurg, Ann Arbor, MI USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Michigan System; University of Michigan	Mathupala, SP (corresponding author), Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI USA.; Mathupala, SP (corresponding author), Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI USA.	smathupala@med.wayne.edu			National Cancer Institute (USA) [CA116257]; Elsa U. Pardee Foundation (MI, USA) [410320]; Marvin E. Klein, MD, Charitable Trust; NATIONAL CANCER INSTITUTE [R01CA116257] Funding Source: NIH RePORTER	National Cancer Institute (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Elsa U. Pardee Foundation (MI, USA); Marvin E. Klein, MD, Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by CA116257, National Cancer Institute (USA) [www.cancer.gov]; 410320, Elsa U. Pardee Foundation (MI, USA) [www.pardeefoundation.org]; and Marvin E. Klein, MD, Charitable Trust.	Bates MK, 2012, CULTURING CELLS HYPO; Colen CB, 2011, METABOLIC TARGETING, DOI [10.1593/neo.11134, DOI 10.1593/NEO.11134]; Evans SM, 2004, CANCER RES, V64, P1886, DOI 10.1158/0008-5472.CAN-03-2424; Evans SM, 2004, CLIN CANCER RES, V10, P8177, DOI 10.1158/1078-0432.CCR-04-1081; Hockel M, 2001, SEMIN ONCOL, V28, P36, DOI 10.1016/S0093-7754(01)90211-8; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Li M, ARDUINO RES BIOTECH; LUBBERS DW, 1995, ACTA ANAESTH SCAND, V39, P37; Margolis M, 2012, ARDUINO COOKBOOK, Vxx; Mathupala SP, 2007, J BIOENERG BIOMEMBR, V39, P73, DOI 10.1007/s10863-006-9062-x; Monk S, 2013, PRACTICAL ELECT INVE, Vxxv; Monk S, 2012, PROGRAMMING ARDUINO, Vxiv; OPITZ N, 1987, INT ANESTHESIOL CLIN, V25, P177; Rau M, 2014, TRUE HYPOXIA REPLICA; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wu DL, 2011, JOVE-J VIS EXP, DOI 10.3791/2899	18	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148923	10.1371/journal.pone.0148923	http://dx.doi.org/10.1371/journal.pone.0148923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862760	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600124
J	Hua, YF; Wang, GQ; Jiang, W; Huang, J; Chen, GC; Lu, CD				Hua, Yong-Fei; Wang, Gao-Qing; Jiang, Wei; Huang, Jing; Chen, Guo-Chong; Lu, Cai-De			Vitamin C Intake and Pancreatic Cancer Risk: A Meta-Analysis of Published Case-Control and Cohort Studies	PLOS ONE			English	Article							NUTRITIONAL FACTORS; LIFE-STYLE; PHYSICIANS HEALTH; TREND ESTIMATION; DIETARY FACTORS; NUTRIENT INTAKE; MICRONUTRIENTS; CARCINOGENESIS; ANTIOXIDANTS; MEN	Background Observational studies inconsistently reported the relationship between vitamin C intake and risk of pancreatic cancer. We conducted a meta-analysis of published case-control and cohort studies to quantify the association. Methods Potentially eligible studies were found on PubMed and EMBASE databases through May 31, 2015. A random-effects model was assigned to compute summary point estimates with corresponding 95% confidence intervals (CIs). Subgroup and meta-regression analyses were also performed to explore sources of heterogeneity. Results Our final analyses included 20 observational studies comprising nearly 5 thousand cases of pancreatic cancer. When comparing the highest with the lowest categories of vitamin C intake, the summary odds ratio/relative risk for case-control studies (14 studies), cohort studies (6 studies) and all studies combined was 0.58 (95% CI: 0.52-0.66), 0.93 (95% CI: 0.78-1.11) and 0.66 (95% CI: 0.58-0.75), respectively. The difference in the findings between case-control and cohort studies was statistically significant (P < .001). Possible publication bias was shown in the meta-analysis of case-control studies. Conclusion There is insufficient evidence to conclude any relationship between vitamin C intake and risk of pancreatic cancer. The strong inverse association observed in case-control studies may be affected by biases (eg, recall and selection biases) that particularly affect case-control studies and/or potential publication bias. Future prospective studies of vitamin C intake and pancreatic cancer are needed.	[Hua, Yong-Fei; Wang, Gao-Qing; Jiang, Wei; Huang, Jing; Lu, Cai-De] Ningbo Med Treatment Ctr Lihuili Hosp, Dept Hepatobiliary & Pancreat Surg, Ningbo 315000, Zhejiang, Peoples R China; [Chen, Guo-Chong] Soochow Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Suzhou 215123, Peoples R China	Soochow University - China	Lu, CD (corresponding author), Ningbo Med Treatment Ctr Lihuili Hosp, Dept Hepatobiliary & Pancreat Surg, Ningbo 315000, Zhejiang, Peoples R China.	lucaide@nbu.edu.cn	Chen, Guo-Chong/K-4046-2017					Anderson LN, 2009, CANCER CAUSE CONTROL, V20, P825, DOI 10.1007/s10552-009-9303-5; BAGHURST PA, 1991, AM J EPIDEMIOL, V134, P167, DOI 10.1093/oxfordjournals.aje.a116069; Banim PJR, 2013, GUT, V62, P1489, DOI 10.1136/gutjnl-2011-301908; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bjelakovic Goran, 2008, Cochrane Database Syst Rev, pCD004183, DOI 10.1002/14651858.CD004183.pub3; Bravi F, 2011, ANN ONCOL, V22, P202, DOI 10.1093/annonc/mdq302; Cappellani A, 2012, EUR REV MED PHARMACO, V16, P192; DEMESQUITA HBB, 1991, INT J CANCER, V48, P540, DOI 10.1002/ijc.2910480411; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FALK RT, 1988, AM J EPIDEMIOL, V128, P324, DOI 10.1093/oxfordjournals.aje.a114972; Fan H, 2015, SCI REP-UK, V5, DOI 10.1038/srep13973; Garcea G, 2005, PANCREATOLOGY, V5, P514, DOI 10.1159/000087493; Gaziano JM, 2009, JAMA-J AM MED ASSOC, V301, P52, DOI 10.1001/jama.2008.862; GHADIRIAN P, 1991, INT J CANCER, V47, P1, DOI 10.1002/ijc.2910470102; Gong ZH, 2010, INT J CANCER, V127, P1893, DOI 10.1002/ijc.25208; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Han XS, 2013, CANCER-AM CANCER SOC, V119, P1314, DOI 10.1002/cncr.27936; Heinen MM, 2012, INT J CANCER, V130, P147, DOI 10.1002/ijc.25989; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOWE GR, 1990, INT J CANCER, V45, P604, DOI 10.1002/ijc.2910450405; HOWE GR, 1992, INT J CANCER, V51, P365, DOI 10.1002/ijc.2910510306; Inoue-Choi M, 2011, CANCER EPIDEM BIOMAR, V20, P711, DOI 10.1158/1055-9965.EPI-11-0026; Jansen Rick J, 2013, J Gastrointest Cancer, V44, P152, DOI 10.1007/s12029-012-9441-y; Jeurnink SM, 2015, INT J CANCER, V136, pE665, DOI 10.1002/ijc.29175; JI BT, 1995, CANCER EPIDEM BIOMAR, V4, P885; KALAPOTHAKI V, 1993, CANCER CAUSE CONTROL, V4, P383, DOI 10.1007/BF00051342; Leung PS, 2009, ANTIOXID REDOX SIGN, V11, P135, DOI 10.1089/ars.2008.2109; Lin YS, 2005, J GASTROENTEROL, V40, P297, DOI 10.1007/s00535-004-1537-0; Lowenfels AB, 2006, BEST PRACT RES CL GA, V20, P197, DOI 10.1016/j.bpg.2005.10.001; McCullough ML, 2004, ONCOGENE, V23, P6349, DOI 10.1038/sj.onc.1207716; Michl P, 2013, GUT, V62, P317, DOI 10.1136/gutjnl-2012-303588; OLSEN GW, 1991, CANCER CAUSE CONTROL, V2, P291, DOI 10.1007/BF00051668; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; SHIBATA A, 1994, INT J CANCER, V58, P46, DOI 10.1002/ijc.2910580109; Silverman DT, 1998, JNCI-J NATL CANCER I, V90, P1710, DOI 10.1093/jnci/90.22.1710; Stolzenberg-Solomon RZ, 2002, AM J EPIDEMIOL, V155, P783, DOI 10.1093/aje/155.9.783; Wang L, 2014, AM J CLIN NUTR, V100, P915, DOI 10.3945/ajcn.114.085480; World Cancer Research Fund/ American Institute for Cancer Research, 2012, CONT UPD PROJ SUMM F; Woutersen RA, 1999, FOOD CHEM TOXICOL, V37, P981, DOI 10.1016/S0278-6915(99)00093-9; Wu QJ, 2015, EUR J CANC PREV; ZATONSKI W, 1991, INT J CANCER, V48, P390, DOI 10.1002/ijc.2910480314	42	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148816	10.1371/journal.pone.0148816	http://dx.doi.org/10.1371/journal.pone.0148816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859881	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400091
J	Kim, SY; Jeong, BH; Park, HY; Jeon, K; Han, SJ; Shin, SJ; Koh, WJ				Kim, Su-Young; Jeong, Byeong-Ho; Park, Hye Yun; Jeon, Kyeongman; Han, Seung Jung; Shin, Sung Jae; Koh, Won-Jung			Association of ISMav6 with the Pattern of Antibiotic Resistance in Korean Mycobacterium avium Clinical Isolates but No Relevance between Their Genotypes and Clinical Features	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; NONTUBERCULOUS MYCOBACTERIA; INSERTION-SEQUENCE; SUBSP HOMINISSUIS; GENETIC DIVERSITY; LUNG-DISEASE; IDENTIFICATION; IS1245; STRAINS; DIFFERENTIATION	The aim of this study was to genetically characterize clinical isolates from patients diagnosed with Mycobacterium avium lung disease and to investigate the clinical significance. Multi-locus sequencing analysis (MLSA) and pattern of insertion sequence analysis of M. avium isolates from 92 Korean patients revealed that all isolates were M. avium subspecies hominissuis. In hsp65 sequevar analysis, codes 2, 15, and 16 were most frequently found (88/92) with similar proportions among cases additionally two isolates belonging to code N2 and an unreported code were identified, respectively. In insertion element analysis, all isolates were IS1311 positive and IS900 negative. Four of the M. avium subsp. hominissuis isolates did not harbor IS1245 and 1 of the M. avium isolates intriguingly harbored DT1, which is thought to be a M. intracellulare-specific element. M. avium subsp. hominissuis harboring ISMav6 is prevalent in Korea. No significant association between clinical manifestation and treatment response has been found in patients with the hsp65 code type and ISMav6, indicating that no specific strain/genotype among M. avium subsp. hominissuis organisms was a major source of M. avium lung disease. Interestingly, the presence of ISMav6 was correlated with greater resistance to moxifloxacin. Conclusively, the genotype of Korean M. avium subsp. hominissuis isolates is not a disease determinant responsible for lung disease and specific virulent factors of M. avium subsp. hominissuis need to be investigated further.	[Kim, Su-Young; Jeong, Byeong-Ho; Park, Hye Yun; Jeon, Kyeongman; Koh, Won-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea; [Han, Seung Jung; Shin, Sung Jae] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Microbiol,Inst Immunol & Immunol Dis, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System	Koh, WJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea.; Shin, SJ (corresponding author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Microbiol,Inst Immunol & Immunol Dis, Seoul, South Korea.	sjshin@yuhs.ac; wjkoh@skku.edu	Koh, Won Jung/C-9595-2011; park, hy/O-5934-2014; Kim, Su-Young/GVT-4242-2022; Jeon, Kyeongman/F-5963-2019; Koh, Won-Jung/D-9586-2018	Kim, Su-Young/0000-0002-6369-3399; Jeon, Kyeongman/0000-0002-4822-1772; Koh, Won-Jung/0000-0002-4756-3527; Jeong, Byeong-Ho/0000-0002-3124-1718; Shin, Sung Jae/0000-0003-0854-4582	Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HR14C0006, HI15C2778]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [NRF-2015R1A2A1A01003959]	Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by a grant of the Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HR14C0006 and HI15C2778, http://www.htdream.kr/, SJS and WJK) and by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (NRF-2015R1A2A1A01003959, http://www.nrf.re.kr/, WJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2003, J CLIN MICROBIOL, V41, P5699, DOI 10.1128/JCM.41.12.5699-5708.2003; Bartos M, 2006, J MICROBIOL METH, V64, P333, DOI 10.1016/j.mimet.2005.05.009; Ben Salah I, 2008, MICROBIOL-SGM, V154, P3715, DOI 10.1099/mic.0.2008/020164-0; Bewick V, 2004, CRIT CARE, V8, P46, DOI 10.1186/cc2428; Brode SK, 2014, INT J TUBERC LUNG D, V18, P1370, DOI 10.5588/ijtld.14.0120; Clinical and Laboratory Standards Institute (CLSI), 2011, M24A2 CLSI; Dai JL, 2011, J CLIN MICROBIOL, V49, P144, DOI 10.1128/JCM.00957-10; Despierres L, 2012, EUR J CLIN MICROBIOL, V31, P1373, DOI 10.1007/s10096-011-1452-2; Dvorska L, 2002, J CLIN MICROBIOL, V40, P3712, DOI 10.1128/JCM.40.10.3712-3719.2002; Englund S, 1999, DIAGN MICR INFEC DIS, V33, P163, DOI 10.1016/S0732-8893(98)00098-4; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; GUERRERO C, 1995, J CLIN MICROBIOL, V33, P304, DOI 10.1128/JCM.33.2.304-307.1995; Harmsen D, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-26; Hashemi-Shahraki A, 2013, INFECT GENET EVOL, V20, P312, DOI 10.1016/j.meegid.2013.08.027; Ichikawa K, 2009, J MED MICROBIOL, V58, P945, DOI 10.1099/jmm.0.008623-0; Iwamoto T, 2012, INFECT GENET EVOL, V12, P846, DOI 10.1016/j.meegid.2011.06.018; Jang MA, 2014, J CLIN MICROBIOL, V52, P1207, DOI 10.1128/JCM.03053-13; Jeong BH, 2015, AM J RESP CRIT CARE, V191, P96, DOI 10.1164/rccm.201408-1545OC; Johansen TB, 2005, J CLIN MICROBIOL, V43, P2500, DOI 10.1128/JCM.43.5.2500-2502.2005; Kikuchi T, 2009, THORAX, V64, P901, DOI 10.1136/thx.2009.114603; Kim SY, 2012, INT J TUBERC LUNG D, V16, P1393, DOI 10.5588/ijtld.12.0147; Koh WJ, 2013, TUBERC RESPIR DIS, V75, P199, DOI 10.4046/trd.2013.75.5.199; Koh WJ, 2012, CHEST, V142, P1482, DOI 10.1378/chest.12-0494; Kolb J, 2014, INT J MED MICROBIOL, V304, P941, DOI 10.1016/j.ijmm.2014.06.001; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Macheras E, 2011, J CLIN MICROBIOL, V49, P491, DOI 10.1128/JCM.01274-10; Mijs W, 2002, INT J SYST EVOL MICR, V52, P1505, DOI [10.1099/ijs.0.02037-0, 10.1099/00207713-52-5-1505]; Oliveira RS, 2003, J CLIN MICROBIOL, V41, P44, DOI 10.1128/JCM.41.1.44-49.2003; Rabello MCDS, 2010, J CLIN MICROBIOL, V48, P2257, DOI 10.1128/JCM.02256-09; Rindi L, 2014, INFECT GENET EVOL, V21, P375, DOI 10.1016/j.meegid.2013.12.007; ROIZ MP, 1995, J CLIN MICROBIOL, V33, P1389, DOI 10.1128/JCM.33.5.1389-1391.1995; Schweickert B, 2008, EMERG INFECT DIS, V14, P1443, DOI 10.3201/eid1409.071032; Shin SJ, 2013, CLIN INFECT DIS, V57, P32, DOI 10.1093/cid/cit172; Shin SJ, 2010, J CLIN MICROBIOL, V48, P4057, DOI 10.1128/JCM.00904-10; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatano Y, 2012, EUR J CLIN MICROBIOL, V31, P445, DOI 10.1007/s10096-011-1326-7; THOREL MF, 1990, INT J SYST BACTERIOL, V40, P254, DOI 10.1099/00207713-40-3-254; Tran QT, 2014, J CLIN MICROBIOL, V52, P1201, DOI 10.1128/JCM.03399-13; Turenne CY, 2006, J CLIN MICROBIOL, V44, P433, DOI 10.1128/JCM.44.2.433-440.2006; Wallace RJ, 2013, J CLIN MICROBIOL, V51, P1747, DOI 10.1128/JCM.00186-13	40	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148917	10.1371/journal.pone.0148917	http://dx.doi.org/10.1371/journal.pone.0148917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859598	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400105
J	Ying, ZK; Chen, MJ; Xie, XY; Wang, XK; Kherada, N; Desikan, R; Mihai, G; Burns, P; Sun, QH; Rajagopalan, S				Ying, Zhekang; Chen, Minjie; Xie, Xiaoyun; Wang, Xiaoke; Kherada, Nisharahmed; Desikan, Rajagopal; Mihai, Georgeta; Burns, Patrick; Sun, Qinghua; Rajagopalan, Sanjay			Lipoicmethylenedioxyphenol Reduces Experimental Atherosclerosis through Activation of Nrf2 Signaling	PLOS ONE			English	Article							ALPHA-LIPOIC ACID; DEFICIENT MICE; IN-VIVO; ANTIOXIDANT; EXPRESSION; MECHANISMS; CHOLESTEROL; FACTOR-2; MIGRATION; PROTECTS	Objective Oxidative stress is implicated in the pathogenesis of atherosclerosis, and Nrf2 is the transcriptional factor central in cellular antioxidant responses. In the present study, we investigate the effect of a dihydrolipoic acid derivative lipoicmethylenedioxyphenol (LMDP) on the progression of atherosclerosis and test whether its effect on atherosclerosis is mediated by Nrf2. Methods and Results Both magnetic resonance imaging (MRI) scanning and en face analysis reveal that 14 weeks of treatment with LMDP markedly reduced atherosclerotic burden in a rabbit balloon vascular injury model. Myograph analyses show decreased aortic contractile response to phenylephrine and increased aortic response to acetylcholine and insulin in LMDP-treated animals, suggesting that LMDP inhibits atherosclerosis through improving vascular function. A role of Nrf2 signaling in mediating the amelioration of vascular function by LMDP was supported by increased Nrf2 translocation into nuclear and increased expression of Nrf2 target genes. Furthermore, chemotaxis analysis with Boydem chamber shows that leukocytes isolated from LMDP-treated rabbits had reduced chemotaxis, and knock-down of Nrf2 significantly reduced the effect of LMDP on the chemotaxis of mouse macrophages. Conclusion Our results support that LMDP has an anti-atherosclerotic effect likely through activation of Nrf2 signaling and subsequent inhibition of macrophage chemotaxis.	[Ying, Zhekang; Chen, Minjie] Tongji Univ, Sch Med, East Hosp, Dept Cardiol, Shanghai 200120, Peoples R China; [Ying, Zhekang; Chen, Minjie; Wang, Xiaoke; Rajagopalan, Sanjay] Univ Maryland, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21201 USA; [Xie, Xiaoyun; Kherada, Nisharahmed; Desikan, Rajagopal; Mihai, Georgeta; Burns, Patrick] Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Xie, Xiaoyun] Tongji Univ, Sch Med, Tongji Hosp, Div Geriatr Med, Shanghai 200092, Peoples R China; [Desikan, Rajagopal] InVasc Therapeut, Tucker, GA USA; [Desikan, Rajagopal] VIT Univ, Sch Adv Sci, Dept Chem & Pharmaceut Chem, Vellore 632014, Tamil Nadu, India	Tongji University; University System of Maryland; University of Maryland Baltimore; University System of Ohio; Ohio State University; Tongji University; Vellore Institute of Technology	Ying, ZK (corresponding author), Tongji Univ, Sch Med, East Hosp, Dept Cardiol, Shanghai 200120, Peoples R China.; Ying, ZK (corresponding author), Univ Maryland, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21201 USA.	yingzhekang@hotmail.com	Burns, Patrick/C-5943-2013	Burns, Patrick/0000-0001-5229-3886	National Natural Science Foundation of China [81270342, 81500216]; American Heart Association [11POST7640030, 13SDG17070131]; National Institutes of Health [R01ES024516, R01ES013406, R01ES015146]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024516, R01ES015146, R01ES013406] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/ No. 81270342 to ZY and 81500216 to MC), the American Heart Association (http://www.heart.org 11POST7640030, 13SDG17070131 to ZY) and the National Institutes of Health (https://grants.nih.gov/grants/oer.htm R01ES024516 to ZY and R01ES013406 and R01ES015146 to SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; LMMP was synthesized by Dr. Rajagopal Desikan, which is protected by a patent (Patent number: 8198317) that belongs to the Ohio State University Research Foundation and Invasc Therapeutic. This work was supported by the National Natural Science Foundation of China (Grant No. 81270342 to Z.Y. and 81500216 to M.C.), the American Heart Association (11POST7640030, 13SDG17070131 to Z.Y.) and the National Institutes of Health (R01ES024516 to Z.Y. and R01ES013406 and R01ES015146 to S.R.).	Amom Z, 2008, J CLIN BIOCHEM NUTR, V43, P88, DOI 10.3164/jcbn.2008051; Barajas B, 2011, ARTERIOSCL THROM VAS, V31, P58, DOI 10.1161/ATVBAHA.110.210906; Chen XL, 2006, AM J PHYSIOL-HEART C, V290, pH1862, DOI 10.1152/ajpheart.00651.2005; Collins AR, 2012, ARTERIOSCLER THROMB; Copple IM, 2012, ADV PHARMACOL, V63, P43, DOI 10.1016/B978-0-12-398339-8.00002-1; Ding Y, 2014, INT J CARDIOL, V175, P508, DOI 10.1016/j.ijcard.2014.06.045; Doggrell SA, 2004, EXPERT OPIN INV DRUG, V13, P1641, DOI 10.1517/13543784.13.12.1641; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Fayad ZA, 2000, CIRCULATION, V101, P2503, DOI 10.1161/01.CIR.101.21.2503; Freigang S, 2011, EUR J IMMUNOL, V41, P2040, DOI 10.1002/eji.201041316; Kim HS, 2012, P NATL ACAD SCI USA, V109, pE2803, DOI 10.1073/pnas.1212596109; Levonen AL, 2007, ARTERIOSCL THROM VAS, V27, P741, DOI 10.1161/01.ATV.0000258868.80079.4d; Lii CK, 2010, J NUTR, V140, P885, DOI 10.3945/jn.110.121418; Montezano AC, 2012, CAN J CARDIOL, V28, P288, DOI 10.1016/j.cjca.2012.01.017; Ogborne RM, 2005, ARTERIOSCL THROM VAS, V25, P2100, DOI 10.1161/01.ATV.0000183745.37161.6e; Park SJ, 2012, INT J MOL SCI, V13, P7915, DOI 10.3390/ijms13077915; Sawada H, 2012, ATHEROSCLEROSIS, V225, P83, DOI 10.1016/j.atherosclerosis.2012.08.023; Schreibelt G, 2006, J IMMUNOL, V177, P2630, DOI 10.4049/jimmunol.177.4.2630; Shay KP, 2012, BBA-MOL CELL RES, V1823, P1102, DOI 10.1016/j.bbamcr.2012.04.002; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Sussan TE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003791; Tinkel J, 2012, CARDIOL REV, V20, P77, DOI 10.1097/CRD.0b013e31823dbbad; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Ying ZK, 2012, J LIPID RES, V53, P879, DOI 10.1194/jlr.M022806; Ying ZK, 2011, ARTERIOSCL THROM VAS, V31, P536, DOI 10.1161/ATVBAHA.110.219287; Ying ZK, 2010, LIFE SCI, V86, P95, DOI 10.1016/j.lfs.2009.11.009; Zakkar M, 2009, ARTERIOSCL THROM VAS, V29, P1851, DOI 10.1161/ATVBAHA.109.193375; Zhang WJ, 2008, CIRCULATION, V117, P421, DOI 10.1161/CIRCULATIONAHA.107.725275; Zulkhairi A, 2008, BIOMED PHARMACOTHER, V62, P716, DOI 10.1016/j.biopha.2006.12.003	31	7	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148305	10.1371/journal.pone.0148305	http://dx.doi.org/10.1371/journal.pone.0148305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859892	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400028
J	Gao, LL; Turner, MK; Chao, SM; Kolmer, J; Anderson, JA				Gao, Liangliang; Turner, M. Kathryn; Chao, Shiaoman; Kolmer, James; Anderson, James A.			Genome Wide Association Study of Seedling and Adult Plant Leaf Rust Resistance in Elite Spring Wheat Breeding Lines	PLOS ONE			English	Article							SELECTION; SOFTWARE; PROGRAM; TRAITS; NUMBER; UG99; QTL	Leaf rust is an important disease, threatening wheat production annually. Identification of resistance genes or QTLs for effective field resistance could greatly enhance our ability to breed durably resistant varieties. We applied a genome wide association study (GWAS) approach to identify resistance genes or QTLs in 338 spring wheat breeding lines from public and private sectors that were predominately developed in the Americas. A total of 46 QTLs were identified for field and seedling traits and approximately 20-30 confer field resistance in varying degrees. The 10 QTLs accounting for the most variation in field resistance explained 26-30% of the total variation (depending on traits: percent severity, coefficient of infection or response type). Similarly, the 10 QTLs accounting for most of the variation in seedling resistance to different races explained 24-34% of the variation, after correcting for population structure. Two potentially novel QTLs (QLr. umn-1AL, QLr. umn-4AS) were identified. Identification of novel genes or QTLs and validation of previously identified genes or QTLs for seedling and especially adult plant resistance will enhance understanding of leaf rust resistance and assist breeding for resistant wheat varieties. We also developed computer programs to automate field and seedling rust phenotype data conversions. This is the first GWAS study of leaf rust resistance in elite wheat breeding lines genotyped with high density 90K SNP arrays.	[Gao, Liangliang; Turner, M. Kathryn; Anderson, James A.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA; [Kolmer, James] USDA ARS Cereal Dis Lab, St Paul, MN 55108 USA; [Kolmer, James] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA; [Chao, Shiaoman] USDA ARS Biosci Res Lab, Fargo, ND 58102 USA	University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities	Anderson, JA (corresponding author), Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA.; Kolmer, J (corresponding author), USDA ARS Cereal Dis Lab, St Paul, MN 55108 USA.; Kolmer, J (corresponding author), Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA.	Jim.Kolmer@ars.usda.gov; ander319@umn.edu	Anderson, James/AAI-2477-2021	Anderson, James/0000-0003-4655-6517; Gao, Liangliang/0000-0002-3864-0631	United States Department of Agriculture National Institute of Food and Agriculture (USDA-NIFA) [2011-68002-30029]; ARS [ARS-0424595] Funding Source: Federal RePORTER	United States Department of Agriculture National Institute of Food and Agriculture (USDA-NIFA)(United States Department of Agriculture (USDA)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study is part of the Triticeae Coordinated Agriculture Project (TCAP, www.triticeaecap.org), funded by the United States Department of Agriculture National Institute of Food and Agriculture (USDA-NIFA) grant no. 2011-68002-30029.	[Anonymous], 2014, R LANG ENV STAT COMP; Babiker EM, 2015, THEOR APPL GENET, V128, P605, DOI 10.1007/s00122-015-2456-6; Bajgain P, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0628-9; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bernardo R., 2010, BREEDING QUANTITATIV, V2; Bernardo R, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2012.11.0028; Bipinraj A, 2011, J APPL GENET, V52, P171, DOI 10.1007/s13353-010-0026-9; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chapman JA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0582-8; Chu CG, 2009, THEOR APPL GENET, V119, P263, DOI 10.1007/s00122-009-1035-0; Darino MA, 2015, EUPHYTICA, V206, P135, DOI 10.1007/s10681-015-1486-0; Draz I. S., 2015, Annals of Agricultural Science (Cairo), V60, P29; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Eu-ahsunthornwattana J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004445; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gao LL, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0404-4; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Guttieri MJ, 2015, CROP SCI; Hirsch CN, 2014, PLANT CELL, V26, P121, DOI 10.1105/tpc.113.119982; Huerta-Espino J, 2011, EUPHYTICA, V179, P143, DOI 10.1007/s10681-011-0361-x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jordan KW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0606-4; Kertho A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129580; Kolmer JA, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0274-9; Kolmer JA, 2011, PLANT DIS, V95, P1032, DOI 10.1094/PDIS-04-11-0275; Kolmer JA, 2003, CROP SCI, V43, P1266, DOI 10.2135/cropsci2003.1266; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Lagudah ES, 2006, THEOR APPL GENET, V114, P21, DOI 10.1007/s00122-006-0406-z; Letta T, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.08.0026; Li ZF, 2014, CROP SCI, V54, P1907, DOI 10.2135/cropsci2014.02.0162; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037146; Liu ZL, 2013, CROP SCI, V53, P1566, DOI 10.2135/cropsci2012.09.0532; Maccaferri M, 2015, G3-GENES GENOM GENET, V5, P449, DOI 10.1534/g3.114.014563; Maccaferri M, 2010, MOL BREEDING, V26, P189, DOI 10.1007/s11032-009-9353-0; Marais GF, 2008, PLANT BREEDING, V127, P340, DOI 10.1111/j.1439-0523.2008.01513.x; Marroni F, 2011, TREE GENET GENOMES, V7, P1011, DOI 10.1007/s11295-011-0391-5; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; McIntosh R., 2013, CATALOGUE GENE SYMBO; McIntosh R., 1995, WHEAT RUSTS ATLAS RU, DOI [10.1071/9780643101463, DOI 10.1071/9780643101463]; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosewarne GM, 2012, THEOR APPL GENET, V124, P1283, DOI 10.1007/s00122-012-1786-x; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Singh D, 2009, EUPHYTICA, V169, P253, DOI 10.1007/s10681-009-9959-7; Stakman E.C., 1962, E617 USDAARS; Stubbs R., 1986, CEREAL DIS METHODOLO; Thavamanikumar S, 2015, G3-GENES GENOM GENET, V5, P1991, DOI 10.1534/g3.115.019745; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yu LX, 2011, THEOR APPL GENET, V123, P1257, DOI 10.1007/s00122-011-1664-y; Zegeye H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105593; Zhang DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103747; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	63	99	100	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148671	10.1371/journal.pone.0148671	http://dx.doi.org/10.1371/journal.pone.0148671			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849364	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000153
J	Hansen, MJ; Schaerf, TM; Krause, J; Ward, AJW				Hansen, M. J.; Schaerf, T. M.; Krause, J.; Ward, A. J. W.			Crimson Spotted Rainbowfish (Melanotaenia duboulayi) Change Their Spatial Position according to Nutritional Requirement	PLOS ONE			English	Article							ROACH RUTILUS-RUTILUS; STICKLEBACKS GASTEROSTEUS-ACULEATUS; BROWN CAPUCHIN MONKEYS; DECISION-MAKING; FORAGING BEHAVIOR; ANIMAL GROUPS; SELFISH HERD; FISH SHOALS; PREDATOR AVOIDANCE; INDIVIDUALS LEAD	Decision making in moving animal groups has been shown to be disproportionately influenced by individuals at the front of groups. Therefore, an explanation of state-dependent positioning of individuals within animal groups may provide a mechanism for group movement decisions. Nutritional state is dynamic and can differ between members of the same group. It is also known to drive animal movement decisions. Therefore, we assayed 6 groups of 8 rainbowfish foraging in a flow tank. Half of the fish had been starved for 24h and half had been fed 1h prior to experimental start. Groups were assayed again one week later but individuals were allocated to the opposite nutritional treatment. During the assay the positions of individually identified fish were recorded as were the number of food items they each ate and the position within the group they acquired them from. Food-deprived fish were more often found towards the front of the shoal; the mean weighted positional score of food-deprived fish was significantly larger than that of well-fed fish. Individuals were not consistent in their position within a shoal between treatments. There was a significant positive correlation between mean weighted positional score and number of food items acquired which displays an obvious benefit to front positions. These results suggest that positional preferences are based on nutritional state and provide a mechanism for state-dependent influence on group decision-making as well as increasing our understanding of what factors are important for group functioning.	[Hansen, M. J.; Schaerf, T. M.; Ward, A. J. W.] Univ Sydney, Anim Behav Lab, Sch Biol Sci, Sydney, NSW 2006, Australia; [Schaerf, T. M.] Univ New England, Sch Sci & Technol, Armidale, NSW 2351, Australia; [Krause, J.] Liebniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, D-12587 Berlin, Germany; [Krause, J.] Humbolt Univ Berlin, Fac Life Sci, Thaer Inst, Berlin, Germany	University of Sydney; University of New England; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Humboldt University of Berlin	Hansen, MJ (corresponding author), Univ Sydney, Anim Behav Lab, Sch Biol Sci, Sydney, NSW 2006, Australia.	matthew.hansen@sydney.edu.au	Krause, Jens/J-4381-2013; Schaerf, Timothy/M-7821-2015	Krause, Jens/0000-0002-1289-2857; Ward, Ashley/0000-0003-0842-533X; Schaerf, Timothy/0000-0001-6642-8374	Australian Research Council [DP130101670]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council via DP130101670.	Beauchamp G, 2014, CAN J ZOOL, V92, P785, DOI 10.1139/cjz-2014-0037; Beauchamp G, 2007, ANIM BEHAV, V73, P445, DOI 10.1016/j.anbehav.2006.09.004; Beecham JA, 1999, J THEOR BIOL, V198, P533, DOI 10.1006/jtbi.1999.0930; Beekman M, 2006, ANIM BEHAV, V71, P161, DOI 10.1016/j.anbehav.2005.04.009; Bibost AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080907; BILL RG, 1976, SCIENCE, V193, P1146, DOI 10.1126/science.193.4258.1146; BLACK JM, 1992, ANIM BEHAV, V44, P41, DOI 10.1016/S0003-3472(05)80752-3; Brown C, 2000, THESIS U QUEENSLAND; Bumann D, 1997, BEHAVIOUR, V134, P1063, DOI 10.1163/156853997X00403; BUMANN D, 1993, BEHAVIOUR, V125, P189, DOI 10.1163/156853993X00236; Burns ALJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036567; Colleter M, 2011, ANIM BEHAV, V81, P1231, DOI 10.1016/j.anbehav.2011.03.011; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Dambach M, 1999, J INSECT PHYSIOL, V45, P423, DOI 10.1016/S0022-1910(98)00141-3; DeBlois EM, 1996, OECOLOGIA, V108, P192, DOI 10.1007/BF00333231; Diwold K, 2011, SWARM INTELL-US, V5, P121, DOI 10.1007/s11721-011-0054-z; Dyer JRG, 2009, PHILOS T R SOC B, V364, P781, DOI 10.1098/rstb.2008.0233; FORRESTER GE, 1991, ANIM BEHAV, V42, P701, DOI 10.1016/S0003-3472(05)80116-2; Gilbert C, 2006, PHYSIOL BEHAV, V88, P479, DOI 10.1016/j.physbeh.2006.04.024; Gueron S, 1996, J THEOR BIOL, V182, P85, DOI 10.1006/jtbi.1996.0144; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hansen MJ, 2015, BEHAV ECOL SOCIOBIOL, V69, P1713, DOI 10.1007/s00265-015-1983-0; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; Hirsch BT, 2007, Q REV BIOL, V82, P9, DOI 10.1086/511657; HUTH A, 1992, J THEOR BIOL, V156, P365, DOI 10.1016/S0022-5193(05)80681-2; JANSON CH, 1990, ANIM BEHAV, V40, P910, DOI 10.1016/S0003-3472(05)80993-5; JANSON CH, 1990, ANIM BEHAV, V40, P922, DOI 10.1016/S0003-3472(05)80994-7; Janson S, 2005, ANIM BEHAV, V70, P349, DOI 10.1016/j.anbehav.2004.10.018; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Keenleyside M. H. A., 1955, Behaviour, V8, P183, DOI 10.1163/156853955X00229; Kenny D. A., 1987, STAT SOCIAL BEHAV SC; Killen S. S., 2011, P ROYAL SOC B; King AJ, 2009, COMMUN INTEGR BIOL, V2, P146; King AJ, 2011, INT J PRIMATOL, V32, P1245, DOI 10.1007/s10764-011-9526-7; Klok CJ, 1999, FUNCT ECOL, V13, P417, DOI 10.1046/j.1365-2435.1999.00324.x; KRAUSE J, 1994, BIOL REV, V69, P187, DOI 10.1111/j.1469-185X.1994.tb01505.x; Krause J, 1998, J FISH BIOL, V52, P494, DOI 10.1006/jfbi.1997.0595; Krause J, 1998, BEHAVIOUR, V135, P1031, DOI 10.1163/156853998792913519; KRAUSE J, 1993, OECOLOGIA, V93, P356, DOI 10.1007/BF00317878; KRAUSE J, 1993, ANIM BEHAV, V45, P1019, DOI 10.1006/anbe.1993.1119; KRAUSE J, 1992, BEHAV ECOL SOCIOBIOL, V30, P177, DOI 10.1007/BF00166700; KRAUSE J, 1993, J FISH BIOL, V43, P309, DOI 10.1111/j.1095-8649.1993.tb01194.x; Krause J, 2000, FISH FISH, V1, P82, DOI 10.1111/j.1467-2979.2000.tb00001.x; Krause J, 2002, LIVING GROUPS; Leblond C, 2006, BEHAVIOUR, V143, P1263, DOI 10.1163/156853906778691603; MAJOR PF, 1978, ANIM BEHAV, V26, P760, DOI 10.1016/0003-3472(78)90142-2; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; Marras S, 2015, BEHAV ECOL SOCIOBIOL, V69, P219, DOI 10.1007/s00265-014-1834-4; McClure M, 2011, BEHAV ECOL SOCIOBIOL, V65, P1573, DOI 10.1007/s00265-011-1167-5; McGuigan K, 2003, EVOLUTION, V57, P104; MORGAN MJ, 1988, ANIM BEHAV, V36, P1317, DOI 10.1016/S0003-3472(88)80200-8; Morrell LJ, 2008, BEHAV ECOL, V19, P909, DOI 10.1093/beheco/arn050; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; OCONNELL CP, 1972, J FISH RES BOARD CAN, V29, P285, DOI 10.1139/f72-047; Portugal SJ, 2014, NATURE, V505, P399, DOI 10.1038/nature12939; Priyadarshana T, 2006, HYDROBIOLOGIA, V568, P341, DOI 10.1007/s10750-006-0201-5; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Rands SA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-51; RAYOR LS, 1990, BEHAV ECOL SOCIOBIOL, V27, P77, DOI 10.1007/BF00168449; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; ROBINSON CJ, 1989, J FISH BIOL, V35, P459, DOI 10.1111/j.1095-8649.1989.tb02997.x; ROBINSON CJ, 1989, J FISH BIOL, V34, P631, DOI 10.1111/j.1095-8649.1989.tb03341.x; ROMEY WL, 1995, BEHAV ECOL SOCIOBIOL, V37, P195, DOI 10.1007/s002650050181; Rowcliffe JM, 2004, J ANIM ECOL, V73, P97, DOI 10.1111/j.1365-2656.2004.00783.x; RYER CH, 1995, ANIM BEHAV, V49, P411, DOI 10.1006/anbe.1995.0054; RYER CH, 1992, ANIM BEHAV, V44, P69, DOI 10.1016/S0003-3472(05)80756-0; Schultz KM, 2008, J EXP BIOL, V211, P3287, DOI 10.1242/jeb.018994; Stankowich T, 2003, ANIM BEHAV, V66, P589, DOI 10.1006/anbe.2003.2232; Stroeymeyt N, 2011, J EXP BIOL, V214, P3046, DOI 10.1242/jeb.059188; Sueur C, 2010, J EXP BIOL, V213, P1338, DOI 10.1242/jeb.039016; Sueur C, 2013, BEHAV ECOL SOCIOBIOL, V67, P457, DOI 10.1007/s00265-012-1466-5; Sueur C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000917; Svendsen JC, 2003, J FISH BIOL, V62, P834, DOI 10.1046/j.1095-8649.2003.00068.x; Swaney W, 2001, ANIM BEHAV, V62, P591, DOI 10.1006/anbe.2001.1788; Teichroeb JA, 2015, INT J PRIMATOL, V36, P154, DOI 10.1007/s10764-015-9818-4; The MathWorks Inc, 2014, MATLAB STAT TOOLB RE; Voelkl B, 2015, P NATL ACAD SCI USA, V112, P2115, DOI 10.1073/pnas.1413589112; Ward A., 2016, SOCIALITY BEHAV GROU; Ward AJW, 2005, ENVIRON BIOL FISH, V72, P155, DOI 10.1007/s10641-004-9078-1; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; Ward AJW, 2002, J ANIM ECOL, V71, P10, DOI 10.1046/j.0021-8790.2001.00571.x	83	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148334	10.1371/journal.pone.0148334	http://dx.doi.org/10.1371/journal.pone.0148334			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849566	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000071
J	Higuchi, T; Nagami, T; Nakata, H; Watanabe, M; Isaka, T; Kanosue, K				Higuchi, Takatoshi; Nagami, Tomoyuki; Nakata, Hiroki; Watanabe, Masakazu; Isaka, Tadao; Kanosue, Kazuyuki			Contribution of Visual Information about Ball Trajectory to Baseball Hitting Accuracy	PLOS ONE			English	Article							TARGET POSITION; MOVEMENTS; PLAYERS; SPIN; BAT; TRACKING; BATTERS	The contribution of visual information about a pitched ball to the accuracy of baseball-bat contact may vary depending on the part of trajectory seen. The purpose of the present study was to examine the relationship between hitting accuracy and the segment of the trajectory of the flying ball that can be seen by the batter. Ten college baseball field players participated in the study. The systematic error and standardized variability of ball-bat contact on the bat coordinate system and pitcher-to-catcher direction when hitting a ball launched from a pitching machine were measured with or without visual occlusion and analyzed using analysis of variance. The visual occlusion timing included occlusion from 150 milliseconds (ms) after the ball release (R+150), occlusion from 150 ms before the expected arrival of the launched ball at the home plate (A-150), and a condition with no occlusion (NO). Twelve trials in each condition were performed using two ball speeds (31.9 m.s(-1) and 40.3 m.s(-1)). Visual occlusion did not affect the mean location of ball-bat contact in the bat's long axis, short axis, and pitcher-to-catcher directions. Although the magnitude of standardized variability was significantly smaller in the bat's short axis direction than in the bat's long axis and pitcher-to-catcher directions (p < 0.001), additional visible time from the R+150 condition to the A-150 and NO conditions resulted in a further decrease in standardized variability only in the bat's short axis direction (p < 0.05). The results suggested that there is directional specificity in the magnitude of standardized variability with different visible time. The present study also confirmed the limitation to visual information is the later part of the ball trajectory for improving hitting accuracy, which is likely due to visuo-motor delay.	[Higuchi, Takatoshi; Nagami, Tomoyuki; Kanosue, Kazuyuki] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Higuchi, Takatoshi] Ritsumeikan Univ, Res Org Sci & Engn, Kusatsu, Japan; [Nakata, Hiroki] Nara Womens Univ, Fac Human Life & Environm, Nara 630, Japan; [Watanabe, Masakazu] Fukuoka Univ, Fac Sports Sci, Fukuoka 81401, Japan; [Isaka, Tadao] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Japan	Waseda University; Ritsumeikan University; Nara Womens University; Fukuoka University; Ritsumeikan University	Higuchi, T (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.; Higuchi, T (corresponding author), Ritsumeikan Univ, Res Org Sci & Engn, Kusatsu, Japan.	t-higuchi@fuji.waseda.jp			Japan Society for the Promotion of Science [0026969]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by Japan Society for the Promotion of Science under Grant-in-Aid for JSPS Fellows (grant number: 0026969) (URL: https://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair R. K., 2002, PHYS BASEBALL, P121; Alaways LW, 2001, J SPORT SCI, V19, P349, DOI 10.1080/02640410152006126; Bahill A. T., 2008, APPL BIOMEDICAL ENG, P445; BAHILL AT, 1984, AM SCI, V72, P249; Bahill AT, 1979, AM SCI, V240, P249, DOI [10.1038/scientificamerican0179-108, DOI 10.1038/SCIENTIFICAMERICAN0179-108]; Bosco G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049381; Brenner E, 1997, J MOTOR BEHAV, V29, P297, DOI 10.1080/00222899709600017; Brenner E, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00342; Cross R, 1998, AM J PHYS, V66, P772, DOI 10.1119/1.19030; Cross R, 2011, PHYSICS OF BASEBALL & SOFTBALL, P235, DOI 10.1007/978-1-4419-8113-4_14; Day BL, 2000, EXP BRAIN RES, V130, P159, DOI 10.1007/s002219900218; DELUCIA PR, 1985, PERCEPT MOTOR SKILL, V61, P143, DOI 10.2466/pms.1985.61.1.143; DeRenne C, 2007, SCI APPROACH HITTING, P1; Engel KC, 2000, J NEUROPHYSIOL, V83, P3483, DOI 10.1152/jn.2000.83.6.3483; Fadde PJ, 2006, TECHNOLOGY INSTRUCT, V4, P265; Fogt NF, 2014, OPTOMETRY VISION SCI, V91, P200, DOI 10.1097/OPX.0000000000000148; Gray R, 2002, J EXP PSYCHOL HUMAN, V28, P1131, DOI 10.1037//0096-1523.28.5.1131; Gray R, 2013, J EXP PSYCHOL HUMAN, V39, P1124, DOI 10.1037/a0030729; Gray R, 2009, J EXP PSYCHOL-APPL, V15, P91, DOI 10.1037/a0015591; Higuchi T, 2013, PERCEPT MOTOR SKILL, V116, P627, DOI 10.2466/30.23.25.PMS.116.2.627-639; Higuchi T, 2013, J APPL BIOMECH, V29, P279, DOI 10.1123/jab.29.3.279; Jinji T, 2006, SPORT BIOMECH, V5, P197, DOI 10.1080/14763140608522874; MCLEOD P, 1987, PERCEPTION, V16, P49, DOI 10.1068/p160049; Muller S, 2006, J SCI MED SPORT, V9, P446, DOI 10.1016/j.jsams.2006.03.029; Nagami T, 2011, MED SCI SPORT EXER, V43, P2321, DOI 10.1249/MSS.0b013e318220e728; Nathan AM, 2000, AM J PHYS, V68, P979, DOI 10.1119/1.1286119; PAULIGNAN Y, 1991, EXP BRAIN RES, V87, P407; Radlo SJ, 2001, RES Q EXERCISE SPORT, V72, P22, DOI 10.1080/02701367.2001.10608928; Renshaw I, 2000, J SPORT SCI, V18, P951, DOI 10.1080/026404100446757; SHAFFER B, 1993, CLIN ORTHOP RELAT R, P285; Szymanski DJ, 2009, J STRENGTH COND RES, V23, P1338, DOI 10.1519/JSC.0b013e318194e09c; Uchida Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031530; WELCH CM, 1995, J ORTHOP SPORT PHYS, V22, P193, DOI 10.2519/jospt.1995.22.5.193	33	21	21	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148498	10.1371/journal.pone.0148498	http://dx.doi.org/10.1371/journal.pone.0148498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26848742	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000111
J	Iwakura, H; Dote, K; Bando, M; Koyama, H; Hosoda, K; Kangawa, K; Nakao, K				Iwakura, Hiroshi; Dote, Katsuko; Bando, Mika; Koyama, Hiroyuki; Hosoda, Kiminori; Kangawa, Kenji; Nakao, Kazuwa			Establishment of Leptin-Responsive Cell Lines from Adult Mouse Hypothalamus	PLOS ONE			English	Article							DIET-INDUCED OBESITY; GENE-EXPRESSION; IN-VITRO; C-FOS; RESISTANCE; MICE; INSULIN; RECEPTOR; PROTEIN; NEURONS	Leptin resistance is considered to be the primary cause of obesity. However, the cause of leptin resistance remains incompletely understood, and there is currently no cure for the leptin-resistant state. In order to identify novel drug-target molecules that could overcome leptin resistance, it would be useful to develop in vitro assay systems for evaluating leptin resistance. In this study, we established immortalized adult mouse hypothalamus-derived cell lines, termed adult mouse hypothalamus (AMH) cells, by developing transgenic mice in which SV40 Tag was overexpressed in chromogranin A-positive cells in a tamoxifen-dependent manner. In order to obtain leptin-responsive clones, we selected clones based on the phosphorylation levels of STAT3 induced by leptin. The selected clones were fairly responsive to leptin in terms of STAT3, ERK, and Akt phosphorylation and induction of c-Fos mRNA induction. Pretreatment with leptin, insulin, and palmitate attenuated the c-Fos mRNA response to leptin, suggesting that certain aspects of leptin resistance might be reconstituted in this cellular model. These cell lines are useful tools for understanding the molecular nature of the signal disturbance in the leptin-resistant state and for identifying potential target molecules for drugs that relieve leptin resistance, although they have drawbacks including de-differentiated nature and lack of long-time stability.	[Iwakura, Hiroshi; Dote, Katsuko; Bando, Mika; Koyama, Hiroyuki; Hosoda, Kiminori; Kangawa, Kenji; Nakao, Kazuwa] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto, Japan; [Koyama, Hiroyuki] Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Kyoto, Japan; [Hosoda, Kiminori] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan; [Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr Res Inst, Osaka, Japan	Kyoto University; Kyoto University; Kyoto University; National Cerebral & Cardiovascular Center - Japan	Iwakura, H (corresponding author), Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto, Japan.	hiwaku@kuhp.kyoto-u.ac.jp		Iwakura, Hiroshi/0000-0001-8033-0736	Takeda Pharmaceutical Co. Ltd.; Ministry of Education, Culture, Sports, Science and Technology of Japan	Takeda Pharmaceutical Co. Ltd.(Takeda Pharmaceutical Company Ltd); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Takeda Pharmaceutical Co. Ltd. and funds from the Ministry of Education, Culture, Sports, Science and Technology of Japan. HI received above funding. [http://www.takeda.com/; http://www.mext.go.jp/english/] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belsham DD, 2004, ENDOCRINOLOGY, V145, P393, DOI 10.1210/en.2003-0946; Belsham DD, 2009, FASEB J, V23, P4256, DOI 10.1096/fj.09-133454; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Brown R, 2009, J NEUROIMMUNOL, V209, P96, DOI 10.1016/j.jneuroim.2009.02.001; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Chiappini F, 2014, J CLIN INVEST, V124, P3781, DOI 10.1172/JCI68585; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cui H, 2005, J NEUROSCI, V25, P9497, DOI 10.1523/JNEUROSCI.2269-05.2005; Cui H, 2006, FASEB J, V20, P2654, DOI 10.1096/fj.06-5989fje; Dhillon SS, 2011, ENDOCRINOLOGY, V152, P4138, DOI 10.1210/en.2011-0178; Dhillon SS, 2011, REGUL PEPTIDES, V167, P192, DOI 10.1016/j.regpep.2011.01.005; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Friedman J, 2014, J ENDOCRINOL, V223, pT1, DOI 10.1530/JOE-14-0405; George M, 2014, J CARDIOVASC PHARM T, V19, P65, DOI 10.1177/1074248413501017; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; HASHIMOTO N, 1992, J BIOL CHEM, V267, P13811; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Huo LH, 2006, DIABETES, V55, P567, DOI 10.2337/diabetes.55.03.06.db05-1143; Iwakura H, 2002, J CLIN ENDOCR METAB, V87, P4885, DOI 10.1210/jc.2002-020882; Iwakura H, 2011, ENDOCRINOLOGY, V152, P2619, DOI 10.1210/en.2010-1455; Iwakura H, 2010, ENDOCRINOLOGY, V151, P2940, DOI 10.1210/en.2010-0090; Iwakura H, 2009, AM J PHYSIOL-ENDOC M, V297, pE802, DOI 10.1152/ajpendo.00205.2009; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; KULAS DT, 1995, J BIOL CHEM, V270, P2435, DOI 10.1074/jbc.270.6.2435; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Loh K, 2011, CELL METAB, V14, P684, DOI 10.1016/j.cmet.2011.09.011; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; MIYAZAKI J, 1989, GENE, V79, P269; MOLLER NPH, 1995, J BIOL CHEM, V270, P23126, DOI 10.1074/jbc.270.39.23126; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Nazarians-Armavil A, 2013, MOL ENDOCRINOL, V27, P990, DOI 10.1210/me.2012-1338; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Reed AS, 2010, DIABETES, V59, P894, DOI 10.2337/db09-1024; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Velloso LA, 2015, ENDOCR REV, V36, P245, DOI 10.1210/er.2014-1100; Wolowczuk I, 2008, CLIN DEV IMMUNOL, P1, DOI 10.1155/2008/639803; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou YJ, 2013, FRONT MED-PRC, V7, P207, DOI 10.1007/s11684-013-0263-5	48	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148639	10.1371/journal.pone.0148639	http://dx.doi.org/10.1371/journal.pone.0148639			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849804	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000145
J	Reagan, AJ; Dubief, Y; Dodds, PS; Danforth, CM				Reagan, Andrew J.; Dubief, Yves; Dodds, Peter Sheridan; Danforth, Christopher M.			Predicting Flow Reversals in a Computational Fluid Dynamics Simulated Thermosyphon Using Data Assimilation	PLOS ONE			English	Article							NATURAL CIRCULATION; CONVECTION LOOP; KALMAN FILTER; CHAOTIC FLOW; MODEL	A thermal convection loop is a annular chamber filled with water, heated on the bottom half and cooled on the top half. With sufficiently large forcing of heat, the direction of fluid flow in the loop oscillates chaotically, dynamics analogous to the Earth's weather. As is the case for state-of-the-art weather models, we only observe the statistics over a small region of state space, making prediction difficult. To overcome this challenge, data assimilation (DA) methods, and specifically ensemble methods, use the computational model itself to estimate the uncertainty of the model to optimally combine these observations into an initial condition for predicting the future state. Here, we build and verify four distinct DA methods, and then, we perform a twin model experiment with the computational fluid dynamics simulation of the loop using the Ensemble Transform Kalman Filter (ETKF) to assimilate observations and predict flow reversals. We show that using adaptively shaped localized covariance outperforms static localized covariance with the ETKF, and allows for the use of less observations in predicting flow reversals. We also show that a Dynamic Mode Decomposition (DMD) of the temperature and velocity fields recovers the low dimensional system underlying reversals, finding specific modes which together are predictive of reversal direction.	[Reagan, Andrew J.; Dodds, Peter Sheridan; Danforth, Christopher M.] Univ Vermont, Dept Math & Stat, Vermont Complex Syst Ctr, Computat Story Lab, Burlington, VT 05405 USA; [Reagan, Andrew J.; Dubief, Yves; Dodds, Peter Sheridan; Danforth, Christopher M.] Univ Vermont, Vermont Adv Comp Core, Burlington, VT 05405 USA; [Dubief, Yves] Univ Vermont, Sch Engn, Vermont Complex Syst Ctr, Burlington, VT 05405 USA	University of Vermont; University of Vermont; University of Vermont	Reagan, AJ (corresponding author), Univ Vermont, Dept Math & Stat, Vermont Complex Syst Ctr, Computat Story Lab, Burlington, VT 05405 USA.; Reagan, AJ (corresponding author), Univ Vermont, Vermont Adv Comp Core, Burlington, VT 05405 USA.	andrew.reagan@uvm.edu			Vermont Space Grant Consortium; NASA EPSCoR; NSF-DMS [0940271]; Mathematics & Climate Research Network; Vermont Advanced Computing Center	Vermont Space Grant Consortium; NASA EPSCoR(National Aeronautics & Space Administration (NASA)); NSF-DMS(National Science Foundation (NSF)); Mathematics & Climate Research Network; Vermont Advanced Computing Center	This work was made possible by funding from the Vermont Space Grant Consortium, NASA EPSCoR, NSF-DMS Grant No. 0940271, the Mathematics & Climate Research Network and the Vermont Advanced Computing Center.	[Anonymous], 2009, NATURE, DOI DOI 10.1038/nature07634; Asur S., 2010, Proceedings 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology (WI-IAT), P492, DOI 10.1109/WI-IAT.2010.63; Bauer P, 2015, NATURE, V525, P47, DOI 10.1038/nature14956; Bishop CH, 2001, MON WEATHER REV, V129, P420, DOI 10.1175/1520-0493(2001)129<0420:ASWTET>2.0.CO;2; Bishop CH, 2011, MON WEATHER REV, V139, P1241, DOI 10.1175/2010MWR3403.1; Burroughs EA, 2005, J FLUID MECH, V543, P203, DOI 10.1017/S0022112005006361; CREVELING HF, 1975, J FLUID MECH, V67, P65, DOI 10.1017/S0022112075000171; Danforth CM, 2008, J ATMOS SCI, V65, P1467, DOI 10.1175/2007JAS2419.1; Danforth CM, 2007, MON WEATHER REV, V135, P281, DOI 10.1175/MWR3289.1; Desrayaud G, 2006, INT J HEAT FLUID FL, V27, P154, DOI 10.1016/j.ijheatfluidflow.2005.04.002; EHRHARD P, 1990, J FLUID MECH, V217, P487, DOI 10.1017/S0022112090000817; Glenn D, 2013, THESIS U VERMONT; GORMAN M, 1986, PHYSICA D, V19, P255, DOI 10.1016/0167-2789(86)90022-9; GORMAN M, 1984, PHYS REV LETT, V52, P2241, DOI 10.1103/PhysRevLett.52.2241; Harris KD, 2011, ARXIV11085685; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Hunt BR, 2007, PHYSICA D, V230, P112, DOI 10.1016/j.physd.2006.11.008; ISSA RI, 1986, J COMPUT PHYS, V62, P40, DOI 10.1016/0021-9991(86)90099-9; Jasak H., 2007, INT WORKSH COUPL MET, V1000, P1; Jiang YY, 2003, J HEAT TRANS-T ASME, V125, P612, DOI 10.1115/1.1571846; Kalnay E., 2003, ATMOSPHERIC MODELING, DOI DOI 10.1017/CBO9780511802270; Kalnay E, 2007, TELLUS A, V59, P758, DOI 10.1111/J.1600-0870.2007.00261.X; KELLER JB, 1966, J FLUID MECH, V26, P599, DOI 10.1017/S0022112066001423; Li H, 2009, MON WEATHER REV, V137, P3407, DOI 10.1175/2009MWR2766.1; LORENC AC, 1986, Q J ROY METEOR SOC, V112, P1177, DOI 10.1002/qj.49711247414; Louisos WF, 2013, INT J HEAT MASS TRAN, V61, P565, DOI 10.1016/j.ijheatmasstransfer.2013.02.015; Ott E, 2004, TELLUS A, V56, P415, DOI 10.1111/j.1600-0870.2004.00076.x; Ridouane E, 2010, INT J HEAT MASS TRAN, V53, P76, DOI 10.1016/j.ijheatmasstransfer.2009.10.003; Savely R, 1972, TECHNICAL REPORT; Sornette D, 2006, INT J FORECASTING, V22, P153, DOI 10.1016/j.ijforecast.2005.02.004; Tu J.H., 2013, PREPRINTARXIV; Welander P., 1995, INT GEOPHYS SERIES, P59; Yang SC, 2006, J ATMOS SCI, V63, P2340, DOI 10.1175/JAS3739.1; Yuen PK, 1999, PHYS FLUIDS, V11, P1435, DOI 10.1063/1.870007	34	2	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148134	10.1371/journal.pone.0148134	http://dx.doi.org/10.1371/journal.pone.0148134			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849061	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000042
J	Stein, C; Notzold, RR; Riedl, S; Bouchard, C; Bauer, UM				Stein, Claudia; Noetzold, Rene Reiner; Riedl, Stefanie; Bouchard, Caroline; Bauer, Uta-Maria			The Arginine Methyltransferase PRMT6 Cooperates with Polycomb Proteins in Regulating HOXA Gene Expression	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HISTONE H3; RETINOIC ACID; HUMAN GENOME; TRANSCRIPTIONAL REPRESSION; DEVELOPMENTAL REGULATORS; TUMOR-SUPPRESSOR; TARGET GENES; METHYLATION; CHROMATIN	Protein arginine methyltransferase 6 (PRMT6) catalyses asymmetric dimethylation of histone H3 at arginine 2 (H3R2me2a), which has been shown to impede the deposition of histone H3 lysine 4 trimethylation (H3K4me3) by blocking the binding and activity of the MLL1 complex. Importantly, the genomic occurrence of H3R2me2a has been found to coincide with histone H3 lysine 27 trimethylation (H3K27me3), a repressive histone mark generated by the Polycomb repressive complex 2 (PRC2). Therefore, we investigate here a putative crosstalk between PRMT6-and PRC-mediated repression in a cellular model of neuronal differentiation. We show that PRMT6 and subunits of PRC2 as well as PRC1 are bound to the same regulatory regions of rostral HOXA genes and that they control the differentiation-associated activation of these genes. Furthermore, we find that PRMT6 interacts with subunits of PRC1 and PRC2 and that depletion of PRMT6 results in diminished PRC1/PRC2 and H3K27me3 occupancy and in increased H3K4me3 levels at these target genes. Taken together, our data uncover a novel, additional mechanism of how PRMT6 contributes to gene repression by cooperating with Polycomb proteins.	[Stein, Claudia; Noetzold, Rene Reiner; Riedl, Stefanie; Bouchard, Caroline; Bauer, Uta-Maria] Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany	Philipps University Marburg	Bauer, UM (corresponding author), Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany.	bauer@imt.uni-marburg.de			German Research Foundation/ Deutsche Forschungsgemeinschaft (DFG) [TRR81, BA2292/1-3]	German Research Foundation/ Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by German Research Foundation/ Deutsche Forschungsgemeinschaft (DFG) (http://www.dfg.de), grant no. TRR81 (project 3), BA2292/1-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BONCINELLI E, 1991, TRENDS GENET, V7, P329, DOI 10.1016/0168-9525(91)90423-N; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Casadio F, 2013, P NATL ACAD SCI USA, V110, P14894, DOI 10.1073/pnas.1312925110; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Di Lorenzo A, 2011, FEBS LETT, V585, P2024, DOI 10.1016/j.febslet.2010.11.010; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gayatri S, 2014, BBA-GENE REGUL MECH, V1839, P702, DOI 10.1016/j.bbagrm.2014.02.015; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Herglotz J, 2013, ONCOGENE, V32, P2565, DOI 10.1038/onc.2012.274; Houldsworth J, 2002, CELL GROWTH DIFFER, V13, P257; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Kleinschmidt MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041446; Kuvardina ON, 2015, BLOOD, V125, P3570, DOI 10.1182/blood-2014-11-610519; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lakowski TM, 2008, J BIOL CHEM, V283, P10015, DOI 10.1074/jbc.M710176200; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee YH, 2012, STEM CELLS DEV, V21, P2613, DOI 10.1089/scd.2011.0330; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; Michaud-Levesque J, 2009, J BIOL CHEM, V284, P21338, DOI 10.1074/jbc.M109.005322; Miranda TB, 2005, BIOCHEM BIOPH RES CO, V336, P831, DOI 10.1016/j.bbrc.2005.08.179; Miyagishima H, 2003, HISTOCHEM CELL BIOL, V120, P111, DOI 10.1007/s00418-003-0551-2; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Neault M, 2012, NUCLEIC ACIDS RES, V40, P9513, DOI 10.1093/nar/gks764; NOMURA M, 1994, DIFFERENTIATION, V57, P39, DOI 10.1046/j.1432-0436.1994.5710039.x; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Phalke S, 2012, NUCLEIC ACIDS RES, V40, P9534, DOI 10.1093/nar/gks858; Ren XJ, 2008, MOL CELL BIOL, V28, P2884, DOI 10.1128/MCB.00949-07; Rosenfeld JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-143; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Scaramuzzino C, 2015, NEURON, V85, P88, DOI 10.1016/j.neuron.2014.12.031; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schoorlemmer J, 1997, EMBO J, V16, P5930, DOI 10.1093/emboj/16.19.5930; Sgarra R, 2006, J BIOL CHEM, V281, P3764, DOI 10.1074/jbc.M510231200; Singhroy DN, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-73; Stein C, 2012, NUCLEIC ACIDS RES, V40, P9522, DOI 10.1093/nar/gks767; Suzuki M, 2002, DEVELOPMENT, V129, P4171; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Waldmann T, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-11; Xu M, 2014, MOL CELL BIOL, V34, P3867, DOI 10.1128/MCB.00567-14	54	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148892	10.1371/journal.pone.0148892	http://dx.doi.org/10.1371/journal.pone.0148892			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848759	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000183
J	Jurado-Parras, MT; Delgado-Garcia, JM; Sanchez-Campusano, R; Gassmann, M; Bettler, B; Gruart, A				Teresa Jurado-Parras, M.; Delgado-Garcia, Jose M.; Sanchez-Campusano, Raudel; Gassmann, Martin; Bettler, Bernhard; Gruart, Agnes			Presynaptic GABA(B) Receptors Regulate Hippocampal Synapses during Associative Learning in Behaving Mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SUBUNITS GABA(B1A/B); SYNAPTIC PLASTICITY; CA3-CA1 SYNAPSE; ACQUISITION; CHANNELS; ROLES; LTP	GABA(B) receptors are the G-protein-coupled receptors for GABA, the main inhibitory neurotransmitter in the central nervous system. Pharmacological activation of GABAB receptors regulates neurotransmission and neuronal excitability at pre- and postsynaptic sites. Electrophysiological activation of GABA(B) receptors in brain slices generally requires strong stimulus intensities. This raises the question as to whether behavioral stimuli are strong enough to activate GABA(B) receptors. Here we show that GABA(B1a)(-/-) mice, which constitutively lack presynaptic GABA(B) receptors at glutamatergic synapses, are impaired in their ability to acquire an operant learning task. In vivo recordings during the operant conditioning reveal a deficit in learning-dependent increases in synaptic strength at CA3-CA1 synapses. Moreover, GABA(B1a)(-/-) mice fail to synchronize neuronal activity in the CA1 area during the acquisition process. Our results support that activation of presynaptic hippocampal GABA(B) receptors is important for acquisition of a learning task and for learning-associated synaptic changes and network dynamics.	[Teresa Jurado-Parras, M.; Delgado-Garcia, Jose M.; Sanchez-Campusano, Raudel; Gruart, Agnes] Pablo de Olavide Univ, Div Neurosci, Seville 41013, Spain; [Gassmann, Martin; Bettler, Bernhard] Univ Basel, Dept Biomed, CH-4056 Basel, Switzerland	Universidad Pablo de Olavide; University of Basel	Gruart, A (corresponding author), Pablo de Olavide Univ, Div Neurosci, Seville 41013, Spain.; Bettler, B (corresponding author), Univ Basel, Dept Biomed, CH-4056 Basel, Switzerland.	bernhard.bettler@unibas.ch; agrumas@upo.es	bettler, bernhard/AAO-8018-2020; Sánchez-Campusano, Raudel/K-9254-2014; Delgado-Garcia, Jose M./V-1567-2019	Sánchez-Campusano, Raudel/0000-0003-3132-2769; Bettler, Bernhard/0000-0003-0842-8207	Spanish Ministry of Economy and Competitiveness [BFU2014-56692-R]; Swiss National Science Foundation [3100A0-117816]; European Community's Seventh Framework Program (DEVANX) [201714]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community's Seventh Framework Program (DEVANX)	This study was supported by grants from the Spanish Ministry of Economy and Competitiveness (BFU2014-56692-R) to AG and JMD-G, and from the Swiss National Science Foundation (3100A0-117816) to BB, and a grant from the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement No 201714 (DEVANX) to AG, JMD-G, and BB.	Biermann B, 2010, J NEUROSCI, V30, P1385, DOI 10.1523/JNEUROSCI.3172-09.2010; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; Chalifoux JR, 2011, CURR OPIN NEUROBIOL, V21, P339, DOI 10.1016/j.conb.2011.02.004; Craig MT, 2013, J PHYSIOL-LONDON, V591, P835, DOI 10.1113/jphysiol.2012.248088; Davies CH, 1996, J PHYSIOL-LONDON, V496, P451, DOI 10.1113/jphysiol.1996.sp021698; Gassmann M, 2012, NAT REV NEUROSCI, V13, P380, DOI 10.1038/nrn3249; Gottlieb M, 2006, NEUROBIOL DIS, V23, P374, DOI 10.1016/j.nbd.2006.03.017; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Gruart A, 2012, J NEUROSCI, V32, P17431, DOI 10.1523/JNEUROSCI.4339-12.2012; Guetg N, 2009, J NEUROSCI, V29, P1414, DOI 10.1523/JNEUROSCI.3697-08.2009; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; Hasan MT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3258; Jacobson LH, 2006, J NEUROSCI, V26, P8800, DOI 10.1523/JNEUROSCI.2076-06.2006; Johnson JM, 2010, BEHAV PROCESS, V84, P705, DOI 10.1016/j.beproc.2010.04.008; Kohl MM, 2010, ADV PHARMACOL, V58, P205, DOI 10.1016/S1054-3589(10)58009-8; Kulik A, 2003, J NEUROSCI, V23, P11026; Lopez-Bendito G, 2004, HIPPOCAMPUS, V14, P836, DOI 10.1002/hipo.10221; Madronal N, 2007, J NEUROSCI, V27, P12139, DOI 10.1523/JNEUROSCI.3397-07.2007; Madronal N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011130; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Palmer LM, 2012, SCIENCE, V335, P989, DOI 10.1126/science.1217276; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Sahun I, 2007, J NEUROSCI, V27, P2253, DOI 10.1523/JNEUROSCI.4055-06.2007; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; Schwaller B, 2004, MOL CELL NEUROSCI, V25, P650, DOI 10.1016/j.mcn.2003.12.006; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732; Jurado-Parras MT, 2013, J NEUROSCI, V33, P2293, DOI 10.1523/JNEUROSCI.1013-12.2013; Turecek R, 2014, NEURON, V82, P1032, DOI 10.1016/j.neuron.2014.04.015; Valles-Ortega J, 2011, EMBO MOL MED, V3, P667, DOI 10.1002/emmm.201100174; Vertkin I, 2015, P NATL ACAD SCI USA, V112, pE3291, DOI 10.1073/pnas.1424810112; Vienne J, 2010, J NEUROSCI, V30, P14194, DOI 10.1523/JNEUROSCI.3145-10.2010; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	35	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148800	10.1371/journal.pone.0148800	http://dx.doi.org/10.1371/journal.pone.0148800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848590	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000170
J	Xing, MM; Lv, HH; Ma, J; Xu, DH; Li, HL; Yang, LM; Kang, JG; Wang, XW; Fang, ZY				Xing, Miaomiao; Lv, Honghao; Ma, Jian; Xu, Donghui; Li, Hailong; Yang, Limei; Kang, Jungen; Wang, Xiaowu; Fang, Zhiyuan			Transcriptome Profiling of Resistance to Fusarium oxysporum f. sp conglutinans in Cabbage (Brassica oleracea) Roots	PLOS ONE			English	Article							RNA-SEQ DATA; SALICYLIC-ACID; WILT RESISTANCE; ESSENTIAL COMPONENT; ARABIDOPSIS; GENE; PROTEINS; DEFENSE; IDENTIFICATION; EXPRESSION	Fusarium wilt caused by Fusarium oxysporum f. sp. conglutinans (FOC) is a destructive disease of Brassica crops, which results in severe yield losses. There is little information available about the mechanism of disease resistance. To obtain an overview of the transcriptome profiles in roots of R4P1, a Brassica oleracea variety that is highly resistant to fusarium wilt, we compared the transcriptomes of samples inoculated with FOC and samples inoculated with distilled water. RNA-seq analysis generated more than 136 million 100-bp clean reads, which were assembled into 62,506 unigenes (mean size = 741 bp). Among them, 49,959 (79.92%) genes were identified based on sequence similarity searches, including SwissProt (29,050, 46.47%), Gene Ontology (GO) (33,767, 54.02%), Clusters of Orthologous Groups (KOG) (14,721, 23.55%) and Kyoto Encyclopedia of Genes and Genomes Pathway database (KEGG) (12,974, 20.76%) searches; digital gene expression analysis revealed 885 differentially expressed genes (DEGs) between infected and control samples at 4, 12, 24 and 48 hours after inoculation. The DEGs were assigned to 31 KEGG pathways. Early defense systems, including the MAPK signaling pathway, calcium signaling and salicylic acid-mediated hypersensitive response (SA-mediated HR) were activated after pathogen infection. SA-dependent systemic acquired resistance (SAR), ethylene (ET)- and jasmonic (JA)-mediated pathways and the lignin biosynthesis pathway play important roles in plant resistance. We also analyzed the expression of defense-related genes, such as genes encoding pathogenesis-related (PR) proteins, UDP-glycosyltransferase (UDPG), pleiotropic drug resistance, ATP-binding cassette transporters (PDR-ABC transporters), myrosinase, transcription factors and kinases, which were differentially expressed. The results of this study may contribute to efforts to identify and clone candidate genes associated with disease resistance and to uncover the molecular mechanism underlying FOC resistance in cabbage.	[Xing, Miaomiao; Ma, Jian; Li, Hailong; Kang, Jungen] Beijing Acad Agr & Forestry Sci, Key Lab Biol & Genet Improvement Hort Crops North, Beijing Vegetable Res Ctr, Minist Agr, 50 Zhanghua St, Beijing 100097, Peoples R China; [Lv, Honghao; Xu, Donghui; Yang, Limei; Wang, Xiaowu; Fang, Zhiyuan] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Key Lab Biol & Genet Improvement Hort Crops, Minist Agr, 12 Zhongguancun Nandajie St, Beijing 100081, Peoples R China	Beijing Academy of Agriculture & Forestry; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs	Kang, JG (corresponding author), Beijing Acad Agr & Forestry Sci, Key Lab Biol & Genet Improvement Hort Crops North, Beijing Vegetable Res Ctr, Minist Agr, 50 Zhanghua St, Beijing 100097, Peoples R China.; Wang, XW (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Key Lab Biol & Genet Improvement Hort Crops, Minist Agr, 12 Zhongguancun Nandajie St, Beijing 100081, Peoples R China.	kangjungen@nercv.org; wangxiaowu@caas.cn	Wang, Xiaowu/L-2579-2019; Lv, Honghao/AFS-6332-2022	fang, zhi yuan/0000-0003-1664-759X; Lv, Honghao/0000-0003-2635-3042	National Natural Science Foundation of China [31171958]; National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period [2012BAD02B01, 2014BAD01B08]; Beijing Science and Technology Commission Project [Z141105002314020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period; Beijing Science and Technology Commission Project	This work was financially supported by grants from the National Natural Science Foundation of China (31171958), the Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period (2012BAD02B01, 2014BAD01B08), and the Beijing Science and Technology Commission Project (Z141105002314020).	Agarwal P, 2014, MOL BIOL REP, V41, P599, DOI 10.1007/s11033-013-2897-4; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Bernardi R, 2000, FEBS LETT, V467, P296, DOI 10.1016/S0014-5793(00)01179-0; Berrocal-Lobo M, 2004, MOL PLANT MICROBE IN, V17, P763, DOI 10.1094/MPMI.2004.17.7.763; Bieri S, 2004, PLANT CELL, V16, P3480, DOI 10.1105/tpc.104.026682; Blanco F, 2005, PLANT MOL BIOL, V59, P927, DOI 10.1007/s11103-005-2227-x; Capella AN, 2001, PLANTA, V213, P691, DOI 10.1007/s004250100548; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; COLLINGE DB, 1993, PLANT J, V3, P31, DOI 10.1046/j.1365-313X.1993.t01-1-00999.x; Derckel JP, 1998, PHYSIOL PLANTARUM, V104, P56, DOI 10.1034/j.1399-3054.1998.1040108.x; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; Edgar CI, 2006, AUSTRALAS PLANT PATH, V35, P581, DOI 10.1071/AP06060; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Jiang Ming, 2011, Scientia Agricultura Sinica, V44, P3053; Kang J, 2010, SCREENING CABBAGE GE, P15; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Leister RT, 2005, PLANT CELL, V17, P1268, DOI 10.1105/tpc.104.029637; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Chun-Yu, 2012, BMC Genomics, V13, P374, DOI 10.1186/1471-2164-13-374; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Liu J, 2009, PLANT SIGNAL BEHAV, V4, P1107, DOI 10.4161/psb.4.12.9944; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Lu GY, 2011, EUR J PLANT PATHOL, V131, P585, DOI 10.1007/s10658-011-9833-z; LuHongHao, 2011, Acta Horticulturae Sinica, V38, P875; Lv HH, 2013, MOL BREEDING, V32, P961, DOI 10.1007/s11032-013-9925-x; Lv HH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1094; Lyons R, 2015, PLOS ONE, V10, P1; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; MCGREGOR DI, 1988, CAN J PLANT SCI, V68, P367, DOI 10.4141/cjps88-048; Metraux JP, 2002, EUPHYTICA, V124, P237, DOI 10.1023/A:1015690702313; Migocka M, 2012, PLANT GROWTH REGUL, V67, P171, DOI 10.1007/s10725-012-9674-6; MITHEN RF, 1992, PLANT BREEDING, V108, P60, DOI 10.1111/j.1439-0523.1992.tb00100.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagano AJ, 2008, PLANT CELL PHYSIOL, V49, P969, DOI 10.1093/pcp/pcn075; Noel LD, 2007, PLANT CELL, V19, P4061, DOI 10.1105/tpc.107.051896; Nomura Y., 1976, Journal of the Central Agricultural Experiment Station, P141; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Pu ZJ, 2012, MOL BREEDING, V30, P809, DOI 10.1007/s11032-011-9665-8; Rahmanpour S, 2010, EUR J PLANT PATHOL, V128, P429, DOI 10.1007/s10658-010-9685-y; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Rietz S, 2011, NEW PHYTOL, V191, P107, DOI 10.1111/j.1469-8137.2011.03675.x; Sarwar M, 1998, PLANT SOIL, V201, P103, DOI 10.1023/A:1004381129991; Shang Y, 2009, CHINESE SCI BULL, V54, P3249, DOI 10.1007/s11434-009-0553-0; Shimizu M, 2015, THEOR APPL GENET, V128, P119, DOI 10.1007/s00122-014-2416-6; Singh I, 2012, J BIOSCIENCES, V37, P563, DOI 10.1007/s12038-012-9208-4; Smith E., 1899, SCI AM SUPPL, V48, P19981, DOI DOI 10.1038/SCIENTIFICAMERICAN11181899-19981SUPP; Snyder WC, 1940, AM J BOT, V27, P64, DOI 10.2307/2436688; Song JT, 2006, MOL CELLS, V22, P233; Tian RP, 2009, CHINESE AGR SCI B, V5, P39; Trewavas A, 1999, PLANT PHYSIOL, V120, P1, DOI 10.1104/pp.120.1.1; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Vidhyasekaran P., 2015, PLANT HORMONE SIGNAL, P27; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Xiao J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-197; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Yan SP, 2014, CURR OPIN PLANT BIOL, V20, P64, DOI 10.1016/j.pbi.2014.04.006; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhu QH, 2013, GENE, V512, P259, DOI 10.1016/j.gene.2012.10.036; 李明远, 2003, [植物保护, Plant Protection], V29, P44	68	30	32	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148048	10.1371/journal.pone.0148048	http://dx.doi.org/10.1371/journal.pone.0148048			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849436	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000034
J	Yuan, T; Zhang, JY; Zhao, GY; Zhou, YQ; Zhang, CQ; Wang, JHC				Yuan, Ting; Zhang, Jianying; Zhao, Guangyi; Zhou, Yiqin; Zhang, Chang-Qing; Wang, James H-C.			Creating an Animal Model of Tendinopathy by Inducing Chondrogenic Differentiation with Kartogenin	PLOS ONE			English	Article							TENDON STEM-CELLS; EXTRACELLULAR-MATRIX; ACHILLES-TENDON; TENDINOSIS; PATHOGENESIS; EXPRESSION	Previous animal studies have shown that long term rat treadmill running induces over-use tendinopathy, which manifests as proteoglycan accumulation and chondrocytes-like cells within the affected tendons. Creating this animal model of tendinopathy by long term treadmill running is however time-consuming, costly and may vary among animals. In this study, we used a new approach to develop an animal model of tendinopathy using kartogenin (KGN), a bio-compound that can stimulate endogenous stem/progenitor cells to differentiate into chondrocytes. KGN-beads were fabricated and implanted into rat Achilles tendons. Five weeks after implantation, chondrocytes and proteoglycan accumulation were found at the KGN implanted site. Vascularity as well as disorganization in collagen fibers were also present in the same site along with increased expression of the chondrocyte specific marker, collagen type II (Col. II). In vitro studies confirmed that KGN was released continuously from KGN-alginate in vivo beads and induced chondrogenic differentiation of tendon stem/progenitor cells (TSCs) suggesting that chondrogenesis after KGN-bead implantation into the rat tendons is likely due to the aberrant differentiation of TSCs into chondrocytes. Taken together, our results showed that KGN-alginate beads can be used to create a rat model of tendinopathy, which, at least in part, reproduces the features of over-use tendinopathy model created by long term treadmill running. This model is mechanistic (stem cell differentiation), highly reproducible and precise in creating localized tendinopathic lesions. It is expected that this model will be useful to evaluate the effects of various topical treatments such as NSAIDs and platelet-rich plasma (PRP) for the treatment of tendinopathy.	[Yuan, Ting; Zhang, Jianying; Zhao, Guangyi; Zhou, Yiqin; Wang, James H-C.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, MechanoBiol Lab, Pittsburgh, PA 15261 USA; [Yuan, Ting; Zhang, Chang-Qing] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Orthopaed Surg, Shanghai 200030, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Shanghai Jiao Tong University	Wang, JHC (corresponding author), Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, MechanoBiol Lab, Pittsburgh, PA 15261 USA.	wanghc@pitt.edu		zhang, changqing/0000-0002-7408-4126	National Institutes of Health [AR061395, AR065949, AR060920]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060920, R01AR065949, R01AR061395] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health AR061395, AR065949, and AR060920 (JHW).; This work was supported by NIH AR061395, AR065949, and AR060920 (JHW). We thank Dr. Nirmala Xavier for assistance in preparing the manuscript.	Abraham T, 2011, BMC MUSCULOSKEL DIS, V12, P1471; Archambault JM, 2007, J ORTHOP RES, V25, P617, DOI 10.1002/jor.20347; ASTROM M, 1995, CLIN ORTHOP RELAT R, P151; Bell R, 2013, J BIOMECH, V46, P498, DOI 10.1016/j.jbiomech.2012.10.020; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Buck FM, 2009, AM J ROENTGENOL, V193, P1367, DOI 10.2214/AJR.09.2738; Cetti R, 2003, ACTA ORTHOP SCAND, V74, P78, DOI 10.1080/00016470310013707; Corps AN, 2006, RHEUMATOLOGY, V45, P291, DOI 10.1093/rheumatology/kei152; Da Violante G, 2002, BIOL PHARM BULL, V25, P1600, DOI 10.1248/bpb.25.1600; Fu SC, 2007, CLIN J SPORT MED, V17, P129, DOI 10.1097/JSM.0b013e318037998f; Fung DT, 2010, J BIOMECH, V43, P274, DOI 10.1016/j.jbiomech.2009.08.039; Glazebrook MA, 2008, J ORTHOP RES, V26, P840, DOI 10.1002/jor.20546; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Hsu RWW, 2004, J ORTHOP RES, V22, P221, DOI 10.1016/S0736-0266(03)00138-4; Jiang DP, 2013, HISTOL HISTOPATHOL, V28, P1537, DOI 10.14670/HH-28.1537; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P1507, DOI 10.2106/00004623-199173100-00009; Kearney R, 2010, FOOT ANKLE INT, V31, P689, DOI 10.3113/FAI.2010.0689; Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004; Khan MH, 2005, CLIN J SPORT MED, V15, P27, DOI 10.1097/00042752-200501000-00006; Krishna Sayana Murali, 2005, Foot Ankle Clin, V10, P309; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marsolais D, 2001, J ORTHOPAED RES, V19, P1203, DOI 10.1016/S0736-0266(01)00031-6; Mishra A, 2006, AM J SPORT MED, V34, P1774, DOI 10.1177/0363546506288850; Ng GYF, 2011, CONNECT TISSUE RES, V52, P466, DOI 10.3109/03008207.2011.562334; Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027; Parkinson J, 2010, ARTHRITIS RHEUM-US, V62, P3028, DOI 10.1002/art.27587; Riley G, 2004, RHEUMATOLOGY, V43, P131, DOI 10.1093/rheumatology/keg448; Rui YF, 2010, TISSUE ENG PT A, V16, P1549, DOI 10.1089/ten.TEA.2009.0529; Samiric T, 2009, MATRIX BIOL, V28, P230, DOI 10.1016/j.matbio.2009.04.001; Scott A, 2007, ARTHRITIS RHEUM-US, V56, P871, DOI 10.1002/art.22426; Silva RD, 2011, INT J CLIN EXP PATHO, V4, P683; Stone D, 1999, J ORTHOP RES, V17, P168, DOI 10.1002/jor.1100170204; Sullo A, 2001, J Orthop Sci, V6, P349, DOI 10.1007/s007760100031; Wang JHC, 2006, CLIN ORTHOP RELAT R, P320, DOI 10.1097/01.blo.0000195927.81845.46; Wang James H-C, 2014, Muscles Ligaments Tendons J, V4, P35; Wang YJ, 2005, J BONE MINER RES, V20, P1624, DOI 10.1359/JBMR.050516; Xu YH, 2008, CLIN ORTHOP RELAT R, V466, P1528, DOI 10.1007/s11999-008-0286-4; Yuan Ting, 2013, Muscles Ligaments Tendons J, V3, P139; Zhang JY, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.8; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071740; Zhang JY, 2010, J ORTHOP RES, V28, P639, DOI 10.1002/jor.21046; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10	43	18	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148557	10.1371/journal.pone.0148557	http://dx.doi.org/10.1371/journal.pone.0148557			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848746	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000369554000123
J	Bonnier, G; Kober, T; Schluep, M; Du Pasquier, R; Krueger, G; Meuli, R; Granziera, C; Roche, A				Bonnier, Guillaume; Kober, Tobias; Schluep, Myriam; Du Pasquier, Renaud; Krueger, Gunnar; Meuli, Reto; Granziera, Cristina; Roche, Alexis			A New Approach for Deep Gray Matter Analysis Using Partial-Volume Estimation	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; T2-WEIGHTED MRI; MYELIN; BRAIN; NEURODEGENERATION; HISTOLOGY	Introduction The existence of partial volume effects in brain MR images makes it challenging to understand physio-pathological alterations underlying signal changes due to pathology across groups of healthy subjects and patients. In this study, we implement a new approach to disentangle gray and white matter alterations in the thalamus and the basal ganglia. The proposed method was applied to a cohort of early multiple sclerosis (MS) patients and healthy subjects to evaluate tissue-specific alterations related to diffuse inflammatory or neurode-generative processes. Method Forty-three relapsing-remitting MS patients and nineteen healthy controls underwent 3T MRI including: (i) fluid-attenuated inversion recovery, double inversion recovery, magnetizationprepared gradient echo for lesion count, and (ii) T1 relaxometry. We applied a partial volume estimation algorithm to T1 relaxometry maps to gray and white matter local concentrations as well as T1 values characteristic of gray and white matter in the thalamus and the basal ganglia. Statistical tests were performed to compare groups in terms of both global T1 values, tissue characteristic T1 values, and tissue concentrations. Results Significant increases in global T1 values were observed in the thalamus (p = 0.038) and the putamen (p = 0.026) in RRMS patients compared to HC. In the Thalamus, the T1 increase was associated with a significant increase in gray matter characteristic T1 (p = 0.0016) with no significant effect in white matter. Conclusion The presented methodology provides additional information to standard MR signal averaging approaches that holds promise to identify the presence and nature of diffuse pathology in neuro-inflammatory and neurodegenerative diseases.	[Bonnier, Guillaume; Kober, Tobias; Granziera, Cristina] Siemens Healthcare IM BM PI, Adv Clin Imaging Technol, Lausanne, Switzerland; [Bonnier, Guillaume; Kober, Tobias; Granziera, Cristina; Roche, Alexis] Ecole Polytech Fed Lausanne, LTS5, Lausanne, Switzerland; [Bonnier, Guillaume; Schluep, Myriam; Du Pasquier, Renaud; Granziera, Cristina] CHU Vaudois, Dept Clin Neurosci, LREN & Neuroimmunol Lab, Lausanne, Switzerland; [Kober, Tobias; Meuli, Reto; Roche, Alexis] CHU Vaudois, Dept Radiol, Lausanne, Switzerland; [Krueger, Gunnar] Siemens Med Solut USA IM MR COL NEZ, Burlington, MA USA	Siemens AG; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Siemens AG	Bonnier, G (corresponding author), Siemens Healthcare IM BM PI, Adv Clin Imaging Technol, Lausanne, Switzerland.; Bonnier, G (corresponding author), Ecole Polytech Fed Lausanne, LTS5, Lausanne, Switzerland.; Bonnier, G (corresponding author), CHU Vaudois, Dept Clin Neurosci, LREN & Neuroimmunol Lab, Lausanne, Switzerland.	guillaume.bonnier@unil.ch	Du Pasquier, Renaud/O-8588-2016	Du Pasquier, Renaud/0000-0002-2786-3434; Roche, Alexis/0000-0002-4821-6893; Granziera, Cristina/0000-0002-4917-8761	Swiss National Science Foundation [PZ00P3_131914/11]; Swiss MS Society; Societe Academique Vaudoise; Siemens Healthcare; Siemens Medical Solutions	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss MS Society; Societe Academique Vaudoise; Siemens Healthcare(Siemens AG); Siemens Medical Solutions(Siemens AG)	This work was supported by The Swiss National Science Foundation under grant PZ00P3_131914/11, and The Swiss MS Society and the Societe Academique Vaudoise. The funding sources had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. The funder Siemens Healthcare and Siemens Medical Solutions provided support in the form of salaries for authors GK, TK, and AR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Accolla EA, 2014, HUM BRAIN MAPP, V35, P5083, DOI 10.1002/hbm.22533; Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; Chakravarty MM, 2006, NEUROIMAGE, V30, P359, DOI 10.1016/j.neuroimage.2005.09.041; Cifelli A, 2002, ANN NEUROL, V52, P650, DOI 10.1002/ana.10326; Deistung A, 2013, NEUROIMAGE, V65, P299, DOI 10.1016/j.neuroimage.2012.09.055; Garman RH, 2011, TOXICOL PATHOL, V39, P22, DOI 10.1177/0192623310389621; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Grydeland H, 2013, J NEUROSCI, V33, P18618, DOI 10.1523/JNEUROSCI.2811-13.2013; Harrison TJ., 1975, J ANAT 3, V119, P626; Klaver R, 2013, PRION, V7, P66, DOI 10.4161/pri.23499; Kober T, 2012, INVEST RADIOL, V47, P346, DOI 10.1097/RLI.0b013e31824600e9; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Minagar A, 2013, NEUROLOGY, V80, P210, DOI 10.1212/WNL.0b013e31827b910b; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Papadopoulos D, 2009, BRAIN PATHOL, V19, P238, DOI 10.1111/j.1750-3639.2008.00177.x; Roche A, 2011, MED IMAGE ANAL, V15, P830, DOI 10.1016/j.media.2011.05.002; Sadikot AF, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00071; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Schmitter D, 2015, NEUROIMAGE-CLIN, V7, P7, DOI 10.1016/j.nicl.2014.11.001; van Landeghem FKH, 2007, REGUL PEPTIDES, V142, P52, DOI 10.1016/j.regpep.2007.01.008; Vercellino M, 2009, J NEUROPATH EXP NEUR, V68, P489, DOI 10.1097/NEN.0b013e3181a19a5a; Walhovd KB, 2014, NEUROSCIENCE, V276, P2, DOI 10.1016/j.neuroscience.2014.06.058	22	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148631	10.1371/journal.pone.0148631	http://dx.doi.org/10.1371/journal.pone.0148631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845760	Green Published, Green Submitted, gold			2022-12-27	WOS:000369552800078
J	Hurlburt, RT; Alderson-Day, B; Kuhn, S; Fernyhough, C				Hurlburt, Russell T.; Alderson-Day, Ben; Kuehn, Simone; Fernyhough, Charles			Exploring the Ecological Validity of Thinking on Demand: Neural Correlates of Elicited vs. Spontaneously Occurring Inner Speech	PLOS ONE			English	Article							AUDITORY VERBAL HALLUCINATIONS; IMAGERY; EXPERIENCE; CORTEX; FMRI; SCHIZOPHRENIA; LANGUAGE; BRAIN; ACTIVATIONS; PERCEPTION	Psychology and cognitive neuroscience often use standardized tasks to elicit particular experiences. We explore whether elicited experiences are similar to spontaneous experiences. In an MRI scanner, five participants performed tasks designed to elicit inner speech (covertly repeating experimenter-supplied words), inner seeing, inner hearing, feeling, and sensing. Then, in their natural environments, participants were trained in four days of random-beep-triggered Descriptive Experience Sampling (DES). They subsequently returned to the scanner for nine 25-min resting-state sessions; during each they received four DES beeps and described those moments (9 x 4 = 36 moments per participant) of spontaneously occurring experience. Enough of those moments included spontaneous inner speech to allow us to compare brain activation during spontaneous inner speech with what we had found in task-elicited inner speech. ROI analysis was used to compare activation in two relevant areas (Heschl's gyrus and left inferior frontal gyrus). Task-elicited inner speech was associated with decreased activation in Heschl's gyrus and increased activation in left inferior frontal gyrus. However, spontaneous inner speech had the opposite effect in Heschl's gyrus and no significant effect in left inferior frontal gyrus. This study demonstrates how spontaneous phenomena can be investigated in MRI and calls into question the assumption that task-created phenomena are often neurophysiologically and psychologically similar to spontaneously occurring phenomena.	[Hurlburt, Russell T.] Univ Nevada, Psychol, Las Vegas, NV 89154 USA; [Alderson-Day, Ben; Fernyhough, Charles] Univ Durham, Psychol, Durham, England; [Kuehn, Simone] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany; [Kuehn, Simone] Univ Clin Hamburg Eppendorf, Clin & Policlin Psychiat & Psychotherapy, Hamburg, Germany	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Durham University; Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hurlburt, RT (corresponding author), Univ Nevada, Psychol, Las Vegas, NV 89154 USA.	russ@unlv.nevada.edu	Kuehn, Simone/P-6145-2014; Fernyhough, Charles/A-1057-2010; Hurlburt, Russell/O-6949-2017	Fernyhough, Charles/0000-0002-3822-710X; Hurlburt, Russell/0000-0003-4672-2562; Alderson-Day, Ben/0000-0003-0546-8043; Kuhn, Simone/0000-0001-6823-7969	Max Planck Institute; Wellcome Trust [WT098455, WT103817]	Max Planck Institute(Foundation CELLEX); Wellcome Trust(Wellcome TrustEuropean Commission)	This project was supported by the Max Planck Institute and funded by Wellcome Trust (http://www.wellcome.ac.uk/) grants WT098455 and WT103817 to CF. These institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew ZK, 2013, NEUROIMAGE, V73, P191, DOI 10.1016/j.neuroimage.2012.08.020; Alderson-Day B, 2015, SOC COGN AF IN PRESS; Aleman A, 2005, CEREB CORTEX, V15, P221, DOI 10.1093/cercor/bhh124; Allen P, 2008, NEUROSCI BIOBEHAV R, V32, P175, DOI 10.1016/j.neubiorev.2007.07.012; Baciu MV, 1999, NMR BIOMED, V12, P293, DOI 10.1002/(SICI)1099-1492(199908)12:5<293::AID-NBM573>3.0.CO;2-6; Belardinelli MO, 2009, ACTA PSYCHOL, V132, P190, DOI 10.1016/j.actpsy.2009.06.009; Brett MA, 2002, 2002 8 INT C FUNCT M; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Curio G, 2000, HUM BRAIN MAPP, V9, P183, DOI 10.1002/(SICI)1097-0193(200004)9:4<183::AID-HBM1>3.0.CO;2-Z; Delamillieure P, 2010, BRAIN RES BULL, V81, P565, DOI 10.1016/j.brainresbull.2009.11.014; Diaz BA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00271; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Fegen D, 2015, NEUROIMAGE, V105, P120, DOI 10.1016/j.neuroimage.2014.10.034; Fernyhough C, 2004, NEW IDEAS PSYCHOL, V22, P49, DOI 10.1016/j.newideapsych.2004.09.001; Fernyhough C, 2013, HALLUCINATION: PHILOSOPHY AND PSYCHOLOGY, P87; Fitch WT, 2014, ANN NY ACAD SCI, V1316, P87, DOI 10.1111/nyas.12406; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; Ganis G, 2004, COGNITIVE BRAIN RES, V20, P226, DOI 10.1016/j.cogbrainres.2004.02.012; Geva S, 2011, BRAIN, V134, P3071, DOI 10.1093/brain/awr232; Gorgolewski KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097176; Grush R, 2004, BEHAV BRAIN SCI, V27, P377, DOI 10.1017/S0140525X04000093; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; Heavey CL, 2008, CONSCIOUS COGN, V17, P798, DOI 10.1016/j.concog.2007.12.006; Hoffman RE, 2011, BIOL PSYCHIAT, V69, P407, DOI 10.1016/j.biopsych.2010.09.050; Hurlburt R., 1993, SAMPLING INNER EXPER; Hurlburt R. T., 2007, PROPONENT MEETS SKEP; Hurlburt R. T., 2011, INVESTIGATING PRISTI, P117; Hurlburt R. T., 2006, PHENOMENOL COGN SCI, V5, P271, DOI [10.1075/aicr.64, DOI 10.1007/s11097-006-9024-0, DOI 10.1007/S11097-006-9024-0]; Hurlburt R. T., 1990, SAMPLING NORMAL SCHI; Hurlburt R. T., 2006, EXPLORING INNER EXPE; Hurlburt RT, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01535; Hurlburt RT, 2015, CONSCIOUS COGN, V31, P148, DOI 10.1016/j.concog.2014.11.002; Hurlburt RT, 2013, CONSCIOUS COGN, V22, P1477, DOI 10.1016/j.concog.2013.10.003; Hurlburt RT, 2011, J CONSCIOUSNESS STUD, V18, P206; Hurlburt RT, 2009, J CONSCIOUSNESS STUD, V16, P156; Jardri R, 2011, AM J PSYCHIAT, V168, P73, DOI 10.1176/appi.ajp.2010.09101522; Jones SR, 2007, CLIN PSYCHOL REV, V27, P140, DOI 10.1016/j.cpr.2006.10.001; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Kuhn S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01393; Kuhn S, 2012, SCHIZOPHRENIA BULL, V38, P779, DOI 10.1093/schbul/sbq152; Matthews PM, 2004, J NEUROL NEUROSUR PS, V75, P6; McGuire PK, 1996, PSYCHOL MED, V26, P29, DOI 10.1017/S0033291700033699; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paus T, 1996, EUR J NEUROSCI, V8, P2236, DOI 10.1111/j.1460-9568.1996.tb01187.x; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Schwitzgebel E, 2011, J CONSCIOUSNESS STUD, V18, P288; Shergill SS, 2002, HUM BRAIN MAPP, V16, P219, DOI 10.1002/hbm.10046; Shergill SS, 2001, PSYCHOL MED, V31, P241, DOI 10.1017/S003329170100335X; Shergill SS, 2000, ARCH GEN PSYCHIAT, V57, P1033, DOI 10.1001/archpsyc.57.11.1033; Simons CJP, 2010, BIOL PSYCHIAT, V67, P232, DOI 10.1016/j.biopsych.2009.09.007; Tian X, 2013, J COGNITIVE NEUROSCI, V25, P1020, DOI 10.1162/jocn_a_00381; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Zatorre RJ, 2005, NEURON, V47, P9, DOI 10.1016/j.neuron.2005.06.013	54	44	46	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147932	10.1371/journal.pone.0147932	http://dx.doi.org/10.1371/journal.pone.0147932			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PF	26845028	Green Published, Green Accepted, gold			2022-12-27	WOS:000369552800022
J	McShane, A; Hok, E; Tomberlin, J; Eriani, G; Geslain, R				McShane, Ariel; Hok, Eveline; Tomberlin, Jensen; Eriani, Gilbert; Geslain, Renaud			The Enzymatic Paradox of Yeast Arginyl-tRNA Synthetase: Exclusive Arginine Transfer Controlled by a Flexible Mechanism of tRNA Recognition	PLOS ONE			English	Article							AMINOACYL-TRANSFER-RNAS; IDENTITY ELEMENTS; ANTICODON LOOP; GENETIC-CODE; IN-VIVO; DETERMINANTS; TRANSCRIPTS; PROMOTER; ACCEPTOR; BINDING	Identity determinants are essential for the accurate recognition of transfer RNAs by aminoacyl-tRNA synthetases. To date, arginine determinants in the yeast Saccharomyces cerevisiae have been identified exclusively in vitro and only on a limited number of tRNA Arginine isoacceptors. In the current study, we favor a full cellular approach and expand the investigation of arginine determinants to all four tRNA Arg isoacceptors. More precisely, this work scrutinizes the relevance of the tRNA nucleotides at position 20, 35 and 36 in the yeast arginylation reaction. We built 21 mutants by site-directed mutagenesis and tested their functionality in YAL5, a previously engineered yeast knockout deficient for the expression of tRNA Arg CCG. Arginylation levels were also monitored using Northern blot. Our data collected in vivo correlate with previous observations. C35 is the prominent arginine determinant followed by G36 or U36 (G/U36). In addition, although there is no major arginine determinant in the D loop, the recognition of tRNA Arg ICG relies to some extent on the nucleotide at position 20. This work refines the existing model for tRNA Arg recognition. Our observations indicate that yeast Arginyl-tRNA synthetase (yArgRS) relies on distinct mechanisms to aminoacylate the four isoacceptors. Finally, according to our refined model, yArgRS is able to accommodate tRNA Arg scaffolds presenting N34, C/G35 and G/A/U36 anticodons while maintaining specificity. We discuss the mechanistic and potential physiological implications of these findings.	[McShane, Ariel; Hok, Eveline; Tomberlin, Jensen; Geslain, Renaud] Coll Charleston, Dept Biol, Lab tRNA Biol, Charleston, SC 29424 USA; [Eriani, Gilbert] Univ Strasbourg, Inst Biol Mol & Cellulaire, CNRS, Architecture & Reactivite ARN, 15 Rue Rene Descartes, F-67084 Strasbourg, France	College of Charleston; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Geslain, R (corresponding author), Coll Charleston, Dept Biol, Lab tRNA Biol, Charleston, SC 29424 USA.	geslainr@cofc.edu		Eriani, Gilbert/0000-0002-8518-4675; McShane, Ariel/0000-0003-3281-1302	SC INBRE grant from the National Institute of General Medical Science - NIH [P20GM103499]; Centre National de la Recherche Scientifique [ANR11SVSE8-025-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103499] Funding Source: NIH RePORTER	SC INBRE grant from the National Institute of General Medical Science - NIH; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a SC INBRE grant from the National Institute of General Medical Science - NIH (P20GM103499 to Renaud Geslain) and a grant from the Centre National de la Recherche Scientifique (ANR11SVSE8-025-01 to Gilbert Eriani).	ACHSEL T, 1993, EMBO J, V12, P3333, DOI 10.1002/j.1460-2075.1993.tb06003.x; ASAHARA H, 1994, J MOL BIOL, V236, P738, DOI 10.1006/jmbi.1994.1186; Cantara WA, 2012, J MOL BIOL, V416, P579, DOI 10.1016/j.jmb.2011.12.054; Delagoutte B, 2000, EMBO J, V19, P5599, DOI 10.1093/emboj/19.21.5599; Eriani G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130042; Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5; Fender A, 2004, NUCLEIC ACIDS RES, V32, P5076, DOI 10.1093/nar/gkh843; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; GALLI G, 1981, NATURE, V294, P626, DOI 10.1038/294626a0; Geslain R, 2003, NUCLEIC ACIDS RES, V31, P4729, DOI 10.1093/nar/gkg685; Geslain R, 2000, RNA, V6, P434, DOI 10.1017/S1355838200992331; Geslain R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1083; Geslain R, 2010, J MOL BIOL, V396, P821, DOI 10.1016/j.jmb.2009.12.018; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Giege R, 2012, WIRES RNA, V3, P37, DOI 10.1002/wrna.103; Guigou L, 2005, BIOCHEMISTRY-US, V44, P16540, DOI 10.1021/bi051575h; Hendrickson TL, 2001, P NATL ACAD SCI USA, V98, P13473, DOI 10.1073/pnas.251549298; Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Khatter H, 2015, NATURE, V520, P640, DOI 10.1038/nature14427; Kiga D, 2001, EUR J BIOCHEM, V268, P6207, DOI 10.1046/j.0014-2956.2001.02570.x; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; MCCLAIN WH, 1988, SCIENCE, V241, P1804, DOI 10.1126/science.2459773; NAMEKI N, 1995, NUCLEIC ACIDS RES, V23, P2831, DOI 10.1093/nar/23.15.2831; SCHULMAN LH, 1989, SCIENCE, V246, P1595, DOI 10.1126/science.2688091; Senger B, 1997, BIOCHEMISTRY-US, V36, P8269, DOI 10.1021/bi970206l; Sissler M, 1996, EMBO J, V15, P5069, DOI 10.1002/j.1460-2075.1996.tb00887.x; Soma A, 1999, J MOL BIOL, V293, P1029, DOI 10.1006/jmbi.1999.3219; TAMURA K, 1992, NUCLEIC ACIDS RES, V20, P2335, DOI 10.1093/nar/20.9.2335; Tamura T, 1992, Nucleic Acids Symp Ser, P143; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Yao YN, 2004, BIOCHEM BIOPH RES CO, V313, P129, DOI 10.1016/j.bbrc.2003.11.107; YESLAND KD, 1993, NUCLEIC ACIDS RES, V21, P5079, DOI 10.1093/nar/21.22.5079	34	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148460	10.1371/journal.pone.0148460	http://dx.doi.org/10.1371/journal.pone.0148460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844776	Green Published, gold, Green Submitted			2022-12-27	WOS:000369552800060
J	Sonakowska, L; Wlodarczyk, A; Wilczek, G; Wilczek, P; Student, S; Rost-Roszkowska, MM				Sonakowska, Lidia; Wlodarczyk, Agnieszka; Wilczek, Grazyna; Wilczek, Piotr; Student, Sebastian; Rost-Roszkowska, Magdalena Maria			Cell Death in the Epithelia of the Intestine and Hepatopancreas in Neocaridina heteropoda (Crustacea, Malacostraca)	PLOS ONE			English	Article							PALAEMONETES-ARGENTINUS CRUSTACEA; PENAEUS-SEMISULCATUS CRUSTACEA; MIDGUT EPITHELIUM; FUNCTIONAL CYTOLOGY; AUTOPHAGY; APOPTOSIS; MITOCHONDRIAL; DECAPODA; HISTOLOGY; CARIDEA	The endodermal region of the digestive system in the freshwater shrimp Neocaridina heteropoda (Crustacea, Malacostraca) consists of a tube-shaped intestine and large hepatopancreas, which is formed by numerous blind-ended tubules. The precise structure and ultrastructure of these regions were presented in our previous studies, while here we focused on the cell death processes and their effect on the functioning of the midgut. We used transmission electron microscopy, light and confocal microscopes to describe and detect cell death, while a quantitative assessment of cells with depolarized mitochondria helped us to establish whether there is the relationship between cell death and the inactivation of mitochondria. Three types of the cell death were observed in the intestine and hepatopancreas-apoptosis, necrosis and autophagy. No differences were observed in the course of these processes in males and females and or in the intestine and hepatopancreas of the shrimp that were examined. Our studies revealed that apoptosis, necrosis and autophagy only involves the fully developed cells of the midgut epithelium that have contact with the midgut lumen-D-cells in the intestine and B-and F-cells in hepatopancreas, while E-cells (midgut stem cells) did not die. A distinct correlation between the accumulation of E-cells and the activation of apoptosis was detected in the anterior region of the intestine, while necrosis was an accidental process. Degenerating organelles, mainly mitochondria were neutralized and eventually, the activation of cell death was prevented in the entire epithelium due to autophagy. Therefore, we state that autophagy plays a role of the survival factor.	[Sonakowska, Lidia; Wlodarczyk, Agnieszka; Rost-Roszkowska, Magdalena Maria] Univ Silesia, Dept Anim Histol & Embryol, Bankowa 9, PL-40007 Katowice, Poland; [Wilczek, Grazyna] Univ Silesia, Dept Anim Physiol & Ecotoxicol, Bankowa 9, PL-40007 Katowice, Poland; [Wilczek, Piotr] Heart Prosthesis Inst, Bioengn Lab, Wolnosci 345a, PL-41800 Zabrze, Poland; [Student, Sebastian] Silesian Tech Univ, Fac Automat Control Elect & Comp Sci, Akad 16, PL-44100 Gliwice, Poland	University of Silesia in Katowice; University of Silesia in Katowice; Silesian University of Technology	Rost-Roszkowska, MM (corresponding author), Univ Silesia, Dept Anim Histol & Embryol, Bankowa 9, PL-40007 Katowice, Poland.	magdalena.rost-roszkowska@us.edu.pl	Student, Sebastian/H-7895-2013; Rost-Roszkowska, Magdalena/AAM-7005-2020	Student, Sebastian/0000-0003-1812-5496; Wilczek, Piotr/0000-0002-4968-6512; Wilczek, Grazyna/0000-0002-3276-0333; Wlodarczyk, Agnieszka/0000-0002-2374-4892; Rost-Roszkowska, Magdalena/0000-0001-7124-8423	GCONiI-Upper-Silesian Center for Scientific Computation [POIG.02.03.01-24-099/13]	GCONiI-Upper-Silesian Center for Scientific Computation	This work was performed using the infrastructure supported by POIG.02.03.01-24-099/13 grant: "GCONiI-Upper-Silesian Center for Scientific Computation".	ALMOHANNA SY, 1989, MAR BIOL, V101, P535, DOI 10.1007/BF00541656; ALMOHANNA SY, 1986, J MAR BIOL ASSOC UK, V66, P403, DOI 10.1017/S0025315400043034; ARNAUD J, 1978, CELL TISSUE RES, V187, P333; Ceccaldi H.J., 1989, AQUACULTURE, V9, P243, DOI DOI 10.1007/S00248-011-9936-2; Diaz AC, 2010, BRAZ ARCH BIOL TECHN, V53, P599, DOI 10.1590/S1516-89132010000300013; Cuartas Elena Irene, 2003, Biociencias (Porto Alegre), V11, P53; Fernandez-Checa JC, 2003, BIOCHEM BIOPH RES CO, V304, P471, DOI 10.1016/S0006-291X(03)00619-3; Franzetti E, 2012, APOPTOSIS, V17, P305, DOI 10.1007/s10495-011-0675-0; Garcia JJ, 2001, IN VITRO CELL DEV-AN, V37, P353, DOI 10.1290/1071-2690(2001)037<0353:PACMCC>2.0.CO;2; Guimaraes CA, 2004, EUR J BIOCHEM, V271, P1638, DOI 10.1111/j.1432-1033.2004.04084.x; Jain MV, 2013, J CELL MOL MED, V17, P12, DOI 10.1111/jcmm.12001; Karasov WH, 2011, ANNU REV PHYSIOL, V73, P69, DOI 10.1146/annurev-physiol-012110-142152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; LIGHTNER DV, 1994, AQUACULTURE, V122, P9, DOI 10.1016/0044-8486(94)90329-8; Lipovsek S, 2016, PROTOPLASMA, V253, P457, DOI 10.1007/s00709-015-0824-3; Lipovsek S, 2015, ARTHROPOD STRUCT DEV, V44, P131, DOI 10.1016/j.asd.2014.12.002; Lipovsek S, 2014, ARTHROPOD STRUCT DEV, V43, P493, DOI 10.1016/j.asd.2014.06.001; Lockshin RA, 2002, CURR OPIN CELL BIOL, V14, P727, DOI 10.1016/S0955-0674(02)00383-6; Maghsoudi N., 2012, Experimental Oncology, V34, P146; MAJNO G, 1995, AM J PATHOL, V146, P3; Malagoli D, 2010, AUTOPHAGY, V6, P575, DOI 10.4161/auto.6.5.11962; Martin LJ, 2010, PHARMACEUTICALS, V3, P839, DOI 10.3390/ph3040839; Masson I., 2001, THESIS; Menze MA, 2010, APOPTOSIS, V15, P293, DOI 10.1007/s10495-009-0443-6; Mijaljica D, 2012, INT J MOL SCI, V13, P3618, DOI 10.3390/ijms13033618; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Nicholls DG, 2002, INT J BIOCHEM CELL B, V34, P1372, DOI 10.1016/S1357-2725(02)00077-8; Orrenius S, 2004, TOXICOL LETT, V149, P19, DOI 10.1016/j.toxlet.2003.12.017; Park YE, 2009, AUTOPHAGY, V5, P795, DOI 10.4161/auto.8901; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Rost MM, 2006, ARTHROPOD STRUCT DEV, V35, P69, DOI 10.1016/j.asd.2005.10.001; Rost-Roszkowska MM, 2015, MICRON, V68, P130, DOI 10.1016/j.micron.2014.10.003; Rost-Roszkowska MM, 2012, ARTHROPOD STRUCT DEV, V41, P271, DOI 10.1016/j.asd.2012.01.001; Rost-Roszkowska MM, 2010, TISSUE CELL, V42, P24, DOI 10.1016/j.tice.2009.06.003; Rost-Roszkowska MM, 2008, CAN J ZOOL, V86, P1179, DOI 10.1139/Z08-096; Saleh AM, 2003, TOXICOL APPL PHARM, V190, P47, DOI 10.1016/S0041-008X(03)00126-1; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Sonakowska L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126900; Sousa LG, 2007, REV BIOL TROP, V55, P79; Sousa LG, 2001, BIOCELL, V25, P275; Sousa LG, 2000, BIOCELL, V24, P189; Sousa L, 2006, BIOCELL, V30, P287; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Teixeira AD, 2013, ARTHROPOD STRUCT DEV, V42, P237, DOI 10.1016/j.asd.2013.02.004; TRUMP BF, 1981, CELL DEATH BIOL PATH, P209; Urbanek A, 2015, MICRON, V69, P25, DOI 10.1016/j.micron.2014.11.003; Vaidyanathan R, 2006, APOPTOSIS, V11, P1643, DOI 10.1007/s10495-006-8783-y; VOGT G, 1994, AQUAT TOXICOL, V28, P223, DOI 10.1016/0166-445X(94)90035-3; VOGT G, 1990, DIS AQUAT ORGAN, V9, P45, DOI 10.3354/dao009045; Wang Y, 2004, J CELL SCI, V117, P1525, DOI 10.1242/jcs.00994; Wertz IE, 1996, TRENDS BIOCHEM SCI, V21, P359, DOI 10.1016/0968-0004(96)40002-0; Wilczek G, 2014, ECOTOX ENVIRON SAFE, V101, P157, DOI 10.1016/j.ecoenv.2013.09.034; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zakeri Z, 2002, J IMMUNOL METHODS, V265, P3, DOI 10.1016/S0022-1759(02)00067-4	59	28	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147582	10.1371/journal.pone.0147582	http://dx.doi.org/10.1371/journal.pone.0147582			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844766	Green Published, gold, Green Submitted			2022-12-27	WOS:000369552800010
J	Gong, HX; Zhang, KB; Wu, LM; Baigorri, BF; Yin, Y; Geng, XC; Xu, JR; Zhu, J				Gong, Hong-xia; Zhang, Ke-bei; Wu, Lian-ming; Baigorri, Brian F.; Yin, Yan; Geng, Xiao-chuan; Xu, Jian-Rong; Zhu, Jiong			Dual Energy Spectral CT Imaging for Colorectal Cancer Grading: A Preliminary Study	PLOS ONE			English	Article							TUMOR ANGIOGENESIS; COMPUTED-TOMOGRAPHY; LIVER METASTASES; BREAST-LESIONS; COLON-CANCER; CARCINOMA; INVOLVEMENT; RECURRENCE; STRATEGIES; ONCOLOGY	Objectives To assess the diagnostic value of dual energy spectral CT imaging for colorectal cancer grading using the quantitative iodine density measurements in both arterial phase (AP) and venous phase (VP). Methods 81 colorectal cancer patients were divided into two groups based on their pathological findings: a low grade group including well (n = 13) and moderately differentiated cancer (n = 24), and a high grade group including poorly differentiated (n = 42) and signet ring cell cancer (n = 2). Iodine density (ID) in the lesions was derived from the iodine-based material decomposition (MD) image and normalized to that in the psoas muscle to obtain normalized iodine density (NID). The difference in ID and NID between AP and VP was calculated. Results The ID and NID values of the low grade cancer group were, 14.65 +/- 3.38mg/mL and 1.70 +/- 0.33 in AP, and 21.90 +/- 3.11mg/mL and 2.05 +/- 0.32 in VP, respectively. The ID and NID values for the high grade cancer group were 20.63 +/- 3.72mg/mL and 2.95 +/- 0.72 in AP, and 26.27 +/- 3.10mg/mL and 3.51 +/- 1.12 in VP, respectively. There was significant difference for ID and NID between the low grade and high grade cancer groups in both AP and VP (all p< 0.001). ROC analysis indicated that NID of 1.92 in AP provided 70.3% sensitivity and 97.7% specificity in differentiating low grade cancer from high grade cancer. Conclusions The quantitative measurement of iodine density in AP and VP can provide useful information to differentiate low grade colorectal cancer from high grade colorectal cancer with NID in AP providing the greatest diagnostic value.	[Gong, Hong-xia; Zhang, Ke-bei; Wu, Lian-ming; Yin, Yan; Geng, Xiao-chuan; Xu, Jian-Rong; Zhu, Jiong] Shanghai Jiao Tong Univ, Sch Med, Dept Radiol, Renji Hosp, Shanghai 200127, Peoples R China; [Baigorri, Brian F.] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27516 USA	Shanghai Jiao Tong University; University of North Carolina; University of North Carolina Chapel Hill	Xu, JR; Zhu, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Radiol, Renji Hosp, Shanghai 200127, Peoples R China.	xujianr@yeah.net; jiongzhurenji@126.com			National Basic Research Program of China [2012CB932600]; Shanghai Leading Academic Discipline Project [S30203]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This study was supported by the National Basic Research Program of China (no. 2012CB932600) and Shanghai Leading Academic Discipline Project (no. S30203).; Thanks for Dr. Li Jianying's technical support in understanding spectral CT imaging and in editing the manuscript. This study was supported by the National Basic Research Program of China (no. 2012CB932600) and Shanghai Leading Academic Discipline Project (no. S30203).	Ahsan H, 1998, ANN INTERN MED, V128, P900, DOI 10.7326/0003-4819-128-11-199806010-00006; Bipat S, 2004, RADIOLOGY, V232, P773, DOI 10.1148/radiol.2323031368; BOSSI P, 1995, CANCER RES, V55, P5049; Choi HJ, 1998, ONCOLOGY-BASEL, V55, P575, DOI 10.1159/000011915; Diculescu Mircea, 2002, Rom J Gastroenterol, V11, P183; Elmas N, 2002, EUR J RADIOL, V42, P206, DOI 10.1016/S0720-048X(02)00036-0; Engel CJ, 1996, AM J SURG PATHOL, V20, P1260, DOI 10.1097/00000478-199610000-00012; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Furman-Haran E, 2005, CANCER-AM CANCER SOC, V104, P708, DOI 10.1002/cncr.21225; Geyer LL, 2012, EUR J RADIOL, V81, P3711, DOI 10.1016/j.ejrad.2011.02.043; Gollub MJ, 2007, RADIOL CLIN N AM, V45, P85, DOI 10.1016/j.rcl.2006.10.003; Hamilton SR, 2000, WHO CLASSIFICATION T; Hayashi M, 1999, AM J ROENTGENOL, V172, P969, DOI 10.2214/ajr.172.4.10587130; Hugh TJ, 1997, SURG ONCOL, V6, P19, DOI 10.1016/S0960-7404(97)00002-9; Iyer RB, 2002, AM J ROENTGENOL, V179, P3, DOI 10.2214/ajr.179.1.1790003; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Lennon AM, 2003, AM J CLIN PATHOL, V119, P108, DOI 10.1309/J6BDTWM2M792TN2V; Li M, 2012, INVEST RADIOL, V47, P58, DOI 10.1097/RLI.0b013e318229fef3; Maruyama M, 2014, ACTA RADIOL; Paparo F, 2013, EUR J RADIOL, V82, pE1, DOI 10.1016/j.ejrad.2012.08.021; Poston GJ, 2004, SURG ONCOL, V13, P125, DOI 10.1016/j.suronc.2004.08.001; SACLARIDES TJ, 1994, DIS COLON RECTUM, V37, P921, DOI 10.1007/BF02052599; Smith NJ, 2007, BRIT J CANCER, V96, P1030, DOI 10.1038/sj.bjc.6603646; Smith RA, 2003, CA-CANCER J CLIN, V53, P27, DOI 10.3322/canjclin.53.1.27; Soyer P, 2012, ABDOM IMAGING, V37, P1092, DOI 10.1007/s00261-012-9844-z; Teifke A, 2006, RADIOLOGY, V239, P351, DOI 10.1148/radiol.2392050205; Walsh JME, 2003, JAMA-J AM MED ASSOC, V289, P1288, DOI 10.1001/jama.289.10.1288; Wang Zhong-qiu, 2003, Zhonghua Yi Xue Za Zhi, V83, P1882; Zerhouni EA, 1996, RADIOLOGY, V200, P443, DOI 10.1148/radiology.200.2.8685340	29	16	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0147756	10.1371/journal.pone.0147756	http://dx.doi.org/10.1371/journal.pone.0147756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859405	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400013
J	Milic, NM; Trajkovic, GZ; Bukumiric, ZM; Cirkovic, A; Nikolic, IM; Milin, JS; Milic, NV; Savic, MD; Corac, AM; Marinkovic, JM; Stanisavljevic, DM				Milic, Natasa M.; Trajkovic, Goran Z.; Bukumiric, Zoran M.; Cirkovic, Andja; Nikolic, Ivan M.; Milin, Jelena S.; Milic, Nikola V.; Savic, Marko D.; Corac, Aleksandar M.; Marinkovic, Jelena M.; Stanisavljevic, Dejana M.			Improving Education in Medical Statistics: Implementing a Blended Learning Model in the Existing Curriculum	PLOS ONE			English	Article							STUDENT OUTCOMES; ONLINE; INTERNET; BIOSTATISTICS; INSTRUCTION; EFFICACY; SCHOOL	Background Although recent studies report on the benefits of blended learning in improving medical student education, there is still no empirical evidence on the relative effectiveness of blended over traditional learning approaches in medical statistics. We implemented blended along with on-site (i.e. face-to-face) learning to further assess the potential value of web-based learning in medical statistics. Methods This was a prospective study conducted with third year medical undergraduate students attending the Faculty of Medicine, University of Belgrade, who passed (440 of 545) the final exam of the obligatory introductory statistics course during 2013-14. Student statistics achievements were stratified based on the two methods of education delivery: blended learning and on-site learning. Blended learning included a combination of face-to-face and distance learning methodologies integrated into a single course. Results Mean exam scores for the blended learning student group were higher than for the on-site student group for both final statistics score (89.36 +/- 6.60 vs. 86.06 +/- 8.48; p = 0.001) and knowledge test score (7.88 +/- 1.30 vs. 7.51 +/- 1.36; p = 0.023) with a medium effect size. There were no differences in sex or study duration between the groups. Current grade point average (GPA) was higher in the blended group. In a multivariable regression model, current GPA and knowledge test scores were associated with the final statistics score after adjusting for study duration and learning modality (p<0.001). Conclusion This study provides empirical evidence to support educator decisions to implement different learning environments for teaching medical statistics to undergraduate medical students. Blended and on-site training formats led to similar knowledge acquisition; however, students with higher GPA preferred the technology assisted learning format. Implementation of blended learning approaches can be considered an attractive, cost-effective, and efficient alternative to traditional classroom training in medical statistics.	[Milic, Natasa M.; Trajkovic, Goran Z.; Bukumiric, Zoran M.; Cirkovic, Andja; Nikolic, Ivan M.; Milin, Jelena S.; Milic, Nikola V.; Savic, Marko D.; Marinkovic, Jelena M.; Stanisavljevic, Dejana M.] Univ Belgrade, Inst Med Stat & Informat, Fac Med, Belgrade, Serbia; [Corac, Aleksandar M.] Univ Pristina, Fac Med, Dept Publ Hlth, Kosovska Mitrovica, Serbia	University of Belgrade; Universiteti i Prishtines	Milic, NM (corresponding author), Univ Belgrade, Inst Med Stat & Informat, Fac Med, Belgrade, Serbia.	Milic.Natasa@mayo.edu		Milin Lazovic, Jelena/0000-0002-4655-2383; Cirkovic, Andja/0000-0002-7542-5690; Marinkovic, Jelena/0000-0001-8852-384X	Ministry of Education, Science and Technological Development of the Republic of Serbia [37016]	Ministry of Education, Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This study was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (project No. 37016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-37; Anderson K, 2010, J ACAD LIBR, V36, P495, DOI 10.1016/j.acalib.2010.08.005; [Anonymous], 2011, EUR J DENT EDUC, V15, P110, DOI 10.1111/j.1600-0579.2010.00651.x; [Anonymous], 2008, BLENDED LEARNING HIG; Baldwin CD, 2001, ACAD MED, V76, P549, DOI 10.1097/00001888-200105000-00093; Bernardo V, 2004, INT J MED INFORM, V73, P731, DOI 10.1016/j.ijmedinf.2004.06.002; Chew E, 2008, EDUC TECHNOL SOC, V11, P344; Chumley-Jones HS, 2002, ACAD MED, V77, pS86, DOI 10.1097/00001888-200210001-00028; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cook DA, 2008, JAMA-J AM MED ASSOC, V300, P1181, DOI 10.1001/jama.300.10.1181; D'Alessandro Donna M, 2004, BMC Med Educ, V4, P10, DOI 10.1186/1472-6920-4-10; Delialioglu O, 2008, COMPUT EDUC, V51, P474, DOI 10.1016/j.compedu.2007.06.006; Dowling C. l. Godfrey J. M. Gyles N, 2003, ACCOUNT EDUC, V12, P373, DOI [DOI 10.1080/0963928032000154512, https://doi.org/10.1080/0963928032000154512, 10.1080/0963928032000154512]; Fieschi M, 2002, MED INFORM INTERNET, V27, P1, DOI 10.1080/14639230110105301; Fordis M, 2005, JAMA-J AM MED ASSOC, V294, P1043, DOI 10.1001/jama.294.9.1043; Harden RM, 2002, MED TEACH, V24, P261, DOI 10.1080/01421590220141008; Hui W, 2008, J COMPUT ASSIST LEAR, V24, P245, DOI [10.1111/j.1365-2729.2007.00257.x, 10.1111/J.1365-2729.2007.00257.X]; Kaelber DC, 2001, ACAD MED, V76, P548, DOI 10.1097/00001888-200105000-00092; Kiviniemi MT, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-47; Larson DK., 2009, J ASYNCHRONOUS LEARN, V13, P31, DOI DOI 10.24059/OLJ.V13I1.1675; Lewin LO, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-33; Lim J., 2008, J INSTRUCTIONAL PSYC, V35, P113; McGready J, 2013, PREV MED, V56, P142, DOI 10.1016/j.ypmed.2012.11.020; Means B, 2013, TEACH COLL REC, V115; Onwuegbuzie A. J., 2000, ASSESS EVAL HIGH EDU, V25, P321, DOI [DOI 10.1080/713611437, 10.1080/713611437]; Osguthorpe RT., 2003, Q REV DISTANCE ED, V4, P227; Pereira JA, 2007, MED EDUC, V41, P189, DOI 10.1111/j.1365-2929.2006.02672.x; Shaffer K, 2004, ACAD RADIOL, V11, P1059, DOI 10.1016/j.acra.2004.05.018; Smucny J, 2004, FAM MED, V36, P622; So HJ, 2008, COMPUT EDUC, V51, P318, DOI 10.1016/j.compedu.2007.05.009; Solimeno A, 2008, COMPUT EDUC, V51, P109, DOI 10.1016/j.compedu.2007.04.003; Stanisavljevic D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112567; Weissgerber TL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002128; Windish DM, 2007, JAMA-J AM MED ASSOC, V298, P1010, DOI 10.1001/jama.298.9.1010; Xu D, 2011, ONLINE HYBRID COURSE; Xu YJ, 2008, J ED ONLINE, V5; Zebrack JR, 2005, J GEN INTERN MED, V20, P68, DOI 10.1111/j.1525-1497.2005.40062.x	37	19	21	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148882	10.1371/journal.pone.0148882	http://dx.doi.org/10.1371/journal.pone.0148882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859832	gold, Green Published			2022-12-27	WOS:000370038400099
J	Mortensen, JL; Reed, JM				Mortensen, Jennifer L.; Reed, J. Michael			Population Viability and Vital Rate Sensitivity of an Endangered Avian Cooperative Breeder, the White-Breasted Thrasher (Ramphocinclus brachyurus)	PLOS ONE			English	Article							RED-COCKADED WOODPECKERS; LIFE-HISTORY TRAITS; SIMULATION-MODEL; DYNAMICS; SURVIVAL; DISPERSAL; CONSEQUENCES; PREDICTIONS; DEMOGRAPHY; LANDSCAPE	Social behaviors can significantly affect population viability, and some behaviors might reduce extinction risk. We used population viability analysis to evaluate effects of past and proposed habitat loss on the White-breasted Thrasher (Ramphocinclus brachyurus), a cooperatively breeding songbird with a global population size of <2000 individuals. We used an individual-based approach to build the first demographic population projection model for this endangered species, parameterizing the model with data from eight years of field study before and after habitat loss within the stronghold of the species' distribution. The recent habitat loss resulted in an approximately 18% predicted decline in population size; this estimate was mirrored by a separate assessment using occupancy data. When mortality rates remained close to the pre-habitat loss estimate, quasi-extinction probability was low under extant habitat area, but increased with habitat loss expected after current plans for resort construction are completed. Post-habitat loss mortality rate estimates were too high for projected populations to persist. Vital rate sensitivity analyses indicated that population growth rate and population persistence were most sensitive to juvenile mortality. However, observed values for adult mortality were closest to the threshold value above which populations would crash. Adult mortality, already relatively low, may have the least capacity to change compared to other vital rates, whereas juvenile mortality may have the most capacity for improvement. Results suggest that improving mortality estimates and determining the cause(s) of juvenile mortality should be research priorities. Despite predictions that aspects of cooperative systems may result in variation in reproduction or juvenile mortality being the most sensitive vital rates, adult mortality was the most sensitive in half of the demographic models of other avian cooperative breeders. Interestingly, vital rate sensitivity differed by model type. However, studies that explicitly modeled the species' cooperative breeding system found reproduction to be the most sensitive rate.	[Mortensen, Jennifer L.; Reed, J. Michael] Tufts Univ, Dept Biol, Medford, MA USA	Tufts University	Mortensen, JL (corresponding author), Tufts Univ, Dept Biol, Medford, MA USA.	mortejen@gmail.com		Mortensen, Jennifer/0000-0001-9162-7033	P.E.O. Scholar Award; Tufts University Faculty Research Award	P.E.O. Scholar Award; Tufts University Faculty Research Award	This research was partially supported by a P.E.O. Scholar Award to JLM (http://www.peointernational.org/about-peo-scholar-awards-psa). Publication costs were supported by a Tufts University Faculty Research Award to JMR (http://ase.tufts.edu/faculty/awards/frac/Application.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya HR, 2001, SCI TOTAL ENVIRON, V274, P283, DOI 10.1016/S0048-9697(01)00750-1; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Andrews AJ, 2007, SPATIAL TEMPORAL VAR; Colomer MA, 2011, ECOL MODEL, V222, P33, DOI 10.1016/j.ecolmodel.2010.09.012; [Anonymous], 2014, R LANG ENV STAT COMP; Anthony D, 2008, IMPORTANT BIRD AREAS; ASKINS RA, 1991, BIOTROPICA, V23, P481, DOI 10.2307/2388270; Beauchamp G, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0844; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Beissinger SR, 2014, PEERJ, V2, DOI 10.7717/peerj.549; BirdLife International, 2008, STAT WORLDS BIRDS IN; BirdLife International, 2015, SPEC FACTSH RAMPH BR; BOYCE MS, 1992, ANNU REV ECOL SYST, V23, P481, DOI 10.1146/annurev.es.23.110192.002405; Breininger DR, 1999, WILDLIFE SOC B, V27, P810; Brook Barry W., 1997, Pacific Conservation Biology, V3, P125; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; Brown J.L., 1987, HELPING COMMUNAL BRE; CASWELL H, 1978, THEOR POPUL BIOL, V14, P215, DOI 10.1016/0040-5809(78)90025-4; Caswell H, 1989, MATRIX POPULATION MO; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Clark ME, 2007, ECOL MODEL, V209, P110, DOI 10.1016/j.ecolmodel.2007.06.008; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Cooper CB, 2002, ECOL APPL, V12, P1576, DOI 10.1890/1051-0761(2002)012[1576:LPADSS]2.0.CO;2; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Coutts SR, 2014, POPUL ECOL, V56, P7, DOI 10.1007/s10144-013-0422-1; Cross PC, 2001, CONSERV BIOL, V15, P1335, DOI 10.1046/j.1523-1739.2001.00031.x; CURRY RL, 1989, J ANIM ECOL, V58, P441, DOI 10.2307/4841; Duca C, 2009, BIOL CONSERV, V142, P563, DOI 10.1016/j.biocon.2008.11.010; Ernest P, 2005, PRASLIN BAY RESORT S; Faaborg J, 1995, AUK, V112, P503, DOI 10.2307/4088741; Fagan WF, 2006, ECOL LETT, V9, P51, DOI 10.1111/j.1461-0248.2005.00845.x; Fefferman NH, 2006, J WILDLIFE MANAGE, V70, P649, DOI 10.2193/0022-541X(2006)70[649:AVRSAF]2.0.CO;2; Felix ML, 2014, GOJ BLAN PLAN ACTION; Ferrer M, 2013, BIOL CONSERV, V159, P32, DOI 10.1016/j.biocon.2012.10.011; Fox J., 2019, R COMPANION APPL REG, V.; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Gerber LR, 2006, FRONT ECOL ENVIRON, V4, P419, DOI 10.1890/1540-9295(2006)4[419:IBDIDM]2.0.CO;2; Gonzalez-Suarez M, 2008, CONSERV BIOL, V22, P1608, DOI 10.1111/j.1523-1739.2008.00995.x; Goutte A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3313; Graveson R, 2003, 3 FCG INT LTD; Grimm V, 2005, CONSERV BIOL, V19, P578, DOI 10.1111/j.1523-1739.2005.000163.x; Hambler C, 2011, BIOL CONSERV, V144, P713, DOI 10.1016/j.biocon.2010.09.004; He FL, 2012, ECOLOGY, V93, P974, DOI 10.1890/11-1786.1; Henle K, 2004, BIODIVERS CONSERV, V13, P9, DOI 10.1023/B:BIOC.0000004312.41575.83; HEPPELL SS, 1994, J WILDLIFE MANAGE, V58, P479, DOI 10.2307/3809319; Johnston JP, 1997, AM NAT, V150, P771, DOI 10.1086/286093; Kesler DC, 2007, BIOL CONSERV, V136, P520, DOI 10.1016/j.biocon.2006.12.023; Lacy R.C., 2014, VORTEX STOCHASTIC SI; LACY RC, 1993, WILDLIFE RES, V20, P45, DOI 10.1071/WR9930045; Lacy RC, 2012, VORTEX STOCHASTIC SI; Lacy Robert C., 2000, Ecological Bulletins, V48, P39; Letcher BH, 1998, BIOL CONSERV, V86, P1, DOI 10.1016/S0006-3207(98)00019-6; Lopez-Lopez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037862; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; MAGUIRE LA, 1995, J WILDLIFE MANAGE, V59, P533, DOI 10.2307/3802460; MCCARTHY MA, 1995, BIOL CONSERV, V73, P93, DOI 10.1016/0006-3207(95)00046-7; McCarthy MA, 1996, ECOL MODEL, V85, P151, DOI 10.1016/0304-3800(94)00191-X; McCarthy MA, 2003, CONSERV BIOL, V17, P982, DOI 10.1046/j.1523-1739.2003.01570.x; Miller PS., 2005, VORTEX STOCHASTIC SI; Morris W. F., 2002, QUANTITATIVE CONSERV; Mortensen J, 2009, SHORT TERM BEHAV DEM; O'Grady JJ, 2008, ANIM CONSERV, V11, P442, DOI 10.1111/j.1469-1795.2008.00201.x; Oborny B, 2005, OIKOS, V109, P291; Pe'er G, 2013, CONSERV BIOL, V27, P644, DOI 10.1111/cobi.12076; Pfister CA, 1998, P NATL ACAD SCI USA, V95, P213, DOI 10.1073/pnas.95.1.213; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Reed DH, 2003, BIOL CONSERV, V113, P23, DOI 10.1016/S0006-3207(02)00346-4; Reed JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1648; Reed JM, 2014, CONSERV BIOL, V28, P867, DOI 10.1111/cobi.12274; Reed JM, 2005, ECOL MODEL, V183, P411, DOI 10.1016/j.ecolmodel.2004.02.025; Reed JM, 1999, CONSERV BIOL, V13, P232, DOI 10.1046/j.1523-1739.1999.013002232.x; Reed JM, 1996, AUK, V113, P608, DOI 10.2307/4088981; Reed JM, 1998, BIOL CONSERV, V84, P35, DOI 10.1016/S0006-3207(97)00077-3; Reed JM, 2002, CONSERV BIOL, V16, P7, DOI 10.1046/j.1523-1739.2002.99419.x; Riehl C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2245; Root KV, 1998, ECOL APPL, V8, P854, DOI 10.1890/1051-0761(1998)008[0854:ETEOHQ]2.0.CO;2; Ruiz-Gutierrez V, 2012, AUK, V129, P500, DOI 10.1525/auk.2012.11171; SAETHER BE, 1988, NATURE, V331, P616, DOI 10.1038/331616a0; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Salguero-Gomez R, 2010, AM NAT, V176, P710, DOI 10.1086/657044; Schiegg K, 2002, J ANIM ECOL, V71, P710, DOI 10.1046/j.1365-2656.2002.00637.x; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Stacey P.B., 1990, COOPERATIVE BREEDING; STACEY PB, 1992, ECOL APPL, V2, P18, DOI 10.2307/1941886; Stahl JT, 2006, ECOL MODEL, V198, P23, DOI 10.1016/j.ecolmodel.2006.04.001; Sutherland WJ, 1998, ANIM BEHAV, V56, P801, DOI 10.1006/anbe.1998.0896; TEAR TH, 1993, SCIENCE, V262, P976, DOI 10.1126/science.262.5136.976; Temple H, 2005, ECOLOGY COOPERATIVE; Temple HJ, 2006, MOL ECOL, V15, P3449, DOI 10.1111/j.1365-294X.2006.03006.x; Temple HJ, 2009, IBIS, V151, P99, DOI 10.1111/j.1474-919X.2008.00867.x; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; Votier SC, 2008, J ANIM ECOL, V77, P974, DOI 10.1111/j.1365-2656.2008.01421.x; WAIDE RB, 1991, BIOTROPICA, V23, P475, DOI 10.2307/2388269; Walters JR, 2002, ECOL APPL, V12, P249, DOI 10.1890/1051-0761(2002)012[0249:PVAFRC]2.0.CO;2; WAUER RH, 1992, WILSON BULL, V104, P656; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; White RL, 2012, BIRD CONSERV INT, V22, P468, DOI 10.1017/S0959270912000184; Wiley James W., 1993, Bird Conservation International, V3, P319; Wittmer HU, 2010, BIOL CONSERV, V143, P86, DOI 10.1016/j.biocon.2009.09.007; Woolfenden G.E., 1984, FLORIDA SCRUB JAY DE; Young RP, 2010, BIRD CONSERV INT, V20, P354, DOI 10.1017/S0959270910000080; Zeigler SL, 2014, ECOL APPL, V24, P2144, DOI 10.1890/13-1275.1	103	15	15	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148928	10.1371/journal.pone.0148928	http://dx.doi.org/10.1371/journal.pone.0148928			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859690	Green Submitted, gold, Green Published			2022-12-27	WOS:000370038400106
J	Smiljanic, J; Chatterjee, A; Kauppinen, T; Dankulov, MM				Smiljanic, Jelena; Chatterjee, Arnab; Kauppinen, Tomi; Dankulov, Marija Mitrovic			A Theoretical Model for the Associative Nature of Conference Participation	PLOS ONE			English	Article							SCIENTIFIC IMPACT; CONFERENCE ATTENDANCE; CAREER; DISTRIBUTIONS; PERSISTENCE; FEEDBACK; SCIENCE; BALLS	Participation in conferences is an important part of every scientific career. Conferences provide an opportunity for a fast dissemination of latest results, discussion and exchange of ideas, and broadening of scientists' collaboration network. The decision to participate in a conference depends on several factors like the location, cost, popularity of keynote speakers, and the scientist's association with the community. Here we discuss and formulate the problem of discovering how a scientist's previous participation affects her/his future participations in the same conference series. We develop a stochastic model to examine scientists' participation patterns in conferences and compare our model with data from six conferences across various scientific fields and communities. Our model shows that the probability for a scientist to participate in a given conference series strongly depends on the balance between the number of participations and non-participations during his/her early connections with the community. An active participation in a conference series strengthens the scientist's association with that particular conference community and thus increases the probability of future participations.	[Smiljanic, Jelena; Dankulov, Marija Mitrovic] Univ Belgrade, Inst Phys Belgrade, Comp Sci Lab, Pregrevica 118, Belgrade 11080, Serbia; [Smiljanic, Jelena] Univ Belgrade, Sch Elect Engn, POB 35-54, Belgrade 11120, Serbia; [Chatterjee, Arnab] Saha Inst Nucl Phys, Condensed Matter Phys Div, 1-AF Bidhannagar, Kolkata 700064, India; [Kauppinen, Tomi] Aalto Univ, Sch Sci, POB 11000, FI-00076 Aalto, Finland	University of Belgrade; University of Belgrade; Saha Institute of Nuclear Physics; Aalto University	Dankulov, MM (corresponding author), Univ Belgrade, Inst Phys Belgrade, Comp Sci Lab, Pregrevica 118, Belgrade 11080, Serbia.	mitrovic@ipb.ac.rs	Dankulov, Marija Mitrovic/I-3007-2012; Kauppinen, Tomi/K-6118-2012; Kauppinen, Tomi/P-4287-2019; Smiljanic, Jelena/AIC-4573-2022; Chatterjee, Arnab/C-1928-2009	Dankulov, Marija Mitrovic/0000-0002-8484-3501; Kauppinen, Tomi/0000-0003-3479-7022; Kauppinen, Tomi/0000-0003-3479-7022; Chatterjee, Arnab/0000-0001-8639-0115; Smiljanic, Jelena/0000-0003-0124-1909	Ministry of Education, Science, and Technological Development of the Republic of Serbia [ON171017]; European Commission [675121]	Ministry of Education, Science, and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by ON171017, The Ministry of Education, Science, and Technological Development of the Republic of Serbia (http://www.mpn.gov.rs/: J.S. and M.M.D.); and 675121, The European Commission (http://ec.europa.eu/index_en.htm: M.M.D.).	Azoulay P, 2010, Q J ECON, V125, P549, DOI 10.1162/qjec.2010.125.2.549; Borghans L, 2010, LABOUR ECON, V17, P868, DOI 10.1016/j.labeco.2010.04.009; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Cioffi-Revilla C, 2010, WIRES COMPUT STAT, V2, P259, DOI 10.1002/wics.95; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Deville P, 2014, SCI REP-UK, V4, DOI 10.1038/srep04770; Drinea E, 2002, SIAM PROC S, P308; Friedkin NE, 2004, ANNU REV SOCIOL, V30, P409, DOI 10.1146/annurev.soc.30.012703.110625; Garfield E, 1988, SCIENTIST, V2, P294; Garfield E, 1977, ESSAYS INFORM SCI, V3, P668; Johnson N., 1977, URN MODELS THEIR APP; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Mair J, 2009, TOURISM MANAGE, V30, P400, DOI 10.1016/j.tourman.2008.08.002; Majumdar SN, 1999, CURR SCI INDIA, V77, P370; Oliveira RI, 2009, RANDOM STRUCT ALGOR, V34, P454, DOI 10.1002/rsa.20261; Pemantle R, 2007, PROBAB SURV, V4, P1, DOI 10.1214/07-PS094; Petersen AM, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds/s13688-014-0024-y; Petersen AM, 2012, P NATL ACAD SCI USA, V109, P5213, DOI 10.1073/pnas.1121429109; Petersen AM, 2011, P NATL ACAD SCI USA, V108, P18, DOI 10.1073/pnas.1016733108; Radicchi F, 2008, P NATL ACAD SCI USA, V105, P17268, DOI 10.1073/pnas.0806977105; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056103; Schweitzer F, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds/s13688-014-0035-8; Sen P., 2014, SOCIOPHYSICS INTRO; Sessions LF, 2010, INFORM COMMUN SOC, V13, P375, DOI 10.1080/13691180903468954; Sinatra R, 2014, APS M, P17004; van Dijk J, 2006, PAP REG SCI, V85, P483, DOI 10.1111/j.1435-5957.2006.00102.x; Wang DS, 2013, SCIENCE, V342, P127, DOI 10.1126/science.1237825; Witt SF, 1995, TOURISM MANAGE, V16, P559, DOI 10.1016/0261-5177(95)00079-8; Wu J, 2013, SCIENTOMETRICS, V96, P683, DOI 10.1007/s11192-013-0978-8	30	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148528	10.1371/journal.pone.0148528	http://dx.doi.org/10.1371/journal.pone.0148528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859404	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400049
J	Whitmarsh, T; Treece, GM; Gee, AH; Poole, KES				Whitmarsh, Tristan; Treece, Graham M.; Gee, Andrew H.; Poole, Kenneth E. S.			The Effects on the Femoral Cortex of a 24 Month Treatment Compared to an 18 Month Treatment with Teriparatide: A Multi-Trial Retrospective Analysis	PLOS ONE			English	Article							BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; CORTICAL BONE; CLINICAL CT; OSTEOPOROSIS; ALENDRONATE; RALOXIFENE; THICKNESS; FRACTURES; MASS	Background Teriparatide (TPTD) is an anabolic agent indicated for the treatment of severely osteoporotic patients who are at high risk of fragility fractures. The originally approved duration of TPTD treatment in several regions, including Europe, was 18 months. However, studies of areal bone mineral density (aBMD) showed additional benefit when treatment is continued beyond 18 months, and the drug is currently licenced for 24 months. Improvements in cortical structure at the proximal femur have already been shown in patients given TPTD for 24 months using quantitative computed tomography (QCT). Here, we investigate whether cortical and endocortical trabecular changes differ between an 18- and 24-month treatment. Methods Since an 18-versus 24-month TPTD study using QCT has not been conducted, we studied combined QCT data from four previous clinical trials. Combined femoral QCT data from three 18-month TPTD studies ('18-month group') were compared with data from a fourth 24-month trial ('24-month group'). Cortical parameters were measured over the entire proximal femur which allowed for a comparison of the mean changes as well as a visual comparison of the colour maps of changes after 18 and 24 months TPTD. Results For both the combined 18-month group and the 24-month group, overall cortical thickness and endocortical trabecular density increased, while overall cortical bone mineral density decreased. While the changes in the 24-month group were of greater magnitude compared to the 18-month group, the differences were only significant for the endocortical trabecular density (ECTD), corrected for age, weight, femoral neck T-score, total hip T-score and the baseline mean ECTD. Conclusion Although the combination of data from different clinical trials is not optimal, these data support the concept that the duration of TPTD in the 18-24 month phase is of clinical relevance when considering improvement in hip structure.	[Whitmarsh, Tristan; Treece, Graham M.; Gee, Andrew H.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Poole, Kenneth E. S.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Whitmarsh, T (corresponding author), Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.	tw401@cam.ac.uk			Eli Lilly; Cambridge NIHR Biomedical research Centre; Evelyn Trust	Eli Lilly(Eli Lilly); Cambridge NIHR Biomedical research Centre(National Institute for Health Research (NIHR)); Evelyn Trust	This study was funded by Eli Lilly. TW, GMT, AHG and KESP received research grants from Eli Lilly. KESP is also funded by the Cambridge NIHR Biomedical research Centre. The Evelyn Trust funded GMT. The funders had no role in study design, data analysis or decision to publish, but were involved in collection of data and had the chance to review the manuscript once written.	Boonen S, 2008, J CLIN ENDOCR METAB, V93, P852, DOI 10.1210/jc.2007-0711; Borggrefe J, 2010, J BONE MINER RES, V25, P472, DOI 10.1359/jbmr.090820; Cosman F, 2013, J BONE MINER RES, V28, P1328, DOI 10.1002/jbmr.1853; Cosman F, 2009, J CLIN ENDOCR METAB, V94, P3772, DOI 10.1210/jc.2008-2719; Ettinger B, 2004, J BONE MINER RES, V19, P745, DOI 10.1359/JBMR.040117; Finkelstein JS, 2010, J CLIN ENDOCR METAB, V95, P1838, DOI 10.1210/jc.2009-1703; Kleerekoper Michael, 2014, J Bone Joint Surg Am, V96, pe90; McClung MR, 2005, ARCH INTERN MED, V165, P1762, DOI 10.1001/archinte.165.15.1762; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Obermayer-Pietsch BM, 2008, J BONE MINER RES, V23, P1591, DOI 10.1359/JBMR.080506; Poole KES, 2015, J BONE MINER RES, V30, P46, DOI 10.1002/jbmr.2325; Poole KES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016190; Treece GM, 2015, MED IMAGE ANAL, V20, P249, DOI 10.1016/j.media.2014.11.012; Treece GM, 2012, MED IMAGE ANAL, V16, P952, DOI 10.1016/j.media.2012.02.008; Treece GM, 2010, MED IMAGE ANAL, V14, P276, DOI 10.1016/j.media.2010.01.003; Treece GM, 2015, J BONE MINER RES, V30, P2067, DOI 10.1002/jbmr.2552; Whitmarsh T, 2015, J BONE MINER RES, V30, P1309, DOI 10.1002/jbmr.2454	17	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0147722	10.1371/journal.pone.0147722	http://dx.doi.org/10.1371/journal.pone.0147722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859142	gold, Green Submitted, Green Published			2022-12-27	WOS:000370038400011
J	Zito, A; Bromuro, C; Mandili, G; Chiani, P; Horenstein, AL; Malavasi, F; Cauda, R; Cassone, A; Torosantucci, A				Zito, Andrea; Bromuro, Carla; Mandili, Giorgia; Chiani, Paola; Horenstein, Alberto L.; Malavasi, Fabio; Cauda, Roberto; Cassone, Antonio; Torosantucci, Antonella			A Murine, Bispecific Monoclonal Antibody Simultaneously Recognizing beta-Glucan and MP65 Determinants in Candida Species	PLOS ONE			English	Article							MEDIATED IMMUNE-RESPONSE; 65-KILODALTON MANNOPROTEIN; INVASIVE CANDIDIASIS; 65-KDA MANNOPROTEIN; BLOOD-STREAM; MAIN TARGET; SOLID-PHASE; ALBICANS; ANTIGEN; PURIFICATION	There is a real medical need of new diagnostic tools for the early recognition of invasive Candida infections. We exploited a rather simple and rapid redox methodology to construct a bispecific monoclonal antibody (bsmAb) that combines a monoclonal antibody (mAb) directed against 1,3-beta-D-glucan, a well-known, pan-fungal diagnostic biomarker, with a mAb recognizing MP65, a major immunogenic mannoprotein secreted by C.albicans and other Candida species. The bsmAb (MP65/bglu mAb) was successfully produced and purified at high yields and proved to bind and reveal simultaneously, with high sensitivity, the beta-glucan and MP65 antigens in both purified and native forms. The MP65/bglu mAb is the first bispecific antibody generated against a fungal microorganism and may prove useful for the concurrent detection of different and clinically significant Candida biomarkers in patient sera.	[Zito, Andrea; Mandili, Giorgia; Horenstein, Alberto L.; Malavasi, Fabio] Univ Turin, Immunogenet Lab, Turin, Italy; [Zito, Andrea; Mandili, Giorgia; Horenstein, Alberto L.; Malavasi, Fabio] Univ Turin, Dept Med Sci, CeRMS, Turin, Italy; [Zito, Andrea; Mandili, Giorgia; Horenstein, Alberto L.; Malavasi, Fabio] Transplant Immunol Citta Salute & Sci, Turin, Italy; [Bromuro, Carla; Chiani, Paola; Torosantucci, Antonella] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy; [Mandili, Giorgia] Univ Turin, Dept Mol Biotechnol, Citta Salute & Sci, Turin, Italy; [Cauda, Roberto] Univ Cattolica Sacro Cuore, Inst Infect Dis, Rome, Italy; [Cassone, Antonio] Univ Perugia, Ctr Funct Genom Genet & Biol, I-06100 Perugia, Italy	University of Turin; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Perugia	Torosantucci, A (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	antonella.torosantucci@iss.it	Chiani, Paola/AAC-4436-2021; /AAQ-2983-2020; TOROSANTUCCI, ANTONELLA/C-9594-2016; BROMURO, CARLA/C-9591-2016; Cassone, Antonio/J-4666-2019	Chiani, Paola/0000-0001-9836-3579; TOROSANTUCCI, ANTONELLA/0000-0002-0074-4486; BROMURO, CARLA/0000-0002-5668-9009; CAUDA, Roberto/0000-0002-1498-4229; MALAVASI, Fabio/0000-0002-1844-174X	Fondo per gli investimenti della ricerca di base (FIRB, Rome, Italy); Fondazione Ricerca Molinette (Torino, Italy); Fondazione CRT (Torino, Italy); Gilead Fellowship Program	Fondo per gli investimenti della ricerca di base (FIRB, Rome, Italy); Fondazione Ricerca Molinette (Torino, Italy); Fondazione CRT (Torino, Italy)(Fondazione CRT); Gilead Fellowship Program(Gilead Sciences)	The work in Torino was supported by the Fondo per gli investimenti della ricerca di base (FIRB, Rome, Italy), Fondazione Ricerca Molinette and Fondazione CRT (both in Torino, Italy) to FM. Work in Rome was granted by the Gilead Fellowship Program 2012 to RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvanitis M, 2014, CLIN MICROBIOL REV, V27, P490, DOI 10.1128/CMR.00091-13; Berzaghi R, 2009, CLIN VACCINE IMMUNOL, V16, P1538, DOI 10.1128/CVI.00176-09; BROMURO C, 1994, J MED VET MYCOL, V32, P447; Byrne H, 2013, TRENDS BIOTECHNOL, V31, P621, DOI 10.1016/j.tibtech.2013.08.007; Carlring J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022533; Clancy CJ, 2013, CLIN INFECT DIS, V56, P1284, DOI 10.1093/cid/cit006; De Bernardis F, 2007, J INFECT DIS, V195, P149, DOI 10.1086/509891; Delaloye J, 2014, VIRULENCE, V5, P161, DOI 10.4161/viru.26187; DEMONTE L, 1990, DEV BIOLOGICALS, V71, P15; DEMONTE LB, 1990, P NATL ACAD SCI USA, V87, P2941, DOI 10.1073/pnas.87.8.2941; DiGiandomenico A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009655; Dmitriev DA, 2001, CLIN CHIM ACTA, V309, P57, DOI 10.1016/S0009-8981(01)00531-9; Garey KW, 2006, CLIN INFECT DIS, V43, P25, DOI 10.1086/504810; Gomez MJ, 1996, INFECT IMMUN, V64, P2577, DOI 10.1128/IAI.64.7.2577-2584.1996; Gramer Michael J, 2013, MAbs, V5, P962, DOI 10.4161/mabs.26233; Guttikonda S, 2007, J IMMUNOL METHODS, V327, P1, DOI 10.1016/j.jim.2007.06.010; Harms BD, 2014, METHODS, V65, P95, DOI 10.1016/j.ymeth.2013.07.017; Hellwig SMM, 2001, INFECT IMMUN, V69, P4846, DOI 10.1128/IAI.69.8.4846-4850.2001; Horenstein AL, 2003, J IMMUNOL METHODS, V275, P99, DOI 10.1016/S0022-1759(03)00006-1; HORENSTEIN AL, 1993, INT J CLIN LAB RES, V23, P199, DOI 10.1007/BF02592309; Horenstein Alberto L., 2005, V308, P191; Kontermann RE, 2012, MABS-AUSTIN, V4, P182, DOI 10.4161/mabs.4.2.19000; Kulshreshtha P, 2011, MOL IMMUNOL, V48, P1958, DOI 10.1016/j.molimm.2011.05.024; La Valle R, 2000, INFECT IMMUN, V68, P6777, DOI 10.1128/IAI.68.12.6777-6784.2000; Labrijn AF, 2013, P NATL ACAD SCI USA, V110, P5145, DOI 10.1073/pnas.1220145110; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindorfer MA, 2001, J IMMUNOL, V167, P2240, DOI 10.4049/jimmunol.167.4.2240; MALAVASI F, 1993, YEAR IMMUN, V7, P74; Moran C, 2010, AM J INFECT CONTROL, V38, P78, DOI 10.1016/j.ajic.2009.06.014; Morrell M, 2005, ANTIMICROB AGENTS CH, V49, P3640, DOI 10.1128/AAC.49.9.3640-3645.2005; NISTICO P, 1992, J CLIN INVEST, V90, P1093, DOI 10.1172/JCI115925; Ouchterlony O., 1953, ACTA PATHOL MIC SC, V32, P230; Owais M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091255; Sarkar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032340; Spiess C, 2013, NAT BIOTECHNOL, V31, P753, DOI 10.1038/nbt.2621; Strop P, 2012, J MOL BIOL, V420, P204, DOI 10.1016/j.jmb.2012.04.020; TARDITI L, 1992, J CHROMATOGR, V599, P13, DOI 10.1016/0021-9673(92)85453-Z; TOROSANTUCCI A, 1993, J INFECT DIS, V168, P427, DOI 10.1093/infdis/168.2.427; Torosantucci A, 2005, J EXP MED, V202, P597, DOI 10.1084/jem.20050749; Torosantucci A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005392; Torres M, 2008, TRENDS IMMUNOL, V29, P91, DOI 10.1016/j.it.2007.11.004; Wagstaffe SJ, 2012, ANAL CHEM, V84, P5876, DOI 10.1021/ac203403d; Wang GJ, 1999, J AGR FOOD CHEM, V47, P1262, DOI 10.1021/jf980702w; Xia YM, 2013, MOL IMMUNOL, V56, P28, DOI 10.1016/j.molimm.2013.04.004; Yang CC, 1999, BIOCHEM MOL BIOL INT, V47, P1039; Yang ZY, 2014, J INFECT DIS, V210, P964, DOI 10.1093/infdis/jiu196	46	9	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148714	10.1371/journal.pone.0148714	http://dx.doi.org/10.1371/journal.pone.0148714			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859561	Green Submitted, gold, Green Published			2022-12-27	WOS:000370038400069
J	Dave, PV; Shah, AN; Nimavat, PB; Modi, BB; Pujara, KR; Patel, P; Mehariya, K; Rade, KV; Shekar, S; Sachdeva, KS; Oeltmann, JE; Kumar, AMV				Dave, Paresh Vamanrao; Shah, Amar Niranjan; Nimavat, Pankaj B.; Modi, Bhavesh B.; Pujara, Kirit R.; Patel, Pradip; Mehariya, Keshabhai; Rade, Kiran Vaman; Shekar, Soma; Sachdeva, Kuldeep S.; Oeltmann, John E.; Kumar, Ajay M. V.			Direct Observation of Treatment Provided by a Family Member as Compared to Non-Family Member among Children with New Tuberculosis: A Pragmatic, Non-Inferiority, Cluster-Randomized Trial in Gujarat, India	PLOS ONE			English	Article							DIRECTLY OBSERVED THERAPY; METAANALYSIS; STRATEGIES; ADHERENCE; DOTS	Background The World Health Organization recommends direct observation of treatment (DOT) to support patients with tuberculosis (TB) and to ensure treatment completion. As per national programme guidelines in India, a DOT provider can be anyone who is acceptable and accessible to the patient and accountable to the health system, except a family member. This poses challenges among children with TB who may be more comfortable receiving medicines from their parents or family members than from unfamiliar DOT providers. We conducted a non-inferiority trial to assess the effect of family DOT on treatment success rates among children with newly diagnosed TB registered for treatment during June-September 2012. Methods We randomly assigned all districts (n = 30) in Gujarat to the intervention (n = 15) or usual-practice group (n = 15). Adult family members in the intervention districts were given the choice to become their child's DOT provider. DOT was provided by a non-family member in the usual-practice districts. Using routinely collected clinic-based TB treatment cards, we compared treatment success rates (cured and treatment completed) between the two groups and the non-inferiority limit was kept at 5%. Results Of 624 children with newly diagnosed TB, 359 (58%) were from intervention districts and 265 (42%) were from usual-practice districts. The two groups were similar with respect to baseline characteristics including age, sex, type of TB, and initial body weight. The treatment success rates were 344 (95.8%) and 247 (93.2%) (p = 0.11) among the intervention and usual-practice groups respectively. Conclusion DOT provided by a family member is not inferior to DOT provided by a non-family member among new TB cases in children and can attain international targets for treatment success.	[Dave, Paresh Vamanrao; Nimavat, Pankaj B.; Modi, Bhavesh B.; Pujara, Kirit R.; Patel, Pradip; Mehariya, Keshabhai] Govt Gujarat, Dept Hlth & Family Welf, Gandhinagar, Gujarat, India; [Shah, Amar Niranjan; Rade, Kiran Vaman] WHO Country Off India, New Delhi, India; [Shekar, Soma] Govt India, Natl TB Inst, Bangalore, Karnataka, India; [Sachdeva, Kuldeep S.] Govt India, Minist Hlth & Family Welf, Cent TB Div, New Delhi, India; [Oeltmann, John E.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Kumar, Ajay M. V.] South East Asia Reg Off, Int Union TB & Lung Dis, New Delhi, India	Centers for Disease Control & Prevention - USA	Shah, AN (corresponding author), WHO Country Off India, New Delhi, India.	dr.amar.mph@gmail.com	Rade, Kiran/AAU-9564-2020	Rade, Kiran/0000-0001-7601-0780; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531	Government Revised National Tuberculosis Control Program, Gujarat, India	Government Revised National Tuberculosis Control Program, Gujarat, India	Study cost regarding data collection, supervision & monitoring was borne by Government Revised National Tuberculosis Control Program, Gujarat, India. The study was conducted as a part of the 'TB Operations Research Training Project' aimed to build operational research capacity within the Government of India's RNTCP. This training project was conceived and implemented jointly by Central TB Division (Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India), The National TB Institute (Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, Bangalore, India), World Health Organization (India Country Office), The International Union Against Tuberculosis and Lung Diseases (The Union, South-East Asia Regional Office, New Delhi, India) and U.S. Centers for Disease Control and Prevention (Division of TB Elimination, Atlanta, USA). The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Arora V, 2005, TUBERCULOSIS CONTROL, V12, P115; Arora V. K., 2003, Indian Journal of Tuberculosis, V50, P143; BAYER R, 1995, LANCET, V345, P1545, DOI 10.1016/S0140-6736(95)91090-5; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; Central TB Division, 2012, RNTCP PERF IND; Central TB Division, 2011, MAN RNTCP YOUR AR TR; Central TB Division. National Expert Committee on Diagnosis and Management of Tuberculosis under RNTCP, 2015, M MIN REC CONS STAT; Finlay A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-56; Frieden TR, 2007, B WORLD HEALTH ORGAN, V85, P407, DOI 10.2471/BLT.06.038927; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Hunchangsith P, 2012, VALUE HEALTH, V15, pS50, DOI 10.1016/j.jval.2011.11.006; MOODIE AS, 1967, AM REV RESPIR DIS, V95, P384; Moonan PK, 2013, CLIN INFECT DIS, V57, P1062, DOI 10.1093/cid/cit431; National AIDS Control Organization and Central TB Division, INT TRAIN MOD HIV TB, P81; Newell JN, 2006, LANCET, V367, P903, DOI 10.1016/S0140-6736(06)68380-3; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Pasipanodya JG, 2013, CLIN INFECT DIS, V57, P1065, DOI 10.1093/cid/cit434; Pasipanodya JG, 2013, CLIN INFECT DIS, V57, P21, DOI 10.1093/cid/cit167; Pope DS, 2003, INT J TUBERC LUNG D, V7, P611; Sealed Envelope Ltd, 2012, POWER CALCULATOR BIN; Seaworth BJ, 2013, CLIN INFECT DIS, V57, P1063, DOI 10.1093/cid/cit432; Steffen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014014; *TUB CHEM CTR, 1959, B WORLD HEALTH ORGAN, V21, P51; Vijay S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010043; Volmink J, 1997, BMJ-BRIT MED J, V315, P1403, DOI 10.1136/bmj.315.7120.1403; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; Walley JD, 2001, LANCET, V357, P664, DOI 10.1016/S0140-6736(00)04129-5; Wandwalo E, 2004, INT J TUBERC LUNG D, V8, P1248; World Health Organization, 2013, DEFINITIONS REPORTIN; Wright J, 2004, TROP MED INT HEALTH, V9, P559, DOI 10.1111/j.1365-3156.2004.01230.x; Zwarenstein M, 1998, LANCET, V352, P1340, DOI 10.1016/S0140-6736(98)04022-7	31	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148488	10.1371/journal.pone.0148488	http://dx.doi.org/10.1371/journal.pone.0148488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849442	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000106
J	Davis, KN; Tao, R; Li, C; Gao, Y; Gondre-Lewis, MC; Lipska, BK; Shin, JH; Xie, B; Ye, TZ; Weinberger, DR; Kleinman, JE; Hyde, TM				Davis, Kasey N.; Tao, Ran; Li, Chao; Gao, Yuan; Gondre-Lewis, Marjorie C.; Lipska, Barbara K.; Shin, Joo Heon; Xie, Bin; Ye, Tianzhang; Weinberger, Daniel R.; Kleinman, Joel E.; Hyde, Thomas M.			GAD2 Alternative Transcripts in the Human Prefrontal Cortex, and in Schizophrenia and Affective Disorders	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; GAMMA-AMINOBUTYRIC-ACID; BIPOLAR DISORDER; MESSENGER-RNA; MICE LACKING; GABA; EXPRESSION; BRAIN; REELIN; DEPRESSION	Genetic variation and early adverse environmental events work together to increase risk for schizophrenia. gamma-aminobutyric acid (GABA), the major inhibitory neurotransmitter in adult mammalian brain, plays a major role in normal brain development, and has been strongly implicated in the pathobiology of schizophrenia. GABA synthesis is controlled by two glutamic acid decarboxylase (GAD) genes, GAD1 and GAD2, both of which produce a number of alternative transcripts. Genetic variants in the GAD1 gene are associated with increased risk for schizophrenia, and reduced expression of its major transcript in the human dorsolateral prefrontal cortex (DLPFC). No consistent changes in GAD2 expression have been found in brains from patients with schizophrenia. In this work, with the use of RNA sequencing and PCR technologies, we confirmed and tracked the expression of an alternative truncated transcript of GAD2 (ENST00000428517) in human control DLPFC homogenates across lifespan besides the well-known full length transcript of GAD2. In addition, using quantitative RT-PCR, expression of GAD2 full length and truncated transcripts were measured in the DLPFC of patients with schizophrenia, bipolar disorder and major depression. The expression of GAD2 full length transcript is decreased in the DLPFC of schizophrenia and bipolar disorder patients, while GAD2 truncated transcript is increased in bipolar disorder patients but decreased in schizophrenia patients. Moreover, the patients with schizophrenia with completed suicide or positive nicotine exposure showed significantly higher expression of GAD2 full length transcript. Alternative transcripts of GAD2 may be important in the growth and development of GABA-synthesizing neurons as well as abnormal GABA signaling in the DLPFC of patients with schizophrenia and affective disorders.	[Davis, Kasey N.; Lipska, Barbara K.] NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, Intramural Res Program,NIH, Bethesda, MD 20892 USA; [Davis, Kasey N.; Tao, Ran; Li, Chao; Gao, Yuan; Shin, Joo Heon; Xie, Bin; Ye, Tianzhang; Weinberger, Daniel R.; Kleinman, Joel E.; Hyde, Thomas M.] Johns Hopkins Univ, Sch Med, Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Weinberger, Daniel R.; Hyde, Thomas M.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Johns Hopkins Univ Med Campus, Baltimore, MD 21205 USA; [Weinberger, Daniel R.; Hyde, Thomas M.] Johns Hopkins Univ, Sch Med, Neurol, Johns Hopkins Univ Med Campus, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Davis, Kasey N.; Gondre-Lewis, Marjorie C.] Howard Univ, Coll Med, Dept Anat, Lab Neurodev, Washington, DC 20059 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Howard University	Hyde, TM (corresponding author), Johns Hopkins Univ, Sch Med, Lieber Inst Brain Dev, Baltimore, MD 21205 USA.	thomas.hyde@libd.org	Gondre-Lewis, Marjorie/M-8055-2017; Lipska, Barbara K/E-4569-2017		NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002903] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Battaglioli G, 2003, J NEUROCHEM, V86, P879, DOI 10.1046/j.1471-4159.2003.01910.x; Bernstein HG, 2013, CNS NEUROL DISORD-DR, V12, P900, DOI 10.2174/18715273113129990091; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; Chan SO, 1997, MOL BRAIN RES, V46, P318, DOI 10.1016/S0169-328X(97)00031-4; Choi SY, 2002, J NEUROSCI, V22, P5271; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Costa E., 2004, Critical Reviews in Neurobiology, V16, P1, DOI 10.1615/CritRevNeurobiol.v16.i12.10; Dracheva S, 2004, J NEUROSCI RES, V76, P581, DOI 10.1002/jnr.20122; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Fatemi SH, 2009, SCHIZOPHR RES, V111, P138, DOI 10.1016/j.schres.2009.03.002; Fatemi SH, 2000, MOL PSYCHIATR, V5, P654, DOI 10.1038/sj.mp.4000783; Fatemi SH, 2000, MOL PSYCHIATR, V5, P571, DOI 10.1038/sj.mp.4000794; Fatemi SH, 2005, SCHIZOPHR RES, V72, P109, DOI 10.1016/j.schres.2004.02.017; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Glausier JR, 2015, BIOL PSYCHIAT, V77, P167, DOI 10.1016/j.biopsych.2014.05.010; Gos T, 2009, J AFFECT DISORDERS, V113, P45, DOI 10.1016/j.jad.2008.04.021; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; GREIF KF, 1991, NEUROCHEM RES, V16, P235, DOI 10.1007/BF00966086; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; Heckers S, 2002, ARCH GEN PSYCHIAT, V59, P521, DOI 10.1001/archpsyc.59.6.521; Heldt SA, 2004, NEUROPSYCHOPHARMACOL, V29, P1610, DOI 10.1038/sj.npp.1300468; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hyde TM, 2011, J NEUROSCI, V31, P11088, DOI 10.1523/JNEUROSCI.1234-11.2011; Jaffe AE, 2015, NAT NEUROSCI, V18, P154, DOI 10.1038/nn.3898; Kanaani J, 2010, J CELL BIOL, V190, P911, DOI 10.1083/jcb.200912101; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Kelly DL, 2011, SCHIZOPHRENIA BULL, V37, P832, DOI 10.1093/schbul/sbp152; Laeng P, 2004, J NEUROCHEM, V91, P238, DOI 10.1111/j.1471-4159.2004.02725.x; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Lujan R, 2005, NEUROSCIENCE, V130, P567, DOI 10.1016/j.neuroscience.2004.09.042; Manent JB, 2007, NEUROSCIENTIST, V13, P268, DOI 10.1177/1073858406298918; Marty S, 1996, NEURON, V16, P565, DOI 10.1016/S0896-6273(00)80075-6; Moyer CE, 2012, BIOL PSYCHIAT, V72, P734, DOI 10.1016/j.biopsych.2012.04.010; Patel AB, 2006, J NEUROCHEM, V97, P385, DOI 10.1111/j.1471-4159.2006.03741.x; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004371; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Straub RE, 2007, MOL PSYCHIATR, V12, P854, DOI 10.1038/sj.mp.4001988; Tao R, 2012, J NEUROSCI, V32, P5216, DOI 10.1523/JNEUROSCI.4626-11.2012; Taylor SF, 2015, SCHIZOPHR RES, V167, P84, DOI 10.1016/j.schres.2014.10.011; Tian N, 1999, P NATL ACAD SCI USA, V96, P12911, DOI 10.1073/pnas.96.22.12911; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Walls AB, 2010, J NEUROCHEM, V115, P1398, DOI 10.1111/j.1471-4159.2010.07043.x; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5	49	12	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148558	10.1371/journal.pone.0148558	http://dx.doi.org/10.1371/journal.pone.0148558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848839	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000124
J	Rivera, AL; Estanol, B; Senties-Madrid, H; Fossion, R; Toledo-Roy, JC; Mendoza-Temis, J; Morales, IO; Landa, E; Robles-Cabrera, A; Moreno, R; Frank, A				Leonor Rivera, Ana; Estanol, Bruno; Senties-Madrid, Horacio; Fossion, Ruben; Toledo-Roy, Juan C.; Mendoza-Temis, Joel; Morales, Irving O.; Landa, Emmanuel; Robles-Cabrera, Adriana; Moreno, Rene; Frank, Alejandro			Heart Rate and Systolic Blood Pressure Variability in the Time Domain in Patients with Recent and Long-Standing Diabetes Mellitus	PLOS ONE			English	Article							AUTONOMIC NEUROPATHY; BARORECEPTOR REFLEX; NEONATAL SEPSIS; MORTALITY; TESTS; VARIABLES; CAPACITY; DYNAMICS; BEAT; AGE	Diabetes Mellitus (DM) affects the cardiovascular response of patients. To study this effect, interbeat intervals (IBI) and beat-to-beat systolic blood pressure (SBP) variability of patients during supine, standing and controlled breathing tests were analyzed in the time domain. Simultaneous noninvasive measurements of IBI and SBP for 30 recently diagnosed and 15 long-standing DM patients were compared with the results for 30 rigorously screened healthy subjects (control). A statistically significant distinction between control and diabetic subjects was provided by the standard deviation and the higher moments of the distributions (skewness, and kurtosis) with respect to the median. To compare IBI and SBP for different populations, we define a parameter, a, that combines the variability of the heart rate and the blood pressure, as the ratio of the radius of the moments for IBI and the same radius for SBP. As diabetes evolves, a decreases, standard deviation of the IBI detrended signal diminishes (heart rate signal becomes more "rigid"), skewness with respect to the median approaches zero (signal fluctuations gain symmetry), and kurtosis increases (fluctuations concentrate around the median). Diabetes produces not only a rigid heart rate, but also increases symmetry and has leptokurtic distributions. SBP time series exhibit the most variable behavior for recently diagnosed DM with platykurtic distributions. Under controlled breathing, SBP has symmetric distributions for DM patients, while control subjects have non-zero skewness. This may be due to a progressive decrease of parasympathetic and sympathetic activity to the heart and blood vessels as diabetes evolves.	[Leonor Rivera, Ana; Estanol, Bruno; Fossion, Ruben; Toledo-Roy, Juan C.; Mendoza-Temis, Joel; Morales, Irving O.; Landa, Emmanuel; Frank, Alejandro] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City 04510, DF, Mexico; [Leonor Rivera, Ana; Fossion, Ruben; Toledo-Roy, Juan C.; Mendoza-Temis, Joel; Morales, Irving O.; Landa, Emmanuel; Frank, Alejandro] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico; [Leonor Rivera, Ana] Univ Nacl Autonoma Mexico, Ctr Fis Aplicada & Tecnol Avanzada, Queretaro, Mexico; [Leonor Rivera, Ana; Estanol, Bruno; Fossion, Ruben; Toledo-Roy, Juan C.; Mendoza-Temis, Joel; Morales, Irving O.; Landa, Emmanuel; Frank, Alejandro] Lab Nacl Ciencias Complejidad, Mexico City, DF, Mexico; [Estanol, Bruno; Senties-Madrid, Horacio; Robles-Cabrera, Adriana; Moreno, Rene] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Lab Neurofisiol, Dept Neurol & Psiquiatria, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Rivera, AL (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City 04510, DF, Mexico.; Rivera, AL (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico.; Rivera, AL (corresponding author), Univ Nacl Autonoma Mexico, Ctr Fis Aplicada & Tecnol Avanzada, Queretaro, Mexico.; Rivera, AL (corresponding author), Lab Nacl Ciencias Complejidad, Mexico City, DF, Mexico.	ana.rivera@nucleares.unam.mx	Toledo-Roy, Juan Claudio/N-6666-2019; Rivera, Ana Leonor/L-4433-2019; Fossion, Ruben/X-1682-2019; Rivera, Ana Leonor/B-5062-2010; Nucleares, Instituto/AAK-6270-2020; Toledo-Roy, Juan/G-6071-2019	Toledo-Roy, Juan Claudio/0000-0002-0267-3378; Rivera, Ana Leonor/0000-0002-0296-7966; Fossion, Ruben/0000-0001-8456-2075; Rivera, Ana Leonor/0000-0002-0296-7966; Toledo-Roy, Juan/0000-0002-0267-3378	UNAM; CONACYT [0133524, 0232647]	UNAM(Universidad Nacional Autonoma de Mexico); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Finantial funding for this work was supplied by UNAM (http://www.nucleares.unam.mx/) and CONACYT (http://www.conacyt.gob.mx/) under grants 0133524 and 0232647. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S., 2011, CURR NEUROBIOL, V2, P101; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 1995, DIABETES CARE S1, V18, P59, DOI [10.2337/diacare.18.1.S59, DOI 10.2337/DIACARE.18.1.S59]; APPEL ML, 1989, J AM COLL CARDIOL, V14, P1139, DOI 10.1016/0735-1097(89)90408-7; Bauer A, 2006, LANCET, V367, P1674, DOI 10.1016/S0140-6736(06)68735-7; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Camm AJ, 1996, EUR HEART J, V17, P354; COWLEY AW, 1973, CIRC RES, V32, P564, DOI 10.1161/01.RES.32.5.564; Estañol Bruno, 2011, Arch. Cardiol. Méx., V81, P330; EWING DJ, 1985, DIABETES CARE, V8, P491, DOI 10.2337/diacare.8.5.491; Floras JS, 2013, CAN J CARDIOL, V29, P557, DOI 10.1016/j.cjca.2013.02.012; Fossion R, 2013, [Frontiers in Biology, 生物学前沿], V8, P247; FREEMAN R, 1991, ARCH NEUROL-CHICAGO, V48, P185, DOI 10.1001/archneur.1991.00530140079020; GOLDSTEIN IB, 1988, DIABETES CARE, V11, P774, DOI 10.2337/diacare.11.10.774; Griffin MP, 2001, PEDIATRICS, V107, P97, DOI 10.1542/peds.107.1.97; Haagglund H, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00356; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Huikuri HV, 2000, CIRCULATION, V101, P47, DOI 10.1161/01.CIR.101.1.47; Kilpatrick ES, 2010, DIABETES CARE, V33, P2442, DOI 10.2337/dc10-1000; KITNEY R I, 1982, Automedica (London), V4, P155; Kovatchev BP, 2003, PEDIATR RES, V54, P892, DOI 10.1203/01.PDR.0000088074.97781.4F; LEVY MN, 1971, CIRC RES, V29, P437, DOI 10.1161/01.RES.29.5.437; MALPAS SC, 1990, DIABETES, V39, P1177, DOI 10.2337/diabetes.39.10.1177; MANCIA G, 1983, CIRC RES, V53, P96, DOI 10.1161/01.RES.53.1.96; Parati G, 2000, J HYPERTENS, V18, P7, DOI 10.1097/00004872-200018010-00003; Parati G, 2013, DIABETES CARE, V36, pS312, DOI 10.2337/dcS13-2043; Parati G, 2013, NAT REV CARDIOL, V10, P143, DOI 10.1038/nrcardio.2013.1; Pop-Busui R, 2010, DIABETES CARE, V33, P434, DOI 10.2337/dc09-1294; Robles-Cabrera A, 2014, REV NEUROLOGIA, V59, P508, DOI 10.33588/rn.5911.2014314; Rosengard-Barlund M, 2011, DIABETOLOGIA, V54, P1862, DOI 10.1007/s00125-011-2164-y; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Schmitt DT, 2007, AM J PHYSIOL-REG I, V293, pR1923, DOI 10.1152/ajpregu.00372.2007; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sharma VK, 2015, J CLIN DIAGN RES, V9, pCC08, DOI 10.7860/JCDR/2015/15373.6662; SMITH SA, 1982, BRIT MED J, V285, P1599, DOI 10.1136/bmj.285.6355.1599; Sucharita S, 2011, Indian J Endocrinol Metab, V15, P198, DOI 10.4103/2230-8210.83406; Sucharita S, 2002, PHYSIOL MEAS, V23, P347, DOI 10.1088/0967-3334/23/2/310; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Van Den Akker T. J., 1983, Automedica, V4, P201; Weston PJ, 1996, CLIN SCI, V91, P59, DOI 10.1042/cs0910059; Ziegler D, 2008, DIABETES CARE, V31, P556, DOI 10.2337/dc07-1615	42	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148378	10.1371/journal.pone.0148378	http://dx.doi.org/10.1371/journal.pone.0148378			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849653	Green Submitted, gold, Green Published			2022-12-27	WOS:000369554000084
J	Pasa, MK; Alom, KR; Bashri, Z; Vermund, SH				Pasa, M. Kamal; Alom, Kazi Robiul; Bashri, Zubaida; Vermund, Sten H.			Sharing of Needles and Syringes among Men Who Inject Drugs: HIV Risk in Northwest Bangladesh	PLOS ONE			English	Article							USERS; INDIA; AIDS	Introduction Injection drug use is prevalent in northwestern Bangladesh. We sought to explore the context of needle/syringe sharing among persons who inject drugs (PWID), examining risk exposures to blood-borne infections like the human immunodeficiency virus (HIV) and hepatitis in a region where these dual epidemics are likely to expand. Methods We used a qualitative research approach to learn about injection practices, conducting 60 in-depth interviews among PWID. We then conducted 12 focus group discussions (FGDs) that generated a checklist of salient issues, and followed up with personal observations of typical days at the drug-use venues. Content and interpretative frameworks were used to analyze qualitative information and socio-demographic information, using SPSS software. Results We found that needle/syringe-sharing behaviours were integrated into the overall social and cultural lives of drug users. Sharing behaviours were an central component of PWID social organization. Sharing was perceived as an inherent element within reciprocal relationships, and sharing was tied to beliefs about drug effects, economic adversity, and harassment due to their drug user status. Carrying used needles/syringes to drug-use venues was deemed essential since user-unfriendly needle-syringe distribution schedules of harm reduction programmes made it difficult to access clean needles/syringes in off-hours. PWID had low self-esteem. Unequal power relationships were reported between the field workers of harm reduction programmes and PWID. Field workers expressed anti-PWID bias and judgmental attitudes, and also had had misconceptions about HIV and hepatitis transmission. PWID were especially disturbed that no assistance was forthcoming from risk reduction programme staff when drug users manifested withdrawal symptoms. Conclusion Interventions must take social context into account when scaling up programmes in diverse settings. The social organization of PWID include values that foster needle-syringe sharing. Utilization and impact of risk reduction programmes might be improved with expanded clean needle/syringe distribution at times and venues convenient for PWID, better trained and non-judgmental staff, and medical assistance for health problems, including drug withdrawal symptoms.	[Pasa, M. Kamal; Alom, Kazi Robiul] Rajshahi Univ, Dept Anthropol, Rajshani, Bangladesh; [Bashri, Zubaida] Rajshahi Univ, Inst Environm Sci, Rajshani, Bangladesh; [Vermund, Sten H.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Vermund, Sten H.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	University of Rajshahi; University of Rajshahi; Vanderbilt University; Vanderbilt University	Pasa, MK (corresponding author), Rajshahi Univ, Dept Anthropol, Rajshani, Bangladesh.	kamal_pasa@yahoo.com	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698	Bangladesh University Grants Commission	Bangladesh University Grants Commission	Bangladesh University Grants Commission provided funding for the study.	Azim T, 2008, SUBSTANCE USE MISUSE, V43; Azim T, 2008, J HEALTH POPUL NUTR, V26, P311; Azim Tasnim, 2006, Harm Reduct J, V3, P33, DOI 10.1186/1477-7517-3-33; Azim T, 2015, INT J DRUG POLICY, V26, pS16, DOI 10.1016/j.drugpo.2014.09.003; Battjes RJ, 1994, CONTEXT HIV RISK DRU; Brown B. S., 1993, HDB RISK AIDS INJECT; Chakrapani V, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-9; Des Jarlais CD, 1986, SOCIAL DIMENSION AID; Fernando D., 1991, AIDS and Public Policy Journal, V6, P116; Grace CW, 1994, CONTEXT HIV RISK DRU; Haider Muhiuddin, 2008, Bangladesh Med Res Counc Bull, V34, P54; Hossain K J, 2012, Int J STD AIDS, V23, pe1, DOI 10.1258/ijsa.2009.009168; Howard J, 1972, ITS GOOD DONT EVEN T; Kane SA, 1992, THE TIME OF AIDS; Koester SK, 1994, CONTEXT RISK ETHNOGR; Koester SK, 1992, ANN M COLL PROBL DRU; Larance B, 2011, DRUG ALCOHOL REV, V30, P246, DOI 10.1111/j.1465-3362.2011.00304.x; MAGURA S, 1989, AM J PUBLIC HEALTH, V79, P459, DOI 10.2105/AJPH.79.4.459; Malow R. M., 1992, PSYCHOL ADDICT BEHAV, V6, P131, DOI [DOI 10.1037/H0080614, 10.1037/h0080614]; Ministry of Health and Family Welfare (MoHFW) Bangladesh, 2011, NAT HIV SER SURV 201; Murphy S., 1987, CONTEMP DRUG PROBL, V14, P373; Needle RH, 1994, CONTEXT HIV RISK DRU; PAGE JB, 1990, MED ANTHROPOL Q, V4, P56, DOI 10.1525/maq.1990.4.1.02a00050; POWER R, 1988, BRIT J ADDICT, V83, P649; Rafiey H, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-21; Reddy A, 2008, INT J DRUG POLICY, V19, pS37, DOI 10.1016/j.drugpo.2007.11.015; Samo RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081715; Sarkar K, 2006, SUBST USE MISUSE, V41, P341, DOI 10.1080/10826080500410991; Shariful Islam SM, 2015, J ADDICT, V2015; Stephens RC, 1994, CONTEXT HIV RISK DRU; Uddin MJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1151; Waldorf D, 1989, AIDS DRUGS PROSTITUT; WATTERS JK, 1988, J PSYCHOACTIVE DRUGS, V20, P173, DOI 10.1080/02791072.1988.10524491	33	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148276	10.1371/journal.pone.0148276	http://dx.doi.org/10.1371/journal.pone.0148276			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26848756	Green Published, gold			2022-12-27	WOS:000369554000063
J	Tyler, AD; Christianson, S; Knox, NC; Mabon, P; Wolfe, J; Van Domselaar, G; Graham, MR; Sharma, MK				Tyler, Andrea D.; Christianson, Sara; Knox, Natalie C.; Mabon, Philip; Wolfe, Joyce; Van Domselaar, Gary; Graham, Morag R.; Sharma, Meenu K.			Comparison of Sample Preparation Methods Used for the Next-Generation Sequencing of Mycobacterium tuberculosis	PLOS ONE			English	Article							LIBRARY PREPARATION; GENOME ASSEMBLIES; BACTERIAL GENOME; DNA EXTRACTION; BIAS; CONSTRUCTION; ACCURATE	The advent and widespread application of next-generation sequencing (NGS) technologies to the study of microbial genomes has led to a substantial increase in the number of studies in which whole genome sequencing (WGS) is applied to the analysis of microbial genomic epidemiology. However, microorganisms such as Mycobacterium tuberculosis (MTB) present unique problems for sequencing and downstream analysis based on their unique physiology and the composition of their genomes. In this study, we compare the quality of sequence data generated using the Nextera and TruSeq isolate preparation kits for library construction prior to Illumina sequencing-by-synthesis. Our results confirm that MTB NGS data quality is highly dependent on the purity of the DNA sample submitted for sequencing and its guanine-cytosine content (or GC-content). Our data additionally demonstrate that the choice of library preparation method plays an important role in mitigating downstream sequencing quality issues. Importantly for MTB, the Illumina TruSeq library preparation kit produces more uniform data quality than the Nextera XT method, regardless of the quality of the input DNA. Furthermore, specific genomic sequence motifs are commonly missed by the Nextera XT method, as are regions of especially high GC-content relative to the rest of the MTB genome. As coverage bias is highly undesirable, this study illustrates the importance of appropriate protocol selection when performing NGS studies in order to ensure that sound inferences can be made regarding mycobacterial genomes.	[Tyler, Andrea D.; Christianson, Sara; Wolfe, Joyce; Sharma, Meenu K.] Publ Hlth Agcy Canada, Natl Reference Ctr Mycobacteriol, Natl Microbiol Lab, Winnipeg, MB, Canada; [Knox, Natalie C.; Mabon, Philip; Van Domselaar, Gary; Graham, Morag R.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Sci Technol Cores & Serv Div, Winnipeg, MB, Canada; [Van Domselaar, Gary; Graham, Morag R.; Sharma, Meenu K.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Van Domselaar, Gary] Univ Manitoba, Dept Comp Sci, Winnipeg, MB R3T 2N2, Canada	Public Health Agency of Canada; Public Health Agency of Canada; University of Manitoba; University of Manitoba	Tyler, AD (corresponding author), Publ Hlth Agcy Canada, Natl Reference Ctr Mycobacteriol, Natl Microbiol Lab, Winnipeg, MB, Canada.	andrea.d.tyler@phac-aspc.gc.ca; meenu.sharma@phac-aspc.gc.ca	Sharma, Meenu/AAE-2536-2022; Sharma, Meenu/GWM-5030-2022	Sharma, Meenu/0000-0002-6020-9995; Knox, Natalie/0000-0001-6133-7799	Canadian federal Genomics Research and Development Initiative (GRDI) from the Government of Canada; Public Health Agency of Canada	Canadian federal Genomics Research and Development Initiative (GRDI) from the Government of Canada; Public Health Agency of Canada	This study was funded through an intramural grant from the Canadian federal Genomics Research and Development Initiative (GRDI) from the Government of Canada and the Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Andrews S, FASTQC QUALITY CONTR; [Anonymous], 2013, PROKKA PROKARYOTIC G; [Anonymous], 2014, SMALT; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Butler WR, 2001, CLIN MICROBIOL REV, V14, P704, DOI 10.1128/CMR.14.4.704-726.2001; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062856; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; De Almeida Isabela Neves, 2013, BMC Res Notes, V6, P561, DOI 10.1186/1756-0500-6-561; Espitia C, 1999, MICROBIOL-UK, V145, P3487, DOI 10.1099/00221287-145-12-3487; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Illumina inc, 2015, NEXT XT DNA LIBR PER, P48; Illumina inc, 2012, TRUSEQ DNA SAMPL PRE, P148; Jones MB, 2015, P NATL ACAD SCI USA, V112, P14024, DOI 10.1073/pnas.1519288112; Kato-Maeda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058235; Kerpedjiev P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-100; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Lan JH, 2015, HUM IMMUNOL, V76, P166, DOI 10.1016/j.humimm.2014.12.016; Liao YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08747; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; Merker M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082551; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Ng PC, 2010, METHODS MOL BIOL, V628, P215, DOI 10.1007/978-1-60327-367-1_12; Nguyen D, 2003, AM J RESP CRIT CARE, V168, P1353, DOI 10.1164/rccm.200307-910OC; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Petkau A., 2015, PIPELINE IDENTIFYING; Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588; Pightling AW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104579; POULET S, 1995, ARCH MICROBIOL, V163, P87, DOI 10.1007/s002030050176; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Scott D, 2015, CURR MICROBIOL, V70, P338, DOI 10.1007/s00284-014-0721-6; Stein A, 2010, NUCLEIC ACIDS RES, V38, P709, DOI 10.1093/nar/gkp1043; Thermo Fisher Scientific, 2008, 260 280 260 230 RATI, P2; Timms VJ, 2015, J MICROBIOL METH, V112, P99, DOI 10.1016/j.mimet.2015.03.016; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3	46	35	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148676	10.1371/journal.pone.0148676	http://dx.doi.org/10.1371/journal.pone.0148676			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849565	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000155
J	Eriksson, H; Milberg, A; Hjelm, K; Friedrichsen, M				Eriksson, Helene; Milberg, Anna; Hjelm, Katarina; Friedrichsen, Maria			End of Life Care for Patients Dying of Stroke: A Comparative Registry Study of Stroke and Cancer	PLOS ONE			English	Article							PALLIATIVE CARE; TEAM; PROFESSIONALS; PREFERENCES; DEMENTIA; FAMILY; DEATH; NEEDS; PAIN	Background Although stroke is a significant public health challenge and the need for palliative care has been emphasized for these patients, there is limited data on end-of-life care for patients dying from stroke. Objective To study the end-of-life care during the last week of life for patients who had died of stroke in terms of registered symptom, symptom management, and communication, in comparison with patients who had died of cancer. Design This study is a retrospective, comparative registry study. Methods A retrospective comparative registry study was performed using data from a Swedish national quality register for end-of-life care based on WHO's definition of Palliative care. Data from 1626 patients who had died of stroke were compared with data from 1626 patients who had died of cancer. Binary logistic analyses were used to calculate odds ratios, with 95% CI. Results Compared to patients who was dying of cancer, the patients who was dying of stroke had a significantly higher prevalence of having death rattles registered, but a significantly lower prevalence of, nausea, confusion, dyspnea, anxiety, and pain. In addition, the stroke group had significantly lower odds ratios for health care staff not to know whether all these six symptoms were present or not. Patients who was dying of stroke had significantly lower odds ratio of having informative communication from a physician about the transition to end-of-life care and of their family members being offered bereavement follow-up. Conclusions The results indicate on differences in end-of-life care between patients dying of stroke and those dying from cancer. To improve the end-of-life care in clinical practice and ensure it has consistent quality, irrespective of diagnosis, education and implementation of palliative care principles are necessary.	[Eriksson, Helene; Milberg, Anna; Hjelm, Katarina; Friedrichsen, Maria] Linkoping Univ, Dept Social & Welf Studies, Norrkoping, Sweden; [Milberg, Anna; Friedrichsen, Maria] Vrinnevi Hosp, Palliat Educ & Res Ctr, Norrkoping, Sweden; [Milberg, Anna; Friedrichsen, Maria] Vrinnevi Hosp, Dept Adv Home Care, Norrkoping, Sweden	Linkoping University	Eriksson, H (corresponding author), Linkoping Univ, Dept Social & Welf Studies, Norrkoping, Sweden.	Helene.m.eriksson@liu.se			Stroke Riksforbund [2012-00185]; Stahls stiftelse [4813101041]; Forss [479071]	Stroke Riksforbund; Stahls stiftelse; Forss	This work was supported by Stroke Riksforbund (number: 2012-00185) 30 000SEK Stahls stiftelse (number: 4813101041) 200 000 SEK Forss (number: 479071) 150 000 SEK (Helene Eriksson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDINGTONHALL J, 1995, STROKE, V26, P2242, DOI 10.1161/01.STR.26.12.2242; Bito Seiji, 2007, BMC Med Ethics, V8, P7, DOI 10.1186/1472-6939-8-7; Bruera E, 2013, PALLIATIVE MED, V27, P939, DOI 10.1177/0269216313477177; Burton CR, 2012, BMC PALLIAT CARE, V11, DOI 10.1186/1472-684X-11-22; Creutzfeldt CJ, 2015, STROKE, V46, P2714, DOI 10.1161/STROKEAHA.115.008224; Creutzfeldt CJ, 2012, STROKE, V43, P3405, DOI 10.1161/STROKEAHA.112.673376; de Boer ME, 2015, PALLIATIVE MED, V29, P451, DOI 10.1177/0269216314563427; Epstein RM, 2010, HEALTH AFFAIR, V29, P1489, DOI 10.1377/hlthaff.2009.0888; Eriksson H, 2014, J NEUROSCI NURS, V46, P162, DOI 10.1097/JNN.0000000000000049; Helvig E, 2015, VASC HEALTH RISK MAN, V11, P507, DOI 10.2147/VHRM.S85814; Henoch I, 2016, SCAND J CARING SCI, V30, P5, DOI 10.1111/scs.12253; Holloway RG, 2014, STROKE, V45, P1887, DOI 10.1161/STR.0000000000000015; Kehl KA, 2013, AM J HOSP PALLIAT ME, V30, P601, DOI 10.1177/1049909112468222; Liljehult J, 2015, ACTA NEUROL SCAND; Lindblom AK, 2012, J NURS MANAGE, V20, P206, DOI 10.1111/j.1365-2834.2011.01376.x; Lundstrom S, 2012, PALLIATIVE MED, V26, P313, DOI 10.1177/0269216311414758; Martinsson L, 2011, ACTA ONCOL, V50, P642, DOI 10.3109/0284186X.2011.554434; Mazzocato C, 2010, EUR J NEUROL, V17, P73, DOI 10.1111/j.1468-1331.2009.02744.x; Meleis AI., 2011, THEORETICAL NURSING; Monacelli F, 2013, CLIN TER, V164, pE23, DOI 10.7417/CT.2013.1516; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Norrving Bo, 2007, Int J Stroke, V2, P139, DOI 10.1111/j.1747-4949.2007.00109.x; Ntlholang O, 2015, IRISH J MED SCI; Payne S, 2010, PALLIATIVE MED, V24, P146, DOI 10.1177/0269216309350252; Rejno A, 2013, BMC NURS, V12, DOI 10.1186/1472-6955-12-13; Rejno A, 2012, NURS ETHICS, V19, P642, DOI 10.1177/0969733011412099; Roberts SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131836; San Luis COV, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-21; The National Board of Health and Welfare, 2014, BRYTP; Thomas RL, 2014, MED J AUSTRALIA, V201, P452, DOI 10.5694/mja14.00623; van der Steen JT, 2015, J PAIN SYMPTOM MANAG, V50, P659, DOI 10.1016/j.jpainsymman.2015.05.015; Weil J, 2015, PALLIATIVE MED, V29, P293, DOI 10.1177/0269216314560801; World Health Organization, WHO DEF PALL CAR 201	33	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147694	10.1371/journal.pone.0147694	http://dx.doi.org/10.1371/journal.pone.0147694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845149	Green Submitted, gold, Green Published			2022-12-27	WOS:000369552800013
J	Gottschlich, C				Gottschlich, Carsten			Convolution Comparison Pattern: An Efficient Local Image Descriptor for Fingerprint Liveness Detection	PLOS ONE			English	Article							TEXTURE CLASSIFICATION; FEATURES; ALGORITHM; SCALE	We present a new type of local image descriptor which yields binary patterns from small image patches. For the application to fingerprint liveness detection, we achieve rotation invariant image patches by taking the fingerprint segmentation and orientation field into account. We compute the discrete cosine transform (DCT) for these rotation invariant patches and attain binary patterns by comparing pairs of two DCT coefficients. These patterns are summarized into one or more histograms per image. Each histogram comprises the relative frequencies of pattern occurrences. Multiple histograms are concatenated and the resulting feature vector is used for image classification. We name this novel type of descriptor convolution comparison pattern (CCP). Experimental results show the usefulness of the proposed CCP descriptor for fingerprint liveness detection. CCP outperforms other local image descriptors such as LBP, LPQ and WLD on the LivDet 2013 benchmark. The CCP descriptor is a general type of local image descriptor which we expect to prove useful in areas beyond fingerprint liveness detection such as biological and medical image processing, texture recognition, face recognition and iris recognition, liveness detection for face and iris images, and machine vision for surface inspection and material classification.	[Gottschlich, Carsten] Univ Gottingen, Inst Math Stochast, Goldschmidtstr 7, D-37077 Gottingen, Germany	University of Gottingen	Gottschlich, C (corresponding author), Univ Gottingen, Inst Math Stochast, Goldschmidtstr 7, D-37077 Gottingen, Germany.	gottschlich@math.uni-goettingen.de			German Research Foundation (DFG); Open Access Publication Funds of the University of Gottingen; Felix-Bernstein-Institute for Mathematical Statistics in the Biosciences; Niedersachsen Vorab of the Volkswagen Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Funds of the University of Gottingen; Felix-Bernstein-Institute for Mathematical Statistics in the Biosciences; Niedersachsen Vorab of the Volkswagen Foundation	The author gratefully acknowledges support by the German Research Foundation (DFG) and the Open Access Publication Funds of the University of Gottingen, and by the Felix-Bernstein-Institute for Mathematical Statistics in the Biosciences and the Niedersachsen Vorab of the Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar A, 2006, IEEE IMAGE PROC, P321, DOI 10.1109/ICIP.2006.313158; AHMED N, 1974, IEEE T COMPUT, VC 23, P90, DOI 10.1109/T-C.1974.223784; Amornraksa T, 2006, ELECTRON LETT, V42, P522, DOI 10.1049/el:20064330; Arora SS, 2014, IEEE T PATTERN ANAL, V36, P2452, DOI 10.1109/TPAMI.2014.2330609; Bazen AM, 2002, IEEE T PATTERN ANAL, V24, P905, DOI 10.1109/TPAMI.2002.1017618; Britanak V., 2006, DISCRETE COSINE SINE, DOI [10.1016/b978-012373624-6/50003-5, DOI 10.1016/B978-012373624-6/50003-5]; Cao K, 2012, PATTERN RECOGN, V45, P151, DOI 10.1016/j.patcog.2011.04.016; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen J, 2010, IEEE T PATTERN ANAL, V32, P1705, DOI 10.1109/TPAMI.2009.155; Chen XJ, 2006, IEEE T INF FOREN SEC, V1, P169, DOI 10.1109/TIFS.2006.873605; Chen XJ, 2006, IEEE T IMAGE PROCESS, V15, P767, DOI 10.1109/TIP.2005.860597; DUDA RO, 2001, PATTERN CLASSIFICATI; Eltzner B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126346; Ghiani L., 2013, INT CONF BIOMETR, P1; Ghiani L., 2012, P MULT SEC WORKSH MM, P157, DOI [DOI 10.1145/2361407.2361434, 10.1145/2361407.2361434]; GONZALEZ R., 2002, DIGITAL IMAGE PROCES; Gottschlich C, 2012, IET BIOMETRICS, V1, P105, DOI 10.1049/iet-bmt.2012.0003; Gottschlich C, 2015, P ISPA ZAGR CROAT, P85; Gottschlich C., 2010, FINGERPRINT GROWTH P; Gottschlich C., 2015, ARXIV150304729CSCV; Gottschlich C, 2014, 2014 IEEE/IAPR INTERNATIONAL JOINT CONFERENCE ON BIOMETRICS (IJCB 2014); Gottschlich C, 2014, IET BIOMETRICS, V3, P291, DOI 10.1049/iet-bmt.2013.0065; Gottschlich C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110214; Gottschlich C, 2012, IEEE T IMAGE PROCESS, V21, P2220, DOI 10.1109/TIP.2011.2170696; Gottschlich C, 2009, IEEE T INF FOREN SEC, V4, P802, DOI 10.1109/TIFS.2009.2033219; Gragnaniello D, 2014, ELECTRON LETT, V50, P439, DOI 10.1049/el.2013.4044; Gragnaniello Diego, 2013, Proceedings of the 2013 IEEE Workshop on Biometric Measurements and Systems for Security and Medical Applications (BIOMS), P46, DOI 10.1109/BIOMS.2013.6656148; Gragnaniello D, 2015, IEEE T INF FOREN SEC, V10, P849, DOI 10.1109/TIFS.2015.2404294; Gragnaniello D, 2015, PATTERN RECOGN, V48, P1050, DOI 10.1016/j.patcog.2014.05.021; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Jirachaweng S, 2007, LECT NOTES COMPUT SC, V4642, P96; Johnson-Laird PN, 2013, PSYCHOL LEARN MOTIV, V59, P1, DOI 10.1016/B978-0-12-407187-2.00001-0; Kylberg G, 2013, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2013-17; Larkin KG, 2007, OPT EXPRESS, V15, P8667, DOI 10.1364/OE.15.008667; Lategahn H, 2010, IEEE T IMAGE PROCESS, V19, P1548, DOI 10.1109/TIP.2010.2042100; Lazebnik S, 2005, IEEE T PATTERN ANAL, V27, P1265, DOI 10.1109/TPAMI.2005.151; Li G, 2013, P 18 INT C DIG SIGN, P1; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Marasco E, 2015, ACM COMPUT SURV, V47, DOI 10.1145/2617756; Marasco E, 2012, PATTERN RECOGN LETT, V33, P1148, DOI 10.1016/j.patrec.2012.01.009; Menotti D, 2015, IEEE T INF FOREN SEC, V10, P864, DOI 10.1109/TIFS.2015.2398817; Nguyen A, 2015, ARXIV14121897V3CSCV; Nikam Shankar Bhausaheb, 2008, 2008 1st International Conference on Emerging Trends in Engineering and Technology (ICETET), P675, DOI 10.1109/ICETET.2008.134; Nogueira RF, 2014, 2014 IEEE WORKSHOP ON BIOMETRIC MEASUREMENTS AND SYSTEMS FOR SECURITY AND MEDICAL APPLICATIONS (BIOMS) PROCEEDINGS, P22, DOI 10.1109/BIOMS.2014.6951531; Oehlmann L., 2015, BIOM FOR IWBF 2015 I, P1; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Ojansivu V, 2008, LECT NOTES COMPUT SC, V5099, P236, DOI 10.1007/978-3-540-69905-7_27; Paulino AA, 2013, IEEE T INF FOREN SEC, V8, P31, DOI 10.1109/TIFS.2012.2223678; Peters J, 2017, ADAPT COMPUT MACH LE; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Salomon D., 2007, DATA COMPRESSION, VFourth; Sintorn IM, 2014, INT C PATT RECOG, P3227, DOI 10.1109/ICPR.2014.556; Sousedik C, 2014, IET BIOMETRICS, V3, P219, DOI 10.1049/iet-bmt.2013.0020; Szeliski R, 2011, TEXTS COMPUT SCI, P1, DOI 10.1007/978-1-84882-935-0; Thai DH, 2015, ARXIV150102113CSCV; Thai DH, IET BIOMETRICS; Tuytelaars T, 2007, FOUND TRENDS COMPUT, V3, P177, DOI 10.1561/0600000017; Varma M, 2005, INT J COMPUT VISION, V62, P61, DOI 10.1007/s11263-005-4635-4; Varma M, 2009, IEEE T PATTERN ANAL, V31, P2032, DOI 10.1109/TPAMI.2008.182; Wang YL, 2010, IEEE IMAGE PROC, P3109, DOI 10.1109/ICIP.2010.5654009; Witten IH, 2011, MOR KAUF D, P1	61	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148552	10.1371/journal.pone.0148552	http://dx.doi.org/10.1371/journal.pone.0148552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844544	gold, Green Published, Green Submitted			2022-12-27	WOS:000369552800069
J	Xiao, J; Chen, D; Lin, XX; Peng, SF; Xiao, MF; Huang, WH; Wang, YC; Peng, JB; Zhang, W; Ouyang, DS; Chen, Y				Xiao, Jian; Chen, Dan; Lin, Xiu-Xian; Peng, Shi-Fang; Xiao, Mei-Fang; Huang, Wei-Hua; Wang, Yi-Cheng; Peng, Jing-Bo; Zhang, Wei; Ouyang, Dong-Sheng; Chen, Yao			Screening of Drug Metabolizing Enzymes for the Ginsenoside Compound K In Vitro: An Efficient Anti-Cancer Substance Originating from Panax Ginseng	PLOS ONE			English	Article							HUMAN LIVER-MICROSOMES; HUMAN CYTOCHROME-P450 ENZYMES; GENETIC POLYMORPHISMS; INHIBITION; CYP; IMPACT; POTENT	Ginsenoside compound K (CK), a rare ginsenoside originating from Panax Ginseng, has been found to possess unique pharmacological activities specifically as anti-cancers. However, the role of cytochrome P450s (CYPs) in the metabolism of CK is unclear. In this study, we screened the CYPs for the metabolism of CK in vitro using human liver microsomes (HLMs) or human recombinant CYPs. The results showed that CK inhibited the enzyme activities of CYP2C9 and CYP3A4 in the HLMs. The K-m and V-max values of CK were 84.20+/-21.92 mu M and 0.28+/-0.04 nmol/mg protein/min, respectively, for the HLMs; 34.63+/-10.48 mu M and 0.45+/-0.05 nmol/nmol P450/min, respectively, for CYP2C9; and 27.03+/-5.04 mu M and 0.68+/-0.04 nmol/nmol P450/min, respectively, for CYP3A4. The IC50 values were 16.00 mu M and 9.83 mu M, and K-i values were 14.92 mu M and 11.42 mu M for CYP2C9 and CYP3A4, respectively. Other human CYP isoforms, including CYP1A2, CYP2A6, CYP2D6, CYP2E1, and CYP2C19, showed minimal or no effect on CK metabolism. The results suggested that CK was a substrate and also inhibitors for both CYP2C9 and CYP3A4. Patients using CK in combination with therapeutic drugs that are substrates of CYP2C9 and CYP3A4 for different reasons should be careful, although the inhibiting potency of CK is much poorer than that of enzyme-specific inhibitors.	[Xiao, Jian; Chen, Dan; Lin, Xiu-Xian; Huang, Wei-Hua; Wang, Yi-Cheng; Peng, Jing-Bo; Zhang, Wei; Ouyang, Dong-Sheng; Chen, Yao] Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha, Hunan, Peoples R China; [Xiao, Jian; Chen, Dan; Lin, Xiu-Xian; Huang, Wei-Hua; Wang, Yi-Cheng; Peng, Jing-Bo; Zhang, Wei; Ouyang, Dong-Sheng; Chen, Yao] Cent S Univ, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China; [Peng, Shi-Fang; Xiao, Mei-Fang] Cent S Univ, Xiangya Hosp, Dept Hepatol & Infect Dis, Changsha, Hunan, Peoples R China; [Peng, Shi-Fang; Xiao, Mei-Fang] Cent S Univ, Xiangya Hosp, Hlth Management Ctr, Changsha, Hunan, Peoples R China; [Xiao, Jian] Cent S Univ, Xiangya Hosp, Dept Pharm, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University; Central South University	Chen, Y (corresponding author), Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha, Hunan, Peoples R China.; Chen, Y (corresponding author), Cent S Univ, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China.	cbohua@163.com	Chen, Yao/AAJ-5658-2020; Chen, Dan/GRY-2691-2022	Chen, Dan/0000-0002-1570-9034; Huang, Wei-Hua/0000-0003-4167-8304; Chen, Yao/0000-0001-7231-9860	National Scientific Foundation of China [81302850, 81300204, 31400306]; China Postdoctoral Science Foundation [2013M531817, 2014T70793]; Science and Technology Plan Projects of Hunan Province [2014RS4011]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Plan Projects of Hunan Province	This work was supported by the National Scientific Foundation of China (Grants 81302850, 81300204, 31400306); the China Postdoctoral Science Foundation (Grants 2013M531817, 2014T70793); and the Science and Technology Plan Projects of Hunan Province (Grant 2014RS4011).	Bourrie M, 1996, J PHARMACOL EXP THER, V277, P321; Chen JZ, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2013.03.02; Chen JY, 2015, J PHARMACOL EXP THER, V353, P71, DOI 10.1124/jpet.114.220665; Chen Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-24; Christensen LP, 2009, ADV FOOD NUTR RES, V55, P1, DOI 10.1016/S1043-4526(08)00401-4; CORNISHB.A, 1974, BIOCHEM J, V137, P143, DOI 10.1042/bj1370143; Dorado P, 2014, PHARMACOGENOMICS, V15, P261, DOI 10.2217/pgs.13.243; Ghozlan MF, 2015, BLOOD COAGULATION FI; Goey AKL, 2013, CANCER TREAT REV, V39, P773, DOI 10.1016/j.ctrv.2012.12.008; Helms Steve, 2004, Altern Med Rev, V9, P259; Hirota T, 2013, DRUG METAB PHARMACOK, V28, P28, DOI 10.2133/dmpk.DMPK-12-RV-085; Huang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113819; Kim YJ, 2014, J GINSENG RES, V38, P66, DOI 10.1016/j.jgr.2013.11.001; Kong WM, 2011, MOLECULES, V16, P7344, DOI 10.3390/molecules16097344; Lee JI, 2010, CLIN PHARMACOKINET, V49, P295, DOI 10.2165/11319980-000000000-00000; Leggett S, 2015, NUTR CANCER, V67, P373, DOI 10.1080/01635581.2015.1004731; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087810; Li X, 2013, CHEM-BIOL INTERACT, V204, P140, DOI 10.1016/j.cbi.2013.05.007; Lin JH, 2006, PHARM RES-DORDR, V23, P1089, DOI 10.1007/s11095-006-0277-7; Liu Y, 2006, TOXICOL SCI, V91, P356, DOI 10.1093/toxsci/kfj164; Malati CY, 2012, J CLIN PHARMACOL, V52, P932, DOI 10.1177/0091270011407194; Qin CZ, 2014, BIOMED CHROMATOGR, V28, P197, DOI 10.1002/bmc.3003; Smith PJ, 2014, ASIA-PAC J CLIN ONCO, V10, P1, DOI 10.1111/ajco.12115; Taavitsainen P, 2001, DRUG METAB DISPOS, V29, P217; Yamane M, 2015, XENOBIOTICA, V45, P230, DOI 10.3109/00498254.2014.976296; Yang XD, 2015, FITOTERAPIA, V100, P208, DOI 10.1016/j.fitote.2014.11.019; Zhang ZY, 2013, INT J MOL SCI, V14, P2980, DOI 10.3390/ijms14022980	27	18	19	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147183	10.1371/journal.pone.0147183	http://dx.doi.org/10.1371/journal.pone.0147183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845774	gold, Green Published, Green Submitted			2022-12-27	WOS:000369552800008
J	McGill, JL; Nair, ADS; Cheng, CM; Rusk, RA; Jaworski, DC; Ganta, RR				McGill, Jodi L.; Nair, Arathy D. S.; Cheng, Chuanmin; Rusk, Rachel A.; Jaworski, Deborah C.; Ganta, Roman R.			Vaccination with an Attenuated Mutant of Ehrlichia chaffeensis Induces Pathogen-Specific CD4(+) T Cell Immunity and Protection from Tick-Transmitted Wild-Type Challenge in the Canine Host	PLOS ONE			English	Article							HUMAN MONOCYTOTROPIC EHRLICHIOSIS; UNITED-STATES; ANAPLASMA-PHAGOCYTOPHILUM; HUMORAL IMMUNITY; ANIMAL-MODEL; IFN-GAMMA; INFECTION; MICE; RESPONSES; INOCULATION	Ehrlichia chaffeensis is a tick-borne rickettsial pathogen and the causative agent of human monocytic ehrlichiosis. Transmitted by the Amblyomma americanum tick, E. chaffeensis also causes disease in several other vertebrate species including white-tailed deer and dogs. We have recently described the generation of an attenuated mutant strain of E. chaffeensis, with a mutation in the Ech_0660 gene, which is able to confer protection from secondary, intravenous-administered, wild-type E. chaffeensis infection in dogs. Here, we extend our previous results, demonstrating that vaccination with the Ech_0660 mutant protects dogs from physiologic, tick-transmitted, secondary challenge with wild-type E. chaffeensis; and describing, for the first time, the cellular and humoral immune responses induced by Ech_0660 mutant vaccination and wild-type E. chaffeensis infection in the canine host. Both vaccination and infection induced a rise in E. chaffeensis-specific antibody titers and a significant Th1 response in peripheral blood as measured by E. chaffeensis antigen-dependent CD4(+) T cell proliferation and IFN. production. Further, we describe for the first time significant IL-17 production by peripheral blood leukocytes from both Ech_0660 mutant vaccinated animals and control animals infected with wild-type E. chaffeensis, suggesting a previously unrecognized role for IL-17 and Th17 cells in the immune response to rickettsial pathogens. Our results are a critical first step towards defining the role of the immune system in vaccine-induced protection from E. chaffeensis infection in an incidental host; and confirm the potential of the attenuated mutant clone, Ech_0660, to be used as a vaccine candidate for protection against tick-transmitted E. chaffeensis infection.	[McGill, Jodi L.; Nair, Arathy D. S.; Cheng, Chuanmin; Jaworski, Deborah C.; Ganta, Roman R.] Kansas State Univ, Coll Vet Med, Ctr Excellence Vector Borne Dis, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Rusk, Rachel A.] Kansas State Univ, Coll Vet Med, Pathobiol Grad Program, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Kansas State University; Kansas State University	McGill, JL (corresponding author), Kansas State Univ, Coll Vet Med, Ctr Excellence Vector Borne Dis, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	jlmcgill@vet.k-state.edu			PHS from the National Institute of Allergy and Infectious Diseases [AI070908]; KSU-CVM; National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103638]; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070908, R01AI070908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103638] Funding Source: NIH RePORTER	PHS from the National Institute of Allergy and Infectious Diseases; KSU-CVM; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by PHS grant number AI070908 from the National Institute of Allergy and Infectious Diseases to RRG, and KSU-CVM start-up funds to JLM. Research reported in this publication was also supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20 GM103638 to JLM. This manuscript is contribution number 16-102-J from the Kansas Agricultural Experiment Station. Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Andrew DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076664; Bitsaktsis C, 2004, J IMMUNOL, V172, P6894, DOI 10.4049/jimmunol.172.11.6894; Bitsaktsis C, 2007, INFECT IMMUN, V75, P4933, DOI 10.1128/IAI.00705-07; Bitsaktsis C, 2006, J IMMUNOL, V177, P4644, DOI 10.4049/jimmunol.177.7.4644; Breitschwerdt EB, 1998, ANTIMICROB AGENTS CH, V42, P362; BUHLES WC, 1974, J INFECT DIS, V130, P357, DOI 10.1093/infdis/130.4.357; Cheng CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132657; Cheng CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003171; Cheng Chuanmin, 2008, Curr Protoc Microbiol, VChapter 3, DOI 10.1002/9780471729259.mc03a01s9; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; ENG TR, 1990, JAMA-J AM MED ASSOC, V264, P2251, DOI 10.1001/jama.264.17.2251; Feng HM, 2004, INFECT IMMUN, V72, P966, DOI 10.1128/IAI.72.2.966-971.2004; FISHBEIN DB, 1994, ANN INTERN MED, V120, P736, DOI 10.7326/0003-4819-120-9-199405010-00003; Ganta RR, 2007, INFECT IMMUN, V75, P135, DOI 10.1128/IAI.01127-06; Ganta RR, 2004, INFECT IMMUN, V72, P159, DOI 10.1128/IAI.72.1.159-167.2004; Ganta RR, 2002, INFECT IMMUN, V70, P380, DOI 10.1128/IAI.70.1.380-388.2002; Ismail N, 2004, J IMMUNOL, V172, P1786, DOI 10.4049/jimmunol.172.3.1786; Ismail N, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-26; Kawahara M, 1996, MICROBIOL IMMUNOL, V40, P575, DOI 10.1111/j.1348-0421.1996.tb01111.x; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Levin ML, 2004, INFECT IMMUN, V72, P4723, DOI 10.1128/IAI.72.8.4723-4730.2004; McBride JW, 2010, EXPERT REV VACCINES, V9, P1071, DOI [10.1586/erv.10.93, 10.1586/ERV.10.93]; Nair ADS, 2015, INFECT IMMUN, V83, P2827, DOI 10.1128/IAI.00487-15; Nair ADS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109056; O'Meara CP, 2014, IMMUNOL CELL BIOL, V92, P287, DOI 10.1038/icb.2013.92; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Pedersen LG, 2002, VET IMMUNOL IMMUNOP, V88, P111, DOI 10.1016/S0165-2427(02)00139-3; Pretorius A, 2008, VACCINE, V26, P4363, DOI 10.1016/j.vaccine.2008.06.006; Shkap V, 2007, TRENDS PARASITOL, V23, P420, DOI 10.1016/j.pt.2007.07.003; Singu V, 2005, INFECT IMMUN, V73, P79, DOI 10.1128/IAI.73.1.79-87.2005; Sirigireddy KR, 2005, J MOL DIAGN, V7, P308, DOI 10.1016/S1525-1578(10)60559-4; Sotomayor EA, 2001, AM J PATHOL, V158, P757, DOI 10.1016/S0002-9440(10)64018-7; Stevenson HL, 2006, INFECT IMMUN, V74, P4856, DOI 10.1128/IAI.00246-06; Stuen S, 2003, CLIN DIAGN LAB IMMUN, V10, P692, DOI 10.1128/CDLI.10.4.692-695.2003; Walker DH, 1996, EMERG INFECT DIS, V2, P18, DOI 10.3201/eid0201.960102; Wikel S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00337; Winslow GM, 2005, ANN NY ACAD SCI, V1063, P395, DOI 10.1196/annals.1355.071; Winslow GM, 2000, INFECT IMMUN, V68, P2187, DOI 10.1128/IAI.68.4.2187-2195.2000; Winslow GM, 1998, INFECT IMMUN, V66, P3892, DOI 10.1128/IAI.66.8.3892-3899.1998; Yabsley MJ, 2010, VET PARASITOL, V167, P136, DOI 10.1016/j.vetpar.2009.09.015; Yager E, 2005, INFECT IMMUN, V73, P8009, DOI 10.1128/IAI.73.12.8009-8016.2005; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Yu XJ, 2007, VET PARASITOL, V143, P337, DOI 10.1016/j.vetpar.2006.08.027; Zhang XF, 2003, J MED MICROBIOL, V52, P1021, DOI 10.1099/jmm.0.05234-0	44	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148229	10.1371/journal.pone.0148229	http://dx.doi.org/10.1371/journal.pone.0148229			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841025	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200103
J	Alcaraz, LD; Martinez-Sanchez, S; Torres, I; Ibarra-Laclette, E; Herrera-Estrella, L				David Alcaraz, Luis; Martinez-Sanchez, Shamayim; Torres, Ignacio; Ibarra-Laclette, Enrique; Herrera-Estrella, Luis			The Metagenome of Utricularia gibba's Traps: Into the Microbial Input to a Carnivorous Plant	PLOS ONE			English	Article							ESCHERICHIA-COLI; BLADDERWORT UTRICULARIA; PSEUDOMONAS-AERUGINOSA; RHIZOSPHERE MICROBIOME; COMPLETE GENOME; BACTERIAL; SEQUENCES; PROTEIN; DNA; 2-OXOGLUTARATE	The genome and transcriptome sequences of the aquatic, rootless, and carnivorous plant Utricularia gibba L. (Lentibulariaceae), were recently determined. Traps are necessary for U. gibba because they help the plant to survive in nutrient-deprived environments. The U. gibba's traps (Ugt) are specialized structures that have been proposed to selectively filter microbial inhabitants. To determine whether the traps indeed have a microbiome that differs, in composition or abundance, from the microbiome in the surrounding environment, we used whole-genome shotgun (WGS) metagenomics to describe both the taxonomic and functional diversity of the Ugt microbiome. We collected U. gibba plants from their natural habitat and directly sequenced the metagenome of the Ugt microbiome and its surrounding water. The total predicted number of species in the Ugt was more than 1,100. Using pangenome fragment recruitment analysis, we were able to identify to the species level of some key Ugt players, such as Pseudomonas monteilii. Functional analysis of the Ugt metagenome suggests that the trap microbiome plays an important role in nutrient scavenging and assimilation while complementing the hydrolytic functions of the plant.	[David Alcaraz, Luis; Martinez-Sanchez, Shamayim] Univ Nacl Autonoma Mexico, Dept Ecol Biodiversidad, Lab Nacl Ciencias Sostenibilidad, Inst Ecol, AP 70-275, Mexico City 04510, DF, Mexico; [Torres, Ignacio] Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Antigua Carretera Patzcuaro 8701, Morelia 58190, Michoacan, Mexico; [Ibarra-Laclette, Enrique] Inst Ecol AC, Red Estudios Mol Avanzados, Carretera Antigua Coatepec 351, El Haya Xalapa 91070, Veracruz, Mexico; [Ibarra-Laclette, Enrique; Herrera-Estrella, Luis] Inst Politecn Nacl CINVESTAV, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad LANGEBIO, Km 9-6 Carretera Irapuato Leon, Guanajuato 36821, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto de Ecologia - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Alcaraz, LD (corresponding author), Univ Nacl Autonoma Mexico, Dept Ecol Biodiversidad, Lab Nacl Ciencias Sostenibilidad, Inst Ecol, AP 70-275, Mexico City 04510, DF, Mexico.	lalcaraz@iecologia.unam.mx	Alcaraz, Luis David/D-1352-2011; Herrera-Estrella, Luis/AAL-2472-2020; Herrera-Estrella, Luis/ABC-7431-2020	Alcaraz, Luis David/0000-0003-3284-0605; Herrera-Estrella, Luis/0000-0001-7936-3856; 	HHMI grant [55007646];  [DGAPA-PAPIIT-UNAM IA200514];  [CONACyT CB0237387]	HHMI grant(Howard Hughes Medical Institute); ; 	This work was supported by the HHMI grant 55007646 to LHE. LDA and SMS were supported by grants DGAPA-PAPIIT-UNAM IA200514, and CONACyT CB0237387. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the HHMI grant 55007646 to LHE. LDA and SMS were supported by grants DGAPA-PAPIIT-UNAM IA200514, and CONACyT CB0237387. We thank the valuable comments and suggestions of three anonymous reviewers.	Adamczack J, 2014, J BIOL CHEM, V289, P30753, DOI 10.1074/jbc.M114.603886; Allali N, 2002, J BACTERIOL, V184, P3224, DOI 10.1128/JB.184.12.3224-3231.2002; Baek JH, 2006, FEMS MICROBIOL LETT, V264, P104, DOI 10.1111/j.1574-6968.2006.00440.x; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; BOLLINGER JM, 1995, J BIOL CHEM, V270, P14031, DOI 10.1074/jbc.270.23.14031; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Bunik VI, 2009, BIOCHEM J, V422, P405, DOI 10.1042/BJ20090722; Cao HX, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00526; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dorador C, 2013, FUND APPL LIMNOL, V182, P135, DOI 10.1127/1863-9135/2013/0393; Dueholm MS, 2014, BACTERIA USED BIOAUG, V2, P2010, DOI [10.1128/genomeA.00524-14, DOI 10.1128/GENOMEA.00524-14]; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Elomari M, 1997, ISOLATED CLIN SPECIM, V60, P846; Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P375, DOI 10.1111/j.1755-148X.2012.00989.x; Fouts DE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000141; Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111; Frisli T, 2013, J APPL MICROBIOL, V114, P141, DOI 10.1111/jam.12035; Galkin VE, 2006, STRUCTURE, V14, P983, DOI 10.1016/j.str.2006.04.001; Ghai R, 2012, SCI REP-UK, V2, DOI 10.1038/srep00490; Gilboa R, 2002, J BIOL CHEM, V277, P19811, DOI 10.1074/jbc.M202058200; Gliessmon SR, 1988, AGROECOLOGY ECOLOGIC; Gotelli N, 2013, ENCY BIODIVERSITY, V5; Gross M, 2006, MOL MICROBIOL, V59, P590, DOI 10.1111/j.1365-2958.2005.04956.x; Hardoim PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030438; He SM, 2010, NAT METHODS, V7, P807, DOI [10.1038/nmeth.1507, 10.1038/NMETH.1507]; HINTON DM, 1995, MYCOPATHOLOGIA, V129, P117, DOI 10.1007/BF01103471; Hodges M, 2002, J EXP BOT, V53, P905, DOI 10.1093/jexbot/53.370.905; Horne I, 2002, CLONING EXPRESSION P, P2687; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Ibarra-Laclette E, 2013, NATURE, V498, P94, DOI 10.1038/nature12132; Ibarra-Laclette E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-101; Izumi A, 2012, PROTEINS, V80, P2799, DOI 10.1002/prot.24177; Juang TCC, 2011, BOT STUD, V52, P47; Knief C, 2012, ISME J, V6, P1378, DOI 10.1038/ismej.2011.192; Krause A, 2006, NAT BIOTECHNOL, V24, P1385, DOI 10.1038/nbt1243; Kurihara S, 2009, J BACTERIOL, V191, P2776, DOI 10.1128/JB.01314-08; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Laalami S, 2014, CELL MOL LIFE SCI, V71, P1799, DOI 10.1007/s00018-013-1472-4; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LI XZ, 1995, ANTIMICROB AGENTS CH, V39, P1948, DOI 10.1128/AAC.39.9.1948; Liu Y, 2014, MAR GENOM, V15, P1, DOI 10.1016/j.margen.2014.04.005; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Madhaiyan M, 2013, GENOME ANNOUNC, V1, P3, DOI [10.1128/genomeA.00023-13.7, DOI 10.1128/GENOMEA.00023-13.7]; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mendes LW, 2014, ISME J, V8, P1577, DOI 10.1038/ismej.2014.17; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miao JF, 2013, INT IMMUNOPHARMACOL, V16, P429, DOI 10.1016/j.intimp.2013.05.007; Moore A., 2009, ABSTRACTS PROGRAMS G, P41; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nagashima S, 2012, J BACTERIOL, V194, P3541, DOI 10.1128/JB.00511-12; Nakatsu CH, 2006, INT J SYST EVOL MICR, V56, P983, DOI 10.1099/ijs.0.63524-0; Nawrocki E.P., 2009, STRUCTURAL RNA HOMOL, DOI 10.7936/K78050MP; Ortiz-Castro R, 2011, P NATL ACAD SCI USA, V108, P7253, DOI 10.1073/pnas.1006740108; Palchevskiy V, 2006, J BACTERIOL, V188, P3902, DOI 10.1128/JB.01974-05; Paulson JN, 2011, GENOME BIOL, V12, P12, DOI 10.1186/1465-6906-12-S1-P17; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Perez-Gutierrez RA, 2013, ISME J, V7, P487, DOI 10.1038/ismej.2012.119; Poole K, 1996, MOL MICROBIOL, V21, P713, DOI 10.1046/j.1365-2958.1996.281397.x; Quadt-Hallman A, 1997, BACTERIAL ENDOPHYTES, V582, P577; Richards JH, 2001, AM J BOT, V88, P170, DOI 10.2307/2657137; Santiago-Rodriguez TM, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-435; Schleifer KH., 2009, BERGEYS MANUAL SYSTE, P19, DOI [DOI 10.1007/978-0-387-68489-5_3, 10.1007/978-0-387-68489-5_3]; Sessitsch A, 2012, MOL PLANT MICROBE IN, V25, P28, DOI 10.1094/MPMI-08-11-0204; Sirova D, 2003, NEW PHYTOL, V159, P669, DOI 10.1046/j.1469-8137.2003.00834.x; Sirova D, 2014, ANN BOT-LONDON, V114, P125, DOI 10.1093/aob/mcu067; Sirova D, 2010, J EXP BOT, V61, P99, DOI 10.1093/jxb/erp286; Sirova D, 2009, AQUAT BOT, V90, P129, DOI 10.1016/j.aquabot.2008.07.007; Taghavi S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000943; Vos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030600; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wei CY, 2014, BIOL FERT SOILS, V50, P657, DOI 10.1007/s00374-013-0878-3; Wilke A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-141; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Ziegler K, 2001, FEMS MICROBIOL LETT, V196, P13, DOI 10.1111/j.1574-6968.2001.tb10533.x	82	12	13	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148979	10.1371/journal.pone.0148979	http://dx.doi.org/10.1371/journal.pone.0148979			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859489	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400113
J	Dubberke, ER; Olsen, MA; Stwalley, D; Kelly, CP; Gerding, DN; Young-Xu, Y; Mahe, C				Dubberke, Erik R.; Olsen, Margaret A.; Stwalley, Dustin; Kelly, Ciaran P.; Gerding, Dale N.; Young-Xu, Yinong; Mahe, Cedric			Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis	PLOS ONE			English	Article							CARE-ASSOCIATED INFECTIONS; UNITED-STATES; DISEASE; EPIDEMIOLOGY; HOSPITALS; NOROVIRUS; OUTBREAK; BURDEN	Background Population attributable risk percent (PAR%) is an epidemiological tool that provides an estimate of the percent reduction in total disease burden if that disease could be entirely eliminated among a subpopulation. As such, PAR% is used to efficiently target prevention interventions. Due to significant limitations in current Clostridium difficile Infection (CDI) prevention practices and the development of new approaches to prevent CDI, such as vaccination, we determined the PAR% for CDI in various subpopulations in the Medicare 5% random sample. Methods This was a retrospective cohort study using the 2009 Medicare 5% random sample. Comorbidities, infections, and healthcare exposures during the 12 months prior to CDI were identified. CDI incidence and PAR% were calculated for each condition/exposure. Easy to identify subpopulations that could be targeted from prevention interventions were identified based on PAR%. Findings There were 1,465,927 Medicare beneficiaries with 9,401 CDI cases for an incidence of 677/100,000 persons. Subpopulations representing less than 15% of the entire population and with a PAR% >= 30% were identified. These included deficiency anemia (PAR%=37.9%), congestive heart failure (PAR%=30.2%), fluid and electrolyte disorders (PAR%=29.6%), urinary tract infections (PAR%=40.5%), pneumonia (PAR%=35.2%), emergent hospitalization (PAR%=48.5%) and invasive procedures (PAR%=38.9%). Stratification by age and hospital exposures indicates hospital exposures are more strongly associated with CDI than age. Significance Small and identifiable subpopulations that account for relatively large proportions of CDI cases in the elderly were identified. These data can be used to target specific subpopulations for CDI prevention interventions.	[Dubberke, Erik R.; Olsen, Margaret A.; Stwalley, Dustin] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Olsen, Margaret A.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Kelly, Ciaran P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA; [Gerding, Dale N.] Edward Hines Jr Vet Affairs Hosp, Hines, IL USA; [Gerding, Dale N.] Loyola Univ, Chicago Stritch Sch Med, Maywood, IL 60153 USA; [Young-Xu, Yinong] Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH USA; [Mahe, Cedric] Sanofi Pasteur, Lyon, France	Washington University (WUSTL); Washington University (WUSTL); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago; Dartmouth College; Sanofi-Aventis; Sanofi France	Dubberke, ER (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	edubberk@dom.wustl.edu			Sanofi-Pasteur; Washington University Center for Administrative Data Research (CADR); Washington University Institute of Clinical and Translational Sciences grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [UL1 TR000448]; Agency for Healthcare Research and Quality (AHRQ) [R24 HS19455]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R24HS019455] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER	Sanofi-Pasteur; Washington University Center for Administrative Data Research (CADR); Washington University Institute of Clinical and Translational Sciences grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The funding for this study was provided by Sanofi-Pasteur. The sponsor participated in study design, interpretation of data, and preparation and review of the manuscript. Support was also provided by the Washington University Center for Administrative Data Research (CADR). CADR Research is supported in part by the Washington University Institute of Clinical and Translational Sciences grant UL1 TR000448 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) and Grant Number R24 HS19455 through the Agency for Healthcare Research and Quality (AHRQ). The funder provided support in the form of salaries for author CM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2012, MMWR MORB MORTAL WKL, V61, P157; Bateman BT, 2013, J THORAC CARDIOV SUR, V146, P472, DOI 10.1016/j.jtcvs.2013.02.075; Bignardi GE, 2007, J HOSP INFECT, V67, P198, DOI 10.1016/j.jhin.2007.07.001; Campbell RJ, 2009, INFECT CONT HOSP EP, V30, P526, DOI 10.1086/597507; Chitnis AS, 2013, JAMA INTERN MED, V173, P1359, DOI 10.1001/jamainternmed.2013.7056; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Cunha BA, 2008, J HOSP INFECT, V70, P98, DOI 10.1016/j.jhin.2008.06.001; Dubberke ER, 2008, EMERG INFECT DIS, V14, P1031, DOI 10.3201/eid1407.070867; Dubberke ER, 2007, CLIN INFECT DIS, V45, P1543, DOI 10.1086/523582; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; Dubberke ER, 2011, INFECT CONT HOSP EP, V32, P360, DOI 10.1086/658944; Ghose C, 2015, INFECT DIS CLIN N AM, V29, P145, DOI 10.1016/j.idc.2014.11.013; Goto M, 2014, CLIN INFECT DIS, V58, P688, DOI 10.1093/cid/cit737; Kuntz JL, 2012, EMERG INFECT DIS, V18, P960, DOI 10.3201/eid1806.111528; Kuntz JL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-194; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Muto CA, 2005, INFECT CONT HOSP EP, V26, P273, DOI 10.1086/502539; NORTHRIDGE ME, 1995, AM J PUBLIC HEALTH, V85, P1202, DOI 10.2105/AJPH.85.9.1202; Poole C, 2015, ANN EPIDEMIOL, V25, P147, DOI 10.1016/j.annepidem.2014.11.015; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268; Zilberberg MD, 2008, EMERG INFECT DIS, V14, P929, DOI 10.3201/eid1406.071447; Zilberberg MD, 2011, INFECT CONT HOSP EP, V32, P649, DOI 10.1086/660360	27	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0146822	10.1371/journal.pone.0146822	http://dx.doi.org/10.1371/journal.pone.0146822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859403	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400004
J	Gillis, K; Bala, G; Roosens, B; Remory, I; Hernot, S; Droogmans, S; Cosyns, B				Gillis, Kris; Bala, Gezim; Roosens, Bram; Remory, Isabel; Hernot, Sophie; Droogmans, Steven; Cosyns, Bernard			Quantification of Calcium Amount in a New Experimental Model: A Comparison between Ultrasound and Computed Tomography	PLOS ONE			English	Article							AORTIC-VALVE CALCIFICATION; ECHOCARDIOGRAPHIC-ASSESSMENT; ELECTRON-MICROSCOPY; STENOSIS; BIOPROSTHESES; DISEASE; HEART; SPECTROSCOPY; PROGRESSION; DEPOSITS	Purpose Calcification is an important prognostic factor in aortic valve stenosis. However, there is no ultrasound (US) method available to accurately quantify calcification in this setting to date. We aimed to validate a new US method for measuring the amount of calcium in an in vitro model, and compare it to computed tomography (CT), the current imaging gold standard. Materials and Methods An agar phantom (2% agar) was made, containing 9 different amounts of calcium-hydroxyapatite Ca-5(PO4)(3)OH (2 to 50mg). The phantoms were imaged with micro-CT and US (10 MHz probe). The calcium area (area(calcium)) and its maximum pixel value (PVmax) were obtained. These values were summed to calculate CT and US calcium scores (Sigma(area(calcium) x PVmax)) and volumes (Sigma area(calcium)). Both US-and CT-calcium scores were compared with the calcium amounts, and with each other. Results Both calcium scores correlated significantly with the calcium amount (R-2 = 0.9788, p<0.0001 and R-2 = 0.8154, p<0.0001 for CT and US respectively). Furthermore, there was a significant correlation between US and CT for calcium volumes (R-2 = 0.7392, p<0.0001) and scores (R-2 = 0.7391, p<0.0001). Conclusion We developed a new US method that accurately quantifies the amount of calcium in an in vitro model. Moreover it is strongly correlated with CT.	[Gillis, Kris; Bala, Gezim; Roosens, Bram; Remory, Isabel; Hernot, Sophie; Droogmans, Steven; Cosyns, Bernard] Vrije Univ Brussel, Fac Med & Pharm, Vivo Cellular & Mol Imaging ICMI Lab, Brussels, Belgium; [Gillis, Kris; Bala, Gezim; Roosens, Bram; Droogmans, Steven; Cosyns, Bernard] Univ Ziekenhuis Brussel UZ Brussel, Dept Cardiol, Ctr Hart En Vaatziekten CHVZ, Brussels, Belgium	Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel	Gillis, K (corresponding author), Vrije Univ Brussel, Fac Med & Pharm, Vivo Cellular & Mol Imaging ICMI Lab, Brussels, Belgium.	gilliskris@yahoo.com	Droogmans, Steven/B-8786-2008; Droogmans, Steven/AAI-6531-2020	Droogmans, Steven/0000-0003-3985-3249; Remory, Isabel/0000-0003-4785-0371; Hernot, Sophie/0000-0002-8739-6137; Roosens, Bram/0000-0002-0871-8303; Gillis, Kris/0000-0002-8003-9487; Bala, Gezim/0000-0002-7613-0712				Aksoy O, 2014, CLIN CARDIOL, V37, P26, DOI 10.1002/clc.22212; Al-Nakib LH, 2014, J BAGHDAD COLL DENTI, P92, DOI [10.0001/303, DOI 10.0001/303]; Bahler RC, 1999, AM J CARDIOL, V84, P1044, DOI 10.1016/S0002-9149(99)00496-8; Baumgartner H, 2009, EUR J ECHOCARDIOGR, V10, P1, DOI 10.1093/ejechocard/jen303; Bertazzo S, 2013, NAT MATER, V12, P576, DOI [10.1038/NMAT3627, 10.1038/nmat3627]; Bushberg JT, 2002, ESSENTIAL PHYS MED I, P497; Colli A, 2012, ANN CARDIOTHORAC SUR, V1, P156, DOI 10.3978/j.issn.2225-319X.2012.07.01; Colli A, 2011, J THORAC CARDIOV SUR, V142, P1229, DOI 10.1016/j.jtcvs.2011.04.026; Corciu AI, 2010, INT J CARDIOL, V142, P288, DOI 10.1016/j.ijcard.2009.01.021; Cottignoli V, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/542687; David TE, 2013, NAT REV CARDIOL, V10, P375, DOI 10.1038/nrcardio.2013.72; Delogne C, 2007, J MICROSC-OXFORD, V228, P62, DOI 10.1111/j.1365-2818.2007.01824.x; Garcia-Garcia HM, 2011, INT J CARDIOVAS IMAG, V27, P215, DOI 10.1007/s10554-010-9789-7; Gillis K, 2014, EUR HEART J-CARD IMG, V15, P1042, DOI 10.1093/ehjci/jeu067; Hao Y, 2014, EUR REV MED PHARMACO, V18, P1398; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Lee JS, 2012, ATHEROSCLEROSIS, V224, P340, DOI 10.1016/j.atherosclerosis.2012.07.023; LEE YS, 1993, J ELECTRON MICROSC, V42, P156; Lequerica JL, 2008, PHYS MED BIOL, V53, pN25, DOI 10.1088/0031-9155/53/4/N01; Mahesh M, 2007, RADIOGRAPHICS, V27, DOI 10.1148/rg.275075045; Messika-Zeitoun D, 2004, CIRCULATION, V110, P356, DOI 10.1161/01.CIR.0000135469.82545.D0; Mikroulis D, 2002, J MATER SCI-MATER M, V13, P885, DOI 10.1023/A:1016556514203; Mohler ER, 1999, J HEART VALVE DIS, V8, P254; Mohler ER, 2001, CIRCULATION, V103, P1522, DOI 10.1161/01.cir.103.11.1522; Nute JL, 2015, INVEST RADIOL, V50, P9, DOI 10.1097/RLI.0000000000000089; Orzechowska S, 2014, J HEART VALVE DIS, V23, P40; Otton JM, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-5; Pawade TA, 2015, J AM COLL CARDIOL, V66, P561, DOI 10.1016/j.jacc.2015.05.066; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; Roosens B, 2013, CARDIOVASC ULTRASOUN, V11, DOI 10.1186/1476-7120-11-4; Roosens B, 2011, CARDIOVASC TOXICOL, V11, P244, DOI 10.1007/s12012-011-9118-y; Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903; SCHOEN FJ, 1987, CIRCULATION, V76, P1061, DOI 10.1161/01.CIR.76.5.1061; Shen M, 1998, ANN THORAC SURG, V66, pS236, DOI 10.1016/S0003-4975(98)01102-3; Yousry M, 2012, CLIN PHYSIOL FUNCT I, V32, P470, DOI 10.1111/j.1475-097X.2012.01153.x; Zell K, 2007, PHYS MED BIOL, V52, pN475, DOI 10.1088/0031-9155/52/20/N02	36	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148904	10.1371/journal.pone.0148904	http://dx.doi.org/10.1371/journal.pone.0148904			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859304	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400102
J	Peres, M; Xu, HL; Wu, G				Peres, Mihaela; Xu, Helian; Wu, Gang			Community Evolution in International Migration Top1 Networks	PLOS ONE			English	Article							MOBILITY	Focusing on each country's topmost destination/origin migration relation with other countries, this study builds top1 destination networks and top1 origin networks in order to understand their skeletal construction and community dynamics. Each top1 network covers approximately 50% of the complete migrant network stock for each decade between 1960 and 2000. We investigate the community structure by implementing the Girvan-Newman algorithm and compare the number of components and communities to illustrate their differences. We find that (i) both top1 networks (origin and destination) exhibited communities with a clear structure and a surprising evolution, although 80% edges persist between each decade; (ii) top1 destination networks focused on developed countries exhibiting shorter paths and preferring more advance countries, while top1 origin networks focused both on developed as well as more substantial developing nations that presented a longer path and more stable groups; (iii) only few countries have a decisive influence on community evolution of both top1 networks. USA took the leading position as a destination country in top1 destination networks, while China and India were the main Asian emigration countries in top1 origin networks; European countries and the Russian Federation played an important role in both.	[Peres, Mihaela; Xu, Helian] Hunan Univ, Sch Econ & Trade, Changsha 410082, Hunan, Peoples R China; [Wu, Gang] Southwest Univ Finance & Econ, Sch Int Business, Chengdu, Peoples R China	Hunan University; Southwestern University of Finance & Economics - China	Xu, HL (corresponding author), Hunan Univ, Sch Econ & Trade, Changsha 410082, Hunan, Peoples R China.; Wu, G (corresponding author), Southwest Univ Finance & Econ, Sch Int Business, Chengdu, Peoples R China.	xuhelian@163.com; wugang@swufe.edu.cn			National Natural Science Foundation of China [41371134, 71503213]; Fundamental Research Funds for Central Universities [JBK150118]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	HX acknowledges support from the National Natural Science Foundation of China, Grant No. 41371134 (http://www.nsfc.gov.cn/); GW acknowledges support from the National Natural Science Foundation of China, Grant No. 71503213 (http://www.nsfc.gov.cn/) and the Fundamental Research Funds for Central Universities, Grant No. JBK150118. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, SOCIAL EC NETWORKS; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Borner K, 2007, ANNU REV INFORM SCI, V41, P537, DOI 10.1002/aris.2007.1440410119; Brockmann D, 2008, IEEE PERVAS COMPUT, V7, P28, DOI 10.1109/MPRV.2008.77; Castles Stephen, 2005, AGE MIGRATION INT PO; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Davis KF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053723; Dreher A, 2008, MEASURING GLOBALISAT, DOI 10.1007/978-0-387-74069-0; Fagiolo G, 2013, PHYS SOC; Fagiolo G, 2012, PHYS SOC, DOI [10.2139/ssrn.2191190, DOI 10.2139/SSRN.2191190]; Fagiolo G, 2014, LEM WORKING PAPER SE; Fagiolo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097331; Fagiolo G, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012812; FELD SL, 1981, AM J SOCIOL, V86, P1015, DOI 10.1086/227352; Fisher MH, 2015, MIGRATION WORLD HIST; Freeman L., 2004, DEV SOCIAL NETWORK A; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Konar M, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010307; MASSEY DS, 1993, POPUL DEV REV, V19, P431, DOI 10.2307/2938462; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; OECD, 2008, PROF IMM POP 21 CENT; Ozden C, 2011, WORLD BANK ECON REV, V25, P12, DOI 10.1093/wber/lhr024; Parsons CR, 2007, QUANTIFYING INT MIGR, DOI [10.1596/1813-9450-4165, DOI 10.1596/1813-9450-4165]; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; R Development Core Team, 2013, R LANG ENV STAT COMP; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; Tranos E, 2012, INT MIGRATION GLOBAL, DOI [10.2139/ssrn.2176744, DOI 10.2139/SSRN.2176744]; United Nations-Department of Economic and Social Affairs Population Division, INT MIGR REP 2013; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1999, AM J SOCIOL, V105, P493, DOI 10.1086/210318; Watts DJ, 2004, ANNU REV SOCIOL, V30, P243, DOI 10.1146/annurev.soc.30.020404.104342; West D.B., 1996, INTRO GRAPH THEORY; World Bank, 2014, GLOB EC PROSP SHIFT; Zhou M, 2016, SOC NETWORKS, V44, P9, DOI 10.1016/j.socnet.2015.07.006	41	8	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148615	10.1371/journal.pone.0148615	http://dx.doi.org/10.1371/journal.pone.0148615			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859406	Green Published, gold, Green Submitted			2022-12-27	WOS:000370038400058
J	Xu, LH; Zhang, TH; Zheng, LN; Li, HJ; Tang, YY; Luo, XG; Sheng, JH; Wang, JJ				Xu, LiHua; Zhang, TianHong; Zheng, LiNa; Li, HuiJun; Tang, YingYing; Luo, XingGuang; Sheng, JianHua; Wang, JiJun			Psychometric Properties of Prodromal Questionnaire-Brief Version among Chinese Help-Seeking Individuals	PLOS ONE			English	Article							CLINICAL HIGH-RISK; ULTRA-HIGH RISK; INTERRATER RELIABILITY; YOUNG-PEOPLE; PSYCHOSIS; SCHIZOPHRENIA; VALIDITY; PQ; EXPERIENCES; VALIDATION	Prodromal Questionnaire (PQ) and Structured Interview for Prodromal Syndromes (SIPS) have been used as a two-stage process for identifying subjects at clinical high risk (CHR) of psychosis. The Prodromal Questionnaire-Brief version (PQ-B) contains 21 items derived from the PQ. The present study aimed to examine the psychometric properties of PQ-B in a Chinese help-seeking outpatient sample and to explore which items can better predict CHR diagnosis by SIPS and future transition to psychosis. In our preliminary epidemiological study, 1461 patients from a pool of 2101 individuals (15-45 years of age) completed the two-stage process. In the present study, 239 (20%) people were randomly selected among the sample who met the initial PQ-B screening criteria but had no positive diagnosis on SIPS, as well as 72 individuals with negative results on both PQ-B and SIPS, 89 prodromal and 105 psychotic subjects, yielding a total of 505 participants. The internal consistency coefficient for the PQ-B was good, with a Cronbach's alpha of 0.897. The concordant validity of PQ-B with SIPS dichotomized diagnosis of prodrome/psychosis versus no psychosis was 0.54. To ensure 80% or a higher sensitivity and a certain specificity, 7 and 24 were respectively set as the cutoff points for the PQ-B total score and distress score for Chinese help-seeking outpatients. A logistic regression model based on six PQ-B items could allow predicting the psychotic diagnosis on SIPS, with an accuracy of 65.8%. Prodromal individuals who scored higher on the 12th item of PQ-B (Do you worry at times that something may be wrong with your mind?) were less likely to convert to psychosis. PQ-B is a useful instrument for screening CHR subjects, but the cutoff score may be higher than that recommended by the author scores for help-seeking individuals in outpatient clinics. Some specific PQ-B items may have significant predictive power on dichotomized SIPS diagnoses and deserve special attention from researchers in future studies.	[Xu, LiHua; Zhang, TianHong; Tang, YingYing; Sheng, JianHua; Wang, JiJun] Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai Key Lab Psychot Disorders, BioX Inst,Minist Educ,Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Zheng, LiNa] Liaocheng Peoples Hosp, Dept Psychiat, Liaocheng, Shandong, Peoples R China; [Li, HuiJun] Florida A&M Univ, Dept Psychol, Tallahassee, FL USA; [Li, HuiJun] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Psychiat, Boston, MA 02215 USA; [Luo, XingGuang] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Luo, XingGuang] VA Connecticut Healthcare Syst, West Haven Campus, West Haven, CT USA; [Luo, XingGuang] Beijing Huilongguan Hosp, Biol Psychiat Res Ctr, Beijing, Peoples R China	Shanghai Jiao Tong University; State University System of Florida; Florida A&M University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Zhang, TH; Sheng, JH; Wang, JJ (corresponding author), Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai Key Lab Psychot Disorders, BioX Inst,Minist Educ,Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China.	zhang_tianhong@126.com; sjh-lyl@263.net; jijunwang27@163.com	Xu, Lihua/ABF-4012-2021	Zhang, TianHong/0000-0002-5379-7119	National Natural Science Foundation of China [81201043, 81171267, 81171280, 81372122, 81261120410, 81361120403]; Shanghai Science and Technology Committee [14411961400, 15411967200]; National Key Clinical Disciplines at Shanghai Mental Health Center (Office of Medical Affairs, Ministry of Health) [2011-873]; Shanghai Key Laboratory of Psychotic Disorders [13dz2260500]; Shanghai health system advanced appropriate technology [2013SY003]; Shanghai Municipal Natural Science Foundation [12ZR1448400]; Shanghai Jiao Tong University Foundation [14JCRY04, YG2014MS40]; National Key Clinical Disciplines at Shanghai Mental Health Center (OMAMH) [2011-873]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); National Key Clinical Disciplines at Shanghai Mental Health Center (Office of Medical Affairs, Ministry of Health); Shanghai Key Laboratory of Psychotic Disorders; Shanghai health system advanced appropriate technology; Shanghai Municipal Natural Science Foundation; Shanghai Jiao Tong University Foundation; National Key Clinical Disciplines at Shanghai Mental Health Center (OMAMH)	1. National Natural Science Foundation of China (81201043, 81171267, 81171280, 81372122, 81261120410,81361120403) (www.nsfc.gov.cn) (the study design, data collection and analysis) 2. Shanghai Science and Technology Committee (14411961400, 15411967200) (www.stcsm.gov.cn) (the study design, data collection and analysis) 3. National Key Clinical Disciplines at Shanghai Mental Health Center (Office of Medical Affairs, Ministry of Health, 2011-873; OMAMH, 2011-873) (www.smhc.org.cn) (data collection and analysis) 4. Shanghai Key Laboratory of Psychotic Disorders (13dz2260500) (www.smhc.org.cn) (data collection and analysis) 5. Shanghai health system advanced appropriate technology (2013SY003) (www.wsjsw.gov.cn/wsj/) (data collection and analysis) 6. Shanghai Municipal Natural Science Foundation (12ZR1448400) (www.stcsm.gov.cn) (preparation of the manuscript) 7. Shanghai Jiao Tong University Foundation (14JCRY04, YG2014MS40) (www.sjtu.edu.cn) (revised the manuscript)	Association AP, DIAGN STAT MAN MENT; Beck A.T., 1967, DEPRESSION CLIN EXPT; Bortolon C, 2015, COMPR PSYCHIAT, V57, P97, DOI 10.1016/j.comppsych.2014.10.011; Cassano P, 2012, PSYCHIAT SERV, V63, P482, DOI 10.1176/appi.ps.201100271; Chen FZ, 2016, EARLY INTERV PSYCHIA, V10, P308, DOI 10.1111/eip.12173; Chiu SC, 2010, J FORMOS MED ASSOC, V109, P647, DOI 10.1016/S0929-6646(10)60105-2; Fusar-Poli P, 2014, PSYCHOL MED, V44, P17, DOI 10.1017/S0033291713000184; Fusar-Poli P, 2013, JAMA PSYCHIAT, V70, P107, DOI 10.1001/jamapsychiatry.2013.269; Guloksuz S, 2015, PSYCHOL MED, V45, P2389, DOI 10.1017/S0033291715000380; Hafner H, 1998, SOC PSYCH PSYCH EPID, V33, P380, DOI 10.1007/s001270050069; HOLLON SD, 1980, COGNITIVE THER RES, V4, P383, DOI 10.1007/BF01178214; Ising HK, 2012, SCHIZOPHRENIA BULL, V38, P1288, DOI 10.1093/schbul/sbs068; Jarrett M, 2012, SCHIZOPHR RES, V136, P1, DOI 10.1016/j.schres.2012.01.025; Kammermann J, 2009, FORTSCHR NEUROL PSYC, V77, P278, DOI 10.1055/s-0028-1109227; Kline E, 2012, SCHIZOPHR RES, V141, P72, DOI 10.1016/j.schres.2012.07.022; Loewy RL, 2012, EARLY INTERV PSYCHIA, V6, P69, DOI 10.1111/j.1751-7893.2011.00286.x; Loewy RL, 2011, SCHIZOPHR RES, V129, P42, DOI 10.1016/j.schres.2011.03.029; Loewy RL, 2005, SCHIZOPHR RES, V77, P141, DOI 10.1016/j.schres.2005.03.007; Markarian Y, 2010, CLIN PSYCHOL REV, V30, P78, DOI 10.1016/j.cpr.2009.09.005; Miller T, 2004, SCHIZOPHRENIA RES; Miller TJ, 1999, PSYCHIAT QUART, V70, P273, DOI 10.1023/A:1022034115078; Miller TJ, 2003, SCHIZOPHRENIA BULL, V29, P703, DOI 10.1093/oxfordjournals.schbul.a007040; Miller TJ, 2002, AM J PSYCHIAT, V159, P863, DOI 10.1176/appi.ajp.159.5.863; Muller M, 2010, SCHIZOPHR RES, V123, P217, DOI 10.1016/j.schres.2010.08.018; O'Brien MP, 2014, J CONSULT CLIN PSYCH, V82, P90, DOI 10.1037/a0034667; Okewole AO, 2015, SCHIZOPHR RES, V164, P281, DOI 10.1016/j.schres.2015.01.006; Piskulic D, 2015, PSYCHIAT RES, V225, P93, DOI 10.1016/j.psychres.2014.10.021; Solis M, 2014, NATURE, V508, pS12, DOI 10.1038/508S12a; Therman S, 2014, INT J METH PSYCH RES, V23, P62, DOI 10.1002/mpr.1427; Yung AR, 2005, AUST NZ J PSYCHIAT, V39, P964, DOI 10.1080/j.1440-1614.2005.01714.x; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P353, DOI 10.1093/schbul/22.2.353; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P283, DOI 10.1093/schbul/22.2.283; Zhang TH, 2014, SCHIZOPHR RES, V152, P391, DOI 10.1016/j.schres.2013.11.039; [郑丽娜 Zheng Lina], 2012, [中国心理卫生杂志, Chinese Mental Health Journal], V26, P571	34	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148935	10.1371/journal.pone.0148935	http://dx.doi.org/10.1371/journal.pone.0148935			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859774	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400107
J	Garcia-Gonzalez, R; Aldezabal, A; Laskurain, NA; Margalida, A; Novoa, C				Garcia-Gonzalez, Ricardo; Aldezabal, Arantza; Amaia Laskurain, Nere; Margalida, Antoni; Novoa, Claude			Influence of Snowmelt Timing on the Diet Quality of Pyrenean Rock Ptarmigan (Lagopus muta pyrenaica): Implications for Reproductive Success	PLOS ONE			English	Article							CLIMATE-CHANGE; CHEMICAL-COMPOSITION; BREEDING SUCCESS; PLANT PHENOLOGY; LARGE-SCALE; GROUSE; ALPINE; WEATHER; BIRDS; CONSEQUENCES	The Pyrenean rock ptarmigan (Lagopus muta pyrenaica) is the southernmost subspecies of the species in Europe and is considered threatened as a consequence of changes in landscape, human pressure, climate change, and low genetic diversity. Previous studies have shown a relationship between the date of snowmelt and reproductive success in the Pyrenean ptarmigan. It is well established that birds laying early in the breeding season have higher reproductive success, but the specific mechanism for this relationship is debated. We present an explicative model of the relationship between snowmelt date and breeding success mediated by food quality for grouse in alpine environments. From microhistological analyses of 121 faecal samples collected during three years in the Canigou Massif (Eastern Pyrenees), and the assessment of the chemical composition of the main dietary components, we estimated the potential quality of individual diets. Potential dietary quality was correlated with free-urate faecal N, a proxy of the digestible protein content ingested by ptarmigan, and both were correlated with phenological stage of consumed plants, which in turn depends on snowmelt date. Our findings suggest that the average snowmelt date is subject to a strong interannual variability influencing laying date. In years of early snowmelt, hens benefit from a longer period of high quality food resources potentially leading to a higher breeding success. On the contrary, in years of late snowmelt, hens begin their breeding period in poorer nutrient condition because the peaks of protein content of their main food items are delayed with respect to laying date, hence reducing breeding performance. We discuss the possible mismatch between breeding and snowmelt timing.	[Garcia-Gonzalez, Ricardo] CSIC, Inst Pirenaico Ecol, Jaca, Spain; [Aldezabal, Arantza; Amaia Laskurain, Nere] Univ Basque Country, Plant Biol & Ecol Dept, Bilbao, Spain; [Margalida, Antoni] Univ Lleida, Fac Life Sci & Engn, Div Wildlife, Dept Anim Prod, Lleida, Spain; [Margalida, Antoni] Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland; [Novoa, Claude] Off Natl Chasse & Faune Sauvage, Prades, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); University of Basque Country; Universitat de Lleida; University of Bern	Margalida, A (corresponding author), Univ Lleida, Fac Life Sci & Engn, Div Wildlife, Dept Anim Prod, Lleida, Spain.; Margalida, A (corresponding author), Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland.	amargalida@prodan.udl.cat	Aldezabal, Arantza/V-7930-2017; Margalida, Antoni/AAG-5337-2020; Margalida, Antoni/A-2723-2011; Margalida, Antoni/A-2723-2011	Aldezabal, Arantza/0000-0001-7917-7690; Margalida, Antoni/0000-0002-0576-3993; Laskurain, Nere Amaia/0000-0002-9521-8584; Garcia-Gonzalez, Ricardo/0000-0001-5625-8690; Margalida, Antoni/0000-0002-7383-671X; Margalida, Antoni/0000-0002-3904-6212	Office National de la Chasse et de la Faune Sauvage (France); Consejo Superior de Investigaciones Cientificas (Spain); RTA (Agricultural Technologies and Resources) [2005-00160-C02-02, MAM 2484/2002]; LEDDRA project Desertification process and land degradation (SICA-EU) [FW7 ENV.2009.2.1.3.2]; Ministry of Economy and Competitiveness [RYC-2012-11867]	Office National de la Chasse et de la Faune Sauvage (France); Consejo Superior de Investigaciones Cientificas (Spain); RTA (Agricultural Technologies and Resources); LEDDRA project Desertification process and land degradation (SICA-EU); Ministry of Economy and Competitiveness	This study was conducted under the framework of a contract between the Office National de la Chasse et de la Faune Sauvage (France) and Consejo Superior de Investigaciones Cientificas (Spain). Additional funds were provided by RTA (Agricultural Technologies and Resources) 2005-00160-C02-02 and MAM 2484/2002 Spanish projects. LEDDRA project FW7 ENV.2009.2.1.3.2 Desertification process and land degradation (SICA-EU) also provided supplementary funds for publication process. AM was supported by a Ramon y Cajal research contract from the Ministry of Economy and Competitiveness (RYC-2012-11867).	Afonso I, 2006, LAGOPODO ALPINO LAGO, P11; ALBON SD, 1992, OIKOS, V65, P502, DOI 10.2307/3545568; ANDREEV AV, 1988, CAN J ZOOL, V66, P1382, DOI 10.1139/z88-203; [Anonymous], 1982, FOURRAGES; [Anonymous], 1965, ANATOMY DICOTYLEDONS; Arlettaz R, 2010, BIOSCIENCE, V60, P835, DOI 10.1525/bio.2010.60.10.10; BARNETT JK, 1994, J RANGE MANAGE, V47, P114, DOI 10.2307/4002817; Bech N, 2013, HEREDITY, V111, P402, DOI 10.1038/hdy.2013.62; Bech N, 2009, ANIM CONSERV, V12, P138, DOI 10.1111/j.1469-1795.2008.00233.x; Bety J, 2003, AM NAT, V162, P110, DOI 10.1086/375680; Blanco-Fontao B, 2009, J ORNITHOL, V151, P901; Bolos O.de., 1990, FLORA MANUAL DELS PA; Bossert A., 1980, Ornithologische Beobachter, V77, P121; Both C, 2004, P ROY SOC B-BIOL SCI, V271, P1657, DOI 10.1098/rspb.2004.2770; BOUDAREL P, 1991, ACTA BIOL MONTANA, V10, P11; BRITTAS R, 1988, ORNIS SCAND, V19, P49, DOI 10.2307/3676527; Carey Cynthia, 1996, P324; Cattadori IM, 2000, WILDLIFE BIOL, V6, P213, DOI 10.2981/wlb.2000.018; Chapin F. S. III, 1975, Arctic and Alpine Research, V7, P209, DOI 10.2307/1549997; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; CLARKE JA, 1992, CONDOR, V94, P622, DOI 10.2307/1369247; Coppack T, 2004, ADV ECOL RES, V35, P131, DOI 10.1016/S0065-2504(04)35007-5; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Davies S, 2014, HORM BEHAV, V66, P41, DOI 10.1016/j.yhbeh.2014.04.003; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; DELBARRIO G, 1990, MT RES DEV, V10, P227, DOI 10.2307/3673602; DRENT RH, 1980, ARDEA, V68, P225; Dunn P, 2004, ADV ECOL RES, V35, P69, DOI 10.1016/S0065-2504(04)35004-X; ERIKSTAD KE, 1983, ORNIS SCAND, V14, P249, DOI 10.2307/3676311; Figueroa I, 2009, ETHOL ECOL EVOL, V21, P251, DOI 10.1080/08927014.2009.9522480; Filacorda S, 1997, WILDLIFE BIOL, V3, P187, DOI 10.2981/wlb.1997.023; Fisher R.A., 1963, STAT TABLES BIOL AGR, V6th; Garcia-Gonzalez R, PLOS ONE IN PRESS; Garcia-Gonzalez R., 2013, PASTOS NUEVOS RETOS, P41; Garcia-Gonzalez R, 1987, ACTA BIOL MONTANA, V7, P35; GASAWAY WC, 1976, COMP BIOCHEM PHYS A, V53, P109, DOI 10.1016/S0300-9629(76)80021-7; GONZALEZ G, 1989, REV ECOL-TERRE VIE, V44, P347; Grabowski MM, 2013, POLAR BIOL, V36, P1097, DOI 10.1007/s00300-013-1332-6; Haferkamp MR, 2005, RANGELAND ECOL MANAG, V58, P155, DOI 10.2111/04-01.1; HANNON SJ, 1988, AUK, V105, P330, DOI 10.2307/4087498; Huntley B., 2007, CLIMATIC ATLAS EUROP; Imperio S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081598; Isern-Vallverdu J, 1990, B SAN VEG PLAGAS, V20, P311; Jensen GH, 2014, POLAR BIOL, V37, P1, DOI 10.1007/s00300-013-1404-7; JONES PJ, 1976, IBIS, V118, P547, DOI 10.1111/j.1474-919X.1976.tb03516.x; KADMON R, 1993, ECOLOGY, V74, P816, DOI 10.2307/1940808; Korner C, 1999, ALPINE PLANT LIFE FU; LAINE KM, 1987, OIKOS, V50, P389, DOI 10.2307/3565500; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Liebezeit JR, 2014, POLAR BIOL, V37, P1309, DOI 10.1007/s00300-014-1522-x; Lopez-Moreno JI, 2008, GLOBAL PLANET CHANGE, V61, P300, DOI 10.1016/j.gloplacha.2007.10.004; Lopez-Moreno JI, 2005, ARCT ANTARCT ALP RES, V37, P253, DOI 10.1657/1523-0430(2005)037[0253:RVOSDI]2.0.CO;2; Ludwig GX, 2006, P ROY SOC B-BIOL SCI, V273, P2009, DOI 10.1098/rspb.2006.3538; Margalida A, 2007, J ORNITHOL, V148, P309, DOI 10.1007/s10336-007-0133-5; Marinas A, 2006, PIRINEOS, V161, P85, DOI DOI 10.3989/pirineos.2006.v161.4; Martin K, 2004, INTEGR COMP BIOL, V44, P177, DOI 10.1093/icb/44.2.177; Martinez C., 1985, Donana Acta Vertebrata, V12, P174; Molau U, 2005, AM J BOT, V92, P422, DOI 10.3732/ajb.92.3.422; Moller AP, 2008, OECOLOGIA, V155, P845, DOI 10.1007/s00442-007-0944-3; MORTON ML, 1978, CONDOR, V80, P285, DOI 10.2307/1368037; MOSS R, 1972, BRIT J NUTR, V27, P285, DOI 10.1079/BJN19720093; MOSS R, 1972, J ANIM ECOL, V41, P411, DOI 10.2307/3477; Moss R., 1968, Symposia of the Zoological Society of London, VNo. 21, P207; MOSS R, 1984, IBIS, V126, P212, DOI 10.1111/j.1474-919X.1984.tb08000.x; MOSS R, 1990, ORNIS SCAND, V21, P115, DOI 10.2307/3676806; Newton I, 1989, LIFETIME REPROD BIRD; Nielsen JT, 2003, IBIS, V145, P1; Novoa C, 1999, REV ECOL-TERRE VIE, V54, P149; Novoa C, 2008, IBIS, V150, P270, DOI 10.1111/j.1474-919X.2007.00771.x; Oberbauer SF, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0481; OWEN M, 1975, J WILDLIFE MANAGE, V39, P271, DOI 10.2307/3799903; Pendlebury CJ, 2004, J EXP BIOL, V207, P2065, DOI 10.1242/jeb.00999; Penteriani V, 2003, IBIS, V145, pE77, DOI 10.1046/j.1474-919X.2003.00159.x; Penuelas J, 2002, GLOBAL CHANGE BIOL, V8, P531, DOI 10.1046/j.1365-2486.2002.00489.x; Price MV, 1998, ECOLOGY, V79, P1261, DOI 10.1890/0012-9658(1998)079[1261:EOEWOP]2.0.CO;2; PROP J, 1991, OECOLOGIA, V87, P19, DOI 10.1007/BF00323775; PROP J, 1993, ORNIS SCAND, V24, P110, DOI 10.2307/3676360; PULLIAINEN E, 1991, HOLARCTIC ECOL, V14, P156; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Revermann R, 2012, J ORNITHOL, V153, P891, DOI 10.1007/s10336-012-0819-1; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Sanz JJ, 2003, GLOBAL CHANGE BIOL, V9, P461, DOI 10.1046/j.1365-2486.2003.00575.x; Sawa Y, 2011, BIRD STUDY, V58, P200, DOI 10.1080/00063657.2011.559532; Scherini GC, 2003, ARDEA, V91, P11; Sedinger JS, 1997, CONDOR, V99, P314, DOI 10.2307/1369937; SMYTH KE, 1984, CAN J ZOOL, V62, P2250, DOI 10.1139/z84-327; Storch I, 2000, WILDLIFE BIOL, V6, P195, DOI 10.2981/wlb.2000.016; TERPSTRA K, 1974, Zeitschrift fuer Tierphysiologie Tierernaehrung und Futtermittelkunde, V32, P306; Theurillat JP, 2000, PHYTOCOENOLOGIA, V30, P439; Van der Wal R, 2000, OECOLOGIA, V123, P108, DOI 10.1007/s004420050995; van Rees H, 1984, RANGELAND J, V6, P86; Visser ME, 2009, P ROY SOC B-BIOL SCI, V276, P2323, DOI 10.1098/rspb.2009.0213; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; Wilson S, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-9; Wilson S, 2010, J AVIAN BIOL, V41, P319, DOI 10.1111/j.1600-048X.2009.04945.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; [No title captured]	98	10	11	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148632	10.1371/journal.pone.0148632	http://dx.doi.org/10.1371/journal.pone.0148632			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849356	Green Published, gold			2022-12-27	WOS:000369554000141
J	Fernandez-Reiriz, MJ; Irisarri, J; Labarta, U				Jose Fernandez-Reiriz, Mara; Irisarri, Jade; Labarta, Uxio			Flexibility of Physiological Traits Underlying Inter-Individual Growth Differences in Intertidal and Subtidal Mussels Mytilusgalloprovincialis	PLOS ONE			English	Article							MYTILUS-GALLOPROVINCIALIS LMK; CLAM RUDITAPES-PHILIPPINARUM; ROCKY SHORE ORIGIN; CRASSOSTREA-GIGAS; FEEDING-BEHAVIOR; ENVIRONMENTAL PARAMETERS; CLEARANCE RATE; FOOD REGIMES; SEED ORIGIN; EDULIS	Mussel seed (Mytilusgalloprovincialis) gathered from the intertidal and subtidal environments of a Galician embayment (NW, Spain) were maintained in the laboratory during five months to select fast (F) and slow (S) growing mussels. The physiological basis underlying inter-individual growth variations were compared for F and S mussels from both origins. Fast growing seemed to be a consequence of greater energy intake (20% higher clearance and ingestion rate) and higher food absorption rate coupled with low metabolic costs. The enhanced energy absorption (around 65% higher) resulted in 3 times higher Scope for Growth in F mussels (20.5 +/- 4.9 J h(-1)) than S individuals (7.3 +/- 1.1 J h(-1)). The higher clearance rate of F mussels appears to be linked with larger gill filtration surface compared to S mussels. Intertidal mussels showed higher food acquisition and absorption per mg of organic weight (i.e. mass-specific standardization) than subtidal mussels under the optimal feeding conditions of the laboratory. However, the enhanced feeding and digestive rates were not enough to compensate for the initial differences in tissue weight between mussels of similar shell length collected from the intertidal and subtidal environments. At the end of the experiment, subtidal individuals had higher gill efficiency, which probably lead to higher total feeding and absorption rates relative to intertidal individuals.	[Jose Fernandez-Reiriz, Mara; Irisarri, Jade; Labarta, Uxio] CSIC, Inst Invest Marinas, Vigo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Fernandez-Reiriz, MJ (corresponding author), CSIC, Inst Invest Marinas, Vigo, Spain.	mjreiriz@iim.csic.es	Labarta, Uxio/D-5644-2012		project Physiology and Genetic of Growth in Commercial Bivalves 'FIGEBIV' [AGL2013-49144-C3-2-R]; JAE-Predoc CSIC-FSE	project Physiology and Genetic of Growth in Commercial Bivalves 'FIGEBIV'; JAE-Predoc CSIC-FSE	This work was funded by the project Physiology and Genetic of Growth in Commercial Bivalves 'FIGEBIV' (AGL2013-49144-C3-2-R). JI was funded by JAE-Predoc CSIC-FSE 2012-2015.	Alfaro AC, 2008, MAR BIOL RES, V4, P376, DOI 10.1080/17451000802022879; [Anonymous], 1983, SHELL FORMATION MO 1; Babarro JMF, 2000, J MAR BIOL ASSOC UK, V80, P865, DOI 10.1017/S0025315400002848; Babarro JMF, 2000, J SHELLFISH RES, V19, P187; Babarro JMF, 2000, J SHELLFISH RES, V19, P195; Bayne B. L., 1985, EFFECTS STRESS POLLU; Bayne BL, 2004, INTEGR COMP BIOL, V44, P425, DOI 10.1093/icb/44.6.425; Bayne BL, 1999, PHYSIOL BIOCHEM ZOOL, V72, P705, DOI 10.1086/316714; Camacho AP, 1995, AQUACULTURE, V138, P349, DOI 10.1016/0044-8486(95)01139-0; CONOVER RJ, 1966, LIMNOL OCEANOGR, V11, P338, DOI 10.4319/lo.1966.11.3.0338; de Sousa JT, 2011, J EXP MAR BIOL ECOL, V406, P46, DOI 10.1016/j.jembe.2011.06.001; Fernandez-Reiriz MJ, 2001, J COMP PHYSIOL B, V171, P449; Filgueira R, 2006, LIMNOL OCEANOGR-METH, V4, P284, DOI 10.4319/lom.2006.4.284; Filgueira R, 2008, REV BIOL MAR OCEANOG, V43, P391; FISCHER H, 1983, MAR ECOL PROG SER, V12, P59, DOI 10.3354/meps012059; Freites L, 2003, CIENC MAR, V29, P603, DOI 10.7773/cm.v29i42.196; Freites L, 2002, COMP BIOCHEM PHYS B, V132, P453, DOI 10.1016/S1096-4959(02)00057-X; Freites L, 2002, AQUACULTURE, V207, P97, DOI 10.1016/S0044-8486(01)00752-9; HAWKINS AJS, 1990, MAR BIOL, V105, P197, DOI 10.1007/BF01344287; Iglesias JIP, 1996, J SHELLFISH RES, V15, P673; IVLEV VS, 1966, J FISH RES BOARD CAN, V23, P1727, DOI 10.1139/f66-160; Fernandez-Reiriz MJ, 2012, MAR ECOL PROG SER, V454, P65, DOI 10.3354/meps09660; Fernandez-Reiriz MJ, 2015, AQUACULTURE, V446, P42, DOI 10.1016/j.aquaculture.2015.04.025; Labarta U, 1997, MAR ECOL PROG SER, V152, P167, DOI 10.3354/meps152167; Leitao A, 2001, AQUACULTURE, V193, P39, DOI 10.1016/S0044-8486(00)00488-9; MALLET AL, 1987, J EXP MAR BIOL ECOL, V108, P217, DOI 10.1016/0022-0981(87)90086-4; Navarro JM, 2003, J EXP MAR BIOL ECOL, V287, P13, DOI 10.1016/S0022-0981(02)00501-4; Perez-Camacho A, 2014, ECOL INDIC, V45, P538, DOI 10.1016/j.ecolind.2014.05.015; Perez-Camacho A, 2013, AQUACULTURE, V406, P172, DOI 10.1016/j.aquaculture.2013.05.019; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; Tamayo D, 2015, J EXP MAR BIOL ECOL, V471, P92, DOI 10.1016/j.jembe.2015.05.017; Tamayo D, 2014, MAR BIOL, V161, P1627, DOI 10.1007/s00227-014-2447-1; Tamayo D, 2013, J COMP PHYSIOL B, V183, P893, DOI 10.1007/s00360-013-0764-1; Tamayo D, 2011, AQUACULTURE, V321, P113, DOI 10.1016/j.aquaculture.2011.08.024; TEDENGREN M, 1990, MAR ECOL PROG SER, V59, P221, DOI 10.3354/meps059221; Widdows J., 1985, P161; Winberg G.G., 1960, FISH RES BOARD CAN, V194, P185; Wolowicz M, 1999, HALIOTIS, V28, P1; WORRALL CM, 1983, MAR ECOL PROG SER, V12, P267, DOI 10.3354/meps012267	39	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148245	10.1371/journal.pone.0148245	http://dx.doi.org/10.1371/journal.pone.0148245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849372	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000057
J	Krupka, M; Masek, J; Barkocziova, L; Knotigova, PT; Kulich, P; Plockova, J; Lukac, R; Bartheldyova, E; Koudelka, S; Chaloupkova, R; Sebela, M; Zyka, D; Droz, L; Effenberg, R; Ledvina, M; Miller, AD; Turanek, J; Raska, M				Krupka, Michal; Masek, Josef; Barkocziova, Lucia; Knotigova, Pavlina Turanek; Kulich, Pavel; Plockova, Jana; Lukac, Robert; Bartheldyova, Eliska; Koudelka, Stepan; Chaloupkova, Radka; Sebela, Marek; Zyka, Daniel; Droz, Ladislav; Effenberg, Roman; Ledvina, Miroslav; Miller, Andrew D.; Turanek, Jaroslav; Raska, Milan			The Position of His-Tag in Recombinant OspC and Application of Various Adjuvants Affects the Intensity and Quality of Specific Antibody Response after Immunization of Experimental Mice	PLOS ONE			English	Article							OUTER SURFACE PROTEIN; LYME-DISEASE VACCINE; BORRELIA-BURGDORFERI; LIPOPHILIC DERIVATIVES; MOLECULAR ANALYSIS; IMMUNE-RESPONSE; GENE-TRANSFER; EPITOPE; EXPRESSION; IMMUNOGENICITY	Lyme disease, Borrelia burgdorferi-caused infection, if not recognized and appropriately treated by antibiotics, may lead to chronic complications, thus stressing the need for protective vaccine development. The immune protection is mediated by phagocytic cells and by Borrelia-specific complement-activating antibodies, associated with the Th1 immune response. Surface antigen OspC is involved in Borrelia spreading through the host body. Previously we reported that recombinant histidine tagged (His-tag) OspC (rOspC) could be attached onto liposome surfaces by metallochelation. Here we report that levels of OspC-specific antibodies vary substantially depending upon whether rOspC possesses an N' or C' terminal His-tag. This is the case in mice immunized: (a) with rOspC proteoliposomes containing adjuvants MPLA or non-pyrogenic MDP analogue MT06; (b) with free rOspC and Montanide PET GEL A; (c) with free rOspC and alum; or (d) with adjuvant-free rOspC. Stronger responses are noted with all N'-terminal His-tag rOspC formulations. OspC-specific Th1-type antibodies predominate post-immunization with rOspC proteoliposomes formulated with MPLA or MT06 adjuvants. Further analyses confirmed that the structural features of soluble N' and C' terminal His-tag rOspC and respective rOspC proteoliposomes are similar including their thermal stabilities at physiological temperatures. On the other hand, a change in the position of the rOspC His-tag from N' to C' terminal appears to affect substantially the immunogenicity of rOspC arguably due to steric hindrance of OspC epitopes by the C' terminal His-tag itself and not due to differences in overall conformations induced by changes in the His-tag position in rOspC variants.	[Krupka, Michal; Barkocziova, Lucia; Raska, Milan] Palacky Univ Olomouc, Fac Med & Dent, Dept Immunol, Olomouc, Czech Republic; [Masek, Josef; Knotigova, Pavlina Turanek; Kulich, Pavel; Plockova, Jana; Lukac, Robert; Bartheldyova, Eliska; Koudelka, Stepan; Turanek, Jaroslav; Raska, Milan] Vet Res Inst, Dept Pharmacol & Immunotherapy, CS-62132 Brno, Czech Republic; [Koudelka, Stepan; Chaloupkova, Radka] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic; [Chaloupkova, Radka] Masaryk Univ, Loschmidt Labs, Dept Expt Biol, Brno, Czech Republic; [Chaloupkova, Radka] Masaryk Univ, Res Ctr Toxic Cpds Environm RECETOX, Brno, Czech Republic; [Sebela, Marek] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic; [Zyka, Daniel; Droz, Ladislav] Apigenex, Prague, Czech Republic; [Effenberg, Roman; Ledvina, Miroslav] Univ Chem & Technol, Dept Chem Nat Cpds, Prague, Czech Republic; [Miller, Andrew D.] Kings Coll London, Inst Pharmaceut Sci, London, England; [Miller, Andrew D.] GlobalAcom Ltd, London, England	Palacky University Olomouc; Czech Veterinary Research Institute; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Masaryk University Brno; Palacky University Olomouc; University of Chemistry & Technology, Prague; University of London; King's College London	Raska, M (corresponding author), Palacky Univ Olomouc, Fac Med & Dent, Dept Immunol, Olomouc, Czech Republic.; Turanek, J; Raska, M (corresponding author), Vet Res Inst, Dept Pharmacol & Immunotherapy, CS-62132 Brno, Czech Republic.	turanek@vuvel.cz; raskamil@uab.edu	Miller, Andrew/G-8291-2019; Mašek, Josef/B-3734-2015; Chaloupkova, Radka/M-5565-2016; Bartheldyová, Eliška/Z-1784-2019; Sebela, Marek/AAL-2747-2020; Raska, Milan/E-9813-2013	Miller, Andrew/0000-0003-0661-249X; Mašek, Josef/0000-0001-6788-8487; Chaloupkova, Radka/0000-0002-3539-7445; Sebela, Marek/0000-0001-9835-1375; Raska, Milan/0000-0002-8572-7246; Effenberg, Roman/0000-0001-9046-2011; Krupka, Michal/0000-0002-9699-7903	Palacky University, Olomouc, Czech Republic [LF_2014_020, LF_2015_009]; CENATOX; European Union FP7 REGPOT - Human Bridge [316345]; Grant Agency of Czech Republic [GAP503/12/G147]; Ministry of Education, Youth and Sports [CZ.1.07/2.3.00/20.0164, LO1304, LO1214, LM2011028]; Czech Ministry of Agriculture [MZE0002716202]; Technological Agency of Czech Republic TACR [TA01011165, TA02010760]; European Social Fund; State Budget of the Czech Republic - Project FNUSA-ICRC [CZ.1.07/2.3.00/30.0043]; Ministry of Education, Youth and Sports	Palacky University, Olomouc, Czech Republic(Czech Republic Government); CENATOX; European Union FP7 REGPOT - Human Bridge; Grant Agency of Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Czech Ministry of Agriculture(Ministry of Agriculture, Czech Republic); Technological Agency of Czech Republic TACR; European Social Fund(European Social Fund (ESF)); State Budget of the Czech Republic - Project FNUSA-ICRC; Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	These studies were supported by LF_2014_020 and LF_2015_009 (Palacky University, Olomouc, Czech Republic) (MR, MK); project CENATOX; Grant of the European Union FP7 REGPOT - Human Bridge 316345 (RC); Grant Agency of Czech Republic, GAP503/12/G147 (JT); the Ministry of Education, Youth and Sports CZ.1.07/2.3.00/20.0164 (MR, JT) and LO1304, LO1214 and LM2011028 (RC); MZE0002716202 Czech Ministry of Agriculture (JT); Technological Agency of Czech Republic TACR TA01011165 - Multiepitopic vaccine against boreliosis (to JT, MR, ML); TA02010760 - Development of anticancer immunotherapeutics of new generation (ML, LD). SK was supported by the European Social Fund and the State Budget of the Czech Republic - Project FNUSA-ICRC, support for neurological research and development teams through postdoc position formations CZ.1.07/2.3.00/30.0043. The teams headed by Jaroslav Turanek, Milan Raska, and Andrew D. Miller are obligated to the Ministry of Education, Youth and Sports for supporting of the project "FIT" (Pharmacology, Immunotherapy, nanoToxicology). The funder provided support in the form of salaries for authors (DZ, LD), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altin JG, 2006, METHODS, V40, P39, DOI 10.1016/j.ymeth.2006.05.027; [Anonymous], MOL VACCINES PROPHYL; Bielecka MK, 2015, INFECT IMMUN, V83, P730, DOI 10.1128/IAI.01815-14; Boardman BK, 2008, INFECT IMMUN, V76, P3844, DOI 10.1128/IAI.00467-08; Bockenstedt LK, 1996, J IMMUNOL, V157, P5496; BOCKENSTEDT LK, 1993, J IMMUNOL, V151, P900; Buckles EL, 2006, CLIN VACCINE IMMUNOL, V13, P1162, DOI 10.1128/CVI.00099-06; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Comstedt P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113294; Earnhart CG, 2007, HUM VACCINES, V3, P281, DOI 10.4161/hv.4661; Earnhart CG, 2007, CLIN VACCINE IMMUNOL, V14, P628, DOI 10.1128/CVI.00409-06; Earnhart CG, 2007, VACCINE, V25, P3419, DOI 10.1016/j.vaccine.2006.12.051; Earnhart CG, 2007, VACCINE, V25, P466, DOI 10.1016/j.vaccine.2006.07.052; ERDILE LF, 1993, INFECT IMMUN, V61, P81, DOI 10.1128/IAI.61.1.81-90.1993; Figueroa CM, 2010, BIOCHIMIE, V92, P81, DOI 10.1016/j.biochi.2009.09.013; FIKRIG E, 1990, SCIENCE, V250, P553, DOI 10.1126/science.2237407; FUCHS R, 1992, MOL MICROBIOL, V6, P503, DOI 10.1111/j.1365-2958.1992.tb01495.x; Gilmore RD, 1999, INFECT IMMUN, V67, P5463, DOI 10.1128/IAI.67.10.5463-5469.1999; Halperin JJ, 2015, INFECT DRUG RESIST, V8, DOI 10.2147/IDR.S66739; Hipler K, 2013, COMPONDS DERIVED NOR; Jobe DA, 2003, CLIN DIAGN LAB IMMUN, V10, P573, DOI 10.1128/CDLI.10.4.573-578.2003; Knotigova PT, 2015, PHARM RES-DORDR, V32, P1186, DOI 10.1007/s11095-014-1516-y; Koide S, 2005, J MOL BIOL, V350, P290, DOI 10.1016/j.jmb.2005.04.066; Kowalska M, 2010, PHYTOCHEMISTRY, V71, P1970, DOI 10.1016/j.phytochem.2010.08.013; Krupka M, 2015, IMMUNOL LETT, V166, P36, DOI 10.1016/j.imlet.2015.05.010; Krupka Michal, 2005, Biomedical Papers (Olomouc), V149, P261; Krupka M, 2012, J CONTROL RELEASE, V160, P374, DOI 10.1016/j.jconrel.2012.02.017; Krupka M, 2011, ARCH IMMUNOL THER EX, V59, P261, DOI 10.1007/s00005-011-0128-z; Krupka Michal, 2007, Biomedical Papers (Olomouc), V151, P175; Kumaran D, 2001, EMBO J, V20, P971, DOI 10.1093/emboj/20.5.971; Lantos PM, 2015, INFECT DIS CLIN N AM, V29, P325, DOI 10.1016/j.idc.2015.02.006; Lovrich SD, 2005, CLIN DIAGN LAB IMMUN, V12, P746, DOI 10.1128/CDLI.12.6.746-751.2005; MA JN, 1994, VACCINE, V12, P925, DOI 10.1016/0264-410X(94)90036-1; Malliaros J, 2004, VACCINE, V22, P3968, DOI 10.1016/j.vaccine.2004.03.054; Masek J, 2011, J CONTROL RELEASE, V151, P193, DOI 10.1016/j.jconrel.2011.01.016; Masek J, 2011, ANAL BIOCHEM, V408, P95, DOI 10.1016/j.ab.2010.08.023; Mayer A, 2004, BRIT J CANCER, V90, P2402, DOI 10.1038/sj.bjc.6601888; Munson EL, 2000, INFECT IMMUN, V68, P5496, DOI 10.1128/IAI.68.10.5496-5501.2000; Petrovska B, 2014, CYTOGENET GENOME RES, V143, P78, DOI 10.1159/000365311; PROBERT WS, 1994, INFECT IMMUN, V62, P1920, DOI 10.1128/IAI.62.5.1920-1926.1994; Rudenko N, 2011, TICKS TICK-BORNE DIS, V2, P123, DOI 10.1016/j.ttbdis.2011.04.002; Schulte-Spechtel U, 2006, INT J MED MICROBIOL, V296, P250, DOI 10.1016/j.ijmm.2006.01.006; Srivastava SY, 2008, J BACTERIOL, V190, P3429, DOI 10.1128/JB.00085-08; Tilly K, 2008, INFECT DIS CLIN N AM, V22, P217, DOI 10.1016/j.idc.2007.12.013; Turanek J, 2011, BIOMEDICAL SCIENCE, ENGINEERING AND TECHNOLOGY, P653; Wang GQ, 1999, FEMS MICROBIOL LETT, V177, P289, DOI 10.1111/j.1574-6968.1999.tb13745.x; WILSKE B, 1993, INFECT IMMUN, V61, P2182, DOI 10.1128/IAI.61.5.2182-2191.1993	47	15	15	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148497	10.1371/journal.pone.0148497	http://dx.doi.org/10.1371/journal.pone.0148497			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848589	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000110
J	Motloch, LJ; Larbig, R; Gebing, T; Reda, S; Schwaiger, A; Leitner, J; Wolny, M; Eckardt, L; Hoppe, UC				Motloch, Lukas Jaroslaw; Larbig, Robert; Gebing, Tina; Reda, Sara; Schwaiger, Astrid; Leitner, Johannes; Wolny, Martin; Eckardt, Lars; Hoppe, Uta C.			By Regulating Mitochondrial Ca2+-Uptake UCP2 Modulates Intracellular Ca2+	PLOS ONE			English	Article							SINGLE-CHANNEL PROPERTIES; SENSITIVE K+ CHANNELS; UNCOUPLING PROTEIN-2; OXIDATIVE-PHOSPHORYLATION; CALCIUM UNIPORTER; INWARD CURRENT; RETICULUM; HEART; MCU; MEMBRANE	Introduction The possible role of UCP2 in modulating mitochondrial Ca2+-uptake (mCa(2+)-uptake) via the mitochondrial calcium uniporter (MCU) is highly controversial. Methods Thus, we analyzed mCa(2+)-uptake in isolated cardiac mitochondria, MCU single-channel activity in cardiac mitoplasts, dual Ca2+-transients from mitochondrial ((Ca2+)m) and intracellular compartment ((Ca2+)c) in the whole-cell configuration in cardiomyocytes of wildtype (WT) and UCP2(-/-) mice. Results Isolated mitochondria showed a Ru360 sensitive mCa(2+)-uptake, which was significantly decreased in UCP2(-/-) (229.4 +/- 30.8 FU vs. 146.3 +/- 23.4 FU, P<0.05). Single-channel registrations confirmed a Ru360 sensitive voltage-gated Ca2+-channel in mitoplasts, i.e. mCa1, showing a reduced single-channel activity in UCP2(-/-) (Po, total: 0.34 +/- 0.05% vs. 0.07 +/- 0.01%, P<0.05). In UCP2(-/-) cardiomyocytes (Ca2+)m was decreased (0.050 +/- 0.009 FU vs. 0.021 +/- 0.005 FU, P<0.05) while (Ca2+)c was unchanged (0.032 +/- 0.002 FU vs. 0.028 +/- 0.004 FU, P>0.05) and transsarcolemmal Ca2+-influx was inhibited suggesting a possible compensatory mechanism. Additionally, we observed an inhibitory effect of ATP on mCa(2+)-uptake in WT mitoplasts and (Ca2+)m of cardiomyocytes leading to an increase of (Ca2+)c while no ATP dependent effect was observed in UCP2(-/-). Conclusion Our results indicate regulatory effects of UCP2 on mCa(2+)-uptake. Furthermore, we propose, that previously described inhibitory effects on MCU by ATP may be mediated via UCP2 resulting in changes of excitation contraction coupling.	[Motloch, Lukas Jaroslaw; Larbig, Robert; Gebing, Tina; Reda, Sara; Schwaiger, Astrid; Leitner, Johannes; Wolny, Martin; Hoppe, Uta C.] Paracelsus Med Univ, Dept Internal Med 2, Salzburg, Austria; [Larbig, Robert; Eckardt, Lars] Univ Hosp Muenster, Dept Cardiovasc Med, Div Electrophysiol, Munster, Germany	Paracelsus Private Medical University; University of Munster	Motloch, LJ (corresponding author), Paracelsus Med Univ, Dept Internal Med 2, Salzburg, Austria.	lukas.motloch@pmu.ac.at		Motloch, Lukas Jaroslaw/0000-0002-5829-6743	Marga and Walter Boll-Stiftung; Paracelsus Medical University, Salzburg [R-12/04038-LAR]	Marga and Walter Boll-Stiftung; Paracelsus Medical University, Salzburg	This work was supported by grants from the Marga and Walter Boll-Stiftung (UCH) and the Paracelsus Medical University, Salzburg (R-12/04038-LAR; LJM and RL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja M, 2014, EMBO REP, V15, P205, DOI 10.1002/embr.201438446; Altschafl BA, 2007, BBA-BIOMEMBRANES, V1768, P1784, DOI 10.1016/j.bbamem.2007.04.011; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Balke CW, 1998, CARDIOVASC RES, V37, P290, DOI 10.1016/S0008-6363(97)00272-1; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P., 2007, V45, P481; Bondarenko AI, 2015, PFLUG ARCH EUR J PHY, V467, P2509, DOI 10.1007/s00424-015-1727-z; Bondarenko AI, 2014, PFLUG ARCH EUR J PHY, V466, P1411, DOI 10.1007/s00424-013-1383-0; Bondarenko AI, 2013, PFLUG ARCH EUR J PHY, V465, P997, DOI 10.1007/s00424-013-1224-1; Bratic A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002324; Brookes PS, 2008, NAT CELL BIOL, V10, P1235, DOI 10.1038/ncb1108-1235; Chaudhuri D, 2013, ELIFE, V2, DOI 10.7554/eLife.00704; De Marchi U, 2011, J BIOL CHEM, V286, P32533, DOI 10.1074/jbc.M110.216044; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Echtay KS, 2001, P NATL ACAD SCI USA, V98, P1416, DOI 10.1073/pnas.98.4.1416; Er F, 2004, CIRCULATION, V110, P3100, DOI 10.1161/01.CIR.0000146900.84943.E0; Fieni F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2325; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gassanov N, 2006, CELL CALCIUM, V39, P175, DOI 10.1016/j.ceca.2005.10.008; Gimeno RE, 1997, DIABETES, V46, P900, DOI 10.2337/diabetes.46.5.900; Graier WF, 2007, PFLUG ARCH EUR J PHY, V455, P375, DOI 10.1007/s00424-007-0296-1; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; Holmuhamedov EL, 1998, AM J PHYSIOL-HEART C, V275, pH1567, DOI 10.1152/ajpheart.1998.275.5.H1567; HOLMUHAMEDOV EL, 1986, EUR J BIOCHEM, V158, P543, DOI 10.1111/j.1432-1033.1986.tb09788.x; Hoppe UC, 1998, CARDIOVASC RES, V38, P788, DOI 10.1016/S0008-6363(98)00047-9; Hoppe UC, 2010, FEBS LETT, V584, P1975, DOI 10.1016/j.febslet.2010.04.017; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kohlhaas M, 2010, CIRCULATION, V121, P1606, DOI 10.1161/CIRCULATIONAHA.109.914911; Korge P, 2001, AM J PHYSIOL-HEART C, V280, pH2203, DOI 10.1152/ajpheart.2001.280.5.H2203; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Lange PS, 2003, CARDIOVASC RES, V59, P321, DOI 10.1016/S0008-6363(03)00434-6; Larbig R, 2010, J PHYSIOL-LONDON, V588, P3266, DOI 10.1113/jphysiol.2010.187708; Lesnefsky EJ, 1997, AM J PHYSIOL-HEART C, V273, pH1544, DOI 10.1152/ajpheart.1997.273.3.H1544; Li YC, 2007, FASEB J, V21, P2474, DOI 10.1096/fj.06-7345com; Litsky ML, 1997, BIOCHEMISTRY-US, V36, P7071, DOI 10.1021/bi970180y; Lu XY, 2013, CIRC RES, V112, P424, DOI 10.1161/CIRCRESAHA.111.300501; Maack C, 2006, CIRC RES, V99, P172, DOI 10.1161/01.RES.0000232546.92777.05; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; Michels G, 2009, CIRCULATION, V119, P2435, DOI 10.1161/CIRCULATIONAHA.108.835389; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; Nichols CB, 2010, CIRC RES, V107, P747, DOI 10.1161/CIRCRESAHA.109.216127; O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Pi JB, 2009, ENDOCRINOLOGY, V150, P3040, DOI 10.1210/en.2008-1642; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Pott C, 2005, CIRC RES, V97, P1288, DOI 10.1161/01.RES.0000196563.84231.21; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Tian XY, 2012, CIRC RES, V110, P1211, DOI [10.1161/CIRCRESAHA.111.262170, 10.1161/circresaha.111.262170]; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Waldeck-Weiermair M, 2013, J BIOL CHEM, V288, P15367, DOI 10.1074/jbc.M113.462259; Waldeck-Weiermair M, 2010, CELL CALCIUM, V47, P433, DOI 10.1016/j.ceca.2010.03.004; Williams GSB, 2013, P NATL ACAD SCI USA, V110, P10479, DOI 10.1073/pnas.1300410110; Wu ZF, 2009, ANTIOXID REDOX SIGN, V11, P1805, DOI [10.1089/ars.2009.2427, 10.1089/ARS.2009.2427]; Zazueta C, 1999, J BIOENERG BIOMEMBR, V31, P551, DOI 10.1023/A:1005464927366; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zhang J, 2008, PROTEOMICS, V8, P1564, DOI 10.1002/pmic.200700851; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215	62	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148359	10.1371/journal.pone.0148359	http://dx.doi.org/10.1371/journal.pone.0148359			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849136	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000079
J	Moura-Massari, VO; Cunha, FS; Gomes, LG; Gomes, DBD; Marcondes, JAM; Madureira, G; de Mendonca, BB; Bachega, TASS				Moura-Massari, Vivian Oliveira; Cunha, Flavia Siqueira; Gomes, Larissa Garcia; Diniz Gomes, Diogo Bugano; Miguel Marcondes, Jose Antonio; Madureira, Guiomar; de Mendonca, Berenice Bilharinho; Sartori Sanchez Bachega, Tania A.			The Presence of Clitoromegaly in the Nonclassical Form of 21-Hydroxylase Deficiency Could Be Partially Modulated by the CAG Polymorphic Tract of the Androgen Receptor Gene	PLOS ONE			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; X-CHROMOSOME INACTIVATION; POLYCYSTIC-OVARY-SYNDROME; CLINICAL-PRACTICE GUIDELINE; PROSTATE-CANCER; REPEAT POLYMORPHISM; BRAZILIAN PATIENTS; NORMAL WOMEN; RISK; ASSOCIATION	Background In the nonclassical form (NC), good correlation has been observed between genotypes and 17OH-progesterone (17-OHP) levels. However, this correlation was not identified with regard to the severity of hyperandrogenic manifestations, which could depend on interindividual variability in peripheral androgen sensitivity. Androgen action is modulated by the polymorphic CAG tract (nCAG) of the androgen receptor (AR) gene and by polymorphisms in 5 alpha-reductase type 2 (SRD5A2) enzyme, both of which are involved in the severity of hyperandrogenic disorders. Objectives To analyze whether nCAG-AR and SRD5A2 polymorphisms influence the severity of the nonclassical phenotype. Patients NC patients (n = 114) diagnosed by stimulated-17OHP >= 10 ng/mL were divided into groups according to the beginning of hyperandrogenic manifestations (pediatric and adolescent/adult) and CYP21A2 genotypes (C/C: homozygosis for mild mutations; A/C: compound heterozygosis for severe/mild mutations). Methods CYP21A2 mutations were screened by allelic-specific PCR, MLPA and/or sequencing. HpaII-digested and HpaII-undigested DNA samples underwent GeneScan analysis to study nCAG, and the SRD5A2 polymorphisms were screened by RLFP. Results Mean nCAG did not differ among pediatric, adolescent/adult and asymptomatic subjects. In the C/C genotype, we observed a significantly lower frequency of longer CAG alleles in pediatric patients than in adolescent/adults (p = 0.01). In patients carrying the A/C genotype, the frequencies of shorter and longer CAG alleles did not differ between pediatric patients and adolescent/adults (p>0.05). Patients with clitoromegaly had significantly lower weighted CAG biallelic mean than those without it: 19.1 +/- 2.7 and 21.6 +/- 2.5, respectively (p = 0.007), independent of the CYP21A2 genotype's severity. The SRD5A2 polymorphisms were not associated with the variability of hyperandrogenic NC phenotypes. Conclusions In this series, we observed a modulatory effect of the CAG-AR tract on clinical manifestations of the NC form. Although the NC form is a monogenic disorder, our preliminary data suggested that the interindividual variability of the hyperandrogenic phenotype could arise from polygenic interactions.	[Moura-Massari, Vivian Oliveira; Cunha, Flavia Siqueira; Gomes, Larissa Garcia; Miguel Marcondes, Jose Antonio; Madureira, Guiomar; de Mendonca, Berenice Bilharinho; Sartori Sanchez Bachega, Tania A.] Univ Sao Paulo, Fac Med, Lab Hormonios & Genet Mol LIM 42, Unidade Suprarrenal,Disciplina Endocrinol,Hosp Cl, Sao Paulo, Brazil; [Diniz Gomes, Diogo Bugano] Univ Sao Paulo, Fac Med, Hosp Clin, Dept Clin Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Cunha, FS (corresponding author), Univ Sao Paulo, Fac Med, Lab Hormonios & Genet Mol LIM 42, Unidade Suprarrenal,Disciplina Endocrinol,Hosp Cl, Sao Paulo, Brazil.	endoflavia@gmail.com; tbachega@usp.br	Mendonca, Berenice/AAS-3742-2021; Bachega, Tania A S S/C-3361-2013	Mendonca, Berenice/0000-0003-1762-1084; Bachega, Tania A S S/0000-0002-5219-3153; Gomes, Larissa/0000-0002-0902-0142	Sao Paulo Research Foundation (FAPESP) [2014/07878-4, 08/51624-6, 05/04726-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [308318/2012-9, 305743/2011-2]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by grants from the Sao Paulo Research Foundation (FAPESP) #2014/07878-4, to Moura-Massari V by FAPESP #08/51624-6 and FAPESP #05/04726-0, and to Bachega TASS and Mendonca BB by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) #308318/2012-9 and 305743/2011-2, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovic T, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-109; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Araujo RS, 2007, J CLIN ENDOCR METAB, V92, P4028, DOI 10.1210/jc.2006-2163; Bachega TASS, 2000, CLIN ENDOCRINOL, V52, P601, DOI 10.1046/j.1365-2265.2000.00995.x; Bachega TASS, 1998, J CLIN ENDOCR METAB, V83, P4416, DOI 10.1210/jc.83.12.4416; Bebermeier JH, 2006, J MOL MED, V84, P919, DOI 10.1007/s00109-006-0081-1; Ben-Shachar S, 2015, HORM METAB RES, V47, P491, DOI 10.1055/s-0034-1389901; Bidet M, 2009, J CLIN ENDOCR METAB, V94, P1570, DOI 10.1210/jc.2008-1582; Billerbeck AEC, 1999, J CLIN ENDOCR METAB, V84, P2870, DOI 10.1210/jc.84.8.2870; Brown J, 2005, J PEDIATR ENDOCR MET, V18, P3; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Cleves MA, 2005, STATA J, V5, P141, DOI 10.1177/1536867X0500500201; Costa-Barbosa FA, 2010, CLIN ENDOCRINOL, V73, P700, DOI 10.1111/j.1365-2265.2010.03871.x; Dasgupta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012401; Deneux C, 2001, J CLIN ENDOCR METAB, V86, P207, DOI 10.1210/jc.86.1.207; Ezquieta B, 2002, ACTA PAEDIATR, V91, P892, DOI 10.1080/080352502760148595; FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440, DOI 10.1210/jcem-21-11-1440; Finkielstain GP, 2011, J CLIN ENDOCR METAB, V96, pE161, DOI 10.1210/jc.2010-0319; GALE RE, 1994, BLOOD, V83, P2899, DOI 10.1182/blood.V83.10.2899.2899; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; Goodarzi MO, 2006, J CLIN ENDOCR METAB, V91, P4085, DOI 10.1210/jc.2006-0227; Hickey T, 2002, J CLIN ENDOCR METAB, V87, P161, DOI 10.1210/jc.87.1.161; HIGASHI Y, 1991, J BIOCHEM-TOKYO, V109, P638, DOI 10.1093/oxfordjournals.jbchem.a123433; Hsing AW, 2000, CANCER RES, V60, P5111; Ibanez L, 2003, J CLIN ENDOCR METAB, V88, P3333, DOI 10.1210/jc.2002-021791; Kaupert LC, 2010, HORM RES PAEDIAT, V73, P238, DOI 10.1159/000284387; Krone N, 2000, J CLIN ENDOCR METAB, V85, P1059, DOI 10.1210/jc.85.3.1059; Lappalainen S, 2008, J CLIN ENDOCR METAB, V93, P1304, DOI 10.1210/jc.2007-2707; Li QX, 2013, MOL BIOL REP, V40, P3597, DOI 10.1007/s11033-012-2434-x; Li ZH, 2003, J UROLOGY, V169, P2378, DOI 10.1097/01.ju.0000056152.57018.31; Makridakis NM, 1999, LANCET, V354, P975, DOI 10.1016/S0140-6736(98)11282-5; Martin KA, 2008, J CLIN ENDOCR METAB, V93, P1105, DOI 10.1210/jc.2007-2437; Mifsud A, 2001, FERTIL STERIL, V75, P275, DOI 10.1016/S0015-0282(00)01693-9; Mishra DK, 2005, CLIN GENET, V68, P55, DOI 10.1111/j.1399-0004.2005.00450.x; Moran C, 2000, AM J OBSTET GYNECOL, V183, P1468, DOI 10.1067/mob.2000.108020; Moura-Massari VO, 2013, HORM METAB RES, V45, P301, DOI 10.1055/s-0032-1330007; Nam RK, 2001, UROLOGY, V57, P199, DOI 10.1016/S0090-4295(00)00928-6; New MI, 2004, ANN NY ACAD SCI, V1038, P14, DOI 10.1196/annals.1315.009; Ogata T, 2001, CLIN ENDOCRINOL, V54, P835, DOI 10.1046/j.1365-2265.2001.01205.x; PEGORARO E, 1994, AM J HUM GENET, V54, P989; Ribeiro ML, 2002, BRAZ J MED BIOL RES, V35, P205, DOI 10.1590/S0100-879X2002000200009; Rocha RO, 2008, CLIN ENDOCRINOL, V68, P226, DOI 10.1111/j.1365-2265.2007.03023.x; Samtani R, 2011, J UROLOGY, V185, P2334, DOI 10.1016/j.juro.2011.02.043; Shah NA, 2008, J CLIN ENDOCR METAB, V93, P1939, DOI 10.1210/jc.2008-0038; Sharp A, 2000, HUM GENET, V107, P343, DOI 10.1007/s004390000382; Shimbo M, 2005, EUR UROL, V47, P557, DOI 10.1016/j.eururo.2004.10.016; Skrgatic L, 2012, J STEROID BIOCHEM, V128, P107, DOI 10.1016/j.jsbmb.2011.11.006; Speiser PW, 2010, J CLIN ENDOCR METAB, V95, P4133, DOI 10.1210/jc.2009-2631; Speiser PW, 2000, MOL GENET METAB, V71, P527, DOI 10.1006/mgme.2000.3036; SPEISER PW, 1988, NEW ENGL J MED, V319, P19, DOI 10.1056/NEJM198807073190104; SPEISER PW, 1992, HUM GENET, V88, P647, DOI 10.1007/BF02265290; TUSIELUNA MT, 1990, J BIOL CHEM, V265, P20916; VERKAUF BS, 1992, OBSTET GYNECOL, V80, P41; WEDELL A, 1994, J CLIN ENDOCR METAB, V78, P1145, DOI 10.1210/jc.78.5.1145; Weintrob N, 2000, EUR J ENDOCRINOL, V143, P397, DOI 10.1530/eje.0.1430397; White PC, 2012, SEMIN REPROD MED, V30, P400, DOI 10.1055/s-0032-1324724; Wilson RC, 2007, MOL GENET METAB, V90, P414, DOI 10.1016/j.ymgme.2006.12.005; Xita N, 2008, HUM REPROD, V23, P693, DOI 10.1093/humrep/dem382; Zouboulis CC, 2004, EXP DERMATOL, V13, P5, DOI 10.1111/j.1600-0625.2004.00255.x	59	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148548	10.1371/journal.pone.0148548	http://dx.doi.org/10.1371/journal.pone.0148548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848581	Green Published, gold			2022-12-27	WOS:000369554000122
J	Bua, G; Manaresi, E; Bonvicini, F; Gallinella, G				Bua, Gloria; Manaresi, Elisabetta; Bonvicini, Francesca; Gallinella, Giorgio			Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor Cells	PLOS ONE			English	Article							IN-VITRO; CYCLE ARREST; INTERNAL POLYADENYLATION; NONSTRUCTURAL PROTEIN; PRODUCTIVE INFECTION; PERIPHERAL-BLOOD; P-ANTIGEN; VIRUS; APOPTOSIS; RECEPTOR	The pathogenic Parvovirus B19 (B19V) is characterized by a strict adaptation to erythroid progenitor cells (EPCs), a heterogeneous population of differentiating cells with diverse phenotypic and functional properties. In our work, we studied the dynamics of B19V infection in EPCs in dependence on the cell differentiation stage, in terms of distribution of infected cells, synthesis of viral nucleic acids and production of infectious virus. EPCs at early differentiation stage led to an abortive infection, without viral genome replication and a very low transcriptional activity. EPCs at later stages were permissive, with highest levels of viral replicative activity at day 9 (+3.0 Log from 2 to 48 hpi) and lower levels at day 18 (+1.5 Log from 2 to 48 hpi). B19V DNA increment was in accordance with the percentage of cells positive to flow-FISH assay (41.4% at day 9, 1.1% at day 18). Quantitation of total RNA indicated a close association of genome replication and transcription with viral RNA accumulation within infected cells related to viral DNA increase during the course of infection. Analysis of the different classes of mRNAs revealed two distinct pattern of genome expression profile with a fine regulation in the frequency utilization of RNA processing signals: an early phase, when cleavage at the proximal site leading to a higher relative production of mRNA for NS protein, and a late phase, when cleavage at the distal site was more frequent leading to higher relative abundance of mRNA for VP and 11 kDA proteins. Infectious virus was released from cells at day 6-15, but not at day 18. Our results, providing a detailed description of B19V replication and expression profile in differentiating EPCs, highlight the very tight adaptation of B19V to a specific cellular target defined both by its erythroid lineage and its differentiation stage.	[Bua, Gloria; Manaresi, Elisabetta; Bonvicini, Francesca; Gallinella, Giorgio] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Gallinella, Giorgio] Univ Bologna, Orsola Malpighi Hosp Microbiol, Bologna, Italy	University of Bologna; University of Bologna	Gallinella, G (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy.	giorgio.gallinella@unibo.it	Gallinella, Giorgio/H-6864-2017	Gallinella, Giorgio/0000-0003-1118-6341; BUA, GLORIA/0000-0003-0826-3713				Bonvicini F, 2006, VIROLOGY, V347, P447, DOI 10.1016/j.virol.2005.12.014; Bonvicini F, 2008, VIROLOGY, V381, P168, DOI 10.1016/j.virol.2008.09.002; Bonvicini F, 2015, ANTIVIR RES, V113, P11, DOI 10.1016/j.antiviral.2014.11.004; Bonvicini F, 2013, J CLIN MICROBIOL, V51, P3753, DOI 10.1128/JCM.01970-13; Bonvicini F, 2011, J CLIN MICROBIOL, V49, P3514, DOI 10.1128/JCM.00854-11; BROWN KE, 1994, NEW ENGL J MED, V330, P1192, DOI 10.1056/NEJM199404283301704; BROWN KE, 1993, SCIENCE, V262, P114, DOI 10.1126/science.8211117; Brown KE, 2000, BEST PRACT RES CL HA, V13, P245, DOI 10.1053/beha.1999.0071; BROWN KE, 1991, J GEN VIROL, V72, P741, DOI 10.1099/0022-1317-72-3-741; Chen AY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002088; Chen AY, 2010, FUTURE VIROL, V5, P731, DOI 10.2217/FVL.10.56; Chen AY, 2010, J VIROL, V84, P12385, DOI 10.1128/JVI.01229-10; Chen AY, 2010, BLOOD, V115, P1070, DOI 10.1182/blood-2009-04-215756; Chisaka H, 2003, REV MED VIROL, V13, P347, DOI 10.1002/rmv.395; Cotmore SF, 2014, ARCH VIROL, V159, P1239, DOI 10.1007/s00705-013-1914-1; Filippone C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009496; Gallinella G, 2004, CLIN CHEM, V50, P759, DOI 10.1373/clinchem.2003.027292; Gallinella G, 2000, VIROLOGY, V278, P361, DOI 10.1006/viro.2000.0673; Gallinella G., 2013, ISRN VIROL, DOI [10.5402/2013/898730, DOI 10.5402/2013/898730]; Guan WX, 2008, J VIROL, V82, P9951, DOI 10.1128/JVI.01162-08; Guan WX, 2011, J BIOL CHEM, V286, P24793, DOI 10.1074/jbc.M111.227439; Guan WX, 2011, J VIROL, V85, P2463, DOI 10.1128/JVI.01708-10; Guo YM, 2010, BLOOD, V115, P4569, DOI 10.1182/blood-2009-08-239202; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Hemauer A, 1999, J GEN VIROL, V80, P627, DOI 10.1099/0022-1317-80-3-627; Leisi R, 2015, BIOCONJUGATE CHEM, V26, P1923, DOI 10.1021/acs.bioconjchem.5b00321; Leisi R, 2013, J VIROL, V87, P13161, DOI 10.1128/JVI.02548-13; Lou S, 2012, J VIROL, V86, P10748, DOI 10.1128/JVI.01007-12; Luo Y, 2015, FUTURE VIROL, V10, P155, DOI 10.2217/FVL.14.103; Luo Y, 2013, J VIROL, V87, P12766, DOI 10.1128/JVI.02333-13; Luo Y, 2013, FUTURE VIROL, V8, P245, DOI 10.2217/FVL.13.5; Luo Y, 2011, J VIROL, V85, P8046, DOI 10.1128/JVI.00831-11; Manaresi E, 2015, J VIROL METHODS, V223, P50, DOI 10.1016/j.jviromet.2015.07.013; Merryweather-Clarke AT, 2011, BLOOD, V117, pE96, DOI 10.1182/blood-2010-07-290825; Moffatt S, 1998, J VIROL, V72, P3018, DOI 10.1128/JVI.72.4.3018-3028.1998; Morita E, 2003, J VIROL, V77, P2915, DOI 10.1128/JVI.77.5.2915-2921.2003; Morita E, 2001, J VIROL, V75, P7555, DOI 10.1128/JVI.75.16.7555-7563.2001; MORTIMER PP, 1983, NATURE, V302, P426, DOI 10.1038/302426a0; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; OZAWA K, 1986, SCIENCE, V233, P883, DOI 10.1126/science.3738514; OZAWA K, 1987, BLOOD, V70, P384, DOI 10.1182/blood.V70.2.384.384; Pillet S, 2004, VIROLOGY, V327, P1, DOI 10.1016/j.virol.2004.06.020; Pillet S, 2008, J VIROL, V82, P8951, DOI 10.1128/JVI.00929-08; Puccetti C, 2012, PRENATAL DIAG, V32, P897, DOI 10.1002/pd.3930; Quattrocchi S, 2012, J VIROL, V86, P9274, DOI 10.1128/JVI.01004-12; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; SCHWARZ TF, 1992, J VIROL, V66, P1273, DOI 10.1128/JVI.66.2.1273-1276.1992; SERKE S, 1991, BRIT J HAEMATOL, V79, P6, DOI 10.1111/j.1365-2141.1991.tb07999.x; Sol N, 1999, J VIROL, V73, P8762, DOI 10.1128/JVI.73.10.8762-8770.1999; SRIVASTAVA A, 1988, J VIROL, V62, P3059, DOI 10.1128/JVI.62.8.3059-3063.1988; TAKAHASHI T, 1990, BLOOD, V75, P603; Tewary SK, 2014, VIROLOGY, V449, P297, DOI 10.1016/j.virol.2013.11.031; Tolfvenstam T, 2009, SEMIN FETAL NEONAT M, V14, P218, DOI 10.1016/j.siny.2009.01.007; von Landenberg P, 2007, AUTOIMMUN REV, V6, P278, DOI 10.1016/j.autrev.2006.09.006; Wan ZH, 2010, J CLIN INVEST, V120, P3530, DOI 10.1172/JCI41805; Weigel-Kelley KA, 2003, BLOOD, V102, P3927, DOI 10.1182/blood-2003-05-1522; Weigel-Kelley KA, 2001, J VIROL, V75, P4110, DOI 10.1128/JVI.75.9.4110-4116.2001; Wong S, 2008, J VIROL, V82, P2470, DOI 10.1128/JVI.02247-07; Wong S, 2006, J CLIN VIROL, V35, P407, DOI 10.1016/j.jcv.2005.12.008; Yaegashi N, 1999, J INFECTION, V39, P68, DOI 10.1016/S0163-4453(99)90105-6; YOUNG N, 1984, J CLIN INVEST, V74, P2024, DOI 10.1172/JCI111625; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840; YOUNG NS, 1984, J CLIN INVEST, V73, P224, DOI 10.1172/JCI111195; Zhi N, 2006, J VIROL, V80, P5941, DOI 10.1128/JVI.02430-05	64	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148547	10.1371/journal.pone.0148547	http://dx.doi.org/10.1371/journal.pone.0148547			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845771	gold, Green Published, Green Submitted			2022-12-27	WOS:000369552800068
J	Kumar, J; Sharma, VK; Singh, DK; Mishra, A; Gond, SK; Verma, SK; Kumar, A; Kharwar, RN				Kumar, Jitendra; Sharma, Vijay K.; Singh, Dheeraj K.; Mishra, Ashish; Gond, Surendra K.; Verma, Satish K.; Kumar, Anuj; Kharwar, Ravindra Nath			Epigenetic Activation of Antibacterial Property of an Endophytic Streptomyces coelicolor Strain AZRA 37 and Identification of the Induced Protein Using MALDI TOF MS/MS	PLOS ONE			English	Article							ASSISTED-LASER-DESORPTION/IONIZATION; SP NOV.; RAPID IDENTIFICATION; MYCOFLORA; DIVERSITY; BARK; LEAF; NEEM; DNA	The endophytic Streptomyces coelicolor strain AZRA 37 was isolated from the surface sterilized root of Azadirachta indica A. Juss., commonly known as neem plant in India. Since only a few reports are available regarding epigenetic modulations of microbial entities, S. coelicolor was treated with different concentrations of 5-azacytidine for this purpose and evaluated for its antibacterial potential against five human pathogenic bacteria (Aeromonas hydrophila IMS/GN11, Enterococcus faecalis IMS/GN7, Salmonella typhi MTCC 3216, Shigella flexneri ATCC 12022 and Staphylococcus aureus ATCC 25923). The crude extract obtained from cultures treated with 25 mu M concentration of 5-azacytidine, was found effective against all five pathogenic bacteria tested while the untreated control was only active against 3 pathogenic bacteria. HPLC analysis of crude compounds from treated cultures showed a greater number of compounds than that of the control. Extraction of whole cell protein and its SDS PAGE analysis showed an additional major protein band in 25 mu M 5-azacytidine treated culture and MALDI TOF MS/MS analysis revealed that this protein belongs to the porin family.	[Kumar, Jitendra; Sharma, Vijay K.; Singh, Dheeraj K.; Mishra, Ashish; Verma, Satish K.; Kharwar, Ravindra Nath] Banaras Hindu Univ, Dept Bot, Mycopathol & Microbial Technol Lab, Varanasi 221005, Uttar Pradesh, India; [Gond, Surendra K.] Visva Bharati, Dept Bot, Santini Ketan, Bolpur, India; [Kumar, Anuj] Budhha PG Coll, Dept Bot, Kushinagar, India	Banaras Hindu University (BHU); Visva Bharati University	Kharwar, RN (corresponding author), Banaras Hindu Univ, Dept Bot, Mycopathol & Microbial Technol Lab, Varanasi 221005, Uttar Pradesh, India.	rnkharwar@yahoo.com	Sharma, Vijay Kumar/J-5353-2019; Verma, Satish K./J-6398-2019; Gond, Surendra/ABB-6182-2021; Singh, Dheeraj Kumar/ABS-8460-2022; Sharma, Vijay Kumar K/E-3541-2019	Singh, Dheeraj Kumar/0000-0001-8297-5191; Sharma, Vijay Kumar K/0000-0002-2330-5830; Gond, Surendra/0000-0002-2737-9028; Verma, Satish Kumar/0000-0003-4470-5398	CSIR, New Delhi; Department of Science and Technology (Science and Engineering Research Board), New Delhi [SB/EMEQ-121/2014]	CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (Science and Engineering Research Board), New Delhi(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines)	Funded by the CSIR, New Delhi, for financial support as JRF and SRF to JK; the Department of Science and Technology (Science and Engineering Research Board), New Delhi, for financial support to RNK as project (SB/EMEQ-121/2014, 21-7-2014).	Baltz RH, 2008, CURR OPIN PHARMACOL, V8, P557, DOI 10.1016/j.coph.2008.04.008; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Beau J, 2012, MAR DRUGS, V10, P762, DOI 10.3390/md10040762; BENSON DR, 1993, MICROBIOL REV, V57, P293, DOI 10.1128/MMBR.57.2.293-319.1993; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Castillo U, 2003, J NAT PRODUCTS, V66, P709; de la Cruz M, 2012, CHEM BIODIVERS, V9, P1095, DOI 10.1002/cbdv.201100362; Du HJ, 2013, INT J SYST EVOL MICR, V63, P900, DOI 10.1099/ijs.0.041491-0; Fenselau C, 2001, MASS SPECTROM REV, V20, P157, DOI 10.1002/mas.10004; FERNANDEZ M, 1995, GENE, V157, P221, DOI 10.1016/0378-1119(94)00672-F; Gangwar M, 2015, INT J ADV RES, V3, P1062; Gangwar M, 2014, AFR J MICOBIOL RES, V92, P182; Genilloud O, 2011, J IND MICROBIOL BIOT, V38, P375, DOI 10.1007/s10295-010-0882-7; Gohain A, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv158; Gond SK, 2010, MANAGEMENT OF FUNGAL PLANT PATHOGENS, P183, DOI 10.1079/9781845936037.0183; Holland RD, 1996, RAPID COMMUN MASS SP, V10, P1227, DOI 10.1002/(SICI)1097-0231(19960731)10:10<1227::AID-RCM659>3.0.CO;2-6; Janso JE, 2010, APPL ENVIRON MICROB, V76, P4377, DOI 10.1128/AEM.02959-09; Kaewkla O, 2013, INT J SYST EVOL MICR, V63, P1249, DOI 10.1099/ijs.0.041343-0; Kaewkla O, 2012, INT J SYST EVOL MICR, V62, P1687, DOI 10.1099/ijs.0.033258-0; Kharwar RN, 2008, CURR SCI INDIA, V95, P228; Klackta C, 2011, BBA-BIOMEMBRANES, V1808, P1601, DOI 10.1016/j.bbamem.2010.11.011; KUSTER E, 1964, NATURE, V202, P928, DOI 10.1038/202928a0; Passardi A, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0139468, 10.1371/journal.pone.0134732]; POSPIECH A, 1995, TRENDS GENET, V11, P217, DOI 10.1016/S0168-9525(00)89052-6; Qin S, 2009, APPL ENVIRON MICROB, V75, P6176, DOI 10.1128/AEM.01034-09; Rajagopal K, 2000, CURR SCI INDIA, V78, P1375; Ruelle V, 2004, RAPID COMMUN MASS SP, V18, P2013, DOI 10.1002/rcm.1584; SCHUMACHER JD, 2014, THESIS, P1; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Udeinya IJ, 2004, T ROY SOC TROP MED H, V98, P435, DOI 10.1016/j.trstmh.2003.10.016; Verma VC, 2007, MICROB ECOL, V54, P119, DOI 10.1007/s00248-006-9179-9; Verma VC, 2006, J AGR TECHNOLOGY, V2, P329; Verma VC, 2013, INT NANO LETT, V3, DOI 10.1186/2228-5326-3-21; Verma VC, 2011, INDIAN J MICROBIOL, V51, P469, DOI 10.1007/s12088-011-0121-6; Verma VC, 2009, MICROB ECOL, V57, P749, DOI 10.1007/s00248-008-9450-3; Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184; Williams TL, 2003, J AM SOC MASS SPECTR, V14, P342, DOI 10.1016/S1044-0305(03)00065-5; Yu ZG, 2011, J ANTIBIOT, V64, P159, DOI 10.1038/ja.2010.147; Zhao GZ, 2011, J NAT PRODUCTS, V74, P862	41	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147876	10.1371/journal.pone.0147876	http://dx.doi.org/10.1371/journal.pone.0147876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844762	gold, Green Published, Green Submitted			2022-12-27	WOS:000369552800020
J	Liu, YZ; Qiu, L; Wang, YX; Aimurola, H; Zhao, YY; Li, S; Xu, ZJ				Liu, Yongzhe; Qiu, Lan; Wang, Yanxun; Aimurola, Halimulati; Zhao, Yuyue; Li, Shan; Xu, Zuojun			The Circulating Treg/Th17 Cell Ratio Is Correlated with Relapse and Treatment Response in Pulmonary Sarcoidosis Patients after Corticosteroid Withdrawal	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; REGULATORY T-CELLS; CD4(+); PREDICTION; CYTOKINES; PROGRESS; TH1	Objectives Pulmonary sarcoidosis is an immune-mediated disease, and some patients can be effectively treated with corticosteroids. However, nearly half of all sarcoidosis patients relapse after corticosteroid withdrawal. Different subsets of CD4+ helper T cells participate in the immunopathogenesis of sarcoidosis. Thus, the aims of our study were to investigate whether the circulating subsets of CD4+ helper T cells were associated with sarcoidosis relapse and with its remission after retreatment. Additionally, we identified a useful biomarker for predicting the relapse and remission of sarcoidosis patients. Methods Forty-two patients were enrolled in the present study who had previously been diagnosed with pulmonary sarcoidosis and treated with corticosteroids. The patients were allocated into either a stable group if they exhibited sustained remission (n = 22) or a relapse group if they experienced clinical or radiological recurrence after treatment withdrawal (n = 20). Peripheral blood cells were collected from these patients and analyzed to determine the frequencies of subsets of circulating CD4+ helper T cells by flow cytometry. The patients in the relapse group were retreated with corticosteroids and immunosuppressive agents and were then reevaluated to determine the frequencies of dynamic subsets of circulating CD4+ helper T cells after remission. Results The frequencies of circulating Tregs were significantly increased concomitant with a decrease in the circulating Th17 cell frequency in the relapsed patients compared with the stable patients. The Treg/Th17 ratio was negatively correlated with sarcoidosis activity and was sensitive to retreatment. In addition, the percentage of isolated CD45RO+Ki67+ Tregs was higher in the patients who were stable and in those who recovered after retreatment than in those who relapsed. Conclusions An imbalance between Tregs and Th17 cells is associated with pulmonary sarcoidosis relapse after corticosteroid withdrawal. The circulating Treg/Th17 ratio could serve as an alternative marker for monitoring pulmonary sarcoidosis relapse after the end of corticosteroid treatment and for rapidly predicting the response to retreatment.	[Liu, Yongzhe; Wang, Yanxun; Zhao, Yuyue; Li, Shan; Xu, Zuojun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Resp Med, Beijing 100730, Peoples R China; [Liu, Yongzhe; Wang, Yanxun; Zhao, Yuyue; Li, Shan; Xu, Zuojun] Peking Union Med Coll, Beijing 100730, Peoples R China; [Qiu, Lan] 2 Jikun Hosp, Dept Internal Med, Urumqi 830013, Xinjiang Uyghur, Peoples R China; [Aimurola, Halimulati] Chest Hosp Xinjiang Uyghur Autonomous Reg, Dept Resp Med, Urumqi 830049, Xinjiang Uyghur, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xu, ZJ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Resp Med, Beijing 100730, Peoples R China.; Xu, ZJ (corresponding author), Peking Union Med Coll, Beijing 100730, Peoples R China.	xuzj@hotmail.com			National Natural Science Foundation of China [81170055]; China Postdoctoral Science Foundation [2015M570973]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (No. 81170055) and China Postdoctoral Science Foundation (No. 2015M570973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou KM, 2006, J INTERF CYTOK RES, V26, P400, DOI 10.1089/jir.2006.26.400; Baughman RP, 2014, EUR RESPIR J, V43, P337, DOI 10.1183/09031936.00138913; Baumer I, 1997, AM J RESP CELL MOL, V16, P171; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Broos CE, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0265-8; Chen ES, 2011, NAT REV RHEUMATOL, V7, P457, DOI 10.1038/nrrheum.2011.93; Erdal BS, 2012, RESP MED, V106, P893, DOI 10.1016/j.rmed.2012.02.007; Facco M, 2011, THORAX, V66, P144, DOI 10.1136/thx.2010.140319; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gottlieb JE, 1997, CHEST, V111, P623, DOI 10.1378/chest.111.3.623; Grunewald Johan, 2007, Proc Am Thorac Soc, V4, P461, DOI 10.1513/pats.200606-130MS; Grutters JC, 2006, EUR RESPIR J, V28, P627, DOI 10.1183/09031936.06.00105805; HOLLINGER WM, 1985, AM REV RESPIR DIS, V132, P65; Huang H, 2013, INT J MOL SCI, V14, P21463, DOI 10.3390/ijms141121463; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Iannuzzi MC, 2011, JAMA-J AM MED ASSOC, V305, P391, DOI 10.1001/jama.2011.10; Idali F, 2008, CLIN EXP IMMUNOL, V152, P127, DOI 10.1111/j.1365-2249.2008.03609.x; Inui N, 2001, J ALLERGY CLIN IMMUN, V107, P337, DOI 10.1067/mai.2001.112273; Ji LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050909; Judson MA, 2015, RESP MED, V109, P526, DOI 10.1016/j.rmed.2015.01.019; LIEBERMAN J, 1975, AM J MED, V59, P365, DOI 10.1016/0002-9343(75)90395-2; Long SA, 2011, J IMMUNOL, V187, P2061, DOI 10.4049/jimmunol.1003224; Milburn HJ, 1997, CLIN EXP IMMUNOL, V108, P105, DOI 10.1046/j.1365-2249.1997.d01-979.x; MITCHELL DN, 1974, AM REV RESPIR DIS, V110, P774; Miyara M, 2006, J EXP MED, V203, P359, DOI 10.1084/jem.20050648; Oda K, 2014, RESPIR INVESTIG, V52, P179, DOI 10.1016/j.resinv.2013.12.003; Ostadkarampour M, 2014, CLIN EXP IMMUNOL, V178, P342, DOI 10.1111/cei.12403; Oswald-Richter KA, 2013, J IMMUNOL, V190, P5446, DOI 10.4049/jimmunol.1202891; Panselinas E, 2012, CHEST, V142, P827, DOI 10.1378/chest.12-1060; Paramothayan NS, 2005, COCHRANE DB SYST REV, V2; Prasse A, 2000, CLIN EXP IMMUNOL, V122, P241, DOI 10.1046/j.1365-2249.2000.01365.x; Ramstein J, 2015, AM J RESP CRIT CARE; Rappl G, 2011, CLIN IMMUNOL, V140, P71, DOI 10.1016/j.clim.2011.03.015; Taflin C, 2009, AM J PATHOL, V174, P497, DOI 10.2353/ajpath.2009.080580; ten Berge B, 2012, RHEUMATOLOGY, V51, P37, DOI 10.1093/rheumatology/ker316; Tondell A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/438070; Urbankowski T, 2012, POL ARCH MED WEWN, V122, P320, DOI 10.20452/pamw.1341; Valeyre D, 2014, LANCET, V383, P1155, DOI 10.1016/S0140-6736(13)60680-7; Vorselaars ADM, 2014, EUR RESPIR J, V43, P602, DOI 10.1183/09031936.00055213; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Zhang JG, 2010, EBM 2010: INTERNATIONAL CONFERENCE ON ENGINEERING AND BUSINESS MANAGEMENT, VOLS 1-8, P5	41	15	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148207	10.1371/journal.pone.0148207	http://dx.doi.org/10.1371/journal.pone.0148207			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845566	Green Published, gold, Green Submitted			2022-12-27	WOS:000369552800036
J	Golob, T; Makarovic, M; Suklan, J				Golob, Tea; Makarovic, Matej; Suklan, Jana			National Development Generates National Identities	PLOS ONE			English	Article								The purpose of the article is to test the relationship between national identities and modernisation. We test the hypotheses that not all forms of identity are equally compatible with modernisation as measured by Human Development Index. The less developed societies are characterised by strong ascribed national identities based on birth, territory and religion, but also by strong voluntarist identities based on civic features selected and/or achieved by an individual. While the former decreases with further modernisation, the latter may either decrease or remain at high levels and coexist with instrumental supranational identifications, typical for the most developed countries. The results, which are also confirmed by multilevel regression models, thus demonstrate that increasing modernisation in terms of development contributes to the shifts from classical, especially ascribed, identities towards instrumental identifications. These findings are particularly relevant in the turbulent times increasingly dominated by the hardly predictable effects of the recent mass migrations.	[Golob, Tea; Makarovic, Matej; Suklan, Jana] Sch Adv Social Studies Nova Gorica, Nova Gorica, Slovenia		Suklan, J (corresponding author), Sch Adv Social Studies Nova Gorica, Nova Gorica, Slovenia.	jana.suklan@fuds.si	Suklan, Jana/AAJ-7025-2020; Suklan, Jana/AAB-1004-2020; Makarovič, Matej/AAA-3213-2021; Golob, Tea/AAA-3198-2021	Suklan, Jana/0000-0001-8665-6593; Golob, Tea/0000-0003-4314-3231; Makarovic, Matej/0000-0001-7864-4285				Alsamawi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110881; Anderson B, 1983, IMAGINED COMMUNITIES; [Anonymous], INTRO GUIDE HLM HLM; Archer M. S., 2003, STRUCTURE AGENCY INT, DOI [10.1017/cbo9781139087315.001, DOI 10.1017/CBO9781139087315.001]; Assmann Jan, 1988, KULTUR GEDACHTNIS, P9; Beck U., 2006, COSMOPOLITAN VISION; Brunczel B., 2010, DISILLUSIONING MODER; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chen XJ, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036101; Cimini G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113470; Gellner Ernest, 1983, NEW PERSPECTIVES; GESIS Data Archive, 2003, DAT INT SOC SURV PRO; GESIS Data Archive, 1995, DAT INT SOC SURV PRO; GESIS-Leibniz-Institut fur Sozialwissenschaften, 2012, DAT EUR 77; Giordano C, 1998, ETHNICITY NATION CUL; Jones FL, 2001, EUR SOCIOL REV, V17, P103, DOI 10.1093/esr/17.2.103; Kavcic K, 2010, MANAG CHALLENGES CON, P80; Luhmann N., 1995, SOCIAL SYSTEMS; Luzar B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094429; Nax HH, 2015, SCI REP, V5; Nora P., 2011, HERITAGE MEMORY IDEN, pX; Orchard V., 2002, EUR J SOC THEORY, V5, P419, DOI [DOI 10.1177/136843102760513839, 10.1177/136843102760513839]; Parsons Talcott., 1968, STRUCTURE SOCIAL ACT; Perc M, 2013, CHAOS SOLITON FRACT, V56, P1, DOI 10.1016/j.chaos.2013.06.002; Raudenbush S., 2013, HLM 7 01 COMPUTER SO; Seidi D, 2004, MUNICH BUSINESS RES, V2, P1; Smith A.D., 1991, NATL IDENTITY; Turner-Zwinkels FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137879; United Nations Development Programme, 2012, DAT HUM DEV IND HDI; Wertsch J., 2011, HERITAGE MEMORY IDEN, P25, DOI DOI 10.4135/9781446250839; Winter T, 2011, CULTURES GLOBALIZA 4	31	4	4	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146584	10.1371/journal.pone.0146584	http://dx.doi.org/10.1371/journal.pone.0146584			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841050	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200011
J	Baiamonte, M; Parker, MO; Vinson, GP; Brennan, CH				Baiamonte, Matteo; Parker, Matthew O.; Vinson, Gavin P.; Brennan, Caroline H.			Sustained Effects of Developmental Exposure to Ethanol on Zebrafish Anxiety-Like Behaviour	PLOS ONE			English	Article							PRENATAL ALCOHOL EXPOSURE; CORTICOTROPIN-RELEASING-FACTOR; PITUITARY-ADRENAL RESPONSES; ELEVATED PLUS-MAZE; SPECTRUM DISORDERS; SEX-DIFFERENCES; BETA-ENDORPHIN; STRESS; MECHANISMS; FEMALES	In zebrafish developmentally exposed to ambient ethanol (20mM-50mM) 1-9 days post fertilization (dpf), the cortisol response to stress has been shown to be significantly attenuated in larvae, juveniles and 6 month old adults. These data are somewhat at variance with similar studies in mammals, which often show heightened stress responses. To test whether these cortisol data correlate with behavioural changes in treated animals, anxiety-like behaviour of zebrafish larvae (9dpf and 10dpf) and juveniles (23dpf) was tested in locomotor assays designed to this end. In open field tests treated animals were more exploratory, spending significantly less time at the periphery of the arena. Behavioural effects of developmental exposure to ethanol were sustained in 6-month-old adults, as judged by assessment of thigmotaxis, novel tank diving and scototaxis. Like larvae and juveniles, developmentally treated adults were generally more exploratory, and spent less time at the periphery of the arena in thigmotaxis tests, less time at the bottom of the tank in the novel tank diving tests, and less time in the dark area in scototaxis tests. The conclusion that ethanol- exposed animals showed less anxiety-like behaviour was validated by comparison with the effects of diazepam treatment, which in thigmotaxis and novel tank diving tests had similar effects to ethanol pretreatment. There is thus a possible link between the hypophysealpituitary- interrenal axis and the behavioural actions of developmental ethanol exposure. The mechanisms require further elucidation.	[Baiamonte, Matteo; Vinson, Gavin P.; Brennan, Caroline H.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Parker, Matthew O.] Univ Portsmouth, Sch Hlth Sci & Social Work, Portsmouth, Hants, England	University of London; Queen Mary University London; University of Portsmouth	Brennan, CH (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	c.h.brennan@qmul.ac.uk	Parker, Matthew/J-6815-2019	Parker, Matthew/0000-0002-7172-5231	National Centre for the replacement, refinement and reduction of animals in research, UK [G1000053]; Biotechnology and Biological Science Research Council, UK; Royal Society, UK; Biotechnology and Biological Sciences Research Council [976807] Funding Source: researchfish; National Centre for the Replacement [G1000053/1] Funding Source: researchfish	National Centre for the replacement, refinement and reduction of animals in research, UK; Biotechnology and Biological Science Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society, UK(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Centre for the Replacement	This work was supported by https://www.nc3rs.org.uk, G1000053, National Centre for the replacement, refinement and reduction of animals in research, UK, to CHB and MOP; http://www.bbsrc.ac.uk, Biotechnology and Biological Science Research Council, UK, to MB; and https://royalsociety.org, Royal Society, UK, to CHB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinoff B, 2003, ALCOHOL CLIN EXP RES, V27, P1420, DOI 10.1097/01.ALC.0000087581.13912.64; Baiamonte M, 2015, PLOS ONE; Bailey JM, 2015, NEUROTOXICOL TERATOL, V48, P1, DOI 10.1016/j.ntt.2015.01.005; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Boyd KN, 2010, J NEUROCHEM, V115, P142, DOI 10.1111/j.1471-4159.2010.06904.x; Boyd KN, 2010, J NEUROCHEM, V112, P784, DOI 10.1111/j.1471-4159.2009.06509.x; Brennan CH, 2010, ZEBRAFISH MODELS NEU; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; Cachat J, 2010, BEHAV BRAIN RES, V208, P371, DOI 10.1016/j.bbr.2009.12.004; Carneiro LMV, 2005, NEUROTOXICOL TERATOL, V27, P585, DOI 10.1016/j.ntt.2005.06.006; Carvan MJ, 2004, NEUROTOXICOL TERATOL, V26, P757, DOI 10.1016/j.ntt.2004.06.016; COLANGELO W, 1982, PROG NEUROBIOL, V19, P271, DOI 10.1016/0301-0082(82)90009-0; Collier AD, 2014, PROG NEURO-PSYCHOPH, V55, P16, DOI 10.1016/j.pnpbp.2014.05.014; Colwill RM, 2011, REV NEUROSCIENCE, V22, P63, DOI 10.1515/RNS.2011.008; de Abreu MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103232; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; ELLIS FW, 1966, J PHARMACOL EXP THER, V153, P121; Evrard Sergio Gustavo, 2010, Vertex, V21, P260; Fernandes Y, 2009, ALCOHOL CLIN EXP RES, V33, P601, DOI 10.1111/j.1530-0277.2008.00874.x; Gabriel KI, 2006, PSYCHONEUROENDOCRINO, V31, P1046, DOI 10.1016/j.psyneuen.2006.06.003; Gangisetty O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113228; Glavas MM, 2007, ALCOHOL CLIN EXP RES, V31, P1598, DOI 10.1111/j.1530-0277.2007.00460.x; Grossman L, 2010, BEHAV BRAIN RES, V214, P277, DOI 10.1016/j.bbr.2010.05.039; Haley DW, 2006, ALCOHOL CLIN EXP RES, V30, P2055, DOI 10.1111/j.1530-0277.2006.00251.x; Hellemans KGC, 2010, NEUROSCI BIOBEHAV R, V34, P791, DOI 10.1016/j.neubiorev.2009.06.004; Hellemans KGC, 2010, ALCOHOL CLIN EXP RES, V34, P633, DOI 10.1111/j.1530-0277.2009.01132.x; Hellemans KGC, 2008, ANN NY ACAD SCI, V1144, P154, DOI 10.1196/annals.1418.016; JONES KL, 1973, LANCET, V2, P999; Keedwell PA, 2001, ADDICT BIOL, V6, P247, DOI 10.1080/13556210120056580; Kily LJM, 2008, J EXP BIOL, V211, P1623, DOI 10.1242/jeb.014399; Kim CK, 1999, ALCOHOL CLIN EXP RES, V23, P301, DOI 10.1097/00000374-199902000-00016; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koob GF, 2010, BRAIN RES, V1314, P3, DOI 10.1016/j.brainres.2009.11.008; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; Marchesi C, 1997, PSYCHIAT RES, V72, P187, DOI 10.1016/S0165-1781(97)00101-7; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Maximino C, 2010, NAT PROTOC, V5, P209, DOI 10.1038/nprot.2009.225; Mead EA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00154; O'Connor MJ, 2009, DEV DISABIL RES REV, V15, P225, DOI 10.1002/ddrr.74; Osborn JA, 1996, PSYCHONEUROENDOCRINO, V21, P127, DOI 10.1016/0306-4530(95)00037-2; Osborn JA, 1998, ALCOHOL CLIN EXP RES, V22, P685, DOI 10.1097/00000374-199805000-00021; Paintner A, 2012, J CHILD NEUROL, V27, P258, DOI 10.1177/0883073811428376; Parker MO, 2014, PROG NEURO-PSYCHOPH, V55, P94, DOI 10.1016/j.pnpbp.2014.03.011; Parker MO, 2015, AQUAT TOXICOL; Richardson HN, 2008, EUR J NEUROSCI, V28, P1641, DOI 10.1111/j.1460-9568.2008.06455.x; Richendrfer H, 2012, BEHAV BRAIN RES, V228, P99, DOI 10.1016/j.bbr.2011.11.041; Rose AK, 2010, ALCOHOL CLIN EXP RES, V34, P2011, DOI 10.1111/j.1530-0277.2010.01298.x; Sarnyai Z, 2001, PHARMACOL REV, V53, P209; Schambra UB, 2015, NEUROTOXICOL TERATOL, V51, P1, DOI 10.1016/j.ntt.2015.07.003; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Slone JL, 2002, NEUROTOXICOL TERATOL, V24, P173, DOI 10.1016/S0892-0362(01)00186-6; Stewart A, 2011, PROG NEURO-PSYCHOPH, V35, P1421, DOI 10.1016/j.pnpbp.2010.11.035; Taylor A N, 1988, Adv Exp Med Biol, V245, P311; TAYLOR AN, 1981, ALCOHOL CLIN EXP RES, V5, P237, DOI 10.1111/j.1530-0277.1981.tb04895.x; TAYLOR AN, 1982, PHARMACOL BIOCHEM BE, V16, P585; TAYLOR AN, 1986, ALCOHOL, V3, P255, DOI 10.1016/0741-8329(86)90034-0; Tran S, 2014, PROG NEURO-PSYCHOPH, V55, P87, DOI 10.1016/j.pnpbp.2014.02.008; Uban KA, 2013, PSYCHONEUROENDOCRINO, V38, P1953, DOI 10.1016/j.psyneuen.2013.02.017; Vinson GP, 2013, ENDOCR CONNECT, V2, DOI 10.1530/EC-13-0028; Vinson GP, 2009, MOL CELL ENDOCRINOL, V300, P2, DOI 10.1016/j.mce.2008.09.008; WEINBERG J, 1992, ALCOHOL, V9, P219, DOI 10.1016/0741-8329(92)90057-H; WEINBERG J, 1988, ALCOHOL CLIN EXP RES, V12, P647, DOI 10.1111/j.1530-0277.1988.tb00258.x; Weinberg J, 2008, J NEUROENDOCRINOL, V20, P470, DOI 10.1111/j.1365-2826.2008.01669.x; Weinberg J, 1996, ALCOHOL CLIN EXP RES, V20, P122, DOI 10.1111/j.1530-0277.1996.tb01054.x	64	35	35	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148425	10.1371/journal.pone.0148425	http://dx.doi.org/10.1371/journal.pone.0148425			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862749	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600070
J	Pahk, K; Rhee, S; Kim, S; Choe, JG				Pahk, Kisoo; Rhee, Seunghong; Kim, Sungeun; Choe, Jae Gol			Predictive Role of Functional Visceral Fat Activity Assessed by Preoperative F-18 FDG PET/CT for Regional Lymph Node or Distant Metastasis in Patients with Colorectal Cancer	PLOS ONE			English	Article							METABOLIC-ACTIVITY; ADIPOSE-TISSUE; OBESITY; INFLAMMATION	Objectives To investigate the role of functional visceral fat activity assessed by preoperative F-18 fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) in colorectal cancer (CRC) for predicting regional lymph node (LN) or distant metastasis. Method We evaluated 131 patients with newly diagnosed CRC. They all underwent pre-operative 18F-FDG PET/CT and surgery. Functional fat activity was measured by maximum standardized uptake value (SUVmax) using 18F-FDG PET/CT. Functional visceral fat activity was measured by SUVmax of visceral fat/SUVmax of subcutaneous fat (V/S) ratio. Mann-Whitney U test, chi(2) test, Fisher's exact test, receiver-operating characteristic (ROC) analysis, Spearrman's correlation coefficient, and uni- and multivariate logistic regression statistical analyses were done. Results Patients with higher V/S ratio displayed a significantly higher rate of regional LN (p = 0.004) and distant metastasis (p<0.001). In addition, V/S ratio was the only factor that was significantly associated with distant metastasis. An optimal cut-off V/S ratio of 1.88 was proposed for predicting distant metastasis with a sensitivity of 84.6% and specificity of 78.8% (area under the curve: 0.86; p<0.0001) Conclusion Functional visceral fat activity is significantly associated with distant metastasis in CRC patients. Furthermore, V/S ratio can be useful as a complementary factor in predicting distant metastasis.	[Pahk, Kisoo; Rhee, Seunghong; Kim, Sungeun; Choe, Jae Gol] Korea Univ, Coll Med, Dept Nucl Med, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine)	Choe, JG (corresponding author), Korea Univ, Coll Med, Dept Nucl Med, Seoul 136705, South Korea.	choejg@korea.ac.kr	Pahk, Kisoo/AAD-5965-2020	Pahk, Kisoo/0000-0003-2971-4202				Bardou M, 2013, GUT, V62, P933, DOI 10.1136/gutjnl-2013-304701; Brunken R, 2008, J NUCL CARDIOL, V15, pS7; Bucerius J, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000725; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Christen T, 2010, JACC-CARDIOVASC IMAG, V3, P843, DOI 10.1016/j.jcmg.2010.06.004; Gholami S, 2015, J NUCL CARDIOL, V22, P468, DOI 10.1007/s12350-015-0069-8; Guiu B, 2010, GUT, V59, P341, DOI 10.1136/gut.2009.188946; Hamilton TD, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-542; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Ishizuka M, 2012, ANTICANCER RES, V32, P1409; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kantola T, 2012, BRIT J CANCER, V107, P1729, DOI 10.1038/bjc.2012.456; Lee WS, 2013, J SURG RES, V182, P49, DOI 10.1016/j.jss.2012.08.051; Moon HG, 2008, ANN SURG ONCOL, V15, P1918, DOI 10.1245/s10434-008-9891-4; Nieman KM, 2013, BBA-MOL CELL BIOL L, V1831, P1533, DOI 10.1016/j.bbalip.2013.02.010; Rickles AS, 2013, J GASTROINTEST SURG, V17, P133, DOI 10.1007/s11605-012-2045-9; Riondino S, 2014, WORLD J GASTROENTERO, V20, P5177, DOI 10.3748/wjg.v20.i18.5177; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Tarkin JM, 2014, NAT REV CARDIOL, V11, P443, DOI 10.1038/nrcardio.2014.80; van Kruijsdijk RCM, 2009, CANCER EPIDEM BIOMAR, V18, P2569, DOI 10.1158/1055-9965.EPI-09-0372; Vanfleteren LEGW, 2014, RESP MED, V108, P883, DOI 10.1016/j.rmed.2014.04.001	21	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148776	10.1371/journal.pone.0148776	http://dx.doi.org/10.1371/journal.pone.0148776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862754	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600106
J	Hajek, A; Konig, HH				Hajek, Andre; Koenig, Hans-Helmut			The Effect of Intra- and Intergenerational Caregiving on Subjective Well-Being - Evidence of a Population Based Longitudinal Study among Older Adults in Germany	PLOS ONE			English	Article							QUALITY-OF-LIFE; STRESS PROCESS; HEALTH; DISTRESS; BURDEN; CARE; ADAPTATION; VALIDATION; PREDICTORS; BENEFITS	Objective To examine whether intra-and intergenerational caregiving affect subjective well-being (SWB) of the caregivers longitudinally. Methods Data were drawn from the German Ageing Survey (DEAS), which is a population-based longitudinal study of individuals living in Germany aged 40 and over. The waves in 2002, 2008 and 2011 were used (with 10,434 observations). SWB was examined in a broad sense, covering affective (AWB) and cognitive well-being (CWB), positive (PA) and negative affect (NA) as well as functional and mental health. While intragenerational caregiving was defined as providing care for spouse/partner, intergenerational caregiving was defined as providing care for mother, father, mother-in-law, father-in-law, partner's mother or partner's father. Results Fixed effects regressions adjusting for sociodemographic factors, social network, self-efficacy and morbidity showed that intergenerational informal care did not affect the various SWB outcome measures. Intragenerational caregiving affected CWB (women) and mental health (total sample and men), whereas it did not affect the other outcome variables. Conclusion Our findings highlight the importance of intragenerational caregiving for mental health (men) and cognitive well-being (women). Consequently, interventions to avoid mental illness due to intragenerational caregiving are urgently needed.	[Hajek, Andre; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Hlth Econ, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Hajek, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Hlth Econ, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany.	a.hajek@uke.de	König, Hans-Helmut/P-1211-2018	König, Hans-Helmut/0000-0001-5711-6862; Hajek, Andre/0000-0002-6886-2745				Amirkhanyan AA, 2006, J GERONTOL B-PSYCHOL, V61, pS248, DOI 10.1093/geronb/61.5.S248; ARCHBOLD PG, 1983, FAM RELAT, V32, P39, DOI 10.2307/583977; Beach SR, 2000, PSYCHOL AGING, V15, P259, DOI 10.1037//0882-7974.15.2.259; Brodaty Henry, 2009, Dialogues Clin Neurosci, V11, P217; Burton LC, 2003, GERONTOLOGIST, V43, P230, DOI 10.1093/geront/43.2.230; Busseri MA, 2011, PERS SOC PSYCHOL REV, V15, P290, DOI 10.1177/1088868310391271; Cameron C., 2005, MICROECONOMETRICS US, P1056; Carretero S, 2009, ARCH GERONTOL GERIAT, V49, P74, DOI 10.1016/j.archger.2008.05.004; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chen Tian-Hui, 2005, J Zhejiang Univ Sci B, V6, P936, DOI 10.1631/jzus.2005.B0936; Chiu HC, 2005, INT J GERIATR PSYCH, V20, P635, DOI 10.1002/gps.1292; Clark AE, 2013, ECONOMICA, V80, P496, DOI 10.1111/ecca.12007; Cooper C, 2010, J AFFECT DISORDERS, V121, P136, DOI 10.1016/j.jad.2009.05.001; Cooper C, 2014, CLIN GERIATR MED, V30, P839, DOI 10.1016/j.cger.2014.08.011; Cooper C, 2010, BRIT J PSYCHIAT, V196, P480, DOI 10.1192/bjp.bp.109.071811; Diener E, 2008, APPL PSYCHOL-INT REV, V57, P37, DOI 10.1111/j.1464-0597.2008.00353.x; Eid M, 2004, SOC INDIC RES, V65, P245, DOI 10.1023/B:SOCI.0000003801.89195.bc; Eisele M, 2015, BRIT J GEN PRACT, V65, pE716, DOI 10.3399/bjgp15X687337; Engstler H., 2010, ALTERN WANDEL BEFUND, P34; Ferrer-i-Carbonell A, 2004, ECON J, V114, P641, DOI 10.1111/j.1468-0297.2004.00235.x; Gallant MP, 1998, RES AGING, V20, P267, DOI 10.1177/0164027598203001; Hirst M, 2005, SOC SCI MED, V61, P697, DOI 10.1016/j.socscimed.2005.01.001; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Kim H, 2012, J ADV NURS, V68, P846, DOI 10.1111/j.1365-2648.2011.05787.x; Konig HH, 2009, MED CARE, V47, P255, DOI 10.1097/MLR.0b013e318184759e; Conde-Sala JL, 2010, INT J NURS STUD, V47, P1262, DOI 10.1016/j.ijnurstu.2010.03.001; Luhmann M, 2012, J PERS SOC PSYCHOL, V102, P592, DOI 10.1037/a0025948; Markowitz JS, 2003, ALZ DIS ASSOC DIS, V17, P209, DOI 10.1097/00002093-200310000-00003; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Powdthavee N, 2009, SOC SCI MED, V69, P1834, DOI 10.1016/j.socscimed.2009.09.023; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rinaldi P, 2005, INT J GERIATR PSYCH, V20, P168, DOI 10.1002/gps.1267; Roth DL, 2015, GERONTOLOGIST, V55, P309, DOI 10.1093/geront/gnu177; Schiel S., 2011, METHODENBERICHT DTSC; Thibaut J., 1959, SOCIAL PSYCHOL GROUP; UNESCO, 2011, INT STAND CLASS ED I; WALKER AJ, 1992, J GERONTOL, V47, pS130, DOI 10.1093/geronj/47.3.S130; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59	41	17	17	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148916	10.1371/journal.pone.0148916	http://dx.doi.org/10.1371/journal.pone.0148916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859511	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400104
J	Kieslich, CA; Tamamis, P; Guzman, YA; Onel, M; Floudas, CA				Kieslich, Chris A.; Tamamis, Phanourios; Guzman, Yannis A.; Onel, Melis; Floudas, Christodoulos A.			Highly Accurate Structure-Based Prediction of HIV-1 Coreceptor Usage Suggests Intermolecular Interactions Driving Tropism	PLOS ONE			English	Article							V3 LOOP; GP120; CHEMOKINE; ENTRY; RECEPTOR; CXCR4; CCR5; COFACTOR; PROTEASE	HIV-1 entry into host cells is mediated by interactions between the V3-loop of viral glycoprotein gp120 and chemokine receptor CCR5 or CXCR4, collectively known as HIV-1 coreceptors. Accurate genotypic prediction of coreceptor usage is of significant clinical interest and determination of the factors driving tropism has been the focus of extensive study. We have developed a method based on nonlinear support vector machines to elucidate the interacting residue pairs driving coreceptor usage and provide highly accurate coreceptor usage predictions. Our models utilize centroid-centroid interaction energies from computationally derived structures of the V3-loop: coreceptor complexes as primary features, while additional features based on established rules regarding V3-loop sequences are also investigated. We tested our method on 2455 V3-loop sequences of various lengths and subtypes, and produce a median area under the receiver operator curve of 0.977 based on 500 runs of 10-fold cross validation. Our study is the first to elucidate a small set of specific interacting residue pairs between the V3-loop and coreceptors capable of predicting coreceptor usage with high accuracy across major HIV-1 subtypes. The developed method has been implemented as a web tool named CRUSH, CoReceptor USage prediction for HIV-1, which is available at http://ares.tamu.edu/CRUSH/.	[Kieslich, Chris A.; Tamamis, Phanourios; Guzman, Yannis A.; Onel, Melis; Floudas, Christodoulos A.] Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX USA; [Kieslich, Chris A.; Tamamis, Phanourios; Guzman, Yannis A.; Onel, Melis; Floudas, Christodoulos A.] Texas A&M Univ, Texas A&M Energy Inst, College Stn, TX USA; [Guzman, Yannis A.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Princeton University	Floudas, CA (corresponding author), Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX USA.; Floudas, CA (corresponding author), Texas A&M Univ, Texas A&M Energy Inst, College Stn, TX USA.	floudas@tamu.edu		Tamamis, Phanourios/0000-0002-3342-2651; Kieslich, Chris/0000-0002-1845-6589	Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries; Office of the Vice President for Research	Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries; Office of the Vice President for Research	The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research.	Aiamkitsumrit B, 2014, CURR HIV RES, V12, P132, DOI 10.2174/1570162X12666140526121746; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Altmann A, 2007, ANTIVIR THER, V12, P169; Archer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049602; Bartlett AD, 2014, AIDS, V28, P1611, DOI 10.1097/QAD.0000000000000288; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Borchers HW, 2014, PRACMA PRACTICAL NUM; Bozek K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002977; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Cashin K, 2013, RETROVIROLOGY, V10, P1; Cashin K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08543; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Dybowski JN, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000743; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Gibson RM, 2014, ANTIMICROB AGENTS CH, V58, P2167, DOI 10.1128/AAC.02710-13; Gorham RD, 2011, ANN BIOMED ENG, V39, P1252, DOI 10.1007/s10439-010-0226-9; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Heider D, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-14; Hou TJ, 2009, PROTEINS, V74, P837, DOI 10.1002/prot.22192; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kieslich CA, 2013, AIDS RES HUM RETROV, V29, P1386, DOI [10.1089/aid.2012.0173, 10.1089/AID.2012.0173]; Levy Y, 2003, J PHYS CHEM B, V107, P3068, DOI 10.1021/jp0219956; Lise S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-365; Meyer D, 2014, E1071 MISC FUNCTIONS; Montagna C, 2014, AIDS RES HUM RETROV, V30, P1203, DOI 10.1089/aid.2014.0006; Olejnik M, 2014, BIOINFORMATICS, V30, P3272, DOI 10.1093/bioinformatics/btu535; Pfeifer N, 2012, BIOINFORMATICS, V28, pI589, DOI 10.1093/bioinformatics/bts373; Pillai S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; R Core Team, 2021, R LANGUAGE ENV STAT; Rajgaria R, 2008, PROTEINS, V70, P950, DOI 10.1002/prot.21561; Sander O, 2007, PLOS COMPUT BIOL, V3, P555, DOI 10.1371/journal.pcbi.0030058; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Tamamis P, 2014, BMC BIOPHYS, V7, DOI 10.1186/2046-1682-7-5; Tamamis P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095767; Tamamis P, 2013, BIOPHYS J, V105, P1502, DOI 10.1016/j.bpj.2013.07.049; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Younai FS, 2013, INT J ORAL SCI, V5, P191, DOI 10.1038/ijos.2013.76	48	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148974	10.1371/journal.pone.0148974	http://dx.doi.org/10.1371/journal.pone.0148974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859389	Green Published, gold, Green Submitted			2022-12-27	WOS:000370038400112
J	Solano-Aguilar, G; Molokin, A; Botelho, C; Fiorino, AM; Vinyard, B; Li, R; Chen, C; Urban, J; Dawson, H; Andreyeva, I; Haverkamp, M; Hibberd, PL				Solano-Aguilar, Gloria; Molokin, Aleksey; Botelho, Christine; Fiorino, Anne-Maria; Vinyard, Bryan; Li, Robert; Chen, Celine; Urban, Joseph, Jr.; Dawson, Harry; Andreyeva, Irina; Haverkamp, Miriam; Hibberd, Patricia L.			Transcriptomic Profile of Whole Blood Cells from Elderly Subjects Fed Probiotic Bacteria Lactobacillus rhamnosus GG ATCC 53103 (LGG) in a Phase I Open Label Study	PLOS ONE			English	Article							NF-KAPPA-B; DIFFERENTIAL EXPRESSION ANALYSIS; LACTIC-ACID BACTERIA; RNA-SEQ; GENE-EXPRESSION; STATISTICAL-METHODS; CYTOKINE PRODUCTION; IMMUNE-RESPONSES; DENDRITIC CELLS; HUMAN MONOCYTES	We examined gene expression of whole blood cells (WBC) from 11 healthy elderly volunteers participating on a Phase I open label study before and after oral treatment with Lactobacillus rhamnosus GG-ATCC 53103 (LGG)) using RNA-sequencing (RNA-Seq). Elderly patients (65-80 yrs) completed a clinical assessment for health status and had blood drawn for cellular RNA extraction at study admission (Baseline), after 28 days of daily LGG treatment (Day 28) and at the end of the study (Day 56) after LGG treatment had been suspended for 28 days. Treatment compliance was verified by measuring LGG-DNA copy levels detected in host fecal samples. Normalized gene expression levels in WBC RNA were analyzed using a paired design built within three analysis platforms (edgeR, DESeq2 and TSPM) commonly used for gene count data analysis. From the 25,990 transcripts detected, 95 differentially expressed genes (DEGs) were detected in common by all analysis platforms with a nominal significant difference in gene expression at Day 28 following LGG treatment (FDR<0.1; 77 decreased and 18 increased). With a more stringent significance threshold (FDR< 0.05), only two genes (FCER2 and LY86), were down-regulated more than 1.5 fold and met the criteria for differential expression across two analysis platforms. The remaining 93 genes were only detected at this threshold level with DESeq2 platform. Data analysis for biological interpretation of DEGs with an absolute fold change of 1.5 revealed down-regulation of overlapping genes involved with Cellular movement, Cell to cell signaling interactions, Immune cell trafficking and Inflammatory response. These data provide evidence for LGG-induced transcriptional modulation in healthy elderly volunteers because pre-treatment transcription levels were restored at 28 days after LGG treatment was stopped. To gain insight into the signaling pathways affected in response to LGG treatment, DEG were mapped using biological pathways and genomic data mining packages to indicate significant biological relevance.	[Solano-Aguilar, Gloria; Molokin, Aleksey; Chen, Celine; Urban, Joseph, Jr.; Dawson, Harry] ARS, Diet Genom & Immunol Lab, Beltsville Human Nutr Res Ctr, USDA, Beltsville, MD USA; [Botelho, Christine; Fiorino, Anne-Maria; Andreyeva, Irina; Haverkamp, Miriam; Hibberd, Patricia L.] Massachusetts Gen Hosp, Div Global Hlth, Boston, MA 02114 USA; [Vinyard, Bryan] ARS, Stat Grp, Northeast Area, USDA, Beltsville, MD USA; [Li, Robert] ARS, Anim Genom & Improvement Lab, USDA, Beltsville, MD USA	United States Department of Agriculture (USDA); Harvard University; Massachusetts General Hospital; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Solano-Aguilar, G (corresponding author), ARS, Diet Genom & Immunol Lab, Beltsville Human Nutr Res Ctr, USDA, Beltsville, MD USA.	Gloria.SolanoAguilar@ars.usda.gov	Dawson, Harry/ABG-2734-2021	Dawson, Harry/0000-0002-7648-9952; Hibberd, Patricia/0000-0002-7455-8117; Urban, Joseph/0000-0002-1590-8869; Molokin, Aleksey/0000-0002-4571-7641	National Institutes of Health, National Center for Complementary and Alternative Medicine (NIH/NCCAM) [3U01AT002952, 3K24AT003683]; National Institute of Health, National Center for Advancing Translational Sciences (NIH/NCATS) [1UL1 TR001102]; United States Department of Agriculture, Agricultural Research Service (USDA-ARS) [8040-51000-058-03]; Harvard Catalyst; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [U01AT002952] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT003683] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Complementary and Alternative Medicine (NIH/NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Institute of Health, National Center for Advancing Translational Sciences (NIH/NCATS); United States Department of Agriculture, Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Harvard Catalyst; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding support was provided by National Institutes of Health, National Center for Complementary and Alternative Medicine (NIH/NCCAM); http://nccam.nih.gov; 3U01AT002952 (PLH) and 3K24AT003683 (PLH), the Harvard Catalyst and National Institute of Health, National Center for Advancing Translational Sciences (NIH/NCATS); http://www.ncats.nih.gov; 1UL1 TR001102 (PLH) and United States Department of Agriculture, Agricultural Research Service (USDA-ARS); http://www.ars.usda.gov; project no 8040-51000-058-03. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of NCCAM or USDA. NIH/NCCAM Program Officer Linda Duffy, PhD, MPH, contributed to the structuring of the U01 study design, inclusion of validation approaches and implementations of protocols under phased regulatory approved IND. Other than Dr. Duffy's contributions, the funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Acharya M, 2010, CLIN EXP IMMUNOL, V162, P12, DOI 10.1111/j.1365-2249.2010.04210.x; Alvarado S, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-21; Ammoscato F, 2013, NEUROGASTROENT MOTIL, V25, P984, DOI 10.1111/nmo.12232; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashraf R, 2014, J DAIRY SCI, V97, P2542, DOI 10.3168/jds.2013-7459; Auer PL, 2012, BRIEF FUNCT GENOMICS, V11, P57, DOI 10.1093/bfgp/elr041; Bajaj JS, 2014, ALIMENT PHARM THER, V39, P1113, DOI 10.1111/apt.12695; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Chavagnat F, 2002, FEMS MICROBIOL LETT, V217, P177, DOI 10.1111/j.1574-6968.2002.tb11472.x; Chiba E, 2013, INT IMMUNOPHARMACOL, V17, P373, DOI 10.1016/j.intimp.2013.06.024; Chung LM, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-110; Colitti M, 2012, VET IMMUNOL IMMUNOP, V147, P136, DOI 10.1016/j.vetimm.2012.04.001; Cooper AM, 2012, J IMMUNOL, V188, P3199, DOI 10.4049/jimmunol.1102689; Coward WR, 2002, J IMMUNOL, V169, P5287, DOI 10.4049/jimmunol.169.9.5287; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Delroisse JM, 2008, MICROBIOL RES, V163, P663, DOI 10.1016/j.micres.2006.09.004; Demasius W, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-93; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Dorr C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125045; Douillard FP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003683; Gagro A, 2003, EUR J IMMUNOL, V33, P1889, DOI 10.1002/eji.200323357; Gewurz BE, 2012, P NATL ACAD SCI USA, V109, P2467, DOI 10.1073/pnas.1120542109; Ghadimi D, 2010, INFLAMM BOWEL DIS, V16, P410, DOI 10.1002/ibd.21057; Guo Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S8-S2; Haarman M, 2006, APPL ENVIRON MICROB, V72, P2359, DOI 10.1128/AEM.72.4.2359-2365.2006; Hibberd PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113456; Joosten SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073230; Joseph P, 2013, J APPL TOXICOL, V33, P1193, DOI 10.1002/jat.2861; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kalliomaki M, 2003, CURR OPIN ALLERGY CL, V3, P15, DOI [10.1097/00130832-200302000-00003, 10.1097/01.all.0000053262.39029.a1]; Kasper B, 2007, J IMMUNOL, V179, P2584, DOI 10.4049/jimmunol.179.4.2584; Kawase M, 2010, LETT APPL MICROBIOL, V51, P6, DOI 10.1111/j.1472-765X.2010.02849.x; Kim HJ, 2013, J APPL MICROBIOL, V115, P872, DOI 10.1111/jam.12268; Kim HJ, 2014, CLIN IMMUNOL, V153, P178, DOI 10.1016/j.clim.2014.04.008; Kim Y, 2013, PSYCHIAT RES, V210, P287, DOI 10.1016/j.psychres.2013.05.026; Klaenhammer TR, 2012, NAT REV IMMUNOL, V12, P728, DOI 10.1038/nri3312; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kraft S, 2002, J INVEST DERMATOL, V118, P830, DOI 10.1046/j.1523-1747.2002.01757.x; Kvam VM, 2012, AM J BOT, V99, P248, DOI 10.3732/ajb.1100340; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee Sang Kil, 2012, Korean J Gastroenterol, V60, P86; Li BS, 2014, J INVEST DERMATOL, V134, P1828, DOI 10.1038/jid.2014.28; Li DY, 2000, ARTERIOSCL THROM VAS, V20, P1116, DOI 10.1161/01.ATV.20.4.1116; Li H, 2008, P NATL ACAD SCI USA, V105, P20179, DOI 10.1073/pnas.0807121105; Lievin-Le Moal V, 2014, CLIN MICROBIOL REV, V27, P167, DOI 10.1128/CMR.00080-13; Lin D, 2009, J HEART LUNG TRANSPL, V28, P927, DOI 10.1016/j.healun.2009.04.025; Lin WH, 2013, INT IMMUNOPHARMACOL, V15, P703, DOI 10.1016/j.intimp.2012.10.025; Liu YC, 2013, BIOINFORMATICS, V29, P308, DOI [10.1093/bioinformatics/btt688, 10.1093/bioinformatics/bts690]; Luoto R, 2014, J ALLERGY CLIN IMMUN, V133, P405, DOI 10.1016/j.jaci.2013.08.020; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Mastrokolias A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-28; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Miettinen M, 2012, GUT MICROBES, V3, P510, DOI 10.4161/gmic.21736; Mirpuri J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051955; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Oh SM, 2004, ONCOGENE, V23, P8282, DOI 10.1038/sj.onc.1208021; Peffers MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4278; Peng XX, 2014, J VIROL, V88, P8768, DOI 10.1128/JVI.00768-14; Pujols L, 2012, J PHARMACOL EXP THER, V343, P184, DOI 10.1124/jpet.111.190710; Rask C, 2013, CLIN EXP IMMUNOL, V172, P321, DOI 10.1111/cei.12055; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robles JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-484; Rodes L, 2013, J MICROBIOL BIOTECHN, V23, P518, DOI 10.4014/jmb.1205.05018; Rodes L, 2013, ARTIF CELL NANOMED B, V41, P116, DOI 10.3109/10731199.2012.712047; Schultz M, 2003, J DAIRY RES, V70, P165, DOI 10.1017/S0022029903006034; Schwochow D, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-33; Segers ME, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S7; Segev DL, 2001, J BIOL CHEM, V276, P26799, DOI 10.1074/jbc.M103092200; Shin H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091041; Shu HB, 2000, P NATL ACAD SCI USA, V97, P9156, DOI 10.1073/pnas.160213497; Solano-Aguilar G, 2008, APPL ENVIRON MICROB, V74, P6338, DOI 10.1128/AEM.00309-08; Solano-Aguilar G, 2013, J PEDIATR GASTR NUTR, V56, P503, DOI 10.1097/MPG.0b013e318282aa12; Song HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035552; St Laurent G, 2013, METHODS, V63, P18, DOI 10.1016/j.ymeth.2013.03.027; Staples KJ, 2007, J IMMUNOL, V178, P4779, DOI 10.4049/jimmunol.178.8.4779; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomosada Y, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-40; Toung JM, 2011, GENOME RES, V21, P991, DOI 10.1101/gr.116335.110; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Baarlen P, 2011, P NATL ACAD SCI USA, V108, P4562, DOI 10.1073/pnas.1000079107; van Beveren NJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033473; van der Does AM, 2012, J IMMUNOL, V188, P5012, DOI 10.4049/jimmunol.1102777; Ventura M, 2003, APPL ENVIRON MICROB, V69, P6908, DOI 10.1128/AEM.69.11.6908-6922.2003; Vong L, 2014, J IMMUNOL, V192, P1870, DOI 10.4049/jimmunol.1302286; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200; Wang YH, 2013, J NUTR BIOCHEM, V24, P1609, DOI 10.1016/j.jnutbio.2013.02.001; Watanabe Y, 2012, DIABETES, V61, P1199, DOI 10.2337/db11-1182; Wright HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058598; Yang D, 2004, J IMMUNOL, V173, P6134, DOI 10.4049/jimmunol.173.10.6134; Yendrek Craig R, 2012, BMC Res Notes, V5, P506, DOI 10.1186/1756-0500-5-506; Yu J, 2007, J IMMUNOL, V179, P7684, DOI 10.4049/jimmunol.179.11.7684; Zelaya H, 2014, INT IMMUNOPHARMACOL, V19, P161, DOI 10.1016/j.intimp.2013.12.020; Zhang ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103207	102	14	15	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0147426	10.1371/journal.pone.0147426	http://dx.doi.org/10.1371/journal.pone.0147426			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859761	gold, Green Submitted, Green Published			2022-12-27	WOS:000370038400008
J	Zheng, WS; Men, HW; Li, J; Xing, Y; Wu, B; Wang, ZL; Li, JJ; Teng, DH; Shi, Y; Li, J; Jiang, P; Cai, JZ				Zheng, Weisheng; Men, Hewei; Li, Jing; Xing, Yu; Wu, Bin; Wang, Zhenglu; Li, Junjie; Teng, Dahong; Shi, Yuan; Li, Jiang; Jiang, Pu; Cai, Jinzhen			Global MicroRNA Expression Profiling of Mouse Livers following Ischemia-Reperfusion Injury at Different Stages	PLOS ONE			English	Article							HEPATIC ISCHEMIA/REPERFUSION INJURY; TRANSPLANTATION; IDENTIFICATION; TRANSLATION; SIGNATURE; MECHANISM; BEDSIDE; BENCH; STEM	Hepatic ischemia-reperfusion injury is a dynamic process consisting of two stages: ischemia and reperfusion, and triggers a cascade of physiological and biochemical events. Given the important role of microRNAs in regulating gene expression, we analyzed gene expression changes in mouse livers at sham control, ischemia stage, and reperfusion stage. We generated global expression profiles of microRNA and mRNA genes in mouse livers subjected to ischemia-reperfusion injury at the three stages, respectively. Comparison analysis showed that reperfusion injury had a distinct expression profile whereas the ischemia sample and the sham control were clustered together. Consistently, there are 69 differentially expressed microRNAs between the reperfusion sample and the sham control whereas 28 differentially expressed microRNAs between the ischemia sample and the sham control. We further identified two modes of microRNA expression changes in ischemia-reperfusion injury. Functional analysis of both the differentially expressed microRNAs in the two modes and their target mRNAs revealed that ischemia injury impaired mitochondrial function, nutrient consumption, and metabolism process. In contrast, reperfusion injury led to severe tissue inflammation that is predominantly an innate-immune response in the ischemia-reperfusion process. Our staged analysis of gene expression profiles provides new insights into regulatory mechanisms of microRNAs in mouse hepatic IR injury.	[Zheng, Weisheng; Men, Hewei; Xing, Yu; Wu, Bin; Wang, Zhenglu; Li, Junjie; Teng, Dahong; Shi, Yuan; Li, Jiang; Cai, Jinzhen] Tianjin First Cent Hosp, Dept Transplant Surg, Tianjin, Peoples R China; [Zheng, Weisheng] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Li, Jing] Tianjin First Cent Hosp, Dept Gastroenterol, Tianjin, Peoples R China; [Jiang, Pu] Chongqing Med Univ, Dept Forens Med, Coll Basic Med, Chongqing, Peoples R China; [Li, Jing] Tianjin Med Univ, Tianjin, Peoples R China	Tianjin Medical University; Tongji University; Tianjin Medical University; Chongqing Medical University; Tianjin Medical University	Cai, JZ (corresponding author), Tianjin First Cent Hosp, Dept Transplant Surg, Tianjin, Peoples R China.; Jiang, P (corresponding author), Chongqing Med Univ, Dept Forens Med, Coll Basic Med, Chongqing, Peoples R China.	jiangpu_e@163.com; caijinzhen@sina.com	Linong, Ji/AAB-6543-2020		National Natural Science Foundation of China [81170443, 81400680]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (81170443, 81400680). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahde R, 2010, BRIT J SURG, V97, P1461, DOI 10.1002/bjs.7176; Banga NR, 2005, BRIT J SURG, V92, P528, DOI 10.1002/bjs.5004; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borozan I, 2006, AM J TRANSPLANT, V6, P806, DOI 10.1111/j.1600-6143.2006.01254.x; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen Q, 2013, TRANSPL P, V45, P492, DOI 10.1016/j.transproceed.2012.10.045; Defamie V, 2008, AM J TRANSPLANT, V8, P1221, DOI 10.1111/j.1600-6143.2008.02249.x; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fondevilla C, 2003, EXP MOL PATHOL, V74, P86, DOI 10.1016/S0014-4800(03)00008-X; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gao SM, 2010, BIOCHEM BIOPH RES CO, V403, P203, DOI 10.1016/j.bbrc.2010.10.137; Gehrau RC, 2013, TRANSPLANTATION, V96, P926, DOI 10.1097/TP.0b013e3182a20398; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Iwakawa HO, 2015, TRENDS CELL BIOL, V25, P651, DOI 10.1016/j.tcb.2015.07.011; Jiang W, 2011, TRANSPL P, V43, P1462, DOI 10.1016/j.transproceed.2011.01.191; Klune JR, 2010, SURG CLIN N AM, V90, P665, DOI 10.1016/j.suc.2010.04.003; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lentsch AB, 2000, HEPATOLOGY, V32, P169, DOI 10.1053/jhep.2000.9323; Navarro-Sabate A, 2006, LIVER TRANSPLANT, V12, P1615, DOI 10.1002/lt.20863; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Vascotto C, 2006, PROTEOMICS, V6, P3455, DOI 10.1002/pmic.200500770; Wu He-Shui, 2004, Hepatobiliary Pancreat Dis Int, V3, P250; Xu CF, 2009, OMICS, V13, P513, DOI 10.1089/omi.2009.0035; Yu CH, 2009, DIGEST DIS SCI, V54, P2362, DOI 10.1007/s10620-008-0629-8; Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225	29	9	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148677	10.1371/journal.pone.0148677	http://dx.doi.org/10.1371/journal.pone.0148677			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859886	Green Published, gold, Green Submitted			2022-12-27	WOS:000370038400064
J	Arizpe, J; Kravitz, DJ; Walsh, V; Yovel, G; Baker, CI				Arizpe, Joseph; Kravitz, Dwight J.; Walsh, Vincent; Yovel, Galit; Baker, Chris I.			Differences in Looking at Own- and Other-Race Faces Are Subtle and Analysis-Dependent: An Account of Discrepant Reports	PLOS ONE			English	Article							ERRONEOUS STATISTICAL MAPS; ABOLISH CULTURAL-DIVERSITY; EYE-MOVEMENTS; SCAN FACES; RECOGNITION; BIAS; DATABASE; CONTACT; IMAP; IDENTIFICATION	The Other-Race Effect (ORE) is the robust and well-established finding that people are generally poorer at facial recognition of individuals of another race than of their own race. Over the past four decades, much research has focused on the ORE because understanding this phenomenon is expected to elucidate fundamental face processing mechanisms and the influence of experience on such mechanisms. Several recent studies of the ORE in which the eye-movements of participants viewing own-and other-race faces were tracked have, however, reported highly conflicting results regarding the presence or absence of differential patterns of eye-movements to own-versus other-race faces. This discrepancy, of course, leads to conflicting theoretical interpretations of the perceptual basis for the ORE. Here we investigate fixation patterns to own-versus other-race (African and Chinese) faces for Caucasian participants using different analysis methods. While we detect statistically significant, though subtle, differences in fixation pattern using an Area of Interest (AOI) approach, we fail to detect significant differences when applying a spatial density map approach. Though there were no significant differences in the spatial density maps, the qualitative patterns matched the results from the AOI analyses reflecting how, in certain contexts, Area of Interest (AOI) analyses can be more sensitive in detecting the differential fixation patterns than spatial density analyses, due to spatial pooling of data with AOIs. AOI analyses, however, also come with the limitation of requiring a priori specification. These findings provide evidence that the conflicting reports in the prior literature may be at least partially accounted for by the differences in the statistical sensitivity associated with the different analysis methods employed across studies. Overall, our results suggest that detection of differences in eye-movement patterns can be analysis-dependent and rests on the assumptions inherent in the given analysis.	[Arizpe, Joseph; Kravitz, Dwight J.; Baker, Chris I.] NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA; [Arizpe, Joseph; Walsh, Vincent] UCL, Inst Cognit Neurosci, Appl Cognit Neurosci Grp, Mortimer St, London, England; [Arizpe, Joseph] Univ Tennessee, Ctr Hlth Sci, Dept Neurol, Memphis, TN 38163 USA; [Arizpe, Joseph] Le Bonheur Childrens Hosp, Memphis, TN USA; [Kravitz, Dwight J.] George Washington Univ, Dept Psychol, Washington, DC 20052 USA; [Yovel, Galit] Tel Aviv Univ, Dept Psychol, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of London; University College London; University of Tennessee System; University of Tennessee Health Science Center; George Washington University; Tel Aviv University	Arizpe, J (corresponding author), NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA.; Arizpe, J (corresponding author), UCL, Inst Cognit Neurosci, Appl Cognit Neurosci Grp, Mortimer St, London, England.; Arizpe, J (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Neurol, Memphis, TN 38163 USA.; Arizpe, J (corresponding author), Le Bonheur Childrens Hosp, Memphis, TN USA.	JosephArizpe@ucl.ac.uk	Baker, Chris/P-8442-2019; Arizpe, Joseph M/N-1399-2014; Yovel, Galit/GPT-4409-2022; Kravitz, Dwight/AAO-5860-2020	Baker, Chris/0000-0001-6861-8964; Arizpe, Joseph M/0000-0001-8958-7757; Yovel, Galit/0000-0003-0971-2357; Kravitz, Dwight/0000-0002-8108-1329	National Institutes of Mental Health [MH002909-07]; United States-Israel Binational Science Foundation [2007034]; National Institutes of Mental Health; United States-Israel Binational Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002909] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The Intramural Program of the National Institutes of Mental Health (https://intramural.nimh.nih.gov), grant number MH002909-07, funded JA, DJK, and CIB. The United States-Israel Binational Science Foundation (http://www.bsf.org.il), for application number 2007034, funded GY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Intramural Program of the National Institutes of Mental Health and by the United States-Israel Binational Science Foundation.	Arizpe J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031106; Arizpe JM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01027; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; BOTHWELL RK, 1989, PERS SOC PSYCHOL B, V15, P19, DOI 10.1177/0146167289151002; Brielmann AA, 2014, VISION RES, V100, P105, DOI 10.1016/j.visres.2014.04.011; BRIGHAM JC, 1982, J PERS SOC PSYCHOL, V42, P673, DOI 10.1037/0022-3514.42.4.673; BRIGHAM JC, 1985, J SOC ISSUES, V41, P139, DOI 10.1111/j.1540-4560.1985.tb01133.x; Caldara R, 2011, BEHAV RES METHODS, V43, P864, DOI 10.3758/s13428-011-0092-x; Caldara R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009708; Chance JE., 1996, PSYCHOL ISSUES EYEWI, P153; CHIRORO P, 1995, Q J EXP PSYCHOL-A, V48, P879, DOI 10.1080/14640749508401421; CROSS JF, 1971, PERCEPT PSYCHOPHYS, V10, P393, DOI 10.3758/BF03210319; Friston KJ, 2006, NEUROIMAGE, V30, P1077, DOI 10.1016/j.neuroimage.2005.08.012; Fu GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037688; Gao W, 2008, IEEE T SYST MAN CY A, V38, P149, DOI 10.1109/TSMCA.2007.909557; Goldinger SD, 2009, J EXP PSYCHOL LEARN, V35, P1105, DOI 10.1037/a0016548; Henderson JM, 2005, MEM COGNITION, V33, P98, DOI 10.3758/BF03195300; Hessels RS, 2016, BEHAV RES METHODS, V48, P1694, DOI 10.3758/s13428-015-0676-y; Hills PJ, 2013, VIS COGN, V21, P876, DOI 10.1080/13506285.2013.834016; Hills PJ, 2013, COGNITION, V129, P586, DOI 10.1016/j.cognition.2013.08.012; Hsiao JHW, 2008, PSYCHOL SCI, V19, P998, DOI 10.1111/j.1467-9280.2008.02191.x; Hu C, 2014, VISION RES, V102, P1, DOI 10.1016/j.visres.2014.05.010; Hu YZ, 2013, NEUROSCI BULL, V29, P553, DOI 10.1007/s12264-013-1367-2; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; Kealey R, 2008, J VIS, V8, P892, DOI DOI 10.1167/8.6.892; Kelly DJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00095; Kelly DJ, 2011, DEVELOPMENTAL SCI, V14, P1176, DOI 10.1111/j.1467-7687.2011.01067.x; LAVRAKAS PJ, 1976, PERCEPT PSYCHOPHYS, V20, P475, DOI 10.3758/BF03208285; Leonards U, 2007, CURR BIOL, V17, pR8, DOI 10.1016/j.cub.2006.11.046; LINDSAY DS, 1991, J APPL PSYCHOL, V76, P587, DOI 10.1037/0021-9010.76.4.587; MacLin O.H., 2004, N AM J PSYCHOL, V6, P189; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; McManus IC, 2013, PERCEPTION, V42, P1075, DOI 10.1068/p7520; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Miellet S, 2014, PERCEPTION, V43, P451, DOI 10.1068/p7682; Miellet S, 2012, J EYE MOVEMENT RES, V5; Miellet S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00034; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Nakabayashi K, 2012, J EXP PSYCHOL LEARN, V38, P61, DOI 10.1037/a0024853; Nakano T, 2010, P ROY SOC B-BIOL SCI, V277, P2935, DOI 10.1098/rspb.2010.0587; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Or CCF, 2015, J VISION, V15, DOI 10.1167/15.13.12; OTOOLE AJ, 1994, MEM COGNITION, V22, P208, DOI 10.3758/BF03208892; Phillips PJ, 2000, IEEE T PATTERN ANAL, V22, P1090, DOI 10.1109/34.879790; Phillips PJ, 1998, IMAGE VISION COMPUT, V16, P295, DOI 10.1016/S0262-8856(97)00070-X; PLATZ SJ, 1988, J APPL SOC PSYCHOL, V18, P972, DOI 10.1111/j.1559-1816.1988.tb01187.x; Rodger H, 2010, PERCEPTION, V39, P1491, DOI 10.1068/p6750; Sangrigoli S, 2005, PSYCHOL SCI, V16, P440; Saxe R, 2006, NEUROIMAGE, V30, P1088, DOI 10.1016/j.neuroimage.2005.12.062; Sekiguchi T, 2011, ACTA PSYCHOL, V137, P1, DOI 10.1016/j.actpsy.2011.01.014; Senju A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074017; Senju A, 2013, INT J BEHAV DEV, V37, P131, DOI 10.1177/0165025412465360; SHAPIRO PN, 1986, PSYCHOL BULL, V100, P139, DOI 10.1037/0033-2909.100.2.139; Shepherd J.W., 1974, INT J PSYCHOL, V9, P205, DOI [10.1080/00207597408247104, DOI 10.1080/00207597408247104]; Slone AE, 2000, BASIC APPL SOC PSYCH, V22, P71, DOI 10.1207/15324830051036162; Tan CBY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029714; Toglia, 2007, HDB EYEWITNESS PSYCH, V2, P257; Walker PM, 2006, APPL COGNITIVE PSYCH, V20, P461, DOI 10.1002/acp.1191; Wang QD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052203; Watanabe K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016919; Wright DB, 2003, APPL COGNITIVE PSYCH, V17, P365, DOI 10.1002/acp.898; Wu EXW, 2012, SOC NEUROSCI-UK, V7, P202, DOI 10.1080/17470919.2011.596946; Yarbus A.L., 1965, ROLE EYE MOVEMENTS V; Yi L, 2014, AUTISM RES, V7, P72, DOI 10.1002/aur.1340; Yi L, 2013, J VISION, V13, DOI 10.1167/13.10.5	65	19	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148253	10.1371/journal.pone.0148253	http://dx.doi.org/10.1371/journal.pone.0148253			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26849447	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000058
J	Bao, Y; Song, WM; Pan, J; Jiang, CM; Srivastava, R; Li, B; Zhu, LY; Su, HY; Gao, XS; Liu, H; Yu, X; Yang, L; Cheng, XH; Zhang, HX				Bao, Yan; Song, Wei-Meng; Pan, Jing; Jiang, Chun-Mei; Srivastava, Renu; Li, Bei; Zhu, Lu-Ying; Su, Hong-Yan; Gao, Xiao-Shu; Liu, Hua; Yu, Xiang; Yang, Lei; Cheng, Xian-Hao; Zhang, Hong-Xia			Overexpression of the NDR1/HIN1-Like Gene NHL6 Modifies Seed Germination in Response to Abscisic Acid and Abiotic Stresses in Arabidopsis	PLOS ONE			English	Article							MOSAIC-VIRUS INFECTION; TUBBY-LIKE PROTEINS; HYPERSENSITIVE RESPONSE; SIGNAL-TRANSDUCTION; MEMBRANE-PROTEIN; LEAF SENESCENCE; THALIANA NHL10; EXPRESSION; TOLERANCE; NDR1	NHL (NDR1/HIN1-like) genes play crucial roles in pathogen induced plant responses to biotic stress. Here, we report the possible function of NHL6 in plant response to abscisic acid (ABA) and abiotic stress. NHL6 was highly expressed in non-germinated seeds, and its expression was strongly induced by ABA and multiple abiotic stress signals. Loss-of-function of NHL6 decreased sensitivity to ABA in the early developmental stages including seed germination and post-germination seedling growth of the nhl6 mutants. However, overexpression of NHL6 increased sensitivity to ABA, salt and osmotic stress of the transgenic plants. Further studies indicated that the increased sensitivity in the 35S:: NHL6 overexpressing plants could be a result of both ABA hypersensitivity and increased endogenous ABA accumulation under the stress conditions. It was also seen that the ABA-responsive element binding factors AREB1, AREB2 and ABF3 could regulate NHL6 expression at transcriptional level. Our results indicate that NHL6 plays an important role in the abiotic stresses-induced ABA signaling and biosynthesis, particularly during seed germination and early seedling development in Arabidopsis.	[Bao, Yan; Zhu, Lu-Ying; Su, Hong-Yan; Cheng, Xian-Hao; Zhang, Hong-Xia] Ludong Univ, Coll Agr, 186 Hongqizhong Rd, Yantai 264025, Peoples R China; [Bao, Yan; Song, Wei-Meng; Pan, Jing; Jiang, Chun-Mei; Li, Bei; Gao, Xiao-Shu; Liu, Hua; Yu, Xiang; Zhang, Hong-Xia] Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, 300 Fenglin Rd, Shanghai 200032, Peoples R China; [Bao, Yan; Srivastava, Renu] Iowa State Univ, Inst Plant Sci, Ames, IA 50011 USA; [Bao, Yan; Srivastava, Renu] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Yang, Lei] Nanjing Univ, Coll Life Sci, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China	Ludong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Iowa State University; Iowa State University; Nanjing University	Cheng, XH; Zhang, HX (corresponding author), Ludong Univ, Coll Agr, 186 Hongqizhong Rd, Yantai 264025, Peoples R China.; Zhang, HX (corresponding author), Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	chengxianhao@sohu.com; hxzhang@sippe.ac.cn	Yu, Xiang/H-9666-2019; Bao, Yan/AAQ-3173-2020; LIU, HUA/M-7659-2019	Yu, Xiang/0000-0002-5730-8802; Bao, Yan/0000-0002-9870-5943; yang, lei/0000-0003-2009-7316	National Natural Science Foundation of China [31171169, 31371228, 31370670, 31400226, 31470661]; National Mega Project of GMO Crops [2013ZX08001-003, 2013ZX08004002-006, 2014ZX0800942B]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA08030108]; Natural Science Foundation of Shandong Province of China [ZR2014CM004]; Natural Science Foundation of Jiangsu Province of China [BK2012306]; Shanghai Key Laboratory of Bio-Energy Crops	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega Project of GMO Crops; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of Shandong Province of China(Natural Science Foundation of Shandong Province); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Shanghai Key Laboratory of Bio-Energy Crops	This work has been jointly supported by the following grants: the National Natural Science Foundation of China (31171169, 31371228, 31370670, 31400226, 31470661); the National Mega Project of GMO Crops (2013ZX08001-003, 2013ZX08004002-006, 2014ZX0800942B); the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA08030108); the Natural Science Foundation of Shandong Province of China (ZR2014CM004); the Natural Science Foundation of Jiangsu Province of China (BK2012306); and Shanghai Key Laboratory of Bio-Energy Crops.	Antoni R, 2013, PLANT PHYSIOL, V161, P931, DOI 10.1104/pp.112.208678; Bao Y, 2014, PLANT MOL BIOL, V86, P471, DOI 10.1007/s11103-014-0241-6; Bao Y, 2014, NEW PHYTOL, V202, P174, DOI 10.1111/nph.12644; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Cacas JL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-144; Century KS, 1997, SCIENCE, V278, P1963, DOI 10.1126/science.278.5345.1963; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coppinger P, 2004, PLANT J, V40, P225, DOI 10.1111/j.1365-313X.2004.02203.x; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dormann P, 2000, PLANT PHYSIOL BIOCH, V38, P789, DOI 10.1016/S0981-9428(00)01186-4; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; GALAU GA, 1986, PLANT MOL BIOL, V7, P155, DOI 10.1007/BF00021327; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Goda H, 2008, PLANT J, V55, P526, DOI [10.1111/j.1365-313X.2008.03510.x, 10.1111/j.0960-7412.2008.03510.x]; Gopalan S, 1996, PLANT CELL, V8, P1095, DOI 10.1105/tpc.8.7.1095; Guo YF, 2005, CURR TOP DEV BIOL, V71, P83, DOI 10.1016/S0070-2153(05)71003-6; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; JEFFERSON RA, 1987, EMBO J, V6, P3901; Knepper C, 2011, PLANT PHYSIOL, V156, P286, DOI 10.1104/pp.110.169656; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Letunic I, 2002, NUCLEIC ACIDS RES, V40, pD302, DOI DOI 10.1093/NAR/GKR931; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Liu H, 2010, PLANT CELL ENVIRON, V33, P1989, DOI 10.1111/j.1365-3040.2010.02200.x; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pontier D, 1999, PLANT MOL BIOL, V39, P1243, DOI 10.1023/A:1006133311402; Reitz MU, 2012, PLANT PHYSIOL, V160, P349, DOI 10.1104/pp.112.201319; Rodriguez PL, 1998, FEBS LETT, V421, P185, DOI 10.1016/S0014-5793(97)01558-5; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI 10.1016/S1360-1385(01)02187-2; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Varet A, 2003, PLANT PHYSIOL, V132, P2023, DOI 10.1104/pp.103.020438; Varet A, 2002, MOL PLANT MICROBE IN, V15, P608, DOI 10.1094/MPMI.2002.15.6.608; Vilaine F, 2013, PLANT CELL, V25, P1689, DOI 10.1105/tpc.113.111849; Yang L, 2008, PLANT MOL BIOL, V66, P329, DOI 10.1007/s11103-007-9267-3; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zheng MS, 2005, PLANT SCI, V168, P415, DOI 10.1016/j.plantsci.2004.09.016; Zheng MS, 2004, PLANTA, V218, P740, DOI 10.1007/s00425-003-1169-2; Zhu JQ, 2009, PHYSIOL PLANTARUM, V136, P407, DOI 10.1111/j.1399-3054.2009.01235.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	46	24	27	5	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148572	10.1371/journal.pone.0148572	http://dx.doi.org/10.1371/journal.pone.0148572			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849212	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000128
J	Betran, AP; Ye, JF; Moller, AB; Zhang, J; Gulmezoglu, AM; Torloni, MR				Betran, Ana Pilar; Ye, Jianfeng; Moller, Anne-Beth; Zhang, Jun; Guelmezoglu, A. Metin; Torloni, Maria Regina			The Increasing Trend in Caesarean Section Rates: Global, Regional and National Estimates: 1990-2014	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; DELIVERY RATES; CLASSIFICATION; PREFERENCES; WOMEN; MODE; CARE	Background Caesarean section (CS) rates continue to evoke worldwide concern because of their steady increase, lack of consensus on the appropriate CS rate and the associated additional short-and long-term risks and costs. We present the latest CS rates and trends over the last 24 years. Methods We collected nationally-representative data on CS rates between 1990 to 2014 and calculated regional and subregional weighted averages. We conducted a longitudinal analysis calculating differences in CS rates as absolute change and as the average annual rate of increase (AARI). Results According to the latest data from 150 countries, currently 18.6% of all births occur by CS, ranging from 6% to 27.2% in the least and most developed regions, respectively. Latin America and the Caribbean region has the highest CS rates (40.5%), followed by Northern America (32.3%), Oceania (31.1%), Europe (25%), Asia (19.2%) and Africa (7.3%). Based on the data from 121 countries, the trend analysis showed that between 1990 and 2014, the global average CS rate increased 12.4% (from 6.7% to 19.1%) with an average annual rate of increase of 4.4%. The largest absolute increases occurred in Latin America and the Caribbean (19.4%, from 22.8% to 42.2%), followed by Asia (15.1%, from 4.4% to 19.5%), Oceania (14.1%, from 18.5% to 32.6%), Europe (13.8%, from 11.2% to 25%), Northern America (10%, from 22.3% to 32.3%) and Africa (4.5%, from 2.9% to 7.4%). Asia and Northern America were the regions with the highest and lowest average annual rate of increase (6.4% and 1.6%, respectively). Conclusion The use of CS worldwide has increased to unprecedented levels although the gap between higher- and lower-resource settings remains. The information presented is essential to inform policy and global and regional strategies aimed at optimizing the use of CS.	[Betran, Ana Pilar; Moller, Anne-Beth; Guelmezoglu, A. Metin] WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; [Ye, Jianfeng] Fudan Univ, Dept Clin Epidemiol, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [Zhang, Jun] Shanghai Jiao Tong Univ, Minist Educ, Shanghai Key Lab Childrens Environm Hlth, Xinhua Hosp,Sch Med, Shanghai 200030, Peoples R China; [Torloni, Maria Regina] Univ Fed Sao Paulo, Evidence Based Healthcare Postgrad Program, Sao Paulo, Brazil	The World Bank; United Nations Population Fund; World Health Organization; Fudan University; Shanghai Jiao Tong University; Universidade Federal de Sao Paulo (UNIFESP)	Betran, AP (corresponding author), WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland.	betrana@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Abdel-Aleem H, 2013, INT J GYNECOL OBSTET, V123, P119, DOI 10.1016/j.ijgo.2013.05.011; American College of Obstetricians and Gynecologists & Society for Maternal-Fetal Medicine, 2014, OBST CAR CONS SAF PR; Angeja ACE, 2006, BJOG-INT J OBSTET GY, V113, P1253, DOI 10.1111/j.1471-0528.2006.01069.x; [Anonymous], 1985, LANCET, V2, P436; [Anonymous], 2015, WHORHR1502; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Betran AP, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0043-6; Betran AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097769; Betran AP, 2015, BJOG; Bruggmann D, 2015, INT J ENV RES PUB HE, V12, P14690, DOI 10.3390/ijerph121114690; Gibbons L, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.026; Gregory Kimberly D, 2012, Am J Perinatol, V29, P7, DOI 10.1055/s-0031-1285829; Hartmann KE., 2012, STRATEGIES REDUCE CE; Hellerstein S, 2015, BJOG-INT J OBSTET GY, V122, P160, DOI 10.1111/1471-0528.12971; Huang X, 2011, EUR J OBSTET GYN R B, V158, P204, DOI 10.1016/j.ejogrb.2011.05.006; Khunpradit S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005528.pub2; Lin HC, 2004, OBSTET GYNECOL, V103, P128, DOI 10.1097/01.AOG.0000102935.91389.53; Linton A, 2004, BIRTH-ISS PERINAT C, V31, P3, DOI 10.1111/j.0730-7659.2004.0268.x; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Macfarlane A., 2015, BJOG; Marshall NE, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.035; Mi J, 2014, LANCET, V383, P1463, DOI 10.1016/S0140-6736(14)60716-9; Ministry of Health and Population [Egypt] El-Zanaty Associates [Egypt] ICF International, 2015, 2014 EG DEM HLTH SUR; Raisanen S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-120; Renfrew MJ, 2014, LANCET, V384, P1129, DOI 10.1016/S0140-6736(14)60789-3; Ronsmans C, 2006, LANCET, V368, P1516, DOI 10.1016/S0140-6736(06)69639-6; Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71; Stanton CK, 2005, B WORLD HEALTH ORGAN, V83, P449; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Timor-Tritsch IE, 2012, AM J OBSTET GYNECOL, V207, P14, DOI 10.1016/j.ajog.2012.03.007; Torloni MR, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-78; Torloni MR, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d276; Torloni MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014566; United Nations, 2013, WORLD POP AG 2013; United Nations Children's Fund (UNICEF), MULT IND CLUST SURV; United Nations Statistics Division, COMP MACR CONT REG G; USAID. The DHS Program Demographic and Health Surveys, DHS PROGR DEM HLTH S; Victora CG, 2006, LANCET, V367, P1796, DOI 10.1016/S0140-6736(06)68780-1; Vogel JP, 2015, LANCET GLOB HEALTH, V3, pE260, DOI 10.1016/S2214-109X(15)70094-X; World Health Organization, EUR HLTH ALL DAT; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB; Zwecker P, 2011, AM J PERINAT, V28, P277, DOI 10.1055/s-0030-1271213	42	456	488	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148343	10.1371/journal.pone.0148343	http://dx.doi.org/10.1371/journal.pone.0148343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849801	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000073
J	Chang, CM; Yin, WY; Wei, CK; Wu, CC; Su, YC; Yu, CH; Lee, CC				Chang, Chun-Ming; Yin, Wen-Yao; Wei, Chang-Kao; Wu, Chin-Chia; Su, Yu-Chieh; Yu, Chia-Hui; Lee, Ching-Chih			Adjusted Age-Adjusted Charlson Comorbidity Index Score as a Risk Measure of Perioperative Mortality before Cancer Surgery	PLOS ONE			English	Article							SHORT-TERM; PATIENT READMISSION; RADICAL CYSTECTOMY; OLDER-ADULTS; MORBIDITY; IMPACT; VALIDATION; OUTCOMES; PANCREATICODUODENECTOMY; PREDICTORS	Background Identification of patients at risk of death from cancer surgery should aid in preoperative preparation. The purpose of this study is to assess and adjust the age-adjusted Charlson comorbidity index (ACCI) to identify cancer patients with increased risk of perioperative mortality. Methods We identified 156,151 patients undergoing surgery for one of the ten common cancers between 2007 and 2011 in the Taiwan National Health Insurance Research Database. Half of the patients were randomly selected, and a multivariate logistic regression analysis was used to develop an adjusted-ACCI score for estimating the risk of 90-day mortality by variables from the original ACCI. The score was validated. The association between the score and perioperative mortality was analyzed. Results The adjusted-ACCI score yield a better discrimination on mortality after cancer surgery than the original ACCI score, with c-statics of 0.75 versus 0.71. Over 80 years of age, 70-80 years, and renal disease had the strongest impact on mortality, hazard ratios 8.40, 3.63, and 3.09 (P < 0.001), respectively. The overall 90-day mortality rates in the entire cohort varied from 0.9%, 2.9%, 7.0%, and 13.2% in four risk groups stratifying by the adjusted-ACCI score; the adjusted hazard ratio for score 4-7, 8-11, and >= 12 was 2.84, 6.07, and 11.17 (P < 0.001), respectively, in 90-day mortality compared to score 0-3. Conclusions The adjusted-ACCI score helps to identify patients with a higher risk of 90-day mortality after cancer surgery. It might be particularly helpful for preoperative evaluation of patients over 80 years of age.	[Chang, Chun-Ming; Yin, Wen-Yao; Wei, Chang-Kao; Wu, Chin-Chia; Yu, Chia-Hui] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Surg, Chiayi, Taiwan; [Lee, Ching-Chih] Kaohsiung Vet Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kaohsiung, Taiwan; [Lee, Ching-Chih] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Su, Yu-Chieh] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Hematol Oncol, Dept Internal Med, Chiayi, Taiwan; [Su, Yu-Chieh] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Ctr Canc, Chiayi, Taiwan; [Chang, Chun-Ming; Yin, Wen-Yao; Wei, Chang-Kao; Wu, Chin-Chia] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lee, Ching-Chih] Triserv Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Kaohsiung Veterans General Hospital; National Defense Medical Center; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Tri-Service General Hospital	Lee, CC (corresponding author), Kaohsiung Vet Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kaohsiung, Taiwan.; Lee, CC (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Lee, CC (corresponding author), Triserv Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan.	hematcd2@hotmail.com		Su, Yu-Chieh/0000-0002-1771-9017				Adam R, 2010, BRIT J SURG, V97, P366, DOI 10.1002/bjs.6889; Aust JB, 2005, ANN SURG, V241, P1024, DOI 10.1097/01.sla.0000165196.32207.dd; Bainbridge D, 2012, LANCET, V380, P1075, DOI 10.1016/S0140-6736(12)60990-8; Bar B, 2011, STROKE, V42, P2944, DOI 10.1161/STROKEAHA.111.617639; Birnbaum DJ, 2015, ANN SURG ONCOL, V22, P1000, DOI 10.1245/s10434-014-4016-8; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cleves MA, 1997, J CLIN EPIDEMIOL, V50, P903, DOI 10.1016/S0895-4356(97)00091-7; Daskivich TJ, 2011, CANCER-AM CANCER SOC, V117, P4642, DOI 10.1002/cncr.26104; Dehal A, 2013, BREAST CANCER RES TR, V139, P469, DOI 10.1007/s10549-013-2543-9; Erichsen R, 2013, BRIT J CANCER, V109, P2005, DOI 10.1038/bjc.2013.541; Extermann M, 2000, EUR J CANCER, V36, P453, DOI 10.1016/S0959-8049(99)00319-6; Frenkel WJ, 2014, J AM GERIATR SOC, V62, P342, DOI 10.1111/jgs.12635; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Hyder O, 2013, JAMA SURG, V148, P1095, DOI 10.1001/jamasurg.2013.2509; Jepsen P, 2008, HEPATOLOGY, V48, P214, DOI 10.1002/hep.22341; Kirkland LL, 2011, AM J MED QUAL, V26, P461, DOI 10.1177/1062860611402188; Koppie TM, 2008, CANCER-AM CANCER SOC, V112, P2384, DOI 10.1002/cncr.23462; Langan RC, 2016, AM J SURG, V211, P70, DOI 10.1016/j.amjsurg.2015.04.014; Langan RC, 2015, SURGERY, V158, P366, DOI 10.1016/j.surg.2015.02.022; Marchena-Gomez J, 2009, ANN VASC SURG, V23, P458, DOI 10.1016/j.avsg.2008.10.008; Mayr R, 2012, EUR UROL, V62, P662, DOI 10.1016/j.eururo.2012.03.057; Neuman HB, 2013, ANN SURG ONCOL, V20, P1427, DOI 10.1245/s10434-012-2721-8; Ng ACC, 2013, RESPIRATION, V85, P408, DOI 10.1159/000342024; Ouellette JR, 2004, J GASTROINTEST SURG, V8, P1061, DOI 10.1016/j.gassur.2004.09.045; Riall TS, 2011, J AM GERIATR SOC, V59, P647, DOI 10.1111/j.1532-5415.2011.03353.x; Riall Taylor S, 2009, Adv Surg, V43, P233; Robbins JR, 2013, GYNECOL ONCOL, V131, P593, DOI 10.1016/j.ygyno.2013.10.007; Schneider EB, 2012, J AM COLL SURGEONS, V215, P607, DOI 10.1016/j.jamcollsurg.2012.07.007; Schneider EB, 2012, J AM COLL SURGEONS, V214, P390, DOI 10.1016/j.jamcollsurg.2011.12.025; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Simons JP, 2009, ANN SURG, V250, P929, DOI 10.1097/SLA.0b013e3181bc9c2f; Singh Santosh Kumar, 2015, J Gastrointest Cancer, V46, P399, DOI 10.1007/s12029-015-9766-4; Smith T, 2014, AGE AGEING, V43, P464, DOI 10.1093/ageing/afu065; Taiwan Cancer Registry, 2015, 5 YEARS SURV CANC; Turrentine FE, 2006, J AM COLL SURGEONS, V203, P865, DOI 10.1016/j.jamcollsurg.2006.08.026; Voskuijl T, 2014, CLIN ORTHOP RELAT R, V472, P1638, DOI 10.1007/s11999-013-3394-8; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2987, DOI 10.1001/jama.285.23.2987; Wong SL, 2015, ANN SURG, V261, P632, DOI 10.1097/SLA.0000000000000690; World Health Organization, CANC FACT SHEET	40	56	58	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148076	10.1371/journal.pone.0148076	http://dx.doi.org/10.1371/journal.pone.0148076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848761	Green Published, gold			2022-12-27	WOS:000369554000039
J	Clooney, AG; Fouhy, F; Sleator, RD; Driscoll, AO; Stanton, C; Cotter, PD; Claesson, MJ				Clooney, Adam G.; Fouhy, Fiona; Sleator, Roy D.; Driscoll, Aisling O'; Stanton, Catherine; Cotter, Paul D.; Claesson, Marcus J.			Comparing Apples and Oranges?: Next Generation Sequencing and Its Impact on Microbiome Analysis	PLOS ONE			English	Article							ION TORRENT; ILLUMINA; PLATFORMS; BACTERIAL; IDENTIFICATION; TECHNOLOGIES; EXTRACTION; ASSEMBLER; CELL; DNA	Rapid advancements in sequencing technologies along with falling costs present widespread opportunities for microbiome studies across a vast and diverse array of environments. These impressive technological developments have been accompanied by a considerable growth in the number of methodological variables, including sampling, storage, DNA extraction, primer pairs, sequencing technology, chemistry version, read length, insert size, and analysis pipelines, amongst others. This increase in variability threatens to compromise both the reproducibility and the comparability of studies conducted. Here we perform the first reported study comparing both amplicon and shotgun sequencing for the three leading next-generation sequencing technologies. These were applied to six human stool samples using Illumina HiSeq, MiSeq and Ion PGM shotgun sequencing, as well as amplicon sequencing across two variable 16S rRNA gene regions. Notably, we found that the factor responsible for the greatest variance in microbiota composition was the chosen methodology rather than the natural inter-individual variance, which is commonly one of the most significant drivers in microbiome studies. Amplicon sequencing suffered from this to a large extent, and this issue was particularly apparent when the 16S rRNA V1-V2 region amplicons were sequenced with MiSeq. Somewhat surprisingly, the choice of taxonomic binning software for shotgun sequences proved to be of crucial importance with even greater discriminatory power than sequencing technology and choice of amplicon. Optimal N50 assembly values for the HiSeq was obtained for 10 million reads per sample, whereas the applied MiSeq and PGM sequencing depths proved less sufficient for shotgun sequencing of stool samples. The latter technologies, on the other hand, provide a better basis for functional gene categorisation, possibly due to their longer read lengths. Hence, in addition to highlighting methodological biases, this study demonstrates the risks associated with comparing data generated using different strategies. We also recommend that laboratories with particular interests in certain microbes should optimise their protocols to accurately detect these taxa using different techniques.	[Clooney, Adam G.; Claesson, Marcus J.] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Fouhy, Fiona; Stanton, Catherine; Cotter, Paul D.] TEAGASC, Food Res Ctr, Fermoy, Cork, Ireland; [Clooney, Adam G.; Sleator, Roy D.] Cork Inst Technol, Dept Biol Sci, Cork, Ireland; [Driscoll, Aisling O'] Cork Inst Technol, Dept Comp, Cork, Ireland; [Clooney, Adam G.; Fouhy, Fiona; Sleator, Roy D.; Driscoll, Aisling O'; Stanton, Catherine; Cotter, Paul D.; Claesson, Marcus J.] Natl Univ Ireland Univ Coll Cork, APC Microbiome Inst, Cork, Ireland	University College Cork; Teagasc; Cork Institute of Technology; Cork Institute of Technology; University College Cork	Claesson, MJ (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland.; Cotter, PD (corresponding author), TEAGASC, Food Res Ctr, Fermoy, Cork, Ireland.; Cotter, PD; Claesson, MJ (corresponding author), Natl Univ Ireland Univ Coll Cork, APC Microbiome Inst, Cork, Ireland.	paul.cotter@teagasc.ie; m.claesson@ucc.ie	Cotter, Paul/AAX-5449-2021; Claesson, Marcus/AAE-4145-2019; Stanton, Catherine/A-9549-2015; Cotter, Paul/B-7781-2008	Cotter, Paul/0000-0002-5465-9068; Claesson, Marcus/0000-0002-5712-0623; Stanton, Catherine/0000-0002-6724-7011; Cotter, Paul/0000-0002-5465-9068; Fouhy, Fiona/0000-0002-8285-7694; Clooney, Adam/0000-0003-4881-9544	Science Foundation Ireland (SFI) [SFI/12/RC/2273, 11/PI/1137]; FP7 [603038]	Science Foundation Ireland (SFI)(Science Foundation Ireland); FP7	This publication has emanated from research supported in part by a research grant from Science Foundation Ireland (SFI) under Grant Number SFI/12/RC/2273 and 11/PI/1137 and by FP7 funded CFMATTERS (Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified, Grant Agreement no. 603038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard G, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0747-1; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Beck J, 2014, NEUROBIOL AGING, V35, P261, DOI 10.1016/j.neurobiolaging.2013.07.017; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brozynska M, 2014, DIRECT CHLOROPLAST S; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Freitas TAK, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv180; Frey KG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-96; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lonardi S, 2015, BIOINFORMATICS, V31, P2972, DOI 10.1093/bioinformatics/btv311; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; NEEFS JM, 1993, NUCLEIC ACIDS RES, V21, P3025, DOI 10.1093/nar/21.13.3025; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Pylro VS, 2014, J MICROBIOL METH, V107, P30, DOI 10.1016/j.mimet.2014.08.018; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Salipante SJ, 2014, APPL ENVIRON MICROB, V80, P7583, DOI 10.1128/AEM.02206-14; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Sinclair L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116955; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; Tremblay J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00771; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van der Veen BE, 2014, GENOMICS, V104, P459, DOI 10.1016/j.ygeno.2014.10.008; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Wang J, 2014, SCI WORLD J, DOI 10.1155/2014/931515; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061516; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	38	154	158	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148028	10.1371/journal.pone.0148028	http://dx.doi.org/10.1371/journal.pone.0148028			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849217	gold, Green Submitted, Green Published			2022-12-27	WOS:000369554000032
J	Espino, FE; Bibit, JA; Sornillo, JB; Tan, A; von Seidlein, L; Ley, B				Espino, Fe Esperanza; Bibit, Jo-Anne; Sornillo, Johanna Beulah; Tan, Alvin; von Seidlein, Lorenz; Ley, Benedikt			Comparison of Three Screening Test Kits for G6PD Enzyme Deficiency: Implications for Its Use in the Radical Cure of Vivax Malaria in Remote and Resource-Poor Areas in the Philippines	PLOS ONE			English	Article							GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; PLASMODIUM-VIVAX; FILTER-PAPER; PRIMAQUINE; DIAGNOSIS; UPDATE; ASSAY	Objective We evaluated a battery of Glucose-6-Phosphate Dehydrogenase diagnostic point-of-care tests (PoC) to assess the most suitable product in terms of performance and operational characteristics for remote areas. Methods Samples were collected in Puerto Princesa City, Palawan, Philippines and tested for G6PD deficiency with a fluorescent spot test (FST; Procedure 203, Trinity Biotech, Ireland), the semiquantitative WST8/1-methoxy PMS (WST; Dojindo, Japan) and the Carestart G6PD Rapid Diagnostic Test (CSG; AccessBio, USA). Results were compared to spectrophotometry (Procedure 345, Trinity Biotech, Ireland). Sensitivity and specificity were calculated for each test with cut-off activities of 10%, 20%, 30% and 60% of the adjusted male median. Results The adjusted male median was 270.5 IU/10(12) RBC. FST and WST were tested on 621 capillary blood samples, the CSG was tested on venous and capillary blood on 302 samples. At 30% G6PD activity, sensitivity for the FST was between 87.7%(95% CI: 76.8% to 93.9%) and 96.5% (95% CI: 87.9% to 99.5%) depending on definition of intermediate results; the WST was 84.2%(95% CI: 72.1% to 92.5%); and the CSG was between 68.8% (95% CI: 41.3% to 89.0%) and 93.8% (95% CI: 69.8% to 99.8%) when the test was performed on capillary or venous blood respectively. Sensitivity of FST and CSG (tested with venous blood) were comparable (p>0.05). The analysis of venous blood samples by the CSG yielded significantly higher results than FST and CSG performed on capillary blood (p<0.05). Sensitivity of the CSG varied depending on source of blood used (p<0.05). Conclusion The operational characteristics of the CSG were superior to all other test formats. Performance and operational characteristics of the CSG performed on venous blood suggest the test to be a good alternative to the FST.	[Espino, Fe Esperanza; Bibit, Jo-Anne; Sornillo, Johanna Beulah] Res Inst Trop Med, Dept Hlth, Dept Parasitol, Muntinlupa, Philippines; [Tan, Alvin] Res Inst Trop Med, Dept Hlth, Dept Epidemiol & Biostat, Muntinlupa, Philippines; [von Seidlein, Lorenz] Mahidol Oxford Res Unit, Bangkok, Thailand; [Ley, Benedikt] Menzies Sch Hlth Res, Darwin, NT, Australia; [Ley, Benedikt] Charles Darwin Univ, Global & Trop Hlth Div, Darwin, NT 0909, Australia	Philippine Department Health; Research Institute for Tropical Medicine - Philippines; Philippine Department Health; Research Institute for Tropical Medicine - Philippines; Mahidol Oxford Tropical Medicine Research Unit (MORU); Charles Darwin University; Menzies School of Health Research; Charles Darwin University	Espino, FE (corresponding author), Res Inst Trop Med, Dept Hlth, Dept Parasitol, Muntinlupa, Philippines.	fe.espino2012@gmail.com		Ley, Benedikt/0000-0002-5734-0845; Sornillo, Johanna Beulah/0000-0001-8331-0845	Asia Pacific Malaria Elimination Network [107-08]	Asia Pacific Malaria Elimination Network	This work was supported by Asia Pacific Malaria Elimination Network (apmen.org) grant ID 107-08 to FE.	Adu-Gyasi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125796; [Anonymous], 1989, B WORLD HEALTH ORGAN, V67, P601; Baird JK, 2014, TRANSL RES; Bancone G, 2015, AM J TROP MED HYG, V92, P818, DOI 10.4269/ajtmh.14-0696; BEUTLER E, 1979, BRIT J HAEMATOL, V43, P465, DOI 10.1111/j.1365-2141.1979.tb03774.x; BEUTLER E, 1991, NEW ENGL J MED, V324, P169; De Niz M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-210; Domingo GJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-391; Fernando D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-351; Galappaththy GNL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004389.pub3; Howes RE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-418; Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339; Hundsdoerfer P, 2002, ACTA HAEMATOL-BASEL, V108, P102, DOI 10.1159/000064749; John GK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-280; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028357; Kuwahata M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-223; LaRue N, 2014, AM J TROP MED HYG, V91, P854, DOI 10.4269/ajtmh.14-0194; Leslie T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000283; Ley B, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0896-8; Ley B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-147; Manganelli Genesia, 2013, Cardiovascular & Hematological Disorders - Drug Targets, V13, P73; Meissner PE, 2005, BRIT J HAEMATOL, V131, P395, DOI 10.1111/j.1365-2141.2005.05778.x; Minucci A, 2012, BLOOD CELL MOL DIS, V48, P154, DOI 10.1016/j.bcmd.2012.01.001; MPAC, 2015, POINT OF CAR G6PD TE; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Padilla C, 2003, PEDIATR INT, V45, P10, DOI 10.1046/j.1442-200X.2003.01676.x; Padilla CD, 2007, J INHERIT METAB DIS, V30, P490, DOI 10.1007/s10545-007-0687-7; Padilla Carmencita David, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P87; Padilla CD, 2012, J COMMUN GENET, V3, P35, DOI 10.1007/s12687-011-0076-7; Roca-Feltrer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116143; Saha N, 1984, Ann Acad Med Singap, V13, P494; Tantular IS, 2003, TROP MED INT HEALTH, V8, P569, DOI 10.1046/j.1365-3156.2003.01055.x; von Seidlein L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-112; Walsh DS, 2004, J INFECT DIS, V190, P1456, DOI 10.1086/424468	34	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148172	10.1371/journal.pone.0148172	http://dx.doi.org/10.1371/journal.pone.0148172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849445	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000046
J	Koppram, R; Mapelli, V; Albers, E; Olsson, L				Koppram, Rakesh; Mapelli, Valeria; Albers, Eva; Olsson, Lisbeth			The Presence of Pretreated Lignocellulosic Solids from Birch during Saccharomyces cerevisiae Fermentations Leads to Increased Tolerance to Inhibitors - A Proteomic Study of the Effects	PLOS ONE			English	Article							ACETIC-ACID; XYLOSE; YEAST; EXPRESSION; CELLULASE; STRAIN; INVOLVEMENT; PATHWAY; ETHANOL; BIOMASS	The fermentation performance of Saccharomyces cerevisiae in the cellulose to ethanol conversion process is largely influenced by the components of pretreated biomass. The insoluble solids in pretreated biomass predominantly constitute cellulose, lignin, and -to a lesser extent-hemicellulose. It is important to understand the effects of water-insoluble solids (WIS) on yeast cell physiology and metabolism for the overall process optimization. In the presence of synthetic lignocellulosic inhibitors, we observed a reduced lag phase and enhanced volumetric ethanol productivity by S. cerevisiae CEN. PK 113-7D when the minimal medium was supplemented with WIS of pretreated birch or spruce and glucose as the carbon source. To investigate the underlying molecular reasons for the effects of WIS, we studied the response of WIS at the proteome level in yeast cells in the presence of acetic acid as an inhibitor. Comparisons were made with cells grown in the presence of acetic acid but without WIS in the medium. Altogether, 729 proteins were detected and quantified, of which 246 proteins were significantly up-regulated and 274 proteins were significantly down-regulated with a fold change >= 1.2 in the presence of WIS compared to absence of WIS. The cells in the presence of WIS up-regulated several proteins related to cell wall, glycolysis, electron transport chain, oxidative stress response, oxygen and radical detoxification and unfolded protein response; and down-regulated most proteins related to biosynthetic pathways including amino acid, purine, isoprenoid biosynthesis, aminoacyl-tRNA synthetases and pentose phosphate pathway. Overall, the identified differentially regulated proteins may indicate that the likelihood of increased ATP generation in the presence of WIS was used to defend against acetic acid stress at the expense of reduced biomass formation. Although, comparative proteomics of cells with and without WIS in the acetic acid containing medium revealed numerous changes, a direct effect of WIS on cellular physiology remains to be investigated.	[Koppram, Rakesh; Mapelli, Valeria; Albers, Eva; Olsson, Lisbeth] Chalmers Univ Technol, Dept Chem & Biol Engn, Ind Biotechnol, S-41296 Gothenburg, Sweden; [Koppram, Rakesh] Austrian Ctr Ind Biotechnol, Vienna, Austria	Chalmers University of Technology; Austrian Centre of Industrial Biotechnology	Olsson, L (corresponding author), Chalmers Univ Technol, Dept Chem & Biol Engn, Ind Biotechnol, S-41296 Gothenburg, Sweden.	lisbeth.olsson@chalmers.se	Mapelli, Valeria/E-4434-2014	Mapelli, Valeria/0000-0001-8724-3221; /0000-0002-0827-5442; Albers, Eva/0000-0002-1921-3415	Nordic Energy Top-level Research Initiative [TFI PK-bio 02]	Nordic Energy Top-level Research Initiative	This work was supported by Nordic Energy Top-level Research Initiative, TFI PK-bio 02, "HG Biofuels". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida B, 2009, PROTEOMICS, V9, P720, DOI 10.1002/pmic.200700816; Almeida JRM, 2007, J CHEM TECHNOL BIOT, V82, P340, DOI 10.1002/jctb.1676; Ask M, 2013, BIOTECHNOLOGY BIOFUE, V6; Ask M, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-87; Balat M, 2011, ENERG CONVERS MANAGE, V52, P858, DOI 10.1016/j.enconman.2010.08.013; Berlin A, 2006, J BIOTECHNOL, V125, P198, DOI 10.1016/j.jbiotec.2006.02.021; Cappellaro C, 1998, J BACTERIOL, V180, P5030, DOI 10.1128/JB.180.19.5030-5037.1998; Carmelo V, 1996, ARCH MICROBIOL, V166, P315, DOI 10.1007/s002030050389; Casey E, 2010, FEMS YEAST RES, V10, P385, DOI 10.1111/j.1567-1364.2010.00623.x; Ding MZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043474; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Eliasson A, 2000, APPL ENVIRON MICROB, V66, P3381, DOI 10.1128/AEM.66.8.3381-3386.2000; Ferreira T, 2001, J BIOL CHEM, V276, P29613, DOI 10.1074/jbc.R100022200; Hasunuma T, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-2; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Huttlin EL, 2007, J PROTEOME RES, V6, P392, DOI 10.1021/pr0603194; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Jeoh T, 2007, BIOTECHNOL BIOENG, V98, P112, DOI 10.1002/bit.21408; Jeppsson M, 2003, FEMS YEAST RES, V3, P167, DOI 10.1016/S1567-1356(02)00186-1; Jorgensen H, 2007, BIOTECHNOL BIOENG, V96, P862, DOI 10.1002/bit.21115; Kawahata M, 2006, FEMS YEAST RES, V6, P924, DOI 10.1111/j.1567-1364.2006.00089.x; Koppram R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-32; Kuyper M, 2005, FEMS YEAST RES, V5, P399, DOI 10.1016/j.femsyr.2004.09.010; Kuyper M, 2005, FEMS YEAST RES, V5, P925, DOI 10.1016/j.femsyr.2005.04.004; Lindberg L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073936; Mira NP, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-79; Nissen TL, 2000, YEAST, V16, P463, DOI 10.1002/(SICI)1097-0061(20000330)16:5<463::AID-YEA535>3.0.CO;2-3; Pampulha ME, 2000, FEMS MICROBIOL LETT, V184, P69, DOI 10.1016/S0378-1097(00)00022-7; Piper P, 2001, MICROBIOL-SGM, V147, P2635, DOI 10.1099/00221287-147-10-2635; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Wang RF, 2014, BIORESOURCE TECHNOL, V172, P303, DOI 10.1016/j.biortech.2014.09.028; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wisselink HW, 2007, APPL ENVIRON MICROB, V73, P4881, DOI 10.1128/AEM.00177-07; Yin QY, 2005, J BIOL CHEM, V280, P20894, DOI 10.1074/jbc.M500334200; Zhou H, 2012, METAB ENG, V14, P611, DOI 10.1016/j.ymben.2012.07.011	35	6	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148635	10.1371/journal.pone.0148635	http://dx.doi.org/10.1371/journal.pone.0148635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849651	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000144
J	Pastor, A; Fernandez-Aranda, F; Fito, M; Jimenez-Murcia, S; Botella, C; Fernandez-Real, JM; Fruhbeck, G; Tinahones, FJ; Fagundo, AB; Rodriguez, J; Aguera, Z; Langohr, K; Casanueva, FF; de la Torre, R				Pastor, Antoni; Fernandez-Aranda, Fernando; Fito, Montserrat; Jimenez-Murcia, Susana; Botella, Cristina; Fernandez-Real, Jose M.; Fruehbeck, Gema; Tinahones, Francisco J.; Fagundo, Ana B.; Rodriguez, Joan; Agueera, Zaida; Langohr, Klaus; Casanueva, Felipe F.; de la Torre, Rafael			A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women	PLOS ONE			English	Article							ENERGY-BALANCE; FOOD-INTAKE; ODOR IDENTIFICATION; SYSTEM; APPETITE; BRAIN; DISCRIMINATION; SENSITIVITY; MECHANISMS; 2-ARACHIDONOYL-GLYCEROL	The endocannabinoid (eCB) system can promote food intake by increasing odor detection in mice. The eCB system is over-active in human obesity. Our aim is to measure circulating eCB concentrations and olfactory capacity in a human sample that includes people with obesity and explore the possible interaction between olfaction, obesity and the eCB system. The study sample was made up of 161 females with five groups of body mass index subcategories ranging from under-weight to morbidly obese. We assessed olfactory capacity with the "Sniffin 'Sticks" test, which measures olfactory threshold-discrimination-identification (TDI) capacity. We measured plasma concentrations of the eCBs 2-arachidonoylglycerol (2-AG) and N-arachidonoylethanolamine or anandamide (AEA), and several eCB-related compounds, 2-acylglycerols and N-acylethanolamines. 2-AG and other 2-acylglycerols fasting plasma circulating plasma concentrations were higher in obese and morbidly obese subjects. AEA and other N-acylethanolamine circulating concentrations were lower in under-weight subjects. Olfactory TDI scores were lower in obese and morbidly obese subjects. Lower TDI scores were independently associated with higher 2-AG fasting plasma circulating concentrations, higher % body fat, and higher body mass index, after controlling for age, smoking, menstruation, and use of contraceptives. Our results show that obese subjects have a lower olfactory capacity than non-obese ones and that elevated fasting plasma circulating 2-AG concentrations in obesity are linked to a lower olfactory capacity. In agreement with previous studies we show that eCBs AEA and 2-AG, and their respective congeners have a distinct profile in relation to body mass index. The present report is the first study in humans in which olfactory capacity and circulating eCB concentrations have been measured in the same subjects.	[Pastor, Antoni; Rodriguez, Joan; de la Torre, Rafael] IMIM Hosp del Mar Med Res Inst, Integrat Pharmacol & Syst Neurosci Res Grp, Neurosci Res Program, Barcelona, Spain; [Fernandez-Aranda, Fernando; Jimenez-Murcia, Susana; Fagundo, Ana B.; Agueera, Zaida] Univ Hosp Bellvitge IDIBELL, Dept Psychiat, Barcelona, Spain; [Fito, Montserrat] IMIM Hosp del Mar Med Res Inst, Cardiovasc Risk & Nutr Res Grp, Inflammatory & Cardiovasc Disorders Res Program, Barcelona, Spain; [Jimenez-Murcia, Susana] Univ Barcelona, Dept Clin Sci, Sch Med, Barcelona, Spain; [Botella, Cristina] Univ Jaume 1, Dept Basic Psychol Clin & Psychobiol, Castellon de La Plana, Spain; [Fernandez-Real, Jose M.] Hosp Dr Josep Trueta, Dept Diabet Endocrinol & Nutr, Inst Invest Biomed Girona IdIBGi, Girona, Spain; [Fruehbeck, Gema] Univ Navarra, IdiSNA, Univ Navarra Clin, Dept Endocrinol & Nutr, E-31080 Pamplona, Spain; [Tinahones, Francisco J.] Hosp Clin Univ Virgen de Victoria, Dept Diabet Endocrinol & Nutr, Malaga, Spain; [Langohr, Klaus] Univ Politecn Cataluna, Dept Stat & Operat Res, Barcelona, Spain; [Casanueva, Felipe F.] Univ Santiago de Compostela, Complejo Hosp Univ Santiago, Div Endocrine, Santiago De Compostela, Spain; [Pastor, Antoni] Univ Autonoma Barcelona, Dept Pharmacol, Sch Med, E-08193 Barcelona, Spain; [Pastor, Antoni; Fernandez-Aranda, Fernando; Fito, Montserrat; Jimenez-Murcia, Susana; Botella, Cristina; Fernandez-Real, Jose M.; Fruehbeck, Gema; Tinahones, Francisco J.; Casanueva, Felipe F.; de la Torre, Rafael] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERObn, Madrid, Spain; [de la Torre, Rafael] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Barcelona; Universitat Jaume I; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); University of Navarra; Universitat Politecnica de Catalunya; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Pompeu Fabra University	de la Torre, R (corresponding author), IMIM Hosp del Mar Med Res Inst, Integrat Pharmacol & Syst Neurosci Res Grp, Neurosci Res Program, Barcelona, Spain.; de la Torre, R (corresponding author), Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERObn, Madrid, Spain.; de la Torre, R (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain.	rtorre@imim.es	Botella, Cristina/F-9230-2010; Tinahones, Francisco José/AAB-2882-2020; Fito, Montserrat/C-1822-2012; de la Torre, Rafael/D-3561-2018; Fernandez-Aranda, Fernando/L-9762-2014; Pastor, Antoni/AAD-4638-2020; Langohr, Klaus/B-7825-2012; Fernández-Real, Jose Manuel/AGH-3599-2022; JIMENEZ-MURCIA, SUSANA/L-9786-2014; FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; AGÜERA, ZAIDA/K-9771-2014	Botella, Cristina/0000-0001-8783-6959; Fito, Montserrat/0000-0002-1817-483X; de la Torre, Rafael/0000-0002-6765-1866; Fernandez-Aranda, Fernando/0000-0002-2968-9898; Pastor, Antoni/0000-0003-3692-0696; Langohr, Klaus/0000-0001-7075-9192; Fernández-Real, Jose Manuel/0000-0002-7442-9323; JIMENEZ-MURCIA, SUSANA/0000-0002-3596-8033; FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; AGÜERA, ZAIDA/0000-0003-4453-4939; Tinahones, Francisco J/0000-0001-6871-4403; Fagundo, Ana Beatriz/0000-0003-1703-9457	Instituto Salud Carlos III [FIS PI11/210, FIS14/290]; Centro de Investigacion Biomedica en Red. Fisiopatologia de la Obesidad y Nutricion (CIBEROB); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [2014 SGR 1672]	Instituto Salud Carlos III(Instituto de Salud Carlos III); Centro de Investigacion Biomedica en Red. Fisiopatologia de la Obesidad y Nutricion (CIBEROB); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	The work was supported by the following: Instituto Salud Carlos III, http://www.isciii.es, FIS PI11/210, FIS14/290; Centro de Investigacion Biomedica en Red. Fisiopatologia de la Obesidad y Nutricion (CIBEROB), http://www.ciberobn.es; and Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), www.gencat.cat/agaur/, 2014 SGR 1672. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2009, RHINOLOGY, V47, P160; Aschenbrenner K, 2008, LARYNGOSCOPE, V118, P135, DOI 10.1097/MLG.0b013e318155a4b9; Barrera JG, 2011, NAT REV ENDOCRINOL, V7, P507, DOI 10.1038/nrendo.2011.77; Ben-Shabat S, 1998, EUR J PHARMACOL, V353, P23, DOI 10.1016/S0014-2999(98)00392-6; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Borrelli F, 2009, BEST PRACT RES CL EN, V23, P33, DOI 10.1016/j.beem.2008.10.003; Bragulat V, 2009, FOOD RELATED ODOR PR, V18, P1566, DOI [DOI 10.1038/0BY.2010.57, 10.1038/oby.2010.57]; Brisbois TD, 2011, ANN ONCOL, V22, P2086, DOI 10.1093/annonc/mdq727; Broberger C, 2005, J INTERN MED, V258, P301, DOI 10.1111/j.1365-2796.2005.01553.x; Cameron JD, 2012, APPETITE, V58, P978, DOI 10.1016/j.appet.2012.02.050; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; Di Marzo V, 2009, DIABETOLOGIA, V52, P213, DOI 10.1007/s00125-008-1178-6; Di Marzo V, 2009, INT J OBESITY, V33, pS18, DOI 10.1038/ijo.2009.67; Di Marzo V, 2011, NAT NEUROSCI, V14, P9, DOI 10.1038/nn.2720; Djordjevic J, 2008, NEUROBIOL AGING, V29, P693, DOI 10.1016/j.neurobiolaging.2006.11.014; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Engeli S, 2014, OBESITY, V22, pE70, DOI 10.1002/oby.20728; Fagundo AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066387; Fezza F, 2014, MOLECULES, V19, P17078, DOI 10.3390/molecules191117078; Gonthier MP, 2007, OBESITY, V15, P837, DOI 10.1038/oby.2007.581; Gottfried JA, 2010, NAT REV NEUROSCI, V11, P628, DOI 10.1038/nrn2883; Gunstad J, 2007, COMPR PSYCHIAT, V48, P57, DOI 10.1016/j.comppsych.2006.05.001; Hansen KB, 2011, J CLIN ENDOCR METAB, V96, pE1409, DOI 10.1210/jc.2011-0647; Harrold JA, 2002, BRAIN RES, V952, P232, DOI 10.1016/S0006-8993(02)03245-6; Hedner M, 2010, J CLIN EXP NEUROPSYC, V32, P1062, DOI 10.1080/13803391003683070; Hoover KC, 2010, AM J PHYS ANTHROPOL, P63, DOI 10.1002/ajpa.21441; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Jansen Anita, 2003, Eat Behav, V4, P197, DOI 10.1016/S1471-0153(03)00011-4; Bermudez-Silva FJ, 2012, J PSYCHOPHARMACOL, V26, P114, DOI 10.1177/0269881111408458; Kadohisa M, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00066; Kanoski SE, 2011, PHYSIOL BEHAV, V103, P59, DOI 10.1016/j.physbeh.2010.12.003; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; Ketterer C, 2011, INT J OBESITY, V35, P1135, DOI 10.1038/ijo.2010.251; Kirkham TC, 2009, INT REV PSYCHIATR, V21, P163, DOI 10.1080/09540260902782810; Massa F, 2010, J NEUROSCI, V30, P6273, DOI 10.1523/JNEUROSCI.2648-09.2010; Matias I, 2007, BRIT J PHARMACOL, V152, P676, DOI 10.1038/sj.bjp.0707424; Monteleone P, 2005, NEUROPSYCHOPHARMACOL, V30, P1216, DOI 10.1038/sj.npp.1300695; Monteleone P, 2012, J CLIN ENDOCR METAB, V97, pE917, DOI 10.1210/jc.2011-3018; Mu HL, 2004, PROG LIPID RES, V43, P105, DOI 10.1016/S0163-7827(03)00050-X; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Palouzier-Paulignan B, 2012, CHEM SENSES, V37, P769, DOI 10.1093/chemse/bjs059; Pastor A, 2014, J LIPID RES, V55, P966, DOI 10.1194/jlr.D043794; Richardson BE, 2004, OBES SURG, V14, P967, DOI 10.1381/0960892041719617; Rivera P, 2013, EUR J NEUROSCI, V37, P105, DOI 10.1111/ejn.12012; Rolls ET, 2011, INT J OBESITY, V35, P550, DOI 10.1038/ijo.2010.155; Rolls ET, 1997, PHYSIOL BEHAV, V61, P461, DOI 10.1016/S0031-9384(96)00464-7; Shepherd GM, 2007, ANN NY ACAD SCI, V1121, P87, DOI 10.1196/annals.1401.032; Shepherd GM, 2006, NATURE, V444, P316, DOI 10.1038/nature05405; Soria-Gomez E, 2014, NAT NEUROSCI, V17, P407, DOI 10.1038/nn.3647; Stafford LD, 2015, CHEM SENSES, V40, P279, DOI 10.1093/chemse/bjv007; Stafford LD, 2011, CHEM SENSES, V36, P189, DOI 10.1093/chemse/bjq114; Stevenson RJ, 2010, CHEM SENSES, V35, P3, DOI 10.1093/chemse/bjp083; Syed SK, 2012, AM J PHYSIOL-ENDOC M, V303, pE1469, DOI 10.1152/ajpendo.00269.2012; Thanos PK, 2013, SYNAPSE, V67, P171, DOI 10.1002/syn.21627; Thiebaud N, 2014, J NEUROSCI, V34, P6970, DOI 10.1523/JNEUROSCI.3366-13.2014; Tong J, 2011, J NEUROSCI, V31, P5841, DOI 10.1523/JNEUROSCI.5680-10.2011; Tourino C, 2010, INT J OBESITY, V34, P557, DOI 10.1038/ijo.2009.262; Trellakis S, 2011, REGUL PEPTIDES, V167, P112, DOI 10.1016/j.regpep.2010.12.005; Yeomans MR, 2006, PHYSIOL BEHAV, V89, P10, DOI [10.1016/j.physbeh.2006.04.010, 10.1016/j.physbeh.2006.01.029]; Zheng H, 2009, INT J OBESITY, V33, pS8, DOI 10.1038/ijo.2009.65	62	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148734	10.1371/journal.pone.0148734	http://dx.doi.org/10.1371/journal.pone.0148734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849214	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000164
J	Sullivan, LL; Danielson, BJ; Harpole, WS				Sullivan, Lauren L.; Danielson, Brent J.; Harpole, W. Stanley			Mammalian Herbivores Alter the Population Growth and Spatial Establishment of an Early-Establishing Grassland Species	PLOS ONE			English	Article							DISTANCE SEED DISPERSAL; CHAMAECRISTA-FASCICULATA; INSECT HERBIVORY; PLANT; COMPETITION; CONSEQUENCES; DETERMINANTS; DIVERSITY; SELECTION; PATTERNS	Plant-herbivore interactions influence the establishment context of plant species, as herbivores alter the community context in which individual species establish, and the spatial relationship between individuals and their source population as plants invade. This relationship can be described using an establishment kernel, which takes into account movement through seed dispersal, and subsequent establishment of adults. Mammalian herbivores are hypothesized to influence plant population growth and establishment through a combination of consumption of seeds and seedlings, and movement of seeds. While the movement abilities of plants are well known, we have very few empirical mechanistic tests of how biotic factors like mammalian herbivores influence this spread potential. As herbivores of all sizes are abundant on the landscape, we asked the question, how do mammalian herbivores influence the population growth, spatial establishment, and the community establishment context of an early-recruiting native prairie legume, Chamaecrista fasciculata? We planted C. fasciculata in source populations within a four-acre tallgrass prairie restoration in plots with and without herbivores, and monitored its establishment with respect to distance from the source populations. We found that herbivores decreased population growth, and decreased the mean and range establishment distance. Additionally, C. fasciculata established more often without herbivores, and when surrounded by weedy, annual species. Our results provide insight into how the interactions between plants and herbivores can alter the spatial dynamics of developing plant communities, which is vital for colonization and range spread with fragmentation and climate change. Mammalian herbivores have the potential to both slow rates of establishment, but also determine the types of plant communities that surround invading species. Therefore, it is essential to consider the herbivore community when attempting to restore functioning plant communities.	[Sullivan, Lauren L.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Sullivan, Lauren L.; Danielson, Brent J.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Harpole, W. Stanley] UFZ Helmholtz Ctr Environm Res, Dept Physiol Divers, Permoserstr 15, D-04318 Leipzig, Germany; [Harpole, W. Stanley] German Ctr Integrat Biodivers Res iDiv, Deutsch Pl 5e, D-04103 Leipzig, Germany; [Harpole, W. Stanley] Univ Halle Wittenberg, Inst Biol, Kirchtor 1, D-06108 Halle, Saale, Germany	University of Minnesota System; University of Minnesota Twin Cities; Iowa State University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Martin Luther University Halle Wittenberg	Sullivan, LL (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.; Sullivan, LL (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	lsulliva@umn.edu	Harpole, William S/C-2814-2013	Harpole, William S/0000-0002-3404-9174	Iowa Living Roadway Trust Fund [90-00-LRTF-211, 90-00-LRTF-307]; Audubon Toyota TogetherGreen Fellowship; National Science Foundation GRFP; Iowa State University, Department of Ecology Evolution and Organismal Biology	Iowa Living Roadway Trust Fund; Audubon Toyota TogetherGreen Fellowship; National Science Foundation GRFP(National Science Foundation (NSF)); Iowa State University, Department of Ecology Evolution and Organismal Biology	Funding for this work was provided by the Iowa Living Roadway Trust Fund << http://www.iowadot.gov/lrtf/>> project numbers: 90-00-LRTF-211 and 90-00-LRTF-307, the Audubon Toyota TogetherGreen Fellowship << http://www.togethergreen.org/>>, the National Science Foundation GRFP << https://www.nsfgrfp.org/>>, and the Iowa State University, Department of Ecology Evolution and Organismal Biology << http://www.eeob.iastate.edu/>>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Baer SG, 2002, ECOL APPL, V12, P1688, DOI 10.1890/1051-0761(2002)012[1688:CIESAF]2.0.CO;2; Bolker B., 2014, BBMLE TOOLS GEN MAXI; Bolker B, 2008, ECOLOGICAL MODELS DA; BROWN VK, 1989, OIKOS, V54, P67, DOI 10.2307/3565898; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; Chang G, 2009, BEHAV PROCESS, V82, P7, DOI 10.1016/j.beproc.2009.03.002; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Comita LS, 2014, J ECOL, V102, P845, DOI 10.1111/1365-2745.12232; CONNELL J H, 1971, P298; Craven S.R., 1994, DAMAGE PREVENTION CO; Durham CA, 2004, J AGR RESOUR ECON, V29, P112; Elzinga JA, 2007, TRENDS ECOL EVOL, V22, P432, DOI 10.1016/j.tree.2007.05.006; Eskelinen A, 2008, J ECOL, V96, P155, DOI 10.1111/j.1365-2745.2007.01322.x; FENSTER CB, 1991, AM J BOT, V78, P13, DOI 10.2307/2445224; FENSTER CB, 1991, EVOLUTION, V45, P398, DOI 10.1111/j.1558-5646.1991.tb04413.x; Harper J. L., 1974, Annual Review of Ecology and Systematics, V5, P419, DOI 10.1146/annurev.es.05.110174.002223; Higgins SI, 2008, J ECOL, V96, P679, DOI 10.1111/j.1365-2745.2008.01391.x; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Honek A, 2011, BASIC APPL ECOL, V12, P89, DOI 10.1016/j.baae.2010.11.003; Howe HF, 2002, ECOL LETT, V5, P30, DOI 10.1046/j.1461-0248.2002.00276.x; Hulme PE, 1996, J ECOL, V84, P609, DOI 10.2307/2261482; Hyatt LA, 2003, OIKOS, V103, P590, DOI 10.1034/j.1600-0706.2003.12235.x; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Katul GG, 2005, AM NAT, V166, P368, DOI 10.1086/432589; Klein EK, 2013, METHODS ECOL EVOL, V4, P1059, DOI 10.1111/2041-210X.12110; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; LEE TD, 1982, ECOLOGY, V63, P1363, DOI 10.2307/1938864; Levine JM, 2003, ANNU REV ECOL EVOL S, V34, P549, DOI 10.1146/annurev.ecolsys.34.011802.132400; LOUDA SM, 1982, ECOL MONOGR, V52, P25, DOI 10.2307/2937343; Marazzi B., 2010, PREP FLORA N AM N ME; Maron JL, 1998, ECOLOGY, V79, P1281, DOI 10.1890/0012-9658(1998)079[1281:IHAABI]2.0.CO;2; Martin LM, 2005, J APPL ECOL, V42, P327, DOI 10.1111/j.1365-2664.2005.01019.x; MCCANNY SJ, 1985, OIKOS, V45, P148, DOI 10.2307/3565232; MURDOCH WW, 1966, AM NAT, V100, P219, DOI 10.1086/282415; Nathan R, 2004, J ECOL, V92, P733, DOI 10.1111/j.0022-0477.2004.00914.x; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Orrock JL, 2008, ECOLOGY, V89, P1168, DOI 10.1890/07-0223.1; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; Plummer M, 2014, RJAGS BAYESIAN GRAPH; Rios RS, 2008, OECOLOGIA, V156, P577, DOI 10.1007/s00442-008-1024-z; Rutter MT, 2004, EVOLUTION, V58, P2657, DOI 10.1111/j.0014-3820.2004.tb01619.x; Salmon T., 2010, VOLES MEADOW MICE; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; SCHUPP EW, 1995, ECOSCIENCE, V2, P267, DOI 10.1080/11956860.1995.11682293; Soons MB, 2004, ECOLOGY, V85, P3056, DOI 10.1890/03-0522; Teller BJ, 2014, ECOLOGY, V95, P2694, DOI 10.1890/14-0474.1; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; VANDERWALL SB, 1993, OECOLOGIA, V96, P246, DOI 10.1007/BF00317738; Vittoz P, 2007, BOT HELV, V117, P109, DOI 10.1007/s00035-007-0797-8	55	4	4	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147715	10.1371/journal.pone.0147715	http://dx.doi.org/10.1371/journal.pone.0147715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849564	gold, Green Published			2022-12-27	WOS:000369554000023
J	Talbert, EE; Smuder, AJ; Kwon, OS; Sollanek, KJ; Wiggs, MP; Powers, SK				Talbert, Erin E.; Smuder, Ashley J.; Kwon, Oh Sung; Sollanek, Kurt J.; Wiggs, Michael P.; Powers, Scott K.			Blockage of the Ryanodine Receptor via Azumolene Does Not Prevent Mechanical Ventilation-Induced Diaphragm Atrophy	PLOS ONE			English	Article							CALCIUM-RELEASE CHANNELS; SKELETAL-MUSCLE; SOLEUS MUSCLE; CONTRACTILE PROPERTIES; DISUSE ATROPHY; DYSFUNCTION; CA2+; WEAKNESS; RATS; MITOCHONDRIA	Mechanical ventilation (MV) is a life-saving intervention for patients in respiratory failure. However, prolonged MV causes the rapid development of diaphragm muscle atrophy, and diaphragmatic weakness may contribute to difficult weaning from MV. Therefore, developing a therapeutic countermeasure to protect against MV-induced diaphragmatic atrophy is important. MV-induced diaphragm atrophy is due, at least in part, to increased production of reactive oxygen species (ROS) from diaphragm mitochondria and the activation of key muscle proteases (i.e., calpain and caspase-3). In this regard, leakage of calcium through the ryanodine receptor (RyR1) in diaphragm muscle fibers during MV could result in increased mitochondrial ROS emission, protease activation, and diaphragm atrophy. Therefore, these experiments tested the hypothesis that a pharmacological blockade of the RyR1 in diaphragm fibers with azumolene (AZ) would prevent MV-induced increases in mitochondrial ROS production, protease activation, and diaphragmatic atrophy. Adult female Sprague-Dawley rats underwent 12 hours of full-support MV while receiving either AZ or vehicle. At the end of the experiment, mitochondrial ROS emission, protease activation, and fiber cross-sectional area were determined in diaphragm muscle fibers. Decreases in muscle force production following MV indicate that the diaphragm took up a sufficient quantity of AZ to block calcium release through the RyR1. However, our findings reveal that AZ treatment did not prevent the MV-induced increase in mitochondrial ROS emission or protease activation in the diaphragm. Importantly, AZ treatment did not prevent MV-induced diaphragm fiber atrophy. Thus, pharmacological inhibition of the RyR1 in diaphragm muscle fibers is not sufficient to prevent MV-induced diaphragm atrophy.	[Talbert, Erin E.; Smuder, Ashley J.; Kwon, Oh Sung; Sollanek, Kurt J.; Wiggs, Michael P.; Powers, Scott K.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA; [Kwon, Oh Sung] George E Wahlen Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT USA; [Kwon, Oh Sung] Univ Utah, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84112 USA; [Sollanek, Kurt J.] Sonoma State Univ, Dept Kinesiol, Rohnert Pk, CA 94928 USA; [Wiggs, Michael P.] Univ Texas Tyler, Dept Hlth & Kinesiol, Tyler, TX 75799 USA	State University System of Florida; University of Florida; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; California State University System; Sonoma State University; University of Texas System; University of Texas at Tyler	Talbert, EE (corresponding author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.; Talbert, EE (corresponding author), Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA.	erin.talbert@osumc.edu	Kwon, Oh Sung/AAL-4116-2021; Talbert, Erin/AAM-5535-2020	Talbert, Erin/0000-0003-4587-0950	American Heart Association [11PRE6520001]; National Institutes of Health [R01 HL087839, R21 AR064956]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR064956] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	These experiments were supported by American Heart Association (www.heart.org) Predoctoral Fellowship 11PRE6520001 to EETand National Institutes of Health (www.nih.gov) R01 HL087839 and R21 AR064956 to SKP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005; Andersson DC, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-9; Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Betters JL, 2004, AM J RESP CRIT CARE, V170, P1179, DOI 10.1164/rccm.200407-939OC; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Combes A, 2003, CRIT CARE MED, V31, P1373, DOI 10.1097/01.CCM.0000065188.87029.C3; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Feissner RF, 2009, FRONT BIOSCI-LANDMRK, V14, P1197, DOI 10.2741/3303; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Fischer DR, 2001, SHOCK, V15, P200, DOI 10.1097/00024382-200115030-00007; Fruen BR, 1997, J BIOL CHEM, V272, P26965, DOI 10.1074/jbc.272.43.26965; Gellerich FN, 2008, J BIOL CHEM, V283, P30715, DOI 10.1074/jbc.M709555200; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hussain SNA, 2010, AM J RESP CRIT CARE, V182, P1377, DOI 10.1164/rccm.201002-0234OC; Ingalls CP, 1999, J APPL PHYSIOL, V87, P386, DOI 10.1152/jappl.1999.87.1.386; Kachaeva EV, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/493618; Kandarian SC, 2002, EXERC SPORT SCI REV, V30, P111, DOI 10.1097/00003677-200207000-00004; Kavazis AN, 2009, FREE RADICAL BIO MED, V46, P842, DOI 10.1016/j.freeradbiomed.2009.01.002; LEBOURDELLES G, 1994, AM J RESP CRIT CARE, V149, P1539, DOI 10.1164/ajrccm.149.6.8004310; Lee I, 2002, MOL CELL BIOCHEM, V234, P63, DOI 10.1023/A:1015921513720; LESLIE GC, 1989, BRIT J PHARMACOL, V97, P1151, DOI 10.1111/j.1476-5381.1989.tb12573.x; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; McClung JM, 2007, AM J RESP CRIT CARE, V175, P150, DOI 10.1164/rccm.200601-142OC; Min K, 2015, J PHYSIOL-LONDON, V593, P2017, DOI 10.1113/jphysiol.2014.286518; Miwa S, 2003, BIOCHEM SOC T, V31, P1300; Nelson WB, 2012, CRIT CARE MED; Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003; Picard M, 2012, AM J RESPIR CRIT CAR; Powers SK, 2013, AM J PHYSIOL-REG I, V305, pR464, DOI 10.1152/ajpregu.00231.2013; Powers SK, 2011, CRIT CARE MED, V39, P1749, DOI 10.1097/CCM.0b013e3182190b62; Powers SK, 2002, J APPL PHYSIOL, V92, P1851, DOI 10.1152/japplphysiol.00881.2001; Schaffer S. W., 2007, MITOCHONDRIA DYNAMIC; SEGAL SS, 1986, AM J PHYSIOL, V250, pC474, DOI 10.1152/ajpcell.1986.250.3.C474; Shanely RA, 2002, AM J RESP CRIT CARE, V166, P1369, DOI 10.1164/rccm.200202-088OC; Smuder AJ, 2012, CRIT CARE MED, V40, P927, DOI 10.1097/CCM.0b013e3182374a84; Smuder AJ, 2012, J APPL PHYSIOL, V112, P501, DOI 10.1152/japplphysiol.01086.2011; Sudo RT, 2008, BASIC CLIN PHARMACOL, V102, P308, DOI 10.1111/j.1742-7843.2007.00156.x; Trouillet JL, 2009, J THORAC CARDIOV SUR, V138, P948, DOI 10.1016/j.jtcvs.2009.05.034; Wehrens XHT, 2005, P NATL ACAD SCI USA, V102, P9607, DOI 10.1073/pnas.0500353102; Whidden MA, 2010, J APPL PHYSIOL, V108, P1376, DOI 10.1152/japplphysiol.00098.2010; Zhang YF, 2005, J PHARMACOL EXP THER, V314, P94, DOI 10.1124/jpet.105.084046	42	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148161	10.1371/journal.pone.0148161	http://dx.doi.org/10.1371/journal.pone.0148161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849371	gold, Green Published			2022-12-27	WOS:000369554000045
J	Ulusoy, M; Sipahi, R				Ulusoy, Melda; Sipahi, Rifat			Experimental Evaluation of a Braille-Reading-Inspired Finger Motion Adaptive Algorithm	PLOS ONE			English	Article							DISPLAYS	Braille reading is a complex process involving intricate finger-motion patterns and finger-rubbing actions across Braille letters for the stimulation of appropriate nerves. Although Braille reading is performed by smoothly moving the finger from left-to-right, research shows that even fluent reading requires right-to-left movements of the finger, known as "reversal". Reversals are crucial as they not only enhance stimulation of nerves for correctly reading the letters, but they also show one to re-read the letters that were missed in the first pass. Moreover, it is known that reversals can be performed as often as in every sentence and can start at any location in a sentence. Here, we report experimental results on the feasibility of an algorithm that can render a machine to automatically adapt to reversal gestures of one's finger. Through Braille-reading-analogous tasks, the algorithm is tested with thirty sighted subjects that volunteered in the study. We find that the finger motion adaptive algorithm (FMAA) is useful in achieving cooperation between human finger and the machine. In the presence of FMAA, subjects' performance metrics associated with the tasks have significantly improved as supported by statistical analysis. In light of these encouraging results, preliminary experiments are carried out with five blind subjects with the aim to put the algorithm to test. Results obtained from carefully designed experiments showed that subjects' Braille reading accuracy in the presence of FMAA was more favorable then when FMAA was turned off. Utilization of FMAA in future generation Braille reading devices thus holds strong promise.	[Ulusoy, Melda; Sipahi, Rifat] Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA	Northeastern University	Sipahi, R (corresponding author), Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA.	rifat@coe.neu.edu		Sipahi, Rifat/0000-0001-9307-5324	NSF (US) [0921360]; National Science Foundation [0921360]	NSF (US)(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	The theme of this paper was inspired by the authors' previous (now expired) grant under NSF (US) (http://www.nsf.gov/awardsearch/showAward?AWD_ID=0921360). The work was performed after grant expiration.; This study was inspired from authors previous research supported by National Science Foundation Award no. 0921360. Authors gratefully acknowledge all volunteers that participated in the study, and are gratefully with National Braille Press (88 St. Stephen Street, Boston 02115) for their welcoming of collaborations. Some parts of this study are under intellectual property protection at Northeastern University University (INV-16001 Provisional. Inventors: Rifat Sipahi & Melda Ulusoy). Authors have no further declarations.	American Foundation of the Blind. Estimated Number of Adult Braille Readers in the United States, 1996, J VISUAL IMPAIRMENT, V90, P287; [Anonymous], PSYCHONOMIC B REV, V22; Antle AN, P 5 INT C TANG EMB E; Aranyanak I, 2013, BEHAV RES METHODS, V45, P216, DOI 10.3758/s13428-012-0235-8; BALINT L, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON SYSTEMS, MAN AND CYBERNETICS, VOLS 1-5, P292, DOI 10.1109/ICSMC.1995.537774; Bar-Cohen Y, 2009, SPIE NEWSROOM, V11; Bertelson P, 1995, LANGUAGE TOUCH CASE, P91; Cassidy J, 2014, BBC NEWS; Cho HC, 2006, 2006 SICE-ICASE INTERNATIONAL JOINT CONFERENCE, VOLS 1-13, P1909; Davies M., 2008, CORPUS CONT AM ENGLI; Drewes H, P 4 INT C MOB TECHN; Erin J, 2004, J VISUAL IMPAIRMENT, V98; Eui Chul L, KSII T INTERNET INFO, V7, P834; Fricke J., 1994, Computers for Handicapped Persons. 4th International Conference, ICCHP '94 Proceedings, P461; Fricke J., 1997, IEE C DEV TACT DISPL; Hable R, 2013, INT C MOB BUS ICMB, P18; Hughes B, 2014, SCI STUD READ, V18, P94, DOI 10.1080/10888438.2013.802203; Hughes B, 2011, HUM MOVEMENT SCI, V30, P711, DOI 10.1016/j.humov.2010.05.005; Kane Shaun K, 2008, P 10 INT ACM SIGACCE, P73, DOI DOI 10.1145/1414471.1414487; Kato Y, 2007, IEEE T ELECTRON DEV, V54, P202, DOI 10.1109/TED.2006.888678; Kawaguchi Yoshihisa, 2010, Proceedings of the SICE 2010 - 49th Annual Conference of the Society of Instrument and Control Engineers of Japan, P379; Kwon HJ, 2009, SENSOR ACTUAT A-PHYS, V154, P238, DOI 10.1016/j.sna.2008.10.002; Laver K, 2012, PRESENCE-TELEOP VIRT, V21, P183, DOI 10.1162/PRES_a_00098; Lee EC, 2009, OPT ENG, V48, DOI 10.1117/1.3158992; Legge GE., 1999, VIS IMPAIR RES, V1, P131, DOI [10.1076/vimr.1.3.131.4438, DOI 10.1076/VIMR.1.3.131.4438]; Leung R, 2007, ICMI'07: PROCEEDINGS OF THE NINTH INTERNATIONAL CONFERENCE ON MULTIMODAL INTERFACES, P374; Levesque V., 2005, ACM T APPL PERCEPTIO, V2, P132, DOI [10.1145/1060581.1060587, DOI 10.1145/1060581.1060587]; Levesque V, 2007, WORLD HAPTICS 2007: SECOND JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P115; Linjama J, P 3 NORD C HUM COMP; Matsushima F, 2014, COMMUN COMPUT PHYS, V435, P361, DOI DOI 10.1007/978-3-319-07854-0; Matysek M., 2009, P SOC PHOTO-OPT INS, V7287, DOI DOI 10.1117/12.819217; Nicol Heather N, 2013, ASSETS 13, P1, DOI 10.1017/S0032247412000666; NORCIO AF, 1989, IEEE T SYST MAN CYB, V19, P399, DOI 10.1109/21.31042; Quenqua Douglas, 2014, NY TIMES; Ramstein C., 1996, ASSETS '96. The Second Annual ACM Conference on Assistive Technologies, P37, DOI 10.1145/228347.228355; Ren KL, 2008, SENSOR ACTUAT A-PHYS, V143, P335, DOI 10.1016/j.sna.2007.10.083; Roberts J W, 2004, US Patent, Patent No. [6,776,619B1, 6776619, 6,776,619]; Roberts John, 2000, SID S, V31, P1130, DOI DOI 10.1889/1.1832864; Runyan NH, 2011, P SOC PHOTO-OPT INS; Russomanno A, 2015, IEEE T HAPTICS, P1; Schiff W., 1982, TACTUAL PERCEPTION S, P7; Syed F, 2015, NEW ENGL J MED, V372, P1377, DOI 10.1056/NEJMc1414481; TEIGEN KH, 1994, THEOR PSYCHOL, V4, P525, DOI 10.1177/0959354394044004; Ulusoy M, 2015, FINGER MOTION ADAPTI; Ulusoy M, 2015, THESIS NE U; Ulusoy M, 2014, IEEE HAPTICS SYM, P431, DOI 10.1109/HAPTICS.2014.6775494; Vidal-Verdu F, 2007, IEEE T NEUR SYS REH, V15, P119, DOI 10.1109/TNSRE.2007.891375	47	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148356	10.1371/journal.pone.0148356	http://dx.doi.org/10.1371/journal.pone.0148356			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849058	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000078
J	Chen, JL; Gao, JL; Yuan, F				Chen, Jianglong; Gao, Jinlong; Yuan, Feng			Growth Type and Functional Trajectories: An Empirical Study of Urban Expansion in Nanjing, China	PLOS ONE			English	Article							LAND-USE CHANGE; YANGTZE-RIVER DELTA; ENVIRONMENTAL-CHANGE; ECONOMIC TRANSITION; METROPOLITAN-AREA; DRIVING FORCES; HANGZHOU; DYNAMICS; PATTERNS; CITIES	Drawing upon the Landsat satellite images of Nanjing from 1985, 1995, 2001, 2007, and 2013, this paper integrates the convex hull analysis and common edge analysis at double scales, and develops a comprehensive matrix analysis to distinguish the different types of urban land expansion. The results show that Nanjing experienced rapid urban expansion, dominated by a mix of residential and manufacturing land from 1985 to 2013, which in turn has promoted Nanjing's shift from a compact mononuclear city to a polycentric one. Spatial patterns of three specific types of growth, namely infilling, extension, and enclave were quite different in four consecutive periods. These patterns result primarily from the existing topographic constraints, as well as government-oriented urban planning and policies. By intersecting the function maps, we also reveal the functional evolution of newly-developed urban land. Moreover, both self-enhancing and mutual promotion of the newly developed functions are surveyed over the last decade. Our study confirms that the integration of a multi-scale method and multi-perspective analysis, such as the spatiotemporal patterns and functional evolution, helps us to better understand the rapid urban growth in China.	[Chen, Jianglong; Gao, Jinlong; Yuan, Feng] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Key Lab Watershed Geog Sci, Nanjing 210008, Jiangsu, Peoples R China; [Gao, Jinlong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, JL (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, Key Lab Watershed Geog Sci, Nanjing 210008, Jiangsu, Peoples R China.; Gao, JL (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	jlgao@niglas.ac.cn	Gao, Jinlong/H-6609-2015	Gao, Jinlong/0000-0001-9910-3621	National Natural Science Foundation of China [70873120, 41130750]; Ford Foundation of the USA [0155-0883]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ford Foundation of the USA	The authors would acknowledge the financial support of the National Natural Science Foundation of China (70873120 and 41130750) and the Ford Foundation of the USA (0155-0883). The funders contributed to study design and data collection.	Angel S, 2011, PROG PLANN, V75, P53, DOI 10.1016/j.progress.2011.04.001; Auch RF, 2012, GEOGR REV, V102, P53, DOI 10.1111/j.1931-0846.2012.00130.x; Bai XM, 2014, NATURE, V509, P158, DOI 10.1038/509158a; Batisani N, 2009, APPL GEOGR, V29, P235, DOI 10.1016/j.apgeog.2008.08.007; BATTY M, 1995, NATURE, V377, P574, DOI 10.1038/377574a0; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Bloom DE, 2008, SCIENCE, V319, P772, DOI 10.1126/science.1153057; Chen H, 2015, SUSTAINABILITY-BASEL, V7, P5682, DOI 10.3390/su7055682; Cheng HQ, 2003, LANDSCAPE URBAN PLAN, V62, P199; Cui C, 2015, ENVIRON PLANN A, V47, P625, DOI 10.1068/a140079p; Ding CR, 2011, CHIN ECON, V44, P46, DOI 10.2753/CES1097-1475440104; Feng JA, 2010, ENVIRON PLANN B, V37, P838, DOI 10.1068/b35078; Feng JX, 2014, TIJDSCHR ECON SOC GE, V105, P315, DOI 10.1111/tesg.12068; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Gao JL, 2015, SUSTAINABILITY-BASEL, V7, P10281, DOI 10.3390/su70810281; [高金龙 Gao Jinlong], 2014, [地理研究, Geographical Research], V33, P1892; Gao JL, 2014, HABITAT INT, V44, P461, DOI 10.1016/j.habitatint.2014.09.002; He CY, 2006, APPL GEOGR, V26, P323, DOI 10.1016/j.apgeog.2006.09.006; Huston S, 2015, CITIES, V48, P66, DOI 10.1016/j.cities.2015.05.005; Lambin E. F., 2010, LAND USE LAND COVER; Li H, 2015, APPL GEOGR, V56, P177, DOI 10.1016/j.apgeog.2014.11.029; Liao FHF, 2014, STOCH ENV RES RISK A, V28, P801, DOI 10.1007/s00477-012-0620-y; [刘纪远 Liu Jiyuan], 2003, [地理学报, Acta Geographica Sinica], V58, P885; Liu XP, 2010, LANDSCAPE ECOL, V25, P671, DOI 10.1007/s10980-010-9454-5; Liu Y, 2011, ENVIRON PLANN B, V38, P706, DOI 10.1068/b37009; Luo J, 2009, LANDSCAPE URBAN PLAN, V91, P51, DOI 10.1016/j.landurbplan.2008.11.010; MAKSE HA, 1995, NATURE, V377, P608, DOI 10.1038/377608a0; Martellozzo F, 2011, ENVIRON PLANN B, V38, P1085, DOI 10.1068/b36090; Qian H, 2012, URBAN POLICY RES, V30, P403, DOI 10.1080/08111146.2012.737778; Qian Z, 2013, CITIES, V30, P77, DOI 10.1016/j.cities.2011.12.010; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Seto KC, 2012, P NATL ACAD SCI USA, V109, P7687, DOI 10.1073/pnas.1117622109; Seto KC, 2003, LAND ECON, V79, P106, DOI 10.2307/3147108; Shi YQ, 2012, LANDSCAPE URBAN PLAN, V105, P425, DOI 10.1016/j.landurbplan.2012.01.017; Sui DZ, 2001, LANDSCAPE URBAN PLAN, V53, P37, DOI 10.1016/S0169-2046(00)00136-5; Turner BL, 2007, P NATL ACAD SCI USA, V104, P20666, DOI 10.1073/pnas.0704119104; Verburg PH, 2004, ENVIRON PLANN B, V31, P125, DOI 10.1068/b307; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wei Y, 2014, LANDSCAPE URBAN PLAN, V128, P1, DOI 10.1016/j.landurbplan.2014.04.015; Wei YD, 2015, GEOGR REV, V105, P156, DOI 10.1111/j.1931-0846.2014.12063.x; Wei YD, 2014, STOCH ENV RES RISK A, V28, P757, DOI 10.1007/s00477-013-0840-9; Wu F, 1998, ENVIRON PLANN A, V30, P1077, DOI 10.1068/a301077; Wu KY, 2012, APPL GEOGR, V34, P137, DOI 10.1016/j.apgeog.2011.11.006; Wu WJ, 2015, LANDSCAPE URBAN PLAN, V134, P93, DOI 10.1016/j.landurbplan.2014.10.010; Xu C, 2007, LANDSCAPE ECOL, V22, P925, DOI 10.1007/s10980-007-9079-5; Yuan F, 2016, CITIES, V50, P82, DOI 10.1016/j.cities.2015.08.015; Yue WZ, 2010, ENVIRON PLANN A, V42, P563, DOI 10.1068/a42116; Zhang JX, 2006, REG STUD, V40, P3, DOI 10.1080/00343400500449085; Zheng HW, 2014, HABITAT INT, V41, P272, DOI 10.1016/j.habitatint.2013.08.006	50	19	22	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148389	10.1371/journal.pone.0148389	http://dx.doi.org/10.1371/journal.pone.0148389			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PF	26845155	Green Published, Green Submitted, gold			2022-12-27	WOS:000369552800053
J	Li, Y; Cai, XJ; Guan, YQ; Wang, L; Wang, SY; Li, YY; Fu, Y; Gao, XY; Su, GH				Li, Ying; Cai, Xiaojun; Guan, Yuqing; Wang, Lei; Wang, Shuya; Li, Yueyan; Fu, Ying; Gao, Xiaoyuan; Su, Guohai			Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; PROTEIN-KINASE; MYOCARDIAL FIBROSIS; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; GLOBULAR DOMAIN; ANGIOTENSIN; MICRORNA-133A; EXPRESSION; INHIBITION	Adiponectin and miR-133a are key regulators in cardiac hypertrophy. However, whether APN has a potential effect on miR-133a remains unclear. In this study, we aimed to investigate whether APN could regulate miR-133a expression in Angiotensin II (Ang II) induced cardiac hypertrophy in vivo and in vitro. Lentiviral-mediated adiponectin treatment attenuated cardiac hypertrophy induced by Ang II infusion in male wistar rats as determined by reduced cell surface area and mRNA levels of atrial natriuretic peptide (ANF) and brain natriuretic peptide (BNP), also the reduced left ventricular end-diastolic posterior wall thickness (LVPWd) and end-diastolic interventricular septal thickness (IVSd). Meanwhile, APN elevated miR-133a level which was downregulated by Ang II. To further investigate the underlying molecular mechanisms, we treated neonatal rat ventricular myocytes (NRVMs) with recombinant rat APN before Ang II stimulation. Pretreating cells with recombinant APN promoted AMP-activated protein kinase (AMPK) phosphorylation and inhibited ERK activation. By using the inhibitor of AMPK or a lentiviral vector expressing AMPK short hairpin RNA (shRNA) cancelled the positive effect of APN on miR-133a. The ERK inhibitor PD98059 reversed the downregulation of miR-133a induced by Ang II. These results indicated that the AMPK activation and ERK inhibition were responsible for the positive effect of APN on miR-133a. Furthermore, adiponectin receptor 1 (AdipoR1) mRNA expression was inhibited by Ang II stimulation. The positive effects of APN on AMPK activation and miR-133a, and the inhibitory effect on ERK phosphorylation were inhibited in NRVMs transfected with lentiviral AdipoR1shRNA. In addition, APN depressed the elevated expression of connective tissue growth factor (CTGF), a direct target of miR-133a, through the AMPK pathway. Taken together, our data indicated that APN reversed miR-133a levels through AMPK activation, reduced ERK1/2 phosphorylation in cardiomyocytes stimulated with Ang II, revealing a previously undemonstrated and important link between APN and miR-133a.	[Li, Ying; Cai, Xiaojun; Guan, Yuqing; Wang, Lei; Li, Yueyan; Gao, Xiaoyuan; Su, Guohai] Shandong Univ, Dept Cardiol, Jinan Cent Hosp, Jinan 250100, Peoples R China; [Li, Ying] Shandong Univ, Jinan Cent Hosp, Cent Lab, Jinan 250100, Peoples R China; [Wang, Shuya; Fu, Ying] Shandong Univ, Sch Med, Jinan 250100, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Su, GH (corresponding author), Shandong Univ, Dept Cardiol, Jinan Cent Hosp, Jinan 250100, Peoples R China.	guohaisu0531@126.com	wang, shuya/AHD-2495-2022; Li, Ying/GYU-4167-2022	wang, shuya/0000-0002-9360-9194; Li, Ying/0000-0002-4286-876X	National Natural Science Foundation of China [81170087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (No. 81170087), http://www.nsfc.gov.cn/. G Su received the funding.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Amin RH, 2010, AM J PHYSIOL-HEART C, V299, pH690, DOI 10.1152/ajpheart.01032.2009; Cao TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103793; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Castoldi G, 2012, J CELL PHYSIOL, V227, P850, DOI 10.1002/jcp.22939; Chang JL, 2010, DIABETES, V59, P2949, DOI 10.2337/db10-0582; Chen TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118909; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Drawnel FM, 2012, J CELL BIOL, V199, P783, DOI 10.1083/jcb.201111095; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Essick EE, 2011, AM J PHYSIOL-HEART C, V301, pH984, DOI 10.1152/ajpheart.00428.2011; Fang F, 2013, AM J PHYSIOL-RENAL, V304, pF1366, DOI 10.1152/ajprenal.00137.2012; Feng Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.462; Fujita K, 2008, ARTERIOSCL THROM VAS, V28, P863, DOI 10.1161/ATVBAHA.107.156687; Koitabashi N, 2007, HYPERTENSION, V49, P1120, DOI 10.1161/HYPERTENSIONAHA.106.077537; Konishi M, 2011, CARDIOVASC RES, V89, P309, DOI 10.1093/cvr/cvq335; Koutsoulidou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125341; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Lee YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070246; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CB, 2009, J CELL MOL MED, V13, P4444, DOI 10.1111/j.1582-4934.2008.00484.x; Li GM, 2006, J GENE MED, V8, P889, DOI 10.1002/jgm.894; Li HB, 2015, FREE RADICAL BIO MED, V84, P311, DOI 10.1016/j.freeradbiomed.2015.03.007; Li L, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1155/2013/467245; Li Y, 2013, ACTA PHARMACOL SIN, V34, P960, DOI 10.1038/aps.2013.19; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Liu YL, 2015, CARDIORENAL MED, V5, P79, DOI 10.1159/000371454; Luo J, 2014, ONCOL LETT, V7, P1043, DOI 10.3892/ol.2014.1841; Luo XB, 2010, CELL PHYSIOL BIOCHEM, V25, P571, DOI 10.1159/000315076; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; McCollum LT, 2012, AM J PHYSIOL-HEART C, V302, pH801, DOI 10.1152/ajpheart.00908.2011; Morikawa H, 2007, MOL MED, V13, P240, DOI 10.2119/2006-00093.Morikawa; Myers R, 2015, CIRC-ARRHYTHMIA ELEC, V8, P942, DOI 10.1161/CIRCEP.114.002162; Okamoto Y, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/313179; Ouchi N, 2003, HYPERTENSION, V42, P231, DOI 10.1161/01.HYP.0000083488.67550.B8; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2006, TRENDS CARDIOVAS MED, V16, P141, DOI 10.1016/j.tcm.2006.03.001; Rosin NL, 2013, AM J PATHOL, V182, P714, DOI 10.1016/j.ajpath.2012.11.014; Sang HQ, 2015, BIOMED PHARMACOTHER, V71, P185, DOI 10.1016/j.biopha.2015.02.030; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Sriramula S, 2008, HYPERTENSION, V51, P1345, DOI 10.1161/HYPERTENSIONAHA.107.102152; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Wang B, 2008, J MOL CELL CARDIOL, V45, P193, DOI 10.1016/j.yjmcc.2008.05.005; Wang J, 2012, CELL MOL LIFE SCI, V69, P3561, DOI 10.1007/s00018-012-1126-y; Wen P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103079; Wu XD, 2003, DIABETES, V52, P1355, DOI 10.2337/diabetes.52.6.1355; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yin XS, 2013, MOL CELL BIOCHEM, V379, P1, DOI 10.1007/s11010-012-1552-z; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhong L, 2015, CARDIOVASC RES, V106, P261, DOI 10.1093/cvr/cvv108	51	22	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148482	10.1371/journal.pone.0148482	http://dx.doi.org/10.1371/journal.pone.0148482			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845040	Green Published, gold, Green Submitted			2022-12-27	WOS:000369552800062
J	Mariotti-Ferrandiz, E; Pham, HP; Dulauroy, S; Gorgette, O; Klatzmann, D; Cazenave, PA; Pied, S; Six, A				Mariotti-Ferrandiz, Encarnita; Pham, Hang-Phuong; Dulauroy, Sophie; Gorgette, Olivier; Klatzmann, David; Cazenave, Pierre-Andre; Pied, Sylviane; Six, Adrien			A TCR beta Repertoire Signature Can Predict Experimental Cerebral Malaria	PLOS ONE			English	Article							CD8(+) T-CELLS; PLASMODIUM-FALCIPARUM; CONTINUOUS CULTURES; MITOGENIC ACTIVITY; MURINE MALARIA; PATHOGENESIS; GENES; ALPHA; MICE; SEQUESTRATION	Cerebral Malaria (CM) is associated with a pathogenic T cell response. Mice infected by P. berghei ANKA clone 1.49 (PbA) developing CM(CM+) present an altered PBL TCR repertoire, partly due to recurrently expanded T cell clones, as compared to non-infected and CM- infected mice. To analyse the relationship between repertoire alteration and CM, we performed a kinetic analysis of the TRBV repertoire during the course of the infection until CM-related death in PbA-infected mice. The repertoires of PBL, splenocytes and brain lymphocytes were compared between infected and non-infected mice using a high-throughput CDR3 spectratyping method. We observed a modification of the whole TCR repertoire in the spleen and blood of infected mice, from the fifth and the sixth day post-infection, respectively, while only three TRBV were significantly perturbed in the brain of infected mice. Using multivariate analysis and statistical modelling, we identified a unique TCR beta signature discriminating CM+ from CTR mice, enriched during the course of the infection in the spleen and the blood and predicting CM onset. These results highlight a dynamic modification and compartmentalization of the TCR diversity during the course of PbA infection, and provide a novel method to identify disease-associated TCR beta signature as diagnostic and prognostic biomarkers.	[Mariotti-Ferrandiz, Encarnita; Dulauroy, Sophie; Gorgette, Olivier; Cazenave, Pierre-Andre; Pied, Sylviane; Six, Adrien] Univ Paris 06, CNRS, Sorbonne Univ, URA 1961, F-75005 Paris, France; [Mariotti-Ferrandiz, Encarnita; Dulauroy, Sophie; Gorgette, Olivier; Cazenave, Pierre-Andre; Pied, Sylviane; Six, Adrien] CNRS, URA 1961, F-75005 Paris, France; [Mariotti-Ferrandiz, Encarnita; Dulauroy, Sophie; Gorgette, Olivier; Cazenave, Pierre-Andre; Pied, Sylviane; Six, Adrien] Inst Pasteur, Immunophysiopathol Infect, F-75015 Paris, France; [Mariotti-Ferrandiz, Encarnita; Pham, Hang-Phuong; Klatzmann, David; Six, Adrien] Univ Paris 06, Sorbonne Univ, UMR 7211, UPMC Immunol Immunopathol Immunotherapy, F-75013 Paris, France; [Mariotti-Ferrandiz, Encarnita; Pham, Hang-Phuong; Klatzmann, David; Six, Adrien] INSERM, U959, Immunol Immunopathol Immunotherapy, F-75013 Paris, France; [Pham, Hang-Phuong] Hop La Pitie Salpetriere, iPEPS ICM, ILTOO Pharma, F-75013 Paris, France; [Dulauroy, Sophie] Inst Pasteur, CNRS, URA 1961, Dev Tissus Lymphoides, F-75015 Paris, France; [Gorgette, Olivier] Inst Pasteur, Plate Forme Microscopie Ultrastruct, F-75015 Paris, France; [Cazenave, Pierre-Andre; Pied, Sylviane] Univ Lille 2, Inst Pasteur Lille, INSERM 1019, CIIL,CNRS 8204, F-59000 Lille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Six, A (corresponding author), Univ Paris 06, CNRS, Sorbonne Univ, URA 1961, F-75005 Paris, France.; Six, A (corresponding author), Inst Pasteur, Immunophysiopathol Infect, F-75015 Paris, France.; Six, A (corresponding author), Univ Paris 06, Sorbonne Univ, UMR 7211, UPMC Immunol Immunopathol Immunotherapy, F-75013 Paris, France.; Six, A (corresponding author), INSERM, U959, Immunol Immunopathol Immunotherapy, F-75013 Paris, France.	adrien.six@upmc.fr	Mariotti-Ferrandiz, Encarnita/O-3262-2019	Mariotti-Ferrandiz, Encarnita/0000-0002-8770-0186; Klatzmann, David/0000-0002-0054-3422; Pied, Sylviane/0000-0003-0642-1423; Six, Adrien/0000-0001-5898-555X; PHAM, Hang-Phuong/0000-0002-7896-7401; Cazenave, Pierre-Andre/0000-0002-1345-8526	Assistance Publique-Hopitaux de Paris; Universite Pierre and Marie Curie (Paris VI); LabEx Transimmunom [ANR-11-IDEX-0004-02]; LabEx Parafrap [ANR-11-LABX-0024]; LIA CNRS DBT SIGID ("Systems Immunology and genetics of infectious diseases"); Ministere de la Recherche et de la Technologie; Fondation de France; Institut Pasteur	Assistance Publique-Hopitaux de Paris; Universite Pierre and Marie Curie (Paris VI); LabEx Transimmunom; LabEx Parafrap; LIA CNRS DBT SIGID ("Systems Immunology and genetics of infectious diseases"); Ministere de la Recherche et de la Technologie; Fondation de France(Fondation de France); Institut Pasteur(European Commission)	This work has been funded by Assistance Publique-Hopitaux de Paris, Universite Pierre and Marie Curie (Paris VI), LabEx Transimmunom (ANR-11-IDEX-0004-02), LabEx Parafrap (ANR-11-LABX-0024) and LIA CNRS DBT SIGID ("Systems Immunology and genetics of infectious diseases"). EMF & HPP have been supported by a doctoral fellowship from Ministere de la Recherche et de la Technologie, as well as by Fondation de France and Institut Pasteur for EMF.	Bagot S, 2004, INFECT IMMUN, V72, P2817, DOI 10.1128/IAI.72.5.2817-2826.2004; BALLET JJ, 1981, INFECT IMMUN, V33, P758, DOI 10.1128/IAI.33.3.758-762.1981; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERENDT AR, 1994, PARASITOL TODAY, V10, P412, DOI 10.1016/0169-4758(94)90238-0; Boubou MI, 1999, INT IMMUNOL, V11, P1553, DOI 10.1093/intimm/11.9.1553; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CHOU HS, 1987, P NATL ACAD SCI USA, V84, P1992, DOI 10.1073/pnas.84.7.1992; Collette A, 2004, J IMMUNOL, V173, P4568, DOI 10.4049/jimmunol.173.7.4568; Collette A, 2003, J IMMUNOL METHODS, V278, P105, DOI 10.1016/S0022-1759(03)00225-4; Collette A, 2002, BIOINFORMATICS, V18, P329, DOI 10.1093/bioinformatics/18.2.329; CURFS JHAJ, 1989, CLIN EXP IMMUNOL, V75, P136; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; FINLEY RW, 1982, J IMMUNOL, V129, P2213; GABRIELSEN AA, 1982, AM J TROP MED HYG, V31, P441, DOI 10.4269/ajtmh.1982.31.441; Gorgette O, 2002, INFECT IMMUN, V70, P3701, DOI 10.1128/IAI.70.7.3701-3706.2002; Gorochov G, 1998, NAT MED, V4, P215, DOI 10.1038/nm0298-215; GRAU GE, 1986, J IMMUNOL, V137, P2348; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; GRAU GE, 1987, IMMUNOLOGY, V61, P521; Guiyedi V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000389; Han M, 1999, J IMMUNOL, V163, P301; Heitjan DF, 1991, APPL STAT, V40, P1329; Hermsen C, 1997, PARASITOLOGY, V114, P7, DOI 10.1017/S0031182096008293; Howland SW, 2013, EMBO MOL MED, V5, P984, DOI 10.1002/emmm.201202273; Lau LS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004135; Lefranc MP, 2007, IMMUNOGENETICS, V59, P899, DOI 10.1007/s00251-007-0260-4; LOUIE MC, 1989, J EXP MED, V170, P1987, DOI 10.1084/jem.170.6.1987; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Miyakoda M, 2008, J IMMUNOL; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Pied S, 1997, INT IMMUNOL, V9, P17, DOI 10.1093/intimm/9.1.17; Poh CM, 2014, INFECT IMMUN, V82, P4854, DOI 10.1128/IAI.02180-14; Renia L, 2006, INT J PARASITOL, V36, P547, DOI 10.1016/j.ijpara.2006.02.007; Rubin DB, 2004, MULTIPLE IMPUTATION; Schenker N, 1996, COMPUT STAT DATA AN, V22, P425, DOI 10.1016/0167-9473(95)00057-7; Shimodaira H, 2004, ANN STAT, V32, P2616, DOI 10.1214/009053604000000823; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Buuren S, 2011, J STAT SOFTW, V45, P1; WADE T, 1988, J IMMUNOL, V141, P2165; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Yanez DM, 1996, J IMMUNOL, V157, P1620; Zinocker S, 2015, J IMMUNOL, V194, P929, DOI 10.4049/jimmunol.1402168	45	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0147871	10.1371/journal.pone.0147871	http://dx.doi.org/10.1371/journal.pone.0147871			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844551	Green Submitted, Green Published, gold			2022-12-27	WOS:000369552800019
J	Guerrieri, E; Giorgini, M; Cascone, P; Carpenito, S; van Achterberg, C				Guerrieri, Emilio; Giorgini, Massimo; Cascone, Pasquale; Carpenito, Simona; van Achterberg, Cees			Species Diversity in the Parasitoid Genus Asobara (Hymenoptera: Braconidae) from the Native Area of the Fruit Fly Pest Drosophila suzukii (Diptera: Drosophilidae)	PLOS ONE			English	Article							INVASION; DNA	Drosophila suzukii (Matsumura), commonly known as Spotted Wing Drosophila (SWD), is a worldwide serious economic threat to the production of berries and stone fruits. The chemical control widely used against this pest is often not able to preventing yield losses because wild flora offers an abundance of fruits to D. suzukii where the pest is able to reproduce and from where it recolonizes neighbouring cultivated fields. Alternatively, within Integrated Pest Management protocols for D. suzukii, biological control could play a key role by reducing its populations particularly in non-cultivated habitats, thus increasing the effectiveness and reducing the side negative effects of other management strategies. Because of the scarcity and of the low efficiency of autochthonous parasitoids in the new invaded territories, in the last few years, a number of surveys started in the native area of D. suzukii to find parasitoid species to be evaluated in quarantine structures and eventually released in the field, following a classical biological control approach. This paper reports the results of these surveys carried out in South Korea and for the first time in China. Among the parasitoids collected, those belonging to the genus Asobara Foerster resulted dominant both by number and species diversity. By combining morphological characters and the mitochondrial COI gene as a molecular marker, we identified seven species of Asobara, of which two associated with D. suzukii, namely A. japonica and A leveri, and five new to science, namely Asobara brevicauda, A. elongata, A mesocauda, A unicolorata, A. triangulata. Our findings offer new opportunity to find effective parasitoids to be introduced in classical biological control programmes in the territories recently invaded by D. suzukii.	[Guerrieri, Emilio; Giorgini, Massimo; Cascone, Pasquale; Carpenito, Simona] Natl Res Council Italy, Inst Sustainable Plant Protect, Portici, Na, Italy; [van Achterberg, Cees] Nat Biodivers Ctr, NL-2300 RA Leiden, Netherlands; [Guerrieri, Emilio] Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England	Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR); Naturalis Biodiversity Center; Natural History Museum London	Guerrieri, E (corresponding author), Natl Res Council Italy, Inst Sustainable Plant Protect, Portici, Na, Italy.; Guerrieri, E (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	emilio.guerrieri@ipsp.cnr.it	Guerrieri, Emilio/ABB-7498-2020; GIORGINI, MASSIMO/AAX-3458-2020; Cascone, Pasquale/J-7992-2016	GIORGINI, MASSIMO/0000-0001-8670-0945; Cascone, Pasquale/0000-0002-4097-1974	PIRSES [318246]; FP7 project Ameliorating the Sustainable Control of Invasive Insects [PIRSES 318246]	PIRSES; FP7 project Ameliorating the Sustainable Control of Invasive Insects	PIRSES 318246 ASCII Ameliorating the sustainable control of invasive insects https://ec.europa.eu/research/participants/portal4/desktop/en/opportunities/fp7/calls/fp7-people-2012-irses.html vasive insects (2012).; This work has been supported by FP7 project Ameliorating the Sustainable Control of Invasive Insects (PIRSES 318246).	Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Chabert S, 2012, BIOL CONTROL, V63, P40, DOI 10.1016/j.biocontrol.2012.05.005; Cini A, 2014, J PEST SCI, V87, P559, DOI 10.1007/s10340-014-0617-z; Depra M, 2014, J PEST SCI, V87, P379, DOI 10.1007/s10340-014-0591-5; Fischer M., 1988, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V90, P93; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gabarra R, 2015, BIOCONTROL, V60, P331, DOI 10.1007/s10526-014-9646-z; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hernandez-Ortiz V, 2004, B ENTOMOL RES, V94, P487, DOI 10.1079/BER2004325; Kasuya N, 2013, APPL ENTOMOL ZOOL, V48, P87, DOI 10.1007/s13355-012-0156-0; Lasa Rodrigo, 2015, Florida Entomologist, V98, P987, DOI 10.1653/024.098.0332; Lee JC, 2015, ANN ENTOMOL SOC AM, V108, P117, DOI 10.1093/aesa/sau014; Mitsui H, 2007, J NAT HIST, V41, P1731, DOI 10.1080/00222930701504797; Nomano FY, 2015, J APPL ENTOMOL, V139, P105, DOI 10.1111/jen.12141; Novkovic B, 2011, ENTOMOL SCI, V14, P333, DOI 10.1111/j.1479-8298.2011.00459.x; NOYES JS, 1982, J NAT HIST, V16, P315, DOI 10.1080/00222938200770261; Ometto L, 2013, GENOME BIOL EVOL, V5, P745, DOI 10.1093/gbe/evt034; Polaszek A, 2004, ZOOL SCR, V33, P403, DOI 10.1111/j.0300-3256.2004.00161.x; Schulmeister S, 2002, CLADISTICS, V18, P455, DOI 10.1111/j.1096-0031.2002.tb00287.x; Stacconi M. V. Rossi, 2013, Entomologia, V1, P11, DOI 10.4081/entomologia.2013.e3; Stacconi MVR, 2015, BIOL CONTROL, V84, P28, DOI 10.1016/j.biocontrol.2015.02.003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Achterberg C., 1993, Zoologische Verhandelingen (Leiden), V283, P1; van Achterberg C, 1988, ZOOL VERH, V249, P1; Walsh DB, 2011, J INTEGRATE PEST MAN, V67, P1358; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wharton RA, 1980, U CALIFORNIA PUBLICA, V88, P1; Yu DSK, 2012, TAXAPAD 2012 ICHNEUM	31	39	42	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147382	10.1371/journal.pone.0147382	http://dx.doi.org/10.1371/journal.pone.0147382			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840953	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200036
J	Bailleul, AM; Scannella, JB; Horner, JR; Evans, DC				Bailleul, Alida M.; Scannella, John B.; Horner, John R.; Evans, David C.			Fusion Patterns in the Skulls of Modern Archosaurs Reveal That Sutures Are Ambiguous Maturity Indicators for the Dinosauria	PLOS ONE			English	Article							BITE-FORCE PERFORMANCE; CRANIOFACIAL ONTOGENY; CRANIAL SUTURES; TYRANNOSAURIDAE DINOSAURIA; AMERICAN ALLIGATORS; GROWTH; CLOSURE; ORNITHISCHIA; BONE; CERATOPSIDAE	The sutures of the skulls of vertebrates are generally open early in life and slowly close as maturity is attained. The assumption that all vertebrates follow this pattern of progressive sutural closure has been used to assess maturity in the fossil remains of non-avian dinosaurs. Here, we test this assumption in two members of the Extant Phylogenetic Bracket of the Dinosauria, the emu, Dromaius novaehollandiae and the American alligator, Alligator mississippiensis, by investigating the sequence and timing of sutural fusion in their skulls. As expected, almost all the sutures in the emu skull progressively close (i.e., they get narrower) and then obliterate during ontogeny. However, in the American alligator, only two sutures out of 36 obliterate completely and they do so during embryonic development. Surprisingly, as maturity progresses, many sutures of alligators become wider in large individuals compared to younger, smaller individuals. Histological and histomorphometric analyses on two sutures and one synchondrosis in an ontogenetic series of American alligator confirmed our morphological observations. This pattern of sutural widening might reflect feeding biomechanics and dietary changes through ontogeny. Our findings show that progressive sutural closure is not always observed in extant archosaurs, and therefore suggest that cranial sutural fusion is an ambiguous proxy for assessing maturity in non-avian dinosaurs.	[Bailleul, Alida M.; Scannella, John B.; Horner, John R.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Bailleul, Alida M.; Scannella, John B.; Horner, John R.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Evans, David C.] Univ Toronto, Royal Ontario Museum, Toronto, ON, Canada; [Evans, David C.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Bailleul, Alida M.] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Royal Ontario Museum; University of Toronto; University of Toronto; University of Missouri System; University of Missouri Columbia	Bailleul, AM (corresponding author), Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA.; Bailleul, AM (corresponding author), Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA.; Bailleul, AM (corresponding author), Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO USA.	bailleula@missouri.edu			M.A Fritz Travel grant; Evolving Earth Foundation; Jurassic Foundation; Geological Society of America; Sigma Xi; Paleontology Department at the MOR	M.A Fritz Travel grant; Evolving Earth Foundation; Jurassic Foundation; Geological Society of America; Sigma Xi; Paleontology Department at the MOR	Travel costs for AMB to the ROM were funded by the M.A Fritz Travel grant. This research was supported by grants from the Evolving Earth Foundation (http://www.evolvingearth.org/evolvingearthgrants/grantsmain.htm), the Jurassic Foundation, the Geological Society of America, and Sigma Xi (https://www.sigmaxi.org/programs/grants-in-aid) to AMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank D. Collins at Montana Emu Ranch for providing emu heads; M. Holland and P. Bannon for preparing emu skulls; K. Seymour at the Royal Ontario Museum (ROM) for his assistance; G. Hurlburt for providing information about the types of skeletonization for the ROM alligator specimens; C. Woodruff at the Museum of the Rockies for his help in skeletonization protocols; N. Atwood for figure compilation and discussions; R. Elsey for her insights and for providing alligator specimens; T. Carr for conversations regarding ontograms, and C. Holliday and K. Middleton for discussions. For various help with histology and specimen preparation, we thank B. Harmon, D. Laudier, E-T Lamm, H. Flora and J. Gardner. We greatly thank J. Cray (Editor) and A. Tavares and S. Herring (reviewers) for their helpful comments and for improving the quality of this manuscript. We also thank the Paleontology Department at the MOR and Gerry Orhstrom for support. Travel costs for AMB to the ROM were funded by the M. A Fritz Travel grant. This research was supported by grants from the Evolving Earth Foundation, the Jurassic Foundation, the Geological Society of America and Sigma Xi to AMB.	Barmann EV, 2012, J MAMM EVOL, V19, P43, DOI 10.1007/s10914-011-9176-8; Bakker R.T., 1988, HUNTERIA, V1, P1, DOI DOI 10.5281/ZEN0D0.1037529; BIEWENER AA, 1983, J EXP BIOL, V105, P147; Brochu C. A., 1992, ONTOGENY POSTCRANIUM; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brown B., 1940, Annals of the New York Academy of Sciences, V40, P133; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; CHABRECK RH, 1979, HERPETOLOGICA, V35, P51; Chinsamy-Turan A, 2001, ENCY LIFE SCI, P1; Chopra SRK, 1957, CRANIAL SUTURE CLOSU, P67; COHEN MM, 1993, AM J MED GENET, V47, P581, DOI 10.1002/ajmg.1320470507; Cole A, 2003, PALAEONTOLOGICAL ASS, V52, P29; Coombs W.P. Jr, 1990, P456; Curtis N, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0442; Davies SJJF., 2002, RATITES TINAMOUS TIN; DELANY MF, 1986, J WILDLIFE MANAGE, V50, P348, DOI 10.2307/3801926; DELANY MF, 1990, J HERPETOL, V24, P418, DOI 10.2307/1565063; DODSON P, 1975, J ZOOL, V175, P315; Dwight T., 1890, BOSTON MED SURG J, V122, P389, DOI DOI 10.1056/NEJM189004241221701; Erickson GM, 2004, J ZOOL, V262, P21, DOI 10.1017/S0952836903004400; Erickson GM, 2003, J ZOOL, V260, P317, DOI 10.1017/S0952836903003819; Evans DC, 2005, LIFE O PAST, P349; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frederickson JA, 2014, PEERJ, V2, DOI 10.7717/peerj.252; Gamer M, 2012, IRR VARIOUS COEFFICI; Goonewardene LA, 2003, J APPL POULTRY RES, V12, P27, DOI 10.1093/japr/12.1.27; Goswami A, 2013, J EVOLUTION BIOL, V26, P1294, DOI 10.1111/jeb.12127; Grzimek B., 2003, GRZIMEKS ANIMAL LIFE, V8; HERRING SW, 1972, ACTA ANAT, V83, P222; Herring SW, 2000, CRANIOSYNOSTOSIS, P3; Hershkovitz I, 1997, AM J PHYS ANTHROPOL, V103, P393, DOI 10.1002/(SICI)1096-8644(199707)103:3<393::AID-AJPA8>3.0.CO;2-R; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Horner JR, J ANATOMY; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; JASLOW CR, 1990, J BIOMECH, V23, P313, DOI 10.1016/0021-9290(90)90059-C; JASLOW CR, 1995, J ZOOL, V235, P193; JASLOW CR, 1989, ZOOL J LINN SOC-LOND, V95, P273, DOI 10.1111/j.1096-3642.1989.tb02312.x; Joanen T., 1987, WILDLIFE MANAGEMENT, P329; JOLLIE MALCOLM T., 1957, J MORPH, V100, P389, DOI 10.1002/jmor.1051000302; Knaup Britta, 2004, J Orofac Orthop, V65, P467, DOI 10.1007/s00056-004-0415-y; KOKICH V G, 1986, P81; Kopher RA, 2003, J BONE MINER RES, V18, P521, DOI 10.1359/jbmr.2003.18.3.521; Krogman WM, 1930, AM J ANAT, V46, P315, DOI 10.1002/aja.1000460206; Lamm ET, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P55; Landon DB, 1998, J WILDLIFE MANAGE, V62, P674, DOI 10.2307/3802343; Lee YN, 1996, J VERTEBR PALEONTOL, V16, P232, DOI 10.1080/02724634.1996.10011311; Longrich NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032623; Maddison WP, 2011, MESQUITE MODULAR SYS; Maisano JA, 2002, J VERTEBR PALEONTOL, V22, P268, DOI 10.1671/0272-4634(2002)022[0268:TFOSEA]2.0.CO;2; Mao JJ, 2002, J DENT RES, V81, P810, DOI 10.1177/154405910208101203; Mao JJ, 2005, CURR OPIN ORTHOP, V16, P331; Marieb EN, 2014, ESSENTIALS HUMAN ANA; Marshall C. L., 2000, EMBRYONIC GROWTH PAT; Mehrara BJ, 1999, PLAST RECONSTR SURG, V104, P1003, DOI 10.1097/00006534-199909040-00016; Minnaar M., 1992, EMU FARMERS HDB; Peptan AI, 2008, BONE, V42, P432, DOI 10.1016/j.bone.2007.05.014; PERSSON M, 1979, ARCH ORAL BIOL, V24, P283, DOI 10.1016/0003-9969(79)90090-6; PERSSON M, 1977, AM J ORTHOD DENTOFAC, V72, P42, DOI 10.1016/0002-9416(77)90123-3; PERSSON M, 1978, J ANAT, V125, P313; Rafferty KL, 2003, J MORPHOL, V257, P33, DOI 10.1002/jmor.10104; Rauhut OWM, 2004, CAN J EARTH SCI, V41, P1109, DOI 10.1139/E04-053; Rayfield EJ, 2005, ZOOL J LINN SOC-LOND, V144, P309, DOI 10.1111/j.1096-3642.2005.00176.x; Rayfield EJ, 2004, P ROY SOC B-BIOL SCI, V271, P1451, DOI 10.1098/rspb.2004.2755; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Ryan MJ, 2001, PALAIOS, V16, P482, DOI 10.2307/3515564; Sahni D, 2005, FORENSIC SCI INT, V148, P199, DOI 10.1016/j.forsciint.2004.06.002; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Schroeder Michael A., 2005, P303; Schweikher FP, 1930, AM J ANAT, V45, P443, DOI 10.1002/aja.1000450305; Sereno PC, 2009, SCIENCE, V326, P418, DOI 10.1126/science.1177428; Sullivan RM, 2003, J VERTEBR PALEONTOL, V23, P181, DOI 10.1671/0272-4634(2003)23[181:ROTDSL]2.0.CO;2; Sun ZY, 2004, ANAT REC PART A, V276A, P150, DOI 10.1002/ar.a.20002; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Todd TW, 1925, AM J PHYS ANTHROPOL, V8, P23, DOI 10.1002/ajpa.1330080103; Vij K, 2006, BONE, V38, P722, DOI 10.1016/j.bone.2005.10.028; Wilson LAB, 2009, J ANAT, V214, P339, DOI 10.1111/j.1469-7580.2008.01031.x; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Woodward A, 1992, EXPT ALLIGATOR HARVE; Woodward AR, 1995, J HERPETOL, V29, P507, DOI 10.2307/1564733; Woodward HN, 2015, PALEOBIOLOGY, V41, P503, DOI 10.1017/pab.2015.19; Woodward HN, 2011, J HERPETOL, V45, P339; Xu X, 2004, NATURE, V431, P838, DOI 10.1038/nature02898; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007	85	56	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147687	10.1371/journal.pone.0147687	http://dx.doi.org/10.1371/journal.pone.0147687			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862766	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600034
J	Cho, JH; Gao, JX				Cho, Jin-Hee; Gao, Jianxi			Cyber War Game in Temporal Networks	PLOS ONE			English	Article								In a cyber war game where a network is fully distributed and characterized by resource constraints and high dynamics, attackers or defenders often face a situation that may require optimal strategies to win the game with minimum effort. Given the system goal states of attackers and defenders, we study what strategies attackers or defenders can take to reach their respective system goal state (i.e., winning system state) with minimum resource consumption. However, due to the dynamics of a network caused by a node's mobility, failure or its resource depletion over time or action(s), this optimization problem becomes NP-complete. We propose two heuristic strategies in a greedy manner based on a node's two characteristics: resource level and influence based on k-hop reachability. We analyze complexity and optimality of each algorithm compared to optimal solutions for a small-scale static network. Further, we conduct a comprehensive experimental study for a large-scale temporal network to investigate best strategies, given a different environmental setting of network temporality and density. We demonstrate the performance of each strategy under various scenarios of attacker/defender strategies in terms of win probability, resource consumption, and system vulnerability.	[Cho, Jin-Hee] US Army Res Lab, Computat & Informat Sci Directorate, Adelphi, MD 20783 USA; [Gao, Jianxi] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Gao, Jianxi] Northeastern Univ, Dept Phys, Boston, MA 02115 USA	United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); Northeastern University; Northeastern University	Gao, JX (corresponding author), Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA.; Gao, JX (corresponding author), Northeastern Univ, Dept Phys, Boston, MA 02115 USA.	jianxi.gao@gmail.com	Gao, Jianxi/C-8494-2015; Gao, Jianxi/I-1300-2013	Gao, Jianxi/0000-0002-3952-208X; Gao, Jianxi/0000-0002-3952-208X	Army Research Laboratory via the Network Science Collaborative Technology Alliance (NS CTA) program [W911NF-09-2-0053]; John Templeton Foundation: Mathematical and Physical Sciences [PFI-777]; Defense Threat Reduction Agency Basic Research [HDTRA1-10-1-0100]; European Commission [FP7317532, 641191]; National Natural Science Foundation of China [61374160, 71201132]	Army Research Laboratory via the Network Science Collaborative Technology Alliance (NS CTA) program; John Templeton Foundation: Mathematical and Physical Sciences; Defense Threat Reduction Agency Basic Research(United States Department of DefenseDefense Threat Reduction Agency); European Commission(European CommissionEuropean Commission Joint Research Centre); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Research was, in part, for Dr. Jianxi Gao, sponsored by the Army Research Laboratory via the Network Science Collaborative Technology Alliance (NS CTA) program and was accomplished under Cooperative Agreement Number W911NF-09-2-0053. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Army Research Laboratory or the U.S. Government. Dr. Jianxi Gao also acknowledges the support of the John Templeton Foundation: Mathematical and Physical Sciences grant number PFI-777; The Defense Threat Reduction Agency Basic Research Grant No. HDTRA1-10-1-0100; European Commission grant numbers FP7317532 (MULTIPLEX) and 641191 (CIMPLEX); and the National Natural Science Foundation of China (Grants 61374160 and 71201132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Ben-Asher N, 2015, ADV INFORM SECUR, V56, P207, DOI 10.1007/978-3-319-14039-1_10; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brummitt CD, 2012, P NATL ACAD SCI USA, V109, pE680, DOI 10.1073/pnas.1110586109; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Bunde S A, 1996, FRACTALS DISORDERED; Cheng J, 2012, PVLDB; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Cohen R., 2010, COMPLEX NETWORKS STR; Gao JX, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062816; Gao JX, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066134; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Gao J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.092002; Gartner FC, 2003, IC200320 EPFL SCH CO; Gomez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Hu Peng, 2015, 2015 IEEE International Vacuum Electronics Conference (IVEC), P1, DOI 10.1109/IVEC.2015.7223874; JOHNSON DB, 1977, J ACM, V24, P1, DOI 10.1145/321992.321993; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Liu XM, 2015, CHAOS SOLITON FRACT, V80, P125, DOI 10.1016/j.chaos.2015.08.009; Mieghem PV, 2013, PHYS REV LETT, V110, P1; MUKHERJEE B, 1994, IEEE NETWORK, V8, P26, DOI 10.1109/65.283931; Neri FM, 2010, J ROYAL SOC INTERFAC; Newell A, 2013, P 43 ANN IEEE IFIP I, P1; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Parshani R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.048701; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Peng H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144153; Suweis S, 2013, NATURE, V500, P449, DOI 10.1038/nature12438; Valdez LD, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036108; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Zhang ZH, 2008, ARES 2008: PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON AVAILABILITY, SECURITY AND RELIABILITY, P352, DOI 10.1109/ARES.2008.75; Zhu MH, 2011, P AMER CONTR CONF, P4063	34	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148674	10.1371/journal.pone.0148674	http://dx.doi.org/10.1371/journal.pone.0148674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859840	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400063
J	Engelmann, F; Rivera, A; Park, B; Messerle-Forbes, M; Jensen, JT; Messaoudi, I				Engelmann, Flora; Rivera, Andrea; Park, Byung; Messerle-Forbes, Marci; Jensen, Jeffrey T.; Messaoudi, Ilhem			Impact of Estrogen Therapy on Lymphocyte Homeostasis and the Response to Seasonal Influenza Vaccine in Post-Menopausal Women	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; SYSTEMIC ANTIBODY-RESPONSES; BLOOD MONONUCLEAR-CELLS; TUMOR-NECROSIS-FACTOR; T-CELLS; TNF-ALPHA; IMMUNE-RESPONSES; IFN-GAMMA; RECEPTOR; INTERLEUKIN-6	It is widely recognized that changes in levels of ovarian steroids modulate severity of autoimmune disease and immune function in young adult women. These observations suggest that the loss of ovarian steroids associated with menopause could affect the age-related decline in immune function, known as immune senescence. Therefore, in this study, we determined the impact of menopause and estrogen therapy (ET) on lymphocyte subset frequency as well as the immune response to seasonal influenza vaccine in three different groups: 1) young adult women (regular menstrual cycles, not on hormonal contraception); 2) post-menopausal (at least 2 years) women who are not receiving any form of hormone therapy (HT) and 3) post-menopausal hysterectomized women receiving ET. Although the numbers of circulating CD4 and CD20 B cells were reduced in the post-menopausal group receiving ET, we also detected a better preservation of naive B cells, decreased CD4 T cell inflammatory cytokine production, and slightly lower circulating levels of the pro-inflammatory cytokine IL-6. Following vaccination, young adult women generated more robust antibody and T cell responses than both post-menopausal groups. Despite similar vaccine responses between the two post-menopausal groups, we observed a direct correlation between plasma 17 beta estradiol (E2) levels and fold increase in IgG titers within the ET group. These findings suggest that ET affects immune homeostasis and that higher plasma E2 levels may enhance humoral responses in post-menopausal women.	[Engelmann, Flora; Rivera, Andrea; Messaoudi, Ilhem] Univ Calif Riverside, Div Biomed Sci, Sch Med, Riverside, CA 92521 USA; [Park, Byung] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Div Biostat, Portland, OR 97201 USA; [Messerle-Forbes, Marci; Jensen, Jeffrey T.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Jensen, Jeffrey T.; Messaoudi, Ilhem] Oregon Natl Primate Res Ctr, Div Reprod Sci, Beaverton, OR USA; [Messaoudi, Ilhem] Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR USA	University of California System; University of California Riverside; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon National Primate Research Center	Messaoudi, I (corresponding author), Univ Calif Riverside, Div Biomed Sci, Sch Med, Riverside, CA 92521 USA.; Messaoudi, I (corresponding author), Oregon Natl Primate Res Ctr, Div Reprod Sci, Beaverton, OR USA.; Messaoudi, I (corresponding author), Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR USA.	messaoud@ucr.edu	Jensen, Jeffrey T/C-7421-2014	Jensen, Jeffrey T/0000-0002-4733-1224	Center for Gender Differences at OHSU; Leadership in Aging Research Fellowship from the Brookdale Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD085809] Funding Source: NIH RePORTER	Center for Gender Differences at OHSU; Leadership in Aging Research Fellowship from the Brookdale Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from the Center for Gender Differences at OHSU, and a Leadership in Aging Research Fellowship from the Brookdale Foundation.	Agematsu K, 2000, HISTOL HISTOPATHOL, V15, P573, DOI 10.14670/HH-15.573; Al-Harthi L, 2001, AIDS, V15, P1535, DOI 10.1097/00002030-200108170-00011; Al-Harthi L, 2000, J INTERF CYTOK RES, V20, P719, DOI 10.1089/10799900050116426; Angstwurm MWA, 1997, CYTOKINE, V9, P370, DOI 10.1006/cyto.1996.0178; Baeten JM, 2001, AM J OBSTET GYNECOL, V185, P380, DOI 10.1067/mob.2001.115862; Baeza I, 2010, J NEUROIMMUNOL, V219, P90, DOI 10.1016/j.jneuroim.2009.12.008; Baeza I, 2011, BIOGERONTOLOGY, V12, P227, DOI 10.1007/s10522-010-9317-0; Bluming AZ, 2009, CANCER J, V15, P93, DOI 10.1097/PPO.0b013e31819e332a; Brooks-Asplund EM, 2002, CYTOKINE, V19, P193, DOI 10.1006/cyto.2002.1963; Butts CL, 2007, INT IMMUNOL, V19, P287, DOI 10.1093/intimm/dxl145; Calder AE, 2011, NEUROIMMUNOMODULAT, V18, P281, DOI 10.1159/000329496; Calippe B, 2010, J IMMUNOL, V185, P1169, DOI 10.4049/jimmunol.0902383; CARLSTEN H, 1992, CELL IMMUNOL, V144, P190, DOI 10.1016/0008-8749(92)90236-I; Carroll ML, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-184; CLEMENTS ML, 1986, J CLIN MICROBIOL, V23, P66, DOI 10.1128/JCM.23.1.66-72.1986; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; De Martinis M, 2005, FEBS LETT, V579, P2035, DOI 10.1016/j.febslet.2005.02.055; Deguchi K, 2001, MENOPAUSE, V8, P266, DOI 10.1097/00042192-200107000-00008; Delpy L, 2005, J IMMUNOL, V175, P5050, DOI 10.4049/jimmunol.175.8.5050; Effros Rita B, 2005, Discov Med, V5, P293; Engelmann F, 2010, AGE DORDR; Evans MJ, 1997, CLIN IMMUNOL IMMUNOP, V82, P258, DOI 10.1006/clin.1996.4300; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franklin RD, 1999, J REPROD IMMUNOL, V42, P93, DOI 10.1016/S0165-0378(98)00086-2; Gameiro Catia, 2010, Front Biosci (Elite Ed), V2, P1299; Gameiro CM, 2010, MATURITAS, V67, P316, DOI 10.1016/j.maturitas.2010.08.003; GIGLIO T, 1994, LIFE SCI, V54, P1305, DOI 10.1016/0024-3205(94)00508-7; Giuliani N, 2001, EXP GERONTOL, V36, P547, DOI 10.1016/S0531-5565(00)00220-5; Hsu HC, 2006, MECH AGEING DEV, V127, P231, DOI 10.1016/j.mad.2005.10.001; Hughes GC, 2008, J IMMUNOL, V180, P2029, DOI 10.4049/jimmunol.180.4.2029; Jansen R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-33; Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5; Kanda N, 1999, J ALLERGY CLIN IMMUN, V103, P282, DOI 10.1016/S0091-6749(99)70503-8; Karpuzoglu E, 2009, CLIN REV ALLERG IMMU, V40, P16; Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003; Khan D, 2010, EUR J IMMUNOL, V40, P2549, DOI 10.1002/eji.201040303; Kim WU, 2010, CLIN EXP IMMUNOL, V161, P453, DOI 10.1111/j.1365-2249.2010.04194.x; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Kovats S, 2010, SEX HORMONES AND IMMUNITY TO INFECTION, P53, DOI 10.1007/978-3-642-02155-8_3; Kozlowski PA, 2002, J IMMUNOL, V169, P566, DOI 10.4049/jimmunol.169.1.566; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Kumru S, 2004, J REPROD IMMUNOL, V63, P31, DOI 10.1016/j.jri.2004.02.001; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; McElhaney JE, 2009, CURR OPIN IMMUNOL, V21, P418, DOI 10.1016/j.coi.2009.05.023; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; McNerlan SE, 2002, EXP GERONTOL, V37, P227, DOI 10.1016/S0531-5565(01)00188-7; Nguyen DC, 2011, VACCINE, V29, P2515, DOI 10.1016/j.vaccine.2011.01.080; PAAVONEN T, 1981, J EXP MED, V154, P1935, DOI 10.1084/jem.154.6.1935; Pennock JW, 2009, VACCINE, V27, P5830, DOI 10.1016/j.vaccine.2009.07.052; Polanczyk MJ, 2006, J NEUROSCI RES, V84, P370, DOI 10.1002/jnr.20881; Porter VR, 2001, EXP GERONTOL, V36, P311, DOI 10.1016/S0531-5565(00)00195-9; Rider V, 2001, J RHEUMATOL, V28, P2644; Salem Mohamed Labib, 2004, Current Drug Targets - Inflammation and Allergy, V3, P97, DOI 10.2174/1568010043483944; Sandmand M, 2003, GERONTOLOGY, V49, P155, DOI 10.1159/000069174; Saucedo R, 2002, GYNECOL OBSTET INVES, V53, P114, DOI 10.1159/000053005; Stopinska-Gluszak U, 2006, J REPROD IMMUNOL, V69, P65, DOI 10.1016/j.jri.2005.07.006; Suenaga R, 1998, J RHEUMATOL, V25, P1305; Vasto S, 2009, MECH AGEING DEV, V130, P40, DOI 10.1016/j.mad.2008.06.003; Verthelyi D, 2000, IMMUNOLOGY, V100, P384, DOI 10.1046/j.1365-2567.2000.00047.x; Verthelyi DI, 1998, CELL IMMUNOL, V189, P125, DOI 10.1006/cimm.1998.1372; Vural P, 2006, PHARMACOL RES, V53, P367, DOI 10.1016/j.phrs.2006.01.005; Vural P, 2006, PHARMACOL RES, V54, P298, DOI 10.1016/j.phrs.2006.06.006; Wagner Wolfgang M, 2004, Biogerontology, V5, P63, DOI 10.1023/B:BGEN.0000017832.57617.66; Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x; WEISS NS, 1980, NEW ENGL J MED, V303, P1195, DOI 10.1056/NEJM198011203032102; Yasui T, 2007, MATURITAS, V56, P396, DOI 10.1016/j.maturitas.2006.11.002; Zanni F, 2003, EXP GERONTOL, V38, P981, DOI 10.1016/S0531-5565(03)00160-8	68	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0149045	10.1371/journal.pone.0149045	http://dx.doi.org/10.1371/journal.pone.0149045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859566	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400123
J	Graves, N; Page, K; Martin, E; Brain, D; Hall, L; Campbell, M; Fulop, N; Jimmeison, N; White, K; Paterson, D; Barnett, AG				Graves, Nicholas; Page, Katie; Martin, Elizabeth; Brain, David; Hall, Lisa; Campbell, Megan; Fulop, Naomi; Jimmeison, Nerina; White, Katherine; Paterson, David; Barnett, Adrian G.			Cost-Effectiveness of a National Initiative to Improve Hand Hygiene Compliance Using the Outcome of Healthcare Associated Staphylococcus aureus Bacteraemia	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; LENGTH-OF-STAY; DECISION-MAKING; SAVE-LIVES; INDICATOR; ECONOMICS; EFFICACY; PROGRAM; RATES	Background The objective is to estimate the incremental cost-effectiveness of the Australian National Hand Hygiene Inititiave implemented between 2009 and 2012 using healthcare associated Staphylococcus aureus bacteraemia as the outcome. Baseline comparators are the eight existing state and territory hand hygiene programmes. The setting is the Australian public healthcare system and 1,294,656 admissions from the 50 largest Australian hospitals are included. Methods The design is a cost-effectiveness modelling study using a before and after quasi-experimental design. The primary outcome is cost per life year saved from reduced cases of healthcare associated Staphylococcus aureus bacteraemia, with cost estimated by the annual on-going maintenance costs less the costs saved from fewer infections. Data were harvested from existing sources or were collected prospectively and the time horizon for the model was 12 months, 2011-2012. Findings No useable pre-implementation Staphylococcus aureus bacteraemia data were made available from the 11 study hospitals in Victoria or the single hospital in Northern Territory leaving 38 hospitals among six states and territories available for cost-effectiveness analyses. Total annual costs increased by $2,851,475 for a return of 96 years of life giving an incremental cost-effectiveness ratio (ICER) of $29,700 per life year gained. Probabilistic sensitivity analysis revealed a 100% chance the initiative was cost effective in the Australian Capital Territory and Queensland, with ICERs of $1,030 and $8,988 respectively. There was an 81% chance it was cost effective in New South Wales with an ICER of $33,353, a 26% chance for South Australia with an ICER of $64,729 and a 1% chance for Tasmania and Western Australia. The 12 hospitals in Victoria and the Northern Territory incur annual on-going maintenance costs of $1.51M; no information was available to describe cost savings or health benefits. Conclusions The Australian National Hand Hygiene Initiative was cost-effective against an Australian threshold of $42,000 per life year gained. The return on investment varied among the states and territories of Australia.	[Graves, Nicholas; Page, Katie; Martin, Elizabeth; Brain, David; Hall, Lisa; Campbell, Megan; White, Katherine; Barnett, Adrian G.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Fulop, Naomi] UCL, Dept Appl Hlth Res, London, England; [Jimmeison, Nerina] Queensland Univ Technol, Sch Management, Brisbane, Qld 4001, Australia; [Jimmeison, Nerina] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia	Queensland University of Technology (QUT); University of London; University College London; Queensland University of Technology (QUT); University of Queensland	Graves, N (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	n.graves@qut.edu.au	Page, Katie/H-4283-2019; Barnett, Adrian/I-9850-2012; Martin, Elizabeth/O-3573-2019; Hall, Lisa/H-6322-2012	Page, Katie/0000-0001-9183-9175; Barnett, Adrian/0000-0001-6339-0374; Martin, Elizabeth/0000-0003-0252-8303; Fulop, Naomi/0000-0001-5306-6140; Graves, Nicholas/0000-0002-5559-3267; Paterson, David/0000-0003-2079-4437; Campbell, Megan/0000-0002-6056-6140; Brain, David/0000-0002-6612-348X; Jimmieson, Nerina/0000-0003-4901-7949; White, Katherine/0000-0002-0345-4724	National Health and Medical Research Council [553081]; Australian Commission on Safety and Quality in Health Care; Hand Hygiene Australia; Centre for Healthcare Related Infection Surveillance and Prevention, Communicable Diseases Branch, Queensland Health	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Commission on Safety and Quality in Health Care; Hand Hygiene Australia; Centre for Healthcare Related Infection Surveillance and Prevention, Communicable Diseases Branch, Queensland Health	Financial support for this study was provided by a National Health and Medical Research Council Partnership grant (number 553081) with financial and in-kind support from Australian Commission on Safety and Quality in Health Care, Hand Hygiene Australia, and jurisdictional health departments. Representatives of the Australian Commission on Safety and Quality in Health Care attended research governance meetings to provide feedback on the progress of the project, but the design and conduct is the sole responsibility of the investigators awarded the grant. The funders had no veto on study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Centre for Healthcare Related Infection Surveillance and Prevention, Communicable Diseases Branch, Queensland Health, supports the salaries of NG & DP. We are grateful to all the infection control practitioners who took their time to answer the costing survey and provide other information about the implementation of the National Hand Hygiene Initiative. All authors have no relationships with companies that might have an interest in the submitted work; their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and they have no non-financial interests that may be relevant to the submitted work.	ACSQHC, 2012, SURV HEALTHC ASS INF; Allegranzi B, GLOBAL IMPLEMENTATIO, P1474; Australian Comission on Safety and Quality in Health Care, 2013, IMPL GUID SURV STAPH; Australian Institute of Health and Welfare, 2013, HLTH SERV SER, V50; Australian Institute of Health and Welfare, 2010, AUSTR HLTH SER, V12; Australian Institute of Health and Welfare, 2013, HLTH SERV SER, V53; Australian Institute of Health and Welfare (AIHW), 2012, LIF EXP; Azim S, 2014, MED J AUSTRALIA, V200, P534, DOI 10.5694/mja13.11203; Barnett A. G., 2014, Healthcare Infection, V19, P128, DOI 10.1071/HI14033; Barnett AG, 2014, INFECT CONT HOSP EP, V35, P1029, DOI 10.1086/677160; Barnett AG, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003587; Barnett AG, 2011, VALUE HEALTH, V14, P381, DOI 10.1016/j.jval.2010.09.008; Beyersmann J, 2006, INFECT CONT HOSP EP, V27, P493, DOI 10.1086/503375; Brown C.A., 2006, BMC MED RES METHODOL, V6, P54, DOI DOI 10.1186/1471-2288-6-54; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Claxton K, 2005, HEALTH ECON, V14, P339, DOI 10.1002/hec.985; Collignon PJ, 2006, MED J AUSTRALIA, V184, P404, DOI 10.5694/j.1326-5377.2006.tb00291.x; Collignon Pj, STAPHYLOCOCCUS AUREU; Dick AW, DECADE INVESTMENT IN, P1527; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; George B HA, 2001, PHARMACOECONOMICS; Gould DJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005186.pub3; Graves N, 2004, EMERG INFECT DIS, V10, P561, DOI 10.3201/eid1004.020754; Graves N, 2007, INFECT CONT HOSP EP, V28, P178, DOI 10.1086/510787; Graves N, 2013, INFECT CONT HOSP EP, V34, P424, DOI 10.1086/669862; Graves N, 2010, CLIN INFECT DIS, V50, P1017, DOI 10.1086/651110; Grayson ML, 2008, MED J AUSTRALIA, V188, P633, DOI 10.5694/j.1326-5377.2008.tb01820.x; Grayson ML, 2009, MED J AUSTRALIA, V191, P420, DOI 10.5694/j.1326-5377.2009.tb02873.x; Hand Hygiene Australia, 2014, NAT DAT; Harris AD, 2004, CLIN INFECT DIS, V38, P1586, DOI 10.1086/420936; Huis A, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-92; Johnson PDR, 2005, MED J AUSTRALIA, V183, P509, DOI 10.5694/j.1326-5377.2005.tb07151.x; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Lawes T, 2015, LANCET INFECT DIS, V15, P1438, DOI 10.1016/S1473-3099(15)00315-1; Lawes T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006596; Lawes TG, 2012, CLIN INFECT DIS, V55, P1027, DOI 10.1093/cid/cis602; Luangasanatip N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3728; McLaws ML, 2009, MED J AUSTRALIA, V191, pS26; Naikoba S, 2001, EFFECTIVENESS INTERV; National Institute for Health and Clinical Excellence, GUID METH TECHN APPR; Page K, 2014, J HOSP INFECT, V88, P141, DOI 10.1016/j.jhin.2014.06.005; Page K, 2013, J HOSP INFECT, V84, P200, DOI 10.1016/j.jhin.2013.03.006; Page K, J HOSP INFE IN PRESS; Pantle AC, 2009, MED J AUSTRALIA, V191, pS8; Perencevich EN, 2007, INFECT CONT HOSP EP, V28, P1121, DOI 10.1086/521852; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Playford EG, 2012, MED J AUSTRALIA, V197, P29, DOI 10.5694/mja12.10677; Rechner IJ, 2005, ANAESTH INTENS CARE, V33, P477, DOI 10.1177/0310057X0503300409; Reichardt C, 2013, J HOSP INFECT, V83, pS11, DOI 10.1016/S0195-6701(13)60004-3; Russo PL, 2015, AM J INFECT CONTROL, V43, P773, DOI 10.1016/j.ajic.2015.02.029; Sax H, 2007, J HOSP INFECT, V67, P9, DOI 10.1016/j.jhin.2007.06.004; Schweizer ML, SEARCHING OPTIMAL HA, P1537; Srigley JA, 2014, BMJ QUAL SAF, V23, P974, DOI 10.1136/bmjqs-2014-003080; Stewardson AJ, 2014, INFECT CONT HOSP EP, V35, P1294, DOI 10.1086/678063; Stone SP, EVALUATION NATL CLEA, P1756; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11; WEINSTEIN MC, 1977, NEW ENGL J MED, V296, P716, DOI 10.1056/NEJM197703312961304	58	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148190	10.1371/journal.pone.0148190	http://dx.doi.org/10.1371/journal.pone.0148190			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859688	Green Published, gold			2022-12-27	WOS:000370038400025
J	Hatai, H; Lepelley, A; Zeng, WY; Hayden, MS; Ghosh, S				Hatai, Hirotsugu; Lepelley, Alice; Zeng, Wangyong; Hayden, Matthew S.; Ghosh, Sankar			Toll-Like Receptor 11 (TLR11) Interacts with Flagellin and Profilin through Disparate Mechanisms	PLOS ONE			English	Article							TOXOPLASMA-GONDII PROFILIN; DOUBLE-STRANDED-RNA; PROTEOLYTIC CLEAVAGE; CPG-DNA; RECOGNITION; ACTIVATION; INFECTION; FRAGMENT; BACTERIA; IMMUNITY	Toll-like receptors (TLRs) are innate immune receptors that sense a variety of pathogen-associated molecular patterns (PAMPs) by interacting with them and subsequently initiating signal transduction cascades that elicit immune responses. TLR11 has been shown to interact with two known protein PAMPs: Salmonella and E. coli flagellin FliC and Toxoplasma gondii profilin-like protein. Given the highly divergent biology of these pathogens recognized by TLR11, it is unclear whether common mechanisms are used to recognize these distinct protein PAMPs. Here we show that TLR11 interacts with these two PAMPs using different receptor domains. Furthermore, TLR11 binding to flagellin and profilin exhibits differential dependency on pH and receptor ectodomain cleavage.	[Hatai, Hirotsugu; Lepelley, Alice; Hayden, Matthew S.; Ghosh, Sankar] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY USA; [Hatai, Hirotsugu] Univ Tokyo, Grad Sch Med, Dept Pathol Immunol & Microbiol, Bunkyo Ku, Tokyo, Japan; [Zeng, Wangyong; Hayden, Matthew S.] Columbia Univ, Coll Phys & Surg, Dept Dermatol, New York, NY USA	Columbia University; University of Tokyo; Columbia University	Ghosh, S (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY USA.	sg2715@columbia.edu	Lepelley, Alice/P-1197-2018	Lepelley, Alice/0000-0001-8656-7291; Hayden, Matthew/0000-0003-1670-6430; Hatai, Hitoshi/0000-0002-9063-7616	Japan Society for the Promotion of Science [243602]; NIH [R37-AI33443]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Japan Society for the Promotion of Science (Grant-in-Aid for JSPS Fellows; 243602 to HH), NIH grant R37-AI33443 and institutional support from Columbia University to SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KL, 2014, IMMUNOL REV, V260, P206, DOI 10.1111/imr.12180; Cai ZY, 2009, J BIOL CHEM, V284, P33088, DOI 10.1074/jbc.M109.050757; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Garcia-Cattaneo A, 2012, P NATL ACAD SCI USA, V109, P9053, DOI 10.1073/pnas.1115091109; Huh JW, 2014, P NATL ACAD SCI USA, V111, P7072, DOI 10.1073/pnas.1322838111; Kanno A, 2013, INT IMMUNOL, V25, P413, DOI 10.1093/intimm/dxt007; Koblansky AA, 2013, IMMUNITY, V38, P119, DOI 10.1016/j.immuni.2012.09.016; Kucera K, 2010, J MOL BIOL, V403, P616, DOI 10.1016/j.jmb.2010.09.022; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; MACNAB RM, 1992, ANNU REV GENET, V26, P131, DOI 10.1146/annurev.ge.26.120192.001023; Mathur R, 2012, CELL, V151, P590, DOI 10.1016/j.cell.2012.08.042; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Murakami Y, 2014, J IMMUNOL, V193, P5208, DOI 10.4049/jimmunol.1400386; Onji M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2949; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Peter ME, 2009, J IMMUNOL, V182, P7690, DOI 10.4049/jimmunol.0900819; Pifer R, 2011, J BIOL CHEM, V286, P3307, DOI 10.1074/jbc.M110.171025; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Raetz M, 2013, J IMMUNOL, V191, P4818, DOI 10.4049/jimmunol.1301301; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shi ZC, 2012, J BIOL CHEM, V287, P43417, DOI 10.1074/jbc.M112.411009; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Toscano F, 2013, J IMMUNOL, V190, P764, DOI 10.4049/jimmunol.1202173; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	31	35	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148987	10.1371/journal.pone.0148987	http://dx.doi.org/10.1371/journal.pone.0148987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859749	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400116
J	Onogi, A; Ideta, O; Yoshioka, T; Ebana, K; Yamasaki, M; Iwata, H				Onogi, Akio; Ideta, Osamu; Yoshioka, Takuma; Ebana, Kaworu; Yamasaki, Masanori; Iwata, Hiroyoshi			Uncovering a Nuisance Influence of a Phenological Trait of Plants Using a Nonlinear Structural Equation: Application to Days to Heading and Culm Length in Asian Cultivated Rice (Oryza Sativa L.)	PLOS ONE			English	Article							SOMATIC-CELL SCORE; FLOWERING TIME; MILK-YIELD; INFERRING RELATIONSHIPS; NATURAL VARIATION; DATE; HEIGHT; MODELS; LOCI; GENE	Phenological traits of plants, such as flowering time, are linked to growth phase transition. Thus, phenological traits often influence other traits through the modification of the duration of growth period. This influence is a nuisance in plant breeding because it hampers genetic evaluation of the influenced traits. Genetic effects on the influenced traits have two components, one that directly affects the traits and one that indirectly affects the traits via the phenological trait. These cannot be distinguished by phenotypic evaluation and ordinary linear regression models. Consequently, if a phenological trait is modified by introgression or editing of the responsible genes, the phenotypes of the influenced traits can change unexpectedly. To uncover the influence of the phenological trait and evaluate the direct genetic effects on the influenced traits, we developed a nonlinear structural equation (NSE) incorporating a nonlinear influence of the phenological trait. We applied the NSE to real data for cultivated rice (Oryza sativa L.): days to heading (DH) as a phenological trait and culm length (CL) as the influenced trait. This showed that CL of the cultivars that showed extremely early heading was shortened by the strong influence of DH. In a simulation study, it was shown that the NSE was able to infer the nonlinear influence and direct genetic effects with reasonable accuracy. However, the NSE failed to infer the linear influence in this study. When no influence was simulated, an ordinary bi-trait linear model (OLM) tended to infer the genetic effects more accurately. In such cases, however, by comparing the NSE and OLM using an information criterion, we could assess whether the nonlinear assumption of the NSE was appropriate for the data analyzed. This study demonstrates the usefulness of the NSE in revealing the phenotypic influence of phenological traits.	[Onogi, Akio; Iwata, Hiroyoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan; [Ideta, Osamu] Natl Agr & Food Res Org, Western Reg Agr Res Ctr, Fukuyama, Hiroshima, Japan; [Yoshioka, Takuma; Yamasaki, Masanori] Kobe Univ, Food Resources Educ & Res Ctr, Grad Sch Agr Sci, Kasai, Hyogo, Japan; [Ebana, Kaworu] Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki, Japan	University of Tokyo; National Agriculture & Food Research Organization - Japan; Kobe University; National Institute of Agrobiological Sciences - Japan	Iwata, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan.	aiwata@mail.ecc.u-tokyo.ac.jp	Yamasaki, Masanori/C-5193-2018	Yamasaki, Masanori/0000-0001-7759-3965	JSPS KAKENHI [25252002, 14J10661, 15H04436]; Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [NVR-0002]; Grants-in-Aid for Scientific Research [15H04436] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant Numbers 25252002, 14J10661 and 15H04436, and by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation, NVR-0002).	Bauer DJ, 2005, STRUCT EQU MODELING, V12, P513, DOI 10.1207/s15328007sem1204_1; Bennett D, 2012, THEOR APPL GENET, V124, P697, DOI 10.1007/s00122-011-1740-3; Bogard M, 2011, J EXP BOT, V62, P3621, DOI 10.1093/jxb/err061; Bollen KA, 1989, STRUCTURAL EQUATIONS; de los Campos G, 2006, J DAIRY SCI, V89, P4445, DOI 10.3168/jds.S0022-0302(06)72493-6; Dhungana P, 2007, CROP SCI, V47, P477, DOI 10.2135/cropsci2006.06.0425; Endelman JB, 2012, G3-GENES GENOM GENET, V2, P1405, DOI 10.1534/g3.112.004259; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Endo-Higashi N, 2011, PLANT CELL PHYSIOL, V52, P1083, DOI 10.1093/pcp/pcr059; Ergon A, 2006, THEOR APPL GENET, V112, P232, DOI 10.1007/s00122-005-0115-z; Gelman A., 2014, BAYESIAN DATA ANAL, VThird; Gianola D, 2004, GENETICS, V167, P1407, DOI 10.1534/genetics.103.025734; Godoy AS, 1999, EUPHYTICA, V105, P155, DOI 10.1023/A:1003490016166; Guo RX, 2012, BIOMETRICS, V68, P567, DOI 10.1111/j.1541-0420.2012.01751.x; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hori K, 2013, PLANT J, V76, P36, DOI 10.1111/tpj.12268; Hori K, 2012, BREEDING SCI, V62, P223, DOI 10.1270/jsbbs.62.223; Hori K, 2009, BREEDING SCI, V59, P285, DOI 10.1270/jsbbs.59.285; KENNY DA, 1984, PSYCHOL BULL, V96, P201, DOI 10.1037/0033-2909.96.1.201; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Kumudini S, 2001, CROP SCI, V41, P391, DOI 10.2135/cropsci2001.412391x; Li ZK, 2003, THEOR APPL GENET, V108, P141, DOI 10.1007/s00122-003-1401-2; LI ZK, 1995, THEOR APPL GENET, V91, P374, DOI 10.1007/BF00220902; Matsubara K, 2012, PLANT CELL PHYSIOL, V53, P709, DOI 10.1093/pcp/pcs028; Ogiso E, 2010, PLANT PHYSIOL, V152, P808, DOI 10.1104/pp.109.148908; Onogi A, 2015, THEOR APPL GENET, V128, P41, DOI 10.1007/s00122-014-2411-y; Sabadin PK, 2012, THEOR APPL GENET, V124, P1389, DOI 10.1007/s00122-012-1795-9; SAKAI KAN-ICHI, 1964, RADIAT BOT, V4, P141, DOI 10.1016/S0033-7560(64)80065-X; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; SCHAPAUGH WT, 1980, CROP SCI, V20, P529, DOI 10.2135/cropsci1980.0011183X002000040028x; Song XY, 2010, J COMPUT GRAPH STAT, V19, P590, DOI 10.1198/jcgs.2010.09094; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; Weng XY, 2014, PLANT PHYSIOL, V164, P735, DOI 10.1104/pp.113.231308; Wu XL, 2007, J DAIRY SCI, V90, P3508, DOI 10.3168/jds.2006-762; Wu XL, 2008, GENET SEL EVOL, V40, P333, DOI 10.1051/gse:2008009; Wu XL, 2010, J ANIM BREED GENET, V127, P3, DOI 10.1111/j.1439-0388.2009.00835.x; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Zou GH, 2012, J EXP BOT, V63, P5451, DOI 10.1093/jxb/ers205	39	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148609	10.1371/journal.pone.0148609	http://dx.doi.org/10.1371/journal.pone.0148609			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859143	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400056
J	Patil, NK; Luan, LM; Bohannon, JK; Guo, Y; Hernandez, A; Fensterheim, B; Sherwood, ER				Patil, Naeem K.; Luan, Liming; Bohannon, Julia K.; Guo, Yin; Hernandez, Antonio; Fensterheim, Benjamin; Sherwood, Edward R.			IL-15 Superagonist Expands mCD8(+)T, NK and NKT Cells after Burn Injury but Fails to Improve Outcome during Burn Wound Infection	PLOS ONE			English	Article							TYROSINE KINASE-3 LIGAND; DENDRITIC CELLS; TRANS-PRESENTATION; ORGAN DYSFUNCTION; INDUCED APOPTOSIS; IN-VIVO; SEPSIS; INTERLEUKIN-15; RECEPTOR; SURVIVAL	Background Severely burned patients are highly susceptible to opportunistic infections and sepsis, owing to the loss of the protective skin barrier and immunological dysfunction. Interleukin-15 (IL-15) belongs to the IL-2 family of common gamma chain cytokines and stimulates the proliferation and activation of T (specifically memory CD8), NK and NKT cells. It has been shown to preserve T cell function and improve survival during cecal ligation and puncture (CLP)-induced sepsis in mice. However, the therapeutic efficacy of IL-15 or IL-15 superagonist (SA) during infection after burn injury has not been evaluated. Moreover, very few, if any, studies have examined, in detail, the effect of burn injury and infection on the adaptive immune system. Thus, we examined the effect of burn and sepsis on adaptive immune cell populations and the effect of IL-15 SA treatment on the host response to infection. Methods Mice were subjected to a 35% total body surface area burn, followed by wound infection with Pseudomonas aeruginosa. In some experiments, IL-15 SA was administered after burn injury, but before infection. Leukocytes in spleen, liver and peritoneal cavity were characterized using flow cytometry. Bacterial clearance, organ injury and survival were also assessed. Results Burn wound infection led to a significant decline in total white blood cell and lymphocyte counts and induced organ injury and sepsis. Burn injury caused decline in CD4(+) and CD8(+) T cells in the spleen, which was worsened by infection. IL-15 treatment inhibited this decline and significantly increased cell numbers and activation, as determined by CD69 expression, of CD4(+), CD8(+), B, NK and NKT cells in the spleen and liver after burn injury. However, IL-15 SA treatment failed to prevent burn wound sepsis- induced loss of CD4(+), CD8(+), B, NK and NKT cells and failed to improve bacterial clearance and survival. Conclusion Cutaneous burn injury and infection cause significant adaptive immune dysfunction. IL-15 SA does not augment host resistance to burn wound sepsis in mice despite inducing proliferation and activation of lymphocyte subsets.	[Patil, Naeem K.; Luan, Liming; Bohannon, Julia K.; Hernandez, Antonio; Sherwood, Edward R.] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN USA; [Guo, Yin; Fensterheim, Benjamin; Sherwood, Edward R.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Sherwood, ER (corresponding author), Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN USA.; Sherwood, ER (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA.	edward.r.sherwood@vanderbilt.edu	Patil, Naeem/O-9252-2016; Guo, Yin/W-6588-2018	Patil, Naeem/0000-0002-5323-0729	National Institute of Health [GM66885, NIH R01 GM66885]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347, R01GM066885] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health RO1 grant-GM66885. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Institute of Health grant NIH R01 GM66885. The authors thank Dr. Kelli Boyd of the Translational Pathology Shared Resource at Vanderbilt University for assistance with running CBC analyses and serum ALT, AST and BUN	Abraham E, 2007, CRIT CARE MED, V35, P2408, DOI 10.1097/01.CCM.0000282072.56245.91; Abu-Sittah G S, 2012, Ann Burns Fire Disasters, V25, P26; Ahmad A, 2005, CURR HIV RES, V3, P261, DOI 10.2174/1570162054368093; Ahmad R, 2007, J MOL BIOL, V367, P25, DOI 10.1016/j.jmb.2006.12.060; Aluarado R, 2009, BURNS, V35, P4, DOI 10.1016/j.burns.2008.03.008; Anguille S, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-109; Blaser BW, 2006, BLOOD, V108, P2463, DOI 10.1182/blood-2006-04-019059; Bohannon JK, 2015, J LEUKOC BIOL; Bohannon J, 2008, J IMMUNOL, V180, P3038, DOI 10.4049/jimmunol.180.5.3038; Bohannon J, 2010, J IMMUNOL, V185, P2847, DOI 10.4049/jimmunol.0903619; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Castillo EF, 2009, J IMMUNOL, V183, P4948, DOI 10.4049/jimmunol.0900719; Chalekson CP, 2002, PLAST RECONSTR SURG, V109, P1338, DOI 10.1097/00006534-200204010-00020; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Craciun FL, 2010, J IMMUNOL, V185, P6930, DOI 10.4049/jimmunol.1002300; Cui GW, 2014, P NATL ACAD SCI USA, V111, P1915, DOI 10.1073/pnas.1318281111; Doherty TM, 1996, J IMMUNOL, V156, P735; Eckmann L, 2001, MICROBES INFECT, V3, P1191, DOI 10.1016/S1286-4579(01)01479-4; Fitzwater J, 2003, J TRAUMA, V54, P959, DOI 10.1097/01.TA.0000029382.26295.AB; Fukuzuka K, 2000, J TRAUMA, V49, P710, DOI 10.1097/00005373-200010000-00020; Fukuzuka K, 2000, AM J PHYSIOL-REG I, V278, pR1005, DOI 10.1152/ajpregu.2000.278.4.R1005; Gamelli RL, 1998, J TRAUMA, V44, P469, DOI 10.1097/00005373-199803000-00008; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Guo Y, 2015, J IMMUNOL, V195, P2353, DOI 10.4049/jimmunol.1500300; Han KP, 2011, CYTOKINE, V56, P804, DOI 10.1016/j.cyto.2011.09.028; Hiromatsu T, 2003, J INFECT DIS, V187, P1442, DOI 10.1086/374643; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Howard TS, 2013, J BURN CARE RES, V34, P413, DOI 10.1097/BCR.0b013e3182685e11; Inoue S, 2010, J IMMUNOL, V184, P1401, DOI 10.4049/jimmunol.0902307; Jeschke MG, 2015, EBIOMEDICINE, V2, P1536, DOI 10.1016/j.ebiom.2015.07.040; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Khawam K, 2009, CANCER RES, V69, P1561, DOI 10.1158/0008-5472.CAN-08-3198; Kraft R, 2012, LANCET, V379, P1013, DOI 10.1016/S0140-6736(11)61345-7; Latenser BA, 2009, CRIT CARE MED, V37, P2819, DOI 10.1097/CCM.0b013e3181b3a08f; Lodolce J, 2002, MOL IMMUNOL, V39, P537, DOI 10.1016/S0161-5890(02)00211-0; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Ma LL, 2002, J IMMUNOL, V169, P5787, DOI 10.4049/jimmunol.169.10.5787; Maeurer MJ, 2000, INFECT IMMUN, V68, P2962, DOI 10.1128/IAI.68.5.2962-2970.2000; Mann EA, 2012, SHOCK, V37, P4, DOI 10.1097/SHK.0b013e318237d6bf; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; Mattei F, 2001, J IMMUNOL, V167, P1179, DOI 10.4049/jimmunol.167.3.1179; Mercer-Jones MA, 1999, INFLAMMATION, V23, P305; Patil NK, 2014, AM J PHYSIOL-RENAL, V306, pF734, DOI 10.1152/ajprenal.00643.2013; Peck-Palmer OM, 2009, SHOCK, V31, P359, DOI 10.1097/SHK.0b013e31818ba2a2; Pelletier M, 2002, FEBS LETT, V532, P164, DOI 10.1016/S0014-5793(02)03668-2; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Shelley O, 2003, SHOCK, V20, P123, DOI 10.1097/01.shk.0000079426.52617.00; Shen HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050238; Shindo Y, 2015, SHOCK, V43, P334, DOI 10.1097/SHK.0000000000000317; Sim GC, 2014, CYTOKINE GROWTH F R, V25, P377, DOI 10.1016/j.cytogfr.2014.07.018; Stanojcic M, 2015, ANN SURG; Steel JC, 2012, TRENDS PHARMACOL SCI, V33, P35, DOI 10.1016/j.tips.2011.09.004; Tagaya Y, 1996, EMBO J, V15, P4928, DOI 10.1002/j.1460-2075.1996.tb00873.x; Toliver-Kinsky TE, 2005, J IMMUNOL, V174, P404, DOI 10.4049/jimmunol.174.1.404; Toliver-Kinsky TE, 2003, INFECT IMMUN, V71, P3058, DOI 10.1128/IAI.71.6.3058-3067.2003; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; Valvis SM, 2015, J INVEST DERMATOL, V135, P2119, DOI 10.1038/jid.2015.123; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Wang Z, 2015, J PHARMACOL EXP THER, V352, P61, DOI 10.1124/jpet.114.219394; Wesche-Soldato DE, 2007, CURR DRUG TARGETS, V8, P493, DOI 10.2174/138945007780362764; Williams FN, 2009, CRIT CARE, V13, DOI 10.1186/cc8170; Wysocka M, 2005, J IMMUNOL, V174, P7398, DOI 10.4049/jimmunol.174.11.7398	65	19	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148452	10.1371/journal.pone.0148452	http://dx.doi.org/10.1371/journal.pone.0148452			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859674	Green Published, gold, Green Submitted			2022-12-27	WOS:000370038400043
J	Peng, Q; Wu, B; Jiang, ML; Jin, J; Hou, ZP; Zheng, J; Zhang, JY; Duan, WZ				Peng, Qi; Wu, Bin; Jiang, Mali; Jin, Jing; Hou, Zhipeng; Zheng, Jennifer; Zhang, Jiangyang; Duan, Wenzhen			Characterization of Behavioral, Neuropathological, Brain Metabolic and Key Molecular Changes in zQ175 Knock-In Mouse Model of Huntington's Disease	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; MUTANT HUNTINGTIN; MESSENGER-RNA; TRANSGENIC MICE; NUCLEAR-LOCALIZATION; ENERGY-METABOLISM; STRIATAL NEURONS; GENE-EXPRESSION; LEVELS DECREASE; PROTEIN LENGTH	Huntington's disease (HD) is caused by an expansion of the trinucleotide poly (CAG) tract located in exon 1 of the huntingtin (Htt) gene leading to progressive neurodegeneration in selected brain regions, and associated functional impairments in motor, cognitive, and psychiatric domains. Since the discovery of the gene mutation that causes the disease, mouse models have been developed by different strategies. Recently, a new model, the zQ175 knock-in (KI) line, was developed in an attempt to have the Htt gene in a context and causing a phenotype that more closely mimics HD in humans. The behavioral phenotype was characterized across the independent laboratories and important features reminiscent of human HD are observed in zQ175 mice. In the current study, we characterized the zQ175 model housed in an academic laboratory under reversed dark-light cycle, including motor function, in vivo longitudinal structural MRI imaging for brain volume, MRS for striatal metabolites, neuropathology, as well as a panel of key disease marker proteins in the striatum at different ages. Our results suggest that homozygous zQ175 mice exhibited significant brain atrophy before the motor deficits and brain metabolite changes. Altered striatal medium spiny neuronal marker, postsynaptic marker protein and complement component C1qC also characterized zQ175 mice. Our results confirmed that the zQ175 KI model is valuable in understanding of HD-like pathophysiology and evaluation of potential therapeutics. Our data also provide suggestions to select appropriate outcome measurements in preclinical studies using the zQ175 mice.	[Peng, Qi; Wu, Bin; Jiang, Mali; Jin, Jing; Zheng, Jennifer; Duan, Wenzhen] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Neurobiol, Baltimore, MD 21205 USA; [Wu, Bin] China Med Univ, Dept Gen Practice, Hosp 1, Shenyang 110001, Liaoning Provin, Peoples R China; [Hou, Zhipeng; Zhang, Jiangyang] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; [Duan, Wenzhen] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Duan, Wenzhen] Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD USA	Johns Hopkins University; China Medical University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Duan, WZ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Neurobiol, Baltimore, MD 21205 USA.; Duan, WZ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.; Duan, WZ (corresponding author), Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD USA.	wduan2@jhmi.edu		Zhang, Jiangyang/0000-0003-0740-2662; Zhang, Jiangyang/0000-0003-4146-8163	Cure Huntington's Disease Initiative (CHDI) Inc Foundation [A5972, A7887]; National Institute of Health [R01NS082338]; CHDI foundation [A7887, A-5972]; NINDS [NS082338]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070909, R01NS082338] Funding Source: NIH RePORTER	Cure Huntington's Disease Initiative (CHDI) Inc Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the Cure Huntington's Disease Initiative (CHDI) Inc Foundation (A5972, A7887) and National Institute of Health R01NS082338 to W.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank David Howland, Larry Park at CHDI Foundation for their excellent advice. This research is supported by CHDI foundation (A-5972 and A7887 to WD) and NINDS (NS082338 to WD)	ALBIN RL, 1991, ANN NEUROL, V30, P542, DOI 10.1002/ana.410300406; Augood SJ, 1997, ANN NEUROL, V42, P215, DOI 10.1002/ana.410420213; Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Chan EYW, 2002, HUM MOL GENET, V11, P1939, DOI 10.1093/hmg/11.17.1939; Denovan-Wright EM, 2000, NEUROSCIENCE, V98, P705, DOI 10.1016/S0306-4522(00)00157-3; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; GRAMSBERGEN JB, 1986, ARCH NEUROL-CHICAGO, V43, P1276, DOI 10.1001/archneur.1986.00520120056016; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hebb ALO, 2004, NEUROSCIENCE, V123, P967, DOI 10.1016/j.neuroscience.2003.11.009; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Hu H, 2004, EUR J NEUROSCI, V20, P3351, DOI 10.1111/j.1460-9568.2004.03796.x; Jenkins BG, 2005, J NEUROCHEM, V95, P553, DOI 10.1111/j.1471-4159.2005.03411.x; Jin J, 2015, HUM MOL GENET, V24, P2508, DOI 10.1093/hmg/ddv016; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Kuo YT, 2005, J MAGN RESON IMAGING, V21, P334, DOI 10.1002/jmri.20285; Lee CYD, 2013, FEBS J, V280, P4382, DOI 10.1111/febs.12418; Lerch JP, 2008, NEUROIMAGE, V41, P243, DOI 10.1016/j.neuroimage.2008.02.019; Lerch JP, 2008, NEUROIMAGE, V39, P32, DOI 10.1016/j.neuroimage.2007.08.033; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; McCaw EA, 2004, EUR J BIOCHEM, V271, P4909, DOI 10.1111/j.1432-1033.2004.04460.x; Menalled L, 2000, EXP NEUROL, V162, P328, DOI 10.1006/exnr.1999.7327; Menalled LB, 2002, J NEUROSCI, V22, P8266; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Nithianantharajah J, 2008, NEUROBIOL DIS, V29, P490, DOI 10.1016/j.nbd.2007.11.006; Nopoulos PC, 2011, BRAIN, V134, P137, DOI 10.1093/brain/awq280; Powers WJ, 2007, P NATL ACAD SCI USA, V104, P2945, DOI 10.1073/pnas.0609833104; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Reynolds NC, 2005, BRAIN RES, V1031, P82, DOI 10.1016/j.brainres.2004.10.030; RICHFIELD EK, 1995, ANN NEUROL, V37, P335, DOI 10.1002/ana.410370309; Rosas HD, 2001, NEUROLOGY, V57, P1025, DOI 10.1212/WNL.57.6.1025; Rosas HD, 2014, NEUROLOGY, V82, P850, DOI 10.1212/WNL.0000000000000187; Saleh N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004962; Sanchez-Pernaute R, 1999, NEUROLOGY, V53, P806, DOI 10.1212/WNL.53.4.806; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Sturrock A, 2010, NEUROLOGY, V75, P1702, DOI 10.1212/WNL.0b013e3181fc27e4; Tkac I, 2012, J CEREBR BLOOD F MET, V32, P1977, DOI 10.1038/jcbfm.2012.104; Unschuld PG, 2012, MOVEMENT DISORD, V27, P895, DOI 10.1002/mds.25010; van Dellen A, 2000, NEUROREPORT, V11, P3751, DOI 10.1097/00001756-200011270-00032; van den Bogaard SJA, 2011, J NEUROL, V258, P2230, DOI 10.1007/s00415-011-6099-5; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P3823, DOI 10.1093/hmg/ddi407; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Zacharoff L, 2012, J CEREBR BLOOD F MET, V32, P502, DOI 10.1038/jcbfm.2011.157	45	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148839	10.1371/journal.pone.0148839	http://dx.doi.org/10.1371/journal.pone.0148839			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859386	Green Published, gold, Green Submitted			2022-12-27	WOS:000370038400094
J	Yoo, TK; Kim, DW; Choi, SB; Oh, E; Park, JS				Yoo, Tae Keun; Kim, Deok Won; Choi, Soo Beom; Oh, Ein; Park, Jee Soo			Simple Scoring System and Artificial Neural Network for Knee Osteoarthritis Risk Prediction: A Cross-Sectional Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; RADIOGRAPHIC OSTEOARTHRITIS; MODEL; ASSOCIATION; REGRESSION; DIAGNOSIS; ADULTS; PAIN	Background Knee osteoarthritis (OA) is the most common joint disease of adults worldwide. Since the treatments for advanced radiographic knee OA are limited, clinicians face a significant challenge of identifying patients who are at high risk of OA in a timely and appropriate way. Therefore, we developed a simple self-assessment scoring system and an improved artificial neural network (ANN) model for knee OA. Methods The Fifth Korea National Health and Nutrition Examination Surveys (KNHANES V-1) data were used to develop a scoring system and ANN for radiographic knee OA. A logistic regression analysis was used to determine the predictors of the scoring system. The ANN was constructed using 1777 participants and validated internally on 888 participants in the KNHANES V-1. The predictors of the scoring system were selected as the inputs of the ANN. External validation was performed using 4731 participants in the Osteoarthritis Initiative (OAI). Area under the curve (AUC) of the receiver operating characteristic was calculated to compare the prediction models. Results The scoring system and ANN were built using the independent predictors including sex, age, body mass index, educational status, hypertension, moderate physical activity, and knee pain. In the internal validation, both scoring system and ANN predicted radiographic knee OA (AUC 0.73 versus 0.81, p<0.001) and symptomatic knee OA (AUC 0.88 versus 0.94, p<0.001) with good discriminative ability. In the external validation, both scoring system and ANN showed lower discriminative ability in predicting radiographic knee OA (AUC 0.62 versus 0.67, p<0.001) and symptomatic knee OA (AUC 0.70 versus 0.76, p<0.001). Conclusions The self-assessment scoring system may be useful for identifying the adults at high risk for knee OA. The performance of the scoring system is improved significantly by the ANN. We provided an ANN calculator to simply predict the knee OA risk.	[Yoo, Tae Keun] Yonsei Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Kim, Deok Won; Choi, Soo Beom; Park, Jee Soo] Yonsei Univ, Coll Med, Dept Med Engn, Seoul, South Korea; [Kim, Deok Won; Choi, Soo Beom] Yonsei Univ, Grad Program Biomed Engn, Seoul 120749, South Korea; [Park, Jee Soo] Yonsei Univ, Coll Med, Dept Med, Seoul, South Korea; [Oh, Ein] Yonsei Univ, Coll Med, Dept Anaesthesiol & Pain Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, DW (corresponding author), Yonsei Univ, Coll Med, Dept Med Engn, Seoul, South Korea.; Kim, DW (corresponding author), Yonsei Univ, Grad Program Biomed Engn, Seoul 120749, South Korea.	kdw@yuhs.ac	Yoo, Tae Keun/Q-3620-2019; PARK, JEE SOO/AAY-2851-2020	Yoo, Tae Keun/0000-0003-0890-8614; Park, Jee Soo/0000-0001-9976-6599	National Research Foundation of Korea (NRF) grant - Korea government (MEST) [2012R1A2A2A03045612]	National Research Foundation of Korea (NRF) grant - Korea government (MEST)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2012R1A2A2A03045612). URL: www.nrf.re.kr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2012R1A2A2A03045612).	Bang H, 2007, ARCH INTERN MED, V167, P374, DOI 10.1001/archinte.167.4.374; BAXT WG, 1995, LANCET, V346, P1135, DOI 10.1016/S0140-6736(95)91804-3; Burse K, 2011, COMM COM INF SC, V147, P67; CHRISTY PS, 1995, NEURORADIOLOGY, V37, P89; Chu CR, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3845; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Dunlop DD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2472; Dunlop DD, 2011, ARTHRITIS RHEUM-US, V63, P127, DOI 10.1002/art.27760; Eller-Vainicher C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027277; Felson DT, 1997, ARTHRITIS RHEUM, V40, P728, DOI 10.1002/art.1780400420; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Ghoshal UC, 2008, HEPATOL INT, V2, P31, DOI 10.1007/s12072-007-9026-1; Gillen M, 2007, AM J IND MED, V50, P245, DOI 10.1002/ajim.20429; Grobman WA, 2006, AM J OBSTET GYNECOL, V194, P888, DOI 10.1016/j.ajog.2005.09.002; HART DJ, 1995, J RHEUMATOL, V22, P1118; Heiat A, 2002, INFORM SOFTWARE TECH, V44, P911, DOI 10.1016/S0950-5849(02)00128-3; Jabbour E, 2011, BLOOD, V117, P1822, DOI 10.1182/blood-2010-07-293977; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P485, DOI 10.1136/ard.16.4.485; Kerkhof HJM, 2014, ANN RHEUM DIS, V73, P2116, DOI 10.1136/annrheumdis-2013-203620; KONONENKO I, 1993, APPL ARTIF INTELL, V7, P317, DOI 10.1080/08839519308949993; Lawrentschuk N, 2011, INT UROL NEPHROL, V43, P23, DOI 10.1007/s11255-010-9750-7; Lee MS, 2011, ENVIRON RES, V111, P171, DOI 10.1016/j.envres.2010.10.006; Lee S, 2012, ARTHRITIS RHEUM-US, V64, P3947, DOI 10.1002/art.37696; Losina E, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0771-3; McAlindon TE, 1999, AM J MED, V106, P151, DOI 10.1016/S0002-9343(98)00413-6; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Morvan J, 2009, ARTHRIT RHEUM-ARTHR, V61, P92, DOI 10.1002/art.24079; Motsinger-Reif AA, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-3; Muraki S, 2009, OSTEOARTHR CARTILAGE, V17, P1137, DOI 10.1016/j.joca.2009.04.005; Muthuri SG, 2011, OSTEOARTHR CARTILAGE, V19, P1286, DOI 10.1016/j.joca.2011.07.015; Neogi T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2844; Oh K, 2007, KOREAN J EPIDEMIOL, V29, P139; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Peat G, 2007, ARTHRIT RHEUM-ARTHR, V57, P794, DOI 10.1002/art.22785; Peat G, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3779; Razi MA, 2005, EXPERT SYST APPL, V29, P65, DOI 10.1016/j.eswa.2005.01.006; Reichmann WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017345; Richmond J, 2009, J AM ACAD ORTHOP SUR, V17, P591, DOI 10.5435/00124635-200909000-00006; Schett G, 2010, ANN RHEUM DIS, V69, P1573, DOI 10.1136/ard.2009.123661; Takahashi H, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3157; Tam SF, 2004, INT J REHABIL RES, V27, P65, DOI 10.1097/00004356-200403000-00009; Yao W, 2012, IEEE T NEUR NET LEAR, V23, P247, DOI 10.1109/TNNLS.2011.2178560; Yoshida S, 2002, J RHEUMATOL, V29, P1454; Yoshimura N, 2011, J RHEUMATOL, V38, P921, DOI 10.3899/jrheum.100569; Zhang W, 2010, ANN RHEUM DIS, V69, P483, DOI 10.1136/ard.2009.113100; Zhang WY, 2011, ANN RHEUM DIS, V70, P1599, DOI 10.1136/ard.2011.149807; Zou Jinming, 2008, V458, P15	47	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148724	10.1371/journal.pone.0148724	http://dx.doi.org/10.1371/journal.pone.0148724			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859664	Green Published, gold, Green Submitted			2022-12-27	WOS:000370038400070
J	Chang, YT; Wu, CC; Tang, TY; Lu, CT; Lai, CS; Shen, CH				Chang, Yi-Ting; Wu, Chih-Chen; Tang, Tsung-Yung; Lu, Chun-Te; Lai, Chih-Sheng; Shen, Ching-Hui			Differences between Total Intravenous Anesthesia and Inhalation Anesthesia in Free Flap Surgery of Head and Neck Cancer	PLOS ONE			English	Article							PROPOFOL; RECONSTRUCTION; COMPLICATIONS; PREDICTORS; SEVOFLURANE; INJURY	Background Many studies have evaluated risk factors associated with complications after free flap surgery, but these studies did not evaluate the impact of anesthesia management. The goal of the current study was to evaluate the differences between patients who received inhalation and total intravenous anesthesia (TIVA) in free flap surgery. Methods One hundred and fifty-six patients who underwent free flap surgery for head and neck cancer were retrospectively divided into the TIVA (96 patients) and the inhalation group (87 patients). Perioperative hemodynamic data and postoperative medical complications were determined by documented medical records. Results Ninety-six patients in the TIVA group were compared with 87 patients who received inhalation anesthesia. There were no differences in gender, age, classification of physical status based on American Society for Anesthesiologists (ASA) score, and cormobidities between the two groups. Patients in the TIVA group required less perioperative crystalloid (4172.46 +/- 1534.95 vs. 5183.91 +/- 1416.40 ml, p < 0.0001) and colloid (572.46 +/- 335.14 vs. 994.25 +/- 434.65 ml, p < 0.0001) to maintain hemodynamic stability. Although the mean anesthesia duration was shorter in the TIVA group (11.02 +/- 2.84 vs. 11.70 +/- 1.96 hours, p = 0.017), the blood loss was similar between groups (p = 0.71). There was no difference in surgical complication rate, but patients in the TIVA group developed fewer pulmonary complications (18 vs. 47, p = 0.0008). After multivariate regression, patients in the TIVA group had a significantly reduced risk of pulmonary complication compared with the inhalation group (Odds ratio 0.41, 95% CI 0.18-0.92). Conclusions Total intravenous anesthesia was associated with significantly fewer pulmonary complications in patients who received free flap reconstruction.	[Chang, Yi-Ting; Wu, Chih-Chen; Tang, Tsung-Yung; Shen, Ching-Hui] Taichung Vet Gen Hosp, Dept Anesthesiol, Taichung, Taiwan; [Lu, Chun-Te; Lai, Chih-Sheng] Taichung Vet Gen Hosp, Dept Surg, Div Plast & Reconstruct Surg, Taichung, Taiwan; [Shen, Ching-Hui] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Shen, CH (corresponding author), Taichung Vet Gen Hosp, Dept Anesthesiol, Taichung, Taiwan.; Shen, CH (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.	forscipaper@gmail.com		Chang, Yi-Ting/0000-0003-3421-742X				Booi DI, 2011, EUR J PLAST SURG, V34, P81, DOI 10.1007/s00238-010-0466-9; BrooksBrunn JA, 1997, CHEST, V111, P564, DOI 10.1378/chest.111.3.564; Clark JR, 2007, HEAD NECK-J SCI SPEC, V29, P1090, DOI 10.1002/hed.20639; Cole CD, 2007, NEUROSURGERY, V61, P369, DOI 10.1227/01.neu.0000303996.74526.30; Deryck YLJM, 2010, ACTA ANAESTH SCAND, V54, P979, DOI 10.1111/j.1399-6576.2010.02267.x; Gooneratne H, 2013, Acta Anaesthesiol Scand, V57, P1293, DOI 10.1111/aas.12180; Gupta A, 2004, ANESTH ANALG, V98, P632, DOI 10.1213/01.ANE.0000103187.70627.57; Hagau N, 2009, MICROSURG, V29, P161, DOI 10.1002/micr.20584; Haughey BH, 2001, OTOLARYNG HEAD NECK, V125, P10, DOI 10.1067/mhn.2001.116788; Kam PCA, 2007, ANAESTHESIA, V62, P690, DOI 10.1111/j.1365-2044.2007.05055.x; Kato R, 2002, CAN J ANAESTH, V49, P777, DOI 10.1007/BF03017409; le Nobel GJ, 2012, LARYNGOSCOPE, V122, P1014, DOI 10.1002/lary.22454; Ng JM, 2011, CURR OPIN ANESTHESIO, V24, P37, DOI 10.1097/ACO.0b013e32834141f7; Patel RS, 2010, HEAD NECK-J SCI SPEC, V32, P1345, DOI 10.1002/hed.21331; Sudheer PS, 2006, ANAESTHESIA, V61, P138, DOI 10.1111/j.1365-2044.2005.04464.x; Votta-Velis EG, 2007, ANESTH ANALG, V105, P1363, DOI 10.1213/01.ane.0000281144.06703.0d; Wei LG, 2013, J ANESTH, V27, P366, DOI 10.1007/s00540-012-1539-7; Zhong T, 2011, PLAST RECONSTR SURG, V128, P1153, DOI 10.1097/PRS.0b013e318221da56	18	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147713	10.1371/journal.pone.0147713	http://dx.doi.org/10.1371/journal.pone.0147713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849439	gold, Green Submitted, Green Published			2022-12-27	WOS:000369554000022
J	Kragstrup, TW; Jalilian, B; Keller, KK; Zhang, XW; Laustsen, JK; Stengaard-Pedersen, K; Hetland, ML; Horslev-Petersen, K; Junker, P; Ostergaard, M; Hauge, EM; Hvid, M; Vorup-Jensen, T; Deleuran, B				Kragstrup, Tue Wenzel; Jalilian, Babak; Keller, Kresten Krarup; Zhang, Xianwei; Laustsen, Julie Kristine; Stengaard-Pedersen, Kristian; Hetland, Merete Lund; Horslev-Petersen, Kim; Junker, Peter; Ostergaard, Mikkel; Hauge, Ellen-Margrethe; Hvid, Malene; Vorup-Jensen, Thomas; Deleuran, Bent			Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment Response	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; COLLAGEN-INDUCED ARTHRITIS; MONOCLONAL-ANTIBODY; EXPERIMENTAL-MODEL; SKG-ARTHRITIS; ADALIMUMAB; REMISSION; INTEGRINS; CLEAVAGE; PLASMA	Introduction In rheumatoid arthritis (RA) immune activation and presence of autoantibodies may precede clinical onset of disease, and joint destruction can progress despite remission. However, the underlying temporal changes of such immune system abnormalities in the inflammatory response during treat-to-target strategies remain poorly understood. We have previously reported low levels of the soluble form of CD18 (sCD18) in plasma from patients with chronic RA and spondyloarthritis. Here, we study the changes of sCD18 before and during treatment of early RA and following arthritis induction in murine models of rheumatoid arthritis. Methods The level of sCD18 was analyzed with a time-resolved immunoflourometric assay in 1) plasma from early treatment naive RA patients during a treat-to-target strategy (the OPERA cohort), 2) plasma from chronic RA patients, 3) serum from SKG and CIA mice following arthritis induction, and 4) supernatants from synovial fluid mononuclear cells (SFMCs) and peripheral blood mononuclear cells (PBMCs) from 6 RA patients cultured with TNF alpha or adalimumab. Results Plasma levels of sCD18 were decreased in chronic RA patients compared with early RA patients and in early RA patients compared with healthy controls. After 12 months of treatment the levels in early RA patients were similar to healthy controls. This normalization of plasma sCD18 levels was more pronounced in patients with very early disease who achieved an early ACR response. Plasma sCD18 levels were associated with radiographic progression. Correspondingly, the serum level of sCD18 was decreased in SKG mice 6 weeks after arthritis induction compared with healthy littermates. The sCD18 levels in both SKG and CIA mice exhibited a biphasic course after arthritis induction with an initial increase above baseline followed by a decline. Shedding of CD18 from RA SFMC and RA PBMC cultures was increased by TNF alpha and decreased by adalimumab. Conclusions The plasma sCD18 levels were altered in patients with RA, in mice with autoimmune arthritis and in cell cultures treated with TNFa and adalimumab. Decreased levels of plasma sCD18 could reflect autoimmunity in transition from early to chronic disease and normalization in response to treatment could reflect autoimmunity in remission.	[Kragstrup, Tue Wenzel; Jalilian, Babak; Zhang, Xianwei; Laustsen, Julie Kristine; Hvid, Malene; Vorup-Jensen, Thomas; Deleuran, Bent] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Kragstrup, Tue Wenzel; Keller, Kresten Krarup; Stengaard-Pedersen, Kristian; Hauge, Ellen-Margrethe; Deleuran, Bent] Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus, Denmark; [Hetland, Merete Lund; Ostergaard, Mikkel] Rigshosp, Copenhagen Ctr Arthrit Res, Glostrup, Denmark; [Hetland, Merete Lund; Ostergaard, Mikkel] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Horslev-Petersen, Kim] Univ Southern Denmark, Odense, Denmark; [Junker, Peter] Odense Univ Hosp, DK-5000 Odense, Denmark; [Hauge, Ellen-Margrethe; Hvid, Malene; Deleuran, Bent] Aarhus Univ, Dept Clin Med, Aarhus, Denmark	Aarhus University; Aarhus University; Rigshospitalet; University of Copenhagen; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Aarhus University	Kragstrup, TW (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.; Kragstrup, TW (corresponding author), Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus, Denmark.	kragstrup@biomed.au.dk	Hetland, Merete L/AAE-5297-2019; zhang, xuan/GQO-8953-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GRX-9733-2022; zhang, xu/GYE-3558-2022; zhang, xian/GYA-0290-2022; zhang, xuan/AAN-9914-2020; Keller, Kresten Krarup/S-2067-2019; Vorup-Jensen, Thomas/N-9082-2016	Hetland, Merete L/0000-0003-4229-6818; zhang, xuan/0000-0001-8775-1699; zhang, xuan/0000-0001-8775-1699; Keller, Kresten Krarup/0000-0003-2474-3389; Deleuran, Bent/0000-0002-7079-1587; Kragstrup, Tue Wenzel/0000-0002-6439-397X; Jalilian, Babak/0000-0001-9484-7429; Vorup-Jensen, Thomas/0000-0002-4140-6563; Horslev-Petersen, Kim/0000-0002-5475-7610	Danish Multiple Sclerosis Association; Novo Nordisk Foundation; Danish Council for Independent Research Medical Sciences	Danish Multiple Sclerosis Association; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF))	The work was supported by the Danish Multiple Sclerosis Association, the Novo Nordisk Foundation and the Danish Council for Independent Research Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend WP, 2012, NAT REV RHEUMATOL, V8, P573, DOI 10.1038/nrrheum.2012.134; Bullard DC, 1996, J IMMUNOL, V157, P3153; Chara L, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3928; Cohen SB, 2008, ARTHRITIS RHEUM, V58, P1299, DOI 10.1002/art.23417; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Eskan MA, 2012, NAT IMMUNOL, V13, P465, DOI 10.1038/ni.2260; Evans BJ, 2006, BLOOD, V107, P3593, DOI 10.1182/blood-2005-09-3695; Gjelstrup LC, 2010, J IMMUNOL, V185, P4154, DOI 10.4049/jimmunol.1000952; Gomez IG, 2012, J BIOL CHEM, V287, P4581, DOI 10.1074/jbc.M111.321182; HOLMDAHL R, 1989, APMIS, V97, P575, DOI 10.1111/j.1699-0463.1989.tb00446.x; Horslev-Petersen K, 2016, ANN RHEUM DIS, V75, P1645, DOI 10.1136/annrheumdis-2015-208166; Horslev-Petersen K, 2014, ANN RHEUM DIS, V73, P654, DOI 10.1136/annrheumdis-2012-202735; JASIN HE, 1992, ARTHRITIS RHEUM-US, V35, P541, DOI 10.1002/art.1780350508; KAVANAUGH AF, 1994, ARTHRITIS RHEUM, V37, P992, DOI 10.1002/art.1780370703; Kavanaugh AF, 1996, J RHEUMATOL, V23, P1338; Kavanaugh AF, 1997, ARTHRITIS RHEUM, V40, P849, DOI 10.1002/art.1780400511; Keller KK, 2011, CLIN EXP RHEUMATOL, V29, P536; Keller KK, 2013, RHEUMATOL INT, V33, P1127, DOI 10.1007/s00296-012-2500-7; Kobayashi K, 2006, INFLAMM RES, V55, P335, DOI 10.1007/s00011-006-5208-x; Kragstrup TW, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-263; Kragstrup TW, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4471; Lowin T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3464; Major EO, 2010, ANNU REV MED, V61, P35, DOI 10.1146/annurev.med.080708.082655; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nielsen GK, 2014, METHODS MOL BIOL, V1100, P355, DOI 10.1007/978-1-62703-724-2_30; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Shin HY, 2008, J CELL PHYSIOL, V214, P528, DOI 10.1002/jcp.21235; Shu Q, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3812; Solomon DH, 2014, ARTHRITIS RHEUMATOL, V66, P775, DOI 10.1002/art.38323; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Suchard SJ, 2010, J IMMUNOL, V184, P3917, DOI 10.4049/jimmunol.0901095; Tanaka Y, 2013, ANN RHEUM DIS, V72, P124, DOI 10.1136/annrheumdis-2012-202350; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; Vaisar T, 2009, MOL CELL PROTEOMICS, V8, P1044, DOI 10.1074/mcp.M800449-MCP200; Watterson SH, 2010, J MED CHEM, V53, P3814, DOI 10.1021/jm100348u; Zen K, 2011, BLOOD, V117, P4885, DOI 10.1182/blood-2010-05-287722	37	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148486	10.1371/journal.pone.0148486	http://dx.doi.org/10.1371/journal.pone.0148486			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849368	Green Published, gold			2022-12-27	WOS:000369554000105
J	Lenartowicz, E; Kesy, J; Ruszkowska, A; Soszynska-Jozwiak, M; Michalak, P; Moss, WN; Turner, DH; Kierzek, R; Kierzek, E				Lenartowicz, Elzbieta; Kesy, Julita; Ruszkowska, Agnieszka; Soszynska-Jozwiak, Marta; Michalak, Paula; Moss, Walter N.; Turner, Douglas H.; Kierzek, Ryszard; Kierzek, Elzbieta			Self-Folding of Naked Segment 8 Genomic RNA of Influenza A Virus	PLOS ONE			English	Article							SELECTIVE 2'-HYDROXYL ACYLATION; SECONDARY STRUCTURE; VIRAL-RNA; THERMODYNAMIC PROPERTIES; STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; INTERNAL LOOP; NMR STRUCTURE; NUCLEOPROTEIN; BINDING	Influenza A is a negative sense RNA virus that kills hundreds of thousands of humans each year. Base pairing in RNA is very favorable, but possibilities for RNA secondary structure of the influenza genomic RNA have not been investigated. This work presents the first experimentally-derived exploration of potential secondary structure in an influenza A naked (protein-free) genomic segment. Favorable folding regions are revealed by in vitro chemical structure mapping, thermodynamics, bioinformatics, and binding to isoenergetic microarrays of an entire natural sequence of the 875 nt segment 8 vRNA and of a smaller fragment. Segment 8 has thermodynamically stable and evolutionarily conserved RNA structure and encodes essential viral proteins NEP and NS1. This suggests that vRNA self-folding may generate helixes and loops that are important at one or more stages of the influenza life cycle.	[Lenartowicz, Elzbieta; Kesy, Julita; Ruszkowska, Agnieszka; Soszynska-Jozwiak, Marta; Michalak, Paula; Kierzek, Ryszard; Kierzek, Elzbieta] Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland; [Moss, Walter N.; Turner, Douglas H.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA	Polish Academy of Sciences; University of Rochester	Kierzek, E (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland.	elzbieta.kierzek@ibch.poznan.pl	Moss, Walter/H-8096-2019; Lenartowicz, Elzbieta/AAG-3134-2021; Piasecka, Julita/AAL-6552-2020; Lenartowicz, Elzbieta/G-3757-2016	Moss, Walter/0000-0001-6419-5570; Piasecka, Julita/0000-0003-1261-3878; Lenartowicz, Elzbieta/0000-0002-3596-4470; Kierzek, Elzbieta/0000-0002-5563-003X; Kierzek, Ryszard/0000-0002-7644-0016	National Science Center [N N301 788 440, UMO-2013/08/M/NZ1/01062, UMO-2011/03/B/NZ1/00576, UMO-2011/03/B/ST5/01098, UMO-2013/08/A/ST5/00295]; National Institutes of Health [R03TW008739, GM22939]; NIH [R03TW008739, GM22939]; FOGARTY INTERNATIONAL CENTER [R03TW008739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022939] Funding Source: NIH RePORTER	National Science Center(National Science Centre, Poland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Center grants: N N301 788 440 and UMO-2013/08/M/NZ1/01062 to EK, UMO-2011/03/B/NZ1/00576, UMO-2011/03/B/ST5/01098 and UMO-2013/08/A/ST5/00295 to RK and by National Institutes of Health grants: R03TW008739 to EK and DHT and GM22939 to DHT.; This work was supported by National Science Center grants: N N301 788 440 and UMO-2013/08/M/NZ1/01062 to EK, UMO-2011/03/B/NZ1/00576, UMO-2011/03/B/ST5/01098 and UMO-2013/08/A/ST5/00295 to RK and by NIH grants: R03TW008739 to EK and DHT and GM22939 to DHT. We thank Prof. Baek Kim for the gift of plasmid containing the sequence of segment 8 and Prof. Luis Martinez-Sobrido for information about the strain used. DHT thanks Prof. Susan Schroeder for insight into interpretation of data.	Afanassiev V, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e66; Arranz R, 2012, SCIENCE, V338, P1634, DOI 10.1126/science.1228172; Bae SH, 2001, P NATL ACAD SCI USA, V98, P10602, DOI 10.1073/pnas.191268798; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; CROTHERS DM, 1974, J MOL BIOL, V87, P63, DOI 10.1016/0022-2836(74)90560-9; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; Essere B, 2013, P NATL ACAD SCI USA, V110, pE3840, DOI 10.1073/pnas.1308649110; Flick R, 1999, J GEN VIROL, V80, P2565, DOI 10.1099/0022-1317-80-10-2565; Fournier E, 2012, VACCINE, V30, P7359, DOI 10.1016/j.vaccine.2012.09.079; Fournier E, 2012, NUCLEIC ACIDS RES, V40, P2197, DOI 10.1093/nar/gkr985; Fratczak A, 2011, BIOCHEMISTRY-US, V50, P7647, DOI 10.1021/bi200463p; Fratczak A, 2009, BIOCHEMISTRY-US, V48, P514, DOI 10.1021/bi8021069; Fujii K, 2005, J VIROL, V79, P3766, DOI 10.1128/JVI.79.6.3766-3774.2005; Gavazzi C, 2013, P NATL ACAD SCI USA, V110, P16604, DOI 10.1073/pnas.1314419110; Gavazzi C, 2013, NUCLEIC ACIDS RES, V41, P1241, DOI 10.1093/nar/gks1181; Ge Q, 2006, ANTIMICROB AGENTS CH, V50, P3724, DOI 10.1128/AAC.00644-06; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gruber AR, 2010, BIOCOMPUT-PAC SYM, P69; Gultyaev AP, 2014, RNA BIOL, V11, P942, DOI 10.4161/rna.29730; Gultyaev AP, 2010, INT REV IMMUNOL, V29, P533, DOI 10.3109/08830185.2010.507828; Gultyaev AP, 2010, RNA BIOL, V7, P125, DOI 10.4161/rna.7.2.11287; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hofacker IL, 2004, BIOINFORMATICS, V20, P1495, DOI 10.1093/bioinformatics/bth108; HSU MT, 1987, P NATL ACAD SCI USA, V84, P8140, DOI 10.1073/pnas.84.22.8140; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jiang T, 2014, BIOCHEMISTRY-US, V53, P5236, DOI 10.1021/bi500611j; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kierzek E, 2006, BIOCHEMISTRY-US, V45, P581, DOI 10.1021/bi051409+; Kierzek E, 2005, NUCLEIC ACIDS RES, V33, P5082, DOI 10.1093/nar/gki789; Kierzek E, 2003, NUCLEIC ACIDS RES, V31, P4461, DOI 10.1093/nar/gkg632; Kierzek E, 2008, NUCLEIC ACIDS RES, V36, P1770, DOI 10.1093/nar/gkm1085; Kierzek E, 2009, BIOCHEMISTRY-US, V48, P11344, DOI 10.1021/bi901264v; Kierzek E, 2009, J MOL BIOL, V390, P428, DOI 10.1016/j.jmb.2009.04.048; Kierzek R, 2015, NUCLEIC ACIDS RES, V43, P1, DOI 10.1093/nar/gku1303; Kladwang W, 2014, BIOCHEMISTRY-US, V53, P3063, DOI 10.1021/bi5003426; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; Krasilnikov AS, 2003, NATURE, V421, P760, DOI 10.1038/nature01386; Lerman YV, 2011, RNA, V17, P1664, DOI 10.1261/rna.2641911; Liang RT, 2010, BIOCHEMISTRY-US, V49, P8155, DOI 10.1021/bi100286n; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, P3738, DOI 10.1093/nar/gkn266; Lu ZJ, 2009, RNA, V15, P1805, DOI 10.1261/rna.1643609; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Moeller A, 2012, SCIENCE, V338, P1631, DOI 10.1126/science.1227270; Moss WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038323; Moss WN, 2011, RNA, V17, P991, DOI 10.1261/rna.2619511; Nguyen-Van-Tam JS, 2003, VACCINE, V21, P1762, DOI 10.1016/S0264-410X(03)00069-0; Pasternak A, 2008, BIOCHEMISTRY-US, V47, P1249, DOI 10.1021/bi701758z; Pasternak A, 2007, NUCLEIC ACIDS RES, V35, P4055, DOI 10.1093/nar/gkm421; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; Poland GA, 2007, VACCINE, V25, P3057, DOI 10.1016/j.vaccine.2007.01.050; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Priore SF, 2015, BIOCHEMISTRY-US, V54, P3413, DOI 10.1021/bi501564d; Priore SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070615; Priore SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035989; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Schroeder SJ, 2014, BIOCHEMISTRY-US, V53, P6728, DOI 10.1021/bi501051k; Schroeder SJ, 2011, BIOPHYS J, V101, P167, DOI 10.1016/j.bpj.2011.05.053; Shao Y, 2007, RNA, V13, P1631, DOI 10.1261/rna.546207; Shapshak P, 2011, MOL DIAGN THER, V15, P63, DOI 10.2165/11590660-000000000-00000; Soszynska-Jozwiak M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141132; Suspene R, 2011, J VIROL, V85, P2458, DOI 10.1128/JVI.02138-10; Suzuki Y, 2013, INFECT GENET EVOL, V13, P175, DOI 10.1016/j.meegid.2012.10.007; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; YAMANAKA K, 1990, J BIOL CHEM, V265, P11151; Zhang T, 2011, INT IMMUNOPHARMACOL, V11, P2057, DOI 10.1016/j.intimp.2011.08.019; Zheng WJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003624; Znosko BM, 2002, BIOCHEMISTRY-US, V41, P14969, DOI 10.1021/bi020326f; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	82	23	23	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148281	10.1371/journal.pone.0148281	http://dx.doi.org/10.1371/journal.pone.0148281			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848969	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000065
J	Myers, CA; Slack, T; Martin, CK; Broyles, ST; Heymsfield, SB				Myers, Candice A.; Slack, Tim; Martin, Corby K.; Broyles, Stephanie T.; Heymsfield, Steven B.			Change in Obesity Prevalence across the United States Is Influenced by Recreational and Healthcare Contexts, Food Environments, and Hispanic Populations	PLOS ONE			English	Article							BODY-MASS INDEX; GEOGRAPHIC-DISTRIBUTION; US; COUNTY; DISPARITIES; ADULTS	Objective To examine change in county-level adult obesity prevalence between 2004 and 2009 and identify associated community characteristics. Methods Change in county-level adult (>= 20 years) obesity prevalence was calculated for a 5-year period (2004-2009). Community measures of economic, healthcare, recreational, food environment, population structure, and education contexts were also calculated. Regression analysis was used to assess community characteristics associated (p<0.01) with change in adult obesity prevalence. Results Mean +/- SD change in obesity prevalence was 5.1 +/- 2.4%. Obesity prevalence decreased in 1.4% (n = 44) and increased in 98% (n = 3,060) of counties from 2004-2009. Results showed that both baseline levels and increases in physically inactive adults were associated with greater increases in obesity prevalence, while baseline levels of and increases in physician density and grocery store/supercenter density were related to smaller increases in obesity rates. Baseline levels of the Hispanic population share were negatively linked to changing obesity levels, while places with greater Hispanic population growth saw greater increases in obesity. Conclusions Most counties in the U.S. experienced increases in adult obesity prevalence from 2004 to 2009. Findings suggest that community-based interventions targeting adult obesity need to incorporate a range of community factors, such as levels of physical inactivity, access to physicians, availability of food outlets, and ethnic/racial population composition.	[Myers, Candice A.; Martin, Corby K.; Broyles, Stephanie T.; Heymsfield, Steven B.] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Slack, Tim] Louisiana State Univ, Dept Sociol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University	Myers, CA (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	candice.myers@pbrc.edu	Heymsfield, Steven B/N-1968-2017; Myers, Candice/N-1979-2017; Broyles, Stephanie/C-8647-2011; Martin, Corby K./N-1976-2017	Heymsfield, Steven B/0000-0003-1127-9425; Myers, Candice/0000-0003-1923-3448; Broyles, Stephanie/0000-0003-3168-0056; Martin, Corby K./0000-0002-8125-4015	American Heart Association [11GRNT7750027]; NORC Center Grant - NIDDK [2P30DK072476]; National Institute of General Medical Sciences of the National Institutes of Health [1 U54 GM104940]; National Heart Lung and Blood Institute of the National Institutes of Health [1 F32 HL123242]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL123242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NORC Center Grant - NIDDK; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was partially supported by 1) 11GRNT7750027 from the American Heart Association, 2) NORC Center Grant #2P30DK072476 entitled "Nutritional Programming: Environmental and Molecular Interactions" sponsored by NIDDK, 3) 1 U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health, which funds the Louisiana Clinical and Translational Science Center, and 4) 1 F32 HL123242 from the National Heart Lung and Blood Institute of the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott G, 2014, OBESITY, V22, P2413, DOI 10.1002/oby.20853; Ahern M, 2011, J RURAL HEALTH, V27, P367, DOI 10.1111/j.1748-0361.2011.00378.x; An R, 2014, ISRN OBESITY, V2014, P6; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Anselin L, 2005, EXPLORING SPATIAL DA; Barker LE, 2011, AM J PREV MED, V40, P434, DOI 10.1016/j.amepre.2010.12.019; Black JL, 2008, NUTR REV, V66, P2, DOI 10.1111/j.1753-4887.2007.00001.x; Cadwell BL., 2005, J DATA SCI, V8, P173; Center for Disease Control and Prevention, 2009, CTR DIS CONTR PREV D; Chi G, 2008, POPUL RES POLICY REV, V27, P17, DOI 10.1007/s11113-007-9051-8; Crimmins EM, 2007, AM J PUBLIC HEALTH, V97, P1305, DOI 10.2105/AJPH.2006.091892; Drewnowski A, 2014, INT J OBESITY, V38, P833, DOI 10.1038/ijo.2013.179; Dwyer-Lindgren L, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-7; Ennis S. R., 2011, HISPANIC POPULATION; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Ford PB, 2008, NUTR REV, V66, P216, DOI 10.1111/j.1753-4887.2008.00026.x; Gregg EW, 2010, JAMA-J AM MED ASSOC, V303, P933; Gutierrez-Fisac JL, 1999, INT J OBESITY, V23, P342, DOI 10.1038/sj.ijo.0800823; Hillemeier MM, 2003, HEALTH SERV RES, V38, P1645, DOI 10.1111/j.1475-6773.2003.00198.x; Jenkins JC, 2001, AM SOCIOL REV, V66, P718, DOI 10.2307/3088955; Kutner M. H., 2004, APPL LINEAR REGRESSI; Kwan MP, 2012, ANN ASSOC AM GEOGR, V102, P958, DOI 10.1080/00045608.2012.687349; Le A, 2014, OBESITY, V22, P300, DOI 10.1002/oby.20451; Michimi A, 2010, AM J PREV MED, V39, pE1, DOI 10.1016/j.amepre.2010.04.008; Moreno JP, 2015, J RACIAL ETHN HEALTH, P1; Morland KB, 2009, HEALTH PLACE, V15, P491, DOI 10.1016/j.healthplace.2008.09.004; Myers CA, 2015, OBESITY, V23, P481, DOI 10.1002/oby.20963; Pouliou T, 2009, PREV MED, V48, P362, DOI 10.1016/j.ypmed.2009.01.017; Roux AVD, 2007, AM J PUBLIC HEALTH, V97, P493, DOI 10.2105/AJPH.2006.087734; Saib MS, 2014, INT J ENV RES PUB HE, V11, P3765, DOI 10.3390/ijerph110403765; Shrestha SS, 2012, OPEN DIABETES J, V5, P29, DOI DOI 10.2174/1876524601205010029; Singleton CR, AM J PREVENTIVE MED; Slack T, 2014, OBESITY, V22, P868, DOI 10.1002/oby.20502; Slack T, 2012, SOC SCI RES, V41, P263, DOI 10.1016/j.ssresearch.2011.10.001; Sturm R, 2014, CA-CANCER J CLIN, V64, P337, DOI 10.3322/caac.21237; US Bureau of the Census, POP EST; Vanhulst J., 2015, POPULATION RES POLIC, P1; Voss PR, 2006, POPUL RES POLICY REV, V25, P369, DOI 10.1007/s11113-006-9007-4	38	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148394	10.1371/journal.pone.0148394	http://dx.doi.org/10.1371/journal.pone.0148394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26849803	gold, Green Published			2022-12-27	WOS:000369554000085
J	Phanthanawiboon, S; Limkittikul, K; Sakai, Y; Takakura, N; Saijo, M; Kurosu, T				Phanthanawiboon, Supranee; Limkittikul, Kriengsak; Sakai, Yusuke; Takakura, Nobuyuki; Saijo, Masayuki; Kurosu, Takeshi			Acute Systemic Infection with Dengue Virus Leads to Vascular Leakage and Death through Tumor Necrosis Factor-alpha and Tie2/Angiopoietin Signaling in Mice Lacking Type I and II Interferon Receptors	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; AG129 MICE; PLASMA LEAKAGE; ANGIOPOIETIN-1; MODEL; DISEASE; IMMUNOPATHOGENESIS; PATHOGENESIS; EXPRESSION; SURVIVAL	Severe dengue is caused by host responses to viral infection, but the pathogenesis remains unknown. This is, in part, due to the lack of suitable animal models. Here, we report a nonmouse-adapted low-passage DENV-3 clinical isolate, DV3P12/08, derived from recently infected patients. DV3P12/08 caused a lethal systemic infection in type I and II IFN receptor KO mice (IFN-alpha/beta/gamma R KO mice), which have the C57/BL6 background. Infection with DV3P12/08 induced a cytokine storm, resulting in severe vascular leakage (mainly in the liver, kidney and intestine) and organ damage, leading to extensive hemorrhage and rapid death. DV3P12/08 infection triggered the release of large amounts of TNF-alpha, IL-6, and MCP-1. Treatment with a neutralizing anti-TNF-alpha antibody (Ab) extended survival and reduced liver damage without affecting virus production. Anti-IL-6 neutralizing Ab partly prolonged mouse survival. The anti-TNF-alpha Ab suppressed IL-6, MCP-1, and IFN-gamma levels, suggesting that the severe response to infection was triggered by TNF-alpha. High levels of TNF-alpha mRNA were expressed in the liver and kidneys, but not in the small intestine, of infected mice. Conversely, high levels of IL-6 mRNA were expressed in the intestine. Importantly, treatment with Angiopoietin-1, which is known to stabilize blood vessels, prolonged the survival of DV3P12/08-infected mice. Taken together, the results suggest that an increased level of TNF-alpha together with concomitant upregulation of Tie2/Angiopoietin signaling have critical roles in severe dengue infection.	[Phanthanawiboon, Supranee; Sakai, Yusuke; Takakura, Nobuyuki; Kurosu, Takeshi] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 565, Japan; [Limkittikul, Kriengsak] Mahidol Univ, Dept Trop Pediat, Fac Trop Med, Bangkok 10700, Thailand; [Saijo, Masayuki] Natl Inst Infect Dis, Dept Virol 1, Shinjyuku Ku, Tokyo, Japan; [Phanthanawiboon, Supranee] Khon Kaen Univ, Fac Med, Dept Microbiol, Res & Diagnost Ctr Emerging Infect Dis, Khon Kaen, Thailand; [Sakai, Yusuke] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Pathol, Yamaguchi, Yamaguchi, Japan; [Kurosu, Takeshi] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan	Osaka University; Mahidol University; National Institute of Infectious Diseases (NIID); Khon Kaen University; Yamaguchi University; National Institute of Infectious Diseases (NIID)	Kurosu, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 565, Japan.	kurosu@niid.go.jp	Saijo, Masayuki/L-2697-2019	Saijo, Masayuki/0000-0001-5458-7298	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [21790444, 15K14885]; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by: 1. A grant-in-aid (21790444 and 15K14885) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan for supporting reagents, preparation of the manuscript. 2. A program of the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) (http://www.crnid.riken.jp/jgrid/) launched by a project commissioned by the MEXT for supporting reagents, preparation of the manuscript.	Atrasheuskaya A, 2003, FEMS IMMUNOL MED MIC, V35, P33, DOI 10.1111/j.1574-695X.2003.tb00646.x; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; David S, 2011, CYTOKINE, V55, P251, DOI 10.1016/j.cyto.2011.04.005; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Fuchs J, 2014, VACCINE, V32, P6537, DOI 10.1016/j.vaccine.2014.08.087; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Huang YQ, 2000, BLOOD, V95, P1993, DOI 10.1182/blood.V95.6.1993; Kurane I, 2007, COMP IMMUNOL MICROB, V30, P329, DOI 10.1016/j.cimid.2007.05.010; Lei HY, 2001, J BIOMED SCI, V8, P377, DOI 10.1007/BF02255946; Michels M, 2012, AM J TROP MED HYG, V87, P943, DOI 10.4269/ajtmh.2012.12-0020; Milam KE, 2015, TISSUE BARRIERS, V3, DOI DOI 10.4161/21688362.2014.957508; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031; Overbergh L, 2003, J Biomol Tech, V14, P33; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Sancakdar E, 2015, PEDIATR INFECT DIS J, V34, pE200, DOI 10.1097/INF.0000000000000706; Sarathy VV, 2015, J VIROL, V89, P1254, DOI 10.1128/JVI.01320-14; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Setthapramote C, 2012, BIOCHEM BIOPH RES CO, V423, P867, DOI 10.1016/j.bbrc.2012.06.057; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; Shu PY, 2003, J CLIN MICROBIOL, V41, P2408, DOI 10.1128/JCM.41.6.2408-2416.2003; Srichaikul T, 2000, BEST PRACT RES CL HA, V13, P261, DOI 10.1053/beha.2000.0073; Stein DA, 2008, J ANTIMICROB CHEMOTH, V62, P555, DOI 10.1093/jac/dkn221; Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; van de Weg CAM, 2014, J CLIN VIROL, V60, P328, DOI 10.1016/j.jcv.2014.05.001; Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008; Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022; Witzenbichler B, 2005, CIRCULATION, V111, P97, DOI 10.1161/01.CIR.0000151287.08202.8E	35	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148564	10.1371/journal.pone.0148564	http://dx.doi.org/10.1371/journal.pone.0148564			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844767	Green Published, Green Submitted, gold			2022-12-27	WOS:000369552800070
J	Robertson, D; Zanartu, M; Cook, D				Robertson, Daniel; Zanartu, Matias; Cook, Douglas			Comprehensive, Population-Based Sensitivity Analysis of a Two-Mass Vocal Fold Model	PLOS ONE			English	Article							AIR-FLOW; CHAOTIC VIBRATIONS; NONLINEAR DYNAMICS; VOICE; BIFURCATIONS; PARAMETERS; PHONATION; SPEAKERS; TRACT	Previous vocal fold modeling studies have generally focused on generating detailed data regarding a narrow subset of possible model configurations. These studies can be interpreted to be the investigation of a single subject under one or more vocal conditions. In this study, a broad population-based sensitivity analysis is employed to examine the behavior of a virtual population of subjects and to identify trends between virtual individuals as opposed to investigating a single subject or model instance. Four different sensitivity analysis techniques were used in accomplishing this task. Influential relationships between model input parameters and model outputs were identified, and an exploration of the model's parameter space was conducted. Results indicate that the behavior of the selected two-mass model is largely dominated by complex interactions, and that few input-output pairs have a consistent effect on the model. Results from the analysis can be used to increase the efficiency of optimization routines of reduced-order models used to investigate voice abnormalities. Results also demonstrate the types of challenges and difficulties to be expected when applying sensitivity analyses to more complex vocal fold models. Such challenges are discussed and recommendations are made for future studies.	[Robertson, Daniel; Cook, Douglas] New York Univ Abu Dhabi, Div Engn, Abu Dhabi, U Arab Emirates; [Zanartu, Matias] Univ Tecn Federico Santa Maria, Dept Elect Engn, Valparaiso, Chile	Universidad Tecnica Federico Santa Maria	Cook, D (corresponding author), New York Univ Abu Dhabi, Div Engn, Abu Dhabi, U Arab Emirates.	douglascook@nyu.edu	Zañartu, Matías/I-3133-2012; Robertson, Daniel J/F-1864-2018; Cook, Douglas/AAN-2311-2021; Cook, Douglas/B-3318-2017; Zañartu, Matías/N-1338-2019	Zañartu, Matías/0000-0001-5581-4392; Robertson, Daniel J/0000-0003-1089-0249; Cook, Douglas/0000-0002-1731-1978; Zañartu, Matías/0000-0001-5581-4392				Anderson-Cook C.M., 2016, RESPONSE SURFACE MET; Avanzini F, 2006, ACTA ACUST UNITED AC, V92, P731; Baken RJ, 2000, CLIN MEASUREMENT SPE; Berry DA, 1996, J VOICE, V10, P129, DOI 10.1016/S0892-1997(96)80039-7; Birkholz P., 2011, 1 INT WORKSHOP PERFO; Birkholz P, 2011, INTERSPEECH; Birkholz P, 2011, IEEE T AUDIO SPEECH, V19, P1422, DOI 10.1109/TASL.2010.2091632; Chan K., 2000, SENSITIVITY ANAL; CHILDERS DG, 1991, J ACOUST SOC AM, V90, P2394, DOI 10.1121/1.402044; Cook D, 2009, THESIS PURDUE U; Cook D, 2014, J BIOMECH, V47, P1241, DOI 10.1016/j.jbiomech.2014.01.040; Cook DD, 2009, J ACOUST SOC AM, V126, P2002, DOI 10.1121/1.3183592; COTTER SC, 1979, BIOMETRIKA, V66, P317; Czitrom V, 1999, AM STAT, V53, P126, DOI 10.2307/2685731; de Vries MP, 2002, J ACOUST SOC AM, V111, P1847, DOI 10.1121/1.1323716; Dejonckere PH, 2009, FOLIA PHONIATR LOGO, V61, P171, DOI 10.1159/000219952; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; DYKSTRA O, 1971, TECHNOMETRICS, V13, P682; Erath BD, 2013, SPEECH COMMUNICATION; Erath BD, 2011, J ACOUST SOC AM, V130, P389, DOI 10.1121/1.3586785; Golowasch J, 2002, J NEUROPHYSIOL, V87, P1129, DOI 10.1152/jn.00412.2001; HERZEL H, 1995, CHAOS, V5, P30, DOI 10.1063/1.166078; HILLMAN RE, 1989, J SPEECH HEAR RES, V32, P373, DOI 10.1044/jshr.3202.373; HOLMBERG EB, 1988, J ACOUST SOC AM, V84, P511, DOI 10.1121/1.396829; Horacek J, 2005, J FLUID STRUCT, V20, P853, DOI 10.1016/j.jfluidstructs.2005.05.003; ISHIZAKA K, 1972, AT&T TECH J, V51, P1233, DOI 10.1002/j.1538-7305.1972.tb02651.x; Jiang JJ, 2003, J ACOUST SOC AM, V114, P2198, DOI 10.1121/1.1610462; Jiang JJ, 2001, J ACOUST SOC AM, V110, P2120, DOI 10.1121/1.1395596; Kalos M. H., 2008, MONTE CARLO METHODS; KIEFER J, 1959, J ROY STAT SOC B, V21, P272; Lohscheller J, 2007, MED IMAGE ANAL, V11, P400, DOI 10.1016/j.media.2007.04.005; Lous NJC, 1998, ACUSTICA, V84, P1135; Lucero JC, 2005, J ACOUST SOC AM, V117, P1362, DOI 10.1121/1.1853235; Mehta DD, 2011, J ACOUST SOC AM, V130, P3999, DOI 10.1121/1.3658441; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Osheroff DD, 2004, ORAL SPEECH PURDUE U; PELORSON X, 1994, J ACOUST SOC AM, V96, P3416, DOI 10.1121/1.411449; Perkell J, 1997, SPEECH COMMUN, V22, P227, DOI 10.1016/S0167-6393(97)00026-5; PERKELL JS, 1994, J ACOUST SOC AM, V96, P695, DOI 10.1121/1.410307; Pickup BA, 2011, J ACOUST SOC AM, V129, P2121, DOI 10.1121/1.3557046; Schwarz R, 2008, J ACOUST SOC AM, V123, P2717, DOI 10.1121/1.2902167; Sciamarella D, 2004, ACTA ACUST UNITED AC, V90, P746; Sommer DE, 2012, J ACOUST SOC AM, V132, pEL271, DOI 10.1121/1.4734013; STEINECKE I, 1995, J ACOUST SOC AM, V97, P1874, DOI 10.1121/1.412061; Stevens K.N., 2000, ACOUSTIC PHONETICS, V30; STORY BH, 1995, J ACOUST SOC AM, V97, P1249, DOI 10.1121/1.412234; Su MC, 2002, J LARYNGOL OTOL, V116, P447, DOI 10.1258/0022215021911257; Tao C, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061922; Titze I. R., 2000, PRINCIPLES VOICE PRO; Titze IR, 2008, J ACOUST SOC AM, V123, P2733, DOI 10.1121/1.2832337; TITZE IR, 1992, J ACOUST SOC AM, V91, P2936, DOI 10.1121/1.402929; Titze IR, 2002, J ACOUST SOC AM, V112, P1064, DOI 10.1121/1.1496080; Tokuda IT, 2010, J ACOUST SOC AM, V127, P1528, DOI 10.1121/1.3299201; Ximenes JA, 2005, ANN OTO RHINOL LARYN, V114, P390, DOI 10.1177/000348940511400510; Yang AX, 2010, J ACOUST SOC AM, V127, P1014, DOI 10.1121/1.3277165; Zanartu M, 2007, J ACOUST SOC AM, V121, P1119, DOI 10.1121/1.2409491; Zhang Y, 2004, J ACOUST SOC AM, V115, P1266, DOI 10.1121/1.1648974	57	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148309	10.1371/journal.pone.0148309	http://dx.doi.org/10.1371/journal.pone.0148309			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845452	gold, Green Published			2022-12-27	WOS:000369552800045
J	Smith, TB; Parker, M; Steinkamp, PN; Weleber, RG; Smith, N; Wilson, DJ				Smith, Travis B.; Parker, Maria; Steinkamp, Peter N.; Weleber, Richard G.; Smith, Ning; Wilson, David J.		VPA Clinical Trial Study Grp; EZ Working Grp	Structure-Function Modeling of Optical Coherence Tomography and Standard Automated Perimetry in the Retina of Patients with Autosomal Dominant Retinitis Pigmentosa	PLOS ONE			English	Article							VISUAL-FIELD LOSS; USHER-SYNDROME; MULTIFOCAL ELECTRORETINOGRAM; NATURAL COURSE; SENSITIVITY; THICKNESS; TRANSFORMATIONS; BOUNDARIES; THRESHOLD; RECEPTOR	Purpose To assess relationships between structural and functional biomarkers, including new topographic measures of visual field sensitivity, in patients with autosomal dominant retinitis pigmentosa. Methods Spectral domain optical coherence tomography line scans and hill of vision (HOV) sensitivity surfaces from full-field standard automated perimetry were semi-automatically aligned for 60 eyes of 35 patients. Structural biomarkers were extracted from outer retina b-scans along horizontal and vertical midlines. Functional biomarkers were extracted from local sensitivity profiles along the b-scans and from the full visual field. These included topographic measures of functional transition such as the contour of most rapid sensitivity decline around the HOV, herein called HOV slope for convenience. Biomarker relationships were assessed pairwise by coefficients of determination (R-2) from mixed-effects analysis with automatic model selection. Results Structure-function relationships were accurately modeled (conditional R-2>0.8 in most cases). The best-fit relationship models and correlation patterns for horizontally oriented biomarkers were different than vertically oriented ones. The structural biomarker with the largest number of significant functional correlates was the ellipsoid zone (EZ) width, followed by the total photoreceptor layer thickness. The strongest correlation observed was between EZ width and HOV slope distance (marginal R-2 = 0.85, p<10(-10)). The mean sensitivity defect at the EZ edge was 7.6 dB. Among all functional biomarkers, the HOV slope mean value, HOV slope mean distance, and maximum sensitivity along the b-scan had the largest number of significant structural correlates. Conclusions Topographic slope metrics show promise as functional biomarkers relevant to the transition zone. EZ width is strongly associated with the location of most rapid HOV decline.	[Smith, Travis B.; Parker, Maria; Steinkamp, Peter N.; Weleber, Richard G.; Wilson, David J.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Smith, Ning] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA	Oregon Health & Science University; Kaiser Permanente	Smith, TB (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	smittrav@ohsu.edu		Ferris, Frederick/0000-0002-4933-0639; Iannaccone, Alessandro/0000-0001-5737-8424	Foundation Fighting Blindness Clinical Research Institute (FFB-CRI); FFB-CRI; Department of Defense [W81XWH-09-2-0189]	Foundation Fighting Blindness Clinical Research Institute (FFB-CRI); FFB-CRI; Department of Defense(United States Department of Defense)	This work was supported by Maryrose Sylvester and the Foundation Fighting Blindness Clinical Research Institute (FFB-CRI). The VPA Clinical Trial is co-sponsored by the FFB-CRI and the Department of Defense (W81XWH-09-2-0189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa S, 2009, EYE, V23, P304, DOI 10.1038/sj.eye.6703076; Barteselli G, 2013, AM J OPHTHALMOL, V156, P588, DOI 10.1016/j.ajo.2013.04.030; Battu R, 2015, EYE, V29, P895, DOI 10.1038/eye.2015.61; BERSON EL, 1985, AM J OPHTHALMOL, V99, P240, DOI 10.1016/0002-9394(85)90351-4; Birch DG, 2015, OPHTHALMOLOGY, V122, P833, DOI 10.1016/j.ophtha.2014.11.005; Birch DG, 2013, JAMA OPHTHALMOL, V131, P1143, DOI 10.1001/jamaophthalmol.2013.4160; Birch DG, 2011, INVEST OPHTH VIS SCI, V52, P7141, DOI 10.1167/iovs.11-7509; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Burnham KP, 2002, MODEL SELECTION MULT, P81; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Fakin A, 2012, VISION RES, V75, P60, DOI 10.1016/j.visres.2012.08.017; Fishman GA, 2007, RETINA-J RET VIT DIS, V27, P601, DOI 10.1097/01.iae.0000246675.88911.2c; FLAMMER J, 1985, INVEST OPHTH VIS SCI, V26, P176; Grobbel JM, 2011, THESIS U TUBINGEN; HEIJL A, 1987, ARCH OPHTHALMOL-CHIC, V105, P1544; Hood DC, 2011, BIOMED OPT EXPRESS, V2, P1106, DOI 10.1364/BOE.2.001106; Hood DC, 2011, INVEST OPHTH VIS SCI, V52, P101, DOI 10.1167/iovs.10-5799; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P2328, DOI 10.1167/iovs.08-2936; Iannaccone A, 2004, INVEST OPHTH VIS SCI, V45, P784, DOI 10.1167/iovs.03-0906; Jacobson SG, 2010, INVEST OPHTH VIS SCI, V51, P1079, DOI 10.1167/iovs.09-4372; Jacobson SG, 2009, INVEST OPHTH VIS SCI, V50, P1886, DOI 10.1167/iovs.08-3122; JACOBSON SG, 1986, OPHTHALMOLOGY, V93, P1604; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; Lujan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1486, DOI 10.1167/iovs.10-5946; MASSOF RW, 1990, CLIN VISION SCI, V5, P1; McKean-Cowdin R, 2007, AM J OPHTHALMOL, V143, P1013, DOI 10.1016/j.ajo.2007.02.022; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Ramachandran R, 2013, TRANSL VIS SCI TECHN, V2, DOI 10.1167/tvst.2.7.5; Rangaswamy NV, 2010, INVEST OPHTH VIS SCI, V51, P4213, DOI 10.1167/iovs.09-4945; Roman AJ, 2005, EXP EYE RES, V80, P259, DOI 10.1016/j.exer.2004.09.008; Schiefer U, 2009, INVEST OPHTH VIS SCI, V50, P488, DOI 10.1167/iovs.08-2229; Seiple W, 2004, DOC OPHTHALMOL, V109, P255, DOI 10.1007/s10633-005-0567-0; Smith T, 2015, INVEST OPHTHALMOL VI, V56; Spry PGD, 2002, OPTOMETRY VISION SCI, V79, P93, DOI 10.1097/00006324-200202000-00010; Swanson WH, 2000, OPHTHALMOLOGY, V107, P1950, DOI 10.1016/S0161-6420(00)00356-0; TIBSHIRANI R, 1988, J AM STAT ASSOC, V83, P394, DOI 10.2307/2288855; Weleber RG, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.2.14; Wen Y, 2012, INVEST OPHTH VIS SCI, V53, P833, DOI 10.1167/iovs.11-8410; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	40	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148022	10.1371/journal.pone.0148022	http://dx.doi.org/10.1371/journal.pone.0148022			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845445	Green Submitted, Green Published, gold			2022-12-27	WOS:000369552800025
J	Chen, ZQ; Yu, K; Zhu, F; Gorczynski, R				Chen, Zhiqi; Yu, Kai; Zhu, Fang; Gorczynski, Reginald			Over-Expression of CD200 Protects Mice from Dextran Sodium Sulfate Induced Colitis	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; TOLL-LIKE RECEPTORS; REGULATORY T-CELLS; INTESTINAL BACTERIA; MOLECULE OX-2; MURINE MODEL; INFLAMMATION; TOLERANCE; PATHOGENESIS; INDUCTION	Background and aim CD200: CD200 receptor (CD200R) interactions lead to potent immunosuppression and inhibition of autoimmune inflammation. We investigated the effect of "knockout" of CD200 or CD200R, or over-expression of CD200, on susceptibility to dextran sodium sulfate (DSS) induced colitis, a mouse model of inflammatory bowel disease (IBD). Methods Acute or chronic colitis was induced by administration of dextran sodium sulfate (DSS) in four groups of age-matched C57BL/6 female mice: (1) CD200-transgenic mice (CD200tg); (2) wild-type (WT) mice; (3) CD200 receptor 1-deficient (CD200R1KO) mice; and (4) CD200-deficient (CD200KO) mice. The extent of colitis was determined using a histological scoring system. Colon tissues were collected for quantitative RT-PCR and Immunohistochemical staining. Supernatants from colonic explant cultures and mononuclear cells isolated from colonic tissue were used for ELISA. Results CD200KO and CD200R1KO mice showed greater sensitivity to acute colitis than WT mice, with accelerated loss of body weight, significantly higher histological scores, more severe infiltration of macrophages, neutrophils and CD3+ cells, and greater expression of macrophage-derived inflammatory cytokines, whose production was inhibited in vitro (in WT/CD200KO mouse cells) by CD200. In contrast, CD200tg mice showed less sensitivity to DSS compared with WT mice, with attenuation of all of the features seen in other groups. In a chronic colitis model, greater infiltration of Foxp3(+) regulatory T (Treg) cells was seen in the colon of CD200tg mice compared to WT mice, and anti-CD25 mAb given to these mice attenuated protection. Conclusions The CD200: CD200R axis plays an immunoregulatory role in control of DSS induced colitis in mice.	[Chen, Zhiqi; Yu, Kai; Zhu, Fang; Gorczynski, Reginald] Univ Toronto, Univ Hlth Network, Toronto Hosp, Transplant Res Div,Dept Surg & Immunol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Gorczynski, R (corresponding author), Univ Toronto, Univ Hlth Network, Toronto Hosp, Transplant Res Div,Dept Surg & Immunol, Toronto, ON, Canada.	rgorczynski@uhnres.utoronto.ca	Gorczynski, Reginald/AAA-1435-2019; Zhu, Fang/L-3411-2016		Canadian Institute of Health Research [777532247]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institute of Health Research (777532247 to R.M.G.).	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Araki A, 2005, J GASTROENTEROL, V40, P16, DOI 10.1007/s00535-004-1492-9; Bain CC, 2012, IMMUNOBIOLOGY, V217, P643, DOI 10.1016/j.imbio.2011.11.004; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Berndt BE, 2007, J IMMUNOL, V179, P6255, DOI 10.4049/jimmunol.179.9.6255; Boudakov I, 2007, TRANSPLANTATION, V84, P251, DOI 10.1097/01.tp.0000269795.04592.cc; Broderick C, 2002, AM J PATHOL, V161, P1669, DOI 10.1016/S0002-9440(10)64444-6; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Chitnis T, 2007, AM J PATHOL, V170, P1695, DOI 10.2353/ajpath.2007.060677; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Clark DA, 2003, AM J REPROD IMMUNOL, V50, P187, DOI 10.1034/j.1600-0897.2003.00086.x; Di Sabatino A, 2012, INFLAMM BOWEL DIS, V18, P368, DOI 10.1002/ibd.21735; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Eijkelkamp N, 2007, GUT, V56, P847, DOI 10.1136/gut.2006.107094; Fantini MC, 2006, GUT, V55, P671, DOI 10.1136/gut.2005.072801; Fuchs A, 2013, CURR OPIN GASTROEN, V29, P581, DOI 10.1097/MOG.0b013e328365d339; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Geem D, 2012, JOVE-J VIS EXP, DOI 10.3791/4040; Gorczynski R, 2004, J IMMUNOL, V172, P7744, DOI 10.4049/jimmunol.172.12.7744; Gorczynski RM, 2009, J IMMUNOL, V183, P1560, DOI 10.4049/jimmunol.0900200; Gorczynski RM, 1998, TRANSPLANTATION, V65, P1106, DOI 10.1097/00007890-199804270-00016; Gorczynski RM, 2001, CLIN IMMUNOL, V101, P328, DOI 10.1006/clim.2001.5117; Gorczynski RM, 1999, J IMMUNOL, V163, P1654; Gross P, 2012, INFLAMM BOWEL DIS, V18, P1900, DOI 10.1002/ibd.22900; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim Yoon Suk, 2011, Immune Netw, V11, P416, DOI 10.4110/in.2011.11.6.416; Kretz-Rommel A, 2007, J IMMUNOL, V178, P5595, DOI 10.4049/jimmunol.178.9.5595; Li X, 2010, CLIN IMMUNOL, V134, P169, DOI 10.1016/j.clim.2009.09.012; Melgar S, 2008, STRESS, V11, P348, DOI 10.1080/10253890701820166; Melgar S, 2008, INT IMMUNOPHARMACOL, V8, P836, DOI 10.1016/j.intimp.2008.01.036; Mizoguchi E, 2000, INT IMMUNOL, V12, P597, DOI 10.1093/intimm/12.5.597; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Pizarro TT, 2007, ANNU REV MED, V58, P433, DOI 10.1146/annurev.med.58.121205.100607; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Stevceva Liljana, 2001, BMC Clin Pathol, V1, P3, DOI 10.1186/1472-6890-1-3; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Szebeni B, 2008, CLIN EXP IMMUNOL, V151, P34, DOI 10.1111/j.1365-2249.2007.03531.x; Takedatsu H, 2008, GASTROENTEROLOGY, V135, P552, DOI 10.1053/j.gastro.2008.04.037; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Vadasz Z, 2013, FEBS LETT, V587, P2074, DOI 10.1016/j.febslet.2013.05.023; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wong KK, 2012, CANCER RES, V72, P4931, DOI 10.1158/0008-5472.CAN-12-1390; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yu K, 2005, TRANSPLANTATION, V80, P394, DOI 10.1097/01.tp.0000168152.72560.82; Yu K, 2011, IMMUNOL LETT, V141, P116, DOI 10.1016/j.imlet.2011.09.002; Yuan Q, 2007, J EXP MED, V204, P1327, DOI 10.1084/jem.20062076; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	58	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146681	10.1371/journal.pone.0146681	http://dx.doi.org/10.1371/journal.pone.0146681			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26841120	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200012
J	Dickert, S; Kleber, J; Vastfjjall, D; Slovic, P				Dickert, Stephan; Kleber, Janet; Vaestfjjaell, Daniel; Slovic, Paul			Mental Imagery, Impact, and Affect: A Mediation Model for Charitable Giving	PLOS ONE			English	Article							MECHANISMS; VICTIM; DONATIONS; ALTRUISM; NUMERACY; SYMPATHY	One of the puzzling phenomena in philanthropy is that people can show strong compassion for identified individual victims but remain unmoved by catastrophes that affect large numbers of victims. Two prominent findings in research on charitable giving reflect this idiosyncrasy: The (1) identified victim and (2) victim number effects. The first of these suggests that identifying victims increases donations and the second refers to the finding that people's willingness to donate often decreases as the number of victims increases. While these effects have been documented in the literature, their underlying psychological processes need further study. We propose a model in which identified victim and victim number effects operate through different cognitive and affective mechanisms. In two experiments we present empirical evidence for such a model and show that different affective motivations (donor-focused vs. victim-focused feelings) are related to the cognitive processes of impact judgments and mental imagery. Moreover, we argue that different mediation pathways exist for identifiability and victim number effects.	[Dickert, Stephan; Kleber, Janet] WU Vienna Univ Econ & Business, Dept Mkt, Vienna, Austria; [Dickert, Stephan; Vaestfjjaell, Daniel] Linkoping Univ, Dept Psychol, Linkoping, Sweden; [Kleber, Janet] Alpen Adria Univ Klagenfurt, Dept Psychol, Klagenfurt, Austria; [Vaestfjjaell, Daniel; Slovic, Paul] Decis Res, Eugene, OR USA; [Slovic, Paul] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	Vienna University of Economics & Business; Linkoping University; University of Klagenfurt; University of Oregon	Dickert, S (corresponding author), WU Vienna Univ Econ & Business, Dept Mkt, Vienna, Austria.; Dickert, S (corresponding author), Linkoping Univ, Dept Psychol, Linkoping, Sweden.	stephan.dickert@wu.ac.at		Vastfjall, Daniel/0000-0003-2873-4500	US National Science Foundation [SES-1227729]; Swedish Research Council (VR); Direct For Social, Behav & Economic Scie [1227729, 1427414] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Swedish Research Council (VR)(Swedish Research Council); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This material is based upon work supported by the US National Science Foundation under Grant No. SES-1227729, and the Swedish Research Council (VR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; Bartels DM, 2006, ORGAN BEHAV HUM DEC, V100, P76, DOI 10.1016/j.obhdp.2005.10.004; Bartels DM, 2011, J EXP SOC PSYCHOL, V47, P50, DOI 10.1016/j.jesp.2010.08.003; BATSON CD, 1990, AM PSYCHOL, V45, P336, DOI 10.1037/0003-066X.45.3.336; Bekkers R, 2011, NONPROF VOLUNT SEC Q, V40, P924, DOI 10.1177/0899764010380927; Cryder CE, 2013, ORGAN BEHAV HUM DEC, V120, P15, DOI 10.1016/j.obhdp.2012.08.002; Cryder CE, 2012, J EXP SOC PSYCHOL, V48, P441, DOI 10.1016/j.jesp.2011.09.009; Dickert S, 2012, SYNTHESE, V189, P681, DOI 10.1007/s11229-012-0137-4; Dickert S, 2011, JUDGM DECIS MAK, V6, P638; Dickert S, 2011, J BEHAV DECIS MAKING, V24, P361, DOI 10.1002/bdm.697; Dickert S, 2009, JUDGM DECIS MAK, V4, P297; Duncan B, 2004, J PUBLIC ECON, V88, P2159, DOI 10.1016/S0047-2727(03)00037-9; Ein-Gar D, 2013, J CONSUM PSYCHOL, V23, P197, DOI 10.1016/j.jcps.2012.09.002; Erlandsson A, 2015, ORGAN BEHAV HUM DEC, V127, P1, DOI 10.1016/j.obhdp.2014.11.003; Erlandsson A, 2014, J BEHAV DECIS MAKING, V27, P37, DOI 10.1002/bdm.1789; Fetherstonhaugh D, 1997, J RISK UNCERTAINTY, V14, P283, DOI 10.1023/A:1007744326393; Friedrich J., 1999, J CONSUM PSYCHOL, V8, P277, DOI [DOI 10.1207/S15327663JCP0803_05, 10.1207/s15327663jcp0803_05]; Gneezy U, 2014, SCIENCE, V346, P632, DOI 10.1126/science.1253932; Hamilton DL, 1996, PSYCHOL REV, V103, P336, DOI 10.1037/0033-295X.103.2.336; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hays RD, 2012, J GEN INTERN MED, V27, P1402, DOI 10.1007/s11606-012-2182-6; Hsee CK, 2013, PSYCHOL SCI, V24, P1801, DOI 10.1177/0956797613482947; Jenni KE, 1997, J RISK UNCERTAINTY, V14, P235, DOI 10.1023/A:1007740225484; Kleber J, 2013, J EXP SOC PSYCHOL, V49, P699, DOI 10.1016/j.jesp.2013.02.009; Kline R.B., 2011, PRINCIPLES PRACTICE; Kogut T, 2005, J BEHAV DECIS MAKING, V18, P157, DOI 10.1002/bdm.492; Kogut T, 2005, ORGAN BEHAV HUM DEC, V97, P106, DOI 10.1016/j.obhdp.2005.02.003; Kogut T, 2007, ORGAN BEHAV HUM DEC, V104, P150, DOI 10.1016/j.obhdp.2007.04.006; Kogut T, 2011, J EXP SOC PSYCHOL, V47, P748, DOI 10.1016/j.jesp.2011.02.011; Kogut T, 2011, COGNITION EMOTION, V25, P1491, DOI 10.1080/02699931.2010.547563; Loewenstein G, 2007, REV GEN PSYCHOL, V11, P112, DOI 10.1037/1089-2680.11.2.112; National Philanthropic Trust, 2015, CHAR GIV STAT; Nordgren LF, 2011, SOC PSYCHOL PERS SCI, V2, P97, DOI 10.1177/1948550610382308; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Rubaltelli E, 2012, COGNITION EMOTION, V26, P769, DOI 10.1080/02699931.2011.613921; Slovic P, 2002, HEURISTICS BIASES PS, P397, DOI [DOI 10.1017/CBO9780511808098.025, 10.1017/CBO9780511808098.025]; Slovic P., 2010, IRRATIONAL ECONOMIST, P30; Slovic P, 2007, JUDGM DECIS MAK, V2, P79; Slovic P, 2010, PSYCHOL INQ, V21, P387, DOI 10.1080/1047840X.2010.521119; Small DA, 2003, J RISK UNCERTAINTY, V26, P5, DOI 10.1023/A:1022299422219; Small DA, 2007, ORGAN BEHAV HUM DEC, V102, P143, DOI 10.1016/j.obhdp.2006.01.005; Small DA, 2010, ORGAN BEHAV HUM DEC, V112, P151, DOI 10.1016/j.obhdp.2010.03.001; Smith RW, 2013, J CONSUM RES, V39, P961, DOI 10.1086/666470; StataCorp, 2013, STATA STAT SOFTW REL; Vastfjall D, 2008, JUDGM DECIS MAK, V3, P64; Vastfjall D, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00616; Vastfjall D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100115; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105	49	26	26	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148274	10.1371/journal.pone.0148274	http://dx.doi.org/10.1371/journal.pone.0148274			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859848	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000370038400027
J	Duan, QH; Chen, Z; Chen, C; Zhang, ZB; Lu, ZQ; Yang, YL; Zhang, L				Duan, Qionghong; Chen, Zi; Chen, Cong; Zhang, Zhengbin; Lu, Zhouqin; Yang, Yalong; Zhang, Lin			The Prevalence of Drug-Resistant Tuberculosis in Mainland China: An Updated Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RECURRENT TUBERCULOSIS; MULTIDRUG-RESISTANT	Background In recent years, drug resistant tuberculosis (DR-TB) particularly the emergence of multidrug-resistant tuberculosis (MDR-TB) has become a major public health issue. The most recent study regarding the prevalence of drug-resistant tuberculosis in mainland China was a meta-analysis published in 2011, and the subjects from the included studies were mostly enrolled before 2008, thus making it now obsolete. Current data on the national prevalence of DR-TB is needed. This review aims to provide a comprehensive and up-to-date assessment of the status of DR-TB epidemic in mainland China. Methods A systematic review and meta-analysis of studies regarding the prevalence of drug-resistant tuberculosis in mainland China was performed. Pubmed/MEDLINE, EMBASE, the Cochrane central database, the Chinese Biomedical Literature Database and the China National Knowledge Infrastructure Database were searched for studies relevant to drug-resistant tuberculosis that were published between January 1, 2012 and May 18, 2015. Comprehensive Meta-Analysis (V2.2, Biostat) software was used to analyse the data. Results A total of fifty-nine articles, published from 2012 to 2015, were included in our review. The result of this meta-analysis demonstrated that among new cases, the rate of resistance to any drug was 20.1% (18.0%-22.3%; n/N = 7203/34314) and among retreatment cases, the rate was 49.8% (46.0%-53.6%; n/N = 4155/8291). Multi-drug resistance among new and retreatment cases was 4.8% (4.0%-5.7%; n/N = 2300/42946) and 26.3% (23.1%-29.7%; n/N = 3125/11589) respectively. The results were significantly heterogeneous (p<0.001, I-2 tests). Resistance to isoniazid was the most common resistance observed, and HRSE (H: isoniazid; R: rifampicin; S: streptomycin; E: ethambutol) was the most common form for MDR among both new and retreatment cases. Different drug resistance patterns were found by subgroup analysis according to geographic areas, subject enrolment time, and methods of drug susceptibility test (DST). Conclusions The prevalence of resistance to any drug evidently dropped for both new and retreatment cases, and multi-drug resistance declined among new cases but became more prevalent among retreatment cases compared to the data before 2008. Therefore, drug-resistant tuberculosis, particularly multi-drug-resistant tuberculosis among retreatment TB cases is a public health issue in China that requires a constant attention in order to prevent increase in MDR-TB cases.	[Duan, Qionghong; Chen, Zi; Chen, Cong; Zhang, Zhengbin; Lu, Zhouqin] Wuhan TB Inst, Dept TB Prevent, Wuhan, Hubei, Peoples R China; [Yang, Yalong; Zhang, Lin] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Thyroid Breast Surg, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Zhang, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Thyroid Breast Surg, Wuhan 430074, Hubei, Peoples R China.	zhanglin3@medmail.com.cn		Yang, Yalong/0000-0002-4167-3311	Hubei Provincial Natural Science Foundation of China [2015CFB310]; Hubei Provincial Health and Family Planning Commission [WJ2015MB163]; Wuhan Health and Family Planning Commission [WG14B10]; Projects for Young and Middle-aged Key Medical Experts in Wuhan [[2014]77]	Hubei Provincial Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Provincial Health and Family Planning Commission; Wuhan Health and Family Planning Commission; Projects for Young and Middle-aged Key Medical Experts in Wuhan	The work was supported by the following: Hubei Provincial Natural Science Foundation of China, 2015CFB310, http://www.hbstd.gov.cn/, Qionghong Duan; Projects Funded by Hubei Provincial Health and Family Planning Commission, WJ2015MB163, http://www.hbwsjs.gov.cn/, Qionghong Duan; Projects Funded by Wuhan Health and Family Planning Commission, WG14B10, http://www.whwsjs.gov.cn/, Qionghong Duan; and Projects for Young and Middle-aged Key Medical Experts in Wuhan, [2014]77, http://www.whwsjs.gov.cn/, Qionghong Duan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GUID PROGR MAN DRUG; Bang D, 2010, INT J TUBERC LUNG D, V14, P447; Chinese Ministry of Health, 2010, NAT BAS SURV DRUG RE; Dobler CC, 2009, EUR RESPIR J, V33, P160, DOI 10.1183/09031936.00104108; El Sahly HM, 2004, INT J TUBERC LUNG D, V8, P333; Group NTS, 2002, J CHIN ANTITUBERC, V24, P65; Group NTS, 2012, J CHIN ANTITUBERC, V34, P485; Leibert E, 2014, THER CLIN RISK MANAG, V10, P597, DOI 10.2147/TCRM.S37743; Li X, 2010, J CHIN ANTITUBERC, V32, P676; Lynch JB, 2013, MED CLIN N AM, V97, P553, DOI 10.1016/j.mcna.2013.03.012; Migliori GB, 2009, CLIN CHEST MED, V30, P637, DOI 10.1016/j.ccm.2009.08.015; Nasiri MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129073; Rostom A, 2004, Evid Rep Technol Assess (Summ), P1; Umubyeyi AN, 2007, INT J TUBERC LUNG D, V11, P860; van der Werf MJ, 2012, EUR RESPIR J, V39, P1511, DOI 10.1183/09031936.00125711; WHO, 2014, GLOB TUB REP 2014; Yang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020343; Zumla A, 2015, LANCET RESP MED, V3, P220, DOI 10.1016/S2213-2600(15)00063-6	18	31	33	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148041	10.1371/journal.pone.0148041	http://dx.doi.org/10.1371/journal.pone.0148041			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859846	Green Published, gold, Green Submitted			2022-12-27	WOS:000370038400018
J	Guse, J; Schweigert, E; Kulms, G; Heinen, I; Martens, C; Guse, AH				Guse, Jennifer; Schweigert, Eva; Kulms, Gerhild; Heinen, Ines; Martens, Claudia; Guse, Andreas H.			Effects of Mentoring Speed Dating as an Innovative Matching Tool in Undergraduate Medical Education: A Mixed Methods Study	PLOS ONE			English	Article							ACADEMIC-MEDICINE; QUALITATIVE RESEARCH; PROGRAMS; STUDENTS; FACULTY; JUNIOR	Objectives Choosing the right mentor is crucial for effective mentorship. Yet, many medical students have difficulties finding a suitable mentor. Thus we developed mentoring speed dating (MSD) as a promising matching tool to connect students and faculty mentors successfully. The purpose of this study was to explore mentees' and mentors' experience with MSD and investigate the impact of MSD on the perceived mentorship quality and continuance of the mentoring relationship. Methods The authors completed a mixed methods study at the University Medical Center Hamburg-Eppendorf, Germany, between June 2011 and March 2014. They conducted four focus groups with mentees and mentors who participated in a mentoring speed dating event and analyzed transcripts using conventional content analysis with inductive categorizing. In addition, three mentoring cohorts (two matched via MSD, one matched via conventional online profiles) were surveyed on mentorship satisfaction and the 1-year continuance of their mentorship was monitored. Fifteen mentees and fifteen mentors participated in the focus groups. The authors identified several themes such as short and long term benefits of MSD and fulfillment of expectations. Benefits included finding out about the personal connection, matching expectations, providing an efficient overview of candidates. The survey was completed by 93 students (n = 29 without MSD; n = 64 with MSD). Independent t-tests and multivariate analysis of variance were used to analyze the impact of MSD on student's mentorship satisfaction. Results There were significant differences in responses to the items "Commitment of mentor" (p = .019) and "Constructive feedback" (p = .038) among the students who attended MSD and the students without MSD. After one year far more mentoring relationships existed among those mentees who participated in MSD in comparison to the "no MSD group". Conclusion MSD is a valuable matching tool with beneficial effects on the mentorship quality. It enhances essential factors in the mentoring relationship such as commitment and satisfaction.	[Guse, Jennifer; Schweigert, Eva; Kulms, Gerhild; Heinen, Ines; Martens, Claudia] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Guse, Andreas H.] Deans Off Educ & Students Affairs, Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Guse, Andreas H.] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany; [Martens, Claudia] Hamburg Univ Appl Sci, Fac Life Sci, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hochschule Angewandte Wissenschaft Hamburg	Guse, AH (corresponding author), Deans Off Educ & Students Affairs, Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany.; Guse, AH (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany.	guse@uke.de		Guse, Jennifer/0000-0001-5020-929X	Claussen-Simon-Stiftung, Hamburg, Germany [0678/150]	Claussen-Simon-Stiftung, Hamburg, Germany	Funding provided by Claussen-Simon-Stiftung, Hamburg, Germany (grant no 0678/150), web site: www.claussen-simon-stiftung.de/startseite. html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday LA, 2006, DESIGNING CONDUCTING; Allen TD, 2006, J APPL PSYCHOL, V91, P567, DOI 10.1037/0021-9010.91.3.567; Allen TD, 2006, PERS PSYCHOL, V59, P125, DOI 10.1111/j.1744-6570.2006.00747.x; [Anonymous], 2007, HDB MENTORING WORK T; Beech BM, 2013, ACAD MED, V88, P541, DOI 10.1097/ACM.0b013e31828589e3; Berk R. A., 2010, INT J MENTORING COAC, V8, P85; Berk RA, 2005, ACAD MED, V80, P66, DOI 10.1097/00001888-200501000-00017; Buddeberg-Fischer B, 2006, MED TEACH, V28, P248, DOI 10.1080/01421590500313043; Castillo-Page L, 2012, ACAD MED, V87; Cook DA, 2010, MED TEACH, V32, P692, DOI 10.3109/01421591003686278; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1060, DOI 10.1001/jama.292.9.1060; Dimitriadis K, 2012, MED EDUC ONLINE, V17, DOI 10.3402/meo.v17i0.17242; Eby LTD, 2013, PSYCHOL BULL, V139, P441, DOI 10.1037/a0029279; Eby LT, 2004, J VOCAT BEHAV, V65, P255, DOI 10.1016/j.jvb.2003.07.001; Eby LT, 2008, BLACKWELL HDB MENTOR, P7; Finkel EJ, 2008, CURR DIR PSYCHOL SCI, V17, P193, DOI 10.1111/j.1467-8721.2008.00573.x; Frambach JM, 2013, ACAD MED, V88; Frei E, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-32; Gray J, 2003, CLIN INVEST MED, V26, P315; Houser M. L., 2007, HUMAN COMMUNICATION, V10, P69; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jackson VA, 2003, ACAD MED, V78, P328, DOI 10.1097/00001888-200303000-00020; Johnson W.B., 2007, BLACKWELL HDB MENTOR, P49, DOI DOI 10.1002/9780470691960.CH4; Koopman RJ, 2005, MED TEACH, V27, P734, DOI 10.1080/01421590500271209; Kurre J, 2012, INT J MED EDUC, V3, P216, DOI 10.5116/ijme.508b.9bd6; Mayring P., 2003, QUALITATIVE INHALTSA; Meinel FG, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-68; Nick JM, 2012, NURS RES PRACT, V2012, DOI 10.1155/2012/937906; Onwuegbuzie A.J., 2009, INT J QUALITATIVE ME, V8, P1, DOI [10.1177/160940690900800301, DOI 10.1177/160940690900800301]; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Rabatin JS, 2004, J GEN INTERN MED, V19, P569, DOI 10.1111/j.1525-1497.2004.30137.x; Rotering-Steinberg S, 2009, MENTORING THEORETISC, P31; Sambunjak D, 2006, JAMA-J AM MED ASSOC, V296, P1103, DOI 10.1001/jama.296.9.1103; Sambunjak D, 2010, J GEN INTERN MED, V25, P72, DOI 10.1007/s11606-009-1165-8; Seeliger C, PERFECT MATCH IMPACT; Straus SE, 2013, ACAD MED, V88, P82, DOI 10.1097/ACM.0b013e31827647a0; Straus SE, 2009, ACAD MED, V84, P135, DOI 10.1097/ACM.0b013e31819301ab; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Viator R. E., 1999, ACCOUNT HORIZ, V13, P37, DOI [10.2308/acch.1999.13.1.37, DOI 10.2308/ACCH.1999.13.1.37]; Wanberg CR, 2006, J VOCAT BEHAV, V69, P410, DOI 10.1016/j.jvb.2006.05.010	40	14	14	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0147444	10.1371/journal.pone.0147444	http://dx.doi.org/10.1371/journal.pone.0147444			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859845	Green Published, gold			2022-12-27	WOS:000370038400009
J	Qiu, XS; Fu, Q; Meng, CC; Yu, SQ; Zhan, Y; Dong, LN; Song, CP; Sun, YJ; Tan, L; Hu, SL; Wang, XQ; Liu, XW; Peng, DX; Liu, XF; Ding, C				Qiu, Xusheng; Fu, Qiang; Meng, Chunchun; Yu, Shengqing; Zhan, Yuan; Dong, Luna; Song, Cuiping; Sun, Yingjie; Tan, Lei; Hu, Shunlin; Wang, Xiaoquan; Liu, Xiaowen; Peng, Daxin; Liu, Xiufan; Ding, Chan			Newcastle Disease Virus V Protein Targets Phosphorylated STAT1 to Block IFN-I Signaling	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; TRANSCRIPTIVE COMPLEX; ALPHA-INTERFERON; PREVENTING STAT1; VIRULENT-STRAIN; EXPRESSION; CDNA; GENERATION; CHICKEN; GAMMA	Newcastle disease virus (NDV) V protein is considered as an effector for IFN antagonism, however, the mechanism remains unknown. In this study, the expression of STAT1 and phospho-STAT1 in cells infected with NDV or transfected with V protein-expressing plasmids were analyzed. Our results showed that NDV V protein targets phospho-STAT1 reduction in the cells depends on the stimulation of IFN-alpha. In addition, a V-deficient genotype VII recombinant NDV strain rZJ1-VS was constructed using reverse genetic technique to confirm the results. The rZJ1-VS lost the ability to reduce phospho-STAT1 and induced higher expression of IFN-responsive genes in infected cells. Furthermore, treatment with an ubiquitin E1 inhibitor PYR-41 demonstrated that phospho-STAT1 reduction was caused by degradation, but not de-phosphorylation. We conclude that NDV V protein targets phospho-STAT1 degradation to block IFN-alpha signaling, which adds novel knowledge to the strategies used by paramyxoviruses to evade IFN.	[Qiu, Xusheng; Fu, Qiang; Meng, Chunchun; Yu, Shengqing; Zhan, Yuan; Dong, Luna; Song, Cuiping; Sun, Yingjie; Tan, Lei; Ding, Chan] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China; [Fu, Qiang; Hu, Shunlin; Wang, Xiaoquan; Liu, Xiaowen; Peng, Daxin; Liu, Xiufan] Yangzhou Univ, Key Lab Anim Infect Dis, Yangzhou 225009, Jiangsu, Peoples R China; [Peng, Daxin; Liu, Xiufan; Ding, Chan] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Yangzhou University	Ding, C (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China.; Liu, XF (corresponding author), Yangzhou Univ, Key Lab Anim Infect Dis, Yangzhou 225009, Jiangsu, Peoples R China.; Liu, XF; Ding, C (corresponding author), Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.	xfliu@yzu.edu.cn; shoveldeen@shvri.ac.cn	Peng, Daxin/AAJ-3476-2021		Chinese National High-tech R&D Program (863 Program) [2011AA10A209]; National Natural Science Foundation of China [31101822]; Chinese Special Fund for Agro-scientific Research in the Public Interest [201303033]	Chinese National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Special Fund for Agro-scientific Research in the Public Interest	This work was funded by (1) the Chinese National High-tech R&D Program (863 Program, 2011AA10A209), http://program.most.gov.cn/, the funder played a role in study design and data collection and analysis. (2) National Natural Science Foundation of China (31101822), http://www.nsfc.gov.cn/, the funder played a role in study design and data collection and analysis. (3) Chinese Special Fund for Agro-scientific Research in the Public Interest (201303033), http://www.moa.gov.cn/, the funder played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamares JG, 2010, VIRUS RES, V147, P153, DOI 10.1016/j.virusres.2009.10.020; Alexander D.J., 1998, LAB MANUAL ISOLATION, P156; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Goodbourn S, 2009, J INTERF CYTOK RES, V29, P539, DOI 10.1089/jir.2009.0071; HAMAGUCHI M, 1985, VIROLOGY, V147, P295, DOI 10.1016/0042-6822(85)90132-1; HAMAGUCHI M, 1983, VIROLOGY, V128, P105, DOI 10.1016/0042-6822(83)90322-7; Haspel RL, 1996, EMBO J, V15, P6262, DOI 10.1002/j.1460-2075.1996.tb01016.x; Horvath CM, 2004, EUR J BIOCHEM, V271, P4621, DOI 10.1111/j.1432-1033.2004.04425.x; Horvath CM, 2004, CYTOKINE GROWTH F R, V15, P117, DOI 10.1016/j.cytogfr.2004.02.003; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Huang ZH, 2003, J VIROL, V77, P8676, DOI 10.1128/JVI.77.16.8676-8685.2003; Jang J, 2010, APPL MICROBIOL BIOT, V85, P1509, DOI 10.1007/s00253-009-2189-z; Johnson KN, 2000, J VIROL, V74, P5123, DOI 10.1128/JVI.74.11.5123-5132.2000; Jun-Qing W, 2013, CHIN J ANIM INFECT D, V21, P1; Karlin D, 2003, J GEN VIROL, V84, P3239, DOI 10.1099/vir.0.19451-0; Kato A, 2003, BMC IMMUNOL, V4, P8; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim SH, 2012, J VIROL, V86, P11394, DOI 10.1128/JVI.01922-12; Krishnamurthy S, 2000, VIROLOGY, V278, P168, DOI 10.1006/viro.2000.0618; Krishnamurthy S, 2006, J VIROL, V80, P5145, DOI 10.1128/JVI.02618-05; Kumar R, 2013, INDIAN J VIROL, V24, P278, DOI 10.1007/s13337-013-0148-x; Lee CK, 1997, J BIOL CHEM, V272, P21872, DOI 10.1074/jbc.272.35.21872; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Liu HL, 2008, RES VET SCI, V85, P612, DOI 10.1016/j.rvsc.2008.02.013; Liu YL, 2007, ARCH VIROL, V152, P1241, DOI 10.1007/s00705-007-0961-x; Locke DP, 2000, VIRUS RES, V69, P55, DOI 10.1016/S0168-1702(00)00175-1; Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039; Mebatsion T, 2001, J VIROL, V75, P420, DOI 10.1128/JVI.75.1.420-428.2001; OIE B. S. C., 2014, MAN DIAGN TESTS VACC, P5; Onomoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019799; Osaki M, 2003, BIOCHEM J, V369, P103, DOI 10.1042/BJ20020928; Palosaari H, 2003, J VIROL, V77, P7635, DOI 10.1128/JVI.77.13.7635-7644.2003; Parisien JP, 2001, VIROLOGY, V283, P230, DOI 10.1006/viro.2001.0856; Park MS, 2003, J VIROL, V77, P9522, DOI 10.1128/JVI.77.17.9522-9532.2003; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Rodriguez JJ, 2003, J VIROL, V77, P11842, DOI 10.1128/JVI.77.21.11842-11845.2003; Rodriguez JJ, 2002, J VIROL, V76, P11476, DOI 10.1128/JVI.76.22.11476-11483.2002; Saif YM, 2008, NEWCASTLE DIS OTHER; SAMSON ACR, 1991, J GEN VIROL, V72, P1709, DOI 10.1099/0022-1317-72-7-1709; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shengqing Y, 2002, VIROLOGY, V301, P206, DOI 10.1006/viro.2002.1539; Stepnowski P, 2004, HUM EXP TOXICOL, V23, P513, DOI 10.1191/0960327104ht480oa; STEWARD M, 1993, J GEN VIROL, V74, P2539, DOI 10.1099/0022-1317-74-12-2539; Sun YJ, 2013, MOL IMMUNOL, V53, P321, DOI 10.1016/j.molimm.2012.08.022; Susta L, 2013, MICROB PATHOGENESIS, V61-62, P73, DOI 10.1016/j.micpath.2013.05.009; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Yeow WS, 1997, INT J BIOCHEM CELL B, V29, P513, DOI 10.1016/S1357-2725(96)00105-7; Yokosawa N, 2002, J VIROL, V76, P12683, DOI 10.1128/JVI.76.24.12683-12690.2002; Yu Y, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-120; Yusoff K, 2001, AVIAN PATHOL, V30, P439, DOI 10.1080/03079450120078626; Zou J, 2005, VIRUS GENES, V30, P13, DOI 10.1007/s11262-004-4577-x	58	34	39	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148560	10.1371/journal.pone.0148560	http://dx.doi.org/10.1371/journal.pone.0148560			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859759	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400053
J	Rommel, A; Varnaccia, G; Lahmann, N; Kottner, J; Kroll, LE				Rommel, Alexander; Varnaccia, Gianni; Lahmann, Nils; Kottner, Jan; Kroll, Lars Eric			Occupational Injuries in Germany: Population-Wide National Survey Data Emphasize the Importance of Work-Related Factors	PLOS ONE			English	Article							HEALTH INTERVIEW SURVEY; UNINTENTIONAL INJURIES; JOB DEMANDS; LIFE-STYLE; RISK; WORKPLACE; AGE; CONSTRUCTION; ACCIDENTS; SMOKING	Unintentional injuries cause much of the global mortality burden, with the workplace being a common accident setting. Even in high-income economies, occupational injury figures remain remarkably high. Because risk factors for occupational injuries are prone to confounding, the present research takes a comprehensive approach. To better understand the occurrence of occupational injuries, sociodemographic factors and work-and health-related factors are tested simultaneously. Thus, the present analysis aims to develop a comprehensive epidemiological model that facilitates the explanation of varying injury rates in the workplace. The representative phone survey German Health Update 2010 provides information on medically treated occupational injuries sustained in the year prior to the interview. Data were collected on sociodemographics, occupation, working conditions, health-related behaviors, and chronic diseases. For the economically active population (18-70 years, n = 14,041), the 12-month prevalence of occupational injuries was calculated with a 95% confidence interval (CI). Blockwise multiple logistic regression was applied to successively include different groups of variables. Overall, 2.8% (95% CI 2.4-3.2) of the gainfully employed population report at least one occupational injury (women: 0.9%; 95% CI 0.7-1.2; men: 4.3%; 95% CI 3.7-5.0). In the fully adjusted model, male gender (OR 3.16) and age 18-29 (OR 1.54), as well as agricultural (OR 5.40), technical (OR 3.41), skilled service (OR 4.24) or manual (OR 5.12), and unskilled service (OR 3.13) or manual (OR 4.97) occupations are associated with higher chances of occupational injuries. The same holds for frequent stressors such as heavy carrying (OR 1.78), working in awkward postures (OR 1.46), environmental stress (OR 1.48), and working under pressure (OR 1.41). Among health-related variables, physical inactivity (OR 1.47) and obesity (OR 1.73) present a significantly higher chance of occupational injuries. While the odds for most work-related factors were as expected, the associations for health-related factors such as smoking, drinking, and chronic diseases were rather weak. In part, this may be due to context-specific factors such as safety and workplace regulations in high-income countries like Germany. This assumption could guide further research, taking a multi-level approach to international comparisons.	[Rommel, Alexander; Varnaccia, Gianni; Kroll, Lars Eric] Robert Koch Inst, Epidemiol & Hlth Monitoring, Gen Pape Str 62-66, D-12101 Berlin, Germany; [Lahmann, Nils] Charite, Inst Hlth Sci Educ & Nursing, Augustenburger Pl 1, D-13353 Berlin, Germany; [Kottner, Jan] Charite, Clin Res Ctr Hair & Skin Sci, Charitepl 1, D-10117 Berlin, Germany	Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rommel, A (corresponding author), Robert Koch Inst, Epidemiol & Hlth Monitoring, Gen Pape Str 62-66, D-12101 Berlin, Germany.	RommelA@rki.de	; Kottner, Jan/N-2365-2013	Lahmann, Nils/0000-0002-6934-5387; Kottner, Jan/0000-0003-0750-3818	German Federal Ministry of Health; Robert Koch Institute; RKI; German Federal Ministry of Health; Robert Koch Institute; RKI	German Federal Ministry of Health; Robert Koch Institute; RKI; German Federal Ministry of Health; Robert Koch Institute; RKI	The health survey German Health Update 2010 is part of the Federal Health Monitoring (FHM) in Germany. The FHM is done by the Robert Koch Institute (RKI) on behalf of the Federal Ministry of Health. The ministry finances the RKI and gives substantial funds for the FHM. Three of the authors (AR LEK GV) are employees of the RKI. No one of the authors received specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The study was funded by the German Federal Ministry of Health and the Robert Koch Institute.	[Anonymous], 2014, SICH GES BEI ARB 201; [Anonymous], 2012, DAT FAKT ERG STUD GE; Aust F., 2009, UMFRAGEFORSCHUNG, P195, DOI 10.1007/978-3-531-91852-5_10; Badura B, 2013, FEHLZEITEN REPORT 20; Bhattacherjee A, 2003, J OCCUP HEALTH, V45, P382, DOI 10.1539/joh.45.382; Bhattacherjee A, 2013, INT J OCCUP MED ENV, V26, P910, DOI 10.2478/s13382-013-0165-4; BLOSSFELD HP, 1987, AM J SOCIOL, V93, P89, DOI 10.1086/228707; Bundesanstalt fur Arbeitsschutz und Arbeitsmedizin, 2011, SICH GES BEI ARB 201; Bureau of Labor Statistics, 2014, EMPL REP WORKPL INJ; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; CELLIER JM, 1995, PERCEPT MOTOR SKILL, V80, P931, DOI 10.2466/pms.1995.80.3.931; Centers for Disease Control and Prevention, 2009, BEH RISK FACT SURV S; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; Chau N, 2004, INT ARCH OCC ENV HEA, V77, P60, DOI 10.1007/s00420-003-0460-7; Chau N, 2009, OCCUP MED-OXFORD, V59, P114, DOI 10.1093/occmed/kqp002; Dembe AE, 2004, J OCCUP ENVIRON HYG, V1, P542, DOI 10.1080/15459620490478376; Dong XW, 2005, SCAND J WORK ENV HEA, V31, P329, DOI 10.5271/sjweh.915; Eurostat, 2014, NONF ACC WORK EC ACT; Gabler S, 2002, INT J PUBLIC OPIN R, V14, P339, DOI 10.1093/ijpor/14.3.339; Hamalainen P, 2009, J SAFETY RES, V40, P125, DOI 10.1016/j.jsr.2008.12.010; Hanecke K, 1998, SCAND J WORK ENV HEA, V24, P43; Holbrook A, 2008, ADV TELEPHONE SURVEY; ICECI Coordination and Maintenance Group, 2004, INT CLASS EXT CAUS I; International Labour Organization, 2014, CREAT SAF HLTH WORKP; Khanzode VV, 2012, SAFETY SCI, V50, P1355, DOI 10.1016/j.ssci.2011.12.015; Khlat M, 2008, PUBLIC HEALTH, V122, P771, DOI 10.1016/j.puhe.2007.09.012; Kouvonen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077178; Kroll L, 2011, GBE KOMPAKT, V2; Kroll LE, 2011, METHODS DATA ANAL, V5, P63; Kubo J, 2014, OCCUP ENVIRON MED, V71, P159, DOI 10.1136/oemed-2013-101653; Lange C, 2015, INT J EPIDEMIOL, V44, P442, DOI 10.1093/ije/dyv067; Li F, 2013, ACCIDENT ANAL PREV, V51, P243, DOI 10.1016/j.aap.2012.11.029; Lin TC, 2013, SCAND J WORK ENV HEA, V39, P268, DOI 10.5271/sjweh.3347; Lombardi DA, 2012, CHRONOBIOL INT, V29, P556, DOI 10.3109/07420528.2012.675253; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu ML, 2014, INT J BEHAV MED, V21, P42, DOI 10.1007/s12529-013-9325-y; Musa AI, 2013, THEOR ISS ERGON SCI, V14, P99, DOI 10.1080/1463922X.2011.611271; Nakata A, 2006, SOC SCI MED, V63, P2452, DOI 10.1016/j.socscimed.2006.06.009; Nakata A, 2006, AM J IND MED, V49, P658, DOI 10.1002/ajim.20338; Oh JH, 2003, SOC SCI MED, V57, P2173, DOI 10.1016/S0277-9536(03)00073-X; Palmer KT, 2008, OCCUP ENVIRON MED, V65, P757, DOI 10.1136/oem.2007.037440; Pollack KM, 2007, INJURY PREV, V13, P297, DOI 10.1136/ip.2006.014787; Ramchand R, 2009, EFFECTS SUBSTANCES U; Rasmussen K, 2011, AM J IND MED, V54, P143, DOI 10.1002/ajim.20911; Rinnert K, 2009, DIABETOLOGE, V5, P531, DOI 10.1007/s11428-009-0440-y; RYAN J, 1992, AM J PUBLIC HEALTH, V82, P29, DOI 10.2105/AJPH.82.1.29; SACKS JJ, 1994, PREV MED, V23, P515, DOI 10.1006/pmed.1994.1070; Smith P, 2012, J OCCUP ENVIRON MED, V54, P841, DOI 10.1097/JOM.0b013e31824e11f7; Sprince NL, 2008, J OCCUP ENVIRON MED, V50, P804, DOI 10.1097/JOM.0b013e318168efcf; Uehli K, 2014, SLEEP MED REV, V18, P61, DOI 10.1016/j.smrv.2013.01.004; Varnaccia G, 2014, BUNDESGESUNDHEITSBLA, V57, P604, DOI 10.1007/s00103-014-1961-0; Veazie MA, 2000, ALCOHOL CLIN EXP RES, V24, P1811, DOI 10.1097/00000374-200012000-00010; VEAZIE MA, 1994, ANNU REV PUBL HEALTH, V15, P203, DOI 10.1146/annurev.pu.15.050194.001223; Wagstaff AS, 2011, SCAND J WORK ENV HEA, V37, P173, DOI 10.5271/sjweh.3146; WAKSBERG J, 1978, J AM STAT ASSOC, V73, P40, DOI 10.2307/2286513; Wen CP, 2005, TOB CONTROL, V14, pI28, DOI 10.1136/tc.2003.005629; Wilkins Kathryn, 2007, Health Rep, V18, P25; Williamson A, 2011, ACCIDENT ANAL PREV, V43, P498, DOI 10.1016/j.aap.2009.11.011; Zheng L, 2010, AM J IND MED, V53, P588, DOI 10.1002/ajim.20833	59	24	26	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148798	10.1371/journal.pone.0148798	http://dx.doi.org/10.1371/journal.pone.0148798			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6MN	26859560	Green Submitted, gold, Green Published			2022-12-27	WOS:000370038400087
J	Blanchard, S; Saillet, S; Ivanov, A; Benquet, P; Benar, CG; Pelegrini-Issac, M; Benali, H; Wendling, F				Blanchard, Solenna; Saillet, Sandrine; Ivanov, Anton; Benquet, Pascal; Benar, Christian-George; Pelegrini-Issac, Melanie; Benali, Habib; Wendling, Fabrice			A New Computational Model for Neuro-Glio-Vascular Coupling: Astrocyte Activation Can Explain Cerebral Blood Flow Nonlinear Response to Interictal Events	PLOS ONE			English	Article							BRAIN ELECTRICAL-ACTIVITY; ARTERIOLAR SMOOTH-MUSCLE; MATHEMATICAL-MODEL; GABA RELEASE; GLUTAMATE TRANSPORTER; BIOPHYSICAL MODEL; PREFRONTAL CORTEX; ENERGY-METABOLISM; SYNAPTIC ACTIVITY; IN-VIVO	Developing a clear understanding of the relationship between cerebral blood flow (CBF) response and neuronal activity is of significant importance because CBF increase is essential to the health of neurons, for instance through oxygen supply. This relationship can be investigated by analyzing multimodal (fMRI, PET, laser Doppler...) recordings. However, the important number of intermediate (non-observable) variables involved in the underlying neurovascular coupling makes the discovery of mechanisms all the more difficult from the sole multimodal data. We present a new computational model developed at the population scale (voxel) with physiologically relevant but simple equations to facilitate the interpretation of regional multimodal recordings. This model links neuronal activity to regional CBF dynamics through neuro-glio-vascular coupling. This coupling involves a population of glial cells called astrocytes via their role in neurotransmitter (glutamate and GABA) recycling and their impact on neighboring vessels. In epilepsy, neuronal networks generate epileptiform discharges, leading to variations in astrocytic and CBF dynamics. In this study, we took advantage of these large variations in neuronal activity magnitude to test the capacity of our model to reproduce experimental data. We compared simulations from our model with isolated epileptiform events, which were obtained in vivo by simultaneous local field potential and laser Doppler recordings in rats after local bicuculline injection. We showed a predominant neuronal contribution for low level discharges and a significant astrocytic contribution for higher level discharges. Besides, neuronal contribution to CBF was linear while astrocytic contribution was nonlinear. Results thus indicate that the relationship between neuronal activity and CBF magnitudes can be nonlinear for isolated events and that this nonlinearity is due to astrocytic activity, highlighting the importance of astrocytes in the interpretation of regional recordings.	[Blanchard, Solenna; Benquet, Pascal; Wendling, Fabrice] Univ Rennes 1, INSERM U1099, Lab Traitement Signal & Image, Rennes, France; [Saillet, Sandrine; Ivanov, Anton; Benar, Christian-George] Aix Marseille Univ, INSERM UMRS 1106, Inst Neurosci Syst, Marseille, France; [Pelegrini-Issac, Melanie; Benali, Habib] Sorbonne Univ, Univ Paris 06, CNRS, INSERM,Lab Imagerie Biomed, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Blanchard, S (corresponding author), Univ Rennes 1, INSERM U1099, Lab Traitement Signal & Image, Rennes, France.	solenna.blanchard@univ-rennes1.fr	Benquet, Pascal/ABC-6954-2020; Wendling, Fabrice/F-8924-2013; WENDLING, Fabrice/P-9574-2019	WENDLING, Fabrice/0000-0003-2428-9665; Pelegrini-Issac, Melanie/0000-0003-3260-5795; Blanchard, Solenna/0000-0003-0732-1926; Ivanov, Anton/0000-0002-8650-6322; Saillet, Sandrine/0000-0002-3747-3261; Benquet, Pascal/0000-0003-0217-5886	Agence Nationale de la Recherche [ANR 2010 BLAN 030901]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by a grant from the Agence Nationale de la Recherche ANR 2010 BLAN 030901 named MULTIMODEL project: http://www.agence-nationale-recherche.fr/?Project=ANR-10-BLAN-0309. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Goycolea C, 2008, NEURON, V57, P420, DOI 10.1016/j.neuron.2007.12.022; Anderson CM, 2000, GLIA, V32, P1; Aradi I, 2002, J PHYSIOL-LONDON, V538, P227, DOI 10.1113/jphysiol.2001.013054; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Aubert A, 2005, J CEREBR BLOOD F MET, V25, P1476, DOI 10.1038/sj.jcbfm.9600144; Aubert A, 2002, NEUROIMAGE, V17, P1162, DOI 10.1006/nimg.2002.1224; Aubert A, 2001, ACTA BIOTHEOR, V49, P301, DOI 10.1023/A:1014286728421; Auger C, 1998, J NEUROSCI, V18, P4532; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Banaji M, 2005, MATH BIOSCI, V194, P125, DOI 10.1016/j.mbs.2004.10.005; Banaji M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000212; Bennett MR, 2008, J THEOR BIOL, V252, P123, DOI 10.1016/j.jtbi.2008.01.022; Bennett MR, 2008, J THEOR BIOL, V250, P172, DOI 10.1016/j.jtbi.2007.08.024; Bojak I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041902; Buxton RB, 2012, NEUROIMAGE, V62, P953, DOI 10.1016/j.neuroimage.2012.01.012; Calvetti D, 2011, J THEOR BIOL, V274, P12, DOI 10.1016/j.jtbi.2010.12.007; Cauli Bruno, 2010, Front Neuroenergetics, V2, P9, DOI 10.3389/fnene.2010.00009; Chander BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048802; Cloutier M, 2009, J COMPUT NEUROSCI, V27, P391, DOI 10.1007/s10827-009-0152-8; Dubeau S, 2011, NEUROIMAGE, V57, P1480, DOI 10.1016/j.neuroimage.2011.04.030; Dvorzhak A, 2010, J PHYSIOL-LONDON, V588, P2351, DOI 10.1113/jphysiol.2010.187054; Friston KJ, 2000, NEUROIMAGE, V12, P466, DOI 10.1006/nimg.2000.0630; Gaohua Lu, 2009, Theor Biol Med Model, V6, P26, DOI 10.1186/1742-4682-6-26; GARLIN AB, 1995, J NEUROCHEM, V64, P2572; Giove F, 2009, BIOPHYSICS BIOENGINE, V2, P1; Grimbert F, 2006, NEURAL COMPUT, V18, P3052, DOI 10.1162/neco.2006.18.12.3052; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; Hascup ER, 2010, J NEUROCHEM, V115, P1608, DOI 10.1111/j.1471-4159.2010.07066.x; Hascup KN, 2008, J PHARMACOL EXP THER, V324, P725, DOI 10.1124/jpet.107.131698; Heja L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007153; Hires SA, 2008, P NATL ACAD SCI USA, V105, P4411, DOI 10.1073/pnas.0712008105; Huneau C, 2013, EPILEPSIA, V54, P2219, DOI 10.1111/epi.12406; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; JANSEN BH, 1993, BIOL CYBERN, V68, P275, DOI 10.1007/BF00224863; JANSEN BH, 1995, BIOL CYBERN, V73, P357, DOI 10.1007/BF00199471; Jolivet R, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004036; Kim K, 2011, J CELL PHYSIOL, V226, P2484, DOI 10.1002/jcp.22609; Kinney GA, 2002, J NEUROPHYSIOL, V88, P2899, DOI 10.1152/jn.00037.2002; Kowianski P, 2013, NEUROSCI RES, V75, P171, DOI 10.1016/j.neures.2013.01.014; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Lee CCJ, 2009, J COMPUT NEUROSCI, V26, P459, DOI 10.1007/s10827-008-0122-6; Lee M, 2011, GLIA, V59, P1600, DOI 10.1002/glia.21202; Leybaert L, 2005, J CEREBR BLOOD F MET, V25, P2, DOI 10.1038/sj.jcbfm.9600001; LIU QR, 1993, J BIOL CHEM, V268, P2106; Lopes da Silva F, 2002, ENCY HUMAN BRAIN, P147; Losi G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00132; MASON GF, 1995, J CEREBR BLOOD F MET, V15, P12, DOI 10.1038/jcbfm.1995.2; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Molaee-Ardekani B, 2010, NEUROIMAGE, V52, P1109, DOI 10.1016/j.neuroimage.2009.12.049; Mysona B, 2009, CELL TISSUE RES, V335, P477, DOI 10.1007/s00441-008-0742-1; Nusser Z, 2001, BIOPHYS J, V80, P1251, DOI 10.1016/S0006-3495(01)76101-2; Occhipinti R, 2007, ANN BIOMED ENG, V35, P886, DOI 10.1007/s10439-007-9270-5; Patel AB, 2005, P NATL ACAD SCI USA, V102, P5588, DOI 10.1073/pnas.0501703102; Postnov DE, 2007, BIOSYSTEMS, V89, P84, DOI 10.1016/j.biosystems.2006.04.012; Reato D, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00081; Riera JJ, 2008, NEUROIMAGE, V40, P1436, DOI 10.1016/j.neuroimage.2007.12.051; Rowley NM, 2012, NEUROCHEM INT, V61, P546, DOI 10.1016/j.neuint.2012.02.013; Schousboe Arne, 2013, Front Endocrinol (Lausanne), V4, P102, DOI 10.3389/fendo.2013.00102; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Sibson NR, 1997, P NATL ACAD SCI USA, V94, P2699, DOI 10.1073/pnas.94.6.2699; Sotero RC, 2008, NEUROIMAGE, V39, P290, DOI 10.1016/j.neuroimage.2007.08.001; Sotero RC, 2007, NEUROIMAGE, V35, P149, DOI 10.1016/j.neuroimage.2006.10.027; Suzuki K, 2001, J CELL SCI, V114, P3717; Tan J, 1999, J PHARMACOL EXP THER, V289, P1600; Uludag K, 2014, NEUROIMAGE; Vanzetta I, 2010, J NEUROPHYSIOL, V103, P3139, DOI 10.1152/jn.01048.2009; Vazquez AL, 2006, NEUROIMAGE, V32, P1642, DOI 10.1016/j.neuroimage.2006.04.195; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wendling F, 2005, J CLIN NEUROPHYSIOL, V22, P343; Wendling F, 2002, EUR J NEUROSCI, V15, P1499, DOI 10.1046/j.1460-9568.2002.01985.x; Wendling F, 2000, BIOL CYBERN, V83, P367, DOI 10.1007/s004220000160; White HS, 2002, J PHARMACOL EXP THER, V302, P636, DOI 10.1124/jpet.102.034819; Wolf F, 2008, SCIENCE, V320, P1597, DOI 10.1126/science.1160122; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200	77	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147292	10.1371/journal.pone.0147292	http://dx.doi.org/10.1371/journal.pone.0147292			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849643	gold, Green Published			2022-12-27	WOS:000369554000012
J	Haighton, C; Wilson, G; Ling, J; McCabe, K; Crosland, A; Kaner, E				Haighton, Catherine; Wilson, Graeme; Ling, Jonathan; McCabe, Karen; Crosland, Ann; Kaner, Eileen			A Qualitative Study of Service Provision for Alcohol Related Health Issues in Mid to Later Life	PLOS ONE			English	Article							AT-RISK DRINKING; OLDER-ADULTS; USE DISORDERS; SUBSTANCE-ABUSE; ELDERLY-PEOPLE; SOCIAL ECOLOGY; PRIMARY-CARE; INTERVENTION; CONSUMPTION; AGE	Aims Epidemiological surveys over the last 20 years show a steady increase in the amount of alcohol consumed by older age groups. Physiological changes and an increased likelihood of health problems and medication use make older people more likely than younger age groups to suffer negative consequences of alcohol consumption, often at lower levels. However, health services targeting excessive drinking tend to be aimed at younger age groups. The aim of this study was to gain an in-depth understanding of experiences of, and attitudes towards, support for alcohol related health issues in people aged 50 and over. Methods Qualitative interviews (n = 24, 12 male/12 female, ages 51-90 years) and focus groups (n = 27, 6 male/21 female, ages 50-95 years) were carried out with a purposive sample of participants who consumed alcohol or had been dependent. Findings Participants' alcohol misuse was often covert, isolated and carefully regulated. Participants tended to look first to their General Practitioner for help with alcohol. Detoxification courses had been found effective for dependent participants but only in the short term; rehabilitation facilities were appreciated but seen as difficult to access. Activities, informal groups and drop-in centres were endorsed. It was seen as difficult to secure treatment for alcohol and mental health problems together. Barriers to seeking help included functioning at a high level, concern about losing positive aspects of drinking, perceived stigma, service orientation to younger people, and fatalistic attitudes to help-seeking. Facilitators included concern about risk of fatal illness or pressure from significant people. Conclusion Primary care professionals need training on improving the detection and treatment of alcohol problems among older people. There is also a compelling need to ensure that aftercare is in place to prevent relapse. Strong preferences were expressed for support to be provided by those who had experienced alcohol problems themselves.	[Haighton, Catherine; Wilson, Graeme; Kaner, Eileen] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ling, Jonathan; McCabe, Karen; Crosland, Ann] Univ Sunderland, Dept Pharm Hlth & Well Being, Sunderland, England; [Wilson, Graeme] Univ Edinburgh, Reid Sch Mus, Edinburgh, Midlothian, Scotland	Newcastle University - UK; University of Sunderland; University of Edinburgh	Haighton, C (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	katie.haighton@newcastle.ac.uk	Kaner, Eileen/ABF-2444-2020; Wilson, Graeme/AAQ-2499-2020; Ling, Jonathan/AAY-4098-2020; Haighton, Catherine/H-1528-2015	Wilson, Graeme/0000-0003-2587-257X; Ling, Jonathan/0000-0003-2932-4474; Haighton, Catherine/0000-0002-8061-0428; Kaner, Eileen/0000-0002-7169-9344	United Kingdom Charity Age UK South Tyneside; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Medical Research Council [MR/K02325X/1, 1528022] Funding Source: researchfish	United Kingdom Charity Age UK South Tyneside; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are most grateful and extend our sincere thanks to all the people who took part in the study. This research was supported by a grant from the United Kingdom Charity Age UK South Tyneside (http://www.ageuk.org.uk/southtyneside/). The organisation assisted in the identification and recruitment of study participants as described in the methods section of the manuscript. Apart from this, the funders had no role in study design, analysis, decision to publish, or preparation of the manuscript. CH and JL are fully funded staff members and AC and EK are Senior Investigators of Fuse the Centre for Translational Research in Public Health, a UKCRC Public Health Research Centre of Excellence. Funding for Fuse from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, is gratefully acknowledged.	Aira M, 2005, INT J GERIATR PSYCH, V20, P680, DOI 10.1002/gps.1340; Aira M, 2008, FAM PRACT, V25, P445, DOI 10.1093/fampra/cmn065; Alcohol Concern, 2002, ALC MIS OLD PEOPL FA; [Anonymous], NVIVO QUAL DAT AN SO; Bakhshi Savita, 2014, Br J Community Nurs, V19, P370, DOI 10.12968/bjcn.2014.19.8.370; Barrett L. L., 2005, PRESCRIPTION DRUG US; Benshoff JJ, 2003, J REHABIL, V69, P43; Berks J, 2008, INT PSYCHOGERIATR, V20, P1090, DOI 10.1017/S1041610208007497; Blow FC, 2000, J GERIATR PSYCH NEUR, V13, P115, DOI 10.1177/089198870001300304; Caputo F, 2012, EXP GERONTOL, V47, P411, DOI 10.1016/j.exger.2012.03.019; Clarke A. E., 2005, SITUATIONAL ANAL GRO; Cohen DA, 2000, PREV MED, V30, P146, DOI 10.1006/pmed.1999.0609; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Coulson CE., 2014, GERIATRIC MENTAL HLT, V2, P3, DOI [DOI 10.1016/J.GMHC.2014.09.001, 10.1016/j.gmhc.2014.09.001]; Crome I, 2008, AGE AGEING, V37, P120, DOI 10.1093/ageing/afm150; Crome P, 1991, INT HDB ADDICTION BE; Dar K, 2006, ADV PSYCHIAT TREAT, V12, P173, DOI [DOI 10.1192/apt.12.3.173, 10.1192/apt.12.3.173]; Dare J, 2014, SOCIAL ENGAGEMENT SE, DOI 10.111/hsc.12110; Dawson DA, 2005, ADDICTION, V100, P281, DOI 10.1111/j.1360-0443.2004.00964.x; Department of Economic and Social Affairs Population Division, 2013, WORLD POP AG 2013; Department of Health, 2006, MOD CAR ALC MIS DEP; Department of Health, 2012, GOV ALC STRAT; Department of Health, 2001, NAT SERV FRAM OLD PE; Duru OK, 2015, ALCOHOL CLIN EXP RES, V39, P1227, DOI 10.1111/acer.12754; Ettner SL, 2014, J STUD ALCOHOL DRUGS, V75, P447, DOI 10.15288/jsad.2014.75.447; Fingerhood M, 2000, J AM GERIATR SOC, V48, P985, DOI 10.1111/j.1532-5415.2000.tb06900.x; Fleming MF, 1999, J FAM PRACTICE, V48, P378; Gilson KM, 2014, SUBST USE MISUSE, P1; Haarni I., 2010, NORDIC STUDIES ALCOH, V27, P241, DOI DOI 10.1177/145507251002700304; Johnson I, 2000, INT J GERIATR PSYCH, V15, P575, DOI 10.1002/1099-1166(200007)15:7<575::AID-GPS151>3.0.CO;2-0; Kaner EFS, 2001, BRIT J GEN PRACT, V51, P822; Ling J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-892; Lock CA, 2004, FAM PRACT, V21, P270, DOI 10.1093/fampra/cmh310; Lock CA, 2002, J ADV NURS, V39, P333, DOI 10.1046/j.1365-2648.2002.02294.x; Lock CA, 2004, PRIM HEALTH CARE RES, V5, P162, DOI DOI 10.1191/1463423604PC1940A; McCabe KE, 2016, PERSPECT PUBLIC HEAL, V136, P83, DOI 10.1177/1757913915597259; Moore AA, 2003, J AM GERIATR SOC, V51, P44, DOI 10.1034/j.1601-5215.2002.51008.x; Moore Alison A, 2007, Am J Geriatr Pharmacother, V5, P64, DOI 10.1016/j.amjopharm.2007.03.006; Mulinga JD, 1999, INT J GERIATR PSYCH, V14, P564; National Institute on Alcohol Abuse and Alcoholism, 1995, DIAGN CRIT ALC AB DE, P30; O'Connell H, 2004, INT J GERIATR PSYCH, V19, P1074, DOI 10.1002/gps.1214; O'Connell H, 2003, BMJ-BRIT MED J, V327, P664, DOI 10.1136/bmj.327.7416.664; Office for National Statistics, 2013, ALC REL DEATH UK 201; Office for National Statistics, 2010, DRINK AD BEH KNOWL 2; Office for National Statistics, 2013, CHAPT 2 DRINK GEN LI; Oslin DW, 2006, PSYCHIAT SERV, V57, P954, DOI 10.1176/appi.ps.57.7.954; Oslin DW, 2002, AM J GERIAT PSYCHIAT, V10, P740; Reid MC, 1998, J GEN INTERN MED, V13, P729, DOI 10.1046/j.1525-1497.1998.00223.x; Robinson OC, 2014, QUAL RES PSYCHOL, V11, P25, DOI 10.1080/14780887.2013.801543; Royal College of Psychiatrists, 2011, OUR INV ADD; Sacco P, 2015, AGING MENT HEALTH, V19, P279, DOI 10.1080/13607863.2014.933307; Stokols D, 1996, AM J HEALTH PROMOT, V10, P247, DOI 10.4278/0890-1171-10.4.247; Stokols D, 2000, BEHAV MED, V26, P129, DOI 10.1080/08964280009595760; Strauss A, 1997, GROUNDED THEORY PRAC; Thomas VS, 2001, J AM GERIATR SOC, V49, P415, DOI 10.1046/j.1532-5415.2001.49085.x; Wadd S, 2011, WORKING OLDER DRINKE; Ward L, 2011, QUAL AGEING OLDER AD, V12, P239, DOI 10.1108/14717791111191171; Watson JM, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17250; Williams RD, 2006, USE SOCIAL ECOLOGY M, V21, P228; Wilson GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071792; World Health Organisation, 2004, WHAT MAIN RISK FACT; World Health Organization, 2012, GOOD HLTH ADDS LIF Y	62	17	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148601	10.1371/journal.pone.0148601	http://dx.doi.org/10.1371/journal.pone.0148601			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26848583	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000369554000134
J	Kim, DW; Kim, DK; Jo, A; Jin, HR; Eun, KM; Mo, JH; Cho, SH				Kim, Dae Woo; Kim, Dong-Kyu; Jo, Ara; Jin, Hong Ryul; Eun, Kyoung Mi; Mo, Ji-Hun; Cho, Seong H.			Age-Related Decline of Neutrophilic Inflammation Is Associated with Better Postoperative Prognosis in Non-eosinophilic Nasal Polyps	PLOS ONE			English	Article							ENDOSCOPIC SINUS SURGERY; CHRONIC RHINOSINUSITIS; EXPRESSION; FEATURES; PROFILE	Background Innate and adaptive immune responses change with increasing age and affect the course of diseases. Previous study investigated immunologic alteration in Western nasal polyps (NP) which is mostly eosinophilic. However, there are no reports regarding age-related immune changes of non-eosinophilic NP (NE-NP) which is a predominant subtype in Asian population. Methods A total of 153 subjects, including 20 with control, 63 with chronic rhinosinusitis (CRS) without NP (CRSsNP), and 70 with CRS with NP were enrolled. Age-related changes in computed tomography (CT), cytokines and clinical information were investigated. Tissue samples were analyzed for protein levels of IL-5, IL-17A, IL-23, interferon (IFN)-gamma, CCL-11, and CXCL-8, using Luminex immunoassay and for mRNA expression levels of interleukin (IL)-5, IL-17A, IL-23p19, IFN-gamma, CCL-11, CXCL-1, CXCL-2, CXCL-8, and CXCR2 by quantitative RT-PCR. Immunohistochemistry (IHC) was performed for the number of inflammatory cells. Results We observed that Lund-Mackay CT scores decreased with age in NE-NP. The number of human neutrophil elastase-positive cells and myeloperoxidase gene expression decreased in older patients with NE-NP, but not in control subjects, CRSsNP, and E-NP. Neutrophil-associated cytokines including IL-17A and IL-23, were negatively correlated with age in NENP at the protein and mRNA levels. Additionally, the expression of CXCR2, a receptor for CXCL-1 and CXCL-2, was decreased with age in NE-NP. However, there were no age-related changes in blood neutrophil count, and neutrophil-recruiting chemokines such as CXCL-1, CXCL-2, and CXCL-8. Elderly NE-NP patients showed better endoscopic scores at 12 months after surgery compared with the non-elderly. Conclusion Age-related decline in neutrophil inflammation may favorably affect postoperative results in elderly patients with NE-NP.	[Kim, Dae Woo; Jin, Hong Ryul; Eun, Kyoung Mi] Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, Dae Woo; Jo, Ara; Cho, Seong H.] Univ S Florida, Coll Med, Dept Internal Med, Div Allergy Immunol, Tampa, FL 33612 USA; [Kim, Dong-Kyu] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Chunchon, South Korea; [Kim, Dong-Kyu] Hallym Univ, Coll Med, Nanobio Regenerat Med Inst, Chunchon, South Korea; [Mo, Ji-Hun] Dankook Univ, Coll Med, Dept Otorhinolaryngol, Cheonan, South Korea	Seoul National University (SNU); Seoul National University Hospital; State University System of Florida; University of South Florida; Hallym University; Hallym University; Dankook University	Cho, SH (corresponding author), Univ S Florida, Coll Med, Dept Internal Med, Div Allergy Immunol, Tampa, FL 33612 USA.	scho2@health.usf.edu	; Mo, Ji-Hun/E-5586-2011	Jo, Ara/0000-0002-2781-8529; Kim, Dong-Kyu/0000-0003-4917-0177; Mo, Ji-Hun/0000-0003-1331-364X	Ministry of Science, ICT and Future Planning [NRF-2014R1A1A1005598]; NIH [1K23AI110731]; American Heart Association [11SDG7590063]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI110731] Funding Source: NIH RePORTER	Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dae Woo Kim has received the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2014R1A1A1005598). Seong H Cho has received grant support from NIH 1K23AI110731 and American Heart Association 11SDG7590063. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busse PJ, 2010, J ALLERGY CLIN IMMUN, V126, P690, DOI 10.1016/j.jaci.2010.08.011; Cao PP, 2014, CLIN EXP ALLERGY, V44, P690, DOI 10.1111/cea.12304; Cho SH, 2015, AM J RESP CELL MOL, V53, P601, DOI 10.1165/rcmb.2015-0207RC; Cho SH, 2012, J ALLERGY CLIN IMMUN, V129, P858, DOI 10.1016/j.jaci.2011.12.002; Dalboni TM, 2013, CYTOKINE, V61, P716, DOI 10.1016/j.cyto.2013.01.016; Fokkens Wytske J, 2012, Rhinol Suppl, V23, P1; Fulop T, 1997, MECH AGEING DEV, V96, P15, DOI 10.1016/S0047-6374(96)01881-7; Hanania NA, 2011, J ALLERGY CLIN IMMUN, V128, pS4, DOI 10.1016/j.jaci.2011.06.048; Hellquist HB, 1996, ALLERGY ASTHMA PROC, V17, P237, DOI 10.2500/108854196778662264; Kim DK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139945; Kim DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111352; Kim JW, 2007, OTOLARYNG HEAD NECK, V137, P925, DOI 10.1016/j.otohns.2007.07.036; Krings JG, 2014, LARYNGOSCOPE, V124, P838, DOI 10.1002/lary.24401; Lee JY, 2007, LARYNGOSCOPE, V117, P1084, DOI 10.1097/MLG.0b013e318058197a; Lund V J, 1995, Ann Otol Rhinol Laryngol Suppl, V167, P17; Lund VJ, 1997, OTOLARYNG HEAD NECK, V117, pS35, DOI 10.1016/S0194-5998(97)70005-6; Mahdavinia M, 2015, J ALLERGY CLIN IMMUN, V135, P576, DOI 10.1016/j.jaci.2014.08.031; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Payne SC, 2011, LARYNGOSCOPE, V121, P2262, DOI 10.1002/lary.21969; Pothoven KL, 2015, J ALLERGY CLIN IMMUN, V136, P737, DOI 10.1016/j.jaci.2015.01.043; Shi LL, 2013, ALLERGY, V68, P101, DOI 10.1111/all.12064; Shin HW, 2015, J ALLERGY CLIN IMMUN, V135, P1476, DOI 10.1016/j.jaci.2015.01.003; Shin JM, 2015, INT FORUM ALLERGY RH, V5, P541, DOI 10.1002/alr.21506; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Tokunaga T, 2015, ALLERGY, V70, P995, DOI 10.1111/all.12644; Yu ZJ, 2015, INT FORUM ALLERGY RH, V5, P734, DOI 10.1002/alr.21530	26	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148442	10.1371/journal.pone.0148442	http://dx.doi.org/10.1371/journal.pone.0148442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849431	gold, Green Submitted, Green Published			2022-12-27	WOS:000369554000094
J	Li, B; Zhao, YH; Liu, H; Meng, B; Wang, JT; Qi, TJ; Zhang, H; Li, T; Zhao, PQ; Sun, H; Xu, J; Song, HB; Dong, Z; An, FS				Li, Bo; Zhao, Yunhe; Liu, Hui; Meng, Bin; Wang, Jitao; Qi, Tianjun; Zhang, Hui; Li, Tao; Zhao, Peiqing; Sun, Hui; Xu, Jia; Song, Haibo; Dong, Zhe; An, Fengshuang			Visfatin Destabilizes Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-8; ENDOTHELIAL-CELLS; NEUTROPHIL ELASTASE; MMP-2/9 PRODUCTION; IN-VITRO; EXPRESSION; MACROPHAGES; ACTIVATION; STROMELYSIN; NAMPT	Objectives Although there is evidence that visfatin is associated with atherogenesis, the effect of visfatin on plaque stability has not yet been explored. Methods In vivo, vulnerable plaques were established by carotid collar placement in apolipoprotein E-deficient (ApoE(-/-)) mice, and lentivirus expressing visfatin (lenti-visfatin) was locally infused in the carotid artery. The lipid, macrophage, smooth muscle cell (SMC) and collagen levels were evaluated, and the vulnerability index was calculated. In vitro, RAW264.7 cells were stimulated with visfatin, and the MMPs expressions were assessed by western blot and immunofluorescence. And the mechanism that involved in visfatin-induced MMP-8 production was investigated. Results Transfection with lenti-visfatin significantly promoted the expression of visfatin which mainly expressed in macrophages in the plaque. Lenti-visfatin transfection significantly promoted the accumulation of lipids and macrophages, modulated the phenotypes of smooth muscle cells and decreased the collagen levels in the plaques, which significantly decreased the plaque stability. Simultaneously, transfection with lenti-visfatin significantly up-regulated the expression of MMP-8 in vivo, as well as MMP-1, MMP-2 and MMP-9. Recombinant visfatin dose-and time-dependently up-regulated the in vitro expression of MMP-8 in macrophages. Visfatin promoted the translocation of NF-kappa B, and inhibition of NF-kappa B significantly reduced visfatin-induced MMP-8 production. Conclusions Visfatin increased MMP-8 expression, promoted collagen degradation and increased the plaques vulnerability index.	[Li, Bo; Zhao, Yunhe; Meng, Bin; Wang, Jitao; Qi, Tianjun; Zhang, Hui; Li, Tao; Zhao, Peiqing; Sun, Hui] Cent Hosp Zibo, Dept Cardiol, Zibo, Peoples R China; [Liu, Hui; An, Fengshuang] Shandong Univ, Dept Cardiol, Qilu Hosp, Jinan 250100, Peoples R China; [Xu, Jia; Song, Haibo] Zibo Maternal & Child Hlth Hosp, Prenatal Diag Ctr, Zibo, Peoples R China; [Dong, Zhe] China Japan Friendship Hosp, Dept Cardiol, Beijing, Peoples R China	Shandong University; China-Japan Friendship Hospital	An, FS (corresponding author), Shandong Univ, Dept Cardiol, Qilu Hosp, Jinan 250100, Peoples R China.; Dong, Z (corresponding author), China Japan Friendship Hosp, Dept Cardiol, Beijing, Peoples R China.	sdwhdz@hotmail.com; anfengshuang@sina.com	zhao, peiqing/E-6602-2014	Zhao, Peiqing/0000-0002-9311-1927	Science Foundation of Shandong Province [ZR2014HP005]; Natural Science Foundation of China [81370325, 81500286]	Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Science Foundation of Shandong Province (ZR2014HP005) and Natural Science Foundation of China (no. 81370325 and no. 81500286).	Adya R, 2008, CARDIOVASC RES, V78, P356, DOI 10.1093/cvr/cvm111; Adya R, 2008, DIABETES CARE, V31, P758, DOI 10.2337/dc07-1544; Bessa SS, 2010, EUR J INTERN MED, V21, P530, DOI 10.1016/j.ejim.2010.09.011; Cirillo P, 2012, THROMB RES, V130, P403, DOI 10.1016/j.thromres.2012.06.007; Dahl TB, 2007, CIRCULATION, V115, P972, DOI 10.1161/CIRCULATIONAHA.106.665893; Dalamaga M, 2012, MED HYPOTHESES, V79, P617, DOI 10.1016/j.mehy.2012.07.036; Dollery CM, 2003, CIRCULATION, V107, P2829, DOI 10.1161/01.CIR.0000072792.65250.4A; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Fan YQ, 2011, INT J MOL MED, V27, P607, DOI 10.3892/ijmm.2011.621; Fang CC, 2013, CARDIOVASC RES, V99, P146, DOI 10.1093/cvr/cvt060; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; HASTY KA, 1987, J BIOL CHEM, V262, P10048; ITOH Y, 1995, J BIOL CHEM, V270, P16518, DOI 10.1074/jbc.270.28.16518; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Kadoglou NPE, 2010, EXP CLIN ENDOCR DIAB, V118, P75, DOI 10.1055/s-0029-1237360; Kim SR, 2008, BBA-MOL CELL RES, V1783, P886, DOI 10.1016/j.bbamcr.2008.01.004; Knauper V, 1996, EUR J BIOCHEM, V235, P187, DOI 10.1111/j.1432-1033.1996.00187.x; La VD, 2011, J PERIODONTOL, V82, P122, DOI 10.1902/jop.2010.100342; Laxton RC, 2009, CIRC RES, V105, P921, DOI 10.1161/CIRCRESAHA.109.200279; Lee WJ, 2009, INT J OBESITY, V33, P465, DOI 10.1038/ijo.2009.24; Lenglet S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/659282; Li B, 2014, INT J CARDIOL, V174, P179, DOI 10.1016/j.ijcard.2014.03.186; Li B, 2013, ATHEROSCLEROSIS, V228, P370, DOI 10.1016/j.atherosclerosis.2013.03.023; Li JJ, 2012, ARTERIOSCL THROM VAS, V32, P1158, DOI 10.1161/ATVBAHA.112.246108; Molloy KJ, 2004, CIRCULATION, V110, P337, DOI 10.1161/01.CIR.0000135588.65188.14; Moulton KS, 2003, P NATL ACAD SCI USA, V100, P4736, DOI 10.1073/pnas.0730843100; Nokhbehsaim M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/437123; OKADA Y, 1989, FEBS LETT, V249, P353, DOI 10.1016/0014-5793(89)80657-X; Sandeep S, 2007, METABOLISM, V56, P565, DOI 10.1016/j.metabol.2006.12.005; Segawa K, 2006, BIOCHEM BIOPH RES CO, V349, P875, DOI 10.1016/j.bbrc.2006.07.083; Wang P, 2009, CARDIOVASC RES, V81, P370, DOI 10.1093/cvr/cvn288; Xu L, 2005, J BIOL CHEM, V280, P548, DOI 10.1074/jbc.M411036200; Yang JM, 2011, J CELL MOL MED, V15, P602, DOI 10.1111/j.1582-4934.2010.01028.x; Yilmaz MI, 2009, CLIN TRANSPLANT, V23, P241, DOI 10.1111/j.1399-0012.2008.00921.x; Yu XY, 2010, HORM METAB RES, V42, P507, DOI 10.1055/s-0030-1249059; Zhang XC, 2014, J CARDIOVASCULAR PHA; Zhang XC, 2014, J CARDIOVASC PHARM, V64, P318, DOI 10.1097/FJC.0000000000000117	37	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148273	10.1371/journal.pone.0148273	http://dx.doi.org/10.1371/journal.pone.0148273			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848572	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000062
J	Picot, M; Billard, JM; Dombret, C; Albac, C; Karameh, N; Daumas, S; Hardin-Pouzet, H; Mhaouty-Kodja, S				Picot, Marie; Billard, Jean-Marie; Dombret, Carlos; Albac, Christelle; Karameh, Nida; Daumas, Stephanie; Hardin-Pouzet, Helene; Mhaouty-Kodja, Sakina			Neural Androgen Receptor Deletion Impairs the Temporal Processing of Objects and Hippocampal CA1-Dependent Mechanisms	PLOS ONE			English	Article							LONG-TERM POTENTIATION; FREE TESTOSTERONE; COGNITIVE PERFORMANCE; SYNAPTIC PLASTICITY; RECOGNITION MEMORY; PREFRONTAL CORTEX; GONADAL-HORMONES; DENDRITIC THORNS; NMDA RECEPTORS; SPATIAL MEMORY	We studied the role of testosterone, mediated by the androgen receptor (AR), in modulating temporal order memory for visual objects. For this purpose, we used male mice lacking AR specifically in the nervous system. Control and mutant males were gonadectomized at adulthood and supplemented with equivalent amounts of testosterone in order to normalize their hormonal levels. We found that neural AR deletion selectively impaired the processing of temporal information for visual objects, without affecting classical object recognition or anxiety-like behavior and circulating corticosterone levels, which remained similar to those in control males. Thus, mutant males were unable to discriminate between the most recently seen object and previously seen objects, whereas their control littermates showed more interest in exploring previously seen objects. Because the hippocampal CA1 area has been associated with temporal memory for visual objects, we investigated whether neural AR deletion altered the functionality of this region. Electrophysiological analysis showed that neural AR deletion affected basal glutamate synaptic transmission and decreased the magnitude of N-methyl-D-aspartate receptor (NMDAR) activation and high-frequency stimulation-induced long-term potentiation. The impairment of NMDAR function was not due to changes in protein levels of receptor. These results provide the first evidence for the modulation of temporal processing of information for visual objects by androgens, via AR activation, possibly through regulation of NMDAR signaling in the CA1 area in male mice.	[Picot, Marie; Dombret, Carlos; Albac, Christelle; Karameh, Nida; Daumas, Stephanie; Hardin-Pouzet, Helene; Mhaouty-Kodja, Sakina] Univ Paris 06, INSERM, Neurosci Paris Seine, Unite Mixte Rech UMR S1130, Paris, France; [Picot, Marie; Dombret, Carlos; Albac, Christelle; Karameh, Nida; Daumas, Stephanie; Hardin-Pouzet, Helene; Mhaouty-Kodja, Sakina] Univ Paris 06, CNRS, UMR 8246, Paris, France; [Picot, Marie; Dombret, Carlos; Albac, Christelle; Karameh, Nida; Daumas, Stephanie; Hardin-Pouzet, Helene; Mhaouty-Kodja, Sakina] Univ Paris 06, Sorbonne Univ, UM CR18, Paris, France; [Billard, Jean-Marie] Univ Paris 05, Ctr Psychiat & Neurosci, Sorbonne Paris Cite, UMR 894, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Mhaouty-Kodja, S (corresponding author), Univ Paris 06, INSERM, Neurosci Paris Seine, Unite Mixte Rech UMR S1130, Paris, France.; Mhaouty-Kodja, S (corresponding author), Univ Paris 06, CNRS, UMR 8246, Paris, France.; Mhaouty-Kodja, S (corresponding author), Univ Paris 06, Sorbonne Univ, UM CR18, Paris, France.	sakina.mhaouty-kodja@upmc.fr	Billard, Jean-Marie/ABD-4987-2020	Hardin-Pouzet, Helene/0000-0001-9401-2456; Mhaouty-Kodja, Sakina/0000-0001-9743-5243; Daumas, Stephanie/0000-0001-7048-7617; PICOT, Marie/0000-0002-5331-9723	Interdisciplinary Programme "Longevite et Vieillissement" of the Centre National de la Recherche Scientifique	Interdisciplinary Programme "Longevite et Vieillissement" of the Centre National de la Recherche Scientifique	This work was supported by a grant from the Interdisciplinary Programme "Longevite et Vieillissement" of the Centre National de la Recherche Scientifique.	Alexander GM, 1998, HORM BEHAV, V33, P85, DOI 10.1006/hbeh.1998.1439; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Ceccarelli I, 2001, BEHAV BRAIN RES, V123, P65, DOI 10.1016/S0166-4328(01)00195-4; Cherrier MM, 2002, J CLIN ENDOCR METAB, V87, P3090, DOI 10.1210/jc.87.7.3090; Cho J, 2015, SCIENCE, V350, P82, DOI 10.1126/science.aac7368; Day M, 2005, BEHAV BRAIN RES, V164, P128, DOI 10.1016/j.bbr.2005.05.011; Downes JJ, 2002, NEUROPSYCHOLOGIA, V40, P853, DOI 10.1016/S0028-3932(01)00172-5; Driscoll I, 2007, CURR ALZHEIMER RES, V4, P33, DOI 10.2174/156720507779939878; Edinger KL, 2004, BEHAV NEUROSCI, V118, P1352, DOI 10.1037/0735-7044.118.6.1352; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Frye CA, 2004, PSYCHONEUROENDOCRINO, V29, P1019, DOI 10.1016/j.psyneuen.2003.10.004; Galea LAM, 2008, CAN J EXP PSYCHOL, V62, P247, DOI 10.1037/a0014501; Gibbs RB, 2008, ENDOCRINOLOGY, V149, P3176, DOI 10.1210/en.2007-1645; GOLDSTEIN JL, 1972, J CLIN INVEST, V51, P1647, DOI 10.1172/JCI106966; Golomb JD, 2008, MEM COGNITION, V36, P947, DOI 10.3758/MC.36.5.947; Gonzalez-Burgos I, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/309494; Hajszan T, 2007, ENDOCRINOLOGY, V148, P1963, DOI 10.1210/en.2006-1626; Handa RJ, 2008, HORM BEHAV, V53, P741, DOI 10.1016/j.yhbeh.2007.09.012; Hannesson DK, 2004, J NEUROSCI, V24, P4596, DOI 10.1523/JNEUROSCI.5517-03.2004; Harley CW, 2000, HIPPOCAMPUS, V10, P693; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Hatanaka Y, 2009, BIOCHEM BIOPH RES CO, V381, P728, DOI 10.1016/j.bbrc.2009.02.130; Hauser E, 2009, BEHAV NEUROSCI, V123, P1339, DOI 10.1037/a0017681; Hoge J, 2007, NEUROBIOL LEARN MEM, V88, P225, DOI 10.1016/j.nlm.2007.04.013; HOPKINS RO, 1995, BRAIN COGNITION, V27, P180, DOI 10.1006/brcg.1995.1016; Howell S, 2001, HORM RES, V56, P86, DOI 10.1159/000048142; Huerta PT, 2000, NEURON, V25, P473, DOI 10.1016/S0896-6273(00)80909-5; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P955, DOI 10.1002/hipo.20455; Isgor C, 2003, J NEUROBIOL, V55, P179, DOI 10.1002/neu.10200; Janowsky JS, 2006, TRENDS COGN SCI, V10, P77, DOI 10.1016/j.tics.2005.12.010; Junjaud G, 2006, J NEUROCHEM, V98, P1159, DOI 10.1111/j.1471-4159.2006.03944.x; KERR JE, 1995, ENDOCRINOLOGY, V136, P3213, DOI 10.1210/en.136.8.3213; Kesner RP, 2010, BEHAV BRAIN RES, V215, P299, DOI 10.1016/j.bbr.2009.12.029; Kesner RP, 2010, NEUROBIOL LEARN MEM, V93, P111, DOI 10.1016/j.nlm.2009.08.010; Kimoto T, 2010, ENDOCRINOLOGY, V151, P5795, DOI 10.1210/en.2010-0581; Kollen M, 2010, NEUROBIOL AGING, V31, P129, DOI 10.1016/j.neurobiolaging.2008.03.010; Kramar EA, 2009, J NEUROSCI, V29, P12982, DOI 10.1523/JNEUROSCI.3059-09.2009; Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419; Leranth C, 2003, J NEUROSCI, V23, P1588; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Mitchell JB, 1998, BEHAV BRAIN RES, V97, P107, DOI 10.1016/S0166-4328(98)00032-1; Moffat SD, 2002, J CLIN ENDOCR METAB, V87, P5001, DOI 10.1210/jc.2002-020419; Ooishi Y, 2012, J STEROID BIOCHEM, V131, P37, DOI 10.1016/j.jsbmb.2011.10.004; Packard MG, 1996, BEHAV NEUROSCI, V110, P626; Pause BM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00033; Pettorossi VE, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.185; Picot M, 2014, ENDOCRINOLOGY, V155, P502, DOI 10.1210/en.2013-1639; Potier B, 2000, EXP GERONTOL, V35, P1185, DOI 10.1016/S0531-5565(00)00122-4; Pouliot WA, 1996, SYNAPSE, V23, P10, DOI 10.1002/(SICI)1098-2396(199605)23:1<10::AID-SYN2>3.3.CO;2-Z; Raskin K, 2012, ENDOCRINOLOGY, V153, P3376, DOI 10.1210/en.2012-1001; Raskin K, 2009, J NEUROSCI, V29, P4461, DOI 10.1523/JNEUROSCI.0296-09.2009; Rossbach UL, 2010, MOL CELL ENDOCRINOL, V314, P143, DOI 10.1016/j.mce.2009.07.027; Shankar S, 1998, J NEUROPHYSIOL, V79, P334, DOI 10.1152/jn.1998.79.1.334; Skucas VA, 2013, J NEUROSCI, V33, P2338, DOI 10.1523/JNEUROSCI.3857-12.2013; Tanaka M, 2013, NEUROPHARMACOLOGY, V75, P262, DOI 10.1016/j.neuropharm.2013.07.029; Thilers PP, 2006, PSYCHONEUROENDOCRINO, V31, P565, DOI 10.1016/j.psyneuen.2005.12.005; Tsurugizawa T, 2005, BIOCHEM BIOPH RES CO, V337, P1345, DOI 10.1016/j.bbrc.2005.09.188; Winkler JM, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-51; Zuloaga DG, 2008, HORM BEHAV, V54, P758, DOI 10.1016/j.yhbeh.2008.08.004	61	20	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148328	10.1371/journal.pone.0148328	http://dx.doi.org/10.1371/journal.pone.0148328			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849367	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000069
J	Xie, L; Dolai, S; Kang, YH; Liang, T; Xie, HL; Qin, TR; Yang, L; Chen, LY; Gaisano, HY				Xie, Li; Dolai, Subhankar; Kang, Youhou; Liang, Tao; Xie, Huanli; Qin, Tairan; Yang, Lu; Chen, Liangyi; Gaisano, Herbert Y.			Syntaxin-3 Binds and Regulates Both R- and L-Type Calcium Channels in Insulin-Secreting INS-1832/13 Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; GATED CA2+ CHANNEL; PROTEIN EXPRESSION; EXOCYTOSIS; RELEASE; MEMBRANE; GRANULES; CA(V)1.2; ISLETS; LINES	Syntaxin (Syn)-1A mediates exocytosis of predocked insulin-containing secretory granules (SGs) during first-phase glucose-stimulated insulin secretion (GSIS) in part via its interaction with plasma membrane (PM)-bound L-type voltage-gated calcium channels (Ca-v). In contrast, Syn-3 mediates exocytosis of newcomer SGs that accounts for second-phase GSIS. We now hypothesize that the newcomer SG Syn-3 preferentially binds and modulates R-type Ca-v opening, which was postulated to mediate second-phase GSIS. Indeed, glucose-stimulation of pancreatic islet beta-cell line INS-1 induced a predominant increase in interaction between Syn-3 and Ca(v)a1 pore-forming subunits of R-type Ca(v)2.3 and to lesser extent L-type Ca(v)s, while confirming the preferential interactions between Syn-1A with L-type (Ca(v)1.2, Ca(v)1.3) Ca(v)s. Consistently, direct binding studies employing heterologous HEK cells confirmed that Syn-3 preferentially binds Ca(v)2.3, whereas Syn-1A prefers L-type Ca(v)s. We then used siRNA knockdown (KD) of Syn-3 in INS-1 to study the endogenous modulatory actions of Syn-3 on Ca-v channels. Syn-3 KD enhanced Ca2+ currents by 46% attributed mostly to R-and L-type Ca(v)s. Interestingly, while the transmembrane domain of Syn-1A is the putative functional domain modulating Ca-v activity, it is the cytoplasmic domain of Syn-3 that appears to modulate Ca-v activity. We conclude that Syn-3 may mimic Syn-1A in the ability to bind and modulate Ca(v)s, but preferring Ca(v)2.3 to perhaps participate in triggering fusion of newcomer insulin SGs during second-phase GSIS.	[Xie, Li; Dolai, Subhankar; Kang, Youhou; Liang, Tao; Xie, Huanli; Qin, Tairan; Gaisano, Herbert Y.] Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada; [Yang, Lu; Chen, Liangyi] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China	University of Toronto; Peking University	Gaisano, HY (corresponding author), Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada.	herbert.gaisano@utoronto.ca	Chen, Liangyi/F-1352-2010	Chen, Liangyi/0000-0003-1270-7321	Canadian Institute of Health Research [MOP 86544, MOP 69083]; National Science Foundation of China [81222020]; 3D (Diet, Digestive Tract and Disease) Centre - Canadian Foundation for Innovation and Ontario Research Fund [19442]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 3D (Diet, Digestive Tract and Disease) Centre - Canadian Foundation for Innovation and Ontario Research Fund	This work was supported by grants to H. Y. Gaisano from the Canadian Institute of Health Research (MOP 86544 and MOP 69083) and grants to L. Chen from the National Science Foundation of China (81222020). Some of the equipment used in this study was supported by the 3D (Diet, Digestive Tract and Disease) Centre funded by the Canadian Foundation for Innovation and Ontario Research Fund, project number 19442.	Arien H, 2003, J BIOL CHEM, V278, P29231, DOI 10.1074/jbc.M301401200; Atlas D, 2001, J NEUROCHEM, V77, P972, DOI 10.1046/j.1471-4159.2001.00347.x; Atlas D, 2013, ANNU REV BIOCHEM, V82, P607, DOI 10.1146/annurev-biochem-080411-121438; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Cohen R, 2004, NEUROSCIENCE, V128, P831, DOI 10.1016/j.neuroscience.2004.07.027; Cohen R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001273; Davalli AM, 1996, J ENDOCRINOL, V150, P195, DOI 10.1677/joe.0.1500195; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Gaisano HY, 2014, TRENDS ENDOCRIN MET, V25, P381, DOI 10.1016/j.tem.2014.03.005; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Hohmeier HE, 2004, MOL CELL ENDOCRINOL, V228, P121, DOI 10.1016/j.mce.2004.04.017; Huang XH, 2001, AM J PHYSIOL-CELL PH, V281, pC740, DOI 10.1152/ajpcell.2001.281.3.C740; Ji JZ, 2002, DIABETES, V51, P1425, DOI 10.2337/diabetes.51.5.1425; Jing XJ, 2005, J CLIN INVEST, V115, P146, DOI 10.1172/JCI200522518; Kang Y, 2002, DIABETOLOGIA, V45, P231, DOI 10.1007/s00125-001-0718-0; Kang YH, 2004, J BIOL CHEM, V279, P47125, DOI 10.1074/jbc.M404954200; Lam PPL, 2013, DIABETES, V62, P2416, DOI 10.2337/db12-1380; Nitert MD, 2008, J MOL ENDOCRINOL, V41, P1, DOI 10.1677/JME-07-0133; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Pedersen MG, 2009, P NATL ACAD SCI USA, V106, P7432, DOI 10.1073/pnas.0901202106; Pfeffer SR, 2013, CELL, V155, P1203, DOI 10.1016/j.cell.2013.11.014; Reinbothe TM, 2013, DIABETOLOGIA, V56, P340, DOI 10.1007/s00125-012-2758-z; Schulla V, 2003, EMBO J, V22, P3844, DOI 10.1093/emboj/cdg389; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Taylor JT, 2005, AM J PHYSIOL-ENDOC M, V289, pE900, DOI 10.1152/ajpendo.00101.2005; Trus M, 2001, NEUROSCIENCE, V104, P599, DOI 10.1016/S0306-4522(01)00083-5; Trus M, 2007, BIOCHEMISTRY-US, V46, P14461, DOI 10.1021/bi7016816; Wheeler MB, 1996, ENDOCRINOLOGY, V137, P1340, DOI 10.1210/en.137.4.1340; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Xie L, 2015, DIABETOLOGIA, V58, P1250, DOI 10.1007/s00125-015-3545-4; Xie L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067561; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Yang SN, 1999, P NATL ACAD SCI USA, V96, P10164, DOI 10.1073/pnas.96.18.10164; Yang SN, 2005, J CLIN INVEST, V115, P16, DOI 10.1172/JCI200523970; Zhu D, 2013, DIABETOLOGIA, V56, P359, DOI 10.1007/s00125-012-2757-0; Zhu D, 2012, CELL METAB, V16, P238, DOI 10.1016/j.cmet.2012.07.001	41	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147862	10.1371/journal.pone.0147862	http://dx.doi.org/10.1371/journal.pone.0147862			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848587	Green Published, gold			2022-12-27	WOS:000369554000026
J	Xu, G; Huang, J; Yang, Y; Yao, YA				Xu, Gang; Huang, Jian; Yang, Yong; Yao, Yin-an			Transcriptome Analysis of Flower Sex Differentiation in Jatropha curcas L. Using RNA Sequencing	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; SMALL AUXIN; MICROARRAY ANALYSIS; FUNCTIONAL-ANALYSIS; CELL-PROLIFERATION; NEGATIVE REGULATOR; GENE-EXPRESSION; CRABS-CLAW; ARABIDOPSIS; MERISTEM	Background Jatropha curcas is thought to be a promising biofuel material, but its yield is restricted by a low ratio of instaminate / staminate flowers (1/10-1/30). Furthermore, valuable information about flower sex differentiation in this plant is scarce. To explore the mechanism of this process in J. curcas, transcriptome profiling of flower development was carried out, and certain genes related with sex differentiation were obtained through digital gene expression analysis of flower buds from different phases of floral development. Results After Illumina sequencing and clustering, 57,962 unigenes were identified. A total of 47,423 unigenes were annotated, with 85 being related to carpel and stamen differentiation, 126 involved in carpel and stamen development, and 592 functioning in the later development stage for the maturation of staminate or instaminate flowers. Annotation of these genes provided comprehensive information regarding the sex differentiation of flowers, including the signaling system, hormone biosynthesis and regulation, transcription regulation and ubiquitin-mediated proteolysis. A further expression pattern analysis of 15 sex-related genes using quantitative real-time PCR revealed that gibberellin-regulated protein 4-like protein and AMP-activated protein kinase are associated with stamen differentiation, whereas auxin response factor 6-like protein, AGAMOUS-like 20 protein, CLAVATA1, RING-H2 finger protein ATL3J, auxin-induced protein 22D, and r2r3-myb transcription factor contribute to embryo sac development in the instaminate flower. Cytokinin oxidase, Unigene28, auxin repressed-like protein ARP1, gibberellin receptor protein GID1 and auxin-induced protein X10A are involved in both stages mentioned above. In addition to its function in the differentiation and development of the stamens, the gibberellin signaling pathway also functions in embryo sac development for the instaminate flower. The auxin signaling pathway also participates in both stamen development and embryo sac development. Conclusions Our transcriptome data provide a comprehensive gene expression profile for flower sex differentiation in Jatropha curcas, as well as new clues and information for further study in this field.	[Xu, Gang] Guizhou Univ, Res Inst Forest Resources & Environm, Guiyang 550003, Guizhou, Peoples R China; [Huang, Jian; Yang, Yong] Guizhou Univ, Ctr Res & Dev Fine Chem, Minist Educ, Key Lab Green Pesticide & Agr Bioengn, Guiyang 550003, Guizhou, Peoples R China; [Yao, Yin-an] Southwest Univ Sci & Technol, Sch Life Sci & Engn, Mianyang, Sichuan, Peoples R China; [Xu, Gang] Guizhou Univ, Inst Entomol, Guiyang 550003, Guizhou, Peoples R China	Guizhou University; Guizhou University; Southwest University of Science & Technology - China; Guizhou University	Yao, YA (corresponding author), Southwest Univ Sci & Technol, Sch Life Sci & Engn, Mianyang, Sichuan, Peoples R China.	yaoya@ms.xjb.ac.cn			National Natural Science Foundation of China [31060103, 31270660]; Social development Research Project of Guizhou Province [20083009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social development Research Project of Guizhou Province	This work was supported by No. 31060103 and No. 31270660 National Natural Science Foundation of China (http://www.nsfc.gov.cn to XG), 20083009 Social development Research Project of Guizhou Province (http://kjt.gzst.gov.cn to XG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Alvarez J, 1999, DEVELOPMENT, V126, P2377; Aubert D, 1998, PLANT MOL BIOL, V36, P871, DOI 10.1023/A:1005938624418; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; Borg M, 2011, PLANT CELL, V23, P534, DOI 10.1105/tpc.110.081059; Bowman JL, 1999, DEVELOPMENT, V126, P2387; Brown GG, 2003, PLANT J, V35, P262, DOI 10.1046/j.1365-313X.2003.01799.x; Carvalho CR, 2008, PLANT SCI, V174, P613, DOI 10.1016/j.plantsci.2008.03.010; Chae K, 2012, PLANT J, V71, P684, DOI 10.1111/j.1365-313X.2012.05024.x; CLARK SE, 1993, DEVELOPMENT, V119, P397; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Costa GGL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-462; Dehgan B, 1992, MORPHOLOGY FRAGENERI; Durbak AR, 2011, GENETICS, V189, P177, DOI 10.1534/genetics.111.130930; Foidl N, 1996, BIORESOURCE TECHNOL, V58, P77, DOI 10.1016/S0960-8524(96)00111-3; Francis G, 2005, NAT RESOUR FORUM, V29, P12, DOI 10.1111/j.1477-8947.2005.00109.x; GEE MA, 1991, PLANT CELL, V3, P419, DOI 10.1105/tpc.3.4.419; Gocal GFW, 1999, PLANT PHYSIOL, V119, P1271, DOI 10.1104/pp.119.4.1271; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Heller J, 1996, THESIS INT PLANT GEN; Huang S, 2003, PLANT PHYSIOL, V131, P1270, DOI 10.1104/pp.102.018598; Huang YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-691; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Kant S, 2009, PLANT SIGNAL BEHAV, V4, P1174, DOI 10.4161/psb.4.12.10043; Kant S, 2009, PLANT PHYSIOL, V151, P691, DOI 10.1104/pp.109.143875; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kayes JM, 1998, DEVELOPMENT, V125, P3843; Kazama T, 2003, FEBS LETT, V544, P99, DOI 10.1016/S0014-5793(03)00480-0; Kim HB, 2007, MOL CELLS, V23, P115; Kong YY, 2013, PLANT CELL PHYSIOL, V54, P609, DOI 10.1093/pcp/pct028; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lee MW, 2001, MOL PLANT MICROBE IN, V14, P527, DOI 10.1094/MPMI.2001.14.4.527; Liu HZ, 2008, PLANT MOL BIOL, V68, P17, DOI 10.1007/s11103-008-9349-x; Liu LYD, 2014, PLANT CELL PHYSIOL, V55, P942, DOI 10.1093/pcp/pcu029; Lu YQ, 2011, PLANT J, V67, P13, DOI 10.1111/j.1365-313X.2011.04569.x; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Mandaokar A, 2009, PLANT PHYSIOL, V149, P851, DOI 10.1104/pp.108.132597; MCCLURE BA, 1989, SCIENCE, V243, P91, DOI 10.1126/science.11540631; MCCLURE BA, 1987, PLANT MOL BIOL, V9, P611, DOI 10.1007/BF00020537; Molnar G, 2002, PLANTA, V215, P127, DOI 10.1007/s00425-001-0723-z; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Murray F, 2003, PLANT J, V33, P481, DOI 10.1046/j.1365-313X.2003.01641.x; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Nakamura T, 2004, BIOCHEM SOC T, V32, P571, DOI 10.1042/BST0320571; Natarajan P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-606; Pan BZ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-974; Park S, 2003, TREE PHYSIOL, V23, P815, DOI 10.1093/treephys/23.12.815; Raffaele S, 2006, FEBS LETT, V580, P3498, DOI 10.1016/j.febslet.2006.05.027; REDDY ASN, 1990, PLANT MOL BIOL, V14, P127, DOI 10.1007/BF00018554; Roxrud I, 2007, PLANT CELL PHYSIOL, V48, P471, DOI 10.1093/pcp/pcm016; Ruonala R, 2006, PLANT J, V46, P628, DOI 10.1111/j.1365-313X.2006.02722.x; Sato S, 2011, DNA RES, V18, P65, DOI 10.1093/dnares/dsq030; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P2791, DOI 10.1105/tpc.105.034454; Spartz AK, 2012, PLANT J, V70, P978, DOI 10.1111/j.1365-313X.2012.04946.x; Steiner C, 2003, BBA-GENE STRUCT EXPR, V1625, P123, DOI 10.1016/S0167-4781(02)00598-5; Tewari DN., 2007, JATROPHA BIODIESEL; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Wang W, 2011, CHINA BIOTECHNOL, V31, P38; Wang Z, 2005, PLANT MOL BIOL, V58, P721, DOI 10.1007/s11103-005-8267-4; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P1892, DOI 10.1093/nar/gkl118; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705	67	29	32	6	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0145613	10.1371/journal.pone.0145613	http://dx.doi.org/10.1371/journal.pone.0145613			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848843	Green Published, Green Submitted, gold			2022-12-27	WOS:000369554000004
J	Yano, S; Takehara, K; Miwa, S; Kishimoto, H; Hiroshima, Y; Murakami, T; Urata, Y; Kagawa, S; Bouvet, M; Fujiwara, T; Hoffman, RM				Yano, Shuya; Takehara, Kiyoto; Miwa, Shinji; Kishimoto, Hiroyuki; Hiroshima, Yukihiko; Murakami, Takashi; Urata, Yasuo; Kagawa, Shunsuke; Bouvet, Michael; Fujiwara, Toshiyoshi; Hoffman, Robert M.			Improved Resection and Outcome of Colon-Cancer Liver Metastasis with Fluorescence-Guided Surgery Using In Situ GFP Labeling with a Telomerase-Dependent Adenovirus in an Orthotopic Mouse Model	PLOS ONE			English	Article							PATIENT; CELLS; PROTEIN; TUMORS	Fluorescence-guided surgery (FGS) of cancer is an area of intense development. In the present report, we demonstrate that the telomerase-dependent green fluorescent protein (GFP)-containing adenovirus OBP-401 could label colon-cancer liver metastasis in situ in an orthotopic mouse model enabling successful FGS. OBP-401-GFP-labeled liver metastasis resulted in complete resection with FGS, in contrast, conventional bright-light surgery (BLS) did not result in complete resection of the metastasis. OBP-401-FGS reduced the recurrence rate and prolonged over-all survival compared with BLS. In conclusion, adenovirus OBP-401 is a powerful tool to label liver metastasis in situ with GFP which enables its complete resection, not possible with conventional BLS.	[Yano, Shuya; Takehara, Kiyoto; Miwa, Shinji; Hiroshima, Yukihiko; Murakami, Takashi; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Yano, Shuya; Takehara, Kiyoto; Miwa, Shinji; Hiroshima, Yukihiko; Murakami, Takashi; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Yano, Shuya; Takehara, Kiyoto; Kishimoto, Hiroyuki; Kagawa, Shunsuke; Fujiwara, Toshiyoshi] Okayama Univ, Grad Sch Med, Dept Surg Gastroenterol, Okayama 7008530, Japan; [Urata, Yasuo] Oncolys BioPharm Inc, Tokyo, Japan	Anti Cancer Inc; University of California System; University of California San Diego; Okayama University; Oncolys BioPharma	Hoffman, RM (corresponding author), AntiCancer Inc, San Diego, CA USA.; Hoffman, RM (corresponding author), Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA.	all@anticancer.com	Yano, Shuya/AAL-8028-2020; Kagawa, Shunsuke/B-2189-2011; Miwa, Shinji/AAI-9309-2020	Miwa, Shinji/0000-0002-5962-8287; Kagawa, Shunsuke/0000-0002-3610-8211; Murakami, Takashi/0000-0002-9429-5705	National Cancer Institute [CA132971, CA142669]; Ministry of Education, Science and culture, Japan; Ministry of Health and Welfare, Japan; NATIONAL CANCER INSTITUTE [R01CA142669, R01CA132971] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ministry of Education, Science and culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute grant numbers CA132971 and CA142669 to MB and by grants-in-Aid from the Ministry of Education, Science and culture, Japan and grants from the Ministry of Health and Welfare, Japan to TF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouvet M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003375; Hiroshima Y, 2014, J LAPAROENDOSC ADV S, V24, P241, DOI 10.1089/lap.2013.0418; Hiroshima Y, 2014, J SURG RES, V187, P510, DOI 10.1016/j.jss.2013.11.1083; Kishimoto H, 2006, NAT MED, V12, P1213, DOI 10.1038/nm1404; Kishimoto H, 2011, CELL CYCLE, V10, P2737, DOI 10.4161/cc.10.16.16756; Kishimoto H, 2009, MOL CANCER THER, V8, P3001, DOI 10.1158/1535-7163.MCT-09-0556; Kishimoto H, 2009, P NATL ACAD SCI USA, V106, P14514, DOI 10.1073/pnas.0906388106; Lintoiu-Ursut B, 2015, J Med Life, V8 Spec Issue, P12; Maawy AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097965; Metildi CA, 2013, J SURG RES, V179, P87, DOI 10.1016/j.jss.2012.08.052; Momiyama M, 2012, J SURG RES, V178, P280, DOI 10.1016/j.jss.2012.03.020; Murakami T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138752; Nemunaitis J, 2010, MOL THER, V18, P429, DOI 10.1038/mt.2009.262; Uchugonova A, 2011, J CELL BIOCHEM, V112, P2046, DOI 10.1002/jcb.23122; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Yang M, 2000, P NATL ACAD SCI USA, V97, P1206, DOI 10.1073/pnas.97.3.1206; Yano S, 2015, CANCER GENE THER, V22, P344, DOI 10.1038/cgt.2015.26; Yano S, 2015, BMJ OPEN RESPIR RES, V2, DOI 10.1136/bmjresp-2015-000096; Yano S, 2015, MOL THER, V23, P1182, DOI 10.1038/mt.2015.63; Yano S, 2015, ONCOTARGET, V6, P13133, DOI 10.18632/oncotarget.3811; Yano S, 2013, CLIN CANCER RES, V19, P6495, DOI 10.1158/1078-0432.CCR-13-0742	21	32	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148760	10.1371/journal.pone.0148760	http://dx.doi.org/10.1371/journal.pone.0148760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849435	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000166
J	Zahedi, A; On, V; Lin, SC; Bays, BC; Omaiye, E; Bhanu, B; Talbot, P				Zahedi, Atena; On, Vincent; Lin, Sabrina C.; Bays, Brett C.; Omaiye, Esther; Bhanu, Bir; Talbot, Prue			Evaluating Cell Processes, Quality, and Biomarkers in Pluripotent Stem Cells Using Video Bioinformatics	PLOS ONE			English	Article							FEATURE-SELECTION; IN-VITRO; REGION DETECTION; HUMAN HEALTH; MOUSE; SMOKE; TOXICITY; EXPOSURE; DISEASE; MODEL	There is a foundational need for quality control tools in stem cell laboratories engaged in basic research, regenerative therapies, and toxicological studies. These tools require automated methods for evaluating cell processes and quality during in vitro passaging, expansion, maintenance, and differentiation. In this paper, an unbiased, automated high-content profiling toolkit, StemCellQC, is presented that non-invasively extracts information on cell quality and cellular processes from time-lapse phase-contrast videos. Twenty four (24) morphological and dynamic features were analyzed in healthy, unhealthy, and dying human embryonic stem cell (hESC) colonies to identify those features that were affected in each group. Multiple features differed in the healthy versus unhealthy/dying groups, and these features were linked to growth, motility, and death. Biomarkers were discovered that predicted cell processes before they were detectable by manual observation. StemCellQC distinguished healthy and unhealthy/dying hESC colonies with 96% accuracy by non-invasively measuring and tracking dynamic and morphological features over 48 hours. Changes in cellular processes can be monitored by StemCellQC and predictions can be made about the quality of pluripotent stem cell colonies. This toolkit reduced the time and resources required to track multiple pluripotent stem cell colonies and eliminated handling errors and false classifications due to human bias. StemCellQC provided both user-specified and classifier-determined analysis in cases where the affected features are not intuitive or anticipated. Video analysis algorithms allowed assessment of biological phenomena using automatic detection analysis, which can aid facilities where maintaining stem cell quality and/or monitoring changes in cellular processes are essential. In the future StemCellQC can be expanded to include other features, cell types, treatments, and differentiating cells.	[Zahedi, Atena; Bhanu, Bir] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [On, Vincent; Bhanu, Bir] Univ Calif Riverside, Dept Elect & Comp Engn, Riverside, CA 92521 USA; [On, Vincent; Bhanu, Bir] Univ Calif Riverside, Ctr Res Intelligent Syst, Riverside, CA 92521 USA; [Zahedi, Atena; Lin, Sabrina C.; Omaiye, Esther; Talbot, Prue] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Zahedi, Atena; Lin, Sabrina C.; Omaiye, Esther; Talbot, Prue] Univ Calif Riverside, UCR Stem Cell Ctr & Core, Riverside, CA 92521 USA; [Bays, Brett C.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Talbot, P (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.; Talbot, P (corresponding author), Univ Calif Riverside, UCR Stem Cell Ctr & Core, Riverside, CA 92521 USA.	talbot@ucr.edu	Talbot, Prue/AAY-3896-2021	Omaiye, Esther E./0000-0002-6010-4798; Zahedi, Atena/0000-0002-1005-9845; Bhanu, Bir/0000-0001-8971-6416	NSF IGERT grant in Video Bioinformatics [DGE 0903667]; California Institute for Regenerative Medicine [NE-A0005A-1E]; Tobacco-Related Disease Research Program of CA [22RT-0127, 20PT-0184]	NSF IGERT grant in Video Bioinformatics; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Tobacco-Related Disease Research Program of CA	The authors thank Dr. Albert Cruz (IGERT Fellow) and Dr. Seyyed Farhad Razavi who helped with parts of the software implementation and Jackie Whitehead for her suggestions on the manuscript. This work is supported by a NSF IGERT grant in Video Bioinformatics (DGE 0903667), the California Institute for Regenerative Medicine (# NE-A0005A-1E), and grants from the Tobacco-Related Disease Research Program of CA (# 22RT-0127 and #20PT-0184).	Alworth SV, 2010, J BIOMOL SCREEN, V15, P968, DOI 10.1177/1087057110373546; Barbaric I, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.006; Bermingham ML, 2015, SCI REP-UK, V5, DOI 10.1038/srep10312; Bradley CK, 2011, STEM CELLS DEV, V20, P495, DOI 10.1089/scd.2010.0120; Cawley GC, 2007, ADV NEURAL INFORM PR, P209; Chen KG, 2014, CELL STEM CELL, V14, P13, DOI 10.1016/j.stem.2013.12.005; Cover T. M., 1991, ELEMENTS INFORM THEO; DEBERG M, 2000, COMPUTATIONAL GEOMET; Dieterich P, 2008, P NATL ACAD SCI USA, V105, P459, DOI 10.1073/pnas.0707603105; Duda R.O., 2000, PATTERN CLASSIFICATI; Fogh BS, 2014, J HISTOCHEM CYTOCHEM, V62, P172, DOI 10.1369/0022155413517701; Gini C, 1912, VARIABILITE MUTABILI; Grandjean P, 2008, BASIC CLIN PHARMACOL, V102, P73, DOI 10.1111/j.1742-7843.2007.00114.x; Guan B. X., 2011, 2011 IEEE International Conference on Healthcare Informatics, Imaging and Systems Biology, P307, DOI 10.1109/HISB.2011.30; Guan B. X., 2012, IEEE 2 INT C HEALTHC, P75, DOI DOI 10.1109/HISB.2012.25; Guan BX, 2014, IEEE ACM T COMPUT BI, V11, P604, DOI 10.1109/TCBB.2014.2306836; Guan BX, 2013, I S BIOMED IMAGING, P418; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Ke HN, 2011, CELL ADHES MIGR, V5, P6, DOI 10.4161/cam.5.1.13175; Knoll M, 1998, REPROD TOXICOL, V12, P57, DOI 10.1016/S0890-6238(97)00100-7; KNOLL M, 1995, BIOL REPROD, V53, P29, DOI 10.1095/biolreprod53.1.29; Lin S, 2009, HUM REPROD, V24, P386, DOI 10.1093/humrep/den419; Lin Sabrina, 2010, J Vis Exp, DOI 10.3791/1933; Lin S, 2011, METHODS MOL BIOL, V690, P31, DOI 10.1007/978-1-60761-962-8_2; Lin S, 2010, TOXICOL SCI, V118, P202, DOI 10.1093/toxsci/kfq241; Liu H, 1995, PROC INT C TOOLS ART, P388, DOI 10.1109/TAI.1995.479783; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Megyola CM, 2013, STEM CELLS, V31, P895, DOI 10.1002/stem.1323; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Montgomery D. C., 2001, ENG STAT; Nguyen XV, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P512, DOI 10.1145/2623330.2623611; Nichols J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008128; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Shapiro L., 2001, COMPUTER VISION; Sheehy SP, 2014, STEM CELL REP, V2, P282, DOI 10.1016/j.stemcr.2014.01.015; Smith LA, 1999, INT FLAIRS C, P5, DOI 10.1.1.50.2192; Tabar V, 2014, NAT REV GENET, V15, P82, DOI 10.1038/nrg3563; Talbot P, 2014, HANDBOOK OF NANOTOXICOLOGY, NANOMEDICINE AND STEM CELL USE IN TOXICOLOGY, P379; Talbot P, 2011, CURR TOP MED CHEM, V11, P1638; Tokunaga K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06996; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Wang XL, 2013, SOFT MATTER, V9, P4160, DOI 10.1039/c3sm27818b; WEI LJ, 1981, J AM STAT ASSOC, V76, P1006, DOI 10.2307/2287603; Winter M, 2011, NAT PROTOC, V6, P1942, DOI 10.1038/nprot.2011.422; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686; Zhao Zheng, 2010, ADV FEATURE SELECTIO; Zhu ZR, 2013, DEVELOPMENT, V140, P705, DOI 10.1242/dev.086165	48	17	17	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148642	10.1371/journal.pone.0148642	http://dx.doi.org/10.1371/journal.pone.0148642			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848582	Green Published, gold			2022-12-27	WOS:000369554000146
J	Zhu, BY; Xia, YX				Zhu, Boyao; Xia, Yongxiang			Link Prediction in Weighted Networks: A Weighted Mutual Information Model	PLOS ONE			English	Article							COMPLEX NETWORKS	The link-prediction problem is an open issue in data mining and knowledge discovery, which attracts researchers from disparate scientific communities. A wealth of methods have been proposed to deal with this problem. Among these approaches, most are applied in unweighted networks, with only a few taking the weights of links into consideration. In this paper, we present a weighted model for undirected and weighted networks based on the mutual information of local network structures, where link weights are applied to further enhance the distinguishable extent of candidate links. Empirical experiments are conducted on four weighted networks, and results show that the proposed method can provide more accurate predictions than not only traditional unweighted indices but also typical weighted indices. Furthermore, some in-depth discussions on the effects of weak ties in link prediction as well as the potential to predict link weights are also given. This work may shed light on the design of algorithms for link prediction in weighted networks.	[Zhu, Boyao; Xia, Yongxiang] Zhejiang Univ, Coll Informat Sci & Elect Engn, Hangzhou 310027, Zhejiang, Peoples R China	Zhejiang University	Xia, YX (corresponding author), Zhejiang Univ, Coll Informat Sci & Elect Engn, Hangzhou 310027, Zhejiang, Peoples R China.	xiayx@zju.edu.cn	Xia, Yongxiang/D-2439-2015		National Natural Science Foundation of China [61573310]; Zhejiang Provincial Natural Science Foundation of China [LY15F030006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The authors were supported by the National Natural Science Foundation of China under Grant No. 61573310, and Zhejiang Provincial Natural Science Foundation of China under Grant No. LY15F030006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic LA, 2003, SOC NETWORKS, V25, P211, DOI 10.1016/S0378-8733(03)00009-1; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Cover TM, 2012, ELEMENTS INFORM THEO, DOI DOI 10.1002/047174882X; Csermely P, 2006, WEAK LINKS STABILIZE; Du WB, 2015, APPL MATH COMPUT, V268, P832, DOI 10.1016/j.amc.2015.06.062; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Huang Z, 2005, ACM-IEEE J CONF DIG, P141, DOI 10.1145/1065385.1065415; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kleinberg J, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0378; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Liu HF, 2013, EPL-EUROPHYS LETT, V101, DOI 10.1209/0295-5075/101/18004; Liu Z, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/48007; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Lu LY, 2015, P NATL ACAD SCI USA, V112, P2325, DOI 10.1073/pnas.1424644112; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Lu LY, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/18001; Murata T, 2007, PROCEEDINGS OF THE IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE, P85, DOI 10.1109/WI.2007.52; Sa H. R., 2010, P 3 INT WORKSH WEB T; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Tan F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107056; Wang P, 2015, SCI CHINA INFORM SCI, V58, DOI 10.1007/s11432-014-5237-y; Wang WQ, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/28004; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang Q.-M., 2015, SCI REPORTS, V5; Zhang QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055437; Zhao J., 2015, SCI REPORTS, V5; Zhou T, 2009, EUR PHYS J B, V71, P623, DOI 10.1140/epjb/e2009-00335-8; Zhu BB, 2015, SCI REP-UK, V5, DOI 10.1038/srep08797	31	41	47	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148265	10.1371/journal.pone.0148265	http://dx.doi.org/10.1371/journal.pone.0148265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849659	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000060
J	Hedner, C; Borg, D; Nodin, B; Karnevi, E; Jirstrom, K; Eberhard, J				Hedner, Charlotta; Borg, David; Nodin, Bjorn; Karnevi, Emelie; Jirstrom, Karin; Eberhard, Jakob			Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma	PLOS ONE			English	Article							PHASE-II TRIAL; ADVANCED ESOPHAGOGASTRIC CANCER; GASTROESOPHAGEAL JUNCTION; PROTEIN EXPRESSION; PHOSPHATIDYLINOSITOL 3-KINASE; TISSUE MICROARRAYS; GENE AMPLIFICATION; BIOMARKER ANALYSIS; HER3 EXPRESSION; ERBB EGFR	Background Gastric and esophageal adenocarcinomas are major global cancer burdens. These cancer forms are characterized by a poor prognosis and a modest response to chemo-radio-and targeted treatment. Hence there is an obvious need for further enhanced diagnostic and treatment strategies. The aim of this study was to examine the expression and prognostic impact of human epidermal growth factor receptor 1 (HER1/EGFR) and 3 (HER3), as well as the occurrence of EGFR and KRAS mutations in gastric and esophageal adenocarcinoma. Methods Immunohistochemical expression of EGFR and HER3 was analysed in all primary tumours and a subset of lymph node metastases in a consecutive cohort of 174 patients with adenocarcinoma of the stomach, cardia and esophagus. The anti-HER3 antibody used was validated by siRNA-mediated knockdown, immunohistochemistry and quantitative real-time PCR. EGFR and KRAS mutation status was analysed by pyrosequencing tecchnology. Results and Discussion High EGFR expression was an independent risk factor for shorter overall survival (OS), whereas high HER3 expression was associated with a borderline significant trend towards a longer OS. KRAS mutations were present in only 4% of the tumours and had no prognostic impact. All tumours were EGFR wild-type. These findings contribute to the ongoing efforts to decide on the potential clinical value of different HERs and druggable mutations in gastric and esophageal adenocarcinomas, and attention is drawn to the need for more standardised investigational methods.	[Hedner, Charlotta; Borg, David; Nodin, Bjorn; Karnevi, Emelie; Jirstrom, Karin; Eberhard, Jakob] Lund Univ, Div Oncol & Pathol, Dept Clin Sci Lund, Skane Univ Hosp, S-22185 Lund, Sweden	Lund University; Skane University Hospital	Hedner, C (corresponding author), Lund Univ, Div Oncol & Pathol, Dept Clin Sci Lund, Skane Univ Hosp, S-22185 Lund, Sweden.	charlotta.hedner@med.lu.se		Borg, David/0000-0001-9461-7391	Swedish Cancer Society [KJ 2014/540]; Crafoord Foundation; Olle Engkvist Foundation; Anna Lisa and Sven-Eric Lundgren Foundation; Mrs Berta Kamprad Foundation; Lund University Faculty of Medicine; Lund University Hospital Research Grants; Swedish Government Grant for Clinical Research	Swedish Cancer Society(Swedish Cancer Society); Crafoord Foundation; Olle Engkvist Foundation; Anna Lisa and Sven-Eric Lundgren Foundation; Mrs Berta Kamprad Foundation; Lund University Faculty of Medicine; Lund University Hospital Research Grants; Swedish Government Grant for Clinical Research	This work was supported by Swedish Cancer Society, KJ 2014/540, the Crafoord Foundation, to JE; the Olle Engkvist Foundation, to JE; the Anna Lisa and Sven-Eric Lundgren Foundation, to JE; the Mrs Berta Kamprad Foundation, to JE; Lund University Faculty of Medicine, to KJ; Lund University Hospital Research Grants, to KJ; and the Swedish Government Grant for Clinical Research, to CH JE KJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SM, 2015, ONCOLOGIST, V20, P499, DOI 10.1634/theoncologist.2014-0378; Amin DN, 2010, SEMIN CELL DEV BIOL, V21, P944, DOI 10.1016/j.semcdb.2010.08.007; Anagnostou VK, 2010, CANCER EPIDEM BIOMAR, V19, P982, DOI 10.1158/1055-9965.EPI-10-0097; Baiocchi G, 2009, INT J COLORECTAL DIS, V24, P1059, DOI 10.1007/s00384-009-0702-6; Bang YJ, 2010, LANCET, V376, P1302; Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313; Bhargava R, 2006, CANCER-AM CANCER SOC, V106, P1857, DOI 10.1002/cncr.21782; Bosetti C, 2008, INT J CANCER, V122, P1118, DOI 10.1002/ijc.23232; Buas MF, 2013, SEMIN RADIAT ONCOL, V23, P3, DOI 10.1016/j.semradonc.2012.09.008; Campbell MR, 2010, CLIN CANCER RES, V16, P1373, DOI 10.1158/1078-0432.CCR-09-1218; Chen C, 2013, ARCH MED RES, V44, P380, DOI 10.1016/j.arcmed.2013.07.001; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Desai MD, 2013, EXPERT OPIN INV DRUG, V22, P341, DOI 10.1517/13543784.2013.761972; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Dragovich T, 2006, J CLIN ONCOL, V24, P4922, DOI 10.1200/JCO.2006.07.1316; Dutton SJ, 2014, LANCET ONCOL, V15, P894, DOI 10.1016/S1470-2045(14)70024-5; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; FEDI P, 1994, MOL CELL BIOL, V14, P492, DOI 10.1128/MCB.14.1.492; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferry DR, 2007, CLIN CANCER RES, V13, P5869, DOI 10.1158/1078-0432.CCR-06-1970; Fichter CD, 2014, INT J CANCER, V135, P1517, DOI 10.1002/ijc.28771; Fristedt R, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-83; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Gibson MK, 2003, CLIN CANCER RES, V9, P6461; Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064; He XX, 2015, J CLIN PATHOL, V68, P374, DOI 10.1136/jclinpath-2014-202657; Hechtman JF, 2012, ARCH PATHOL LAB MED, V136, P691, DOI 10.5858/arpa.2011-0168-RS; Hedner C, 2016, HISTOPATHOLOGY, V68, P230, DOI 10.1111/his.12744; Hedner C, 2014, VIRCHOWS ARCH, V465, P649, DOI 10.1007/s00428-014-1667-6; Hsieh AC, 2007, BRIT J CANCER, V97, P453, DOI 10.1038/sj.bjc.6603910; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Janmaat ML, 2006, J CLIN ONCOL, V24, P1612, DOI 10.1200/JCO.2005.03.4900; Jarde T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138336; Jiang N, 2014, MOL CANCER THER, V13, P1826, DOI 10.1158/1535-7163.MCT-13-1093; Jonsson L, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-11; Kim JS, 2009, BRIT J CANCER, V100, P732, DOI 10.1038/sj.bjc.6604936; Kim MA, 2008, HISTOPATHOLOGY, V52, P738, DOI 10.1111/j.1365-2559.2008.03021.x; Kimura M, 2004, VIRCHOWS ARCH, V445, P255, DOI 10.1007/s00428-004-1048-7; Kocarnik JM, 2015, GASTROENTEROL REP, V3, P269, DOI 10.1093/gastro/gov046; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lauwers GY, 2009, SURG PATHOLOGY GI TR, P563; Ledel F, 2015, ACTA ONCOL, V54, P480, DOI 10.3109/0284186X.2014.983654; LoRusso P, 2013, CLIN CANCER RES, V19, P3078, DOI 10.1158/1078-0432.CCR-12-3051; Luber B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-509; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Mujoo K, 2014, ONCOTARGET, V5, P10222, DOI 10.18632/oncotarget.2655; Oba K, 2013, EUR J CANCER, V49, P1565, DOI 10.1016/j.ejca.2012.12.016; Ocana A, 2013, JNCI-J NATL CANCER I, V105, P266, DOI 10.1093/jnci/djs501; Okines AFC, 2010, J CLIN ONCOL, V28, P3945, DOI 10.1200/JCO.2010.29.2847; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; QUINN CM, 1994, HISTOPATHOLOGY, V25, P247, DOI 10.1111/j.1365-2559.1994.tb01324.x; Rao S, 2010, ANN ONCOL, V21, P2213, DOI 10.1093/annonc/mdq247; Ruschoff J, 2012, MODERN PATHOL, V25, P637, DOI 10.1038/modpathol.2011.198; Ruschoff J, 2010, VIRCHOWS ARCH, V457, P299, DOI 10.1007/s00428-010-0952-2; Seo AN, 2015, VIRCHOWS ARCH, V466, P645, DOI 10.1007/s00428-015-1747-2; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Society AC, 2011, GLOB CANC FACTS FIG; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Takahashi Naoki, 2014, BMC Res Notes, V7, P271, DOI 10.1186/1756-0500-7-271; Tao JJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005125; Terashima M, 2012, CLIN CANCER RES, V18, P5992, DOI 10.1158/1078-0432.CCR-12-1318; Thiel A, 2015, APMIS, V123, P365, DOI 10.1111/apm.12359; Torhorst J, 2001, AM J PATHOL, V159, P2249, DOI 10.1016/S0002-9440(10)63075-1; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Vyberg M, 2016, VIRCHOWS ARCH, V468, P19, DOI 10.1007/s00428-015-1829-1; Wainberg ZA, 2011, BRIT J CANCER, V105, P760, DOI 10.1038/bjc.2011.280; Wang KL, 2007, CANCER-AM CANCER SOC, V109, P658, DOI 10.1002/cncr.22445; Wei QC, 2007, INT J ONCOL, V31, P493; Wilkinson NW, 2004, J GASTROINTEST SURG, V8, P448, DOI 10.1016/j.gassur.2004.01.006; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Yoon HH, 2014, CANCER-AM CANCER SOC, V120, P415, DOI 10.1002/cncr.28435	73	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148101	10.1371/journal.pone.0148101	http://dx.doi.org/10.1371/journal.pone.0148101			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844548	gold, Green Published, Green Submitted			2022-12-27	WOS:000369552800029
J	Soldateli, B; Vigo, A; Giugliani, ERJ				Soldateli, Betina; Vigo, Alvaro; Justo Giugliani, Elsa Regina			Effect of Pattern and Duration of Breastfeeding on the Consumption of Fruits and Vegetables among Preschool Children	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; ADOLESCENT MOTHERS; EATING BEHAVIOR; 1ST YEAR; LIFE; GRANDMOTHERS; NUTRITION; AGE	Background The duration and pattern of breastfeeding can influence the consumption of fruits and vegetables in later childhood. Objective To investigate the association between pattern and duration of breastfeeding and consumption of fruits and vegetables in children aged between 4 and 7 years. Methods We conducted a secondary analysis using data from a former randomized clinical trial with 323 adolescent mothers, their children, and maternal grandmothers, when they cohabited. Information on infant feeding was collected monthly during the first 6 months of life, every two months until the child was 1 year old over and when children were between 4 and 7 years old. The associations between duration of breastfeeding and exclusive breastfeeding and consumption of fruits and vegetables were tested by a logistic regression model. Results Approximately 60% and 45% of children consumed fruits and vegetables, respectively, five or more times a week. Consumption of vegetables among 4-7-year-old children was higher in children who were breastfed for 12 months or longer (OR 2.7; 95% CI 1.49-4.93); however, exclusive breastfeeding duration did not have a significant association with consumption of vegetables (OR 1.5; 95% CI 0.70-3.04). There was no association between weekly consumption of fruits and duration of breastfeeding (OR 1.3; 95% CI 0.71-2.30) or exclusive breastfeeding (OR 0.7; 95% CI 0.34-1.44). Conclusions Longer duration of breastfeeding was positively associated with consumption of vegetables in children aged 4-7 years; however, there was no association with consumption of fruits. Exclusive breastfeeding duration did not have influence on consumption of fruits or vegetables.	[Soldateli, Betina; Vigo, Alvaro; Justo Giugliani, Elsa Regina] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Soldateli, B (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.	betinasoldateli@hotmail.com	Giugliani, Elsa Regina Justo/Y-9236-2019; Vigo, Alvaro/S-2243-2019	Vigo, Alvaro/0000-0002-5797-9470	Fund for Research and Event Promotion Hospital de Clinicas de Porto Alegre	Fund for Research and Event Promotion Hospital de Clinicas de Porto Alegre	This study received financial support from the Fund for Research and Event Promotion Hospital de Clinicas de Porto Alegre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, PESQ PREV AL MAT CAP; [Anonymous], 2013, CAD SAUD CRIANC; Beauchamp GK, 2011, DIGESTION, V83, P1, DOI 10.1159/000323397; Bica OC, 2014, BIRTH-ISS PERINAT C, V41, P39, DOI 10.1111/birt.12097; Bortolini GA, 2012, CAD SAUDE PUBLICA, V28, P1759, DOI 10.1590/S0102-311X2012000900014; Brasil, 2009, SAUD CRIANC NUTR INF; Brasil. Ministerio da Saude, 2009, PESQ NAC DEM SAUD CR; Burnier D, 2011, EUR J CLIN NUTR, V65, P196, DOI 10.1038/ejcn.2010.238; Cooke LJ, 2004, PUBLIC HEALTH NUTR, V7, P295, DOI 10.1079/PHN2003527; de Lauzon-Guillain B, 2013, AM J CLIN NUTR, V98, P804, DOI 10.3945/ajcn.112.057026; de Oliveira LD, 2012, EARLY HUM DEV, V88, P357, DOI 10.1016/j.earlhumdev.2011.09.010; Dubois L, 2011, PUBLIC HEALTH NUTR, V14, P1096, DOI 10.1017/S1368980010003769; Forestell CA, 2007, PEDIATRICS, V120, P1247, DOI 10.1542/peds.2007-0858; Grieger JA, 2011, PUBLIC HEALTH NUTR, V14, P1939, DOI 10.1017/S1368980011001030; Khalessi A, 2013, J REPROD INFANT PSYC, V31, P299, DOI 10.1080/02646838.2013.784898; Moller LM, 2013, BRIT J NUTR, V109, P564, DOI 10.1017/S0007114512001237; Organization WH, 2016, GLOBAL STATUS REPORT; Perrine CG, 2014, PEDIATRICS, V134, pS50, DOI 10.1542/peds.2014-0646I; Savage JS, 2007, J LAW MED ETHICS, V35, P22, DOI 10.1111/j.1748-720X.2007.00111.x; Schwartz R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131884; Tu MT, 2006, PSYCHONEUROENDOCRINO, V31, P812, DOI 10.1016/j.psyneuen.2006.03.006; Valmorbida JL, 2014, J PEDIAT-BRAZIL, V90, P464, DOI 10.1016/j.jped.2014.02.002; Vitolo MR, 2010, J NUTR, V140, P2002, DOI 10.3945/jn.110.125211	23	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148357	10.1371/journal.pone.0148357	http://dx.doi.org/10.1371/journal.pone.0148357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26844543	gold, Green Published, Green Submitted			2022-12-27	WOS:000369552800049
J	Vanneste, Y; van de Loo, M; Feron, F; Rots-de Vries, C; van de Goor, I				Vanneste, Yvonne; van de Loo, Marlou; Feron, Frans; Rots-de Vries, Carin; van de Goor, Ien			Attitudes towards Addressing Medical Absenteeism of Students: A Qualitative Study among Principals and Special Education Needs Coordinators in Dutch Secondary Schools	PLOS ONE			English	Article							HEALTH-PROMOTION; INTERVENTIONS; DISSEMINATION; DROPOUTS; ABSENCE; YOUTH; CARE; GAP	Background Reducing school absenteeism benefits the health and educational opportunities of young people. The Dutch intervention Medical Advice for Sick-reported Students (abbreviated as MASS) was developed to address school absenteeism due to sickness reporting, also called medical absenteeism. This study is part of a research project on the effectiveness of MASS and explores factors that influence the implementation and dissemination of the intervention, from schools' perspectives. The research questions include reasons schools have to implement MASS, their experiences in the implementation of MASS and their views on what is needed to ensure sustainable implementation. Methods A qualitative research method was used. Semi-structured interviews were held with nine principals and eight special education needs coordinators, working in nine secondary schools that apply MASS. Inductive content analysis was carried out. Findings The main reasons for schools to address medical absenteeism were their concerns about students' well-being and future prospects and their wish to share these concerns with students' parents. Participants also mentioned the wish to raise the threshold for reporting sick. According to the participants, MASS makes it easier for teachers to enter into conversation with students and their parents about medical absence. MASS prevents damage to the relationship with parents and medical problems being missed. In implementing MASS the main obstacles are teachers' dialogue about medical absence with students and their parents, teachers' follow-up of the feedback of the youth health care physicians (YHCPs), and correct registration. The participants were convinced that MASS also improves collaboration with parents regarding the optimization of care for students. Conclusions MASS allows schools to identify students at risk of dropout at an early stage and to optimise guidance of these students. The intervention matches schools' need to address medical absenteeism by providing a clear framework, an approach from concern rather than control, and socio-medical expertise through the collaboration with YHCPs. MASS can support schools to maximize the number of students graduating and to improve parental involvement in school. These outcomes may help to put the subject of addressing medical absenteeism on the agenda of all schools, and contribute to prioritization, support adoption and secure sustainable implementation and dissemination of MASS.	[Vanneste, Yvonne; Rots-de Vries, Carin] Reg Publ Hlth Serv West Brabant, Dept Youth Hlth Care, Tilburg, Netherlands; [Vanneste, Yvonne; van de Loo, Marlou; Feron, Frans] Maastricht Univ, Dept Social Med, NL-6200 MD Maastricht, Netherlands; [Vanneste, Yvonne; Rots-de Vries, Carin; van de Goor, Ien] Tilburg Univ, Sch Social & Behav Sci, NL-5000 LE Tilburg, Netherlands	Maastricht University; Tilburg University	Vanneste, Y (corresponding author), Reg Publ Hlth Serv West Brabant, Dept Youth Hlth Care, Tilburg, Netherlands.; Vanneste, Y (corresponding author), Maastricht Univ, Dept Social Med, NL-6200 MD Maastricht, Netherlands.; Vanneste, Y (corresponding author), Tilburg Univ, Sch Social & Behav Sci, NL-5000 LE Tilburg, Netherlands.	y.vanneste@ggdwestbrabant.nl	Feron, Frans J.M./B-1748-2014	Vanneste, Yvonne/0000-0003-1273-7854	zonmw [70-72000-98-111]	zonmw(Netherlands Organization for Health Research and Development)	This work was supported by www.zonmw.nl, grant number: 70-72000-98-111. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allensworth DD, 2011, HEALTH EDUC BEHAV, V38, P331, DOI 10.1177/1090198111417709; Avvisati F, 2010, REV ECON POLIT, V120, P759, DOI 10.3917/redp.205.0759; Bartholomew LK, 1998, HEALTH EDUC BEHAV, V25, P545, DOI 10.1177/109019819802500502; Basch CE, 2011, J SCHOOL HEALTH, V81, P593, DOI 10.1111/j.1746-1561.2011.00632.x; Battin-Pearson S, 2000, J EDUC PSYCHOL, V92, P568, DOI 10.1037//0022-0663.92.3.568; Beker M, RAPP JEUGD 1997 SOC; Christenson SL, 2004, CURR DIR PSYCHOL SCI, V13, P36, DOI 10.1111/j.0963-7214.2004.01301010.x; Deschesnes M, 2003, HEALTH PROMOT INT, V18, P387, DOI 10.1093/heapro/dag410; Eckstein Z, 1999, EC SOC, V67, P125, DOI [10.1111/1468-0262.00081, DOI 10.1111/1468-0262.00081]; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; FIXSEN DL, 1993, J APPL BEHAV ANAL, V26, P597, DOI 10.1901/jaba.1993.26-597; Glaser BG, 2012, DISCOVERY GROUNDED T; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Hawkrigg S, 2014, ARCH DIS CHILD, V99, P954, DOI 10.1136/archdischild-2013-304595; Higgins CT, 2008, HEALTH IMPACTS OF ED; Iton A, 2006, TACKLING HLTH INEQUI, P115; Kearney CA, 2003, PROF PSYCHOL-RES PR, V34, P57, DOI 10.1037//0735-7028.34.1.57; KLERMAN LV, 1988, PEDIATR CLIN N AM, V35, P1253; Kuo AA, 2006, PEDIATRICS, V118, P1692, DOI 10.1542/peds.2006-0620; Maxqda, MAXQD 10 ART TEXT AN; Michaud PA, 1998, J ADOLESCENT HEALTH, V22, P326, DOI 10.1016/S1054-139X(97)00240-1; NIPO het marktonderzoeksinstituut, 2002, RAPP SCHOOLV VOORTG; Nutbeam D, 1998, HEALTH PROMOT INT, V13, P27, DOI 10.1093/heapro/13.1.27; O'toole L, 2012, LEARNING WELL BEING; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Rots-De Vries C., 2010, THESIS; RUMBERGER RW, 1995, AM EDUC RES J, V32, P583, DOI 10.2307/1163325; Rychetnik L, 1997, HEALTH EDUC RES, V12, P491, DOI 10.1093/her/12.4.491; Samdal O, 2011, HEALTH EDUC, V111, P367, DOI 10.1108/09654281111161211; Schoenwald SK, 2001, PSYCHIATR SERV, V52, P1190, DOI 10.1176/appi.ps.52.9.1190; Schrijvers C, 2009, 270171001 RIVM; Shute VJ, 2011, EDUC RES INT, V2011, DOI 10.1155/2011/915326; Suhrcke M, 2011, IMPACT HLTH HLTH BEH; Vanneste Y. T. M., 2015, Open Journal of Preventive Medicine, V5, P111, DOI 10.4236/ojpm.2015.53013; Vanneste YTM, 2012, TIJDS GEZONDHEIDSWET, V90, P412, DOI 10.; WEITZMAN M, 1982, PEDIATRICS, V69, P739; Wieske RCN, 2012, INT J PUBLIC HEALTH, V57, P637, DOI 10.1007/s00038-011-0305-1; Woolf SH, 2007, AM J PUBLIC HEALTH, V97, P679, DOI 10.2105/AJPH.2005.084848	38	6	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148427	10.1371/journal.pone.0148427	http://dx.doi.org/10.1371/journal.pone.0148427			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PF	26845688	Green Published, Green Submitted, gold			2022-12-27	WOS:000369552800057
J	Boulding, T; Wu, F; McCuaig, R; Dunn, J; Sutton, CR; Hardy, K; Tu, WJ; Bullman, A; Yip, D; Dahlstrom, JE; Rao, S				Boulding, Tara; Wu, Fan; McCuaig, Robert; Dunn, Jennifer; Sutton, Christopher R.; Hardy, Kristine; Tu, Wenjuan; Bullman, Amanda; Yip, Desmond; Dahlstrom, Jane E.; Rao, Sudha			Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer	PLOS ONE			English	Article							PROTEIN-KINASE PHOSPHATASE-1; DUAL-SPECIFICITY PHOSPHATASES; GENE-EXPRESSION; C-THETA; PKC-THETA; PHOSPHORYLATION; CHROMATIN; P300; JNK; IDENTIFICATION	Dual-specificity phosphatases (DUSPs) dephosphorylate threonine/serine and tyrosine residues on their substrates. Here we show that DUSP1, DUSP4, and DUSP6 are involved in epithelial-to-mesenchymal transition (EMT) and breast cancer stem cell (CSC) regulation. DUSP1, DUSP4, and DUSP6 are induced during EMT in a PKC pathway signal-mediated EMT model. We show for the first time that the key chromatin-associated kinase PKC-theta directly regulates a subset of DUSP family members. DUSP1, DUSP4, and DUSP6 globally but differentially co-exist with enhancer and permissive active histone post-translational modifications, suggesting that they play distinct roles in gene regulation in EMT/CSCs. We show that nuclear DUSP4 associates with the key acetyltransferase p300 in the context of the chromatin template and dynamically regulates the interplay between two key phosphorylation marks: the 1834 (active) and 89 (inhibitory) residues central to p300's acetyltransferase activity. Furthermore, knockdown with small-interfering RNAs (siRNAs) shows that DUSP4 is required for maintaining H3K27ac, a mark mediated by p300. DUSP1, DUSP4, and DUSP6 knockdown with siRNAs shows that they participate in the formation of CD44(hi)/CD24(lo)/EpCAM(+) breast CSCs: DUSP1 knockdown reduces CSC formation, while DUSP4 and DUSP6 knockdown enhance CSC formation. Moreover, DUSP6 is overexpressed in patient-derived HER2(+) breast carcinomas compared to benign mammary tissue. Taken together, these findings illustrate novel pleiotropic roles for DUSP family members in EMT and CSC regulation in breast cancer.	[Boulding, Tara; Wu, Fan; McCuaig, Robert; Dunn, Jennifer; Sutton, Christopher R.; Hardy, Kristine; Tu, Wenjuan; Rao, Sudha] Univ Canberra, Fac ESTeM, Hlth Res Inst, Bruce, ACT 2617, Australia; [Bullman, Amanda; Dahlstrom, Jane E.] Canberra Hosp, ACT Pathol, Anat Pathol, Garran, ACT 2605, Australia; [Bullman, Amanda; Yip, Desmond; Dahlstrom, Jane E.] Australian Natl Univ, ANU Med Sch, Acton, ACT 2601, Australia; [Yip, Desmond] Canberra Hosp, Dept Med Oncol, Garran, ACT 2605, Australia	University of Canberra; Australian National University; Canberra Hospital; Australian National University; Australian National University; Canberra Hospital	Rao, S (corresponding author), Univ Canberra, Fac ESTeM, Hlth Res Inst, Bruce, ACT 2617, Australia.	Sudha.Rao@canberra.edu.au	Dunn, Jennifer/ABA-7400-2021; WU, FAN/P-3132-2015; Rao, Sudha/AAW-5192-2020; Yip, Desmond/G-2043-2014; Dahlstrom, Jane/E-4683-2018	WU, FAN/0000-0001-7763-8852; Rao, Sudha/0000-0001-9547-947X; Yip, Desmond/0000-0002-2806-2401; Hardy, Kristine/0000-0003-1660-4477; McCuaig, Robert D./0000-0003-0124-4173; Dahlstrom, Jane/0000-0001-5608-693X	National Health and Medical Research Council (NHMRC) [APP1068065]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by National Health and Medical Research Council (NHMRC) APP1068065. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2008, J MICROSC-OXFORD, V230, P121, DOI 10.1111/j.1365-2818.2008.01967.x; Al-Ejeh F, 2011, CARCINOGENESIS, V32, P650, DOI 10.1093/carcin/bgr028; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Armes JE, 2004, ONCOGENE, V23, P5697, DOI 10.1038/sj.onc.1207740; Avraham A, 1998, EUR J IMMUNOL, V28, P2320, DOI 10.1002/(SICI)1521-4141(199808)28:08<2320::AID-IMMU2320>3.0.CO;2-K; Folgueira MAAK, 2009, ONCOL REP, V22, P805, DOI 10.3892/or_00000503; Baglia ML, 2014, BREAST CANCER RES TR, V148, P211, DOI 10.1007/s10549-014-3127-z; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Cai BB, 2006, J BIOL CHEM, V281, P25215, DOI 10.1074/jbc.M512627200; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Candas D, 2014, CANCER RES, V74, P7498, DOI 10.1158/0008-5472.CAN-14-0844; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Castelli M, 2004, J BIOL CHEM, V279, P44731, DOI 10.1074/jbc.M407669200; Chang JT, 2013, CANCER LETT, V341, P16, DOI 10.1016/j.canlet.2013.03.004; Crowell S, 2014, J BIOL CHEM, V289, P28753, DOI 10.1074/jbc.M114.591925; Cui YK, 2006, CANCER RES, V66, P5950, DOI 10.1158/0008-5472.CAN-05-3243; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dinic J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10082; He H, 2010, PROSTATE, V70, P1119, DOI 10.1002/pros.21146; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamdje AHN, 2014, WORLD J CLIN CASES, V2, P769, DOI 10.12998/wjcc.v2.i12.769; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kim H, 2015, J BREAST CANCER, V18, P1, DOI [10.4048/jbc.2015.18.11, 10.4048/jbc.2015.18.1.1]; Kinney CM, 2009, AM J PHYSIOL-CELL PH, V296, pC242, DOI 10.1152/ajpcell.00492.2008; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Landry RP, 2012, J PAIN, V13, P836, DOI 10.1016/j.jpain.2012.05.013; Lazo JS, 2002, MOL PHARMACOL, V61, P720, DOI 10.1124/mol.61.4.720; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu Y, 2013, EXP CELL RES, V319, P3140, DOI 10.1016/j.yexcr.2013.08.023; Loda M, 1996, AM J PATHOL, V149, P1553; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Lucci MA, 2010, CELL ONCOL, V32, P361, DOI 10.3233/CLO-2010-0520; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manzano RG, 2014, INT J ONCOL, V45, P2250, DOI 10.3892/ijo.2014.2648; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; NIEDEL JE, 1983, P NATL ACAD SCI-BIOL, V80, P36, DOI 10.1073/pnas.80.1.36; Nunes-Xavier C, 2011, ANTI-CANCER AGENT ME, V11, P109, DOI 10.2174/187152011794941190; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Rojo F, 2009, CLIN CANCER RES, V15, P3530, DOI 10.1158/1078-0432.CCR-08-2070; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Small GW, 2007, CANCER RES, V67, P4459, DOI 10.1158/0008-5472.CAN-06-2644; Sutcliffe EL, 2011, MOL CELL, V41, P704, DOI 10.1016/j.molcel.2011.02.030; Sutcliffe EL, 2009, MOL CELL BIOL, V29, P1972, DOI 10.1128/MCB.01590-08; Szerlong HJ, 2010, J BIOL CHEM, V285, P31954, DOI 10.1074/jbc.M110.148718; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Vogt A, 2008, MOL CANCER THER, V7, P330, DOI 10.1158/1535-7163.MCT-07-2165; Wang HY, 2003, CANCER LETT, V191, P229, DOI 10.1016/S0304-3835(02)00612-2; Ward Y, 2001, MOL CELL BIOL, V21, P5958, DOI 10.1128/MCB.21.17.5958-5969.2001; Watson MB, 2007, ACTA ONCOL, V46, P651, DOI 10.1080/02841860601156157; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yuan LW, 2000, J BIOL CHEM, V275, P40946, DOI 10.1074/jbc.M007832200; Zafar A, 2015, GENOM DATA, V3, P28, DOI 10.1016/j.gdata.2014.11.002; Zafar A, 2014, MOL CELL BIOL, V34, P2961, DOI 10.1128/MCB.01693-13; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111	61	41	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148065	10.1371/journal.pone.0148065	http://dx.doi.org/10.1371/journal.pone.0148065			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859151	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400020
J	Clauss, S; Wakili, R; Hildebrand, B; Kaab, S; Hoster, E; Klier, I; Martens, E; Hanley, A; Hanssen, H; Halle, M; Nickel, T				Clauss, Sebastian; Wakili, Reza; Hildebrand, Bianca; Kaeaeb, Stefan; Hoster, Eva; Klier, Ina; Martens, Eimo; Hanley, Alan; Hanssen, Henner; Halle, Martin; Nickel, Thomas			MicroRNAs as Biomarkers for Acute Atrial Remodeling in Marathon Runners (The miRathon Study - A Sub-Study of the Munich Marathon Study)	PLOS ONE			English	Article							MUSCLE-SPECIFIC MICRORNA; CIRCULATING MICRORNAS; DIASTOLIC DYSFUNCTION; POTENTIAL BIOMARKER; ENDURANCE EXERCISE; TISSUE DOPPLER; HEART-FAILURE; FOLLOW-UP; FIBRILLATION; RISK	Introduction Physical activity is beneficial for individual health, but endurance sport is associated with the development of arrhythmias like atrial fibrillation. The underlying mechanisms leading to this increased risk are still not fully understood. MicroRNAs are important mediators of proarrhyth-mogenic remodeling and have potential value as biomarkers in cardiovascular diseases. Therefore, the objective of our study was to determine the value of circulating microRNAs as potential biomarkers for atrial remodeling in marathon runners (miRathon study). Methods 30 marathon runners were recruited into our study and were divided into two age-matched groups depending on the training status: elite (ER, >= 55 km/week, n = 15) and non-elite runners (NER, <= 40 km/week, n = 15). All runners participated in a 10 week training program before the marathon. MiRNA plasma levels were measured at 4 time points: at baseline (V1), after a 10 week training period (V2), immediately after the marathon (V3) and 24h later (V4). Additionally, we obtained clinical data including serum chemistry and echocardiography at each time point. Results MiRNA plasma levels were similar in both groups over time with more pronounced changes in ER. After the marathon miR-30a plasma levels increased significantly in both groups. MiR-1 and miR-133a plasma levels also increased but showed significant changes in ER only. 24h after the marathon plasma levels returned to baseline. MiR-26a decreased significantly after the marathon in elite runners only and miR-29b showed a non-significant decrease over time in both groups. In ER miRNA plasma levels showed a significant correlation with LA diameter, in NER miRNA plasma levels did not correlate with echocardiographic parameters. Conclusion MiRNAs were differentially expressed in the plasma of marathon runners with more pronounced changes in ER. Plasma levels in ER correlate with left atrial diameter suggesting that circulating miRNAs could potentially serve as biomarkers of atrial remodeling in athletes.	[Clauss, Sebastian; Wakili, Reza; Hildebrand, Bianca; Kaeaeb, Stefan; Klier, Ina; Martens, Eimo; Nickel, Thomas] Univ Munich, Med Klin & Poliklin 1, Campus Grosshadern, Munich, Germany; [Clauss, Sebastian; Wakili, Reza; Kaeaeb, Stefan; Halle, Martin] DZHK German Ctr Cardiovasc Res, Partner Site Munich, Munich Heart Alliance, Munich, Germany; [Clauss, Sebastian; Hanley, Alan] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA; [Hoster, Eva] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Hanssen, Henner; Halle, Martin] Tech Univ Munich, Klinikum Rechts Isar MRI, Dept Prevent & Sports Med, D-80290 Munich, Germany; [Hanssen, Henner] Univ Basel, Inst Exercise & Hlth Sci, Sports Med, Basel, Switzerland	University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Harvard University; Massachusetts General Hospital; University of Munich; Technical University of Munich; University of Basel	Clauss, S (corresponding author), Univ Munich, Med Klin & Poliklin 1, Campus Grosshadern, Munich, Germany.; Clauss, S (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Munich, Munich Heart Alliance, Munich, Germany.; Clauss, S (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA.	sebastian.clauss@med.uni-muenchen.de	Hoster, Eva/M-2795-2019; Martens, Eimo/AAX-3975-2021; Clauss, Sebastian/HDL-7189-2022	Hoster, Eva/0000-0002-0749-1389; Martens, Eimo/0000-0002-5801-0901; Clauss, Sebastian/0000-0002-5675-6128; Halle, Martin/0000-0003-3065-530X; Hanssen, Henner/0000-0001-5501-4205	Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme [PIOF-GA-2012-328352]; German Centre for Cardiovascular Research (DZHK); Heinrich and Lotte Muehlfenzl Foundation	Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; German Centre for Cardiovascular Research (DZHK); Heinrich and Lotte Muehlfenzl Foundation	This study was supported by Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (PIOF-GA-2012-328352), SC; German Centre for Cardiovascular Research (DZHK), SC, RW, SK, MH; and Heinrich and Lotte Muehlfenzl Foundation, TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Clauss was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (PIOF-GA-2012-328352). Dres. Clauss, Kaab, Wakili, Halle were supported by the German Centre for Cardiovascular Research (DZHK). Dr. Nickel was supported by the Heinrich and Lotte Muehlfenzl Foundation, which provides educational grants for young scientists.	Abhayaratna WP, 2006, J AM COLL CARDIOL, V47, P2357, DOI 10.1016/j.jacc.2006.02.048; Ashor AW, 2015, SPORTS MED, V45, P279, DOI 10.1007/s40279-014-0272-9; Baggish AL, 2014, J APPL PHYSIOL, V116, P522, DOI 10.1152/japplphysiol.01141.2013; Baldesberger S, 2008, EUR HEART J, V29, P71, DOI 10.1093/eurheartj/ehm555; Banzet S, 2013, J APPL PHYSIOL, V115, P1237, DOI 10.1152/japplphysiol.00075.2013; Baumgart BR, 2016, TOXICOL APPL PHARM, V312, P26, DOI 10.1016/j.taap.2015.10.007; Benito B, 2011, CIRCULATION, V123, P13, DOI 10.1161/CIRCULATIONAHA.110.938282; Biffi M, 2002, HEART, V87, P443, DOI 10.1136/heart.87.5.443; Blume GG, 2011, EUR J ECHOCARDIOGR, V12, P421, DOI 10.1093/ejechocard/jeq175; Chen Y, 2014, J MOL CELL CARDIOL, V77, P113, DOI 10.1016/j.yjmcc.2014.10.001; Choi JI, 2008, CIRC J, V72, P2051, DOI 10.1253/circj.CJ-08-0428; Clauss SS, 2015, ARRHYTHMIA ELECTROPH, V4, P10; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Dawson K, 2013, CIRCULATION, V127, P1466, DOI 10.1161/CIRCULATIONAHA.112.001207; De Rosa S, 2011, CIRCULATION, V124, P1936, DOI 10.1161/CIRCULATIONAHA.111.037572; Doss JF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2156-2; Drighil A, 2008, EUR J ECHOCARDIOGR, V9, P530, DOI 10.1093/ejechocard/jen125; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Eijsvogels TMH, 2016, PHYSIOL REV, V96, P99, DOI 10.1152/physrev.00029.2014; Elosua R, 2006, INT J CARDIOL, V108, P332, DOI 10.1016/j.ijcard.2005.05.020; Fagard R, 2003, HEART, V89, P1455, DOI 10.1136/heart.89.12.1455; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; Girmatsion Z, 2009, HEART RHYTHM, V6, P1802, DOI 10.1016/j.hrthm.2009.08.035; Guasch E, 2013, J AM COLL CARDIOL, V62, P68, DOI 10.1016/j.jacc.2013.01.091; Hanssen H, 2011, ATHEROSCLEROSIS, V216, P433, DOI 10.1016/j.atherosclerosis.2011.02.009; Hanssen H, 2011, CLIN SCI, V120, P143, DOI 10.1042/CS20100206; Khan H, 2015, HEART RHYTHM, V12, P1424, DOI 10.1016/j.hrthm.2015.03.024; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kratz A, 2002, AM J CLIN PATHOL, V118, P856, DOI 10.1092/BTWQ5YMYVQ67QK9L; Luo XB, 2013, J CLIN INVEST, V123, P1939, DOI 10.1172/JCI62185; MANIER G, 1991, EUR HEART J, V12, P1183, DOI 10.1093/eurheartj/12.11.1183; Mattioli AV, 1996, CARDIOLOGY, V87, P205, DOI 10.1159/000177088; Melduni RM, 2012, J ATR FIBRILLATION, V5, P87; Melduni RM, 2008, J AM SOC ECHOCARDIOG, V21, P848, DOI 10.1016/j.echo.2007.12.001; Melduni RM, 2011, J AM COLL CARDIOL, V58, P953, DOI 10.1016/j.jacc.2011.05.021; Melman YF, 2015, CIRCULATION, V131, P2202, DOI 10.1161/CIRCULATIONAHA.114.013220; Mooren FC, 2014, AM J PHYSIOL-HEART C, V306, pH557, DOI 10.1152/ajpheart.00711.2013; Neilan TG, 2006, EUR HEART J, V27, P1079, DOI 10.1093/eurheartj/ehi813; Nickel T, 2012, ATHEROSCLEROSIS, V220, P219, DOI 10.1016/j.atherosclerosis.2011.09.036; Nielsen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087308; Ono S, 2015, J CLIN MED, V4, P1890, DOI 10.3390/jcm4101890; Padrao AI, 2016, PROTEOMICS, V16, P816, DOI 10.1002/pmic.201500382; Park CS, 2012, EUR HEART J-CARD IMG, V13, P938, DOI 10.1093/ehjci/jes069; Patil Harshal R, 2012, Mo Med, V109, P312; Pelliccia A, 2005, J AM COLL CARDIOL, V46, P690, DOI 10.1016/j.jacc.2005.04.052; Pena LL, 2003, CIRCULATION, V107, P1210, DOI 10.1161/01.CIR.0000055013.92097.40; Psaty BM, 1997, CIRCULATION, V96, P2455; Rosenberg MA, 2012, EUR HEART J, V33, P904, DOI 10.1093/eurheartj/ehr378; Shan HL, 2009, CARDIOVASC RES, V83, P465, DOI 10.1093/cvr/cvp130; Sinner MF, 2011, CARDIOGENETICS, V1, P35, DOI 10.4081/cardiogenetics.2011.sl.e7; SISCOVICK DS, 1984, NEW ENGL J MED, V311, P874, DOI 10.1056/NEJM198410043111402; Terentyev D, 2009, CIRC RES, V104, P514, DOI 10.1161/CIRCRESAHA.108.181651; Tiberio P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/731479; Tsang TSM, 2002, J AM COLL CARDIOL, V40, P1636, DOI 10.1016/S0735-1097(02)02373-2; Uhlemann M, 2014, EUR J PREV CARDIOL, V21, P484, DOI 10.1177/2047487312467902; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vasan RS, 2003, AM J CARDIOL, V91, P1079, DOI 10.1016/S0002-9149(03)00152-8; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; Verma A, 2006, J CARDIOVASC ELECTR, V17, P741, DOI 10.1111/j.1540-8167.2006.00488.x; Wakili R, 2012, HERZ, V37, P166, DOI 10.1007/s00059-012-3594-0; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yuda S, 1998, J AM COLL CARDIOL, V31, P1097, DOI 10.1016/S0735-1097(98)00058-8; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	66	63	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148599	10.1371/journal.pone.0148599	http://dx.doi.org/10.1371/journal.pone.0148599			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859843	Green Published, Green Submitted, gold			2022-12-27	WOS:000370038400054
J	Hayat, T; Qayyum, S; Imtiaz, M; Alsaedi, A				Hayat, Tasawar; Qayyum, Sumaira; Imtiaz, Maria; Alsaedi, Ahmed			Impact of Cattaneo-Christov Heat Flux in Jeffrey Fluid Flow with Homogeneous-Heterogeneous Reactions	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; MODEL	Two-dimensional stretched flow of Jeffrey fluid in view of Cattaneo-Christov heat flux is addressed. Effects of homogeneous-heterogeneous reactions are also considered. Suitable transformations are used to form ordinary differential equations. Convergent series solutions are computed. Impact of significant parameters on the velocity, temperature, concentration and skin friction coefficient is addressed. Analysis of thermal relaxation is made. The obtained results show that ratio of relaxation to retardation times and Deborah number have inverse relation for velocity profile. Temperature distribution has decreasing behavior for Prandtl number and thermal relaxation time. Also concentration decreases for larger values of strength of homogeneous reaction parameter while it increases for strength of heterogeneous reaction parameter.	[Hayat, Tasawar; Qayyum, Sumaira; Imtiaz, Maria] Quaid I Azam Univ 45320, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Dept Math, Nonlinear Anal & Appl Math NAAM Res Grp, Fac Sci, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Imtiaz, M (corresponding author), Quaid I Azam Univ 45320, Dept Math, Islamabad, Pakistan.	mi_qau@gmail.com	Hayat, Tasawar/Y-2524-2019; Imtiaz, Maria/AAE-2547-2021; Alsaedi, Ahmed/A-2094-2013; Qayyum, Sumaira/AAA-7476-2019	Alsaedi, Ahmed/0000-0003-3452-8922; 				Abbasbandy Saeid, 2014, Mathematical and Computational Applications, V19, P124; Abbasi FM, 2015, AIP ADV, V5, DOI 10.1063/1.4914549; Bachok N, 2011, COMMUN NONLINEAR SCI, V16, P4296, DOI 10.1016/j.cnsns.2011.01.008; Cao BY, 2007, J APPL PHYS, V102, DOI 10.1063/1.2775215; Cattaneo C., 1948, ATTI SEMIN MAT FIS, V3, P83, DOI DOI 10.1007/978-3-642-11051-1_5; CHAUDHARY MA, 1995, FLUID DYN RES, V16, P311, DOI 10.1016/0169-5983(95)00015-6; Christov CI, 2009, MECH RES COMMUN, V36, P481, DOI 10.1016/j.mechrescom.2008.11.003; Ciarletta M, 2010, MECH RES COMMUN, V37, P445, DOI 10.1016/j.mechrescom.2010.06.002; Das K., 2012, INDIAN J MATH, V54, P19; Dong Y, 2011, J APPL PHYS, V110, DOI 10.1063/1.3634113; Farooq M, 2015, J MECH, V33, P1; Farooq U, 2015, COMPUT FLUIDS, V111, P69, DOI 10.1016/j.compfluid.2015.01.005; Fourier J.-B.J., 1822, THEORIE ANAL CHALEUR; Hamad M. A. A., 2013, J FLUIDS, V2013, P8; Han SH, 2014, APPL MATH LETT, V38, P87, DOI 10.1016/j.aml.2014.07.013; Hayat T, 2015, AIP ADV, V5, DOI 10.1063/1.4908602; Hayat T, 2012, NUCL ENG DES, V243, P15, DOI 10.1016/j.nucengdes.2011.11.005; Hayat T, 2015, THERM SCI, DOI [10.2298/TSCI140922067H, DOI 10.2298/TSCI140922067H]; Hayat T, 2016, J AEROSPACE ENG, V29, DOI 10.1061/(ASCE)AS.1943-5525.0000568; Hayat T, 2015, J MAGN MAGN MATER, V395, P294, DOI 10.1016/j.jmmm.2015.07.092; Hayat T, 2015, Z NATURFORSCH A, V70, P333, DOI 10.1515/zna-2014-0280; Kameswaran PK, 2013, INT J HEAT MASS TRAN, V57, P465, DOI 10.1016/j.ijheatmasstransfer.2012.10.047; Khan WA, 2012, J HEAT TRANS-T ASME, V134, DOI 10.1115/1.4007138; Merkin JH, 1996, MATH COMPUT MODEL, V24, P125, DOI 10.1016/0895-7177(96)00145-8; Mustafa M, 2015, AIP ADV, V5, DOI 10.1063/1.4917306; Rashidi MM, 2014, ADV MECH ENG, DOI 10.1155/2014/735939; Reddy GB, 2015, AIN SHAMS ENG J, V6, P355, DOI 10.1016/j.asej.2014.09.004; Straughan B, 2010, INT J HEAT MASS TRAN, V53, P95, DOI 10.1016/j.ijheatmasstransfer.2009.10.001; Sui JZ, 2015, INT J HEAT MASS TRAN, V85, P1023, DOI 10.1016/j.ijheatmasstransfer.2015.02.014; Tibullo V, 2011, MECH RES COMMUN, V38, P77, DOI 10.1016/j.mechrescom.2010.10.008; [特里帕蒂D Tripathi D], 2011, [应用数学和力学, Applied Mathematics and Mechanics], V32, P1148; Turkyilmazoglu M, 2013, INT J HEAT MASS TRAN, V57, P82, DOI 10.1016/j.ijheatmasstransfer.2012.10.006; Zhang MK, 2014, INT J THERM SCI, V84, P9, DOI 10.1016/j.ijthermalsci.2014.04.014	33	82	82	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148662	10.1371/journal.pone.0148662	http://dx.doi.org/10.1371/journal.pone.0148662			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859675	Green Submitted, Green Published, gold			2022-12-27	WOS:000370038400061
J	Wood, CE; Chang, EI; Richards, EM; Rabaglino, MB; Keller-Wood, M				Wood, Charles E.; Chang, Eileen I.; Richards, Elaine M.; Belen Rabaglino, Maria; Keller-Wood, Maureen			Transcriptomics Modeling of the Late-Gestation Fetal Pituitary Response to Transient Hypoxia	PLOS ONE			English	Article							HEMODYNAMIC-RESPONSES; ANTERIOR-PITUITARY; CYTOSCAPE PLUGIN; BLOOD-FLOW; SHEEP; HYPOXEMIA; EXPRESSION; ESTRADIOL; HORMONE; NEWBORN	Background The late-gestation fetal sheep responds to hypoxia with physiological, neuroendocrine, and cellular responses that aid in fetal survival. The response of the fetus to hypoxia represents a coordinated effort to maximize oxygen transfer from the mother and minimize wasteful oxygen consumption by the fetus. While there have been many studies aimed at investigating the coordinated physiological and endocrine responses to hypoxia, and while immunohistochemical or in situ hybridization studies have revealed pathways supporting the endocrine function of the pituitary, there is little known about the coordinated cellular response of the pituitary to the hypoxia. Results Thirty min hypoxia (from 17.0 +/- 1.7 to 8.0 +/- 0.8 mm Hg, followed by 30 min normoxia) upregulated 595 and downregulated 790 genes in fetal pituitary (123-132 days' gestation; term = 147 days). Network inference of up-and down-regulated genes revealed a high degree of functional relatedness amongst the gene sets. Gene ontology analysis revealed upregulation of cellular metabolic processes (e.g., RNA synthesis, response to estrogens) and downregulation of protein phosphorylation, protein metabolism, and mitosis. Genes found to be at the center of the network of upregulated genes included genes important for purine binding and signaling. At the center of the downregulated network were genes involved in mRNA processing, DNA repair, sumoylation, and vesicular trafficking. Transcription factor analysis revealed that both up-and down-regulated gene sets are enriched for control by several transcription factors (e.g., SP1, MAZ, LEF1, NRF1, ELK1, NFAT, E12, PAX4) but not for HIF-1, which is known to be an important controller of genomic responses to hypoxia. Conclusions The multiple analytical approaches used in this study suggests that the acute response to 30 min of transient hypoxia in the late-gestation fetus results in reduced cellular metabolism and a pattern of gene expression that is consistent with cellular oxygen and ATP starvation. In this early time point, we see a vigorous gene response. But, like the hypothalamus, the transcriptomic response is not consistent with mediation by HIF-1. If HIF-1 is a significant controller of gene expression in the fetal pituitary after hypoxia, it must be at a later time.	[Wood, Charles E.; Chang, Eileen I.] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA; [Richards, Elaine M.; Keller-Wood, Maureen] Univ Florida, Coll Pharm, Dept Pharmacodynam, Gainesville, FL 32610 USA; [Belen Rabaglino, Maria] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA; [Belen Rabaglino, Maria] Consejo Nacl Invest Cient & Tecn, CEPROCOR, Cordoba, Argentina	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Wood, CE (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA.	woodc@ufl.edu		Chang, Eileen/0000-0002-3444-7260; Rabaglino, Maria/0000-0002-0099-045X; Keller-Wood, Maureen/0000-0002-1443-9212	National Institute of Child Health and Human Development [HD057561, HD033053]; National Institute of Diabetes, Digestive, and Kidney Diseases [T32DK076541]; NIH [HD057561, HD033053, T32DK076541]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD033053, R01HD057561] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK076541] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes, Digestive, and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from National Institute of Child Health and Human Development HD057561 and HD033053 to CEW, and from the National Institute of Diabetes, Digestive, and Kidney Diseases T32DK076541 to EIC (trainee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH grants HD057561 and HD033053 to CEW, and T32DK076541 to EIC (trainee) and CEW (PI). We thank Ms. Xiaoying (Lisa) Fang, and Ms. Kristina Steinfeldt, and for their expert technical assistance. Also, we thank the Genomics Division of the University of Florida's Interdisciplinary Center for Biotech Research for the use of the Agilent Bioanalyzer and Agilent scanner.	ANTOLOVICH GC, 1989, ENDOCRINOLOGY, V124, P1333, DOI 10.1210/endo-124-3-1333; Barcroft SJ, 1947, RES PRENATAL LIFE 1; BARD H, 1976, PEDIATR RES, V10, P823, DOI 10.1203/00006450-197610000-00002; BODDY K, 1974, ENDOCRINOLOGY, V94, P588, DOI 10.1210/endo-94-2-588; Butler TG, 1999, J PHYSIOL-LONDON, V516, P907, DOI 10.1111/j.1469-7793.1999.0907u.x; Chang EI, 2015, NEONATOLOGY, V107, P249, DOI 10.1159/000369374; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Fletcher AJW, 2006, AM J PHYSIOL-HEART C, V291, pH3023, DOI 10.1152/ajpheart.00504.2006; Gardner DS, 2004, J PHYSIOL-LONDON, V557, P1021, DOI 10.1113/jphysiol.2004.061796; Hasegawa T, 2013, HUM PATHOL, V44, P1271, DOI 10.1016/j.humpath.2012.10.013; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ingerman E, 2013, J CELL BIOL, V200, P619, DOI 10.1083/jcb.201211069; ITSKOVITZ J, 1991, PEDIATR RES, V30, P381, DOI 10.1203/00006450-199110000-00016; IWAMOTO HS, 1979, CIRC RES, V44, P430, DOI 10.1161/01.RES.44.3.430; JONES CT, 1977, J ENDOCRINOL, V72, P279, DOI 10.1677/joe.0.0720279; Koltsova SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110597; LIGGINS GC, 1968, J ENDOCRINOL, V40, P371, DOI 10.1677/joe.0.0400371; LIGGINS GC, 1967, AM J OBSTET GYNECOL, V98, P1080, DOI 10.1016/0002-9378(67)90031-2; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; MCMILLEN IC, 1995, J ENDOCRINOL, V144, P569, DOI 10.1677/joe.0.1440569; MESCHIA G, 1965, Q J EXP PHYSIOL CMS, V50, P466, DOI 10.1113/expphysiol.1965.sp001812; MESCHIA G, 1961, Q J EXP PHYSIOL CMS, V46, P95, DOI 10.1113/expphysiol.1961.sp001520; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muller PAJ, 2009, TRAFFIC, V10, P514, DOI 10.1111/j.1600-0854.2009.00892.x; PAGE RB, 1982, AM J PHYSIOL, V243, pE427, DOI 10.1152/ajpendo.1982.243.6.E427; Perez-Cadahia B, 2011, BIOCHEM CELL BIOL, V89, P61, DOI 10.1139/O10-138; Rabaglino MB, 2012, PHYSIOL GENOMICS, V44, P669, DOI 10.1152/physiolgenomics.00127.2011; Rayl EA, 1996, J BIOL CHEM, V271, P2225, DOI 10.1074/jbc.271.4.2225; Reimsnider SK, 2004, J ENDOCRINOL, V180, P303, DOI 10.1677/joe.0.1800303; Richardson B, 1996, PEDIATR RES, V40, P337, DOI 10.1203/00006450-199608000-00024; ROBINSON J S, 1979, Journal of Developmental Physiology (Eynsham), V1, P379; ROSENBERG AA, 1982, AM J PHYSIOL, V242, pH862, DOI 10.1152/ajpheart.1982.242.5.H862; Rurak D, 2013, AM J PHYSIOL-REG I, V304, pR908, DOI 10.1152/ajpregu.00430.2012; RURAK DW, 1978, J PHYSIOL-LONDON, V277, P341, DOI 10.1113/jphysiol.1978.sp012275; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Schaub CE, 2009, NEONATOLOGY, V96, P115, DOI 10.1159/000208793; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHELDON RE, 1979, AM J OBSTET GYNECOL, V135, P1071, DOI 10.1016/0002-9378(79)90739-7; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Toubas PL, 1973, CIRCULATION       S4, V38, P47; VEDECKIS WV, 1989, CANCER RES, V49, pS2295; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood CE, 2003, J PHYSIOL-LONDON, V549, P573, DOI 10.1113/jphysiol.2002.038398; Wood CE, 1999, AM J PHYSIOL-REG I, V277, pR1541, DOI 10.1152/ajpregu.1999.277.6.R1541; WOOD CE, 1983, ENDOCRINOLOGY, V112, P1930, DOI 10.1210/endo-112-6-1930; WOOD CE, 1982, AM J PHYSIOL, V243, pE278, DOI 10.1152/ajpendo.1982.243.4.E278; Wood CE, 2014, PHYSIOL GENOMICS, V46, P523, DOI 10.1152/physiolgenomics.00186.2013; Wood CE, 2013, PHYSIOL GENOMICS, V45, P521, DOI 10.1152/physiolgenomics.00005.2013; Wood CE, 2011, NEONATOLOGY, V100, P155, DOI 10.1159/000324431; World Medical A. & American Physiological, 2002, AM J PHYSIOL-REG I, V283, pR281; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang XF, 2014, BMC BIOINFORMATICS, V15, DOI [10.1186/1471-2105-15-186, 10.1186/1471-2105-15-335]	56	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148465	10.1371/journal.pone.0148465	http://dx.doi.org/10.1371/journal.pone.0148465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859870	Green Published, gold			2022-12-27	WOS:000370038400045
J	Zeng, MQ; Wang, L; Chen, CF; Zeng, FC; Huang, L; Xue, RZ; Chen, JJ; Gao, BM; Tang, ZY				Zeng, Mingqiang; Wang, Ling; Chen, Caifang; Zeng, Fanchang; Huang, Liang; Xue, Ruizhi; Chen, Junjie; Gao, Benmin; Tang, Zhengyan			Factors Associated with Knowledge of and Willingness for Adult Male Circumcision in Changsha, China	PLOS ONE			English	Article							HIV PREVENTION; ACCEPTABILITY; MEN; RISK; INFECTIONS; HIV/AIDS	Background Male circumcision (MC) has been shown to reduce the risk of male genital diseases. MC is not commonly practiced among Chinese males and little is known about the factors associated with their knowledge of and willingness for MC. This study was to explore the knowledge regarding the foreskin among Chinese males and to identify factors associated with their willingness to undergo circumcision. Methods A total of 237 patients with redundant prepuce/phimosis were interviewed through face-to-face interviews. The items on the questionnaire included: demographics, an objective scale assessing knowledge about the foreskin, willingness to have MC, the attitudes of sexual partners and doctors toward redundant prepuce/phimosis, and the approaches that patients used to acquire knowledge regarding the prepuce. Univariate analysis and multiple logistic regression analysis were performed to identify factors that are associated with willingness to be circumcised (WTC). Results A total of 212 patients completed the interview. Multivariable logistic regression showed that three factors were significantly associated with WTC: being married (OR = 0.43), perceiving redundant prepuce/phimosis as a disease (OR = 1.93), and if a patient's partner supported MC (OR = 1.39). 58% (n = 122) had received information about the foreskin from another party: 18% (n = 37) from school, 8% (n = 17) from family, 17% (n = 36) from friends, 27% (n = 57) from health care providers. About 4% (n = 8) believed that their partners disliked their redundant prepuce/phimosis. 20% (n = 42) had received doctors' advice to undergo circumcision. Conclusion Knowledge about the foreskin was low among Chinese males. Our study elucidates the factors associated with WTC and suggests that more education of the population about the foreskin can help improve the recognition of a correctible abnormality and help patients assess the potential role of MC in their health.	[Zeng, Mingqiang; Zeng, Fanchang; Huang, Liang; Xue, Ruizhi; Chen, Junjie; Gao, Benmin; Tang, Zhengyan] Cent S Univ, Dept Urol, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Wang, Ling] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA; [Chen, Caifang] Cent S Univ, Xiangya Hosp, Dept Geriatr Med, Changsha, Hunan, Peoples R China	Central South University; University System of Ohio; Ohio State University; Central South University	Tang, ZY (corresponding author), Cent S Univ, Dept Urol, Xiangya Hosp, Changsha, Hunan, Peoples R China.	xytzyan@163.com	Wang, Ling/AAN-3433-2021					Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Ben Kun-Long, 2009, Zhonghua Nan Ke Xue, V15, P395; Blank S, 2012, PEDIATRICS, V130, pE756, DOI 10.1542/peds.2012-1990; Brito MO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007687; Cox G, 2012, SURG GUIDE CIRCUMCIS, P243, DOI [10.1007/978-1-4471-2858-8_21, DOI 10.1007/978-1-4471-2858-8_21]; Diseker RA, 2000, SEX TRANSM INFECT, V76, P474, DOI 10.1136/sti.76.6.474; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gust DA, 2011, SEX TRANSM DIS, V38, P536, DOI 10.1097/OLQ.0b013e318207f5b0; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019814; Mattson CL, 2005, AIDS CARE, V17, P182, DOI 10.1080/09540120512331325671; Mavhu W, 2011, TROP MED INT HEALTH, V16, P589, DOI 10.1111/j.1365-3156.2011.02744.x; Morris B. J., 2012, Open Journal of Preventive Medicine, V2, P79, DOI 10.4236/ojpm.2012.21012; Morris BJ, 2013, J SEX MED, V10, P2644, DOI 10.1111/jsm.12293; Morris BJ, 2013, J UROLOGY, V189, P2118, DOI 10.1016/j.juro.2012.11.114; Nelson CP, 2005, J UROLOGY, V173, P978, DOI 10.1097/01.ju.0000145758.80937.7d; Tieu HV, 2010, SEX TRANSM DIS, V37, P352, DOI 10.1097/OLQ.0b013e3181c9963a; Tobian AAR, 2011, LANCET, V378, P314, DOI 10.1016/S0140-6736(11)61162-8; Tobian AAR, 2010, ARCH PEDIAT ADOL MED, V164, P78, DOI 10.1001/archpediatrics.2009.232; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; World Health Organization, 2007, WORLD BANK INF PACK; Yang XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030198	25	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2016	11	2							e0148832	10.1371/journal.pone.0148832	http://dx.doi.org/10.1371/journal.pone.0148832			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6MN	26859292	gold, Green Published, Green Submitted			2022-12-27	WOS:000370038400093
J	AL-Tannir, MA; El-Bakri, N; Abu-Shaheen, AK				AL-Tannir, Mohamad A.; El-Bakri, Nahid; Abu-Shaheen, Amani K.			Knowledge, Attitudes and Perceptions of Saudis towards Participating in Clinical Trials	PLOS ONE			English	Article							INTERVIEWS EXAMINING ATTITUDES; INFORMED-CONSENT; CANCER-PATIENTS; COMMUNICATION; CHEMOTHERAPY; OUTCOMES; PATIENT; AFRICA	Aim To assess the knowledge, attitudes, and perceptions of Saudis towards participating in clinical trials (CTs). Methods A cross-sectional study was conducted on 232 Saudi adult patients and their companions visiting adult outpatient clinics at King Fahad Medical City, Riyadh, Saudi Arabia. Data were collected using a self-administered questionnaire based on information obtained from the literature. The questionnaire was divided into four sections, one covering the respondents' demographics, and the other three assessing knowledge, attitudes, and perceptions towards participating in CTs. Results A total of 148 (63.8%) respondents were males, and 52 (22.4%) participants had been invited to participate in a CT previously. Of those, 39 (75%) participated. Knowledge about the essential elements of informed consent ranged from 55.7% (number of participants needed) to 85.7% (confidentiality of personal information). The majority (163, 73.8%) of respondents was willing to participate in a CT after consulting their family physician and 130 (58.0%) respondents would be motivated to participate in a CT if they were healthy. Only 36.8% of the respondents believed that patients who participated in a CT received the best care. Moreover, 110 (48.7%) respondents believed that research was conducted in a responsible and ethical manner. Conclusions The present study assessed the current understanding of CTs among Saudi participants. Although the majority of participants had an acceptable level of knowledge about CTs, they exhibited conditional attitudes and misperceptions towards participating in a CT. Increased patient awareness may improve patients' attitudes towards ethical conduct of CTs.	[AL-Tannir, Mohamad A.; El-Bakri, Nahid; Abu-Shaheen, Amani K.] King Fahad Med City, Res Ctr, Riyadh, Saudi Arabia	King Fahad Medical City	AL-Tannir, MA (corresponding author), King Fahad Med City, Res Ctr, Riyadh, Saudi Arabia.	maltannir@kfmc.med.sa		Al-Tannir, Mohamad/0000-0002-7739-8446	King Fahad Medical City, Riyadh [012-030]	King Fahad Medical City, Riyadh	This work was supported by King Fahad Medical City, Riyadh. 012-030 to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht TL, 1999, J CLIN ONCOL, V17, P3324, DOI 10.1200/JCO.1999.17.10.3324; *AM CANC SOC, 2001, CANC FACTS FIG; [Anonymous], 2002, ETH RES REL HEALTHC; Asai A, 2004, BIOETHICS, V18, P448, DOI 10.1111/j.1467-8519.2004.00409.x; Bergenmar M, 2011, CLIN TRIALS, V8, P77, DOI 10.1177/1740774510384516; Cameron P, 2013, CURR ONCOL, V20, pE193, DOI 10.3747/co.20.1323; CASSILETH BR, 1982, JAMA-J AM MED ASSOC, V248, P968, DOI 10.1001/jama.248.8.968; Comis RL, 2003, J CLIN ONCOL, V21, P830, DOI 10.1200/JCO.2003.02.105; Ellis PM, 1998, AUST NZ J PUBL HEAL, V22, P528, DOI 10.1111/j.1467-842X.1998.tb01432.x; Fallowfield LJ, 1998, EUR J CANCER, V34, P1554, DOI 10.1016/S0959-8049(98)00193-2; Featherstone K, 2002, SOC SCI MED, V55, P709, DOI 10.1016/S0277-9536(01)00197-6; FETTING JH, 1990, J CLIN ONCOL, V8, P1476, DOI 10.1200/JCO.1990.8.9.1476; GANZ PA, 1990, CANCER, V65, P2394, DOI 10.1002/1097-0142(19900515)65:10+<2394::AID-CNCR2820651509>3.0.CO;2-#; Grant CH, 2000, HEALTH COMMUN, V12, P23, DOI 10.1207/S15327027HC1201_02; Kass Nancy E, 2005, IRB, V27, P1, DOI 10.2307/3563534; Khalil Susan S, 2007, BMC Med Ethics, V8, P9, DOI 10.1186/1472-6939-8-9; Madsen SM, 2002, J INTERN MED, V251, P156, DOI 10.1046/j.1365-2796.2002.00949.x; McMillan JR, 2004, J MED ETHICS, V30, P204, DOI 10.1136/jme.2002.001263; Nair SC, 2013, CONTEMP CLIN TRIALS, V36, P704, DOI 10.1016/j.cct.2013.05.009; Preziosi MP, 1997, NEW ENGL J MED, V336, P370, DOI 10.1056/NEJM199701303360511; Robinson EJ, 2005, HEALTH TECHNOL ASSES, V9, pIII; SHELDON JM, 1993, CANCER INVEST, V11, P57, DOI 10.3109/07357909309020261; SIMINOFF LA, 1989, J CLIN ONCOL, V7, P1192, DOI 10.1200/JCO.1989.7.9.1192; Sugarman Jeremy, 1998, IRB, V20, P1, DOI 10.2307/3564262; Taban H, 2011, MARMARA MED J, V24, P181, DOI 10.5472/MMJ.2011.02155.1; Tanai C, 2009, BRIT J CANCER, V100, P1037, DOI 10.1038/sj.bjc.6604982; Toerien M, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-52; Wendler David, 2005, IRB, V27, P1	28	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0143893	10.1371/journal.pone.0143893	http://dx.doi.org/10.1371/journal.pone.0143893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PR	26848750	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000003
J	Balcazar-Lopez, E; Mendez-Lorenzo, LH; Batista-Garcia, RA; Esquivel-Naranjo, U; Ayala, M; Kumar, VV; Savary, O; Cabana, H; Herrera-Estrella, A; Folch-Mallol, JL				Balcazar-Lopez, Edgar; Helena Mendez-Lorenzo, Luz; Alberto Batista-Garcia, Ramon; Esquivel-Naranjo, Ulises; Ayala, Marcela; Kumar, Vaidyanathan Vinoth; Savary, Olivier; Cabana, Hubert; Herrera-Estrella, Alfredo; Luis Folch-Mallol, Jorge			Xenobiotic Compounds Degradation by Heterologous Expression of a Trametes sanguineus Laccase in Trichoderma atroviride	PLOS ONE			English	Article							FUNGAL LACCASES; REESEI; GENE	Fungal laccases are enzymes that have been studied because of their ability to decolorize and detoxify effluents; they are also used in paper bleaching, synthesis of polymers, bioremediation, etc. In this work we were able to express a laccase from Trametes (Pycnoporus) sanguineus in the filamentous fungus Trichoderma atroviride. For this purpose, a transformation vector was designed to integrate the gene of interest in an intergenic locus near the blu17 terminator region. Although monosporic selection was still necessary, stable integration at the desired locus was achieved. The native signal peptide from T. sanguineus laccase was successful to secrete the recombinant protein into the culture medium. The purified, heterologously expressed laccase maintained similar properties to those observed in the native enzyme (Km and kcat and kcat/km values for ABTS, thermostability, substrate range, pH optimum, etc). To determine the bioremediation potential of this modified strain, the laccase-overexpressing Trichoderma strain was used to remove xenobiotic compounds. Phenolic compounds present in industrial wastewater and bisphenol A (an endocrine disruptor) from the culture medium were more efficiently removed by this modified strain than with the wild type. In addition, the heterologously expressed laccase was able to decolorize different dyes as well as remove benzo[a] pyrene and phenanthrene in vitro, showing its potential for xenobiotic compound degradation.	[Balcazar-Lopez, Edgar; Helena Mendez-Lorenzo, Luz; Alberto Batista-Garcia, Ramon] Univ Autonoma Estado Morelos, Fac Ciencias, Av Univ 1001, Cuernavaca, Mor, Mexico; [Balcazar-Lopez, Edgar; Helena Mendez-Lorenzo, Luz; Alberto Batista-Garcia, Ramon; Luis Folch-Mallol, Jorge] Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Av Univ 1001, Cuernavaca, Morelos, Mexico; [Esquivel-Naranjo, Ulises] Univ Autonoma Queretaro, Fac Ciencias Nat, Unidad Microbiol Basica & Aplicada, Anillo Vial Fray Junipero Serra Km 8 S-N, Santiago De Qro 76000, Mexico; [Ayala, Marcela] Univ Nacl Autonoma Mexico, Inst Biotecnol, Av Univ 2001, Cuernavaca, Morelos, Mexico; [Kumar, Vaidyanathan Vinoth; Savary, Olivier; Cabana, Hubert] Univ Sherbrooke, Dept Civil Engn, 2500 Blvd Univ, Sherbrooke, PQ J1K 2R1, Canada; [Kumar, Vaidyanathan Vinoth] SRM Univ, Dept Biotechnol, Sch Bioengn, Bioproc Lab, Kattankulathur 603203, Tamil Nadu, India; [Herrera-Estrella, Alfredo] Lab Nacl Genom Biodiversidad, Cinvestav Campus Guanajuato,Km 9-6 Libramiento No, Irapuato 36821, Mexico	Universidad Autonoma del Estado de Morelos; Universidad Autonoma del Estado de Morelos; Universidad Autonoma de Queretaro; Universidad Nacional Autonoma de Mexico; University of Sherbrooke; SRM Institute of Science & Technology Chennai; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Folch-Mallol, JL (corresponding author), Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Av Univ 1001, Cuernavaca, Morelos, Mexico.	jordi@uaem.mx	Vaidyanathan, Vinoth kumar/B-2606-2011; Herrera-Estrella, Alfredo/F-3185-2011; Ayala, Marcela/A-4876-2008; Herrera-Estrella, Alfredo/J-8210-2019; Esquivel, Edgardo/GLR-3607-2022	Herrera-Estrella, Alfredo/0000-0002-4589-6870; Herrera-Estrella, Alfredo/0000-0002-4589-6870; Balcazar, Edgar/0000-0003-0616-309X; Batista-Garcia, Ramon Alberto/0000-0002-1032-0767; Cabana, Hubert/0000-0003-3417-6816; Ayala, Marcela/0000-0002-1234-4287; ESQUIVEL-NARANJO, EDGARDO ULISES/0000-0002-1934-7042; Folch-Mallol, Jorge/0000-0002-1860-8175	Consejo Nacional de Ciencia y Tecnologia from the Mexican government [CB-153789-Q]; Consejo Nacional de Ciencia y Tecnologia; Consejo Nacional de Ciencia y Tecnologia-Secretaria de Energia project [150001]; BBVA-Bancomer; Natural Sciences and Engineering Research Council of Canada	Consejo Nacional de Ciencia y Tecnologia from the Mexican government; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia-Secretaria de Energia project; BBVA-Bancomer(BBVA Foundation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was partially funded by a grant of Consejo Nacional de Ciencia y Tecnologia (http://www.conacyt.gob.mx/) CB-153789-Q from the Mexican government. EB-L and RAB-G had a scholarship from Consejo Nacional de Ciencia y Tecnologia. LHM-L had a scholarship from Consejo Nacional de Ciencia y Tecnologia-Secretaria de Energia project 150001. EB-L had a mobility grant from BBVA-Bancomer-2011. The work was also partially funded by a grant from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala M, 2011, J BIOL INORG CHEM, V16, P63, DOI 10.1007/s00775-010-0702-6; Ba S, 2013, CRIT REV BIOTECHNOL, V33, P404, DOI 10.3109/07388551.2012.725390; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; BOYD AC, 1995, GENE, V153, P57, DOI 10.1016/0378-1119(94)00788-T; Bulter T, 2003, APPL ENVIRON MICROB, V69, P987, DOI 10.1128/AEM.69.2.987-995.2003; Camarero S, 2012, APPL ENVIRON MICROB, V78, P1370, DOI 10.1128/AEM.07530-11; Carlile MJD, 2001, FUNGI, V1; d'Acunzo F, 2006, NEW J CHEM, V30, P583, DOI 10.1039/b516719a; Dantan-Gonzalez E, 2008, INT MICROBIOL, V11, P163, DOI 10.2436/20.1501.01.56; Del Carratore R, 2011, BIOTECHNOL LETT, V33, P1201, DOI 10.1007/s10529-011-0557-0; E.P.A, 2010, BISPH ACT PLAN 2010; Esquivel-Naranjo EU, 2007, MICROBIOL-SGM, V153, P3909, DOI 10.1099/mic.0.2007/007302-0; Hamzah A, 2012, SAINS MALAYS, V41, P71; Han MJ, 2004, J MICROBIOL, V42, P94; HERRERAESTRELLA A, 1990, MOL MICROBIOL, V4, P839, DOI 10.1111/j.1365-2958.1990.tb00654.x; Hoshida H, 2005, BIOSCI BIOTECH BIOCH, V69, P1090, DOI 10.1271/bbb.69.1090; Jolivalt C, 2005, APPL MICROBIOL BIOT, V66, P450, DOI 10.1007/s00253-004-1717-0; KARHUNEN T, 1993, MOL GEN GENET, V241, P515, DOI 10.1007/BF00279893; Kovacs K, 2009, BIORESOURCE TECHNOL, V100, P1350, DOI 10.1016/j.biortech.2008.08.006; Krastanov A. I., 2007, Bulgarian Journal of Agricultural Science, V13, P349; Kunamneni A, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-32; Lee H, 2010, FOLIA MICROBIOL, V55, P447, DOI 10.1007/s12223-010-0075-9; Lee H, 2014, J MICROBIOL METH, V97, P56, DOI 10.1016/j.mimet.2013.12.007; Lomascolo A, 2011, APPL MICROBIOL BIOT, V92, P1129, DOI 10.1007/s00253-011-3596-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Majeau JA, 2010, BIORESOURCE TECHNOL, V101, P2331, DOI 10.1016/j.biortech.2009.10.087; Mayer AM, 2002, PHYTOCHEMISTRY, V60, P551, DOI 10.1016/S0031-9422(02)00171-1; Nishibori N, 2013, J BIOSCI BIOENG, V115, P394, DOI 10.1016/j.jbiosc.2012.10.025; Ortega SN, 2011, BIODEGRADATION, V22, P43, DOI 10.1007/s10532-010-9374-8; Pardo I, 2012, BIOTECHNOL BIOENG, V109, P2978, DOI 10.1002/bit.24588; RAEDER U, 1985, LETT APPL MICROBIOL, V1, P17, DOI 10.1111/j.1472-765X.1985.tb01479.x; Rodriguez E, 1999, CURR MICROBIOL, V38, P27, DOI 10.1007/PL00006767; Sack U, 1997, APPL ENVIRON MICROB, V63, P3919, DOI 10.1128/AEM.63.10.3919-3925.1997; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; Scott RD, 1931, IND ENG CHEM, V3, P0067, DOI 10.1021/ac50073a034; Torres-Duarte C, 2012, APPL BIOCHEM BIOTECH, V168, P864, DOI 10.1007/s12010-012-9825-2; Valderrama B, 2002, CHEM BIOL, V9, P555, DOI 10.1016/S1074-5521(02)00149-7; Cazares-Garcia SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055295; Vite-Vallejo O, 2009, ENZYME MICROB TECH, V45, P233, DOI 10.1016/j.enzmictec.2009.05.007; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wildt S, 2005, NAT REV MICROBIOL, V3, P119, DOI 10.1038/nrmicro1087; Zeilinger S, 2004, CURR GENET, V45, P54, DOI 10.1007/s00294-003-0454-8; Zhang JW, 2012, J BIOSCI BIOENG, V113, P697, DOI 10.1016/j.jbiosc.2012.01.016	44	33	34	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147997	10.1371/journal.pone.0147997	http://dx.doi.org/10.1371/journal.pone.0147997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849129	gold, Green Submitted, Green Published			2022-12-27	WOS:000369554000031
J	Chuang, MK; Chang, CH; Chan, CY				Chuang, Min-Kai; Chang, Chin-Hao; Chan, Chih-Yang			The Effect of Haemodialysis Access Types on Cardiac Performance and Morbidities in Patients with Symptomatic Heart Disease	PLOS ONE			English	Article							VASCULAR ACCESS; ARTERIOVENOUS-FISTULAS; FAILURE; OUTPUT; CKD	Background Little is known about whether the arteriovenous type haemodialysis access affects cardiac function and whether it is still advantageous to the uremic patient with symptomatic heart disease. Methods We conducted a retrospective comparative study. Patients with heart disease and end-stage renal disease that had a new chronic access created between January 2007 and December 2008 and met the inclusion criteria were assessed. The endpoint was major adverse event (MAE)-free survivals of arteriovenous access (AVA) and tunneled cuffed double-lumen central venous catheter (CVC) groups. Whether accesses worsened heart failure was also evaluated. Results There were 43 CVC patients and 60 AVA patients. The median follow-up time from access creation was 27.6 months (IQR 34.7, 10.9 similar to 45.6). Although CVC patients were older than AVA patients (median age 78.0, IQR 14.0 vs. 67.5, IQR 16.0, respectively, p = .009), they manifested non-inferior MAE-free survival (mean 17.1, 95% CI 10.3 similar to 24.0 vs. 12.9, 95% CI 8.5 similar to 17.4 months in CVC and AVA patients, respectively, p = .290). During follow-up, more patients in the AVA group than in the CVC group deteriorated in heart failure status (35 of 57 vs. 10 of 42, respectively, odds ratio 5.1, p < .001). Preoperative-postoperative pairwise comparison of echocardiographic scans revealed an increased number of abnormal findings in the AVA group (Z = 3.91, p < .001), but not in the CVC group. Conclusions In patients with both symptomatic heart disease and end stage renal disease (ESRD), CVC patients showed non-inferior MAE-free survival in comparison to those in the AVA group. AV type access could deteriorate heart failure. Accordingly, uremic patients with symptomatic heart disease are not ideal candidates for AV type access creation.	[Chuang, Min-Kai] Natl Taiwan Univ Hosp, Dept Surg, Yun Lin Branch, Yunlin, Taiwan; [Chang, Chin-Hao] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Chan, Chih-Yang] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chan, CY (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.	chanchihyang@gmail.com		CHAN, CHIH-YANG/0000-0001-6705-1177				Amerling R, 2011, BLOOD PURIFICAT, V31, P113, DOI 10.1159/000322695; [Anonymous], 2007, ABR LIF TABL TAIW 20; Bansal N, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-115; Bansal N, 2013, CLIN J AM SOC NEPHRO, V8, P355, DOI 10.2215/CJN.06020612; Beigi AA, 2009, J VASC ACCESS, V10, P160, DOI 10.1177/112972980901000305; Cai QZ, 2014, J AM SOC NEPHROL, V25, P1599, DOI 10.1681/ASN.2013080899; Ethier J, 2008, NEPHROL DIAL TRANSPL, V23, P3219, DOI 10.1093/ndt/gfn261; Hemodialysis Adequacy 2006, 2006, AM J KIDNEY DIS, V48, pS2, DOI [10.1053/j.ajkd.2006.03.051, DOI 10.1053/J.AJKD.2006.03.051]; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Lok CE, 2007, CLIN J AM SOC NEPHRO, V2, P1043, DOI 10.2215/CJN.01080307; Lok CE, 2006, J AM SOC NEPHROL, V17, P3204, DOI 10.1681/ASN.2006030190; MacRae JM, 2006, SEMIN DIALYSIS, V19, P349, DOI 10.1111/j.1525-139X.2006.00185.x; MacRae JM, 2004, AM J KIDNEY DIS, V43, DOI 10.1053/j.ajkd.2004.01.016; Movilli E, 2010, AM J KIDNEY DIS, V55, P682, DOI 10.1053/j.ajkd.2009.11.008; Murray BM, 2004, AM J KIDNEY DIS, V44, P1090, DOI 10.1053/j.ajkd.2004.06.031; Ng LJ, 2011, NEPHROL DIAL TRANSPL, V26, P3659, DOI 10.1093/ndt/gfr063; Santoro D, 2010, MINERVA UROL NEFROL, V62, P81; Santoro D, 2014, INT J NEPHROL RENOV, V7, P281, DOI 10.2147/IJNRD.S46643; Soleimani MJ, 2012, IRAN J KIDNEY DIS, V6, P198; Valek M, 2010, ASAIO J, V56, P200, DOI 10.1097/MAT.0b013e3181ce6757; Yigla M, 2006, SEMIN DIALYSIS, V19, P353, DOI 10.1111/j.1525-139X.2006.00186.x; Zile MR, 2008, CIRCULATION, V118, P1433, DOI 10.1161/CIRCULATIONAHA.108.783910	22	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148278	10.1371/journal.pone.0148278	http://dx.doi.org/10.1371/journal.pone.0148278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848850	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000064
J	Lee, YI; Lee, HM; Jo, JK; Lee, S; Hong, SK; Byun, SS; Lee, SE; Oh, JJ				Lee, Young Ik; Lee, Hak Min; Jo, Jung Ki; Lee, Sangchul; Hong, Sung Kyu; Byun, Seok-Soo; Lee, Sang Eun; Oh, Jong Jin			Association between Seminal Vesicle Invasion and Prostate Cancer Detection Location after Transrectal Systemic Biopsy among Men Who Underwent Radical Prostatectomy	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; MULTIVARIATE-ANALYSIS; ADENOCARCINOMA; INVOLVEMENT; RECURRENCE; PREDICTION; NOMOGRAM; MARGINS; RATES	Background Our hypothesis is that the location of the seminal vesicles near the base of the prostate, the more positive cores are detected in the base, the greater the risk of seminal vesicle invasion. Therefore we investigate the clinical outcomes of base dominant prostate cancer (BDPC) in transrectal ultrasound (TRUS) - guided biopsies compared with anteromiddle dominant prostate cancer (AMPC). Methods From November 2003 to June 2014, a total of 990 intermediate and high risk prostate cancer (PCa) patients who underwent radical prostatectomy (RP) were enrolled and stratified into two groups according to proportion of positive cores-BDPC group had >= 33.3% ratio of positive cores from the prostate base among all positive cores and AMPC group < 33.3% in systemic biopsy. Between two groups, we compared the rate of pathologic outcomes and biochemical recurrence (BCR). We performed multivariate logistic regression model to confirm the significance of BDPC to seminal vesicle invasion (SVI) and Cox proportional hazard analysis to BCR. Results Among these 990 PCa patients, the 487 patients in BDPC group had more advanced clinical stage (p< 0.001), a higher biopsy GS (p = 0.002), and a higher rate of extracapsular extension (ECE), SVI and BCR (all p< 0.001) than AMPC group. The patients in BDPC group had poor BCR free survival rate via Kaplan-meier analysis (p< 0.001). The ratio of the base positive cores was a significant predictor to SVI in multivariate analysis (p < 0.001) and significant predictor of BCR in multivariate Cox proportional analysis (hazard ratio: 1.466, p = 0.004). Conclusions BDPC in TRUS-guided prostate biopsies was significantly associated with SVI and BCR after adjusting for other clinical factors. Therefore, BDPC should be considered to be a more aggressive tumor despite an otherwise similar cancer profile.	[Lee, Young Ik; Lee, Hak Min; Jo, Jung Ki; Lee, Sangchul; Hong, Sung Kyu; Byun, Seok-Soo; Lee, Sang Eun; Oh, Jong Jin] Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea	Seoul National University (SNU)	Oh, JJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea.	bebsuzzang@naver.com			SNUBH (Seoul National University Bundang Hospital) Research Fund [14-2015-031]; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2014R1A1A2059658]	SNUBH (Seoul National University Bundang Hospital) Research Fund; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported by grant no 14-2015-031 from the SNUBH (Seoul National University Bundang Hospital) Research Fund and supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (NRF-2014R1A1A2059658). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; CATALONA WJ, 1994, J UROLOGY, V152, P1837, DOI 10.1016/S0022-5347(17)32397-2; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Chan ESY, 2012, CHINESE MED J-PEKING, V125, P2432, DOI 10.3760/cma.j.issn.0366-6999.2012.14.006; DAMICO AV, 1995, J UROLOGY, V154, P131, DOI 10.1016/S0022-5347(01)67248-3; de Rooij M, 2015, EUR UROL, DOI [10.1016/j.eururo, DOI 10.1016/J.EURURO]; Debras B, 1998, EUR UROL, V33, P271, DOI 10.1159/000019579; EPSTEIN JI, 1993, J UROLOGY, V149, P1040, DOI 10.1016/S0022-5347(17)36291-2; Epstein JI, 1996, AM J SURG PATHOL, V20, P286, DOI 10.1097/00000478-199603000-00004; Guillonneau B, 1997, EUR UROL, V32, P160, DOI 10.1159/000480851; Heidenreich A, 2008, EUR UROL, V53, P68, DOI 10.1016/j.eururo.2007.09.002; Huang L, 2014, WORLD J GASTROENTERO, V20, P17804, DOI 10.3748/wjg.v20.i47.17804; Hull GW, 2002, J UROLOGY, V167, P528, DOI 10.1016/S0022-5347(01)69079-7; Irmisch A, 2013, EXP CELL RES, V319, P1604, DOI 10.1016/j.yexcr.2013.02.012; Koh H, 2003, J UROLOGY, V170, P1203, DOI 10.1097/01.ju.0000085074.62960.7b; OHORI M, 1993, AM J SURG PATHOL, V17, P1252, DOI 10.1097/00000478-199312000-00006; OHORI M, 1995, J UROLOGY, V154, P1818, DOI 10.1016/S0022-5347(01)66792-2; Partin AW, 2001, UROLOGY, V58, P843, DOI 10.1016/S0090-4295(01)01441-8; Pins MR, 2004, PROSTATE CANCER P D, V7, P243, DOI 10.1038/sj.pcan.4500722; Roemeling S, 2007, CANCER-AM CANCER SOC, V110, P2218, DOI 10.1002/cncr.23029; Tefilli MV, 1998, J UROLOGY, V160, P802, DOI 10.1016/S0022-5347(01)62791-5; VandenOuden D, 1997, BRIT J UROL, V79, P203, DOI 10.1046/j.1464-410X.1997.33011.x; VILLERS AA, 1990, J UROLOGY, V143, P1183, DOI 10.1016/S0022-5347(17)40220-5; Yamaguchi H, 2015, CANCERS, V7, P2054, DOI 10.3390/cancers7040876; Yip SKH, 2010, CURR OPIN UROL, V20, P80, DOI 10.1097/MOU.0b013e3283337bf0	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148690	10.1371/journal.pone.0148690	http://dx.doi.org/10.1371/journal.pone.0148690			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848747	gold, Green Published, Green Submitted			2022-12-27	WOS:000369554000159
J	Liebergesell, M; Reu, B; Stahl, U; Freiberg, M; Welk, E; Kattge, J; Cornelissen, JHC; Penuelas, J; Wirth, C				Liebergesell, Mario; Reu, Bjrn; Stahl, Ulrike; Freiberg, Martin; Welk, Erik; Kattge, Jens; Cornelissen, J. Hans C.; Penuelas, Josep; Wirth, Christian			Functional Resilience against Climate-Driven Extinctions - Comparing the Functional Diversity of European and North American Tree Floras	PLOS ONE			English	Article							ECOSYSTEM PROCESSES; PLANT TRAITS; WORLD MAP; BIODIVERSITY; FOREST; CLASSIFICATION; COMMUNITIES; FRAMEWORK; ECONOMICS; SERVICES	Future global change scenarios predict a dramatic loss of biodiversity for many regions in the world, potentially reducing the resistance and resilience of ecosystem functions. Once before, during Plio-Pleistocene glaciations, harsher climatic conditions in Europe as compared to North America led to a more depauperate tree flora. Here we hypothesize that this climate driven species loss has also reduced functional diversity in Europe as compared to North America. We used variation in 26 traits for 154 North American and 66 European tree species and grid-based co-occurrences derived from distribution maps to compare functional diversity patterns of the two continents. First, we identified similar regions with respect to contemporary climate in the temperate zone of North America and Europe. Second, we compared the functional diversity of both continents and for the climatically similar subregions using the functional dispersion-index (FDis) and the functional richness index (FRic). Third, we accounted in these comparisons for grid-scale differences in species richness, and, fourth, investigated the associated trait spaces using dimensionality reduction. For gymnosperms we find similar functional diversity on both continents, whereas for angiosperms functional diversity is significantly greater in Europe than in North America. These results are consistent across different scales, for climatically similar regions and considering species richness patterns. We decomposed these differences in trait space occupation into differences in functional diversity vs. differences in functional identity. We show that climate-driven species loss on a continental scale might be decoupled from or at least not linearly related to changes in functional diversity. This might be important when analyzing the effects of climate-driven biodiversity change on ecosystem functioning.	[Liebergesell, Mario; Freiberg, Martin; Wirth, Christian] Univ Leipzig, Dept Special Bot & Funct Biodivers, D-04109 Leipzig, Germany; [Reu, Bjrn] Univ Ind Santander, Escuela Biol, Bucaramanga 680002, Colombia; [Stahl, Ulrike; Kattge, Jens] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Welk, Erik] Univ Halle Saale, Dept Geobot, Halle, Germany; [Cornelissen, J. Hans C.] Vrije Univ Amsterdam, Dept Ecol Sci, Syst Ecol, Amsterdam, Netherlands; [Penuelas, Josep] CSIC, Global Ecol Unit CREAF CSIC UAB, Barcelona 08193, Catalonia, Spain; [Penuelas, Josep] CREAF, Barcelona 08193, Catalonia, Spain; [Wirth, Christian] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Leipzig University; Universidad Industrial de Santander; Max Planck Society; Martin Luther University Halle Wittenberg; Vrije Universiteit Amsterdam; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF)	Liebergesell, M (corresponding author), Univ Leipzig, Dept Special Bot & Funct Biodivers, D-04109 Leipzig, Germany.	mario.liebergesell@uni-leipzig.de	Penuelas, Josep/D-9704-2011; Kattge, Jens/J-8283-2016; Wirth, Christian/A-4446-2016; Reu, Björn/HDM-4363-2022; WELK, Erik/AGL-4971-2022	Penuelas, Josep/0000-0002-7215-0150; Kattge, Jens/0000-0002-1022-8469; Stahl, Ulrike/0000-0002-5659-910X; Reu, Bjorn/0000-0001-5271-6420	FunDivEUROPE project; TRY initiative on plant traits; DIVERSITAS; IGBP; Global Land Project; UK Natural Environment Research Council (NERC) through its program QUEST (Quantifying and Understanding the Earth System); French Foundation for Biodiversity Research (FRB); GIS "Climat, Environnement et Societe" France; FunDivEUROPE project - European Union Seventh Framework Programme [265171]; European Research Council [ERC-2013-SyG-610028 IMBALANCE-P]	FunDivEUROPE project; TRY initiative on plant traits; DIVERSITAS; IGBP; Global Land Project; UK Natural Environment Research Council (NERC) through its program QUEST (Quantifying and Understanding the Earth System)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); French Foundation for Biodiversity Research (FRB); GIS "Climat, Environnement et Societe" France; FunDivEUROPE project - European Union Seventh Framework Programme; European Research Council(European Research Council (ERC)European Commission)	We thank two anonymous reviewers for reviewing the manuscript and giving constructive comments. This research was supported by the FunDivEUROPE project and the TRY initiative on plant traits (http://www.trydb.org). The TRY initiative and database is hosted, developed and maintained at the Max Planck Institute for Biogeochemistry, Jena, Germany. TRY is/has been supported by DIVERSITAS, IGBP, the Global Land Project, the UK Natural Environment Research Council (NERC) through its program QUEST (Quantifying and Understanding the Earth System), the French Foundation for Biodiversity Research (FRB), and GIS "Climat, Environnement et Societe" France.; This research was supported by the FunDivEUROPE project, receiving funding from the European Union Seventh Framework Programme (FP7/2007-2013, http://cordis.europa.eu/fp7) under grant agreement no 265171. The study was supported by the TRY initiative on plant traits (http://www.trydb.org). The TRY initiative and database is hosted, developed and maintained at the Max Planck Institute for Biogeochemistry, Jena, Germany. TRY is/has been supported by DIVERSITAS, IGBP, the Global Land Project, the UK Natural Environment Research Council (NERC) through its program QUEST (Quantifying and Understanding the Earth System), the French Foundation for Biodiversity Research (FRB), and GIS "Climat, Environnement et Societe" France. JP research was supported by the European Research Council Synergy grant ERC-2013-SyG-610028 IMBALANCE-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1989, NATURE, P339; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; [Anonymous], 2005, MILLENNIUM ECOSYSTEM; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Baraloto C, 2010, ECOL LETT, V13, P1338, DOI 10.1111/j.1461-0248.2010.01517.x; Beck D.E., 1990, SILVICS N AM, V2, P406; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Brown CM, 2012, SYST BIOL, V61, P941, DOI 10.1093/sysbio/sys047; Bunker DE, 2005, SCIENCE, V310, P1029, DOI 10.1126/science.1117682; Cardinale BJ, 2012, NATURE, V489, P326, DOI 10.1038/nature11373; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Cheaib A, 2012, ECOL LETT, V15, P533, DOI 10.1111/j.1461-0248.2012.01764.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Duong T., 2013, KS KERNEL SMOOTHING; Eiserhardt WL, 2015, ECOL LETT, V18, P263, DOI 10.1111/ele.12409; FAO, 2006, GLOB FOR RES ASS 200; FAO - The United Nations Food and Agriculture Organization, 2001, GLOB EC ZON GLOB FOR; Gamfeldt L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2328; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; Handa IT, 2014, NATURE, V509, P218, DOI 10.1038/nature13247; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lang G, 1994, QUARTARE VEGETATIONS; LATHAM RE, 1993, OIKOS, V67, P325, DOI 10.2307/3545479; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Lavorel S., 2007, PLANT FUNCTIONAL TYP; Little E., 1999, DIGITAL REPRESENTATI; Manthey M, 2007, J BIOGEOGR, V34, P1028, DOI 10.1111/j.1365-2699.2006.01669.x; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Miles P.D., 2001, FOREST INVENTORY ANA; Mouillot D, 2007, OECOLOGIA, V152, P729, DOI 10.1007/s00442-007-0688-0; Nadrowski K, 2010, CURR OPIN ENV SUST, V2, P75, DOI 10.1016/j.cosust.2010.02.003; Oksanen J., 2009, RPACKAGEVERSION; Pavoine S, 2009, OIKOS, V118, P391, DOI 10.1111/j.1600-0706.2008.16668.x; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Stahl U, 2013, ECOSPHERE, P4; Stier AC, 2013, OIKOS, V122, P171, DOI 10.1111/j.1600-0706.2012.20726.x; Svenning JC, 2003, ECOL LETT, V6, P646, DOI 10.1046/j.1461-0248.2003.00477.x; Swenson NG, 2012, GLOBAL ECOL BIOGEOGR, V21, P798, DOI 10.1111/j.1466-8238.2011.00727.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Walter H, 1991, OKOLOGIE ERDE, V4; Weiher E, 2010, BIOL DIVERSITY FRONT, P175; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; Wirth C, 2009, ECOL STUD-ANAL SYNTH, V207, P81, DOI 10.1007/978-3-540-92706-8_5; York RA, 2011, RESTOR ECOL, V19, P14, DOI 10.1111/j.1526-100X.2009.00537.x; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	55	15	16	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148607	10.1371/journal.pone.0148607	http://dx.doi.org/10.1371/journal.pone.0148607			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26848836	Green Published, gold			2022-12-27	WOS:000369554000136
J	Lu, M; An, HM; Li, LL				Lu, Min; An, Huaming; Li, Liangliang			Genome Survey Sequencing for the Characterization of the Genetic Background of Rosa roxburghii Tratt and Leaf Ascorbate Metabolism Genes	PLOS ONE			English	Article							MICROSATELLITE MARKERS; VITAMIN-C; ACID; IDENTIFICATION; EVOLUTION; PLANTS; SIZE; CLASSIFICATION; INSIGHTS; PATHWAY	Rosa roxburghii Tratt is an important commercial horticultural crop in China that is recognized for its nutritional and medicinal values. In spite of the economic significance, genomic information on this rose species is currently unavailable. In the present research, a genome survey of R. roxburghii was carried out using next-generation sequencing (NGS) technologies. Total 30.29 Gb sequence data was obtained by HiSeq 2500 sequencing and an estimated genome size of R. roxburghii was 480.97 Mb, in which the guanine plus cytosine (GC) content was calculated to be 38.63%. All of these reads were technically assembled and a total of 627,554 contigs with a N50 length of 1.484 kb and furthermore 335,902 scaffolds with a total length of 409.36 Mb were obtained. Transposable elements (TE) sequence of 90.84 Mb which comprised 29.20% of the genome, and 167,859 simple sequence repeats (SSRs) were identified from the scaffolds. Among these, the mono-(66.30%), di-(25.67%), and tri-(6.64%) nucleotide repeats contributed to nearly 99% of the SSRs, and sequence motifs AG/CT (28.81%) and GAA/TTC (14.76%) were the most abundant among the dinucleotide and trinucleotide repeat motifs, respectively. Genome analysis predicted a total of 22,721 genes which have an average length of 2311.52 bp, an average exon length of 228.15 bp, and average intron length of 401.18 bp. Eleven genes putatively involved in ascorbate metabolism were identified and its expression in R. roxburghii leaves was validated by quantitative real-time PCR (qRT-PCR). This is the first report of genome-wide characterization of this rose species.	[Lu, Min; An, Huaming; Li, Liangliang] Guizhou Univ, Coll Agr, Guiyang 550003, Guizhou, Peoples R China; [An, Huaming; Li, Liangliang] Guizhou Engn Res Ctr Fruit Crops, Guiyang, Guizhou, Peoples R China	Guizhou University	An, HM (corresponding author), Guizhou Univ, Coll Agr, Guiyang 550003, Guizhou, Peoples R China.; An, HM (corresponding author), Guizhou Engn Res Ctr Fruit Crops, Guiyang, Guizhou, Peoples R China.	anhuaming@hotmail.com			National Natural Science Foundation of China [31360475]; special project of major science and technology in Guizhou Province, P.R. China [20136006-1]; natural science foundation in Guizhou Province, P.R. China [20122169]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special project of major science and technology in Guizhou Province, P.R. China; natural science foundation in Guizhou Province, P.R. China	This work was supported by grants from the National Natural Science Foundation of China (31360475, AHM), http://www.nsfc.gov.cn; the special project of major science and technology in Guizhou Province, P.R. China (20136006-1, AHM), http://kjt.gzst.gov.cn; and the natural science foundation in Guizhou Province, P.R. China (20122169, LM), http://www.nsfc.gov.cn. The funders provided support in the form of salaries for authors [AMH and LM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; An HM, 2007, J HORTIC SCI BIOTECH, V82, P627, DOI 10.1080/14620316.2007.11512283; An HuaMing, 2005, Acta Horticulturae Sinica, V32, P994; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Bennetzen JL, 2000, PLANT CELL, V12, P1021, DOI 10.1105/tpc.12.7.1021; Bryc K, 2013, GENETICS, V195, P553, DOI 10.1534/genetics.113.154500; Chagne D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092644; Chen Nansheng, 2004, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s05; Chen Z, 2003, P NATL ACAD SCI USA, V100, P3525, DOI 10.1073/pnas.0635176100; Conklin PL, 2004, PLANT CELL ENVIRON, V27, P959, DOI 10.1111/j.1365-3040.2004.01203.x; Cruz-Rus E, 2011, J EXP BOT, V62, P4191, DOI 10.1093/jxb/err122; Darlington C. D., 1955, CHROMOSOME ATLAS FLO; Davey MW, 2000, J SCI FOOD AGR, V80, P825, DOI [10.1002/(SICI)1097-0010(20000515)80:7<825::AID-JSFA598>3.0.CO;2-6, 10.1002/(SICI)1097-0010(20000515)80:7&lt;825::AID-JSFA598&gt;3.0.CO;2-6]; Debener T, 2009, CRIT REV PLANT SCI, V28, P267, DOI 10.1080/07352680903035481; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Fan WeiGuo, 2011, Acta Horticulturae Sinica, V38, P1609; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Han YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq862; He Z., 1984, ACTA HORTICULTURAE S, V11, P271; Hirakawa H, 2015, DNA RES, V22, P171, DOI 10.1093/dnares/dsv002; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jiao Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-201; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Kraaijeveld K, 2010, EVOL BIOL, V37, P227, DOI 10.1007/s11692-010-9093-4; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li Yingrui, 2010, Human Genomics, V4, P271; Linster CL, 2007, J BIOL CHEM, V282, P18879, DOI 10.1074/jbc.M702094200; Liu QL, 2005, J MOUNTAIN AGR BIOL, V24, P522; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Petrov DA, 2001, TRENDS GENET, V17, P23, DOI 10.1016/S0168-9525(00)02157-0; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Ravishankar KV, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0289-2; Renfree MB, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r81; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shi XL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1954; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smulders MJM, 2012, WILD CROP RELATIVES, P277; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; The Potato Genome Sequencing Consortium, 2011, NATURE, V475, P1; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Vinogradov AE, 1999, J MOL EVOL, V49, P376, DOI 10.1007/PL00006561; Wen XP, 2004, J HORTIC SCI BIOTECH, V79, P189, DOI 10.1080/14620316.2004.11511747; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yan XQ, 2015, GENE, V561, P54, DOI 10.1016/j.gene.2015.02.054; Yokoya K, 2000, ANN BOT-LONDON, V85, P557, DOI 10.1006/anbo.1999.1102; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhou W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069909; ZHU WF, 1984, J GUIZHOU AGR COLL, V3, P1	63	45	57	12	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0147530	10.1371/journal.pone.0147530	http://dx.doi.org/10.1371/journal.pone.0147530			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849133	Green Published, gold, Green Submitted			2022-12-27	WOS:000369554000019
J	Warda, AK; Tempelaars, MH; Boekhorst, J; Abee, T; Groot, MNN				Warda, Alicja K.; Tempelaars, Marcel H.; Boekhorst, Jos; Abee, Tjakko; Groot, Masja N. Nierop			Identification of CdnL, a Putative Transcriptional Regulator Involved in Repair and Outgrowth of Heat-Damaged Bacillus cereus Spores	PLOS ONE			English	Article							LOW-GC-CONTENT; GENE-EXPRESSION; RECOVERY MEDIUM; DNA-DAMAGE; SUBTILIS; CARD; GERMINATION; RESISTANCE; INJURY; INACTIVATION	Spores are widely present in the environment and are common contaminants in the food chain, creating a challenge for food industry. Nowadays, heat treatments conventionally applied in food processing may become milder to comply with consumer desire for products with higher sensory and nutritional values. Consequently subpopulations of spores may emerge that are sublethally damaged rather than inactivated. Such spores may germinate, repair damage, and eventually grow out leading to uncontrolled spoilage and safety issues. To gain insight into both the behaviour of damaged Bacillus cereus spores, and the process of damage repair, we assessed the germination and outgrowth performance using OD595 measurements and microscopy combined with genome-wide transcription analysis of untreated and heat-treated spores. The first two methods showed delayed germination and outgrowth of heat-damaged B. cereus ATCC14579 spores. A subset of genes uniquely expressed in heat-treated spores was identified with putative roles in the outgrowth of damaged spores, including cdnL (BC4714) encoding the putative transcriptional regulator CdnL. Next, a B. cereus ATCC14579 cdnL (BC4714) deletion mutant was constructed and assessment of outgrowth from heat-treated spores under food relevant conditions showed increased damage compared to wild type spores. The approach used in this study allows for identification of candidate genes involved in spore damage repair. Further identification of cellular parameters and characterisation of the molecular processes contributing to spore damage repair may provide leads for better control of spore outgrowth in foods.	[Warda, Alicja K.; Boekhorst, Jos; Abee, Tjakko; Groot, Masja N. Nierop] TI Food & Nutr, Wageningen, Netherlands; [Warda, Alicja K.; Tempelaars, Marcel H.; Abee, Tjakko] Wageningen Univ, Food Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Warda, Alicja K.; Groot, Masja N. Nierop] Wageningen UR Food & Biobased Res, Wageningen, Netherlands; [Boekhorst, Jos] NIZO Food Res BV, Ede, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; Wageningen University & Research; NIZO Food Research	Abee, T (corresponding author), TI Food & Nutr, Wageningen, Netherlands.; Abee, T (corresponding author), Wageningen Univ, Food Microbiol Lab, NL-6700 AP Wageningen, Netherlands.	tjakko.abee@wur.nl	warda, Alicja/ABF-2403-2020; Tempelaars, Marcel/C-5077-2008	warda, Alicja/0000-0001-8317-6455; Boekhorst, Jos/0000-0002-4807-7838; Tempelaars, Marcel/0000-0003-0635-5606	TI Food and Nutrition (TIFN), a public-private partnership on precompetitive research in food and nutrition; TIFN	TI Food and Nutrition (TIFN), a public-private partnership on precompetitive research in food and nutrition; TIFN	The project is funded by TI Food and Nutrition (TIFN), a public-private partnership on precompetitive research in food and nutrition. The public partners are responsible for the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The private partners have contributed to the project through regular discussion. The TIFN provided support in the form of salaries for authors [AKW, MHT, JB, TA, MNNG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. NIZO food research (http://www.nizo.com) is a contract research organization. NIZO was paid by TIFN to provide input on experimental design, bioinformatics analysis and data interpretation (i.e. the salary of Jos Boekhorst was indirectly paid by TIFN). NIZO has no financial interest in any specific outcome of the study.	Abee T, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S9; Aguirre JS, 2015, INT J FOOD MICROBIOL, V202, P20, DOI 10.1016/j.ijfoodmicro.2015.02.020; Aguirre JS, 2012, INT J FOOD MICROBIOL, V153, P444, DOI 10.1016/j.ijfoodmicro.2011.12.012; Andersson A, 1995, INT J FOOD MICROBIOL, V28, P145, DOI 10.1016/0168-1605(95)00053-4; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; BARACH JT, 1975, APPL MICROBIOL, V30, P873, DOI 10.1128/AEM.30.5.873-875.1975; Barraza-Salas M, 2010, FEMS MICROBIOL LETT, V302, P159, DOI 10.1111/j.1574-6968.2009.01845.x; Bassi D, 2013, FOOD MICROBIOL, V33, P11, DOI 10.1016/j.fm.2012.08.004; Bernal-Bernal D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121322; Bettegowda C, 2006, NAT BIOTECHNOL, V24, P1573, DOI 10.1038/nbt1256; Campos SS, 2014, J BACTERIOL, V196, P568, DOI 10.1128/JB.01259-13; Cazemier AE, 2001, J APPL MICROBIOL, V90, P761, DOI 10.1046/j.1365-2672.2001.01302.x; Coleman WH, 2009, J APPL MICROBIOL, V106, P1600, DOI 10.1111/j.1365-2672.2008.04127.x; Coleman WH, 2007, J BACTERIOL, V189, P8458, DOI 10.1128/JB.01242-07; Cortezzo DE, 2004, J APPL MICROBIOL, V97, P838, DOI 10.1111/j.1365-2672.2004.02370.x; Dembek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064011; Dierick K, 2005, J CLIN MICROBIOL, V43, P4277, DOI 10.1128/JCM.43.8.4277-4279.2005; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehling-Schulz M, 2004, MOL NUTR FOOD RES, V48, P479, DOI 10.1002/mnfr.200400055; Ellermeier CD, 2006, CELL, V124, P549, DOI 10.1016/j.cell.2005.11.041; Faille C, 1997, J FOOD PROTECT, V60, P544, DOI 10.4315/0362-028X-60.5.544; FEEHERRY F, 1987, APPL ENVIRON MICROB, V53, P365, DOI 10.1128/AEM.53.2.365-370.1987; Gaillard S, 2005, INT J FOOD MICROBIOL, V105, P53, DOI 10.1016/j.ijfoodmicro.2005.04.009; Garcia D, 2010, INT J FOOD MICROBIOL, V140, P146, DOI 10.1016/j.ijfoodmicro.2010.04.005; Garcia-Moreno D, 2010, NUCLEIC ACIDS RES, V38, P4586, DOI 10.1093/nar/gkq214; Gioia J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000928; Granum P.E., 2005, FOODBORNE PATHOGENS; Hornstra LM, 2005, APPL ENVIRON MICROB, V71, P774, DOI 10.1128/AEM.71.2.774-781.2005; Kaur G, 2014, PROTEINS, V82, P879, DOI 10.1002/prot.24419; Keijser BJF, 2007, J BACTERIOL, V189, P3624, DOI 10.1128/JB.01736-06; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; Mader U, 2012, NUCLEIC ACIDS RES, V40, pD1278, DOI 10.1093/nar/gkr923; Mols M, 2011, INT J FOOD MICROBIOL, V151, P119, DOI 10.1016/j.ijfoodmicro.2011.08.004; Ramirez-Guadiana FH, 2012, J BACTERIOL, V194, P6096, DOI 10.1128/JB.01340-12; Schoeni JL, 2005, J FOOD PROTECT, V68, P636, DOI 10.4315/0362-028X-68.3.636; Segev E, 2013, J BACTERIOL, V195, P1875, DOI 10.1128/JB.00093-13; Segev E, 2012, CELL, V148, P139, DOI 10.1016/j.cell.2011.11.059; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Setlow P., 2014, MICROBIOL SPECTR, P201, DOI [DOI 10.1128/MICROBIOLSPEC.TBS-0003-2012, DOI 10.1128/microbiolspec.TBS-0003-2012]; Sinai L, 2015, MOL CELL, V57, P695, DOI 10.1016/j.molcel.2014.12.019; Smelt JPPM, 2008, INT J FOOD MICROBIOL, V128, P34, DOI 10.1016/j.ijfoodmicro.2008.08.023; Srivastava DB, 2013, P NATL ACAD SCI USA, V110, P12619, DOI 10.1073/pnas.1308270110; Stallings CL, 2011, TRANSCR-AUSTIN, V2, P15, DOI 10.4161/trns.2.1.13628; Stringer SC, 2011, FOOD MICROBIOL, V28, P228, DOI 10.1016/j.fm.2010.03.003; Tabit FT, 2010, INT J FOOD MICROBIOL, V140, P207, DOI 10.1016/j.ijfoodmicro.2010.03.033; Ter Beek A, 2011, FOOD MICROBIOL, V28, P678, DOI 10.1016/j.fm.2010.07.003; van Melis CCJ, 2011, FOOD MICROBIOL, V28, P275, DOI 10.1016/j.fm.2010.04.005; van Schaik W, 2007, J BACTERIOL, V189, P4384, DOI 10.1128/JB.00313-07; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warda AK, 2015, INT J FOOD MICROBIOL, V201, P27, DOI 10.1016/j.ijfoodmicro.2015.02.010; Yang XF, 2008, INFECT IMMUN, V76, P4439, DOI 10.1128/IAI.00740-08	52	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148670	10.1371/journal.pone.0148670	http://dx.doi.org/10.1371/journal.pone.0148670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849219	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000152
J	Zou, Z; Yang, LF; Wang, DH; Huang, QX; Mo, YY; Xie, GS				Zou, Zhi; Yang, Lifu; Wang, Danhua; Huang, Qixing; Mo, Yeyong; Xie, Guishui			Gene Structures, Evolution and Transcriptional Profiling of the WRKY Gene Family in Castor Bean (Ricinus communis L.)	PLOS ONE			English	Article							DRAFT GENOME SEQUENCE; ABSCISIC-ACID; EXPRESSION PROFILES; NEGATIVE REGULATORS; ARABIDOPSIS WRKY33; BINDING PROTEINS; WIDE ANALYSIS; RESISTANCE; SENESCENCE; SUPERFAMILY	WRKY proteins comprise one of the largest transcription factor families in plants and form key regulators of many plant processes. This study presents the characterization of 58 WRKY genes from the castor bean (Ricinus communis L., Euphorbiaceae) genome. Compared with the automatic genome annotation, one more WRKY-encoding locus was identified and 20 out of the 57 predicted gene models were manually corrected. All RcWRKY genes were shown to contain at least one intron in their coding sequences. According to the structural features of the present WRKY domains, the identified RcWRKY genes were assigned to three previously defined groups (I-III). Although castor bean underwent no recent whole-genome duplication event like physic nut (Jatropha curcas L., Euphorbiaceae), comparative genomics analysis indicated that one gene loss, one intron loss and one recent proximal duplication occurred in the RcWRKY gene family. The expression of all 58 RcWRKY genes was supported by ESTs and/or RNA sequencing reads derived from roots, leaves, flowers, seeds and endosperms. Further global expression profiles with RNA sequencing data revealed diverse expression patterns among various tissues. Results obtained from this study not only provide valuable information for future functional analysis and utilization of the castor bean WRKY genes, but also provide a useful reference to investigate the gene family expansion and evolution in Euphorbiaceus plants.	[Zou, Zhi; Yang, Lifu; Wang, Danhua; Mo, Yeyong; Xie, Guishui] Chinese Acad Trop Agr Sci, Rubber Res Inst, Minist Agr, Danzhou Invest & Expt Stn Trop Crops, Danzhou, Hainan, Peoples R China; [Huang, Qixing] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Tropical Agricultural Sciences	Zou, Z; Xie, GS (corresponding author), Chinese Acad Trop Agr Sci, Rubber Res Inst, Minist Agr, Danzhou Invest & Expt Stn Trop Crops, Danzhou, Hainan, Peoples R China.	zouzhi2008@126.com; xie23300459@163.com	Zou, Zhi/F-1266-2018	Zou, Zhi/0000-0003-2881-1932	National Natural Science Foundation of China [31371556]; Fundamental Research Funds for Rubber Research Institute, CATAS [1630022015004]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-34-GW5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Rubber Research Institute, CATAS; Earmarked Fund for Modern Agro-industry Technology Research System	The Funding should be the National Natural Science Foundation of China (31371556), the Fundamental Research Funds for Rubber Research Institute, CATAS (1630022015004) and the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-34-GW5).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Brown AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030100; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chandrasekaran U, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-33; Chandrasekaran U, 2014, PLANT GROWTH REGUL, V72, P203, DOI 10.1007/s10725-013-9846-z; Chen H, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-281; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen XT, 2013, PLANT CELL REP, V32, P1589, DOI 10.1007/s00299-013-1469-3; Devaiah BN, 2007, PLANT PHYSIOL, V143, P1789, DOI 10.1104/pp.106.093971; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Encinas-Villarejo S, 2009, J EXP BOT, V60, P3043, DOI 10.1093/jxb/erp152; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Glockner G, 2002, NATURE, V418, P79, DOI 10.1038/nature00847; Guo CL, 2014, J EXP BOT, V65, P1513, DOI 10.1093/jxb/eru007; He HS, 2012, PLANT CELL REP, V31, P1199, DOI 10.1007/s00299-012-1241-0; Hsu FC, 2013, PLANT CELL, V25, P2699, DOI 10.1105/tpc.113.114447; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Huang XS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2233-6; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Journot-Catalino N, 2006, PLANT CELL, V18, P3289, DOI 10.1105/tpc.106.044149; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li HL, 2012, GENE, V503, P248, DOI 10.1016/j.gene.2012.04.069; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Li J, 2006, PLANT J, V46, P477, DOI 10.1111/j.1365-313X.2006.02712.x; Li J, 2013, NEW PHYTOL, V200, P455, DOI 10.1111/nph.12378; Li SJ, 2011, PLANTA, V233, P1237, DOI 10.1007/s00425-011-1375-2; Li ZH, 2012, J INTEGR PLANT BIOL, V54, P526, DOI 10.1111/j.1744-7909.2012.01136.x; Ling J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-471; Liu R, 2013, J EXP BOT, V64, P5443, DOI 10.1093/jxb/ert307; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muthamilarasan M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00910; Pandey SP, 2010, PLANT J, V64, P912, DOI 10.1111/j.1365-313X.2010.04387.x; Prochnik S, 2012, TROP PLANT BIOL, V5, P88, DOI 10.1007/s12042-011-9088-z; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Rahman AYA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-75; Rinerson CI, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0456-y; Rivarola M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021743; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; Ross CA, 2007, J INTEGR PLANT BIOL, V49, P827, DOI 10.1111/j.1744-7909.2007.00504.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Rushton PJ, 1995, PLANT MOL BIOL, V29, P691, DOI 10.1007/BF00041160; Schluttenhofer C, 2015, PLANT PHYSIOL, V167, P295, DOI 10.1104/pp.114.251769; Schon M, 2013, MOL PLANT MICROBE IN, V26, P758, DOI 10.1094/MPMI-11-12-0265-R; Shang Y, 2010, PLANT CELL, V22, P1909, DOI 10.1105/tpc.110.073874; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Troncoso-Ponce MA, 2011, PLANT J, V68, P1014, DOI 10.1111/j.1365-313X.2011.04751.x; Ulker B, 2007, PLANTA, V226, P125, DOI 10.1007/s00425-006-0474-y; Van Aken O, 2013, PLANT PHYSIOL, V162, P254, DOI 10.1104/pp.113.215996; Wu PZ, 2015, PLANT J, V81, P810, DOI 10.1111/tpj.12761; Xiong WD, 2013, GENE, V524, P124, DOI 10.1016/j.gene.2013.04.047; Xu W, 2014, NUCLEIC ACIDS RES, V42, P6987, DOI 10.1093/nar/gku375; Xu W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-785; Yamasaki K, 2012, J BIOL CHEM, V287, P7683, DOI 10.1074/jbc.M111.279844; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zhou X, 2011, MOL CELLS, V31, P303, DOI 10.1007/s10059-011-0047-1; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; [邹智 Zou Zhi], 2013, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V35, P36	69	28	30	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2016	11	2							e0148243	10.1371/journal.pone.0148243	http://dx.doi.org/10.1371/journal.pone.0148243			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PR	26849139	Green Submitted, Green Published, gold			2022-12-27	WOS:000369554000055
J	Cohen, O; Geva, D; Lahad, M; Bolotin, A; Leykin, D; Goldberg, A; Aharonson-Daniel, L				Cohen, Odeya; Geva, Diklah; Lahad, Mooli; Bolotin, Arkady; Leykin, Dima; Goldberg, Avishay; Aharonson-Daniel, Limor			Community Resilience throughout the Lifespan - The Potential Contribution of Healthy Elders	PLOS ONE			English	Article							OLDER-PEOPLE; VULNERABILITY; PLACE; MODEL; WATER; TOOL	An increase in the exposure and predisposition of civilian populations to disasters has been recorded in the last decades. In major disasters, as demonstrated recently in Nepal (2015) and previously in Haiti (2010), external aid is vital, yet in the first hours after a disaster, communities must usually cope alone with the challenge of providing emergent lifesaving care. Communities therefore need to be prepared to handle emergency situations. Mapping the needs of the populations within their purview is a trying task for decision makers and community leaders. In this context, the elderly are traditionally treated as a susceptible population with special needs. The current study aimed to explore variations in the level of community resilience along the lifespan. The study was conducted in nine small to mid-size towns in Israel between August and November 2011 (N = 885). The Conjoint Community Resiliency Assessment Measure (CCRAM), a validated instrument for community resilience assessment, was used to examine the association between age and community resilience score. Statistical analysis included spline and logistic regression models that explored community resiliency over the lifespan in a way that allowed flexible modeling of the curve without prior constraints. This innovative statistical approach facilitated identification of the ages at which trend changes occurred. The study found a significant rise in community resiliency scores in the age groups of 61-75 years as compared with younger age bands, suggesting that older people in good health may contribute positively to building community resiliency for crisis. Rather than focusing on the growing medical needs and years of dependency associated with increased life expectancy and the resulting climb in the proportion of elders in the population, this paper proposes that active "young at heart" older people can be a valuable resource for their community.	[Cohen, Odeya; Goldberg, Avishay; Aharonson-Daniel, Limor] Ben Gurion Univ Negev, Fac Hlth Sci, Recanati Sch Community Hlth Profess, Dept Emergency Med, Beer Sheva, Israel; [Cohen, Odeya; Leykin, Dima; Goldberg, Avishay; Aharonson-Daniel, Limor] Ben Gurion Univ Negev, PREPARED Ctr Emergency Response Res, IL-84105 Beer Sheva, Israel; [Geva, Diklah] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Epidemiol, Beer Sheva, Israel; [Lahad, Mooli; Leykin, Dima] Tel Hai Acad Coll, Dept Psychol, Kiryat Shmona, Israel; [Lahad, Mooli; Leykin, Dima] CSPC, Kiryat Shmona, Israel; [Bolotin, Arkady] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Publ Hlth, Beer Sheva, Israel; [Goldberg, Avishay] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Hlth Syst Management, Beer Sheva, Israel; [Goldberg, Avishay] Ben Gurion Univ Negev, Guilford Glazer Fac Business & Management, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Tel Hai Academy College; Ben Gurion University; Ben Gurion University; Ben Gurion University	Aharonson-Daniel, L (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Recanati Sch Community Hlth Profess, Dept Emergency Med, Beer Sheva, Israel.; Aharonson-Daniel, L (corresponding author), Ben Gurion Univ Negev, PREPARED Ctr Emergency Response Res, IL-84105 Beer Sheva, Israel.	limorad@bgu.ac.il	Aharonson-Daniel, Limor/F-1998-2012	Aharonson-Daniel, Limor/0000-0003-4585-6892; Cohen, Odeya/0000-0002-2427-6381				Aharonson-Daniel L, 2012, 2 INT PREP RSP EM DI; Alessa L, 2008, ENVIRON MANAGE, V42, P523, DOI 10.1007/s00267-008-9152-0; Alessa L, 2008, GLOBAL ENVIRON CHANG, V18, P153, DOI 10.1016/j.gloenvcha.2007.05.007; Benson WF., 2007, CDC HLTH AGING PROGR; Castleden M, 2011, J PUBLIC HEALTH-UK, V33, P369, DOI 10.1093/pubmed/fdr027; Centers for Disease Control and Prevention School Health, 2011, MMWR RECOMMENDATIONS; Chandra A., 2010, UNDERSTANDING COMMUN, DOI DOI 10.7249/WR737; Charles ST, 2010, PSYCHOL BULL, V136, P1068, DOI 10.1037/a0021232; Cohen O, 2013, TECHNOL FORECAST SOC, V80, P1732, DOI 10.1016/j.techfore.2012.12.009; Cornell VJ, 2012, AUST J EMERG MANAG, V27, P49; Cutter SL, 2010, J HOMEL SECUR EMERG, V7; Cutter SL, 2008, GLOBAL ENVIRON CHANG, V18, P598, DOI 10.1016/j.gloenvcha.2008.07.013; Endfield GH, 2012, P NATL ACAD SCI USA, V109, P3676, DOI 10.1073/pnas.1114831109; Frijters P, 2012, J ECON BEHAV ORGAN, V82, P525, DOI 10.1016/j.jebo.2012.03.008; Goroshit SKM, 2013, J COMMUNITY PSYCHOL, V41, P631, DOI 10.1002/jcop.21561; Jan S, 2012, NEW ENGL J MED, V367, P2272, DOI 10.1056/NEJMp1213492; Jeste DV, 2011, SCHIZOPHRENIA BULL, V37, P451, DOI 10.1093/schbul/sbr026; Kaszniak Alfred W, 2012, Curr Top Behav Neurosci, V10, P51, DOI 10.1007/7854_2011_163; Kimhi S, 2012, AM J GERIAT PSYCHIAT, V20, P391, DOI 10.1097/JGP.0b013e31821106b3; Lacruz ME, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-579; Lahad M, CSPC COMMUNITY STRES; Lahad M., 2012, EUR PARL; Leykin D, 2013, AM J COMMUN PSYCHOL, V52, P313, DOI 10.1007/s10464-013-9596-0; Magis K, 2010, SOC NATUR RESOUR, V23, P401, DOI 10.1080/08941920903305674; Marsh LC, 2001, SPLINE REGRESSION MO, P49; Maxwell D, 2012, P NATL ACAD SCI USA, V109, P12321, DOI 10.1073/pnas.0913215108; McSweeney K, 2011, P NATL ACAD SCI USA, V108, P5203, DOI 10.1073/pnas.1014123108; Muttarak R, 2014, ECOL SOC, V19, DOI 10.5751/ES-06476-190142; Nelson DR, 2011, WIRES CLIM CHANGE, V2, P113, DOI 10.1002/wcc.91; Norris FH, 2008, AM J COMMUN PSYCHOL, V41, P127, DOI 10.1007/s10464-007-9156-6; Owens GP, 2005, INT J GERIATR PSYCH, V20, P1118, DOI 10.1002/gps.1408; Pekovic V, 2007, GENERATIONS, V31, P37; Pfefferbaum RL, 2012, COMMUNITY ENGAGEMENT, P275; Pfefferbaum RL, 2013, J PUBLIC HEALTH MAN, V19, P250, DOI 10.1097/PHH.0b013e318268aed8; Poortinga W, 2012, HEALTH PLACE, V18, P286, DOI 10.1016/j.healthplace.2011.09.017; Rabinovici M, 1985, THE 6 AGES OF MAN; Rumbach A, 2014, ECOL SOC, V19, DOI 10.5751/ES-06189-190119; Ryff CD, 2014, PSYCHOTHER PSYCHOSOM, V83, P10, DOI 10.1159/000353263; Schaie K Warner, 2010, ISSBD Bull, V57, P24; Seff LR, 2007, DESIGNING MODEL ALL; Stone AA, 2010, P NATL ACAD SCI USA, V107, P9985, DOI 10.1073/pnas.1003744107; Stranahan AM, 2012, NAT REV NEUROSCI, V13, P209, DOI 10.1038/nrn3151; Van den Bogaard L, 2014, AGEING SOC, V34, P1170, DOI 10.1017/S0144686X13000019; van Hooijdonk C, 2007, SOC SCI MED, V64, P1326, DOI 10.1016/j.socscimed.2006.10.041; Wild K, 2011, AGEING SOC, V1, P1; Wiles JL, 2013, J AGING STUD, V27, P93, DOI 10.1016/j.jaging.2012.12.001; Wiles JL, 2012, SOC SCI MED, V74, P416, DOI 10.1016/j.socscimed.2011.11.005; Wilson GA, 2012, GEOFORUM, V43, P1218, DOI 10.1016/j.geoforum.2012.03.008; Wunder C, 2013, REV ECON STAT, V95, P154, DOI 10.1162/REST_a_00222	49	21	21	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148125	10.1371/journal.pone.0148125	http://dx.doi.org/10.1371/journal.pone.0148125			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9PF	26844889	gold, Green Submitted, Green Published			2022-12-27	WOS:000369552800031
J	Daniyan, MO; Boshoff, A; Prinsloo, E; Pesce, ER; Blatch, GL				Daniyan, Michael O.; Boshoff, Aileen; Prinsloo, Earl; Pesce, Eva-Rachele; Blatch, Gregory L.			The Malarial Exported PFA0660w Is an Hsp40 Co-Chaperone of PfHsp70-x	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CRYSTAL-STRUCTURE; YEAST HSP40; MOLECULAR CHAPERONE; ESCHERICHIA-COLI; HSP70 CHAPERONES; J PROTEINS; DNAJ; DIMERIZATION; PARASITE	Plasmodium falciparum, the human pathogen responsible for the most dangerous malaria infection, survives and develops in mature erythrocytes through the export of proteins needed for remodelling of the host cell. Molecular chaperones of the heat shock protein (Hsp) family are prominent members of the exportome, including a number of Hsp40s and a Hsp70. PFA0660w, a type II Hsp40, has been shown to be exported and possibly form a complex with PfHsp70-x in the infected erythrocyte cytosol. However, the chaperone properties of PFA0660w and its interaction with human and parasite Hsp70s are yet to be investigated. Recombinant PFA0660w was found to exist as a monomer in solution, and was able to significantly stimulate the ATPase activity of PfHsp70-x but not that of a second plasmodial Hsp70 (PfHsp70-1) or a human Hsp70 (HSPA1A), indicating a potential specific functional partnership with PfHsp70-x. Protein binding studies in the presence and absence of ATP suggested that the interaction of PFA0660w with PfHsp70-x most likely represented a co-chaperone/chaperone interaction. Also, PFA0660w alone produced a concentration-dependent suppression of rhodanese aggregation, demonstrating its chaperone properties. Overall, we have provided the first biochemical evidence for the possible role of PFA0660w as a chaperone and as co-chaperone of PfHsp70-x. We propose that these chaperones boost the chaperone power of the infected erythrocyte, enabling successful protein trafficking and folding, and thereby making a fundamental contribution to the pathology of malaria.	[Daniyan, Michael O.; Pesce, Eva-Rachele; Blatch, Gregory L.] Rhodes Univ, Dept Biochem & Microbiol, Biomed Biotechnol Res Unit, ZA-6140 Grahamstown, South Africa; [Boshoff, Aileen; Prinsloo, Earl] Rhodes Univ, Biotechnol Innovat Ctr, ZA-6140 Grahamstown, South Africa; [Pesce, Eva-Rachele; Blatch, Gregory L.] Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic 8001, Australia; [Daniyan, Michael O.] Obafemi Awolowo Univ, Fac Pharm, Dept Pharmacol, Ife, Nigeria	Rhodes University; Rhodes University; Victoria University; Obafemi Awolowo University	Pesce, ER; Blatch, GL (corresponding author), Rhodes Univ, Dept Biochem & Microbiol, Biomed Biotechnol Res Unit, ZA-6140 Grahamstown, South Africa.; Pesce, ER; Blatch, GL (corresponding author), Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic 8001, Australia.	eva-rachele.pesce@vu.edu.au; gregory.blatch@vu.edu.au	Blatch, Gregory Lloyd/Q-5900-2019; Prinsloo, Earl/F-9737-2012; Daniyan, Michael/AAO-4661-2020	Blatch, Gregory Lloyd/0000-0003-0778-8577; Prinsloo, Earl/0000-0002-3048-4304; Daniyan, Michael/0000-0003-3669-3542	National Research Foundation (NRF); Medical Research Council (MRC) of South Africa; Department of Science and Technology; NRF of South Africa; Education Trust Fund (ETF) Academic Staff Training and Development (AST&D) scholarship of Obafemi Awolowo University, Ile-Ife, Nigeria; Rhodes University Council research bursary	National Research Foundation (NRF); Medical Research Council (MRC) of South Africa(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Science and Technology(Department of Science & Technology (India)); NRF of South Africa; Education Trust Fund (ETF) Academic Staff Training and Development (AST&D) scholarship of Obafemi Awolowo University, Ile-Ife, Nigeria; Rhodes University Council research bursary	This work was supported by grants from the National Research Foundation (NRF) and Medical Research Council (MRC) of South Africa. The ProteOn XPR36 IAS was purchased from a National Nanotechnology Equipment Programme grant from the Department of Science and Technology and the NRF of South Africa. Michael O. Daniyan was a recipient of the Education Trust Fund (ETF) Academic Staff Training and Development (AST&D) scholarship of Obafemi Awolowo University, Ile-Ife, Nigeria and a Rhodes University Council research bursary.	Allan RK, 2006, J BIOL CHEM, V281, P7161, DOI 10.1074/jbc.M512406200; Banumathy G, 2002, J BIOL CHEM, V277, P3902, DOI 10.1074/jbc.M110513200; Batas B, 1999, J BIOTECHNOL, V68, P149, DOI 10.1016/S0168-1656(98)00197-7; BEHR C, 1992, J IMMUNOL, V149, P3321; Bell SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020047; Botha M, 2007, INT J BIOCHEM CELL B, V39, P1781, DOI 10.1016/j.biocel.2007.02.011; Botha M, 2011, CELL STRESS CHAPERON, V16, P389, DOI 10.1007/s12192-010-0250-6; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; CHEETHAM ME, 1994, EUR J BIOCHEM, V226, P99, DOI 10.1111/j.1432-1033.1994.tb20030.x; Chiang AN, 2009, BIOORGAN MED CHEM, V17, P1527, DOI 10.1016/j.bmc.2009.01.024; Cockburn IL, 2014, BIOL CHEM, V395, P1353, DOI 10.1515/hsz-2014-0138; Cockburn IL, 2011, BIOL CHEM, V392, P431, DOI 10.1515/BC.2011.040; Curtis CF, 2006, J AM MOSQUITO CONTR, V22, P501, DOI 10.2987/8756-971X(2006)22[501:IBFMMC]2.0.CO;2; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Grover M, 2013, PARASITE, V20, DOI 10.1051/parasite/2012002; Haldar K, 2007, CURR OPIN HEMATOL, V14, P203, DOI 10.1097/MOH.0b013e3280f31b2d; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hatherley R, 2014, J BIOMOL STRUCT DYN, V32, P1766, DOI 10.1080/07391102.2013.834849; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Hosse RJ, 2009, ANAL BIOCHEM, V385, P346, DOI 10.1016/j.ab.2008.11.026; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kulzer S, 2012, CELL MICROBIOL, V14, P1784, DOI 10.1111/j.1462-5822.2012.01840.x; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; KUMAR N, 1990, INFECT IMMUN, V58, P1408, DOI 10.1128/IAI.58.5.1408-1414.1990; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Matambo TS, 2004, PROTEIN EXPRES PURIF, V33, P214, DOI 10.1016/j.pep.2003.09.010; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; Njunge JM, 2013, CURR PHARM DESIGN, V19, P387, DOI 10.2174/138161213804143734; Pesce ER, 2014, PARASITOLOGY, V141, P1167, DOI 10.1017/S003118201300228X; Prinsloo E, 2012, IUBMB LIFE, V64, P266, DOI 10.1002/iub.607; Przyborski JM, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00034; Ramya TNC, 2006, BIOCHEM BIOPH RES CO, V348, P585, DOI 10.1016/j.bbrc.2006.07.082; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Shi YY, 2005, J BIOL CHEM, V280, P22761, DOI 10.1074/jbc.M503643200; Shonhai A, 2008, PROTEIN PEPTIDE LETT, V15, P1117, DOI 10.2174/092986608786071067; Silberg JJ, 1998, J BACTERIOL, V180, P6617, DOI 10.1128/JB.180.24.6617-6624.1998; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stephens LL, 2011, PROTEIN EXPRES PURIF, V77, P159, DOI 10.1016/j.pep.2011.01.005; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Toutain CM, 2003, MOL GENET GENOMICS, V268, P761, DOI 10.1007/s00438-002-0`/93-z; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2014, WHO MDG 6 COMB HIV A; Wu YK, 2005, J MOL BIOL, V346, P1005, DOI 10.1016/j.jmb.2004.12.040; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009	55	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2016	11	2							e0148517	10.1371/journal.pone.0148517	http://dx.doi.org/10.1371/journal.pone.0148517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9PF	26845441	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000369552800065
